PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Anaissi, A; Goyal, M; Catchpoole, DR; Braytee, A; Kennedy, PJ				Anaissi, Ali; Goyal, Madhu; Catchpoole, Daniel R.; Braytee, Ali; Kennedy, Paul J.			Ensemble Feature Learning of Genomic Data Using Support Vector Machine	PLOS ONE			English	Article							GENE SELECTION; CLUSTERING ANALYSIS; MICROARRAY DATA; RANDOM FOREST; CLASSIFICATION; PATTERNS; TUMOR; BIAS	The identification of a subset of genes having the ability to capture the necessary information to distinguish classes of patients is crucial in bioinformatics applications. Ensemble and bagging methods have been shown to work effectively in the process of gene selection and classification. Testament to that is random forest which combines random decision trees with bagging to improve overall feature selection and classification accuracy. Surprisingly, the adoption of these methods in support vector machines has only recently received attention but mostly on classification not gene selection. This paper introduces an ensemble SVM-Recursive Feature Elimination (ESVM-RFE) for gene selection that follows the concepts of ensemble and bagging used in random forest but adopts the backward elimination strategy which is the rationale of RFE algorithm. The rationale behind this is, building ensemble SVM models using randomly drawn bootstrap samples from the training set, will produce different feature rankings which will be subsequently aggregated as one feature ranking. As a result, the decision for elimination of features is based upon the ranking of multiple SVM models instead of choosing one particular model. Moreover, this approach will address the problem of imbalanced datasets by constructing a nearly balanced bootstrap sample. Our experiments show that ESVM-RFE for gene selection substantially increased the classification performance on five microarray datasets compared to state-of-the-art methods. Experiments on the childhood leukaemia dataset show that an average 9% better accuracy is achieved by ESVM-RFE over SVM-RFE, and 5% over random forest based approach. The selected genes by the ESVM-RFE algorithm were further explored with Singular Value Decomposition (SVD) which reveals significant clusters with the selected data.	[Anaissi, Ali; Goyal, Madhu; Braytee, Ali; Kennedy, Paul J.] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst QCIS, Fac Engn & Informat Technol, Broadway, NSW 2007, Australia; [Catchpoole, Daniel R.] Childrens Hosp Westmead, Childrens Canc Res Unit, Tumour Bank, Locked Bag 4001, Westmead, NSW 2145, Australia	University of Technology Sydney; University of Sydney	Anaissi, A (corresponding author), Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst QCIS, Fac Engn & Informat Technol, Broadway, NSW 2007, Australia.	Ali.Anaissi@uts.edu.au	Kennedy, Paul/GPC-6789-2022; Goyal, Madhu/Z-2860-2019	Kennedy, Paul/0000-0001-7837-3171; Goyal, Madhu/0000-0003-2853-9393; Braytee, Ali/0000-0003-2561-6496				Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Anaissi A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-261; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Ding JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511-S11; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Han H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S7; Kressel UHG, 1999, ADVANCES IN KERNEL METHODS, P255; Lee YK, 2004, J AM STAT ASSOC, V99, P67, DOI 10.1198/016214504000000098; Nie F., 2010, ADV NEURAL INFORM PR, V23, DOI DOI 10.1007/978-3-319-10690-8_12; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sathishkumar E, 2013, ARXIV 13062118 2013; Tong MCX, 2013, COMPUT BIOL MED, V43, P729, DOI 10.1016/j.compbiomed.2013.03.010; Valentini G, 2004, J MACH LEARN RES, V5, P725; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]	31	22	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157330	10.1371/journal.pone.0157330	http://dx.doi.org/10.1371/journal.pone.0157330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304923	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800048
J	Dangles, O; Loirat, J; Freour, C; Serre, S; Vacher, J; Le Roux, X				Dangles, Olivier; Loirat, Jean; Freour, Claire; Serre, Sandrine; Vacher, Jean; Le Roux, Xavier			Research on Biodiversity and Climate Change at a Distance: Collaboration Networks between Europe and Latin America and the Caribbean	PLOS ONE			English	Article								Biodiversity loss and climate change are both globally significant issues that must be addressed through collaboration across countries and disciplines. With the December 2015 COP21 climate conference in Paris and the recent creation of the Intergovernmental Platform on Biodiversity and Ecosystem Services (IPBES), it has become critical to evaluate the capacity for global research networks to develop at the interface between biodiversity and climate change. In the context of the European Union (EU) strategy to stand as a world leader in tackling global challenges, the European Commission has promoted ties between the EU and Latin America and the Caribbean (LAC) in science, technology and innovation. However, it is not clear how these significant interactions impact scientific cooperation at the interface of biodiversity and climate change. We looked at research collaborations between two major regions-the European Research Area (ERA) and LAC-that addressed both biodiversity and climate change. We analysed the temporal evolution of these collaborations, whether they were led by ERA or LAC teams, and which research domains they covered. We surveyed publications listed on the Web of Science that were authored by researchers from both the ERA and LAC and that were published between 2003 and 2013. We also run similar analyses on other topics and other continents to provide baseline comparisons. Our results revealed a steady increase in scientific co-authorships between ERA and LAC countries as a result of the increasingly complex web of relationships that has been weaved among scientists from the two regions. The ERA-LAC co-authorship increase for biodiversity and climate change was higher than those reported for other topics and for collaboration with other continents. We also found strong differences in international collaboration patterns within the LAC: co-publications were fewest from researchers in low- and lower-middle-income countries and most prevalent from researchers in emerging countries like Mexico and Brazil. Overall, interdisciplinary publications represented 25.8% of all publications at the interface of biodiversity and climate change in the ERA-LAC network. Further scientific collaborations should be promoted 1) to prevent less developed countries from being isolated from the global cooperation network, 2) to ensure that scientists from these countries are trained to lead visible and recognized biodiversity and climate change research, and 3) to develop common study models that better integrate multiple scientific disciplines and better support decision-making.	[Dangles, Olivier] CNRS, EGCE, IRD, UPR 9034,UR 072, F-91198 Gif Sur Yvette, France; [Dangles, Olivier] Univ Paris Sud 11, F-91405 Orsay, France; [Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Av 12 Octubre & Roca, Quito, Ecuador; [Loirat, Jean; Freour, Claire; Serre, Sandrine] IRD, 44 Bld Dunkerque, F-13572 Marseille, France; [Vacher, Jean] MNHN, UMR PALOC, IRD, F-75005 Paris, France; [Le Roux, Xavier] Univ Lyon 1, CNRS, INRA, Ctr Microbial Ecol,UMR 1418,UMR 5557, 43 Bd 11 Nov 1918, F-69622 Villeurbanne, France; [Le Roux, Xavier] FRB, BiodivERsA, 195 Rue St Jacques, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Pontificia Universidad Catolica del Ecuador; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Dangles, O (corresponding author), CNRS, EGCE, IRD, UPR 9034,UR 072, F-91198 Gif Sur Yvette, France.; Dangles, O (corresponding author), Univ Paris Sud 11, F-91405 Orsay, France.; Dangles, O (corresponding author), Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Av 12 Octubre & Roca, Quito, Ecuador.	olivier.dangles@ird.fr	Dangles, Olivier/C-4924-2009; Serre, Sandrine/ABE-5086-2020	Dangles, Olivier/0000-0002-1987-8433; Serre, Sandrine/0000-0003-3609-3432; LE ROUX, Xavier/0000-0001-9695-0825	ALCUE-Net project (FP7 funded project; Latin America, Caribbean); ALCUE-Net project (European Union Network on Research and Innovation); ERA-NET BiodivERsA (Horizon funded project)	ALCUE-Net project (FP7 funded project; Latin America, Caribbean); ALCUE-Net project (European Union Network on Research and Innovation); ERA-NET BiodivERsA (Horizon funded project)	This research was funded by the ALCUE-Net project (FP7 funded project; Latin America, Caribbean and European Union Network on Research and Innovation; see www.alcuenet.eu), in collaboration with the ERA-NET BiodivERsA (Horizon2020 funded project; see www.biodiversa.org).	Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; CEPAL NU, 2015, EUR UN LAT AM CAR NE; Eggermont H, 2015, GAIA, V24, P243, DOI 10.14512/gaia.24.4.9; European Commission, 2006, STRONG PARTN EUR UN; European Commission, 2010, EU LAC KNOWL AR SCI; European Union, 2015, EUR RES INN ROADM CL EUR RES INN ROADM CL; Frodeman Robert, 2010, OXFORD HDB INTERDISC; Garcia RL, 2014, NUEVA AGENDA, V8, P7; Groombridge B, 2002, WORLD ATLAS BIODIVER; Hannah L, 2011, CLIMATE CHANGE BIOLOGY, P1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Martinez R., 2011, CLIMATE CHANGE BIODI; Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600; Mooney H, 2009, CURR OPIN ENV SUST, V1, P46, DOI 10.1016/j.cosust.2009.07.006; Munang R, 2013, CURR OPIN ENV SUST, V5, P67, DOI 10.1016/j.cosust.2012.12.001; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Perez C, 2010, INT J ENV CULTURAL E, V6, P78; Russell JM, 2014, RES COLLABORATION EU, P49; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Swanson T, 2013, GLOBAL ACTION BIODIV; Tassara Cario, 2013, Investig. desarro., V21, P2; UNEP, 2010, STAT BIOD LAT AM CAR; Valdez Andre Calero, 2012, Active Media Technology. 8th International Conference, AMT 2012. Proceedings, P606, DOI 10.1007/978-3-642-35236-2_61; Wagner C. S., 2005, INT J TECHNOLOGY GLO, V1, P185, DOI [DOI 10.1504/IJTG.2005.007050, 10/c4jn8k]; Weingart P., 2010, OXFORD HDB INTERDISC, P3	27	18	19	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157441	10.1371/journal.pone.0157441	http://dx.doi.org/10.1371/journal.pone.0157441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304924	Green Published, gold			2022-12-26	WOS:000377824800059
J	Matsuhashi, S; Doi, H; Fujiwara, A; Watanabe, S; Minamoto, T				Matsuhashi, Saeko; Doi, Hideyuki; Fujiwara, Ayaka; Watanabe, Sonoko; Minamoto, Toshifumi			Evaluation of the Environmental DNA Method for Estimating Distribution and Biomass of Submerged Aquatic Plants	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; HYDRILLA-VERTICILLATA; EDNA; SAMPLES; HYDROCHARITACEAE; PERSISTENCE; CHALLENGES; REVISION; JAPAN; PCR	The environmental DNA (eDNA) method has increasingly been recognized as a powerful tool for monitoring aquatic animal species; however, its application for monitoring aquatic plants is limited. To evaluate eDNA analysis for estimating the distribution of aquatic plants, we compared its estimated distributions with eDNA analysis, visual observation, and past distribution records for the submerged species Hydrilla verticillata. Moreover, we conducted aquarium experiments using H. verticillata and Egeria densa and analyzed the relationships between eDNA concentrations and plant biomass to investigate the potential for biomass estimation. The occurrences estimated by eDNA analysis closely corresponded to past distribution records, and eDNA detections were more frequent than visual observations, indicating that the method is potentially more sensitive. The results of the aquarium experiments showed a positive relationship between plant biomass and eDNA concentration; however, the relationship was not always significant. The eDNA concentration peaked within three days of the start of the experiment in most cases, suggesting that plants do not release constant amounts of DNA. These results showed that eDNA analysis can be used for distribution surveys, and has the potential to estimate the biomass of aquatic plants.	[Matsuhashi, Saeko; Doi, Hideyuki] Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, Kobe, Hyogo 6500044, Japan; [Fujiwara, Ayaka; Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 657, Japan; [Watanabe, Sonoko] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 724, Japan	University of Hyogo; Kobe University; Hiroshima University	Matsuhashi, S (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, Kobe, Hyogo 6500044, Japan.	sae.matsuhashi@gmail.com	WATANABE, Sonoko/N-8102-2013; Minamoto, Toshifumi/C-6453-2009	WATANABE, Sonoko/0000-0002-4696-3588; Minamoto, Toshifumi/0000-0002-5379-1622	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4RF-1302]; Water Resources Environment Center [2014-04]; Water Resources Environment Center	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Water Resources Environment Center; Water Resources Environment Center	This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan (4RF-1302, http://www.env.go.jp/policy/kenkyu/suishin/english/gaiyou/index.html) to HD and TM, and by a Research Grant from the Water Resources Environment Center (2014-04, http://www.wec.or.jp/support/season/index.html) to SM.; We thank the Natural Science Center for Basic Research and Development, Hiroshima University, for technical support for genetic experiments, and T. Takahara and K. Uchii for help with experiments and their useful comments on this study. This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan (4RF-1302), and by a Research Grant from the Water Resources Environment Center to S. Matsuhashi.	[Anonymous], 2014, R LANG ENV STAT COMP; Barnes MA, 2014, ECOL EVOL, V4, P2584, DOI 10.1002/ece3.1120; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Buckingham GR, 1996, FLA ENTOMOL, V79, P353, DOI 10.2307/3495584; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; COOK CDK, 1982, AQUAT BOT, V13, P485, DOI 10.1016/0304-3770(82)90074-2; COOK CDK, 1984, AQUAT BOT, V19, P73, DOI 10.1016/0304-3770(84)90009-3; Davy CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130965; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Doi H, 2015, ENVIRON SCI TECHNOL, V49, P5601, DOI 10.1021/acs.est.5b00253; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Fujiwara A, 2016, FRESHW SCI, V35, P748, DOI 10.1086/685882; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; HARAMOTO T, 1988, AQUAT BOT, V30, P389, DOI 10.1016/0304-3770(88)90070-8; Higashi-Hiroshima City Board of Education, 2011, AQ PLANTS HIG HIR, P108; Kadono Y., 2004, GLOB ENV STUD, V8, P163; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Langeland Kenneth A., 1996, Castanea, V61, P293; Madeira PT, 1997, AQUAT BOT, V59, P217, DOI 10.1016/S0304-3770(97)00075-2; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scriver M, 2015, AQUAT BOT, V122, P27, DOI 10.1016/j.aquabot.2015.01.003; Shimoda M, 1995, VEGETATION SCI, V11, P23; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Uchii K, 2016, MOL ECOL RESOUR, V16, P415, DOI 10.1111/1755-0998.12460; Wilcox TM, 2015, CONSERV GENET RESOUR, V7, P639, DOI 10.1007/s12686-015-0465-z; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	45	25	28	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156217	10.1371/journal.pone.0156217	http://dx.doi.org/10.1371/journal.pone.0156217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304876	gold, Green Submitted, Green Published			2022-12-26	WOS:000377824800014
J	Enewold, L; Thomas, A				Enewold, Lindsey; Thomas, Anish			Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; 1ST-LINE TREATMENT; OPEN-LABEL; AMERICAN SOCIETY; MUTATIONS; CHEMOTHERAPY; GEFITINIB; MULTICENTER; SMOKING; KRAS	Despite being the basis of one of the most effective interventions in lung cancer, little is known about the patterns of epidermal growth factor receptor (EGFR) mutation testing in the general population. We assessed the frequencies and determinants of EGFR testing and erlotinib treatment among a population-based sample. A random sample (n = 1,358) of patients diagnosed in 2010 with histologically-confirmed NSCLC, as reported to the Surveillance Epidemiology and End Results (SEER) program, had their medical records abstracted and treating physicians queried. Logistic regression was used to identify factors associated with EGFR testing and erlotinib treatment. Survival was examined using Cox proportional hazards regression. The frequency of EGFR testing was 16.8% overall and 22.6% for stage IV adenocarcinoma patients. Given an EGFR mutation, 33.6% of all patients and 48.3% of stage IV patients received erlotinib. Among stage IV patients, increased age, Medicaid/no/unknown insurance status, death within 2 months of diagnosis and comorbidity were inversely associated with EGFR testing; erlotinib treatment was less likely among smokers and patients with non-adenocarcinomas. EGFR-mutation was associated with improved survival, albeit only among stage IV adenocarcinomas. Less than a quarter of NSCLC patients diagnosed in 2010 received EGFR testing and less than half of the patients with EGFR-mutant stage IV tumors received erlotinib. Significant disparities were observed in EGFR mutation testing by health insurance status, comorbidity and age. A national strategy is imperative to ensure that resources and processes are in place to efficiently implement molecular testing of cancer.	[Enewold, Lindsey] NCI, Healthcare Assessment Res Branch, Healthcare Delivery Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Thomas, Anish] NCI, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Enewold, L (corresponding author), NCI, Healthcare Assessment Res Branch, Healthcare Delivery Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA.	lindsey.enewold@nih.gov			National Cancer Institute [HHSN261201000024C, HHSN261201000025C, HHSN261201000032C, HHSN261201000027C, HHSN261201000026C, HHSN261201000140C, HHSN261201000037C, HHSN261201000033C, HHSN261201000034C, HHSN261201000035C, HHSN261201000029C, HHSN261201000031C, HHSN261201000028C, HHSN261201000030C]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute and National Cancer Institute contracts: HHSN261201000024C; HHSN261201000025C, HHSN261201000032C, HHSN261201000027C, HHSN261201000026C, HHSN261201000140C, HHSN261201000037C, HHSN261201000033C, HHSN261201000034C, HHSN261201000035C, HHSN261201000029C, HHSN261201000031C, HHSN261201000028C, and HHSN261201000030C.	American Cancer Society, 2015, CANC FACTS FIG 2015; Araujo LH, 2015, J CLIN ONCOL, V33, P1966, DOI 10.1200/JCO.2014.59.2444; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Ellis PM, 2013, J THORAC ONCOL, V8, P1136, DOI 10.1097/JTO.0b013e31829f6a43; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Harlan LC, 2005, J CLIN ONCOL, V23, P9079, DOI 10.1200/JCO.2004.00.1297; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Lindeman NI, 2013, J THORAC ONCOL, V8, P1343, DOI 10.1097/JTO.0000000000000003; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McQuitty E, 2014, ARCH PATHOL LAB MED, V138, P390, DOI 10.5858/arpa.2013-0225-OA; Miller FA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-131; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moreira AL, 2012, CLIN LUNG CANCER, V13, P334, DOI 10.1016/j.cllc.2012.01.004; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan IW, 2013, LUNG CANCER, V82, P469, DOI 10.1016/j.lungcan.2013.09.018; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sasaki H, 2006, INT J CANCER, V118, P180, DOI 10.1002/ijc.21301; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Wheatley-Price P, 2008, J CLIN ONCOL, V26, P2350, DOI 10.1200/JCO.2007.15.2280; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang SH, 2005, CLIN CANCER RES, V11, P2106, DOI 10.1158/1078-0432.CCR-04-1853; Zhang W, 2014, ARCH PATHOL LAB MED, V138, P543, DOI 10.5858/arpa.2013-0311-OA; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	33	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156728	10.1371/journal.pone.0156728	http://dx.doi.org/10.1371/journal.pone.0156728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294665	Green Published, Green Submitted, gold			2022-12-26	WOS:000377821300011
J	Kristensen, HK; Tistad, M; von Koch, L; Ytterberg, C				Kristensen, Hanne Kaae; Tistad, Malin; von Koch, Lena; Ytterberg, Charlotte			The Importance of Patient Involvement in Stroke Rehabilitation	PLOS ONE			English	Article							LONG-TERM NEEDS; SURVIVORS EXPERIENCES; IMPACT; SELF; CARE; PEOPLE; VIEWS	Objective To investigate the perceived needs for health services by persons with stroke within the first year after rehabilitation, and associations between perceived impact of stroke, involvement in decisions regarding care/treatment, and having health services needs met. Method Data was collected, through a mail survey, from patients with stroke who were admitted to a university hospital in 2012 and had received rehabilitation after discharge from the stroke unit. The rehabilitation lasted an average of 2 to 4.6 months. The Stroke Survivor Needs Survey Questionnaire was used to assess the participants' perceptions of involvement in decisions on care or treatment and needs for health services in 11 problem areas: mobility, falls, incontinence, pain, fatigue, emotion, concentration, memory, speaking, reading, and sight. The perceived impact of stroke in eight areas was assessed using the Stroke Impact Scale (SIS) 3.0. Eleven logistic regression models were created to explore associations between having health services needs met in each problem area respectively (dependent variable) and the independent variables. In all models the independent variables were: age, sex, SIS domain corresponding to the dependent variable, or stroke severity in cases when no corresponding SIS domain was identified, and involvement in decisions on care and treatment. Results The 63 participants who returned the questionnaires had a mean age of 72 years, 33 were male and 30 were female. Eighty percent had suffered a mild stroke. The number of participants who reported problems varied between 51 (80%, mobility) and 24 (38%, sight). Involvement in decisions on care and treatment was found to be associated with having health services needs met in six problem areas: falls, fatigue, emotion, memory, speaking, and reading. Conclusions The results highlight the importance of involving patients in making decisions on stroke rehabilitation, as it appears to be associated with meeting their health services needs.	[Kristensen, Hanne Kaae] Univ Coll Lillebaelt, Hlth Sci Res Ctr, Odense, Denmark; [Kristensen, Hanne Kaae; Ytterberg, Charlotte] Univ Southern Denmark, Res Unit Rehabil, Inst Clin Res, Odense, Denmark; [Tistad, Malin; von Koch, Lena; Ytterberg, Charlotte] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Tistad, Malin] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [von Koch, Lena] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	University of Southern Denmark; Karolinska Institutet; Dalarna University; Karolinska Institutet; Karolinska University Hospital	Kristensen, HK (corresponding author), Univ Coll Lillebaelt, Hlth Sci Res Ctr, Odense, Denmark.; Kristensen, HK (corresponding author), Univ Southern Denmark, Res Unit Rehabil, Inst Clin Res, Odense, Denmark.	hkkr@ucl.dk	von Koch, Lena/P-2310-2018	von Koch, Lena/0000-0002-8560-3016; Kristensen, Hanne Kaae/0000-0002-9596-5571; Ytterberg, Charlotte/0000-0003-3704-8887	Danish Regions; Danish Health Cartel	Danish Regions; Danish Health Cartel	The authors acknowledge Danish Regions and the Danish Health Cartel for funding the study. The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank The UK Stroke Association for providing the Stroke Survivor Needs Survey Questionnaire. Moreover, we thank Danish Regions and the Danish Health Cartel for funding the study.	Brown M, 2014, DISABIL REHABIL, V36, P1020, DOI 10.3109/09638288.2013.825653; Constand MK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-271; Danish Board of Health, 2011, BRAIN INJURY REHABIL; Danish Health and Medicines Authority, 2014, DISEASE MANAGEMENT P; de Port IGLV, 2007, DISABIL REHABIL, V29, P1841, DOI 10.1080/09638280601129157; Docteur E., 2012, PATIENT CENTREDNESS; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Duxbury S, 2012, OCCUP THER HEALTH CA, V26, P16, DOI 10.3109/07380577.2011.621514; Dworzynski K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3615; Flink M, 2015, CLIN REHABIL; Godolphin William, 2009, Healthc Q, V12 Spec No Patient, pe186; Govan L, 2009, STROKE, V40, P3396, DOI 10.1161/STROKEAHA.109.557645; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kersten P, 2002, DISABIL REHABIL, V24, P860, DOI 10.1080/09638280210142167; Kristensen HK, 2015, INT J THER REHABIL, V22, P460, DOI 10.12968/ijtr.2015.22.10.460; Kristensen HK, 2015, DISABIL REHABIL IN P; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Levack William M M, 2015, Cochrane Database Syst Rev, pCD009727, DOI 10.1002/14651858.CD009727.pub2; Lindsay MP, 2010, CANADIAN BEST PRACTI; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Momsen AM, 2012, J REHABIL MED, V44, P901, DOI 10.2340/16501977-1040; National Institute For Health And Care Excellence [NICE], 2013, STROKE REHABILITATIO; Nordin NAM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-118; Peoples H, 2011, SCAND J OCCUP THER, V18, P163, DOI 10.3109/11038128.2010.509887; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; Rosewilliam S, 2015, CLIN REHABIL; Rosewilliam S, 2015, REHABILITATION GOAL, P345; Salter K, 2008, J REHABIL MED, V40, P595, DOI 10.2340/16501977-0238; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Sumathipala K, 2012, CHRONIC ILLN, V8, P31, DOI 10.1177/1742395311423848; Sumsion Thelma, 2006, Can J Occup Ther, V73, P153; Talbot Lise R, 2004, Health Qual Life Outcomes, V2, P53, DOI 10.1186/1477-7525-2-53; Tang WK, 2015, TOP STROKE REHABIL, V22, P194, DOI 10.1179/1074935714Z.0000000024; Tistad M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-40; Tistad M, 2012, J NEUROL SCI, V313, P160, DOI 10.1016/j.jns.2011.08.038; Turner-Stokes L, 2015, INT J THER REHABIL, V22, P210, DOI 10.12968/ijtr.2015.22.5.210; Vincent Claude, 2007, BMC Geriatr, V7, P20; Walsh ME, 2015, DISABIL REHABIL, V37, P1599, DOI 10.3109/09638288.2014.974834; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640; Zimmermann L, 2014, PATIENT EDUC COUNS, V96, P98, DOI 10.1016/j.pec.2014.04.015	46	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157149	10.1371/journal.pone.0157149	http://dx.doi.org/10.1371/journal.pone.0157149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285997	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000041
J	Ota, M; Gonja, H; Koike, R; Fukuchi, S				Ota, Motonori; Gonja, Hideki; Koike, Ryotaro; Fukuchi, Satoshi			Multiple-Localization and Hub Proteins	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; INTERACTION NETWORK; BINDING; PHOSPHORYLATION; RESOURCE; REGIONS; IDEAL; SRC	Protein-protein interactions are fundamental for all biological phenomena, and protein-protein interaction networks provide a global view of the interactions. The hub proteins, with many interaction partners, play vital roles in the networks. We investigated the subcellular localizations of proteins in the human network, and found that the ones localized inmultiple subcellular compartments, especially the nucleus/cytoplasm proteins (NCP), the cytoplasm/cell membrane proteins (CMP), and the nucleus/cytoplasm/cell membrane proteins (NCMP), tend to be hubs. Examinations of keywords suggested that among NCP, those related to post-translational modifications and transcription functions are the major contributors to the large number of interactions. These types of proteins are characterized by a multi-domain architecture and intrinsic disorder. A survey of the typical hub proteins with prominent numbers of interaction partners in the type revealed that most are either transcription factors or co-regulators involved in signaling pathways. They translocate from the cytoplasm to the nucleus, triggered by the phosphorylation and/or ubiquitination of intrinsically disordered regions. Among CMP and NCMP, the contributors to the numerous interactions are related to either kinase or ubiquitin ligase activity. Many of them reside on the cytoplasmic side of the cell membrane, and act as the upstream regulators of signaling pathways. Overall, these hub proteins function to transfer external signals to the nucleus, through the cell membrane and the cytoplasm. Our analysis suggests that multiple-localization is a crucial concept to characterize groups of hub proteins and their biological functions in cellular information processing.	[Ota, Motonori; Gonja, Hideki; Koike, Ryotaro] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Fukuchi, Satoshi] Maebashi Inst Technol, Fac Engn, Maebashi, Gunma, Japan	Nagoya University	Ota, M (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	mota@is.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the "Platform for Drug Discovery, Informatics, and Structural Life Science" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japan Agency for Medical Research and Development (AMED).	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Alberts B., 2014, MOL BIOL CELL; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Durbin R, 1988, BIOL SEQUENCE ANAL P; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Fukuchi S, 2014, NUCLEIC ACIDS RES, V42, pD320, DOI 10.1093/nar/gkt1010; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Fukuchi S, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-29; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hsing M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-80; Huang QL, 2014, J PROTEOME RES, V13, P2735, DOI 10.1021/pr401019d; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Nakai Kenta, 2007, V390, P429; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Veres DV, 2015, NUCLEIC ACIDS RES, V43, pD485, DOI 10.1093/nar/gku1007; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang L, 2014, J THEOR BIOL, V358, P61, DOI 10.1016/j.jtbi.2014.05.008; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156455	10.1371/journal.pone.0156455	http://dx.doi.org/10.1371/journal.pone.0156455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285823	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000013
J	Klushkina, VV; Kyuregyan, KK; Kozhanova, TV; Popova, OE; Dubrovina, PG; Isaeva, OV; Gordeychuk, IV; Mikhailov, MI				Klushkina, Vitalina V.; Kyuregyan, Karen K.; Kozhanova, Tatiana V.; Popova, Oksana E.; Dubrovina, Polina G.; Isaeva, Olga V.; Gordeychuk, Ilya V.; Mikhailov, Mikhail I.			Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia	PLOS ONE			English	Article							S-GENE; CHILDREN; MUTANTS	Vaccination of newborns against hepatitis B (HB) was introduced in Russia in 1998. Since then the incidence of acute HB has rapidly declined. However, prevalence of chronic HB remains stable. The aim of this study was to estimate the effect of vaccination on HBV-associated morbidity, and to assess the prevalence of HBV immune escape variants after 10 years of vaccination. Methods 6,217 sera samples collected from volunteers in six epidemiologically different regions of Russia were tested for serological and molecular markers of HBV infection. A mathematical model developed by the U.S. Centers for Disease Control and Prevention was used to estimate the effect of vaccination and birth dose coverage on the incidence of HB and adverse outcomes of infection. Results Prevalence of HBsAg in the study population varied from 1.2% to 8.2%; anti-HBc detection rates were 13.0-46.2%. HBsAg detection rates in epidemiologically significant cohorts were 0.6-10.5% in women of childbearing age; 0-2.4% in children <= 5 years old; 1.9-8.1% in adults >= 30 years old. Mathematical modeling demonstrated that the current 96.1-99.6% level of birth dose coverage increased the effectiveness of vaccination 10-21 times compared to 50% and 0% birth dose coverage scenarios. HBV DNA was detected in 63 sera samples. The frequency of amino acid substitutions in HBsAg was 38% (24/63). Only in 3% (2/63) the mutations were within the a-determinant of HBsAg (M133T and G145S, one case each). None of the identified mutations eluded HBsAg detection, since all these samples tested positive for HBsAg by commercial ELISA. Conclusion Despite a significant decline in acute HB incidence after the introduction of universal vaccination, many undiagnosed potential sources of infection remain. Low prevalence of HBV immune escape variants is a favorable predictor of vaccine effectiveness in the future.	[Klushkina, Vitalina V.; Kyuregyan, Karen K.; Kozhanova, Tatiana V.; Popova, Oksana E.; Dubrovina, Polina G.; Isaeva, Olga V.; Gordeychuk, Ilya V.; Mikhailov, Mikhail I.] Chumakov Inst Poliomyelitis & Viral Encephalitide, Dept Viral Hepatitis, Moscow, Russia; [Klushkina, Vitalina V.] IM Sechenov First Moscow State Med Univ, Minist Heath Russian Federat, Prophylact Med Fac, Dept Epidemiol & Evidence Based Med, Moscow, Russia	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Sechenov First Moscow State Medical University	Gordeychuk, IV (corresponding author), Chumakov Inst Poliomyelitis & Viral Encephalitide, Dept Viral Hepatitis, Moscow, Russia.	lab.gord@gmail.com	Mikhailov, Mikhail Ivanovich/AAD-6917-2022; Gordeychuk, Ilya/AAD-6017-2022; Kyuregyan, Karen/D-6300-2014; Gordeychuk, Ilya V/D-6515-2014; Mikhailov, Mikhail/E-3531-2014	Mikhailov, Mikhail Ivanovich/0000-0002-6636-6801; Gordeychuk, Ilya/0000-0002-4551-7535; Kyuregyan, Karen/0000-0002-3599-117X; Gordeychuk, Ilya V/0000-0002-4551-7535; Klushkina, Vitalina/0000-0001-8311-8204	Chumakov Institute of Poliomyelitis and Viral Encephalitides	Chumakov Institute of Poliomyelitis and Viral Encephalitides	The work was funded by the Chumakov Institute of Poliomyelitis and Viral Encephalitides without any involvement of additional grants.	Basuni AA, HBV VACCINE ESCAPE V, P115, DOI [10.1385/1-59259-669-X:115, DOI 10.1385/1-59259-669-X:115]; Federal Center of Hygeine and Epidemiology,, 2010, INF PAR DIS MORB RUS; Federal Center of Hygeine and Epidemiology, 2010, INF GROUPS CHILDR AD; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; Ngui SL, 1997, J INFECT DIS, V176, P1360, DOI 10.1086/514133; OON CJ, 1995, VACCINE, V13, P699, DOI 10.1016/0264-410X(94)00080-7; Petersen KM, 2004, PEDIATR INFECT DIS J, V23, P650, DOI 10.1097/01.inf.0000130952.96259.fd; Plotkin SA, 2013, VACCINES; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; Torresi J, 2002, VIROLOGY, V299, P88, DOI 10.1006/viro.2002.1448	11	12	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157161	10.1371/journal.pone.0157161	http://dx.doi.org/10.1371/journal.pone.0157161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280884	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000099
J	Zhu, YJ; Cui, HW; Xia, YF; Gan, H				Zhu, Yongjun; Cui, Hongwang; Xia, Yunfeng; Gan, Hua			RIPK3-Mediated Necroptosis and Apoptosis Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease Progression in Rats	PLOS ONE			English	Article							PROTEIN-KINASE 1; INTERSTITIAL FIBROSIS; SDS-PAGE; RECEPTOR; NECROSIS; INJURY; PROLIFERATION; MECHANISMS; DEATH; MICE	Tubulointerstitial fibrosis (TIF) is caused by the progressive loss of renal tubular cells and the consequent replacement of the extracellular matrix. The progressive depletion of renal tubular cells results from apoptosis and necroptosis; however, the relative significance of each of these cell death mechanisms at different stages during the progression of chronic kidney disease (CKD) remains unclear. We sought to explore the mechanisms of renal tubular cell death during the early and intermediate stages of chronic renal damage of subtotal nephrectomied (SNx) rats. The results of tissue histological assays indicated that the numbers of necrotic dying cells and apoptotic cells were significantly higher in kidney tissues derived from a rat model of CKD. In addition, there was a significant increase in necroptosis observed by transmission electron microscopy (TEM) and an increase in the proportion of TUNEL-positive cells in kidney tissues from SNx rats compared with control rats, and necrostatin-1 (Nec-1) could inhibit necroptosis and reduce the proportion of TUNEL-positive cells. More importantly, we observed a significant increase in the incidence of necroptosis compared with apoptosis by TEM in vivo and in vitro and a significant increase in the proportion of TUNEL-positive tubular epithelial cells that did not express caspase-3 compared with those expressing cleaved caspase-3 in vitro. Furthermore, treatment with Nec-1 and zVAD strongly reduced necroptosis- and apoptosis-mediated renal tubular cell death and decreased the levels of blood urea nitrogen and serum creatinine and tubular damage scores of SNx rats. These results suggest that necroptotic cell death plays a more significant role than apoptosis in mediating the loss of renal tubular cells in SNx rats and that effectively blocking both necroptosis and apoptosis improves renal function and tubular damage at early and intermediate stages of CKD.	[Zhu, Yongjun; Xia, Yunfeng; Gan, Hua] Chongqing Med Univ, Affiliated Hosp 1, Dept Nephrol, Chongqing, Peoples R China; [Zhu, Yongjun] Hainan Med Coll, Affiliated Hosp, Dept Nephrol, Haikou, Peoples R China; [Cui, Hongwang] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China	Chongqing Medical University; Hainan Medical University; Chongqing Medical University	Zhu, YJ; Gan, H (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Nephrol, Chongqing, Peoples R China.; Zhu, YJ (corresponding author), Hainan Med Coll, Affiliated Hosp, Dept Nephrol, Haikou, Peoples R China.	zyj418207195@yeah.net; zgxxchw@sina.com			Chinese National Science and Technology Support Plan [2011BAI10B01]	Chinese National Science and Technology Support Plan	This study was supported by the Chinese National Science and Technology Support Plan (2011BAI10B01).	Amann K, 1996, NEPHROL DIAL TRANSPL, V11, P1003, DOI 10.1093/oxfordjournals.ndt.a027447; Baumann M, 2009, ACTA PHYSIOL, V196, P231, DOI 10.1111/j.1748-1716.2008.01916.x; Bazzi C, 1997, AM J KIDNEY DIS, V29, P27, DOI 10.1016/S0272-6386(97)90005-6; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Dworkin LD, 2004, KIDNEY INT, V65, P409, DOI 10.1111/j.1523-1755.2004.00417.x; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Joo KW, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-98; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Lopez AD, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0200-8; MACKENSENHAEN S, 1981, CLIN NEPHROL, V15, P167; Mene P, 1998, NEPHROL DIAL TRANSPL, V13, P1936, DOI 10.1093/ndt/13.8.1936; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Piecha G, 2008, AM J PHYSIOL-RENAL, V294, pF748, DOI 10.1152/ajprenal.00220.2007; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Sugiyama H, 1996, KIDNEY INT, V49, P103, DOI 10.1038/ki.1996.14; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Thomas GL, 1998, NEPHROL DIAL TRANSPL, V13, P2216, DOI 10.1093/ndt/13.9.2216; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Truong LD, 1996, KIDNEY INT, V50, P200, DOI 10.1038/ki.1996.303; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; WOO KT, 1991, CLIN NEPHROL, V36, P6; Yang B, 2001, KIDNEY INT, V60, P1765, DOI 10.1046/j.1523-1755.2001.00013.x; Yang B, 2001, J AM SOC NEPHROL, V12, P275, DOI 10.1681/ASN.V122275; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhu YJ, 2015, BIOCHEM BIOPH RES CO, V461, P575, DOI 10.1016/j.bbrc.2015.03.164	34	40	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156729	10.1371/journal.pone.0156729	http://dx.doi.org/10.1371/journal.pone.0156729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281190	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000041
J	Shukla, A; Moussa, A; Singh, TR				Shukla, Ankita; Moussa, Ahmed; Singh, Tiratha Raj			DREMECELS: A Curated Database for Base Excision and Mismatch Repair Mechanisms Associated Human Malignancies	PLOS ONE			English	Article							DNA; METHYLATION	DNA repair mechanisms act as a warrior combating various damaging processes that ensue critical malignancies. DREMECELS was designed considering the malignancies with frequent alterations in DNA repair pathways, that is, colorectal and endometrial cancers, associated with Lynch syndrome (also known as HNPCC). Since lynch syndrome carries high risk (similar to 40-60%) for both cancers, therefore we decided to cover all three diseases in this portal. Although a large population is presently affected by these malignancies, many resources are available for various cancer types but no database archives information on the genes specifically for only these cancers and disorders. The database contains 156 genes and two repair mechanisms, base excision repair (BER) and mismatch repair (MMR). Other parameters include some of the regulatory processes that have roles in these disease progressions due to incompetent repair mechanisms, specifically BER and MMR. However, our unique database mainly provides qualitative and quantitative information on these cancer types along with methylation, drug sensitivity, miRNAs, copy number variation (CNV) and somatic mutations data. This database would serve the scientific community by providing integrated information on these disease types, thus sustaining diagnostic and therapeutic processes. This repository would serve as an excellent accompaniment for researchers and biomedical professionals and facilitate in understanding such critical diseases. DREMECELS is publicly available at http://www.bioinfoindia.org/dremecels.	[Shukla, Ankita; Singh, Tiratha Raj] JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India; [Moussa, Ahmed] Abdelmalek Essaadi Univ, ENSA Tangier, LabTIC Lab, BP1818 Route Ziaten, Tangier 90000, Morocco	Jaypee University of Information Technology; Abdelmalek Essaadi University of Tetouan	Singh, TR (corresponding author), JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India.; Moussa, A (corresponding author), Abdelmalek Essaadi Univ, ENSA Tangier, LabTIC Lab, BP1818 Route Ziaten, Tangier 90000, Morocco.	amoussa@uae.ac.ma; tiratharaj@gmail.com	Singh, Tiratha Raj/AAL-4256-2020; Moussa, Ahmed/AAI-1351-2020	Moussa, Ahmed/0000-0003-1628-8179; Shukla, Ankita/0000-0003-1520-755X	Department of Biotechnology and Bioinformatics, JUIT	Department of Biotechnology and Bioinformatics, JUIT	The authors would like to thank the Department of Biotechnology and Bioinformatics, JUIT for providing financial support and technical assistance.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bejjani BA, 2006, J MOL DIAGN, V8, P528, DOI 10.2353/jmoldx.2006.060029; Chen X, 2009, DRUG DISCOV TODAY, V14, P754, DOI 10.1016/j.drudis.2009.05.005; Chow E, 2004, LANCET ONCOL, V5, P600, DOI 10.1016/S1470-2045(04)01595-5; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Forbes S.A., 2008, CURR PROTOC HUM GENE; Ford BN, 2000, CARCINOGENESIS, V21, P1977, DOI 10.1093/carcin/21.11.1977; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; He XM, 2008, NUCLEIC ACIDS RES, V36, pD836, DOI 10.1093/nar/gkm730; Huebert DJ, 2006, METHODS, V40, P365, DOI 10.1016/j.ymeth.2006.07.032; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Kumps FSC, 2009, COPY NUMBER ALTERATI, V182, P176; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martin-Lopez JV, 2013, FAM CANCER, V12, P159, DOI 10.1007/s10689-013-9635-x; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Shilpa V, 2014, MOL MECH MISMATCH RE, V1, P1; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Strafford J Craig, 2012, Rev Obstet Gynecol, V5, P42; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Yano K, 2006, NUCLEIC ACIDS RES, V34, P1532, DOI 10.1093/nar/gkl058	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157031	10.1371/journal.pone.0157031	http://dx.doi.org/10.1371/journal.pone.0157031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276067	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700058
J	Casey, NP; Fujiwara, H; Tanimoto, K; Okamoto, S; Mineno, J; Kuzushima, K; Shiku, H; Yasukawa, M				Casey, Nicholas Paul; Fujiwara, Hiroshi; Tanimoto, Kazushi; Okamoto, Sachiko; Mineno, Junichi; Kuzushima, Kiyotaka; Shiku, Hiroshi; Yasukawa, Masaki			A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy	PLOS ONE			English	Article							ENHANCED ANTITUMOR-ACTIVITY; HEMATOPOIETIC STEM-CELLS; ZINC-FINGER NUCLEASES; TCR GENE-TRANSFER; CANCER REGRESSION; HUMAN-LYMPHOCYTES; DISULFIDE BOND; IN-VIVO; THERAPY; POPULATION	Aurora Kinase A is a cancer-associated protein normally involved in the regulation of mitosis. Being over-expressed in a range of cancers, it is a suitable target for cell-based immunotherapy. Gene transfer of T-cell receptor sequences cognisant of HLA-A*0201-restricted Aurora Kinase A antigen has previously been shown to transfer specific immunoreactivity against the target peptide in a Human Lymphocyte Antigen-restricted manner. While T cell receptor gene-transfer has great potential in overcoming the difficulties of isolating and expanding tumour-reactive lymphocytes from a patient's own cells, one hurdle is potential mispairing and competition between exogenous and endogenous T cell receptor chains. We have used a retroviral vector design bearing a short-interfering RNA that downregulates endogenous T cell receptor chains, without affecting expression of the transgenic T cell receptor sequences. The T cell receptor expression cassette also includes a 2A self-cleaving peptide, resulting in equimolar expression of the T cell receptor alpha and beta chains, further enhancing formation of the desired T cell receptor. Via a simple, modular cloning method, we have cloned the alpha and beta chains of the anti-Aurora Kinase A-reactive T cell receptor into this 'siTCR' vector. We then compared the activity of this vector against the original, 'conventional' vector across a panel of assays. T cell receptors expressed from the siTCR-vector retained the cytotoxic functionality of the original vector, with evidence of reduced off-target reactivity. The rate of expression of correctly-formed T cell receptors was superior using the siTCR design, and this was achieved at lower vector copy numbers. Maintaining T cell receptor efficacy with a reduced vector copy number reduces the risk of genotoxicity. The siTCR design also reduces the risk of mispairing and cross-reactivity, while increasing the functional titre. Such improvements in the safety of T cell receptor gene-transfer will be crucial for clinical applications of this technology.	[Casey, Nicholas Paul; Fujiwara, Hiroshi; Tanimoto, Kazushi; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Hematol Clin Immunol & Infect Dis, Matsuyama, Ehime 790, Japan; [Okamoto, Sachiko; Mineno, Junichi] Takara Bio Inc, CDM Ctr, Shiga, Japan; [Kuzushima, Kiyotaka] Aichi Canc Ctr, Div Immunol, Nagoya, Aichi, Japan; [Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Canc Vaccine & Immunogene Therapy, Tsu, Mie, Japan	Ehime University; Takara Bio Inc.; Aichi Cancer Center; Mie University	Fujiwara, H; Yasukawa, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Hematol Clin Immunol & Infect Dis, Matsuyama, Ehime 790, Japan.	yunarief@m.ehime-u.ac.jp; yasukawa@m.ehime-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKEN 15H04858, 15K09506]; Project for Development of Innovative Research on Cancer Therapeutics; Ministry of Health, Labor and Welfare; Takeda science Foundation; Uehara Memorial Foundation; Princess Takamatsu Cancer Research Fund	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Princess Takamatsu Cancer Research Fund	This work was supported in part by grants from the following: Ministry of Education, Culture, Sports, Science and Technology of Japan (https://www.jsps.go.jp/jgrantsinaid/), grant numbers KAKEN 15H04858 (MY) and 15K09506 (HF); Project for Development of Innovative Research on Cancer Therapeutics (http://www.amed.go.jp/en/program/list/01/03/010.html) (MY); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare (MY); a grant from Takeda science Foundation (MY); a grant from the Uehara Memorial Foundation (MY); and a grant from Princess Takamatsu Cancer Research Fund (MY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two of the authors are employed by Takara Bio Inc. This funder provided support in the form of salaries for these authors (S.O. and J.M.). This funder also provided the original siTCR vector (as noted in the Materials and Methods), and provides research funding to co-author HS for work not related to this study. This funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Takara Bio Inc. provided the salaries for these two employees, and provided the original siTCR vector, but played no role in study design, data collection or analysis, the decision to publish, nor the preparation of the manuscript.	Baldini E, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/816430; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Dropulic Boro, 2005, Curr Hematol Rep, V4, P300; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grube M, 2004, CLIN CANCER RES, V10, P1047, DOI 10.1158/1078-0432.CCR-03-0075; Hamada M, 2003, BRIT J HAEMATOL, V121, P439, DOI 10.1046/j.1365-2141.2003.04311.x; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Ikezoe T, 2007, MOL CANCER THER, V6, P1851, DOI 10.1158/1535-7163.MCT-07-0067; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kim Yonghyun, 2009, Int J Stem Cells, V2, P109; Kitzen JJEM, 2010, CRIT REV ONCOL HEMAT, V73, P99, DOI 10.1016/j.critrevonc.2009.03.009; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Kobayashi H, 2010, CANCER IMMUNOL IMMUN, V59, P1029, DOI 10.1007/s00262-010-0826-0; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Miyazaki Y, 2013, BLOOD, V121, P4894, DOI 10.1182/blood-2012-11-465971; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nagai K, 2012, BLOOD, V119, P368, DOI 10.1182/blood-2011-06-360354; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Ochi T, 2009, BLOOD, V113, P66, DOI 10.1182/blood-2008-06-164889; Okamoto S, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.52; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Preffer FI, 2002, STEM CELLS, V20, P417, DOI 10.1634/stemcells.20-5-417; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sadelain M, 2004, GENE THER, V11, P569, DOI 10.1038/sj.gt.3302243; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SCHWARTZENTRUBER DJ, 1994, J CLIN ONCOL, V12, P1475, DOI 10.1200/JCO.1994.12.7.1475; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; SIEMANN DW, 1986, CANCER RES, V46, P3556; Sommermeyer D, 2006, EUR J IMMUNOL, V36, P3052, DOI 10.1002/eji.200636539; Stauss HJ, 2007, MOL THER, V15, P1744, DOI 10.1038/sj.mt.6300216; Thomas S, 2007, J IMMUNOL, V179, P5803, DOI 10.4049/jimmunol.179.9.5803; Voss RH, 2008, J IMMUNOL, V180, P391, DOI 10.4049/jimmunol.180.1.391; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	55	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156896	10.1371/journal.pone.0156896	http://dx.doi.org/10.1371/journal.pone.0156896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271876	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000043
J	Pukancsik, M; Orban, A; Nagy, K; Matsuo, K; Gekko, K; Maurin, D; Hart, D; Kezsmarki, I; Vertessy, BG				Pukancsik, Maria; Orban, Agnes; Nagy, Kinga; Matsuo, Koichi; Gekko, Kunihiko; Maurin, Damien; Hart, Darren; Kezsmarki, Istvan; Vertessy, Beata G.			Secondary Structure Prediction of Protein Constructs Using Random Incremental Truncation and Vacuum-Ultraviolet CD Spectroscopy	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SYNCHROTRON-RADIATION; SOLUBLE EXPRESSION; BINDING; DOMAIN	A novel uracil-DNA degrading protein factor (termed UDE) was identified in Drosophila melanogaster with no significant structural and functional homology to other uracil-DNA binding or processing factors. Determination of the 3D structure of UDE is excepted to provide key information on the description of the molecular mechanism of action of UDE catalysis, as well as in general uracil-recognition and nuclease action. Towards this long-term aim, the random library ESPRIT technology was applied to the novel protein UDE to overcome problems in identifying soluble expressing constructs given the absence of precise information on domain content and arrangement. Nine constructs of UDE were chosen to decipher structural and functional relationships. Vacuum ultraviolet circular dichroism (VUVCD) spectroscopy was performed to define the secondary structure content and location within UDE and its truncated variants. The quantitative analysis demonstrated exclusive alpha-helical content for the full-length protein, which is preserved in the truncated constructs. Arrangement of alpha-helical bundles within the truncated protein segments suggested new domain boundaries which differ from the conserved motifs determined by sequence-based alignment of UDE homologues. Here we demonstrate that the combination of ESPRIT and VUVCD spectroscopy provides a new structural description of UDE and confirms that the truncated constructs are useful for further detailed functional studies.	[Pukancsik, Maria; Nagy, Kinga; Vertessy, Beata G.] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Pukancsik, Maria; Orban, Agnes; Kezsmarki, Istvan] Budapest Univ Technol & Econ, Dept Phys, H-1111 Budapest, Hungary; [Pukancsik, Maria; Orban, Agnes; Kezsmarki, Istvan] MTA BME Lendulet Magnetoopt Spect Res Grp, H-1111 Budapest, Hungary; [Matsuo, Koichi; Gekko, Kunihiko] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Higashihiroshima 724, Japan; [Maurin, Damien; Hart, Darren] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38044 Grenoble, France; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1111 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Budapest University of Technology & Economics; Budapest University of Technology & Economics; Hiroshima University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Budapest University of Technology & Economics	Pukancsik, M; Vertessy, BG (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.; Pukancsik, M (corresponding author), Budapest Univ Technol & Econ, Dept Phys, H-1111 Budapest, Hungary.; Pukancsik, M (corresponding author), MTA BME Lendulet Magnetoopt Spect Res Grp, H-1111 Budapest, Hungary.; Vertessy, BG (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1111 Budapest, Hungary.	p_marcsi@enzim.hu; vertessy@mail.bme.hu	Vertessy, Beata G/H-6202-2012; Hart, Darren/C-4858-2015	Hart, Darren/0000-0002-3502-2002; Vertessy, Beata G./0000-0002-1288-2982	National Research, Development and Innovation Office, Hungary [OTKA K 109486, 84008, OTKA K 108918]; FRISBI [ANR-10-INSB-05-1102]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]; P-CUBE [INFRA-2008-227764]	National Research, Development and Innovation Office, Hungary; FRISBI; GRAL within the Grenoble Partnership for Structural Biology (PSB); P-CUBE	National Research, Development and Innovation Office, Hungary (OTKA K 109486 and 84008 to BGV, OTKA K 108918 to IK).; The ESPRIT platform is part of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-1102) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB) and funded access was provided by the P-CUBE (INFRA-2008-227764).	Alagna L, 1998, PHYS REV LETT, V80, P4799, DOI 10.1103/PhysRevLett.80.4799; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bekesi A, 2007, BIOCHEM BIOPH RES CO, V355, P643, DOI 10.1016/j.bbrc.2007.01.196; Bekesi A, 2011, FEBS J, V278, P295, DOI 10.1111/j.1742-4658.2010.07951.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Chin DH, 2002, P NATL ACAD SCI USA, V99, P15416, DOI 10.1073/pnas.232591399; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hart DJ, 2006, ACTA CRYSTALLOGR D, V62, P19, DOI 10.1107/S0907444905036097; Hussain R, 2012, COMPREHENSIVE CHIRAL, V8, P438; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Matsuo K, 2005, J BIOCHEM, V138, P79, DOI 10.1093/jb/mvi101; Matsuo K, 2004, J BIOCHEM, V135, P405, DOI 10.1093/jb/mvh048; Matsuo K, 2003, ANAL SCI, V19, P129, DOI 10.2116/analsci.19.129; Matsuo K, 2002, CHEM LETT, P826, DOI 10.1246/cl.2002.826; Matsuo K, 2008, PROTEINS, V73, P104, DOI 10.1002/prot.22055; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Ojima N, 2000, CHEM LETT, P832, DOI 10.1246/cl.2000.832; Ojima N, 2001, CHEM LETT, P522, DOI 10.1246/cl.2001.522; Ostermeier M, 1999, NAT BIOTECHNOL, V17, P1205, DOI 10.1038/70754; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; Pukancsik M, 2010, FEBS J, V277, P1245, DOI 10.1111/j.1742-4658.2009.07556.x; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stephens PJ, 2008, CHIRALITY, V20, P643, DOI 10.1002/chir.20477; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yumerefendi H, 2011, METHODS, V55, P38, DOI 10.1016/j.ymeth.2011.06.007; Yumerefendi H, 2010, J STRUCT BIOL, V172, P66, DOI 10.1016/j.jsb.2010.02.021	39	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156238	10.1371/journal.pone.0156238	http://dx.doi.org/10.1371/journal.pone.0156238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27273007	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000377561000010
J	Kang, JO; Lee, JB; Chang, J				Kang, Jung-Ok; Lee, Jee-Boong; Chang, Jun			Cholera Toxin Promotes Th17 Cell Differentiation by Modulating Expression of Polarizing Cytokines and the Antigen-Presenting Potential of Dendritic Cells	PLOS ONE			English	Article							RECEPTOR; ACTIVATION; RESPONSES; IMMUNITY; IL-17; DEGRADATION; GENERATION; FAMILY; ALPHA; STAT5	Cholera toxin (CT), an exotoxin produced by Vibrio cholera, acts as a mucosal adjuvant. In a previous study, we showed that CT skews differentiation of CD4 T cells to IL-17-producing Th17 cells. Here, we found that intranasal administration of CT induced migration of migratory dendritic cell (DC) populations, CD103(+) DCs and CD11b(hi) DCs, to the lung draining mediastinal lymph nodes (medLN). Among those DC subsets, CD11b(hi) DCs that were relatively immature had a major role in Th17 cell differentiation after administration of CT. CT-treated BMDCs showed reduced expression of MHC class II and CD86, similar to CD11b(hi) DCs in medLN, and these BMDCs promoted Th17 cell differentiation more potently than other BMDCs expressing higher levels of MHC class II and CD86. By analyzing the expression of activation markers such as CD25 and CD69, proliferation and IL-2 production, we determined that CT-treated BMDCs showed diminished antigen-presenting potential to CD4(+) T cells compared with normal BMDCs. We also found that CT-stimulated BMDCs promote activin A expression as well as IL-6 and IL-1 beta, and activin A had a synergic role with TGF-beta 1 in CT-mediated Th17 cell differentiation. Taken together, our results suggest that CT-stimulated DCs promote Th17 cell differentiation by not only modulating antigen-presenting potential but also inducing Th polarizing cytokines.	[Kang, Jung-Ok; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lee, Jee-Boong] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, Kyunggi Do, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU)	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2060008]; Korean Health Technology R& D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0826]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korean Health Technology R& D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2060008) and by a grant of the Korean Health Technology R& D Project, Ministry of Health & Welfare, Republic of Korea (Grant number: HI13C0826) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fang R, 2007, INFECT IMMUN, V75, P3112, DOI 10.1128/IAI.00007-07; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Mather JP, 1997, P SOC EXP BIOL MED, V215, P209; Mattsson J, 2015, MUCOSAL IMMUNOL, V8, P815, DOI 10.1038/mi.2014.111; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Murata T, 1997, ENDOCR J, V44, P35, DOI 10.1507/endocrj.44.35; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shiner EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100175; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Waithman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066136; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yu J, 1997, CYTOKINES CELL MOL T, V3, P169	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157015	10.1371/journal.pone.0157015	http://dx.doi.org/10.1371/journal.pone.0157015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271559	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200028
J	Kaneko, K; Ohkawa, Y; Hashimoto, N; Ohmi, Y; Kotani, N; Honke, K; Ogawa, M; Okajima, T; Furukawa, K; Furukawa, K				Kaneko, Kei; Ohkawa, Yuki; Hashimoto, Noboru; Ohmi, Yuhsuke; Kotani, Norihiro; Honke, Koichi; Ogawa, Mitsutaka; Okajima, Tetsuya; Furukawa, Keiko; Furukawa, Koichi			Neogenin, Defined as a GD3-associated Molecule by Enzyme-mediated Activation of Radical Sources, Confers Malignant Properties via Intracytoplasmic Domain in Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-GD3 MONOCLONAL-ANTIBODY; AMYLOID PRECURSOR PROTEIN; PHASE-I TRIAL; GANGLIOSIDE GD3; METASTATIC MELANOMA; GAMMA-SECRETASE; LIPID RAFTS; T-CELLS; EXPRESSION; CANCER	To investigate mechanisms for increased malignant properties in malignant melanomas by ganglioside GD3, enzyme-mediated activation of radical sources and subsequent mass spectrometry were performed using an anti-GD3 antibody and GD3-positive (GD3+) and GD3-negative (GD3-) melanoma cell lines. Neogenin, defined as a GD3-neighbored molecule, was largely localized in lipid/rafts in GD3+ cells. Silencing of neogenin resulted in the reduction of cell growth and invasion activity. Physical association between GD3 and neogenin was demonstrated by immunoblotting of the immunoprecipitates with anti-neogenin antibody from GD3- cell lysates. The intracytoplasmic domain of neogenin (Ne-ICD) was detected in GD3+ cells at higher levels than in GD3- cells when cells were treated by a proteasome inhibitor but not when simultaneously treated with a gamma-secretase inhibitor. Exogenous GD3 also induced increased Ne-ICD in GD3- cells. Overexpression of Ne-ICD in GD3- cells resulted in the increased cell growth and invasion activity, suggesting that Ne-ICD plays a role as a transcriptional factor to drive malignant properties of melanomas after cleavage with gamma-secretase. gamma-Secretase was found in lipid/rafts in GD3+ cells. Accordingly, immunocyto-staining revealed that GD3, neogenin, and gamma-secretase were co-localized at the leading edge of GD3+ cells. All these results suggested that GD3 recruits gamma-secretase to lipid/rafts, allowing efficient cleavage of neogenin. ChIP-sequencing was performed to identify candidates of target genes of Ne-ICD. Some of them actually showed increased expression after expression of Ne-ICD, probably exerting malignant phenotypes of melanomas under GD3 expression.	[Kaneko, Kei; Hashimoto, Noboru; Ohmi, Yuhsuke; Ogawa, Mitsutaka; Okajima, Tetsuya; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4660065, Japan; [Ohkawa, Yuki; Furukawa, Keiko; Furukawa, Koichi] Chubu Univ, Coll Life & Hlth Sci, Dept Life Biomed Sci, Matsumoto Cho 1200, Kasuigai, Aichi 4878501, Japan; [Kotani, Norihiro] Saitama Med Univ, Fac Med, Dept Biochem, Moroyama, Saitama 3500495, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Kochi 7838505, Japan	Nagoya University; Chubu University; Saitama Medical University; Kochi University	Furukawa, K (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Life Biomed Sci, Matsumoto Cho 1200, Kasuigai, Aichi 4878501, Japan.	koichi@isc.chubu.ac.jp		Kotani, Norihiro/0000-0003-3739-6478	Ministry of Education, Culture, Sports, and Technology of Japan (MEXT) [15H04696, 15K15080, 25670141, 24390078]; Nakamura-Sekizen-kai; Grants-in-Aid for Scientific Research [15K15080, 16J00004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakamura-Sekizen-kai; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 15H04696, 15K15080, 25670141, and 24390078 from the Ministry of Education, Culture, Sports, and Technology of Japan (MEXT). This work was also supported by a scholarship from Nakamura-Sekizen-kai. The authors declare that they have no conflicts of interest with the contents of this article.	Akino T, 2014, CANCER RES, V74, P3716, DOI 10.1158/0008-5472.CAN-13-3116; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; CARUBIA JM, 1984, BIOCHEM BIOPH RES CO, V120, P500, DOI 10.1016/0006-291X(84)91282-8; CHANG HR, 1992, CANCER, V70, P633, DOI 10.1002/1097-0142(19920801)70:3<633::AID-CNCR2820700315>3.0.CO;2-F; CHERESH DA, 1986, CANCER RES, V46, P5112; CHEUNG NKV, 1985, CANCER RES, V45, P2642; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; Cui HX, 2014, J BIOL CHEM, V289, P34871, DOI 10.1074/jbc.M114.571000; DIPPOLD WG, 1985, CANCER RES, V45, P3699; DIPPOLD WG, 1984, CANCER RES, V44, P806; Forero A, 2006, CANCER BIOTHER RADIO, V21, P561, DOI 10.1089/cbr.2006.21.561; FURUKAWA K, 1993, P NATL ACAD SCI USA, V90, P1972, DOI 10.1073/pnas.90.5.1972; FURUKAWA K, 1989, CANCER RES, V49, P191; Furukawa K, 2014, CANCER SCI, V105, P52, DOI 10.1111/cas.12310; Furukawa K, 2012, GLYCOCONJUGATE J, V29, P579, DOI 10.1007/s10719-012-9423-0; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; HAKOMORI S, 1968, P NATL ACAD SCI USA, V59, P254, DOI 10.1073/pnas.59.1.254; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HAKOMORI SI, 1991, CANCER CELL-MON REV, V3, P461; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Hamamura K, 2011, J BIOL CHEM, V286, P18526, DOI 10.1074/jbc.M110.164798; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; Hu YC, 2001, CLIN CANCER RES, V7, P2213; Johnson DB, 2015, JAMA ONCOL, V1, P380, DOI 10.1001/jamaoncol.2015.0565; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Katoh M, 2004, INT J ONCOL, V24, P737; Kim SJ, 2014, ONCOTARGET, V5, P3386, DOI 10.18632/oncotarget.1960; Kirkwood JM, 2000, CANCER, V88, P2693, DOI 10.1002/1097-0142(20000615)88:12<2693::AID-CNCR7>3.3.CO;2-V; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; LLOYD KO, 1989, CANCER RES, V49, P3445; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Luk JM, 2006, J CELL PHYSIOL, V209, P755, DOI 10.1002/jcp.20746; MERRITT WD, 1987, CANCER RES, V47, P1724; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Milla LA, 2014, INT J CANCER, V134, P21, DOI 10.1002/ijc.28330; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Ohkawa Y, 2015, J BIOL CHEM, V290, P16043, DOI 10.1074/jbc.M114.635755; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; PORTOUKALIAN J, 1978, BIOCHEM BIOPH RES CO, V85, P916, DOI 10.1016/0006-291X(78)90630-7; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; Raimondi C, 2011, CURR MED CHEM, V18, P2763, DOI 10.2174/092986711796011238; Scott AM, 2001, J CLIN ONCOL, V19, P3976, DOI 10.1200/JCO.2001.19.19.3976; Shibuya H, 2012, CANCER SCI, V103, P1656, DOI 10.1111/j.1349-7006.2012.02344.x; SIDDIQUI B, 1984, CANCER RES, V44, P5262; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Tatti O, 2015, CANCER RES, V75, P2083, DOI 10.1158/0008-5472.CAN-14-1923; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wargo JA, 2015, SEMIN ONCOL, V42, P601, DOI 10.1053/j.seminoncol.2015.05.007; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wu XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038074; Xing WY, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-352; Yoshida S, 2001, CANCER RES, V61, P4244; Zha Q, 2004, MOL PSYCHIATR, V9, P946, DOI 10.1038/sj.mp.4001509; Zhang QS, 2015, ONCOL REP, V34, P258, DOI 10.3892/or.2015.4004	65	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16630	16643		10.1074/jbc.M115.708834	http://dx.doi.org/10.1074/jbc.M115.708834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288875	Green Published, hybrid			2022-12-26	WOS:000380826700022
J	Yanatori, I; Richardson, DR; Imada, K; Kishi, F				Yanatori, Izumi; Richardson, Des R.; Imada, Kiyoshi; Kishi, Fumio			Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; iron; iron metabolism; protein-protein interaction; transporter; PCBP2; ferroportin1	POLY(RC) BINDING-PROTEIN; FUNCTIONAL-ANALYSIS; METABOLISM; HEPCIDIN; FAMILY; DOMAIN; GENE; LOCALIZATION; NRAMP2/DMT1; MECHANISMS	Ferroportin 1 (FPN1) is an iron export protein found in mammals. FPN1 is important for the export of iron across the basolateral membrane of absorptive enterocytes and across the plasma membrane of macrophages. The expression of FPN1 is regulated by hepcidin, which binds to FPN1 and then induces its degradation. Previously, we demonstrated that divalent metal transporter 1 (DMT1) interacts with the intracellular iron chaperone protein poly(rC)-binding protein 2 (PCBP2). Subsequently, PCBP2 receives iron from DMT1 and then disengages from the transporter. In this study, we investigated the function of PCBP2 in iron export. Mammalian genomes encode four PCBPs (i.e. PCBP1-4). Here, for the first time, we demonstrated using both yeast and mammalian cells that PCBP2, but not PCBP1, PCBP3, or PCBP4, binds with FPN1. Importantly, iron-loaded, but not iron-depleted, PCBP2 interacts with FPN1. The PCBP2-binding domain of FPN1 was identified in its C-terminal cytoplasmic region. The silencing of PCBP2 expression suppressed FPN1-dependent iron export from cells. These results suggest that FPN1 exports iron received from the iron chaperone PCBP2. Therefore, it was found that PCBP2 modulates cellular iron export, which is an important physiological process.	[Yanatori, Izumi; Imada, Kiyoshi; Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, 577 Matsushima, Kurashiki, Okayama 7010192, Japan; [Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia	Kawasaki Medical School; University of Sydney	Kishi, F (corresponding author), Kawasaki Med Sch, Dept Mol Genet, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	fkishi-ygc@umin.ac.jp	Yanatori, Izumi/AAE-1482-2019	Yanatori, Izumi/0000-0002-1945-5473; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	Ministry of Education, Science, and Culture of Japan [22591052]; Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED); Kawasaki Medical School [26-26, 27-50]; National Health and Medical Research Council of Australia (NHMRC); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kawasaki Medical School; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (ID: 22591052), the Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED), and research project grants from Kawasaki Medical School (ID: 26-26, 27-50). The authors declare that they have no conflicts of interest related to the contents of this article.; Recipient of a Senior Principal Research Fellowship and project grants from the National Health and Medical Research Council of Australia (NHMRC) and a travel fellowship from the Japan Society for the Promotion of Science (JSPS).	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Alver RC, 2014, NUCLEIC ACIDS RES, V42, P8389, DOI 10.1093/nar/gku479; Canonne-Hergaux F, 2000, BLOOD, V96, P3964; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Chkheidze AN, 2003, MOL CELL BIOL, V23, P8405, DOI 10.1128/MCB.23.23.8405-8415.2003; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; FUHRMAN B, 1994, ATHEROSCLEROSIS, V111, P65, DOI 10.1016/0021-9150(94)90192-9; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ghanem LR, 2016, MOL CELL BIOL, V36, P304, DOI 10.1128/MCB.00936-15; Ghanem LR, 2014, GENE EXPR PATTERNS, V14, P78, DOI 10.1016/j.gep.2014.01.004; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Kalinowski DS, 2016, BBA-MOL CELL RES, V1863, P727, DOI 10.1016/j.bbamcr.2016.01.026; Kishi F, 1997, MOL IMMUNOL, V34, P839, DOI 10.1016/S0161-5890(97)00110-7; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Lane Darius J R, 2014, Biochem J, V462, pe1, DOI 10.1042/BJ20140720; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Liu FL, 2006, BIOCHEM BIOPH RES CO, V350, P472, DOI 10.1016/j.bbrc.2006.09.073; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Palumaa P, 2013, FEBS LETT, V587, P1902, DOI 10.1016/j.febslet.2013.05.019; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Philpott CC, 2012, J BIOL CHEM, V287, P13518, DOI 10.1074/jbc.R111.326876; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rosakis A, 2005, BIOMETALS, V18, P107, DOI 10.1007/s10534-004-2481-4; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Tabuchi M, 1999, BIOCHEM J, V344, P211, DOI 10.1042/0264-6021:3440211; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Walter BL, 1999, RNA, V5, P1570, DOI 10.1017/S1355838299991483; Walter BL, 2002, J VIROL, V76, P12008, DOI 10.1128/JVI.76.23.12008-12022.2002; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P793, DOI 10.1001/archneur.57.6.793; Yanatori I, 2015, CELL BIOL INT, V39, P427, DOI 10.1002/cbin.10403; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; YOSHIMORI T, 1988, CELL STRUCT FUNCT, V13, P311, DOI 10.1247/csf1975.13.311; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905	58	88	92	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17303	17318		10.1074/jbc.M116.721936	http://dx.doi.org/10.1074/jbc.M116.721936			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27302059	Green Published, hybrid			2022-12-26	WOS:000382643800031
J	Bilgin, R; Ebeoglu, N; Inak, S; Kirpik, MA; Horns, JJ; Sekercioglu, CH				Bilgin, Rasit; Ebeoglu, Nadin; Inak, Sedat; Kirpik, Mehmet Ali; Horns, Joshua J.; Sekercioglu, Cagan H.			DNA Barcoding of Birds at a Migratory Hotspot in Eastern Turkey Highlights Continental Phylogeographic Relationships	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CLIMATE-CHANGE; HISTORY; INTROGRESSION; SPECIATION; PATTERNS	The combination of habitat loss, climate change, direct persecution, introduced species and other components of the global environmental crisis has resulted in a rapid loss of biodiversity, including species, population and genetic diversity. Birds, which inhabit a wide spectrum of different habitat types, are particularly sensitive to and indicative of environmental changes. The Caucasus endemic bird area, part of which covers northeastern Turkey, is one of the world's key regions harboring a unique bird community threatened with habitat loss. More than 75% of all bird species native to Turkey have been recorded in this region, in particular along the Kars-Igdir migratory corridor, stopover, wintering and breeding sites along the Aras River, whose wetlands harbor at least 264 bird species. In this study, DNA barcoding technique was used for evaluating the genetic diversity of land bird species of Aras River Bird Paradise at the confluence of Aras River and Igdir Plains key biodiversity areas. Seventy three COI sequences from 33 common species and 26 different genera were newly generated and used along with 301 sequences that were retrieved from the Barcoding of Life Database (BOLD). Using the sequences obtained in this study, we made global phylogeographic comparisons to define four categories of species, based on barcoding suitability, intraspecific divergence and taxonomy. Our findings indicate that the landbird community of northeastern Turkey has a genetical signature mostly typical of northern Palearctic bird communities while harboring some unique variations. The study also provides a good example of how DNA barcoding can build upon its primary mission of species identification and use available data to integrate genetic variation investigated at the local scale into a global framework. However, the rich bird community of the Aras River wetlands is highly threatened with the imminent construction of the Tuzluca Dam by the government.	[Bilgin, Rasit; Ebeoglu, Nadin] Bogazici Univ, Inst Environm Sci, TR-34342 Istanbul, Turkey; [Inak, Sedat; Kirpik, Mehmet Ali] Kafkas Univ, Fac Sci, Dept Biol, TR-36100 Kars, Turkey; [Horns, Joshua J.; Sekercioglu, Cagan H.] Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA; [Sekercioglu, Cagan H.] Koc Univ, Coll Sci, TR-34450 Istanbul, Turkey; [Sekercioglu, Cagan H.] KuzeyDoga Dernegi, Ortakapi Mah Sehit Yusuf Cad 93-1, TR-36100 Kars, Turkey	Bogazici University; Kafkas University; Utah System of Higher Education; University of Utah; Koc University	Bilgin, R (corresponding author), Bogazici Univ, Inst Environm Sci, TR-34342 Istanbul, Turkey.	rasit.bilgin@boun.edu.tr	Sekercioglu, Cagan H/A-2331-2013; Bilgin, Rasit/A-3129-2016	Sekercioglu, Cagan H/0000-0001-9639-294X; Sekercioglu, Cagan H./0000-0003-3193-0377	Christensen Fund; Whitley Fund; National Geographic Society; Kafkas University; University of Utah; Research Fund of Bogazici University in Istanbul [09S101, 15Y00R4]	Christensen Fund; Whitley Fund; National Geographic Society(National Geographic Society); Kafkas University(Kafkas University); University of Utah; Research Fund of Bogazici University in Istanbul(Bogazici University)	The authors thank the Christensen Fund, the Whitley Fund, National Geographic Society, Kafkas University, and the University of Utah for funding our fieldwork. This study was supported by two grants (Nos: 09S101 and 15Y00R4) from the Research Fund of Bogazici University in Istanbul to RB. The authors are also grateful to our donors, in particular Arkadaslar, Bilge Bahar, Seha Ismen, Lin Lougheed, Batubay Ozkan, and Burak Over for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Illera JC, 2008, MOL PHYLOGENET EVOL, V48, P1145, DOI 10.1016/j.ympev.2008.05.016; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drovetski SV, 2004, J AVIAN BIOL, V35, P105; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Kvist L, 1999, HEREDITY, V82, P495, DOI 10.1038/sj.hdy.6885130; Moyle RG, 2007, J AVIAN BIOL, V38, P317, DOI 10.1111/j.2007.0908-8857.03921.x; Nyari AS, 2007, MOL PHYLOGENET EVOL, V44, P154, DOI 10.1016/j.ympev.2007.02.020; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Schrey AW, 2011, MOL ECOL, V20, P1133, DOI 10.1111/j.1365-294X.2011.05001.x; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sekercioglu CH, 2011, BIOL CONSERV, V144, P2752, DOI 10.1016/j.biocon.2011.06.025; Sekercioglu CH, 2011, SCIENCE, V334, P1637, DOI 10.1126/science.334.6063.1637-b; Svensson L, 1992, BIRDS OF EUROPE; Svensson L, 2010, BIRDS OF EUROPE; Svensson L., 1992, IDENTIFICATION GUIDE; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wormworth J, 2011, WINGED SENTINELS: BIRDS AND CLIMATE CHANGE, P1, DOI 10.1017/CBO9781139150026; Yoo HS, 2006, MOL CELLS, V22, P323; Zink RM, 2008, J ORNITHOL, V149, P399, DOI 10.1007/s10336-008-0276-z; Zink RM, 2009, MOL PHYLOGENET EVOL, V52, P769, DOI 10.1016/j.ympev.2009.05.016	29	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0154454	10.1371/journal.pone.0154454	http://dx.doi.org/10.1371/journal.pone.0154454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304877	Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800003
J	Burroughs, AL; Durr, PA; Boyd, V; Graham, K; White, JR; Todd, S; Barr, J; Smith, I; Baverstock, G; Meers, J; Crameri, G; Wang, LF				Burroughs, A. L.; Durr, P. A.; Boyd, V.; Graham, K.; White, J. R.; Todd, S.; Barr, J.; Smith, I.; Baverstock, G.; Meers, J.; Crameri, G.; Wang, L-F			Hendra Virus Infection Dynamics in the Grey-Headed Flying Fox (Pteropus poliocephalus) at the Southern-Most Extent of Its Range: Further Evidence This Species Does Not Readily Transmit the Virus to Horses	PLOS ONE			English	Article							BATS; HENIPAVIRUS; PARAMYXOVIRUS; ANTIBODIES; ASSAYS; SPP.	Hendra virus (HeV) is an important emergent virus in Australia known to infect horses and humans in certain regions of the east coast. Whilst pteropid bats ("flying foxes") are considered the natural reservoir of HeV, which of the four mainland species is the principal reservoir has been a source of ongoing debate, particularly as shared roosting is common. To help resolve this, we sampled a colony consisting of just one of these species, the grey-headed flying fox, (Pteropus poliocephalus), at the southernmost extent of its range. Using the pooled urine sampling technique at approximately weekly intervals over a two year period, we determined the prevalence of HeV and related paramyxoviruses using a novel multiplex (Luminex) platform. Whilst all the pooled urine samples were negative for HeV nucleic acid, we successfully identified four other paramyxoviruses, including Cedar virus; a henipavirus closely related to HeV. Collection of serum from individually caught bats from the colony showed that antibodies to HeV, as estimated by a serological Luminex assay, were present in between 14.6% and 44.5% of animals. The wide range of the estimate reflects uncertainties in interpreting intermediate results. Interpreting the study in the context of HeV studies from states to the north, we add support for an arising consensus that it is the black flying fox and not the grey-headed flying fox that is the principal source of HeV in spillover events to horses.	[Burroughs, A. L.; Durr, P. A.; Boyd, V.; Graham, K.; White, J. R.; Todd, S.; Barr, J.; Smith, I.; Crameri, G.; Wang, L-F] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Baverstock, G.] City Greater Geelong, Geelong, Vic, Australia; [Burroughs, A. L.; Meers, J.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Wang, L-F] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; National University of Singapore	Durr, PA (corresponding author), Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia.	peter.durr@csiro.au	wang, lin/HHM-2225-2022; wang, lili/HDL-7210-2022; Smith, Ina/H-7225-2013; WHITE, JOHN REGINALD/G-8800-2013; wang, lin/GSE-3040-2022; Durr, Peter/O-2948-2014	Smith, Ina/0000-0001-5807-3737; WHITE, JOHN REGINALD/0000-0003-2112-7185; Durr, Peter/0000-0003-0851-5300; Barr, Jennifer/0000-0001-5266-9142	Commonwealth Scientific and Industrial Research Organisation OCE Science Leader Award; Australian Post-Graduate Award	Commonwealth Scientific and Industrial Research Organisation OCE Science Leader Award; Australian Post-Graduate Award(Australian Government)	This work was supported by the Commonwealth Scientific and Industrial Research Organisation OCE Science Leader Award: L-FW. Australian Post-Graduate Award: ALB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2014, MOL PHYLOGENET EVOL, V77, P83, DOI 10.1016/j.ympev.2014.03.009; Barr J, 2015, J GEN VIROL, V96, P24, DOI 10.1099/vir.0.068106-0; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Boyd V, 2015, J VIROL METHODS, V223, P5, DOI 10.1016/j.jviromet.2015.07.004; Breed AC, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0028816; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Burroughs AL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00177-15; Clayton BA, 2013, ZOONOSES PUBLIC HLTH, V60, P69, DOI 10.1111/j.1863-2378.2012.01501.x; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140670; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125881; Field H., 2004, THESIS; Field H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144055; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Foord AJ, 2014, J VIROL METHODS, V203, P65, DOI 10.1016/j.jviromet.2014.03.018; Foord AJ, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/, DOI 10.1155/2013/]; Goldspink LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128835; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Mahalingam S, 2012, LANCET INFECT DIS, V12, P799, DOI 10.1016/S1473-3099(12)70158-5; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; McNabb L, 2014, J VIROL METHODS, V200, P22, DOI 10.1016/j.jviromet.2014.01.010; Middleton D, 2014, VET CLIN N AM-EQUINE, V30, P579, DOI 10.1016/j.cveq.2014.08.004; Ng JHJ, 2013, AUST J ZOOL, V61, P48, DOI 10.1071/ZO12126; Nowak RM, 1994, WALKERS BATS WORLD; Peel AJ, 2013, J VIROL METHODS, V193, P295, DOI 10.1016/j.jviromet.2013.06.030; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Sendow Indrawati, 2013, PLoS ONE, V8, P1; Smith C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099965; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Thomas D.W., 1988, P77; Victoria State Government, 2011, ASS HENDR VIR SIT VI; Westcott DA, 2004, WILDLIFE RES, V31, P551, DOI 10.1071/WR03091; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	40	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155252	10.1371/journal.pone.0155252	http://dx.doi.org/10.1371/journal.pone.0155252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304985	Green Submitted, gold, Green Published			2022-12-26	WOS:000377824800006
J	Hayashi, M; Watanabe, M; Yukuhiro, F; Nomura, M; Kageyama, D				Hayashi, Masayuki; Watanabe, Masaya; Yukuhiro, Fumiko; Nomura, Masashi; Kageyama, Daisuke			A Nightmare for Males? A Maternally Transmitted Male-Killing Bacterium and Strong Female Bias in a Green Lacewing Population	PLOS ONE			English	Article							SEX-RATIO; TRANSOVARIAL TRANSMISSION; SP-NOV; WOLBACHIA; DROSOPHILA; INFECTION; NEUROPTERA; ARTHROPODS; MECHANISMS; APHIDS	For maternally transmitted microbes, a female-biased host sex ratio is of reproductive advantage. Here we found a strong female bias in a field population of the green lacewing, Mallada desjardinsi (Insecta; Neuroptera). This bias was attributed to the predominance of individuals harboring a maternally inherited male-killing bacterium that was phylogenetically closely related to the plant-pathogenic Spiroplasma phoeniceum and Spiroplasma kunkelii. Among 35 laboratory-reared broods produced by wild-caught females, 21 broods (60%)-all infected with Spiroplasma-consisted of only females (940 individuals). Among 14 broods consisting of both males and females (516 and 635 individuals, respectively), 4 broods were doubly infected with Spiroplasma and Rickettsia, 6 broods were singly infected with Rickettsia, and 3 broods were uninfected (remaining one brood was unknown). Mortality during embryonic and larval development was prominent in all-female broods but not in normal sex ratio broods. Following antibiotic treatment on all-female broods, mortality was significantly reduced and the sex ratio was restored to 1:1. Strong expression and high prevalence of this male-killer is remarkable considering its low density (similar to 10(-5)-10(-4) cells per host mitochondrial gene copy based on quantitative PCR). In addition, a bacterium closely related to Rickettsia bellii was present in 25 of 34 broods (73.5%), irrespective of the sex ratio, with the infection density comparable to other cases of endosymbiosis (similar to 10(-2)-10(-1) cells per mitochondrial gene copy). Higher density of Rickettsia than Spiroplasma was also demonstrated by electron microscopy which visualized both Spiroplasma-like cells and Rickettsia-like cells inside and outside the ovarian cells.	[Hayashi, Masayuki; Nomura, Masashi] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Watanabe, Masaya; Yukuhiro, Fumiko; Kageyama, Daisuke] Natl Inst Agrobiol Sci, Insect Microbe Res Unit, 1-2 Owashi, Tsukuba, Ibaraki, Japan; [Watanabe, Masaya] DOT Int Co Ltd, Clin Operat Div, Chuo Ku, 3-22-13 Hatchobori, Tokyo, Japan	Chiba University; National Institute of Agrobiological Sciences - Japan	Kageyama, D (corresponding author), Natl Inst Agrobiol Sci, Insect Microbe Res Unit, 1-2 Owashi, Tsukuba, Ibaraki, Japan.	kagymad@affrc.go.jp	Kageyama, Daisuke/B-4460-2010	Kageyama, Daisuke/0000-0002-9026-9825; Hayashi, Masayuki/0000-0002-7461-1723	KAKENHI [25450492]; National Institute of Agrobiological Sciences; Chiba University	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute of Agrobiological Sciences; Chiba University	This work was financially supported by KAKENHI, a Grant-in-Aid for Scientific Research (https://www.jsps.go.jp/english/e-grants/), grant No. 25450492 for DK, and by internal grants from the National Institute of Agrobiological Sciences and Chiba University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Brumin M, 2012, APPL ENVIRON MICROB, V78, P5565, DOI 10.1128/AEM.01184-12; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Dunn AM, 2001, ADV PARASIT, V48, P57, DOI 10.1016/S0065-308X(01)48005-5; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayashi M, 2011, APPL ENTOMOL ZOOL, V46, P407, DOI 10.1007/s13355-011-0053-y; Herren JK, 2013, MBIO, V4, DOI 10.1128/mBio.00532-12; Hornett EA, 2006, PLOS BIOL, V4, P1643, DOI 10.1371/journal.pbio.0040283; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Jacob C, 1997, J BACTERIOL, V179, P4802, DOI 10.1128/jb.179.15.4802-4810.1997; Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; Kageyama D, 2004, P ROY SOC B-BIOL SCI, V271, P251, DOI 10.1098/rspb.2003.2604; Kageyama D, 2007, NATURWISSENSCHAFTEN, V94, P333, DOI 10.1007/s00114-006-0195-x; Kageyama Daisuke, 2012, Insects, V3, P161, DOI 10.3390/insects3010161; Kern P, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0095; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; McEwen PK., 2007, LACEWINGS CROP ENV; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Nakanishi K, 2008, P ROY SOC B-BIOL SCI, V275, P1249, DOI 10.1098/rspb.2008.0013; Narita S, 2007, FEMS MICROBIOL ECOL, V61, P235, DOI 10.1111/j.1574-6941.2007.00333.x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; R Development Core Team, 2005, R LANG ENV STAT COMP; Resh V. H., 2009, ENCY INSECTS; Reuter M, 2008, EVOLUTION, V62, P401, DOI 10.1111/j.1558-5646.2007.00300.x; Ryder JJ, 2014, AM NAT, V183, pE89, DOI 10.1086/674827; SAILLARD C, 1987, INT J SYST BACTERIOL, V37, P106, DOI 10.1099/00207713-37-2-106; Sakamoto H, 2007, GENOME, V50, P645, DOI 10.1139/G07-041; SCHALL R, 1991, BIOMETRIKA, V78, P719; Tabata J, 2011, MICROB ECOL, V61, P254, DOI 10.1007/s00248-010-9799-y; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; Watanabe K, 2014, P NATL ACAD SCI USA, V111, P7433, DOI 10.1073/pnas.1402476111; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; WHITCOMB RF, 1986, INT J SYST BACTERIOL, V36, P170, DOI 10.1099/00207713-36-2-170; Whitcomb RF, 1989, MYCOPLASMAS, VV; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149	41	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155794	10.1371/journal.pone.0155794	http://dx.doi.org/10.1371/journal.pone.0155794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304213	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800010
J	Hurtig, A; Sorqvist, P; Ljung, R; Hygge, S; Ronnberg, J				Hurtig, Anders; Sorqvist, Patrik; Ljung, Robert; Hygge, Staffan; Ronnberg, Jerker			Student's Second-Language Grade May Depend on Classroom Listening Position	PLOS ONE			English	Article							SPEECH-PERCEPTION; REVERBERATION; NOISE; COMPREHENSION; ADULTS	The purpose of this experiment was to explore whether listening positions (close or distant location from the sound source) in the classroom, and classroom reverberation, influence students' score on a test for second-language (L2) listening comprehension (i.e., comprehension of English in Swedish speaking participants). The listening comprehension test administered was part of a standardized national test of English used in the Swedish school system. A total of 125 high school pupils, 15 years old, participated. Listening position was manipulated within subjects, classroom reverberation between subjects. The results showed that L2 listening comprehension decreased as distance from the sound source increased. The effect of reverberation was qualified by the participants' baseline L2 proficiency. A shorter reverberation was beneficial to participants with high L2 proficiency, while the opposite pattern was found among the participants with low L2 proficiency. The results indicate that listening comprehension scores-and hence students' grade in English-may depend on students' classroom listening position.	[Hurtig, Anders; Sorqvist, Patrik; Ljung, Robert; Hygge, Staffan] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden; [Hurtig, Anders; Sorqvist, Patrik; Ronnberg, Jerker] Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden; [Hurtig, Anders] Univ Dalarna, Dept Educ Hlth & Social Sci, Falun, Sweden; [Ronnberg, Jerker] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	University of Gavle; Linkoping University; Dalarna University; Linkoping University	Hurtig, A (corresponding author), Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden.; Hurtig, A (corresponding author), Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden.; Hurtig, A (corresponding author), Univ Dalarna, Dept Educ Hlth & Social Sci, Falun, Sweden.	anders.hurtig@hig.se	Hurtig, Anders/GWD-0238-2022; Ronnberg, Jerker/AAW-5049-2021	Sorqvist, Patrik/0000-0002-7584-2275; Hygge, Staffan/0000-0003-4298-7459; Hurtig, Anders/0000-0002-2730-7200	Swedish Research Council [A0204201]; Swedish Research Council Formas [242-2010-1006]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Both the Swedish Research Council (PI: S Hygge - A0204201) and the Swedish Research Council Formas (PI: S Hygge - 242-2010-1006) contributed to the funding of this study.	[Anonymous], 2012, THEORY PRACTICE LANG, DOI [DOI 10.4304/TPLS.2.4.657-663, 10.4304/tpls.2.4.657-663]; Crandell C. C., 1996, ED AUDIOLOGY MONOGRA, V4; Crandell CC, 2000, LANG SPEECH HEAR SER, V31, P362, DOI 10.1044/0161-1461.3104.362; De Martino S, 2001, BRAIN COGNITION, V46, P104; DUKER S, 1965, ELEM SCHOOL J, V65, P321, DOI 10.1086/460227; Everest A. L., 2015, MASTER HDB ACOUSTICS; Hodgson M, 2002, J ACOUST SOC AM, V111, P931, DOI 10.1121/1.1428264; Hurtig A, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02029; Hygge S., 2015, FRONTIERS PSYC UNPUB; Kidd GR, 2007, J ACOUST SOC AM, V122, P418, DOI 10.1121/1.2743154; Kilman L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00651; Klatte M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00578; Klatte M, 2010, NOISE HEALTH, V12, P270, DOI 10.4103/1463-1741.70506; Ljung R., 2009, POOR LISTENING CONDI, DOI [10.1260/135101009789877031, DOI 10.1260/135101009789877031]; Ljung R, 2009, BUILD ACOUST, V16, P301, DOI 10.1260/135101009790291273; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; NABELEK AK, 1974, J SPEECH HEAR RES, V17, P724, DOI 10.1044/jshr.1704.724; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Sorqvist P, 2014, SCAND J PSYCHOL, V55, P91, DOI 10.1111/sjop.12115; Tabri D, 2011, INT J LANG COMM DIS, V46, P411, DOI 10.3109/13682822.2010.519372; Townsend D. J., 1987, COMPREHENDING ORAL W; Villarreal C., 1991, TEX SPEECH; WEBB WB, 1956, J APPL PSYCHOL, V40, P237, DOI 10.1037/h0047579	23	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156533	10.1371/journal.pone.0156533	http://dx.doi.org/10.1371/journal.pone.0156533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304980	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800016
J	Kilany, WH; Safwat, M; Mohammed, SM; Salim, A; Fasina, FO; Fasanmi, OG; Shalaby, AG; Dauphin, G; Hassan, MK; Lubroth, J; Jobre, YM				Kilany, Walid H.; Safwat, Marwa; Mohammed, Samy M.; Salim, Abdullah; Fasina, Folorunso Oludayo; Fasanmi, Olubunmi G.; Shalaby, Azhar G.; Dauphin, Gwenaelle; Hassan, Mohammed K.; Lubroth, Juan; Jobre, Yilma M.			Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; DISEASE VIRUS; MUSCOVY DUCKS; PEKIN DUCKS; VACCINATION; CHICKENS; CHALLENGE; IMMUNITY; POULTRY; VIETNAM	In Egypt, ducks kept for commercial purposes constitute the second highest poultry population, at 150 million ducks/year. Hence, ducks play an important role in the introduction and transmission of avian influenza (AI) in the Egyptian poultry population. Attempts to control outbreaks include the use of vaccines, which have varying levels of efficacy and failure. To date, the effects of vaccine efficacy has rarely been determined in ducks. In this study, we evaluated the protective efficacy of a live recombinant vector vaccine based on a turkey Herpes Virus (HVT) expressing the H5 gene from a clade 2.2 H5N1 HPAIV strain (A/Swan/Hungary/499/2006) (rHVT-H5) and a bivalent inactivated H5N1 vaccine prepared from clade 2.2.1 and 2.2.1.1 H5N1 seeds in Mulard ducks. A 0.3ml/dose subcutaneous injection of rHVT-H5 vaccine was administered to one-day-old ducklings (D1) and another 0.5ml/dose subcutaneous injection of the inactivated MEFLUVAC was administered at 7 days (D7). Four separate challenge experiments were conducted at Days 21, 28, 35 and 42, in which all the vaccinated ducks were challenged with 106EID50/duck of H5N1 HPAI virus (A/chicken/Egypt/128s/2012(H5N1) (clade 2.2.1) via intranasal inoculation. Maternal-derived antibody regression and post-vaccination antibody immune responses were monitored weekly. Ducks vaccinated at 21, 28, 35 and 42 days with the rHVT-H5 and MEFLUVAC vaccines were protected against mortality (80%, 80%, 90% and 90%) and (50%, 70%, 80% and 90%) respectively, against challenges with the H5N1 HPAI virus. The amount of viral shedding and shedding rates were lower in the rHVT-H5 vaccine groups than in the MEFLUVAC groups only in the first two challenge experiments. However, the non-vaccinated groups shed significantly more of the virus than the vaccinated groups. Both rHVT-H5 and MEFLUVAC provide early protection, and rHVT-H5 vaccine in particular provides protection against HPAI challenge.	[Kilany, Walid H.; Safwat, Marwa; Mohammed, Samy M.; Salim, Abdullah; Shalaby, Azhar G.; Hassan, Mohammed K.] Anim Hlth Res Inst, Reference Lab Vet Qual Control Poultry Prod NLQP, POB 264, Giza, Egypt; [Mohammed, Samy M.; Jobre, Yilma M.] ECTAD, Food & Agr Org United Nations FAO, POB 2223, Giza, Egypt; [Fasina, Folorunso Oludayo] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Private Bag X04, Onderstepoort, South Africa; [Fasanmi, Olubunmi G.] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Ibadan, Nigeria; [Fasanmi, Olubunmi G.] Fed Coll Anim Hlth & Prod Technol, Dept Anim Hlth, Ibadan, Nigeria; [Dauphin, Gwenaelle; Lubroth, Juan] FAO, Viale Terme di Caracalla, I-00153 Rome, Italy	Animal Health Research Institute (AHRI); Food & Agriculture Organization of the United Nations (FAO); University of Pretoria; Food & Agriculture Organization of the United Nations (FAO)	Kilany, WH (corresponding author), Anim Hlth Res Inst, Reference Lab Vet Qual Control Poultry Prod NLQP, POB 264, Giza, Egypt.; Fasina, FO (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Private Bag X04, Onderstepoort, South Africa.	WalidHamdy78@yahoo.com; daydupe2003@yahoo.co.uk	Fasina, Folorunso/B-6360-2015	Fasina, Folorunso/0000-0003-3088-8752; Kilany, Walid/0000-0002-4242-507X; Shalaby, azhar/0000-0003-4126-4734	United States Agency for International Development (USAID) [AID-263-IO-11-00001]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was supported by the United States Agency for International Development (USAID) under a grant (AID-263-IO-11-00001, Mod. #3) and within the framework of OSRO/EGY/101/USA, which applies to projects jointly implemented by the FAO, GOVS and NLQP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2011, VACCINE, V29, P6219, DOI 10.1016/j.vaccine.2011.06.090; Abdelwhab EM, 2011, EPIDEMIOL INFECT, V139, P647, DOI 10.1017/S0950268810003122; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; Arafa AS, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.13.21085; Boltz DA, 2009, ARCH VIROL, V154, P939, DOI 10.1007/s00705-009-0385-x; Cagle C, 2011, VACCINE, V29, P6549, DOI 10.1016/j.vaccine.2011.07.004; Cha RM, 2013, VACCINE, V31, P4953, DOI 10.1016/j.vaccine.2013.08.046; Chua Tze-Hoong, 2010, Influenza Res Treat, V2010, P489213, DOI 10.1155/2010/489213; De Vriese J, 2010, AVIAN DIS, V54, P246, DOI 10.1637/8908-043009-Reg.1; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; ElMasry I, 2017, TRANSBOUND EMERG DIS, V64, P805, DOI 10.1111/tbed.12440; Esaki M, 2010, P 59 W POULTR DIS C, P124; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Food and Agriculture Organisation of the United Nations (FAO), 2012, 5 FAO UN; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Guionie O, 2010, AVIAN DIS, V54, P538, DOI 10.1637/8790-040109-Reg.1; Handberg KJ, 2001, AVIAN PATHOL, V30, P243, DOI 10.1080/03079450120054659; Hassan MK, 2013, ARCH VIROL, V158, P1361, DOI 10.1007/s00705-012-1599-x; Hawkins P, 2011, LAB ANIM-UK, V45, P1, DOI 10.1258/la.2010.010031; Henning J, 2010, EMERG INFECT DIS, V16, P1244, DOI 10.3201/eid1608.091540; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kilany W.H., 2015, AVIAN PATHOL, P1; Kilany W, 2014, AVIAN PATHOL, V43, P514, DOI 10.1080/03079457.2014.966302; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Kim JK, 2010, P NATL ACAD SCI USA, V107, P11044, DOI 10.1073/pnas.1006419107; Liu QF, 2015, J VIROL, V89, P7401, DOI 10.1128/JVI.00031-15; Palya V, 2015, AVIAN DIS, DOI [10.1637/11129-050715, DOI 10.1637/11129-050715]; Pantin-Jackwood MJ, 2013, VIRUS RES, V178, P21, DOI 10.1016/j.virusres.2013.07.012; Peyre Marisa, 2009, J Mol Genet Med, V3, P198; Pfeiffer J, 2010, AVIAN DIS, V54, P262, DOI 10.1637/8715-031909-Reg.1; Rauw F, 2012, AVIAN DIS, V56, P913, DOI 10.1637/10172-041012-Reg.1; Rauw F, 2011, VACCINE, V29, P2590, DOI 10.1016/j.vaccine.2011.01.048; Sims LD, 2013, INFLUENZA OTHER RESP, V7, P15, DOI 10.1111/irv.12076; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steensels M, 2009, VACCINE, V27, P646, DOI 10.1016/j.vaccine.2008.11.044; Swayne DE, 2008, AVIAN INFLUENZA, P407; Szeredi L, 2010, ACTA VET HUNG, V58, P341, DOI 10.1556/AVet.58.2010.3.7; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; Wibawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083417; World Organisation for Animal Health (OIE), 2015, MANUAL OF DIAGNOSTIC	40	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156747	10.1371/journal.pone.0156747	http://dx.doi.org/10.1371/journal.pone.0156747			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304069	Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800020
J	Shi, LH; Kim, AJ; Chang, RCA; Chang, JYA; Ying, W; Ko, ML; Zhou, BY; Ko, GYP				Shi, Liheng; Kim, Andy Jeesu; Chang, Richard Cheng-An; Chang, Janet Ya-An; Ying, Wei; Ko, Michael L.; Zhou, Beiyan; Ko, Gladys Yi-Ping			Deletion of miR-150 Exacerbates Retinal Vascular Overgrowth in High-Fat-Diet Induced Diabetic Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; INDUCED INSULIN-RESISTANCE; ADIPOSE-TISSUE; C-MYB; OCULAR NEOVASCULARIZATION; CARDIOVASCULAR-DISEASE; CIRCULATING MICRORNAS; CELL DIFFERENTIATION; MACULAR DEGENERATION	Diabetic retinopathy (DR) is the leading cause of blindness among American adults above 40 years old. The vascular complication in DR is a major cause of visual impairment, making finding therapeutic targets to block pathological angiogenesis a primary goal for developing DR treatments. MicroRNAs (miRs) have been proposed as diagnostic biomarkers and potential therapeutic targets for various ocular diseases including DR. In diabetic animals, the expression levels of several miRs, including miR-150, are altered. The expression of miR-150 is significantly suppressed in pathological neovascularization in mice with hyperoxia-induced retinopathy. The purpose of this study was to investigate the functional role of miR-150 in the development of retinal microvasculature complications in high-fat-diet (HFD) induced type 2 diabetic mice. Wild type (WT) and miR-150 null mutant (miR-150(-/-)) male mice were given a HFD (59% fat calories) or normal chow diet. Chronic HFD caused a decrease of serum miR-150 in WT mice. Mice on HFD for 7 months (both WT and miR-150-/-) had significant decreases in retinal light responses measured by electroretinograms (ERGs). The retinal neovascularization in miR-150(-/-)-HFD mice was significantly higher compared to their age matched WT-HFD mice, which indicates that miR-150 null mutation exacerbates chronic HFD-induced neovascularization in the retina. Overexpression of miR-150 in cultured endothelial cells caused a significant reduction of vascular endothelial growth factor receptor 2 (VEGFR2) protein levels. Hence, deletion of miR-150 significantly increased the retinal pathological angiogenesis in HFD induced type 2 diabetic mice, which was in part through VEGFR2.	[Shi, Liheng; Kim, Andy Jeesu; Chang, Janet Ya-An; Ko, Michael L.; Ko, Gladys Yi-Ping] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Chang, Richard Cheng-An; Ying, Wei; Zhou, Beiyan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Zhou, Beiyan] Univ Connecticut, Ctr Hlth, Sch Med, Dept Immunol, Farmington, CT USA; [Ko, Gladys Yi-Ping] Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Connecticut; Texas A&M University System; Texas A&M University College Station	Ko, GYP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.; Ko, GYP (corresponding author), Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA.	gko@cvm.tamu.edu	Ying, Wei/N-5157-2016; Kim, Andy Jeesu/AAQ-4448-2021	Kim, Andy Jeesu/0000-0003-1124-0213; Zhou, Beiyan/0000-0003-0638-2428	American Diabetes Association [1-13-JF-59]; National Institute of Diabetes and Digestive and Kidney Diseases of National Institutes of Health (NIH) [NIHR01DK098662]; National Eye Institute of NIH [NIHR01EY017452, NIHR21EY023339, NIH-R21EY023339]; NATIONAL EYE INSTITUTE [R21EY023339, R01EY017452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098662] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institute of Diabetes and Digestive and Kidney Diseases of National Institutes of Health (NIH); National Eye Institute of NIH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by 1-13-JF-59 from the American Diabetes Association and NIHR01DK098662 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to BZ, and NIHR01EY017452 and NIHR21EY023339 from the National Eye Institute of NIH to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by 1-13-JF-59 from the American Diabetes Association and NIHR01DK098662 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to B. Zhou, and NIHR01EY017452 and NIH-R21EY023339 from the National Eye Institute of the NIH to G. Ko.	Ahren B, 1997, METABOLISM, V46, P97, DOI 10.1016/S0026-0495(97)90175-X; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Alvarez Y, 2010, DIS MODEL MECH, V3, P236, DOI 10.1242/dmm.003772; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; Binder S, 2012, BRIT J OPHTHALMOL, V96, P1, DOI 10.1136/bjophthalmol-2011-301236; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Bousquet M, 2013, MOL CANCER RES, V11, P912, DOI 10.1158/1541-7786.MCR-13-0002-T; Chang RCA, 2015, INVEST OPHTH VIS SCI, V56, P2367, DOI 10.1167/iovs.14-16143; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chen GQ, 2012, MOL MED REP, V5, P1362, DOI 10.3892/mmr.2012.824; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Chou JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50489; Conte I, 2015, P NATL ACAD SCI USA, V112, pE3236, DOI 10.1073/pnas.1401464112; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Dai G, 2006, GENES CELLS, V11, P859, DOI 10.1111/j.1365-2443.2006.00985.x; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; Eghoj MS, 2012, BRIT J OPHTHALMOL, V96, P21, DOI 10.1136/bjo.2011.203893; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Freund KB, 2013, EXPERT OPIN PHARMACO, V14, P1017, DOI 10.1517/14656566.2013.787410; Gallemore R.P., 2008, REV OPHTHALMOLOGY; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ishida M, 2012, CIRC RES, V110, P253, DOI 10.1161/CIRCRESAHA.111.259499; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Liu CH, 2015, P NATL ACAD SCI USA, V112, P12163, DOI 10.1073/pnas.1508426112; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Lux A, 2007, BRIT J OPHTHALMOL, V91, P1318, DOI 10.1136/bjo.2006.113902; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Narasaraju T, 2015, AM J RESP CELL MOL, V52, P253, DOI 10.1165/rcmb.2013-0021OC; NEWMAN EA, 1984, J NEUROPHYSIOL, V51, P164, DOI 10.1152/jn.1984.51.1.164; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palejwala NV, 2014, DRUG TODAY, V50, P779, DOI 10.1358/dot.2014.50.12.2245587; Park JH, 2011, MOL CELLS, V31, P33, DOI 10.1007/s10059-011-0009-7; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Prakhar P, 2015, J BIOL CHEM, V290, P26576, DOI 10.1074/jbc.M115.662817; Rajagopal R, 2016, DIABETES; Rodriguez-Lebron E, 2013, NEUROBIOL DIS, V54, P456, DOI 10.1016/j.nbd.2013.01.019; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Schulte C, 2015, CARDIOVASC DIAGN THE, V5, P17, DOI 10.3978/j.issn.2223-3652.2014.12.03; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Stahlhut C, 2013, GENOME MED, V5, DOI 10.1186/gm516; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tang YP, 2015, CARDIOVASC RES, V106, P387, DOI 10.1093/cvr/cvv121; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; VINORES SA, 1988, EXP EYE RES, V46, P545, DOI 10.1016/S0014-4835(88)80011-3; WACHTMEISTER L, 1987, DOC OPHTHALMOL, V66, P187, DOI 10.1007/BF00145232; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Witkin AJ, 2011, CURR OPIN OPHTHALMOL, V22, P185, DOI 10.1097/ICU.0b013e3283459724; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Ying W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20176; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	73	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157543	10.1371/journal.pone.0157543	http://dx.doi.org/10.1371/journal.pone.0157543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304911	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800070
J	Wilson, PK; Moore, JR				Wilson, Paige K.; Moore, Jason R.			Assessing the Control of Preservational Environment on Taphonomic and Ecological Patterns in an Oligocene Mammal Fauna from Badlands National Park, South Dakota	PLOS ONE			English	Article							BONE ASSEMBLAGE; FOSSIL; BIODIVERSITY; ABUNDANCES	Comparisons of paleofaunas from different facies are often hampered by the uncertainty in the variation of taphonomic processes biasing the paleoecological parameters of interest. By examining the taphonomic patterns exhibited by different facies in the same stratigraphic interval and area, it is possible to quantify this variation, and assess inter-facies comparability. The fossil assemblages preserved in Badlands National Park (BNP), South Dakota, have long been a rich source for mammalian faunas of the White River Group. To investigate the influence of the variation of taphonomic bias with lithology whilst controlling for the influence of changes in patterns of taphonomic modification with time, taphonomic and paleoecological data were collected from four mammal-dominated fossil assemblages (two siltstone hosted and two sandstone hosted) from a narrow stratigraphic interval within the Oligocene Poleslide Member of the Brule Formation, in the Palmer Creek Unit of BNP. Previous work in the region confirmed that the two major lithologies represent primarily aeolian- and primarily fluvial-dominated depositional environments, respectively. A suite of quantifiable taphonomic and ecological variables was recorded for each of the more than 800 vertebrate specimens studied here (857 specimens were studied in the field, 9 specimens were collected and are reposited at BNP). Distinctly different patterns of taphonomic biasing were observed between the aeolian and fluvial samples, albeit with some variability between all four sites. Fluvial samples were more heavily weathered and abraded, but also contained fewer large taxa and fewer tooth-bearing elements. No quantifiable paleofaunal differences in generic richness or evenness were observed between the respective facies. This suggests that while large vertebrate taxonomic composition in the region did vary with paleodepositional environment, there is no evidence of confounding variation in faunal structure, and therefore differences between the assemblages are attributed to differing preservational environments producing a taphonomic overprint on the assemblages. The lack of apparent taphonomic bias on paleofaunal structure suggests that such paleoecological data can be compared throughout the Poleslide Member, irrespective of lithology.	[Wilson, Paige K.; Moore, Jason R.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; [Wilson, Paige K.] Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA	Dartmouth College; University of New Mexico	Wilson, PK (corresponding author), Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA.; Wilson, PK (corresponding author), Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA.	Paige.K.Wilson.14@dartmouth.edu			John Lindsley Fund	John Lindsley Fund	Supporting funding for the fieldwork and data collection in this research was provided through the John Lindsley Fund, distributed by the Dartmouth College Office of Undergraduate Advising and Research, in 2011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 2003, B NATURAL HIST MUSEU, V58, P59, DOI DOI 10.1017/5096804620300010X; BADGLEY C, 1986, Palaios, V1, P328, DOI 10.2307/3514695; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Behrensmeyer Anna K., 2012, P69; Best MMR, 2000, PALEOBIOLOGY, V26, P80, DOI 10.1666/0094-8373(2000)026<0080:BTITMS>2.0.CO;2; Binford L. R., 1977, THEORY BUILDING ARCH; Binford LR., 1984, FAUNAL REMAINS KLASI; Blob RW, 1996, PALEOBIOLOGY, V22, P422, DOI 10.1017/S0094837300016377; Boaz NT., 2000, ACTA ANTHR SINICA, V19, P224; BRETT C E, 1986, Palaios, V1, P207, DOI 10.2307/3514686; Buckland W, 1823, RELIQUIAE DILUVIANAE; BUMP JD, 1956, AM J SCI, V254, P429, DOI 10.2475/ajs.254.7.429; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlson KJ, 2003, J HUM EVOL, V44, P431, DOI 10.1016/S0047-2484(03)00025-3; Clark J, 1967, OLIGOCENE SEDIMENTAT; Connolly J. P., 1947, National Geographic Magazine Washington, V91, P589; COOK E, 1995, PALAEOGEOGR PALAEOCL, V116, P263, DOI 10.1016/0031-0182(94)00101-D; Dewar EW, 2008, DIETARY ECOLOGY COMM; Efremov IA, 1940, PAN AM GEOLOGIST, V74, P81; Evanoff E, 2010, FIELD GUIDE GEOLOGY, P1; Faith JT, 2006, J ARCHAEOL SCI, V33, P1718, DOI 10.1016/j.jas.2006.03.004; Fiorillo A.R., 1988, ROCKY MT GEOL, V26, P57; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P245, DOI 10.1017/S0094837300012719; Gislason SR, 2011, P NATL ACAD SCI USA, V108, P7307, DOI 10.1073/pnas.1015053108; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Interior USDot, 2008, BADL NAT PARK GEOL R; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; LYMAN RL, 1989, J ARCHAEOL SCI, V16, P293, DOI 10.1016/0305-4403(89)90007-1; Margalef R., 1958, GEN SYST, V3, P36, DOI DOI 10.1016/S0097-8485(01)00073-0; Moore JR, 2007, PALAEOGEOGR PALAEOCL, V253, P317, DOI 10.1016/j.palaeo.2007.06.004; Moore JR, 2009, PALAIOS, V24, P591, DOI 10.2110/palo.2008.p08-135r; Moore JR, 2012, PALAIOS, V27, P220, DOI 10.2110/palo.2011.p11-096r; Oksanen J, 2022, R PACKAGE VERSION; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Prothero D.R., 1994, EOCENE OLIGOCENE TRA; Prothero Donald R., 2004, P156; R Core Team, 2013, R LANG ENV STAT COMP; Scherer R, 2013, BIOMETRICAL J, V55, P246, DOI 10.1002/bimj.201200157; Scherer Ralph, 2014, SIMBOOT SIMULTANEOUS; Scott WB, 1937, MAMMALIAN FAUNA WHIT; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shipman P., 1988, SCANNING ELECT MICRO, ppp. 303; Sokal RR, 1995, BIOMETRY; SPEYER S E, 1986, Palaios, V1, P312, DOI 10.2307/3514694; TERRY DO, 1994, PALAEOGEOGR PALAEOCL, V110, P197, DOI 10.1016/0031-0182(94)90084-1; Voorhies MR, 1969, TAPHONOMY POPULATION; Yesares-Garcia J, 2004, PALAEOGEOGR PALAEOCL, V207, P83, DOI 10.1016/j.palaeo.2004.02.002	51	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157585	10.1371/journal.pone.0157585	http://dx.doi.org/10.1371/journal.pone.0157585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303807	Green Submitted, gold, Green Published			2022-12-26	WOS:000377824800074
J	Kuai, J; Sun, YY; Liu, TT; Zhang, PP; Zhou, M; Wu, JS; Zhou, GS				Kuai, Jie; Sun, Yingying; Liu, Tingting; Zhang, Peipei; Zhou, Min; Wu, Jiangsheng; Zhou, Guangsheng			Physiological Mechanisms behind Differences in Pod Shattering Resistance in Rapeseed (Brassica napus L.) Varieties	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; OILSEED RAPE; LODGING RESISTANCE; BIOSYNTHESIS; ALUMINUM; PROLINE; STRESS; GROWTH; LINES; YIELD	Pod shattering resistance index (SRI) is a key factor affecting the mechanical harvesting of rapeseed. Research on the differences in pod shattering resistance levels of various rapeseed varieties can provide a theoretical basis for varietal breeding and application in mechanical harvesting. The indicators on pod shattering resistance including pod morphology and wall components were evaluated on eight hybrids and open pollinators, respectively, during 2012-2014. The results showed the following: (1) From the current study, SRI varied greatly with variety, and conventional varieties had stronger resistance than hybrid according to the physiological indexes. and (2) Under the experimental conditions, the SRI was linearly related to pod wall weight and the water content in pod walls, and the goodness-of-fit measurements for the regression model of the SRI based on pod wall weight and water content were 0.584** and 0.377*, respectively, reaching the significant level. This illustrated that pod wall weight and the water content in pod walls determined the SRI. (3) Compared with the relative contents of biochemical components in pod walls, the contents of particular biochemical components in pod walls had closer correlations with SRI. Among the biochemical components, the hemicellulose content was the decisive factor for the SRI.	[Kuai, Jie; Sun, Yingying; Liu, Tingting; Zhang, Peipei; Zhou, Min; Wu, Jiangsheng; Zhou, Guangsheng] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China	Huazhong Agricultural University	Zhou, GS (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China.	zhougs@mail.hzau.edu.cn			National Key Technology Research and Development Program [2014BAD11B03]; Industry Technology Research Institute [CARS-13]; Special Funds for Public Welfare Industry (Agriculture) Study of China [201203096]; Fundamental Research Funds for the Central Universities [2013PY001, 2015BQ001]	National Key Technology Research and Development Program(National Key Technology R&D Program); Industry Technology Research Institute; Special Funds for Public Welfare Industry (Agriculture) Study of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded by the National Key Technology Research and Development Program (2014BAD11B03), the Industry Technology Research Institute (CARS-13), the Special Funds for Public Welfare Industry (Agriculture) Study of China (201203096) and the Fundamental Research Funds for the Central Universities (2013PY001; 2015BQ001).	Agrawal AP, 2002, CURR SCI INDIA, V82, P58; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Bennett EJ, 2011, NEW PHYTOL, V190, P838, DOI 10.1111/j.1469-8137.2011.03714.x; Berry PM, 2003, J AGRON CROP SCI, V189, P390, DOI 10.1046/j.0931-2250.2003.00062.x; Cavalieri A, 2014, CROP SCI, V54, P1184, DOI 10.2135/cropsci2013.09.0624; CHHABRA K S, 1990, Indian Journal of Entomology, V52, P423; Child RD, 1998, J EXP BOT, V49, P829, DOI 10.1093/jexbot/49.322.829; Child RD, 2003, J EXP BOT, V54, P1919, DOI 10.1093/jxb/erg209; Dickson TJ, 2014, GROWING SEASON WEATH; Gan Y, 2008, CAN J PLANT SCI, V88, P267, DOI 10.4141/CJPS07028; Giannakoula A, 2008, J PLANT PHYSIOL, V165, P385, DOI 10.1016/j.jplph.2007.01.014; Grant WF, 1996, CAN J PLANT SCI, V76, P447, DOI 10.4141/cjps96-079; JOSEFSSON E, 1968, Z PFLANZENZUCHTUNG, V59, P384; Khan AA, 2000, J PLANT NUTR, V23, P1303, DOI 10.1080/01904160009382101; Kuai J, 2015, FIELD CROP RES, V180, P10, DOI 10.1016/j.fcr.2015.05.004; Liu YH, 2012, ANN BOT-LONDON, V109, P1277, DOI 10.1093/aob/mcs060; MEAKIN PJ, 1990, J EXP BOT, V41, P1003, DOI 10.1093/jxb/41.8.1003; METCALFE D. S., 1957, AGRON JOUR, V49, P130; Mongkolporn O, 2003, PLANT BREEDING, V122, P479, DOI 10.1046/j.0179-9541.2003.00910.x; Morgan CL, 1998, FIELD CROP RES, V58, P153, DOI 10.1016/S0378-4290(98)00099-9; Morgan CL, 2000, J AGR SCI, V135, P347, DOI 10.1017/S0021859699008424; OOKAWA T, 1993, JPN J CROP SCI, V62, P378, DOI 10.1626/jcs.62.378; Pan LG, 2012, BIOMASS BIOENERG, V46, P453, DOI 10.1016/j.biombioe.2012.07.014; Summers JE, 2003, J AGR SCI, V140, P43, DOI 10.1017/S002185960200285X; Tripathi SC, 2003, FIELD CROP RES, V84, P271, DOI 10.1016/S0378-4290(03)00095-9; [王汉中 WANG Hanzhong], 2007, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V29, P101; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Wu ZL, 2014, BIOMASS BIOENERG, V70, P347, DOI 10.1016/j.biombioe.2014.08.025; Yin Y, 2010, J AGR SCI TECH, V12, P16, DOI DOI 10.3969/J.ISSN.1008-0864.2010.03.03; Zuo QingSong, 2014, Acta Agronomica Sinica, V40, P650	30	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157341	10.1371/journal.pone.0157341	http://dx.doi.org/10.1371/journal.pone.0157341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299997	gold, Green Submitted, Green Published			2022-12-26	WOS:000377822200038
J	Li, YF; Wu, Q; Li, C; Liu, L; Du, K; Shen, J; Wu, YQ; Zhao, XF; Zhao, M; Bao, LY; Gao, J; Keep, RF; Xiang, JM				Li, Yangfang; Wu, Qian; Li, Chen; Liu, Ling; Du, Kun; Shen, Jin; Wu, Yuqin; Zhao, Xiaofen; Zhao, Mei; Bao, Lingyun; Gao, Jin; Keep, Richard F.; Xiang, Jianming			Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; RESISTANCE PROTEIN; ABC TRANSPORTERS; MULTIDRUG TRANSPORTER; INHIBITORS; MODEL; CNS; ACCUMULATION; MECHANISM; TARGETS	While the blood-brain barrier (BBB) protects the brain by controlling the access of solutes and toxic substances to brain, it also limits drug entry to treat central nervous system disorders. Many drugs are substrates for ATP-binding cassette (ABC) transporters at the BBB that limit their entry into the brain. The role of those transporters in limiting the entry of the widely prescribed therapeutic, benzylpenicillin, has produced conflicting results. This study investigated the possible potential involvement of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), two ABC transporters, in benzylpenicillin transport at BBB in human using MDCKII cells overexpressing those transporters as well as pharmacological inhibition. MDCKII cells overexpressing human BCRP (MDCKII-BCRP) but not those overexpressing human P-gp (MDCKII-MDR cells) had reduced [H-3]benzylpenicillin uptake. Similarly, inhibiting BCRP increased [H-3]benzylpenicillin uptake in MDCKII-BCRP cells, while inhibiting P-gp in MDCKII-MDR cells had no effect on uptake although there was evidence that benzylpenicillin is a substrate for canine P-gp. While inhibiting BCRP affected [H-3]benzylpenicillin cell concentrations it did not affect transepithelial flux in MDCKII-BCRP cells. In summary, the results indicate that human BCRP and not human P-gp is involved in benzylpenicillin transport. However, targeting BCRP alone was not sufficient to alter transepithelial flux in MDCKII cells. Whether it would be sufficient to alter blood-to-brain flux at the human BBB remains to be investigated.	[Li, Yangfang; Wu, Qian; Liu, Ling; Du, Kun; Shen, Jin; Wu, Yuqin; Zhao, Xiaofen; Zhao, Mei; Bao, Lingyun; Gao, Jin] Kunming Childrens Hosp, Dept Neonate, Kunming, Peoples R China; [Li, Chen; Keep, Richard F.; Xiang, Jianming] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Xiang, JM (corresponding author), Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA.	jmxxdrnx@umich.edu		Keep, Richard/0000-0001-6441-5334	Key Projects of Kunming Science and Technology Bureau [2013-04-01-A-S-0204018]; Department of Neurosurgery, University of Michigan Medical School	Key Projects of Kunming Science and Technology Bureau; Department of Neurosurgery, University of Michigan Medical School	Key Projects of Kunming Science and Technology Bureau grant 2013-04-01-A-S-0204018, YL, by Motor City Golf Classic grant from the Department of Neurosurgery, University of Michigan Medical School, JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baltes S, 2007, NEUROPHARMACOLOGY, V52, P333, DOI 10.1016/j.neuropharm.2006.07.038; Banks WA, 2016, NAT REV DRUG DISCOV, V22, P21; Banks WA, 2012, ENDOCRINOLOGY, V153, P4111, DOI 10.1210/en.2012-1435; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Choi MK, 2009, XENOBIOTICA, V39, P171, DOI 10.1080/00498250802642256; Durmus S, 2013, PHARMACOL RES, V76, P9, DOI 10.1016/j.phrs.2013.06.009; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hartz AMS, 2010, MOL INTERV, V10, P293, DOI 10.1124/mi.10.5.6; Iorio AL, 2015, ANTICANCER AGENTS ME, DOI [10.2174/, DOI 10.2174/]; Kikuchi R, 2003, J PHARMACOL EXP THER, V306, P51, DOI 10.1124/jpet.103.049197; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Kuteykin-Teplyakov K, 2010, BRIT J PHARMACOL, V160, P1453, DOI 10.1111/j.1476-5381.2010.00801.x; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Miller DS, 2015, ADV CANCER RES, V125, P43, DOI 10.1016/bs.acr.2014.10.002; Montenegro L, 2012, J NANOSCI NANOTECHNO, V12, P330, DOI 10.1166/jnn.2012.5174; NORRBY SR, 1986, REV INFECT DIS, V8, pS358; Pardridge WM, 2015, EXPERT OPIN THER TAR, V19, P1059, DOI 10.1517/14728222.2015.1042364; Poelarends GJ, 2000, DRUG RESIST UPDATE, V3, P330, DOI 10.1054/drup.2000.0173; Ramos S R, 1992, Arq Neuropsiquiatr, V50, P289; Roberts JA, 2009, CRIT CARE MED, V37, P2071, DOI 10.1097/CCM.0b013e3181a0054d; Rousselle C, 2002, J DRUG TARGET, V10, P309, DOI 10.1080/10611860290031886; SCHLIAMSER SE, 1991, J ANTIMICROB CHEMOTH, V27, P405, DOI 10.1093/jac/27.4.405; Seelig A, 1998, INT J CLIN PHARM TH, V36, P50; Shen SS, 2010, REV NEUROSCIENCE, V21, P29; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Sindac JA, 2013, J MED CHEM, V56, P9222, DOI 10.1021/jm401330r; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Tajes M, 2014, MOL MEMBR BIOL, V31, P152, DOI 10.3109/09687688.2014.937468; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; Westover D, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0275-x; Xiang JM, 2012, AM J PHYSIOL-REG I, V303, pR1, DOI 10.1152/ajpregu.00518.2011; Xiang JM, 2006, NEUROSCI LETT, V396, P225, DOI 10.1016/j.neulet.2005.11.037; Zhu Min-Li, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P910; Zolnerciks JK, 2011, J PHARM SCI-US, V100, P3055, DOI 10.1002/jps.22566	38	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157576	10.1371/journal.pone.0157576	http://dx.doi.org/10.1371/journal.pone.0157576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300692	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200062
J	Ware, C; Trites, AW; Rosen, DAS; Potvin, J				Ware, Colin; Trites, Andrew W.; Rosen, David A. S.; Potvin, Jean			Averaged Propulsive Body Acceleration (APBA) Can Be Calculated from Biologging Tags That Incorporate Gyroscopes and Accelerometers to Estimate Swimming Speed, Hydrodynamic Drag and Energy Expenditure for Steller Sea Lions	PLOS ONE			English	Article							MARINE MAMMALS; DIVING METABOLISM; KINEMATICS; BUOYANCY; MOVEMENTS; ANIMALS; DIVES	Forces due to propulsion should approximate forces due to hydrodynamic drag for animals horizontally swimming at a constant speed with negligible buoyancy forces. Propulsive forces should also correlate with energy expenditures associated with locomotion-an important cost of foraging. As such, biologging tags containing accelerometers are being used to generate proxies for animal energy expenditures despite being unable to distinguish rotational movements from linear movements. However, recent miniaturizations of gyroscopes offer the possibility of resolving this shortcoming and obtaining better estimates of body accelerations of swimming animals. We derived accelerations using gyroscope data for swimming Steller sea lions (Eumetopias jubatus), and determined how well the measured accelerations correlated with actual swimming speeds and with theoretical drag. We also compared dive averaged dynamic body acceleration estimates that incorporate gyroscope data, with the widely used Overall Dynamic Body Acceleration (ODBA) metric, which does not use gyroscope data. Four Steller sea lions equipped with biologging tags were trained to swim alongside a boat cruising at steady speeds in the range of 4 to 10 kph. At each speed, and for each dive, we computed a measure called Gyro-Informed Dynamic Acceleration (GIDA) using a method incorporating gyroscope data with accelerometer data. We derived a new metric-Averaged Propulsive Body Acceleration (APBA), which is the average gain in speed per flipper stroke divided by mean stroke cycle duration. Our results show that the gyro-based measure (APBA) is a better predictor of speed than ODBA. We also found that APBA can estimate average thrust production during a single stroke-glide cycle, and can be used to estimate energy expended during swimming. The gyroscope-derived methods we describe should be generally applicable in swimming animals where propulsive accelerations can be clearly identified in the signal-and they should also prove useful for dead-reckoning and improving estimates of energy expenditures from locomotion.	[Ware, Colin] Univ New Hampshire, Ctr Coastal & Ocean Mapping, Durham, NH 03824 USA; [Trites, Andrew W.; Rosen, David A. S.] Univ British Columbia, Marine Mammal Res Unit, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada; [Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA	University System Of New Hampshire; University of New Hampshire; University of British Columbia; Saint Louis University	Ware, C (corresponding author), Univ New Hampshire, Ctr Coastal & Ocean Mapping, Durham, NH 03824 USA.	cware@ccom.unh.edu		Trites, Andrew/0000-0003-0342-5322; Ware, Colin/0000-0002-4616-5017	Vancouver Aquarium through the North Pacific Marine Science Foundation; National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation; North Pacific Universities Marine Mammal Research Consortium; NOAA [NA05NOS4001153]; ONR [N000141410395]; US Office of Naval Research	Vancouver Aquarium through the North Pacific Marine Science Foundation; National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation; North Pacific Universities Marine Mammal Research Consortium; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); ONR(Office of Naval Research); US Office of Naval Research(Office of Naval Research)	Financial support was provided by the Vancouver Aquarium and The National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation and the North Pacific Universities Marine Mammal Research Consortium. Funding for the UNH effort was provided by NOAA grant NA05NOS4001153 and ONR grant N000141410395.; We wish to acknowledge the essential role played by the UBC Open Water Research Station, including the technicians and Vancouver Aquarium trainers. This study was supported in part by The National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation and the North Pacific Universities Marine Mammal Research Consortium. Additional funding was provided by the US Office of Naval Research. All research protocols were approved by the UBC Animal Care Committee.	CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cheneval O, 2007, MAR MAMMAL SCI, V23, P94, DOI 10.1111/j.1748-7692.2006.00094.x; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Dole C. E., 1981, FLIGHT THEORY AERODY; ENGLISH AW, 1976, J ZOOL, V178, P341; Euston M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P340, DOI 10.1109/IROS.2008.4650766; Fahlman A, 2008, AQUAT BIOL, V3, P147, DOI 10.3354/ab00074; Fahlman A, 2008, AQUAT BIOL, V2, P75, DOI 10.3354/ab00039; FELDKAMP SD, 1987, J ZOOL, V212, P43, DOI 10.1111/j.1469-7998.1987.tb05113.x; FELDKAMP SD, 1987, J EXP BIOL, V131, P117; Fish FE, 2003, J EXP BIOL, V206, P667, DOI 10.1242/jeb.00144; Fish FE, 1998, J EXP BIOL, V201, P2867; FISH FE, 1993, J EXP BIOL, V185, P179; FISH FE, 1988, J EXP BIOL, V137, P157; Fourati H, 2013, NOVEL MICROELECTRONI, P324; Fourati H, 2011, BIOMED SIGNAL PROCES, V6, P94, DOI 10.1016/j.bspc.2010.06.004; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Hertel H., 1966, STRUCTURE FORM MOVEM; Hindle AG, 2010, AQUAT BIOL, V10, P139, DOI 10.3354/ab00279; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; KOOYMAN GL, 1989, ZOOPHYSIOLOGY SERIES, V23; Luinge HJ, 2005, MED BIOL ENG COMPUT, V43, P273, DOI 10.1007/BF02345966; Lopez LMM, 2015, J EXP BIOL, V218, P1325, DOI 10.1242/jeb.106013; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Noda T, 2014, J EXP MAR BIOL ECOL, V451, P55, DOI 10.1016/j.jembe.2013.10.031; Noda T, 2012, AQUAT BIOL, V16, P265, DOI 10.3354/ab00448; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Shoemake K., 1985, ACM SIGGRAPH COMPUTE, V19, P245, DOI DOI 10.1145/325165.325242; Stelle LL, 2000, J EXP BIOL, V203, P1915; Tanaka H, 2001, J EXP BIOL, V204, P3895; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Webb PW, 2010, INTEGR COMP BIOL, V50, P1155, DOI 10.1093/icb/icq020; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Williams TM., 1987, APPROACHES MARINE MA, P127; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; WILSON RP, 1988, MEERESFORSCHUNG, V32, P155	44	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157326	10.1371/journal.pone.0157326	http://dx.doi.org/10.1371/journal.pone.0157326			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285467	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000057
J	Gadeberg, HC; Bond, RC; Kong, CHT; Chanoit, GP; Ascione, R; Cannell, MB; James, AF				Gadeberg, Hanne C.; Bond, Richard C.; Kong, Cherrie H. T.; Chanoit, Guillaume P.; Ascione, Raimondo; Cannell, Mark B.; James, Andrew F.			Heterogeneity of T-Tubules in Pig Hearts	PLOS ONE			English	Article							RAT ATRIAL MYOCYTES; VENTRICULAR MYOCYTES; CA2+ RELEASE; TRANSVERSE TUBULES; CONTRACTION; MYOCARDIUM; CELLS; SYSTEM; ULTRASTRUCTURE; MUSCLE	Background T-tubules are invaginations of the sarcolemma that play a key role in excitation-contraction coupling in mammalian cardiac myocytes. Although t-tubules were generally considered to be effectively absent in atrial myocytes, recent studies on atrial cells from larger mammals suggest that t-tubules may be more numerous than previously supposed. However, the degree of heterogeneity between cardiomyocytes in the extent of the t-tubule network remains unclear. The aim of the present study was to investigate the t-tubule network of pig atrial myocytes in comparison with ventricular tissue. Methods Cardiac tissue was obtained from young female Landrace White pigs (45-75 kg, 5-6 months old). Cardiomyocytes were isolated by arterial perfusion with a collagenase-containing solution. Ca2+ transients were examined in field-stimulated isolated cells loaded with fluo-4-AM. Membranes of isolated cells were visualized using di-8-ANEPPS. T-tubules were visualized in fixed-frozen tissue sections stained with Alexa-Fluor 488-conjugated WGA. Binary images were obtained by application of a threshold and t-tubule density (TTD) calculated. A distance mapping approach was used to calculate half-distance to nearest t-tubule (HDTT). Results & Conclusion The spatio-temporal properties of the Ca2+ transient appeared to be consistent with the absence of functional t-tubules in isolated atrial myocytes. However, t-tubules could be identified in a sub-population of atrial cells in frozen sections. While all ventricular myocytes had TTD >3% (mean TTD = 6.94 +/- 0.395%, n = 24), this was true of just 5/22 atrial cells. Mean atrial TTD (2.35 +/- 0.457%, n = 22) was lower than ventricular TTD (P<0.0001). TTD correlated with cell-width (r = 0.7756, n = 46, P<0.0001). HDTT was significantly greater in the atrial cells with TTD <= 3% (2.29 +/- 0.16 mu m, n = 17) than in either ventricular cells (1.33 +/- 0.05 mu m, n = 24, P<0.0001) or in atrial cells with TTD >3% (1.65 +/- 0.06 mu m, n = 5, P<0.05). These data demonstrate considerable heterogeneity between pig cardiomyocytes in the extent of t-tubule network, which correlated with cell size.	[Gadeberg, Hanne C.; Bond, Richard C.; Kong, Cherrie H. T.; Cannell, Mark B.; James, Andrew F.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol Cardiovasc, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England; [Chanoit, Guillaume P.] Univ Bristol, Sch Vet Sci, Langford House, Langford BS40 5DU, England; [Ascione, Raimondo] Univ Bristol, Sch Clin Sci, Bristol Royal Infirm, Upper Maudlin St, Bristol BS2 8HW, Avon, England	University of Bristol; University of Bristol; Bristol Royal Infirmary; University of Bristol	Cannell, MB; James, AF (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol Cardiovasc, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England.	mark.cannell@bristol.ac.uk; a.james@bristol.ac.uk	Chanoit, Guillaume P/GSD-3137-2022; Chanoit, Guillaume/AAC-4836-2022; Chanoit, Guillaume PA/T-3702-2017	Chanoit, Guillaume/0000-0002-7414-6403; Chanoit, Guillaume PA/0000-0002-7414-6403	British Heart Foundation [RG/12/10/29802]; British Heart Foundation Clinical Research Training Fellowship [FS/10/68/28492]; British Heart Foundation [PG/14/65/31055, PG/10/40/28369, FS/10/68/28492] Funding Source: researchfish; Medical Research Council [MR/L012723/1] Funding Source: researchfish; MRC [MR/L012723/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation Clinical Research Training Fellowship; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the British Heart Foundation Programme grant RG/12/10/29802, CHTK MBC AFJ, and British Heart Foundation Clinical Research Training Fellowship FS/10/68/28492, RCB AFJ.	AYETTEY AS, 1978, J ANAT, V127, P125; BERLIN JR, 1995, AM J PHYSIOL-HEART C, V269, pH1165, DOI 10.1152/ajpheart.1995.269.3.H1165; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Brette F, 2002, AM J PHYSIOL-HEART C, V283, pH1720, DOI 10.1152/ajpheart.00347.2002; Cannell MB, 2012, J MOL CELL CARDIOL, V52, P298, DOI 10.1016/j.yjmcc.2011.04.014; CANNELL MB, 1984, BIOPHYS J, V45, P913, DOI 10.1016/S0006-3495(84)84238-1; Cannell MB, 2006, HDB BIOL CONFOCAL MI, P488, DOI DOI 10.1007/978-0-387-45524-2_25; CHENG H, 1994, PFLUG ARCH EUR J PHY, V428, P415, DOI 10.1007/BF00724526; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; DOLBER PC, 1994, AM J PHYSIOL-HEART C, V267, pH1279, DOI 10.1152/ajpheart.1994.267.4.H1279; Silva FFE, 2013, GENET MOL BIOL, V36, P520, DOI 10.1590/s1415-47572013005000042; FORBES MS, 1990, J STRUCT BIOL, V103, P266, DOI 10.1016/1047-8477(90)90045-E; FORBES MS, 1988, ANAT RECORD, V222, P362, DOI 10.1002/ar.1092220409; FORSSMAN.WG, 1970, J CELL BIOL, V44, P1, DOI 10.1083/jcb.44.1.1; Frisk M, 2014, AM J PHYSIOL-HEART C, V307, pH609, DOI 10.1152/ajpheart.00295.2014; Garger JC, 2011, GUIDE FOR THE CARE A; GOTOH T, 1983, ACTA ANAT, V115, P168; Greiser M, 2011, CARDIOVASC RES, V89, P722, DOI 10.1093/cvr/cvq389; He JQ, 2001, CARDIOVASC RES, V49, P298, DOI 10.1016/S0008-6363(00)00256-X; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; HIBBS RG, 1969, AM J ANAT, V124, P251, DOI 10.1002/aja.1001240302; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; IIDA H, 1989, CELL TISSUE RES, V257, P325, DOI 10.1007/BF00261836; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Kawai M, 1999, AM J PHYSIOL-HEART C, V277, pH603, DOI 10.1152/ajpheart.1999.277.2.H603; Kockskamper J, 2001, BIOPHYS J, V81, P2590, DOI 10.1016/S0006-3495(01)75903-6; LEGATO MJ, 1973, CIRCULATION, V47, P178, DOI 10.1161/01.CIR.47.1.178; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Lipp P, 1996, J PHYSIOL-LONDON, V497, P599, DOI 10.1113/jphysiol.1996.sp021793; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; MCNUTT NS, 1969, J CELL BIOL, V42, P46, DOI 10.1083/jcb.42.1.46; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; Mitcheson JS, 1996, PFLUG ARCH EUR J PHY, V431, P814, DOI 10.1007/BF02332165; Orchard CH, 2013, J PHYSIOL-LONDON, V591, P4141, DOI 10.1113/jphysiol.2013.254540; Orchard CH, 2009, EXP PHYSIOL, V94, P509, DOI 10.1113/expphysiol.2008.043984; REILAND S, 1978, ACTA RADIOL DIAGN, P15; Richards MA, 2011, AM J PHYSIOL-HEART C, V301, pH1996, DOI 10.1152/ajpheart.00284.2011; RUBIO D, 1989, J VET MED A, V36, P64, DOI 10.1111/j.1439-0442.1989.tb00703.x; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; TIDBALL JG, 1991, CELL TISSUE RES, V264, P293, DOI 10.1007/BF00313966; Trafford AW, 2013, CARDIOVASC RES, V98, P192, DOI 10.1093/cvr/cvt018; Walters EM, 2011, ANN NY ACAD SCI, V1245, P63, DOI 10.1111/j.1749-6632.2011.06345.x; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Woo SH, 2002, J PHYSIOL-LONDON, V543, P439, DOI 10.1113/jphysiol.2002.024190; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186	49	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156862	10.1371/journal.pone.0156862	http://dx.doi.org/10.1371/journal.pone.0156862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281038	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000050
J	Haronikova, L; Coufal, J; Kejnovska, I; Jagelska, EB; Fojta, M; Dvorakova, P; Muller, P; Vojtesek, B; Brazda, V				Haronikova, Lucia; Coufal, Jan; Kejnovska, Iva; Jagelska, Eva B.; Fojta, Miroslav; Dvorakova, Petra; Muller, Petr; Vojtesek, Borivoj; Brazda, Vaclav			IFI16 Preferentially Binds to DNA with Quadruplex Structure and Enhances DNA Quadruplex Formation	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN; CIRCULAR-DICHROISM SPECTROSCOPY; RELEVANT G-QUADRUPLEX; INNATE IMMUNE SENSOR; NUCLEIC-ACID; PROVIDES INSIGHTS; PROMOTER REGION; ACTIVATION; GENE; RNA	Interferon-inducible protein 16 (IFI16) is a member of the HIN-200 protein family, containing two HIN domains and one PYRIN domain. IFI16 acts as a sensor of viral and bacterial DNA and is important for innate immune responses. IFI16 binds DNA and binding has been described to be DNA length-dependent, but a preference for supercoiled DNA has also been demonstrated. Here we report a specific preference of IFI16 for binding to quadruplex DNA compared to other DNA structures. IFI16 binds to quadruplex DNA with significantly higher affinity than to the same sequence in double stranded DNA. By circular dichroism (CD) spectroscopy we also demonstrated the ability of IFI16 to stabilize quadruplex structures with quadruplex-forming oligonucleotides derived from human telomere (HTEL) sequences and the MYC promotor. A novel H/D exchange mass spectrometry approach was developed to assess protein interactions with quadruplex DNA. Quadruplex DNA changed the IFI16 deuteration profile in parts of the PYRIN domain (aa 0-80) and in structurally identical parts of both HIN domains (aa 271-302 and aa 586-617) compared to single stranded or double stranded DNAs, supporting the preferential affinity of IFI16 for structured DNA. Our results reveal the importance of quadruplex DNA structure in IFI16 binding and improve our understanding of how IFI16 senses DNA. IFI16 selectivity for quadruplex structure provides a mechanistic framework for IFI16 in immunity and cellular processes including DNA damage responses and cell proliferation.	[Haronikova, Lucia; Coufal, Jan; Kejnovska, Iva; Jagelska, Eva B.; Fojta, Miroslav; Brazda, Vaclav] Acad Sci Czech Republ, Inst Biophys, Kralovopolska 135, CS-61265 Brno, Czech Republic; [Haronikova, Lucia] Masaryk Univ, Fac Sci, Dept Biochem, Kotlarska 2, CS-61137 Brno, Czech Republic; [Dvorakova, Petra; Muller, Petr; Vojtesek, Borivoj] Masaryk Mem Canc Inst, RECAMO, Zluty Kopec 7, Brno 65653, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; Masaryk Memorial Cancer Institute	Brazda, V (corresponding author), Acad Sci Czech Republ, Inst Biophys, Kralovopolska 135, CS-61265 Brno, Czech Republic.	vaclav@ibp.cz	Brazda, Vaclav/ABH-9460-2020; Muller, Petr/AAK-5014-2021; Kejnovska, Iva/G-9767-2014; Muller, Petr/F-7762-2015; Václav, Brázda/F-9582-2011; Haronikova, Lucia/A-1530-2018	Brazda, Vaclav/0000-0003-2837-4226; Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Václav, Brázda/0000-0003-2837-4226; Haronikova, Lucia/0000-0002-4903-2404	Grant Agency of the Czech Republic [15-21855S, P206/12/G151];  [MEYS-NPSI-LO1413]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); 	This work was supported by the Grant Agency of the Czech Republic: 15-21855S (LH, JC, EBJ, VB), P206/12/G151 (MF, PM, BV) and by MEYS-NPSI-LO1413 (PD).	Aglipay JA, 2003, ONCOGENE, V22, P8931, DOI 10.1038/sj.onc.1207057; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ansari MA, 2013, J VIROL, V87, P8606, DOI 10.1128/JVI.00805-13; Booiman T, 2014, INT J IMMUNOGENET, V41, P518, DOI 10.1111/iji.12157; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Brazda V, 2012, BIOCHEM BIOPH RES CO, V422, P716, DOI 10.1016/j.bbrc.2012.05.065; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Costa S, 2011, BRIT J DERMATOL, V164, P282, DOI 10.1111/j.1365-2133.2010.10097.x; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DAWSON MJ, 1995, BIOCHEM BIOPH RES CO, V214, P152, DOI 10.1006/bbrc.1995.2269; DAWSON MJ, 1995, J CELL BIOCHEM, V57, P39, DOI 10.1002/jcb.240570106; Egistelli L, 2009, J CELL BIOCHEM, V106, P666, DOI 10.1002/jcb.22053; Fekete A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042690; Fujiuchi N, 2004, J BIOL CHEM, V279, P20339, DOI 10.1074/jbc.M400344200; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; GRAY DM, 1995, METHOD ENZYMOL, V246, P19; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13; Johnstone RW, 1998, J BIOL CHEM, V273, P17172, DOI 10.1074/jbc.273.27.17172; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Ni XM, 2016, J MOL CELL BIOL, V8, P51, DOI 10.1093/jmcb/mjv053; Nissen SK, 2014, CLIN EXP IMMUNOL, V177, P295, DOI 10.1111/cei.12317; Ouchi M, 2008, FRONT BIOSCI-LANDMRK, V13, P236, DOI 10.2741/2673; Palacky J, 2013, NUCLEIC ACIDS RES, V41, P1005, DOI 10.1093/nar/gks1135; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Prakash A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/896947; Prakash A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/529828; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quante T, 2012, CELL CYCLE, V11, P3290, DOI 10.4161/cc.21646; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Renciuk D, 2009, NUCLEIC ACIDS RES, V37, P6625, DOI 10.1093/nar/gkp701; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Singh VV, 2013, J VIROL, V87, P4417, DOI 10.1128/JVI.03282-12; Song LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008569; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Tosoni E, 2015, NUCLEIC ACIDS RES, V43, P8884, DOI 10.1093/nar/gkv897; Trcka F, 2014, J BIOL CHEM, V289, P9887, DOI 10.1074/jbc.M113.526046; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Veeranki S, 2012, MOL IMMUNOL, V49, P567, DOI 10.1016/j.molimm.2011.11.004; Virno A, 2007, NUCLEOS NUCLEOT NUCL, V26, P1133, DOI 10.1080/15257770701521854; Vorlickova M, 2012, CHIRALITY, V24, P691, DOI 10.1002/chir.22064; Wang Q, 2011, NUCLEIC ACIDS RES, V39, P6229, DOI 10.1093/nar/gkr164; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Yan HY, 2008, BBA-PROTEINS PROTEOM, V1784, P1087, DOI 10.1016/j.bbapap.2008.04.004; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	64	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157156	10.1371/journal.pone.0157156	http://dx.doi.org/10.1371/journal.pone.0157156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280708	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000097
J	Toyoda, Y; Takada, T; Miyata, H; Ishikawa, T; Suzuki, H				Toyoda, Yu; Takada, Tappei; Miyata, Hiroshi; Ishikawa, Toshihisa; Suzuki, Hiroshi			Regulation of the Axillary Osmidrosis-Associated ABCC11 Protein Stability by N-Linked Glycosylation: Effect of Glucose Condition	PLOS ONE			English	Article							MEDIATED PROTEASOMAL DEGRADATION; HUMAN EARWAX-TYPE; TRANSPORTER ABCC11; CYSTIC-FIBROSIS; BREAST-CANCER; EFFLUX PUMP; CELLS; GENE; EXPRESSION; SECRETION	ATP-binding cassette C11 (ABCC11) is a plasma membrane protein involved in the transport of a variety of lipophilic anions. ABCC11 wild-type is responsible for the high-secretion phenotypes in human apocrine glands, such as that of wet-type ear wax, and the risk of axillary osmidrosis. We have previously reported that mature ABCC11 is a glycoprotein containing two N-linked glycans at Asn838 and Asn844. However, little is known about the role of N-linked glycosylation in the regulation of ABCC11 protein. In the current study, we investigated the effects of N-linked glycosylation on the protein level and localization of ABCC11 using polarized Madin-Darby canine kidney II cells. When the N-linked glycosylation in ABCC11-expressing cells was chemically inhibited by tunicamycin treatment, the maturation of ABCC11 was suppressed and its protein level was significantly decreased. Immunoblotting analyses demonstrated that the protein level of the N-linked glycosylation-deficient mutant (N838Q and N844Q: Q838/844) was about half of the ABCC11 wild-type level. Further biochemical studies with the Q838/844 mutant showed that this glycosylation-deficient ABCC11 was degraded faster than wild-type probably due to the enhancement of the MG132-sensitive protein degradation pathway. Moreover, the incubation of ABCC11 wildtype-expressing cells in a low-glucose condition decreased mature, glycosylated ABCC11, compared with the high-glucose condition. On the other hand, the protein level of the Q838/844 mutant was not affected by glucose condition. These results suggest that N-linked glycosylation is important for the protein stability of ABCC11, and physiological alteration in glucose may affect the ABCC11 protein level and ABCC11-related phenotypes in humans, such as axillary osmidrosis.	[Toyoda, Yu; Takada, Tappei; Miyata, Hiroshi; Suzuki, Hiroshi] Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan; [Ishikawa, Toshihisa] RIKEN Ctr Life Sci Technol, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN	Toyoda, Y (corresponding author), Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan.	ytoyoda-tky@umin.ac.jp	Toyoda, Yu/S-9802-2019	Toyoda, Yu/0000-0002-7411-0531	Japan Society for the Promotion of Science (JSPS) KAKENHI [12J03163, 15H05610]; Grants-in-Aid for Scientific Research [15H05610] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/) KAKENHI grant number 12J03163 and 15H05610 to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The NGO Personalized Medicine & Healthcare (founder and president: Dr. Toshihisa Ishikawa) did not take any role of fund provider in the present study at all. In addition, this non-governmental organization did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Ishikawa only contributed to the writing of the manuscript as a critical reviewer and scientific adviser. In other words, Dr. Ishikawa contributed scientifically, but not financially, to this research.	Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bortfeld M, 2006, NEUROSCIENCE, V137, P1247, DOI 10.1016/j.neuroscience.2005.10.025; Bronsveld I, 2000, GASTROENTEROLOGY, V119, P32, DOI 10.1053/gast.2000.8524; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen GP, 2011, FASEB J, V25, P4531, DOI 10.1096/fj.11-185991; Chen ZS, 2005, MOL PHARMACOL, V67, P545, DOI 10.1124/mol.104.007138; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Dray-Charier N, 1999, HEPATOLOGY, V29, P1624, DOI 10.1002/hep.510290634; Emi Y, 2011, J BIOCHEM, V149, P177, DOI 10.1093/jb/mvq131; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; George A. M., 2016, ABC TRANSPORTERS 40; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Inoue Y, 2010, J PLAST RECONSTR AES, V63, P1369, DOI 10.1016/j.bjps.2009.06.029; Ishikawa Toshihisa, 2013, Frontiers in Genetics, V3, P306, DOI 10.3389/fgene.2012.00306; Ito N, 2015, PHARM RES; Kruh GD, 2007, PFLUG ARCH EUR J PHY, V453, P675, DOI 10.1007/s00424-006-0114-1; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Martin A, 2010, J INVEST DERMATOL, V130, P529, DOI 10.1038/jid.2009.254; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Miura K, 2007, HUM GENET, V121, P631, DOI 10.1007/s00439-007-0356-9; Muthusamy S, 2015, AM J PHYSIOL-CELL PH, V308, pC964, DOI 10.1152/ajpcell.00023.2015; Nakagawa H, 2011, J PHARM SCI-US, V100, P3602, DOI 10.1002/jps.22615; Nakagawa H, 2009, FEBS J, V276, P7237, DOI 10.1111/j.1742-4658.2009.07423.x; Nakano M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-42; Nies AT, 2015, ADV CANCER RES, V125, P217, DOI 10.1016/bs.acr.2014.10.007; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Reginato AM, 2012, NAT REV RHEUMATOL, V8, P610, DOI 10.1038/nrrheum.2012.144; Sasaki M, 2002, J BIOL CHEM, V277, P6497, DOI 10.1074/jbc.M109081200; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Stiburkova B, 2016, RHEUMATOLOGY, V55, P191, DOI 10.1093/rheumatology/kev350; Sugiura T, 2011, J PHARM SCI-US, V100, P3620, DOI 10.1002/jps.22575; Suzuki S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04258; Takada T, 2005, PHARM RES-DORDR, V22, P458, DOI 10.1007/s11095-004-1884-9; Tammur J, 2001, GENE, V273, P89, DOI 10.1016/S0378-1119(01)00572-8; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Toyoda Y, 2013, PHARMACOGENOMICS HUM, P387; Toyoda Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24586; Toyoda Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7670483; Toyoda Y, 2012, DRUG METAB DISPOS, V40, P169, DOI 10.1124/dmd.111.041137; Toyoda Y, 2010, ANTI-CANCER AGENT ME, V10, P617, DOI 10.2174/187152010794473975; Toyoda Y, 2009, FASEB J, V23, P2001, DOI 10.1096/fj.09-129098; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Wakabayashi-Nakao K, 2010, METHODS MOL BIOL, V648, P139, DOI 10.1007/978-1-60761-756-3_9; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Yabuuchi H, 2001, BIOCH BIOPHYS RES CO, V288; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733	55	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157172	10.1371/journal.pone.0157172	http://dx.doi.org/10.1371/journal.pone.0157172			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281343	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000102
J	Vene, N; Mavri, A; Gubensek, M; Tratar, G; Cuderman, TV; Perme, MP; Blinc, A				Vene, Nina; Mavri, Alenka; Gubensek, Mirjam; Tratar, Gregor; Cuderman, Tjasa Vizintin; Perme, Maja Pohar; Blinc, Ales			Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; CLINICAL-OUTCOMES; WARFARIN; MANAGEMENT; INTERRUPTION; APIXABAN; STROKE	Background and Aim Interruption of anticoagulant treatment with warfarin or non-vitamin K antagonist oral anticoagulants (NOAC) represents a vulnerable period with an increased risk of thromboembolic events. What is the incidence of thromboembolic events in real-life patients with non-valvular atrial fibrillation treated with NOAC who had a discontinuation or cessation of treatment in comparison to patients on continuous treatment? Patients and Methods Registry data from 866 patients with non-valvular atrial fibrillation, aged 74.3 (SD 9.8) years, with an average CHADS2 score of 2.1 (SD 1.2), who were started on dabigatran or rivaroxaban, were analysed for thromboembolic events and survival. Patients who had temporary or permanent discontinuation of NOAC were compared to patients on continuous NOAC treatment. Results Among 866 patients started on NOAC, 705 were treated without interruption, 84 patients had temporary interruption (69 because of planned invasive procedures, 10 due to bleeding, 5 for other causes) and 77 had permanent cessation of NOAC treatment. In patients without interruptions, the incidence of thromboembolic events was 1.0 (95% CI 0.4-2.1) per 100 patient-years, while in patients with interruption/cessation the rate of thromboembolic events was 21.6 (95% CI 10.3-45.2) per 100 patient-years, p < 0.001. There was a distinct clustering of thromboembolic events in the first weeks of NOAC discontinuation with the median occurring on day 14 (range 1-37 days) after discontinuation. Conclusion Dabigatran and rivaroxaban offered good protection against thromboembolic events during treatment, but interruption of NOAC treatment increased the short-term thromboembolic risk more than 20-fold.	[Vene, Nina; Mavri, Alenka; Gubensek, Mirjam; Tratar, Gregor; Cuderman, Tjasa Vizintin; Blinc, Ales] Univ Med Ctr Ljubljana, Dept Vasc Dis, Ljubljana, Slovenia; [Mavri, Alenka; Tratar, Gregor; Cuderman, Tjasa Vizintin; Blinc, Ales] Univ Ljubljana, Fac Med, Div Internal Med, Ljubljana, Slovenia; [Perme, Maja Pohar] Univ Ljubljana, Fac Med, Inst Biomed Informat, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana	Blinc, A (corresponding author), Univ Med Ctr Ljubljana, Dept Vasc Dis, Ljubljana, Slovenia.; Blinc, A (corresponding author), Univ Ljubljana, Fac Med, Div Internal Med, Ljubljana, Slovenia.	ales.blinc@kclj.si		Blinc, Ales/0000-0002-7538-1595	University Medical Centre Ljubljana [20120086]	University Medical Centre Ljubljana	This work was funded as a part of the industry-independent tertiary research and development project "Hospital Registry of Patients on Anticoagulation Treatment" of the University Medical Centre Ljubljana, grant No. 20120086, primary investigator Doc. Dr. Alenka Mavri.	Beyer-Westendorf J, 2014, EUR HEART J, V35, P1888, DOI 10.1093/eurheartj/eht557; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P1864; Garcia D, 2014, BLOOD, V124, P3692, DOI 10.1182/blood-2014-08-595496; Garcia DA, 2008, ARCH INTERN MED, V168, P63, DOI 10.1001/archinternmed.2007.23; Gonsalves WI, 2013, MAYO CLIN PROC, V88, P495, DOI 10.1016/j.mayocp.2013.03.006; Granger CB, 2015, AM HEART J, V169, P25, DOI 10.1016/j.ahj.2014.09.006; Healey JS, 2012, CIRCULATION, V126, P343, DOI 10.1161/CIRCULATIONAHA.111.090464; Held C, 2015, EUR HEART J, V36, P1264, DOI 10.1093/eurheartj/ehu463; Kikkert WJ, 2013, CIRC-CARDIOVASC INTE, V6, P391, DOI 10.1161/CIRCINTERVENTIONS.113.000425; Patel MR, 2013, J AM COLL CARDIOL, V61, P651, DOI 10.1016/j.jacc.2012.09.057; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perzborn E, 2014, J THROMB HAEMOST, V12, P1054, DOI 10.1111/jth.12591; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Qureshi W, 2014, AM J CARDIOL, V113, P662, DOI 10.1016/j.amjcard.2013.10.044; Raunso J, 2012, EUR HEART J, V33, P1886, DOI 10.1093/eurheartj/ehr454; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Schulman S, 2015, CIRCULATION, V132, P167, DOI 10.1161/CIRCULATIONAHA.115.015688; Sherwood MW, 2014, CIRCULATION, V129, P1850, DOI 10.1161/CIRCULATIONAHA.113.005754; Thorne KM, 2012, BMJ-BRIT MED J, V345, P4469; Weiler Bethany, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-203910; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261	24	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156943	10.1371/journal.pone.0156943	http://dx.doi.org/10.1371/journal.pone.0156943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280704	Green Submitted, gold, Green Published			2022-12-26	WOS:000377563000057
J	Wang, L; Zhou, R; Zhao, Y; Dong, ST; Zhang, JW; Luo, YH; Huang, N; Shi, M; Bin, JP; Liao, YL; Liao, WJ				Wang, Lin; Zhou, Rui; Zhao, Yang; Dong, Shaoting; Zhang, Jingwen; Luo, Yuhao; Huang, Na; Shi, Min; Bin, Jianping; Liao, Yulin; Liao, Wangjun			MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway	PLOS ONE			English	Article							GROWTH-FACTOR; TUMOR ANGIOGENESIS; VASCULOGENIC MIMICRY; VEGF-A; MESENCHYMAL TRANSITION; BREAST-CANCER; IN-VIVO; METASTASIS; EXPRESSION; TWIST1	Endothelium-dependent angiogenesis is thought to be a crucial step in cancer progression. We previously reported that metastasis-associated in colon cancer-1 (MACC1) contributed to the vasculogenic mimicry in gastric cancer (GC), but it remains unknown whether MACC1 promotes endothelium-dependent angiogenesis of GC and whether TWIST1 is involved in this process. In the present study, we detected MACC1 expression and microvessel density (MVD) by immunohistochemistry in 159 patients with stage I-III GC, and investigated the role of TWIST1 and vascular endothelial growth factor A (VEGF-A) in MACC1-induced endothelium-dependent angiogenesis using nude mice with GC xenografts, and human umbilical vein endothelial cells (HUVECs) that were co-cultured with conditioned media from overexpression and interference MACC1 GC cells. We found that MACC1 expression was positively correlated with an increased MVD and tumor recurrence in GC patients. In GC xenograft models, MACC1 elevated MVD and upregulated the expression of VEGF-A as well as accelerated tumor growth. In addition, MACC1 obviously increased the expression of TWIST1 and induced tube-like formation of HUVECs, whereas attenuation of TWIST1 suppressed the protein expression of VEGF-A and repealed the effect of MACC1 on tube formation. Our findings shed light on the function of MACC1 in endothelium-dependent angiogenesis of GC and suggest potential prognostic and therapeutic value.	[Wang, Lin; Zhou, Rui; Zhao, Yang; Dong, Shaoting; Zhang, Jingwen; Luo, Yuhao; Huang, Na; Shi, Min; Liao, Wangjun] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Bin, Jianping; Liao, Yulin] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liao, WJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	nfyyliaowj@163.com	Zhang, Jing/GWZ-7332-2022; Liao, Yulin/AAP-6315-2021	Wangjun, Liao/0000-0002-1364-8442	National Natural Science Foundation for Young Scientists of China [81302155]; National Natural Science Foundation of China [31271564]; President Foundation of Nanfang Hospital [2015B007]; key Clinical Specialty Discipline Construction Program of China	National Natural Science Foundation for Young Scientists of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); President Foundation of Nanfang Hospital; key Clinical Specialty Discipline Construction Program of China	This study was funded by the National Natural Science Foundation for Young Scientists of China (No. 81302155), the National Natural Science Foundation of China (No. 31271564), the President Foundation of Nanfang Hospital (No. 2015B007), and the key Clinical Specialty Discipline Construction Program of China (to The Department of Oncology, Nanfang Hospital).	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Banerjee AN, 2012, J NANOMATER, V2012, DOI 10.1155/2012/201492; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Che N, 2011, HUM PATHOL, V42, P840, DOI 10.1016/j.humpath.2010.03.010; Chen HX, 2014, ONCOTARGET, V5, P11873, DOI 10.18632/oncotarget.2662; Dehghanian Fariba, 2014, Avicenna Journal of Medical Biotechnology, V6, P192; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Foy KC, 2012, ONCOIMMUNOLOGY, V1, P1048, DOI 10.4161/onci.20708; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Huang N, 2015, ONCOTARGET, V6, P15222, DOI 10.18632/oncotarget.3835; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; Lederer A, 2015, HEPATOLOGY, V62, P841, DOI 10.1002/hep.27885; Li CW, 2016, CANCER RES, V76, P1451, DOI 10.1158/0008-5472.CAN-15-1941; Lin L, 2015, ONCOGENE, V34, P2700, DOI 10.1038/onc.2014.204; Liu TJ, 2013, J CELL MOL MED, V17, P116, DOI 10.1111/j.1582-4934.2012.01653.x; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; MAEDA K, 1995, J CLIN ONCOL, V13, P477, DOI 10.1200/JCO.1995.13.2.477; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Meng FH, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-179; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Qian LW, 2003, INT J CANCER, V104, P542, DOI 10.1002/ijc.10997; Roudnicky F, 2013, CANCER RES, V73, P1097, DOI 10.1158/0008-5472.CAN-12-1855; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Sun L, 2015, CANCER LETT, V357, P242, DOI 10.1016/j.canlet.2014.11.035; Sun T, 2011, HEPATOLOGY, V54, P1690, DOI 10.1002/hep.24543; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; Wang G, 2012, ONCOL LETT, V4, P783, DOI 10.3892/ol.2012.784; Wang L, 2015, ONCOTARGET, V6, P11492, DOI 10.18632/oncotarget.3416; Wang L, 2013, INT J CANCER, V133, P1419, DOI 10.1002/ijc.28140; Wang XL, 2013, INT J CLIN EXP PATHO, V6, P586; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang SW, 2006, ONCOL REP, V15, P15	38	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157137	10.1371/journal.pone.0157137	http://dx.doi.org/10.1371/journal.pone.0157137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280289	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000093
J	Fang, XF; Poulsen, RR; Wang-Hu, J; Shi, O; Calvo, NS; Simmons, CS; Rivkees, SA; Wendler, CC				Fang, Xiefan; Poulsen, Ryan R.; Wang-Hu, John; Shi, Olivia; Calvo, Nicholas S.; Simmons, Chelsey S.; Rivkees, Scott A.; Wendler, Christopher C.			Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes	FASEB JOURNAL			English	Article						DNA methylation; cellular morphology; contractility; transcriptome	METHYLATION; DNMT3A; HEART; ASSOCIATION; PACKAGE	We previously found that in utero caffeine exposure causes down-regulation of DNA methyltransferases (DNMTs) in embryonic heart and results in impaired cardiac function in adulthood. To assess the role of DNMTs in these events, we investigated the effects of reduced DNMT expression on embryonic cardiomyocytes. siRNAs were used to knock down individual DNMT expression in primary cultures of mouse embryonic cardiomyocytes. Immunofluorescence staining was conducted to evaluate cell morphology. A video-based imaging assay and multielectrode array were used to assess cardiomyocyte contractility and electrophysiology, respectively. RNA-Seq and multiplex bisulfite sequencing were performed to examine gene expression and promoter methylation, respectively. At 72 h after transfection, reduced DNMT3a expression, but not DNMT1 or -3b, disrupted sarcomere assembly and decreased beating frequency, contractile movement, amplitude of field action potential, and cytosolic calcium signaling of cardiomyocytes. RNA-Seq analysis revealed that the DNMT3a-deficient cells had deactivated gene networks involved in calcium, endothelin-1, renin-angiotensin, and cardiac -adrenergic receptor signaling, which were not inhibited by DNMT3b siRNA. Moreover, decreased methylation levels were found in the promoters of Myh7, Myh7b, Tnni3, and Tnnt2, consistent with the up-regulation of these genes by DNMT3a siRNA. These data show that DNMT3a plays an important role in regulating embryonic cardiomyocyte gene expression, morphology and function.Fang, X., Poulsen, R. R., Wang-Hu, J., Shi, O., Calvo, N. S., Simmons, C. S., Rivkees, S. A., Wendler, C. C. Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes.	[Fang, Xiefan; Poulsen, Ryan R.; Wang-Hu, John; Shi, Olivia; Rivkees, Scott A.; Wendler, Christopher C.] Univ Florida, Coll Med, Dept Pediat, Child Hlth Res Inst, 1200 Newell Dr,ARB R1-148, Gainesville, FL 32610 USA; [Calvo, Nicholas S.; Simmons, Chelsey S.] Univ Florida, Coll Engn, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wendler, CC (corresponding author), Univ Florida, Coll Med, Dept Pediat, Child Hlth Res Inst, 1200 Newell Dr,ARB R1-148, Gainesville, FL 32610 USA.	cwendler@ufl.edu	Simmons, Chelsey/AAG-8859-2020	Simmons, Chelsey/0000-0001-6973-9813	U.S. National Institutes of Health, National Institute of Child Health and Human Development [R01 HD058086]; Children's Miracle Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058086] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Miracle Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Jason Coleman (University of Florida) for technical assistance in analyzing the calcium signaling data. This work was supported by U.S. National Institutes of Health, National Institute of Child Health and Human Development Grant R01 HD058086 (to S.A.R. and C.C.W.), and by the Children's Miracle Network. Author contributions: X. Fang, S. Rivkees, and C. Wendler designed the research; X. Fang, J. Wang-Hu, O. Shi, and N. Calvo performed the research; X. Fang and R. R. Poulsen analyzed the data; X. Fang and C. Wendler wrote the paper; and N. Calvo and C. Simmons developed the software necessary to perform and record the experiments.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Burridge PW, 2014, AM J TRANSL RES, V6, P724; Buscariollo DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087547; Castillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044139; Chamberlain AA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000976; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Fang XF, 2015, AM J PHYSIOL-CELL PH, V309, pC425, DOI 10.1152/ajpcell.00058.2015; Fang XF, 2015, TOXICOL SCI, V146, P395, DOI 10.1093/toxsci/kfv105; Fang XF, 2014, AM J PHYSIOL-REG I, V307, pR1471, DOI 10.1152/ajpregu.00307.2014; Fang XF, 2013, ENVIRON TOXICOL PHAR, V36, P40, DOI 10.1016/j.etap.2013.02.014; Feng Y, 2013, J NUTR BIOCHEM, V24, P1373, DOI 10.1016/j.jnutbio.2012.11.005; Flores K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-480; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hu JL, 2016, ONCOL REP, V35, P1443, DOI 10.3892/or.2015.4480; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Koczor CA, 2013, PHYSIOL GENOMICS, V45, P597, DOI 10.1152/physiolgenomics.00013.2013; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lachance G, 2014, P NATL ACAD SCI USA, V111, P7783, DOI 10.1073/pnas.1322909111; Lei H, 1996, DEVELOPMENT, V122, P3195; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Sheng W, 2013, INT J MOL MED, V32, P694, DOI 10.3892/ijmm.2013.1427; Tao H, 2014, TOXICOLOGY, V323, P42, DOI 10.1016/j.tox.2014.06.006; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Vujic A, 2015, J MOL CELL CARDIOL, V82, P174, DOI 10.1016/j.yjmcc.2015.03.007; Xu SH, 2014, CURR PHARM DESIGN, V20, P1881, DOI 10.2174/13816128113199990527	39	20	20	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3238	3255		10.1096/fj.201600346R	http://dx.doi.org/10.1096/fj.201600346R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27306334	Green Published			2022-12-26	WOS:000382816300023
J	Ng, HM; Wei, LZ; Lan, L; Huen, MSY				Ng, Hoi-Man; Wei, Leizhen; Lan, Li; Huen, Michael S. Y.			The Lys(63)-deubiquitylating Enzyme BRCC36 Limits DNA Break Processing and Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DAMAGE RESPONSE; GENOMIC STABILITY; TARGETS BRCA1; END RESECTION; NUCLEAR FOCI; COMPLEX; PHOSPHORYLATION; SITES; UBIQUITINATION	Multisubunit protein assemblies offer integrated functionalities for efficient cell signal transduction control. One example of such protein assemblies, the BRCA1-A macromolecular complex, couples ubiquitin recognition and metabolism and promotes cellular responses to DNA damage. Specifically, the BRCA1-A complex not only recognizes Lys(63)-linked ubiquitin (K63-Ub) adducts at the damaged chromatin but is endowed with K63-Ub deubiquitylase (DUB) activity. To explore how the BRCA1-A DUB activity contributes to its function at DNA double strand breaks (DSBs), we used RNAi and genome editing approaches to target BRCC36, the protein subunit that confers the BRCA1-A complex its DUB activity. Intriguingly, we found that the K63-Ub DUB activity, although dispensable for maintaining the integrity of the macromolecular protein assembly, is important in enforcing the accumulation of the BRCA1-A complex onto DSBs. Inactivating BRCC36 DUB attenuated BRCA1-A functions at DSBs and led to unrestrained DSB end resection and hyperactive DNA repair. Together, our findings uncover a pivotal role of BRCC36 DUB in limiting DSB processing and repair and illustrate how cells may physically couple ubiquitin recognition and metabolizing activities for fine tuning of DNA repair processes.	[Ng, Hoi-Man; Huen, Michael S. Y.] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Wei, Leizhen; Lan, Li] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15213 USA	University of Hong Kong; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huen, MSY (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Huen, MSY (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	huen.michael@hku.hk		Huen, Michael Shing-Yan/0000-0003-1774-2425	Research Grants Council Hong Kong Project [17104215]; Outstanding Young Researcher Award from the University of Hong Kong; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118833] Funding Source: NIH RePORTER	Research Grants Council Hong Kong Project; Outstanding Young Researcher Award from the University of Hong Kong(University of Hong Kong); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by funds from Research Grants Council Hong Kong Project 17104215 and the Outstanding Young Researcher Award from the University of Hong Kong (to M. S. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aressy B, 2012, CURR BIOL, V22, pR806, DOI 10.1016/j.cub.2012.07.046; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Castillo A, 2014, CELL REP, V8, P807, DOI 10.1016/j.celrep.2014.06.050; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Guo YY, 2015, J BIOL CHEM, V290, P27545, DOI 10.1074/jbc.M115.672626; Hu X, 2011, J BIOL CHEM, V286, P11734, DOI 10.1074/jbc.M110.200857; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jiang QQ, 2015, J BIOL CHEM, V290, P17724, DOI 10.1074/jbc.R115.667931; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tu ZW, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0427-3; Vikrant, 2014, J BIOMOL STRUCT DYN, V32, P2017, DOI 10.1080/07391102.2013.843473; Vikrant, 2014, BIOCHEM BIOPH RES CO, V446, P1139, DOI 10.1016/j.bbrc.2014.03.073; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wu Q, 2016, MOL CELL, V61, P434, DOI 10.1016/j.molcel.2015.12.017; Zeqiraj E, 2015, MOL CELL, V59, P970, DOI 10.1016/j.molcel.2015.07.028; Zhu B, 2015, ONCOGENE, V34, P2867, DOI 10.1038/onc.2014.229	40	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16197	16207		10.1074/jbc.M116.731927	http://dx.doi.org/10.1074/jbc.M116.731927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27288411	Green Published, hybrid			2022-12-26	WOS:000380585400024
J	Guler, N; Eroglu, C; Yilmaz, H; Karadag, A; Alacam, H; Sunbul, M; Fletcher, TE; Leblebicioglu, H				Guler, Nil; Eroglu, Cafer; Yilmaz, Hava; Karadag, Adil; Alacam, Hasan; Sunbul, Mustafa; Fletcher, Tom E.; Leblebicioglu, Hakan			Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATION; PATHOGENESIS; CASPASE-2; INHIBITOR; PROTEINS; PATHWAY; FLIP	Crimean-Congo Hemorrhagic Fever (CCHF) is a life threatening acute viral infection characterized by fever, bleeding, leukopenia and thrombocytopenia. It is a major emerging infectious diseases threat, but its pathogenesis remains poorly understood and few data exist for the role of apoptosis in acute infection. We aimed to assess apoptotic gene expression in leukocytes in a cross-sectional cohort study of adults with CCHF. Twenty participants with CCHF and 10 healthy controls were recruited at a tertiary CCHF unit in Turkey; at admission baseline blood tests were collected and total RNA was isolated. The RealTime ready Human Apoptosis Panel was used for real-time PCR, detecting differences in gene expression. Participants had CCHF severity grading scores (SGS) with low risk score (10 out of 20) and intermediate or high risk scores (10 out of 20) for mortality. Five of 20 participants had a fatal outcome. Gene expression analysis showed modulation of pro-apoptotic and anti-apoptotic genes that facilitate apoptosis in the CCHF patient group. Dominant extrinsic pathway activation, mostly related with TNF family members was observed. Severe and fatal cases suggest additional intrinsic pathway activation. The clinical significance of relative gene expression is not clear, and larger longitudinal studies with simultaneous measurement of host and viral factors are recommended.	[Guler, Nil] Ondokuz Mayis Univ, Sch Med, Dept Hematol, Samsun, Turkey; [Eroglu, Cafer; Yilmaz, Hava; Sunbul, Mustafa; Fletcher, Tom E.; Leblebicioglu, Hakan] Ondokuz Mayis Univ, Sch Med, Dept Clin Microbiol & Infect Dis, Samsun, Turkey; [Karadag, Adil] Ondokuz Mayis Univ, Sch Med, Dept Med Microbiol, Samsun, Turkey; [Alacam, Hasan] Ondokuz Mayis Univ, Sch Med, Dept Med Biochem, Samsun, Turkey; [Fletcher, Tom E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Ondokuz Mayis University; Ondokuz Mayis University; Ondokuz Mayis University; Ondokuz Mayis University; Liverpool School of Tropical Medicine; University of Liverpool	Guler, N (corresponding author), Ondokuz Mayis Univ, Sch Med, Dept Hematol, Samsun, Turkey.	nilvecay@yahoo.com	Guler, Nil/ABE-4485-2021; Leblebicioglu, Hakan/A-3960-2016	Guler, Nil/0000-0003-0604-6475; Leblebicioglu, Hakan/0000-0002-6033-8543; Fletcher, Tom/0000-0002-3712-415X	Ondokuz Mayis University (Turkey) [PYO.TIP.1901.11.020]; Wellcome Trust [104480/Z/14/Z]; UK Ministry of Defence	Ondokuz Mayis University (Turkey)(Ondokuz Mayis University); Wellcome Trust(Wellcome TrustEuropean Commission); UK Ministry of Defence	This study was supported by Ondokuz Mayis University (Turkey) with project number of PYO.TIP.1901.11.020. TF is funded by Wellcome Trust (104480/Z/14/Z) and the UK Ministry of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci E, 2013, VECTOR-BORNE ZOONOT, V13, P429, DOI 10.1089/vbz.2012.1061; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bakir M, 2015, EUR J CLIN MICROBIOL, V34, P325, DOI 10.1007/s10096-014-2238-0; Baptiste-Okoh N, 2008, CELL CYCLE, V7, P1133, DOI 10.4161/cc.7.9.5805; Barnwal B, 2016, J BIOL CHEM, V291, P582, DOI 10.1074/jbc.M115.667436; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Fisgin NT, 2009, TROP DOCT, V39, P158, DOI 10.1258/td.2008.080092; Ghobrial IM, CA CANC J CLIN, V55, P178; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Guven AS, 2015, PEDIATR INFECT DIS J, V34, P208, DOI 10.1097/INF.0000000000000530; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hui D, 2006, MODERN PATHOL, V19, P1192, DOI 10.1038/modpathol.3800632; Jordan MB, 2011, BLOOD, V118, P4041, DOI 10.1182/blood-2011-03-278127; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lamers F, 2011, ENDOCR-RELAT CANCER, V18, P657, DOI 10.1530/ERC-11-0207; Leblebicioglu H, 2016, ANTIVIR RES, V126, P21, DOI 10.1016/j.antiviral.2015.12.003; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Mao ZG, 2010, APOPTOSIS, V15, P1211, DOI 10.1007/s10495-010-0513-9; Martins SD, 2012, VIRUSES-BASEL, V4, P2736, DOI 10.3390/v4112736; Ozturk B, 2012, INT J INFECT DIS, V16, pE89, DOI 10.1016/j.ijid.2011.06.005; Papa A, 2007, EMERG INFECT DIS, V13, P805, DOI 10.3201/eid1305.061588; Papa A, 2016, J MED VIROL, V88, P21, DOI 10.1002/jmv.24312; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029712; Rojas-Cartagena C, 2005, BIOL REPROD, V73, P1211, DOI 10.1095/biolreprod.105.044131; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Subramaniam K, 2013, CANCER LETT, V332, P151, DOI 10.1016/j.canlet.2012.07.005; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157247	10.1371/journal.pone.0157247	http://dx.doi.org/10.1371/journal.pone.0157247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304063	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000377824800042
J	Jensen, R; Stanojevic, S; Klingel, M; Pizarro, ME; Hall, GL; Ramsey, K; Foong, R; Saunders, C; Robinson, PD; Webster, H; Hardaker, K; Kane, M; Ratjen, F				Jensen, Renee; Stanojevic, Sanja; Klingel, Michelle; Pizarro, Maria Ester; Hall, Graham L.; Ramsey, Kathryn; Foong, Rachel; Saunders, Clare; Robinson, Paul D.; Webster, Hailey; Hardaker, Kate; Kane, Mica; Ratjen, Felix			A Systematic Approach to Multiple Breath Nitrogen Washout Test Quality	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; CYSTIC-FIBROSIS; VENTILATION; CHILDREN	Background Accurate estimates of multiple breath washout (MBW) outcomes require correct operation of the device, appropriate distraction of the subject to ensure they breathe in a manner representative of their relaxed tidal breathing pattern, and appropriate interpretation of the acquired data. Based on available recommendations for an acceptable MBW test, we aimed to develop a protocol to systematically evaluate MBW measurements based on these criteria. Methods 50 MBW test occasions were systematically reviewed for technical elements and whether the breathing pattern was representative of relaxed tidal breathing by an experienced MBW operator. The impact of qualitative and quantitative criteria on inter-observer agreement was assessed across eight MBW operators (n = 20 test occasions, compared using a Kappa statistic). Results Using qualitative criteria, 46/168 trials were rejected: 16.6% were technically unacceptable and 10.7% were excluded due to inappropriate breathing pattern. Reviewer agreement was good using qualitative criteria and further improved with quantitative criteria from (K = 0.53-0.83%) to (K 0.73-0.97%), but at the cost of exclusion of further test occasions in this retrospective data analysis. Conclusions The application of the systematic review improved inter-observer agreement but did not affect reported MBW outcomes.	[Jensen, Renee; Stanojevic, Sanja; Klingel, Michelle; Pizarro, Maria Ester; Webster, Hailey; Kane, Mica; Ratjen, Felix] Hosp Sick Children, Div Resp Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Stanojevic, Sanja; Ratjen, Felix] Univ Toronto, Toronto, ON, Canada; [Pizarro, Maria Ester] Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile; [Hall, Graham L.; Ramsey, Kathryn; Foong, Rachel] Telethon Kids Inst, Perth, WA, Australia; [Hall, Graham L.; Ramsey, Kathryn; Foong, Rachel] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Hall, Graham L.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia; [Ramsey, Kathryn] Univ N Carolina, Chapel Hill, NC USA; [Saunders, Clare] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Saunders, Clare] Univ London Imperial Coll Sci Technol & Med, Dept Gene Therapy, London, England; [Robinson, Paul D.; Hardaker, Kate] Childrens Hosp Westmead, Dept Resp Med, Sydney, NSW, Australia; [Robinson, Paul D.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Pontificia Universidad Catolica de Chile; Telethon Kids Institute; University of Western Australia; Curtin University; University of North Carolina; University of North Carolina Chapel Hill; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University of Sydney; University of Sydney	Stanojevic, S (corresponding author), Hosp Sick Children, Div Resp Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Stanojevic, S (corresponding author), Univ Toronto, Toronto, ON, Canada.	sanja.stanojevic@sickkids.ca	Ramsey, Kathryn A/M-7607-2014; Hall, Graham/C-4775-2008; Robinson, Paul D/AAT-8318-2020; Hall, Graham/AAB-6418-2019; Stanojevic, Sanja/A-4243-2010; Ramsey, Kathryn/AAA-9850-2022; Foong, Rachel/A-4678-2019	Ramsey, Kathryn A/0000-0003-4574-6917; Hall, Graham/0000-0002-6217-9494; Jensen, Renee/0000-0002-0877-9579; Shaw, Michelle/0000-0002-0966-6779; Robinson, Paul/0000-0001-7397-105X; Foong, Rachel/0000-0002-1201-6785; Stanojevic, Sanja/0000-0001-7931-8051; Ratjen, Felix/0000-0003-4057-6592	NHLBI NIH HHS [R01 HL116232] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116232] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aurora P, 2011, AM J RESP CRIT CARE, V183, P752, DOI 10.1164/rccm.200911-1646OC; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; Kent L, 2014, J CYST FIBROS, V13, P123, DOI 10.1016/j.jcf.2013.09.005; Kuczmarski R.J., 2000, CDC GROWTH CHARTS; LARSSON A, 1988, J APPL PHYSIOL, V65, P2030, DOI 10.1152/jappl.1988.65.5.2030; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Schmalisch G, 2006, BMC Pulm Med, V6, P20, DOI 10.1186/1471-2466-6-20; Stahl M, 2014, RESPIRATION, V87, P357, DOI 10.1159/000357075; Summermatter S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132250; Verbanck S, 1997, J APPL PHYSIOL, V83, P1907, DOI 10.1152/jappl.1997.83.6.1907; Yammine S, 2014, J CYST FIBROS, V13, P190, DOI 10.1016/j.jcf.2013.08.010	13	45	45	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157523	10.1371/journal.pone.0157523	http://dx.doi.org/10.1371/journal.pone.0157523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304432	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800066
J	Li, ES; Cheung, PY; Lee, TF; Lu, M; O'Reilly, M; Schmolzer, GM				Li, Elliott S.; Cheung, Po-Yin; Lee, Tze-Fun; Lu, Min; O'Reilly, Megan; Schmolzer, Georg M.			Return of spontaneous Circulation Is Not Affected by Different Chest Compression Rates Superimposed with Sustained Inflations during Cardiopulmonary Resuscitation in Newborn Piglets	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; HIGH AIRWAY PRESSURE; NEONATAL RESUSCITATION; CARDIAC-ARREST; DELIVERY-ROOM; BLOOD-FLOW; VENTILATION RATIO; PORCINE MODEL; AUGMENTATION; IMPROVES	Objective Recently, sustained inflations (SI) during chest compression (CC) have been suggested as an alternative to the current approach during neonatal resuscitation. However, the optimal rate of CC during SI has not yet been established. Our aim was to determine whether different CC rates during SI reduce time to return of spontaneous circulation (ROSC) and improve hemodynamic recovery in newborn piglets with asphyxia-induced bradycardia. Intervention and measurements Term newborn piglets were anesthetized, intubated, instrumented and exposed to 45-min normocapnic hypoxia followed by asphyxia. Resuscitation was initiated when heart rate decreased to 25% of baseline. Piglets were randomized into three groups: CC superimposed by SI at a rate of 90 CC per minute (SI+CC 90, n = 8), CC superimposed by SI at a rate of 120 CC per minute (SI+CC 120, n = 8), or a sham group (n = 6). Cardiac function, carotid blood flow, cerebral oxygenation and respiratory parameters were continuously recorded throughout the experiment. Main results Both treatment groups had similar time of ROSC, survival rates, hemodynamic and respiratory parameters during cardiopulmonary resuscitation. The hemodynamic recovery in the subsequent 4h was similar in both groups and was only slightly lower than sham-operated piglets at the end of experiment. Conclusion Newborn piglets resuscitated by SI+CC 120 did not show a significant advantage in ROSC, survival, and hemodynamic recovery as compared to those piglets resuscitated by SI+CC 90.	[Li, Elliott S.] McGill Univ, Fac Sci, Montreal, PQ, Canada; [Li, Elliott S.; Cheung, Po-Yin; Lee, Tze-Fun; Lu, Min; O'Reilly, Megan; Schmolzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Cheung, Po-Yin; Lee, Tze-Fun; Lu, Min; O'Reilly, Megan; Schmolzer, Georg M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	McGill University; Royal Alexandra Hospital; University of Alberta	Schmolzer, GM (corresponding author), Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada.; Schmolzer, GM (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Schmölzer, Georg M/E-7883-2010; Cheung, Po-Yin/C-2804-2013	Schmölzer, Georg M/0000-0001-9798-2415; Cheung, Po-Yin/0000-0002-7141-1523	Alberta Innovates - Health Solutions Summer-Studentship; Fellowship of the Molly Towell Perinatal Foundation; Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Scholarship; Neonatal Resuscitation Program, Canadian Pediatric Society	Alberta Innovates - Health Solutions Summer-Studentship; Fellowship of the Molly Towell Perinatal Foundation; Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Scholarship; Neonatal Resuscitation Program, Canadian Pediatric Society	The authors would like to that the public for donation money to our funding agencies: Scholarships to support individual authors (salary support) was available for the study: ESL was supported by as Alberta Innovates - Health Solutions Summer-Studentship. MOR is supported by a Fellowship of the Molly Towell Perinatal Foundation. GMS is a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation and a Heart and Stroke Scholarship. The authors would like to thank the Neonatal Resuscitation Program, Canadian Pediatric Society (http://www.cps.ca/en/grants-bourses/details/nrp-research-grant) for supporting the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, CARDIOPULMONARY RESU, V342, P1546; Babbs CF, 2009, RESUSCITATION, V80, P1280, DOI 10.1016/j.resuscitation.2009.07.014; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Berg RA, 2000, CIRCULATION, V101, P1743; BERKOWITZ ID, 1989, PEDIATR RES, V26, P558, DOI 10.1203/00006450-198912000-00006; Chalak LF, 2011, PEDIATR RES, V69, P401, DOI 10.1203/PDR.0b013e3182125f7f; CHANDRA N, 1980, LANCET, V1, P175; CHANDRA N, 1981, AM J CARDIOL, V48, P1053, DOI 10.1016/0002-9149(81)90320-9; Chandra N, 1980, LANCET, V315, P175; Cheung P-Y, 2011, J VIS EXP; HALPERIN HR, 1986, CIRCULATION, V73, P539, DOI 10.1161/01.CIR.73.3.539; Kapadia V, 2012, CLIN PERINATOL, V39, P833, DOI 10.1016/j.clp.2012.09.011; Keszler M, 2015, CURR OPIN PEDIATR, V27, P145, DOI 10.1097/MOP.0000000000000204; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; KOEHLER RC, 1983, CIRCULATION, V67, P266, DOI 10.1161/01.CIR.67.2.266; Li ES-S, 2015, ARCH DIS CHILD FETAL; McGowan JE, 2014, RESUSCITATION, V85, P161, DOI 10.1016/j.resuscitation.2013.12.004; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Pichler G, 2015, NEPHROLOGY, V20, P107, DOI 10.1111/nep.12357; RUDIKOFF MT, 1980, CIRCULATION, V61, P345, DOI 10.1161/01.CIR.61.2.345; Schmolzer GM, 2014, RESUSCITATION, V85, P270, DOI 10.1016/j.resuscitation.2013.10.011; Schmolzer GM, 2013, CIRCULATION, V128, P2495, DOI 10.1161/CIRCULATIONAHA.113.002289; Schmolzer GM, 2014, ARCH DIS CHILD FETAL; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Solevag AL, 2015, ARCH DIS CHILD FETAL; Solevag AL, 2011, ARCH DIS CHILD-FETAL, V96, pF417, DOI 10.1136/adc.2010.200386; Solevag AL, 2010, RESUSCITATION, V81, P1571, DOI 10.1016/j.resuscitation.2010.06.007; Solevag AL, 2015, RESUSCITATION, V96, P151, DOI 10.1016/j.resuscitation.2015.08.001; van Os S, 2014, ACTA PAEDIATR, V103, P796, DOI 10.1111/apa.12650; Wyckoff M, 2000, PEDIATRICS, V106, P618, DOI 10.1542/peds.106.3.618; Wyckoff MH, 2008, SEMIN FETAL NEONAT M, V13, P410, DOI 10.1016/j.siny.2008.04.012; Wyckoff MH, 2013, CIRCULATION, V128, P2468, DOI 10.1161/CIRCULATIONAHA.113.006093; Wyckoff MH, 2012, J PEDIATR-US, V160, P239, DOI 10.1016/j.jpeds.2011.07.041	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157249	10.1371/journal.pone.0157249	http://dx.doi.org/10.1371/journal.pone.0157249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304210	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800043
J	Holman, DB; Hao, XY; Topp, E; Yang, HE; Alexander, TW				Holman, Devin B.; Hao, Xiying; Topp, Edward; Yang, Hee Eun; Alexander, Trevor W.			Effect of Co-Composting Cattle Manure with Construction and Demolition Waste on the Archaeal, Bacterial, and Fungal Microbiota, and on Antimicrobial Resistance Determinants	PLOS ONE			English	Article							FEEDLOT MANURE; ANTIBIOTIC-RESISTANCE; COMMUNITY DYNAMICS; ESCHERICHIA-COLI; SP-NOV; 16S; PREVALENCE; SUCCESSION; IDENTIFICATION; SEQUENCES	Agricultural operations generate large quantities of manure which must be eliminated in a manner that is consistent with public health guidelines. Meanwhile, construction and demolition waste makes up about 25% of total solid municipal waste. Co-composting of manure with construction and demolition waste offers a potential means to make manure safe for soil amendment and also divert construction and demolition waste from municipal landfills. Therefore, the archaeal, bacterial, and fungal microbiota of two different types of composted cattle manure and one co-composted with construction and demolition waste, were assessed over a 99-day composting period. The microbiota of the three compost mixtures did not differ, but significant changes over time and by sampling depth were observed. Bacillus and Halocella, however, were more relatively abundant in composted manure from cattle fed dried distillers' grains and solubles. Proteobacteria and Bacteroidetes were enriched at day 0 and Firmicutes at day 99. The fungal genus Kernia was the most relatively abundant overall and was enriched at day 0. The concentration of 12 antimicrobial resistance determinants in the compost mixtures was also determined, and 10 of these determinants decreased significantly from days 0 to 99. The addition of construction and demolition waste did not affect the persistence of antimicrobial resistance genes or community structure of the compost microbiota and therefore co-composting construction and demolition waste with cattle manure offers a safe, viable way to divert this waste from landfills.	[Holman, Devin B.; Hao, Xiying; Yang, Hee Eun; Alexander, Trevor W.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Topp, Edward] Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Alexander, TW (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	trevor.alexander@agr.gc.ca	Holman, Devin/H-8693-2019	Holman, Devin/0000-0001-5306-3732; Hao, Xiying/0000-0001-6410-9652; Topp, Ed/0000-0002-8273-9372	Agriculture and Agri-Food Canada Growing Forward 2 program; Natural Sciences and Engineering Research Council of Canada	Agriculture and Agri-Food Canada Growing Forward 2 program(Agriculture & Agri Food Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Agriculture and Agri-Food Canada Growing Forward 2 program. DBH was supported by a Natural Sciences and Engineering Research Council of Canada visiting postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08; Alexander TW, 2009, APPL ENVIRON MICROB, V75, P7125, DOI 10.1128/AEM.00944-09; Alexander TW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-19; Arikan OA, 2007, BIORESOURCE TECHNOL, V98, P169, DOI 10.1016/j.biortech.2005.10.041; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bouanane-Darenfed A, 2014, PROKARYOTES, P13, DOI DOI 10.1007/978-3-642-30120-9_395; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Chee-Sanford J., 2011, Antimicrobial resistance in the environment, P203; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; De Gannes V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00164; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hansgate AM, 2005, FEMS MICROBIOL ECOL, V51, P209, DOI 10.1016/j.femsec.2004.08.009; Hao XY, 2014, J ENVIRON QUAL, V43, P1799, DOI 10.2134/jeq2014.02.0087; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Holman DB, 2013, FEMS MICROBIOL ECOL, V85, P1, DOI 10.1111/1574-6941.12093; Insam H, 2007, WASTE MANAG SER, V8, P25; Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P4583, DOI 10.1128/AEM.02584-05; Langarica-Fuentes A, 2014, FEMS MICROBIOL ECOL, V88, P296, DOI 10.1111/1574-6941.12293; Larney FJ, 2000, BIORESOURCE TECHNOL, V75, P139, DOI 10.1016/S0960-8524(00)00040-7; Larney FJ, 2007, BIORESOURCE TECHNOL, V98, P3221, DOI 10.1016/j.biortech.2006.07.005; Larney FJ, 2006, CAN J SOIL SCI, V86, P597, DOI 10.4141/S05-116; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lv BY, 2015, APPL MICROBIOL BIOT, V99, P10703, DOI 10.1007/s00253-015-6884-7; Maeda K, 2010, BIORESOURCE TECHNOL, V101, P9631, DOI 10.1016/j.biortech.2010.07.057; Mathew AG, 2007, FOODBORNE PATHOG DIS, V4, P115, DOI 10.1089/fpd.2006.0066; Mayende L, 2006, SOIL BIOL BIOCHEM, V38, P2963, DOI 10.1016/j.soilbio.2006.03.019; Mehta CM, 2014, WASTE MANAGE, V34, P607, DOI 10.1016/j.wasman.2013.11.012; Morgenstern I, 2012, FUNGAL BIOL-UK, V116, P489, DOI 10.1016/j.funbio.2012.01.010; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; PARKER AD, 1979, MYCOLOGIA, V71, P1206, DOI 10.2307/3759107; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Saludes RB, 2008, BIORESOURCE TECHNOL, V99, P7285, DOI 10.1016/j.biortech.2007.12.080; Schloss PD, 2005, APPL MICROBIOL BIOT, V66, P457, DOI 10.1007/s00253-004-1727-y; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma R, 2009, J ENVIRON QUAL, V38, P567, DOI 10.2134/jeq2007.0638; SIMANKOVA MV, 1993, SYST APPL MICROBIOL, V16, P385, DOI 10.1016/S0723-2020(11)80270-5; Sorokin DY, 2008, EXTREMOPHILES, V12, P431, DOI 10.1007/s00792-008-0148-8; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Tian W, 2013, INT BIODETER BIODEGR, V78, P58, DOI 10.1016/j.ibiod.2012.12.008; Tiquia SM, 2005, ENVIRON TECHNOL, V26, P1101, DOI 10.1080/09593332608618482; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Vahjen W, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0071-3; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Westerholm M, 2011, SYST APPL MICROBIOL, V34, P260, DOI 10.1016/j.syapm.2010.11.018; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xu S, 2015, J ENV QUAL; Zaheer R, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00133	58	38	39	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157539	10.1371/journal.pone.0157539	http://dx.doi.org/10.1371/journal.pone.0157539			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300323	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200060
J	Kinsella, E; Dora, N; Mellis, D; Lettice, L; Deveney, P; Hill, R; Ditzel, M				Kinsella, Elaine; Dora, Natalie; Mellis, David; Lettice, Laura; Deveney, Paul; Hill, Robert; Ditzel, Mark			Use of a Conditional Ubr5 Mutant Allele to Investigate the Role of an N-End Rule Ubiquitin-Protein Ligase in Hedgehog Signalling and Embryonic Limb Development	PLOS ONE			English	Article							STEM-CELLS; INDIAN-HEDGEHOG; SONIC-HEDGEHOG; RETINOIC-ACID; IN-VITRO; CHONDROCYTE MATURATION; RECOMBINASE ACTIVITY; CUBITUS INTERRUPTUS; POLARIZING ACTIVITY; STRUCTURAL BASIS	Hedgehog (Hh) signalling is a potent regulator of cell fate and function. While much is known about the events within a Hh-stimulated cell, far less is known about the regulation of Hh-ligand production. Drosophila Hyperplastic Discs (Hyd), a ubiquitin-protein ligase, represents one of the few non-transcription factors that independently regulates both hh mRNA expression and pathway activity. Using a murine embryonic stem cell system, we revealed that shRNAi of the mammalian homologue of hyd, Ubr5, effectively prevented retinoic-acid-induced Sonic hedgehog (Shh) expression. We next investigated the UBR5: Hh signalling relationship in vivo by generating and validating a mouse bearing a conditional Ubr5 loss-of-function allele. Conditionally deleting Ubr5 in the early embryonic limb-bud mesenchyme resulted in a transient decrease in Indian hedgehog ligand expression and decreased Hh pathway activity, around E13.5. Although Ubr5-deficient limbs and digits were, on average, shorter than control limbs, the effects were not statistically significant. Hence, while loss of UBR5 perturbed Hedgehog signalling in the developing limb, there were no obvious morphological defects. In summary, we report the first conditional Ubr5 mutant mouse and provide evidence for a role for UBR5 in influencing Hh signalling, but are uncertain to whether the effects on Hedgehog signaling were direct (cell autonomous) or indirect (non-cell-autonomous). Elaboration of the cellular/molecular mechanism (s) involved may help our understanding on diseases and developmental disorders associated with aberrant Hh signalling.	[Kinsella, Elaine; Mellis, David; Ditzel, Mark] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Dora, Natalie; Lettice, Laura; Deveney, Paul; Hill, Robert] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Ditzel, M (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Edinburgh, Midlothian, Scotland.	mark.ditzel@ed.ac.uk			Biotechnology and Biological Sciences Research Council [BB/H012869/1]; Edinburgh University; Medical Research Council as part of an IGMM core grant award; BBSRC [BB/H012869/1] Funding Source: UKRI; MRC [MC_U127584494, MC_PC_U127584494] Funding Source: UKRI; Medical Research Council [MC_U127584494, MC_PC_U127584494] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Edinburgh University; Medical Research Council as part of an IGMM core grant award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) as part of a New Investigator Award BB/H012869/1 and by Edinburgh University as part of a Chancellor's Fellowship (both awarded to MD) and the Medical Research Council (http://www.mrc.ac.uk) as part of an IGMM core grant award (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2008, J BIOL CHEM, V283, P29513, DOI 10.1074/jbc.M803681200; Anderson E, 2014, CURR OPIN GENET DEV, V27, P54, DOI 10.1016/j.gde.2014.03.011; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Benavides M, 2013, BBA-MOL CELL RES, V1833, P21, DOI 10.1016/j.bbamcr.2012.10.007; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Byrd N, 2002, DEVELOPMENT, V129, P361; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CLARKE CL, 1990, J BIOL CHEM, V265, P12694; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Frisdal A, 2014, WIRES DEV BIOL, V3, P403, DOI 10.1002/wdev.147; Gao B, 2009, NATURE, V458, P1196, DOI 10.1038/nature07862; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hill RE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0357; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2014, DEVELOPMENT, V141, P1715, DOI 10.1242/dev.095430; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Matta-Camacho E, 2012, ACTA CRYSTALLOGR F, V68, P1158, DOI 10.1107/S1744309112036937; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Moncrieff S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136760; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Scialpi F, 2015, J BIOL CHEM, V290, P12585, DOI 10.1074/jbc.M114.625673; Sears KE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005398; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Smits VA, 2012, CELL CYCLE, V11; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Towers M, 2012, CURR OPIN CELL BIOL, V24, P181, DOI 10.1016/j.ceb.2011.11.005; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang GL, 2014, MECH DEVELOP, V133, P117, DOI 10.1016/j.mod.2014.05.002; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Z, 2010, DEVELOPMENT, V137, P3417, DOI 10.1242/dev.051789	77	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157079	10.1371/journal.pone.0157079	http://dx.doi.org/10.1371/journal.pone.0157079			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299863	gold, Green Published, Green Submitted			2022-12-26	WOS:000377822200027
J	Almeida, JB; Kian, KO; Lima, RC; de Souza, MCC				Almeida, Juliana Barros; Kian, Kauhana Oliveira; Lima, Rosangela Costa; Correa de Souza, Maria Cristina			Total and Abdominal Adiposity and Hypertension in Indigenous Women in Midwest Brazil	PLOS ONE			English	Article							RISK-FACTORS; WAIST CIRCUMFERENCE; OBESITY; PREVALENCE; HEALTH; INDIANS; ADULTS	Background Obesity is a major risk factor for hypertension, and abdominal fat in particular has been more strongly associated with cardiovascular diseases and its prevalence has increased in Brazilian indigenous populations. Objective The objective of this study was to estimate the prevalence of hypertension among indigenous women and its association with total and abdominal obesity after adjustment for confounding factors. Methods This cross-sectional study evaluated indigenous non-pregnant women aged 20-59 years living in two villages of the indigenous reserve of Dourados, state of Mato Grosso do Sul, Brazil. Data were collected by trained interviewers. Households were visited and were selected by simple random sampling using SPSS software version 21. The casting of lots was performed from a list of households located on a map of villages. To locate the selected households, a Global Positioning System device was used. A questionnaire was used to obtain data on socio-demographic, lifestyle and health-related variables and to obtain anthropometric data on weight, height, and waist circumference (WC). Blood pressure was measured twice during home visits. Results Data were collected between June and October 2013 with 362 women. Most of them were aged <40 years (66.3%) and had low educational level (<= 4 years of schooling, 82.0%), had overweight/obesity (74.0%), WC >= 80 cm(83.7%), and family history of hypertension (60.5%). The prevalence of hypertension was 42.0% (CI 95%: 37.0-47.2). In the multivariable analysis, respondents with WC 80-87 cm and >= 88 cm showed approximately 2 times higher prevalence rates of hypertension compared with those with WC <80 cm after adjusting for confounding factors. There was no association between body mass index (BMI) and hypertension in this study. Conclusions The overall prevalence of hypertension was high and associated only with abdominal adiposity but not with BMI.	[Almeida, Juliana Barros; Kian, Kauhana Oliveira; Lima, Rosangela Costa; Correa de Souza, Maria Cristina] Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil	Universidade Federal da Grande Dourados	de Souza, MCC (corresponding author), Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil.	mariasouza@ufgd.edu.br			Foundation for the Advancement of Education, Science, and Technology of the state of Mato Grosso do Sul (Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul - FUNDECT) [TERMO DE OUTORGA: 0063/13]	Foundation for the Advancement of Education, Science, and Technology of the state of Mato Grosso do Sul (Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul - FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	This work was supported by Foundation for the Advancement of Education, Science, and Technology of the state of Mato Grosso do Sul (Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul - FUNDECT) (http://fundect.ledes.net/) (TERMO DE OUTORGA: 0063/13, R$ 19.600,00, MCCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2010, CENS DEM 2010 CAR GE; Black HR, 1997, ARCH INTERN MED, V157, P2413; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, VIG BRAS 2013 VIG FA; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Barros MBD, 2011, CIENC SAUDE COLETIVA, V16, P3755, DOI 10.1590/S1413-81232011001000012; de Oliveira GF, 2011, REV PANAM SALUD PUBL, V29, P315, DOI 10.1590/S1020-49892011000500003; Favaro T, 2007, CAD SAUDE PUBLICA, V23, P785, DOI 10.1590/S0102-311X2007000400006; Florindo AA, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-794, 10.1186/1471-2458-13-1066, 10.1186/1471-2458-13-52]; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Gimeno SGA, 2009, J EPIDEMIOL COMMUN H, V63, P299, DOI 10.1136/jech.2008.077966; Guerrero-Romero F, 2000, J HUM HYPERTENS, V14, P555, DOI 10.1038/sj.jhh.1001067; Instituto Brasileiro de Geografia e Estatistica, 2010, PROJECAO GEOGRAFICA; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mancilha-Carvalho Jairo de Jesus, 2003, Arq. Bras. Cardiol., V80, P295, DOI 10.1590/S0066-782X2003000300005; Manimunda SP, 2011, INDIAN J MED RES, V133, P287; Oliveira GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086278; Organization WH, 2009, GLOB HLTH RISKS MORT; Pavan L, 1999, J HYPERTENS, V17, P749, DOI 10.1097/00004872-199917060-00005; Lourenco AE, 2008, AM J HUM BIOL, V20, P564, DOI 10.1002/ajhb.20781; Rhoades DA, 2007, J AM GERIATR SOC, V55, P87, DOI 10.1111/j.1532-5415.2006.01018.x; Roriz-Cruz M, 2010, HYPERTENSION, V56, pE43, DOI 10.1161/HYPERTENSIONAHA.110.158956; Salvo Vera Lúcia Morais Antonio de, 2009, Rev. bras. epidemiol., V12, P458, DOI 10.1590/S1415-790X2009000300014; Santana Junior JR, 2010, CAMPO TERRITORIO REV, V5, P203; Santos RV, 2003, EPIDEMIOLOGIA SAUDE, P1; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Stoddard P, 2011, SOC SCI MED, V73, P1635, DOI 10.1016/j.socscimed.2011.09.006; Tavares FG, 2013, CIENC SAUDE COLETIVA, V18, P1399, DOI 10.1590/S1413-81232013000500025; WHO, 2013, WHODCOWHD20132; Wofford MR, 2004, CURR PHARM DESIGN, V10, P3621, DOI 10.2174/1381612043382855; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2000, WHO TECHN REP SER, V894; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	36	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0155528	10.1371/journal.pone.0155528	http://dx.doi.org/10.1371/journal.pone.0155528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294870	Green Published, Green Submitted, gold			2022-12-26	WOS:000377821300001
J	Liyanage, KA; Steward, C; Moffat, BA; Opie, NL; Rind, GS; John, SE; Ronayne, S; May, CN; O'Brien, TJ; Milne, ME; Oxley, TJ				Liyanage, Kishan Andre; Steward, Christopher; Moffat, Bradford Armstrong; Opie, Nicholas Lachlan; Rind, Gil Simon; John, Sam Emmanuel; Ronayne, Stephen; May, Clive Newton; O'Brien, Terence John; Milne, Marjorie Eileen; Oxley, Thomas James			Development and Implementation of a Corriedale Ovine Brain Atlas for Use in Atlas-Based Segmentation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; SHEEP; MODEL; REGISTRATION; DISEASE; CORTEX	Segmentation is the process of partitioning an image into subdivisions and can be applied to medical images to isolate anatomical or pathological areas for further analysis. This process can be done manually or automated by the use of image processing computer packages. Atlas-based segmentation automates this process by the use of a pre-labelled template and a registration algorithm. We developed an ovine brain atlas that can be used as a model for neurological conditions such as Parkinson's disease and focal epilepsy. 17 female Corriedale ovine brains were imaged in-vivo in a 1.5T (low-resolution) MRI scanner. 13 of the low-resolution images were combined using a template construction algorithm to form a low-resolution template. The template was labelled to form an atlas and tested by comparing manual with atlas-based segmentations against the remaining four low-resolution images. The comparisons were in the form of similarity metrics used in previous segmentation research. Dice Similarity Coefficients were utilised to determine the degree of overlap between eight independent, manual and atlas-based segmentations, with values ranging from 0 (no overlap) to 1 (complete overlap). For 7 of these 8 segmented areas, we achieved a Dice Similarity Coefficient of 0.5-0.8. The amygdala was difficult to segment due to its variable location and similar intensity to surrounding tissues resulting in Dice Coefficients of 0.0-0.2. We developed a low resolution ovine brain atlas with eight clinically relevant areas labelled. This brain atlas performed comparably to prior human atlases described in the literature and to intra-observer error providing an atlas that can be used to guide further research using ovine brains as a model and is hosted online for public access.	[Liyanage, Kishan Andre; Opie, Nicholas Lachlan; Rind, Gil Simon; John, Sam Emmanuel; Ronayne, Stephen; May, Clive Newton; Oxley, Thomas James] Univ Melbourne, Royal Melbourne Hosp, Vasc Bion Lab, Dept Med, Parkville, Vic, Australia; [Liyanage, Kishan Andre; Steward, Christopher; Moffat, Bradford Armstrong] Univ Melbourne, Royal Melbourne Hosp, Dept Radiol, Parkville, Vic, Australia; [Moffat, Bradford Armstrong] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Opie, Nicholas Lachlan; Rind, Gil Simon; John, Sam Emmanuel; Ronayne, Stephen; May, Clive Newton; Oxley, Thomas James] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [John, Sam Emmanuel] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Parkville, Vic 3052, Australia; [John, Sam Emmanuel] Ctr Neural Engn, Parkville, Vic, Australia; [O'Brien, Terence John] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Milne, Marjorie Eileen] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Liyanage, KA (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Vasc Bion Lab, Dept Med, Parkville, Vic, Australia.; Liyanage, KA (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Radiol, Parkville, Vic, Australia.	kishan.liyanage@gmail.com	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Moffat, Bradford/L-3777-2019; John, Sam/E-6904-2012; Opie, Nicholas/M-3831-2017	O'Brien, Terence/0000-0002-7198-8621; Moffat, Bradford/0000-0002-0278-4801; John, Sam/0000-0003-3780-2210; MILNE, MARJORIE/0000-0001-9327-0357; Opie, Nicholas/0000-0002-0342-9457	Defense Advanced Research Projects Agency (DARPA) [N66001-12-1-4045]; Office of Naval Research (ONR) [N62909-14-1-N020]; National Health and Medical Research Council of Australia (NHMRC) [APP1062532, APP1075117]; Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government's Operational Infrastructure Support Program	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research (ONR)(Office of Naval Research); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government's Operational Infrastructure Support Program	The research was supported by Defense Advanced Research Projects Agency (DARPA) MTO Contract No. N66001-12-1-4045 (TJO); Office of Naval Research (ONR) Global No. N62909-14-1-N020 (TJO); National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1062532 (TJO) and Development Grant APP1075117 (TJO); Defence Health Foundation, Australia (Booster Grant) (TJO); Defence Science Institute, Australia, grant (TJO); Brain Foundation, Australia, research gift (TJO), and the Victorian Government's Operational Infrastructure Support Program (TJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bagley C, 1922, ARCH NEURO PSYCHIATR, V7, P417, DOI 10.1001/archneurpsyc.1922.02190100002001; BASKIN DS, 1994, LIFE SCI, V54, P471, DOI 10.1016/0024-3205(94)00406-4; Brus M, 2013, J COMP NEUROL, V521, P169, DOI 10.1002/cne.23169; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Datta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052140; Erickson BJ, 1998, J DIGIT IMAGING, V11, P74, DOI 10.1007/BF03168729; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Gierthmuehlen M, 2014, J COMP NEUROL, V522, P3590, DOI 10.1002/cne.23631; Grovum WL, 1999, BRAIN RES, V851, P252, DOI 10.1016/S0006-8993(99)02083-1; JOHNSON JI, 1974, J COMP NEUROL, V158, P81, DOI 10.1002/cne.901580106; Klein A, 2010, NEUROIMAGE, V51, P214, DOI 10.1016/j.neuroimage.2010.01.091; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lentz L, 2015, EXP NEUROL, V273, P69, DOI 10.1016/j.expneurol.2015.07.022; Li XJ, 2015, CURR TOP BEHAV NEURO, V22, P149, DOI 10.1007/7854_2013_246; Liyanage KA, 2015, OVINE BRAIN ATLAS; Milne ME, 2015, AM J VET RES; Opdam HI, 2002, EPILEPSIA, V43, P779, DOI 10.1046/j.1528-1157.2002.04202.x; Oxley TJ, 2015, NATURE BIOT IN PRESS; Peperkamp NH, 2015, VET PATHOL, V52, P1057, DOI 10.1177/0300985814560231; Perentos N, 2015, BRAIN, V138, P862, DOI 10.1093/brain/awv026; Salouci M, 2012, ANAT HISTOL EMBRYOL, V41, P227, DOI 10.1111/j.1439-0264.2011.01127.x; Sawiak SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132331; Simpson S, 1911, Q J EXP PHYSIOL, V4, P53, DOI 10.1113/expphysiol.1911.sp000083; Stypulkowski PH, 2011, STEREOT FUNCT NEUROS, V89, P111, DOI 10.1159/000323343; Talairach J., 1988, COPLANAR STEREOTAXIC; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; Yousefi S, 2012, IEEE T BIO-MED ENG, V59, P1808, DOI 10.1109/TBME.2011.2122306; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155974	10.1371/journal.pone.0155974	http://dx.doi.org/10.1371/journal.pone.0155974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285947	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000005
J	Suhr, M; Lederer, FL; Gunther, TJ; Raff, J; Pollmann, K				Suhr, Matthias; Lederer, Franziska L.; Guenther, Tobias J.; Raff, Johannes; Pollmann, Katrin			Characterization of Three Different Unusual S-Layer Proteins from Viridibacillus arvi JG-B58 That Exhibits Two Super-Imposed S-Layer Proteins	PLOS ONE			English	Article							BACILLUS-STEAROTHERMOPHILUS PV72; LYSINIBACILLUS-SPHAERICUS JG-B53; SURFACE-LAYER; LACTOBACILLUS-ACIDOPHILUS; CELL-WALL; MOLECULAR CHARACTERIZATION; CLOSTRIDIUM-DIFFICILE; POLYACRYLAMIDE GELS; WASTE PILE; GENES	Genomic analyses of Viridibacillus arvi JG-B58 that was previously isolated from heavy metal contaminated environment identified three different putative surface layer (S-layer) protein genes namely slp1, slp2, and slp3. All three genes are expressed during cultivation. At least two of the V. arvi JG-B58 S-layer proteins were visualized on the surface of living cells via atomic force microscopy (AFM). These S-layer proteins form a double layer with p4 symmetry. The S-layer proteins were isolated from the cells using two different methods. Purified S-layer proteins were recrystallized on SiO2 substrates in order to study the structure of the arrays and self-assembling properties. The primary structure of all examined Slayer proteins lack some features that are typical for Bacillus or Lysinibacillus S-layers. For example, they possess no SLH domains that are usually responsible for the anchoring of the proteins to the cell wall. Further, the pI values are relatively high ranging from 7.84 to 9.25 for the matured proteins. Such features are typical for S-layer proteins of Lactobacillus species although sequence comparisons indicate a close relationship to S-layer proteins of Lysinibacillus and Bacillus strains. In comparison to the numerous descriptions of S-layers, there are only a few studies reporting the concomitant existence of two different S-layer proteins on cell surfaces. Together with the genomic data, this is the first description of a novel type of S-layer proteins showing features of Lactobacillus as well as of Bacillus-type S-layer proteins and the first study of the cell envelope of Viridibacillus arvi.	[Suhr, Matthias; Lederer, Franziska L.; Guenther, Tobias J.; Raff, Johannes; Pollmann, Katrin] Helmholtz Zentrum Dresden Rossendorf, Helmholtz Inst Freiberg Resource Technol, Freiberg, Germany; [Raff, Johannes] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Freiberg, Germany; [Suhr, Matthias] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Sect Microbial Biotechnol, D-06108 Halle, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Martin Luther University Halle Wittenberg	Pollmann, K (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Helmholtz Inst Freiberg Resource Technol, Freiberg, Germany.	k.pollmann@hzdr.de	Raff, Johannes/GNM-5459-2022	Raff, Johannes/0000-0002-0520-3611; Lederer, Franziska/0000-0002-0452-3242; Suhr, Matthias/0000-0003-3101-0925	German Federal Ministry of Education and Research (BMBF) grant AptaSens [BMBF/DLR01RB0805A]	German Federal Ministry of Education and Research (BMBF) grant AptaSens	The study was partly supported by the German Federal Ministry of Education and Research (BMBF) grant AptaSens (BMBF/DLR01RB0805A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was partly supported by the German Federal Ministry of Education and Research (BMBF) grant AptaSens (BMBF/DLR01RB0805A). We thank Chris Christesen for grammar and spell check of this article as native speaker.	Albert RA, 2007, INT J SYST EVOL MICR, V57, P2729, DOI 10.1099/ijs.0.65256-0; Avall-Jaaskelainen S, 2005, FEMS MICROBIOL REV, V29, P511, DOI 10.1016/j.femsre.2005.04.003; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; BLASER MJ, 1994, MOL MICROBIOL, V14, P453, DOI 10.1111/j.1365-2958.1994.tb02180.x; Boot HJ, 1996, MICROBIOL-SGM, V142, P2375, DOI 10.1099/00221287-142-9-2375; Boot HJ, 1996, MOL MICROBIOL, V21, P799, DOI 10.1046/j.1365-2958.1996.401406.x; Boot HJ, 1996, J BACTERIOL, V178, P5388, DOI 10.1128/jb.178.18.5388-5394.1996; Boot HJ, 1996, MOL MICROBIOL, V21, P1117, DOI 10.1046/j.1365-2958.1996.711442.x; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Claus H, 2005, CAN J MICROBIOL, V51, P731, DOI 10.1139/W05-093; DECHER G, 1992, PROG COLL POL SCI S, V89, P160; DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0; Dworkin J, 1996, MOL MICROBIOL, V19, P1241, DOI 10.1111/j.1365-2958.1996.tb02469.x; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Gunther TJ, 2014, RSC ADV, V4, P51156, DOI 10.1039/c4ra03874f; Heyrman J, 2005, INT J SYST EVOL MICR, V55, P111, DOI 10.1099/ijs.0.63240-0; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jakava-Viljanen M, 2002, J BACTERIOL, V184, P6786, DOI 10.1128/JB.184.24.6786-6795.2002; Kern VJ, 2012, J BACTERIOL, V194, P3833, DOI 10.1128/JB.00402-12; KERN W, 1970, RCA REV, V31, P187; KOVAL SF, 1984, CAN J BIOCHEM CELL B, V62, P1181, DOI 10.1139/o84-152; Kuen B, 1997, J BACTERIOL, V179, P1664, DOI 10.1128/jb.179.5.1664-1670.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lederer FL, 2013, MICROBIOL-SGM, V159, P1097, DOI 10.1099/mic.0.065763-0; LORTAL S, 1992, J GEN MICROBIOL, V138, P611, DOI 10.1099/00221287-138-3-611; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Mesnage S, 2001, MICROBIOL-SGM, V147, P1343, DOI 10.1099/00221287-147-5-1343; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mignot T, 2003, MOL MICROBIOL, V47, P917, DOI 10.1046/j.1365-2958.2003.03345.x; Mignot T, 2002, MOL MICROBIOL, V43, P1615, DOI 10.1046/j.1365-2958.2002.02852.x; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Panak P, 1998, J ALLOY COMPD, V271, P262, DOI 10.1016/S0925-8388(98)00067-X; Pink T, 1996, J BIOTECHNOL, V50, P189, DOI 10.1016/0168-1656(96)01564-7; Pollmann K, 2005, MICROBIOL-SGM, V151, P2961, DOI 10.1099/mic.0.28201-0; PUM D, 1994, THIN SOLID FILMS, V244, P882, DOI 10.1016/0040-6090(94)90592-4; Pum D, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/31/312001; Pum D, 2013, INT J MOL SCI, V14, P2484, DOI 10.3390/ijms14022484; Rad B, 2015, ACS NANO, V9, P180, DOI 10.1021/nn502992x; Raff J, 2017, PROTEIN BAS IN PRESS; RENART J, 1979, P NATL ACAD SCI USA, V76, P3116, DOI 10.1073/pnas.76.7.3116; Rothfuss H, 2006, MICROBIOL-SGM, V152, P2779, DOI 10.1099/mic.0.28971-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; SARA M, 1990, ARCH MICROBIOL, V153, P209, DOI 10.1007/BF00249069; Schar-Zammaretti P, 2003, BIOPHYS J, V85, P4076, DOI 10.1016/S0006-3495(03)74820-6; Sekot G, 2012, ARCH MICROBIOL, V194, P525, DOI 10.1007/s00203-012-0792-3; Selenska-Pobell S, 1999, FEMS MICROBIOL ECOL, V29, P59, DOI 10.1111/j.1574-6941.1999.tb00598.x; Selenska-Pobell S, 2001, ANTON LEEUW INT J G, V79, P149, DOI 10.1023/A:1010237711077; Sleytr U B, 1978, Int Rev Cytol, V53, P1, DOI 10.1016/S0074-7696(08)62240-8; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; SLEYTR UB, 1988, METHOD MICROBIOL, V20, P29, DOI 10.1016/S0580-9517(08)70046-1; Sleytr UB, 2014, FEMS MICROBIOL REV, V38, P823, DOI 10.1111/1574-6976.12063; SMITH SH, 1990, CAN J MICROBIOL, V36, P327, DOI 10.1139/m90-057; STEWART M, 1982, J BACTERIOL, V150, P348, DOI 10.1128/JB.150.1.348-357.1982; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Suhr M, 2016, JOVE-J VIS EXP, DOI 10.3791/53572; Suhr M, 2014, BIOMETALS, V27, P1337, DOI 10.1007/s10534-014-9794-8; Teixeira LM, 2010, MACROMOL BIOSCI, V10, P147, DOI 10.1002/mabi.200900175; Thompson Stuart A, 2002, Ann Periodontol, V7, P43, DOI 10.1902/annals.2002.7.1.43; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YAMADA H, 1981, J BACTERIOL, V148, P322, DOI 10.1128/JB.148.1.322-332.1981; Zwick ME, 2012, GENOME RES, V22, P1512, DOI 10.1101/gr.134437.111	64	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156785	10.1371/journal.pone.0156785	http://dx.doi.org/10.1371/journal.pone.0156785			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285458	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000021
J	Candela, ME; Wang, C; Gunawardena, AT; Zhang, KR; Cantley, L; Yasuhara, R; Usami, Y; Francois, N; Iwamoto, M; van der Flier, A; Zhang, YJ; Qin, L; Han, L; Enomoto-Iwamoto, M				Candela, Maria Elena; Wang, Chao; Gunawardena, Aruni T.; Zhang, Kairui; Cantley, Leslie; Yasuhara, Rika; Usami, Yu; Francois, Noelle; Iwamoto, Masahiro; van der Flier, Arjan; Zhang, Yejia; Qin, Ling; Han, Lin; Enomoto-Iwamoto, Motomi			Alpha 5 Integrin Mediates Osteoarthritic Changes in Mouse Knee Joints	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; ALPHA-5-BETA-1 INTEGRIN; FIBRONECTIN FRAGMENTS; GENE-EXPRESSION; CARTILAGE; PROLIFERATION; HISTOPATHOLOGY; CHONDROLYSIS; COOPERATE; PROTEIN	Osteoarthritis (OA) is one of most common skeletal disorders and can affect synovial joints such as knee and ankle joints. alpha 5 integrin, a major fibronectin receptor, is expressed in articular cartilage and has been demonstrated to play roles in synovial joint development and in the regulation of chondrocyte survival and matrix degradation in articular cartilage. We hypothesized that alpha 5 integrin signaling is involved in pathogenesis of OA. To test this, we generated compound mice that conditionally ablate alpha 5 integrin in the synovial joints using the Gdf5Cre system. The compound mice were born normally and had an overall appearance similar to the control mice. However, when the mutant mice received the OA surgery, they showed stronger resistance to osteoarthritic changes than the control. Specifically the mutant knee joints presented lower levels of cartilage matrix and structure loss and synovial changes and showed stronger biomechanical properties than the control knee joints. These findings indicate that alpha 5 integrin may not be essential for synovial joint development but play a causative role in induction of osteoarthritic changes.	[Candela, Maria Elena; Gunawardena, Aruni T.; Zhang, Kairui; Cantley, Leslie; Usami, Yu; Francois, Noelle; Iwamoto, Masahiro; Enomoto-Iwamoto, Motomi] Childrens Hosp Philadelphia, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA; [Wang, Chao; Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Zhang, Kairui] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China; [Yasuhara, Rika] Showa Univ, Sch Dent, Dept Oral Diag Sci, Div Pathol, Tokyo 142, Japan; [van der Flier, Arjan] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Cambridge, MA USA; [Zhang, Yejia] Univ Penn, Perelman Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA; [Qin, Ling] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Drexel University; Southern Medical University - China; Showa University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Enomoto-Iwamoto, M (corresponding author), Childrens Hosp Philadelphia, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA.	iwamotom1@email.chop.edu	Lin, Han/GRF-1081-2022; Han, Lin/D-2602-2014	Han, Lin/0000-0003-4180-1288; Yasuhara, Rika/0000-0003-2282-6295; van der Flier, Arjan/0000-0002-6911-9291	Arthritis Foundation [6389]; NIH [RO1AR061758, RO1AR046000]; Japanese government: MEXT KAKENHI [15K11050]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062908, R01AR046000, R21AR066824] Funding Source: NIH RePORTER	Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese government: MEXT KAKENHI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Arthritis Foundation (http://www.arthritis.org/?utm_source=google&utm_medium=cpc), Innovative Research Award #6389. NIH Funds: RO1AR061758, RO1AR046000 Grant-in-Aid for Scientific Research, Japanese government: MEXT KAKENHI, 15K11050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte-Becerril M, 2014, J ORTHOP RES, V32, P1161, DOI 10.1002/jor.22649; Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684; Batista MA, 2014, MATRIX BIOL, V38, P84, DOI 10.1016/j.matbio.2014.05.008; BROWN RA, 1990, J RHEUMATOL, V17, P65; Buschmann MD, 1999, ARCH BIOCHEM BIOPHYS, V366, P1, DOI 10.1006/abbi.1999.1197; Candela ME, 2014, MATRIX BIOL, V39, P44, DOI 10.1016/j.matbio.2014.08.015; Davey G, 1999, J CELL SCI, V112, P4663; EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Garciadiego-Cazares D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127166; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Homandberg GA, 1998, OSTEOARTHR CARTILAGE, V6, P231, DOI 10.1053/joca.1998.0116; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P381, DOI 10.1053/joca.2002.0524; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; LUST G, 1987, J RHEUMATOL, V14, P28; Murphy PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120872; Ohta Y, 2015, ARTHRITIS RHEUMATOL, V67, P2679, DOI 10.1002/art.39243; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Pulai JI, 2002, ARTHRITIS RHEUM, V46, P1528, DOI 10.1002/art.10334; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Tanaka N, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4307; Turner CJ, 2015, DEVELOPMENT, V142, P797, DOI 10.1242/dev.117572; van der Flier A, 2010, DEVELOPMENT, V137, P2439, DOI 10.1242/dev.049551; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; Wenham CYJ, 2010, THER ADV MUSCULOSKEL, V2, P349, DOI 10.1177/1759720X10378373; WOODS VL, 1994, ARTHRITIS RHEUM, V37, P537, DOI 10.1002/art.1780370414; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yasuda T, 2003, LAB INVEST, V83, P153, DOI 10.1097/01.LAB.0000056999.08437.B2; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824	39	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156783	10.1371/journal.pone.0156783	http://dx.doi.org/10.1371/journal.pone.0156783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280771	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000048
J	Lu, P; Li, JX; Jin, CG; Jiang, BW; Bai, YM				Lu, Ping; Li, Jingxin; Jin, Chenggong; Jiang, Baiwen; Bai, Yamei			Different Growth Responses of an Invasive Weed and a Native Crop to Nitrogen Pulse and Competition	PLOS ONE			English	Article							SOYBEAN GLYCINE-MAX; PIGWEED AMARANTHUS-RETROFLEXUS; PLANT INVASION; USE EFFICIENCY; MOJAVE DESERT; N-2 FIXATION; INTERFERENCE; ABILITY; CHINA; COMMUNITIES	Resource pulses are a common event in agro-ecosystems. A pot experiment was conducted to assess the effects of nitrogen (N) pulses and competition on the growth of an invasive weed, Amaranthus retroflexus, and a native crop, Glycine max. A. retroflexus and G. max were planted in pure culture with two individuals of one species in each pot and in mixed culture with one A. retroflexus and one G. max individual and subjected to three N pulse treatments. The N treatments included a no-peak treatment (NP) with N applied stably across the growing period, a single-peak treatment (SP) with only one N addition on the planting date, and a double-peak treatment (DP) with two N additions, one on the planting date and the other on the flowering date. N pulse significantly impacted biomass and height of the two species across the whole growing season. However, only the relative growth rate (RGR) of A. retroflexus was significantly affected by N pulse. A. retroflexus had the greatest biomass and height in the SP treatment at the first harvest, and in the DP treatment at the last three harvests. Pure culture G. max produced the greatest biomass in the DP treatment. In mixed culture, G. max produced the greatest biomass in the NP treatment. Biomass production of both species was significantly influenced by species combination, with higher biomass in mixed culture than in pure culture at most growth stages. Relative yield total (RYT) values were all greater than 1.0 at the last three harvests across the three N treatments, suggesting partial resource complementarity occurred when A. retroflexus is grown with G. max. These results indicate that A. retroflexus has a strong adaptive capacity to reduce interspecific competition, likely leading to its invasion of G. max cropland in China.	[Lu, Ping; Jin, Chenggong; Jiang, Baiwen; Bai, Yamei] Northeast Agr Univ, Coll Resources & Environm Sci, Harbin, Peoples R China; [Li, Jingxin] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Jiang, BW (corresponding author), Northeast Agr Univ, Coll Resources & Environm Sci, Harbin, Peoples R China.	neauecology@126.com			National Natural Science Foundation of China [30900218, 31370546]; Science Technology Foundation of Heilongjiang Education Office [12541021]; China Postdoctoral Special Science Foundation [200902368]; Heilongjiang Postdoctoral Science-Research Foundation [LBH-Q11161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Foundation of Heilongjiang Education Office; China Postdoctoral Special Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Science-Research Foundation	PL received the funding of the National Natural Science Foundation of China (contract No. 30900218, 31370546), http://www.nsfc.gov.cn/; PL received the funding of the Science Technology Foundation of Heilongjiang Education Office (contract No. 12541021), http://www.hlje.net; PL received the funding of the China Postdoctoral Special Science Foundation (contract No. 200902368), http://res.chinapostdoctor.org.cn/BshWeb/index.shtml; PL received the funding of the Heilongjiang Postdoctoral Science-Research Foundation (contract No. LBH-Q11161), www.hljbsh.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Relva MA, 2010, BIOL INVASIONS, V12, P303, DOI 10.1007/s10530-009-9623-0; Angonin C, 1996, WEED RES, V36, P175, DOI 10.1111/j.1365-3180.1996.tb01813.x; BASKIN JM, 1977, OECOLOGIA, V30, P377, DOI 10.1007/BF00399768; Bensch CN, 2003, WEED SCI, V51, P37, DOI 10.1614/0043-1745(2003)051[0037:IORPAR]2.0.CO;2; Blackshaw RE, 2003, WEED SCI, V51, P532, DOI 10.1614/0043-1745(2003)051[0532:DROWST]2.0.CO;2; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Clements DR, 2004, AGR ECOSYST ENVIRON, V104, P379, DOI 10.1016/j.agee.2004.03.003; Cong X, 2013, CROPS, V1, P73; Cowan P, 1998, WEED SCI, V46, P533, DOI 10.1017/S0043174500091050; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; Crotser MP, 2000, WEED SCI, V48, P20, DOI 10.1614/0043-1745(2000)048[0020:EOGMCC]2.0.CO;2; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Di W, 2010, J NUCL AGR SCI, V24, P612; DIELEMAN A, 1995, WEED SCI, V43, P612, DOI 10.1017/S0043174500081728; Esque TC, 2010, OECOLOGIA, V164, P253, DOI 10.1007/s00442-010-1617-1; FORCELLA F, 1984, AUST J EXP AGR, V24, P421, DOI 10.1071/EA9840421; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Gan YB, 2003, FIELD CROP RES, V80, P147, DOI 10.1016/S0378-4290(02)00171-5; Glauninger J., 1982, Biology and ecology of weeds [Holzner, W. and Numata, M. (Editors)], P149; Harper J. L, 1977, POPULATION BIOL PLAN; Harrison S, 1999, OECOLOGIA, V121, P99, DOI 10.1007/s004420050910; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; James JJ, 2006, J ARID ENVIRON, V67, P528, DOI 10.1016/j.jaridenv.2006.02.014; KIGEL J, 1994, AMARANTH BIOL CHEM T, P39; KNEZEVIC SZ, 1994, WEED SCI, V42, P568, DOI 10.1017/S0043174500076967; LeBrun EG, 2012, J ANIM ECOL, V81, P884, DOI 10.1111/j.1365-2656.2012.01954.x; LEGERE A, 1989, WEED SCI, V37, P84, DOI 10.1017/S0043174500055909; Li X.J., 2004, PESTIC SCI ADM, V25, P13; Li ZY, 2002, INVASIVE ALIEN PLANT, P106; Lindquist JL, 1998, AGRON J, V90, P787, DOI 10.2134/agronj1998.00021962009000060012x; Liu X, 2008, FIELD CROP RES, V105, P157, DOI 10.1016/j.fcr.2007.09.003; Lu ZJ, 2005, WEED SCI, V53, P600, DOI 10.1614/WS-04-188R2.1; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; NAGATA TADAO, 1959, PROC CROP SCI SOC JAPAN, V28, P79; Niu SL, 2008, J PLANT ECOL-UK, V1, P103, DOI 10.1093/jpe/rtn003; Olson BE, 2003, PLANT SOIL, V254, P457, DOI 10.1023/A:1025536100535; ORWICK PL, 1979, WEED SCI, V27, P665, DOI 10.1017/S0043174500046117; PATTERSON DT, 1995, WEED SCI, V43, P483, DOI 10.1017/S0043174500081510; Puricelli EC, 2003, WEED TECHNOL, V17, P446, DOI 10.1614/0890-037X(2003)017[0446:SAACCI]2.0.CO;2; Qin RM, 2013, NEW PHYTOL, V197, P979, DOI 10.1111/nph.12071; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; SAUER JONATHAN D., 1967, ANN MO BOT GARD, V54, P103, DOI 10.2307/2394998; SHURTLEFF JL, 1985, WEED SCI, V33, P654, DOI 10.1017/S004317450008303X; TODD CE, 2010, OECOLOGIA, V164, P253, DOI DOI 10.1007/S00442-010-1617-1; Van Delden A, 2002, WEED RES, V42, P429, DOI 10.1046/j.1365-3180.2002.00303.x; Vasquez E, 2008, INVAS PLANT SCI MANA, V1, P287, DOI 10.1614/IPSM-08-062.1; Vila M, 2004, BIOL INVASIONS, V6, P59, DOI 10.1023/B:BINV.0000010122.77024.8a; Vitta JI, 1999, WEED RES, V39, P259, DOI 10.1046/j.1365-3180.1999.00142.x; WILSON SD, 1986, ECOLOGY, V67, P1236, DOI 10.2307/1938679; Wu JT, 2013, ECOTOXICOLOGY, V22, P608, DOI 10.1007/s10646-013-1052-2; Xu BC, 2013, ECOL RES, V28, P781, DOI 10.1007/s11284-013-1061-x; Xu HG, 2006, BIOL INVASIONS, V8, P1495, DOI 10.1007/s10530-005-5841-2; Zhang DY, 2010, BRIEF INTRO SOYBEAN	55	9	12	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156285	10.1371/journal.pone.0156285	http://dx.doi.org/10.1371/journal.pone.0156285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280410	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000024
J	Betancourth-Cundar, M; Lima, AP; Hodl, W; Amezquita, A				Betancourth-Cundar, Mileidy; Lima, Albertina P.; Hodl, Walter; Amezquita, Adolfo			Decoupled Evolution between Senders and Receivers in the Neotropical Allobates femoralis Frog Complex	PLOS ONE			English	Article							DART-POISON FROG; EPIPEDOBATES-FEMORALIS; MAXIMUM-LIKELIHOOD; CALL FREQUENCY; BEHAVIOR; RECOGNITION; PREFERENCES; COMMUNICATION; DENDROBATIDAE; INTERFERENCE	During acoustic communication, an audible message is transmitted from a sender to a receiver, often producing changes in behavior. In a system where evolutionary changes of the sender do not result in a concomitant adjustment in the receiver, communication and species recognition could fail. However, the possibility of an evolutionary decoupling between sender and receiver has rarely been studied. Frog populations in the Allobates femoralis cryptic species complex are known for their extensive morphological, genetic and acoustic variation. We hypothesized that geographic variation in acoustic signals of A. femoralis was correlated with geographic changes in communication through changes in male-male recognition. To test this hypothesis, we quantified male call recognition using phonotactic responses to playback experiments of advertisement calls with two, three and four notes in eight localities of the Amazonian basin. Then, we reconstructed the ancestral states of call note number in a phylogenetic framework and evaluated whether the character state of the most recent common ancestor predicted current relative responses to two, three and four notes. The probability of a phonotactic response to advertisement calls of A. femoralis males was strongly influenced by the call mid-frequency and the number of notes in most populations. Positive phonotaxis was complete for calls from each individual's population, and in some populations, it was also partial for allotopic calls; however, in two populations, individuals equally recognized calls with two, three or four notes. This evidence, in conjunction with our results from phylogenetic comparative methods, supports the hypothesis of decoupled evolution between sender and receiver in the male-male communication system of the A. femoralis complex. Thus, signal recognition appears to evolve more slowly than the calls.	[Betancourth-Cundar, Mileidy; Amezquita, Adolfo] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Lima, Albertina P.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Pesquisas Biodiversidade, Manaus, Amazonas, Brazil; [Hodl, Walter] Univ Vienna, Dept Integrat Zool, Vienna, Austria	Universidad de los Andes (Colombia); Institute Nacional de Pesquisas da Amazonia; University of Vienna	Betancourth-Cundar, M (corresponding author), Univ Los Andes, Dept Biol Sci, Bogota, Colombia.	cm.betancourth2026@uniandes.edu.co		Lima, Albertina Pimentel/0000-0003-4586-5633	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas'' - COLCIENCIAS [617]; Faculty of Sciences at the Universidad de los Andes - Colombia [2012-2]; Austrian Science Foundation [FWF-P15345, FWF-P25612]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas'' - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Faculty of Sciences at the Universidad de los Andes - Colombia; Austrian Science Foundation(Austrian Science Fund (FWF))	This work was supported by Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas'' - COLCIENCIAS (Grant Jovenes investigadores e innovadores No. 617, 2013 to MBC) the Faculty of Sciences at the Universidad de los Andes - Colombia (Proyecto Semilla 2012-2 to CMB) and two grants to W. Hodl from the Austrian Science Foundation (FWF-P15345 and FWF-P25612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2005, ANIM BEHAV, V70, P1377, DOI 10.1016/j.anbehav.2005.03.012; Amezquita A, 2006, EVOLUTION, V60, P1874; Amezquita A, 2011, P NATL ACAD SCI USA, V108, P17058, DOI 10.1073/pnas.1104773108; Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Andersson S, 1999, TRENDS ECOL EVOL, V14, P174, DOI 10.1016/S0169-5347(99)01615-8; [Anonymous], 2014, TRACER V1 6; ARAK A, 1993, PHILOS T R SOC B, V340, P207, DOI 10.1098/rstb.1993.0059; Bernal XE, 2009, P R SOC B, V276, P1323, DOI 10.1098/rspb.2008.0935; Bioacoustics Research Program, 2014, RAV PRO INT SOUND AN; BLAIR WF, 1958, AM NAT, V92, P27, DOI 10.1086/282007; Bradbury Jack W., 1998, pi; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dawkins MS, 1996, AM NAT, V148, P937, DOI 10.1086/285964; de Luna AG, 2010, ANIM BEHAV, V79, P739, DOI 10.1016/j.anbehav.2009.12.031; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekstrom C, 2013, MESS MISCELLANEOUS E; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Erdtmann LK, 2011, BEHAVIOUR, V148, P485, DOI 10.1163/000579511X565754; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gerhardt H. C, 1988, EVOLUTION AMPHIBIAN, P253; Gerhardt H. Carl, 1995, Amphibian Biology, V2, P603; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Green S., 1979, SOCIAL BEHAV COMMUNI, P73, DOI DOI 10.1007/978-1-4615-9116-0_3; Hastie T., 1986, STAT SCI, V1, P297; Hodl W, 2004, J COMP PHYSIOL A, V190, P823, DOI 10.1007/s00359-004-0536-1; Hodl W, 1983, WISSENSCHAFTLICHER F, V30, P12; Hoke KL, 2010, J EXP BIOL, V213, P3463, DOI 10.1242/jeb.043992; HOLM S, 1979, SCAND J STAT, V6, P65; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison WP, 2009, MESQUITE MODULAR SYS; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PENGILLEY RK, 1971, J ZOOL, V163, P73; Prohl H, 1999, BEHAV ECOL SOCIOBIOL, V46, P215, DOI 10.1007/s002650050612; Prohl Heike, 1997, Amphibia-Reptilia, V18, P437, DOI 10.1163/156853897X00495; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Read M., 2000, FROGS OF THE ECUATOR; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; ROBERTSON JGM, 1986, ANIM BEHAV, V34, P773, DOI 10.1016/S0003-3472(86)80061-6; ROITHMAIR ME, 1994, HERPETOL J, V4, P77; ROITHMAIR ME, 1992, ETHOLOGY, V92, P331, DOI 10.1111/j.1439-0310.1992.tb00970.x; Rojas B, 2006, ETHOLOGY, V112, P564, DOI 10.1111/j.1439-0310.2005.01190.x; Ron SR, 2008, ANIM BEHAV, V76, P1783, DOI 10.1016/j.anbehav.2008.07.024; Ryan M.J., 1988, P637; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; RYAN MJ, 1992, AM NAT, V139, P1370, DOI 10.1086/285391; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Ryan MJ, 2003, ACTA ZOOL SINICA, P713; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schneider H., 2006, AMPHIBIAN BIOL, V7, P2892; Schwartz JJ, 1998, ANIM BEHAV, V56, P55, DOI 10.1006/anbe.1998.0737; SCHWARTZ JJ, 1985, COPEIA, P27; SCHWARTZ JJ, 1984, BEHAV ECOL SOCIOBIOL, V14, P211, DOI 10.1007/BF00299621; Silverstone PA., 1976, NAT HIST MUS LOS ANG, V27, P1; Simoes PI, 2008, BIOTROPICA, V40, P607, DOI 10.1111/j.1744-7429.2008.00416.x; Simoes PI, 2010, ZOOTAXA, P1; Simoes PI, 2014, TROP CONSERV SCI, V7, P811, DOI 10.1177/194008291400700416; Simoes PI, 2012, CONSERV GENET, V13, P1145, DOI 10.1007/s10592-012-0362-x; SUMMERS K, 1992, ANIM BEHAV, V43, P907, DOI 10.1016/0003-3472(92)90004-S; Summers K, 2000, BEHAVIOUR, V137, P7, DOI 10.1163/156853900501845; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ursprung E, 2011, MOL ECOL, V20, P1759, DOI 10.1111/j.1365-294X.2011.05056.x; Velez A, 2012, ETHOLOGY, V118, P377, DOI 10.1111/j.1439-0310.2012.02021.x; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vitt L. J., 2013, HERPETOLOGY INTRO BI; Weary D, 1993, ANIM BEHAV, V45, P417, DOI [10.1006/anbe.1993.1051, DOI 10.1006/ANBE.1993.1051]; WELLS KD, 1980, BEHAV ECOL SOCIOBIOL, V6, P199, DOI 10.1007/BF00569201; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; WILCZYNSKI W, 1993, J COMP PHYSIOL A, V172, P425, DOI 10.1007/BF00213524; Wiley R. Haven, 1994, P157; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2006, GEN ADDITIVE MODELS	79	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155929	10.1371/journal.pone.0155929	http://dx.doi.org/10.1371/journal.pone.0155929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276054	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700009
J	Buonanno, M; Stanislauskas, M; Ponnaiya, B; Bigelow, AW; Randers-Pehrson, G; Xu, YP; Shuryak, I; Smilenov, L; Owens, DM; Brenner, DJ				Buonanno, Manuela; Stanislauskas, Milda; Ponnaiya, Brian; Bigelow, Alan W.; Randers-Pehrson, Gerhard; Xu, Yanping; Shuryak, Igor; Smilenov, Lubomir; Owens, David M.; Brenner, David J.			207-nm UV Light-A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. II: In-Vivo Safety Studies	PLOS ONE			English	Article							PERCUTANEOUS-ABSORPTION; ULTRAVIOLET-RADIATION; VISIBLE CHANGES; SKIN; EXPRESSION; RESPONSES; CONTAMINATION; IRRADIATION; INVITRO; MARKERS	Background UVC light generated by conventional germicidal lamps is a well-established anti-microbial modality, effective against both bacteria and viruses. However, it is a human health hazard, being both carcinogenic and cataractogenic. Earlier studies showed that single-wavelength far-UVC light (207 nm) generated by excimer lamps kills bacteria without apparent harm to human skin tissue in vitro. The biophysical explanation is that, due to its extremely short range in biological material, 207 nm UV light cannot penetrate the human stratum corneum (the outer dead-cell skin layer, thickness 5-20 mu m) nor even the cytoplasm of individual human cells. By contrast, 207 nm UV light can penetrate bacteria and viruses because these cells are physically much smaller. Aims To test the biophysically-based hypothesis that 207 nm UV light is not cytotoxic to exposed mammalian skin in vivo. Methods Hairless mice were exposed to a bactericidal UV fluence of 157 mJ/cm(2) delivered by a filtered Kr-Br excimer lamp producing monoenergetic 207-nm UV light, or delivered by a conventional 254-nm UV germicidal lamp. Sham irradiations constituted the negative control. Eight relevant cellular and molecular damage endpoints including epidermal hyperplasia, pre-mutagenic UV-associated DNA lesions, skin inflammation, and normal cell proliferation and differentiation were evaluated in mice dorsal skin harvested 48 h after UV exposure. Results While conventional germicidal UV (254 nm) exposure produced significant effects for all the studied skin damage endpoints, the same fluence of 207 nm UV light produced results that were not statistically distinguishable from the zero exposure controls. Conclusions As predicted by biophysical considerations and in agreement with earlier in vitro studies, 207-nm light does not appear to be significantly cytotoxic to mouse skin. These results suggest that excimer-based far-UVC light could potentially be used for its anti-microbial properties, but without the associated hazards to skin of conventional germicidal UV lamps.	[Buonanno, Manuela; Ponnaiya, Brian; Bigelow, Alan W.; Randers-Pehrson, Gerhard; Xu, Yanping; Shuryak, Igor; Smilenov, Lubomir; Brenner, David J.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA; [Stanislauskas, Milda; Owens, David M.] Columbia Univ, Dept Dermatol, Med Ctr, New York, NY 10027 USA; [Owens, David M.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Brenner, DJ (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	djb3@cumc.columbia.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	Columbia University Medical Center; NIH NIAMS Skin Disease Research Center pilot project [5P30AR044535-13]; Ushio Inc. (Tokyo, Japan)	Columbia University Medical Center; NIH NIAMS Skin Disease Research Center pilot project; Ushio Inc. (Tokyo, Japan)	This was funded through internal funding at Columbia University Medical Center. This work was also supported by the NIH NIAMS Skin Disease Research Center pilot project 5P30AR044535-13 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Lynn Shostack for her support and advice. GR-P receives royalty payments from Ushio Inc. (Tokyo, Japan) pursuant to exclusive license and research agreements with Columbia University.	Athar M, 2004, TOXICOL APPL PHARM, V195, P370, DOI 10.1016/j.taap.2003.09.030; BISSETT DL, 1987, PHOTOCHEM PHOTOBIOL, V46, P367, DOI 10.1111/j.1751-1097.1987.tb04783.x; BISSETT DL, 1989, PHOTOCHEM PHOTOBIOL, V50, P763, DOI 10.1111/j.1751-1097.1989.tb02907.x; BRONAUGH RL, 1982, TOXICOL APPL PHARM, V62, P481, DOI 10.1016/0041-008X(82)90149-1; Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968; COLE CA, 1983, PHOTOCHEM PHOTOBIOL, V37, P623, DOI 10.1111/j.1751-1097.1983.tb04531.x; Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50; COOHILL TP, 1986, PHOTOCHEM PHOTOBIOL, V44, P359, DOI 10.1111/j.1751-1097.1986.tb04676.x; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Dawson DV, 2013, INT J COSMETIC SCI, V35, P220, DOI 10.1111/ics.12038; GOLDFARB AR, 1951, SCIENCE, V114, P156, DOI 10.1126/science.114.2954.156; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; GREEN H, 1987, CANCER RES, V47, P410; Haley VB, 2012, INFECT CONT HOSP EP, V33, P565, DOI 10.1086/665710; HAWK JLM, 1988, BRIT J DERMATOL, V118, P27, DOI 10.1111/j.1365-2133.1988.tb01746.x; Hayashi L. C., 1998, Asia-Pacific Journal of Public Health, V10, P57, DOI 10.1177/101053959801000201; Hitzschke L, 2001, P 9 INT S SCI TECHN, P411; HORIO T, 1993, BRIT J DERMATOL, V128, P10, DOI 10.1111/j.1365-2133.1993.tb00139.x; IKAI K, 1985, J INVEST DERMATOL, V85, P82, DOI 10.1111/1523-1747.ep12275365; JOSE JG, 1985, EXP EYE RES, V41, P545, DOI 10.1016/S0014-4835(85)80011-7; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010; LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5; LORIAN V, 1985, DIAGN MICR INFEC DIS, V3, P433, DOI 10.1016/0732-8893(85)90082-3; McDevitt JJ, 2012, APPL ENVIRON MICROB, V78, P1666, DOI 10.1128/AEM.06960-11; Metz M, 2006, AM J PATHOL, V169, P815, DOI 10.2353/ajpath.2006.060037; Metzler DE., 2001, BIOCH CHEM REACTIONS; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Rao BK, 2011, OSTOMY WOUND MANAG, V57, P46; Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Russell LM, 2008, EUR J PHARM BIOPHARM, V69, P861, DOI 10.1016/j.ejpb.2008.02.002; Sander CS, 2002, J INVEST DERMATOL, V118, P618, DOI 10.1046/j.1523-1747.2002.01708.x; Sano T, 2009, ARCH DERMATOL RES, V301, P227, DOI 10.1007/s00403-008-0914-6; SATO K, 1991, J PHARM SCI, V80, P104, DOI 10.1002/jps.2600800203; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schweintzger NA, 2015, EXP DERMATOL; Setlow J., 1966, CURR TOP RADIAT RES, P195; SETLOW RB, 1966, J MOL BIOL, V17, P237, DOI 10.1016/S0022-2836(66)80105-5; SODERBERG PG, 1988, ACTA OPHTHALMOL, V66, P141; Sosnin EA, 2005, INSTRUM EXP TECH+, V48, P663, DOI 10.1007/s10786-005-0118-7; Stocks GW, 2011, J ARTHROPLASTY, V26, P771, DOI 10.1016/j.arth.2010.07.001; Sun T T, 1983, Curr Probl Dermatol, V11, P277; U.S. Department of Health and Human Services, 2000, REP CARC BACKGR DOC; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; VARGHESE AJ, 1969, NATURE, V223, P299, DOI 10.1038/223299a0; Volkova G. A., 1984, Journal of Applied Spectroscopy, V41, P1194, DOI 10.1007/BF00659516; Vollkommer F., 1998, Proceedings of 8th International Symposium on the Science and Technology of Light Sources (LS-8), P51; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; Yin R, 2013, CURR OPIN PHARMACOL, V13, P731, DOI 10.1016/j.coph.2013.08.009	52	59	61	8	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0138418	10.1371/journal.pone.0138418	http://dx.doi.org/10.1371/journal.pone.0138418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275949	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700001
J	Fu, CH; Tsai, WC; Lee, TJ; Huang, CC; Chang, PH; Pang, JHS				Fu, Chia-Hsiang; Tsai, Wan-Chun; Lee, Ta-Jen; Huang, Chi-Che; Chang, Po-Hung; Pang, Jong-Hwei Su			Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; UPPER AIRWAY DISEASE; ALLERGIC-ASTHMA; MURINE MODEL; INFLAMMATION; PROTEIN; DIFFERENTIATION; STATINS; EOTAXIN; HL-60	IL-5-induced chemotaxis of eosinophils is an important feature of allergic airway inflammatory diseases. Simvastatin, a lipid lowering agent, has been shown to exhibit anti-inflammatory and anti-allergic effects. Our aim was to investigate the effect of simvastatin on IL-5-induced eosinophil chemotaxis and its regulatory mechanisms. Eosinophils were derived by treating HL-60 clone 15 (HC15) cells with butyric acid (BA) in an alkaline condition or through direct isolation from human peripheral blood. The expressions of CC chemokine receptor 3 (CCR3) and interleukin (IL)-5 receptors (IL5R alpha and beta) were analyzed using RT/real-time PCR. The granular proteins were stained using fast green. Eotaxin-induced chemotaxis was measured using a transwell migration assay. CCR3 protein expression was revealed by immunocytochemistry. An animal model of allergic rhinitis was established by challenging Sprague-Dawley (R) rats repeatedly with ovalbumin. Butyric acid significantly increased the expression of IL5R alpha and IL5R beta, CCR3 and granular proteins in HC15 cells, indicating the maturation of eosinophils (BA-E cells). IL-5 further enhanced the CCR3 expression at both the mRNA and protein levels and the eotaxin-induced chemotaxis of BAE cells. Simvastatin inhibited the effects of IL-5 on BA-E cells, but not in the presence of mevalonate. Similar results were also exhibited in human primary eosinophils. In vivo animal studies further confirmed that oral simvastatin could significantly suppress the infiltration of eosinophils into turbinate tissues of allergic rats. Therefore, simvastatin was demonstrated to inhibit IL-5-induced CCR3 expression and chemotaxis of eosinophils mediated via the mevalonate pathway. We confirmed that simvastatin also reduced eosinophilic infiltration in allergic rhinitis.	[Fu, Chia-Hsiang; Tsai, Wan-Chun; Huang, Chi-Che; Chang, Po-Hung; Pang, Jong-Hwei Su] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Lee, Ta-Jen; Huang, Chi-Che; Chang, Po-Hung] Chang Gung Mem Hosp, Dept Otolaryngol, Taoyuan, Taiwan; [Tsai, Wan-Chun] Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan; [Pang, Jong-Hwei Su] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Pang, JHS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.; Pang, JHS (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan.	jonghwei@mail.cgu.edu.tw		Lee, Ta-Jen/0000-0003-0508-1359; PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Memorial Hospital [CMRPG392311, CMRPG3C1941]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the Chang Gung Memorial Hospital (CMRPG392311 and CMRPG3C1941).	Akuthota P, 2010, CURR OPIN ALLERGY CL, V10, P14, DOI 10.1097/ACI.0b013e328334f693; Bachert C., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P209; Bystrom J, 2012, CURR OPIN ALLERGY CL, V12, P18, DOI 10.1097/ACI.0b013e32834eccaf; Cowan DC, 2010, THORAX, V65, P891, DOI 10.1136/thx.2010.138990; Desai F, 2009, INT IMMUNOPHARMACOL, V9, P153, DOI 10.1016/j.intimp.2008.10.019; Dursun E, 2003, OTOLARYNG HEAD NECK, V129, P526, DOI 10.1016/S0194-5998(03)01576-6; FISCHKOFF SA, 1984, J EXP MED, V160, P179, DOI 10.1084/jem.160.1.179; FISCHKOFF SA, 1986, BLOOD, V68, P185; FISCHKOFF SA, 1988, LEUKEMIA RES, V12, P679, DOI 10.1016/0145-2126(88)90103-8; Folli C, 2008, EUR ANN ALLERGY CLIN, V40, P84; Fortin M, 2010, CYTOKINE, V52, P194, DOI 10.1016/j.cyto.2010.07.005; Foster CA, 1996, J ALLERGY CLIN IMMUN, V98, pS270, DOI 10.1016/S0091-6749(96)70075-1; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Graziano FM, 1999, ALLERGY ASTHMA PROC, V20, P141, DOI 10.2500/108854199778553055; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Huang CC, 2011, EUR J CLIN INVEST, V41, P507, DOI 10.1111/j.1365-2362.2010.02434.x; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Kenji I, 2005, INT ARCH ALLERGY  S1, V137, P77, DOI [10.1159/000085436, DOI 10.1159/000085436]; Kim DY, 2007, EUR J PHARMACOL, V557, P76, DOI 10.1016/j.ejphar.2006.11.027; Kim MA, 2014, CURR OPIN ALLERGY CL, V14, P49, DOI 10.1097/ACI.0000000000000028; Lampinen M, 2004, ALLERGY, V59, P793, DOI 10.1111/j.1398-9995.2004.00469.x; Leckie Maggie J, 2003, Am J Respir Med, V2, P245; Liu JN, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.55; Maneechotesuwan K, 2013, CLIN EXP ALLERGY, V43, P212, DOI 10.1111/cea.12067; Maneechotesuwan K, 2010, J ALLERGY CLIN IMMUN, V126, P754, DOI 10.1016/j.jaci.2010.08.005; Matthew WR, 2008, OTOLARYNGOL CLIN N A, V41, P283, DOI [10.1016/j.otc.2007.11.005, DOI 10.1016/J.OTC.2007.11.005]; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Michael AD, 2011, OTOLARYNGOL CLIN N A, V44, P685, DOI [10.1016/j.otc.2011.03.005, DOI 10.1016/J.OTC.2011.03.005]; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Montecucco F, 2009, RHEUMATOLOGY, V48, P233, DOI 10.1093/rheumatology/ken466; Nakahara Y, 2001, RESPIRATION, V68, P389, DOI 10.1159/000050532; Park IH, 2012, AM J RHINOL ALLERGY, V26, P7, DOI 10.2500/ajra.2012.26.3679; Qiu ZJ, 2009, J BIOL CHEM, V284, P13099, DOI 10.1074/jbc.M807307200; Robinson AJ, 2009, CLIN EXP ALLERGY, V39, P1866, DOI 10.1111/j.1365-2222.2009.03334.x; Saigusa Hanako, 2006, Nihon Jibiinkoka Gakkai Kaiho, V109, P774; Shen HH, 2006, ACTA PHARMACOL SIN, V27, P1594, DOI 10.1111/j.1745-7254.2006.00446.x; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Tulbah AS, 2014, AAPS PHARMSCITECH, V15, P956, DOI 10.1208/s12249-014-0127-6; Wang WH, 2011, OTOLARYNG HEAD NECK, V144, P982, DOI 10.1177/0194599811400367; Wardlaw AJ, 1999, J ALLERGY CLIN IMMUN, V104, P917, DOI 10.1016/S0091-6749(99)70069-2; Wickert LE, 2014, J LEUKOCYTE BIOL, V95, P951, DOI 10.1189/jlb.0713413; Xu L, 2012, INT IMMUNOPHARMACOL, V12, P556, DOI 10.1016/j.intimp.2012.01.012; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zhu YM, 2011, J IMMUNOL, V186, P516, DOI 10.4049/jimmunol.1000955	45	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157186	10.1371/journal.pone.0157186	http://dx.doi.org/10.1371/journal.pone.0157186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275740	Green Submitted, gold, Green Published			2022-12-26	WOS:000377561700083
J	Wooddell, LJ; Kaburu, SSK; Rosenberg, KL; Meyer, JS; Suomi, SJ; Dettmer, AM				Wooddell, Lauren J.; Kaburu, Stefano S. K.; Rosenberg, Kendra L.; Meyer, Jerrold S.; Suomi, Stephen J.; Dettmer, Amanda M.			Matrilineal Behavioral and Physiological Changes following the Death of a Non-Alpha Matriarch in Rhesus Macaques (Macaca mulatta)	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL ACTIVITY; PAPIO-HAMADRYAS-URSINUS; CORTISOL CONCENTRATIONS; CHACMA BABOONS; HAIR CORTISOL; KILLER WHALES; WILD BABOONS; SOCIAL RANK; MONKEYS; DOMINANCE	In many species, the loss of alpha matriarchs is associated with a number of negative outcomes such as troop fission, eviction, wounding, and reduced vitality. However, whether the dramatic consequences of their loss are due to their role as an old experienced figure or to their alpha status remains unclear. We tested the hypothesis that in a semi-free ranging colony of rhesus macaques (Macaca mulatta), the death of a non-alpha matriarch, who had a large set of kin, would lead to changes in behavior and physiological stress within her matriline. Following her death, her matriline increased in aggression, vigilance, and social grooming. Additionally, hierarchical stability, measured by levels of rank changes, decreased within her matriline, and levels of intense aggression by high-ranking animals were more frequent, as well as matrilineal wounding. Although ordinal rank was positively associated with higher chronic hair cortisol concentrations (HCCs) in the months before the matriarch's death, following her death, only those who experienced large increases in rank within her matriline displayed higher HCCs. Changes in matrilineal stability, aggression, behavior, and HCCs within the other two matrilines in the troop were not evident, although caution is needed due to the small sample sizes. We conclude that the death of the non-alpha matriarch led to matrilineal instability, characterized by higher levels of aggression and subsequent vigilance, rank changes, physiological stress, and grooming. We suggest that non-alpha matriarchs with a large number of kin and social support can be integral to the stability of matrilines.	[Wooddell, Lauren J.; Suomi, Stephen J.; Dettmer, Amanda M.] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Poolesville, MD USA; [Kaburu, Stefano S. K.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Rosenberg, Kendra L.; Meyer, Jerrold S.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Davis; University of Massachusetts System; University of Massachusetts Amherst	Wooddell, LJ (corresponding author), NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Poolesville, MD USA.	lauren.wooddell@nih.gov	Kaburu, Stefano SK/O-5055-2019	Kaburu, Stefano SK/0000-0001-7456-3269; Meyer, Jerrold/0000-0002-8382-7075	Division of Intramural Research, National Institute of Child Health and Human Development [1ZIAHD001107-32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Division of Intramural Research, National Institute of Child Health and Human Development, 1ZIAHD001107-32, awarded to SJS, https://www.nichd.nih.gov/about/org/dir/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barrett L, 2012, PHILOS T R SOC B, V367, P2108, DOI 10.1098/rstb.2012.0113; Beehner JC, 2005, ANIM BEHAV, V69, P1211, DOI 10.1016/j.anbehav.2004.08.014; Beisner BA, 2016, AM J PHYS ANTHROPOL, V160, P102, DOI 10.1002/ajpa.22945; Beisner BA, 2014, AM J PRIMATOL, V76, P111, DOI 10.1002/ajp.22214; Beisner BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077369; Beisner BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016365; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; BERNSTEIN IS, 1985, AM J PRIMATOL, V8, P37, DOI 10.1002/ajp.1350080105; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Brent LJN, 2015, CURR BIOL, V25, P746, DOI 10.1016/j.cub.2015.01.037; Clarke FM, 1997, P ROY SOC B-BIOL SCI, V264, P993, DOI 10.1098/rspb.1997.0137; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; Croft DP, 2015, TRENDS ECOL EVOL, V30, P407, DOI 10.1016/j.tree.2015.04.011; Czoty PW, 2009, J NEUROENDOCRINOL, V21, P68, DOI 10.1111/j.1365-2826.2008.01800.x; Davenport LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011385; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Dettmer AM, 2014, PSYCHONEUROENDOCRINO, V42, P59, DOI 10.1016/j.psyneuen.2014.01.002; Dettmer AM, 2016, AM J PRIMATOL, V78, P238, DOI 10.1002/ajp.22503; Dettmer AM, 2015, AM J PRIMATOL, V77, P346, DOI 10.1002/ajp.22350; DEWAAL F, 1982, CHIMPANZEE POLITICS; Douglas-Hamilton I.O., 1975, ELEPHANTS, V113, P72; Douglas-Hamilton I, 2006, APPL ANIM BEHAV SCI, V100, P87, DOI 10.1016/j.applanim.2006.04.014; Elo A. E., 1978, RATING CHESSPLAYERS; Engh AL, 2006, P ROY SOC B-BIOL SCI, V273, P707, DOI 10.1098/rspb.2005.3378; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Foster EA, 2012, SCIENCE, V337, P1313, DOI 10.1126/science.1224198; Fox HE, 1997, J NEUROSCI, V17, P6463; Franz M, 2015, P R SOC B; GUST DA, 1993, HORM BEHAV, V27, P318, DOI 10.1006/hbeh.1993.1024; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Jennings DJ, 2009, ANIM BEHAV, V77, P343, DOI 10.1016/j.anbehav.2008.10.006; Judge PG, 2006, AM J PRIMATOL, V68, P993, DOI 10.1002/ajp.20290; Kaburu SSK, 2015, ANIM BEHAV, V99, P61, DOI 10.1016/j.anbehav.2014.10.018; Kaburu SSK, 2013, AM J PRIMATOL, V75, P789, DOI 10.1002/ajp.22135; Kachel AF, 2011, P ROY SOC B-BIOL SCI, V278, P384, DOI 10.1098/rspb.2010.1247; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Lindburg D. G., 1971, PRIMATE BEHAV, V2, P2; MALLOW GK, 1980, AGGRESSIVE BEHAV, V6, P217, DOI 10.1002/1098-2337(1980)6:3<217::AID-AB2480060303>3.0.CO;2-V; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; McComb K, 2011, P ROY SOC LOND B BIO; Meyer JS, 2014, ILAR J, V55, P347, DOI 10.1093/ilar/ilu023; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Nieuwenhuijsen K., 1982, Zoo Biology, V1, P5, DOI 10.1002/zoo.1430010103; Novak MA, 1998, AM J PRIMATOL, V46, P213, DOI 10.1002/(SICI)1098-2345(1998)46:3&lt;213::AID-AJP3&gt;3.0.CO;2-L; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Oates-O'Brien RS, 2010, J AM ASSOC LAB ANIM, V49, P196; Pannozzo PL, 2007, ETHOLOGY, V113, P881, DOI 10.1111/j.1439-0310.2007.01392.x; Qin Dong-Dong, 2013, Zoological Research, V34, pE42, DOI 10.3724/SP.J.1141.2013.E02E42; Qin DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11267; RUEHLMANN TE, 1988, AM J PRIMATOL, V14, P125, DOI 10.1002/ajp.1350140203; SADE DS, 1972, FUNCTION EVOLUTIONAR; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1993, RECENT PROG HORM RES, V48, P437; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Soma T, 2012, LEAPING AHEAD, P137; Southwick C. H., 1996, P95; Vessey SH, 1984, POLIT PSYCHOL, P623; Watts DP, 1998, PRIMATES, V39, P71, DOI 10.1007/BF02557744; Wenyuan Qu, 1993, International Journal of Primatology, V14, P607, DOI 10.1007/BF02215450; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wooddell LJ, 2015, AM J PRIMATOL, V77, P80	72	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157108	10.1371/journal.pone.0157108	http://dx.doi.org/10.1371/journal.pone.0157108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275743	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700069
J	Flores-Martinez, A; Zanello, G; Shankar, B; Poole, N				Flores-Martinez, Artemisa; Zanello, Giacomo; Shankar, Bhavani; Poole, Nigel			Reducing Anemia Prevalence in Afghanistan: Socioeconomic Correlates and the Particular Role of Agricultural Assets	PLOS ONE			English	Article							NUTRITION OUTCOMES; WOMEN; INTERVENTIONS; STRATEGIES; HOUSEHOLDS; GOODNESS; BURDEN; HEALTH; MODEL; RISK	This research aims to examine the socio-economic correlates of anemia in women, and potential sources of iron in household diets in Afghanistan. It also examines whether ownership of agricultural (particularly livestock) assets and their use in food production has a role in alleviating anaemia, especially where local markets may be inadequate. We analyse data from the 2010/11 Afghanistan Multiple Indicator Cluster Survey, estimating a logistic regression to examine how anemia status of women is associated with socio-economic covariates. A key result found is that sheep ownership has a protective effect in reducing anemia (prevalence odds ratio of sheep ownership on anemia of 0.83, 95% confidence interval (CI): 0.73-0.94) after controlling for wealth and other covariates. This association is found to be robust to alternative model specifications. Given the central role of red meat in heme iron provision and absorption of non-heme iron, we hypothesise that sheep ownership promotes mutton consumption from own-production in a setting where market-sourced provision of nutritious food is a challenge. We then use the 2011/12 National Risk and Vulnerability Assessment household data to understand the Afghan diet from the perspective of dietary iron provision, and to understand interactions between own-production, market sourcing and mutton consumption. Sheep ownership is found to increase the likelihood that a household consumed mutton (odds ratio of 1.27, 95% CI: 1.15-1.42), the number of days in the week that mutton was consumed (prevalence rate ratio of 1.24. 95% CI: 1.12-1.37) and the quantity of mutton consumed (7 grams/person/week). In the subsample of mutton consumers, households sourcing mutton mostly from own production consumed mutton 1.5 days more frequently on average than households relying on market purchase, resulting in 100 grams per person per week higher mutton intake. Thus this analysis lends support to the notion that the linkage between sheep ownership and anemia risk is at least partly due to consumption arising from own-production in the presence of market incompleteness.	[Flores-Martinez, Artemisa; Shankar, Bhavani; Poole, Nigel] Univ London, SOAS, London, England; [Flores-Martinez, Artemisa; Shankar, Bhavani; Poole, Nigel] Leverhulme Ctr Integrat Res Agr & Hlth, London, England; [Zanello, Giacomo] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	University of London; University of London School Oriental & African Studies (SOAS); University of Reading	Shankar, B (corresponding author), Univ London, SOAS, London, England.; Shankar, B (corresponding author), Leverhulme Ctr Integrat Res Agr & Hlth, London, England.	b.shankar@soas.ac.uk		Poole, Nigel/0000-0002-2157-7883; Zanello, Giacomo/0000-0002-0477-1385; Shankar, Bhavani/0000-0001-8102-321X	UK aid from the UK Government (Department for International Development); UK aid from the UK Government	UK aid from the UK Government (Department for International Development); UK aid from the UK Government(CGIAR)	This article is part of the research generated by the Leveraging Agriculture for Nutrition in South Asia Research (LANSA) research consortium, and is funded by UK aid from the UK Government (Department for International Development).; This article is part of the research generated by the Leveraging Agriculture for Nutrition in South Asia Research (LANSA) research consortium, and is funded by UK aid from the UK Government. The views expressed do not necessarily reflect the UK Government's official policies. We gratefully acknowledge the detailed comments provided by two anonymous referees that have resulted in significant improvements to the paper. We are also grateful for comments provided by an anonymous reviewer as part of an internal review of the paper within the LANSA consortium, and by participants at the iHEA congress Milan, 2015. We thank the Central Statistics Organization, Government of Afghanistan, for access to the NRVA dataset and UNICEF/MICS for access to the AMICS data.	Abbaspour N, 2014, J RES MED SCI, V19, P164; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akhter P, 2005, NUTR FOOD SCI, V35, P109, DOI 10.1108/00346650510585895; [Anonymous], 2015, HUM DEV REP 2015 WOR; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Azzarri C., 2014, 7111 WORLD BANK; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bentley ME, 2003, EUR J CLIN NUTR, V57, P52, DOI 10.1038/sj.ejcn.1601504; Berti PR, 2004, PUBLIC HEALTH NUTR, V7, P599, DOI 10.1079/PHN2003595; Central Statistics Organization, 2014, NAT RISK VULN ASS 20; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; CSO & UNICEF, 2012, AFGH MULT IND CLUST; D'Souza A, 2013, FOOD POLICY, V42, P32, DOI 10.1016/j.foodpol.2013.06.007; D'Souza A, 2012, J DEV STUD, V48, P282, DOI 10.1080/00220388.2011.635422; Dangour AD, 2012, P NUTR SOC, V71, P222, DOI 10.1017/S0029665112000213; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Du SF, 2000, J NUTR, V130, P193, DOI 10.1093/jn/130.2.193; Dwivedi A, 2014, SCN NEWS, V31, P19; Engle-Stone R, 2005, J AGR FOOD CHEM, V53, P10276, DOI 10.1021/jf0518453; *FAO, 1982, 26 FAO; Food and Agriculture Organization, 2008, AFGH LIV CENS 2002 0; GILLESPIE S, 1998, MAJOR ISSUES CONTROL; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P205, DOI 10.1111/j.1365-3016.2012.01282.x; Government of Pakistan, 2011, NAT NUTR SURV PAK; Hallberg L, 1998, AM J CLIN NUTR, V68, P3, DOI 10.1093/ajcn/68.1.3; Hoddinott J, 2013, 63 IFPRI; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Huber D, 2010, B WORLD HEALTH ORGAN, V88, P227, DOI 10.2471/BLT.08.059410; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; HURTADO A, 1945, ARCH INTERN MED, V75, P284, DOI 10.1001/archinte.1945.00210290007002; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; KORN EL, 1990, AM STAT, V44, P270, DOI 10.2307/2684345; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; Levitt E, 2011, MALNUTRITION AFGHANI; Levitt EJ, 2009, FOOD SECUR, V1, P177, DOI 10.1007/s12571-009-0018-y; Masset E., 2012, BMJ-BRIT MED J, V344; Ministry of Public Health and UNICEF, 2013, NAT NUTR SURV AFGH 2; Otte J, 2008, 13 AN SCI C AS AUSTR, P22; Paul P, 2013, STAT MED, V32, P67, DOI 10.1002/sim.5525; Rammohan A, 2012, ADDRESSING FEMALE IR, P1; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruel M. T., 2001, CAN FOOD BASED STRAT; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Thomson EF, 2005, PRODUCTION MAR UNPUB; United Nations, 2015, EC SOC SURV AS PAC 2; Varkey S, 2015, LANCET GLOB HEALTH, V3, pE13, DOI 10.1016/S2214-109X(14)70362-6; World Bank, 2014, TEL STAT END SEPT 20; World Bank, 2015, AFGH POV STAT UPD OV; World Bank and Islamic Republic of Afghanistan, 2012, POV FOOD INS AFGH; World Health Organization, 1992, PREV AN WOM TAB AV I; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS	56	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156878	10.1371/journal.pone.0156878	http://dx.doi.org/10.1371/journal.pone.0156878			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1SU	27271735	Green Published, gold, Green Accepted			2022-12-26	WOS:000377560200025
J	Sarkar, S; Dell'Acqua, F; Walsh, SF; Blackwood, N; Scott, S; Craig, MC; Deeley, Q; Murphy, DGM				Sarkar, Sagari; Dell'Acqua, Flavio; Walsh, Sean Froudist; Blackwood, Nigel; Scott, Stephen; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.			A Whole-Brain Investigation of White Matter Microstructure in Adolescents with Conduct Disorder	PLOS ONE			English	Article							EARLY-ONSET; STRUCTURAL CONNECTIVITY; SEX-DIFFERENCES; FEARFUL FACES; FRONTAL-LOBE; IN-VIVO; ABNORMALITIES; CHILDREN; BOYS; CEREBELLUM	Background The biological basis of severe antisocial behaviour in adolescents is poorly understood. We recently reported that adolescents with conduct disorder (CD) have significantly increased fractional anisotropy (FA) of the uncinate fasciculus (a white matter (WM) tract that connects the amygdala to the frontal lobe) compared to their non-CD peers. However, the extent of WM abnormality in other brain regions is currently unclear. Methods We used tract-based spatial statistics to investigate whole brain WM microstructural organisation in 27 adolescent males with CD, and 21 non-CD controls. We also examined relationships between FA and behavioural measures. Groups did not differ significantly in age, ethnicity, or substance use history. Results The CD group, compared to controls, had clusters of significantly greater FA in 7 brain regions corresponding to: 1) the bilateral inferior and superior cerebellar peduncles, cortico-pontocerebellar tract, posterior limb of internal capsule, and corticospinal tract; 2) right superior longitudinal fasciculus; and 3) left cerebellar WM. Severity of antisocial behavior and callous-unemotional symptoms were significantly correlated with FA in several of these regions across the total sample, but not in the CD or control groups alone. Conclusions Adolescents with CD have significantly greater FA than controls in WM regions corresponding predominantly to the fronto-cerebellar circuit. There is preliminary evidence that variation in WM microstructure may be dimensionally related to behaviour problems in youngsters. These findings are consistent with the hypothesis that antisocial behaviour in some young people is associated with abnormalities in WM 'connectivity'.	[Sarkar, Sagari; Dell'Acqua, Flavio; Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Kings Coll London, Sackler Inst Translat Neurodev, London WC2R 2LS, England; [Sarkar, Sagari; Dell'Acqua, Flavio; Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London WC2R 2LS, England; [Sarkar, Sagari] Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Dell'Acqua, Flavio] Kings Coll London, Natbrainlab, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Kings Coll London, NIHR Biomed Res Ctr Mental Hlth South London, London WC2R 2LS, England; [Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Maudsley NHS Fdn Trust, London, England; [Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Inst Psychiat Psychol & Neurosci, London, England; [Walsh, Sean Froudist] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Scott, Stephen] Kings Coll London, Dept Child & Adolescent Psychiat, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; Icahn School of Medicine at Mount Sinai; University of London; King's College London	Sarkar, S (corresponding author), Kings Coll London, Sackler Inst Translat Neurodev, London WC2R 2LS, England.; Sarkar, S (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London WC2R 2LS, England.; Sarkar, S (corresponding author), Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	Sagari.Sarkar@kcl.ac.uk	Dell'Acqua, Flavio/I-1407-2012; craig, michael/AAG-6641-2020; Froudist-Walsh, Sean/AAY-2567-2020	craig, michael/0000-0002-5311-8673; Deeley, Quinton/0000-0001-5306-0769; Blackwood, Nigel/0000-0002-5909-203X; Sarkar, Sagari/0000-0002-4898-4657; Murphy, Declan/0000-0002-6664-7451; Froudist Walsh, Sean/0000-0003-4070-067X; Dell'Acqua, Flavio/0000-0001-5313-5476	Medical Research Council (MRC, United Kingdom); AIMS Network [G0400061/69344]; MRC [G0800298/87573]; National Institute Health Research (NIHR) Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry; South London & Maudsley NHS Foundation Trust; Medical Research Council (MRC, UK) AIMS Network [G0400061/69344]; MRC [MR/N026063/1, G0400061] Funding Source: UKRI; Medical Research Council [G0400061, MR/N026063/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045] Funding Source: researchfish	Medical Research Council (MRC, United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AIMS Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute Health Research (NIHR) Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry; South London & Maudsley NHS Foundation Trust; Medical Research Council (MRC, UK) AIMS Network(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a private donation (to DGMM), together with infrastructure support from the Mortimer D. and Theresa Sackler Foundation (to DGMM), the Medical Research Council (MRC, United Kingdom), AIMS Network (G0400061/69344, DGMM, principle investigator), an ongoing MRC funded study of brain myelination in neurodevelopmental disorders (G0800298/87573)(to DGMM), and the National Institute Health Research (NIHR) Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry and South London & Maudsley NHS Foundation Trust (to DGMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was generously funded by a private donation; together with infrastructure support from the Mortimer D and Theresa Sackler Foundation, the Medical Research Council (MRC, UK) AIMS Network (G0400061/69344, DGMM, principle investigator), an ongoing MRC funded study of brain myelination in neurodevelopmental disorders (G0800298/87573), and the NIHR Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry and South London & Maudsley NHS Foundation Trust.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596]; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Berns GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006773; BERNTSON GG, 1973, PHYSIOL BEHAV, V11, P81, DOI 10.1016/0031-9384(73)90126-1; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P42; Catani M., 2012, ATLAS HUMAN BRAIN CO, DOI DOI 10.1093/MED/9780199541164.001.0001/MED-9780199541164; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; De Bellis Michael D, 2005, Alcohol Clin Exp Res, V29, P1590, DOI 10.1097/01.alc.0000179368.87886.76; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Descoteaux M, 2008, BIOMEDICAL OPTICS ME; Donnellan MB, 2000, J ABNORM PSYCHOL, V109, P396, DOI 10.1037/0021-843X.109.3.396; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fahim C, 2011, AGGRESSIVE BEHAV, V37, P326, DOI 10.1002/ab.20396; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Finger EC, 2008, ARCH GEN PSYCHIAT, V65, P586, DOI 10.1001/archpsyc.65.5.586; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Forth A.E., 2003, HARE PSYCHOPATHY CHE; Fortier CB, 2014, ALCOHOL CLIN EXP RES, V38, P2925, DOI 10.1111/acer.12568; Frick PJ., 2001, ANTISOCIAL PROCESS S; Gelhorn HL, 2007, COMPR PSYCHIAT, V48, P529, DOI 10.1016/j.comppsych.2007.04.009; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; GOODMAN R, 1995, J CHILD PSYCHOL PSYC, V36, P409, DOI 10.1111/j.1469-7610.1995.tb01299.x; Haney-Caron E, 2014, J PSYCHIATR RES, V48, P111, DOI 10.1016/j.jpsychires.2013.09.015; Herpertz SC, 2008, J CHILD PSYCHOL PSYC, V49, P781, DOI 10.1111/j.1469-7610.2008.01905.x; Hoppenbrouwer SS, 2013, PLOS ONE, V8, P8; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jang SH, 2012, NEUROSCI LETT, V506, P146, DOI 10.1016/j.neulet.2011.10.069; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2002, HUM BRAIN MAPP, V15, P216, DOI 10.1002/hbm.10018; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kessler RC, 1996, AM J ORTHOPSYCHIAT, V66, P17, DOI 10.1037/h0080151; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Kruesi MJP, 2004, PSYCHIAT RES-NEUROIM, V132, P1, DOI 10.1016/j.pscychresns.2004.07.002; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; LYNSKEY MT, 1995, J ABNORM CHILD PSYCH, V23, P281, DOI 10.1007/BF01447558; Maier-Hein KH, 2013, BIOL PSYCHIAT; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marcus DK, 2006, PSYCHOL MED, V36, P1571, DOI 10.1017/S0033291706008245; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nicolas JM, 2000, QJM-MON J ASSOC PHYS, V93, P449, DOI 10.1093/qjmed/93.7.449; Okugawa G, 2006, PROG NEURO-PSYCHOPH, V30, P1408, DOI 10.1016/j.pnpbp.2006.05.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson M, 2008, NORD J PSYCHIAT, P1; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Pfefferbaum A, 1997, ALCOHOL CLIN EXP RES, V21, P521, DOI 10.1111/j.1530-0277.1997.tb03798.x; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Ramnani N, 2006, CEREB CORTEX, V16, P811, DOI 10.1093/cercor/bhj024; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sterzer P, 2005, BIOL PSYCHIAT, V57, P7, DOI 10.1016/j.biopsych.2004.10.008; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; TOMASCH J, 1969, BRAIN RES, V13, P476, DOI 10.1016/0006-8993(69)90261-3; Toritsuka M, 2015, NEURAL PLAST, V2015, P6; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Vloet TD, 2008, BEHAV SCI LAW, V26, P99, DOI 10.1002/bsl.794; Wang YY, 2012, BRAIN RES, V1478, P1, DOI 10.1016/j.brainres.2012.08.038; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weinstein M, 2010, ABNORMAL WHITE MATTE; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Zhang J.-M., 2014, BIOMED RES INT, V2014; Zhang JB, 2014, J AM ACAD CHILD PSY, V53, P466, DOI 10.1016/j.jaac.2013.12.015	92	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0155475	10.1371/journal.pone.0155475	http://dx.doi.org/10.1371/journal.pone.0155475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271503	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200002
J	Burghardt, EL; Flenker, KS; Clark, KC; Miguel, J; Ince, D; Winokur, P; Ford, B; McNamara, JO				Burghardt, Elliot L.; Flenker, Katie S.; Clark, Karen C.; Miguel, Jeff; Ince, Dilek; Winokur, Patricia; Ford, Bradley; McNamara, James O., II			Rapid, Culture-Free Detection of Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							BLOOD; NUCLEASE; IDENTIFICATION; THERMONUCLEASE; INFECTIONS; COAGULASE; FREQUENCY; TESTS; DNASE	S. aureus bacteremia (SAB) is a common condition with high rates of morbidity and mortality. Current methods used to diagnose SAB take at least a day, and often longer. Patients with suspected bacteremia must therefore be empirically treated, often unnecessarily, while assay results are pending. In this proof-of-concept study, we describe an inexpensive assay that detects SAB via the detection of micrococcal nuclease (an enzyme secreted by S. aureus) in patient plasma samples in less than three hours. In total, 17 patient plasma samples from culture-confirmed S. aureus bacteremic individuals were tested. 16 of these yielded greater nuclease assay signals than samples from uninfected controls or individuals with non-S. aureus bacteremia. These results suggest that a nuclease-detecting assay may enable the rapid and inexpensive diagnosis of SAB, which is expected to substantially reduce the mortality and morbidity that result from this condition.	[Burghardt, Elliot L.; Flenker, Katie S.; Clark, Karen C.; Miguel, Jeff; Ince, Dilek; Winokur, Patricia; McNamara, James O., II] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ford, Bradley] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	McNamara, JO (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	james-mcnamara@uiowa.edu	Ince, Dilek/AAW-4724-2021	Ince, Dilek/0000-0001-5446-3789; Winokur, Patricia/0000-0002-4826-1790; McNamara, James/0000-0003-4091-618X; Ford, Bradley/0000-0002-7871-7955	National Institutes of Health [AI101391, AI106738, P30CA086862]; Carver College of Medicine of the University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106738, R21AI101391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver College of Medicine of the University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [AI101391 and AI106738 to J.O.M.]. The TPC is supported by the Carver College of Medicine of the University of Iowa and the National Institutes of Health [P30CA086862]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; BRAKSTAD OG, 1995, APMIS, V103, P219, DOI 10.1111/j.1699-0463.1995.tb01098.x; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; Cuatrecasas P, 1968, Brookhaven Symp Biol, V21, P172; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Diekema DJ, 2002, INT J ANTIMICROB AG, V20, P412, DOI 10.1016/S0924-8579(02)00204-2; DISALVO J W, 1958, Med Techn Bull, V9, P191; Engemann JJ, 2005, INFECT CONT HOSP EP, V26, P534, DOI 10.1086/502580; Hernandez FJ, 2014, NAT MED, V20, P301, DOI 10.1038/nm.3460; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; LACHICA RVF, 1972, APPL MICROBIOL, V23, P994, DOI 10.1128/AEM.23.5.994-997.1972; Lagae-Wiens PRS, 2007, J CLIN MICROBIOL, V45, P3478, DOI 10.1128/JCM.01477-07; Lesens O, 2004, J INFECTION, V48, P245, DOI 10.1016/j.jinf.2003.10.010; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; MADISON BM, 1983, J CLIN MICROBIOL, V18, P722, DOI 10.1128/JCM.18.3.722-724.1983; MENZIES RE, 1977, J CLIN PATHOL, V30, P606, DOI 10.1136/jcp.30.7.606; Ringberg H, 2000, INFECTION, V28, P132, DOI 10.1007/s150100050065; Schilcher K, 2014, J INFECT DIS, V210, P473, DOI 10.1093/infdis/jiu091; Valencia-Shelton F, 2014, FUTURE MICROBIOL, V9, P543, DOI 10.2217/fmb.14.8; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	24	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157234	10.1371/journal.pone.0157234	http://dx.doi.org/10.1371/journal.pone.0157234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305148	Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800040
J	Garin, N; Felix, G; Chuard, C; Genne, D; Carballo, S; Hugli, O; Lamy, O; Marti, C; Nendaz, M; Rutschmann, O; Harbarth, S; Perrier, A				Garin, Nicolas; Felix, Garance; Chuard, Christian; Genne, Daniel; Carballo, Sebastian; Hugli, Olivier; Lamy, Olivier; Marti, Christophe; Nendaz, Mathieu; Rutschmann, Olivier; Harbarth, Stephan; Perrier, Arnaud			Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia	PLOS ONE			English	Article							TREATMENT FAILURE; THROMBOCYTOSIS; EUROPE; TIME; PROCALCITONIN; INFECTIONS; MANAGEMENT; MORTALITY; CHILDREN; ETIOLOGY	Background Assessment of early response to treatment is crucial for the management of community-acquired pneumonia (CAP). Objective To describe the predictors and the outcomes of early clinical stability Methods We did a secondary analysis of a multicentre randomized controlled trial on CAP treatment in which 580 patients hospitalized for moderately severe CAP were included. The association between demographic, clinical and biological variables available at inclusion and early clinical stability (stabilization of vital signs within 72 hours with predetermined cut-offs) was assessed by multivariate logistic regression. The association between early clinical stability and mortality, severe adverse events, and length of stay was also tested. Results Younger age (OR 0.98, 95% CI 0.96-0.99), lower platelet count (OR per 10 G/L increment 0.96, 95% CI 0.94-0.98), lower respiratory rate (OR 0.94, 95% CI 0.90-0.97), absence of hypoxemia (OR 0.58, 95% CI 0.40-0.85), lower numbers of co-morbid conditions (OR 0.82, 95% CI 0.69-0.98) and signs or symptoms (OR 0.78, 95% CI 0.68-0.90) were significantly associated with early clinical stability. Patients with early clinical stability had lower 90-days mortality (3.4% vs. 11.9%, p<0.001), fewer admissions to the intensive care unit (2.7% vs. 8.0%, p = 0.005) and a shorter length of stay (6.0 days, IQR 4.0-10.0 vs. 10.0 days, IQR 7.0-15.0, p<0.001). Conclusions Patients with younger age, less co-morbidity, fewer signs or symptoms, less respiratory compromise, and a lower platelet count are more likely to reach early clinical stability. Patients without early clinical stability have a worse prognosis and warrant close scrutiny.	[Garin, Nicolas; Felix, Garance; Carballo, Sebastian; Marti, Christophe; Nendaz, Mathieu; Perrier, Arnaud] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Garin, Nicolas; Felix, Garance; Carballo, Sebastian; Marti, Christophe; Nendaz, Mathieu; Rutschmann, Olivier; Harbarth, Stephan; Perrier, Arnaud] Fac Med, Geneva, Switzerland; [Garin, Nicolas] Reg Hosp Riviera Chablais, Div Internal Med, Monthey, Switzerland; [Chuard, Christian] Hop Cantonal Fribourg, Div Internal Med, Fribourg, Switzerland; [Genne, Daniel] Ctr Hosp Bienne, Div Internal Med, Biel, Switzerland; [Hugli, Olivier] CHU Vaudois, Dept Emergency Med, CH-1011 Lausanne, Switzerland; [Lamy, Olivier] CHU Vaudois, Div Internal Med, CH-1011 Lausanne, Switzerland; [Rutschmann, Olivier] Univ Hosp Geneva, Emergency Dept, Geneva, Switzerland; [Harbarth, Stephan] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland	University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva	Garin, N (corresponding author), Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland.; Garin, N (corresponding author), Fac Med, Geneva, Switzerland.; Garin, N (corresponding author), Reg Hosp Riviera Chablais, Div Internal Med, Monthey, Switzerland.	Nicolas.Garin@hopitalrivierachablais.ch	Hugli, Olivier/AAA-7057-2020; Genne, Daniel/O-2305-2014; Nendaz, Mathieu R/X-6786-2019	Nendaz, Mathieu R/0000-0003-3795-3254; Hugli, Olivier/0000-0003-2312-1625	Swiss National Science Foundation [3200BO-120074]; Clinical Trial Unit; Department of Internal Medicine of Geneva University Hospitals	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Clinical Trial Unit; Department of Internal Medicine of Geneva University Hospitals	The original study (BICAP trial) was supported by grant 3200BO-120074 from the Swiss National Science Foundation (AP) and grants from the Clinical Trial Unit and the Department of Internal Medicine of Geneva University Hospitals (AP, NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram AR, 2013, CLIN MICROBIOL INFEC, V19, P1174, DOI 10.1111/1469-0691.12173; Aliberti S, 2008, CHEST, V134, P955, DOI 10.1378/chest.08-0334; Aliberti S, 2013, EUR RESPIR J, V42, P742, DOI 10.1183/09031936.00100812; Arancibia F, 2000, AM J RESP CRIT CARE, V162, P154, DOI 10.1164/ajrccm.162.1.9907023; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Blasi F, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-6; Blasi F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-44; Brogly N, 2007, J INFECTION, V55, P136, DOI 10.1016/j.jinf.2007.01.011; Chalmers JD, 2008, AM J MED, V121, P219, DOI 10.1016/j.amjmed.2007.10.033; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Dodig S, 2005, ARCH MED RES, V36, P124, DOI 10.1016/j.arcmed.2004.12.011; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Genne D, 2006, EUR J CLIN MICROBIOL, V25, P159, DOI 10.1007/s10096-006-0113-3; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Harrison MT, 2014, THORAX, V69, P609, DOI 10.1136/thoraxjnl-2013-203996; Hillman K, 2005, LANCET, V365, P2091; Hoogewerf M, 2006, CLIN MICROBIOL INFEC, V12, P1097, DOI 10.1111/j.1469-0691.2006.01535.x; Huang DT, 2008, ANN EMERG MED, V52, P48, DOI 10.1016/j.annemergmed.2008.01.003; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lodise TP, 2015, ANTIMICROB AGENTS CH, V59, P1119, DOI 10.1128/AAC.03643-14; Marti C, 2012, CRIT CARE, V16, DOI 10.1186/cc11447; Menendez R, 2004, CLIN INFECT DIS, V39, P1783, DOI 10.1086/426028; Menendez R, 2009, THORAX, V64, P987, DOI 10.1136/thx.2009.118612; Menendez R, 2007, CHEST, V132, P1348, DOI 10.1378/chest.06-1995; Mirsaeidi M, 2010, CHEST, V137, P416, DOI 10.1378/chest.09-0998; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Ott SR, 2012, EUR RESPIR J, V39, P611, DOI 10.1183/09031936.00098411; Prina E, 2013, CHEST, V143, P767, DOI 10.1378/chest.12-1235; Ramirez JA, 2011, J ANTIMICROB CHEMOTH, V66, pIII3, DOI 10.1093/jac/dkr094; Roson B, 2004, ARCH INTERN MED, V164, P502, DOI 10.1001/archinte.164.5.502; Schuetz P, 2011, EUR RESPIR J, V37, P384, DOI 10.1183/09031936.00035610; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Talbot GH, 2012, CLIN INFECT DIS, V55, P1114, DOI 10.1093/cid/cis566; Torres A, 2014, EUR J CLIN MICROBIOL, V33, P1065, DOI 10.1007/s10096-014-2067-1; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; WOLACH B, 1990, PEDIATR INFECT DIS J, V9, P718, DOI 10.1097/00006454-199010000-00007	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157350	10.1371/journal.pone.0157350	http://dx.doi.org/10.1371/journal.pone.0157350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305046	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800050
J	Wu, HT; Wu, HK; Wang, CL; Yang, YL; Wu, WH; Tsai, TH; Chang, HH				Wu, Hau-Tieng; Wu, Han-Kuei; Wang, Chun-Li; Yang, Yueh-Lung; Wu, Wen-Hsiang; Tsai, Tung-Hu; Chang, Hen-Hong			Modeling the Pulse Signal by Wave-Shape Function and Analyzing by Synchrosqueezing Transform	PLOS ONE			English	Article							TIME-FREQUENCY; SPECTRAL-ANALYSIS; COMPLEX NETWORK; PHOTOPLETHYSMOGRAPHY; DECOMPOSITION; EXTRACTION; SERIES	We apply the recently developed adaptive non-harmonic model based on the wave-shape function, as well as the time-frequency analysis tool called synchrosqueezing transform (SST) to model and analyze oscillatory physiological signals. To demonstrate how the model and algorithm work, we apply them to study the pulse wave signal. By extracting features called the spectral pulse signature, and based on functional regression, we characterize the hemodynamics from the radial pulse wave signals recorded by the sphygmomanometer. Analysis results suggest the potential of the proposed signal processing approach to extract health-related hemodynamics features.	[Wu, Hau-Tieng] Univ Toronto, Dept Math, Toronto, ON M5S 1A1, Canada; [Wu, Han-Kuei; Tsai, Tung-Hu] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Wu, Han-Kuei] Taiwan Landseed Hosp, Dept Chinese Med, Taoyuan, Taiwan; [Wang, Chun-Li] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiovasc, Taoyuan, Taiwan; [Wang, Chun-Li] Chang Gung Univ, Coll Med, Taiyuan, Taiwan; [Yang, Yueh-Lung] Keelung Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Keelung, Taiwan; [Wu, Wen-Hsiang] Yuanpei Univ Med Technol, Dept Healthcare Management, Hsinchu, Taiwan; [Chang, Hen-Hong] China Med Univ, Sch Postbaccalaureate Tradit Chinese Med, Taichung, Taiwan; [Chang, Hen-Hong] China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan; [Chang, Hen-Hong] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan	University of Toronto; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, HH (corresponding author), China Med Univ, Sch Postbaccalaureate Tradit Chinese Med, Taichung, Taiwan.; Chang, HH (corresponding author), China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan.; Chang, HH (corresponding author), China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan.	tcmchh55@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Tsai, Tung-Hu/AAG-4558-2021	Stefanadis, Christodoulos/0000-0001-5974-6454; Tsai, Tung-Hu/0000-0002-9007-2547; Wu, Hau-Tieng/0000-0002-0253-3156	Committee on Chinese Medicine and Pharmacy of the Department of Health, Taiwan [CCMP93-RD-010]; China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan	Committee on Chinese Medicine and Pharmacy of the Department of Health, Taiwan; China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan	The authors are grateful for the support from the Committee on Chinese Medicine and Pharmacy of the Department of Health, Taiwan (CCMP93-RD-010) and China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan.	Ahrabian A, 2015, SIGNAL PROCESS, V106, P331, DOI 10.1016/j.sigpro.2014.08.010; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; AUGER F, 1995, IEEE T SIGNAL PROCES, V43, P1068, DOI 10.1109/78.382394; Baudin F, 2014, FRONTIERS PEDIAT SEC, P2; Braunwald E., 2014, BRAUNWALDS HEART DIS, V10th, P95; Caro C.G., 2011, MECH CIRCULATION, V2nd; Chen CH, 1996, HYPERTENSION, V27, P168, DOI 10.1161/01.HYP.27.2.168; Chen YC, 2014, J R STAT SOC B, V76, P651, DOI 10.1111/rssb.12039; Chui CK, 2016, ANAL APPL, V14, P537, DOI 10.1142/S0219530515500165; Chui CK, 2016, APPL COMPUT HARMON A, V40, P97, DOI 10.1016/j.acha.2015.01.003; Cicone A, 2016, APPL COMPUT HARMON A, V41, P384, DOI 10.1016/j.acha.2016.03.001; Daubechies I, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0193; Daubechies I, 2011, APPL COMPUT HARMON A, V30, P243, DOI 10.1016/j.acha.2010.08.002; Davila MI, 2012, NONCONTACT EXTRACTIO; Flandrin P., 1999, WAVELET ANAL ITS APP, V10; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gil E, 2010, PHYSIOL MEAS, V31, P1271, DOI 10.1088/0967-3334/31/9/015; Hou TY, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0194; Hsu TL, 2006, EXP PHYSIOL, V91, P163, DOI 10.1113/expphysiol.2005.031575; HUANG CM, 2011, EVID-BASED COMPL ALT; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang ZH, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/698630; Jeon YJ, 2011, EVID-BASED COMPL ALT, V2011; Kowalski M, 2018, APPL COMPUT HARMON A, V44, P89, DOI 10.1016/j.acha.2016.03.008; Leung L, 2011, INNOVAIT, V4, P49; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lin YT, 2014, ACTA ANAESTH SCAND, V58, P157, DOI 10.1111/aas.12251; Luo CH, 2012, J ALTERN COMPLEM MED, V18, P924, DOI 10.1089/acm.2012.0047; Malik M., 1995, HEART RATE VARIABILI; McEniery CM, 2014, EUR HEART J, V35, P1719, DOI 10.1093/eurheartj/eht565; Melenovsky V, 2007, J HYPERTENS, V25, P1403, DOI 10.1097/HJH.0b013e32811d69df; Milnor W.R., 1989, HEMODYNAMICS, V2nd Edn; Morris D. C., 1990, CLIN METHODS HIST PH; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Oparil S, 2006, CIRCULATION, V113, P1162, DOI 10.1161/CIRCULATIONAHA.105.609313; Ramsay JO., 1997, FUNCTIONAL DATA ANAL, DOI 10.1007/978-1-4757-7107-7; Ricaud B, 2014, ADV COMPUT MATH, V40, P683, DOI 10.1007/s10444-013-9337-9; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Salvi P., 2012, PULSE WAVES VASCULAR, V154, P196, DOI [10.1007/978-3-319-40501-8, DOI 10.1007/978-3-319-40501-8, 10.1007/978-88-470-2439-7]; Scuteri A, 2001, HYPERTENSION, V38, P1471, DOI 10.1161/hy1201.099291; Tavallali P, 2014, MULTISCALE MODEL SIM, V12, P1458, DOI 10.1137/140957767; TAYLOR MG, 1966, CIRC RES, V18, P585, DOI 10.1161/01.RES.18.5.585; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Wang Yuh-Ying Lin, 2012, J Tradit Complement Med, V2, P164; Wang YYL, 2010, J MED BIOL ENG, V30, P125; Wang YYL, 2004, IEEE T BIO-MED ENG, V51, P193, DOI 10.1109/TBME.2003.820378; WANG YYL, 1991, CIRC RES, V69, P246, DOI 10.1161/01.RES.69.1.246; WEI LY, 1984, AM J ACUPUNCTURE, V12, P205; WEI LY, 1985, IEEE T BIO-MED ENG, V32, P245, DOI 10.1109/TBME.1985.325537; Westerhof BE, 2008, HYPERTENSION, V52, P478, DOI 10.1161/HYPERTENSIONAHA.108.116525; Wiseman N, 2014, PRACTICAL DICT CHINE; Wu HT, 2015, IEEE T BIO-MED ENG, V62, P1159, DOI 10.1109/TBME.2014.2375292; Wu HT, 2013, APPL COMPUT HARMON A, V35, P181, DOI 10.1016/j.acha.2012.08.008; Wu HT, 2015, OPTIMIZING EST UNPUB; Yang H, 2014, APPL COMPUTATIONAL H, V39, P33, DOI DOI 10.1016/J.ACHA.2014.08.004; Zhang JT, 2014, SCAND J STAT, V41, P51, DOI 10.1111/sjos.12025	61	11	12	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157135	10.1371/journal.pone.0157135	http://dx.doi.org/10.1371/journal.pone.0157135			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304979	gold, Green Published, Green Submitted			2022-12-26	WOS:000377824800037
J	Jansen, AML; Geilenkirchen, MA; van Wezel, T; Jagmohan-Changur, SC; Ruano, D; van der Klift, HM; van den Akker, BEWM; Laros, JFJ; van Galen, M; Wagner, A; Letteboer, TGW; Gomez-Garcia, EB; Tops, CMJ; Vasen, HF; Devilee, P; Hes, FJ; Morreau, H; Wijnen, JT				Jansen, Anne M. L.; Geilenkirchen, Marije A.; van Wezel, Tom; Jagmohan-Changur, Shantie C.; Ruano, Dina; van der Klift, Heleen M.; van den Akker, Brendy E. W. M.; Laros, Jeroen F. J.; van Galen, Michiel; Wagner, Anja; Letteboer, Tom G. W.; Gomez-Garcia, Encarna B.; Tops, Carli M. J.; Vasen, Hans F.; Devilee, Peter; Hes, Frederik J.; Morreau, Hans; Wijnen, Juul T.			Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR DEFICIENCY; REVISED BETHESDA GUIDELINES; MLH1 PROMOTER METHYLATION; MICROSATELLITE INSTABILITY; MUTATION CARRIERS; SOMATIC METHYLATION; GERMLINE MUTATION; PROSTATE-CANCER; FREQUENT CAUSE	Background and Aims Lynch Syndrome (LS) is caused by pathogenic germline variants in one of the mismatch repair (MMR) genes. However, up to 60% of MMR-deficient colorectal cancer cases are categorized as suspected Lynch Syndrome (sLS) because no pathogenic MMR germline variant can be identified, which leads to difficulties in clinical management. We therefore analyzed the genomic regions of 15 CRC susceptibility genes in leukocyte DNA of 34 unrelated sLS patients and 11 patients with MLH1 hypermethylated tumors with a clear family history. Methods Using targeted next-generation sequencing, we analyzed the entire non-repetitive genomic sequence, including intronic and regulatory sequences, of 15 CRC susceptibility genes. In addition, tumor DNA from 28 sLS patients was analyzed for somatic MMR variants. Results Of 1979 germline variants found in the leukocyte DNA of 34 sLS patients, one was a pathogenic variant (MLH1 c. 1667+1delG). Leukocyte DNA of 11 patients with MLH1 hypermethylated tumors was negative for pathogenic germline variants in the tested CRC susceptibility genes and for germline MLH1 hypermethylation. Somatic DNA analysis of 28 sLS tumors identified eight (29%) cases with two pathogenic somatic variants, one with a VUS predicted to pathogenic and LOH, and nine cases (32%) with one pathogenic somatic variant (n = 8) or one VUS predicted to be pathogenic (n = 1). Conclusions This is the first study in sLS patients to include the entire genomic sequence of CRC susceptibility genes. An underlying somatic or germline MMR gene defect was identified in ten of 34 sLS patients (29%). In the remaining sLS patients, the underlying genetic defect explaining the MMR deficiency in their tumors might be found outside the genomic regions harboring the MMR and other known CRC susceptibility genes.	[Jansen, Anne M. L.; Geilenkirchen, Marije A.; Jagmohan-Changur, Shantie C.; van der Klift, Heleen M.; Laros, Jeroen F. J.; van Galen, Michiel; Devilee, Peter; Wijnen, Juul T.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Jansen, Anne M. L.; van Wezel, Tom; Ruano, Dina; van den Akker, Brendy E. W. M.; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Wagner, Anja] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Letteboer, Tom G. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Gomez-Garcia, Encarna B.] Univ Hosp Maastricht, Dept Clin Genet, Maastricht, Netherlands; [Tops, Carli M. J.; Hes, Frederik J.; Wijnen, Juul T.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Vasen, Hans F.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wijnen, JT (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.; Wijnen, JT (corresponding author), Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands.	j.wijnen@lumc.nl	DEVILEE, PETER/ABR-2140-2022; van Wezel, Tom/AAL-5626-2021; Gomez, Encarna B/E-6022-2018; van Wezel, Tom/Z-3092-2019; Devilee, Peter/GXV-8005-2022	van Wezel, Tom/0000-0001-5773-7730; Gomez-Garcia, Encarna/0000-0003-4999-8847; tops, funnel/0000-0003-3116-4203; Laros, Jeroen F.J./0000-0002-8715-7371; Vasen, Hans/0000-0003-2682-2603; Hes, Frederik/0000-0002-3025-0882; Devilee, Peter/0000-0002-8023-2009	Dutch Cancer Society [UL2012-5542]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society under study number UL2012-5542 (www.kwf.nl). JTW received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1994, CANCER RES, V54, P1645; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Bauer CM, 2011, FAM CANCER, V10, P37, DOI 10.1007/s10689-010-9388-8; Buchanan DD, 2014, APPL CLIN GENET, V7, P183, DOI 10.2147/TACG.S48625; Castillejo A, 2015, J MED GENET, V52, P498, DOI 10.1136/jmedgenet-2015-103076; Castillejo A, 2014, EUR J CANCER, V50, P2241, DOI 10.1016/j.ejca.2014.05.022; Colas C, 2012, ADV CANCER RES, V113, P121, DOI 10.1016/B978-0-12-394280-7.00004-X; Crepin M, 2012, HUM MUTAT, V33, P180, DOI 10.1002/humu.21617; Crucianelli F, 2014, EPIGENETICS-US, V9, P1431, DOI 10.4161/15592294.2014.970080; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Deng G, 2002, BRIT J CANCER, V86, P574, DOI 10.1038/sj.bjc.6600148; Dowty JG, 2013, HUM MUTAT, V34, P490, DOI 10.1002/humu.22262; Elsayed FA, 2015, EUR J HUM GENET, V23, P1080, DOI 10.1038/ejhg.2014.242; Geurts-Giele WRR, 2014, J PATHOL, V234, P548, DOI 10.1002/path.4419; Goel A, 2011, INT J CANCER, V128, P869, DOI 10.1002/ijc.25422; Haraldsdottir S, 2014, GASTROENTEROLOGY, V147, P1308, DOI 10.1053/j.gastro.2014.08.041; Haraldsdottir S, 2014, GENET MED, V16, P553, DOI 10.1038/gim.2013.193; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hitchins MP, 2016, FAM CANCER, V15, P413, DOI 10.1007/s10689-016-9887-3; Jansen AML, 2015, EUROPEAN J HUMAN GEN; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Khalaf R, 2013, J GASTROINTEST SURG, V17, P1500, DOI 10.1007/s11605-013-2206-5; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Ligtenberg MJL, 2013, FAM CANCER, V12, P169, DOI 10.1007/s10689-012-9591-x; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Mensenkamp AR, 2014, GASTROENTEROLOGY, V146, P643, DOI 10.1053/j.gastro.2013.12.002; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Morak M, 2008, EUR J HUM GENET, V16, P804, DOI 10.1038/ejhg.2008.25; Niessen RC, 2009, GENE CHROMOSOME CANC, V48, P737, DOI 10.1002/gcc.20678; Overbeek LIH, 2007, BRIT J CANCER, V96, P1605, DOI 10.1038/sj.bjc.6603754; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Rahner N, 2008, J PATHOL, V214, P10, DOI 10.1002/path.2263; Raymond VM, 2015, FAM CANCER, V14, P77, DOI 10.1007/s10689-014-9753-0; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rodriguez-Soler M, 2013, GASTROENTEROLOGY, V144, P926, DOI 10.1053/j.gastro.2013.01.044; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tenesa A, 2006, BRIT J CANCER, V95, P239, DOI 10.1038/sj.bjc.6603239; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Valle L, 2007, CLIN GENET, V71, P232, DOI 10.1111/j.1399-0004.2007.00751.x; van der Klift HM, 2015, MOL GENET GENOM MED, V3, P327, DOI 10.1002/mgg3.145; van Roon EHJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-180; Vasen HFA, 2010, GASTROENTEROLOGY, V138, P2300, DOI 10.1053/j.gastro.2010.02.053; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Vreeswijk MPG, 2009, HUM MUTAT, V30, P107, DOI 10.1002/humu.20811; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward RL, 2013, GENET MED, V15, P25, DOI 10.1038/gim.2012.91; Win AK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3405; Win AK, 2011, INT J CANCER, V129, P2256, DOI 10.1002/ijc.25870; Young J, 2001, AM J PATHOL, V159, P2107, DOI 10.1016/S0002-9440(10)63062-3; Yurgelun MB, 2015, GASTROENTEROLOGY, V149, P604, DOI 10.1053/j.gastro.2015.05.006	60	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157381	10.1371/journal.pone.0157381	http://dx.doi.org/10.1371/journal.pone.0157381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300758	Green Published, gold			2022-12-26	WOS:000377822200043
J	Cui, Y; Zhao, JZ; Yi, L; Jiang, YG				Cui, Yan; Zhao, Jizong; Yi, Lei; Jiang, Yugang			microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells	PLOS ONE			English	Article							CANCER STATISTICS; EXPRESSION; APOPTOSIS; THERAPY; GROWTH	Rictor upregulation and mTORC complex 2 (mTORC2) over-activation participate in glioma cell progression, yet the underling mechanisms are not known. We here identified microRNA-153 (miR-153) as a potential anti-Rictor miRNA, which was downregulated in multiple human glioma tissues and glioma cell lines (U87MG, T98G, U373MG and U251MG). miR-153 downregulation was correlated with Rictor (mRNA and protein) upregulation and p-Akt Ser473 (the mTORC2 indicator) over-activation in the glioma tissues and cells. Our in vitro evidences suggested that Rictor could be one primary target of miR-153 in glioma cells. Exogenous overexpression of miR-153 downregulated Rictor (mRNA and protein) and decreased p-Akt Ser473 in U87MG cells, leading to significant growth inhibition and apoptosis activation. Notably, U87MG cells with Rictor shRNA knockdown showed similar phenotypes of cells with miR-153 overexpression. More importantly, in Rictor-silenced U87MG cells, miR-153 expression failed to further affect cell growth nor apoptosis. In vivo, we showed that miR-153 overexpression dramatically inhibited U87MG tumor growth in nude mice. Together, these results suggest that miR-153 downregulation could be one important reason of Rictor upregulation and mTORC2 over-activation in glioma cells. Further, miR153-induced anti-glioma cell activity is possibly via downregulating Rictor.	[Cui, Yan; Zhao, Jizong; Yi, Lei; Jiang, Yugang] Cent South Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha 410011, Hunan, Peoples R China; [Zhao, Jizong] Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China	Central South University; Capital Medical University	Jiang, YG (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha 410011, Hunan, Peoples R China.	jiangyuguang27@sina.com			Second Xiangya Hospital of Central South University [2013-029]	Second Xiangya Hospital of Central South University	This study was supported by the research fund of the Second Xiangya Hospital of Central South University (2013-029, to YJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047741; Chen MB, 2016, ONCOTARGET; Chen MB, 2015, BIOCHEM BIOPH RES CO, V463, P954, DOI 10.1016/j.bbrc.2015.06.041; Chen W, 2015, CA CANC J CLIN; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Duzgun Z, 2016, GENE, V575, P187, DOI 10.1016/j.gene.2015.08.060; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; HUANG AL, 1981, CELL, V27, P245, DOI 10.1016/0092-8674(81)90408-6; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Khasraw M, 2009, NAT REV NEUROL, V5, P646, DOI 10.1038/nrneurol.2009.194; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li X, 2016, ONCOTARGET; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Pollack IF, 2010, NAT REV NEUROL, V6, P533, DOI 10.1038/nrneurol.2010.144; Qin LS, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0174-1; Qin LS, 2013, MOL BIOL REP, V40, P5645, DOI 10.1007/s11033-013-2666-4; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005	32	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156915	10.1371/journal.pone.0156915	http://dx.doi.org/10.1371/journal.pone.0156915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295037	Green Submitted, gold, Green Published			2022-12-26	WOS:000377821300014
J	Kim, JA; Cho, JH; Park, IH; Shin, JM; Lee, SA; Lee, HM				Kim, Jin Ah; Cho, Jae Hoon; Park, Il-Ho; Shin, Jae-Min; Lee, Seoung-Ae; Lee, Heung-Man			Diesel Exhaust Particles Upregulate Interleukins IL-6 and IL-8 in Nasal Fibroblasts	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; POLYP-DERIVED FIBROBLASTS; ALLERGIC RHINITIS; AIR-QUALITY; IN-VITRO; KAPPA-B; ACTIVATION; RHINOSINUSITIS; EXPRESSION; SINUSITIS	Background Diesel exhaust particles (DEP) are a major source of air pollution. Nasal fibroblasts are known to produce various cytokines and chemokines. The aim of this study was to evaluate DEP-induced cytokines and chemokines in nasal fibroblasts and to identify the signaling pathway involved. Methods A cytokine and chemokine array performed after stimulation of nasal fibroblasts with DEP revealed that levels of IL-6 and IL-8 were increased most significantly among various cytokines and chemokines. RT-PCR and ELISA were used to determine the mRNA and protein expression levels of IL-6 and IL-8. Signaling pathways of p-38, Akt, and NF-kappa B were analyzed by western blotting, luciferase assay, and ELISA. Organ cultures of nasal interior turbinate were also developed to demonstrate the ex vivo effect of DEP on the expression of IL-6 and IL-8 and the associated signaling pathway. Results DEP increased the expressions of IL-6 and IL-8 in nasal fibroblasts at mRNA and protein levels. DEP induced phosphorylation of p-38, Akt, and NF-kappa B, whereas inhibitors of p-38, Akt, and NF-kappa B blocked these phophorylations and the expressions of IL-6 and IL-8. These findings were also observed in ex vivo organ culture of nasal inferior turbinate. Conclusions DEP induces expression of IL-6 and IL-8 via p-38, Akt, and NF-kappa B signaling pathways in nasal fibroblasts. This finding suggests that air pollution might induce or aggravate allergic rhinitis or chronic rhinosinusitis.	[Kim, Jin Ah; Lee, Heung-Man] Korea Univ, Coll Med, Biomed Sci, Seoul 136705, South Korea; [Cho, Jae Hoon] Konkuk Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Il-Ho; Shin, Jae-Min; Lee, Heung-Man] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Lee, Seoung-Ae; Lee, Heung-Man] Guro Hosp, Inst Med Devices Clin Trial Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Konkuk University; Konkuk University Medical Center; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Biomed Sci, Seoul 136705, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea.; Lee, HM (corresponding author), Guro Hosp, Inst Med Devices Clin Trial Ctr, Seoul, South Korea.	lhman@korea.ac.kr		PARK, IL-HO/0000-0002-7011-6071	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1512]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512).	Bhattacharyya N, 2009, LARYNGOSCOPE, V119, P429, DOI 10.1002/lary.20097; Cho JS, 2013, CLIN EXP ALLERGY, V43, P1038, DOI 10.1111/cea.12165; Cho JS, 2014, ALLERGY ASTHMA IMMUN, V6, P449, DOI 10.4168/aair.2014.6.5.449; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hartupee J, J MOL CELL IN PRESS; Hashimoto S, 2000, AM J RESP CRIT CARE, V161, P280, DOI 10.1164/ajrccm.161.1.9904110; Hox V, 2015, THORAX, V70, P353, DOI 10.1136/thoraxjnl-2014-205520; Jang AS, 2016, CURR OPIN ALLERGY CL, V16, P13, DOI 10.1097/ACI.0000000000000235; Kafoury Ramzi M, 2005, Int J Environ Res Public Health, V2, P403, DOI 10.3390/ijerph2005030004; Kouzaki H, 2009, AM J RHINOL ALLERGY, V23, P273, DOI 10.2500/ajra.2009.23.3310; Lennard CM, 2000, AM J RHINOL, V14, P367, DOI 10.2500/105065800779954329; Lindgren A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-25; Ma CL, 2004, BIOCHEM PHARMACOL, V67, P1975, DOI 10.1016/j.bcp.2004.01.023; Marino E, 2015, THER ADV CHRONIC DIS, V6, P286, DOI 10.1177/2040622315587256; Mazzarella G, 2007, RESP MED, V101, P1155, DOI 10.1016/j.rmed.2006.11.011; Park IH, 2014, OTOLARYNG HEAD NECK, V150, P148, DOI 10.1177/0194599813513880; Park SJ, 2013, AM J RHINOL ALLERGY, V27, P372, DOI 10.2500/ajra.2013.27.3941; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Shi JB, 2010, ORL-J OTO-RHIN-LARYN, V72, P256, DOI 10.1159/000312687; Simoni M, 2015, J THORAC DIS, V7, P34, DOI 10.3978/j.issn.2072-1439.2014.12.10; Song JJ, 2013, INT J PEDIATR OTORHI, V77, P1659, DOI 10.1016/j.ijporl.2013.07.021; Song JJ, 2012, INT J PEDIATR OTORHI, V76, P334, DOI 10.1016/j.ijporl.2011.12.003; Steerenberg PA, 1998, EXP LUNG RES, V24, P85, DOI 10.3109/01902149809046056; Tau J, 2013, INVEST OPHTH VIS SCI, V54, P4759, DOI 10.1167/iovs.12-10541; Thaw CA, 2011, AM J RESP CELL MOL B, V44, P840, DOI [10. 1165/ rcmb. 2010-0011OC, DOI 10.1165/RCMB.2010-0011OC]; Wolf C, 2002, HEALTH PLACE, V8, P129, DOI 10.1016/S1353-8292(01)00040-5; Zhang N, ALLERGY IN PRESS	27	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157058	10.1371/journal.pone.0157058	http://dx.doi.org/10.1371/journal.pone.0157058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295300	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300018
J	Yoshimasu, K; Barbaresi, WJ; Colligan, RC; Voigt, RG; Weaver, AL; Katusic, SK				Yoshimasu, Kouichi; Barbaresi, William J.; Colligan, Robert C.; Voigt, Robert G.; Weaver, Amy L.; Katusic, Slavica K.			Mediating and Moderating Role of Depression, Conduct Disorder or Attention-Deficit/Hyperactivity Disorder in Developing Adolescent Substance Use Disorders: A Population-Based Study	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; LEARNING-DISABILITIES; CHILDREN; ASSOCIATION; CHILDHOOD; SYMPTOMS; ABUSE; ADHD; DEPENDENCE; ALCOHOL	Objective To evaluate the mediating/moderating effects of common internalizing/externalizing disorders on the association between ADHD and adolescent substance use disorders (SUD) in a population-based birth cohort. Methods Among 5718 children in the birth cohort, 343 ADHD incident cases and 712 matched controls were identified. Psychiatric diagnoses prior to age 19 were classified into DSM-IV categories. The association between ADHD and SUD was summarized (hazard ratios (HR), 95% CI). The effect of depression, CD/ODD, anxiety was evaluated separately. Results Assessment of the joint effects of ADHD and each psychiatric disorder did not support a moderating effect of these disorders on SUD on additive scale. However, the association between ADHD and SUD was partially explained by a mediating role of these psychiatric disorders. Conclusion For clinicians our results emphasize that depression (or CD/ODD) confers greater risk for SUD than ADHD alone. Early detection/treatment of SUD among adolescents with depression (or CD/ODD) is crucial regardless of ADHD.	[Yoshimasu, Kouichi; Katusic, Slavica K.] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MI USA; [Barbaresi, William J.] Boston Childrens Hosp, Dept Med, Div Dev Med, Boston, MA USA; [Colligan, Robert C.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Voigt, Robert G.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Weaver, Amy L.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Yoshimasu, Kouichi] Wakayama Med Univ, Sch Med, Dept Hyg, Wakayama, Japan	Mayo Clinic; Harvard University; Boston Children's Hospital; Mayo Clinic; Baylor College of Medicine; Mayo Clinic; Wakayama Medical University	Katusic, SK (corresponding author), Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MI USA.	katusic.slavica@mayo.edu	Voigt, Robert/AAO-6336-2021		National Institutes of Health [HD29745, AG034676]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by Public Health Service research grants HD29745 and AG034676 from the National Institutes of Health.	American Psychiatric Association, 2013, DESK REFERENCE TO TH; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Arcos-Burgos M, 2012, HUM GENET, V131, P917, DOI 10.1007/s00439-012-1164-4; Barkley R, 2006, ATTENTION DEFICIT HY, P184; Brook DW, 2010, ARCH PEDIAT ADOL MED, V164, P930, DOI 10.1001/archpediatrics.2010.180; Burke JD, 2012, J ABNORM CHILD PSYCH, V40, P35, DOI 10.1007/s10802-011-9558-7; Deas D, 2006, J CLIN PSYCHIAT, V67, P18, DOI 10.4088/JCP.0706e02; Falck RS, 2008, DRUG ALCOHOL DEPEN, V98, P24, DOI 10.1016/j.drugalcdep.2008.04.004; Fergusson DM, 2007, DRUG ALCOHOL DEPEN, V88, pS14, DOI 10.1016/j.drugalcdep.2006.12.011; Goldstein BI, 2009, J AM ACAD CHILD PSY, V48, P1182, DOI 10.1097/CHI.0b013e3181bef6e8; Griswold KS, 2008, AM FAM PHYSICIAN, V77, P331; Haavik J, 2010, EXPERT REV NEUROTHER, V10, P1569, DOI [10.1586/ern.10.149, 10.1586/ERN.10.149]; HAMMILL DD, 1993, J LEARN DISABIL, V26, P295, DOI 10.1177/002221949302600502; Hawton K, 2013, J AFFECT DISORDERS, V151, P821, DOI 10.1016/j.jad.2013.08.020; Katusic SK, 2005, J CHILD ADOL PSYCHOP, V15, P764, DOI 10.1089/cap.2005.15.764; Katusic SK, 2005, ANN EPIDEMIOL, V15, P430, DOI 10.1016/j.annepidem.2004.12.004; Katusic SK, 1998, MAYO CLIN PROC, V73, P1053, DOI 10.4065/73.11.1053; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Kotov R, 2011, ARCH GEN PSYCHIAT, V68, P1003, DOI 10.1001/archgenpsychiatry.2011.107; KURLAND LT, 1981, SCI AM, V245, P54, DOI 10.1038/scientificamerican1081-54; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Levy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105640; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; March JS, 2000, J ABNORM CHILD PSYCH, V28, P527, DOI 10.1023/A:1005179014321; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MOATS LC, 1993, J LEARN DISABIL, V26, P282, DOI 10.1177/002221949302600501; Molina BSG, 2003, J ABNORM PSYCHOL, V112, P497, DOI 10.1037/0021-843X.112.3.497; Nemoda Z, 2011, NEUROSCI BIOBEHAV R, V35, P1665, DOI 10.1016/j.neubiorev.2011.04.002; Pennington BF, 2005, ADV CHILD DEV BEHAV, V33, P263, DOI 10.1016/S0065-2407(05)80010-2; Rose BM, 2004, J DEV BEHAV PEDIATR, V25, P58, DOI 10.1097/00004703-200402000-00013; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P320; Serra-Pinheiro MA, 2013, J ATTEN DISORD, V17, P459, DOI 10.1177/1087054711435362; Shrier LA, 2003, PEDIATRICS, V111, pE699, DOI 10.1542/peds.111.6.e699; Sousa NO, 2011, J PSYCHIATR RES, V45, P829, DOI 10.1016/j.jpsychires.2010.10.012; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Therneau T.M., 2000, MODELING SURVIVAL DA; Tuithof M, 2012, DRUG ALCOHOL DEPEN, V123, P115, DOI 10.1016/j.drugalcdep.2011.10.030; Vidal SI, 2012, EUR ADDICT RES, V18, P253, DOI 10.1159/000337328; Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z; Wilens TE, 2002, J AM ACAD CHILD PSY, V41, P262, DOI 10.1097/00004583-200203000-00005; Williams PL, 2010, AIDS BEHAV, V14, P1072, DOI 10.1007/s10461-010-9782-0; Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133; Yoshimasu Kouichi, 2012, Curr Drug Abuse Rev, V5, P291; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x; Young Joel, 2008, Adolesc Med State Art Rev, V19, P216	45	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157488	10.1371/journal.pone.0157488	http://dx.doi.org/10.1371/journal.pone.0157488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294778	gold, Green Published, Green Submitted			2022-12-26	WOS:000377821300048
J	Haddi, K; Mendes, MV; Barcellos, MS; Lino-Neto, J; Freitas, HL; Guedes, RNC; Oliveira, EE				Haddi, Khalid; Mendes, Marcos V.; Barcellos, Marcelo S.; Lino-Neto, Jose; Freitas, Hemerson L.; Guedes, Raul Narciso C.; Oliveira, Eugenio E.			Sexual Success after Stress? Imidacloprid-Induced Hormesis in Males of the Neotropical Stink Bug Euschistus heros	PLOS ONE			English	Article							WEEVIL SITOPHILUS-ZEAMAIS; NICOTINIC ACETYLCHOLINE-RECEPTORS; STAL HEMIPTERA DELPHACIDAE; CINNAMON ESSENTIAL OILS; MAIZE WEEVIL; COLEOPTERA-CURCULIONIDAE; DROSOPHILA-MELANOGASTER; INSECTICIDE RESISTANCE; BEHAVIORAL AVOIDANCE; CARAUSIUS-MOROSUS	Environmental stress in newly-emerged adult insects can have dramatic consequences on their life traits (e.g., dispersion, survival and reproduction) as adults. For instance, insects sublethally exposed to environmental stressors (e.g., insecticides) can gain fitness benefits as a result of hormesis (i.e., benefits of low doses of compounds that would be toxic at higher doses). Here, we experimentally tested whether sublethal exposure to the insecticide imidacloprid would hormetically affect the sexual fitness of newly-emerged adults of the Neotropical brown stink bug Euschistus heros (Hemiptera: Heteroptera: Pentatomidae), which is the most abundant and prevalent insect pest in Neotropical soybean fields. We evaluated the sexual fitness of four couple combinations: unexposed couples, exposed females, exposed males, and exposed couples. Sublethal exposure to dry residues (i.e., contact) of imidacloprid (at 1% of recommended field rate) did not affect insect survival, but led to higher mating frequencies when at least one member of the couple was exposed. However, the average mating duration was shortened when only females were exposed to imidacloprid. Moreover, exposed males showed higher locomotory (walking) activity, lower respiration rates and induced higher fecundity rates when mated to unexposed females. Although the reproductive tracts of exposed males did not differ morphometrically from unexposed males, their accessory glands exhibited positive reactions for acidic and basic contents. Our findings suggest that males of the Neotropical brown stink bug hormetically increase their sexual fitness when cued by impending insecticidal stress in early adulthood.	[Haddi, Khalid; Mendes, Marcos V.; Freitas, Hemerson L.; Guedes, Raul Narciso C.; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Haddi, Khalid] Univ Fed Vicosa, Programa Posgrad Entomol, BR-36570900 Vicosa, MG, Brazil; [Barcellos, Marcelo S.; Lino-Neto, Jose] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Haddi, K; Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.; Haddi, K (corresponding author), Univ Fed Vicosa, Programa Posgrad Entomol, BR-36570900 Vicosa, MG, Brazil.	khalid.haddi@ufv.br; eugenio@ufv.br	Haddi, Khalid/K-6387-2018; de Oliveira, Eugenio Eduardo/ABE-8935-2021; de Oliveira, Eugênio Eduardo/F-4045-2016; Guedes, Raul Narciso Carvalho/L-3924-2013	Haddi, Khalid/0000-0002-2655-4365; de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549	CAPES Foundation; National Council of Scientific and Technological Development (CNPq); Minas Gerais State Foundation for Research Aid (FAPEMIG); Arthur Bernardes Foundation (FUNARBE)	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Foundation for Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Arthur Bernardes Foundation (FUNARBE)	Grants from the CAPES Foundation, the National Council of Scientific and Technological Development (CNPq), the Minas Gerais State Foundation for Research Aid (FAPEMIG), and the Arthur Bernardes Foundation (FUNARBE) supported this work.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Borges M, 2008, METODOLOGIAS CRIACAO, P18; BURGER JM, 2004, SCI AGING KNOWLEDGE, pPE30, DOI DOI 10.1126/SAGEKE.2004.28.PE30; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Cordeiro EMG, 2013, CHEMOSPHERE, V93, P1111, DOI 10.1016/j.chemosphere.2013.06.030; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Correa AS, 2014, ANN APPL BIOL, V165, P137, DOI 10.1111/aab.12127; Correa AS, 2011, CROP PROT, V30, P1655, DOI 10.1016/j.cropro.2011.08.022; Costantini D, 2014, EARLY LIFE HORMESIS, P39; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Droge-Young EM, 2015, BEHAV ECOL, DOI [10.1093/beheco/arv1191, DOI 10.1093/BEHECO/ARV1191]; Duffield KR, 2015, J EVOLUTION BIOL, V28, P1872, DOI 10.1111/jeb.12703; Farias LR, 2014, NEOTROP ENTOMOL, V43, P106, DOI 10.1007/s13744-013-0187-4; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gatehouse AG, 1997, ANNU REV ENTOMOL, V42, P475, DOI 10.1146/annurev.ento.42.1.475; Ge LQ, 2010, PESTIC BIOCHEM PHYS, V98, P279, DOI 10.1016/j.pestbp.2010.06.019; Ghimire N, 2013, ECOL ECON, V89, P73, DOI 10.1016/j.ecolecon.2013.02.003; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Correa YDG, 2015, PESTIC BIOCHEM PHYS, V125, P31, DOI 10.1016/j.pestbp.2015.06.005; Green K, 2009, ANIM BEHAV, V77, P887, DOI 10.1016/j.anbehav.2008.12.017; Guedes NMP, 2009, J APPL ENTOMOL, V133, P524, DOI 10.1111/j.1439-0418.2009.01391.x; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guedes RNC, 2009, J ECON ENTOMOL, V102, P170, DOI 10.1603/029.102.0124; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; Haddi K, 2015, J ECON ENTOMOL, V108, P2815, DOI 10.1093/jee/tov255; Haddi K, 2015, J ECON ENTOMOL, V108, P362, DOI 10.1093/jee/tou049; Harano T, 2015, J EVOLUTION BIOL, V28, P320, DOI 10.1111/jeb.12563; Jeschke P, 2013, ANGEW CHEM INT EDIT, V52, P9464, DOI 10.1002/anie.201302550; KESTLER P, 1991, COMP BIOCHEM PHYS C, V100, P207, DOI 10.1016/0742-8413(91)90155-M; Kivimagi I, 2013, EUR J ENTOMOL, V110, P47, DOI 10.14411/eje.2013.006; Le Bourg E, 2011, EXP GERONTOL, V46, P345, DOI 10.1016/j.exger.2010.08.003; Lee CY., 2000, J BIOSCIENCES, V11, P107, DOI DOI 10.5772/66461; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Lopez-Martinez G, 2012, J EXP BIOL, V215, P2150, DOI 10.1242/jeb.065631; Mallqui KSV, 2014, J ECON ENTOMOL, V107, P860, DOI 10.1603/EC13526; Matsumura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127042; Morales JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067283; Nicodemo D, 2014, ENVIRON TOXICOL CHEM, V33, P2070, DOI 10.1002/etc.2655; Noguera JC, 2011, FUNCT ECOL, V25, P1144, DOI 10.1111/j.1365-2435.2011.01856.x; Oliveira EE, 2005, NEOTROP ENTOMOL, V34, P981, DOI 10.1590/S1519-566X2005000600015; Oliveira EE, 2007, CHEMOSPHERE, V69, P17, DOI 10.1016/j.chemosphere.2007.04.077; Oliveira EE, 2011, INSECT BIOCHEM MOLEC, V41, P872, DOI 10.1016/j.ibmb.2011.08.001; Oliveira EE, 2010, J NEUROPHYSIOL, V103, P2770, DOI 10.1152/jn.00963.2009; Panizzi AR, 2014, SOJA MANEJO INTEGRAD, P335; Pereira CJ, 2009, CROP PROT, V28, P168, DOI 10.1016/j.cropro.2008.10.001; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Qu YY, 2015, ECOTOXICOLOGY, V24, P479, DOI 10.1007/s10646-014-1396-2; Rix RR, 2015, J PEST SCI, P1; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Salmon AB, 2001, EVOLUTION, V55, P1600, DOI 10.1111/j.0014-3820.2001.tb00679.x; Saluso A, 2011, NEOTROP ENTOMOL, V40, P704, DOI 10.1590/S1519-566X2011000600011; Santos MF, 2016, J PEST SCI, V89, P231, DOI 10.1007/s10340-015-0666-y; Silva CC, 2008, PESQUI AGROPECU BRAS, V43, P575, DOI 10.1590/S0100-204X2008000500004; Silva FAC, 2011, NEOTROP ENTOMOL, V40, P35, DOI 10.1590/S1519-566X2011000100005; Sosa-Gomez DR, 2009, J ECON ENTOMOL, V102, P1209, DOI 10.1603/029.102.0346; Sosa-Gomez DR, 2010, PESQUI AGROPECU BRAS, V45, P767, DOI 10.1590/S0100-204X2010000700019; Sousa AH, 2012, J ECON ENTOMOL, V105, P2187, DOI 10.1603/EC12218; Szczepaniec A, 2013, EXP APPL ACAROL, V59, P307, DOI 10.1007/s10493-012-9614-1; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Unkiewicz-Winiarczyk A, 2012, B ENVIRON CONTAM TOX, V89, P960, DOI 10.1007/s00128-012-0814-5; Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x; Vidau C, 2009, TOXICOL IN VITRO, V23, P589, DOI 10.1016/j.tiv.2009.01.017; Yu YL, 2012, CROP PROT, V34, P59, DOI 10.1016/j.cropro.2011.08.026; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zanuncio TV, 2003, CROP PROT, V22, P941, DOI 10.1016/S0261-2194(03)00094-2	73	40	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156616	10.1371/journal.pone.0156616	http://dx.doi.org/10.1371/journal.pone.0156616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284906	gold, Green Published, Green Submitted			2022-12-26	WOS:000377564000017
J	Hong, MG; Jung, E; Yang, S; Jung, W; Seong, YJ; Park, E; Bramos, A; Kim, KE; Lee, S; Daghlian, G; Seo, JI; Choi, I; Choi, IS; Koh, CJ; Kobielak, A; Ying, QL; Johnson, M; Gardner, D; Wong, AK; Choi, D; Hong, YK				Hong, Mingu; Jung, Eunson; Yang, Sara; Jung, Wonhyuek; Seong, Young Jin; Park, Eunkyung; Bramos, Athanasios; Kim, Kyu Eui; Lee, Sunju; Daghlian, George; Seo, Jung In; Choi, Inho; Choi, In-Seon; Koh, Chester J.; Kobielak, Agnieszka; Ying, Qi-Long; Johnson, Maxwell; Gardner, Daniel; Wong, Alex K.; Choi, Dongwon; Hong, Young-Kwon			Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells	PLOS ONE			English	Article							SECONDARY LYMPHEDEMA; GFP REPORTER; VESSELS; PROX1; EXPRESSION; VISUALIZATION; REGENERATION; METASTASIS; PATTERNS; MICE	Several lymphatic reporter mouse lines have recently been developed to significantly improve imaging of lymphatic vessels. Nonetheless, the usage of direct visualization of lymphatic vessels has not been fully explored and documented. Here, we characterized a new Prox1-tdTomato transgenic lymphatic reporter mouse line, and demonstrated how this animal tool enables the researchers to efficiently assess developmental, surgical and pathological lymphangiogenesis by direct visualization of lymphatic vessels. Moreover, we have derived embryonic stem cells from this reporter line, and successfully differentiated them into lymphatic vessels in vivo. In conclusion, these experimental tools and techniques will help advance lymphatic research.	[Hong, Mingu; Jung, Eunson; Yang, Sara; Jung, Wonhyuek; Seong, Young Jin; Park, Eunkyung; Bramos, Athanasios; Kim, Kyu Eui; Lee, Sunju; Daghlian, George; Seo, Jung In; Choi, Inho; Johnson, Maxwell; Gardner, Daniel; Wong, Alex K.; Choi, Dongwon; Hong, Young-Kwon] Univ So Calif, Div Plast & Reconstruct Surg, Dept Surg, Keck Sch Med, Los Angeles, CA 90033 USA; [Hong, Mingu; Jung, Eunson; Yang, Sara; Jung, Wonhyuek; Seong, Young Jin; Park, Eunkyung; Kim, Kyu Eui; Lee, Sunju; Daghlian, George; Seo, Jung In; Choi, Dongwon; Hong, Young-Kwon] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Choi, Inho] Hoseo Univ, Dept Pharmaceut Engn, Asan, South Korea; [Choi, In-Seon; Koh, Chester J.] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Urol, Houston, TX 77030 USA; [Kobielak, Agnieszka] Univ Warsaw, Ctr New Technol, S Banacha 2c,Room 2107, Warsaw, Poland; [Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Hoseo University; Baylor College of Medicine; University of Warsaw; University of Southern California	Choi, D; Hong, YK (corresponding author), Univ So Calif, Div Plast & Reconstruct Surg, Dept Surg, Keck Sch Med, Los Angeles, CA 90033 USA.; Choi, D; Hong, YK (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	dongwcho@usc.edu; young.hong@usc.edu	Bramos, Athanasios/N-2119-2019; Koh, Chester J./M-8373-2017	Koh, Chester J./0000-0001-8696-5193; Kobielak, Agnieszka/0000-0002-9293-0787; Daghlian, George/0000-0002-4921-0442; Wong, Alex/0000-0002-4068-5230	American Heart Association [13GRNT17060131]; National Institute of Health [R01HL121036, R21HL119583]; Southern California Clinical and Translational Science Institute (SC-CTSI) [KL2TR000131]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL119583, R01HL121036] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern California Clinical and Translational Science Institute (SC-CTSI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by American Heart Association (13GRNT17060131 to YKH), National Institute of Health (R01HL121036 & R21HL119583 to YKH) and Southern California Clinical and Translational Science Institute (SC-CTSI, KL2TR000131 to AKW).	Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Bianchi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122976; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Choi I, 2012, CIRCULATION, V125, P872, DOI 10.1161/CIRCULATIONAHA.111.030296; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hagerling R, 2011, BIOCHEM SOC T, V39, P1674, DOI 10.1042/BST20110722; Iljin K, 2001, FASEB J, V15, P1028, DOI 10.1096/fj.00-0383com; Martinez-Corral I, 2012, P NATL ACAD SCI USA, V109, P6223, DOI 10.1073/pnas.1115542109; Masood R, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.33; Mendez U, 2012, AM J PHYSIOL-HEART C, V302, pH2250, DOI 10.1152/ajpheart.01159.2011; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; PHILIPS FREDERICK S., 1961, CANCER RES, V21, P1577; Raju A, 2015, ANN SURG, V261, P1013, DOI 10.1097/SLA.0000000000000763; Ramirez MI, 1999, DEV DYNAM, V215, P319, DOI 10.1002/(SICI)1097-0177(199908)215:4<319::AID-AJA4>3.0.CO;2-B; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Saban MR, 2004, BLOOD, V104, P3228, DOI 10.1182/blood-2004-04-1428; Seth A, 2014, DEVELOPMENT, V141, P538, DOI 10.1242/dev.099481; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Truman LA, 2012, AM J PATHOL, V180, P1715, DOI 10.1016/j.ajpath.2011.12.026	24	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157126	10.1371/journal.pone.0157126	http://dx.doi.org/10.1371/journal.pone.0157126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280889	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000090
J	Khoramshahi, M; Shukla, A; Raffard, S; Bardy, BG; Billard, A				Khoramshahi, Mahdi; Shukla, Ashwini; Raffard, Stephane; Bardy, Benoit G.; Billard, Aude			Role of Gaze Cues in Interpersonal Motor Coordination: Towards Higher Affiliation in Human-Robot Interaction	PLOS ONE			English	Article							EYE-HAND COORDINATION; JOINT ACTION; EMOTION RECOGNITION; SOCIAL COGNITION; HUMAN LIKENESS; SCHIZOPHRENIA; ATTENTION; DIRECTION; FACES; REAL	Background The ability to follow one another's gaze plays an important role in our social cognition; especially when we synchronously perform tasks together. We investigate how gaze cues can improve performance in a simple coordination task (i.e., the mirror game), whereby two players mirror each other's hand motions. In this game, each player is either a leader or follower. To study the effect of gaze in a systematic manner, the leader's role is played by a robotic avatar. We contrast two conditions, in which the avatar provides or not explicit gaze cues that indicate the next location of its hand. Specifically, we investigated (a) whether participants are able to exploit these gaze cues to improve their coordination, (b) how gaze cues affect action prediction and temporal coordination, and (c) whether introducing active gaze behavior for avatars makes them more realistic and human-like (from the user point of view). Methodology/Principal Findings 43 subjects participated in 8 trials of the mirror game. Each subject performed the game in the two conditions (with and without gaze cues). In this within-subject study, the order of the conditions was randomized across participants, and subjective assessment of the avatar's realism was assessed by administering a post-hoc questionnaire. When gaze cues were provided, a quantitative assessment of synchrony between participants and the avatar revealed a significant improvement in subject reaction-time (RT). This confirms our hypothesis that gaze cues improve the follower's ability to predict the avatar's action. An analysis of the pattern of frequency across the two players' hand movements reveals that the gaze cues improve the overall temporal coordination across the two players. Finally, analysis of the subjective evaluations from the questionnaires reveals that, in the presence of gaze cues, participants found it not only more human-like/realistic, but also easier to interact with the avatar. Conclusion/Significance This work confirms that people can exploit gaze cues to predict another person's movements and to better coordinate their motions with their partners, even when the partner is a computer-animated avatar. Moreover, this study contributes further evidence that implementing biological features, here task-relevant gaze cues, enable the humanoid robotic avatar to appear more human-like, and thus increase the user's sense of affiliation.	[Khoramshahi, Mahdi; Shukla, Ashwini; Billard, Aude] Ecole Polytech Fed Lausanne, Sch Engn, Learning Algorithms & Syst Lab, CH-1015 Lausanne, Switzerland; [Raffard, Stephane] CHRU, Univ Dept Adult Psychiat, Montpellier, France; [Raffard, Stephane] Lab Epsylon, EA 4556, Montpellier, France; [Bardy, Benoit G.] Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France; [Bardy, Benoit G.] Inst Univ France, Paris, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; Institut Universitaire de France	Khoramshahi, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, Learning Algorithms & Syst Lab, CH-1015 Lausanne, Switzerland.	mahdi.khoramshahi@epfl.ch	Raffard, Stéphane/K-9822-2013; Raffard, Stephane/M-3926-2019; Bardy, Benoît/AAU-3078-2021	Raffard, Stephane/0000-0001-5563-0323; 	EU [600010]	EU(European Commission)	This research was supported by EU project AlterEgo under grant agreement number 600010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrist S, 2014, ACMIEEE INT CONF HUM, P25, DOI 10.1145/2559636.2559666; Bailenson JN, 2006, PRESENCE-VIRTUAL AUG, V15, P359, DOI 10.1162/pres.15.4.359; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; Bente G, 2007, LECT NOTES COMPUT SC, V4563, P185; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; BYRNE D, 1961, J ABNORM SOC PSYCH, V62, P713, DOI 10.1037/h0044721; Cazzato D, 2015, LECT NOTES ARTIF INT, V9388, P124, DOI 10.1007/978-3-319-25554-5_13; Coen-Cagli R, 2009, VISION RES, V49, P810, DOI 10.1016/j.visres.2009.02.016; Combs DR, 2008, SCHIZOPHR RES, V105, P68, DOI 10.1016/j.schres.2008.05.018; D'Entremont B, 1997, INFANT BEHAV DEV, V20, P569, DOI 10.1016/S0163-6383(97)90048-5; Drusch K, 2014, SCHIZOPHR RES, V159, P485, DOI 10.1016/j.schres.2014.09.003; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Engell AD, 2007, NEUROPSYCHOLOGIA, V45, P3234, DOI 10.1016/j.neuropsychologia.2007.06.022; Fitzpatrick P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00021; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Fu Y, 2008, IEEE T CIRC SYST VID, V18, P467, DOI 10.1109/TCSVT.2008.918441; Garau M, 2001, P SIGCHI C HUM FACT, P309; Garau Maia, 2003, SYSTEMS P SIGCHI C H, P529, DOI DOI 10.1145/642611.642703; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Hooker CI, 2012, SCHIZOPHR RES, V139, P53, DOI 10.1016/j.schres.2012.05.009; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Ishiguro H, 2007, SPR TRA ADV ROBOT, V28, P118; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jayasekera A. I., 1996, Schizophrenia Research, V18, P218, DOI 10.1016/0920-9964(96)85674-X; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; Khoramshahi M, 2014, 2014 IEEE INT C SYST; Kipp M, 2008, LECT NOTES COMPUT SC, V5208, P191; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Langdon RA, 2012, SCHIZOPHR RES, V136, pS362, DOI 10.1016/S0920-9964(12)71058-7; Lazzari S, 2009, J MOTOR BEHAV, V41, P294, DOI 10.3200/JMBR.41.4.294-304; Liesker H, 2009, EXP BRAIN RES, V197, P395, DOI 10.1007/s00221-009-1928-9; LYDON JE, 1988, SOC COGNITION, V6, P269, DOI 10.1521/soco.1988.6.4.269; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Mason MF, 2005, PSYCHOL SCI, V16, P236, DOI 10.1111/j.0956-7976.2005.00809.x; Meadows MS, 2007, I AVATAR CULTURE CON; Minato T, 2004, LECT NOTES COMPUT SC, V3029, P424; Minato T, 2005, INT C DEVEL LEARN, P106; Minato T, 2006, ADV ROBOTICS, V20, P1147, DOI 10.1163/156855306778522505; Mori M, 2012, IEEE ROBOT AUTOM MAG, V19, P98, DOI 10.1109/MRA.2012.2192811; Mutlu B., 2012, ACM T INTERACT INTEL, V1, P1, DOI [10.1145/2070719.2070725, DOI 10.1145/2070719.2070725]; Mutlu Bilge, 2009, P 4 ACM IEEE INT C H, P61, DOI DOI 10.1145/1514095.1514109; Noris B, 2011, COMPUT VIS IMAGE UND, V115, P476, DOI 10.1016/j.cviu.2010.11.013; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Pattacini U., 2011, THESIS; PAUS T, 1991, SCHIZOPHR RES, V5, P145, DOI 10.1016/0920-9964(91)90041-O; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Rae I., 2013, HRI 07, V15, P36, DOI 10.1145/2470654.2466253; Raffard S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08156; Ramaiah MS, 2013, P IEEE VIRT REAL ANN, P95, DOI 10.1109/VR.2013.6549379; Roux P, 2014, SCHIZOPHR RES, V157, P78, DOI 10.1016/j.schres.2014.04.031; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Silverstein SM, 2001, SCHIZOPHRENIA BULL, V27, P247, DOI 10.1093/oxfordjournals.schbul.a006871; Steptoe W, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P197; Tikhanoff V., 2008, P 8 WORKSHOP PERFORM, P57, DOI [DOI 10.1145/1774674.1774684, 10.1145/1774674.1774684]; Tomasello M., 1995, JOINT ATTENTION ITS, P103; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; Varlet M, 2013, PRESENCE-TELEOP VIRT, V22, P202, DOI 10.1162/PRES_a_00151; Varlet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029772; Volcic R, 2009, PERCEPTION, V38, P174; Yoshikawa Y, 2006, ROBOTICS SCI SYSTEMS; Zhao X, 2015, HRI, P133	71	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156874	10.1371/journal.pone.0156874	http://dx.doi.org/10.1371/journal.pone.0156874			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281341	Green Submitted, gold, Green Published			2022-12-26	WOS:000377563000052
J	Ren, W; Zuo, R; Wang, YN; Wang, HJ; Yang, J; Xin, SK; Han, LY; Zhao, HY; Han, SY; Gao, B; Hu, H; Hu, YJ; Bian, BL; Si, N				Ren, Wei; Zuo, Ran; Wang, Yao-Nan; Wang, Hong-Jie; Yang, Jian; Xin, Shao-Kun; Han, Ling-Yu; Zhao, Hai-Yu; Han, Shu-Yan; Gao, Bo; Hu, Hao; Hu, Yuan-Jia; Bian, Bao-Lin; Si, Nan			Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIX-SCUTELLARIAE EXTRACT; TANDEM MASS-SPECTROMETRY; TYPE-2 DIABETIC-RATS; DU-TANG HLJDT; LOW BIOAVAILABILITY; INTEGRATED PHARMACOKINETICS; LIPOXYGENASE PATHWAY; BIOACTIVE COMPONENTS	Huang-Lian-Jie-Du Decoction (HLJDD) is a classical Traditional Chinese Medicine (TCM) formula with heat-dissipating and detoxifying effects. It is used to treat inflammation-associated diseases. However, no systematic pharmacokinetic (PK) and pharmacodynamic (PD) data concerning the activity of HLJDD under inflammatory conditions is available to date. In the present study, the concentration-time profiles and the hepatic clearance rates (HCR) of 41 major components in rat plasma in response to the oral administration of a clinical dose of HLJDD were investigated by LC-QqQ-MS using a dynamic multiple reaction monitoring (DMRM) method. Additionally, the levels of 7 cytokines (CKs) in the plasma and the body temperature of rats were analyzed. Furthermore, a PK-PD model was established to describe the time course of the hemodynamic and anti-inflammatory effects of HLJDD. As one of the three major active constituents in HLJDD, iridoids were absorbed and eliminated more easily and quickly than alkaloids and flavonoids. Compared with the normal controls, the flavonoids, alkaloids and iridoids in inflamed rats exhibited consistently changing trends of PK behaviors, such as higher bioavailability, slower elimination, delays in reaching the maximum concentration (T-max) and longer substantivity. The HCR of iridoids was different from that of alkaloids and flavonoids in inflamed rats. Furthermore, excellent pharmacodynamic effects of HLJDD were observed in inflamed rats. The levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), IL-1 beta, IL-10, and macrophage inflammatory protein-2 (MIP2) and body temperature significantly decreased after the administration of HLJDD. Based on PK-PD modeling with the three-phase synchronous characterization of time-concentration-effect, flavonoids exhibited one mechanism of action in the anti-inflammatory process, while iridoids and alkaloids showed another mechanism of action. Taken together, the results demonstrated that HLJDD may restrain inflammation synergistically via its major constituents alkaloids, flavonoids and iridoids). A correlation between the exposure concentration of different types of compounds and their anti-inflammatory effects in the body was shown. This study provides a comprehensive understanding of the anti-inflammatory activity of HLJDD.	[Ren, Wei; Wang, Hong-Jie; Yang, Jian; Xin, Shao-Kun; Han, Ling-Yu; Zhao, Hai-Yu; Bian, Bao-Lin; Si, Nan] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China; [Ren, Wei; Wang, Yao-Nan; Xin, Shao-Kun] Capital Med Univ, Beijing 100069, Peoples R China; [Zuo, Ran] Li Kang Hosp, Beijing 102609, Peoples R China; [Hu, Hao; Hu, Yuan-Jia] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Zhuhai, Macao, Peoples R China; [Han, Shu-Yan] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Integrat Chinese & Western Med, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100142, Peoples R China; [Gao, Bo] Anhui Jinchan Biochem Co Ltd, Huaibei 235000, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Capital Medical University; University of Macau; Peking University	Zhao, HY; Si, N (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.	hyzhao@icmm.ac.cn; nsi@icmm.ac.cn	Wei, Ren/J-7185-2019; HU, Hao/H-7813-2018; Hu, Yuanjia/AAW-7721-2021	Wei, Ren/0000-0002-5245-451X; HU, Hao/0000-0001-9441-106X; yuanjia, Hu/0000-0001-5244-8577	National Natural Science Fund Project [81202904]; National Basic Research Program of China [2014CB543003]; Fundamental Research Funds for the Central public welfare research institutes [ZZ070832]; Key Project at Central Government Level for Regulating Funds [2060302]	National Natural Science Fund Project(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central public welfare research institutes; Key Project at Central Government Level for Regulating Funds	The work was aided financially by National Natural Science Fund Project (NO. 81202904), National Basic Research Program of China (NO. 2014CB543003), Fundamental Research Funds for the Central public welfare research institutes (NO. ZZ070832) and Key Project at Central Government Level for Regulating Funds (NO. 2060302). Anhui Jinchan Biochemistry Company Ltd. had a role in data collection and analysis and preparation of the manuscript. Anhui Jinchan Biochemistry Company Ltd. has no role in the study design or decision to publish. The other funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621; Akao T, 2007, J PHARM PHARMACOL, V59, P87, DOI 10.1211/jpp.59.1.0012; Bae SK, 2009, J PHARM SCI-US, V98, P1587, DOI 10.1002/jps.21511; Cai ZX, 2008, J CHROMATOGR A, V1200, P144, DOI 10.1016/j.chroma.2008.05.095; Chaudhry H, 2013, IN VIVO, V27, P669; Chung HJ, 2006, EUR J PHARM SCI, V27, P363, DOI 10.1016/j.ejps.2005.11.008; Dai Y, 1999, LIFE SCI, V66, P19, DOI 10.1016/S0024-3205(99)00557-3; Deng YT, 2008, J CHROMATOGR B, V863, P195, DOI 10.1016/j.jchromb.2007.12.028; Deng YX, 2006, BIOMED CHROMATOGR, V20, P1098, DOI 10.1002/bmc.649; Deng YX, 2012, FITOTERAPIA, V83, P1435, DOI 10.1016/j.fitote.2012.08.007; Dou SS, 2009, CHROMATOGRAPHIA, V69, P659, DOI 10.1365/s10337-008-0945-3; Durairajan SSK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092954; Fang HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/245357; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; He MY, 2014, J ETHNOPHARMACOL, V155, P334, DOI 10.1016/j.jep.2014.05.033; Hu YH, 2013, J ETHNOPHARMACOL, V150, P1137, DOI 10.1016/j.jep.2013.10.038; Jiang HQ, 2009, GUANGMING J CHIN MED, V24, P480; Jin Dan, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P541, DOI 10.3736/jcim20070513; Kang HE, 2009, XENOBIOTICA, V39, P465, DOI 10.1080/00498250902890151; Kim J, 1997, J PHARM PHARMACOL, V49, P878, DOI 10.1111/j.2042-7158.1997.tb06129.x; Lan MH, 2001, J HENAN COLL TRADIT, V16, P58; Li CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067530; Li Guofu, 2011, Zhongguo Zhong Yao Za Zhi, V36, P644; Lin Liang-Tzung, 2013, J Tradit Complement Med, V3, P227, DOI 10.4103/2225-4110.119732; Lin SC, 1996, AM J CHINESE MED, V24, P219, DOI 10.1142/S0192415X96000281; Liu GJ, 2005, JIANGXI J TRADIT CHI, V36, P19; Liu L, 2010, PLANTA MED, V76, P70, DOI 10.1055/s-0029-1185946; Lu J, 2011, J ETHNOPHARMACOL, V134, P911, DOI 10.1016/j.jep.2011.01.049; Lu T, 2007, J ETHNOPHARMACOL, V110, P412, DOI 10.1016/j.jep.2006.09.036; Ma ST, 2015, CHIN J NAT MEDICINES, V13, P30, DOI 10.1016/S1875-5364(15)60004-8; Ma Z, 2005, BLOOD, V105, P3312, DOI 10.1182/blood-2004-10-3915; Ma ZT, 2014, J ASIAN NAT PROD RES, V16, P483, DOI 10.1080/10286020.2014.913577; Miura N, 2007, BIOL PHARM BULL, V30, P495, DOI 10.1248/bpb.30.495; Nishigaki J, 1998, BIOL PHARM BULL, V21, P735; Ohura K, 2012, J PHARM SCI-US, V101, P3264, DOI 10.1002/jps.23182; Penney M, 2014, BRIT J CLIN PHARMACO, V77, P740, DOI 10.1111/bcp.12225; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Sun Jian, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1526; Sun Jian, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1461; Swartz ME, 2005, J LIQ CHROMATOGR R T, V28, P1253, DOI 10.1081/JLC-200053046; Tang YH, 2006, BIOMED CHROMATOGR, V20, P1116, DOI 10.1002/bmc.655; Tsai TH, 2002, BRIT J PHARMACOL, V137, P1314, DOI 10.1038/sj.bjp.0704959; Wang LM, 1997, J PHARM PHARMACOL, V49, P102, DOI 10.1111/j.2042-7158.1997.tb06760.x; Wang N, 2015, J ETHNOPHARMACOL, V164, P309, DOI 10.1016/j.jep.2015.02.025; Wang PR, 2014, J PHARMACEUT BIOMED, V88, P106, DOI 10.1016/j.jpba.2013.08.025; Wei YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/909624; Wen T, 2012, ARTHRITIS RHEUM-US, V64, P2896, DOI 10.1002/art.34528; Wu YH, 2012, J ETHNOPHARMACOL, V140, P55, DOI 10.1016/j.jep.2011.12.002; Xiao Yan-ling, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1767; Xing J, 2005, LIFE SCI, V78, P140, DOI 10.1016/j.lfs.2005.04.072; Yang Y, 2013, LISHIZHEN MED MAT ME, V24, P1599; Yang Y, 2013, J CHROMATOGR A, V1321, P88, DOI 10.1016/j.chroma.2013.10.072; Yi Q, 2012, CURR THER RES CLIN E, V73, P174, DOI 10.1016/j.curtheres.2012.09.002; Yu KH, 2009, J PHARM PHARMACOL, V61, P1197, DOI 10.1211/jpp/61.09.0009; Yue RC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/439690; Yue RC, 2013, J ETHNOPHARMACOL, V145, P465, DOI 10.1016/j.jep.2012.11.010; Zeng HW, 2011, J ETHNOPHARMACOL, V135, P561, DOI 10.1016/j.jep.2011.03.055; Zeng H, 2009, J PHARM PHARMACOL, V61, P1699, DOI [10.1211/jpp/61.12.0016, 10.1211/jpp.61.12.0016]; Zeng MF, 2010, FITOTERAPIA, V81, P490, DOI 10.1016/j.fitote.2010.01.004; Zhang HW, 2014, J ETHNOPHARMACOL, V154, P55, DOI 10.1016/j.jep.2014.03.007; Zhang L, 2005, PHARM RES-DORDR, V22, P1050, DOI 10.1007/s11095-005-5303-7; Zhang XJ, 2014, PHYTOMEDICINE, V21, P615, DOI 10.1016/j.phymed.2013.11.004; Zhu Hua-Xu, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2033; Zhu HX, 2013, PHYTOMEDICINE, V20, P767, DOI 10.1016/j.phymed.2012.11.012; Zhu HX, 2012, J ETHNOPHARMACOL, V141, P158, DOI 10.1016/j.jep.2012.02.014; Zuo R, 2016, XENOBIOTICA, V46, P65, DOI 10.3109/00498254.2015.1048541; Zuo Ran, 2014, Yaoxue Xuebao, V49, P237	67	18	22	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156256	10.1371/journal.pone.0156256	http://dx.doi.org/10.1371/journal.pone.0156256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280291	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000023
J	Zhang, WQ; Jin, X; Zhu, XL; Shan, BQ				Zhang, Wenqiang; Jin, Xin; Zhu, Xiaolei; Shan, Baoqing			Characteristics and Distribution of Phosphorus in Surface Sediments of Limnetic Ecosystem in Eastern China	PLOS ONE			English	Article							SHALLOW EUTROPHIC LAKE; ORGANIC PHOSPHORUS; WATER; EXTRACTION; ALUMINUM; PH; SPECIATION; SORPTION; TAIHU; RIVER	Phosphorus (P) is an essential nutrient for aquatic organisms; however, excessive P inflow to limnetic ecosystems can induce eutrophication. P concentrations in the rivers, wetlands and lakes of Eastern China have been amplified by fertilizer and sewage inputs associated with the development of industry and agriculture. Yet, knowledge of the distribution and speciation of P is lacking at the regional scale. We determined the distribution and speciation of P in limnetic ecosystems in Eastern China using Standards, Measurements and Testing (SMT) and phosphorus nuclear magnetic resonance (P-31-NMR). The results indicate that P pollution in surface sediments was serious. Inorganic P (Pi) was the primary drive of variation in total P (TP) among different river systems, and Pi accounted for 71% to 90% of TP in surface sediment in Eastern China. Also, the concentrations of TP and Pi varied among watersheds and Pi primarily drove the variation in TP in different watersheds. Sediments less than 10-cm deep served as the main P reservoir. Environmental factors affect the speciation and origin of P. NaOH-Pi, HCl-Pi and organic P (Po) were related to pH accordingly at the regional scale. The physicochemical properties of sediments from different limnetic ecosystems affect the P speciation. HCl-Pi was higher in wetland sediments than in riverine and lake sediments in Eastern China. Conversely, NaOH-Pi was lowest in wetland sediments. Total Po concentration was lower in riverine sediments than in other sediments, but Mono-P was higher, with an average concentration of 48 mg kg(-1). Diesters-P was highest in lake sediments. By revealing the regional distribution of TP, Pi and Po, this study will support eutrophication management in Eastern China.	[Zhang, Wenqiang; Jin, Xin; Zhu, Xiaolei; Shan, Baoqing] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing 100085, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Shan, BQ (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing 100085, Peoples R China.	bqshan@rcees.ac.cn			National Natural Science Foundation of China [21507146]; State Key Joint Laboratory of Environment Simulation and Pollution Control (Research Center for Eco-environmental Sciences, Chinese Academy of Sciences) [15Z01ESPCR]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control (Research Center for Eco-environmental Sciences, Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (Grant No. 21507146) and the special fund from the State Key Joint Laboratory of Environment Simulation and Pollution Control (Research Center for Eco-environmental Sciences, Chinese Academy of Sciences) (15Z01ESPCR).	Ahlgren J, 2005, ENVIRON SCI TECHNOL, V39, P867, DOI 10.1021/es049590h; Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; Cade-Menun BJ, 2005, TALANTA, V66, P359, DOI 10.1016/j.talanta.2004.12.024; Cade-Menun BJ, 1996, SOIL SCI, V161, P770, DOI 10.1097/00010694-199611000-00006; Cade-Menun BJ, 2005, MAR CHEM, V97, P293, DOI 10.1016/j.marchem.2005.05.005; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; Chen J, 2000, ACTA MINERALOGICA SI, V20, P112; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DETENBECK NE, 1991, ENVIRON SCI TECHNOL, V25, P403, DOI 10.1021/es00015a004; DIAZ OA, 1994, WATER RES, V28, P1755, DOI 10.1016/0043-1354(94)90248-8; Ding SM, 2013, J ENVIRON SCI, V25, P925, DOI 10.1016/S1001-0742(12)60137-5; Elser J, 2011, NATURE, V478, P29, DOI 10.1038/478029a; Gachter R, 1998, ENVIRON SCI TECHNOL, V32, P3659, DOI 10.1021/es980418l; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hupfer M, 2004, LIMNOL OCEANOGR, V49, P1, DOI 10.4319/lo.2004.49.1.0001; HUPFER M, 1995, LIMNOL OCEANOGR, V40, P610, DOI 10.4319/lo.1995.40.3.0610; [金相灿 Jin Xiangcan], 2004, [生态环境, Ecology and Environment], V13, P493; Kopacek J, 2005, ENVIRON SCI TECHNOL, V39, P8784, DOI 10.1021/es050916b; Kopacek J, 2000, LIMNOL OCEANOGR, V45, P212, DOI 10.4319/lo.2000.45.1.0212; Li C. H., 2006, THESIS; Li N., 2012, ENV SCI, V31, P2911; LIJKLEMA L, 1980, ENVIRON SCI TECHNOL, V14, P537, DOI 10.1021/es60165a013; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; Lu R, 1999, METHODS SOIL AGR CHE; McDowell RW, 2006, J ENVIRON QUAL, V35, P293, DOI 10.2134/jeq2005.0285; Meyers PA, 1997, ORG GEOCHEM, V27, P213, DOI 10.1016/S0146-6380(97)00049-1; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Meyers PA, 1999, J PALEOLIMNOL, V21, P345, DOI 10.1023/A:1008073732192; MORTIMER CH, 1971, LIMNOL OCEANOGR, V16, P387, DOI 10.4319/lo.1971.16.2.0387; Nielsen LP, 2010, NATURE, V463, P1071, DOI 10.1038/nature08790; Obersteiner M, 2013, NAT GEOSCI, V6, P897, DOI 10.1038/ngeo1990; Pan G, 2013, ENVIRON SCI TECHNOL, V47, P9685, DOI 10.1021/es4005619; Pernet-Coudrier B, 2012, ENVIRON SCI TECHNOL, V46, P5294, DOI 10.1021/es3004415; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Qu HJ, 2010, SCI TOTAL ENVIRON, V408, P2075, DOI 10.1016/j.scitotenv.2009.12.015; Qu JH, 2010, CRIT REV ENV SCI TEC, V40, P519, DOI 10.1080/10643380802451953; Reitzel K, 2006, WATER RES, V40, P647, DOI 10.1016/j.watres.2005.12.014; Reitzel K, 2007, BIOGEOCHEMISTRY, V82, P15, DOI 10.1007/s10533-006-9049-z; Ribeiro DC, 2014, ENVIRON SCI TECHNOL, V48, P9205, DOI 10.1021/es501037g; Ruban V, 2001, FRESEN J ANAL CHEM, V370, P224, DOI 10.1007/s002160100753; Ruban V, 2001, J ENVIRON MONITOR, V3, P121, DOI 10.1039/b005672n; Rydin E, 2000, LIMNOL OCEANOGR, V45, P226, DOI 10.4319/lo.2000.45.1.0226; Sattari SZ, 2012, P NATL ACAD SCI USA, V109, P6348, DOI 10.1073/pnas.1113675109; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Shinohara R, 2012, ENVIRON SCI TECHNOL, V46, P10572, DOI 10.1021/es301887z; Turner BL, 2005, TALANTA, V66, P294, DOI 10.1016/j.talanta.2004.11.012; Turner BL, 2003, SOIL SCI SOC AM J, V67, P1168, DOI 10.2136/sssaj2003.1168; Turner BL, 2003, ORG GEOCHEM, V34, P1199, DOI 10.1016/S0146-6380(03)00061-5; Wang LL, 2013, CHINESE GEOGR SCI, V23, P574, DOI 10.1007/s11769-013-0627-4; [王宇 Wang Yu], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2774; Xu D, 2013, J ENVIRON SCI-CHINA, V25, P637, DOI 10.1016/S1001-0742(12)60136-3; Xu D, 2012, J SOIL SEDIMENT, V12, P909, DOI 10.1007/s11368-012-0510-4; Zhang B, 2012, ECOL ENG, V40, P153, DOI 10.1016/j.ecoleng.2011.12.024; Zhang H, 2008, ENVIRON SCI TECHNOL, V42, P2328, DOI 10.1021/es0720208; Zhang RY, 2009, J ENVIRON QUAL, V38, P353, DOI 10.2134/jeq2007.0616; Zhang WQ, 2015, CLEAN-SOIL AIR WATER, V43, P544, DOI 10.1002/clen.201300254; Zhang WQ, 2014, ENVIRON SCI POLLUT R, V21, P3803, DOI 10.1007/s11356-013-2322-5; Zhang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076525; Zhou AM, 2005, WATER RES, V39, P1245, DOI 10.1016/j.watres.2005.01.026; Zhu MY, 2013, ENVIRON POLLUT, V173, P216, DOI 10.1016/j.envpol.2012.10.016	60	12	12	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156488	10.1371/journal.pone.0156488	http://dx.doi.org/10.1371/journal.pone.0156488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281191	Green Submitted, gold, Green Published			2022-12-26	WOS:000377563000031
J	Cai, JN; Jung, JE; Dang, MH; Kim, MA; Yi, HK; Jeon, JG				Cai, Jian-Na; Jung, Ji-Eun; Dang, Minh-Huy; Kim, Mi-Ah; Yi, Ho-Keun; Jeon, Jae-Gyu			Functional Relationship between Sucrose and a Cariogenic Biofilm Formation	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; IN-SITU; ENAMEL DEMINERALIZATION; DENTAL PLAQUE; CARIES INCIDENCE; EXPOSURE; FLUORIDE; GLUCOSYLTRANSFERASES	Sucrose is an important dietary factor in cariogenic biofilm formation and subsequent initiation of dental caries. This study investigated the functional relationships between sucrose concentration and Streptococcus mutans adherence and biofilm formation. Changes in morphological characteristics of the biofilms with increasing sucrose concentration were also evaluated. S. mutans biofilms were formed on saliva-coated hydroxyapatite discs in culture medium containing 0, 0.05, 0.1, 0.5, 1, 2, 5, 10, 20, or 40%(w/v) sucrose. The adherence (in 4-hour biofilms) and biofilm composition (in 46-hour biofilms) of the biofilms were analyzed using microbiological, biochemical, laser scanning confocal fluorescence microscopic, and scanning electron microscopic methods. To determine the relationships, 2nd order polynomial curve fitting was performed. In this study, the influence of sucrose on bacterial adhesion, biofilm composition (dry weight, bacterial counts, and water-insoluble extracellular polysaccharide (EPS) content), and acidogenicity followed a 2nd order polynomial curve with concentration dependence, and the maximum effective concentrations (MECs) of sucrose ranged from 0.45 to 2.4%. The bacterial and EPS bio-volume and thickness in the biofilms also gradually increased and then decreased as sucrose concentration increased. Furthermore, the size and shape of themicro-colonies of the biofilms depended on the sucrose concentration. Around the MECs, the micro-colonies were bigger and more homogeneous than those at 0 and 40%, and were surrounded by enough EPSs to support their structure. These results suggest that the relationship between sucrose concentration and cariogenic biofilm formation in the oral cavity could be described by a functional relationship.	[Cai, Jian-Na; Jung, Ji-Eun; Dang, Minh-Huy; Kim, Mi-Ah; Jeon, Jae-Gyu] Chonbuk Natl Univ, Sch Dent, Dept Prevent Dent, Inst Oral Biosci, Jeonju 561756, South Korea; [Yi, Ho-Keun] Chonbuk Natl Univ, Inst Oral Biosci, Sch Dent, Dept Oral Biochem, Jeonju 561756, South Korea	Jeonbuk National University; Jeonbuk National University	Jeon, JG (corresponding author), Chonbuk Natl Univ, Sch Dent, Dept Prevent Dent, Inst Oral Biosci, Jeonju 561756, South Korea.	dentjjk@jbnu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014R1A4A1005309]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2014R1A4A1005309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires CP, 2006, CARIES RES, V40, P28, DOI 10.1159/000088902; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; Ccahuana-Vasquez RA, 2007, CARIES RES, V41, P9, DOI 10.1159/000096100; Cury J A, 2001, Braz Dent J, V12, P101; Cury JA, 2000, CARIES RES, V34, P491, DOI 10.1159/000016629; Cury JA, 1997, CARIES RES, V31, P356, DOI 10.1159/000262418; de Sousa DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131941; dos Santos MN, 2002, CARIES RES, V36, P347, DOI 10.1159/000065959; HEFTI A, 1979, CARIES RES, V13, P298, DOI 10.1159/000260414; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Imfeld T N, 1983, Monogr Oral Sci, V11, P1; Jeon JG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-228; Kim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145844; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Leme AFP, 2004, J DENT RES, V83, P71, DOI 10.1177/154405910408300114; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; Meldrum RJ, 2003, FOOD MICROBIOL, V20, P97, DOI 10.1016/S0740-0020(02)00083-7; Mogen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133886; Chau NPT, 2014, J DENT, V42, P726, DOI 10.1016/j.jdent.2014.03.009; Pandit S, 2015, J APPL MICROBIOL, V119, P571, DOI 10.1111/jam.12851; Pandit S, 2011, ARCH ORAL BIOL, V56, P643, DOI 10.1016/j.archoralbio.2010.12.012; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; Sendamangalam V, 2011, BIOFOULING, V27, P13, DOI 10.1080/08927014.2010.535897; Takahashi N, 2010, J DENT RES, V89, P1383, DOI 10.1177/0022034510377792; Tenuta LMA, 2006, J DENT RES, V85, P834, DOI 10.1177/154405910608500911; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; Zero DT, 2004, CARIES RES, V38, P277, DOI 10.1159/000077767	34	18	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157184	10.1371/journal.pone.0157184	http://dx.doi.org/10.1371/journal.pone.0157184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275603	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700082
J	Nagai, K; Sairenchi, T; Irie, F; Watanabe, H; Ota, H; Yamagata, K				Nagai, Kei; Sairenchi, Toshimi; Irie, Fujiko; Watanabe, Hiroshi; Ota, Hitoshi; Yamagata, Kunihiro			Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; RENAL DYSFUNCTION; SERUM CREATININE; OUTCOMES; PROTEINURIA; ASSOCIATION; DECLINE	Background Patients with renal impairment are at risk of not only end-stage kidney disease but also cardiovascular disease (CVD). The current definition of CKD stage G3a is eGFR 45-59 ml/min/1.73 m(2) and of G3b is 30-44 ml/min/1.73 m(2), and subjects in the CKD 3a category are considered to be at lower risk of mortality than are those in CKD 3b. Methods We evaluated the outcome of 97,043 people (33,131 men and 63,912 women) living in Ibaraki Prefecture who underwent annual community-based health checkups beginning in 1993 at age 40-80 years and who were followed for a mean of 17.1 years. Results The number of all-causes deaths was 20,534 (10,375 men and 10,159 women), of which 5,995 (2,695men and 3,300 women) were deaths due to CVD. Multivariable-adjusted hazard ratio for CVD death in the eGFR 45-49 ml/min/1.73 m(2) category was significantly increased (1.82; 95% confidential interval, 1.23-2.69) in non-elderly men, whereas all-cause mortality and CVD mortality in elderly men with eGFR 45-49 ml/min/1.73 m(2) were non significant. In contrast, both in non-elderly women and in elderly women with eGFR 45-49 ml/min/1.73 m(2) showed small, but significant, increases in the risks of all-cause mortality and CVD. Conclusions We demonstrated proportionate increases in mortality with decreasing eGFR in a Japanese CKD population. Like patients in the CKD G3b subgroup, non-elderly men and women with an eGFR of 45-49 ml/min/1.73 m(2) (i.e. a part of CKD G3a) are at considerable risk of CVD mortality. Age dependent and eGFR dependent finer risk recognition were required for CVD prevention in clinical practice with regard to CKD patients.	[Nagai, Kei; Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Sairenchi, Toshimi; Watanabe, Hiroshi; Ota, Hitoshi] Ibaraki Hlth Serv Assoc, Ibaraki Hlth Plaza, Mito, Ibaraki, Japan; [Irie, Fujiko] Ibaraki Prefectural Off, Dept Hlth & Welf, Mito, Ibaraki, Japan	University of Tsukuba; Dokkyo Medical University	Yamagata, K (corresponding author), Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan.	k-yamaga@md.tsukuba.ac.jp		Sairenchi, Toshimi/0000-0001-8896-6501; Nagai, Kei/0000-0001-5050-5291	Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan [H17-Kenkou-007, H18-Junkankitou[Seishuu]-Ippan-012, H20-Junkankitou[Seishuu]-Ippan-013, H21-Nanchi-Ippan-059, H23-Junkankitou[Seishuu]-Ippan-005, H26-Junkankitou [Seisaku]-Ippan-001]	Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H18-Junkankitou[Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou[Seishuu]-Ippan-013; Intractable Diseases Conquest Research: H21-Nanchi-Ippan-059; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou[Seishuu]-Ippan-005; and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H26-Junkankitou [Seisaku]-Ippan-001). http://www.mhlw.go.jp/english/new-info/2012.html. This study was also part of Research on Advanced Chronic Kidney Disease (REACH-J), a Practical Research Project for Renal Diseases, from the Japan Agency for Medical Research and Development (AMED). http://www.amed.go.jp/program/list/01/05/017.html.; This work was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H18-Junkankitou[Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou[Seishuu]-Ippan-013; Intractable Diseases Conquest Research: H21-Nanchi-Ippan-059; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou[Seishuu]-Ippan-005; and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H26-Junkankitou [Seisaku]-Ippan-001). This study was also part of Research on Advanced Chronic Kidney Disease (REACH-J), a Practical Research Project for Renal Diseases, from the Japan Agency for Medical Research and Development (AMED).	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; [Anonymous], CLIN EXP NEPHROL, V13, P222; Chalmers J, 1999, J HYPERTENS, V17, P151; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Kasiske BL, 2013, KIDNEY INT SUPPL, V3, P2, DOI 10.1038/kisup.2012.74; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Menon V, 2007, ANN INTERN MED, V147, P19, DOI 10.7326/0003-4819-147-1-200707030-00004; Nagai K, 2015, CLIN EXP NEPHROL, V19, P152, DOI 10.1007/s10157-014-1034-6; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007	24	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156792	10.1371/journal.pone.0156792	http://dx.doi.org/10.1371/journal.pone.0156792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27272675	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200016
J	Nouar, R; Breuzard, G; Bastonero, S; Gorokhova, S; Barbier, P; Devred, F; Kovacic, H; Peyrot, V				Nouar, Roqiya; Breuzard, Gilles; Bastonero, Sonia; Gorokhova, Svetlana; Barbier, Pascale; Devred, Francois; Kovacic, Herve; Peyrot, Vincent			Direct evidence for the interaction of stathmin along the length and the plus end of microtubules in cells	FASEB JOURNAL			English	Article						oncoprotein 18; tubulin; binding; immuno-FRET; FRAP	CYCLE-REGULATED PHOSPHORYLATION; MULTISITE PHOSPHORYLATION; ENERGY-TRANSFER; ONCOPROTEIN 18; IN-VITRO; FLUORESCENCE RECOVERY; PHOSPHOPROTEIN FAMILY; DYNAMIC INSTABILITY; TUBULIN INTERACTION; PROTEIN-KINASE	Stathmin is a prominent destabilizer of microtubules (MTs). Extensive in vitro studies have strongly suggested that stathmin could act by sequestering tubulin and/or by binding to MT tips. In cells, the molecular mechanisms of stathmin binding to tubulin and/or MTs and its implications for the MT dynamics remain unexplored. By using immunofluorescence resonance energy transfer and fluorescence recovery after photobleaching, we analyzed the ability of stathmin and its phosphorylated forms (on Ser16, -25, -38, and -63) to interact with tubulin and MTs in A549 cells. Consistent with in vitro studies, we detected stathmin-tubulin interactions at the MT plus ends and in the cytosol. Of interest, we also observed a novel pool of stathmin bound along the MT. Expression of truncated stathmin and use of MT-stabilizing taxol further showed that the C-terminal domain of stathmin is the main contributor to this binding and that the phosphorylation state of stathmin plays a role in its binding along the MT wall. Our findings demonstrate that stathmin binds directly along the MT wall. This pool of stathmin would be readily available to participate in protofilament dissociation when the moving plus end of a depolymerizing MT reaches stathmin molecules.Nouar, R., Breuzard, G., Bastonero, S., Gorokhova, S., Barbier, P., Devred, F., Kovacic, H., Peyrot, V. Direct evidence for the interaction of stathmin along the length and the plus end of microtubules in cells.	[Nouar, Roqiya; Breuzard, Gilles; Bastonero, Sonia; Barbier, Pascale; Devred, Francois; Kovacic, Herve; Peyrot, Vincent] Aix Marseille Univ, INSERM, Fac Pharm, CRO2,UMR 911, Marseille, France; [Gorokhova, Svetlana] Aix Marseille Univ, INSERM, Fac Med, GMGF,UMR 910, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Breuzard, G; Peyrot, V (corresponding author), Aix Marseille Univ, INSERM, Fac Pharm, CRO2,UMR 911, Marseille, France.	gilles.breuzard@univ-amu.fr; vincent.peyrot@univ-amu.fr	breuzard, gilles/C-4735-2013; Devred, Francois/AAO-6337-2020; Barbier, Pascale/AAE-1781-2019; kovacic, hervé/ABF-2451-2020; Gorokhova, Svetlana/L-9380-2019	Devred, Francois/0000-0001-5990-8898; Gorokhova, Svetlana/0000-0001-6870-4061; breuzard, gilles/0000-0001-8178-2080	Institut National du Cancer, INSERM, and Direction Generale de l'Offre de Soin (DGOS) [Integrated Cancer Research Site (SIRIC) label]; Region Provence Alpes Cotes d'Azur and from ONET Technologies	Institut National du Cancer, INSERM, and Direction Generale de l'Offre de Soin (DGOS) [Integrated Cancer Research Site (SIRIC) label]; Region Provence Alpes Cotes d'Azur and from ONET Technologies(Region Provence-Alpes-Cote d'Azur)	The authors acknowledge the financial support of Institut National du Cancer, INSERM, and Direction Generale de l'Offre de Soin (DGOS) [Integrated Cancer Research Site (SIRIC) label]. R.N. received fellowships from Region Provence Alpes Cotes d'Azur and from ONET Technologies. The authors thank Prof. Andre Sobel (INSERM UMR 839, Universite Pierre et Marie Curie, Paris, France) for the gift of antisera containing rabbit polyclonal anti-pSer16, anti-pSer25, and anti-pSer38 antibodies. V.P. gratefully acknowledges the help of his private relationship, S. Boulay. Author contributions: R. Nouar, G. Breuzard, and S. Bastonero carried out the experimental work; S. Gorokhova generated plasmids Delta Cter-stathmin and Delta Nter-stathmin; R. Nouar, G. Breuzard, S. Bastonero, P. Barbier, F. Devred, and V. Peyrot participated in the data analysis and interpretation; R. Nouar, G. Breuzard, F. Devred, and V. Peyrot participated in the concept and design of the research; and R. Nouar, G. Breuzard, P. Barbier, F. Devred, H. Kovacic, and V. Peyrot wrote the paper. The authors declare no conflicts of interest.	Adebiyi A, 2010, CIRC RES, V106, P1603, DOI 10.1161/CIRCRESAHA.110.216804; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Breuzard G, 2013, J CELL SCI, V126, P2810, DOI 10.1242/jcs.120832; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Devred F, 2008, FEBS LETT, V582, P2484, DOI 10.1016/j.febslet.2008.06.035; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Downing KH, 1998, EUR BIOPHYS J BIOPHY, V27, P431, DOI 10.1007/s002490050153; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gavet O, 1998, J CELL SCI, V111, P3333; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; GREEN KJ, 1983, CELL MOTIL CYTOSKEL, V3, P283, DOI 10.1002/cm.970030402; Gupta KK, 2013, P NATL ACAD SCI USA, V110, P20449, DOI 10.1073/pnas.1309958110; Hallen MA, 2008, BIOPHYS J, V95, P3048, DOI 10.1529/biophysj.108.134593; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Krouglova T, 2003, FEBS LETT, V546, P365, DOI 10.1016/S0014-5793(03)00636-7; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Malesinski S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128704; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Martello LA, 2003, CANCER RES, V63, P1207; Mistry SJ, 1998, BIOCHEM J, V334, P23, DOI 10.1042/bj3340023; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Phair RD, 2004, METHOD ENZYMOL, V375, P393; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; Siegel R M, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.38.pl1; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang YL, 2007, J MICROSC-OXFORD, V228, P123, DOI 10.1111/j.1365-2818.2007.01834.x; Wilson L., 2010, MICROTUBULES; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1	55	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3202	3215		10.1096/fj.201500125R	http://dx.doi.org/10.1096/fj.201500125R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27284003	Green Submitted			2022-12-26	WOS:000382816300020
J	Savas, S; Wei, SZ; Hsu, MH; Falck, JR; Guengerich, FP; Capdevila, JH; Johnson, EF				Savas, Szen; Wei, Shouzou; Hsu, Mei-Hui; Falck, John R.; Guengerich, F. Peter; Capdevila, Jorge H.; Johnson, Eric F.			20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; SALT-SENSITIVE HYPERTENSION; ANDROGEN-INDUCED HYPERTENSION; NA+-CL-COTRANSPORTER; T8590C POLYMORPHISM; OMEGA-HYDROXYLASE; ARACHIDONIC-ACID; CYP4A11 GENE; FUNCTIONAL POLYMORPHISM; CHLORIDE COTRANSPORTER	Male and female homozygous 129/Sv mice carrying four copies of the human cytochrome P450 4A11 gene (CYP4A11) under control of its native promoter (B-129/ Sv-4A11(+/+)) develop hypertension (142 +/- 8 versus 113 +/- 7 mm Hg systolic blood pressure (BP)), and exhibit increased 20-hydroxyeicosatetraenoic acid (20-HETE) in kidney and urine. The hypertension is reversible by a low-sodium diet and by the CYP4A inhibitor HET0016. B-129/ Sv-4A11(+/+) mice display an 18% increase of plasma potassium (p < 0.02), but plasma aldosterone, angiotensin II (ANGII), and renin activities are unchanged. This phenotype resembles human genetic disorders with elevated activity of the sodium chloride co-transporter (NCC) and, accordingly, NCC abundance is increased by 50% in transgenic mice, and NCC levels are normalized by HET0016. ANGII is known to increase NCC abundance, and renal mRNA levels of its precursor angiotensinogen are increased 2-fold in B-129/ Sv-4A11 (+/+), and blockade of the ANGII receptor type 1 with losartan normalizes BP. A pro-hypertensive role for 20-HETE was implicated by normalization of BP and reversal of renal angiotensin mRNA increases by administration of the 20-HETE antagonists 2-((6Z, 15Z)-20-hydroxyicosa- 6,15-dienamido) acetate or (S)-2-((6Z, 15Z)-20hydroxyicosa- 6,15-dienamido) succinate. SGK1 expression is also increased in B-129/ Sv-4A11(+/+) mice and paralleled increases seen for NCC. Losartan, HET0016, and 20-HETE antagonists each normalized SGK1 mRNA expression. These results point to a potential 20-HETE dependence of intrarenal angiotensinogen production and ANGII receptor type 1 activation that are associated with increases in NCC and SGK1 and identify elevated P450 4A11 activity and 20-HETE as potential risk factors for salt-sensitive human hypertension by perturbation of the renal renin-angiotensin axis.	[Savas, Szen; Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Wei, Shouzou; Capdevila, Jorge H.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Falck, John R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Scripps Research Institute; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Johnson, EF (corresponding author), MEM 255,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Public Health Service [R01 HD004445, P01 DK038226]; Welch Foundation [I-0011]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grants R01 HD004445 (to E. F. J.) and P01 DK038226 (to J. H. C., J. R. F., and F. P. G.) and The Welch Foundation Grant I-0011 (to J. R. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acres OW, 2011, HYPERTENSION, V57, P608, DOI 10.1161/HYPERTENSIONAHA.110.165464; Alonso-Galicia M, 1999, AM J PHYSIOL-RENAL, V277, pF790, DOI 10.1152/ajprenal.1999.277.5.F790; Baskin R, 2012, CELL SIGNAL, V24, P435, DOI 10.1016/j.cellsig.2011.09.016; BRASIER AR, 1994, KIDNEY INT, V46, P1564, DOI 10.1038/ki.1994.447; CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385; Capdevila JH, 2015, PROSTAG OTH LIPID M, V120, P40, DOI 10.1016/j.prostaglandins.2015.05.004; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Cheng J, 2012, ARTERIOSCL THROM VAS, V32, P1917, DOI 10.1161/ATVBAHA.112.248344; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Craigie E, 2012, HYPERTENSION, V60, P684, DOI 10.1161/HYPERTENSIONAHA.112.196410; Edson KZ, 2013, BIOCHEMISTRY-US, V52, P8276, DOI 10.1021/bi401208m; Edson KZ, 2013, CURR TOP MED CHEM, V13, P1429; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Fan XQ, 2014, MOL MED REP, V10, P2483, DOI 10.3892/mmr.2014.2492; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Gainer JV, 2008, J AM SOC NEPHROL, V19, P1606, DOI 10.1681/ASN.2008010063; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Garcia V, 2016, J PHARMACOL EXP THER, V356, P525, DOI 10.1124/jpet.115.229377; Garcia V, 2015, PROSTAG OTH LIPID M, V116, P124, DOI 10.1016/j.prostaglandins.2014.12.001; Ge Y, 2013, PROSTAG OTH LIPID M, V102, P42, DOI 10.1016/j.prostaglandins.2013.03.001; Glover M, 2009, J AM SOC NEPHROL, V20, P1314, DOI 10.1681/ASN.2008050542; Hermann M, 2009, ATHEROSCLEROSIS, V207, P476, DOI 10.1016/j.atherosclerosis.2009.06.009; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; Hussain A, 2008, KIDNEY BLOOD PRESS R, V31, P80, DOI 10.1159/000119703; Ito O, 2006, MOL CELL BIOCHEM, V284, P141, DOI 10.1007/s11010-005-9038-x; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Laffer CL, 2008, HYPERTENSION, V51, P767, DOI 10.1161/HYPERTENSIONAHA.107.102921; Laffer CL, 2014, J AM SOC HYPERTENS, V8, P475, DOI 10.1016/j.jash.2014.04.011; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Liu H, 2008, J AM SOC NEPHROL, V19, P714, DOI 10.1681/ASN.2007060713; Liu XL, 2012, GENE, V505, P352, DOI 10.1016/j.gene.2012.02.029; Liu XL, 2009, KIDNEY INT, V75, P1288, DOI 10.1038/ki.2009.67; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Mayer B, 2006, J HYPERTENS, V24, P1965, DOI 10.1097/01.hjh.0000244944.34546.8e; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Navar LG, 2013, KIDNEY INT SUPPL, V3, P321, DOI 10.1038/kisup.2013.67; O'Shaughnessy KM, 2015, PEDIATR NEPHROL, V30, P1903, DOI 10.1007/s00467-014-2956-7; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Powell PK, 1996, ARCH BIOCHEM BIOPHYS, V335, P219, DOI 10.1006/abbi.1996.0501; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; PRAKASH C, 1992, BIOCHEM BIOPH RES CO, V185, P728, DOI 10.1016/0006-291X(92)91686-K; Quigley R, 2009, NEPHRON PHYSIOL, V113, pP23, DOI 10.1159/000235774; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; Savas U, 2009, J BIOL CHEM, V284, P16541, DOI 10.1074/jbc.M902074200; Sodhi K, 2010, HYPERTENSION, V56, P871, DOI 10.1161/HYPERTENSIONAHA.110.154559; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Sparks MA, 2014, COMPR PHYSIOL, V4, P1201, DOI 10.1002/cphy.c130040; Stec DE, 2007, PHYSIOL GENOMICS, V30, P74, DOI 10.1152/physiolgenomics.00003.2007; Stevens VA, 2008, NEPHROL DIAL TRANSPL, V23, P1834, DOI 10.1093/ndt/gfm923; Sugimoto K, 2008, HYPERTENSION, V52, P1142, DOI 10.1161/HYPERTENSIONAHA.108.114082; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Lubbe N, 2013, CURR OPIN NEPHROL HY, V22, P120, DOI 10.1097/MNH.0b013e32835b6551; van der Lubbe N, 2011, KIDNEY INT, V79, P66, DOI 10.1038/ki.2010.290; Ward NC, 2008, HYPERTENSION, V51, P1393, DOI 10.1161/HYPERTENSIONAHA.107.104463; Williams JS, 2011, J HYPERTENS, V29, P1913, DOI 10.1097/HJH.0b013e32834aa786; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Wu CC, 2013, J AM SOC NEPHROL, V24, P1288, DOI 10.1681/ASN.2012070714; Wu JJ, 2013, HUM GENET, V132, P179, DOI 10.1007/s00439-012-1238-3; Yang H, 2014, CLIN EXP HYPERTENS, V36, P398, DOI 10.3109/10641963.2013.846353; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Ying J, 2012, AM J HYPERTENS, V25, P684, DOI 10.1038/ajh.2012.16; Zhang C, 2013, GENET TEST MOL BIOMA, V17, P736, DOI 10.1089/gtmb.2013.0080; Zhang R, 2011, HYPERTENS RES, V34, P645, DOI 10.1038/hr.2011.8; ZOU AP, 1994, AM J PHYSIOL, V266, pF934, DOI 10.1152/ajprenal.1994.266.6.F934	69	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16904	16919		10.1074/jbc.M116.732297	http://dx.doi.org/10.1074/jbc.M116.732297			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298316	Green Published, hybrid			2022-12-26	WOS:000380826700046
J	Wang, L; Zhu, SL; Xu, G; Feng, J; Han, T; Zhao, FP; She, YL; Liu, S; Ye, LB; Zhu, Y				Wang, Li; Zhu, Shengli; Xu, Gang; Feng, Jian; Han, Tao; Zhao, Fanpeng; She, Ying-Long; Liu, Shi; Ye, Linbai; Zhu, Ying			Gene Expression and Antiviral Activity of Interleukin-35 in Response to Influenza A Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; REGULATORY T-CELLS; INNATE IMMUNE-RESPONSE; HEPATITIS-B; PERIPHERAL-BLOOD; INTERFERON-GAMMA; VIRAL REPLICATION; CYTOKINE IL-35; MESSENGER-RNA; IFN-GAMMA	Interleukin-35 (IL-35) is a newly described member of the IL-12 family. It has been reported to inhibit inflammation and autoimmune inflammatory disease and can increase apoptotic sensitivity. Little is known about the role of IL-35 during viral infection. Herein, high levels of IL-35 were found in peripheral blood mononuclear cells and throat swabs from patients with seasonal influenza A virus (IAV) relative to healthy individuals. IAV infection of human lung epithelial and primary cells increased levels of IL-35 mRNA and protein. Further studies demonstrated that IAV-induced IL-35 transcription is regulated by NF-kappa B. IL-35 expression was significantly suppressed by selective inhibitors of cyclooxygenase-2 (COX-2) and inducible nitric-oxide synthase, indicating their involvement in IL-35 expression. Interestingly, IL-35 production may have suppressed IAV RNA replication and viral protein synthesis via induction of type I and III interferons (IFN), leading to activation of downstream IFN effectors, including double-stranded RNA-dependent protein kinase, 2',5'-oligoadenylate synthetase, and myxovirus resistance protein. IL-35 exhibited extensive antiviral activity against the hepatitis B virus, enterovirus 71, and vesicular stomatitis virus. Our results demonstrate that IL-35 is a novel IAV-inducible cytokine, and its production elicits antiviral activity.	[Wang, Li; Zhu, Shengli; Xu, Gang; Feng, Jian; Han, Tao; Zhao, Fanpeng; She, Ying-Long; Liu, Shi; Ye, Linbai; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	yingzhu@whu.edu.cn	Zhu, Shengli/D-5281-2009; Zhao, Fanpeng/X-9816-2019	Zhu, Shengli/0000-0002-0190-2626; 	Major State Basic Research Development Program of China [2013CB911102]; National Natural Science Foundation of China [81461130019, 81271821, 31500149, 31570870]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Major State Basic Research Development Program of China (2013CB911102) and National Natural Science Foundation of China (81461130019, 81271821, 31500149, and 31570870). The authors declare that they have no conflicts of interest with the contents of this article.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Choi HJ, 2001, J INFECT DIS, V184, P560, DOI 10.1086/322805; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Huang CH, 2011, J IMMUNOL, V187, P462, DOI 10.4049/jimmunol.1100259; Imanishi N, 2005, MICROBIOL IMMUNOL, V49, P41, DOI 10.1111/j.1348-0421.2005.tb03638.x; Jafarzadeh A, 2015, J MOL NEUROSCI, V55, P891, DOI 10.1007/s12031-014-0443-z; Kalburgi NB, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/489648; Kriegel MA, 2006, IMMUNOLOGY, V119, P43, DOI 10.1111/j.1365-2567.2006.02404.x; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Li XF, 2015, CLIN SCI, V129, P395, DOI 10.1042/CS20140511; Li YK, 2013, J BIOL CHEM, V288, P20927, DOI 10.1074/jbc.M112.440115; Liu F, 2011, CLIN IMMUNOL, V139, P1, DOI 10.1016/j.clim.2010.12.012; Liu JQ, 2012, J IMMUNOL, V188, P3099, DOI 10.4049/jimmunol.1100106; Liu L, 2012, J BIOL CHEM, V287, P11899, DOI 10.1074/jbc.M111.308064; Liu L, 2011, CLIN CHIM ACTA, V412, P1081, DOI 10.1016/j.cca.2011.02.028; Londrigan SL, 2012, J LEUKOCYTE BIOL, V92, P97, DOI 10.1189/jlb.1011492; Long J, 2013, BIOCHEM BIOPH RES CO, V430, P364, DOI 10.1016/j.bbrc.2012.11.004; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Mohammed NA, 2004, J CLIN PATHOL, V57, P350, DOI 10.1136/jcp.2003.012120; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Pan Y, 2007, BIOCHEM BIOPH RES CO, V359, P70, DOI 10.1016/j.bbrc.2007.05.052; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075368; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pirbonen J, 2002, J IMMUNOL, V169, P5673, DOI 10.4049/jimmunol.169.10.5673; Poleganov MA, 2008, MOL IMMUNOL, V45, P2869, DOI 10.1016/j.molimm.2008.01.021; Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; RONNI T, 1995, J IMMUNOL, V154, P2764; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SHAW MW, 1992, CLIN MICROBIOL REV, V5, P74, DOI 10.1128/CMR.5.1.74-92.1992; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Shi YY, 2015, VIRAL IMMUNOL, V28, P93, DOI 10.1089/vim.2014.0058; Short KR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00653; Tripathi S, 2015, INNATE IMMUN-LONDON, V21, P73, DOI 10.1177/1753425913508992; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087787; Wang Q, 2013, J VIROL, V87, P11244, DOI 10.1128/JVI.01248-13; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wong CK, 2015, INFLAMMATION, V38, P348, DOI 10.1007/s10753-014-0038-4; Xiang XG, 2015, J DIGEST DIS, V16, P1, DOI 10.1111/1751-2980.12218; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Yang JF, 2008, EUR J IMMUNOL, V38, P1204, DOI 10.1002/eji.200838145; Yue X, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-118; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zeng JC, 2013, INT J CLIN EXP PATHO, V6, P1806; Zhou YL, 2015, CYTOKINE, V73, P169, DOI 10.1016/j.cyto.2015.02.003; Zou F, 2007, BIOCHEM BIOPH RES CO, V355, P494, DOI 10.1016/j.bbrc.2007.01.178	70	11	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16863	16876		10.1074/jbc.M115.693101	http://dx.doi.org/10.1074/jbc.M115.693101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27307042	Green Published, hybrid			2022-12-26	WOS:000380826700041
J	Sanchez-Montalva, A; Salvador, F; Rodriguez-Palomares, J; Sulleiro, E; Sao-Aviles, A; Roure, S; Valerio, L; Evangelista, A; Molina, I				Sanchez-Montalva, Adrian; Salvador, Fernando; Rodriguez-Palomares, Jose; Sulleiro, Elena; Sao-Aviles, Augusto; Roure, Silvia; Valerio, Lluis; Evangelista, Arturo; Molina, Israel			Chagas Cardiomyopathy: Usefulness of EKG and Echocardiogram in a Non-Endemic Country	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; RANDOMIZED-TRIAL; DISEASE; BENZNIDAZOLE; ABNORMALITIES; ASSOCIATION; PREDICTORS; PARAMETERS; MORTALITY; DIAGNOSIS	Background Chagas disease (CD) is a major cause of cardiomyopathy in Latin America, and migration movements have now spread the disease worldwide. However, data regarding Chagas cardiomyopathy (CC) and the usefulness of echocardiography in non endemic countries are still scarce. Methods and results We selected 485 patients in the chronic phase of CD from two Spanish settings. Data from physical examination, electrocardiogram (EKG), x-ray, and two dimensional transthoracic echocardiogram were recorded. Trypanosoma cruzi DNA was assessed by PCR in peripheral blood. Patients were stratified according to the Kuschnir classification and a combination of echocardiogram and electrocardiogram findings. Patients mainly came from Bolivia (459; 94.6%). One hundred and forty three patients (31.5%) had at least one electrocardiogram abnormality. Twenty seven patients (5.3%) had an abnormal echocardiography. Patients with abnormal echocardiography were older (47 (IQR 38-57) years vs 41 (IQR 3857) years); p = 0.019) and there was a greater proportion of males (66.7% vs 29.7%); p<0.001). Among echocardiographic variables, diastolic dysfunction was associated with poor cardiac status. In the multivariate analysis, abnormal EKG and gender were associated with abnormal echocardiography. Echocardiography may be spared for males under 30 and females under 45 years old with normal EKG as the likelihood of having an abnormal echocardiography is minimal. Association between T. cruzi DNA in the peripheral blood and cardiac involvement was not observed. Conclusion CC rates in the studied population are low. Age and sex are important determinants for the development of CC, and with the EKG should guide echocardiogram performance.	[Sanchez-Montalva, Adrian; Salvador, Fernando; Sao-Aviles, Augusto; Molina, Israel] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Trop Med Unit,PROSICS, Dept Infect Dis,Int Hlth Program,Catalan Hlth Ins, E-08193 Barcelona, Spain; [Rodriguez-Palomares, Jose; Evangelista, Arturo] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Cardiol, Cardiac Imaging Dept, E-08193 Barcelona, Spain; [Sulleiro, Elena] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Microbiol, E-08193 Barcelona, Spain; [Roure, Silvia; Valerio, Lluis] Univ Autonoma Barcelona, North Metropolitan Int Hlth Unit, PROSICS, Int Hlth Program,Catalan Hlth Inst, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Sanchez-Montalva, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Trop Med Unit,PROSICS, Dept Infect Dis,Int Hlth Program,Catalan Hlth Ins, E-08193 Barcelona, Spain.	adsanche@vhebron.net	Sao Aviles, Augusto/GOH-0884-2022; Rodriguez-Palomares, Jose/AAX-9837-2020	Sulleiro, Elena/0000-0002-9783-6060; Rodriguez Palomares, Jose F/0000-0002-7229-9780; Salvador, Fernando/0000-0002-0546-1354; Molina Romero, Israel/0000-0001-6642-7515; Sao Aviles, Augusto/0000-0001-8497-0909				Abuhab A, 2013, INT J CARDIOL; Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; CARRASCO HA, 1994, INT J CARDIOL, V43, P27, DOI 10.1016/0167-5273(94)90087-6; CARRASCO HA, 1982, AM HEART J, V104, P595, DOI 10.1016/0002-8703(82)90232-0; Cianciulli Tomas F, 2006, Cardiovasc Ultrasound, V4, P18, DOI 10.1186/1476-7120-4-18; COURA J R, 1984, Memorias do Instituto Oswaldo Cruz, V79, P101, DOI 10.1590/S0074-02761984000100012; de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002; Borras SG, 2009, IMMUNOL INVEST, V38, P268, DOI 10.1080/08820130902766589; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Garcia-Alvarez A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000826; Garzon S A, 1995, Sao Paulo Med J, V113, P802; Hidron AI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000688; HIGUCHI MD, 1993, CARDIOVASC PATHOL, V2, P101, DOI 10.1016/1054-8807(93)90021-S; Kierszenbaum F, 1999, CLIN MICROBIOL REV, V12, P210, DOI 10.1128/CMR.12.2.210; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1; Maguire J H, 1982, Bull Pan Am Health Organ, V16, P47; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Munoz J, 2009, ACTA TROP, V111, P51, DOI 10.1016/j.actatropica.2009.02.005; Navarro M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001962; Norman FF, 2011, ANN TROP MED PARASIT, V105, P425, DOI 10.1179/1364859411Y.0000000033; Pazin A, 2006, BRAZ J MED BIOL RES, V39, P483, DOI 10.1590/S0100-879X2006000400008; Perez-Ayala A, 2011, CLIN MICROBIOL INFEC, V17, P1108, DOI 10.1111/j.1469-0691.2010.03423.x; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Ramirez JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000899; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Ribeiro AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002078; Riera C, 2012, AM J TROP MED HYG, V86, P412, DOI 10.4269/ajtmh.2012.11-0111; Salles G, 2003, CIRCULATION, V108, P305, DOI 10.1161/01.CIR.0000079174.13444.9C; Salles GF, 2003, PACE, V26, P1326, DOI 10.1046/j.1460-9592.2003.t01-1-00190.x; Salvador F, 2013, CLIN MICROBIOL INFEC; Silva SDA, 2007, MEM I OSWALDO CRUZ, V102, P845, DOI 10.1590/S0074-02762007000700010; Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; World Health Organization, 2002, WHO TECH REP SER, V905, P1	40	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157597	10.1371/journal.pone.0157597	http://dx.doi.org/10.1371/journal.pone.0157597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308824	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800104
J	Castronovo, M; Ernst, D; Couetoux, A; Fonteneau, R				Castronovo, Michael; Ernst, Damien; Couetoux, Adrien; Fonteneau, Raphael			Benchmarking for Bayesian Reinforcement Learning	PLOS ONE			English	Article							ALGORITHM	In the Bayesian Reinforcement Learning (BRL) setting, agents try to maximise the collected rewards while interacting with their environment while using some prior knowledge that is accessed beforehand. Many BRL algorithms have already been proposed, but the benchmarks used to compare them are only relevant for specific cases. The paper addresses this problem, and provides a new BRL comparison methodology along with the corresponding open source library. In this methodology, a comparison criterion that measures the performance of algorithms on large sets of Markov Decision Processes (MDPs) drawn from some probability distributions is defined. In order to enable the comparison of non-anytime algorithms, our methodology also includes a detailed analysis of the computation time requirement of each algorithm. Our library is released with all source code and documentation: it includes three test problems, each of which has two different prior distributions, and seven state-of-the-art RL algorithms. Finally, our library is illustrated by comparing all the available algorithms and the results are discussed.	[Castronovo, Michael; Ernst, Damien; Couetoux, Adrien; Fonteneau, Raphael] Univ Liege, Inst Montefiore, Syst & Modeling, B-4000 Liege, Belgium	University of Liege	Castronovo, M (corresponding author), Univ Liege, Inst Montefiore, Syst & Modeling, B-4000 Liege, Belgium.	m.castronovo@ulg.ac.be						Asmuth J., 2009, P 25 C UNC ART INT, P19; Asmuth J, 2011, P 21 INT C AUT PLANN; Audibert JY, 2007, LECT NOTES ARTIF INT, V4754, P150; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Castelli M, 2014, WOR CONG NAT BIOL, P1, DOI 10.1109/NaBIC.2014.6921849; Castro PS, 2010, LECT NOTES ARTIF INT, V6321, P200, DOI 10.1007/978-3-642-15880-3_19; Castronovo M., 2013, EUR WORKSHOP REINF L, V24, P1; Dearden R, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P150; Dearden R, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P761; Guez A., 2012, NEURAL INFORM PROCES; Kearns M, 2002, MACH LEARN, V49, P193, DOI 10.1023/A:1017932429737; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Kolter J. Z., 2009, P 26 ANN INT C MACH; Strens, 2000, P 17 INT C MACH LEAR, P943	15	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157088	10.1371/journal.pone.0157088	http://dx.doi.org/10.1371/journal.pone.0157088			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304891	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800036
J	Chan, W; Ismail, H; Mayaki, D; Sanchez, V; Tiedemann, K; Davis, EC; Hussain, SNA				Chan, Wilson; Ismail, Hodan; Mayaki, Dominique; Sanchez, Veronica; Tiedemann, Kerstin; Davis, Elaine C.; Hussain, Sabah N. A.			Fibulin-5 Regulates Angiopoietin-1/Tie-2 Receptor Signaling in Endothelial Cells	PLOS ONE			English	Article							EXPRESSION; TIE2; ALPHA-5-BETA-1; ROLES	Background Fibulin-5 is an extracellular matrix glycoprotein that plays critical roles in vasculogenesis and embryonic development. Deletion of Fibulin-5 in mice results in enhanced skin vascularization and upregulation of the angiogenesis factor angiopoietin-1 (Ang-1), suggesting that Fibulin-5 functions as an angiogenesis inhibitor. In this study, we investigate the inhibitory effects of Fibulin-5 on Ang-1/TIE-2 receptor pathway signaling and cell survival in human endothelial cells. Methodology/Principal Findings Recombinant wild-type and RGE-mutant Fibulin-5 proteins were generated through stable transfection of HEK293 and CHO cells, respectively. In vitro solid phase binding assays using pure proteins revealed that wild-type Fibulin-5 does not bind to Ang-1 or TIE-2 proteins but strongly binds to heparin. Binding assays using human umbilical vein endothelial cells (HUVECs) indicated that wild-type Fibulin-5 strongly binds to cells but RGE-mutant Fibulin-5, which is incapable of binding to integrins, does not. Pre-incubation of HUVECs for 1 hr with Fibulin-5 significantly increased caspase 3/7 activity, ERK1/2 phosphorylation, and expressions of the transcription factor early growth response 1 (EGR1) and the dual-specificity phosphatase 5 (DUSP5). Fibulin-5 also strongly attenuated Ang-1-induced TIE-2 and AKT phosphorylation, decreased Ang-1-induced expressions of the transcription factors Inhibitor of DNA Binding 1 (ID1) and Kruppel-like Factor 2 (KLF2), and reversed the inhibitory effect of Ang-1 on serum deprivation-induced cytotoxicity and caspase 3/7 activity. Conclusion/Significance We conclude that Fibulin-5 strongly binds to the endothelial cell surface through heparinsulfate proteoglycans and possibly integrins and that it exerts strong anti-angiogenic effects by reducing endothelial cell viability and interfering with the signaling pathways of the Ang1/TIE-2 receptor axis.	[Chan, Wilson; Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Ismail, Hodan; Mayaki, Dominique; Sanchez, Veronica; Hussain, Sabah N. A.] McGill Univ, Translat Res Resp Dis, Ctr Hlth, Montreal, PQ, Canada; [Ismail, Hodan; Mayaki, Dominique; Sanchez, Veronica; Hussain, Sabah N. A.] McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada; [Tiedemann, Kerstin] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Tiedemann, Kerstin] Shriners Hosp Children, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Hussain, SNA (corresponding author), McGill Univ, Translat Res Resp Dis, Ctr Hlth, Montreal, PQ, Canada.; Hussain, SNA (corresponding author), McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada.	sabah.hussain@muhc.mcgill.ca	Tiedemann, one/A-9739-2016; Hussain, Sabah/ABC-5315-2021		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by operating grants from the Canadian Institutes of Health Research.	Abdel-Malak NA, 2007, ENDOTHELIUM-J ENDOTH, V14, P285, DOI 10.1080/10623320701678268; Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; Abdel-Malak NA, 2009, ARTERIOSCL THROM VAS, V29, P209, DOI 10.1161/ATVBAHA.108.181073; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Echavarria R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000571; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; Harfouche R, 2002, MICROVASC RES, V64, P135, DOI 10.1006/mvre.2002.2421; Khan Zia A., 2005, Angiogenesis, V8, P183, DOI 10.1007/s10456-005-9017-6; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Olsson AK, 2004, CANCER RES, V64, P9012, DOI 10.1158/0008-5472.CAN-04-2172; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009	33	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156994	10.1371/journal.pone.0156994	http://dx.doi.org/10.1371/journal.pone.0156994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304216	gold, Green Published, Green Submitted			2022-12-26	WOS:000377824800032
J	Rex, TS; Kasmala, L; Bond, WS; Cerrillo, AMD; Wynn, K; Lewin, AS				Rex, Tonia S.; Kasmala, Lorraine; Bond, Wesley S.; Cerrillo, Ana M. de Lucas; Wynn, Kristi; Lewin, Alfred S.			Erythropoietin Slows Photoreceptor Cell Death in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; P23H RHODOPSIN PHOTORECEPTORS; GENE DELIVERY; RAT MODEL; DEGENERATION; MUTATIONS; ACTIVATION; GLAUCOMA; MICE; DEGRADATION	Purpose To test the efficacy of systemic gene delivery of a mutant form of erythropoietin (EPO-R76E) that has attenuated erythropoietic activity, in a mouse model of autosomal dominant retinitis pigmentosa. Methods Ten-day old mice carrying one copy of human rhodopsin with the P23H mutation and both copies of wild-type mouse rhodopsin (hP23H RHO+/-, mRHO(+/+)) were injected into the quadriceps with recombinant adeno-associated virus (rAAV) carrying either enhanced green fluorescent protein (eGFP) or EpoR76E. Visual function (electroretinogram) and retina structure (optical coherence tomography, histology, and immunohistochemistry) were assessed at 7 and 12 months of age. Results The outer nuclear layer thickness decreased over time at a slower rate in rAAV. EpoR76E treated as compared to the rAAV. eGFP injected mice. There was a statistically significant preservation of the electroretinogram at 7, but not 12 months of age. Conclusions Systemic EPO-R76E slows death of the photoreceptors and vision loss in hP23H RHO+/-, mRHO(+/+) mice. Treatment with EPO-R76E may widen the therapeutic window for retinal degeneration patients by increasing the number of viable cells. Future studies might investigate if co-treatment with EPO-R76E and gene replacement therapy is more effective than gene replacement therapy alone.	[Rex, Tonia S.; Kasmala, Lorraine; Bond, Wesley S.; Cerrillo, Ana M. de Lucas; Wynn, Kristi] Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Eye Inst, Nashville, TN 37232 USA; [Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32608 USA	Vanderbilt University; State University System of Florida; University of Florida	Rex, TS (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Eye Inst, Nashville, TN 37232 USA.	tonia.rex@vanderbilt.edu		Lewin, Alfred/0000-0002-4192-9727	NEI [R01EY022349, 1R24EY022012, T32 EY021453, P30-EY008126]; Department of Defense [W81XWH-10-1-0528, W81XWH-13-1-0048, W81XWH-15-1-0096]; Research to Prevent Blindness Career Development Award; Foundation Fighting Blindness; Research to Prevent Blindness Unrestricted Funds	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Defense(United States Department of Defense); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness Unrestricted Funds(Research to Prevent Blindness (RPB))	NEI R01EY022349 (TSR); Department of Defense W81XWH-10-1-0528 (TSR), W81XWH-13-1-0048, and W81XWH-15-1-0096; Research to Prevent Blindness Career Development Award (TSR); NEI 1R24EY022012 (AL); Foundation Fighting Blindness (AL); NEI T32 EY021453 (WSB); Research to Prevent Blindness Unrestricted Funds; NEI P30-EY008126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekeye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083871; Bond WS, 2016, MOL THER, V24, P230, DOI 10.1038/mt.2015.198; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Bricker-Anthony C., 2016, OPTOMETRY VISUAL SCI; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Cerrillo AMD, 2015, GENE THER, V22, P365, DOI 10.1038/gt.2015.12; Chiang WC, 2016, ADV EXP MED BIOL, V854, P185, DOI 10.1007/978-3-319-17121-0_25; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; Comitato A, 2014, INVEST OPHTH VIS SCI, V55, P3555, DOI 10.1167/iovs.14-13917; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Fernandez-Sanchez L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00484; Gorbatyuk MS, 2012, ADV EXP MED BIOL, V723, P191, DOI 10.1007/978-1-4614-0631-0_26; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hempel C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00291; Hines-Beard J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0499-5; Hines-Beard J, 2013, CURR GENE THER, V13, P275; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jantzie LL, 2016, DEV NEUROSCI-BASEL, V38, P15, DOI 10.1159/000441024; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Marrero MB, 1998, KIDNEY INT, V53, P1259, DOI 10.1046/j.1523-1755.1998.00887.x; McGill TJ, 2012, INVEST OPHTH VIS SCI, V53, P6232, DOI 10.1167/iovs.12-9569; Nguyen ATH, 2014, ADV EXP MED BIOL, V801, P471, DOI 10.1007/978-1-4614-3209-8_60; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Ozaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071650; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; Rex TS, 2009, EXP EYE RES, V89, P735, DOI 10.1016/j.exer.2009.06.017; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Sizova OS, 2014, CELL SIGNAL, V26, P665, DOI 10.1016/j.cellsig.2013.12.008; Sullivan T, 2011, NEUROCHEM RES, V36, P613, DOI 10.1007/s11064-010-0272-6; Sullivan TA, 2012, EXP EYE RES, V96, P36, DOI 10.1016/j.exer.2012.01.006; Sullivan TA, 2011, HUM GENE THER, V22, P1191, DOI 10.1089/hum.2011.052; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; Zhao HP, 2015, J NEUROIMMUNE PHARM, V10, P153, DOI 10.1007/s11481-014-9571-z; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157411	10.1371/journal.pone.0157411	http://dx.doi.org/10.1371/journal.pone.0157411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299810	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200047
J	Shah, FA; Johansson, ML; Omar, O; Simonsson, H; Palmquist, A; Thomsen, P				Shah, Furqan A.; Johansson, Martin L.; Omar, Omar; Simonsson, Hanna; Palmquist, Anders; Thomsen, Peter			Laser-Modified Surface Enhances Osseointegration and Biomechanical Anchorage of Commercially Pure Titanium Implants for Bone-Anchored Hearing Systems	PLOS ONE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; DIFFERENT OXIDE THICKNESSES; DENTAL IMPLANTS; ELECTROPOLISHED IMPLANTS; STABILITY MEASUREMENTS; CONDUCTION DEVICES; TISSUE REDUCTION; GENE-EXPRESSION; FOLLOW-UP; IN-VIVO	Osseointegrated implants inserted in the temporal bone are a vital component of bone-anchored hearing systems (BAHS). Despite low implant failure levels, early loading protocols and simplified procedures necessitate the application of implants which promote bone formation, bone bonding and biomechanical stability. Here, screw-shaped, commercially pure titanium implants were selectively laser ablated within the thread valley using an Nd: YAG laser to produce a microtopography with a superimposed nanotexture and a thickened surface oxide layer. State-of-the-art machined implants served as controls. After eight weeks' implantation in rabbit tibiae, resonance frequency analysis (RFA) values increased from insertion to retrieval for both implant types, while removal torque (RTQ) measurements showed 153% higher biomechanical anchorage of the laser-modified implants. Comparably high bone area (BA) and bone-implant contact (BIC) were recorded for both implant types but with distinctly different failure patterns following biomechanical testing. Fracture lines appeared within the bone similar to 30-50 mu m from the laser-modified surface, while separation occurred at the bone-implant interface for the machined surface. Strong correlations were found between RTQ and BIC and between RFA at retrieval and BA. In the endosteal threads, where all the bone had formed de novo, the extracellular matrix composition, the mineralised bone area and osteocyte densities were comparable for the two types of implant. Using resin cast etching, osteocyte canaliculi were observed directly approaching the laser-modified implant surface. Transmission electron microscopy showed canaliculi in close proximity to the laser-modified surface, in addition to a highly ordered arrangement of collagen fibrils aligned parallel to the implant surface contour. It is concluded that the physico-chemical surface properties of laser-modified surfaces (thicker oxide, micro- and nanoscale texture) promote bone bonding which may be of benefit in situations where large demands are imposed on biomechanically stable interfaces, such as in early loading and in compromised conditions.	[Shah, Furqan A.; Johansson, Martin L.; Omar, Omar; Palmquist, Anders; Thomsen, Peter] Univ Gothenburg, Inst Clin Sci, Dept Biomat, Sahlgrenska Acad, Gothenburg, Sweden; [Shah, Furqan A.; Johansson, Martin L.; Omar, Omar; Simonsson, Hanna; Palmquist, Anders; Thomsen, Peter] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden; [Johansson, Martin L.; Simonsson, Hanna] Oticon Med AB, Askim, Sweden	University of Gothenburg; Oticon	Thomsen, P (corresponding author), Univ Gothenburg, Inst Clin Sci, Dept Biomat, Sahlgrenska Acad, Gothenburg, Sweden.; Thomsen, P (corresponding author), BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden.	peter.thomsen@biomaterials.gu.se	Palmquist, Anders/D-2171-2014; Johansson, Martin L/R-2307-2017; Shah, Furqan/Y-9485-2019; Omar, Omar/C-9264-2019; Omar, Omar/I-2126-2017	Palmquist, Anders/0000-0002-6974-2577; Johansson, Martin L/0000-0002-7269-0288; Shah, Furqan/0000-0002-9876-0467; Omar, Omar/0000-0002-2610-1294; Omar, Omar/0000-0002-2610-1294; Thomsen, Peter/0000-0003-3910-6665	Oticon Medical AB; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Swedish Research Council [K2015-52X-09495-28-4]; ALF/LUA Research Grant "Optimization of osseointegration for treatment of transfemoral amputees" [ALFGBG-448851]; IngaBritt and Arne Lundberg Foundation; Hjalmar Svensson Foundation; Vilhelm and Martina Lundgren Vetenskapsfond; Swedish Government Strategic Funding of Materials Science Area of Advance; Department of Biomaterials, University of Gothenburg	Oticon Medical AB; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF/LUA Research Grant "Optimization of osseointegration for treatment of transfemoral amputees"; IngaBritt and Arne Lundberg Foundation; Hjalmar Svensson Foundation; Vilhelm and Martina Lundgren Vetenskapsfond; Swedish Government Strategic Funding of Materials Science Area of Advance; Department of Biomaterials, University of Gothenburg	This study was supported by grants from Oticon Medical AB, the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, the Vastra Gotaland Region, the Swedish Research Council (grant K2015-52X-09495-28-4), the ALF/LUA Research Grant "Optimization of osseointegration for treatment of transfemoral amputees" (ALFGBG-448851), the IngaBritt and Arne Lundberg Foundation, the Hjalmar Svensson Foundation, and the Vilhelm and Martina Lundgren Vetenskapsfond. FAS holds a PhD position financed by the Swedish Government Strategic Funding of Materials Science Area of Advance, provided to Chalmers and Department of Biomaterials, University of Gothenburg. MLJ holds an industrial PhD position financed by Oticon Medical AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Oticon Medical AB) provided support in the form of salaries for MLJ and HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Haq J, 2011, CLIN ORAL IMPLAN RES, V22, P265, DOI 10.1111/j.1600-0501.2010.01990.x; Ballo A, 2011, INT J NANOMED, V6, P3415, DOI 10.2147/IJN.S25867; Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006; Brunette DM, 2001, ENG MAT SER, V7, P171, DOI 10.1007/978- 3-642-56486-4_7; Calvo Bodnia N, 2014, OTOL NEUROTOL, V35, pe301, DOI DOI 10.1097/MA0.0000000000000543; Coutinho MB, 2015, J LARYNGOL OTOL, V129, P1133, DOI 10.1017/S0022215115002510; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Davies JE, 2013, BIOMATERIALS, V34, P3535, DOI 10.1016/j.biomaterials.2013.01.024; Degidi M, 2012, CLIN IMPLANT DENT R, V14, P501, DOI 10.1111/j.1708-8208.2010.00302.x; den Besten CA, 2015, INT J PEDIATR OTORHI, V79, P2050, DOI 10.1016/j.ijporl.2015.09.010; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Donos N, 2014, BRIT DENT J, V217, P425, DOI 10.1038/sj.bdj.2014.911; Dooley KA, 2011, RAMAN SPECTROSCOPIC; Drinias V, 2007, CLIN IMPLANT DENT R, V9, P94, DOI 10.1111/j.1708-8208.2007.00047.x; Dun CAJ, 2012, OTOL NEUROTOL, V33, P192, DOI 10.1097/MAO.0b013e318241c0bf; Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696; Foghsgaard S, 2014, OTOL NEUROTOL, V35, P1238, DOI 10.1097/MAO.0000000000000345; Gamsjaeger S, 2010, BONE, V47, P392, DOI 10.1016/j.bone.2010.04.608; Grandfield K, 2013, NANOSCALE, V5, P4302, DOI 10.1039/c3nr00826f; Hogsbro M, 2015, OTOL NEUROTOL, V36, pe51, DOI 10.1097/MAO.0000000000000647; Horstink L, 2012, OTOL NEUROTOL, V33, P1013, DOI 10.1097/MAO.0b013e318259b36c; Hultcrantz M, 2014, OTOL NEUROTOL, V35, P1480, DOI 10.1097/MAO.0000000000000352; JACOBSSON M, 1992, INT J PEDIATR OTORHI, V24, P235, DOI 10.1016/0165-5876(92)90021-G; Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856; KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057; Kazanci M, 2007, BONE, V41, P456, DOI 10.1016/j.bone.2007.04.200; Kiringoda R, 2013, OTOL NEUROTOL, V34, P790, DOI 10.1097/MAO.0b013e318291c651; Kozielski M, 2011, J MATER SCI-MATER M, V22, P1653, DOI 10.1007/s10856-011-4353-0; Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974; Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4; LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lenneras M, 2015, CLIN IMPLANT DENT R, V17, pE486, DOI 10.1111/cid.12276; Mazet V, 2005, CHEMOMETR INTELL LAB, V76, P121, DOI 10.1016/j.chemolab.2004.10.003; McDermott AL, 2008, INT J PEDIATR OTORHI, V72, P751, DOI 10.1016/j.ijporl.2008.01.035; Mohammadi Shams, 2003, Clin Implant Dent Relat Res, V5, P241, DOI 10.1111/j.1708-8208.2003.tb00207.x; Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y; Nader ME, 2015, LARYNGOSCOPE; Nelissen RC, 2015, EUR ARCH OTORHINOLAR; Nelissen RC, 2016, EUR ARCH OTO-RHINO-L, V273, P105, DOI 10.1007/s00405-015-3593-x; Nelissen RC, 2014, OTOL NEUROTOL, V35, P1486, DOI 10.1097/MAO.0000000000000533; Omar O, 2010, J BIOMED MATER RES A, V92A, P1552, DOI 10.1002/jbm.a.32475; Omar OM, 2011, BIOMATERIALS, V32, P374, DOI 10.1016/j.biomaterials.2010.09.011; Palmquist A, 2012, J R SOC INTERFACE, V9, P396, DOI 10.1098/rsif.2011.0420; Palmquist A, 2011, J BIOMED MATER RES B, V97B, P289, DOI 10.1002/jbm.b.31814; Palmquist A, 2010, J BIOMED MATER RES A, V92A, P1476, DOI 10.1002/jbm.a.32439; Palmquist A, 2009, J BIOMED MATER RES B, V91B, P309, DOI 10.1002/jbm.b.31404; Papsin BC, 1997, LARYNGOSCOPE, V107, P801, DOI 10.1097/00005537-199706000-00015; Roschger A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.065002; Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x; Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x; Shah FA, 2016, ACTA BIOMATER, V36, P296, DOI 10.1016/j.actbio.2016.03.033; Shah FA, 2015, ACS BIOMATER SCI ENG, V1, P305, DOI 10.1021/ab500127y; Shah FA, 2016, ACTA BIOMATER, V30, P357, DOI 10.1016/j.actbio.2015.11.013; Shah FA, 2015, J BIOMED MATER RES A, V103, P1565, DOI 10.1002/jbm.a.35287; Shah FA, 2014, NANOMED-NANOTECHNOL, V10, P1729, DOI 10.1016/j.nano.2014.05.015; Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603; Singam S, 2014, OTOL NEUROTOL, V35, P1596, DOI 10.1097/MAO.0000000000000522; Soares Priscilla Barbosa Ferreira, 2015, Braz. Dent. J., V26, P451, DOI 10.1590/0103-6440201300411; Soo G, 2009, OTOL NEUROTOL, V30, P496, DOI 10.1097/MAO.0b013e31819d34ab; Trtica M, 2006, APPL SURF SCI, V253, P2551, DOI 10.1016/j.apsusc.2006.05.024; Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x	63	67	69	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157504	10.1371/journal.pone.0157504	http://dx.doi.org/10.1371/journal.pone.0157504			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299883	gold, Green Submitted, Green Published			2022-12-26	WOS:000377822200057
J	Baratz-Goldstein, R; Deselms, H; Heim, LR; Khomski, L; Hoffer, BJ; Atlas, D; Pick, CG				Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael; Khomski, Lena; Hoffer, Barry J.; Atlas, Daphne; Pick, Chaim G.			Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI)	PLOS ONE			English	Article							N-ACETYLCYSTEINE AMIDE; NECROSIS-FACTOR-ALPHA; FOCAL CEREBRAL-ISCHEMIA; ALLERGIC AIRWAY DISEASE; NEURONAL CELL-DEATH; OXIDATIVE STRESS; RAT-BRAIN; MITOCHONDRIAL BIOENERGETICS; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS	Mild traumatic brain injury (mTBI) is recognized as a common injury among children, sportsmen, and elderly population. mTBI lacks visible objective structural brain damage but patients frequently suffer from long-lasting cognitive, behavioral and emotional difficulties associated with biochemical and cellular changes. Currently there is no effective treatment for patients with mTBI. The thioredoxin reductase/thioredoxin pathway (TrxR/Trx1) has both anti-inflammatory and anti-oxidative properties. If the system is compromised, Trx1 remains oxidized and triggers cell death via an ASK1-Trx1 signal transduction mechanism. We previously showed tri and tetra peptides which were derived from the canonical -CxxC- motif of the Trx1-active site, called thioredoxin mimetic (TXM) peptides, reversed inflammatory and oxidative stress damage mimicking Trx1 activity. Here, TXM-peptides were examined for protecting cognitive function following weight drop closed-head injury in a mouse model of mTBI. TXM-CB3 (AcCys-Pro-CysNH(2)), TXM-CB13 (DY-70; AcCys-Met-Lys-CysNH(2)) or AD4 (ACysNH(2)) were administered at 50 mg/kg, 60 min after injury and cognitive performance was monitored by the novel-object-recognition and Y-maze tests. Behavioral deficits subsequent to mTBI injury were reversed by a single dose of TXM-CB3, TXM-CB13 and, to a lesser extent, by AD4. TXM-CB13 similar to TXM-CB3 and AD4 reversed oxidative stress-induced phosphorylation of mitogen-activated kinases, p38(MAPK) and c-Jun N-terminal kinase, (JNK) in human neuronal SH-SY5Y cells. We conclude that significantly improved cognitive behavior post mTBI by the TXM-peptides could result from anti-apoptotic, and/or anti-inflammatory activities. Future preclinical studies are required to establish the TXM-peptides as potential therapeutic drugs for brain injuries.	[Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Khomski, Lena; Atlas, Daphne] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Case Western Reserve University; Tel Aviv University	Baratz-Goldstein, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.; Atlas, D (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	renanaba@post.tau.ac.il; daphne.atlas@mail.huji.ac.il	Meijer, Anna/K-5118-2016		Ari and Regine Aprijaskis Fund at Tel-Aviv University; H.L Lauterbach Fund (Hebrew University)	Ari and Regine Aprijaskis Fund at Tel-Aviv University; H.L Lauterbach Fund (Hebrew University)	This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University).	Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Amer J, 2008, BBA-GEN SUBJECTS, V1780, P249, DOI 10.1016/j.bbagen.2007.11.009; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bachnoff N, 2011, FREE RADICAL BIO MED, V50, P1355, DOI 10.1016/j.freeradbiomed.2011.02.026; Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cohen-Kutner M, 2014, REDOX BIOL, V2, P447, DOI 10.1016/j.redox.2013.12.018; Cohen-Kutner M, 2013, BIOCHEM PHARMACOL, V85, P977, DOI 10.1016/j.bcp.2013.01.003; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FAN PY, 1995, CLIN IMMUNOL IMMUNOP, V75, P125, DOI 10.1006/clin.1995.1061; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Finme JW, 2008, VET PATHOL, V45, P307, DOI 10.1354/vp.45-3-307; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kim SR, 2011, AM J RESP CRIT CARE, V183, P1015, DOI 10.1164/rccm.200906-0902OC; Kronenfeld G, 2015, FREE RADICAL BIO MED, V79, P138, DOI 10.1016/j.freeradbiomed.2014.11.021; Lee KS, 2007, EXP MOL MED, V39, P756, DOI 10.1038/emm.2007.82; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Offen D, 2004, J NEUROCHEM, V89, P1241, DOI 10.1111/j.1471-4159.2004.02428.x; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Shenk JC, 2009, J NEUROL SCI, V283, P199, DOI 10.1016/j.jns.2009.03.002; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Yan MS, 2008, NEOPLASIA, V10, P160, DOI 10.1593/neo.07935; Zaitone SA, 2012, PHARMACOL BIOCHEM BE, V100, P347, DOI 10.1016/j.pbb.2011.09.002; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008; Zohar J, 2003, CNS SPECTR, V8, P634, DOI 10.1017/S1092852900008798	59	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157064	10.1371/journal.pone.0157064	http://dx.doi.org/10.1371/journal.pone.0157064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285176	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000037
J	Ormeno, F; Barrientos, C; Ramirez, S; Ponce, I; Valenzuela, L; Sepulveda, S; Bitar, M; Kemmerling, U; Machado, CR; Cabrera, G; Galanti, N				Ormeno, Fernando; Barrientos, Camila; Ramirez, Santiago; Ponce, Ivan; Valenzuela, Lucia; Sepulveda, Sofa; Bitar, Maina; Kemmerling, Ulrike; Machado, Carlos Renato; Cabrera, Gonzalo; Galanti, Norbel			Expression and the Peculiar Enzymatic Behavior of the Trypanosoma cruzi NTH1 DNA Glycosylase	PLOS ONE			English	Article							BASE EXCISION-REPAIR; COLI ENDONUCLEASE-III; ESCHERICHIA-COLI; THYMINE GLYCOL; SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION ELONGATION; FUNCTIONAL-ANALYSIS; OXIDATIVE STRESS; RNA-POLYMERASE; CHAGAS-DISEASE	Trypanosoma cruzi, the etiological agent of Chagas' disease, presents three cellular forms (trypomastigotes, epimastigotes and amastigotes), all of which are submitted to oxidative species in its hosts. However, T. cruzi is able to resist oxidative stress suggesting a high efficiency of its DNA repair machinery. The Base Excision Repair (BER) pathway is one of the main DNA repair mechanisms in other eukaryotes and in T. cruzi as well. DNA glycosylases are enzymes involved in the recognition of oxidative DNA damage and in the removal of oxidized bases, constituting the first step of the BER pathway. Here, we describe the presence and activity of TcNTH1, a nuclear T. cruzi DNA glycosylase. Surprisingly, purified recombinant TcNTH1 does not remove the thymine glycol base, but catalyzes the cleavage of a probe showing an AP site. The same activity was found in epimastigote and trypomastigote homogenates suggesting that the BER pathway is not involved in thymine glycol DNA repair. TcNTH1 DNA-binding properties assayed in silico are in agreement with the absence of a thymine glycol removing function of that parasite enzyme. Over expression of TcNTH1 decrease parasite viability when transfected epimastigotes are submitted to a sustained production of H2O2. Therefore, TcNTH1 is the only known NTH1 orthologous unable to eliminate thymine glycol derivatives but that recognizes and cuts an AP site, most probably by a beta-elimination mechanism. We cannot discard that TcNTH1 presents DNA glycosylase activity on other DNA base lesions. Accordingly, a different DNA repair mechanism should be expected leading to eliminate thymine glycol from oxidized parasite DNA. Furthermore, TcNTH1 may play a role in the AP site recognition and processing.	[Ormeno, Fernando; Barrientos, Camila; Ramirez, Santiago; Ponce, Ivan; Valenzuela, Lucia; Sepulveda, Sofa; Cabrera, Gonzalo; Galanti, Norbel] Univ Chile, Programa Biol Celular & Mol, Inst Ciencias Biomed, Fac Med, Santiago 7, Chile; [Bitar, Maina; Machado, Carlos Renato] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Kemmerling, Ulrike] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Anat & Biol Desarrollo, Santiago 7, Chile	Universidad de Chile; Universidade Federal de Minas Gerais; Universidad de Chile	Cabrera, G; Galanti, N (corresponding author), Univ Chile, Programa Biol Celular & Mol, Inst Ciencias Biomed, Fac Med, Santiago 7, Chile.	gcabrera@med.uchile.cl; ngalanti@med.uchile.cl	MACHADO, CARLOS/AAW-1492-2020; Kemmerling, Ulrike/H-8783-2013	Kemmerling, Ulrike/0000-0002-0201-1665; Valenzuela-Perez, Lucia/0000-0002-5145-303X; Ramirez arevalo, santiago/0000-0002-7335-3005	FONDECYT (Chile) [1130113, 1120230]; ERANET-LAC [ELAC2014/HID-0328]; CNPq (Brazil) [444334/2014-9]; FAPEMIG (Brazil) [APQ-00827-15, APQ-02308-13]	FONDECYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ERANET-LAC; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by FONDECYT (Chile) Grant No 1130113 (to NG); FONDECYT (Chile) Grant 1120230 (to UK); ERANET-LAC grant ELAC2014/HID-0328 (to NG and UK); CNPq (Brazil) Grant No 444334/2014-9 (to CRM); FAPEMIG (Brazil) Grant No APQ-00827-15 (to CRM); and FAPEMIG (Brazil) Grant No APQ-02308-13 (to CRM).; We thank Dr. Ulf Hellman and Dr. Ulla Engstrom, Ludwig Institute for Cancer Research, Box 595, SE - 751 24, Uppsala, Sweden, for the amino acid sequencing of the recombinant TcNTH1 protein expressed in E. coli. Financed by FONDECYT (Chile) Grant No 1130113 (to NG); FONDECYT (Chile) Grant 1120230 (to UK); ERANET-LAC grant ELAC2014/HID-0328 (to NG and UK); CNPq (Brazil) Grant No 444334/2014-9 (to CRM); and FAPEMIG (Brazil) Grant No APQ-00827-15 and APQ-02308-13 (to CRM).	Aguiar PHN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002279; Alanazi M, 2002, NUCLEIC ACIDS RES, V30, P4583, DOI 10.1093/nar/gkf588; Alseth I, 2004, NUCLEIC ACIDS RES, V32, P5119, DOI 10.1093/nar/gkh851; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amino R, 2002, J BIOL CHEM, V277, P6207, DOI 10.1074/jbc.M109874200; ASAHARA H, 1989, BIOCHEMISTRY-US, V28, P4444, DOI 10.1021/bi00436a048; Aspinwall R, 1997, P NATL ACAD SCI USA, V94, P109, DOI 10.1073/pnas.94.1.109; BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Bitar M, 2014, IEEE ACM T COMPUT BI, V11, P1052, DOI 10.1109/TCBB.2014.2325018; Cabrera G, 2011, J CELL BIOCHEM, V112, P2189, DOI 10.1002/jcb.23138; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Carvalho TMU, 1999, MEM I OSWALDO CRUZ, V94, P143, DOI 10.1590/S0074-02761999000700016; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; de Souza W, 2005, HISTOCHEM CELL BIOL, V123, P1, DOI 10.1007/s00418-004-0746-1; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; DECARVALHO TU, 1987, PARASITOL RES, V73, P213, DOI 10.1007/BF00578506; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dolinnaya NG, 2013, BIOCHIMIE, V95, P134, DOI 10.1016/j.biochi.2012.09.008; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Farez-Vidal ME, 2001, NUCLEIC ACIDS RES, V29, P1549, DOI 10.1093/nar/29.7.1549; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Furtado C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042484; Galindo M, 2007, FEBS LETT, V581, P2022, DOI 10.1016/j.febslet.2007.03.093; Genois MM, 2014, MICROBIOL MOL BIOL R, V78, P40, DOI 10.1128/MMBR.00045-13; GIBSON WC, 1986, EMBO J, V5, P1299, DOI 10.1002/j.1460-2075.1986.tb04359.x; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gupta S, 2009, OXIDATIVE STRESS CHA; Gupta S, 2009, FREE RADICAL BIO MED, V47, P1414, DOI 10.1016/j.freeradbiomed.2009.08.008; Harlow E.D., 1988, LAB MANUAL, P579; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Henriksson J, 2002, PARASITOLOGY, V124, P277, DOI 10.1017/S0031182001001093; Hilbert TP, 1996, BIOCHEMISTRY-US, V35, P2505, DOI 10.1021/bi952516e; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Karahalil B, 2003, J BIOL CHEM, V278, P33701, DOI 10.1074/jbc.M301617200; KOW YW, 1987, BIOCHEMISTRY-US, V26, P8200, DOI 10.1021/bi00399a027; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokan HE, 1997, BIOCHEM J, V325, P1; Krzeminski J, 2013, CHEM RES TOXICOL, V26, P1746, DOI 10.1021/tx400296x; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee AJ, 2014, DNA REPAIR, V20, P23, DOI 10.1016/j.dnarep.2014.01.007; Lopes DD, 2008, DNA REPAIR, V7, P1882, DOI 10.1016/j.dnarep.2008.07.018; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; Martin-Plaza J, 2015, J BIOMOL SCREEN, V20, P3, DOI 10.1177/1087057114559907; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; MCCARTHYBURKE C, 1989, GENE, V82, P177, DOI 10.1016/0378-1119(89)90043-7; McCullough AK, 2001, BIOCHEMISTRY-US, V40, P561, DOI 10.1021/bi002404+; Mocquet V, 2007, EMBO J, V26, P2923, DOI 10.1038/sj.emboj.7601730; Morinaga H, 2009, DNA REPAIR, V8, P844, DOI 10.1016/j.dnarep.2009.04.020; Muelas-Serrano S, 2000, PARASITOL RES, V86, P999, DOI 10.1007/PL00008532; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; Oyama M, 2004, BIOCHEM BIOPH RES CO, V321, P183, DOI 10.1016/j.bbrc.2004.06.136; Passos-Silva DG, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/840768; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Perez J, 1999, NUCLEIC ACIDS RES, V27, P771, DOI 10.1093/nar/27.3.771; Piacenza L, 2013, ANTIOXID REDOX SIGN, V19, P723, DOI 10.1089/ars.2012.4618; Piacenza L, 2009, CURR OPIN MICROBIOL, V12, P415, DOI 10.1016/j.mib.2009.06.011; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Postel EH, 2003, P NATL ACAD SCI USA, V100, P13247, DOI 10.1073/pnas.2333230100; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; RADMAN M, 1976, J BIOL CHEM, V251, P1438; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Roldan-Arjona T, 2000, PLANT MOL BIOL, V44, P43, DOI 10.1023/A:1006429114451; RoldanArjona T, 1996, NUCLEIC ACIDS RES, V24, P3307, DOI 10.1093/nar/24.17.3307; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Sarker AH, 1998, J MOL BIOL, V282, P761, DOI 10.1006/jmbi.1998.2042; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Sepulveda S, 2014, J CELL BIOCHEM, V115, P397, DOI 10.1002/jcb.24675; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; SOLARI AJ, 1980, CHROMOSOMA, V78, P239, DOI 10.1007/BF00328395; Spadiliero B, 2002, J CELL BIOCHEM, V85, P798, DOI 10.1002/jcb.10183; Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128; Sugimoto T, 2005, DNA REPAIR, V4, P1270, DOI 10.1016/j.dnarep.2005.06.009; Tornaletti S, 2001, J BIOL CHEM, V276, P45367, DOI 10.1074/jbc.M105282200; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; van Dijk M, 2009, NUCLEIC ACIDS RES; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wallace SS, 2013, ENVIRON MOL MUTAGEN, V54, P691, DOI 10.1002/em.21820; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; World Health Organization, 2012, 2 WHO; World Health Organization, 2015, CHAG DIS AM TRYP; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yonekura S, 2007, J RADIAT RES, V48, P417, DOI 10.1269/jrr.07042; Yoshikawa Y, 2015, FREE RADICAL RES, V49, P1239, DOI 10.3109/10715762.2015.1061186; You HJ, 1999, BIOCHEMISTRY-US, V38, P11298, DOI 10.1021/bi991121i; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	98	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157270	10.1371/journal.pone.0157270	http://dx.doi.org/10.1371/journal.pone.0157270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284968	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000054
J	Kwiatkowska, M; Jarosiewicz, P; Michalowicz, J; Koter-Michalak, M; Huras, B; Bukowska, B				Kwiatkowska, Marta; Jarosiewicz, Pawel; Michalowicz, Jaromir; Koter-Michalak, Maria; Huras, Bogumila; Bukowska, Bozena			The Impact of Glyphosate, Its Metabolites and Impurities on Viability, ATP Level and Morphological changes in Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							AMINOMETHYLPHOSPHONIC ACID; OXIDATIVE STRESS; IN-VITRO; HERBICIDES; BROMFENVINPHOS; CYTOTOXICITY; FORMULATIONS; SPECTROMETRY; PRODUCT; DAMAGE	The toxicity of herbicides to animals and human is an issue of worldwide concern. The present study has been undertaken to assess toxic effect of widely used pesticide-glyphosate, its metabolites: aminomethylphosphonic acid (AMPA) and methylphosphonic acid and its impurities: N-(phosphonomethyl) iminodiacetic acid (PMIDA), N-methylglyphosate, hydroxymethylphosphonic acid and bis-(phosphonomethyl) amine on human peripheral blood mononuclear cells (PBMCs). We have evaluated the effect of those compounds on viability, ATP level, size (FSC-A parameter) and granulation (SSC-A parameter) of the cells studied. Human peripheral blood mononuclear cells were exposed to different concentrations of glyphosate, its metabolites and impurities (0.01-10 mM) for 4 and 24 h. It was found that investigated compounds caused statistically significant decrease in viability and ATP level of PBMCs. The strongest changes in cell viability and ATP level were observed after 24 h incubation of PBMCs with bis-(phosphonomethyl) amine, and particularly PMIDA. Moreover, all studied compounds changed cell granularity, while PMIDA and bis-(phosphonomethyl) amine altered PBMCs size. It may be concluded that bis-(phosphonomethyl) amine, and PMIDA caused a slightly stronger damage to PBMCs than did glyphosate. Changes in the parameters studied in PBMCs were observed only at high concentrations of the compounds examined, which clearly shows that they may occur in this cell type only as a result of acute poisoning of human organism with these substances.	[Kwiatkowska, Marta; Jarosiewicz, Pawel; Michalowicz, Jaromir; Koter-Michalak, Maria; Bukowska, Bozena] Univ Lodz, Dept Environm Pollut Biophys, PL-90131 Lodz, Poland; [Huras, Bogumila] Inst Ind Organ Chem, Warsaw, Poland	University of Lodz	Kwiatkowska, M (corresponding author), Univ Lodz, Dept Environm Pollut Biophys, PL-90131 Lodz, Poland.	m.n.kwiatkowska@wp.pl		Bukowska, Bozena/0000-0003-3044-2953; Michalowicz, Jaromir/0000-0002-7293-596X; Jarosiewicz, Pawel/0000-0002-9104-2593; Koter-Michalak, Maria/0000-0001-8660-4136	Polish National Science Centre [2013/11/N/NZ7/00371]	Polish National Science Centre	This work was supported by the Polish National Science Centre (Contract-2013/11/N/NZ7/00371).	Annett R, 2014, J APPL TOXICOL, V34, P458, DOI 10.1002/jat.2997; Aris A, 2011, REPROD TOXICOL, V31, P528, DOI 10.1016/j.reprotox.2011.02.004; Ayi AA, 2014, FRONTIERCHEM, V94, P1; Benachour N, 2009, CHEM RES TOXICOL, V22, P97, DOI 10.1021/tx800218n; Berge A, 2002, ENVIRON SCI POLLUT R, V19, P3798; Bukowska M, 2004, CELL BIOL INT, V28, P557, DOI 10.1016/j.cellbi.2004.04.013; Diaz-Rua R, 2015, J NUTR BIOCHEM, V26, P398, DOI 10.1016/j.jnutbio.2014.11.013; Duchnowicz P, 2002, PESTIC BIOCHEM PHYS, V74, P1, DOI 10.1016/S0048-3575(02)00139-6; Edwards V, 2015, INTEGRATIVE PHARM TO, V1, P71, DOI DOI 10.15761/IPTG.1000104; Gomes MP, 2014, J EXP BOT, V65, P4691, DOI 10.1093/jxb/eru269; Grube AH, 2011, PESTICIDES IND SALES; Guilherme S, 2014, ENVIRON SCI POLLUT R, V21, P8730, DOI 10.1007/s11356-014-2803-1; Martinez A, 2007, BIOMEDICA, V27, P594, DOI 10.7705/biomedica.v27i4.176; Mesnage R, 2015, FOOD CHEM TOXICOL, V84, P133, DOI 10.1016/j.fct.2015.08.012; Mesnage R, 2013, TOXICOLOGY, V313, P122, DOI 10.1016/j.tox.2012.09.006; Michalowicz J, 2015, TOXICOL IN VITRO, V29, P1464, DOI 10.1016/j.tiv.2015.05.012; Nicotera P, 1998, TOXICOL LETT, V103, P139; Niemann L, 2015, J VERBRAUCH LEBENSM, V10, P3, DOI 10.1007/s00003-014-0927-3; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Ribeiro DN, 2015, J AGR FOOD CHEM, V63, P1689, DOI 10.1021/jf5055722; Ribeiro DN, 2014, PLANTA, V239, P199, DOI 10.1007/s00425-013-1972-3; RILEY DP, 1991, INORG CHEM, V30, P4191, DOI 10.1021/ic00022a020; Saito T, 2012, FORENSIC TOXICOL, V30, P1, DOI 10.1007/s11419-011-0120-7; Schutt F, 2012, INVEST OPHTH VIS SCI, V53, P5354, DOI 10.1167/iovs.12-9845; Sedek L, 1995, ADV CELL BIOL, V35, P17; Shao XZ, 2015, FLUID PHASE EQUILIBR, V390, P7, DOI 10.1016/j.fluid.2015.01.009; She YX, 2012, FOOD CHEM, V132, P502, DOI 10.1016/j.foodchem.2011.09.131; Song HY, 2012, J KOREAN MED SCI, V27, P711, DOI 10.3346/jkms.2012.27.7.711; Sosnowska B, 2015, PESTIC BIOCHEM PHYS, V118, P43, DOI 10.1016/j.pestbp.2014.11.009; Sosnowska B, 2013, INT J BIOL MACROMOL, V57, P38, DOI 10.1016/j.ijbiomac.2013.02.011; Van Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI [10.1002/ps.1518, DOI 10.1002/PS.1518]; Yushchenko DY, 2013, J ANAL CHEM+, V68, P961, DOI 10.1134/S1061934813110166; Zouaoui K, 2013, FORENSIC SCI INT, V226, pE20, DOI 10.1016/j.forsciint.2012.12.010	33	24	24	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156946	10.1371/journal.pone.0156946	http://dx.doi.org/10.1371/journal.pone.0156946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280764	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000058
J	Eckart, N; Song, QF; Yang, R; Wang, RH; Zhu, H; McCallion, AS; Avramopoulos, D				Eckart, Nicole; Song, Qifeng; Yang, Rebecca; Wang, Ruihua; Zhu, Heng; McCallion, Andrew S.; Avramopoulos, Dimitrios			Functional Characterization of Schizophrenia-Associated Variation in CACNA1C	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; GATED CALCIUM-CHANNEL; BIPOLAR DISORDER; C-TERMINUS; METAANALYSIS; REVEALS; TUMORIGENICITY; PKNOX2; CELLS; GENE	Calcium channel subunits, including CACNA1C, have been associated with multiple psychiatric disorders. Specifically, genome wide association studies (GWAS) have repeatedly identified the single nucleotide polymorphism (SNP) rs1006737 in intron 3 of CACNA1C to be strongly associated with schizophrenia and bipolar disorder. Here, we show that rs1006737 marks a quantitative trait locus for CACNA1C transcript levels. We test 16 SNPs in high linkage disequilibrium with rs1007637 and find one, rs4765905, consistently showing allele-dependent regulatory function in reporter assays. We find allele-specific protein binding for 13 SNPs including rs4765905. Using protein microarrays, we identify several proteins binding >= 3 SNPs, but not control sequences, suggesting possible functional interactions and combinatorial haplotype effects. Finally, using circular chromatin conformation capture, we show interaction of the disease-associated region including the 16 SNPs with the CACNA1C promoter and other potential regulatory regions. Our results elucidate the pathogenic relevance of one of the best-supported risk loci for schizophrenia and bipolar disorder.	[Eckart, Nicole; Wang, Ruihua; McCallion, Andrew S.; Avramopoulos, Dimitrios] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Song, Qifeng; Zhu, Heng] Johns Hopkins Univ, Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yang, Rebecca; Avramopoulos, Dimitrios] Johns Hopkins Med, Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Avramopoulos, D (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.; Avramopoulos, D (corresponding author), Johns Hopkins Med, Psychiat & Behav Sci, Baltimore, MD 21205 USA.	adimitr1@jhmi.edu			National Institute of Mental Health grant [MH092515, MH085018]; National Institute of Neurological Disorders and Stroke grant [NINDS NS062972]; NIH grants [MH092515, MH085018]; NINDS grant [R01 NS062972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085018, R01MH092515, R01MH106522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Mental Health grant numbers MH092515 and MH085018 to DA (https://www.nimh.nih.gov/index.shtml); and National Institute of Neurological Disorders and Stroke grant number NINDS NS062972 to ASM (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants MH092515 and MH085018 to D.A. and NINDS grant R01 NS062972 to A.S.M. We thank the Harvard Brain Tissue Resource Center and the University of Maryland National Institute of Child Health and Human Development Brain Bank for providing tissue samples, and to Megan Szymanski Pierce who previously extracted DNA and RNA from STG tissue samples.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Gershon ES, 2014, MOL PSYCHIATR, V19, P890, DOI 10.1038/mp.2013.107; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gomez-Ospina N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060526; GRAHAM FL, 1978, VIROLOGY, V86, P10, DOI 10.1016/0042-6822(78)90003-X; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Guo XB, 2013, GENET EPIDEMIOL, V37, P122, DOI 10.1002/gepi.21688; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Kasai K, 2003, AM J PSYCHIAT, V160, P156, DOI 10.1176/appi.ajp.160.1.156; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin RC, 2003, ANNU REV PSYCHOL, V54, P55, DOI 10.1146/annurev.psych.54.101601.145201; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Owen MJ, 2016, LANCET LOND ENG 0114; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Pers TH, 2016, HUM MOL GENET; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Skuse D, 2003, ANN NY ACAD SCI, V1008, P91, DOI 10.1196/annals.1301.010; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Szymanski M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.17; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wang KS, 2012, J MOL NEUROSCI, V48, P265, DOI 10.1007/s12031-012-9787-4; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Xie Z, 2010, BIOINFORMATICS, V26, P287, DOI 10.1093/bioinformatics/btp631; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P162, DOI 10.1038/mp.2014.143	46	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157086	10.1371/journal.pone.0157086	http://dx.doi.org/10.1371/journal.pone.0157086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276213	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700067
J	Chung, S; Ghelfi, M; Atkinson, J; Parker, R; Qian, JH; Carlin, C; Manor, D				Chung, Stacey; Ghelfi, Mikel; Atkinson, Jeffrey; Parker, Robert; Qian, Jinghui; Carlin, Cathleen; Manor, Danny			Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic -Tocopherol Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid trafficking; lipid transport; phosphatidylinositol signaling; phosphoinositide; vitamin E; tocopherol; tocopherol transfer protein	CASSETTE TRANSPORTER A1; ALPHA-TOCOPHEROL; E-DEFICIENCY; OXIDATIVE STRESS; PLASMA-MEMBRANE; RETINITIS-PIGMENTOSA; LIGAND TRANSFER; OMEGA-HYDROXYLASE; LIPID DROPLETS; C DISEASE	-Tocopherol (vitamin E) is an essential nutrient for all vertebrates. From the eight naturally occurring members of the vitamin E family, -tocopherol is the most biologically active species and is selectively retained in tissues. The hepatic -tocopherol transfer protein (TTP) preferentially selects dietary -tocopherol and facilitates its transport through the hepatocyte and its secretion to the circulation. In doing so, TTP regulates body-wide levels of -tocopherol. The mechanisms by which TTP facilitates -tocopherol trafficking in hepatocytes are poorly understood. We found that the intracellular localization of TTP in hepatocytes is dynamic and responds to the presence of -tocopherol. In the absence of the vitamin, TTP is localized to perinuclear vesicles that harbor CD71, transferrin, and Rab8, markers of the recycling endosomes. Upon treatment with -tocopherol, TTP- and -tocopherol-containing vesicles translocate to the plasma membrane, prior to secretion of the vitamin to the exterior of the cells. The change in TTP localization is specific to -tocopherol and is time- and dose-dependent. The aberrant intracellular localization patterns of lipid binding-defective TTP mutants highlight the importance of protein-lipid interaction in the transport of -tocopherol. These findings provide the basis for a proposed mechanistic model that describes TTP-facilitated trafficking of -tocopherol through hepatocytes.	[Chung, Stacey; Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Nutr, WG 48, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Carlin, Cathleen] Case Western Reserve Univ, Sch Med, Dept Microbiol & Mol Biol, Cleveland, OH 44106 USA; [Ghelfi, Mikel; Atkinson, Jeffrey] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada; [Parker, Robert; Qian, Jinghui] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Brock University; Cornell University	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, WG 48, Cleveland, OH 44106 USA.	dxm178@case.edu		Atkinson, Jeffrey/0000-0003-3710-4893	National Institutes of Health [DK067494]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK067494 (to D. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Atkinson J, 2008, FREE RADICAL BIO MED, V44, P739, DOI 10.1016/j.freeradbiomed.2007.11.010; Azzi A, 2007, FREE RADICAL BIO MED, V43, P16, DOI 10.1016/j.freeradbiomed.2007.03.013; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; BJORNEBOE A, 1987, BIOCHIM BIOPHYS ACTA, V922, P199, DOI 10.1016/0005-2760(87)90155-X; BURTON GW, 1994, P NUTR SOC, V53, P251, DOI 10.1079/PNS19940030; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Copp RP, 1999, BRAIN RES, V822, P80, DOI 10.1016/S0006-8993(99)01090-2; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Etzl RP, 2012, J PERINAT MED, V40, P373, DOI 10.1515/jpm-2011-0307; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Yevenes LF, 2012, BBA-MOL BASIS DIS, V1822, P150, DOI 10.1016/j.bbadis.2011.11.009; Gabsi S, 2001, EUR J NEUROL, V8, P477, DOI 10.1046/j.1468-1331.2001.00273.x; Gao Q, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00049; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hentati A, 1996, ANN NEUROL, V39, P295, DOI 10.1002/ana.410390305; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; INGOLD KU, 1987, ARCH BIOCHEM BIOPHYS, V259, P224, DOI 10.1016/0003-9861(87)90489-9; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Kono N, 2015, TRAFFIC, V16, P19, DOI 10.1111/tra.12231; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; LETH T, 1977, J NUTR, V107, P2236, DOI 10.1093/jn/107.12.2236; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; Morley S, 2008, J BIOL CHEM, V283, P17797, DOI 10.1074/jbc.M800121200; Morley S, 2010, J BIOL CHEM, V285, P35578, DOI 10.1074/jbc.M110.169664; MOWRI H, 1981, EUR J BIOCHEM, V117, P537; Muller-Schmehl K, 2004, FREE RADICAL RES, V38, P413, DOI 10.1080/10715760310001659611; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Olivier M, 2014, BBA-MOL CELL BIOL L, V1841, P1741, DOI 10.1016/j.bbalip.2014.10.003; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00056; Schuelke M, 1999, J PEDIATR-US, V134, P240, DOI 10.1016/S0022-3476(99)70424-5; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shichiri M, 2010, J NUTR BIOCHEM, V21, P451, DOI 10.1016/j.jnutbio.2009.02.002; SOKOL RJ, 1988, ANNU REV NUTR, V8, P351, DOI 10.1146/annurev.nu.08.070188.002031; Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thakur V, 2010, BIOCHEMISTRY-US, V49, P9339, DOI 10.1021/bi100960b; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; TRABER MG, 1989, AM J CLIN NUTR, V49, P517, DOI 10.1093/ajcn/49.3.517; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; TRABER MG, 1993, J LIPID RES, V34, P201; Ulatowski L, 2011, J LIPID RES, V52, P1400, DOI 10.1194/jlr.M015560; Ulatowski L, 2012, FREE RADICAL BIO MED, V53, P2318, DOI 10.1016/j.freeradbiomed.2012.10.528; Ulatowski LM, 2015, NEUROBIOL DIS, V84, P78, DOI 10.1016/j.nbd.2015.04.002; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Yokota T, 1997, ANN NEUROL, V41, P826, DOI 10.1002/ana.410410621; Yokota T, 1996, NEW ENGL J MED, V335, P1770, DOI 10.1056/NEJM199612053352315; Yokota T, 2000, J NEUROL NEUROSUR PS, V68, P521, DOI 10.1136/jnnp.68.4.521; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zhang WX, 2011, J MOL BIOL, V405, P972, DOI 10.1016/j.jmb.2010.11.028; Zhang WX, 2009, LIPIDS, V44, P631, DOI 10.1007/s11745-009-3310-x	79	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17028	17039		10.1074/jbc.M116.734210	http://dx.doi.org/10.1074/jbc.M116.734210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27307040	hybrid, Green Published			2022-12-26	WOS:000382643800010
J	Zogzas, CE; Aschner, M; Mukhopadhyay, S				Zogzas, Charles E.; Aschner, Michael; Mukhopadhyay, Somshuvra			Structural Elements in the Transmembrane and Cytoplasmic Domains of the Metal Transporter SLC30A10 Are Required for Its Manganese Efflux Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAILEY-HAILEY-DISEASE; ESCHERICHIA-COLI; SECRETORY PATHWAY; INTRACELLULAR TRAFFICKING; SUBSTRATE-SPECIFICITY; INDUCED PARKINSONISM; ZINC TRANSPORTERS; HEPATIC CIRRHOSIS; OXIDATIVE DAMAGE; YIIP	Homozygous mutations in SLC30A10 lead to the development of familial manganese-induced parkinsonism. We previously demonstrated that SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its trafficking and efflux activity. Interestingly, other transporters in the SLC30 family mediate zinc efflux. Determining the mechanisms that allow SLC30A10 to transport manganese, which are unclear, is essential to understand its role in parkinsonism. Here, we generated a predicted structure of SLC30A10, based on the structure of the bacterial zinc transporter YiiP, and performed functional studies. In YiiP, side chains of residues Asp-45 and Asp-49 in the second and His-153 and Asp-157 in the fifth transmembrane segments coordinate zinc and are required for transport. In SLC30A10, the corresponding residues are Asn-43 and Asp-47 in the second and His-244 and Asp-248 in the fifth transmembrane segments. Surprisingly, although alanine substitution of Asp-248 abolished manganese efflux, that of Asn-43 and Asp-47 did not. Instead, side chains of charged or polar residues adjacent to Asp-248 in the first (Glu-25) or fourth (Asn-127) transmembrane segments were required. Further analyses revealed that residues His-333 and His-350 in the cytoplasmic C-terminal domain were required for full activity. However, the C-terminal domain failed to transfer manganese transport capability to a related zinc transporter. Overall, our results indicate that residues in the transmembrane and C-terminal domains together confer optimal manganese transport capability to SLC30A10 and suggest that the mechanism of ion coordination in the transmembrane domain of SLC30A10 may be substantially different from that in YiiP/other SLC30 proteins.	[Zogzas, Charles E.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Zogzas, Charles E.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Albert Einstein Coll Med, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton, Austin, TX 78712 USA.	som@austin.utexas.edu		zogzas, charles/0000-0003-0092-6316; Mukhopadhyay, Somshuvra/0000-0002-3420-7830	National Institutes of Health from NIEHS [R00-ES020844, R01-ES024812]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024812, R00ES020844] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R00-ES020844 and R01-ES024812 from NIEHS (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Martin JE, 2016, J BACTERIOL, V198, P1066, DOI 10.1128/JB.00975-15; Masuda M, 2013, SYNAPSE, V67, P205, DOI 10.1002/syn.21632; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Ramos-Castaneda J, 2005, J BIOL CHEM, V280, P9467, DOI 10.1074/jbc.M413243200; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Shusterman E, 2014, METALLOMICS, V6, P1656, DOI 10.1039/c4mt00108g; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wahlberg K, 2016, TOXICOL SCI, V149, P473, DOI 10.1093/toxsci/kfv252; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200	50	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15940	15957		10.1074/jbc.M116.726935	http://dx.doi.org/10.1074/jbc.M116.726935			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27307044	Green Published, hybrid			2022-12-26	WOS:000380585400003
J	Ayana, BA; Negash, S; Yusuf, L; Tigeneh, W; Haile, D				Ayana, Birhanu Abera; Negash, Shiferaw; Yusuf, Lukman; Tigeneh, Wendemagegnhu; Haile, Demewoz			Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia	PLOS ONE			English	Article							QUALITY-OF-LIFE; EUROPEAN ORGANIZATION; VALIDATION; QLQ-C30; TRANSLATION; TURKISH	Background Cancer is a growing public health problem worldwide. The focus of cancer treatment, in addition to curation, is improving the quality of life (QOL). This study aimed to assess the reliability and validity of Amharic version of European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) among gynecological cancer patients in Ethiopia. Methods A facility-based cross-sectional study was conducted using the Amharic version of EORTC QLQ-C30 on 153 gynecological cancer patients in Tikur Anbassa Specialized Hospital (TASH), Addis Ababa, Ethiopia. Descriptive statistics, correlation analysis and multivariable linear regression were employed in statistical analysis. Results The Amharic version of EORTC QLQ-C30 had a Cronbach's a value of 0.81. The internal consistency for each domain of EORTC QLQ-C30 was also acceptable (Cronbach's a >0.7) except for cognitive function domain (Cronbach's alpha = 0.29). Stepwise multivariable linear regression analysis showed that emotional functioning (p<0.001), fatigue (p<0.001) and social functioning (p = 0.004) were the determinative scales of EORTC QLQ-C30 on global health status (GHS). The clinical validity test (Known group validity) showed that there were significant differences in score for twelve out of 15 domains, between surgery and radiation scheduled patients. All items of emotional function, role function, fatigue, and GHS meet the discriminate validity criterion. Conclusion The Amharic version of EORTC QLQ-C30 found to be reliable and had an acceptable validity to assess the QOL for gynecological cancer patients. We recommend further work on the validity and responsiveness of the EORTC QLQ-C30 with stronger design.	[Ayana, Birhanu Abera] Univ Gondar, Dept Gynecol & Obstet, Gondar, Ethiopia; [Negash, Shiferaw; Yusuf, Lukman] Univ Addis Ababa, Dept Gynecol & Obstet, Addis Ababa, Ethiopia; [Tigeneh, Wendemagegnhu] Univ Addis Ababa, Dept Clin Oncol, Addis Ababa, Ethiopia; [Haile, Demewoz] Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia	University of Gondar; Addis Ababa University; Addis Ababa University; Bahir Dar University	Haile, D (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia.	demewozhaile@yahoo.com		Haile, Demewoz/0000-0003-0047-4276	school of Medicine, Addis Ababa University, Ethiopia; Addis Ababa University	school of Medicine, Addis Ababa University, Ethiopia; Addis Ababa University	This study was funded by school of Medicine, Addis Ababa University, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Addis Ababa University for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also thank the study subjects to be participated in this study. We forward our greatest gratitude to EORTC who allowed us to use the questionnaire. Moreover Dr. Dereje H who gave us his advice and comments throughout of the study also deserve our heartfelt thanks.	[Anonymous], 2009, ECONOMIST; Cramer DW, 2012, HEMATOL ONCOL CLIN N, V26, P1, DOI 10.1016/j.hoc.2011.10.009; Davies N, 2009, STRUCTURED REV PATIE; Demirci S, 2011, ASIAN PAC J CANCER P, V12, P1283; Fayers P, 1998, EORTC QLQ C30 REFERE; Fayers P, 2001, EORTC QLQ C30 SCORIN; Goker A, 2011, ASIAN PAC J CANCER P, V12, P3121; Hoopman R, 2006, EUR J CANCER, V42, P1839, DOI 10.1016/j.ejca.2005.08.047; International Agency for Research on Cancer, 2008, GLOBO CAN 2008 FAST; Iyoke CA, 2013, WORLD J OBSTET GYNEC, V2, P1, DOI [10.5317/wjog.v2.i1.1, DOI 10.5317/wjog.v2.i1.1]; Kontodimopoulos N, 2012, SCI WORLD J, DOI 10.1100/2012/842867; Luo N, 2005, QUAL LIFE RES, V14, P1181, DOI 10.1007/s11136-004-4782-z; Masmoudi A, 2009, East Mediterr Health J, V15, P362; Michels Fernanda Alessandra Silva, 2013, Rev. bras. epidemiol., V16, P352, DOI 10.1590/S1415-790X2013000200011; Nejjari Chakib, 2014, BMC Res Notes, V7, P228, DOI 10.1186/1756-0500-7-228; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Scott NW FP, 2008, BEHALF EORTC QUALITY; Sharp LK, 1999, QUAL LIFE RES, V8, P461, DOI 10.1023/A:1008940015696; Shuleta-Qehaja S, 2015, PATIENT PREFER ADHER, V9, P459, DOI 10.2147/PPA.S78334; Silpakit C, 2006, QUAL LIFE RES, V15, P167, DOI 10.1007/s11136-005-0449-7; Tabano Maggi, 2002, Semin Oncol Nurs, V18, P223, DOI 10.1053/sonu.2002.34084; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Wan C, 2008, ANN ONCOL, V19, P2053, DOI 10.1093/annonc/mdn417; Wendemagegnhu T, 2013, PATTERNS CANC UNPUB; Wenzel L, 2003, INT J GYNECOL OBSTET, V83, P211, DOI 10.1016/S0020-7292(03)90123-8	25	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157359	10.1371/journal.pone.0157359	http://dx.doi.org/10.1371/journal.pone.0157359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304066	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800053
J	Himpe, E; Cunha, DA; Song, I; Bugliani, M; Marchetti, P; Cnop, M; Bouwens, L				Himpe, Eddy; Cunha, Daniel A.; Song, Imane; Bugliani, Marco; Marchetti, Piero; Cnop, Miriam; Bouwens, Luc			Phenylpropenoic Acid Glucoside from Rooibos Protects Pancreatic Beta Cells against Cell Death Induced by Acute Injury	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ENZYME GENE-EXPRESSION; B-CELLS; Z-2-(BETA-D-GLUCOPYRANOSYLOXY)-3-PHENYLPROPENOIC ACID; ER STRESS; STREPTOZOTOCIN; APOPTOSIS; MECHANISMS; MASS; INITIATION	Objective Previous studies demonstrated that a phenylpropenoic acid glucoside (PPAG) from rooibos (Aspalathus linearis) extract had anti-hyperglycemic activity and significant protective effects on the pancreatic beta cell mass in a chronic diet-induced diabetes model. The present study evaluated the cytoprotective effect of the phytochemical on beta cells exposed to acute cell stress. Methods Synthetically prepared PPAG was administered orally in mice treated with a single dose of streptozotocin to acutely induce beta cell death and hyperglycemia. Its effect was assessed on beta cell mass, proliferation and apoptotic cell death. Its cytoprotective effect was also studied in vitro on INS-1E beta cells and on human pancreatic islet cells. Results Treatment with the phytochemical PPAG protected beta cells during the first days after the insult against apoptotic cell death, as evidenced by TUNEL staining, and prevented loss of expression of anti-apoptotic protein BCL2 in vivo. In vitro, PPAG protected INS-1E beta cells from streptozotocin-induced apoptosis and necrosis in a BCL2-dependent and independent way, respectively, depending on glucose concentration. PPAG also protected human pancreatic islet cells against the cytotoxic action of the fatty acid palmitate. Conclusions These findings show the potential use of PPAG as phytomedicine which protects the beta cell mass exposed to acute diabetogenic stress.	[Himpe, Eddy; Song, Imane; Bouwens, Luc] Vrije Univ Brussel, Diabet Res Ctr, Cell Differentiat Lab, Brussels, Belgium; [Cunha, Daniel A.; Cnop, Miriam] Univ Libre Bruxelles, Ctr Diabet Res, Brussels, Belgium; [Cnop, Miriam] Erasmus Hosp, Div Endocrinol, Brussels, Belgium; [Bugliani, Marco; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Pisa	Himpe, E (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Cell Differentiat Lab, Brussels, Belgium.	Ehimpe@gmail.com	Bugliani, Marco/I-3168-2019	Bugliani, Marco/0000-0002-1744-1561; Cnop, Miriam/0000-0002-5112-1692; Himpe, Eddy/0000-0001-6624-5877; Bouwens, Luc/0000-0001-5767-7002	Wetenschappelijk Fonds Willy Gepts of the UZ Brussel; Actions de Recherche Concertees de la Communaute Francaise (ARC Consolidator 37C); Fonds National de la Recherche Scientifique [FNRS MIS F.4523.14]	Wetenschappelijk Fonds Willy Gepts of the UZ Brussel; Actions de Recherche Concertees de la Communaute Francaise (ARC Consolidator 37C); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from "Wetenschappelijk Fonds Willy Gepts of the UZ Brussel", "Actions de Recherche Concertees de la Communaute Francaise (ARC Consolidator 37C)", and the "Fonds National de la Recherche Scientifique (FNRS MIS F.4523.14)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin R, 2015, FREE RADICAL RES, V49, P279, DOI 10.3109/10715762.2014.999674; Ahn C, 2015, MOL CELL ENDOCRINOL, V412, P302, DOI 10.1016/j.mce.2015.05.017; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Joubert E, 2013, FOOD CHEM, V136, P1078, DOI 10.1016/j.foodchem.2012.09.014; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marais C, 1996, J CHEM SOC PERK T 1, P2915, DOI 10.1039/p19960002915; Mathijs I, 2014, MOL NUTR FOOD RES, V58, P1980, DOI 10.1002/mnfr.201400211; McCarty MF, 2005, MED HYPOTHESES, V64, P151, DOI 10.1016/j.mehy.2004.03.036; Meier JJ, 2013, DIABETES CARE, V36, pS113, DOI 10.2337/dcS13-2008; MORGAN NG, 1994, BIOSCIENCE REP, V14, P243, DOI 10.1007/BF01209729; Muller CJF, 2013, MOL NUTR FOOD RES, V57, P2216, DOI 10.1002/mnfr.201300294; PIPELEERS D, 1986, P NATL ACAD SCI USA, V83, P5267, DOI 10.1073/pnas.83.14.5267; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Song I, 2015, CURR DRUG TARGETS, V16, P516, DOI 10.2174/1389450116666150204113928; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Uetake R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087667; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Watanabe A, 2012, J NUCL MED, V53, P1585, DOI 10.2967/jnumed.111.102459; Wu JZ, 2015, DIABET METAB SYND OB, V8, P181, DOI 10.2147/DMSO.S82272; Zhu M, 2014, ENDOCRINE, V47, P129, DOI 10.1007/s12020-013-0132-7; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	33	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157604	10.1371/journal.pone.0157604	http://dx.doi.org/10.1371/journal.pone.0157604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299564	Green Published, gold			2022-12-26	WOS:000377822200065
J	Luo, T; Shi, CR; Zhao, X; Zhao, YS; Xu, JQ				Luo, Ting; Shi, Changrong; Zhao, Xing; Zhao, Yunsong; Xu, Jinqiu			Automatic Synthesis of Panoramic Radiographs from Dental Cone Beam Computed Tomography Data	PLOS ONE			English	Article							X-RAY; CT	In this paper, we propose an automatic method of synthesizing panoramic radiographs from dental cone beam computed tomography (CBCT) data for directly observing the whole dentition without the superimposition of other structures. This method consists of three major steps. First, the dental arch curve is generated from the maximum intensity projection (MIP) of 3D CBCT data. Then, based on this curve, the long axial curves of the upper and lower teeth are extracted to create a 3D panoramic curved surface describing the whole dentition. Finally, the panoramic radiograph is synthesized by developing this 3D surface. Both open-bite shaped and closed-bite shaped dental CBCT datasets were applied in this study, and the resulting images were analyzed to evaluate the effectiveness of this method. With the proposed method, a single-slice panoramic radiograph can clearly and completely show the whole dentition without the blur and superimposition of other dental structures. Moreover, thickened panoramic radiographs can also be synthesized with increased slice thickness to show more features, such as the mandibular nerve canal. One feature of the proposed method is that it is automatically performed without human intervention. Another feature of the proposed method is that it requires thinner panoramic radiographs to show the whole dentition than those produced by other existing methods, which contributes to the clarity of the anatomical structures, including the enamel, dentine and pulp. In addition, this method can rapidly process common dental CBCT data. The speed and image quality of this method make it an attractive option for observing the whole dentition in a clinical setting.	[Luo, Ting; Shi, Changrong; Zhao, Xing; Zhao, Yunsong; Xu, Jinqiu] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Luo, Ting; Shi, Changrong; Zhao, Xing; Zhao, Yunsong; Xu, Jinqiu] Beijing Higher Inst Engn Res Ctr Testing & Imagin, Beijing, Peoples R China	Capital Normal University	Zhao, X (corresponding author), Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China.; Zhao, X (corresponding author), Beijing Higher Inst Engn Res Ctr Testing & Imagin, Beijing, Peoples R China.	zhaoxing_1999@126.com	Luo, Tingjin/R-6320-2019	Luo, Tingjin/0000-0002-4328-4627; Luo, Ting/0000-0001-7564-102X	National Natural Science Foundation of China [61371195, 61401289]; Shenzhen ZhongKe TianYue Technology Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen ZhongKe TianYue Technology Co., Ltd.	This work was supported in part by the National Natural Science Foundation of China under Grant 61371195 and Grant 61401289. Shenzhen ZhongKe TianYue Technology Co., Ltd., provided support in the form of a salary for author YSZ, and had a role in the data collection. The specific roles of this author are articulated in the 'author contributions' section.	Akhoondali H., 2009, Journal of Applied Sciences, V9, P2106, DOI 10.3923/jas.2009.2106.2114; AlHarbi S, 2008, ANGLE ORTHOD, V78, P281, DOI 10.2319/121806-516.1; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Barone S, 2015, ASME 2015 INT DES EN; BEGOLE EA, 1980, J DENT RES, V59, P1549, DOI 10.1177/00220345800590092901; Braun S, 1998, ANGLE ORTHOD, V68, P29; Correa LR, 2014, CLIN ORAL IMPLAN RES, V25, P690, DOI 10.1111/clr.12126; Diggs DB, 1962, THESIS; Flores-Mir Carlos, 2014, Dental Press J. Orthod., V19, P45, DOI 10.1590/2176-9451.19.5.045-053.oar; Han Bing, 2011, Proceedings 2011 International Conference on Mechatronic Science, Electric Engineering and Computer (MEC 2011), P1094; Hartigan J., 1975, CLUSTERING ALGORITHM; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hosntalab M, 2008, INT J COMPUT ASS RAD, V3, P257, DOI 10.1007/s11548-008-0230-9; Huang DY, 2011, INT J INNOV COMPUT I, V7, P5631; Jain AK, 2003, LECT NOTES COMPUT SC, V2688, P429; Momeni M, 2008, INT J COMPUTER ASSIS, V3, P339; Paris S, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964963; Sa-ing V, 2013, IEEE ENG MED BIO, P6099, DOI 10.1109/EMBC.2013.6610944; SANIN C, 1970, J DENT RES, V49, P885, DOI 10.1177/00220345700490042801; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Shahbazian M, 2014, CLIN ORAL INVEST, V18, P293, DOI 10.1007/s00784-013-0963-x; Steder B, 2011, IEEE INT CONF ROBOT, P2601, DOI 10.1109/ICRA.2011.5980187; Tal H, 1991, Dentomaxillofac Radiol, V20, P40; Tohnak Sirilawan, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3329; Vandenberghe B, 2010, EUR RADIOL, V20, P2637, DOI 10.1007/s00330-010-1836-1; Vannier MW, 1997, ORAL SURG ORAL MED O, V84, P561, DOI 10.1016/S1079-2104(97)90274-2; WHITE LW, 1977, AM J ORTHOD DENTOFAC, V72, P303, DOI 10.1016/0002-9416(77)90216-0; Yang M, 2014, ENERGY, V68, P385, DOI 10.1016/j.energy.2014.02.076; Yang M, 2014, NDT&E INT, V64, P13, DOI 10.1016/j.ndteint.2014.02.004; Zhou JD, 2004, PROC SPIE, V5404, P373, DOI 10.1117/12.542689	31	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156976	10.1371/journal.pone.0156976	http://dx.doi.org/10.1371/journal.pone.0156976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300554	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200022
J	Mao, LL; Zhang, EM; Wang, ZJ; Li, Y; Zhou, H; Liu, XS; Zhang, HJ; Cai, H; Liang, XD; Sun, YW; Zhang, ZK; Li, W; Yao, WQ; Wei, JC				Mao, Lingling; Zhang, Enmin; Wang, Zijiang; Li, Yan; Zhou, Hang; Liu, Xuesheng; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Sun, Yingwei; Zhang, Zhikai; Li, Wei; Yao, Wenqing; Wei, Jianchun			Phylogenetic Characteristics of Anthrax Outbreaks in Liaoning Province, China, 2001-2015	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; POPULATION-STRUCTURE; REPEAT ANALYSIS; GENOME ANALYSIS; DIVERSITY	Anthrax is a continuous threat in China, especially in rural regions. In July 2015, an anthrax outbreak occurred in Xifeng County, Liaoning Province. A total of 10 cutaneous anthrax cases were reported, with 210 people under medical observation. In this study, the general characteristics of human anthrax outbreak occurred in Liaoning Province were described, and all cases were caused by butchering and contacting sick animal. Meanwhile, the phylogenetic relationship between outbreak-related isolates/samples of the year 2015 and previous Bacillus anthracis strains was analyzed by means of canonical single nucleotide polymorphisms (canSNP), multiple-locus variable-number tandem repeat analysis (MLVA) with 15 markers and single-nucleotide repeats (SNR) analysis. There are two canSNP subgroups found in Liaoning, A. Br. 001/002 and A. Br. Ames, and a total of six MLVA 15 genotypes and five SNR genotypes were observed. The strain collected from anthrax outbreak in Xifeng County in 2015 was classified as A. Br. 001/002 subgroup and identified as MLVA15-29 genotype, with same SNR profile (CL10: 17, CL12: 15, CL33: 29, and CL35: 13). So we conclude that the same clone of B. anthracis caused the anthrax outbreak in Xifeng County in 2015, and this clone is different to previous isolates. Strengthening public health education in China is one of the most important measures to prevent and control anthrax.	[Mao, Lingling; Wang, Zijiang; Liu, Xuesheng; Sun, Yingwei; Yao, Wenqing] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Enmin; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Zhang, Zhikai; Li, Wei; Wei, Jianchun] China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Enmin; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Zhang, Zhikai; Li, Wei; Wei, Jianchun] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Enmin; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Zhang, Zhikai; Li, Wei; Wei, Jianchun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Li, Yan] Tieling Prefecture Ctr Dis Control & Prevent, Tieling, Liaoning Provin, Peoples R China; [Zhou, Hang] China CDC, Div Infect Dis Prevent & Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Center for Disease Control & Prevention	Yao, WQ (corresponding author), Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China.; Wei, JC (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.; Wei, JC (corresponding author), State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Wei, JC (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	wenqingyao@sina.com; weijianchun@icdc.cn			National Priority Development Project on Key Science Instrument [2012YQ09019706]; National Science and Technology Mega-Projects of China [2012ZX10004215, 2013ZX 10004-101]	National Priority Development Project on Key Science Instrument; National Science and Technology Mega-Projects of China	This work was supported by National Priority Development Project on Key Science Instrument (2012YQ09019706, www.caiq.org.cn/) and the National Science and Technology Mega-Projects of China (no. 2012ZX10004215 and no.2013ZX 10004-101, www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Garofolo G, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-11; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Grunow R, 2013, EUROSURVEILLANCE, V18, P2; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kenefic LJ, 2008, J MICROBIOL METH, V73, P269, DOI 10.1016/j.mimet.2007.11.014; Kenefic LJ, 2008, EMERG INFECT DIS, V14, P1494, DOI 10.3201/eid1409.080076; Le Fleche P, 2001, BMC Microbiol, V1, P2; Li S, 2015, EUR J CLIN MICROBIOL, V34, P89, DOI 10.1007/s10096-014-2195-7; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Stratilo CW, 2006, J CLIN MICROBIOL, V44, P777, DOI 10.1128/JCM.44.3.777-782.2006; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; WHO, 2008, ANTHRAX HUMANS ANIMA; Zhou W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135777	24	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157496	10.1371/journal.pone.0157496	http://dx.doi.org/10.1371/journal.pone.0157496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299730	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200056
J	Shi, C; Zheng, Z; Wang, Q; Wang, CD; Zhang, DB; Zhang, M; Chan, P; Wang, XM				Shi, Chen; Zheng, Zheng; Wang, Qi; Wang, Chaodong; Zhang, Dabao; Zhang, Min; Chan, Piu; Wang, Xiaomin			Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; RISK-FACTOR; TAU-SYNUCLEIN; LRRK2 R1628P; ASSOCIATION; MAPT; SNCA; SUSCEPTIBILITY; PROGRESSION; LOCI	Many genetic variants have been linked to familial or sporadic Parkinson's disease (PD), among which those identified in PARK16, BST1, SNCA, LRRK2, GBA and MAPT genes have been demonstrated to be the most common risk factors worldwide. Moreover, complex gene-gene and gene-environment interactions have been highlighted in PD pathogenesis. Compared to studies focusing on the predisposing effects of genes, there is a relative lack of research investigating how these genes and their interactions influence the clinical profiles of PD. In a cohort consisting of 2,011 Chinese Han PD patients, we selected 9 representative variants from the 6 above-mentioned common PD genes to analyze their main and epistatic effects on the Unified Parkinson's Disease Rating Scale (UPDRS) and the Hoehn and Yahr (H-Y) stage of PD. With multiple linear regression models adjusting for medication status, disease duration, gender and age at onset, none of the variants displayed significant main effects on UPDRS or the H-Y scores. However, for gene-gene interaction analyses, 7 out of 37 pairs of variants showed significant or marginally significant associations with these scores. Among these, the GBA rs421016 (L444P)xLRRK2 rs33949390 (R1628P) interaction was consistently significant in relation to UPDRS III and UPDRS total (I+II+III), even after controlling for the family-wise error rate using False Discovery Rate (FDR-corrected p values are 0.0481 and 0.0070, respectively). Although the effects of the remaining pairs of variants did not survive the FDR correction, they showed marginally significant associations with either UPDRS or the H-Y stage (raw p<0.05). Our results highlight the importance of epistatic effects of multiple genes on the determination of PD clinical profiles and may have implications for molecular classification and personalized intervention of the disease.	[Shi, Chen; Wang, Xiaomin] Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Shi, Chen; Zhang, Dabao; Zhang, Min] Capital Med Univ, Sch Biomed Engn, Bioinformat Ctr, Beijing, Peoples R China; [Zheng, Zheng; Wang, Chaodong; Chan, Piu] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Wang, Qi; Zhang, Dabao; Zhang, Min] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Wang, Chaodong; Chan, Piu] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurol, Beijing, Peoples R China; [Chan, Piu] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Chan, Piu] Key Lab Parkinsons Dis Beijing, Beijing, Peoples R China; [Wang, Chaodong] Fujian Med Univ, Affiliated Sanming Hosp 1, Dept Neurol, Sanming, Fujian, Peoples R China; [Chan, Piu; Wang, Xiaomin] Capital Med Univ, Parkinson Dis Ctr, Beijing Inst Brain Disorders, Beijing, Peoples R China; [Zhang, Min] Capital Med Univ, Beijing Inst Brain Disorders, Alzheimer Dis Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Capital Medical University; Fujian Medical University; Capital Medical University; Capital Medical University	Wang, XM (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.; Zhang, M (corresponding author), Capital Med Univ, Sch Biomed Engn, Bioinformat Ctr, Beijing, Peoples R China.; Chan, P (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China.; Zhang, M (corresponding author), Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA.; Chan, P (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurol, Beijing, Peoples R China.; Chan, P (corresponding author), Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China.; Chan, P (corresponding author), Key Lab Parkinsons Dis Beijing, Beijing, Peoples R China.; Chan, P; Wang, XM (corresponding author), Capital Med Univ, Parkinson Dis Ctr, Beijing Inst Brain Disorders, Beijing, Peoples R China.; Zhang, M (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Alzheimer Dis Ctr, Beijing, Peoples R China.	zhangmin@ccmu.edu.cn; pbchan90@gmail.com; xmwang@ccmu.edu.cn	Chan, Piu/I-4580-2016	Chan, Piu/0000-0003-1346-881X	National Basic Research Program of China [2014CB744600, 2011CB504101]; Ministry of Science and Technology of China [2012AA02A514]; Beijing Municipal Commission of Education [KM201410025013]; Beijing Institute for Brain Disorders [BIBDPXM2014_014226_000016, BIBDPXM 2014_014226_000016]; China Scholarship Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Institute for Brain Disorders; China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors gratefully acknowledge the support from the National Basic Research Program of China (2014CB744600 to DZ, 2011CB504101 to PC), the Ministry of Science and Technology of China (2012AA02A514 to PC), Beijing Municipal Commission of Education (KM201410025013 to MZ) and Beijing Institute for Brain Disorders (BIBDPXM2014_014226_000016 to MZ). The China Scholarship Council is also gratefully acknowledged by CS for funding her Visiting Student fellowship.; The National Basic Research Program of China (2014CB744600, 2011CB504101), the Ministry of Science and Technology of China (2012AA02A514), the Beijing Municipal Commission of Education (KM201410025013), the Beijing Institute for Brain Disorders (BIBDPXM 2014_014226_000016), and the China Scholarship Council.	Alcalay RN, 2013, MOVEMENT DISORD, V28, P1966, DOI 10.1002/mds.25647; Biernacka JM, 2011, PARKINSONISM RELAT D, V17, P730, DOI 10.1016/j.parkreldis.2011.07.001; Cheon SM, 2012, J MOV DISORD, V5, P33, DOI 10.14802/jmd.12009; Chung SJ, 2013, PARKINSONISM RELAT D, V19, P595, DOI 10.1016/j.parkreldis.2013.02.008; Devine MJ, 2008, FEBS J, V275, P5748, DOI 10.1111/j.1742-4658.2008.06707.x; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Fidani L, 2006, MOVEMENT DISORD, V21, P1036, DOI 10.1002/mds.20864; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Gan-Or Z, 2008, NEUROLOGY, V70, P2277, DOI 10.1212/01.wnl.0000304039.11891.29; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goris A, 2007, ANN NEUROL, V62, P145, DOI 10.1002/ana.21192; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Huang CL, 2011, EUR J NEUROL, V18, P1227, DOI 10.1111/j.1468-1331.2011.03362.x; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jankovic J, 2005, ARCH NEUROL-CHICAGO, V62, P351, DOI 10.1001/archneur.62.3.351; Kooperberg C, 2009, STAT SCI, V24, P472, DOI 10.1214/09-STS287; Kumaran R, 2015, HUM MOL GENET, V24, pR32, DOI 10.1093/hmg/ddv236; Kumari U, 2009, FEBS J, V276, P6455, DOI 10.1111/j.1742-4658.2009.07344.x; Lang AE, 2007, NEUROLOGY, V68, P948, DOI 10.1212/01.wnl.0000257110.91041.5d; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Li NN, 2013, AM J MED GENET B, V162B, P452, DOI 10.1002/ajmg.b.32143; Lu CS, 2008, NEUROGENETICS, V9, P271, DOI 10.1007/s10048-008-0140-6; Mamah CE, 2005, ANN NEUROL, V57, P439, DOI 10.1002/ana.20387; Manzoni C, 2015, PEERJ, V3, DOI 10.7717/peerj.778; Mao XY, 2010, NEUROSCI LETT, V469, P256, DOI 10.1016/j.neulet.2009.12.007; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Paisan-Ruiz C, 2008, HUM MUTAT, V29, P485, DOI 10.1002/humu.20668; Pihlstrom L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.019; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Pulkes T, 2014, PARKINSONISM RELAT D, V20, P1018, DOI 10.1016/j.parkreldis.2014.06.013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rana HQ, 2013, GENET MED, V15, P146, DOI 10.1038/gim.2012.107; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; Shulman JM, 2014, JAMA NEUROL, V71, P429, DOI 10.1001/jamaneurol.2013.6222; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Wang C, 2014, NEUROBIOL AGING, V35, pel, DOI DOI 10.1016/J.NEUR0BI0LAGING.2013.08.012; Wang CD, 2012, PARKINSONISM RELAT D, V18, P958, DOI 10.1016/j.parkreldis.2012.05.003; Wider C, 2011, EUR J NEUROL, V18, P876, DOI 10.1111/j.1468-1331.2010.03297.x; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Yu L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-54	55	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0155758	10.1371/journal.pone.0155758	http://dx.doi.org/10.1371/journal.pone.0155758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299523	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200005
J	Ou, SH; Chen, MY; Huang, CW; Chen, NC; Wu, CH; Hsu, CY; Chou, KJ; Lee, PT; Fang, HC; Chen, CL				Ou, Shih-Hsiang; Chen, Mei-Yin; Huang, Chien-Wei; Chen, Nai-Ching; Wu, Chien-Hsing; Hsu, Chih-Yang; Chou, Kang-Ju; Lee, Po-Tsang; Fang, Hua-Chang; Chen, Chien-Liang			Potential Role of Vegetarianism on Nutritional and Cardiovascular Status in Taiwanese Dialysis Patients: A Case-Control Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; NONTRADITIONAL RISK-FACTORS; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; ARTERIAL STIFFNESS; MAINTENANCE HEMODIALYSIS; OXIDATIVE STRESS; INFLAMMATION; METAANALYSIS	Background & Objectives Cardiovascular disease remains the most common cause of death for patients on chronic dialysis. End stage renal disease patients undergoing dialysis imposed to reduce phosphorus intake, which likely contributes to development of vegetarian diet behaviors. Vegetarian diets are often lower in protein content, in contradiction to the recommendation that a high protein diet is followed by patients undergoing dialysis. The purpose of the study was to investigate the effects of a vegetarian diet on the nutritional and cardiovascular status of dialysis patients. Design, Setting, Participants, Measurements A study of 21 vegetarian dialysis patients and 42 age-and sex-matched non-vegetarian dialysis patients selected as controls was conducted in the Kaohsiung Veterans General Hospital. Brachial-ankle pulse wave velocity and biochemistry data including total homocysteine levels, serum lipid profiles, high-sensitivity C-reactive protein, vitamin D levels, albumin, and normalized protein catabolic rate were measured. Results Compared with the non-vegetarian control group, vegetarian subjects had lower body weight, body mass index, serum phosphate, blood urea nitrogen, serum creatinine, vitamin D, uric acid, albumin, and normalized protein catabolic rate (p < 0.05). The vegetarian group showed higher brachial-ankle pulse wave velocity than the non-vegetarian group (1926.95 +/- 456.45 and 1684.82 +/- 309.55 cm/sec, respectively, p < 0.05). After adjustment for age, albumin, pre-dialysis systolic blood pressure, and duration of dialysis, vegetarian diet remained an independent risk factor for brachial-ankle pulse wave velocity. Conclusions The present study revealed that patients on dialysis who follow vegetarian diets may experience subclinical protein malnutrition and vitamin D deficiency that could offset the beneficial cardiovascular effects of vegetarianism.	[Ou, Shih-Hsiang; Huang, Chien-Wei; Hsu, Chih-Yang; Chou, Kang-Ju; Lee, Po-Tsang; Fang, Hua-Chang; Chen, Chien-Liang] Kaohsiung Vet Gen Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Mei-Yin] Kaohsiung Vet Gen Hosp, Div Nutr, Kaohsiung, Taiwan; [Ou, Shih-Hsiang; Huang, Chien-Wei; Hsu, Chih-Yang; Chou, Kang-Ju; Lee, Po-Tsang; Fang, Hua-Chang; Chen, Chien-Liang] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Chen, Nai-Ching] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, CL (corresponding author), Kaohsiung Vet Gen Hosp, Div Nephrol, Kaohsiung, Taiwan.; Chen, CL (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan.	cclchen@seed.net.tw	chen, chien-liang/I-6192-2015; Wu, Chien-Hsing/ABI-4006-2020; Huang, Chien-Wei/AAN-9838-2020	chen, chien-liang/0000-0002-9508-8396; Huang, Chien-Wei/0000-0001-5753-9654; Ou, Shih-Fu/0000-0001-5294-3113				Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; Davis BC, 2003, AM J CLIN NUTR, V78, p640S, DOI 10.1093/ajcn/78.3.640S; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hung CJ, 2002, J NUTR, V132, P152, DOI 10.1093/jn/132.2.152; Ingenbleek Y, 2012, NUTRITION, V28, P148, DOI 10.1016/j.nut.2011.04.009; Kahleova H, 2011, DIABETIC MED, V28, P549, DOI 10.1111/j.1464-5491.2010.03209.x; Kalantar-Zadeh K, 2005, CURR OPIN CLIN NUTR, V8, P388, DOI 10.1097/01.mco.0000172578.56396.9e; Kim Eun-Young, 2008, Electrolyte Blood Press, V6, P61, DOI 10.5049/EBP.2008.6.2.61; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Kuang DW, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-143; LAMBERG-ALLARDT C, 1993, AM J CLIN NUTR, V58, P684, DOI 10.1093/ajcn/58.5.684; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; London GM, 2001, J AM SO NEPHROL, V18, P613; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Muntner P, 2004, ANN INTERN MED, V140, P9, DOI 10.7326/0003-4819-140-1-200401060-00006; Noori N, 2011, AM J KIDNEY DIS, V58, P248, DOI 10.1053/j.ajkd.2011.03.017; Noori N, 2010, AM J CLIN NUTR, V92, P1060, DOI 10.3945/ajcn.2010.29188; Obersby D, 2013, BRIT J NUTR, V109, P785, DOI 10.1017/S000711451200520X; Pase MP, 2011, BRIT J NUTR, V106, P974, DOI 10.1017/S0007114511002819; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wang AYM, 2008, AM J CLIN NUTR, V87, P1631, DOI 10.1093/ajcn/87.6.1631; Wu TT, 2011, NEPHROLOGY, V16, P582, DOI 10.1111/j.1440-1797.2011.01464.x; Yamada S, 2015, AM J PHYSIOL-RENAL, V309, pF744, DOI 10.1152/ajprenal.00017.2015; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	28	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156297	10.1371/journal.pone.0156297	http://dx.doi.org/10.1371/journal.pone.0156297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295214	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300005
J	Kovacs-Hostyanszki, A; Foldesi, R; Mozes, E; Szirak, A; Fischer, J; Hanspach, J; Baldi, A				Kovacs-Hostyanszki, Aniko; Foldesi, Rita; Mozes, Edina; Szirak, Adam; Fischer, Joern; Hanspach, Jan; Baldi, Andras			Conservation of Pollinators in Traditional Agricultural Landscapes - New Challenges in Transylvania (Romania) Posed by EU Accession and Recommendations for Future Research	PLOS ONE			English	Article							FLOWER-VISITING INSECTS; LONG-TERM CHANGES; FARMLAND BIRDS; LAND-USE; SEMINATURAL GRASSLANDS; DEPENDENT RESPONSES; NATURAL ENEMIES; BEE ABUNDANCE; BODY-SIZE; WILD BEES	Farmland biodiversity is strongly declining in most of Western Europe, but still survives in traditional low intensity agricultural landscapes in Central and Eastern Europe. Accession to the EU however intensifies agriculture, which leads to the vanishing of traditional farming. Our aim was to describe the pollinator assemblages of the last remnants of these landscapes, thus set the baseline of sustainable farming for pollination, and to highlight potential measures of conservation. In these traditional farmlands in the Transylvanian Basin, Romania (EU accession in 2007), we studied the major pollinator groups-wild bees, hoverflies and butterflies. Landscape scale effects of semi-natural habitats, land cover diversity, the effects of heterogeneity and woody vegetation cover and on-site flower resources were tested on pollinator communities in traditionally managed arable fields and grasslands. Our results showed: (i) semi-natural habitats at the landscape scale have a positive effect on most pollinators, especially in the case of low heterogeneity of the direct vicinity of the studied sites; (ii) both arable fields and grasslands hold abundant flower resources, thus both land use types are important in sustaining pollinator communities; (iii) thus, pollinator conservation can rely even on arable fields under traditional management regime. This has an indirect message that the tiny flower margins around large intensive fields in west Europe can be insufficient conservation measures to restore pollinator communities at the landscape scale, as this is still far the baseline of necessary flower resources. This hypothesis needs further study, which includes more traditional landscapes providing baseline, and exploration of other factors behind the lower than baseline level biodiversity values of fields under agri-environmental schemes (AES).	[Kovacs-Hostyanszki, Aniko; Foldesi, Rita; Mozes, Edina; Szirak, Adam; Baldi, Andras] MTA Ctr Ecol Res, Inst Ecol & Bot, Lendulet Ecosyst Serv Res Grp, Vacratot, Hungary; [Fischer, Joern; Hanspach, Jan] Leuphana Univ, Fac Sustainabil, Luneburg, Germany	Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Leuphana University Luneburg	Kovacs-Hostyanszki, A (corresponding author), MTA Ctr Ecol Res, Inst Ecol & Bot, Lendulet Ecosyst Serv Res Grp, Vacratot, Hungary.	kovacs.aniko@okologia.mta.hu	Fischer, Joern/W-5380-2019; Foldesi, Rita/AAU-7609-2020; Fischer, Joern/C-6625-2012; Baldi, Andras/A-7501-2008	Foldesi, Rita/0000-0002-3500-981X; Fischer, Joern/0000-0003-3187-8978; Baldi, Andras/0000-0001-6063-3721; Hanspach, Jan/0000-0002-6638-8699	'Lendulet' program of the Hungarian Academy of Sciences	'Lendulet' program of the Hungarian Academy of Sciences	A. Kovacs-Hostyanszki was a Bolyai and a MTA Postdoc Fellow (http://mta.hu/english/). The study was supported by the 'Lendulet' program of the Hungarian Academy of Sciences (http://mta.hu/english/).	Alignier A, 2014, BIOL CONTROL, V77, P76, DOI 10.1016/j.biocontrol.2014.06.006; [Anonymous], 2009, BUTTERFLIES EUROPE, DOI DOI 10.1111/j.1365-3113.2006.00333.x; Archer CR, 2014, OIKOS, V123, P401, DOI 10.1111/j.1600-0706.2013.00949.x; Baldi A, 2007, AGR ECOSYST ENVIRON, V118, P307, DOI 10.1016/j.agee.2006.05.021; Baldi A, 2011, BIRD STUDY, V58, P365, DOI 10.1080/00063657.2011.588685; Batary P, 2010, AGR ECOSYST ENVIRON, V136, P35, DOI 10.1016/j.agee.2009.11.004; Benelli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093153; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; de Snoo GR, 2013, CONSERV LETT, V6, P66, DOI 10.1111/j.1755-263X.2012.00296.x; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Delibes-Mateos M, 2009, ENVIRON MANAGE, V43, P1256, DOI 10.1007/s00267-009-9297-5; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donald PF, 2002, AGR ECOSYST ENVIRON, V89, P167, DOI 10.1016/S0167-8809(01)00244-4; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ekroos J, 2013, LANDSCAPE ECOL, V28, P1283, DOI 10.1007/s10980-013-9864-2; European Environment Agency (EEA), 2013, EUR TOP CTR SPAT INF; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Fox R, 2013, INSECT CONSERV DIVER, V6, P5, DOI 10.1111/j.1752-4598.2012.00186.x; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gellrich M, 2007, AGR ECOSYST ENVIRON, V118, P93, DOI 10.1016/j.agee.2006.05.001; Genz A., 2013, MVTNORM MULTIVARIATE; Gilbert N, 2014, NATURE, V510, P455, DOI 10.1038/510455a; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hanspach J, 2014, ECOL SOC, V19, DOI 10.5751/ES-06915-190432; Hartel T, 2010, BIOL CONSERV, V143, P1118, DOI 10.1016/j.biocon.2010.02.006; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jauker F, 2009, LANDSCAPE ECOL, V24, P547, DOI 10.1007/s10980-009-9331-2; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Kovacs-Hostyanszki A, 2011, AGR FOREST ENTOMOL, V13, P59, DOI 10.1111/j.1461-9563.2010.00498.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Loos J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103256; Mand M, 2002, AGR ECOSYST ENVIRON, V89, P69, DOI 10.1016/S0167-8809(01)00319-X; Meyer B, 2009, BASIC APPL ECOL, V10, P178, DOI 10.1016/j.baae.2008.01.001; Michener C.D., 2007, BEES WORLD, Vsecond; Michez D, 2013, ATLAS HYMENOPTERA; Moczar M, 1967, FAUNA HUNGARIAE; Moczar M, 1957, FAUNA HUNGARIAE, V19; Moczar M, 1958, FAUNA HUNGARIAE, V35; Moczar M, 1960, FAUNA HUNGARIAE, V51; Muller A, 2008, BIOL J LINN SOC, V95, P719, DOI 10.1111/j.1095-8312.2008.01113.x; Muller D, 2013, AGR SYST, V117, P66, DOI 10.1016/j.agsy.2012.12.010; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Nieto A., 2014, EUROPEAN RED LIST BE; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Oksanen J., 2008, VEGAN PACKAGE COMMUN; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Pinheiro J, 2013, NLME LINEAR NONLINEA; Plieninger T, 2006, ENVIRON SCI POLICY, V9, P317, DOI 10.1016/j.envsci.2006.03.001; Poyry J, 2009, GLOBAL CHANGE BIOL, V15, P732, DOI 10.1111/j.1365-2486.2008.01789.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raymond L, 2014, AGR ECOSYST ENVIRON, V185, P99, DOI 10.1016/j.agee.2013.12.019; Rogerson P.A., 2001, STAT METHODS GEOGRAP; Rundlof M, 2014, BIOL CONSERV, V172, P138, DOI 10.1016/j.biocon.2014.02.027; Sanderson FJ, 2013, AGR ECOSYST ENVIRON, V168, P16, DOI 10.1016/j.agee.2013.01.015; Schmid-Egger C., 1997, ILLUSTRIERTE BESTIMM; Schmidt MH, 2003, P ROY SOC B-BIOL SCI, V270, P1905, DOI 10.1098/rspb.2003.2469; SSYMANK A, 1993, DEUT ENTOMOL Z, V40, P245; Stanescu Carmen, 2005, Travaux du Museum National d'Histoire Naturelle Grigore Antipa, V48, P177; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Storkey J, 2012, P ROY SOC B-BIOL SCI, V279, P1421, DOI 10.1098/rspb.2011.1686; Stubbs A., 2002, BRIT HOVERFLIES ILLU, V2nd; Sutcliffe LME, 2015, DIVERS DISTRIB, V21, P722, DOI 10.1111/ddi.12288; Tomanovic Z, 2008, EUR J ENTOMOL, V105, P495, DOI 10.14411/eje.2008.064; Tryjanowski P, 2011, ACTA ORNITHOL, V46, P1, DOI 10.3161/000164511X589857; Van Veen M. P., 2004, HOVERFLIES NW EUROPE; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6	80	26	27	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0151650	10.1371/journal.pone.0151650	http://dx.doi.org/10.1371/journal.pone.0151650			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285118	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000377564000001
J	Arruda, WD; Oldeland, J; Paranhos, AC; Pott, A; Cunha, NL; Ishii, IH; Damasceno, GA				Arruda, Wellinton de Sa; Oldeland, Jens; Paranhos Filho, Antonio Conceicao; Pott, Arnildo; Cunha, Nicolay L.; Ishii, Iria Hiromi; Damasceno-Junior, Geraldo Alves			Inundation and Fire Shape the Structure of Riparian Forests in the Pantanal, Brazil	PLOS ONE			English	Article							AMAZONIAN FLOODPLAIN; SEED DISPERSAL; TREE; TOLERANCE; WATER; PERSISTENCE; VEGETATION; DIVERSITY; WETLAND; GROWTH	Inundation and fire can affect the structure of riparian vegetation in wetlands. Our aim was to verify if there are differences in richness, abundance, basal area, composition and topographic preference of woody species in riparian forests related to the fire history, flooding duration, or the interaction between both. The study was conducted in the riparian forests of the Paraguay River some of which were burned three times between 2001 and 2011. We sampled trees with a girth of at least 5 cm at breast height in 150 5 x 10 m plots (79 burned and 71 unburned). We also measured height of the flood mark and estimated the flooding duration of each plot. We performed Generalized Linear Mixed Models to verify differences in richness, basal area, and abundance of individuals associated to interaction of fire and inundation. We used an analysis of similarity (ANOSIM) and indicator species analysis to identify differences in composition of species and the association with burned and unburned area according to different levels of inundation. Finally, we used a hierarchical set of Generalized Linear Models (GLM), the so-called HOF models, to analyse each species' specific response to inundation based on topography and to determine their preferred optimal topographic position for both burned as well as unburned areas. Richness was positively associated with elevation only in burned areas while abundance was negatively influenced by inundation only in burned areas. Basal area was negatively associated with time of inundation independent of fire history. There were 15 species which were significant indicators for at least one combination of the studied factors. We found nine species in burned areas and 15 in unburned areas, with response curves in HOF models along the inundation gradient. From these, five species shifted their optimal position along the inundation gradient in burned areas. The interaction of fire and inundation did not appear to affect the basal area, but it did affect the richness, number of individuals, success of some species, and seemed to shape the boundary of these forests as shown by the difference in the positioning of these species along the inundation gradient.	[Arruda, Wellinton de Sa; Pott, Arnildo; Damasceno-Junior, Geraldo Alves] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Lab Bot, Campo Grande, MS, Brazil; [Oldeland, Jens; Damasceno-Junior, Geraldo Alves] Univ Hamburg, Biodivers Evolut & Ecol Plants BEE Bioctr, Klein Flottbek & Bot Garden, Hamburg, Germany; [Paranhos Filho, Antonio Conceicao] Univ Fed Mato Grosso do Sul, Fac Engn Arquitetura & Urbanismo & Geog, Lab Geoproc Aplicacoes Ambientais, Campo Grande, MS, Brazil; [Cunha, Nicolay L.] Univ Fed Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Ishii, Iria Hiromi] Univ Fed Mato Grosso do Sul, Lab Bot, Campus Pantanal, Corumba, MS, Brazil	Universidade Federal de Mato Grosso do Sul; University of Hamburg; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Damasceno, GA (corresponding author), Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Lab Bot, Campo Grande, MS, Brazil.; Damasceno, GA (corresponding author), Univ Hamburg, Biodivers Evolut & Ecol Plants BEE Bioctr, Klein Flottbek & Bot Garden, Hamburg, Germany.	geraldodamasceno@gmail.com	Damasceno Junior, Geraldo/ABG-2834-2021; Cunha, Nicolay Leme da/D-3212-2012; Filho, Antonio Conceição Paranhos/C-7467-2018	Cunha, Nicolay Leme da/0000-0001-5509-6757; Filho, Antonio Conceição Paranhos/0000-0002-9838-5337; Pott, Arnildo/0000-0002-8599-9276; Oldeland, Jens/0000-0002-7833-4903; Alves Damasceno Junior, Geraldo/0000-0002-4554-9369	Instituto Nacional de Ciencia e Tecnologia em Areas Umidas/CNPq	Instituto Nacional de Ciencia e Tecnologia em Areas Umidas/CNPq	This study was supported by the Instituto Nacional de Ciencia e Tecnologia em Areas Umidas/CNPq, http://www.inau.org.br/homepage.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB'SABER AN, 1988, REV BRASILEIRA GEOGR, V50, P9; Agee JK, 2002, FOREST ECOL MANAG, V167, P57, DOI 10.1016/S0378-1127(01)00690-9; ARMSTRONG W, 1994, ACTA BOT NEERL, V43, P307; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barton K., 2015, MUMIN MULTIMODEL INF; Bates D., 2015, LME4 LINEAR MIXED EF; BELL DT, 1980, AUST J ECOL, V5, P9, DOI 10.1111/j.1442-9993.1980.tb01226.x; Bendix J, 2010, GEOMORPHOLOGY, V116, P297, DOI 10.1016/j.geomorph.2009.09.043; Bendix J, 2010, ECOSYSTEMS, V13, P99, DOI 10.1007/s10021-009-9303-z; Bertazzoni EC, 2011, ACTA BOT BRAS, V25, P476, DOI 10.1590/S0102-33062011000200023; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Breheny P, 2015, VISREG VISUALIZATION; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Crawford RMM, 1996, FOLIA GEOBOT PHYTOTX, V31, P7, DOI 10.1007/BF02803990; Cunha NL, 2012, BRAZ J BIOL, V72, P519, DOI 10.1590/S1519-69842012000300015; Da Silva JD, 1998, PESQUI AGROPECU BRAS, V33, P1703; Damasceno-Junior GA, 2005, FLORA, V200, P119, DOI 10.1016/j.flora.2004.09.002; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; de Oliveira MT, 2014, FOREST ECOL MANAG, V331, P256, DOI 10.1016/j.foreco.2014.08.011; Deng CN, 2012, J FOOD AGRIC ENVIRON, V10, P1329; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fernandes FA, 2007, 61 EMBR PANT, V61; Ferreira LV, 1999, OECOLOGIA, V120, P582, DOI 10.1007/s004420050893; Galdino S, 1997, 23 EMBR PANT, V23; Gelman A., 2007, DATA ANAL USING REGR; Gignoux J, 1997, OECOLOGIA, V110, P576, DOI 10.1007/s004420050198; Gignoux J, 2009, J ECOL, V97, P484, DOI 10.1111/j.1365-2745.2009.01493.x; Hamilton SK, 1996, ARCH HYDROBIOL, V137, P1; Heinl M, 2007, J ARID ENVIRON, V68, P77, DOI 10.1016/j.jaridenv.2005.10.023; Heinl M, 2008, AFR J ECOL, V46, P350, DOI 10.1111/j.1365-2028.2007.00847.x; Higgins SI, 2012, J ECOL, V100, P1400, DOI 10.1111/j.1365-2745.2012.02026.x; Hlavac M, 2015, STARGAZER LATEX HTML; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; HUISMAN J, 1993, J VEG SCI, V4, P37, DOI 10.2307/3235732; Instituto Brasileiro de Geografia e Estatistica-IBGE, 1992, MANUAL TECNICO DA VE; Jansen F, 2013, J VEG SCI, V24, P1108, DOI 10.1111/jvs.12050; JOLY CA, 1994, P ROY SOC EDINB B, V102, P343, DOI 10.1017/S0269727000014330; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Koponen P, 2004, PLANT ECOL, V173, P17, DOI 10.1023/B:VEGE.0000026328.98628.b8; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; KUBITZKI K, 1994, BIOTROPICA, V26, P30, DOI 10.2307/2389108; Lawes MJ, 2013, J ECOL, V101, P517, DOI 10.1111/1365-2745.12035; Lockwood JL, 2003, FRONT ECOL ENVIRON, V1, P462, DOI 10.1890/1540-9295(2003)001[0462:SOTWTI]2.0.CO;2; Lukac M, 2011, ECOL STUD-ANAL SYNTH, V212, P247, DOI 10.1007/978-90-481-9834-4_14; Macedo H.A., 2009, AN 2 S GEOT PANT COR, P452; Maurenza Daniel, 2009, Acta Amaz., V39, P519, DOI 10.1590/S0044-59672009000300005; MITSCH WJ, 1991, LANDSCAPE ECOL, V5, P75, DOI 10.1007/BF00124662; Myster RW, 2006, CAN J FOREST RES, V36, P1121, DOI 10.1139/X06-006; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oksanen J, 2002, ECOL MODEL, V157, P119, DOI 10.1016/S0304-3800(02)00190-4; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Parolin P, 2002, ENVIRON EXP BOT, V48, P177, DOI 10.1016/S0098-8472(02)00036-9; Parolin P, 2009, ANN BOT-LONDON, V103, P359, DOI 10.1093/aob/mcn216; Parolin P, 2013, ECOTROPICA, V19, P15; Pettit NE, 2007, ECOSYSTEMS, V10, P673, DOI 10.1007/s10021-007-9048-5; Pettit NE, 2007, ECOLOGY, V88, P2094, DOI 10.1890/06-1270.1; Pott VJ., 1994, PLANTAS PANTANAL; Roberts DW, 2015, LABDSV ORDINATION MU; Rocha M, 2015, BRAZ J BIOL, V75, P114, DOI 10.1590/1519-6984.08613; Rodriguez-Gonzalez PM, 2010, FOREST ECOL MANAG, V259, P2015, DOI 10.1016/j.foreco.2010.02.012; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Silva LCR, 2013, PLANT SOIL, V373, P829, DOI 10.1007/s11104-013-1822-x; SORIANO BMA, 1997, B PESQUISA, V11; Stellmes Marion, 2013, Biodiversity Ecol, V5, P351, DOI 10.7809/b-e.00288; Strohbach Ben J., 2013, Biodiversity Ecol, V5, P321, DOI 10.7809/b-e.00286; Stromberg JC, 2009, RESTOR ECOL, V17, P327, DOI 10.1111/j.1526-100X.2007.00347.x; Ugurlu E, 2012, INT J BIOMETEOROL, V56, P85, DOI 10.1007/s00484-010-0399-9; Valio Ivany Ferraz Marques, 2001, Revista Brasileira de Botanica, V24, P79, DOI 10.1590/S0100-84042001000100009; Venables WN., 2002, MODERN APPL STAT S 4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wittmann F, 2006, J BIOGEOGR, V33, P1334, DOI 10.1111/j.1365-2699.2006.01495.x; Wittmann F, 2008, FOLIA GEOBOT, V43, P397, DOI 10.1007/s12224-008-9022-9; Zuur Alain F., 2009, P1	76	25	27	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156825	10.1371/journal.pone.0156825	http://dx.doi.org/10.1371/journal.pone.0156825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280879	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000049
J	Chen, C; Sung, KT; Shih, SC; Liu, CC; Kuo, JY; Hou, CJY; Hung, CL; Yeh, HI				Chen, Chi; Sung, Kuo-Tzu; Shih, Shou-Chuan; Liu, Chuan-Chuan; Kuo, Jen-Yuan; Hou, Charles Jia-Yin; Hung, Chung-Lieh; Yeh, Hung-I			Age, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population	PLOS ONE			English	Article							NORMAL EJECTION FRACTION; HEART-FAILURE; CLINICAL CHARACTERISTICS; CARDIOVASCULAR EVENTS; CARDIAC STRUCTURE; RISK-FACTORS; MASS; DISEASE; HYPERTROPHY; DYSFUNCTION	Background Advanced age is associated with left ventricle (LV) remodeling and impaired cardiac function that may increase the risk of heart failure. Even so, studies regarding age-related cardiac remodeling in a large, asymptomatic Asian population remain limited. Materials and Methods We studied 8,410 asymptomatic participants (49.7 +/- 11.7 y, 38.9% women) in a health evaluation cohort (2004-2012) at a tertiary center in Northern Taiwan. We analyzed age-related alterations for all echocardiography-derived cardiac structures/functions and the associations with circulating N-terminal prohormone of brain natriuretic peptide (NT-proBNP). We also explored sex-related differences in these measures. Results In our cohort of 8,410 participants, advanced age was associated with greater LV wall thickness, larger LV total mass (+ 5.08 g/decade), and greater LV mass index (4.41 g/m(2)/decade), as well as increased serum NT-proBNP level (+ 18.89 pg/mL/decade). An accompanying reduction of stress-corrected midwall fractional shortening (-0.1%/decade) with aging was apparent in women after multi-variate adjustment (-0.09%/decade, p = 0.001). Furthermore, women demonstrated greater overall increase in LV wall thickness, LV mass index, and NT-proBNP compared to men (p for interaction: < 0.001). All blood pressure components, including systolic, diastolic, and pulse pressures were independently associated with greater wall thickness and LV mass index after adjustment for confounders (all p < 0.001). The associations between age and cardiac remodeling or mid-wall functions were further confirmed in a subset of study subjects with repeated follow up by GEE model. Conclusions Significant associations of unfavorable LV remodeling and advanced age in our asymptomatic Asian population were observed, along with sex differences. These data may help explain the incidence of some diverse gender-related cardiovascular diseases, especially heart failure.	[Chen, Chi; Sung, Kuo-Tzu; Shih, Shou-Chuan; Kuo, Jen-Yuan; Hou, Charles Jia-Yin; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Sung, Kuo-Tzu; Hou, Charles Jia-Yin; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Mem Hosp, Taipei Branch, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Shih, Shou-Chuan] Mackay Mem Hosp, Taipei Branch, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Liu, Chuan-Chuan] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University	Hung, CL (corresponding author), Mackay Med Coll, Dept Med, New Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Mem Hosp, Taipei Branch, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	jotaro3791@gmail.com	Kuo, Jen-Yuan/AAX-5448-2021		National Science Council [NSC 103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3]; Mackay Memorial Hospital [10271, 10248, 10220, 10253, 10375, 10358, E-102003]	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This work was partly supported by grants of the National Science Council (NSC 103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3), and Mackay Memorial Hospital (10271, 10248, 10220, 10253, 10375, 10358, E-102003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov D, 2011, J CARD FAIL, V17, P547, DOI 10.1016/j.cardfail.2011.03.010; Aune E, 2015, JACC-CARDIOVASC IMAG, V8, P656, DOI 10.1016/j.jcmg.2015.02.014; AURIGEMMA GP, 1995, J AM COLL CARDIOL, V26, P195, DOI 10.1016/0735-1097(95)00153-Q; Bay M, 2003, HEART, V89, P150, DOI 10.1136/heart.89.2.150; Borlaug BA, 2014, NAT REV CARDIOL, V11, P507, DOI 10.1038/nrcardio.2014.83; Borlaug BA, 2009, J AM COLL CARDIOL, V54, P410, DOI 10.1016/j.jacc.2009.05.013; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Cain Peter A, 2009, BMC Med Imaging, V9, P2, DOI 10.1186/1471-2342-9-2; Chahal NS, 2012, JACC-CARDIOVASC IMAG, V5, P1191, DOI 10.1016/j.jcmg.2012.07.014; Chen CC, 2015, CHEMSUSCHEM, V8, P114, DOI 10.1002/cssc.201402886; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Choi EY, 2013, EUR HEART J, V34, P2354, DOI 10.1093/eurheartj/eht133; de Simone G, 2002, Eur J Echocardiogr, V3, P192, DOI 10.1053/euje.2002.0163; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gebhard C, 2013, ECHOCARDIOGR-J CARD, V30, P1143, DOI 10.1111/echo.12264; Gidding SS, 2013, CIRC-CARDIOVASC IMAG, V6, P769, DOI 10.1161/CIRCIMAGING.112.000450; Iwashima Y, 2006, HYPERTENSION, V47, P195, DOI 10.1161/01.HYP.0000200033.14574.14; Kallaras K, 2001, HERZ, V26, P129, DOI 10.1007/s00059-001-2259-1; Kaneko H, 2013, J CARDIOL, V62, P102, DOI 10.1016/j.jjcc.2013.03.013; Katz DH, 2013, AM J CARDIOL, V112, P1158, DOI 10.1016/j.amjcard.2013.05.061; Lai CL, 2011, INT J CARDIOL, V149, P347, DOI 10.1016/j.ijcard.2010.02.015; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LINDROOS M, 1994, AM J CARDIOL, V74, P385, DOI 10.1016/0002-9149(94)90408-1; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; Maurer MS, 2007, J AM COLL CARDIOL, V49, P972, DOI 10.1016/j.jacc.2006.10.061; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Park CM, 2013, HYPERTENSION, V61, P1014, DOI 10.1161/HYPERTENSIONAHA.111.00610; Persson H, 2007, J AM COLL CARDIOL, V49, P687, DOI 10.1016/j.jacc.2006.08.062; Redheuil A, 2011, J AM COLL CARDIOL, V58, P1262, DOI 10.1016/j.jacc.2011.06.012; Turley AJ, 2007, POSTGRAD MED J, V83, P206, DOI 10.1136/pgmj.2006.052886; Velagaleti RS, 2014, AM J CARDIOL, V113, P117, DOI 10.1016/j.amjcard.2013.09.028; Verdecchia P, 2003, AM J HYPERTENS, V16, P895, DOI 10.1016/S0895-7061(03)01018-5; Wong RCC, 2008, ECHOCARDIOGR-J CARD, V25, P805, DOI 10.1111/j.1540-8175.2008.00709.x; Yip GWK, 2009, HEART, V95, P980, DOI 10.1136/hrt.2008.153551; Zhang Y, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-86; Zhang YF, 2014, APPL THERM ENG, V65, P1, DOI 10.1016/j.applthermaleng.2013.12.069; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031	40	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156467	10.1371/journal.pone.0156467	http://dx.doi.org/10.1371/journal.pone.0156467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280886	gold, Green Submitted, Green Published			2022-12-26	WOS:000377563000029
J	Pompa-Garcia, M; Venegas-Gonzalez, A				Pompa-Garcia, Marin; Venegas-Gonzalez, Alejandro			Temporal Variation of Wood Density and Carbon in Two Elevational Sites of Pinus cooperi in Relation to Climate Response in Northern Mexico	PLOS ONE			English	Article							TREE-RING WIDTH; RADIAL VARIATION; BIOMASS; TEMPERATURE; GROWTH; DROUGHT; RECONSTRUCTION; SENSITIVITY; SIGNALS; ACCUMULATION	Forest ecosystems play an important role in the global carbon cycle. Therefore, understanding the dynamics of carbon uptake in forest ecosystems is much needed. Pinus cooperi is a widely distributed species in the Sierra Madre Occidental in northern Mexico and future climatic variations could impact these ecosystems. Here, we analyze the variations of trunk carbon in two populations of P. cooperi situated at different elevational gradients, combining dendrochronological techniques and allometry. Carbon sequestration (50% biomass) was estimated from a specific allometric equation for this species based on: (i) variation of intraannual wood density and (ii) diameter reconstruction. The results show that the population at a higher elevation had greater wood density, basal area, and hence, carbon accumulation. This finding can be explained by an ecological response of trees to adverse weather conditions, which would cause a change in the cellular structure affecting the within-ring wood density profile. The influence of variations in climate on the maximum density of chronologies showed a positive correlation with precipitation and the Multivariate El Nino Southern Oscillation Index during the winter season, and a negative correlation with maximum temperature during the spring season. Monitoring previous conditions to growth is crucial due to the increased vulnerability to extreme climatic variations on higher elevational sites. We concluded that temporal variability of wood density contributes to a better understanding of environmental historical changes and forest carbon dynamics in Northern Mexico, representing a significant improvement over previous studies on carbon sequestration. Assuming a uniform density according to tree age is incorrect, so this method can be used for environmental mitigation strategies, such as for managing P. cooperi, a dominant species of great ecological amplitude and widely used in forest industries.	[Pompa-Garcia, Marin] Univ Juarez Estado Durango, Fac Ciencias Forest, Rio Papaloapan & Blvd Durango S-N, Durango 34120, Durango, Mexico; [Venegas-Gonzalez, Alejandro] Univ Sao Paulo, Wood Anat & Tree Ring Lab, Dept Forest Sci, BR-13418900 Piracicaba, SP, Brazil	Universidad Juarez del Estado de Durango; Universidade de Sao Paulo	Venegas-Gonzalez, A (corresponding author), Univ Sao Paulo, Wood Anat & Tree Ring Lab, Dept Forest Sci, BR-13418900 Piracicaba, SP, Brazil.	avenegasgon@gmail.com	Pompa-García, Marin/F-9544-2019; VENEGAS-GONZALEZ, ALEJANDRO/AAK-1882-2020	Pompa-García, Marin/0000-0001-7156-432X; VENEGAS-GONZALEZ, ALEJANDRO/0000-0003-4568-4533	Universidad Juarez del Estado de Durango; CONACYT [CB-2013/222522]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT); School of Forestry at Northern Arizona University	Universidad Juarez del Estado de Durango; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); School of Forestry at Northern Arizona University	The Universidad Juarez del Estado de Durango, and CONACYT provided funding through Project CB-2013/222522. Alejandro Venegas-Gonzalez was supported by scholarship from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT), during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the support given by the School of Forestry at Northern Arizona University. The Universidad Juarez del Estado de Durango, and CONACYT providing funding through Project CB-2013/222522. We acknowledge the help of Department of Forest Science of University of Sao Paulo, Dr. Mario Tomazello Filho for the x-ray densitometry analysis and Dr. Matheus Chagas Peres for the support in the preparation of samples. Jose Santiago Sanchez provides help with field data gathering. The authors are grateful to Editors and anonymous reviewers for their useful comments and suggestions. Alejandro Venegas-Gonzalezs was supported by scholarship from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT), during the writing of this paper	Adams HD, 2005, J BIOGEOGR, V32, P1629, DOI 10.1111/j.1365-2699.2005.01292.x; [Anonymous], 1996, TREE RINGS ENV DENDR; Auty D, 2014, MODELS PREDICTING WO; Babst F, 2014, OECOLOGIA, V176, P307, DOI 10.1007/s00442-014-3031-6; Babst F, 2014, DENDROCHRONOLOGIA, V32, P153, DOI 10.1016/j.dendro.2014.01.002; Babst F, 2014, NEW PHYTOL, V201, P1289, DOI 10.1111/nph.12589; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Bickford IN, 2011, WEST N AM NATURALIST, V71, P338, DOI 10.3398/064.071.0302; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Bouriaud O, 2005, TREE PHYSIOL, V25, P651, DOI 10.1093/treephys/25.6.651; Brauning A, 2004, GEOPHYS RES LETT, P31; Briffa KR, 2004, GLOBAL PLANET CHANGE, V40, P11, DOI 10.1016/S0921-8181(03)00095-X; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Campioli M, 2011, BIOGEOSCIENCES, V8, P2481, DOI 10.5194/bg-8-2481-2011; Linares JC, 2010, TREE PHYSIOL, V30, P795, DOI 10.1093/treephys/tpq052; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Clark DB, 2015, PLOS ONE, P10; Cleaveland MK, 2003, CLIMATIC CHANGE, V59, P369, DOI 10.1023/A:1024835630188; Cook E. R., 1985, TIME SERIES ANAL APP; Cruz-Cobos F, 2008, AGROCIENCIA-MEXICO, V42, P473; Decoux V, 2004, ANN FOREST SCI, V61, P251, DOI 10.1051/forest:2004018; Etzold S, 2011, ECOSYSTEMS, V14, P1289, DOI 10.1007/s10021-011-9481-3; Fan ZX, 2009, GLOBAL PLANET CHANGE, V65, P1, DOI 10.1016/j.gloplacha.2008.10.001; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; Franceschini T, 2013, TREES-STRUCT FUNCT, V27, P913, DOI 10.1007/s00468-013-0844-6; Frank DC, 2010, NATURE, V463, P527, DOI 10.1038/nature08769; FRITTS HC, 1989, ADV ECOL RES, V19, P111; Gindl W, 2000, TREES-STRUCT FUNCT, V14, P409, DOI 10.1007/s004680000057; Gonzalez-Elizondo M, 2005, FOREST ECOL MANAG, V213, P39, DOI 10.1016/j.foreco.2005.03.012; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; Hietz P, 2013, FUNCT ECOL, V27, P684, DOI 10.1111/1365-2435.12085; Huang JG, 2010, GLOBAL CHANGE BIOL, V16, P711, DOI 10.1111/j.1365-2486.2009.01990.x; Camarero JJ, 2010, NEW PHYTOL, V185, P471, DOI 10.1111/j.1469-8137.2009.03073.x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kerhoulas LP, 2013, FOREST ECOL MANAG, V289, P425, DOI 10.1016/j.foreco.2012.10.036; Kirdyanov AV, 2008, CHEM GEOL, V252, P31, DOI 10.1016/j.chemgeo.2008.01.023; Knapic S, 2007, ANN FOREST SCI, V64, P211, DOI 10.1051/forest:2006105; Lebourgeois F, 2012, TREES-STRUCT FUNCT, V26, P715, DOI 10.1007/s00468-011-0638-7; Luckman BH, 2005, CLIM DYNAM, V24, P131, DOI 10.1007/s00382-004-0511-0; Lupi C, 2011, TREE PHYSL; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Martin-Benito D, 2013, EUR J FOREST RES, V132, P33, DOI 10.1007/s10342-012-0652-3; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Nehrbass-Ahles C, 2014, GLOBAL CHANGE BIOL, V20, P2867, DOI 10.1111/gcb.12599; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parresol BR, 1999, FOREST SCI, V45, P573; Pasho E, 2012, TREES-STRUCT FUNCT, V26, P1875, DOI 10.1007/s00468-012-0756-x; Pederson Neil, 2004, Dendrochronologia, V22, P7, DOI 10.1016/j.dendro.2004.09.005; Pompa-Garcia M, 2014, THEOR APPL CLIMATOL, V117, P495, DOI 10.1007/s00704-013-1018-6; Pompa-Garcia M, 2013, DENDROCHRONOLOGIA, V31, P198, DOI 10.1016/j.dendro.2013.05.003; Raich JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100275; Rammig A., 2014, BIOGEOSCIENCES DISCU, V11, P2537, DOI [10.5194/bgd-11-2537-2014, DOI 10.5194/BGD-11-2537-2014]; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rozas V, 2012, INT J BIOMETEOROL, V56, P787, DOI 10.1007/s00484-011-0479-5; Seager R, 2009, ATMOSFERA, V22, P1; Stahle DW, 2012, CLIM DYNAM, V39, P1431, DOI 10.1007/s00382-011-1205-z; Taki S, 2014, J FOREST RES-JPN, V19, P226, DOI 10.1007/s10310-012-0382-x; Tomazello M, 2008, MADERAS-CIENC TECNOL, V10, P139, DOI 10.4067/S0718-221X2008000200006; van der Maaten E, 2012, ANN FOR RES, V55, P113; Vargas R, 2008, GLOBAL CHANGE BIOL, V14, P109, DOI 10.1111/j.1365-2486.2007.01462.x; Weber P, 2008, FOREST ECOL MANAG, V254, P96, DOI 10.1016/j.foreco.2007.07.031; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wutzler T, 2008, CAN J FOREST RES, V38, P1661, DOI 10.1139/X07-194; Zar J.H., 2010, BIOSTAT ANAL; Zscheischler J, 2014, GEOPHYS RES LETT, V41, P8853, DOI 10.1002/2014GL062409	70	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156782	10.1371/journal.pone.0156782	http://dx.doi.org/10.1371/journal.pone.0156782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272519	Green Submitted, gold, Green Published			2022-12-26	WOS:000377561000037
J	Sastre, E; Caracuel, L; Blanco-Rivero, J; Callejo, M; Xavier, FE; Balfagon, G				Sastre, Esther; Caracuel, Laura; Blanco-Rivero, Javier; Callejo, Maria; Xavier, Fabiano E.; Balfagon, Gloria			Biphasic Effect of Diabetes on Neuronal Nitric Oxide Release in Rat Mesenteric Arteries	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; OXIDATIVE STRESS; UP-REGULATION; L-ARGININE; SYNTHASE; DISEASE; ARGINASE; TETRAHYDROBIOPTERIN; DYSFUNCTION; INHIBITION	Introduction We analysed possible time-dependent changes in nitrergic perivascular innervation function from diabetic rats and mechanisms implicated. Materials and Methods In endothelium-denuded mesenteric arteries from control and four- (4W) and eight-week (8W) streptozotocin-induced diabetic rats the vasoconstriction to EFS (electrical field stimulation) was analysed before and after preincubation with L-NAME. Neuronal NO release was analysed in the absence and presence of L-arginine, tetrahydrobiopterine (BH4) and L-arginine plus BH4. Superoxide anion (O-2(-)), peroxynitrite (ONOO-) and superoxide dismutase (SOD) activity were measured. Expressions of Cu-Zn SOD, nNOS, p-nNOS Ser(1417), p-nNOS Ser(847), and Arginase (Arg) I and II were analysed. Results EFS response was enhanced at 4W, and to a lesser extent at 8W. L-NAME increased EFS response in control rats and at 8W, but not at 4W. NO release was decreased at 4W and restored at 8W. L-arginine or BH4 increased NO release at 4W, but not 8W. SOD activity and O-2(-) generation were increased at both 4W and 8W. ONOO- decreased at 4W while increased at 8W. Cu-Zn SOD, nNOS and p-NOS Ser(1417) expressions remained unmodified at 4W and 8W, whereas p-nNOS Ser(847) was increased at 4W. ArgI was overexpressed at 4W, remaining unmodified at 8W. ArgII expression was similar in all groups. Conclusions Our results show a time-dependent effect of diabetes on neuronal NO release. At 4W, diabetes induced increased O-2(-) generation, nNOS uncoupling and overexpression of ArgI and p-nNOS Ser(847), resulting in decreased NO release. At 8W, NO release was restored, involving normalisation of ArgI and p-nNOS Ser(847) expressions.	[Sastre, Esther; Caracuel, Laura; Blanco-Rivero, Javier; Callejo, Maria; Balfagon, Gloria] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Sastre, Esther; Caracuel, Laura; Blanco-Rivero, Javier; Balfagon, Gloria] Inst Invest La Paz IdIPAZ, Madrid, Spain; [Xavier, Fabiano E.] Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil	Autonomous University of Madrid; Universidade Federal de Pernambuco	Balfagon, G (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.; Balfagon, G (corresponding author), Inst Invest La Paz IdIPAZ, Madrid, Spain.	gloria.balfagon@uam.es	Xavier, Fabiano Elias/G-1253-2012; Xavier, Fabiano/G-1253-2012; Blanco Rivero, Javier/J-6118-2014	Xavier, Fabiano Elias/0000-0003-2028-2562; Balfagon Calvo, Gloria/0000-0001-9477-7950; Xavier, Fabiano/0000-0002-1387-8491; Blanco Rivero, Javier/0000-0001-7232-2314	Ministerio de Economia y Competitividad [SAF2012-38530]; FPI-UAM fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)	Ministerio de Economia y Competitividad(Spanish Government); FPI-UAM fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Ministerio de Economia y Competitividad (SAF2012-38530). ES received a FPI-UAM fellowship. FEX is recipient of research fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Al-Noah Z, 2014, AUTON NEUROSCI-BASIC, V183, P58, DOI 10.1016/j.autneu.2014.03.002; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Arrick DM, 2007, BRAIN RES, V1184, P365, DOI 10.1016/j.brainres.2007.10.004; Bagi Z, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00293; Bendall JK, 2014, ANTIOXID REDOX SIGN, V20, P3040, DOI 10.1089/ars.2013.5566; Blanco-Rivero J, 2011, CLIN SCI, V121, P331, DOI 10.1042/CS20110072; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Capellini VK, 2010, CURR VASC PHARMACOL, V8, P526; Cellek S, 2005, DIABETES, V54, P212, DOI 10.2337/diabetes.54.1.212; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; de las Heras N, 2013, NUTR METAB CARDIOVAS, V23, P1107, DOI 10.1016/j.numecd.2012.11.009; de Queiroz DB, 2015, BRIT J PHARMACOL, V172, P4699, DOI 10.1111/bph.13244; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Durlu NT, 2003, FUND CLIN PHARMACOL, V17, P609; Ferrer M, 1999, LIFE SCI, V66, P337; Ferrer M, 2003, J VASC RES, V40, P509, DOI 10.1159/000075183; Gangula PRR, 2010, AM J PHYSIOL-GASTR L, V298, pG692, DOI 10.1152/ajpgi.00450.2009; Heine CL, 2014, BIOCHEMISTRY-US, V53, P1284, DOI 10.1021/bi401307r; Hoang HH, 2013, CURR OPIN CLIN NUTR, V16, P76, DOI 10.1097/MCO.0b013e32835ad1ef; Jin L, 2007, J PHYSIOL PHARMACOL, V58, P191; Kasamatsu S, 2014, BIOCHEM J, V459, P251, DOI 10.1042/BJ20131262; Krentz AJ, 2007, DIABETES OBES METAB, V9, P781, DOI 10.1111/j.1463-1326.2007.00670.x; Leon BM, 2015, WORLD J DIABETES, V6, P1246, DOI 10.4239/wjd.v6.i13.1246; Marin J, 1998, BRIT J PHARMACOL, V124, P473, DOI 10.1038/sj.bjp.0701856; Melikian N, 2009, TRENDS CARDIOVAS MED, V19, P256, DOI 10.1016/j.tcm.2010.02.007; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Pernow J, 2015, BRIT J PHARMACOL, V172, P4684, DOI 10.1111/bph.13242; Pernow J., 2015, CURR VASC PHARM; Pieper GM, 1997, J PHARMACOL EXP THER, V283, P684; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Ryoo S, 2006, CIRC RES, V99, P951, DOI 10.1161/01.RES.0000247034.24662.b4; Sanchez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036027; Sastre E, 2012, SHOCK, V38, P328, DOI 10.1097/SHK.0b013e31826240ba; Toque HA, 2013, J SEX MED, V10, P1502, DOI 10.1111/jsm.12134; Xavier FE, 2004, J HYPERTENS, V22, P949, DOI 10.1097/00004872-200405000-00017; Xavier FE, 2003, VASC PHARMACOL, V40, P67, DOI 10.1016/S1537-1891(02)00315-4	42	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156793	10.1371/journal.pone.0156793	http://dx.doi.org/10.1371/journal.pone.0156793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272874	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000038
J	Nguyen, T; Shively, JE				Nguyen, Tung; Shively, John E.			Induction of Lumen Formation in a Three-dimensional Model of Mammary Morphogenesis by Transcriptional Regulator ID4 ROLE OF CaMK2D IN THE EPIGENETIC REGULATION OF ID4 GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ADHESION MOLECULE; DIFFERENTIATION 4 ID4; BILIARY GLYCOPROTEIN CD66A; BREAST-CANCER CELLS; NF-KAPPA-B; PROSTATE-CANCER; CYTOPLASMIC DOMAIN; DOWN-REGULATION; HISTONE DEACETYLASE-4; MALIGNANT BREAST	Concomitant loss of lumen formation and cell adhesion protein-CEACAM1 is a hallmark feature of breast cancer. In a three-dimensional culture model, transfection of CEACAM1 into MCF7 breast cells can restore lumen formation by an unknown mechanism. ID4, a transcriptional regulator lacking a DNA binding domain, is highly up-regulated in CEACAM1-transfected MCF7 cells, and when down-regulated with RNAi, abrogates lumen formation. Conversely, when MCF7 cells, which fail to form lumena in a three-dimensional culture, are transfected with ID4, lumen formation is restored, demonstrating that ID4 may substitute for CEACAM1. After showing the ID4 promoter is hypermethylated in MCF7 cells but hypomethylated in MCF/CEACAM1 cells, ID4 expression was induced in MCF7 cells by agents affecting chromatin remodeling and methylation. Mechanistically, CaMK2D was up-regulated in CEACAM1-transfected cells, effecting phosphorylation of HDAC4 and its sequestration in the cytoplasm by the adaptor protein 14-3-3. CaMK2D also phosphorylates CEACAM1 on its cytoplasmic domain and mutation of these phosphorylation sites abrogates lumen formation. Thus, CEACAM1 is able to maintain the active transcription of ID4 by an epigenetic mechanism involving HDAC4 and CaMK2D, and the same kinase enables lumen formation by CEACAM1. Because ID4 can replace CEACAM1 in parental MCF7 cells, it must act downstream from CEACAM1 by inhibiting the activity of other transcription factors that would otherwise prevent lumen formation. This overall mechanism may be operative in other cancers, such as colon and prostate, where the down-regulation of CEACAM1 is observed.	[Nguyen, Tung; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), 1450 E Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson ME, 2009, J CLIN INVEST, V119, P1082, DOI 10.1172/JCI39262; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Chinaranagari S, 2014, ONCOTARGET, V5, P7172, DOI 10.18632/oncotarget.2262; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Federman N, 2014, J PHYSIOL-PARIS, V108, P278, DOI 10.1016/j.jphysparis.2014.06.003; Gray CBB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00015; Hartman J, 2004, ONCOGENE, V23, P8826, DOI 10.1038/sj.onc.1208139; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Itahana Y, 2003, CANCER RES, V63, P7098; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jin L, 2008, EXP BIOL MED, V233, P849, DOI 10.3181/0712-RM-352; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Killoran RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123934; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; Li CL, 2011, BIOCHEM BIOPH RES CO, V409, P125, DOI 10.1016/j.bbrc.2011.04.128; Li Y, 2013, EXP CELL RES, V319, P1061, DOI 10.1016/j.yexcr.2013.02.020; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Liu QA, 2011, ANN DIAGN PATHOL, V15, P30, DOI 10.1016/j.anndiagpath.2010.07.010; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Marley PD, 1996, BIOCHEM BIOPH RES CO, V221, P15, DOI 10.1006/bbrc.1996.0536; Muller P, 2002, J BIOL CHEM, V277, P28376, DOI 10.1074/jbc.C200340200; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Patel D, 2015, BBA-REV CANCER, V1855, P92, DOI 10.1016/j.bbcan.2014.12.002; Patel D, 2014, MOL ENDOCRINOL, V28, P1239, DOI 10.1210/me.2014-1100; Pradeep CR, 2012, ONCOGENE, V31, P907, DOI 10.1038/onc.2011.279; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Sharma P, 2015, BIOCHIMIE, V112, P139, DOI 10.1016/j.biochi.2015.03.006; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Nguyen T, 2014, J BIOL CHEM, V289, P2934, DOI 10.1074/jbc.M113.496992; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Wang JL, 2011, CHINESE J PHYSIOL, V54, P332, DOI 10.4077/CJP.2011.AMM087; Weng CY, 2016, J BIOL CHEM, V291, P16777, DOI 10.1074/jbc.M115.710152; Woodcock JM, 2015, ONCOTARGET, V6, P14522, DOI 10.18632/oncotarget.3995; Yang CC, 2015, ACTA BIOCH BIOPH SIN, V47, P788, DOI 10.1093/abbs/gmv075; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhao H, 2010, PROSTATE CANCER P D, V13, P252, DOI 10.1038/pcan.2010.9	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16766	16776		10.1074/jbc.M115.710160	http://dx.doi.org/10.1074/jbc.M115.710160			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302061	hybrid, Green Published			2022-12-26	WOS:000380826700033
J	Wang, L; Gonzalez, S; Dai, W; Deng, S; Lu, L				Wang, Ling; Gonzalez, Sheyla; Dai, Wei; Deng, Sophie; Lu, Luo			Effect of Hypoxia-regulated Polo-like Kinase 3 (Plk3) on Human Limbal Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL EPITHELIAL-CELLS; C-JUN; SERINE/THREONINE KINASE; STEM/PROGENITOR CELLS; IN-VITRO; KAPPA-B; EXPRESSION; ACTIVATION; APOPTOSIS; NEOVASCULARIZATION	Hypoxic conditions in the cornea affect epithelial function by activating Polo-like kinase 3 (Plk3) signaling and the c-Jun.AP-1 transcription complex, resulting in apoptosis of corneal epithelial cells. Hypoxic stress in the culture conditions also regulates limbal stem cell growth and fate. In this study, we demonstrate that there is a differential response of Plk3 in hypoxic stress-induced primary human limbal stem (HLS) and corneal epithelial (HCE) cells, resulting in different pathways of cell fate. We found that hypoxic stress induced HLS cell differentiation by down-regulating Plk3 activity at the transcription level, which was opposite to the effect of hypoxic stress on Plk3 activation to elicit HCE cell apoptosis, detected by DNA fragmentation and TUNEL assays. Hypoxic stress-induced increases in c-Jun phosphorylation/activation were not observed in HLS cells because Plk3 expression and activity were suppressed in hypoxia-induced HLS cells. Instead, hypoxic stress-induced HLS cell differentiation was monitored by cell cycle analysis and measured by the decrease and increase in p63 and keratin 12 expression, respectively. Hypoxic stress-induced Plk3 signaling to regulate c-Jun activity, resulting in limbal stem cell differentiation and center epithelial apoptosis, was also found in the corneas of wild-type and Plk3(-/-)-deficient mice. Our results, for the first time, reveal the differential effects of hypoxic stress on Plk3 activity in HLS and HCE cells. Instead of apoptosis, hypoxic stress suppresses Plk3 activity to protect limbal stem cells from death and to allow the process of HLS cell differentiation.	[Wang, Ling; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA; [Gonzalez, Sheyla; Deng, Sophie] Univ Calif Los Angeles, David Geffen Sch Med, Julie Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 91020 USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health [EY022364, EY EY021797, CA 090658]; NATIONAL CANCER INSTITUTE [R01CA090658] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022364, R01EY021797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health Grants EY022364 (to L. L.), EY EY021797 (to S. D.), and CA 090658 (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arpitha P, 2005, INVEST OPHTH VIS SCI, V46, P3631, DOI 10.1167/iovs.05-0343; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Conn CW, 2000, CANCER RES, V60, P6826; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Laderoute KR, 2004, MOL CELL BIOL, V24, P4128, DOI 10.1128/MCB.24.10.4128-4137.2004; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Lu JW, 2010, INVEST OPHTH VIS SCI, V51, P5034, DOI 10.1167/iovs.10-5501; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; Miyashita H, 2007, INVEST OPHTH VIS SCI, V48, P3586, DOI 10.1167/iovs.07-0077; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Nishi H, 2002, CANCER RES, V62, P827; Nishida K, 1996, INVEST OPHTH VIS SCI, V37, P1800; O'Callaghan AR, 2011, CURR EYE RES, V36, P691, DOI 10.3109/02713683.2011.556302; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Singh N, 2005, INVEST OPHTH VIS SCI, V46, P1647, DOI 10.1167/iovs.04-1172; Singh N, 2006, INVEST OPHTH VIS SCI, V47, P4787, DOI 10.1167/iovs.06-0419; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; Truong TT, 2011, INVEST OPHTH VIS SCI, V52, P6315, DOI 10.1167/iovs.11-7518; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Xu KP, 2000, TOXICOL SCI, V58, P306, DOI 10.1093/toxsci/58.2.306; Zhang MC, 2006, OCUL IMMUNOL INFLAMM, V14, P359, DOI 10.1080/09273940601001322	41	10	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16519	16529		10.1074/jbc.M116.725747	http://dx.doi.org/10.1074/jbc.M116.725747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27281822	Green Published, hybrid			2022-12-26	WOS:000380826700012
J	Zanetti, SR; Ziblat, A; Torres, NI; Zwirner, NW; Bouzat, C				Zanetti, Samanta R.; Ziblat, Andrea; Torres, Nicolas I.; Zwirner, Norberto W.; Bouzat, Cecilia			Expression and Functional Role of alpha 7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTORS; DENDRITIC CELLS; IMMUNE FUNCTION; CHOLINERGIC SYSTEM; T-CELLS; ALLOSTERIC MODULATION; EFFECTOR FUNCTIONS; ACTIVATION; LIGANDS; NACHRS	The homomeric alpha 7 nicotinic receptor (nAChR) is one of the most abundant nAChRs in the central nervous system where it contributes to cognition, attention, and working memory. alpha 7 nAChR is also present in lymphocytes, dendritic cells (DCs), and macrophages and it is emerging as an important drug target for intervention in inflammation and sepsis. Natural killer (NK) cells display cytotoxic activity against susceptible target cells and modulate innate and adaptive immune responses through their interaction with DCs. We here show that human NK cells also express alpha 7 nAChR. alpha 7 nAChR mRNA is detected by RTPCR and cell surface expression of alpha 7 nAChR is detected by confocal microscopy and flow cytometry using alpha-bungarotoxin, a specific antagonist. Both mRNA and protein levels increase during NK stimulation with cytokines (IL-12, IL-18, and IL-15). Exposure of cytokine-stimulated NK cells to PNU-282987, a specific alpha 7 nAChR agonist, increases intracellular calcium concentration ([Ca2+](i)) mainly released from intracellular stores, indicating that alpha 7 nAChR is functional. Moreover, its activation by PNU-282987 plus a specific positive allosteric modulator greatly enhances the Ca2+ responses in NK cells. Stimulation of NK cells with cytokines and PNU-282987 decreases NF-kappa B levels and nuclear mobilization, down-regulates NKG2D receptors, and decreases NKG2D-dependent cell-mediated cytotoxicity and IFN-gamma production. Also, such NK cells are less efficient to trigger DC maturation. Thus, our results demonstrate the anti-inflammatory role of alpha 7 nAChR in NK cells and suggest that modulation of its activity in these cells may constitute a novel target for regulation of the immune response.	[Zanetti, Samanta R.; Bouzat, Cecilia] Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim INIBIBB, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Ziblat, Andrea; Torres, Nicolas I.; Zwirner, Norberto W.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, C1428ADN, Buenos Aires, DF, Argentina; [Zwirner, Norberto W.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, C1428ADN, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Bouzat, C (corresponding author), Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim INIBIBB, RA-8000 Bahia Blanca, Buenos Aires, Argentina.; Zwirner, NW (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, C1428ADN, Buenos Aires, DF, Argentina.; Zwirner, NW (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, C1428ADN, Buenos Aires, DF, Argentina.	norzwi@gmail.com; inbouzat@criba.edu.ar	Zwirner, Norberto/AAI-8961-2020; torres, nicolas/AAE-4849-2019	Zwirner, Norberto/0000-0001-7098-359X; Torres, Nicolas/0000-0001-6501-185X; Ziblat, Andrea/0000-0003-1469-8836	Fundacion Rene Baron; Fundacion Williams	Fundacion Rene Baron; Fundacion Williams	We thank the staff of Hemotherapy Service, Hospital Interzonal Dr. Jose Penna, Bahia Blanca, Buenos Aires, Argentina, for their valuable assistance. We thank the people of the Blood Bank of the "Carlos Durand" Hospital and of the "Complejo Medico Churruca-Visca" for providing the buffy coats. We thank Fundacion Rene Baron and Fundacion Williams for additional support, Prof. Dr. Gabriela Salvador for providing anti-p65 NF-kappa B mAb, Dr. Veronica Gonzalez-Pardo for providing BAPTA-AM, and Alessandra Zingoni and Angela Santoni from the Laboratory of Molecular Immunology and Immunopathology, Department of Molecular Medicine, Sapienza University of Rome, Italy, for providing the retroviral vectors for the transduction experiments.	Adamczyk M, 2006, CLIN CHEM, V52, P2123, DOI 10.1373/clinchem.2006.074369; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bouzat C, 2012, J PHYSIOL-PARIS, V106, P23, DOI 10.1016/j.jphysparis.2011.09.012; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chernyavsky AI, 2009, INT J IMMUNOPATH PH, V22, P461, DOI 10.1177/039463200902200223; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chijioke O, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00365; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; da Silva RB, 2011, CELL MOL LIFE SCI, V68, P3505, DOI 10.1007/s00018-011-0801-8; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Egea J, 2015, BIOCHEM PHARMACOL, V97, P463, DOI 10.1016/j.bcp.2015.07.032; Fasoli F, 2015, CURR TOP BEHAV NEURO, V23, P1, DOI 10.1007/978-3-319-13665-3_1; Ferlazzo G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00159; Ferlazzo G, 2009, J CLIN IMMUNOL, V29, P265, DOI 10.1007/s10875-009-9283-y; Filippini P, 2012, CURR DRUG TARGETS, V13, P644, DOI 10.2174/138945012800399008; Fogel LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4232; Hao JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057495; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Hoogduijn MJ, 2009, STEM CELLS DEV, V18, P103, DOI 10.1089/scd.2008.0032; Hsueh CM, 2002, J NEUROIMMUNOL, V123, P102, DOI 10.1016/S0165-5728(01)00488-X; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Domaica CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051677; Weinstein LI, 2015, ANN NY ACAD SCI, V1351, P39, DOI 10.1111/nyas.12792; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Kalkman HO, 2016, CELL MOL LIFE SCI, V73, P2511, DOI 10.1007/s00018-016-2175-4; Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kawashima K, 2015, INT IMMUNOPHARMACOL, V29, P127, DOI 10.1016/j.intimp.2015.04.015; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; King JR, 2016, J NEUROCHEM, V138, P532, DOI 10.1111/jnc.13660; King JR, 2015, J BIOL CHEM, V290, P20060, DOI 10.1074/jbc.M115.647040; Lam RA, 2013, ANN MED, V45, P384, DOI 10.3109/07853890.2013.792495; Landais Emilie, 2010, Front Biosci (Elite Ed), V2, P928; Lueders C, 2007, LABMEDICINE, V38, P726, DOI 10.1309/1N2NAYWQ53QVR6FX; Mandal Arundhati, 2015, Hematol Oncol Stem Cell Ther, V8, P47, DOI 10.1016/j.hemonc.2014.11.006; Mignini F., 2003, Autonomic & Autacoid Pharmacology, V23, P1, DOI 10.1046/j.1474-8673.2003.00280.x; Mistry AR, 2007, IMMUNOLOGY, V121, P439, DOI 10.1111/j.1365-2567.2007.02652.x; Nizri E, 2013, AMINO ACIDS, V45, P73, DOI 10.1007/s00726-011-1192-8; Pacheco Rodrigo, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P65; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Poggi A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00027; Pohanka M, 2012, INT J MOL SCI, V13, P2219, DOI 10.3390/ijms13022219; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Qiu YH, 2004, LYMPHOLOGY, V37, P31; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Romee R, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/205796; Rossi LE, 2012, J LEUKOCYTE BIOL, V91, P321, DOI 10.1189/jlb.0711339; Schedel A, 2011, ARTERIOSCL THROM VAS, V31, P928, DOI 10.1161/ATVBAHA.110.218297; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Simard AR, 2013, IMMUNOL CELL BIOL, V91, P195, DOI 10.1038/icb.2013.1; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Tian ZG, 2012, J AUTOIMMUN, V39, P206, DOI 10.1016/j.jaut.2012.05.006; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wu JCF, 2009, J CELL BIOCHEM, V108, P433, DOI 10.1002/jcb.22270; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602; Ziblat A, 2015, EUR J IMMUNOL, V45, P192, DOI 10.1002/eji.201444699; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	77	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16541	16552		10.1074/jbc.M115.710574	http://dx.doi.org/10.1074/jbc.M115.710574			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27284006	Green Published, hybrid			2022-12-26	WOS:000380826700014
J	Funmilayo, E; Yeates, A; Tesco, G				Funmilayo, Eniola; Yeates, Aduke; Tesco, Giuseppina			The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; EPIDERMAL-GROWTH-FACTOR; ALPHA-SECRETASE CLEAVAGE; RECEPTOR DOWN-REGULATION; BETA-SECRETASE; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; GAMMA-SECRETASE; EGFR DEGRADATION; TRAFFICKING	The beta-site amyloid precursor protein-cleaving enzyme (BACE1) is the rate-limiting enzyme in the production of amyloid-beta, the toxic peptide that accumulates in the brain of subjects affected by Alzheimer disease. Our previous studies have shown that BACE1 is degraded via the lysosomal pathway and that that depletion of the trafficking molecule Golgi-localized gamma-ear-containing ARF-binding protein 3 (GGA3) results in increased BACE1 levels and activity because of impaired lysosomal degradation. We also determined that GGA3 regulation of BACE1 levels requires its ability to bind ubiquitin. Accordingly, we reported that BACE1 is ubiquitinated at lysine 501 and that lack of ubiquitination at lysine 501 produces BACE1 stabilization. Ubiquitin conjugation is a reversible process mediated by deubiquitinating enzymes. The ubiquitin-specific peptidase 8 (USP8), an endosome-associated deubiquitinating enzyme, regulates the ubiquitination, trafficking, and lysosomal degradation of several plasma membrane proteins. Here, we report that RNAi-mediated depletion of USP8 reduced levels of both ectopically expressed and endogenous BACE1 in H4 human neuroglioma cells. Moreover, USP8 depletion increased BACE1 ubiquitination, promoted BACE1 accumulation in the early endosomes and late endosomes/lysosomes, and decreased levels of BACE1 in the recycling endosomes. We also found that decreased BACE1 protein levels were accompanied by a decrease in BACE1-mediated amyloid precursor protein cleavage and amyloid-beta levels. Our findings demonstrate that USP8 plays a key role in the trafficking and degradation of BACE1 by deubiquitinating lysine 501. These studies suggest that therapies able to accelerate BACE1 degradation (e.g. by increasing BACE1 ubiquitination) may represent a potential treatment for Alzheimer disease.	[Funmilayo, Eniola; Yeates, Aduke; Tesco, Giuseppina] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, 136 Harrison Ave,Ste 328A, Boston, MA 02111 USA.	giuseppina.tesco@Tufts.edu			National Institutes of Health [NS047243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243, R01NS092497, T32NS061764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Dan Cox for assisting with statistical analysis and Dr. Lai Ding for designing the ImageJ macro used for image analysis. We thank Dr. Alenka Lovy-Wheeler for assistance with confocal microscopy at the Tufts Center for Neuroscience Research (supported by National Institutes of Health Grant NS047243).	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Arnst JL, 2013, ANAL BIOCHEM, V440, P71, DOI 10.1016/j.ab.2013.05.017; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Bruzzone F, 2008, BRAIN RES, V1195, P56, DOI 10.1016/j.brainres.2007.12.014; Buggia-Prevot V, 2013, CELL REP, V5, P1552, DOI 10.1016/j.celrep.2013.12.006; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Ceriani M, 2015, EXP CELL RES, V333, P49, DOI 10.1016/j.yexcr.2015.01.019; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Das U, 2016, NAT NEUROSCI, V19, P55, DOI 10.1038/nn.4188; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Guglielmotto M, 2012, AGING CELL, V11, P834, DOI 10.1111/j.1474-9726.2012.00854.x; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lee EJ, 2009, EXP MOL MED, V41, P555, DOI 10.3858/emm.2009.41.8.061; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Matz A, 2015, CELL DEATH DIFFER, V22, P626, DOI 10.1038/cdd.2014.163; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Oh YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04980; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Scudder SL, 2014, J NEUROSCI, V34, P16637, DOI 10.1523/JNEUROSCI.2452-14.2014; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sirisaengtaksin N, 2014, J BIOL CHEM, V289, P3026, DOI 10.1074/jbc.M113.495671; Slomnicki LP, 2008, ACTA NEUROBIOL EXP, V68, P219; Smith GA, 2016, TRAFFIC, V17, P53, DOI 10.1111/tra.12341; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Weinstock J, 2012, ACS MED CHEM LETT, V3, P789, DOI 10.1021/ml200276j; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x	71	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15753	15766		10.1074/jbc.M116.718023	http://dx.doi.org/10.1074/jbc.M116.718023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27302062	Green Published, hybrid			2022-12-26	WOS:000380584200028
J	Deliano, M; Tabelow, K; Konig, R; Polzehl, J				Deliano, Matthias; Tabelow, Karsten; Koenig, Reinhard; Polzehl, Joerg			Improving Accuracy and Temporal Resolution of Learning Curve Estimation for within- and across-Session Analysis	PLOS ONE			English	Article							INTERVAL ESTIMATION; AVOIDANCE; DYNAMICS; MODEL	Estimation of learning curves is ubiquitously based on proportions of correct responses within moving trial windows. Thereby, it is tacitly assumed that learning performance is constant within the moving windows, which, however, is often not the case. In the present study we demonstrate that violations of this assumption lead to systematic errors in the analysis of learning curves, and we explored the dependency of these errors on window size, different statistical models, and learning phase. To reduce these errors in the analysis of single-subject data as well as on the population level, we propose adequate statistical methods for the estimation of learning curves and the construction of confidence intervals, trial by trial. Applied to data from an avoidance learning experiment with rodents, these methods revealed performance changes occurring at multiple time scales within and across training sessions which were otherwise obscured in the conventional analysis. Our work shows that the proper assessment of the behavioral dynamics of learning at high temporal resolution can shed new light on specific learning processes, and, thus, allows to refine existing learning concepts. It further disambiguates the interpretation of neurophysiological signal changes recorded during training in relation to learning.	[Deliano, Matthias] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, AG Brain Machine Interfaces, Magdeburg, Germany; [Tabelow, Karsten; Polzehl, Joerg] Weierstrass Inst Appl Anal & Stochast, Res Grp Stochast Algorithms & Nonparametr Stat, Berlin, Germany; [Koenig, Reinhard] Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Weierstrass Institute for Applied Analysis & Stochastics; Leibniz Institut fur Neurobiologie (LIN)	Deliano, M (corresponding author), Leibniz Inst Neurobiol, Dept Syst Physiol Learning, AG Brain Machine Interfaces, Magdeburg, Germany.	matthias.deliano@lin-magdeburg.de	Tabelow, Karsten/AAI-4490-2021	Tabelow, Karsten/0000-0003-1274-9951; Polzehl, Joerg/0000-0001-7471-2658				Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bathellier B, 2013, P NATL ACAD SCI USA, V110, P19950, DOI 10.1073/pnas.1312125110; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Brown S, 2003, BEHAV RES METH INS C, V35, P11, DOI 10.3758/BF03195493; Cain CK, 2008, HBK BEHAV NEUROSCI, V17, P103, DOI 10.1016/S1569-7339(07)00007-0; Collett D., 2003, MODELLING SURVIVAL D; Fan J., 1996, MONOGRAPHS STAT APPL, V66, pxvi+341; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G., 2013, R PACKAGE VERSION 12; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; Maia TV, 2010, LEARN BEHAV, V38, P50, DOI 10.3758/LB.38.1.50; MCSWEENEY FK, 1993, J EXP ANAL BEHAV, V60, P621, DOI 10.1901/jeab.1993.60-621; Moutoussis M, 2008, NETWORK-COMP NEURAL, V19, P137, DOI 10.1080/09548980802192784; MYERS CE, 2014, FRONT BEHAV NEUROSCI, V8, DOI DOI 10.3389/FNBEH.2014.00283; Nelder J. A., 1998, MONOGRAPHS STAT APPL; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; R Development Core Team, R LANG ENV STAT COMP; Rothe T, 2009, BRAIN RES, V1297, P143, DOI 10.1016/j.brainres.2009.08.055; Schicknick H, 2006, NEUROPHARMACOLOGY, V50, P671, DOI 10.1016/j.neuropharm.2005.11.013; Seifert B., 2013, LPRIDGE LOCAL POLYNO; Servatius RJ, 2008, BEHAV BRAIN RES, V192, P191, DOI 10.1016/j.bbr.2008.04.006; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; SPEAR NE, 1973, J COMP PHYSIOL PSYCH, V85, P601, DOI 10.1037/h0035314; Stark H, 2008, NEUROSCIENCE, V151, P467, DOI 10.1016/j.neuroscience.2007.11.005; Suzuki Wendy A, 2005, Behav Cogn Neurosci Rev, V4, P67, DOI 10.1177/1534582305280030	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157355	10.1371/journal.pone.0157355	http://dx.doi.org/10.1371/journal.pone.0157355			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303809	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800052
J	Mucke, N; Winheim, S; Merlitz, H; Buchholz, J; Langowski, J; Herrmann, H				Muecke, Norbert; Winheim, Stefan; Merlitz, Holger; Buchholz, Jan; Langowski, Joerg; Herrmann, Harald			In Vitro Assembly Kinetics of Cytoplasmic Intermediate Filaments: A Correlative Monte Carlo Simulation Study	PLOS ONE			English	Article							X-RAY-SCATTERING; TETRAMERIC VIMENTIN; EPIDERMAL KERATIN; DYNAMICS; MECHANISM; NETWORKS; PROTEINS; DOMAINS; INVITRO; LENGTH	Intermediate filament (IF) elongation proceeds via full-width "mini-filaments", referred to as "unit-length" filaments (ULFs), which instantaneously form by lateral association of extended coiled-coil complexes after assembly is initiated. In a comparatively much slower process, ULFs longitudinally interact end-to-end with other ULFs to form short filaments, which further anneal with ULFs and with each other to increasingly longer filaments. This assembly concept was derived from time-lapse electron and atomic force microscopy data. We previously have quantitatively verified this concept through the generation of time-dependent filament length-profiles and an analytical model that describes assembly kinetics well for about the first ten minutes. In this time frame, filaments are shorter than one persistence length, i.e. similar to 1 mu m, and thus filaments were treated as stiff rods associating via their ends. However, when filaments grow several mu m in length over hours, their flexibility becomes a significant factor for the kinetics of the longitudinal annealing process. Incorporating now additional filament length distributions that we have recorded after extended assembly times by total internal reflection fluorescence microscopy (TIRFM), we developed a Monte Carlo simulation procedure that accurately describes the underlying assembly kinetics for large time scales.	[Muecke, Norbert; Winheim, Stefan; Buchholz, Jan; Langowski, Joerg] German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany; [Merlitz, Holger] Xiamen Univ, Dept Phys, Xiamen 361005, Peoples R China; [Merlitz, Holger] Xiamen Univ, ITPA, Xiamen, Peoples R China; [Herrmann, Harald] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Xiamen University; Xiamen University; University of Erlangen Nuremberg	Mucke, N (corresponding author), German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany.	norbert.muecke@dkfz-heidelberg.de	Langowski, Jörg/A-1843-2011	Langowski, Jörg/0000-0001-8600-0666; Mucke, Norbert/0000-0002-0683-4386	German research Foundation (DFG) [HE 1853/11-1, FOR 1228, LA 500/17-1]	German research Foundation (DFG)(German Research Foundation (DFG))	HH and JL received funding from the German research Foundation (DFG), grants HE 1853/11-1, FOR 1228 and LA 500/17-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Aziz A, 2012, J BIOL CHEM, V287, P28349, DOI 10.1074/jbc.M111.334011; Brennich ME, 2014, SOFT MATTER, V10, P2059, DOI 10.1039/c3sm52532e; Brennich ME, 2011, LAB CHIP, V11, P708, DOI 10.1039/c0lc00319k; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Chernyatina AA, 2015, CURR OPIN CELL BIOL, V32, P65, DOI 10.1016/j.ceb.2014.12.007; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Herrmann H, 2003, INT REV CYTOL, V223, P83; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; HOFMANN I, 1991, EUR J CELL BIOL, V56, P328; Hu T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155434; HUIATT TW, 1980, J BIOL CHEM, V255, P6981; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; KAWAMURA M, 1970, J BIOCHEM-TOKYO, V67, P437, DOI 10.1093/oxfordjournals.jbchem.a129267; Kayser J, 2012, SOFT MATTER, V8, P8873, DOI 10.1039/c2sm26032h; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Klenin K, 1998, BIOPHYS J, V74, P780, DOI 10.1016/S0006-3495(98)74003-2; Koster S, 2015, CURR OPIN CELL BIOL, V32, P82, DOI 10.1016/j.ceb.2015.01.001; Kreplak L, 2008, METHODS CELL BIOL, V88; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Mucke N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007756; Niklas KJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00008; Noding B, 2014, BIOPHYS J, V107, P2914, DOI 10.1016/j.bpj.2014.09.050; Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4; PARRY DAD, 1995, PROTEINS, V22, P267, DOI 10.1002/prot.340220307; Portet S, 2013, J THEOR BIOL, V332, P20, DOI 10.1016/j.jtbi.2013.04.004; Portet S, 2009, LANGMUIR, V25, P8817, DOI 10.1021/la900509r; REISLER E, 1980, J MOL BIOL, V143, P129, DOI 10.1016/0022-2836(80)90127-8; Rubinstein M, 2003, POLYM PHYS, V91; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; Winheim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019202	42	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157451	10.1371/journal.pone.0157451	http://dx.doi.org/10.1371/journal.pone.0157451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304995	Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800060
J	Yeh, CH; Stafford, AR; Leslie, BA; Fredenburgh, JC; Weitz, JI				Yeh, Calvin H.; Stafford, Alan R.; Leslie, Beverly A.; Fredenburgh, James C.; Weitz, Jeffrey I.			Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function	PLOS ONE			English	Article							HEPARIN-CATALYZED INHIBITION; HIGH-AFFINITY INTERACTION; RAY CRYSTAL-STRUCTURE; HUMAN ALPHA-THROMBIN; ACTIVE-SITE; ALLOSTERIC LINKAGE; FACTOR-V; STRUCTURAL-CHANGES; ANTITHROMBIN-III; LIGAND-BINDING	Thrombin is a highly plastic molecule whose activity and specificity are regulated by exosites 1 and 2, positively-charged domains that flank the active site. Exosite binding by substrates and cofactors regulates thrombin activity by localizing thrombin, guiding substrates, and by inducing allosteric changes at the active site. Although inter-exosite and exosite-toactive-site allostery have been demonstrated, the impact of active site ligation on exosite function has not been examined. To address this gap, we used surface plasmon resonance to determine the effects of dabigatran and argatroban, active site-directed inhibitors, on thrombin binding to immobilized gamma(A)/gamma(A)-fibrin or glycoprotein Iba peptide via exosite 1 and 2, respectively, and thrombin binding to gamma(A)/gamma'-fibrin or factor Va, which is mediated by both exosites. Whereas dabigatran attenuated binding, argatroban increased thrombin binding to gamma(A)/gamma(A)-and gamma(A)/gamma'-fibrin and to factor Va. The results with immobilized fibrin were confirmed by examining the binding of radiolabeled thrombin to fibrin clots. Thus, dabigatran modestly accelerated the dissociation of thrombin from gamma(A)/gamma(A)-fibrin clots, whereas argatroban attenuated dissociation. Dabigatran had no effect on thrombin binding to glycoprotein Iba peptide, whereas argatroban promoted binding. These findings not only highlight functional effects of thrombin allostery, but also suggest that individual active site-directed thrombin inhibitors uniquely modulate exosite function, thereby identifying potential novel mechanisms of action.	[Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Yeh, Calvin/AAA-1685-2019	Weitz, Jeffrey/0000-0002-1092-7550; 	Canadian Institutes of Health Research [MOP-136820, FRN-3992]; Heart and Stroke Foundation of Canada [T6357]; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded in part by grants from the Canadian Institutes of Health Research (MOP-136820 and FRN-3992) and the Heart and Stroke Foundation of Canada (T6357). C.H.Y. is supported by a Doctoral Scholarship from the Canadian Institutes of Health Research. J.I.W. holds the Canada Research Chair (Tier I) in Thrombosis and the Heart and Stroke Foundation J. Fraser Mustard Chair in Cardiovascular Research at McMaster University. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2009, J THROMB HAEMOST, V7, P1688, DOI 10.1111/j.1538-7836.2009.03563.x; Aziz MHA, 2012, J MED CHEM, V55, P6888, DOI 10.1021/jm300670q; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BODE W, 1992, PROTEIN SCI, V1, P426; BRANDSTETTER H, 1992, J MOL BIOL, V226, P1085, DOI 10.1016/0022-2836(92)91054-S; Croy CH, 2004, BIOCHEMISTRY-US, V43, P5246, DOI 10.1021/bi0499718; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 2000, J BIOL CHEM, V275, P3887, DOI 10.1074/jbc.275.6.3887; DECRISTOFARO R, 1994, J MOL BIOL, V239, P569, DOI 10.1006/jmbi.1994.1396; DECRISTOFARO R, 1995, J MOL BIOL, V245, P447; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354; Fitzgerald D, 1996, CORONARY ARTERY DIS, V7, P455, DOI 10.1097/00019501-199606000-00008; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 2001, J BIOL CHEM, V276, P44828, DOI 10.1074/jbc.M108710200; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hauel NH, 2002, J MED CHEM, V45, P1757, DOI 10.1021/jm0109513; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Kim PY, 2012, J BIOL CHEM, V287, P4652, DOI 10.1074/jbc.M111.317719; Kretz CA, 2006, J BIOL CHEM, V281, P37477, DOI 10.1074/jbc.M607359200; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lechtenberg BC, 2014, J MOL BIOL, V426, P881, DOI 10.1016/j.jmb.2013.11.027; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Li CQ, 2001, J BIOL CHEM, V276, P6161, DOI 10.1074/jbc.M004164200; Li W, 2010, J BIOL CHEM, V285, P38621, DOI 10.1074/jbc.M110.144964; LIU LW, 1991, J BIOL CHEM, V266, P16977; Malovichko MV, 2013, J BIOL CHEM, V288, P8667, DOI 10.1074/jbc.M112.410829; MATHEWS II, 1995, ACTA CRYSTALLOGR D, V51, P550, DOI 10.1107/S0907444994013132; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; NASKI MC, 1990, J BIOL CHEM, V265, P13484; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Ng NMY, 2009, ARCH BIOCHEM BIOPHYS, V489, P48, DOI 10.1016/j.abb.2009.07.012; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Pozzi N, 2013, J THROMB HAEMOST, V11, P1093, DOI 10.1111/jth.12238; Pozzi N, 2011, BIOPHYS CHEM, V159, P6, DOI 10.1016/j.bpc.2011.04.003; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; Sabo TM, 2009, BIOCHEMISTRY-US, V48, P7110, DOI 10.1021/bi900745b; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Treuheit NA, 2011, BIOCHEMISTRY-US, V50, P4590, DOI 10.1021/bi2004069; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vu TT, 2013, J BIOL CHEM, V288, P16862, DOI 10.1074/jbc.M113.464750; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P155, DOI 10.1160/TH07-03-0183; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036; YE J, 1991, J BIOL CHEM, V266, P23016; Zarpellon A, 2011, P NATL ACAD SCI USA, V108, P8628, DOI 10.1073/pnas.1017042108	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157471	10.1371/journal.pone.0157471	http://dx.doi.org/10.1371/journal.pone.0157471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305147	gold, Green Submitted, Green Published			2022-12-26	WOS:000377824800062
J	Bedwell, JS; Potts, GF; Gooding, DC; Trachik, BJ; Chan, CC; Spencer, CC				Bedwell, Jeffrey S.; Potts, Geoffrey F.; Gooding, Diane C.; Trachik, Benjamin J.; Chan, Chi C.; Spencer, Christopher C.			Transdiagnostic Psychiatric Symptoms and Event-Related Potentials following Rewarding and Aversive Outcomes	PLOS ONE			English	Article							SCHIZOPHRENIA-PATIENTS; BEHAVIORAL ACTIVATION; MOTIVATED ATTENTION; BIPOLAR DISORDER; DEPRESSION; PLEASURE; POSITIVITY; ANHEDONIA; DEFICITS; FUTURE	There is a need for a better understanding of transdiagnostic psychiatric symptoms that relate to neurophysiological abnormalities following rewarding and aversive feedback in order to inform development of novel targeted treatments. To address this need, we examined a transdiagnostic sample of 44 adults (mean age: 35.52; 57% female), which consisted of individuals with broadly-defined schizophrenia-spectrum disorders (n = 16), bipolar disorders (n = 10), other mood and anxiety disorders (n = 5), and no history of a psychiatric disorder (n = 13). Participants completed a Pavlovian monetary reward prediction task during 32-channel electroencephalogram recording. We assessed the event-related potentials (ERPs) of feedback-related negativity (FRN), feedback-related positivity (FRP), and the late positive potential (LPP), following better and worse than expected outcomes. Examination of symptom relationships using stepwise regressions across the entire sample revealed that an increase in the clinician-rated Negative Symptoms factor score from the Positive and Negative Syndrome Scale, was related to a decreased LPP amplitude during better than expected (i.e., rewarding) outcomes. We also found that increased self-reported scores on the Schizotypal Personality Questionnaire (Brief-Revised) Disorganized factor related to an increased FRN amplitude during worse than expected (i.e., aversive) outcomes. Across the entire sample, the FRP component amplitudes did not show significant relationships to any of the symptoms examined. Analyses of the three diagnostic groups of schizophrenia-spectrum disorders, bipolar disorders, and nonpsychiatric controls did not reveal any statistically significant differences across the ERP amplitudes and conditions. These findings suggest relationships between specific neurophysiological abnormalities following rewarding and aversive outcomes and particular transdiagnostic psychiatric symptoms.	[Bedwell, Jeffrey S.; Trachik, Benjamin J.; Chan, Chi C.; Spencer, Christopher C.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA; [Potts, Geoffrey F.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Gooding, Diane C.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of South Florida; University of Wisconsin System; University of Wisconsin Madison	Bedwell, JS (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	jeffrey.bedwell@ucf.edu		Chan, Chi/0000-0001-7861-7316; Bedwell, Jeffrey/0000-0002-1205-5792	University of Central Florida Office of Research and Commercialization; College of Sciences (Orlando, Florida, United States of America) [1053929]	University of Central Florida Office of Research and Commercialization; College of Sciences (Orlando, Florida, United States of America)	This study was funded by an internal university "SEED grant" from the University of Central Florida Office of Research and Commercialization and the College of Sciences (Orlando, Florida, United States of America; Research ID: 1053929). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EH, 2016, CLIN EEG NEUROSCI, V47, P11, DOI 10.1177/1550059415598063; Brunia CHM, 2011, CLIN NEUROPHYSIOL, V122, P858, DOI 10.1016/j.clinph.2010.12.039; Caceda R, 2014, J NEUROPSYCH CLIN N, V26, P196, DOI 10.1176/appi.neuropsych.12110268; Callaway DA, 2014, PERSONAL DISORD, V5, P32, DOI 10.1037/per0000041; Cassidy CM, 2014, J PSYCHIATR NEUROSCI, V39, P339, DOI 10.1503/jpn.130207; Cohen AS, 2010, J PERS DISORD, V24, P516, DOI 10.1521/pedi.2010.24.4.516; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Daban C, 2002, PSYCHIAT RES, V113, P83, DOI 10.1016/S0165-1781(02)00228-7; Dichter GS, 2009, BIOL PSYCHIAT, V66, P886, DOI 10.1016/j.biopsych.2009.06.021; Gable PA, 2013, PSYCHOPHYSIOLOGY, V50, P1251, DOI 10.1111/psyp.12135; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Gooding DC, 2014, COMPR PSYCHIAT, V55, P1455, DOI 10.1016/j.comppsych.2014.04.013; Gooding DC, 2014, PSYCHIAT RES, V215, P237, DOI 10.1016/j.psychres.2013.10.012; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hilgard J, 2014, EMOTION, V14, P940, DOI 10.1037/a0036791; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Horan WP, 2012, PSYCHOL MED, V42, P1637, DOI 10.1017/S0033291711002819; Horan WP, 2012, SCHIZOPHR RES, V135, P95, DOI 10.1016/j.schres.2011.11.005; Horan WP, 2010, J ABNORM PSYCHOL, V119, P18, DOI 10.1037/a0017510; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Lejuez CW, 2011, BEHAV MODIF, V35, P111, DOI 10.1177/0145445510390929; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luo PC, 2014, NEUROSCI LETT, V578, P85, DOI 10.1016/j.neulet.2014.06.032; Martin LE, 2009, NEUROREPORT, V20, P1140, DOI 10.1097/WNR.0b013e32832f0dca; Martinez-Horta S, 2014, J NEUROSCI, V34, P5918, DOI 10.1523/JNEUROSCI.0251-14.2014; Mason L, 2016, BIOL PSYCHIAT, V79, P311, DOI 10.1016/j.biopsych.2015.03.014; Mason L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047754; Mason L, 2012, BIOL PSYCHIAT, V71, P530, DOI 10.1016/j.biopsych.2011.10.008; Mori A, 2016, J AFFECT DISORDERS, V189, P254, DOI 10.1016/j.jad.2015.09.036; Morris SE, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00123; Patrick RE, 2015, INT J PSYCHOPHYSIOL, V98, P612, DOI 10.1016/j.ijpsycho.2015.01.006; Phillips ML, 2014, AM J PSYCHIAT, V171, P829, DOI 10.1176/appi.ajp.2014.13081008; Pinheiro AP, 2013, NEUROSCI LETT, V550, P75, DOI 10.1016/j.neulet.2013.06.022; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Proudfit GH, 2015, PSYCHOPHYSIOLOGY, V52, P449, DOI 10.1111/psyp.12370; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Thomsen KR, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00049; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wexler BE, 2014, SCHIZOPHR RES, V158, P163, DOI 10.1016/j.schres.2014.07.012; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME	44	9	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157084	10.1371/journal.pone.0157084	http://dx.doi.org/10.1371/journal.pone.0157084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299996	gold, Green Published, Green Submitted			2022-12-26	WOS:000377822200028
J	Fanget, C; Chauleur, C; Stadler, A; Presles, E; Varlet, MN; Gris, JC; Raia-Barjat, T				Fanget, Cecile; Chauleur, Celine; Stadler, Amandine; Presles, Emilie; Varlet, Marie-Noelle; Gris, Jean-Christophe; Raia-Barjat, Tiphaine			Relationship between Plasma D-Dimer Concentration and Three-Dimensional Ultrasound Placental Volume in Women at Risk for Placental Vascular Diseases: A Monocentric Prospective Study	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; FETAL-GROWTH RESTRICTION; FOR-GESTATIONAL-AGE; 1ST TRIMESTER; ENDOTHELIAL DYSFUNCTION; 2ND TRIMESTER; PREGNANCY; PREECLAMPSIA; PARAMETERS; THROMBOMODULIN	Introduction The aim of this study was to correlate placental volumes deduced from three-dimensional ultrasound and virtual organ computer-aided analysis (VOCAL) software with systemic concentrations of D-dimer and soluble endothelial protein C receptor (sEPCR). Methods This was a monocentric experimental prospective study conducted from October 2008 to July 2009. Forty consecutive patients at risk of placental vascular pathology (PVP) recurrence or occurrence were included. Placental volumes were systematically measured three times (11-14, 16-18 and 20-22 weeks of gestation (WG)) by two independent sonographers. D-dimers and sEPCR plasma concentrations were measured using ELISA kits (Enzyme Linked ImmunoSorbent Assay). Results Eleven patients had a PVP. The plasma D-dimer level was positively correlated with placental volume (r = 0.45, p < 0.001). A smaller placental volume and placental quotient was evidenced in women who developed a PVP at the three gestational ages, and the difference was more pronounced during the third exam (20 WG). No obvious correlation could be demonstrated between the development of a PVP and the levels of D-dimer and sEPCR. There was no significant difference in the values of placental volumes measured by the two sonographers. Conclusion The placenta growth could be a major determinant of the elevation of D-dimer during pregnancy. Consideration of placental volume could allow for modulation of the D-dimer concentrations for restoring their clinical interest.	[Fanget, Cecile; Chauleur, Celine; Stadler, Amandine; Varlet, Marie-Noelle; Raia-Barjat, Tiphaine] Univ Hosp, Dept Gynecol & Obstet, St Etienne, France; [Chauleur, Celine; Presles, Emilie; Raia-Barjat, Tiphaine] Univ St Etienne, Res Unit EA3065, F-42023 Saint Etienne, France; [Gris, Jean-Christophe] Univ Hosp, Haematol Lab, Nimes, France; [Gris, Jean-Christophe] Univ Montpellier, Res Unit EA2992, F-34059 Montpellier, France	CHU de St Etienne; Universite Jean Monnet; Universite de Montpellier; CHU de Nimes; Universite de Montpellier	Raia-Barjat, T (corresponding author), Univ Hosp, Dept Gynecol & Obstet, St Etienne, France.; Raia-Barjat, T (corresponding author), Univ St Etienne, Res Unit EA3065, F-42023 Saint Etienne, France.	tiphaine.barjat@chu-st-etienne.fr	GRIS, Jean-Christophe/AAA-2923-2019; BARJAT, Tiphaine/AAJ-7310-2021	GRIS, Jean-Christophe/0000-0002-9899-9910; Raia-Barjat, Tiphaine/0000-0002-4408-6075				Abramowicz JS, 2007, PLACENTA, V28, pS14, DOI 10.1016/j.placenta.2007.02.004; Baschat AA, 2004, SEMIN PERINATOL, V28, P67, DOI 10.1053/j.semperi.2003.10.014; Belo L, 2002, BJOG-INT J OBSTET GY, V109, P1250, DOI 10.1016/S1470-0328(02)01957-2; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Bujold E, 2009, J OBSTET GYNAECOL CA, V31, P1144, DOI 10.1016/S1701-2163(16)34375-4; Burstein E, 2009, AM J PERINAT, V26, P169, DOI 10.1055/s-0028-1095188; CLAPP JF, 1995, J SOC GYNECOL INVEST, V2, P19, DOI 10.1016/1071-5576(94)00042-Y; Deurloo K, 2007, J CLIN ULTRASOUND, V35, P125, DOI 10.1002/jcu.20306; Dusse LM, 2013, CLIN CHIM ACTA, V415, P226, DOI 10.1016/j.cca.2012.10.006; Ercan S, 2014, J MATEM FETAL NEONAT, V8, P1; FRANCALANCI I, 1995, THROMB RES, V80, P89, DOI 10.1016/0049-3848(95)00153-I; Franchi F, 2001, BRIT J HAEMATOL, V114, P641, DOI 10.1046/j.1365-2141.2001.02964.x; Giavarina D, 2001, CLIN BIOCHEM, V34, P331, DOI 10.1016/S0009-9120(01)00205-3; Gu JM, 2002, J BIOL CHEM, V277, P43335, DOI 10.1074/jbc.M207538200; Hafner E, 2006, ULTRASOUND OBST GYN, V27, P652, DOI 10.1002/uog.2641; Hafner E, 2003, PLACENTA, V24, P336, DOI 10.1053/plac.2002.0918; Hafner E, 2001, PLACENTA, V22, P729, DOI 10.1053/plac.2001.0721; Hafner E, 1998, ULTRASOUND OBST GYN, V12, P97, DOI 10.1046/j.1469-0705.1998.12020097.x; Hafner F, 2001, ULTRASOUND OBST GYN, V18, P116, DOI 10.1046/j.1469-0705.2001.00489.x; Han L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114488; HO CH, 1992, THROMB HAEMOSTASIS, V67, P214; HOWE D, 1994, J CLIN ULTRASOUND, V22, P77, DOI 10.1002/jcu.1870220203; Hurtado V, 2004, BLOOD, V104, P1369, DOI 10.1182/blood-2004-03-0793; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Jeremiah ZA, 2012, INT J WOMENS HEALTH, V4, P437, DOI 10.2147/IJWH.S32655; Law LW, 2009, ULTRASOUND OBST GYN, V34, P283, DOI 10.1002/uog.6455; Metzenbauer M, 2001, PLACENTA, V22, P602, DOI 10.1053/plac.2001.0684; Nishii A, 2009, J OBSTET GYNAECOL RE, V35, P689, DOI 10.1111/j.1447-0756.2008.01007.x; NOLAN TE, 1993, OBSTET GYNECOL, V81, P235; Odeh M, 2011, PRENATAL DIAG, V31, P367, DOI 10.1002/pd.2697; Pinheiro MB, 2014, CLIN CHIM ACTA, V427, P65, DOI 10.1016/j.cca.2013.09.050; Rizzo G, 2008, EUR J OBSTET GYN R B, V138, P147, DOI 10.1016/j.ejogrb.2007.08.015; Saposnik B, 2012, THROMB RES, V129, P152, DOI 10.1016/j.thromres.2011.07.023; Schuchter K, 2001, ULTRASOUND OBST GYN, V18, P590, DOI 10.1046/j.0960-7692.2001.00596.x; Thame M, 2001, OBSTET GYNECOL, V98, P279, DOI 10.1016/S0029-7844(01)01414-4; Wang M, 2013, CLIN CHIM ACTA, V425, P176, DOI 10.1016/j.cca.2013.08.006; Wegrzyn P, 2005, ULTRASOUND OBST GYN, V26, P28, DOI 10.1002/uog.1923; WOLF H, 1989, AM J OBSTET GYNECOL, V160, P121, DOI 10.1016/0002-9378(89)90102-6; Yigiter AB, 2011, J PERINAT MED, V39, P137, DOI [10.1515/JPM.2010.136, 10.1515/jpm.2010.136]	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156593	10.1371/journal.pone.0156593	http://dx.doi.org/10.1371/journal.pone.0156593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294274	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300007
J	Geenens, R; Famaey, N; Gijbels, A; Verhelle, S; Vinckier, S; Sloten, JV; Herijgers, P				Geenens, Rachel; Famaey, Nele; Gijbels, Andy; Verhelle, Silke; Vinckier, Stefan; Sloten, Jos Vander; Herijgers, Paul			Atherosclerosis Alters Loading-Induced Arterial Damage: Implications for Robotic Surgery	PLOS ONE			English	Article							INJURY; CLAMP; SHUNT	Background Lack of intra-operative haptic information during robotic surgery increases the risk for unintended tissue overload and damage. Knowledge about the acute and chronic fundamental relationship between force load and induced damage in healthy and diseased arteries is crucial to enable intra-operative haptic feedback or shared autonomy and improve patient safety. Methods Arteries of wildtype and atherosclerotic mice were clamped in vivo for 2 minutes (0.0N, 0.6N or 1.27N). Histological analysis (Verhoeff's-Van Gieson, Osteopontin, CD45, CD105) was performed immediately, or after 6 hours, 2 weeks or 1 month. Endothelium-dependent and- independent vasodilatation was assessed immediately or 1 month after clamping. Results Endothelium dependent vasodilatation is worse after clamping of wildtype arteries, but is restored after one month. Clamping also results in flattening of the innermost elastic membrane of both genotypes, which is reversed over time for wildtype arteries but not for vessels from atherosclerotic mice. Higher osteopontin content in wildtype and LDLR-/- mice after 2 weeks suggests a phenotypic switch of the medial smooth muscle cells (SMCs), an effect that is reversed after 1 month. While inflammation in the intima diminishes, medial CD45 content rises through time in both genotypes. CD105 staining shows that even manipulation without clamping results in endothelial cell loss in both LDLR+/+ and LDLR-/- mice. Conclusions Arterial clamping induces different acute and long-term injury to the vessel wall of atherosclerotic and healthy arteries.	[Geenens, Rachel; Verhelle, Silke; Herijgers, Paul] Katholieke Univ Leuven, Dept Cardiovasc Sci, Res Unit Expt Cardiac Surg, Herestr 49 Box 7003, B-3000 Leuven, Belgium; [Famaey, Nele; Gijbels, Andy; Sloten, Jos Vander] Katholieke Univ Leuven, Dept Mech Engn, Celestijnenlaan 300 Box 2419, BE-3001 Heverlee, Belgium; [Vinckier, Stefan] KU Leuven VIB, Dept Oncol, Vesalius Res Ctr, Herestr 49 Box 912, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	Herijgers, P (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Res Unit Expt Cardiac Surg, Herestr 49 Box 7003, B-3000 Leuven, Belgium.	paul.herijgers@uzleuven.be	Herijgers, Paul/B-8064-2013	Herijgers, Paul/0000-0003-0951-8132; Famaey, Nele/0000-0002-7374-8912	IWT Flanders and Interdisciplinary Research funding [3E100307]; Centre of Excellence Financing "Cellular Interactions and Heterogeneity in Ischemic Cardiovascular Disease" from the KU Leuven; Research Foundation Flanders [FWO - PDO/12]	IWT Flanders and Interdisciplinary Research funding; Centre of Excellence Financing "Cellular Interactions and Heterogeneity in Ischemic Cardiovascular Disease" from the KU Leuven; Research Foundation Flanders(FWO)	This research was funded by IWT Flanders and Interdisciplinary Research funding (3E100307). Additional funding was obtained from Centre of Excellence Financing "Cellular Interactions and Heterogeneity in Ischemic Cardiovascular Disease" from the KU Leuven and from a postdoctoral fellowship of the Research Foundation Flanders (FWO - PDO/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONE GW, 1989, SURGERY, V105, P465; Dobrin P B, 1992, Ann Vasc Surg, V6, P153, DOI 10.1007/BF02042737; Famaey N, 2012, J MECH BEHAV BIOMED, V12, P107, DOI 10.1016/j.jmbbm.2012.03.010; Famaey N, 2013, BIOMECH MODEL MECHAN, V12, P123, DOI 10.1007/s10237-012-0386-7; Famaey N, 2010, MED ENG PHYS, V32, P437, DOI 10.1016/j.medengphy.2010.04.002; Geenens R, 2016, ANN THORAC CARDIOVAS, V22, P38, DOI 10.5761/atcs.oa.15-00225; Hangler H, 2008, ANN THORAC SURG, V86, P1873, DOI 10.1016/j.athoracsur.2008.06.047; HARVEY JG, 1981, BRIT J SURG, V68, P267, DOI 10.1002/bjs.1800680415; Hsi Charles, 2002, Asian Cardiovasc Thorac Ann, V10, P293; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jackiewic Tanyana A., 1996, Microsurgery, V17, P674, DOI 10.1002/(SICI)1098-2752(1996)17:12<674::AID-MICR4>3.0.CO;2-N; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Margovsky AI, 1999, CARDIOVASC SURG, V7, P457, DOI 10.1016/S0967-2109(98)00154-9; Margovsky AI, 1997, AUST NZ J SURG, V67, P448, DOI 10.1111/j.1445-2197.1997.tb02012.x; Mulligan-Kehoe MJ, 2014, CIRCULATION, V129, P2557, DOI 10.1161/CIRCULATIONAHA.113.007189; Pierce DM, 2015, J MECH BEHAV BIOMED, V41, P92, DOI 10.1016/j.jmbbm.2014.10.003; Puangmali P, 2008, IEEE SENS J, V8, P371, DOI 10.1109/JSEN.2008.917481; Rinaldi B, 2006, BRIT J PHARMACOL, V147, P175, DOI 10.1038/sj.bjp.0706472; Rodriguez E, 2009, SCANDINAVIAN J SURG, P120; Sandow SL, 2009, J ANAT, V214, P258, DOI 10.1111/j.1469-7580.2008.01020.x; Shao JS, 2011, ARTERIOSCL THROM VAS, V31, P1821, DOI 10.1161/ATVBAHA.111.230011; SLAYBACK JB, 1976, AM J SURG, V132, P183, DOI 10.1016/0002-9610(76)90045-3; TANAKA H, 1993, CIRCULATION, V88, P1788, DOI 10.1161/01.CIR.88.4.1788; Vural AH, 2008, J SURG RES, V150, P261, DOI 10.1016/j.jss.2007.12.774	24	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156936	10.1371/journal.pone.0156936	http://dx.doi.org/10.1371/journal.pone.0156936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295082	Green Published, Green Submitted, gold			2022-12-26	WOS:000377821300015
J	Haeckel, A; Appler, F; de Schellenberger, AA; Schellenberger, E				Haeckel, Akvile; Appler, Franziska; de Schellenberger, Angela Ariza; Schellenberger, Eyk			XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; BREAST-CANCER; DOXORUBICIN; PROTEINS; DNA; CARCINOMA; GERMLINE; GROWTH; LINES; KLLN	Increased effectiveness and reduced side effects are general goals in drug research, especially important in cancer therapy. The aim of this study was to design a long-circulating, activatable cytostatic drug that is completely producible in E. coli. Crucial for this goal was the novel unstructured polypeptide XTEN, which acts like polyethylene glycol (PEG) but has many important advantages. Most importantly, it can be produced in E. coli, is less immunogenic, and is biodegradable. We tested constructs containing a fragment of Killin as cytostatic/cytotoxic element, a cell-penetrating peptide, an MMP-2 cleavage site for specific activation, and XTEN for long blood circulation and deactivation of Killin. One of three sequence variants was efficiently expressed in E. coli. As typical for XTEN, it allowed efficient purification of the E. coli lysate by a heat step (10 min 75 degrees C) and subsequent anion exchange chromatography using XTEN as purification tag. After 24 h XTEN-Killin reduced the number of viable cells of HT-1080 tumor cell line to 3.8 +/- 2.0% (p<0.001) compared to untreated controls. In contrast, liver derived non-tumor cells (BRL3A) did not show significant changes in viability. Our results demonstrate the feasibility of completely producing a complex protease-activatable, potentially long-circulating cytostatic/cytotoxic prodrug in E. coli-a concept that could lead to efficient production of highly multifunctional drugs in the future.	[Haeckel, Akvile; de Schellenberger, Angela Ariza; Schellenberger, Eyk] Charite, Dept Radiol, D-13353 Berlin, Germany; [Appler, Franziska] NanoPET Pharma, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schellenberger, E (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	eyk.schellenberger@charite.de		Schellenberger, Eyk/0000-0003-4096-6865; Ariza de Schellenberger, Angela/0000-0002-1005-5780	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) [KFO 213: SCHE 1416/2-2]	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) in the form of salaries for FA and AH (KFO 213: SCHE 1416/2-2). nanoPET Pharma is the current employer of FA. Her contribution for this manuscript was during her PhD program when she was employed in our group at the Charite - University Medicine Berlin. nanoPET Pharma did not support this project, was not involved, and has no rights. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bettina Herwig for language editing. The work was supported by the Deutsche Forschungsgemeinschaft DFG (KFO 213: SCHE 1416/2-2).	Albright CF, 2005, MOL CANCER THER, V4, P751, DOI 10.1158/1535-7163.MCT-05-0006; Alters SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050630; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bennett KL, 2011, GENE CHROMOSOME CANC, V50, P654, DOI 10.1002/gcc.20887; Cho YJ, 2008, P NATL ACAD SCI USA, V105, P5396, DOI 10.1073/pnas.0705410105; Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; Geething NC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010175; Haeckel A, 2014, J NUCL MED, V55, P508, DOI 10.2967/jnumed.113.128108; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Lee GY, 2007, EUR J PHARM BIOPHARM, V67, P646, DOI 10.1016/j.ejpb.2007.03.023; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Mahdi H, 2015, CANCER-AM CANCER SOC, V121, P688, DOI 10.1002/cncr.29106; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Ng EK, 2014, ONCOTARGETS THER, V7, P2085, DOI 10.2147/OTT.S53597; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Qian ZQ, 2015, CHEM COMMUN, V51, P2162, DOI 10.1039/c4cc09441g; Roomi MW, 2014, INT J ONCOL, V44, P986, DOI 10.3892/ijo.2013.2235; Roomi MW, 2009, ONCOL REP, V22, P1283, DOI 10.3892/or_00000566; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Suzuki T, 2012, INT J PHARMACEUT, V436, P636, DOI 10.1016/j.ijpharm.2012.07.049; Taurin S, 2012, J CONTROL RELEASE, V164, P265, DOI 10.1016/j.jconrel.2012.07.013; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang Y, 2014, ENDOCR-RELAT CANCER, V21, P579, DOI 10.1530/ERC-14-0148; Wang Y, 2013, HUM MOL GENET, V22, P2263, DOI 10.1093/hmg/ddt077	30	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157193	10.1371/journal.pone.0157193	http://dx.doi.org/10.1371/journal.pone.0157193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295081	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300027
J	Lee, JY; Cho, K; Park, KA; Oh, SY				Lee, Ju-Yeun; Cho, Kyuyeon; Park, Kyung-Ah; Oh, Sei Yeul			Analysis of Retinal Layer Thicknesses and Their Clinical Correlation in Patients with Traumatic Optic Neuropathy	PLOS ONE			English	Article							NERVE-FIBER LAYER; GANGLION-CELL COMPLEX; VISUAL-FIELD LOSS; COHERENCE TOMOGRAPHY; FUNCTIONAL-CHANGES; EVOKED-POTENTIALS; AXONAL LOSS; SD-OCT; GLAUCOMA; DOMAIN	The aims of this study were 1) To evaluate retinal nerve fiber layer (fRNFL) thickness and ganglion cell layer plus inner plexiform layer (GCIPL) thickness at the fovea in eyes affected with traumatic optic neuropathy (TON) compared with contralateral normal eyes, 2) to further evaluate these thicknesses within 3 weeks following trauma (defined as "early TON"), and 3) to investigate the relationship between these retinal layer thicknesses and visual function in TON eyes. Twenty-nine patients with unilateral TON were included. Horizontal and vertical spectral-domain optical coherence tomography (SD-OCT) scans of the fovea were taken in patients with unilateral TON. The main outcome measure was thickness of the entire retina, fRNFL, and GCIPL in eight areas. Thickness of each retinal layer was compared between affected and unaffected eyes. The correlation between the thickness of each retinal layer and visual function parameters, including best corrected visual acuity, color vision, P100 latency, and P100 amplitude in visual evoked potential (VEP), mean deviation (MD) and visual field index (VFI) in Humphrey visual field analysis in TON eyes was analyzed. Thicknesses of the entire retina, fRNFL, and GCIPL in SD-OCT were significantly thinner (3-36%) in all measurement areas of TON eyes compared to those in healthy eyes (all p<0.05). Whereas, only GCIPL in the outer nasal, superior, and inferior areas was significantly thinner (5-10%) in the early TON eyes than that in the control eyes (all p<0.01). A significant correlation was detected between retinal layer thicknesses and visual function parameters including color vision, P100 latency and P100 amplitude in VEP, MD, and VFI (particularly P100 latency, MD, and VFI) (r = -0.70 to 0.84). Among the retinal layers analyzed in this study, GCIPL (particularly in the superior and inferior areas) was most correlated with these five visual function parameters (r = -0.70 to 0.71). Therefore, evaluation of morphological change of each retinal layer using SD-OCT can help in understanding TON pathophysiology and indirectly assessing visual function. Moreover, evaluation of the morphological change of the GCIPL in TON eyes may be useful to assess visual function in patients with early TON.	[Lee, Ju-Yeun; Cho, Kyuyeon; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu						Alasil T, 2014, AM J OPHTHALMOL, V157, P953, DOI 10.1016/j.ajo.2014.01.014; Arintawati P, 2013, J GLAUCOMA, V22, P713, DOI 10.1097/IJG.0b013e318259b2e1; Bengtsson B, 2008, AM J OPHTHALMOL, V145, P343, DOI 10.1016/j.ajo.2007.09.038; Boone MI, 1996, OPHTHALMOLOGY, V103, P1223, DOI 10.1016/S0161-6420(96)30519-8; Cennamo G, 2015, EYE, V29, P797, DOI 10.1038/eye.2015.35; Chauhan BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040352; Chen Ting, 2015, Zhonghua Yan Ke Za Zhi, V51, P592; Cunha LP, 2009, ARQ BRAS OFTALMOL, V72, P622, DOI 10.1590/S0004-27492009000500004; Dotan G, 2015, CURR EYE RES, V40, P632, DOI 10.3109/02713683.2014.952829; Gabriele ML, 2010, PROG RETIN EYE RES, V29, P556, DOI 10.1016/j.preteyeres.2010.05.005; Gazala M, 2014, GUJARAT MED J, V69, P93; Kanamori A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1067, DOI 10.1001/archophthalmol.2012.470; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Le PV, 2013, INVEST OPHTH VIS SCI, V54, P4287, DOI 10.1167/iovs.12-11388; Lennartsson F, 2014, INVEST OPHTH VIS SCI, V55, P8278, DOI 10.1167/iovs.14-14913; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Miki A, 2015, JPN J OPHTHALMOL, V59, P230, DOI 10.1007/s10384-015-0386-0; Miller NR, 2005, WALSH HOYTS CLIN NEU; Munemasa Y, 2015, PROG RETIN EYE RES, V47, P1, DOI 10.1016/j.preteyeres.2015.03.002; Munguba GC, 2014, INVEST OPHTH VIS SCI, V55, P6505, DOI 10.1167/iovs.14-14525; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Parisi V, 2006, OPHTHALMOLOGY, V113, P216, DOI 10.1016/j.ophtha.2005.10.044; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Prager TC, 1999, J AAPOS, V3, P275, DOI 10.1016/S1091-8531(99)70023-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Renard JP, 2013, J FR OPHTALMOL, V36, P299, DOI 10.1016/j.jfo.2013.01.005; Rosenberg R, 2015, J FR OPHTALMOL, V38, P832, DOI 10.1016/j.jfo.2015.03.015; Rovere G, 2015, INVEST OPHTH VIS SCI, V56, P4487, DOI 10.1167/iovs.15-17145; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Shi W, 2013, CHINESE MED J-PEKING, V126, P1292, DOI 10.3760/cma.j.issn.0366-6999.20122854; Shin HY, 2014, OPHTHALMOLOGY, V121, P93, DOI 10.1016/j.ophtha.2013.06.041; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; TOWLE VL, 1977, INVEST OPHTH VIS SCI, V16, P1073; Valeria B, 2014, INVEST OPHTHALMOL, V55, P5633; Wheat JL, 2012, J GLAUCOMA, V21, P95, DOI 10.1097/IJG.0b013e31820bcfbe; Yaqub Moustafa, 2012, Community Eye Health, V25, P1; Yukita M, 2015, DOC OPHTHALMOL, V130, P149, DOI 10.1007/s10633-014-9478-2	40	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157388	10.1371/journal.pone.0157388	http://dx.doi.org/10.1371/journal.pone.0157388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295139	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300040
J	Smith, HM; Dickman, CR; Banks, PB				Smith, Helen M.; Dickman, Chris R.; Banks, Peter B.			Nest Predation by Commensal Rodents in Urban Bushland Remnants	PLOS ONE			English	Article							RATTUS-RATTUS; HOLLAND HONEYEATER; SMALL MAMMALS; NEW-ZEALAND; BLACK RATS; ARTIFICIAL NESTS; BIRD ASSEMBLAGES; INVASIVE RATS; SHIP RATS; COMMUNITY	Exotic predators are a major threat to native wildlife in many parts of the world. Developing and implementing effective strategies to mitigate their effects requires robust quantitative data so that management can be evidence-based, yet in many ecosystems this is missing. Birds in particular have been severely impacted by exotic mammalian predators, and a plethora of studies on islands record predation of bird eggs, fledglings and adults by exotic species such as rodents, stoats and cats. By comparison, few studies have examined nest predation around mainland urban centres which often act as dispersal hubs, especially for commensal species such as rodents. Here, we experimentally examine nest predation rates in habitat patches with varying black rat (Rattus rattus) densities in Sydney, Australia and test whether these exotic rats have the effects expected of exotic predators using effect size benchmarks. In the case where black rats have replaced native Rattus spp., we expected that black rats, being more arboreal than native Rattus spp., would be a significant source of predation on birds because they can readily access the arboreal niche where many birds nest. We tested this idea using above-ground artificial nests to represent those of typical small bird species such as the New Holland honeyeater (Phylidonyris novaehollandiae). We found that fewer eggs were depredated by rodents on sites where we removed black rats compared to unmanipulated sites, and that the effect size calculated from the total number of eggs surviving beyond the typical incubation period was similar to that expected for an exotic predator. Our results suggest that, although Australian birds have co-evolved with native Rattus species, in the case where black rats have replaced native Rattus species, exotic black rats appear to pose an additive source of predation on birds in remnant habitats, most likely due to their ability to climb more efficiently than their native counterparts. Management of these commensal rodents may be necessary to retain urban birdlife.	[Smith, Helen M.; Dickman, Chris R.; Banks, Peter B.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	University of Sydney	Smith, HM (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	h.smith@sydney.edu.au	Dickman, Christopher/Q-4662-2019	Dickman, Christopher/0000-0002-1067-3730; Smith, Helen/0000-0002-4302-338X; Banks, Peter/0000-0002-4340-6495	Australian Research Council [LP100100600]	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council Grant (LP100100600) received by PBB and CRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; [Anonymous], 2001, AVIAN ECOLOGY CONSER; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2014, JMP VERS 9 0 0; Aplin K.P., 2003, ACIAR MONOGRAPH SERI, V96, P487; ARMSTRONG DP, 1991, AUK, V108, P99; Atkinson I., 1989, P54; Atkinson IAE, 1996, WILDLIFE BIOL, V2, P135, DOI 10.2981/wlb.1996.011; Banks PB, 1999, J APPL ECOL, V36, P1063, DOI 10.1046/j.1365-2664.1999.00463.x; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; Banks PB, 2015, WILDLIFE RES, V42, P86, DOI 10.1071/WR15048; Banks PB, 2012, WILDLIFE RES, V39, P78, DOI 10.1071/WR11086; Banks Peter B., 2011, Australian Zoologist, V35, P1033; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Berry L, 2001, EMU, V101, P191, DOI 10.1071/MU00043; Blackburn TM, 2005, ECOLOGY, V86, P2916, DOI 10.1890/04-1847; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bradley JE, 2003, AUK, V120, P1180, DOI 10.1642/0004-8038(2003)120[1180:RANPIO]2.0.CO;2; BRAITHWAITE RW, 1978, AUST J ECOL, V3, P423, DOI 10.1111/j.1442-9993.1978.tb01190.x; BRAITHWAITE RW, 1978, AUST J ECOL, V3, P109, DOI 10.1111/j.1442-9993.1978.tb00857.x; Buchanan R, 1989, P LINNEAN SOC NEW S; Bytheway JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P715, DOI 10.1007/s00265-013-1494-9; Cain JW, 2006, J WILDLIFE MANAGE, V70, P522, DOI 10.2193/0022-541X(2006)70[522:IOMAON]2.0.CO;2; Cain JW, 2003, J WILDLIFE MANAGE, V67, P600; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; Craddock P, 1997, EFFECT RODENT CONTRO; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DANIEL MJ, 1984, NEW ZEAL J ECOL, V7, P9; De Santo TL, 2001, J FIELD ORNITHOL, V72, P136, DOI 10.1648/0273-8570-72.1.136; DICKMAN CR, 1986, ECOL MONOGR, V56, P221, DOI 10.2307/2937075; EMLEN JT, 1974, CONDOR, V76, P184, DOI 10.2307/1366729; Eswaryani LP, 2005, JURNAL BIOL, VIX, P65; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; FINLAYSON H. H., 1939, TRANS ROY SOC S AUSTRALIA, V63, P88; Garden J, 2006, AUSTRAL ECOL, V31, P126, DOI 10.1111/j.1442-9993.2006.01578.x; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Haythorpe KM, 2012, EMU, V112, P129, DOI 10.1071/MU11046; HOLISOVA V, 1969, Zoologicke Listy, V18, P121; HOOKER S, 1995, NEW ZEAL J ZOOL, V22, P291, DOI 10.1080/03014223.1995.9518044; HUHTALO H, 1977, BIRD STUDY, V24, P179, DOI 10.1080/00063657709476554; Innes J., 2005, HDB NZ MAMMALS, P187; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; Keast Allan, 1995, Australian Zoologist, V30, P3; Kinnear JE, 1998, WILDLIFE RES, V25, P81, DOI 10.1071/WR96072; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Leimgruber P, 2014, MAMM BIOL, V79, P313, DOI 10.1016/j.mambio.2014.04.002; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; Long JL, 2003, INTRO MAMMALS WORLD; Major RE, 1996, AUST J ECOL, V21, P399, DOI 10.1111/j.1442-9993.1996.tb00626.x; MAJOR RE, 1991, AUK, V108, P190; MAJOR RE, 1994, OIKOS, V69, P364, DOI 10.2307/3545849; Major RE, 2010, EMU, V110, P92, DOI 10.1071/MU09058; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; Martin TE, 1988, EVOL ECOL, V2, P37, DOI 10.1007/BF02071587; Marzluff John M., 2001, P19; Matthews A, 1999, ECOGRAPHY, V22, P349, DOI 10.1111/j.1600-0587.1999.tb00572.x; MCFARLAND DC, 1986, EMU, V86, P180, DOI 10.1071/MU9860180; MCFARLAND DC, 1986, EMU, V86, P161, DOI 10.1071/MU9860161; MILES MA, 1976, AM J TROP MED HYG, V25, P671, DOI 10.4269/ajtmh.1976.25.671; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; Murray BR, 1999, WILDLIFE RES, V26, P421, DOI 10.1071/WR97046; Newsome TM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1, DOI 10.1111/geb.12236; O'Donnell CFJ, 2009, NZ J ZOOLOGY, V37, P297, DOI [10.1080/03014223.2010.513395, DOI 10.1080/03014223.2010.513395]; Olsen Penny D., 1996, Bird Conservation International, V6, P63; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Pastorelli J, 1990, URBAN WILDLIFE NEW S; Pelech SA, 2010, OIKOS, V119, P841, DOI 10.1111/j.1600-0706.2009.17786.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Piper SD, 2004, FOREST ECOL MANAG, V203, P361, DOI 10.1016/j.foreco.2004.08.005; Price CJ, 2012, P NATL ACAD SCI USA, V109, P19304, DOI 10.1073/pnas.1210981109; Rangen SA, 2000, AUK, V117, P136, DOI 10.1642/0004-8038(2000)117[0136:VAOAOA]2.0.CO;2; RECHER H F, 1971, Emu, V71, P147; Rose Tania A., 2007, P66; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Ruscoe WA, 2013, CONSERV BIOL, V27, P74, DOI 10.1111/j.1523-1739.2012.01932.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Schodde R, 1988, READERS DIGEST COMPL; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Sorace A, 2002, ORNIS FENNICA, V79, P60; St Clair JJH, 2011, ANIM CONSERV, V14, P66, DOI 10.1111/j.1469-1795.2010.00391.x; St Clair JJH, 2011, BIOL CONSERV, V144, P68, DOI 10.1016/j.biocon.2010.10.006; Stapp P, 2002, J APPL ECOL, V39, P831, DOI 10.1046/j.1365-2664.2002.00754.x; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; Stokes VL, 2012, BEHAV ECOL SOCIOBIOL, V66, P329, DOI 10.1007/s00265-011-1280-5; Stokes VL, 2009, J APPL ECOL, V46, P1239, DOI 10.1111/j.1365-2664.2009.01735.x; Stokes VL, 2009, AUSTRAL ECOL, V34, P395, DOI 10.1111/j.1442-9993.2009.01941.x; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Terborgh John, 1989, HAVE ALL BIRDS GONE; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; Thompson FR, 2004, CONSERV BIOL, V18, P373, DOI 10.1111/j.1523-1739.2004.00167.x; Threlfall C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1144; Watts CHS, 1981, RODENTS AUSTR; WATTS CHS, 1978, WILDLIFE RES, V5, P47; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Zanette L, 2000, AUK, V117, P445, DOI 10.1642/0004-8038(2000)117[0445:NSANPI]2.0.CO;2	105	10	14	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156180	10.1371/journal.pone.0156180	http://dx.doi.org/10.1371/journal.pone.0156180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295091	gold, Green Published, Green Submitted			2022-12-26	WOS:000377821300003
J	Zhao, L; Jiang, XW; Zuo, YJ; Liu, XL; Chin, SW; Haberle, R; Potter, D; Chang, ZY; Wen, J				Zhao, Liang; Jiang, Xi-Wang; Zuo, Yun-Juan; Liu, Xiao-Lin; Chin, Siew-Wai; Haberle, Rosemarie; Potter, Daniel; Chang, Zhao-Yang; Wen, Jun			Multiple Events of Allopolyploidy in the Evolution of the Racemose Lineages in Prunus (Rosaceae) Based on Integrated Evidence from Nuclear and Plastid Data	PLOS ONE			English	Article							PLANT PHYLOGENETICS PROGRESS; SEQUENCE DATA; GENE DATA; SPECIATION; INFERENCE; PLUMS; CLASSIFICATION; PRUNOCERASUS; SYSTEMATICS; POLYPLOIDY	Prunus is an economically important genus well-known for cherries, plums, almonds, and peaches. The genus can be divided into three major groups based on inflorescence structure and ploidy levels: (1) the diploid solitary-flower group (subg. Prunus, Amygdalus and Emplectocladus); (2) the diploid corymbose group (subg. Cerasus); and (3) the polyploid racemose group (subg. Padus, subg. Laurocerasus, and the Maddenia group). The plastid phylogeny suggests three major clades within Prunus: Prunus-Amygdalus-Emplectocladus, Cerasus, and Laurocerasus-Padus-Maddenia, while nuclear ITS trees resolve Laurocerasus-Padus-Maddenia as a paraphyletic group. In this study, we employed sequences of the nuclear loci At103, ITS and s6pdh to explore the origins and evolution of the racemose group. Two copies of the At103 gene were identified in Prunus. One copy is found in Prunus species with solitary and corymbose inflorescences as well as those with racemose inflorescences, while the second copy (II) is present only in taxa with racemose inflorescences. The copy I sequences suggest that all racemose species form a paraphyletic group composed of four clades, each of which is definable by morphology and geography. The tree from the combined At103 and ITS sequences and the tree based on the single gene s6pdh had similar general topologies to the tree based on the copy I sequences of At103, with the combined At103-ITS tree showing stronger support in most clades. The nuclear At103, ITS and s6pdh data in conjunction with the plastid data are consistent with the hypothesis that multiple independent allopolyploidy events contributed to the origins of the racemose group. A widespread species or lineage may have served as the maternal parent for multiple hybridizations involving several paternal lineages. This hypothesis of the complex evolutionary history of the racemose group in Prunus reflects a major step forward in our understanding of diversification of the genus and has important implications for the interpretation of its phylogeny, evolution, and classification.	[Zhao, Liang; Chang, Zhao-Yang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Xi-Wang] Jianghan Univ, Coll Life Sci, Wuhan 430056, Hubei, Peoples R China; [Zuo, Yun-Juan] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai Chenshan Bot Garden, 3888 Chenhua Rd, Shanghai 201602, Peoples R China; [Liu, Xiao-Lin] Weifang Engn Vocat Coll, Sch Appl Chem & Biol Engn, Qingzhou 262500, Shandong, Peoples R China; [Chin, Siew-Wai; Potter, Daniel] Univ Calif Davis, Dept Plant Sci, MS2, Davis, CA 95616 USA; [Haberle, Rosemarie] Pacific Lutheran Univ, Dept Biol, Washington, DC USA; [Wen, Jun] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA	Northwest A&F University - China; Jianghan University; Chinese Academy of Sciences; University of California System; University of California Davis; Pacific Lutheran University; Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA.	wenj@si.edu			Smithsonian Endowment program; National Science Foundation (NSF) [DEB 0515431]; Fundamental Research Funds for the Central Universities [QN2012020, 2452015406]; China Scholarship Council	Smithsonian Endowment program; National Science Foundation (NSF)(National Science Foundation (NSF)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Scholarship Council(China Scholarship Council)	This work was supported by the Smithsonian Endowment program, the National Science Foundation (NSF Award number DEB 0515431 to JW) and Fundamental Research Funds for the Central Universities (No. QN2012020, 2452015406 to LZ). The China Scholarship Council was gratefully acknowledged for financial support of LZ's research visit to the Smithsonian Institution.; This work was supported by the Smithsonian Endowment program, the National Science Foundation (NSF Award number DEB 0515431) and Fundamental Research Funds for the Central Universities (No. QN2012020, 2452015406). The China Scholarship Council was gratefully acknowledged for financial support of L. Zhao's research visit to the Smithsonian Institution. Peiliang Liu and Ning Zhang are acknowledged for assistance with data analyses.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bortiri E, 2006, PLANT SYST EVOL, V259, P53, DOI 10.1007/s00606-006-0427-8; Bortiri E, 2002, AM J BOT, V89, P1697, DOI 10.3732/ajb.89.10.1697; Bortiri E, 2001, SYST BOT, V26, P797; Chin SW, 2014, MOL PHYLOGENET EVOL, V76, P34, DOI 10.1016/j.ympev.2014.02.024; Chin SW, 2013, INT J PLANT SCI, V174, P27, DOI 10.1086/668219; Chin SW, 2010, BOT J LINN SOC, V164, P236, DOI 10.1111/j.1095-8339.2010.01083.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dickinson TA, 2007, PLANT SYST EVOL, V266, P59, DOI 10.1007/s00606-007-0541-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Hosie RC, 1969, CAN FOR SER DEP FISH; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacobson Arthur L., 2007, Madrono, V54, P74, DOI 10.3120/0024-9637(2007)54[74:ANHCPP]2.0.CO;2; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Wen J, 2008, J SYST EVOL, V46, P322, DOI 10.3724/SP.J.1002.2008.08050; KALKMAN C., 1965, BLUMEA, V13, P1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lee S, 2001, AM J BOT, V88, P150, DOI 10.2307/2657135; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Liu XL, 2013, J PLANT RES, V126, P351, DOI 10.1007/s10265-012-0535-1; Lu L.D., 2003, FLORA CHINA, P46, DOI DOI 10.3321/J.ISSN:1000-131X.2003.09.008; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Rehder A., 1940, MANUAL CULTIVATED TR, V2nd; Rohrer Joseph R., 2008, Journal of the Botanical Research Institute of Texas, V2, P401; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Shaw J, 2005, AM J BOT, V92, P2011, DOI 10.3732/ajb.92.12.2011; Shi S, 2013, J INTEGR PLANT BIOL, V55, P1069, DOI 10.1111/jipb.12095; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Tavaud M, 2004, HEREDITY, V93, P631, DOI 10.1038/sj.hdy.6800589; Triplett JK, 2014, NEW PHYTOL, V204, P66, DOI 10.1111/nph.12988; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Watkins R., 1976, Evolution of crop plants., P242; Wen J, 2015, J SYST EVOL, V53, P369, DOI 10.1111/jse.12175; Wen J, 2012, PHYTOKEYS, V11, P39, DOI 10.3897/phytokeys.11.2825; White TL, 2007, FORSET GENETICS; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; YAMAKI S, 1986, J AM SOC HORTIC SCI, V111, P134; Yu T.T., 1986, FLORA REIPUBLICAE PO, V38, P1; Zimmer EA, 2015, J SYST EVOL, V53, P371, DOI 10.1111/jse.12174; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015	48	21	23	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157123	10.1371/journal.pone.0157123	http://dx.doi.org/10.1371/journal.pone.0157123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294529	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300022
J	He, XQ; Song, YQ; Liu, R; Liu, Y; Zhang, F; Zhang, Z; Shen, YT; Xu, L; Chen, MH; Wang, YL; Xu, BH; Yang, XJ; Wang, HL				He, Xiao-Qin; Song, Yue-Qiang; Liu, Rui; Liu, Yu; Zhang, Fei; Zhang, Zhen; Shen, Yu-Ting; Xu, Lin; Chen, Ming-Huang; Wang, Ya-Long; Xu, Bai-Hui; Yang, Xiang-Jun; Wang, Hai-Long			Axin-1 Regulates Meiotic Spindle Organization in Mouse Oocytes	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MICROTUBULE NUCLEATION; CHROMOSOME ALIGNMENT; MITOTIC SPINDLE; GAMMA-TUBULIN; MEIOSIS-I; PROTEIN; CENTROSOME; MITOSIS; ACTIVATION	Axin-1, a negative regulator of Wnt signaling, is a versatile scaffold protein involved in centrosome separation and spindle assembly in mitosis, but its function in mammalian oogenesis remains unknown. Here we examined the localization and function of Axin-1 during meiotic maturation in mouse oocytes. Immunofluorescence analysis showed that Axin-1 was localized around the spindle. Knockdown of the Axin1 gene by microinjection of specific short interfering (si) RNA into the oocyte cytoplasm resulted in severely defective spindles, misaligned chromosomes, failure of first polar body (PB1) extrusion, and impaired pronuclear formation. However, supplementing the culture medium with the Wnt pathway activator LiCl improved spindle morphology and pronuclear formation. Downregulation of Axin1 gene expression also impaired the spindle pole localization of gamma-tubulin/Nek9 and resulted in retention of the spindle assembly checkpoint protein BubR1 at kinetochores after 8.5 h of culture. Our results suggest that Axin-1 is critical for spindle organization and cell cycle progression during meiotic maturation in mouse oocytes.	[He, Xiao-Qin; Liu, Yu; Wang, Ya-Long; Xu, Bai-Hui; Wang, Hai-Long] Xiamen Univ, Organ Transplantat Inst, Coll Med, Xiamen, Fujian Province, Peoples R China; [He, Xiao-Qin; Liu, Rui; Zhang, Fei; Chen, Ming-Huang; Yang, Xiang-Jun] Xiamen Univ, Zhongshan Hosp, Dept Obstet & Gynaecol, Xiamen, Fujian Province, Peoples R China; [Song, Yue-Qiang; Xu, Lin] New England Fertil Inst, Stamford, CT USA; [Zhang, Zhen] Xiamen Inst Food & Drug Qual Control, Xiamen, Fujian Province, Peoples R China; [Shen, Yu-Ting] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China; [He, Xiao-Qin] Fifth Hosp Wuhan, Wuhan, Hubei Province, Peoples R China	Xiamen University; Xiamen University; Tongji University	Wang, HL (corresponding author), Xiamen Univ, Organ Transplantat Inst, Coll Med, Xiamen, Fujian Province, Peoples R China.; Yang, XJ (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Obstet & Gynaecol, Xiamen, Fujian Province, Peoples R China.	xingyun207@126.com; hailongwang@xmu.edu.cn	Song, Yueqiang/AAX-3544-2020		Medical Innovation Foundation of Fujian Province of P. R. China [2009-cxb-66]; Natural Science Foundation of Fujian Province of China [2012J05068]; Fundamental Research Funds for the Central Universities [20720150055]; National Natural Science Foundation of P. R. China [31201695]; Natural Science Foundation of Fujian Province of P. R. China [2012J05068]	Medical Innovation Foundation of Fujian Province of P. R. China; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of P. R. China	This work was supported by the Medical Innovation Foundation of Fujian Province of P. R. China (No. 2009-cxb-66), the Natural Science Foundation of Fujian Province of China (No. 2012J05068), the Fundamental Research Funds for the Central Universities (No. 20720150055) and the National Natural Science Foundation of P. R. China (No. 31201695).; This work was supported by the Natural Science Foundation of Fujian Province of P. R. China (No. 2012J05068), the Medical Innovation Foundation of Fujian Province of P. R. China (No. 2009-cxb-66), the Fundamental Research Funds for the Central Universities (No. 20720150055) and the National Natural Science Foundation of P. R. China (No. 31201695).	Althoff F, 2012, MOL BIOL CELL, V23, P2275, DOI 10.1091/mbc.E12-02-0117; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Gunawardane RN, 2000, CURR TOP DEV BIOL, V49, P55; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Homer HA, 2006, HISTOL HISTOPATHOL, V21, P873, DOI 10.14670/HH-21.873; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Huang X, 2013, HISTOCHEM CELL BIOL, V139, P525, DOI 10.1007/s00418-012-1051-z; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kim SM, 2009, EXP CELL RES, V315, P943, DOI 10.1016/j.yexcr.2009.01.013; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077960; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; Niikura Y, 2010, AGING-US, V2, P999, DOI 10.18632/aging.100255; Niikura Y, 2009, AGING-US, V1, P971, DOI 10.18632/aging.100105; Ruan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049184; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Shan TF, 2015, CELL BIOL INT, V39, P35, DOI 10.1002/cbin.10340; Shen YT, 2013, REPROD FERTILITY DEV; Sonn S, 2011, ZYGOTE, V19, P15, DOI 10.1017/S0967199410000183; Sun SC, 2008, MOL REPROD DEV, V75, P1542, DOI 10.1002/mrd.20891; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Xiong B, 2008, BIOL REPROD, V79, P718, DOI 10.1095/biolreprod.108.069641; Yang SW, 2012, CELL CYCLE, V11, P4366, DOI 10.4161/cc.22690; Yang YJ, 2011, MOL BIOL REP, V38, P2043, DOI 10.1007/s11033-010-0328-3; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang CH, 2011, CELL CYCLE, V10, P1861, DOI 10.4161/cc.10.11.15797; Zhang Na, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P654; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhu XL, 2012, CELL CYCLE, V11, P818, DOI 10.4161/cc.11.4.19329	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157197	10.1371/journal.pone.0157197	http://dx.doi.org/10.1371/journal.pone.0157197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284927	gold, Green Published, Green Submitted			2022-12-26	WOS:000377564000044
J	Seleem, D; Benso, B; Noguti, J; Pardi, V; Murata, RM				Seleem, Dalia; Benso, Bruna; Noguti, Juliana; Pardi, Vanessa; Murata, Ramiro Mendonca			In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms	PLOS ONE			English	Article							MOUSE MODEL; EXPRESSION; INHIBITION; VIRULENCE; LICORICE; INVASION; ACID	Oral candidiasis (OC) is an opportunistic fungal infection with high prevalence among immunocompromised patients. Candida albicans is the most common fungal pathogen responsible for OC, often manifested in denture stomatitis and oral thrush. Virulence factors, such as biofilms formation and secretion of proteolytic enzymes, are key components in the pathogenicity of C. albicans. Given the limited number of available antifungal therapies and the increase in antifungal resistance, demand the search for new safe and effective antifungal treatments. Lichochalcone-A is a polyphenol natural compound, known for its broad protective activities, as an antimicrobial agent. In this study, we investigated the antifungal activity of lichochalcone-A against C. albicans biofilms both in vitro and in vivo. Lichochalcone-A (625 mu M; equivalent to 10x MIC) significantly reduced C. albicans (MYA 2876) biofilm growth compared to the vehicle control group (1% ethanol), as indicated by the reduction in the colony formation unit (CFU)/ml/g of biofilm dry weight. Furthermore, proteolytic enzymatic activities of proteinases and phospholipases, secreted by C. albicans were significantly decreased in the lichochalcone-A treated biofilms. In vivo model utilized longitudinal imaging of OC fungal load using a bioluminescent-engineered C. albicans (SKCa23-Act-gLUC) and coelenterazine substrate. Mice treated with lichochalcone-A topical treatments exhibited a significant reduction in total photon flux over 4 and 5 days post-infection. Similarly, ex vivo analysis of tongue samples, showed a significant decrease in CFU/ml/mg in tongue tissue sample of lichochalcone-A treated group, which suggest the potential of lichochalcone-A as a novel antifungal agent for future clinical use.	[Seleem, Dalia; Noguti, Juliana; Pardi, Vanessa; Murata, Ramiro Mendonca] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA USA; [Benso, Bruna] Univ Austral Chile, Fac Med, Sch Dent, Campus Isla Teja, Valdivia, Chile	University of Southern California; Universidad Austral de Chile	Murata, RM (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA USA.	ramirofop@gmail.com	Pardi, Vanessa/AAV-3252-2021; Benso, Bruna/L-1010-2015; Murata, Ramiro M/P-9052-2014	Benso, Bruna/0000-0002-4425-5174; Murata, Ramiro M/0000-0002-8478-6981; Pardi, Vanessa/0000-0001-7120-4332	National Center for Complementary and Integrative Health of the National Institutes of Health (NIH) [R00AT006507]; Brazilian Federal Agency CAPES [2317/2014-01]; NIH/NIDCR Training grant [T90DE021982]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health (NIH); Brazilian Federal Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH/NIDCR Training grant; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by: National Center for Complementary and Integrative Health of the National Institutes of Health (NIH) under award number R00AT006507, Brazilian Federal Agency CAPES under award number 2317/2014-01 (PhD fellowship to B.B.) and NIH/NIDCR Training grant under award number T90DE021982 (Postdoctoral fellowship to D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; Alnuaimi AD, 2013, FEMS YEAST RES, V13, P689, DOI 10.1111/1567-1364.12068; Badiee P, 2014, INDIAN J MED RES, V139, P195; Bilecova-Rabajdova M, 2013, CENT EUR J PUBL HEAL, V21, P213, DOI 10.21101/cejph.a3886; Borg-von Zepelin M, 1999, J INVEST DERMATOL, V113, P747, DOI 10.1046/j.1523-1747.1999.00747.x; Chen ZJ, 2014, CURR DRUG METAB, V15, P48, DOI 10.2174/138920021501140218125020; Chryssanthou E, 2002, J CLIN MICROBIOL, V40, P3841, DOI 10.1128/JCM.40.10.3841-3844.2002; Correia A, 2010, INFECT IMMUN, V78, P4839, DOI 10.1128/IAI.00248-10; Das I, 2011, INT J INFECT DIS, V15, pE759, DOI 10.1016/j.ijid.2011.06.006; Eggimann P, 2015, J HOSP INFECT, V89, P302, DOI 10.1016/j.jhin.2014.11.006; Gillies M, 2015, CAN MED ASSOC J, V187, pE21, DOI 10.1503/cmaj.140848; Goncalves LM, 2012, J DENT RES, V91, P985, DOI 10.1177/0022034512458689; Gresnigt MS, 2012, J IMMUNOL, V189, P4806, DOI 10.4049/jimmunol.1103551; Hao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067728; Inigo M, 2012, INT J ARTIF ORGANS, V35, P780, DOI 10.5301/ijao.5000170; Klepser ME, 1997, ANTIMICROB AGENTS CH, V41, P1392, DOI 10.1128/AAC.41.6.1392; Lalla Rajesh V, 2013, J Calif Dent Assoc, V41, P263; Lermann U, 2008, MICROBIOL-SGM, V154, P3281, DOI 10.1099/mic.0.2008/022525-0; Messier C, 2012, ORAL DIS, V18, P32, DOI 10.1111/j.1601-0825.2011.01842.x; Messier C, 2011, MYCOSES, V54, pE801, DOI 10.1111/j.1439-0507.2011.02028.x; Mosci P, 2013, VIRULENCE, V4, P250, DOI 10.4161/viru.23529; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Nanteza M, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-143; NCCLS, 2002, PLOS ONE; Neidrauer M, 2014, J MED MICROBIOL, V63, P203, DOI 10.1099/jmm.0.067322-0; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ohta K, 2010, FEMS IMMUNOL MED MIC, V60, P179, DOI 10.1111/j.1574-695X.2010.00734.x; Pande M, 2006, J AGR FOOD CHEM, V54, P10141, DOI 10.1021/jf062206a; Pasetto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115323; Prieto D, 2016, FUTURE MICROBIOL; Ryder N S, 1999, IDrugs, V2, P1253; Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x; Santana IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064645; Shahzad M, 2014, INT J ANTIMICROB AG, V44, P269, DOI 10.1016/j.ijantimicag.2014.05.017; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Sumathy V, 2014, MICROB PATHOGENESIS, V77, P7, DOI 10.1016/j.micpath.2014.10.004; Tang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099103; Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012; Thein ZM, 2007, ARCH ORAL BIOL, V52, P1200, DOI 10.1016/j.archoralbio.2007.06.007; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; Tsui C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw018; Vande Velde G, 2014, CELL MICROBIOL, V16, P115, DOI 10.1111/cmi.12184; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836; Yano J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046311	45	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157188	10.1371/journal.pone.0157188	http://dx.doi.org/10.1371/journal.pone.0157188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284694	gold, Green Submitted, Green Published			2022-12-26	WOS:000377564000043
J	Jiang, HX; Li, XL; Sun, YH; Hou, FJ; Zhang, YF; Li, F; Gu, ZM; Liu, XL				Jiang, Hongxia; Li, Xilian; Sun, Yuhang; Hou, Fujun; Zhang, Yufei; Li, Fei; Gu, Zhimin; Liu, Xiaolin			Insights into Sexual Precocity of Female Oriental River Prawn Macrobrachium nipponense through Transcriptome Analysis	PLOS ONE			English	Article							SHRIMP PENAEUS-MONODON; INSULIN-LIKE PEPTIDES; GENE-EXPRESSION DATA; RNA-SEQ DATA; GLUTATHIONE-PEROXIDASE; MOLECULAR CHARACTERIZATION; MARSUPENAEUS-JAPONICUS; LITOPENAEUS-VANNAMEI; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION	Background The oriental river prawn (Macrobrachium nipponense) is the most prevalent aquaculture species in China. The sexual precocity in this species has received considerable attention in recent years because more and more individuals matured at a small size, which devalues the commercial production. In this study, we developed deep-coverage transcriptomic sequencing data for the ovaries of sexually precocious and normal sexually mature M. nipponense using next-generation RNA sequencing technology and attempted to provide the first insight into the molecular regulatory mechanism of sexual precocity in this species. Results A total of 63,336 unigenes were produced from the ovarian cDNA libraries of sexually precocious and normal sexually mature M. nipponense using Illumina HiSeq 2500 platform. Through BLASTX searches against the NR, STRING, Pfam, Swissprot and KEGG databases, 15,134 unigenes were annotated, accounting for 23.89% of the total unigenes. 5,195 and 3,227 matched unigenes were categorized by GO and COG analysis respectively. 15,908 unigenes were consequently mapped into 332 KEGG pathways, and many reproduction-related pathways and genes were identified. Moreover, 26,008 SSRs were identified from 18,133 unigenes. 80,529 and 80,516 SNPs were yielded from ovarian libraries of sexually precocious and normal sexually mature prawn, respectively, and 29,851 potential SNPs between these two groups were also predicted. After comparing the ovarian libraries of sexually precocious and normal sexually mature prawn, 549 differentially expressed genes (DEGs) and 9 key DEGs that may be related to sexual precocity of M. nipponense were identified. 20 DEGs were selected for validation by quantitative real-time PCR (QPCR) and 19 DEGs show consistent expression between QPCR and RNAseq-based differential expression analysis datasets. Conclusion This is the first report on the large-scale RNA sequencing of ovaries of sexually precocious and normal sexually mature M. nipponense. The annotated transcriptome data will provide fundamental support for future research into the reproduction biology of M. nipponense. The large number of candidate SNPs and SSRs detected in this study could be used as genetic markers for population genetics and functional genomics in this species. More importantly, many DEGs, especially nine key DEGs between sexually precocious and normal sexually mature prawns were identified, which will dramatically improve understanding of molecular regulatory mechanism of sexual precocity of this species.	[Jiang, Hongxia; Sun, Yuhang; Hou, Fujun; Liu, Xiaolin] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Jiang, Hongxia; Li, Xilian; Zhang, Yufei; Li, Fei; Gu, Zhimin] Zhejiang Inst Freshwater Fisheries, Key Lab Hlth Freshwater Aquaculture, Key Lab Freshwater Aquat Anim Genet & Breeding Zh, Agr Minist, Huzhou, Zhejiang, Peoples R China; [Jiang, Hongxia] Henan Normal Univ, Coll Fisheries, Xinxiang, Henan, Peoples R China	Northwest A&F University - China; Henan Normal University	Liu, XL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.; Gu, ZM (corresponding author), Zhejiang Inst Freshwater Fisheries, Key Lab Hlth Freshwater Aquaculture, Key Lab Freshwater Aquat Anim Genet & Breeding Zh, Agr Minist, Huzhou, Zhejiang, Peoples R China.	guzhimin2006@163.com; liuxiaolin@nwsuaf.edu.cn	Zhang, yufei/HHC-7375-2022		Zhejiang Province Key S&T Special Projects of New Variety Breeding, China [2012C12907]; open project of Agriculture Ministry Key Laboratory of Healthy Freshwater Aquaculture [ZJK201506]	Zhejiang Province Key S&T Special Projects of New Variety Breeding, China; open project of Agriculture Ministry Key Laboratory of Healthy Freshwater Aquaculture	The work was financially supported by the Zhejiang Province Key S&T Special Projects of New Variety Breeding, China (No. 2012C12907), and the open project of Agriculture Ministry Key Laboratory of Healthy Freshwater Aquaculture (No. ZJK201506).	Arenas-Rios E, 2007, COMP BIOCHEM PHYS A, V148, P150, DOI 10.1016/j.cbpa.2007.04.003; Arukwe Augustine, 2003, Comp Hepatol, V2, P4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atli G, 2007, COMP BIOCHEM PHYS C, V145, P282, DOI 10.1016/j.cbpc.2006.12.012; Bai HK, 2015, GENE, V562, P22, DOI 10.1016/j.gene.2014.12.008; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Buaklin A, 2013, COMP BIOCHEM PHYS B, V164, P280, DOI 10.1016/j.cbpb.2013.02.004; Cai YX, 2002, HYDROBIOLOGIA, V487, P59, DOI 10.1023/A:1022991224381; Caruso JA, 1999, BIOCHEM PHARMACOL, V58, P1395, DOI 10.1016/S0006-2952(99)00225-7; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Chan SJ, 2000, AM ZOOL, V40, P213; Chandler JC, 2015, GEN COMP ENDOCR, V215, P76, DOI 10.1016/j.ygcen.2014.08.018; Chansela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033154; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Christie AE, 2014, GEN COMP ENDOCR, V206, P235, DOI 10.1016/j.ygcen.2014.04.015; Chu SL, 2006, AQUACULTURE, V251, P537, DOI 10.1016/j.aquaculture.2005.05.040; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Du YX, 2015, AQUACULTURE, V442, P1, DOI 10.1016/j.aquaculture.2015.02.016; Duleba AJ, 1998, FERTIL STERIL, V69, P335, DOI 10.1016/S0015-0282(97)00473-1; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Fu HT, 2012, AQUAC RES, V43, P993, DOI 10.1111/j.1365-2109.2011.03085.x; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Glencross BD, 2001, AQUACULT NUTR, V7, P59, DOI 10.1046/j.1365-2095.2001.00168.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103; Hu KJ, 2004, COMP BIOCHEM PHYS B, V137, P21, DOI 10.1016/j.cbpc.2003.09.010; Ibarra AM, 2007, AQUACULTURE, V268, P23, DOI 10.1016/j.aquaculture.2007.04.028; Iwata H, 2003, ZYGOTE, V11, P1, DOI 10.1017/S0967199403001011; Jansen PAM, 2012, EXP DERMATOL, V21, P889, DOI 10.1111/exd.12022; Jin SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076840; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Le Moullac G, 2003, AQUACULTURE, V227, P89, DOI 10.1016/S0044-8486(03)00497-6; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li X, 2011, AQUACULT INT, V19, P251, DOI 10.1007/s10499-010-9400-1; Lin CM, 2012, CURR NEUROVASC RES, V9, P222; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Makkapan W, 2011, AQUACULTURE, V321, P101, DOI 10.1016/j.aquaculture.2011.08.016; Meunpol O, 2010, FISHERIES SCI, V76, P281, DOI 10.1007/s12562-009-0208-8; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Orn S, 2006, ARCH ENVIRON CON TOX, V51, P237, DOI 10.1007/s00244-005-0103-y; Qian Z, 2014, COMP BIOCHEM PHYS C, V159, P38, DOI 10.1016/j.cbpc.2013.09.009; Qiao H, 2012, COMP BIOCHEM PHYS D, V7, P268, DOI 10.1016/j.cbd.2012.04.003; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Racotta IS, 2003, AQUACULTURE, V227, P107, DOI 10.1016/S0044-8486(03)00498-8; Reddy PS, 2004, GEN COMP ENDOCR, V135, P35, DOI 10.1016/j.ygcen.2003.08.002; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; Sittikankaew K, 2010, AQUACULTURE, V308, pS91, DOI 10.1016/j.aquaculture.2010.06.039; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Soverchia L, 2005, TOXICOL APPL PHARM, V209, P236, DOI 10.1016/j.taap.2005.04.013; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Surai PF, 1998, COMP BIOCHEM PHYS B, V120, P527, DOI 10.1016/S0305-0491(98)10039-1; Tahara D, 2004, COMP BIOCHEM PHYS A, V137, P631, DOI 10.1016/j.cbpb.2003.12.005; Talakhun W, 2012, COMP BIOCHEM PHYS D, V7, P180, DOI 10.1016/j.cbd.2012.02.003; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Thompson JL, 2006, COMP BIOCHEM PHYS B, V144, P86, DOI 10.1016/j.cbpb.2006.01.011; Tingaud-Sequeira A, 2007, GENE, V386, P98, DOI 10.1016/j.gene.2006.08.018; Wang S, 2014, FEBS J, V281, P877, DOI 10.1111/febs.12655; Warrier S, 2002, MOL REPROD DEV, V61, P536, DOI 10.1002/mrd.10106; Wimuttisuk W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076934; Wu LT, 2010, COMP BIOCHEM PHYS B, V155, P26, DOI 10.1016/j.cbpb.2009.09.005; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Xue SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076718; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zhang FY, 2010, COMP BIOCHEM PHYS B, V155, P288, DOI 10.1016/j.cbpb.2009.11.013; Zhang ZP, 2007, COMP BIOCHEM PHYS B, V147, P466, DOI 10.1016/j.cbpb.2007.02.013; Zhao W, 2013, GENET MOL RES, V12, P5215, DOI 10.4238/2013.October.30.6; Zhao WH, 2011, MOL BIOL REP, V38, P1399, DOI 10.1007/s11033-010-0243-7	90	17	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157173	10.1371/journal.pone.0157173	http://dx.doi.org/10.1371/journal.pone.0157173			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280288	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000103
J	Chiu, KW; Nakano, T; Chen, KD; Lin, CC; Hu, TH; Goto, S; Chen, CL				Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Lin, Chih-Che; Hu, Tsung-Hui; Goto, Shigeru; Chen, Chao-Long			Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation	PLOS ONE			English	Article							INTERLEUKIN-28B GENETIC-VARIANTS; CYP2C19 GENOTYPES; POLYMORPHISMS; GRAFT; RECIPIENTS; THERAPY	To investigate the effect of IL28B single nucleotide polymorphisms (SNPs) (rs8099917 and rs12979860) in the donors and recipients on the outcome of Hepatitis C virus-RNA clearance after living donor liver transplantation (LDLT). The rs8099917 and rs12979860 genotypes in 50 donor and recipients pairs were explored on the pre-operative day (POD) and post-operative day 30 (POD30). There was a significant difference in HCV-RNA clearance before (12%, 6/50) and after (48%, 24/50) liver transplantation (P < 0.001). The rs8099917 genotype TT was dominant in both the recipients (82%, 41/50) and donors (86%, 43/50), but had no significant effect on HCV-RNA clearance (87.5%, 21/24) and recurrence (76.9%, 20/26) after LDLT. One recipient was detected with genotype GG on POD, which changed to genotype GT on POD30. Prevalence of rs12979860 genotype CT was 98% (49/50 recipient) and 92% (46/50 donor) and prevalence of genotype CC was 2% (1/50 recipient) and 8% (4/50 donor) on POD and POD30, respectively. Of the 4 recipients with rs12979860 genotype CC on POD30, 3 recipients (12.5%, 3/24) exhibited HCV clearance and 1 experienced recurrence (3.9%, 1/26), however, this was not statistically significant. In conclusion, alterations in IL28B SNP genotype may occur after LDLT, leading to modifications in the host genome or donor proteome by HCV. This predicted mechanism will need to be investigated further.	[Chiu, King-Wah; Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Lin, Chih-Che; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Gen Surg, Kaohsiung, Taiwan; [Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Lin, Chih-Che; Hu, Tsung-Hui; Goto, Shigeru; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan; [Chiu, King-Wah; Hu, Tsung-Hui] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chiu, KW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Chiu, KW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan.; Chiu, KW (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	kwchiu@adm.cgmh.org.tw		Chiu, King-Wah/0000-0003-2108-6539; Nakano, Toshiaki/0000-0003-3701-3449	Chang Gung Memorial Hospital of Taiwan [CMRPG8D1001]	Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital)	This work was supported by grant number CMRPG8D1001 from the Chang Gung Memorial Hospital of Taiwan.	Bewick MA, 2006, J CLIN ONCOL, V24, P5645, DOI 10.1200/JCO.2006.05.9923; Chang YC, 2016, ONCOL REP, V35, P2936, DOI 10.3892/or.2016.4662; Chiu KW, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0140-4; Chiu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071314; Chiu KW, 2012, EUR J CLIN INVEST, V42, P352, DOI 10.1111/j.1365-2362.2011.02589.x; Chiu KW, 2010, ANN TRANSPL, V15, P38; Chiu KW, 2010, CLIN TRANSPLANT, V24, P830, DOI 10.1111/j.1399-0012.2010.01220.x; Chiu KW, 2005, HEPATO-GASTROENTEROL, V52, P1825; Chuang WL, 2013, J GASTROENTEROL, V48, P22, DOI 10.1007/s00535-012-0669-x; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Hung CH, 2013, HEPATOLOGY, V57, P2089, DOI 10.1002/hep.26002; Li SY, 2011, HEPAT MON, V11, P163; Lin CC, 2014, TRANSPLANTATION, V97, pS47, DOI 10.1097/01.tp.0000446277.36181.e7; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2011, HEPATOLOGY, V53, P1403, DOI 10.1002/hep.24117	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156846	10.1371/journal.pone.0156846	http://dx.doi.org/10.1371/journal.pone.0156846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275739	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700041
J	Hepworth, C; Turner, C; Landim, MG; Cameron, D; Gray, JE				Hepworth, Christopher; Turner, Carla; Landim, Marcela Guimaraes; Cameron, Duncan; Gray, Julie E.			Balancing Water Uptake and Loss through the Coordinated Regulation of Stomatal and Root Development	PLOS ONE			English	Article							GENETIC MANIPULATION; SECRETORY PEPTIDE; ABSCISIC-ACID; DENSITY; TOLERANCE; STOMAGEN; AUXIN; SIZE	Root development is influenced by nutrient and water availabilities. Plants are able to adjust many attributes of their root in response to environmental signals including the size and shape of the primary root, lateral roots and root hairs. Here we investigated the response of roots to changes in the levels of leaf transpiration associated with altered stomatal frequency. We found that plants with high stomatal density and conductance produce a larger rooting area and as a result have enhanced phosphate uptake capacity whereas plants with low stomatal conductance produce a smaller root. Manipulating the growth environment of plants indicated that enhanced root growth is most likely a result of an increased demand for water rather than phosphate. Plants manipulated to have an increase or reduction in root hair growth show a reduction or increase respectively, in stomatal conductance and density. Our results demonstrate that plants can balance their water uptake and loss through coordinated regulation of both stomatal and root development.	[Hepworth, Christopher; Cameron, Duncan] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Turner, Carla; Landim, Marcela Guimaraes; Gray, Julie E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Landim, Marcela Guimaraes] Univ Brasilia, Inst Biol, Brasilia, DF, Brazil	University of Sheffield; University of Sheffield; Universidade de Brasilia	Gray, JE (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	J.E.Gray@sheffield.ac.uk	Gray, Julie E/B-4271-2014	Gray, Julie E/0000-0001-9972-5156; Guimaraes Landim, Marcela/0000-0001-9519-5258; Cameron, Duncan/0000-0002-5439-6544; Hepworth, Christopher/0000-0002-7866-8567	Engineering and Physical Sciences Research Council [X/003926-12-45-4]; Biotechnology and Biological Research Council [X/004216-14-16]; Biotechnology and Biological Sciences Research Council [BB/I002154/1, BB/J001805/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1248095] Funding Source: researchfish; BBSRC [BB/I002154/1, BB/J001805/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CH received funding from the Engineering and Physical Sciences Research Council, Grant code: X/003926-12-45-4. CT received funding from the Biotechnology and Biological Research Council, Grant code: X/004216-14-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chater C, 2015, CURR BIOL, V25, P2709, DOI 10.1016/j.cub.2015.09.013; Cui HC, 2014, MOL PLANT, V7, P1727, DOI 10.1093/mp/ssu106; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Datta S, 2011, PLANT SOIL, V346, P1, DOI 10.1007/s11104-011-0845-4; Dodd IC, 2013, NEW PHYTOL, V197, P6, DOI 10.1111/nph.12052; Doheny-Adams T, 2012, PHILOS T R SOC B, V367, P547, DOI 10.1098/rstb.2011.0272; Dow GJ, 2014, NEW PHYTOL, V201, P1205, DOI 10.1111/nph.12586; Franks PJ, 2015, NEW PHYTOL, V207, P188, DOI 10.1111/nph.13347; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Harris Jeanne M., 2015, Plants-Basel, V4, P548, DOI 10.3390/plants4030548; Hepworth C, 2015, NEW PHYTOL, V208, P336, DOI 10.1111/nph.13598; Hewitt, 1966, SAND WATER CULTURE M; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Kwasniewski M, 2016, J EXP BOT, V67, P1079, DOI 10.1093/jxb/erv498; McAdam SAM, 2016, PLANT CELL ENVIRON, V39, P652, DOI 10.1111/pce.12669; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Muraro D, 2013, J THEOR BIOL, V317, P71, DOI 10.1016/j.jtbi.2012.08.032; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Tanaka Y, 2013, NEW PHYTOL, V198, P757, DOI 10.1111/nph.12186; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529; Zhang JY, 2014, P NATL ACAD SCI USA, V111, pE3015, DOI 10.1073/pnas.1400542111	25	19	19	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156930	10.1371/journal.pone.0156930	http://dx.doi.org/10.1371/journal.pone.0156930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275842	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700049
J	McDonald, JE; Larsen, N; Pennington, A; Connolly, J; Wallis, C; Rooks, DJ; Hall, N; McCarthy, AJ; Allison, HE				McDonald, James E.; Larsen, Niels; Pennington, Andrea; Connolly, John; Wallis, Corrin; Rooks, David J.; Hall, Neil; McCarthy, Alan J.; Allison, Heather E.			Characterising the Canine Oral Microbiome by Direct Sequencing of Reverse-Transcribed rRNA Molecules	PLOS ONE			English	Article							COMMUNITY COMPOSITION; PERIODONTAL-DISEASE; DIVERSITY; PCR; ARCHAEA; PROJECT; GENES; AMPLIFICATION; BACTERIA; TAXONOMY	PCR amplification and sequencing of phylogenetic markers, primarily Small Sub-Unit ribosomal RNA (SSU rRNA) genes, has been the paradigm for defining the taxonomic composition of microbiomes. However, `universal' SSU rRNA gene PCR primer sets are likely to miss much of the diversity therein. We sequenced a library comprising purified and reverse-transcribed SSU rRNA (RT-SSU rRNA) molecules from the canine oral microbiome and compared it to a general bacterial 16S rRNA gene PCR amplicon library generated from the same biological sample. In addition, we have developed BIONmeta, a novel, open-source, computer package for the processing and taxonomic classification of the randomly fragmented RT-SSU rRNA reads produced. Direct RT-SSU rRNA sequencing revealed that 16S rRNA molecules belonging to the bacterial phyla Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria and Spirochaetes, were most abundant in the canine oral microbiome (92.5% of total bacterial SSU rRNA). The direct rRNA sequencing approach detected greater taxonomic diversity (1 additional phylum, 2 classes, 1 order, 10 families and 61 genera) when compared with general bacterial 16S rRNA amplicons from the same sample, simultaneously provided SSU rRNA gene inventories of Bacteria, Archaea and Eukarya, and detected significant numbers of sequences not recognised by `universal' primer sets. Proteobacteria and Spirochaetes were found to be under-represented by PCR-based analysis of the microbiome, and this was due to primer mismatches and taxon-specific variations in amplification efficiency, validated by qPCR analysis of 16S rRNA amplicons from a mock community. This demonstrated the veracity of direct RT-SSU rRNA sequencing for molecular microbial ecology.	[McDonald, James E.] Bangor Univ, Sch Biol Sci, Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales; [Larsen, Niels] Danish Genome Inst, Skt Lucas Kirkeplads 8, DK-8000 Aarhus C, Denmark; [Pennington, Andrea; Connolly, John; Rooks, David J.; Hall, Neil; McCarthy, Alan J.; Allison, Heather E.] Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England; [Wallis, Corrin] WALTHAM Ctr Pet Nutr, Freeby Lane, Melton Mowbray LE14 4RT, Melton Mowbray, England	Bangor University; University of Liverpool; Mars; WALTHAM Petcare Science Institute	McDonald, JE (corresponding author), Bangor Univ, Sch Biol Sci, Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales.; Allison, HE (corresponding author), Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.	j.mcdonald@bangor.ac.uk; hallison@liv.ac.uk	Allison, Heather/AAE-8856-2021	Allison, Heather/0000-0003-0017-7992; Hall, Neil/0000-0003-2808-0009; McDonald, James/0000-0002-6328-3752	BBSRC [BB/G017980/1]; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AP was supported by a BBSRC industrial case PhD studentship (BB/G017980/1) awarded to HA.	Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHOI BK, 1994, INFECT IMMUN, V62, P1889, DOI 10.1128/IAI.62.5.1889-1895.1994; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Li XR, 2014, APPL MICROBIOL BIOT, V98, P3777, DOI 10.1007/s00253-014-5583-0; Loesche W J, 1988, Adv Dent Res, V2, P275; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Wallis C, 2015, VET MICROBIOL, V181, P271, DOI 10.1016/j.vetmic.2015.09.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	39	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157046	10.1371/journal.pone.0157046	http://dx.doi.org/10.1371/journal.pone.0157046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276347	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700060
J	Naveen, V; Hsiao, CD				Naveen, Vankadari; Hsiao, Chwan-Deng			NrdR Transcription Regulation: Global Proteome Analysis and Its Role in Escherichia coli Viability and Virulence	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASES; GENE-EXPRESSION; GROWTH; IDENTIFICATION; PROTEINS; BINDING; ENVIRONMENT; COLLECTION; ABUNDANCE; STRATEGY	Bacterial ribonucleotide reductases (RNRs) play an important role in the synthesis of dNTPs and their expression is regulated by the transcription factors, NrdR and Fur. Recent transcriptomic studies using deletion mutants have indicated a role for NrdR in bacterial chemotaxis and in the maintenance of topoisomerase levels. However, NrdR deletion alone has no effect on bacterial growth or virulence in infected flies or in human blood cells. Furthermore, transcriptomic studies are limited to the deletion strain alone, and so are inadequate for drawing biological implications when the NrdR repressor is active or abundant. Therefore, further examination is warranted of changes in the cellular proteome in response to both NrdR overexpression, as well as deletion, to better understand its functional relevance as a bacterial transcription repressor. Here, we profile bacterial fate under conditions of overexpression and deletion of NrdR in E. coli. Biochemical assays show auxiliary zinc enhances the DNA binding activity of NrdR. We also demonstrate at the physiological level that increased nrdR expression causes a significant reduction in bacterial growth and fitness even at normal temperatures, and causes lethality at elevated temperatures. Corroborating these direct effects, global proteome analysis following NrdR overexpression showed a significant decrease in global protein expression. In parallel, studies on complementary expression of downregulated essential genes polA, eno and thiL showed partial rescue of the fitness defect caused by NrdR overexpression. Deletion of downregulated non-essential genes ygfK and trxA upon NrdR overexpression resulted in diminished bacterial growth and fitness suggesting an additional role for NrdR in regulating other genes. Moreover, in comparison with NrdR deletion, E. coli cells overexpressing NrdR showed significantly diminished adherence to human epithelial cells, reflecting decreased bacterial virulence. These results suggest that elevated expression of NrdR could be a suitable means to retard bacterial growth and virulence, as its elevated expression reduces bacterial fitness and impairs host cell adhesion.	[Naveen, Vankadari; Hsiao, Chwan-Deng] Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Mol Cell Biol, Taipei, Taiwan; [Naveen, Vankadari; Hsiao, Chwan-Deng] Acad Sinica, Taipei 115, Taiwan; [Naveen, Vankadari; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Hsiao, CD (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Mol Cell Biol, Taipei, Taiwan.; Hsiao, CD (corresponding author), Acad Sinica, Taipei 115, Taiwan.; Hsiao, CD (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	hsiao@gate.sinica.edu.tw	Vankadari, Naveen/AAE-7381-2020; Hsiao, Chwan-Deng/AAZ-8869-2021	Hsiao, Chwan-Deng/0000-0002-7012-1532; Vankadari, Naveen/0000-0001-9363-080X	Ministry of Science and Technology of Taiwan, Republic of China [MOST 104-2311-B-001-016-MY3]	Ministry of Science and Technology of Taiwan, Republic of China	This work was supported by grants from the Ministry of Science and Technology of Taiwan, Republic of China (MOST 104-2311-B-001-016-MY3 to CDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Ministry of Science and Technology of Taiwan, Republic of China (MOST 104-2311-B-001-016-MY3 to C.-D. H.). We thank Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry for LTQ-Orbitrap data processing and additional technical assistance. We thank Dr. Sue Lin Chao of IMB, and "NBRP-E. coli at NIG" for providing the deletion and over-expressing E. coli strains used in this study. We also thank the Image Core Facility for microscopy and the English Editing Core at the Institute of Molecular Biology, Academia Sinica.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; AUGUSTIN LB, 1994, J BACTERIOL, V176, P378, DOI 10.1128/JB.176.2.378-387.1994; Baba Tomoya, 2008, V416, P171, DOI 10.1007/978-1-59745-321-9_11; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Case ED, 2011, J BACTERIOL, V193, P4396, DOI 10.1128/JB.00294-11; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Crespo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123571; Crona M, 2013, J BIOL CHEM, V288, P8198, DOI 10.1074/jbc.M112.442434; Dassama LMK, 2012, J AM CHEM SOC, V134, P20498, DOI 10.1021/ja309468s; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Dreux N, 2015, INFECT IMMUN, V83, P1305, DOI 10.1128/IAI.02772-14; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Garcia-Ortiz MV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002152; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P773, DOI 10.1089/ars.2006.8.773; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; Grinberg I, 2009, J BACTERIOL, V191, P1169, DOI 10.1128/JB.01145-08; Harcum SW, 2006, J IND MICROBIOL BIOT, V33, P801, DOI 10.1007/s10295-006-0122-3; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Kim HC, 2008, APPL ENVIRON MICROB, V74, P4853, DOI 10.1128/AEM.02756-07; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Letourneau J, 2011, JOVE-J VIS EXP, DOI 10.3791/2783; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Marcos CM, 2012, FEMS YEAST RES, V12, P557, DOI 10.1111/j.1567-1364.2012.00806.x; Margulies C, 1998, NUCLEIC ACIDS RES, V26, P5170, DOI 10.1093/nar/26.22.5170; Maul RW, 2007, J BACTERIOL, V189, P4688, DOI 10.1128/JB.00476-07; McKethan BL, 2013, MOL MICROBIOL, V90, P278, DOI 10.1111/mmi.12364; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Panosa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011328; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; Schyns G, 2005, J BACTERIOL, V187, P8127, DOI 10.1128/JB.187.23.8127-8136.2005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sieber M, 1998, BIOL CHEM, V379, P731; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wu CC, 2012, J BIOL CHEM, V287, P21461, DOI 10.1074/jbc.M112.344358; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134237; Zhang Y, 2015, APMIS, V123, P252, DOI 10.1111/apm.12340	60	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157165	10.1371/journal.pone.0157165	http://dx.doi.org/10.1371/journal.pone.0157165			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275780	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700077
J	Pardos de la Gandara, M; Curry, M; Berger, J; Burstein, D; Della-Latta, P; Kopetz, V; Quale, J; Spitzer, E; Tan, RX; Urban, C; Wang, GQ; Whittier, S; de Lencastre, H; Tomasz, A				Pardos de la Gandara, Maria; Curry, Marie; Berger, Judith; Burstein, David; Della-Latta, Phyllis; Kopetz, Virgina; Quale, John; Spitzer, Eric; Tan, Rexie; Urban, Carl; Wang, Guiqing; Whittier, Susan; de Lencastre, Herminia; Tomasz, Alexander			MRSA Causing Infections in Hospitals in Greater Metropolitan New York: Major Shift in the Dominant Clonal Type between 1996 and 2014	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; MULTIPLEX PCR STRATEGY; METHICILLIN-RESISTANT; MEC ELEMENT; COMMUNITY; SEQUENCE; USA300; VIRULENCE; TRENDS	A surveillance study in 1996 identified the USA100 clone (ST5/SCCmecII)-also known as the "New York/Japan" clone-as the most prevalent MRSA causing infections in 12 New York City hospitals. Here we update the epidemiology of MRSA in seven of the same hospitals eighteen years later in 2013/14. Most of the current MRSA isolates (78 of 121) belonged to the MRSA clone USA300 (CC8/SCCmecIV) but the USA100 clone-dominant in the 1996 survey-still remained the second most frequent MRSA (25 of the 121 isolates) causing 32% of blood stream infections. The USA300 clone was most common in skin and soft tissue infections (SSTIs) and was associated with 84.5% of SSTIs compared to 5% caused by the USA100 clone. Our data indicate that by 2013/14, the USA300 clone replaced the New York/Japan clone as the most frequent cause of MRSA infections in hospitals in Metropolitan New York. In parallel with this shift in the clonal type of MRSA, there was also a striking change in the types of MRSA infections from 1996 to 2014.	[Pardos de la Gandara, Maria; Curry, Marie; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Berger, Judith] St Barnabas Hosp, Div Infect Dis, New York, NY USA; [Burstein, David; Kopetz, Virgina] Univ Richmond, Med Ctr, Dept Pathol, Staten Isl, NY USA; [Della-Latta, Phyllis] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York Presbyterian Hosp, New York, NY USA; [Quale, John] Suny Downstate Med Ctr, Div Infect Dis, Brooklyn, NY 11203 USA; [Quale, John] Kings Cty Hosp, Brooklyn, NY USA; [Spitzer, Eric] Stony Brook Hlth Serv Ctr, Dept Pathol, Stony Brook, NY USA; [Tan, Rexie] St Barnabas Hosp, Dept Microbiol, Bronx, NY USA; [Urban, Carl] New York Presbyterian Queens, Dr James J Rahal Jr Div Infect Dis, Flushing, NY USA; [Wang, Guiqing] Westchester Med Ctr, Dept Pathol, Valhalla, NY USA; [Wang, Guiqing] Westchester Med Ctr, Clin Labs, Valhalla, NY USA; [Wang, Guiqing] New York Med Coll, Valhalla, NY 10595 USA; [Whittier, Susan] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Clin Microbiol Serv, New York, NY USA; [de Lencastre, Herminia] Inst Tecnol Quim & Biol Antonio Xavier ITQB UNL, Mol Genet Lab, Oeiras, Portugal	Rockefeller University; Saint Barnabas Hospital; Columbia University; NewYork-Presbyterian Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Saint Barnabas Hospital; Westchester Medical Center; Westchester Medical Center; New York Medical College; Columbia University; NewYork-Presbyterian Hospital	Tomasz, A (corresponding author), Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	tomasz@rockefeller.edu	de la Gandara, Maria Pardos/G-9933-2017; Spitzer, Eric/T-7455-2019; de la Gandara, Maria Pardos/AAQ-1054-2020	de la Gandara, Maria Pardos/0000-0002-3273-6392; de la Gandara, Maria Pardos/0000-0002-3273-6392; Spitzer, Eric/0000-0002-8794-2441	US Public Health Service [2 RO1 AI457838-15]; RB Roberts Bacterial Antibiotic Resistance Group (BARG); National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); RB Roberts Bacterial Antibiotic Resistance Group (BARG); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Partial support for this study was provided by a US Public Health Service Award 2 RO1 AI457838-15 to AT and by funds from the RB Roberts Bacterial Antibiotic Resistance Group (BARG) to AT.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; [Anonymous], 2014, NEW YORK STAT HOSP A, P1; [Anonymous], 2012, ACIP RECOMMENDA 1206, P1; [Anonymous], 2009, NYS SEX OFF RES REST, P1; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chadha P, 2015, OPEN J MED MICROBIOL, P12; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; CLSI, 2013, PERFORMANCE STANDARD; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; David MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092760; David MZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018217; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P253, DOI 10.1089/mdr.2000.6.253; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Farr AM, 2012, INFECT CONT HOSP EP, V33, P725, DOI 10.1086/666329; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Ingram R., 2007, TRANSPORTING INFECT, P1; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2008, J ANTIMICROB CHEMOTH, V61, P959, DOI 10.1093/jac/dkn021; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Pardos de la Gandara M, 2015, J CLIN MICROBIOL, V53, P2648, DOI 10.1128/JCM.00591-15; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Roberts RB, 2000, MICROB DRUG RESIST, V6, P245, DOI 10.1089/mdr.2000.6.245; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Wilson J, 2011, J HOSP INFECT, V79, P211, DOI 10.1016/j.jhin.2011.05.013	43	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156924	10.1371/journal.pone.0156924	http://dx.doi.org/10.1371/journal.pone.0156924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272665	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000048
J	Vervoort, D; Vuillerme, N; Kosse, N; Hortobagyi, T; Lamoth, CJC				Vervoort, Danique; Vuillerme, Nicolas; Kosse, Nienke; Hortobagyi, Tibor; Lamoth, Claudine J. C.			Multivariate Analyses and Classification of Inertial Sensor Data to Identify Aging Effects on the Timed-Up-and-Go Test	PLOS ONE			English	Article							GAIT VARIABILITY; OLDER-ADULTS; FALL RISK; VALIDITY; RELIABILITY; BALANCE; ACCELEROMETER; IMPAIRMENT; FRAILTY	Many tests can crudely quantify age-related mobility decrease but instrumented versions of mobility tests could increase their specificity and sensitivity. The Timed-up-and-Go (TUG) test includes several elements that people use in daily life. The test has different transition phases: rise from a chair, walk, 180 degrees turn, walk back, turn, and sit-down on a chair. For this reason the TUG is an often used test to evaluate in a standardized way possible decline in balance and walking ability due to age and or pathology. Using inertial sensors, qualitative information about the performance of the sub-phases can provide more specific information about a decline in balance and walking ability. The first aim of our study was to identify variables extracted from the instrumented timed-up-and-go (iTUG) that most effectively distinguished performance differences across age (age 18-75). Second, we determined the discriminative ability of those identified variables to classify a younger (age 18-45) and older age group (age 46-75). From healthy adults (n = 59), trunk accelerations and angular velocities were recorded during iTUG performance. iTUG phases were detected with wavelet-analysis. Using a Partial Least Square (PLS) model, from the 72-iTUG variables calculated across phases, those that explained most of the covariance between variables and age were extracted. Subsequently, a PLS-discriminant analysis (DA) assessed classification power of the identified iTUG variables to discriminate the age groups. 27 variables, related to turning, walking and the stand-to-sit movement explained 71% of the variation in age. The PLS-DA with these 27 variables showed a sensitivity and specificity of 90% and 85%. Based on this model, the iTUG can accurately distinguish young and older adults. Such data can serve as a reference for pathological aging with respect to a widely used mobility test. Mobility tests like the TUG supplemented with smart technology could be used in clinical practice.	[Vervoort, Danique; Kosse, Nienke; Hortobagyi, Tibor; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Vuillerme, Nicolas; Kosse, Nienke] Univ Grenoble Alpes, AGEIS, La Tronche, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	University of Groningen; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France	Lamoth, CJC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	C.J.C.Lamoth@umcg.nl	Lamoth, Claudine JC/N-4325-2013; VUILLERME, Nicolas/U-5767-2019	Lamoth, Claudine JC/0000-0002-6495-2823; VUILLERME, Nicolas/0000-0003-3773-393X; Vervoort, Danique/0000-0002-0121-628X				Al-Jawad Ahmed, 2012, 2012 IEEE International Conference on Multisensor Fusion and Integration for Intelligent Systems (MFI 2012), P212, DOI 10.1109/MFI.2012.6343011; Ayachi FS, 2016, PHYSIOL MEAS, V37, P442, DOI 10.1088/0967-3334/37/3/442; Bidargaddi N, 2007, P ANN INT IEEE EMBS, P1884, DOI 10.1109/IEMBS.2007.4352683; Bonato P, 2010, IEEE ENG MED BIOL, V29, P25, DOI 10.1109/MEMB.2010.936554; Botolfsen P, 2008, PHYSIOTHER RES INT, V13, P94, DOI 10.1002/pri.394; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Danneskiold-Samsoe B, 2009, ACTA PHYSIOL, V197, P1, DOI 10.1111/j.1748-1716.2009.02022.x; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Eriksson L., 2006, MULTI MEGAVARIATE 1; Fernandez EA, 2008, ANN BIOMED ENG, V36, P1305, DOI 10.1007/s10439-008-9492-1; Galan-Mercant A, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-156; Galan-Mercant Alejandro, 2014, BMC Res Notes, V7, P100, DOI 10.1186/1756-0500-7-100; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Godfrey A, 2015, MATURITAS, V82, P116, DOI 10.1016/j.maturitas.2015.04.003; Godfrey A, 2015, PHYSIOL MEAS, V36, pN71, DOI 10.1088/0967-3334/36/5/N71; Greene BR, 2014, AGE AGEING, V43, P406, DOI 10.1093/ageing/aft176; Greene BR, 2010, IEEE T BIO-MED ENG, V57, P2918, DOI 10.1109/TBME.2010.2083659; Greve C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077760; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Herman T, 2014, EXP BRAIN RES, V232, P713, DOI 10.1007/s00221-013-3778-8; Jallon P, 2011, INT CONF ACOUST SPEE, P689; Konig N, 2014, GAIT POSTURE, V39, P615, DOI 10.1016/j.gaitpost.2013.06.014; Kosse NM, 2016, GAIT POSTURE, V46, P112, DOI 10.1016/j.gaitpost.2016.02.022; Kosse NM, 2015, ANN BIOMED ENG, V43, P1935, DOI 10.1007/s10439-014-1232-0; Lara J, 2013, MATURITAS, V76, P189, DOI 10.1016/j.maturitas.2013.07.007; Lockhart Thurmon E, 2013, Biomed Sci Instrum, V49, P224; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Mellone S, 2012, GAIT POSTURE, V36, P163, DOI 10.1016/j.gaitpost.2012.02.006; Mirelman A, 2014, J AM GERIATR SOC, V62, P673, DOI 10.1111/jgs.12734; Montero-Odasso M, 2011, J GERONTOL A-BIOL, V66, P568, DOI 10.1093/gerona/glr007; Moore AZ, 2014, J AM GERIATR SOC, V62, P230, DOI 10.1111/jgs.12653; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Palmerini L, 2013, IEEE T NEUR SYS REH, V21, P664, DOI 10.1109/TNSRE.2012.2236577; Palmerini L, 2011, IEEE ENG MED BIO, P7179, DOI 10.1109/IEMBS.2011.6091814; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Rocchi L, 2014, IEEE T NEUR SYS REH, V22, P1064, DOI 10.1109/TNSRE.2013.2292496; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Sheehan KJ, 2014, GAIT POSTURE, V39, P1034, DOI 10.1016/j.gaitpost.2014.01.003; Soangra R, 1990, P HUM FACT ERG SOC A, V55; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Weiss A, 2011, PHYSIOL MEAS, V32, P2003, DOI 10.1088/0967-3334/32/12/009; Weiss A, 2013, PLOS ONE, V29; Zakaria NA, 2015, COMPUT METHOD BIOMEC, V18, P426, DOI 10.1080/10255842.2013.805211; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	49	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0155984	10.1371/journal.pone.0155984	http://dx.doi.org/10.1371/journal.pone.0155984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271994	Green Submitted, Green Published, gold			2022-12-26	WOS:000377560200004
J	Lo, AS; Mao, XM; Mukherjee, EM; Ellebrecht, CT; Yu, XC; Posner, MR; Payne, AS; Cavacini, LA				Lo, Agnes S.; Mao, Xuming; Mukherjee, Eric M.; Ellebrecht, Christoph T.; Yu, Xiaocong; Posner, Marshall R.; Payne, Aimee S.; Cavacini, Lisa A.			Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; SWAPPED MOLECULES; TARGET; INHIBITION; EXPRESSION; FOLIACEUS; DISEASE; BINDING; REGION; DOMAIN	Pemphigus vulgaris (PV) is characterized by IgG1 and IgG4 autoantibodies to desmoglein (Dsg) 3, causing suprabasal blistering of skin and mucous membranes. IgG4 is the dominant autoantibody subclass in PV and correlates with disease activity, whereas IgG1 can be associated with remittent disease. It is unknown if switching the same variable region between IgG4 and IgG1 directly impacts pathogenicity. Here, we tested whether three pathogenic PV monoclonal antibodies (mAbs) from three different patients demonstrate differences in antigen affinity, epitope specificity, or pathogenicity when expressed as IgG1 or IgG4. F706 anti-Dsg3 IgG4 and F779 anti-Dsg3 IgG1, previously isolated as heterohybridomas, and Px43, a monovalent anti-Dsg3/Dsg1 IgG antibody isolated by phage display, were subcloned to obtain paired sets of IgG1 and IgG4 mAbs. Using ELISA and cell surface staining assays, F706 and F779 demonstrated similar antigen binding affinities of IgG1 and IgG4, whereas Px43 showed 3- to 8-fold higher affinity of IgG4 versus IgG1 by ELISA, but identical binding affinities to human skin, perhaps due to targeting of a quaternary epitope best displayed in tissues. All 3 mAb pairs targeted the same extracellular cadherin (EC) domain on Dsg3, caused Dsg3 internalization in primary human keratinocytes, and caused suprabasal blisters in human skin at comparable doses. We conclude that switching IgG1 and IgG4 subclasses of pathogenic PV mAbs does not directly affect their antigen binding or pathogenic properties.	[Lo, Agnes S.; Yu, Xiaocong; Posner, Marshall R.; Cavacini, Lisa A.] Dana Farber Canc Inst, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Lo, Agnes S.; Yu, Xiaocong; Posner, Marshall R.; Cavacini, Lisa A.] Harvard Univ, Sch Med, Boston, MA USA; [Mao, Xuming; Mukherjee, Eric M.; Ellebrecht, Christoph T.; Payne, Aimee S.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Cavacini, Lisa A.] MassBiologics, 460 Walk Hill St, Boston, MA USA; [Posner, Marshall R.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Pennsylvania; Icahn School of Medicine at Mount Sinai	Cavacini, LA (corresponding author), Dana Farber Canc Inst, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.; Cavacini, LA (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Cavacini, LA (corresponding author), MassBiologics, 460 Walk Hill St, Boston, MA USA.	lisa.cavacini@umassmed.edu		Mukherjee, Eric/0000-0001-8715-1378	Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award; NIAMS/NIH [AR057001, AR064220, P30-AR057217, T32-AR007465, F30-AR065870]; Dermatology Foundation; DFG [EL711/1-1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F30AR065870, T32AR007465, P30AR057217, R56AR064220, R01AR057001] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award (ASL and LAC); in part by NIAMS/NIH grants AR057001, AR064220, P30-AR057217 (ASP) and T32-AR007465, F30-AR065870 (EMM); the Dermatology Foundation (XM); and DFG grant EL711/1-1 (CTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Sosthene Essono, Martin Jadus and Richard Junghans for reviewing this manuscript, and Mark Duval for his assistance with antibody purification and ELISAs. This work was funded by Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award (ASL and LAC); in part by NIAMS/NIH grants AR057001, AR064220, P30-AR057217 (ASP) and T32-AR007465, F30-AR065870 (EMM); the Dermatology Foundation (XM); and DFG grant EL711/1-1 (CTE).	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; BHOL K, 1994, DERMATOLOGY, V189, P85, DOI 10.1159/000246938; Bhol KC, 2002, AUTOIMMUNITY, V35, P87, DOI 10.1080/08916930290016655; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Cho MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5167; DAVID M, 1989, ARCH DERMATOL, V125, P787, DOI 10.1001/archderm.125.6.787; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; Futei Y, 2000, J INVEST DERMATOL, V115, P829, DOI 10.1046/j.1523-1747.2000.00137.x; Futei Y, 2001, J DERMATOL SCI, V26, P55, DOI 10.1016/S0923-1811(00)00158-4; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; Hertl M, 2006, J CLIN INVEST, V116, P1159, DOI 10.1172/JCI28547; Jeannin P, 1998, J IMMUNOL, V160, P3555; Kouno M, 2013, J INVEST DERMATOL, V133, P2212, DOI 10.1038/jid.2013.85; Kricheli D, 2000, BRIT J DERMATOL, V143, P337, DOI 10.1046/j.1365-2133.2000.03659.x; Liu FB, 2003, AIDS RES HUM RETROV, V19, P597, DOI 10.1089/088922203322230969; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mao XM, 2014, J INVEST DERMATOL, V134, P68, DOI 10.1038/jid.2013.224; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Mascaro JM, 1997, CLIN IMMUNOL IMMUNOP, V85, P90, DOI 10.1006/clin.1997.4408; Miranda LR, 2007, J IMMUNOL, V178, P7132, DOI 10.4049/jimmunol.178.11.7132; Ohyama B, 2012, J INVEST DERMATOL, V132, P1158, DOI 10.1038/jid.2011.448; Payne AS, 2007, J INVEST DERMATOL, V127, P1681, DOI 10.1038/sj.jid.5700790; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Payne AS, 2012, DERMATOLOGY GEN MED; Sekiguchi M, 2001, J IMMUNOL, V167, P5439, DOI 10.4049/jimmunol.167.9.5439; Sharma PM, 2009, J INVEST DERMATOL, V129, P2309, DOI 10.1038/jid.2009.41; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Takahashi H, 2007, J INVEST DERMATOL, V127, P324, DOI 10.1038/sj.jid.5700527; Tavakolpour S, 2016, INT IMMUNOPHARMACOL, V34, P139, DOI 10.1016/j.intimp.2016.02.020; Tavakolpour S, 2016, CYTOKINE, V77, P189, DOI 10.1016/j.cyto.2015.09.017; Yeh SW, 2006, CLIN IMMUNOL, V120, P68, DOI 10.1016/j.clim.2006.03.006; ZHANG K, 1994, J IMMUNOL, V152, P3427	33	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156800	10.1371/journal.pone.0156800	http://dx.doi.org/10.1371/journal.pone.0156800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304671	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800023
J	Ardhaoui, M; Ennaifer, E; Letaief, H; Salsabil, R; Lassili, T; Chahed, K; Bougatef, S; Bahrini, A; El Fehri, E; Ouerhani, K; Jimenez, AP; Guizani, I; Boubaker, MS; Ben Alaya, NBE				Ardhaoui, Monia; Ennaifer, Emna; Letaief, Hajer; Salsabil, Rejaibi; Lassili, Thalja; Chahed, Karim; Bougatef, Souha; Bahrini, Asma; El Fehri, Emna; Ouerhani, Kaouther; Jimenez, Adela Paez; Guizani, Ikram; Boubaker, Med Samir; Ben Alaya, Nissaf Bouafif Ep			Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia	PLOS ONE			English	Article							AGE-SPECIFIC PREVALENCE; WOMEN OLDER; VACCINES; DETERMINANTS; FEMALES	Implementation of Human Papillomavirus (HPV) vaccination should be considered a key cervical cancer prevention strategy in Tunisia, where Pap smear screening is not efficient. This study aims to estimate the prevalence and to identify risk factors associated with HPV infection among women from Grand Tunis, Tunisia. We conducted a cross-sectional study, between December 2012 and May 2013. Eligible women for this study were those aged 1865 years, sexually active, who sought medical attention at their primary health care centre or clinic in Grand Tunis, Tunisia and who gave written consent. A liquid-based Pap smear sample was obtained from all women using a cervical brush. Only women with betaglobin positive test were further analysed for HPV detection and typing. A nested-PCR of the L1 region was performed followed by reverse line blot hybridization to facilitate the specific detection of 31 HPV genotypes. Multiple logistic regression modeling was used for the analysis of associations between variables with some considered possible confounders after checking for interactions. A total of 391 women were enrolled in this study and 325 out of the 391 cervical samples were positive for the betaglobin test. Overall HPV prevalence was 13.2% [9.8%-17.5%], with the following most prevalent HPV genotypes: HPV6 (40%), HPV40 (14%), HPV16 (12%), HPV52 (9%), HPV31 and HPV59 (7%), followed by HPV68 (4%). Mean age of HPV positive women was 40.7 +/- 0.92 years. Independently associated risk factors of HPV infection were smoking (OR: 2.8 [0.8-9.6]), low income (OR: 9.6 [1.463.4]), bad housing type (OR: 2.5 [1-6.8]), partner with multiple sexual relationship (OR: 4.5 [0.9-22.9]) and single women (widowed, divorced, separated, never married) (OR: 6.9 [1.142.2]). This study provides the first national-based estimate of HPV prevalence in Tunisia. Our findings contribute to the evidence on the current burden of HPV infection, the critical role of sexual behaviour and socioeconomic status and call for increased support for the screening program in Tunisia to prevent cervical cancer. These results allow us to evaluate the cost-effectiveness of vaccine program implementation in Tunisia in future.	[Ardhaoui, Monia; Ennaifer, Emna; Lassili, Thalja; El Fehri, Emna; Ouerhani, Kaouther; Guizani, Ikram] Inst Pasteur Tunis, Dept Mol Epidemiol Infect Dis, Tunis, Tunisia; [Ardhaoui, Monia; Ennaifer, Emna; Lassili, Thalja; El Fehri, Emna; Ouerhani, Kaouther; Boubaker, Med Samir] Inst Pasteur Tunis, Dept Human & Expt Pathol, Tunis, Tunisia; [Letaief, Hajer; Salsabil, Rejaibi; Chahed, Karim; Bougatef, Souha; Bahrini, Asma; Ben Alaya, Nissaf Bouafif Ep] Observ Natl Malad Nouvelles & Emergentes Tunis, Dept Epidemiol, Tunis, Tunisia; [Salsabil, Rejaibi; Chahed, Karim; Jimenez, Adela Paez] European Ctr Dis Prevent & Control ECDC, Dept Dis Prevent & Control, Solna, Sweden; [Letaief, Hajer] Fac Med Tunis, Dept Prevent Med, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; European Centre for Disease Prevention & Control; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Ardhaoui, M (corresponding author), Inst Pasteur Tunis, Dept Mol Epidemiol Infect Dis, Tunis, Tunisia.; Ardhaoui, M (corresponding author), Inst Pasteur Tunis, Dept Human & Expt Pathol, Tunis, Tunisia.	ardhaouimonia@gmail.com	Rejaibi, Salsabil/HGA-7850-2022	Bouafif ep Ben Alaya, Nissaf/0000-0002-3326-9861; PAEZ JIMENEZ, Adela/0000-0002-8653-610X; Guizani, Ikram/0000-0003-2763-8963	African Development bank [55001550022552]	African Development bank(CGIAR)	The project of "National HPV prevalence in Tunisia" has been granted by the "African Development bank" (http://www.afdb.org/en/) under the grant number: 55001550022552. Grant recipient is Pr. N. Bouafif, Director of the "Observatoire National des Maladies Nouvelles et Emergentes de Tunis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER HM, 1993, SEX TRANSM DIS, V20, P274, DOI 10.1097/00007435-199309000-00007; Bethesda System, 2001, ACTA CYTOLOGICA, V45, P1077; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brismar-Wendel S, 2009, BRIT J CANCER, V101, P511, DOI 10.1038/sj.bjc.6605165; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Chan PKS, 2009, J MED VIROL, V81, P1635, DOI 10.1002/jmv.21575; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Coker AL, 2002, CANCER DETECT PREV, V26, P121, DOI 10.1016/S0361-090X(02)00039-9; De Marco F, 2006, J MED VIROL, V78, P950, DOI 10.1002/jmv.20646; De Vincenzo R, 2013, GYNECOL ONCOL, V130, P642, DOI 10.1016/j.ygyno.2013.05.033; Dillner J, 2015, SEMIN ONCOL, V42, P272, DOI 10.1053/j.seminoncol.2014.12.028; Dimassi K, 2015, INT J GYNECOL OBSTET, V128, P268, DOI 10.1016/j.ijgo.2014.09.019; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; El Mzibri M, 2010, J INFECT DEV CTRIES, V4; Ennaifer Emna, 2014, Tunis Med, V92, P253; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gasperov NM, 2008, PATHOL ONCOL RES, V14, P355, DOI 10.1007/s12253-008-9084-2; Gonzalez P, 2010, CANCER EPIDEM BIOMAR, V19, P3044, DOI 10.1158/1055-9965.EPI-10-0645; Grainge MJ, 2005, EMERG INFECT DIS, V11, P1680, DOI 10.3201/eid1111.050575; Guettiti H, 2014, ASIAN PAC J CANCER P, V15, P9361, DOI 10.7314/APJCP.2014.15.21.9361; Hammouda D, 2011, INT J CANCER, V128, P2224, DOI 10.1002/ijc.25539; Hassen E, 1999, Tunis Med, V77, P497; HAUSEN HZ, 1982, LANCET, V2, P1370; HILDESHEIM A, 1993, SEX TRANSM DIS, V20, P279, DOI 10.1097/00007435-199309000-00008; *IARC WORK GROUP, 1995, IARC MON EV CARC RIS, V64; Jumaan AO, 2013, VACCINE, V31, pG58, DOI 10.1016/j.vaccine.2012.06.097; Liu Zhi-Chang, 2015, Asian Pac J Cancer Prev, V16, P3893; Mbulawa ZZA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1181-8; Mitchell S, 2014, AM J OBSTET GYNECOL, V1, pe1; Moralejo Donna, 2009, Evid Based Nurs, V12, P122, DOI 10.1136/ebn.12.4.122; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; Ogembo RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122488; Ojiyi EC, 2013, ANN MED HEALTH SCI R, V3, P529, DOI 10.4103/2141-9248.122082; Shaltout MF, 2014, INT J INFECT DIS, V29, P226, DOI 10.1016/j.ijid.2014.07.029; Shi Runhua, 2014, BMC Res Notes, V7, P544, DOI 10.1186/1756-0500-7-544; Sudenga SL, 2013, INT J INFECT DIS, V17, pE216, DOI 10.1016/j.ijid.2012.12.027; Unger E. R, 2009, HUM PAP LAB MAN; Villa LL, 2006, VACCINE, V24, P23, DOI 10.1016/j.vaccine.2005.09.001; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization (WHO), 2014, HUM PAP VACC WHO POS; Xu CY, 2012, J OBSTET GYNAECOL RE, V38, P310, DOI 10.1111/j.1447-0756.2011.01624.x	42	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157432	10.1371/journal.pone.0157432	http://dx.doi.org/10.1371/journal.pone.0157432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299955	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200048
J	Dyomin, AG; Koshel, EI; Kiselev, AM; Saifitdinova, AF; Galkina, SA; Fukagawa, T; Kostareva, AA; Gaginskaya, ER				Dyomin, Alexander G.; Koshel, Elena I.; Kiselev, Artem M.; Saifitdinova, Alsu F.; Galkina, Svetlana A.; Fukagawa, Tatsuo; Kostareva, Anna A.; Gaginskaya, Elena R.			Chicken rRNA Gene Cluster Structure	PLOS ONE			English	Article							DNA BARCODE; SEQUENCES; GENOME; MICROCHROMOSOME; EVOLUTION; NUCLEAR; REGION; ITS2; PCR	Ribosomal RNA (rRNA) genes, whose activity results in nucleolus formation, constitute an extremely important part of genome. Despite the extensive exploration into avian genomes, no complete description of avian rRNA gene primary structure has been offered so far. We publish a complete chicken rRNA gene cluster sequence here, including 5'ETS (1836 bp), 18S rRNA gene (1823 bp), ITS1 (2530 bp), 5.8S rRNA gene (157 bp), ITS2 (733 bp), 28S rRNA gene (4441 bp) and 3'ETS (343 bp). The rRNA gene cluster sequence of 11863 bp was assembled from raw reads and deposited to GenBank under KT445934 accession number. The assembly was validated through in situ fluorescent hybridization analysis on chicken metaphase chromosomes using computed and synthesized specific probes, as well as through the reference assembly against de novo assembled rRNA gene cluster sequence using sequenced fragments of BAC-clone containing chicken NOR (nucleolus organizer region). The results have confirmed the chicken rRNA gene cluster validity.	[Dyomin, Alexander G.; Koshel, Elena I.; Saifitdinova, Alsu F.; Galkina, Svetlana A.; Gaginskaya, Elena R.] St Petersburg State Univ, St Petersburg 199034, Russia; [Kiselev, Artem M.; Kostareva, Anna A.] Almazov Fed Med Res Ctr, St Petersburg 197341, Russia; [Kiselev, Artem M.; Kostareva, Anna A.] ITMO Univ, St Petersburg 197101, Russia; [Fukagawa, Tatsuo] Osaka Univ, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Saint Petersburg State University; Almazov National Medical Research Centre; ITMO University; Osaka University	Gaginskaya, ER (corresponding author), St Petersburg State Univ, St Petersburg 199034, Russia.	elena.gaginskaya@gmail.com	Galkina, Svetlana/AAK-7179-2021; Kostareva, Anna/AAO-5429-2020; Demin, Aleksandr G./N-6526-2015; Galkina, Svetlana A./J-2493-2013; Gaginskaya, Elena/C-9963-2013; Saifitdinova, Alsu F/C-1104-2011; Fukagawa, Tatsuo/AAK-3922-2021; Galkina, Svetlana/P-2308-2019; Koshel, Elena I/L-7493-2016; Kiselev, Artem M/H-1283-2016; Kostareva, Anna/H-2204-2016	Galkina, Svetlana A./0000-0002-7034-2466; Gaginskaya, Elena/0000-0003-4967-9053; Saifitdinova, Alsu F/0000-0002-1221-479X; Galkina, Svetlana/0000-0002-7034-2466; Koshel, Elena I/0000-0002-8957-5956; Kiselev, Artem M/0000-0002-5524-6900; Kostareva, Anna/0000-0002-9349-6257	Saint-Petersburg State University [1.50.1043.2014]; Russian Basic Research Foundation [15-04-05684]; RF Government [074-U01]	Saint-Petersburg State University; Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR)); RF Government	The research has been financed by 1. Saint-Petersburg State University Grant #1.50.1043.2014 (AD EK) http://english.spbu.ru/; 2. Russian Basic Research Foundation Grant #15-04-05684 (EG SG AD EK) http://www.rfbr.ru/rffi/eng; 3. RF Government Grant #074-U01 (AnK ArK) http://government.ru/en/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AUER H, 1987, CYTOGENET CELL GENET, V45, P218, DOI 10.1159/000132457; AZAD AA, 1980, NUCLEIC ACIDS RES, V8, P4365, DOI 10.1093/nar/8.19.4365; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bozinovic G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-132; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chikuni K., 1995, J YAMASHINA I ORNITH, V28, P1; Coleman AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079122; Delany ME, 2007, CYTOGENET GENOME RES, V117, P54, DOI 10.1159/000103165; EVERS R, 1995, P NATL ACAD SCI USA, V92, P5827, DOI 10.1073/pnas.92.13.5827; Galkina S, 2006, GENETICA, V128, P241, DOI 10.1007/s10709-005-5776-7; HEDGES SB, 1990, MOL BIOL EVOL, V7, P607; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Koepfli KP, 2015, ANNU REV ANIM BIOSCI, V3, P57, DOI 10.1146/annurev-animal-090414-014900; Masabanda JS, 2004, GENETICS, V166, P1367, DOI 10.1534/genetics.166.3.1367; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Miller MM, 1996, P NATL ACAD SCI USA, V93, P3958, DOI 10.1073/pnas.93.9.3958; Pasko L, 2011, MOL PHYLOGENET EVOL, V61, P760, DOI 10.1016/j.ympev.2011.07.021; Shang WH, 2013, DEV CELL, V24, P635, DOI 10.1016/j.devcel.2013.02.009; Shaw P, 2012, PLANT PHYSIOL, V158, P44, DOI 10.1104/pp.111.188052; Singer M. F., 1991, GENES GENOMES CHANGI; Smirnov E, 2006, FOLIA BIOL-PRAGUE, V52, P59; Solinhac R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-616; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; van Tuinen M, 2000, MOL BIOL EVOL, V17, P451, DOI 10.1093/oxfordjournals.molbev.a026324; Wain HM, 1998, ANIM GENET, V29, P446, DOI 10.1046/j.1365-2052.1998.296374.x; Wang XC, 2015, MOL ECOL RESOUR, V15, P573, DOI 10.1111/1755-0998.12325; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhang XW, 2003, MAGNET RESON MED, V49, P1192, DOI 10.1002/mrm.10460; Zheng Z, 2012, J BIOL CHEM, V287, P19949, DOI 10.1074/jbc.M112.355099; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157464	10.1371/journal.pone.0157464	http://dx.doi.org/10.1371/journal.pone.0157464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299357	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200054
J	Kim, BI; Ki, H; Park, S; Cho, E; Chun, BC				Kim, Bryan Inho; Ki, Hyunok; Park, Sunhee; Cho, Eunhi; Chun, Byung Chul			Effect of Climatic Factors on Hand, Foot, and Mouth Disease in South Korea, 2010-2013	PLOS ONE			English	Article							CHINA; EPIDEMIC; PATTERNS; VACCINE	Hand, foot, and mouth disease (HFMD) causes characteristic blisters and sores mainly in infants and children, and has been monitored in South Korea through sentinel surveillance since 2009. We described the patterns of HFMD occurrence and analyzed the effect of climatic factors on national HFMD incidence. Weekly clinically diagnosed HFMD case rates (per 1,000 outpatients) in sentinel sites and weekly climatic factors, such as average temperature, relative humidity, duration of sunshine, precipitation, and wind speed from 2010 to 2013, were used in this study. A generalized additive model with smoothing splines and climatic variables with time lags of up to 2 weeks were considered in the modeling process. To account for long-term trends and seasonality, we controlled for each year and their corresponding weeks. The autocorrelation issue was also adjusted by using autocorrelation variables. At an average temperature below 18 degrees C, the HFMD rate increased by 10.3% for every 1 degrees C rise in average temperature (95% confidence interval (CI): 8.4, 12.3%). We also saw a 6.6% increase in HFMD rate (95% CI: 3.6, 9.7%) with every 1% increase in relative humidity under 65%, with a 1.5% decrease in HFMD rate observed (95% CI: 0.4, 2.7%) with each 1% humidity increase above 65%. Modeling results have shown that average temperature and relative humidity are related to HFMD rate. Additional research on the environmental risk factors of HFMD transmission is required to understand the underlying mechanism between climatic factors and HFMD incidence.	[Kim, Bryan Inho; Ki, Hyunok; Park, Sunhee; Cho, Eunhi] Korea Ctr Dis Control & Prevent, Div Infect Dis Surveillance, Chungcheongbuk Do, South Korea; [Kim, Bryan Inho; Chun, Byung Chul] Korea Univ, Sch Publ Hlth, Dept Epidemiol & Med Informat, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control; Korea University	Chun, BC (corresponding author), Korea Univ, Sch Publ Hlth, Dept Epidemiol & Med Informat, Seoul, South Korea.	chun@korea.ac.kr	Chun, Byung Chul/AGO-1458-2022; Chun, Byung Chul/AGO-1390-2022; Ibrahim, Essam Hassan/G-1960-2018	Chun, Byung Chul/0000-0001-6576-8916; Chun, Byung Chul/0000-0001-6576-8916; Ibrahim, Essam Hassan/0000-0003-0130-2257				Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Frydenberg Alexis, 2003, Aust Fam Physician, V32, P594; Goksugur Nadir, 2010, N Engl J Med, V362, pe49, DOI 10.1056/NEJMicm0910628; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Jiang M, 2012, NEW ENGL J MED, V367, P91, DOI 10.1056/NEJMc1110981; Li T, 2014, EPIDEMIOL INFECT, V142, P1741, DOI 10.1017/S0950268813002938; Liao YL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1446-6; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mao QY, 2016, EXPERT REV VACCINES, V15, P599, DOI 10.1586/14760584.2016.1138862; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Suzuki Y, 2010, PEDIATR INT, V52, P203, DOI 10.1111/j.1442-200X.2009.02937.x; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2013, GEOSPATIAL HEALTH, V7, P381, DOI 10.4081/gh.2013.95; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	25	41	45	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157500	10.1371/journal.pone.0157500	http://dx.doi.org/10.1371/journal.pone.0157500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285850	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000068
J	Osterloff, J; Nilssen, I; Eide, I; Figueiredo, MAD; Tamega, FTD; Nattkemper, TW				Osterloff, Jonas; Nilssen, Ingunn; Eide, Ingvar; de Oliveira Figueiredo, Marcia Abreu; de Souza Tamega, Frederico Tapajos; Nattkemper, Tim W.			Computational Visual Stress Level Analysis of Calcareous Algae Exposed to Sedimentation	PLOS ONE			English	Article							RHODOLITH DISTRIBUTION; DEEP; CORAL; CONSERVATION; ABUNDANCE; ISSUES	This paper presents a machine learning based approach for analyses of photos collected from laboratory experiments conducted to assess the potential impact of water-based drill cuttings on deep-water rhodolith-forming calcareous algae. This pilot study uses imaging technology to quantify and monitor the stress levels of the calcareous algae Mesophyllum engelhartii (Foslie) Adey caused by various degrees of light exposure, flow intensity and amount of sediment. A machine learning based algorithm was applied to assess the temporal variation of the calcareous algae size (similar to mass) and color automatically. Measured size and color were correlated to the photosynthetic efficiency (maximum quantum yield of charge separation in photosystem II, Phi(PSIImax)) and degree of sediment coverage using multivariate regression. The multivariate regression showed correlations between time and calcareous algae sizes, as well as correlations between fluorescence and calcareous algae colors.	[Osterloff, Jonas; Nattkemper, Tim W.] Univ Bielefeld, Biodata Min Grp, Fac Technol, D-33615 Bielefeld, Germany; [Nilssen, Ingunn; Eide, Ingvar] Statoil ASA, Res & Technol, N-7005 Trondheim, Norway; [Nilssen, Ingunn] Norwegian Univ Sci & Technol, Trondhjem Biol Stn, Dept Biol, N-7491 Trondheim, Norway; [de Oliveira Figueiredo, Marcia Abreu] Inst Pesquisa Jardim Bot Rio de Janeiro, BR-22460030 Rio De Janeiro, RJ, Brazil; [de Oliveira Figueiredo, Marcia Abreu; de Souza Tamega, Frederico Tapajos] Inst Biodiversidade Marinha, BR-22793000 Rio De Janeiro, RJ, Brazil; [de Souza Tamega, Frederico Tapajos] Inst Estudos Mar Almirante Paulo Moreira, BR-28930000 Arraial Do Cabo, RJ, Brazil	University of Bielefeld; Equinor; Norwegian University of Science & Technology (NTNU)	Osterloff, J (corresponding author), Univ Bielefeld, Biodata Min Grp, Fac Technol, D-33615 Bielefeld, Germany.	josterlo@cebitec.uni-bielefeld.de	Tamega, Frederico/ABD-8849-2021; Nattkemper, Tim W/F-3332-2017	Tamega, Frederico/0000-0003-2773-2036; Nattkemper, Tim W/0000-0002-7986-1158; Osterloff, Jonas/0000-0002-5962-5326	STATOIL Brasil Oleo e Gas Ltda (STATOIL Brazil Oil and Gas LLC)	STATOIL Brasil Oleo e Gas Ltda (STATOIL Brazil Oil and Gas LLC)	Financial support was given by STATOIL Brasil Oleo e Gas Ltda (STATOIL Brazil Oil and Gas LLC) (http://www.statoil.com/brazil/). Agencia Nacional de Petroleo, Gas Natural e Biocombustiveis - ANP (National Agency of Petroleum, Natural Gas and Biofuels - ANP) (http://www.anp.gov.br/), Rio de Janeiro, Brazil, has accepted the Project under the Federal Participation Agreement (FPE). The decision to publish was not influenced by the funders.	Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; Basso D, 1998, PALAEOGEOGR PALAEOCL, V137, P173, DOI 10.1016/S0031-0182(97)00099-0; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Bergmann M, 2012, MAR POLLUT BULL, V64, P2734, DOI 10.1016/j.marpolbul.2012.09.018; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Box G. E. P., 1978, Statistics for experimenters. An introduction to design, data analysis and model building.; Buhl-Mortensen P, 2015, MAR BIOL RES, V11, P725, DOI 10.1080/17451000.2014.993651; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Figueiredo MAO, 2015, MAR POLLUT BULL, V95, P81, DOI 10.1016/j.marpolbul.2015.04.040; Forina M, 2007, MULTIVARIATE CALIBRA, V1158; Foster DH., 2010, WILEY IS T SERIES IM, V51; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; Gonzalez R. C., 2018, DIGITAL IMAGE PROCES, V4th, P119; Hall-Spencer J, 1998, J CONCHOL, P271; Henriques MC, 2014, PHYTOTAXA, V190, P112, DOI 10.11646/phytotaxa.190.1.9; IOCCG, 2000, REPORTS INT OCEAN CO; Johnsen G., 2009, ECOSYSTEM BARENTS SE, V9, P139; KEMPF M, 1970, MAR BIOL, V5, P213, DOI 10.1007/BF00346909; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LITTLER MM, 1991, J EXP MAR BIOL ECOL, V150, P163, DOI 10.1016/0022-0981(91)90066-6; LITTLER MM, 1986, DEEP-SEA RES, V33, P881, DOI 10.1016/0198-0149(86)90003-8; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nilssen I, 2015, MAR POLLUT BULL, V96, P374, DOI 10.1016/j.marpolbul.2015.04.045; Ontrup J, 2002, ADV NEUR IN, V14, P1417; Ontrup J., 2009, OCEANS 2009 EUROPE, V17, DOI [10.1109/OCEANSE.2009.5278332, DOI 10.1109/OCEANSE.2009.5278332]; Osterloff J., 2016, METHODS OCEANOG, V15, P114, DOI DOI 10.1016/J.MIO.2016.03.002; Purser A, 2013, BIOGEOSCIENCES, V10, P5779, DOI 10.5194/bg-10-5779-2013; Purser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134076; Purser A, 2009, MAR ECOL PROG SER, V397, P241, DOI 10.3354/meps08154; Riosmena-Rodriguez R, 2010, REEFS ROCK ROLL BIOL, P49; Schoening T., 2016, METHODS OCEANOGR, V15-16, P78, DOI DOI 10.1016/J.MI0.2016.04.002; Schoening T., 2015, 2015 MTSIEEE OCEANS, P1; Schoening T, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00059; Schoening T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038179; Shihavuddin A. S. M., 2012, Proceedings of the International Conference on Computer Vision Theory and Applications. VISAPP 2012, P161; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Steller DL, 2001, ECOSYSTEMS, P72; Stokes M., 1996, STANDARD DEFAULT COL; Tamega FTS, 2013, CATALOGUE BENTHIC MA, P140; Villas-Boas AB, 2014, CRYPTOGAMIE ALGOL, V35, P67, DOI 10.7872/crya.v35.iss1.2014.67; Westad F, 2002, MULTIVARIATE DATA AN; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Wold S, 2012, MATRIX PENCILS, V973, P286; YUEN HK, 1990, IMAGE VISION COMPUT, V8, P71, DOI 10.1016/0262-8856(90)90059-E	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157329	10.1371/journal.pone.0157329	http://dx.doi.org/10.1371/journal.pone.0157329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285611	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000058
J	Usui, J; Tawara-Iida, T; Takada, K; Ebihara, I; Ueda, A; Iwabuchi, S; Ishizu, T; Iitsuka, T; Takemura, K; Kawamura, T; Kaneko, S; Sakai, K; Kai, H; Gomibuchi, T; Nagata, M; Kobayashi, M; Koyama, A; Suka, M; Radhakrishnan, J; Yamagata, K				Usui, Joichi; Tawara-Iida, Takashi; Takada, Kenji; Ebihara, Itaru; Ueda, Atsushi; Iwabuchi, Satoshi; Ishizu, Takashi; Iitsuka, Tadashi; Takemura, Katsumi; Kawamura, Tetsuya; Kaneko, Shuzo; Sakai, Kentaro; Kai, Hirayasu; Gomibuchi, Tomoka; Nagata, Michio; Kobayashi, Masaki; Koyama, Akio; Suka, Machi; Radhakrishnan, Jai; Yamagata, Kunihiro			Temporal Changes in Post-Infectious Glomerulonephritis in Japan (1976-2009)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INFECTION; EXPERIENCE; SPECTRUM; ADULTS	Background The incidence of post-infectious glomerulonephritis (PIGN) in developed countries has decreased over the last 50 years. Here we identified the trends of the incidence of PIGN in Japan during the past four decades. Methods We explored the frequency, clinicopathological findings, and prognosis of PIGN based on 6,369 cases from the Renal Biopsy Database of our institute in the Kanto region of Japan, diagnosed histologically from 1976 to 2009. Results The numbers of PIGN cases were 131 (2.1%) in total, and 2.4%, 1.1%, 2.6% and 2.1% identified in the 1970s, 1980s, 1990s, and 2000s, respectively. Acute glomerulonephritis (AGN), including post-streptococcal glomerulonephritis (PSGN), accounted for almost all of the PIGN cases in the 1970s, but decreased to approx. 40%-50% since the 1990s. In the 1990s, Staphylococcus aureus infection-related nephritis (SARN) showed a rapid increase in rate, reaching 30%. The incidence of hepatitis C virus infection-associated GN (HCVGN) has increased since the 1990s. The average age at onset rose from 33 to 51 years over the study period. These transitions can be summarized as increases in SARN and HCVGN and decreases in PSGN and other types of AGN, since SARN and HCVGN have older onsets compared to PSGN and other AGN types. The clinicopathological features were marked for each PIGN. Regarding the prognosis, the renal death rates of both the SARN and HCVGN groups were significantly higher than those of other PIGN. Conclusion Based on our analysis of the Renal Biopsy Database, the incidence of PIGN in Japan reached its peak in the 1990s. The temporal changes in the incidence of PIGN reflected the trends in infectious diseases of each decade and the continual aging of the population, with a related higher susceptibility to infections.	[Usui, Joichi; Tawara-Iida, Takashi; Kawamura, Tetsuya; Kaneko, Shuzo; Kai, Hirayasu; Koyama, Akio; Yamagata, Kunihiro] Univ Tsukuba, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Nagata, Michio] Univ Tsukuba, Fac Med, Pathol, Tsukuba, Ibaraki, Japan; [Takada, Kenji] Tsukuba Gakuen Hosp, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Ebihara, Itaru] Mito Saiseikai Gen Hosp, Dept Nephrol, Mito, Ibaraki, Japan; [Ueda, Atsushi] Hitachi Gen Hosp, Dept Nephrol, Hitachi, Ibaraki, Japan; [Iwabuchi, Satoshi] Kensei Gen Hosp, Dept Med, Sakuragawa, Ibaraki, Japan; [Ishizu, Takashi] Tsukuba Cent Hosp, Dept Nephrol, Ushiku, Ibaraki, Japan; [Iitsuka, Tadashi; Sakai, Kentaro] Ibaraki Seinan Med Ctr Hosp, Dept Nephrol, Sakai, Ibaraki, Japan; [Takemura, Katsumi] Takemura Nephrol Clin, Kanuma, Tochigi, Japan; [Gomibuchi, Tomoka] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Kobayashi, Masaki] Tokyo Med Univ, Ibaraki Med Ctr, Dept Nephrol, Ami, Ibaraki, Japan; [Koyama, Akio] Ibaraki Prefectural Univ, Ami, Ibaraki, Japan; [Suka, Machi] Jikei Univ, Sch Med, Dept Publ Hlth & Environm Med, Tokyo, Japan; [Radhakrishnan, Jai] Columbia Univ, Div Nephrol, Med Ctr, New York, NY USA	University of Tsukuba; University of Tsukuba; University of Tokyo; Tokyo Medical University; Jikei University; Columbia University	Usui, J (corresponding author), Univ Tsukuba, Dept Nephrol, Tsukuba, Ibaraki, Japan.	j-usui@md.tsukuba.ac.jp			Japan Science Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan	Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant from the Japan Science Technology Agency, the Ministry of Education, Culture, Sport, Science, and Technology, Japan, and a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel G, 2007, CLEV CLIN J MED, V74, P353, DOI 10.3949/ccjm.74.5.353; Arase Y, 1998, INTERNAL MED, V37, P836, DOI 10.2169/internalmedicine.37.836; Azmi AN, 2015, WORLD J HEPATOL, V7, P78, DOI 10.4254/wjh.v7.i1.78; Barsoum RS, 2007, NEPHROL DIAL TRANSPL, V22, P1840, DOI 10.1093/ndt/gfm205; Churg J, 1995, RENAL DIS CLASSIFECA; El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191; Jennette JC., 2015, HEPTINSTALLS PATHOLO; KOYAMA A, 1995, KIDNEY INT, V47, P207, DOI 10.1038/ki.1995.25; McGuire BM, 2006, ANN INTERN MED, V144, P735, DOI 10.7326/0003-4819-144-10-200605160-00007; MONTSENY JJ, 1995, MEDICINE, V74, P63, DOI 10.1097/00005792-199503000-00001; Nasr SH, 2008, MEDICINE, V87, P21, DOI [10.1097/MD.0b013e318161b0fc, 10.1097/md.0b013e318161b0fc]; Nasr SH, 2013, KIDNEY INT, V83, P792, DOI 10.1038/ki.2012.407; Nasr SH, 2011, J AM SOC NEPHROL, V22, P187, DOI 10.1681/ASN.2010060611; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Rodriguez-Iturbe B., 2010, COMPR CLIN NEPHROL, P662, DOI [10.1016/b978-0-323-05876-6.00055-1, DOI 10.1016/B978-0-323-05876-6.00055-1]; Rodriguez-Iturbe B, 2008, J AM SOC NEPHROL, V19, P1855, DOI 10.1681/ASN.2008010092; ROY S, 1990, PEDIATR NEPHROL, V4, P585, DOI 10.1007/BF00858626; SIMON P, 1995, NEPHROLOGIE, V16, P191; Takeda S, 2007, SHOUNIKA RINSHO, V60, P1003; Wen YK, 2010, CLIN NEPHROL, V73, P173	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157356	10.1371/journal.pone.0157356	http://dx.doi.org/10.1371/journal.pone.0157356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286043	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000060
J	Wysocki, AD; Villa, TCS; Arakawa, T; Brunello, MEF; Vendramini, SHF; Monroe, AA; Kritski, AL				Wysocki, Anneliese Domingues; Scatena Villa, Tereza Cristina; Arakawa, Tiemi; Firmino Brunello, Maria Eugenia; Figueiredo Vendramini, Silvia Helena; Monroe, Aline Aparecida; Kritski, Afranio Lineu			Latent Tuberculosis Infection Diagnostic and Treatment Cascade among Contacts in Primary Health Care in a City of Sao Paulo State, Brazil: Cross-Sectional Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVENTIVE THERAPY; ADHERENCE; CHILDREN	Background Diagnosis and treatment of latent tuberculosis infection (LTBI) is a tool for global TB control, especially in close contacts. But data is scarce in high burden countries, under field conditions, including data on the benefits of LTBI management. Objective To analyze the LTBI diagnosis and treatment cascade among contacts in primary health care (PHC) services in Sao Jose do Rio Preto-SP, Brazil. Methods Cross-sectional design, conducted with contacts of pulmonary TB patients followed in all PHC services. Data was collected from May to September 2014 in the Reporting System for TB cases (TBWEB) and Reporting System for Chemoprophylaxis. Medical records and treatment follow-up forms were reviewed and all the nurses responsible for TB in PHC services were interviewed. Results Among 336 contacts included, 267 (79.4%) were screened for TB or LTBI, according to the presence or not of respiratory symptoms. Among those contacts screened, 140 (52.4%) were symptomatic, 9 (3.4%) had TB disease, 106/221 (48%) had positive TST result, meeting the criteria for LTBI treatment, and 64/106 (60.4%) actually started it. Overall, among 267 screened, only 64 (24%) started LTBI treatment. The completion rates of treatment among the contacts who started it, those with positive TST result and those screened were 56.3% (36/64), 16.3%(36/221) and 13.5%(36/267), respectively. Nurses claimed that asymptomatic TB contacts pay no attention to preventive health care and do not seek medical care as they do not have symptoms of the disease. In reviewing the medical records, high proportions of contacts without evaluation, incomplete assessment, incorrect records of contraindication for LTBI treatment, lack of notes regarding the identification and evaluation of contacts were identified. Conclusions There is a need for better organization of the surveillance and investigation routine for contacts in PHC, considering the reorganization of the work process and the features of the local health system.	[Wysocki, Anneliese Domingues] Univ Fed Mato Grosso do Sul, Coll Nursing, Tres Lagoas, MS, Brazil; [Scatena Villa, Tereza Cristina; Arakawa, Tiemi; Firmino Brunello, Maria Eugenia; Monroe, Aline Aparecida] Univ Sao Paulo, Sch Nursing Ribeirao Preto, Dept Publ Hlth, BR-14049 Ribeirao Preto, SP, Brazil; [Figueiredo Vendramini, Silvia Helena] Sch Med Sao Jose do Rio Preto, Dept Publ Hlth Nursing & Profess Orientat, Sao Paulo, Brazil; [Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Sch Med, TB Acad Program, Rio De Janeiro, Brazil; [Wysocki, Anneliese Domingues; Scatena Villa, Tereza Cristina; Arakawa, Tiemi; Firmino Brunello, Maria Eugenia; Figueiredo Vendramini, Silvia Helena; Monroe, Aline Aparecida; Kritski, Afranio Lineu] Brazilian TB Res Network Rede TB, Rio De Janeiro, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Wysocki, AD (corresponding author), Univ Fed Mato Grosso do Sul, Coll Nursing, Tres Lagoas, MS, Brazil.; Wysocki, AD (corresponding author), Brazilian TB Res Network Rede TB, Rio De Janeiro, Brazil.	lilisew@yahoo.com.br	Wysocki, Anneliese Domingues/I-3696-2014; Kritski, Afranio/I-6760-2016; Monroe, Aline Aparecida/C-9568-2017; Villa, Tereza Cristina Scatena/K-7891-2013; Villa, Teresa/GQQ-9643-2022	Wysocki, Anneliese Domingues/0000-0002-8381-9999; Monroe, Aline Aparecida/0000-0003-4073-2735; Villa, Tereza Cristina Scatena/0000-0001-8927-2624; kritski, afranio/0000-0002-5900-6007	US Agency for International Development (USAID); International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA)	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA)	The study was conducted as a part of the TREAT TB program, funded by the US Agency for International Development (USAID), in a virtual approach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the unreserved assistance provided by the training team of the TREAT TB virtual Operational Research Learning Programme. The study was conducted as a part of the TREAT TB program, funded by the US Agency for International Development (USAID), in a virtual approach. This training project was implemented jointly by the SJRP TB control Programme, addressing its need to get better results in TB control. The authors also express their gratitude to the International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA), to the Brazilan Tuberculosis Research Network (Rede TB) and to PHC staff whose collaboration in this study made this research possible.	AISU T, 1995, AIDS, V9, P267, DOI 10.1097/00002030-199509030-00008; Arakawa T, 2011, REV LAT-AM ENFERM, V19, P994, DOI 10.1590/S0104-11692011000400019; Brasil. Programa Nacional de Controle de Tuberculose, 2015, B EP SECR VIG SAUD M, V46, P2; Mendonca AMC, 2015, BRAZ J INFECT DIS, V19, P296, DOI 10.1016/j.bjid.2014.12.005; Caldeira ZMR, 2004, REV SAUDE PUBL, V38, P339, DOI 10.1590/S0034-89102004000300001; Chakhaia T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111773; da Silva DM, 2014, REV ESC ENFERM USP, V48, P1041, DOI 10.1590/S0080-623420140000700012; Pereira ATD, 2008, CAD SAUDE PUBLICA, V24, pS123, DOI 10.1590/S0102-311X2008001300017; Lima Lílian Moura de, 2013, Rev. Gaúcha Enferm., V34, P102; Delai MY, 2012, PUBLIC HEALTH ACTION, V2, P142, DOI 10.5588/pha.12.0064; Duarte R, 2012, INT J TUBERC LUNG D, V16, P55, DOI 10.5588/ijtld.10.0511; Durovni PBP, 2013, THESIS NATL SCH PUBL; Ekwueme OEC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1175; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gebregergs GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125767; Gomes VF, 2011, INT J TUBERC LUNG D, V15, P1637, DOI 10.5588/ijtld.10.0558; Hartwig Shaiana Vilella, 2008, J. bras. pneumol., V34, P298, DOI 10.1590/S1806-37132008000500009; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Mandal P, 2012, QJM-INT J MED, V105, P741, DOI 10.1093/qjmed/hcs045; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Mendes EV, 2012, CUIDADO CONDICOES CR; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Person AK, 2013, CURR PULMONOL REP, V2, P199, DOI 10.1007/s13665-013-0064-y; RIEDER HL, 2002, INTERVENTIONS TUBERC; Rutherford ME, 2013, B WORLD HEALTH ORGAN, V91, P932, DOI 10.2471/BLT.13.118414; Rutherford Merrin E, 2012, BMC Res Notes, V5, P7, DOI 10.1186/1756-0500-5-7; Scatena LM, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005548; Scatena Lúcia Marina, 2009, Rev. Saúde Pública, V43, P389, DOI 10.1590/S0034-89102009005000022; Villa TCS, 2013, REV LAT-AM ENFERM, V21, P190, DOI 10.1590/S0104-11692013000700024; Sharma SK, 2012, CHEST, V142, P761, DOI 10.1378/chest.12-0142; Silva DM, 2012, THE FIEP B, V82, P268; Teixeira TP, 2010, VISITA DOMICILIAR CO, V22, P75; Thanh THT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-713; Tornee Songpol, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P375; van Zyl S, 2006, INT J TUBERC LUNG D, V10, P13; Vasconcellos MM, 2008, REGISTROS SAUDE AVAL, V24, P173; Wakiyama TP, 2012, REV CIENCE SAUDE, V14, P15; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation, 2015, GUID MAN LAT TUB INF	40	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155348	10.1371/journal.pone.0155348	http://dx.doi.org/10.1371/journal.pone.0155348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285720	gold, Green Published, Green Submitted			2022-12-26	WOS:000377564000004
J	Chen, JF; Zavala, C; Ortega, N; Petroli, C; Franco, J; Burgueno, J; Costich, DE; Hearne, SJ				Chen, Jiafa; Zavala, Cristian; Ortega, Noemi; Petroli, Cesar; Franco, Jorge; Burgueno, Juan; Costich, Denise E.; Hearne, Sarah J.			The Development of Quality Control Genotyping Approaches: A Case Study Using Elite Maize Lines	PLOS ONE			English	Article							CONSTRUCTION; GERMPLASM; MARKERS; KASP; SSR; MAP	Quality control (QC) of germplasm identity and purity is a critical component of breeding and conservation activities. SNP genotyping technologies and increased availability of markers provide the opportunity to employ genotyping as a low-cost and robust component of this QC. In the public sector available low-cost SNP QC genotyping methods have been developed from a very limited panel of markers of 1,000 to 1,500 markers without broad selection of the most informative SNPs. Selection of optimal SNPs and definition of appropriate germplasm sampling in addition to platform section impact on logistical and resource-use considerations for breeding and conservation applications when mainstreaming QC. In order to address these issues, we evaluated the selection and use of SNPs for QC applications from large DArTSeq data sets generated from CIMMYT maize inbred lines (CMLs). Two QC genotyping strategies were developed, the first is a "rapid QC", employing a small number of SNPs to identify potential mislabeling of seed packages or plots, the second is a "broad QC", employing a larger number of SNP, used to identify each germplasm entry and to measure heterogeneity. The optimal marker selection strategies combined the selection of markers with high minor allele frequency, sampling of clustered SNP in proportion to marker cluster distance and selecting markers that maintain a uniform genomic distribution. The rapid and broad QC SNP panels selected using this approach were further validated using blind test assessments of related re-generation samples. The influence of sampling within each line was evaluated. Sampling 192 individuals would result in close to 100% possibility of detecting a 5% contamination in the entry, and approximately a 98% probability to detect a 2% contamination of the line. These results provide a framework for the establishment of QC genotyping. A comparison of financial and time costs for use of these approaches across different platforms is discussed providing a framework for institutions involved in maize conservation and breeding to assess the resource use effectiveness of QC genotyping. Application of these research findings, in combination with existing QC approaches, will ensure the regeneration, distribution and use in breeding of true to type inbred germplasm. These findings also provide an effective approach to optimize SNP selection for QC genotyping in other species.	[Chen, Jiafa; Zavala, Cristian; Ortega, Noemi; Petroli, Cesar; Franco, Jorge; Burgueno, Juan; Costich, Denise E.; Hearne, Sarah J.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco 56237, Edo De Mexico, Mexico; [Franco, Jorge] Univ Republ, Dept Biometria, Paysandu 60000, Uruguay	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Universidad de la Republica, Uruguay	Costich, DE; Hearne, SJ (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco 56237, Edo De Mexico, Mexico.	D.Costich@cgiar.org; S.Hearne@cgiar.org	Franco, Jorge/AAF-4161-2020	Franco, Jorge/0000-0001-8082-4007	Sustainable Modernization of Traditional Agriculture (MasAgro) Project by Ministry of Agriculture, Livestock, Rural Development, Fisheries and Nutrition (SAGARPA) of the Government of Mexico	Sustainable Modernization of Traditional Agriculture (MasAgro) Project by Ministry of Agriculture, Livestock, Rural Development, Fisheries and Nutrition (SAGARPA) of the Government of Mexico	The work was supported by Sustainable Modernization of Traditional Agriculture (MasAgro) Project (http://masagro.mx) awarded to CIMMYT by the Ministry of Agriculture, Livestock, Rural Development, Fisheries and Nutrition (SAGARPA) (http://www.sagarpa.gob.mx) of the Government of Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; [Anonymous], 2011, GLOBAL J SCI FRONTIE; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153428; Chen JF, 2012, MOL BREEDING, V30, P1649, DOI 10.1007/s11032-012-9748-1; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; CIMMYT International Maize and Wheat Improvement Center, 2005, LAB PROT CIMMYT APPL, VThird; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Ding JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141619; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ertiro BT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2180-2; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Gaafar R. M., 2006, World Journal of Agricultural Sciences, V2, P29; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Gelman A., 2021, BAYESIAN DATA ANAL; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; He CL, 2014, METHODS MOL BIOL, V1145, P75, DOI 10.1007/978-1-4939-0446-4_7; Islam MN, 2012, NOT BOT HORTI AGROBO, V40, P261; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kaga A, 2011, BREEDING SCI, V61, P566, DOI 10.1270/jsbbs.61.566; MacQueen J.B., 1967, P 5 BERKELEY S MATH, V1, P281; Nakamura T, 2005, J HUM GENET, V50, P53, DOI 10.1007/s10038-004-0220-x; R Core Team, 2013, R LANG ENV STAT COMP; Ren RS, 2015, MOL GENET GENOMICS, V290, P1457, DOI 10.1007/s00438-015-0997-7; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; *SAS I, 1999, SAS US GUID STAT; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; SCHMIDT RJ, 1987, SCIENCE, V238, P960, DOI 10.1126/science.2823388; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Semagn K, 2012, THEOR APPL GENET, V125, P1487, DOI 10.1007/s00122-012-1928-1; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Troggio M, 2008, VITIS, V47, P21; van de Wouw M, 2011, CROP SCI, V51, P736, DOI 10.2135/cropsci2010.09.0511; Warburton ML, 2010, CROP SCI, V50, P467, DOI 10.2135/cropsci2009.02.0089; Warburton ML, 2002, CROP SCI, V42, P1832, DOI 10.2135/cropsci2002.1832; Wen WW, 2012, MOL BREEDING, V29, P951, DOI 10.1007/s11032-011-9696-1; Wen WW, 2011, GENET RESOUR CROP EV, V58, P189, DOI 10.1007/s10722-010-9562-8; Wu M, 2010, MOL PLANT BREED, V4, P381; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yan XM, 2011, IFIP ADV INF COMM TE, V346, P620; Yonemaru J, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct188; Zheng HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066606	47	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157236	10.1371/journal.pone.0157236	http://dx.doi.org/10.1371/journal.pone.0157236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280295	Green Published, gold			2022-12-26	WOS:000377563000113
J	Srinivasan, P; Moss, JA; Gunawardana, M; Churchman, SA; Yang, F; Dinh, CT; Mitchell, JM; Zhang, JN; Fanter, R; Miller, CS; Butkyavichene, I; McNicholl, JM; Smith, TJ; Baum, MM; Smith, JM				Srinivasan, Priya; Moss, John A.; Gunawardana, Manjula; Churchman, Scott A.; Yang, Flora; Dinh, Chuong T.; Mitchell, James M.; Zhang, Jining; Fanter, Rob; Miller, Christine S.; Butkyavichene, Irina; McNicholl, Janet M.; Smith, Thomas J.; Baum, Marc M.; Smith, James M.			Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures	PLOS ONE			English	Article							PREVENT HIV-INFECTION; ANTIRETROVIRAL PREEXPOSURE PROPHYLAXIS; HUMAN-IMMUNODEFICIENCY-VIRUS; PIG-TAILED MACAQUES; SUSTAINED DELIVERY; TRICHOMONAS-VAGINALIS; CHLAMYDIA-TRACHOMATIS; SEXUAL TRANSMISSION; PIGTAIL MACAQUES; MENSTRUAL-CYCLE	Topical preexposure prophylaxis (PrEP) against HIV has been marginally successful in recent clinical trials with low adherence rates being a primary factor for failure. Controlled, sustained release of antiretroviral (ARV) drugs may help overcome these low adherence rates if the product is protective for extended periods of time. The oral combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is currently the only FDA-approved ARV drug for HIV PrEP. A novel pod-intravaginal ring (IVR) delivering TDF and FTC at independently controlled rates was evaluated for efficacy at preventing SHIV162p3 infection in a rigorous, repeat low-dose vaginal exposure model using normally cycling female pigtailed macaques. Six macaques received pod-IVRs containing TDF (65 mg) and FTC (68 mg) every two weeks, and weekly vaginal exposures to 50 TCID50 of SHIV162p3 began one week after the first pod-IVR insertion. All pod-IVR-treated macaques were fully protected throughout the study (P = 0.0002, Log-rank test), whereas all control animals became infected with a median of 4 exposures to infection. The topical, sustained release of TDF and FTC from the pod-IVR maintained protective drug levels in macaques over four months of virus exposures. This novel and versatile delivery system has the capacity to deliver and maintain protective levels of multiple drugs and the protection observed here warrants clinical evaluation of this pod-IVR design.	[Srinivasan, Priya; Mitchell, James M.; McNicholl, Janet M.; Smith, James M.] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Atlanta, GA USA; [Moss, John A.; Gunawardana, Manjula; Yang, Flora; Fanter, Rob; Miller, Christine S.; Smith, Thomas J.; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA USA; [Churchman, Scott A.; Butkyavichene, Irina; Smith, Thomas J.] Auritec Pharmaceut Inc, Pasadena, CA USA; [Dinh, Chuong T.; Zhang, Jining] Total Solut Inc, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Smith, JM (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Atlanta, GA USA.	ajo9@cdc.gov		Moss, John/0000-0001-8091-3245; Baum, Marc/0000-0003-1558-5649	National Institutes of Health [R43AI098743]; Centers for Disease Control and Prevention; Total Solutions, Inc.; Auritec	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Total Solutions, Inc.; Auritec	Auritec, National Institutes of Health under grant R43AI098743 (TJS, SAC, IB); Centers for Disease Control and Prevention, Intramural funding (PS, J.M. Mitchell, J.M. McNicholl, JMS); Total Solutions, Inc. (CTD, JZ). The funders provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Anderson PL, 2014, J ANTIMICROB CHEMOTH, V69, P2470, DOI 10.1093/jac/dku162; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; [Anonymous], 2015, LANCET HIV, V2, pe115, DOI [10.1016/S2352-3018(15)00046-6, DOI 10.1016/S2352-3018(15)00046-6]; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Buckheit RW, 2010, ANTIVIR RES, V85, P142, DOI 10.1016/j.antiviral.2009.10.013; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Dimitrov D, 2012, J AIDS CLIN RES S5; Dobard C, 2014, AIDS RES HUM RETROV, V30, pA13, DOI 10.1089/aid.2014.5013a.abstract; Dobard C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007701; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Elias CJ, 1996, AIDS, V10, pS43; Feng JY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-44; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Gao Y, 2015, DRUG DELIV TRANSL RE, V5, P279, DOI 10.1007/s13346-015-0227-1; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2012, CURR OPIN HIV AIDS, V7, P505, DOI 10.1097/COH.0b013e328358e484; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Gengiah TN, 2014, INT J CLIN PHARM-NET, V36, P70, DOI 10.1007/s11096-013-9861-1; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunawardana M, 2014, J PHARM SCI-US, V103, P3611, DOI 10.1002/jps.24154; Henning T, 2011, J MED PRIMATOL, V40, P214, DOI 10.1111/j.1600-0684.2011.00488.x; Henning TR, 2014, J INFECT DIS, V210, P1239, DOI 10.1093/infdis/jiu240; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kashuba ADM, 2015, JAIDS-J ACQ IMM DEF, V69, P264, DOI 10.1097/QAI.0000000000000607; Kersh EN, 2014, J MED PRIMATOL, V43, P310, DOI 10.1111/jmp.12124; Krakower DS, 2015, CURR HIV-AIDS REP, V12, P127, DOI 10.1007/s11904-014-0253-5; Krakower DS, 2015, DRUGS, V75, P243, DOI 10.1007/s40265-015-0355-4; Kulkarni R, 2014, ANTIMICROB AGENTS CH, V58, P6145, DOI 10.1128/AAC.03591-14; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2015, LANCET IN PRESS, DOI [10.1016/S0140-6736(15)00056-2, DOI 10.1016/S0140-6736(15)00056-2]; Meyers K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114700; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Moss JAB, 2014, MICROBICIDE VAGINAL, P221; Moss JA, 2014, ANTIMICROB AGENTS CH, V58, P5125, DOI 10.1128/AAC.02871-14; Moss JA, 2013, ANTIMICROB AGENTS CH, V57, P3994, DOI 10.1128/AAC.00547-13; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P5952, DOI 10.1128/AAC.01198-12; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P875, DOI 10.1128/AAC.05662-11; Nuttall J, 2010, DRUGS, V70, P1231, DOI 10.2165/10898650-000000000-00000; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Plosker GL, 2013, DRUGS, V73, P279, DOI 10.1007/s40265-013-0024-4; Promadej-Lanier N, 2009, J MED PRIMATOL, V38, P263, DOI 10.1111/j.1600-0684.2009.00354.x; Radzio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050632; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4879; Sluis-Cremer N, 2014, ANTIMICROB AGENTS CH, V58, P2430, DOI 10.1128/AAC.02114-13; Smith JM, 2015, JAIDS-J ACQ IMM DEF, V68, P1, DOI 10.1097/QAI.0000000000000402; Smith JM, 2013, P NATL ACAD SCI USA, V110, P16145, DOI 10.1073/pnas.1311355110; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; U.S. FDA, 1998, GUIDANCE IND BIOANAL; UNAIDS, 2013, GLOBAL REPORT UNAIDS; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Veazey RS, 2013, CURR OPIN HIV AIDS, V8, P295, DOI 10.1097/COH.0b013e328361d096; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778	61	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157061	10.1371/journal.pone.0157061	http://dx.doi.org/10.1371/journal.pone.0157061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275923	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700064
J	Zhao, J; Schnitzler, GR; Iyer, LK; Aronovitz, MJ; Baur, WE; Karas, RH				Zhao, Jin; Schnitzler, Gavin R.; Iyer, Lakshmanan K.; Aronovitz, Mark J.; Baur, Wendy E.; Karas, Richard H.			MicroRNA-Offset RNA Alters Gene Expression and Cell Proliferation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BIOGENESIS; ARGONAUTE2; DISCOVERY; CLEAVAGE; DISTINCT; PROTEIN; MIRNAS	MicroRNA-offset RNAs (moRs) were first identified in simple chordates and subsequently in mouse and human cells by deep sequencing of short RNAs. MoRs are derived from sequences located immediately adjacent to microRNAs (miRs) in the primary miR (pri-miR). Currently moRs are considered to be simply a by-product of miR biosynthesis that lack biological activity. Here we show for the first time that a moR is biologically active. We demonstrate that endogenous or over-expressed moR-21 significantly alters gene expression and inhibits the proliferation of vascular smooth muscle cells (VSMC). In addition, we find that miR-21 and moR-21 may regulate different genes in a given pathway and can oppose each other in regulating certain genes. We report that there is a "seed region" of moR-21 as well as a "seed match region" in the target gene 3'UTR that are indispensable for moR-21-mediated gene down-regulation. We further demonstrate that moR-21-mediated gene repression is Argonaute 2 (Ago2) dependent. Taken together, these findings provide the first evidence that microRNA offset RNA alters gene expression and is biologically active.	[Zhao, Jin; Schnitzler, Gavin R.; Iyer, Lakshmanan K.; Aronovitz, Mark J.; Baur, Wendy E.; Karas, Richard H.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Karas, RH (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.	rkaras@tuftsmedicalcenter.org			NINDS NIH HHS [P30 NS047243] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Bortoluzzi S, 2012, BLOOD, V119, pE120, DOI 10.1182/blood-2011-07-368001; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dueck A, 2014, BIOL CHEM, V395, P611, DOI 10.1515/hsz-2014-0116; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li J, 2014, CELL SIGNAL, V26, P724, DOI 10.1016/j.cellsig.2013.12.013; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SULLIVAN TR, 1995, J CLIN INVEST, V96, P2482, DOI 10.1172/JCI118307; Umbach JL, 2010, VIROLOGY, V405, P592, DOI 10.1016/j.virol.2010.06.036; Yao YX, 2012, J GEN VIROL, V93, P1530, DOI 10.1099/vir.0.040634-0; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	27	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156772	10.1371/journal.pone.0156772	http://dx.doi.org/10.1371/journal.pone.0156772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276022	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700036
J	Niu, XH; He, WY; Song, B; Ou, ZH; Fan, D; Chen, YC; Fan, Y; Sun, XF				Niu, Xiaohua; He, Wenyin; Song, Bing; Ou, Zhanhui; Fan, Di; Chen, Yuchang; Fan, Yong; Sun, Xiaofang			Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in beta-Thalassemia-induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; IPS CELLS; RECENT TRENDS; THERAPY; GENERATION; DISEASE; PATIENT; ANEMIA; NUCLEASES; TALENS	beta-Thalassemia (beta-Thal) is one of the most common genetic diseases in the world. The generation of patient-specific beta-Thal-induced pluripotent stem cells (iPSCs), correction of the disease-causing mutations in those cells, and then differentiation into hematopoietic stem cells offers a new therapeutic strategy for this disease. Here, we designed a CRISPR/Cas9 to specifically target the Homo sapiens hemoglobin beta (HBB) gene CD41/42(-CTTT) mutation. We demonstrated that the combination of single strand oligodeoxynucleotides with CRISPR/Cas9 was capable of correcting the HBB gene CD41/42 mutation in beta-Thal iPSCs. After applying a correction-specific PCR assay to purify the corrected clones followed by sequencing to confirm mutation correction, we verified that the purified clones retained full pluripotency and exhibited normal karyotyping. Additionally, whole-exome sequencing showed that the mutation load to the exomes was minimal after CRISPR/Cas9 targeting. Furthermore, the corrected iPSCs were selected for erythroblast differentiation and restored the expression of HBB protein compared with the parental iPSCs. This method provides an efficient and safe strategy to correct the HBB gene mutation in beta-Thal iPSCs.	[Niu, Xiaohua; He, Wenyin; Song, Bing; Ou, Zhanhui; Fan, Di; Chen, Yuchang; Fan, Yong; Sun, Xiaofang] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China	Guangzhou Medical University	Sun, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China.	xiaofangsun@gzhmu.edu.cn			National Natural Science Foundation of China [31171229, U1132005, 81301184, 81502445]; Natural Science Foundation of Guangdong Province [2014A030312012]; International Cooperation Project of Science and Technology Planning Project of Guangdong Province [2013B51000087]; Science and Information Technology of Guangzhou [201508020258, 201400000003-4, 201400000004-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); International Cooperation Project of Science and Technology Planning Project of Guangdong Province; Science and Information Technology of Guangzhou	This work was supported by National Natural Science Foundation of China Grants 31171229, U1132005, 81301184 and 81502445; Natural Science Foundation of Guangdong Province Grant 2014A030312012; International Cooperation Project of Science and Technology Planning Project of Guangdong Province Grant 2013B51000087; and Science and Information Technology of Guangzhou Key Project Grants 201508020258, 201400000003-4, and 201400000004-4. The authors declare that they have no conflicts of interest with the contents of this article.	Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Chang JC, 2006, P NATL ACAD SCI USA, V103, P1036, DOI 10.1073/pnas.0510177103; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Finotti A, 2015, J BLOOD MED, V6, P69, DOI 10.2147/JBM.S46256; Finotti A, 2014, EXPERT OPIN BIOL TH, V14, P1443, DOI 10.1517/14712598.2014.927434; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Leavitt AD, 2011, CTS-CLIN TRANSL SCI, V4, P298, DOI 10.1111/j.1752-8062.2011.00281.x; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Papapetrou EP, 2005, GENE THER, V12, pS118, DOI 10.1038/sj.gt.3302626; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Ramalingam S, 2014, CURR GENE THER, V14, P461, DOI 10.2174/1566523214666140918101725; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Wang YX, 2009, CELL RES, V19, P1120, DOI 10.1038/cr.2009.100; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456; Yang YY, 2016, STEM CELL TRANSL MED, V5, P267, DOI 10.5966/sctm.2015-0157erratum; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	34	60	65	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16576	16585		10.1074/jbc.M116.719237	http://dx.doi.org/10.1074/jbc.M116.719237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288406	hybrid, Green Published			2022-12-26	WOS:000380826700017
J	Weng, CY; Nguyen, T; Shively, JE				Weng, Chunyue; Nguyen, Tung; Shively, John E.			miRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ADHESION MOLECULE; BILIARY GLYCOPROTEIN CD66A; BREAST EPITHELIAL-CELLS; DNA METHYLTRANSFERASE 1; LOOP-HELIX PROTEIN; CYTOPLASMIC DOMAIN; MUTATIONAL ANALYSIS; COLORECTAL-CANCER; MALIGNANT BREAST; LEUKEMIA-CELLS	Lumen formation of breast epithelium is rapidly lost during tumorigenesis along with expression of cell adhesion molecule CEACAM1. CEACAM1 induces lumena in a three-dimensional culture of MCF7/CEACAM1 cells that otherwise fail to form lumena. We hypothesized miRNAs may be involved because >400 genes were up-or down-regulated in MCF7/CEACAM1 cells and miRNAs may modify global expression patterns. Comparative analysis of miRNA expression in MCF7 versus MCF7/ CEACAM1 cells revealed two miRNAs significantly down-regulated (hsa-miR-30a-3p by 6.73-fold and hsa-miR-342-5p by 5.68-fold). Location of miR-342 within an intron of the EVL gene, hypermethylated and involved in tumorigenesis, suggested that miR-342 overexpression may block lumen formation. In fact, overexpression of miR-342 in MCF7/CEACAM1 cells significantly blocked lumen formation (p < 0.001). ID4, a dominant-negative inhibitor of basic helix-loop-helix transcription factors, up-regulated in MCF7/CEACAM1 cells, down-regulated in breast cancer, and containing a miR-342 binding site, was tested as a potential target of miR-342. The ratio of ID4 to miR-342 increased from 1: 2 in MCF7 cells to 30: 1 in MCF7/ CEACAM1 cells and a miR-342 inhibitor was able to induce 3'-UTR ID4 reporter activity in MCF7 cells. Because 5-methylcytosine methyltransferase DNMT1 is also a potential target of miR-342, we inhibited miR-342 in MCF7 cells and found DNMT1 was up-regulated with no change in EVL expression, suggesting that miR-342 regulates DNMT1 expression but DNMT1 does not affect the EVL expression in these cells. We conclude that the regulation of lumen formation by miR-342 involves at least two of its known targets, namely ID4 and DNMT1.	[Weng, Chunyue] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Weng, Chunyue; Nguyen, Tung; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), 1450 E Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Chinaranagari S, 2014, ONCOTARGET, V5, P7172, DOI 10.18632/oncotarget.2262; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Crippa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087039; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Dery KJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-64; Ferrari N, 2013, J CELL PHYSIOL, V228, P1137, DOI 10.1002/jcp.24285; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; Li XR, 2014, FEBS LETT, V588, P3298, DOI 10.1016/j.febslet.2014.07.020; Lu RZ, 2012, CANCER RES, V72, P2239, DOI 10.1158/0008-5472.CAN-11-3016; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; MCCUAIG K, 1993, GENE, V127, P173, DOI 10.1016/0378-1119(93)90716-G; Mohan KN, 2013, INT REV CEL MOL BIO, V306, P1, DOI 10.1016/B978-0-12-407694-5.00001-8; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Nguyen T, 2016, J BIOL CHEM, V291, P16766, DOI 10.1074/jbc.M115.710160; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Ozeki M, 2008, J LEUKOCYTE BIOL, V84, P769, DOI 10.1189/jlb.1207817; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Patel D, 2015, BBA-REV CANCER, V1855, P92, DOI 10.1016/j.bbcan.2014.12.002; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Ronchetti D, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-37; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Sutherland KD, 2007, CELL CYCLE, V6, P799, DOI 10.4161/cc.6.7.4037; Tandon M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3611; Tao K, 2014, AM J TRANSL RES, V6, P391; Nguyen T, 2014, J BIOL CHEM, V289, P2934, DOI 10.1074/jbc.M113.496992; Umetani N, 2004, CLIN CANCER RES, V10, P7475, DOI 10.1158/1078-0432.CCR-04-0689; Umetani N, 2005, ONCOGENE, V24, P4721, DOI 10.1038/sj.onc.1208538; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wang LL, 2012, ANTIVIR RES, V93, P270, DOI 10.1016/j.antiviral.2011.12.004; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Xie X, 2015, TUMOR BIOL, V36, P5031, DOI 10.1007/s13277-015-3154-3; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053359; Zhao L, 2015, BIOCHEM BIOPH RES CO, V457, P370, DOI 10.1016/j.bbrc.2014.12.119	52	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16777	16786		10.1074/jbc.M115.710152	http://dx.doi.org/10.1074/jbc.M115.710152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302063	Green Published, hybrid			2022-12-26	WOS:000380826700034
J	Kim, YI; Kim, HS; Park, JW				Kim, Young-Il; Kim, Hyoung Sang; Park, Joong-Won			Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase	PLOS ONE			English	Article							PROGNOSIS; DIAGNOSIS; HBSAG	Background The role of serum alpha-fetoprotein (AFP) levels in the surveillance and diagnosis of hepatocellular carcinoma (HCC) is controversial. The aim of this study was to investigate the value of serially measured serum AFP levels in HCC progression or recurrence after initial treatment. Methods A total of 722 consecutive patients newly diagnosed with HCC and treated at the National Cancer Center, Korea, between January 2004 and December 2009 were enrolled. The AFP ratios between 4-8 weeks post-treatment and those at the time of HCC progression or recurrence were obtained. Multivariate logistic regression analysis was performed to correlate the post-treatment AFP ratios with the presence of HCC progression or recurrence. Results The etiology of HCC was related to chronic hepatitis B virus (HBV) infection in 562 patients (77.8%), chronic hepatitis C virus (HCV) infection in 74 (10.2%), and non-viral cause in 86 (11.9%). There was a significant decrease in serum AFP levels from the baseline to 4 to 8 weeks after treatment (median AFP, 319.6 ng/mL vs. 49.6 ng/mL; p < 0.001). Multivariate analysis showed that an AFP ratio > 1.0 was an independently associated with HCC progression or recurrence. Among the different causes of HCC analyzed, this association was significant only for HCC related to chronic hepatitis B (p < 0.001) and non-viral causes (p < 0.05), and limited only to patients who had normal alanine aminotransferase (ALT) levels. Conclusion Serial measurements of serum AFP ratios could be helpful in detecting progression or recurrence in treated patients with HBV-HCC and normal ALT.	[Kim, Young-Il; Kim, Hyoung Sang; Park, Joong-Won] Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea	National Cancer Center - Korea (NCC)	Park, JW (corresponding author), Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea.	jwpark@ncc.re.kr			National Cancer Center, Korea [1510520]	National Cancer Center, Korea	This study was supported by a grant from the National Cancer Center, Korea (#1510520).; This study was supported by a grant from the National Cancer Center, Korea (#1510520). We thank Prof. Byung-Ho Nam (Biometric Research, National Cancer Center, Korea) for a precise consult on statistical analysis.	Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Di Bisceglie AM, 2005, J HEPATOL, V43, P434, DOI 10.1016/j.jhep.2005.03.019; Hakeem AR, 2012, ALIMENT PHARM THER, V35, P987, DOI 10.1111/j.1365-2036.2012.05060.x; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Korean-Liver-Canc-Study-Grp-KLCSG, 2015, GUT LIVER, V9, P267, DOI 10.5009/gnl14460; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; LEE HS, 1991, HEPATOLOGY, V14, P68, DOI 10.1002/hep.1840140112; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; LIAW YF, 1986, LIVER, V6, P133; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Manghisi G, 1998, HEPATOLOGY, V28, P751; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Richardson P, 2012, CLIN GASTROENTEROL H, V10, P428, DOI 10.1016/j.cgh.2011.11.025; Song DS, 2012, CLIN MOL HEPATOL, V18, P258, DOI 10.3350/cmh.2012.18.3.258; Spangenberg HC, 2006, SEMIN LIVER DIS, V26, P385, DOI 10.1055/s-2006-951606; Tan CK, 2003, J CLIN ONCOL, V21, P2294, DOI 10.1200/JCO.2003.03.151; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Toro A, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-40; Toso C, 2015, HEPATOLOGY, V62, P158, DOI 10.1002/hep.27787; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Ueno S, 2002, HEPATOL RES, V24, P395, DOI 10.1016/S1386-6346(02)00144-4; Wong GLH, 2014, HEPATOLOGY, V59, P986, DOI 10.1002/hep.26739	26	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157299	10.1371/journal.pone.0157299	http://dx.doi.org/10.1371/journal.pone.0157299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304617	gold, Green Submitted, Green Published			2022-12-26	WOS:000377824800045
J	Wang, F; Coe, RA; Karki, S; Wanchana, S; Thakur, V; Henry, A; Lin, HC; Huang, JL; Peng, SB; Quick, WP				Wang, Fei; Coe, Robert A.; Karki, Shanta; Wanchana, Samart; Thakur, Vivek; Henry, Amelia; Lin, Hsiang-Chun; Huang, Jianliang; Peng, Shaobing; Quick, William Paul			Overexpression of OsSAP16 Regulates Photosynthesis and the Expression of a Broad Range of Stress Response Genes in Rice (Oryza sativa L.)	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; INDUCED STOMATAL CLOSURE; HETEROTRIMERIC G-PROTEIN; T-DNA; ABC TRANSPORTER; ABSCISIC-ACID; DIFFERENTIAL EXPRESSION; DROUGHT-RESISTANCE; HYDROGEN-PEROXIDE; MESOPHYLL CONDUCTANCE	This study set out to identify and characterize transcription factors regulating photosynthesis in rice. Screening populations of rice T-DNA activation lines led to the identification of a T-DNA mutant with an increase in intrinsic water use efficiency (iWUE) under well-watered conditions. Flanking sequence analysis showed that the T-DNA construct was located upstream of LOC_Os07g38240 (OsSAP16) encoding for a stress-associated protein (SAP). A second mutant identified with activation in the same gene exhibited the same phenotype; expression of OsSAP16 was shown to be enhanced in both lines. There were no differences in stomatal development or morphology in either of these mutants, although overexpression of OsSAP16 reduced stomatal conductance. This phenotype limited CO2 uptake and the rate of photosynthesis, which resulted in the accumulation of less biomass in the two mutants. Whole transcriptome analysis showed that overexpression of OsSAP16 led to global changes in gene expression consistent with the function of zinc-finger transcription factors. These results show that the gene is involved in modulating the response of rice to drought stress through regulation of the expression of a set of stress-associated genes.	[Wang, Fei; Huang, Jianliang; Peng, Shaobing] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Improvement, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan 430070, Hubei Province, Peoples R China; [Coe, Robert A.; Karki, Shanta; Wanchana, Samart; Thakur, Vivek; Lin, Hsiang-Chun; Quick, William Paul] Int Rice Res Inst, Rice Ctr C4, Los Banos, Philippines; [Henry, Amelia] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Philippines	Huazhong Agricultural University; CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI)	Wang, F (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Improvement, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan 430070, Hubei Province, Peoples R China.	fwang@mail.hzau.edu.cn	Wanchana, Samart/AAF-5773-2020; Karki, Shanta/AAO-2373-2021	Henry, Amelia/0000-0001-6255-5480; Wanchana, Samart/0000-0002-5459-3425; Lin, Hsiang-Chun/0000-0003-1108-2622	Bill and Melinda Gates Foundation under C4 Rice Center at IRRI	Bill and Melinda Gates Foundation under C4 Rice Center at IRRI	This work was funded by Bill and Melinda Gates Foundation under the C4 Rice Center at IRRI.; This work was funded by Bill and Melinda Gates Foundation under the C4 Rice Center at IRRI. The authors wish to thank Irma Canicosa for the photosynthesis measurements, Julius Ver Sagun for assistance with the PCR and Abigail Mabilangan for assistance with the microscopy.	Adachi S, 2011, J EXP BOT, V62, P1927, DOI 10.1093/jxb/erq387; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Balazadeh S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00234; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Chae L, 2009, MOL PLANT, V2, P84, DOI 10.1093/mp/ssn083; Chen YL, 2004, PLANT PHYSIOL, V136, P4096, DOI 10.1104/pp.104.047837; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2010, TRANSCR-AUSTIN, V1, P41, DOI 10.4161/trns.1.1.12064; Dansana PK, 2014, PLANT CELL REP, V33, P1425, DOI 10.1007/s00299-014-1626-3; DESILVA DLR, 1985, NEW PHYTOL, V101, P555, DOI 10.1111/j.1469-8137.1985.tb02861.x; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Ding ZJ, 2014, PLANT J, V79, P13, DOI 10.1111/tpj.12538; Dixit AR, 2011, THESIS; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HAYASHI H, 1992, SCIENCE, V258, P1350, DOI 10.1126/science.1455228; Henry A, 2012, J EXP BOT, V63, P4751, DOI 10.1093/jxb/ers150; Hsing YI, 2007, PLANT MOL BIOL, V63, P351, DOI 10.1007/s11103-006-9093-z; Hsu KH, 2014, PLANT MOL BIOL, V86, P125, DOI 10.1007/s11103-014-0217-6; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Huang SS, 2001, PLANT PHYSIOL, V125, P573, DOI 10.1104/pp.125.2.573; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jeong DH, 2002, PLANT PHYSIOL, V130, P1636, DOI 10.1104/pp.014357; Jin Y, 2007, GENOMICS, V90, P265, DOI 10.1016/j.ygeno.2007.03.019; Kajala K, 2011, J EXP BOT, V62, P3001, DOI 10.1093/jxb/err022; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Klein M, 2004, PLANT J, V39, P219, DOI 10.1111/j.1365-313X.2004.02125.x; Kollist H, 2014, NEW PHYTOL, V203, P44, DOI 10.1111/nph.12832; KOORNNEEF M, 1982, MUTAT RES, V93, P109, DOI 10.1016/0027-5107(82)90129-4; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kuromori T, 2011, PLANT J, V67, P885, DOI 10.1111/j.1365-313X.2011.04641.x; Kusumi K, 2012, J EXP BOT, V63, P5635, DOI 10.1093/jxb/ers216; LANGE OL, 1971, PLANTA, V100, P76, DOI 10.1007/BF00386887; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li B, 2011, BMC BIOINFORMATICS, P12; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JH, 2009, PLANT PHYSIOL, V150, P114, DOI 10.1104/pp.109.137067; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093290; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Ocheltree TW, 2012, PLANT CELL ENVIRON, V35, P1040, DOI 10.1111/j.1365-3040.2011.02470.x; Ohsumi A, 2007, ANN BOT-LONDON, V99, P265, DOI 10.1093/aob/mcl253; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Skirycz A, 2011, NAT BIOTECHNOL, V29, P212, DOI 10.1038/nbt.1800; Sundaresan V, 1996, TRENDS PLANT SCI, V1, P184, DOI 10.1016/1360-1385(96)10022-4; Suzuki Y, 2001, PLANT MOL BIOL, V45, P123, DOI 10.1023/A:1006455130098; Taylaran RD, 2011, J EXP BOT, V62, P4067, DOI 10.1093/jxb/err126; Tyagi H, 2014, PLANT SCI, V225, P68, DOI 10.1016/j.plantsci.2014.05.016; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Fits L, 2001, TRANSGENIC RES, V10, P513, DOI 10.1023/A:1013087011562; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Vij S, 2006, MOL GENET GENOMICS, V276, P565, DOI 10.1007/s00438-006-0165-1; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Xiong DL, 2015, FUNCT PLANT BIOL, V42, P347, DOI 10.1071/FP14166; Xu YF, 1997, JPN J CROP SCI, V66, P616, DOI 10.1626/jcs.66.616; Yi J, 2013, J PLANT BIOL, V56, P85, DOI 10.1007/s12374-013-0905-9; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zubko E, 2002, PLANT J, V29, P797, DOI 10.1046/j.1365-313X.2002.01256.x	83	8	9	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157244	10.1371/journal.pone.0157244	http://dx.doi.org/10.1371/journal.pone.0157244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303811	gold, Green Published, Green Submitted			2022-12-26	WOS:000377824800041
J	Tao, WD; Zhang, XX; Zhao, FZ; Huang, KL; Ma, HJ; Wang, Z; Ye, L; Ren, HQ				Tao, Wenda; Zhang, Xu-Xiang; Zhao, Fuzheng; Huang, Kailong; Ma, Haijun; Wang, Zhu; Ye, Lin; Ren, Hongqiang			High Levels of Antibiotic Resistance Genes and Their Correlations with Bacterial Community and Mobile Genetic Elements in Pharmaceutical Wastewater Treatment Bioreactors	PLOS ONE			English	Article							SEWAGE-TREATMENT PLANT; TETRACYCLINE RESISTANCE; METAGENOMIC APPROACH; ACTIVATED-SLUDGE; ANTIMICROBIAL RESISTANCE; SULFONAMIDE ANTIBIOTICS; RECEIVING RIVER; PLASMID; SYSTEM; DIVERSITY	To understand the diversity and abundance of antibiotic resistance genes (ARGs) in pharmaceutical wastewater treatment bioreactors, the ARGs in sludge from two full-scale pharmaceutical wastewater treatment plants (PWWTPs) were investigated and compared with sludge samples from three sewage treatment plants (STPs) using metagenomic approach. The results showed that the ARG abundances in PWWTP sludge ranged from 54.7 to 585.0 ppm, which were higher than those in STP sludge (27.2 to 86.4 ppm). Moreover, the diversity of ARGs in PWWTP aerobic sludge (153 subtypes) was higher than that in STP aerobic sludge (118 subtypes). In addition, it was found that the profiles of ARGs in PWWTP aerobic sludge were similar to those in STP aerobic sludge but different from those in PWWTP anaerobic sludge, suggesting that dissolve oxygen (DO) could be one of the important factors affecting the profiles of ARGs. In PWWTP aerobic sludge, aminoglycoside, sulfonamide and multidrug resistance genes were frequently detected. While, tetracycline, macrolide-lincosamide-streptogramin and polypeptide resistance genes were abundantly present in PWWTP anaerobic sludge. Furthermore, we investigated the microbial community and the correlation between microbial community and ARGs in PWWTP sludge. And, significant correlations between ARG types and seven bacterial genera were found. In addition, the mobile genetic elements (MGEs) were also examined and correlations between the ARGs and MGEs in PWWTP sludge were observed. Collectively, our results suggested that the microbial community and MGEs, which could be affected by DO, might be the main factors shaping the profiles of ARGs in PWWTP sludge.	[Tao, Wenda; Zhang, Xu-Xiang; Zhao, Fuzheng; Huang, Kailong; Ma, Haijun; Wang, Zhu; Ye, Lin; Ren, Hongqiang] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Environm Hlth Res Ctr, Sch Environm, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University	Zhang, XX; Ye, L (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Environm Hlth Res Ctr, Sch Environm, Nanjing 210023, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; linye@nju.edu.cn	zhang, xu/GYE-3558-2022; Zhao, Fuzheng/H-1590-2015; 王, 铸/I-3824-2016; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; Zhao, Fuzheng/J-8280-2019; zhang, xian/GYA-0290-2022; Ye, Lin/F-9709-2013; Zhu, Wang/AAT-1740-2021; hq, ren/AGA-1128-2022	Zhao, Fuzheng/0000-0002-9911-4360; 王, 铸/0000-0002-6763-8194; Ye, Lin/0000-0002-4682-8917; Ren, Hong-qiang/0000-0001-6136-800X	Excellent Youth Foundation of Jiangsu Scientific Committee [SBK2015010297]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2014BAC08B04]; Key Technology Research and Development Program of Jiangsu Province [BE2013704]	Excellent Youth Foundation of Jiangsu Scientific Committee; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Technology Research and Development Program of Jiangsu Province	This study was financially supported by the Excellent Youth Foundation of Jiangsu Scientific Committee (SBK2015010297), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2014BAC08B04) and Key Technology Research and Development Program of Jiangsu Province (BE2013704).; This study was financially supported by the Excellent Youth Foundation of Jiangsu Scientific Committee (SBK2015010297), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2014BAC08B04) and Key Technology Research and Development Program of Jiangsu Province (BE2013704). We also thank the High Performance Computing Center (HPCC) of Nanjing University for the help of computation.	Fernandez-Fuentes MA, 2014, INT J FOOD MICROBIOL, V172, P49, DOI 10.1016/j.ijfoodmicro.2013.11.032; Arzese AR, 2000, J ANTIMICROB CHEMOTH, V45, P577, DOI 10.1093/jac/45.5.577; Boente RF, 2010, ANAEROBE, V16, P190, DOI 10.1016/j.anaerobe.2010.02.003; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Chen BW, 2013, ENVIRON SCI TECHNOL, V47, P12753, DOI 10.1021/es403818e; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Fang H, 2015, ENVIRON SCI TECHNOL, V49, P1095, DOI 10.1021/es504157v; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gao P, 2012, SCI TOTAL ENVIRON, V421, P173, DOI 10.1016/j.scitotenv.2012.01.061; Gutierrez IR, 2010, J SOIL SEDIMENT, V10, P537, DOI 10.1007/s11368-009-0168-8; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P955, DOI 10.1093/jac/dkt454; Huang MH, 2015, J HAZARD MATER, V298, P303, DOI 10.1016/j.jhazmat.2015.05.039; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Ibarbalz FM, 2013, WATER RES, V47, P3854, DOI 10.1016/j.watres.2013.04.010; Klein G, 2000, J APPL MICROBIOL, V89, P815, DOI 10.1046/j.1365-2672.2000.01187.x; Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Li B, 2010, ENVIRON SCI TECHNOL, V44, P3468, DOI 10.1021/es903490h; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu MM, 2014, WATER RES, V63, P33, DOI 10.1016/j.watres.2014.05.045; Liu MM, 2012, ENVIRON SCI TECHNOL, V46, P7551, DOI 10.1021/es301145m; Ma LP, 2014, APPL MICROBIOL BIOT, V98, P5195, DOI 10.1007/s00253-014-5511-3; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miao Y, 2015, WATER RES, V76, P43, DOI 10.1016/j.watres.2015.02.042; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Novo A, 2013, WATER RES, V47, P1875, DOI 10.1016/j.watres.2013.01.010; Ouyang WY, 2015, APPL MICROBIOL BIOT, V99, P5697, DOI 10.1007/s00253-015-6416-5; Pai MP, 2000, ANN PHARMACOTHER, V34, P495, DOI 10.1345/aph.19138; Ploy MC, 2000, CLIN CHEM LAB MED, V38, P483, DOI 10.1515/CCLM.2000.070; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quintiliani Richard Jr., 1995, P1308; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; SPEER BS, 1991, J BACTERIOL, V173, P176, DOI 10.1128/jb.173.1.176-183.1991; Szczepanowski R, 2004, MICROBIOL-SGM, V150, P3613, DOI 10.1099/mic.0.27317-0; Tang SS, 2014, ADV DRUG DELIVER REV, V78, P3, DOI 10.1016/j.addr.2014.08.003; Thomson JM, 2005, CURR OPIN MICROBIOL, V8, P518, DOI 10.1016/j.mib.2005.08.014; Tojo S, 2015, ANTIMICROB AGENTS CH, V59, P7799, DOI 10.1128/AAC.01932-15; Varela AR, 2014, WATER RES, V54, P327, DOI 10.1016/j.watres.2014.02.003; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Vesth T, 2013, STAND GENOMIC SCI, V9, P431, DOI 10.4056/sigs.2981345; Vishnivetskaya TA, 2014, FEMS MICROBIOL ECOL, V87, P217, DOI 10.1111/1574-6941.12219; Wang JL, 2015, SCI TOTAL ENVIRON, V526, P366, DOI 10.1016/j.scitotenv.2015.05.046; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113603; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Xiong WG, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00061; Xiong WG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00194; Xu J, 2015, CHEMOSPHERE, V119, P1379, DOI 10.1016/j.chemosphere.2014.02.040; Yang Y, 2014, WATER RES, V62, P97, DOI 10.1016/j.watres.2014.05.019; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Zhang T, 2015, APPL MICROBIOL BIOT, V99, P7771, DOI 10.1007/s00253-015-6688-9; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z; Zhou LJ, 2013, SCI TOTAL ENVIRON, V452, P365, DOI 10.1016/j.scitotenv.2013.03.010	63	49	53	9	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156854	10.1371/journal.pone.0156854	http://dx.doi.org/10.1371/journal.pone.0156854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294780	gold, Green Published, Green Submitted			2022-12-26	WOS:000377821300012
J	Shen, QH; Kirschbaum, MUF; Hedley, MJ; Arbestain, MC				Shen, Qinhua; Kirschbaum, Miko U. F.; Hedley, Mike J.; Arbestain, Marta Camps			Testing an Alternative Method for Estimating the Length of Fungal Hyphae Using Photomicrography and Image Processing	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; MEMBRANE-FILTER TECHNIQUE; SOIL AGGREGATION; MYCELIUM; QUANTIFICATION; COMMUNITIES; PHOSPHORUS; BIOMASS	This study aimed to develop and test an unbiased and rapid methodology to estimate the length of external arbuscular mycorrhizal fungal (AMF) hyphae in soil. The traditional visual gridline intersection (VGI) method, which consists in a direct visual examination of the intersections of hyphae with gridlines on a microscope eyepiece after aqueous extraction, membrane-filtration, and staining (e.g., with trypan blue), was refined. For this, (i) images of the stained hyphae were taken by using a digital photomicrography technique to avoid the use of the microscope and the method was referred to as "digital gridline intersection" (DGI) method; and (ii), the images taken in (i) were processed and the hyphal length was measured by using ImageJ software, referred to as the "photomicrography-ImageJ processing" (PIP) method. The DGI and PIP methods were tested using known grade lengths of possum fur. Then they were applied to measure the hyphal lengths in soils with contrasting phosphorus (P) fertility status. Linear regressions were obtained between the known lengths (L-known) of possum fur and the values determined by using either the DGI (L-DGI) (L-DGI = 0.37 + 0.97 x L-known, r(2) = 0.86) or PIP (L-PIP) methods (L-PIP = 0.33 + 1.01 x L-known, r(2) = 0.98). There were no significant (P > 0.05) differences between the L-DGI and L-PIP values. While both methods provided accurate estimation (slope of regression being 1.0), the PIP method was more precise, as reflected by a higher value of r(2) and lower coefficients of variation. The average hyphal lengths (6.5-19.4 m g(-1)) obtained by the use of these methods were in the range of those typically reported in the literature (3-30 m g(-1)). Roots growing in P-deficient soil developed 2.5 times as many hyphae as roots growing in P-rich soil (17.4 vs 7.2 m g(-1)). These tests confirmed that the use of digital photomicrography in conjunction with either the grid-line intersection principle or image processing is a suitable method for the measurement of AMF hyphal lengths in soils for comparative investigations.	[Shen, Qinhua; Hedley, Mike J.; Arbestain, Marta Camps] Massey Univ, Inst Agr & Environm, New Zealand Biochar Res Ctr, Private Bag 11222, Palmerston North 4442, New Zealand; [Kirschbaum, Miko U. F.] Landcare Res, Private Bag 11-052, Palmerston North 4442, New Zealand	Massey University; Landcare Research - New Zealand	Shen, QH (corresponding author), Massey Univ, Inst Agr & Environm, New Zealand Biochar Res Ctr, Private Bag 11222, Palmerston North 4442, New Zealand.	Q.shen@massey.ac.nz		Hedley, Michael James/0000-0002-3739-2533; Camps Arbestain, Marta/0000-0002-5354-2087; Shen, Qinhua/0000-0001-8767-6852	New Zealand Biochar Research Centre	New Zealand Biochar Research Centre	The New Zealand Biochar Research Centre granted to QHS for this research project at Massey University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1984, NEW PHYTOL, V97, P437, DOI 10.1111/j.1469-8137.1984.tb03609.x; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BARDGETT RD, 1991, AGR ECOSYST ENVIRON, V34, P115, DOI 10.1016/0167-8809(91)90099-J; Boddington CL, 1999, SOIL BIOL BIOCHEM, V31, P479, DOI 10.1016/S0038-0717(98)00145-X; Brundrett M., 1994, PRACTICAL METH ODS M; Camenzind T, 2013, SOIL BIOL BIOCHEM, V64, P96, DOI 10.1016/j.soilbio.2013.04.011; Colla G, 2008, BIOL FERT SOILS, V44, P501, DOI 10.1007/s00374-007-0232-8; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; DODD JC, 1994, ADV LIF SCI, P147; ELMHOLT S, 1987, SOIL BIOL BIOCHEM, V19, P679, DOI 10.1016/0038-0717(87)90047-2; GREEN DC, 1994, MYCORRHIZA, V5, P105, DOI 10.1007/BF00202341; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hynes M. M., 2008, MICROSC MICROANAL, P139; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Leifheit EF, 2015, SOIL BIOL BIOCHEM, V81, P323, DOI 10.1016/j.soilbio.2014.12.003; Mallard F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064387; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; MORGAN P, 1991, SOIL BIOL BIOCHEM, V23, P609, DOI 10.1016/0038-0717(91)90072-R; PACOVSKY RS, 1982, PLANT SOIL, V68, P143, DOI 10.1007/BF02374736; R Core Team, 2013, R LANG ENV STAT COMP; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Sheffield J, 2008, MICROSC MICROANAL S2, V14, P898, DOI DOI 10.1017/S1431927608088752; Shen Q, 2016, J SOIL SCI IN PRESS; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; STAHL PD, 1995, SOIL BIOL BIOCHEM, V27, P1091, DOI 10.1016/0038-0717(94)00204-E; Sylvia DM, 1992, QUANTIFICATION EXTER, V53; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wu QS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05823; Zhang ZZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142371; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	31	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157017	10.1371/journal.pone.0157017	http://dx.doi.org/10.1371/journal.pone.0157017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284995	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000036
J	Link, D; de Lorenzo, MF				Link, Daniel; de Lorenzo, Michael F.			Seasonal Pacing - Match Importance Affects Activity in Professional Soccer	PLOS ONE			English	Article							PREMIER LEAGUE SOCCER; ELITE SOCCER; PERFORMANCE; FATIGUE; PLAYERS; TIME; PROFILES; FOOTBALL; FITNESS	This research explores the influence of match importance on player activity in professional soccer. Therefore, we used an observational approach and analyzed 1,211 matches of German Bundesliga and 2nd Bundesliga. The importance measurement employed is based on post season consequences of teams involved in a match. This means, if a match result could potentially influence the final rank, and this rank would lead to different consequences for a team, such as qualification for Champions League opposed to qualification for Europe League, then this match is classified as important; otherwise not. Activity was quantified by TOTAL DISTANCE COVERED, SPRINTS, FAST RUNS, DUELS, FOULS and ATTEMPTS. Running parameters were recorded using a semi-automatic optical tracking system, while technical variables were collected by professional data loggers. Based on our importance classification, low important matches occurred at the beginning of round 29. A two-way ANOVA indicates significantly increased FAST RUNS (+4%, d = 0.3), DUELS (+16%, d = 1.0) and FOULS (+36%, d = 1.2) in important matches compared to low important ones. For FAST RUNS and FOULS, this effect only exists in Bundesliga. A comparison of the two leagues show that TOTAL DISTANCE COVERED (+3%, d = 0.9), SPRINTS (+25%, d = 1.4) and FAST RUNS (+15%, d = 1.4) are higher compared to 2nd Bundesliga, whilst FOULS is less in Bundesliga (-7%, d = 0.3). No difference in player activity was found between matches at the beginning of a season (round 1-6) and at the end of a season (round 29-34). We conclude that match importance influences player activity in German professional soccer. The most reasonable explanation is a conscious or unconscious pacing strategy, motivated by preserving abilities or preventing injury. Since this tendency mainly exists in Bundesliga, this may suggest that more skilled players show a higher awareness for the need of pacing.	[Link, Daniel] Tech Univ Munich, Dept Exercise Sci & Sport Informat, D-80290 Munich, Germany; [de Lorenzo, Michael F.] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia	Technical University of Munich; Royal Melbourne Institute of Technology (RMIT)	Link, D (corresponding author), Tech Univ Munich, Dept Exercise Sci & Sport Informat, D-80290 Munich, Germany.	daniel.link@tum.de		Link, Daniel/0000-0003-3606-2986				Bedford A, 2006, J SPORT SCI MED, V5, P509; Bendiksen M, 2012, MED SCI SPORT EXER, V44, P1595, DOI 10.1249/MSS.0b013e31824cc23b; Bloomfield JR., 2005, J SPORT SCI, V23, P192, DOI DOI 10.1080/02640410512331334413; Bradley PS, 2013, J SPORT SCI, V31, P1627, DOI 10.1080/02640414.2013.796062; Bradley PS, 2013, HUM MOVEMENT SCI, V32, P808, DOI 10.1016/j.humov.2013.06.002; Bradley PS, 2011, J SPORT SCI, V29, P821, DOI 10.1080/02640414.2011.561868; Carling C, 2011, J SPORT SCI, V29, P63, DOI 10.1080/02640414.2010.521945; Carling C, 2010, J SCI MED SPORT, V13, P126, DOI 10.1016/j.jsams.2008.09.004; Castellano J, 2011, INT J SPORTS MED, V32, P415, DOI 10.1055/s-0031-1271771; DFL, 2014, DEF OFF SPIELD; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; Di Salvo V, 2013, INT J SPORTS MED, V34, P526, DOI 10.1055/s-0032-1327660; Drust B, 2007, SPORTS MED, V37, P783, DOI 10.2165/00007256-200737090-00003; Edwards AM, 2009, SPORTS MED, V39, P1, DOI 10.2165/00007256-200939010-00001; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Gabbett TJ, 2007, J SPORT SCI, V25, P1507, DOI 10.1080/02640410701215066; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Harper LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110995; Lago-Penas C, 2011, J SPORT SCI MED, V10, P465; Link D, 2015, J STRENGTH CONDITION; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Morris C., 1977, OPTIM STRATEG SPORTS, V5, P131; Mugglestone C, 2013, INT J SPORTS MED, V34, P514, DOI 10.1055/s-0032-1327647; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Paul DJ, 2015, IJSPP, P10; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Schilling M. F., 1994, MATH MAG, V67, P282; Siegle M, 2013, J SPORT SCI, V31, P166, DOI 10.1080/02640414.2012.723131; Silva JR, 2013, J STRENGTH COND RES, V27, P20, DOI 10.1519/JSC.0b013e31824e1946; Silva JR, 2011, J STRENGTH COND RES, V25, P2729, DOI 10.1519/JSC.0b013e31820da078; Varley MC, 2012, INT J SPORT PHYSIOL, V7, P183, DOI 10.1123/ijspp.7.2.183	31	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157127	10.1371/journal.pone.0157127	http://dx.doi.org/10.1371/journal.pone.0157127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281051	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000091
J	Reynard, O; Jacquot, F; Evanno, G; Mai, HL; Salama, A; Martinet, B; Duvaux, O; Bach, JM; Conchon, S; Judor, JP; Perota, A; Lagutina, I; Duchi, R; Lazzari, G; Le Berre, L; Perreault, H; Lheriteau, E; Raoul, H; Volchkov, V; Galli, C; Soulillou, JP				Reynard, Olivier; Jacquot, Frederic; Evanno, Gwenalle; Mai, Hoa Le; Salama, Apolline; Martinet, Bernard; Duvaux, Odile; Bach, Jean-Marie; Conchon, Sophie; Judor, Jean-Paul; Perota, Andrea; Lagutina, Irina; Duchi, Roberto; Lazzari, Giovanna; Le Berre, Ludmilla; Perreault, Helene; Lheriteau, Elsa; Raoul, Herve; Volchkov, Viktor; Galli, Cesare; Soulillou, Jean-Paul			Anti-EBOV GP IgGs Lacking alpha 1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs	PLOS ONE			English	Article							RABBIT ANTITHYMOCYTE GLOBULIN; HEMORRHAGIC-FEVER; VIRUS INFECTION; MOLECULAR CHARACTERIZATION; MONOCLONAL-ANTIBODY; NONHUMAN-PRIMATES; IMMUNOGLOBULIN-G; GLYCOPROTEIN; PROPHYLAXIS; DISEASE	Polyclonal xenogenic IgGs, although having been used in the prevention and cure of severe infectious diseases, are highly immunogenic, which may restrict their usage in new applications such as Ebola hemorrhagic fever. IgG glycans display powerful xenogeneic antigens in humans, for example alpha 1-3 Galactose and the glycolyl form of neuraminic acid Neu5Gc, and IgGs deprived of these key sugar epitopes may represent an advantage for passive immunotherapy. In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. For this purpose, a double knock-out pig lacking alpha 1-3 Galactose and Neu5Gc was immunized against virus-like particles displaying surface EBOV glycoprotein GP. Following purification from serum, hyperimmune polyclonal IgGs were obtained, exhibiting an anti-EBOV GP titer of 1:100,000 and a virus neutralizing titer of 1:100. Guinea pigs were injected intramuscularly with purified IgGs on day 0 and day 3 post-EBOV infection. Compared to control animals treated with IgGs from non-immunized double KO pigs, the anti-EBOV IgGs-treated animals exhibited a significantly prolonged survival and a decreased virus load in blood on day 3. The data obtained indicated that IgGs lacking alpha 1-3 Galactose and Neu5Gc, two highly immunogenic epitopes in humans, have a protective effect upon EBOV infection.	[Reynard, Olivier; Volchkov, Viktor] Univ Lyon 1, Ecole Normale Super Lyon, INSERM, CIRI,CNRS,UMR5308,U1111,Mol Basis Viral Pathogen, F-69365 Lyon, France; [Jacquot, Frederic; Raoul, Herve] INSERM, Jean Merieux Lab BSL4, US003, F-69008 Lyon, France; [Evanno, Gwenalle; Salama, Apolline; Duvaux, Odile; Bach, Jean-Marie; Lheriteau, Elsa; Soulillou, Jean-Paul] Xenothera, Nantes, France; [Mai, Hoa Le; Martinet, Bernard; Conchon, Sophie; Judor, Jean-Paul; Le Berre, Ludmilla] INSERM, UMR 1064, Nantes, France; [Mai, Hoa Le; Martinet, Bernard; Conchon, Sophie; Judor, Jean-Paul; Le Berre, Ludmilla] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Mai, Hoa Le; Martinet, Bernard; Conchon, Sophie; Judor, Jean-Paul; Le Berre, Ludmilla; Soulillou, Jean-Paul] Univ Nantes, Nantes, France; [Bach, Jean-Marie] Univ Nantes, IECM, EA4644, ONIRIS,USC1383,INRA, Nantes, France; [Perota, Andrea; Lagutina, Irina; Duchi, Roberto; Lazzari, Giovanna; Galli, Cesare] Avantea, Lab Reprod Technol, Cremona, Italy; [Lazzari, Giovanna; Galli, Cesare] Avantea Fdn, Cremona, Italy; [Perreault, Helene] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Galli, Cesare] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; University of Manitoba; University of Bologna	Volchkov, V (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, INSERM, CIRI,CNRS,UMR5308,U1111,Mol Basis Viral Pathogen, F-69365 Lyon, France.; Raoul, H (corresponding author), INSERM, Jean Merieux Lab BSL4, US003, F-69008 Lyon, France.; Soulillou, JP (corresponding author), Xenothera, Nantes, France.; Soulillou, JP (corresponding author), Univ Nantes, Nantes, France.; Galli, C (corresponding author), Avantea, Lab Reprod Technol, Cremona, Italy.; Galli, C (corresponding author), Avantea Fdn, Cremona, Italy.; Galli, C (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy.	herve.raoul@inserm.fr; viktor.volchkov@inserm.fr; cesaregalli@avantea.it; jean-paul.soulillou@univ-nantes.fr	Bach, Jean-Marie/AAR-1086-2020; reynard, olivier AJ/M-8069-2014; Volchkov, Viktor/M-7846-2014	reynard, olivier AJ/0000-0001-7536-355X; Bach, Jean-Marie/0000-0002-5265-8854; Conchon, Sophie/0000-0003-2602-3385; Volchkov, Viktor/0000-0001-7896-8706	Institut national de la sante et de la recherche medicale (INSERM), Agence Nationale de la Recherche [ANR-14-EBOL-002-01]; European Union [278976]; Xenothera; Avantea	Institut national de la sante et de la recherche medicale (INSERM), Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission); Xenothera; Avantea	This work was supported by Institut national de la sante et de la recherche medicale (INSERM), Agence Nationale de la Recherche (ANR-14-EBOL-002-01) and the European Union FP7 project ANTIGONE (278976). The companies Xenothera and Avantea co-funded the study, and only provided financial support in the form of authors' salaries and/or research materials. The funders provided support in the form of salaries for authors AS, GE, AP, RD, and IL or consultance for JPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, XENOTRANSPLANTATION, V22, pS2, DOI [10.1111/xen.12204, DOI 10.1111/XEN.12204]; Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881; Bal C, 2015, LANCET INFECT DIS, V15, P285, DOI 10.1016/S1473-3099(14)71072-2; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Berry JD, 2011, NEW BIOTECHNOL, V28, P489, DOI 10.1016/j.nbt.2011.03.018; Bounds CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137786; Buelow R, 2007, ERNST SCHERING FOUND, V4, P83; CASADEVALL A, 1995, CLIN INFECT DIS, V21, P150, DOI 10.1093/clinids/21.1.150; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Conchon S, 2013, XENOTRANSPLANTATION, V20, P370; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Couvrat-Desvergnes G, 2015, J CLIN INVEST, V125, P4655, DOI 10.1172/JCI82267; Cross RW, 2015, J INFECT DIS, V212, pS305, DOI 10.1093/infdis/jiv237; de La Vega MA, 2015, J CLIN INVEST, V125, P4421, DOI 10.1172/JCI83162; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Dolnik O, 2015, J INFECT DIS, V212, pS322, DOI 10.1093/infdis/jiv268; Dowall SD, 2016, J INFECT DIS, V213, P1124, DOI 10.1093/infdis/jiv565; DWEK RA, 1995, J ANAT, V187, P279; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Faye O, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001908; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Feng XM, 2014, HAEMATOLOGICA, V99, P1433, DOI 10.3324/haematol.2014.106542; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; Gitelman SE, 2013, LANCET DIABETES ENDO, V1, P306, DOI 10.1016/S2213-8587(13)70065-2; Jahrling PB, 1996, ARCH VIROL, P135; Jahrling PB, 2007, J INFECT DIS, V196, pS400, DOI 10.1086/520587; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lanini S, 2015, J CLIN INVEST, V125, P4692, DOI 10.1172/JCI83111; Lopez PG, 2016, GLYCOCONJUGATE J, V33, P79, DOI 10.1007/s10719-015-9637-z; Mateo M, 2011, J INFECT DIS, V204, pS1011, DOI 10.1093/infdis/jir338; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Nakayama E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00267; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Reynard O, 2015, J INFECT DIS, V212, pS372, DOI 10.1093/infdis/jiv303; Roux D, 2012, J ANTIMICROB CHEMOTH, V67, P2785, DOI 10.1093/jac/dks335; Sadek RF, 1999, J INFECT DIS, V179, pS24, DOI 10.1086/514311; Salama A, 2015, XENOTRANSPLANTATION, V22, P85, DOI 10.1111/xen.12142; Sano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078119; SOULILLOU JP, 1990, NEW ENGL J MED, V322, P1175, DOI 10.1056/NEJM199004263221702; Takada A, 2013, IMMUNOTHERAPY-UK, V5, P441, DOI [10.2217/IMT.13.29, 10.2217/imt.13.29]; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472	53	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156775	10.1371/journal.pone.0156775	http://dx.doi.org/10.1371/journal.pone.0156775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280712	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000047
J	Sridhar, S; Steele-Mortimer, O				Sridhar, Sushmita; Steele-Mortimer, Olivia			Inherent Variability of Growth Media Impacts the Ability of Salmonella Typhimurium to Interact with Host Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ORGANIC-ACID PRODUCTION; PATHOGENICITY ISLAND 1; III SECRETION SYSTEMS; D-GLUCARIC ACID; IN-VITRO; GASTROINTESTINAL-TRACT; EPITHELIAL-CELLS; MAMMALIAN-CELLS; HELA-CELLS	Efficient invasion of non-phagocytic cells, such as intestinal epithelial cells, by Salmonella Typhimurium is dependent on the Salmonella Pathogenicity Island 1 (SPI-1)-encoded Type Three Secretion System. The environmental cues involved in SPI-1 induction are not well understood. In vitro, various conditions are used to induce SPI-1 and the invasive phenotype. Although lysogeny broth (LB) is widely used, multiple formulations exist, and variation can arise due to intrinsic differences in complex components. Minimal media are also susceptible to variation. Still, the impact of these inconsistencies on Salmonella virulence gene expression has not been well studied. The goal of this project is to identify growth conditions in LB and minimal mediumthat affect SPI-1 induction in vitro using both whole population and single cell analysis. Here we show, using a fluorescent reporter of the SPI-1 gene prgH, that growth of Salmonella in LB yields variable induction. Deliberate modification of media components can influence the invasive profile. Finally, we demonstrate that changes in SPI-1 inducing conditions can affect the ability of Salmonella to replicate intracellularly. These data indicate that the specific media growth conditions impact how the bacteria interact with host cells.	[Sridhar, Sushmita; Steele-Mortimer, Olivia] NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Steele-Mortimer, O (corresponding author), NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	omortimer@niaid.nih.gov			Intramural Research Program of the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001111, ZIAAI000909] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the Intramural Research Program of the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Intramural Research Program of the NIH, NIAID. We would like to thank Aaron Carmody for expert flow cytometry support, Anita Mora for figures, and members of the lab for helpful comments throughout the process.	Altier C, 2005, J MICROBIOL, V43, P85; ARGENZIO RA, 1975, AM J PHYSIOL, V228, P454, DOI 10.1152/ajplegacy.1975.228.2.454; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Blair JMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063912; BOHNHOFF M, 1964, J EXP MED, V120, P805, DOI 10.1084/jem.120.5.805; Bowden SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096266; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; ERNST RK, 1990, INFECT IMMUN, V58, P2014, DOI 10.1128/IAI.58.6.2014-2016.1990; Espinosa E, 2014, MOL MICROBIOL, V91, P1057, DOI 10.1111/mmi.12500; Ezraty B, 2014, FREE RADICAL BIO MED, V74, P245, DOI 10.1016/j.freeradbiomed.2014.07.010; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Jiang LY, 2015, CURR MICROBIOL, V70, P315, DOI 10.1007/s00284-014-0720-7; JONES GW, 1981, J GEN MICROBIOL, V127, P351; Kage H, 2008, J BACTERIOL, V190, P2470, DOI 10.1128/JB.01385-07; KHORAMIANFALSAFI T, 1990, MICROB PATHOGENESIS, V9, P47, DOI 10.1016/0882-4010(90)90039-S; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Lamichhane-Khadka R, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130146; Lamichhane-Khadka R, 2011, J BACTERIOL, V193, P5824, DOI 10.1128/JB.05456-11; Le Bouguenec C, 2011, INT J MED MICROBIOL, V301, P1, DOI 10.1016/j.ijmm.2010.04.021; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; MARSH CA, 1985, ANAL BIOCHEM, V145, P266, DOI 10.1016/0003-2697(85)90360-4; MATSUI M, 1972, CHEM PHARM BULL, V20, P845; Moon TS, 2010, METAB ENG, V12, P298, DOI 10.1016/j.ymben.2010.01.003; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; SCHIEMANN DA, 1991, INFECT IMMUN, V59, P437, DOI 10.1128/IAI.59.1.437-440.1991; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Singer HM, 2014, J BACTERIOL, V196, P1448, DOI 10.1128/JB.01438-13; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7; 2010, COLD SPRING HARBOR P	42	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157043	10.1371/journal.pone.0157043	http://dx.doi.org/10.1371/journal.pone.0157043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280414	gold, Green Submitted, Green Published			2022-12-26	WOS:000377563000074
J	Guido, N; Starostina, E; Leake, D; Saaem, I				Guido, Nicholas; Starostina, Elena; Leake, Devin; Saaem, Ishtiaq			Improved PCR Amplification of Broad Spectrum GC DNA Templates	PLOS ONE			English	Article							CHEMICAL-SYNTHESIS; GENE SYNTHESIS; HEMOPHILIA-A; BETAINE; ENHANCEMENT; REGIONS; MIXTURE; GENOME	Many applications in molecular biology can benefit from improved PCR amplification of DNA segments containing a wide range of GC content. Conventional PCR amplification of DNA sequences with regions of GC less than 30%, or higher than 70%, is complex due to secondary structures that block the DNA polymerase as well as mispriming and mis-annealing of the DNA. This complexity will often generate incomplete or nonspecific products that hamper downstream applications. In this study, we address multiplexed PCR amplification of DNA segments containing a wide range of GC content. In order to mitigate amplification complications due to high or low GC regions, we tested a combination of different PCR cycling conditions and chemical additives. To assess the fate of specific oligonucleotide ( oligo) species with varying GC content in a multiplexed PCR, we developed a novel method of sequence analysis. Here we show that subcycling during the amplification process significantly improved amplification of short template pools (similar to 200 bp), particularly when the template contained a low percent of GC. Furthermore, the combination of subcycling and 7-deaza-dGTP achieved efficient amplification of short templates ranging from 10-90% GC composition. Moreover, we found that 7-deaza-dGTP improved the amplification of longer products (similar to 1000 bp). These methods provide an updated approach for PCR amplification of DNA segments containing a broad range of GC content.	[Guido, Nicholas; Starostina, Elena; Leake, Devin; Saaem, Ishtiaq] Gen9 Inc, Res & Dev, Cambridge, MA USA		Saaem, I (corresponding author), Gen9 Inc, Res & Dev, Cambridge, MA USA.	isaaem@gen9bio.com			Gen9 Inc; DARPA grant [W911QX-13-C-0040]	Gen9 Inc; DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Gen9 employees' work was funded by Gen9 Inc and DARPA grant W911QX-13-C-0040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; Burbelo PD, 2010, AM J TRANSL RES, V2, P381; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chakrabarti R, 2001, NUCLEIC ACIDS RES, V29, P2377, DOI 10.1093/nar/29.11.2377; Chakrabarti R, 2001, GENE, V274, P293, DOI 10.1016/S0378-1119(01)00621-7; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; D'Souza GGM, 2007, PHARM RES-DORDR, V24, P228, DOI 10.1007/s11095-006-9150-y; Frackman S, 1998, BETAIN DMSO ENHANCIN, P27; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jacobson J, 2011, WIPO; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Kang J, 2005, J BIOCHEM BIOPH METH, V64, P147, DOI 10.1016/j.jbbm.2005.06.003; Kilian NL, 2006, THROMB HAEMOSTASIS, V95, P746, DOI 10.1160/TH05-09-0605; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Liu Q, 1998, BIOTECHNIQUES, V25, P1022, DOI 10.2144/98256rr01; Ma SY, 2012, TRENDS BIOTECHNOL, V30, P147, DOI 10.1016/j.tibtech.2011.10.002; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mantilla-Capacho JM, 2007, AM J HEMATOL, V82, P283, DOI 10.1002/ajh.20865; Musso M, 2006, J MOL DIAGN, V8, P544, DOI 10.2353/jmoldx.2006.060058; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Ragni MV, 2009, HAEMOPHILIA, V15, P1074, DOI 10.1111/j.1365-2516.2009.02058.x; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Saaem I, 2010, ACS APPL MATER INTER, V2, P491, DOI 10.1021/am900884b; Sahdev S, 2007, MOL CELL PROBE, V21, P303, DOI 10.1016/j.mcp.2007.03.004; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Stirling David, 2003, Methods Mol Biol, V226, P101; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	34	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156478	10.1371/journal.pone.0156478	http://dx.doi.org/10.1371/journal.pone.0156478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271574	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000017
J	Ljungman, L; Boger, M; Ander, M; Ljotsson, B; Cernvall, M; von Essen, L; Hoven, E				Ljungman, Lisa; Boger, Marike; Ander, Malin; Ljotsson, Brjann; Cernvall, Martin; von Essen, Louise; Hoven, Emma			Impressions That Last: Particularly Negative and Positive Experiences Reported by Parents Five Years after the End of a Child's Successful Cancer Treatment or Death	PLOS ONE			English	Article							POSTTRAUMATIC STRESS SYMPTOMS; QUALITATIVE RESEARCH; SURVIVORS; GROWTH; CHALLENGES; SUPPORT; MOTHERS; IMPACT; GRIEF	Objective To describe the experience of parenting a child diagnosed with cancer by examining particularly negative and positive experiences reported by parents of childhood cancer survivors and parents of children lost to cancer. Methods 168 parents (88 mothers, 80 fathers) participated. Data were collected five years after the end of successful treatment or the child's death. The parents' experiences were identified by open-ended semi-structured questions about particularly negative and positive experiences of the child's cancer. An inductive approach was used in which the manifest verbal content of the answers was analysed using content analysis. Results The analysis revealed eight categories of negative experience (child late effects; distressing events; healthcare; impaired relationships; long-term psychological consequences; own reactions; surrounding institutions; the fact that the child got cancer) and seven categories of positive experience (healthcare; improved relationships; long-term consequences for the child; personal development; support systems; treatment outcome; unexpected joy). The categories were related to past events or to the present situation. The findings indicate variations in experiences between parents of survivors and bereaved parents, and between fathers and mothers, as some experiences were only reported by parents of survivors and some experiences were only reported by mothers. Conclusions The results highlight the importance of past and present events to parents, and accordingly the long-lasting impact of paediatric cancer on parents. The results also point to the wide range of negative as well as positive experiences involved in parenting a child diagnosed with cancer, and provide a comprehensive understanding of the overall experience for parents of children with cancer. Specifically, the findings give guidance to healthcare providers by illustrating the need to provide healthcare personnel with continuous training in communication skills, offering parents opportunities to meet other parents in the same situation and increasing the access to psychosocial supportive services and psychological care.	[Ljungman, Lisa; Boger, Marike; Ander, Malin; Cernvall, Martin; von Essen, Louise; Hoven, Emma] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden; [Ljotsson, Brjann] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Ljungman, L (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden.	lisa.ljungman@pubcare.uu.se		Ljungman, Lisa/0000-0002-4512-8900; Hoven, Emma/0000-0001-9335-9714	Swedish Research Council [K2008-70X-20836-01- 3, K2011-70X-20836-04-4]; Swedish Cancer Society [2007/1015, 2010/726]; Swedish Childhood Cancer Foundation [PROJ08/010]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission)	Support was provided by The Swedish Research Council (grant numbers K2008-70X-20836-01- 3, K2011-70X-20836-04-4, LvE) [http://www.vr.se/ inenglish.4.12fff4451215cbd83e4800015152.html]; The Swedish Cancer Society (grant numbers 2007/1015, 2010/726, LvE) [https://www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society]; The Swedish Childhood Cancer Foundation (grant numbers PROJ08/010, LvE) [http://www. barncancerfonden.se/in-english/about-us/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by grants from the Swedish Research Council (grant numbers K2008-70X-20836-01-3, K2011-70X-20836-04-4, PI Louise von Essen), the Swedish Cancer Society (grant numbers 2007/1015, 2010/726, PI Louise von Essen) and the Swedish Childhood Cancer Foundation (grant numbers PROJ08/010, PI Louise von Essen). We gratefully acknowledge all the parents who participated in this study, the coordinating nurses at the paediatric oncology centres, research assistant Susanne Lorenz and Ulrika Poder, PhD, for their excellent work in terms of the collection and management of data.	Aho AL, 2009, AM J MENS HEALTH, V3, P93, DOI 10.1177/1557988307302094; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058; Bruce M, 2006, CLIN PSYCHOL REV, V26, P233, DOI 10.1016/j.cpr.2005.10.002; Bryant Rosalind, 2003, J Pediatr Nurs, V18, P113, DOI 10.1053/jpdn.2003.11; Chesler MA, 2001, QUAL HEALTH RES, V11, P363, DOI 10.1177/104973201129119163; Engelkemeyer SM, 2008, J TRAUMA STRESS, V21, P344, DOI 10.1002/jts.20338; Forinder U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126905; Forsey M, 2013, PSYCHO-ONCOLOGY, V22, P260, DOI 10.1002/pon.2084; Gibbins J, 2012, J PEDIATR ONCOL NURS, V29, P253, DOI 10.1177/1043454212452791; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gustafsson G., 2013, CHILDHOOD CANC INCID; Hungerbuehler I, 2011, J HEALTH PSYCHOL, V16, P1259, DOI 10.1177/1359105311405872; Kolb B., 2009, FUNDAMENTALS HUMAN N, V6th Edn; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Kreicbergs UC, 2007, J CLIN ONCOL, V25, P3307, DOI 10.1200/JCO.2006.10.0743; Ljungman L, 2015, PSYCHO-ONCOLOGY, V24, P1792, DOI 10.1002/pon.3856; Ljungman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103340; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; McCarthy MC, 2012, J TRAUMA STRESS, V25, P558, DOI 10.1002/jts.21745; McCarthy MC, 2010, J PALLIAT MED, V13, P1321, DOI 10.1089/jpm.2010.0037; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meert KL, 2010, ARCH PEDIAT ADOL MED, V164, P1045, DOI 10.1001/archpediatrics.2010.187; Michel G, 2010, CHILD CARE HLTH DEV, V36, P123, DOI 10.1111/j.1365-2214.2009.01034.x; Norberg AL, 2008, ACTA ONCOL, V47, P267, DOI 10.1080/02841860701558773; Norris RE, 2012, NAT REV CANCER, V12, P776, DOI 10.1038/nrc3370; Patterson JM, 2004, PSYCHO-ONCOLOGY, V13, P390, DOI 10.1002/pon.761; Poder U, 2008, PSYCHO-ONCOLOGY, V17, P430, DOI 10.1002/pon.1263; Quin S, 2004, SOC WORK HEALTH CARE, V39, P129, DOI 10.1300/J010v39n01_09; Rosenberg AR, 2013, J PALLIAT MED, V16, P645, DOI 10.1089/jpm.2012.0494; Rosenberg AR, 2012, PEDIATR BLOOD CANCER, V58, P503, DOI 10.1002/pbc.23386; Steele AC, 2013, J PEDIAT HEMATOL ONC, V35, P253, DOI 10.1097/MPH.0b013e31828afe05; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vrijmoet-Wiersma CMJ, 2008, J PEDIATR PSYCHOL, V33, P694, DOI 10.1093/jpepsy/jsn007; Wakefield CE, 2011, PEDIATR BLOOD CANCER, V56, P524, DOI 10.1002/pbc.22725	37	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157076	10.1371/journal.pone.0157076	http://dx.doi.org/10.1371/journal.pone.0157076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272318	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000061
J	Nazarbahjat, N; Kadir, FA; Ariffin, A; Abdulla, MA; Abdullah, Z; Yehye, WA				Nazarbahjat, Nafal; Kadir, Farkaad A.; Ariffin, Azhar; Abdulla, Mahmood A.; Abdullah, Zanariah; Yehye, Wageeh A.			Antioxidant Properties and Gastroprotective Effects of 2-(Ethylthio)Benzohydrazones on Ethanol-Induced Acute Gastric Mucosal Lesions in Rats	PLOS ONE			English	Article							LEAF EXTRACT; ULCER; INJURY; PATHOGENESIS; OMEPRAZOLE; STRESS; LANSOPRAZOLE; GASTROPATHY; INHIBITORS; INDUCTION	A series of new 2-(ethylthio)benzohydrazone derivatives (1-6) were prepared and characterised by IR, 1H NMR, and 13C NMR spectroscopy and mass spectrometry. The newly prepared compounds were screened for their in vitro antioxidant activities using free radical scavenging 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assays. Among them, most powerful antioxidant, compound 1 has been selected in order to illustrate anti-ulcer effect on ethanol-induced gastric mucosal lesions in rats. Four groups of Sprague Dawley rats were respectively treated with 10% Tween 20 as ulcer control group, 20 mg/kg omeprazole as reference group, 50 mg/kg and 100 mg/kg compound 1 as experimental animals. Macroscopically, ulcer control group showed extensive hemorrhagic lesions of gastric mucosa compared with omeprazole or compound 1. Rats pre-treated with compound 1 showed increased in gastric pH and gastric mucus. Histologically, ulcer control group showed severe damage to gastric mucosa with edema and leucocytes infiltration of submucosal layer. In immunohistochemical analysis, rats which were pre-treated with compound 1 showed up-regulation of HSP70 and down-regulation of Bax proteins. In conclusion, the gastroprotective effect of compound 1 may be due to its antioxidant activity, and/or due to up-regulation of HSP70 and down-regulation of Bax protein in stained tissue section.	[Nazarbahjat, Nafal; Ariffin, Azhar; Abdullah, Zanariah] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Kadir, Farkaad A.] Int Med Univ, Fac Med, Div Human Biol, Kuala Lumpur 57000, Malaysia; [Abdulla, Mahmood A.] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Yehye, Wageeh A.] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Block 3A,Inst Postgrad Studies Bldg, Kuala Lumpur, Malaysia	Universiti Malaya; International Medical University Malaysia; Universiti Malaya; Universiti Malaya	Ariffin, A (corresponding author), Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia.; Kadir, FA (corresponding author), Int Med Univ, Fac Med, Div Human Biol, Kuala Lumpur 57000, Malaysia.	faalhadi@yahoo.com; azhar70@um.edu.my	ARIFFIN, AZHAR/B-5353-2010; Musa, Ilina Syazwani/P-7977-2016; Yehye, Wageeh/I-9135-2012; Kashmola, Nafal/AAT-4411-2020	ARIFFIN, AZHAR/0000-0002-3626-8901; Musa, Ilina Syazwani/0000-0001-9095-4083; Abdulqader, Farqad/0000-0002-0574-7723; yehye, wageeh/0000-0003-1543-9887	University of Malaya Research Grant UMRG [RG149-11AFR, RPO43A-15HTM];  [PG033-2012B]	University of Malaya Research Grant UMRG; 	This work was supported by: 1. University of Malaya Research Grant UMRG (RG149-11AFR); 2. University of Malaya Research Grant UMRG (RPO43A-15HTM); 3. Postgraduate graduate research grant (PG033-2012B); http://umresearch.um.edu.my/mainpage.php?module=Maklumat&kategori=86&id=63&papar=1.	Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002; AlRashdi AS, 2012, EVIDENCE BASED COMPL, V2012; Alrdahe S.S., 2010, WORLD ACAD SCI ENG T, V43, P883; [Anonymous], 1996, GUIDE CARE USE LAB A; Bardi D. A. A., 2011, Scientific Research and Essays, V6, P3232; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Cheng HC, 2005, DIGEST DIS SCI, V50, P1194, DOI 10.1007/s10620-005-2759-6; Cheng LX, 2010, BIOORG MED CHEM LETT, V20, P2417, DOI 10.1016/j.bmcl.2010.03.039; de Heer MI, 1999, J ORG CHEM, V64, P6969, DOI 10.1021/jo9901485; Despaigne AAR, 2009, POLYHEDRON, V28, P3797, DOI 10.1016/j.poly.2009.07.059; Devaraj VC, 2011, SAUDI PHARM J, V19, P171, DOI 10.1016/j.jsps.2011.03.003; Dhuley J. N., 1999, Indian Journal of Pharmacology, V31, P128; El-Sayed NA, 2010, EUR J MED CHEM, V45, P3147, DOI 10.1016/j.ejmech.2010.04.005; Gerhauser C, 2003, MUTAT RES-FUND MOL M, V523, P163, DOI 10.1016/S0027-5107(02)00332-9; Ghosh R, 2007, INDIAN J PHARMACOL, V39, P214, DOI 10.4103/0253-7613.36544; Goel R. K., 2002, Indian Journal of Pharmacology, V34, P100; Gorinstein S, 2003, J NUTR BIOCHEM, V14, P154, DOI 10.1016/S0955-2863(02)00278-4; Hajrezaie M, 2012, ACUTE TOXICITY GASTR, DOI [10.1371/journal.pone.0051537, DOI 10.1371/JOURNAL.PONE.0051537]; Hajrezaie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121529; Ismail IF, 2012, EVIDENCE BASED COMPL, V2012; Jainu Mallika, 2006, Indian J Med Res, V123, P799; Karadag A, 2009, FOOD ANAL METHOD, V2, P41, DOI 10.1007/s12161-008-9067-7; Karthikeyan MS, 2006, BIOORGAN MED CHEM, V14, P7482, DOI 10.1016/j.bmc.2006.07.015; Ketuly KA, 2011, J MED PLANTS RES, V5, P514; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P211; Kwiecien S, 2012, J PHYSIOL PHARMACOL, V63, P143; Lapenna D, 1996, FEBS LETT, V382, P189, DOI 10.1016/0014-5793(96)00155-X; Lee W-L, 2013, OXIDATIVE MED CELLUL, V2013; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mahmood A. A., 2011, Scientific Research and Essays, V6, P2306; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Mikami KI, 2006, J GASTROEN HEPATOL, V21, P1669, DOI 10.1111/j.1440-1746.2006.04328.x; MOZSIK G, 1988, DIGEST DIS SCI, V33, P92, DOI 10.1007/BF01536637; Mughrabi FF, 2010, INT C SCI SOC RES CS; MURALIDHARAN P, 2009, J SCI RES, V1, P345, DOI DOI 10.3329/JSR.V1I2.1625; Nakamura T, 2014, EVIDENCE BASED COMPL, V2014; Nazarbahjat N, 2014, MOLECULES, V19, P11520, DOI 10.3390/molecules190811520; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; Sairam K., 2001, Indian Journal of Experimental Biology, V39, P137; Sathish D, 2011, CURR DRUG DELIV, V8, P494, DOI 10.2174/156720111796642273; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Sidahmed HMA, 2013, PHYTOMEDICINE, V20, P834, DOI 10.1016/j.phymed.2013.03.002; Sidahmed HMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121060; Sidahmed HMA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-183; Singh KD, 2015, ASIAN J PHARM CLIN R, V8; Susan G, 1999, INDIAN J PHARM, V31, P431; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Umamaheswari M, 2007, J ETHNOPHARMACOL, V110, P464, DOI 10.1016/j.jep.2006.10.017; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u; Yehye WA, 2015, EUR J MED CHEM, V101, P295, DOI 10.1016/j.ejmech.2015.06.026; Zhang LY, 2011, BIOORG MED CHEM LETT, V21, P5722, DOI 10.1016/j.bmcl.2011.08.018	58	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156022	10.1371/journal.pone.0156022	http://dx.doi.org/10.1371/journal.pone.0156022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272221	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000006
J	Reinhart, JM; Motsinger-Reif, A; Dickey, A; Yale, S; Trepanier, LA				Reinhart, Jennifer M.; Motsinger-Reif, Alison; Dickey, Allison; Yale, Steven; Trepanier, Lauren A.			Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide Antimicrobials	PLOS ONE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; TOXIC EPIDERMAL NECROLYSIS; ADVERSE DRUG-REACTIONS; SULFAMETHOXAZOLE-INDUCED HYPERSENSITIVITY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ENZYME GENE POLYMORPHISMS; STEVENS-JOHNSON-SYNDROME; HIV-INFECTED PATIENTS; INDUCED LIVER-INJURY; TRIMETHOPRIM-SULFAMETHOXAZOLE	Background Hypersensitivity (HS) reactions to sulfonamide antibiotics occur uncommonly, but with potentially severe clinical manifestations. A familial predisposition to sulfonamide HS is suspected, but robust predictive genetic risk factors have yet to be identified. Strongly linked genetic polymorphisms have been used clinically as screening tests for other HS reactions prior to administration of high-risk drugs. Objective The purpose of this study was to evaluate for genetic risk of sulfonamide HS in the immunocompetent population using genome-wide association. Methods Ninety-one patients with symptoms after trimethoprim-sulfamethoxazole (TMP-SMX) attributable to "probable" drug HS based on medical record review and the Naranjo Adverse Drug Reaction Probability Scale, and 184 age-and sex-matched patients who tolerated a therapeutic course of TMP-SMX, were included in a genome-wide association study using both common and rare variant techniques. Additionally, two subgroups of HS patients with a more refined clinical phenotype (fever and rash; or fever, rash and eosinophilia) were evaluated separately. Results For the full dataset, no single nucleotide polymorphisms were suggestive of or reached genome-wide significance in the common variant analysis, nor was any genetic locus significant in the rare variant analysis. A single, possible gene locus association (COL12A1) was identified in the rare variant analysis for patients with both fever and rash, but the sample size was very small in this subgroup (n = 16), and this may be a false positive finding. No other significant associations were found for the subgroups. Conclusions No convincing genetic risk factors for sulfonamide HS were identified in this population. These negative findings may be due to challenges in accurately confirming the phenotype in exanthematous drug eruptions, or to unidentified gene-environment interactions influencing sulfonamide HS.	[Reinhart, Jennifer M.; Trepanier, Lauren A.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Motsinger-Reif, Alison; Dickey, Allison] N Carolina State Univ, Dept Stat, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Yale, Steven] Marshfield Clin Res Fdn, Marshfield, WI USA; [Yale, Steven] North Florida Reg Med Ctr, Gainesville, FL USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University	Trepanier, LA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.	lauren.trepanier@wisc.edu	Motsinger-Reif, Alison/I-4167-2018	Motsinger-Reif, Alison/0000-0003-1346-2493; Reinhart, Jennifer/0000-0002-3021-5075	NIH [R01 GM100784, T32 OD010423]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by NIH R01 GM100784 [http://www.nih.gov] and NIH T32 OD010423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfirevic A, 2009, PHARMACOGENOMICS, V10, P531, DOI 10.2217/PGS.09.6; [Anonymous], 2008, ZIAG; Ates NA, 2004, ARCH DERMATOL RES, V295, P429, DOI 10.1007/s00403-003-0446-z; Avgeri SG, 2009, INT J ANTIMICROB AG, V33, P394, DOI 10.1016/j.ijantimicag.2008.09.010; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bousquet PJ, 2008, CURR PHARM DESIGN, V14, P2792, DOI 10.2174/138161208786369731; CARR A, 1993, J INFECT DIS, V167, P180, DOI 10.1093/infdis/167.1.180; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cribb AE, 1996, ADVERSE DRUG REACT T, V15, P9; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Del-Aguila JL, 2014, PHARMACOGENOMICS J, V14, P35, DOI 10.1038/tpj.2013.3; DELOMENIE C, 1994, BRIT J CLIN PHARMACO, V38, P581, DOI 10.1111/j.1365-2125.1994.tb04401.x; Drekonja DM, 2008, PRIMARY CARE, V35, P345, DOI 10.1016/j.pop.2008.01.001; Drekonja DM, 2009, DIAGN MICR INFEC DIS, V63, P201, DOI 10.1016/j.diagmicrobio.2008.10.001; Eliaszewicz M, 2002, J AM ACAD DERMATOL, V47, P40, DOI 10.1067/mjd.2002.120468; Gill HJ, 1999, PHARMACOGENETICS, V9, P43, DOI 10.1097/00008571-199902000-00007; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; GRUCHALLA RS, 1991, J ALLERGY CLIN IMMUN, V88, P784, DOI 10.1016/0091-6749(91)90186-R; Gupta D, 2008, JCR-J CLIN RHEUMATOL, V14, P267, DOI 10.1097/RHU.0b013e31817a7e30; HARLE DG, 1988, MOL IMMUNOL, V25, P1347, DOI 10.1016/0161-5890(88)90050-8; HENNESSY S, 1995, J GEN INTERN MED, V10, P380, DOI 10.1007/BF02599836; Hicks D, 2014, HUM MOL GENET, V23, P2353, DOI 10.1093/hmg/ddt637; Hubiche T, 2011, DERMATOLOGY, V222, P140, DOI 10.1159/000324506; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Kardaun SH, 2013, BRIT J DERMATOL, V169, P1071, DOI 10.1111/bjd.12501; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Korbila IP, 2009, CAN FAM PHYSICIAN, V55, P60; LANCASTER HO, 1961, AUST J STAT, V3, P20, DOI 10.1111/j.1467-842X.1961.tb00058.x; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; McCarty Gale A, 2005, AMIA Annu Symp Proc, P1049; MEDINA I, 1990, NEW ENGL J MED, V323, P776, DOI 10.1056/NEJM199009203231202; Mohanasundaram J, 1998, J Indian Med Assoc, V96, P21; Mooney MA, 2014, TRENDS GENET, V30, P390, DOI 10.1016/j.tig.2014.07.004; Morelli JG, 1999, J PEDIATR-US, V134, P365, DOI 10.1016/S0022-3476(99)70472-5; Morimoto T, 2006, INTERNAL MED, V45, P101, DOI 10.2169/internalmedicine.45.1352; Motsinger-Reif AA, 2013, PHARMACOGENET GENOM, V23, P383, DOI 10.1097/FPC.0b013e32833d7b45; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Nelson MR, 2009, PHARMACOGENOMICS J, V9, P23, DOI 10.1038/tpj.2008.4; Neuman MG, 2013, TRANSL RES, V161, P430, DOI 10.1016/j.trsl.2012.12.012; Neuman MG, 2000, CLIN BIOCHEM, V33, P517, DOI 10.1016/S0009-9120(00)00146-6; ORTIZ JE, 1982, ANN PLAS SURG, V9, P249, DOI 10.1097/00000637-198209000-00011; Ozkaya-Bayazit E, 2001, J AM ACAD DERMATOL, V45, P712, DOI 10.1067/mjd.2001.117854; Patel RM, 2008, INDIAN J DERMATOL VE, V74, DOI 10.4103/0378-6323.42883; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Pirmohamed M, 2000, PHARMACOGENETICS, V10, P705, DOI 10.1097/00008571-200011000-00005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Putnam PP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-369; Quiralte J, 1999, J ALLERGY CLIN IMMUN, V103, P685, DOI 10.1016/S0091-6749(99)70243-5; Rabaud C, 2001, SCAND J INFECT DIS, V33, P759, DOI 10.1080/003655401317074581; Reilly TP, 1998, BIOCHEM PHARMACOL, V55, P803, DOI 10.1016/S0006-2952(97)00547-9; RIEDER MJ, 1989, ANN INTERN MED, V110, P286, DOI 10.7326/0003-4819-110-4-286; Rizzo R, 2010, BREAST CANCER RES TR, V124, P593, DOI 10.1007/s10549-010-1034-5; Rodriguez M, 2004, CLIN INFECT DIS, V38, pE76, DOI 10.1086/383150; Ryan C, 1998, WMJ, V97, P23; Sacco JC, 2012, PHARMACOGENET GENOM, V22, P733, DOI 10.1097/FPC.0b013e328357a735; Saka B, 2010, Med Trop (Mars), V70, P255; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; SHEAR NH, 1986, ANN INTERN MED, V105, P179, DOI 10.7326/0003-4819-105-2-179; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Thomas M, 2009, SCAND J INFECT DIS, V41, P862, DOI 10.3109/00365540903214256; Walmsley SL, 1998, J ACQ IMMUN DEF SYND, V19, P498, DOI 10.1097/00042560-199812150-00009; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang D, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-32; Westphal GA, 2000, INT ARCH OCC ENV HEA, V73, P384, DOI 10.1007/s004200000159; Wolkenstein P, 2005, J INVEST DERMATOL, V125, P1080, DOI 10.1111/j.0022-202X.2005.23939.x; WOLKENSTEIN P, 1995, PHARMACOGENETICS, V5, P255, DOI 10.1097/00008571-199508000-00011; WOLKENSTEIN P, 1995, ARCH DERMATOL, V131, P544, DOI 10.1001/archderm.131.5.544; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu J, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0331-3; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zielinska E, 1998, EUR J CLIN PHARMACOL, V54, P779, DOI 10.1007/s002280050551	79	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156000	10.1371/journal.pone.0156000	http://dx.doi.org/10.1371/journal.pone.0156000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272151	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000005
J	Cui, LL; Sheng, Y; Sun, M; Hu, JM; Qin, YY; Chen, ZJ				Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang			Chronic Pelvic Inflammation Diminished Ovarian Reserve as Indicated by Serum Anti Mulerrian Hormone	PLOS ONE			English	Article							MULLERIAN HORMONE; ANTRAL FOLLICLES; WOMEN; RESISTANCE; OBESITY	Objective To explore the potential damaging effect of chronic pelvic inflammation on ovarian reserve. Design Case-control study. Patients A total of 122 women with bilateral tubal occlusion, diagnosed by hysterosalipingography (HSG) and 217 women with normal fallopians were recruited. Measurements Serum anti-Mullerian hormone (AMH), basic follicle-stimulating hormone (FSH), luteining hormone (LH), estradiol (E-2), and testosterone (T) were measured; and antral follicle counts (AFCs) were recorded. Results Significantly lower level of AMH was observed in women with bilateral tubal occlusion compared to control group [2.62 (2.95) ng/ml vs. 3.37 (3.11) ng/ml, P = 0.03], and the difference remained after adjustment of BMI (P-adjust = 0.04). However, no statistical difference was found in the levels of FSH [7.00 (2.16) IU/L vs. 6.74 (2.30) IU/L], LH [4.18 (1.52) IU/L vs. 4.63 (2.52) IU/L], E-2 [35.95 (20.40) pg/ml vs. 34.90 (17.85) pg/ml], T [25.07 +/- 11.46 ng/dl vs. 24.84 +/- 12.75 ng/dl], and AFC [6.00 (4.00) vs. 7.00 (4.00)] between two groups (p>0.05). Conclusions Women with bilateral tubal occlusion showed decreased AMH level, suggesting that chronic pelvic inflammation may diminish ovarian reserve. More caution should be paid when evaluating the detriment of PID on female fertility.	[Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250001, Peoples R China; [Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan 250001, Peoples R China; [Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250001, Peoples R China; [Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200000, Peoples R China; [Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200000, Peoples R China	Shandong University; Shanghai Jiao Tong University	Qin, YY; Chen, ZJ (corresponding author), Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250001, Peoples R China.; Qin, YY; Chen, ZJ (corresponding author), Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China.; Qin, YY; Chen, ZJ (corresponding author), Shandong Prov Key Lab Reprod Med, Jinan 250001, Peoples R China.; Qin, YY; Chen, ZJ (corresponding author), Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250001, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200000, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200000, Peoples R China.	qyy106@yahoo.com; chenzijiang@hotmail.com	Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022; Li, Yuan/GXV-1310-2022	Chen, Zi-Jiang/0000-0001-6637-6631	National Natural Science Foundation of China [81501223]; Scientific Research Foundation of Shandong Province of Outstanding Young Scientist [BS2014YY013]; National Basic Research Program of China (973 Program) [2012CB944700]; State Key Program of National Natural Science Foundation of China [81430029]; Science research foundation item of no-earnings health vocation [201402004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Shandong Province of Outstanding Young Scientist; National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science research foundation item of no-earnings health vocation	This research was supported by National Natural Science Foundation of China (81501223), the Scientific Research Foundation of Shandong Province of Outstanding Young Scientist (BS2014YY013), National Basic Research Program of China (973 Program) (2012CB944700), the State Key Program of National Natural Science Foundation of China (81430029), and Science research foundation item of no-earnings health vocation (201402004).	Borodin Iu I., 1991, ARKH ANAT GISTOL EMB, V100, P37; Chen MJ, 2008, HUM REPROD, V23, P952, DOI 10.1093/humrep/den015; de Souza FHC, 2015, CLIN EXP RHEUMATOL, V33, P44; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Du BT, 2006, FERTIL STERIL, V85, P366, DOI 10.1016/j.fertnstert.2005.07.1316; El-Halawaty S, 2011, GYNECOL ENDOCRINOL, V27, P401, DOI 10.3109/09513590.2010.495433; Freeman EW, 2007, FERTIL STERIL, V87, P101, DOI 10.1016/j.fertnstert.2006.05.074; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Kiraly O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004901; Lin RH, 2015, ONCOTARGET, V6, P2856, DOI 10.18632/oncotarget.3091; Nteeba J, 2013, MOL REPROD DEV, V80, P948, DOI 10.1002/mrd.22231; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Roth Z, 2013, J DAIRY SCI, V96, P6499, DOI 10.3168/jds.2013-6903; Senates Ebubekir, 2013, J Crohns Colitis, V7, pe29, DOI 10.1016/j.crohns.2012.03.003; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Skalba P, 2011, EUR J OBSTET GYN R B, V158, P254, DOI 10.1016/j.ejogrb.2011.06.006; Zhao WH, 2014, GYNECOL OBSTET INVES, V77, P169, DOI 10.1159/000358393	19	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156130	10.1371/journal.pone.0156130	http://dx.doi.org/10.1371/journal.pone.0156130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27272680	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200006
J	Palko, JR; Morris, HJ; Pan, XL; Harman, CD; Koehl, KL; Gelatt, KN; Plummer, CE; Komaromy, AM; Liu, J				Palko, Joel R.; Morris, Hugh J.; Pan, Xueliang; Harman, Christine D.; Koehl, Kristin L.; Gelatt, Kirk N.; Plummer, Caryn E.; Komaromy, Andras M.; Liu, Jun			Influence of Age on Ocular Biomechanical Properties in a Canine Glaucoma Model with ADAMTS10 Mutation	PLOS ONE			English	Article							NERVE HEAD BIOMECHANICS; UVEOSCLERAL OUTFLOW; POSTERIOR SCLERA; VOLUME CHANGE; INTRAOCULAR-PRESSURE; INHERITED GLAUCOMA; MATRIX STIFFNESS; LAMINA-CRIBROSA; IOP ELEVATIONS; CROSS-LINKING	Soft tissue often displays marked age-associated stiffening. This study aims to investigate how age affects scleral biomechanical properties in a canine glaucoma model with ADAMTS10 mutation, whose extracellular matrix is concomitantly influenced by the mutation and an increased mechanical load from an early age. Biomechanical data was acquired from ADAMTS10-mutant dogs (n = 10, 21 to 131 months) and normal dogs (n = 5, 69 to 113 months). Infusion testing was first performed in the whole globes to measure ocular rigidity. After infusion experiments, the corneas were immediately trephined to prepare scleral shells that were mounted on a pressurization chamber to measure strains in the posterior sclera using an inflation testing protocol. Dynamic viscoelastic mechanical testing was then performed on dissected posterior scleral strips and the data were combined with those reported earlier by our group from the same animal model (Palko et al, IOVS 2013). The association between age and scleral biomechanical properties was evaluated using multi-variate linear regression. The relationships between scleral properties and the mean and last measured intraocular pressure (IOP) were also evaluated. Our results showed that age was positively associated with complex modulus (p<0.001) and negatively associated with loss tangent (p<0.001) in both the affected and the normal groups, suggesting an increased stiffness and decreased mechanical damping with age. The regression slopes were not different between the groups, although the complex modulus was significantly lower in the affected group (p = 0.041). The posterior circumferential tangential strain was negatively correlated with complex modulus (R = -0.744, p = 0.006) showing consistent mechanical evaluation between the testing methods. Normalized ocular rigidity was negatively correlated with the last IOP in the affected group (p = 0.003). Despite a mutation that affects the extracellular matrix and a chronic IOP elevation in the affected dogs, age-associated scleral stiffening and loss of mechanical damping were still prominent and had a similar rate of change as in the normal dogs.	[Palko, Joel R.; Morris, Hugh J.; Liu, Jun] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Palko, Joel R.] Washington Univ, Dept Ophthalmol, St Louis, MO USA; [Pan, Xueliang] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Harman, Christine D.; Koehl, Kristin L.; Komaromy, Andras M.] Michigan State Univ, Dept Small Anim Clin Sci, Lansing, MI USA; [Gelatt, Kirk N.; Plummer, Caryn E.; Komaromy, Andras M.] Univ Florida, Dept Small Anim Clin Sci, Gainesville, FL USA; [Komaromy, Andras M.] Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA; [Liu, Jun] Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Washington University (WUSTL); University System of Ohio; Ohio State University; Michigan State University; State University System of Florida; University of Florida; University of Pennsylvania; University System of Ohio; Ohio State University	Liu, J (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Komaromy, AM (corresponding author), Michigan State Univ, Dept Small Anim Clin Sci, Lansing, MI USA.; Komaromy, AM (corresponding author), Univ Florida, Dept Small Anim Clin Sci, Gainesville, FL USA.; Komaromy, AM (corresponding author), Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA.; Liu, J (corresponding author), Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA.	komaromy@cvm.msu.edu; liu.314@osu.edu		Liu, Jun/0000-0001-5984-4169; Pan, Xueliang/0000-0002-2342-3212	NIH [RO1EY020929]; University of Pennsylvania Research Foundation; Michigan State University Faculty Startup Funds; Edward Sheppard and Family; Gwathmey-Adams Laboratory for Vision Research; NATIONAL EYE INSTITUTE [R01EY020929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; Michigan State University Faculty Startup Funds; Edward Sheppard and Family; Gwathmey-Adams Laboratory for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded in part by NIH grant RO1EY020929, University of Pennsylvania Research Foundation, Michigan State University Faculty Startup Funds, Edward Sheppard and Family, and Gwathmey-Adams Laboratory for Vision Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, VISCOELASTIC PROPERT; Asrani S, 2000, J GLAUCOMA, V9, P134; BARRIE KP, 1985, AM J VET RES, V46, P84; BARRIE KP, 1985, AM J VET RES, V46, P89; Beaton L, 2015, BIOMED OPT EXPRESS, V6, P1694, DOI 10.1364/BOE.6.001694; BROOKS DE, 1989, AM J VET RES, V50, P936; BROOKS DE, 1995, EXP EYE RES, V60, P71, DOI 10.1016/S0014-4835(05)80085-5; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Downs JC, 2015, EXP EYE RES, V133, P19, DOI 10.1016/j.exer.2015.02.011; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Evans H.E., 2013, MILLERS ANATOMY DOG; FRIBERG TR, 1988, EXP EYE RES, V47, P429, DOI 10.1016/0014-4835(88)90053-X; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gelatt KN, 1998, J GLAUCOMA, V7, P187; GELATT KN, 1977, INVEST OPHTH VIS SCI, V16, P1135; GELATT KN, 1981, AM J VET RES, V42, P1691; Gelatt KN, 1976, T SECTION OPHTHALM 1, V81; Geraghty B, 2012, J MECH BEHAV BIOMED, V16, P181, DOI 10.1016/j.jmbbm.2012.10.011; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Gong HY, 2009, EXP EYE RES, V88, P729, DOI 10.1016/j.exer.2009.01.015; GREENE PR, 1985, AM J OPTOM PHYS OPT, V62, P870; Grytz R, 2014, INVEST OPHTH VIS SCI, V55, P8163, DOI 10.1167/iovs.14-14029; Gum G. G., 1983, ORTHOGRADE RAPID A 1, V5, P117; JANSSON F, 1961, ACTA OPHTHALMOL, V39, P899; Kallel F, 1997, ULTRASONIC IMAGING, V19, P195, DOI 10.1177/016173469701900303; Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kutz WE, J BIOL CHEM, V286, P17156; Liu J, 2009, INVEST OPHTH VIS SCI, V50, P2224, DOI 10.1167/iovs.08-2365; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Morris HJ, 2013, INVEST OPHTH VIS SCI, V54, P7215, DOI 10.1167/iovs.13-12441; Nagata N, 2011, J VET MED SCI, V73, P1585, DOI 10.1292/jvms.11-0251; Palko JR, 2013, INVEST OPHTH VIS SCI, V54, P2685, DOI 10.1167/iovs.12-10621; Palko JR, 2011, EXP EYE RES, V93, P825, DOI 10.1016/j.exer.2011.09.018; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; PEIFFER RL, 1980, AM J VET RES, V41, P1808; PERKINS ES, 1981, EXP EYE RES, V33, P141, DOI 10.1016/S0014-4835(81)80062-0; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rufer F, 2005, CORNEA, V24, P259; Sagara T, 1999, ARCH OPHTHALMOL-CHIC, V117, P794; SAMUELSON DA, 1983, GLAUCOMA, V5, P174; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Silverman RH, 2009, ULTRASOUND MED BIOL, V35, P839, DOI 10.1016/j.ultrasmedbio.2008.11.009; Slack JM, 2012, VET REC, V171, P373, DOI 10.1136/vr.100967; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Tang JH, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007365; THIJSSEN JM, 1985, ULTRASOUND MED BIOL, V11, P157, DOI 10.1016/0301-5629(85)90018-3	53	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156466	10.1371/journal.pone.0156466	http://dx.doi.org/10.1371/journal.pone.0156466			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271467	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200009
J	Vogel, MW; Giorni, A; Vegh, V; Pellicer-Guridi, R; Reutens, DC				Vogel, Michael W.; Giorni, Andrea; Vegh, Viktor; Pellicer-Guridi, Ruben; Reutens, David C.			Rotatable Small Permanent Magnet Array for Ultra-Low Field Nuclear Magnetic Resonance Instrumentation: A Concept Study	PLOS ONE			English	Article							CONCOMITANT GRADIENTS; NMR; MRI	Object We studied the feasibility of generating the variable magnetic fields required for ultra-low field nuclear magnetic resonance relaxometry with dynamically adjustable permanent magnets. Our motivation was to substitute traditional electromagnets by distributed permanent magnets, increasing system portability. Materials and Methods The finite element method (COMSOL (R)) was employed for the numerical study of a small permanent magnet array to calculate achievable magnetic field strength, homogeneity, switching time and magnetic forces. A manually operated prototype was simulated and constructed to validate the numerical approach and to verify the generated magnetic field. Results A concentric small permanent magnet array can be used to generate strong sample pre-polarisation and variable measurement fields for ultra-low field relaxometry via simple prescribed magnet rotations. Using the array, it is possible to achieve a pre-polarisation field strength above 100 mT and variable measurement fields ranging from 20-50 mu T with 200 ppm absolute field homogeneity within a field-of-view of 5 x 5 x 5 cubic centimetres. Conclusions A dynamic small permanent magnet array can generate multiple highly homogeneous magnetic fields required in ultra-low field nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) instruments. This design can significantly reduce the volume and energy requirements of traditional systems based on electromagnets, improving portability considerably.	[Vogel, Michael W.; Giorni, Andrea; Vegh, Viktor; Pellicer-Guridi, Ruben; Reutens, David C.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	University of Queensland	Vogel, MW (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	michael.vogel@cai.uq.edu.au	Reutens, David/C-7226-2018	Pellicer-Guridi, Ruben/0000-0001-9263-4921; Reutens, David/0000-0002-1652-9369; Vegh, Viktor/0000-0002-4310-1421	Australian Research Council [DE140100229]; Australian National Health and Medical Research Council [628952, 631352]; Bill & Melinda Gates Foundation [OPP1007237]	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	M. W. Vogel is financially supported by the Australian Research Council (http://www.arc.gov.au/) Discovery Early Career Research Award No. DE140100229. D. C. Reutens is supported by the Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) program grant No. 628952 and No. 631352. Parts of this project are supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/) (OPP1007237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Bjork R, 2010, J MAGN MAGN MATER, V322, P3664, DOI 10.1016/j.jmmm.2010.07.022; Burghoff M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2006981; Cooley CZ, 2015, MAGN RESON MED, V73, P872, DOI 10.1002/mrm.25147; Espy MA, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2365473; Espy M, 2013, J MAGN RESON, V228, P1, DOI 10.1016/j.jmr.2012.11.030; Espy M, 2009, IEEE T APPL SUPERCON, V19, P835, DOI 10.1109/TASC.2009.2018517; Haake E. M., 1999, MAGNETIC RESONANCE I; Hennig J, 2008, MAGN RESON MATER PHY, V21, P5, DOI 10.1007/s10334-008-0105-7; Keeler J., 2013, UNDERSTANDING NMR SP; Kraus R., 2014, ULTRALOW FIELD NUCL; Ledbetter MP, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.107601; Lee SK, 2005, MAGN RESON MED, V53, P9, DOI 10.1002/mrm.20316; MACOVSKI A, 1993, MAGNET RESON MED, V30, P221, DOI 10.1002/mrm.1910300211; Matlachov AN, 2004, J MAGN RESON, V170, P1, DOI 10.1016/j.jmr.2004.05.015; McDermott R, 2004, J LOW TEMP PHYS, V135, P793, DOI 10.1023/B:JOLT.0000029519.09286.c5; McDermott R, 2002, SCIENCE, V295, P2247, DOI 10.1126/science.1069280; Moresi G, 2003, CONCEPT MAGN RESON B, V19B, P35, DOI 10.1002/cmr.b.10082; Nieminen JO, 2010, J MAGN RESON, V207, P213, DOI 10.1016/j.jmr.2010.09.001; Raich H, 2004, CONCEPT MAGN RESON B, V23B, P16, DOI 10.1002/cmr.b.20018; Sarracanie M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15177; Soltner H, 2010, CONCEPT MAGN RESON A, V36A, P211, DOI 10.1002/cmr.a.20165; Sun N, 2011, IEEE J SOLID-ST CIRC, V46, P342, DOI 10.1109/JSSC.2010.2074630; Trahrns L, 2010, MAGN RESON IMAGING, V28, P1244, DOI 10.1016/j.mri.2010.02.004; Vesanen PT, 2013, MAGN RESON MED, V69, P1795, DOI 10.1002/mrm.24413; Vogel MW, 2013, MED PHYS, V40, DOI 10.1118/1.4800491; Volegov P, 2010, IFMBE PROC, V28, P82; Volegov PL, 2005, J MAGN RESON, V175, P103, DOI 10.1016/j.jmr.2005.03.015; Zalesskiy SS, 2014, CHEM REV, V114, P5641, DOI 10.1021/cr400063g; Zhu ZQ, 2001, IEE P-ELECT POW APPL, V148, P299, DOI 10.1049/ip-epa:20010479; Zotev VS, 2007, SUPERCOND SCI TECH, V20, pS367, DOI 10.1088/0953-2048/20/11/S13	31	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157040	10.1371/journal.pone.0157040	http://dx.doi.org/10.1371/journal.pone.0157040			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271886	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200030
J	Cui, K; Wang, HY; Liao, SX; Tang, Q; Li, L; Cui, YZ; He, Y				Cui, Kai; Wang, Haiying; Liao, Shengxi; Tang, Qi; Li, Li; Cui, Yongzhong; He, Yuan			Transcriptome Sequencing and Analysis for Culm Elongation of the World's Largest Bamboo (Dendrocalamus sinicus)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RNA-SEQ; GENE-EXPRESSION; ARABIDOPSIS; PLANT; CO2; MARKERS; TOOL; IDENTIFICATION; ASSIMILATION	Dendrocalamus sinicus is the world's largest bamboo species with strong woody culms, and known for its fast-growing culms. As an economic bamboo species, it was popularized for multi-functional applications including furniture, construction, and industrial paper pulp. To comprehensively elucidate the molecular processes involved in its culm elongation, Illumina paired-end sequencing was conducted. About 65.08 million high-quality reads were produced, and assembled into 81,744 unigenes with an average length of 723 bp. A total of 64,338 (79%) unigenes were annotated for their functions, of which, 56,587 were annotated in the NCBI non-redundant protein database and 35,262 were annotated in the Swiss-Prot database. Also, 42,508 and 21,009 annotated unigenes were allocated to gene ontology (GO) categories and clusters of orthologous groups (COG), respectively. By searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG), 33,920 unigenes were assigned to 128 KEGG pathways. Meanwhile, 8,553 simple sequence repeats (SSRs) and 81,534 single-nucleotide polymorphism (SNPs) were identified, respectively. Additionally, 388 transcripts encoding lignin biosynthesis were detected, among which, 27 transcripts encoding Shikimate O-hydroxycinnamoyltransferase (HCT) specifically expressed in D. sinicus when compared to other bamboo species and rice. The phylogenetic relationship between D. sinicus and other plants was analyzed, suggesting functional diversity of HCT unigenes in D. sinicus. We conjectured that HCT might lead to the high lignin content and giant culm. Given that the leaves are not yet formed and culm is covered with sheaths during culm elongation, the existence of photosynthesis of bamboo culm is usually neglected. Surprisedly, 109 transcripts encoding photosynthesis were identified, including photosystem I and II, cytochrome b6/f complex, photosynthetic electron transport and F-type ATPase, and 24 transcripts were characterized as antenna proteins that regarded as the main tool for capturing light of plants, implying stem photosynthesis plays a key role during culm elongation due to the unavailability of its leaf. By real-time quantitative PCR, the expression level of 6 unigenes was detected. The results showed the expression level of all genes accorded with the transcriptome data, which confirm the reliability of the transcriptome data. As we know, this is the first study underline the D. sinicus transcriptome, which will deepen the understanding of the molecular mechanisms of culm development. The results may help variety improvement and resource utilization of bamboos.	[Cui, Kai; Wang, Haiying; Liao, Shengxi; Li, Li; Cui, Yongzhong; He, Yuan] Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Peoples R China; [Tang, Qi] Hunan Agr Univ, Hunan Coinnovat Ctr Utilizat Bot Funct Ingredient, Changsha 410128, Hunan, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Hunan Agricultural University	Liao, SX (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Peoples R China.	cafjone@126.com		Tang, Qi/0000-0003-2385-4263	National Natural Science Foundation of China [31300501]; Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2014QB020, riricaf2013002M]; China Scholarship Council [201503270020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Non-profit Research Institution of CAF; China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Grant No. 31300501), the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (Grant No. CAFYBB2014QB020 and Grant No. riricaf2013002M), and the China Scholarship Council (Grant No. 201503270020).; This work was supported by the National Natural Science Foundation of China (Grant No. 31300501), the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (Grant No. CAFYBB2014QB020 and Grant No. riricaf2013002M), and the China Scholarship Council (Grant No. 201503270020).	[Anonymous], 2011, MACROMOL RAPID COMM, V32, P1297, DOI 10.1002/marc.201100488; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Avila E, 2014, PHOTOSYNTHETICA, V52, P3, DOI 10.1007/s11099-014-0004-2; Banik RL, 2015, TROP FOREST, P43, DOI 10.1007/978-3-319-14133-6_3; Banik RL, 2000, SILVICULTURE FIELD G, P1; Bloemen J, 2013, J EXP BOT, V64, P2129, DOI 10.1093/jxb/ert071; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Busch FA, 2013, PLANT CELL ENVIRON, V36, P200, DOI 10.1111/j.1365-3040.2012.02567.x; Cardoso DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-66; Carocha V, 2015, NEW PHYTOL, V206, P1297, DOI 10.1111/nph.13313; Chen CY, 2010, PHYTOCHEMISTRY, V71, P1270, DOI 10.1016/j.phytochem.2010.05.011; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089495; Chen TH, 2009, PHYTOCHEMISTRY, V70, P25, DOI 10.1016/j.phytochem.2008.10.004; Chiu WB, 2006, NEW PHYTOL, V170, P53, DOI 10.1111/j.1469-8137.2005.01638.x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui K, 2012, J PROTEOME RES, V11, P2492, DOI 10.1021/pr2011878; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Dong YR, 2012, AM J BOT, V99, pE347, DOI 10.3732/ajb.1200029; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui YJ, 2010, J INTEGR PLANT BIOL, V52, P1008, DOI 10.1111/j.1744-7909.2010.00965.x; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hansen NML, 2008, BIOMACROMOLECULES, V9, P1493, DOI 10.1021/bm800053Z; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hsieh CW, 2006, J AGR FOOD CHEM, V54, P3101, DOI 10.1021/jf052711s; Hui C.M., 2014, APPL MECH MAT, V522, P1084, DOI [10.4028/www.scientific.net/AMM.522-524.1084, DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.522-524.1084]; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang ZH, 2012, PHOTOSYNTHETICA, V50, P129, DOI 10.1007/s11099-012-0009-7; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; McGuire MA, 2009, J EXP BOT, V60, P3809, DOI 10.1093/jxb/erp222; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA, P12; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Shi ZJ, 2013, BIOENERG RES, V6, P1212, DOI 10.1007/s12155-013-9321-8; Sun Q, 2003, J EXP BOT, V54, P1627, DOI 10.1093/jxb/erg167; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Teskey RO, 2008, NEW PHYTOL, V177, P17, DOI 10.1111/j.1469-8137.2007.02286.x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ueda K., 1960, B KYOTO U FORESTRY, V30, P1; Vandegehuchte MW, 2015, NEPHROL DIAL TRANSPL, P1; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu YJ, 2006, PROTEOMICS, V6, P5898, DOI 10.1002/pmic.200600278; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yang L, 2015, PLANT CELL REP, V34, P2001, DOI 10.1007/s00299-015-1846-1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi TP., 2008, ICONOGRAPHIA BAMBUSO; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang LQ, 2003, GENOME RES, V13, P2533, DOI 10.1101/gr.1318503; Zhang X, 2011, BIOENERG RES, V4, P246, DOI 10.1007/s12155-011-9147-1; Zhou MB, 2011, PLANT MOL BIOL REP, V29, P224, DOI 10.1007/s11105-010-0222-0	70	15	22	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157362	10.1371/journal.pone.0157362	http://dx.doi.org/10.1371/journal.pone.0157362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304219	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800054
J	Jaffe, A; Giveon, S; Wulffhart, L; Oberman, B; Freedman, L; Ziv, A; Kalter-Leibovici, O				Jaffe, Anat; Giveon, Shmuel; Wulffhart, Liat; Oberman, Bernice; Freedman, Laurence; Ziv, Arnona; Kalter-Leibovici, Ofra			Diabetes among Ethiopian Immigrants to Israel: Exploring the Effects of Migration and Ethnicity on Diabetes Risk	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE; BODY-COMPOSITION; PREVALENCE; GLUCOSE; POPULATIONS; MELLITUS; INSULIN; RESIDENT; OBESITY	Objective Diabetes prevalence among ethnic minorities and immigrants often differs from the majority indigenous population. We compared diabetes prevalence, incidence and risk among Ethiopian and non-Ethiopian Jews. Within these main groups, we controlled for the effect of migration on diabetes risk by comparing the subgroups of Ethiopian and former Soviet Union (FSU) immigrants, and compared both with Israeli-born non-Ethiopian Jews. Methods The study cohort included adult Ethiopian (n = 8,398) and age-matched non-Ethiopian Jews (n = 15,977) and subgroups: Ethiopian immigrants (n = 7,994), FSU immigrants (n = 1,541) and Israeli-born non-Ethiopian Jews (n = 10,828). Diabetes prevalence, annual incidence, and hazard ratios (HRs) adjusted for sex and metabolic syndrome (MetS)-components, were determined in three age groups (<50yrs, 50-59yrs, and >= 60yrs). Comparisons of body mass index (BMI) at diabetes incidence were made. Results Younger (<50yrs) Ethiopians had higher prevalence rates, 3.6% (95% CI: 3.1-4.1) and annual incidence, 0.9% (95% CI: 0.8-1.0) than non-Ethiopians, 2.7% (95% CI: 2.3-3.0) and 0.5% (95% CI: 0.4-0.6), respectively. These differences were particularly pronounced among Ethiopian women. Diabetes risk among Ethiopians was higher and adjustment for MetS-components was important only for BMI, which further increased hazard ratio (HR) estimates associated with Ethiopian ethnicity from 1.81 (95% CI: 1.50-2.17) to 2.31 (95% CI: 1.91-2.79). The same differences were seen when comparing Ethiopian to FSU immigrants. BMI before incident diabetes was lower among younger Ethiopian immigrants than younger FSU immigrants and Israeli-born. Conclusions Ethiopian ethnicity is associated with increased diabetes risk, which is age and BMI dependent. Young Ethiopians<50yrs, particularly women, had the greatest increase in risk. Lower BMI cut-offs should be defined to reflect diabetes risk among Ethiopians.	[Jaffe, Anat] Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel; [Giveon, Shmuel] Tel Aviv Univ, Sackler Sch Med, Dept Family Practice, Clalit Hlth Serv,Dept Family Practice, IL-69978 Tel Aviv, Israel; [Wulffhart, Liat; Oberman, Bernice; Freedman, Laurence] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Biostat, Ramat Gan, Israel; [Ziv, Arnona] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Informat & Comp, Ramat Gan, Israel; [Jaffe, Anat; Kalter-Leibovici, Ofra] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Cardiovasc Epidemiol, Ramat Gan, Israel; [Kalter-Leibovici, Ofra] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Clalit Health Services; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Jaffe, A (corresponding author), Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel.; Jaffe, A (corresponding author), Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Cardiovasc Epidemiol, Ramat Gan, Israel.	anatjaffe@gmail.com		Jaffe, Anat/0000-0003-3976-0923				Abebe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060081; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Balde NM, 2007, DIABETES METAB, V33, P114, DOI 10.1016/j.diabet.2006.10.001; BURSZTYN M, 1993, J HYPERTENS, V11, P455, DOI 10.1097/00004872-199304000-00018; BURSZTYN M, 1995, J HYPERTENS, V13, P57; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Cohen A M, 1993, Diabetes Res, V23, P65; COHEN AM, 1961, METABOLISM, V10, P50; COHEN MP, 1988, DIABETES, V37, P824, DOI 10.2337/diabetes.37.6.824; Cooper RS, 1997, DIABETES CARE, V20, P343, DOI 10.2337/diacare.20.3.343; Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551; Feldman M, 1998, THE ETHIOPIAN EXODUS; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Gill G, 2009, DIABETOLOGIA, V52, P8, DOI 10.1007/s00125-008-1167-9; GREEN MS, 1991, J EPIDEMIOL COMMUN H, V45, P281, DOI 10.1136/jech.45.4.281; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hilawe EH, 2013, B WORLD HEALTH ORGAN, V91, P671, DOI 10.2471/BLT.12.113415; Hosler AS, 2004, ETHNIC DIS, V14, P372; Kalchiem-Dekel O, 2015, J DIABETES, V7, P531, DOI 10.1111/1753-0407.12215; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Langley-Evans S, 2015, NUTR HLTH DIS LIFESP; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; Mbanya JC, 2006, DIS MORTALITY SUBSAH; Mbanya JCN, 1999, DIABETES CARE, V22, P434, DOI 10.2337/diacare.22.3.434; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Meeks KAC, 2015, DIABETES RES CLIN PR, V110, P137, DOI 10.1016/j.diabres.2015.09.017; Murphy GAV, 2014, DIABETES CARE, V37, pE64, DOI 10.2337/dc13-2096; RAVUSSIN E, 1994, DIABETES CARE, V17, P1067, DOI 10.2337/diacare.17.9.1067; ROSENTHAL T, 1989, J HYPERTENS, V7, pS53, DOI 10.1097/00004872-198902001-00016; RUBINSTEIN A, 1993, ISRAEL J MED SCI, V29, P344; Wai WS, 2012, OBESITY, V20, P1887, DOI 10.1038/oby.2011.103; Wilf-Miron R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-729	36	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157354	10.1371/journal.pone.0157354	http://dx.doi.org/10.1371/journal.pone.0157354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300299	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200040
J	Khan, SA; Jackson, RT; Momen, B				Khan, Saira A.; Jackson, Robert T.; Momen, Bahram			The Relationship between Diet Quality and Acculturation of Immigrated South Asian American Adults and Their Association with Metabolic Syndrome	PLOS ONE			English	Article							DEPARTMENT-OF-AGRICULTURE; HEALTHY EATING INDEX; DISEASE RISK-FACTORS; UNITED-STATES; PATTERNS; ATHEROSCLEROSIS; PREVALENCE; RESIDENCE; INDIANS; OBESITY	Even though the total SA American population is increasing rapidly, there is a paucity of information on the relationship between diet quality, acculturation and health outcomes such as Metabolic Syndrome (MetS) in the low-income South Asian (SA) sub-population. Our goal was to examine diet quality, degree of acculturation and their potential influence on MetS in a diverse sample of SA Americans. A convenience sample of 401 adult SA men and women were studied using a cross-sectional study design. Volunteers from two low-income community health clinics in Maryland were interviewed by questionnaires. MetS, defined by the consensus harmonized definition by the presence of >= 3 of the 5 abnormal indicators, was studied. An interviewer obtained an automated self-administered 24-hour Recall (ASA24) and an acculturation index (using a previously validated (SL-ASIA). SA had a composite HEI2010 score of 68 suggesting an overall need for diet improvements. Males had a higher diet quality (mean HEI2010 score) than females. Males with MetS had lower diet quality (68) than males without MetS (73). The converse was true for females (68 vs. 65). Americanized (more acculturated) subjects had a higher diet quality compared to less acculturated SA. Small differences were found in diet quality scores among SA adults from different countries. Less acculturated females, had a higher percentage of MetS and lower diet quality compared to males. These results suggest that interventions are needed in males and females who were less acculturated because they may have greater MetS and lower diet quality compared to more Americanized SA.	[Khan, Saira A.; Jackson, Robert T.] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Momen, Bahram] Univ Maryland, Dept Environm Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Khan, SA (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	skhan12@umd.edu		Khan, Saira/0000-0002-1894-7839				Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 1995, REL VAL SUIJJ LEW AS, P17; [Anonymous], COMP HEI 2005 HEI 20; Bharmal N, 2015, J IMMIGR MINOR HEALT, V17, P781, DOI 10.1007/s10903-013-9973-7; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Britten P, 2012, J ACAD NUTR DIET, V112, P1648, DOI 10.1016/j.jand.2012.05.021; Chakraborty BM, 2010, COLLEGIUM ANTROPOL, V34, P1179; Dodani S, 2011, J EPIDEMIOL COMMUN H, V65, pA237, DOI 10.1136/jech.2011.142976h.100; Flowers E, 2010, METAB SYNDR RELAT D, V8, P417, DOI 10.1089/met.2009.0097; Gadgil MD, 2014, J ACAD NUTR DIET, V114, P238, DOI 10.1016/j.jand.2013.09.021; Gany F, 2012, J HEALTH CARE POOR U, V23, P615, DOI 10.1353/hpu.2012.0070; Garduno-Diaz SD, 2013, J HUM NUTR DIET, V26, P145, DOI 10.1111/j.1365-277X.2012.01284.x; Guenther P. M., 2014, J NUTR; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Gupta R, 2004, INT J CARDIOL, V97, P257, DOI 10.1016/j.ijcard.2003.11.003; Huynh QL, 2009, J CROSS CULT PSYCHOL, V40, P256, DOI 10.1177/0022022108328919; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kawada T., 2014, INT J CARDIOLOGY; KENNEDY ET, 1995, J AM DIET ASSOC, V95, P1103, DOI 10.1016/S0002-8223(95)00300-2; Khan SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004952; Khanna R, 2013, INDIAN J MED RES, V137, P295; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; McGuire S, 2011, ADV NUTR, V2, P293, DOI 10.3945/an.111.000430; Misra A, 2003, INDIAN J MED RES, V117, P170; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Misra R, 2010, J DIABETES COMPLICAT, V24, P145, DOI 10.1016/j.jdiacomp.2009.01.003; Narayan KMV, 2010, J AM COLL CARDIOL, V55, P966, DOI 10.1016/j.jacc.2009.07.075; Oza-Frank R, 2013, J IMMIGR MINOR HEALT, V15, P918, DOI 10.1007/s10903-012-9683-6; Perez-Escamilla R, 2011, AM J CLIN NUTR, V93, p1163S, DOI 10.3945/ajcn.110.003467; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Poudyal H, 2015, PROG LIPID RES, V59, P172, DOI 10.1016/j.plipres.2015.07.002; Ram CVS, 2012, J CLIN HYPERTENS, V14, P561, DOI 10.1111/j.1751-7176.2012.00652.x; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Roshania R, 2008, OBESITY, V16, P2669, DOI 10.1038/oby.2008.425; Sheikh AJ, 2001, GENDER LEVELS ACCULT; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; SUINN RM, 1987, EDUC PSYCHOL MEAS, V47, P401, DOI 10.1177/0013164487472012; SUINN RM, 1992, EDUC PSYCHOL MEAS, V52, P1041, DOI 10.1177/0013164492052004028; Wang ET, 2010, J AM COLL NUTR, V29, P130, DOI 10.1080/07315724.2010.10719826	41	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156851	10.1371/journal.pone.0156851	http://dx.doi.org/10.1371/journal.pone.0156851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299862	gold, Green Published, Green Submitted			2022-12-26	WOS:000377822200017
J	Lee, ES; Vedanthan, R; Jeemon, P; Kamano, JH; Kudesia, P; Rajan, V; Engelgau, M; Moran, AE				Lee, Edward S.; Vedanthan, Rajesh; Jeemon, Panniyammakal; Kamano, Jemima H.; Kudesia, Preeti; Rajan, Vikram; Engelgau, Michael; Moran, Andrew E.			Quality Improvement for Cardiovascular Disease Care in Low- and Middle-Income Countries: A Systematic Review	PLOS ONE			English	Review							ACUTE CORONARY SYNDROMES; TYPE-2 DIABETES-MELLITUS; CLUSTER-RANDOMIZED-TRIAL; RHEUMATIC HEART-DISEASE; SECONDARY PREVENTION; HEALTH-INSURANCE; BLOOD-PRESSURE; RISK-FACTORS; POLYPILL POLYCAP; PEER SUPPORT	Background The majority of global cardiovascular disease (CVD) burden falls on people living in low- and middle-income countries (LMICs). In order to reduce preventable CVD mortality and morbidity, LMIC health systems and health care providers need to improve the delivery and quality of CVD care. Objectives As part of the Disease Control Priorities Three (DCP3) Study efforts addressing quality improvement, we reviewed and summarized currently available evidence on interventions to improve quality of clinic-based CVD prevention and management in LMICs. Methods We conducted a narrative review of published comparative clinical trials that evaluated efficacy or effectiveness of clinic-based CVD prevention and management quality improvement interventions in LMICs. Conditions selected a priori included hypertension, diabetes, hyperlipidemia, coronary artery disease, stroke, rheumatic heart disease, and congestive heart failure. MEDLINE and EMBASE electronic databases were systematically searched. Studies were categorized as occurring at the system or patient/provider level and as treating the acute or chronic phase of CVD. Results From 847 articles identified in the electronic search, 49 met full inclusion criteria and were selected for review. Selected studies were performed in 19 different LMICs. There were 10 studies of system level quality improvement interventions, 38 studies of patient/provider interventions, and one study that fit both criteria. At the patient/provider level, regardless of the specific intervention, intensified, team-based care generally led to improved medication adherence and hypertension control. At the system level, studies provided evidence that introduction of universal health insurance coverage improved hypertension and diabetes control. Studies of system and patient/provider level acute coronary syndrome quality improvement interventions yielded inconclusive results. The duration of most studies was less than 12 months. Conclusions The results of this review suggest that CVD care quality improvement can be successfully implemented in LMICs. Most studies focused on chronic CVD conditions; more acute CVD care quality improvement studies are needed. Longer term interventions and follow-up will be needed in order to assess the sustainability of quality improvement efforts in LMICs.	[Lee, Edward S.] Univ So Calif, Keck Sch Med, Dept Med, Palliat & Gen Internal Med,Div Geriatr, Los Angeles, CA 90033 USA; [Vedanthan, Rajesh] Icahn Sch Med Mt Sinai, Div Cardiol, Dept Med, New York, NY 10029 USA; [Jeemon, Panniyammakal] Publ Hlth Fdn India, Ctr Control Chron Condit, Cochin, Kerala, India; [Kamano, Jemima H.] Moi Univ, Coll Hlth Sci, Eldoret, Kenya; [Kamano, Jemima H.] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Kudesia, Preeti] World Bank, Hlth Nutr & Populat Global Practice, Kathmandu, Nepal; [Rajan, Vikram] World Bank, Jakarta, Indonesia; [Engelgau, Michael] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Moran, Andrew E.] Columbia Univ, Div Gen Med, Dept Med, Med Ctr, New York, NY USA	University of Southern California; Icahn School of Medicine at Mount Sinai; Public Health Foundation of India; Moi University; The World Bank; The World Bank; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University	Moran, AE (corresponding author), Columbia Univ, Div Gen Med, Dept Med, Med Ctr, New York, NY USA.	aem35@cumc.columbia.edu		Vedanthan, Rajesh/0000-0001-7138-2382; Jeemon, Panniyammakal/0000-0003-4172-4307; kamano, jemima/0000-0003-2179-8202	U.S. National Heart, Lung and Blood Institute career development award [K08 HL089675-01]; Fogarty International Center of the U.S. National Institutes of Health [K01 TW 009218-05]; Department of Biotechnology India Alliance clinical and public health intermediate career fellowship; Wellcome Trust	U.S. National Heart, Lung and Blood Institute career development award; Fogarty International Center of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Biotechnology India Alliance clinical and public health intermediate career fellowship(Wellcome Trust DBT India Alliance); Wellcome Trust(Wellcome TrustEuropean Commission)	AEM was supported by a grant from the U.S. National Heart, Lung and Blood Institute career development award (K08 HL089675-01; www.nhlbi.nih.gov). RV was supported by a grant from the Fogarty International Center of the U.S. National Institutes of Health (K01 TW 009218-05; www.flc.nih.gov). PJ is supported by a Wellcome Trust, Department of Biotechnology India Alliance clinical and public health intermediate career fellowship (www.wellcome.ac.uk). The views expressed in this article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, National Institutes of Health, or the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2013, J HYPERTENS, V31, P201, DOI 10.1097/HJH.0b013e32835b0842; Ahmadipour H, 2010, INT J PREVENTIVE MED, V1, P50; Alexander T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003850; Alhalaiqa F, 2012, J HUM HYPERTENS, V26, P117, DOI 10.1038/jhh.2010.133; Anchala R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001213; Andryukhin A, 2010, EUR J GEN PRACT, V16, P205, DOI 10.3109/13814788.2010.527938; Arevian Mary, 2005, J Interprof Care, V19, P444, DOI 10.1080/13561820500215095; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Binanay CA, 2015, J AM COLL CARDIOL, V66, P2550, DOI 10.1016/j.jacc.2015.09.086; Bleich SN, 2007, BMJ-BRIT MED J, V335, P875, DOI 10.1136/bmj.39350.617616.BE; Bocchi EA, 2008, CIRC-HEART FAIL, V1, P115, DOI 10.1161/CIRCHEARTFAILURE.107.744870; Carapetis JR, 2008, NAT CLIN PRACT CARD, V5, P411, DOI 10.1038/ncpcardio1185; Chan JCN, 2014, JAMA INTERN MED, V174, P972, DOI 10.1001/jamainternmed.2014.655; de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2; Doval HC, 2005, BMJ-BRIT MED J, V331, P425, DOI 10.1136/bmj.38516.398067.E0; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; Erhun WO, 2005, PUBLIC HEALTH, V119, P792, DOI 10.1016/j.puhe.2004.11.009; FDA, 2014, BRIEFING DOCUMENT CA; Ferrante D, 2010, J AM COLL CARDIOL, V56, P372, DOI 10.1016/j.jacc.2010.03.049; Flather MD, 2011, AM HEART J, V162, P700, DOI 10.1016/j.ahj.2011.07.027; Gaziano TA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-240; Gaziano TA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-170; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Goodarzi M, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-10; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hendriks ME, 2014, JAMA INTERN MED, V174, P555, DOI 10.1001/jamainternmed.2013.14458; International Telecommunication Union, 2014, THE WORLD IN 2014 IC; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Khonsari S, 2015, EUR J CARDIOVASC NUR, V14, P170, DOI 10.1177/1474515114521910; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Lohr KN, 1990, MEDICARE A STRATEGY; Macharia WM, 2009, AFR HEALTH SCI, V9, P118; Mendis S, 2010, B WORLD HEALTH ORGAN, V88, P412, DOI 10.2471/BLT.08.062364; Mohammadi Eesa, 2006, Int J Nurs Pract, V12, P153, DOI 10.1111/j.1440-172X.2006.00563.x; Nazzal C, 2008, REV MED CHILE, V136, P1231, DOI /S0034-98872008001000001; Nesari M, 2010, JPN J NURS SCI, V7, P121, DOI 10.1111/j.1742-7924.2010.00146.x; Obreli-Neto PR, 2011, INT J CLIN PHARM-NET, V33, P642, DOI 10.1007/s11096-011-9518-x; Ortega KC, 2010, CLINICS, V65, P857, DOI 10.1590/S1807-59322010000900008; Peng B, 2014, STROKE, V45, P515, DOI 10.1161/STROKEAHA.113.001424; Piette JD, 2012, TELEMED E-HEALTH, V18, P613, DOI 10.1089/tmj.2011.0271; Prabhakaran D, 2008, NATL MED J INDIA, V21, P107; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Qureshi NN, 2007, BMJ-BRIT MED J, V335, P1030, DOI 10.1136/bmj.39360.617986.AE; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Ramachandran A, 2013, LANCET DIABETES ENDO, V1, P191, DOI 10.1016/S2213-8587(13)70067-6; Ramanath KV, 2012, J YOUNG PHARM, V4, P95, DOI 10.4103/0975-1483.96623; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; Reutens AT, 2012, DIABETES RES CLIN PR, V98, P38, DOI 10.1016/j.diabres.2012.06.002; Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720; Rotheram-Borus MJ, 2012, DIABETES EDUCATOR, V38, P357, DOI 10.1177/0145721712444617; Sekhri N, 2011, HEALTH AFFAIR, V30, P1498, DOI 10.1377/hlthaff.2010.0461; Shetty Ananth Samith, 2011, J Assoc Physicians India, V59, P711; Sosa-Rubi SG, 2009, B WORLD HEALTH ORGAN, V87, P512, DOI 10.2471/BLT.08.053256; Steyn K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20796; Tan MY, 2011, HEALTH EDUC RES, V26, P896, DOI 10.1093/her/cyr047; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; Trujillo AJ, 2010, HEALTH AFFAIR, V29, P2180, DOI 10.1377/hlthaff.2010.0463; Vedanthan R, 2015, GLOB HEART, V10, P313, DOI 10.1016/j.gheart.2015.09.003; Walker RW, 2013, LANCET GLOB HEALTH, V1, pE282, DOI 10.1016/S2214-109X(13)70068-8; World Health Organisation, 2008, TASK SHIFTING GLOBAL; Yu BR, 2013, AM J MANAG CARE, V19, pE22; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2012, CIRC-CARDIOVASC QUAL, V5, P463, DOI 10.1161/CIRCOUTCOMES.111.963637; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zou GY, 2015, J PUBLIC HEALTH-UK, V37, P241, DOI 10.1093/pubmed/fdu013	67	34	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157036	10.1371/journal.pone.0157036	http://dx.doi.org/10.1371/journal.pone.0157036			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299563	Green Submitted, gold, Green Published			2022-12-26	WOS:000377822200025
J	Marzano, M; Fosso, B; Manzari, C; Grieco, F; Intranuovo, M; Cozzi, G; Mule, G; Scioscia, G; Valiente, G; Tullo, A; Sbisa, E; Pesole, G; Santamaria, M				Marzano, Marinella; Fosso, Bruno; Manzari, Caterina; Grieco, Francesco; Intranuovo, Marianna; Cozzi, Giuseppe; Mule, Giuseppina; Scioscia, Gaetano; Valiente, Gabriel; Tullo, Apollonia; Sbisa, Elisabetta; Pesole, Graziano; Santamaria, Monica			Complexity and Dynamics of the Winemaking Bacterial Communities in Berries, Musts, and Wines from Apulian Grape Cultivars through Time and Space	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; MALOLACTIC FERMENTATION; SACCHAROMYCES-CEREVISIAE; STARTER CULTURES; YEAST; STRAINS; BIODIVERSITY; KNOWLEDGE; PCR; DNA	Currently, there is very little information available regarding the microbiome associated with the wine production chain. Here, we used an amplicon sequencing approach based on high-throughput sequencing (HTS) to obtain a comprehensive assessment of the bacterial community associated with the production of three Apulian red wines, from grape to final product. The relationships among grape variety, the microbial community, and fermentation was investigated. Moreover, the winery microbiota was evaluated compared to the autochthonous species in vineyards that persist until the end of the winemaking process. The analysis highlighted the remarkable dynamics within the microbial communities during fermentation. A common microbial core shared among the examined wine varieties was observed, and the unique taxonomic signature of each wine appellation was revealed. New species belonging to the genus Halomonas were also reported. This study demonstrates the potential of this metagenomic approach, supported by optimized protocols, for identifying the biodiversity of the wine supply chain. The developed experimental pipeline offers new prospects for other research fields in which a comprehensive view of microbial community complexity and dynamics is desirable.	[Marzano, Marinella; Fosso, Bruno; Manzari, Caterina; Pesole, Graziano; Santamaria, Monica] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Grieco, Francesco] CNR, Operat Unit Lecce, Inst Sci Food Prod, Lecce, Le, Italy; [Intranuovo, Marianna; Pesole, Graziano] Univ Bari A Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Cozzi, Giuseppe; Mule, Giuseppina] CNR, Inst Sci Food Prod, I-70126 Bari, Italy; [Scioscia, Gaetano] IBM Corp, GBS BAO Adv Analyt Serv, Bari, Italy; [Scioscia, Gaetano] IBM Corp, MBLab, Bari, Italy; [Valiente, Gabriel] Univ Politecn Cataluna, Algorithms Bioinformat Complex & Formal Methods R, Barcelona, Spain; [Tullo, Apollonia; Sbisa, Elisabetta] CNR, Inst Biomed Technol, Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); International Business Machines (IBM); International Business Machines (IBM); Universitat Politecnica de Catalunya; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Pesole, G; Santamaria, M (corresponding author), CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.; Pesole, G (corresponding author), Univ Bari A Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	g.pesole@ibbe.cnr.it; m.santamaria@ibbe.cnr.it	Sbisa', Elisabetta/AAW-9727-2020; Fosso, Bruno/P-1538-2018; Grieco, Francesco/B-6590-2015; Marzano, Marinella/T-7306-2018; Valiente, Gabriel/AAH-4424-2021; Pesole, Graziano/K-5283-2019; Mule, Giuseppina/B-6478-2015; Tullo, Apollonia/AAX-1079-2020; Santamaria, Monica/AAQ-3050-2020	Fosso, Bruno/0000-0003-2324-086X; Grieco, Francesco/0000-0002-8599-6091; Mule, Giuseppina/0000-0002-9094-1888; Tullo, Apollonia/0000-0002-5081-4745; Marzano, Marinella/0000-0002-9996-8817	"Laboratorio di Bioinformatica per la Biodiversita Molecolare'' (MBLab) [DM19410]; "Biotecnologie degli alimenti per l'innovazione e la competitivita delle principali filiere regionali: estensione della conservabilita e aspetti funzionali - BiotecA" [QCBRAJ6]	"Laboratorio di Bioinformatica per la Biodiversita Molecolare'' (MBLab); "Biotecnologie degli alimenti per l'innovazione e la competitivita delle principali filiere regionali: estensione della conservabilita e aspetti funzionali - BiotecA"	This study was partially supported by the following Projects: "Laboratorio di Bioinformatica per la Biodiversita Molecolare'' (MBLab) (Project code DM19410), "Biotecnologie degli alimenti per l'innovazione e la competitivita delle principali filiere regionali: estensione della conservabilita e aspetti funzionali - BiotecA" (Project code QCBRAJ6),	Alexandre H, 2004, INT J FOOD MICROBIOL, V93, P141, DOI 10.1016/j.ijfoodmicro.2003.10.013; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arahal DR, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P811, DOI 10.1007/0-387-30746-x_28; Baiano A, 2009, J FOOD SCI, V74, pC258, DOI 10.1111/j.1750-3841.2009.01101.x; Barata A, 2012, MICROB ECOL, V64, P416, DOI 10.1007/s00248-012-0041-y; Bauer R., 2004, South African Journal of Enology and Viticulture, V25, P74; Bergholz TM, 2014, TRENDS MICROBIOL, V22, P275, DOI 10.1016/j.tim.2014.01.006; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capozzi V, 2010, LETT APPL MICROBIOL, V50, P327, DOI 10.1111/j.1472-765X.2010.02795.x; Capozzi V, 2015, MICROBIOL RES, V181, P75, DOI 10.1016/j.micres.2015.10.005; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Revel G, 1999, J AGR FOOD CHEM, V47, P4003, DOI 10.1021/jf981383b; du Toit M, 2011, FOOD BIOPROCESS TECH, V4, P876, DOI 10.1007/s11947-010-0448-8; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fosso B, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0595-z; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Garofalo C, 2015, J APPL MICROBIOL, V118, P1395, DOI 10.1111/jam.12789; Godalova Z, 2016, INT J FOOD MICROBIOL, V217, P110, DOI 10.1016/j.ijfoodmicro.2015.10.015; HENICKKLING T, 1994, AM J ENOL VITICULT, V45, P464; Jeong SH, 2013, ANTON LEEUW INT J G, V103, P503, DOI 10.1007/s10482-012-9832-x; Kergourlay G, 2015, INT J FOOD MICROBIOL, V213, P31, DOI 10.1016/j.ijfoodmicro.2015.09.010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasik M, 2013, EUR FOOD RES TECHNOL, V237, P843, DOI 10.1007/s00217-013-2083-x; Lonvaud-Funel A, 1999, ANTON LEEUW INT J G, V76, P317, DOI 10.1023/A:1002088931106; Lonvaud-Funel A, 2008, BIOFUTUR, P26; LONVAUDFUNEL A, 1988, J SCI FOOD AGR, V44, P183, DOI 10.1002/jsfa.2740440209; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manzari C, 2015, BIOL INVASIONS, V17, P923, DOI 10.1007/s10530-014-0810-2; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Nakamura S, 2007, J AGR FOOD CHEM, V55, P10388, DOI 10.1021/jf072407u; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Piao HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00809; Pinto C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00905; Renouf V, 2006, FOOD MICROBIOL, V23, P136, DOI 10.1016/j.fm.2005.01.019; Renouf V, 2007, APPL MICROBIOL BIOT, V75, P149, DOI 10.1007/s00253-006-0798-3; Robinson Jancis, 2015, OXFORD COMPANION WIN, V4th; Ruiz P, 2010, APPL MICROBIOL BIOT, V86, P1555, DOI 10.1007/s00253-010-2492-8; Savazzini F, 2006, ANAL CHIM ACTA, V563, P274, DOI 10.1016/j.aca.2005.10.078; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Singh Jagtar, 2009, Biotechnology Journal, V4, P480, DOI 10.1002/biot.200800201; Siret R, 2000, J AGR FOOD CHEM, V48, P5035, DOI 10.1021/jf991168a; Taylor MW, 2014, ENVIRON MICROBIOL, V16, P2848, DOI 10.1111/1462-2920.12456; Tessonniere H, 2009, INT J FOOD MICROBIOL, V129, P237, DOI 10.1016/j.ijfoodmicro.2008.11.027; Tristezza M, 2016, LWT-FOOD SCI TECHNOL, V66, P406, DOI 10.1016/j.lwt.2015.10.064; Tristezza M, 2013, FOOD MICROBIOL, V36, P335, DOI 10.1016/j.fm.2013.07.001; Tufariello M, 2014, LWT-FOOD SCI TECHNOL, V58, P35, DOI 10.1016/j.lwt.2014.03.016; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zoecklein B. W., 2000, Small Fruits Review, V1, P63, DOI 10.1300/J301v01n01_08	54	35	35	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157383	10.1371/journal.pone.0157383	http://dx.doi.org/10.1371/journal.pone.0157383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299312	Green Published, gold			2022-12-26	WOS:000377822200044
J	Lv, YC; Tang, YY; Zhang, P; Wan, W; Yao, F; He, PP; Xie, W; Mo, ZC; Shi, JF; Wu, JF; Peng, J; Liu, D; Cayabyab, FS; Zheng, XL; Tang, XY; Ouyang, XP; Tang, CK				Lv, Yun-Cheng; Tang, Yan-Yan; Zhang, Ping; Wan, Wei; Yao, Feng; He, Ping-Ping; Xie, Wei; Mo, Zhong-Cheng; Shi, Jin-Feng; Wu, Jian-Feng; Peng, Juan; Liu, Dan; Cayabyab, Francisco S.; Zheng, Xi-Long; Tang, Xiang-Yang; Ouyang, Xin-Ping; Tang, Chao-Ke			Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis	PLOS ONE			English	Article							CASSETTE TRANSPORTER A1; KRUPPEL-LIKE FACTOR-2; APOLIPOPROTEIN-E; DOWN-REGULATION; CHOLESTEROL; EXPRESSION; GENE; CANCER; CELLS; MICE	ATP-binding cassette transporter A1 (ABCA1) plays a critical role in maintaining cellular cholesterol homeostasis. The purpose of this study is to identify the molecular mechanism (s) underlying ABCA1 epigenetic modification and determine its potential impact on ABCA1 expression in macrophage-derived foam cell formation and atherosclerosis development. DNA methylation induced foam cell formation from macrophages and promoted atherosclerosis in apolipoprotein E-deficient (apoE(-/-)) mice. Bioinformatics analyses revealed a large CpG island (CGI) located in the promoter region of ABCA1. Histone methyltransferase enhancer of zeste homolog 2 (EZH2) downregulated ABCA1 mRNA and protein expression in THP-1 and RAW264.7 macrophage-derived foam cells. Pharmacological inhibition of DNA methyltransferase 1 (DNMT1) with 5-Aza-dC or knockdown of DNMT1 prevented the downregulation of macrophage ABCA1 expression, suggesting a role of DNA methylation in ABCA1 expression. Polycomb protein EZH2 induced DNMT1 expression and methyl-CpG-binding protein-2 (MeCP2) recruitment, and stimulated the binding of DNMT1 and MeCP2 to ABCA1 promoter, thereby promoting ABCA1 gene DNA methylation and atherosclerosis. Knockdown of DNMT1 inhibited EZH2-induced downregulation of ABCA1 in macrophages. Conversely, EZH2 overexpression stimulated DNMT1-induced ABCA1 gene promoter methylation and atherosclerosis. EZH2-induced downregulation of ABCA1 gene expression promotes foam cell formation and the development of atherosclerosis by DNA methylation of ABCA1 gene promoter.	[Lv, Yun-Cheng; Tang, Yan-Yan; Yao, Feng; He, Ping-Ping; Xie, Wei; Mo, Zhong-Cheng; Shi, Jin-Feng; Wu, Jian-Feng; Peng, Juan; Liu, Dan; Ouyang, Xin-Ping; Tang, Chao-Ke] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang 421001, Hunan, Peoples R China; [Lv, Yun-Cheng; Wan, Wei; Tang, Xiang-Yang] Univ South China, Lab Clin Anat, Hengyang 421001, Peoples R China; [Tang, Yan-Yan] Cent S Univ, Key Lab Carcinogenesis, Chinese Minist Hlth, Changsha 410013, Hunan, Peoples R China; [Tang, Yan-Yan] Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Canc Res Inst, Changsha 410013, Hunan, Peoples R China; [Zhang, Ping] Hunan Univ Sci & Engn, Sch Elect & Informat Engn, Yongzhou 425100, Hunan, Peoples R China; [Zhang, Ping] Cent S Univ, Sch Informat Sci & Engn, Changsha 410000, Hunan, Peoples R China; [Cayabyab, Francisco S.] Univ Saskatchewan, Coll Med, Dept Surg, Saskatoon, SK S7N 5E5, Canada; [Zheng, Xi-Long] Univ Calgary, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta, Hlth Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Tang, Xiang-Yang] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, WCI Suite C5018,1701 Uppergate Dr, Atlanta, GA 30322 USA	University of South China; University of South China; Central South University; Central South University; Central South University; University of Saskatchewan; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Emory University	Ouyang, XP; Tang, CK (corresponding author), Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang 421001, Hunan, Peoples R China.	y1655@163.com; tangchaoke@qq.com	莫, 中成/AAY-8561-2020; Cayabyab, Francisco/HHR-8711-2022	Zheng, Xi-Long/0000-0002-0889-1827	National Natural Sciences Foundation of China [81370377, 81300158]; Hunan Provincial Natural Science Foundation of China [14JJ2091]; Aid Program for Science and Technology Department of Human Province [2015JC3083]; Scientific Research Fund of Hunan Provincial Education Department [12C0339]; start-up funds for Ph.Ds in University of South China [2014XQD37]; Zhengxiang scholar program of the University of South China; construct program of key discipline in Hunan Province	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Aid Program for Science and Technology Department of Human Province; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); start-up funds for Ph.Ds in University of South China; Zhengxiang scholar program of the University of South China; construct program of key discipline in Hunan Province	The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81370377 and 81300158), the Hunan Provincial Natural Science Foundation of China (14JJ2091), the Aid Program for Science and Technology Department of Human Province (2015JC3083), the Scientific Research Fund of Hunan Provincial Education Department (12C0339), the start-up funds for Ph.Ds in University of South China (2014XQD37), Zhengxiang scholar program (prof. Xiangyang Tang) of the University of South China and the construct program of the key discipline in Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81370377 and 81300158), the Hunan Provincial Natural Science Foundation of China (14JJ2091), the Aid Program for Science and Technology Department of Human Province (2015JC3083), the Scientific Research Fund of Hunan Provincial Education Department (12C0339), The start-up funds for Ph.Ds in University of South China (2014XQD37), Zhengxiang scholar program (prof. Xiangyang Tang) of the University of South China and the construct program of the key discipline in Hunan Province.	Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bowen NJ, 2004, CELL MOL LIFE SCI, V61, P2163, DOI 10.1007/s00018-004-4177-x; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Connelly JJ, 2013, HUM MOL GENET, V22, P5107, DOI 10.1093/hmg/ddt365; De Paoli F, 2014, CIRC J, V78, P1775, DOI 10.1253/circj.CJ-14-0621; Delaney C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056253; Dunn J, 2015, ARTERIOSCL THROM VAS, V35, P1562, DOI 10.1161/ATVBAHA.115.305042; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Hu YW, 2015, ARTERIOSCL THROM VAS, V35, P87, DOI 10.1161/ATVBAHA.114.304296; Kanduri M, 2013, EPIGENETICS-US, V8, P1280, DOI 10.4161/epi.26546; Kumar A, 2013, ARTERIOSCL THROM VAS, V33, P1936, DOI 10.1161/ATVBAHA.113.301765; Li GJ, 2009, BLOOD, V114, P3422, DOI 10.1182/blood-2009-01-200170; Lu Q, 2013, CIRC J, V77, P2399, DOI 10.1253/circj.CJ-12-1616; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Mo ZC, 2014, CIRC J, V78, P2760, DOI 10.1253/circj.CJ-14-0193; Newman PE, 1999, MED HYPOTHESES, V53, P421, DOI 10.1054/mehy.1998.0794; Probst MCO, 2004, ATHEROSCLEROSIS, V175, P269, DOI 10.1016/j.atherosclerosis.2004.02.019; Ramirez CM, 2013, CIRC RES, V112, P1592, DOI 10.1161/CIRCRESAHA.112.300626; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Ye D, 2011, CURR DRUG TARGETS, V12, P647, DOI 10.2174/138945011795378522; Yeh JL, 2013, ATHEROSCLEROSIS, V226, P364, DOI 10.1016/j.atherosclerosis.2012.12.005; Yin K, 2011, J BIOL CHEM, V286, P13834, DOI 10.1074/jbc.M110.202275; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Yu CE, 2013, HUM MOL GENET, V22, P5036, DOI 10.1093/hmg/ddt354; Zaina S, 2015, ARTERIOSCL THROM VAS, V35, P1835, DOI 10.1161/ATVBAHA.115.305630; Zhang DH, 2014, CIRC J, V78, P1915, DOI 10.1253/circj.CJ-14-0233; Zhao GJ, 2014, INT J CARDIOL, V171, pE93, DOI 10.1016/j.ijcard.2013.11.093	34	45	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157265	10.1371/journal.pone.0157265	http://dx.doi.org/10.1371/journal.pone.0157265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295295	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300030
J	Bafna, JA; Soni, GV				Bafna, Jayesh A.; Soni, Gautam V.			Fabrication of Low Noise Borosilicate Glass Nanopores for Single Molecule Sensing	PLOS ONE			English	Article							SOLID-STATE NANOPORES; RESISTIVE-PULSE TECHNIQUE; DNA TRANSLOCATION; NANOCAPILLARIES; TRANSPORT; MEMBRANES	We show low-cost fabrication and characterization of borosilicate glass nanopores for single molecule sensing. Nanopores with diameters of similar to 100 nm were fabricated in borosilicate glass capillaries using laser assisted glass puller. We further achieve controlled reduction and nanometer-size control in pore diameter by sculpting them under constant electron beam exposure. We successfully fabricate pore diameters down to 6 nm. We next show electrical characterization and low-noise behavior of these borosilicate nanopores and compare their taper geometries. We show, for the first time, a comprehensive characterization of glass nanopore conductance across six-orders of magnitude (1M-1 mu M) of salt conditions, highlighting the role of buffer conditions. Finally, we demonstrate single molecule sensing capabilities of these devices with real-time translocation experiments of individual lambda-DNA molecules. We observe distinct current blockage signatures of linear as well as folded DNA molecules as they undergo voltage-driven translocation through the glass nanopores. We find increased signal to noise for single molecule detection for higher trans-nanopore driving voltages. We propose these nanopores will expand the realm of applications for nanopore platform.	[Bafna, Jayesh A.; Soni, Gautam V.] Raman Res Inst, Bangalore 560080, Karnataka, India	Department of Science & Technology (India); Raman Research Institute (RRI)	Soni, GV (corresponding author), Raman Res Inst, Bangalore 560080, Karnataka, India.	gvsoni@rri.res.in	Gautam, Soni/E-6502-2017	Soni, Gautam/0000-0002-0134-5583	Raman Research Institute India; Department of Biotechnology, India	Raman Research Institute India; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	GVS received startup funds from Raman Research Institute India and Ramalingaswami Fellowship from Department of Biotechnology, India. Raman Research Institute and Department of Biotechnology, India had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Balan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17775; Beamish E, 2013, JOVE-J VIS EXP, DOI 10.3791/51081; Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Briggs K, 2014, SMALL, V10, P2077, DOI 10.1002/smll.201303602; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Calin P, NANOTECHNOLOGY, V26; Carlsen AT, 2014, ACS NANO, V8, P4754, DOI 10.1021/nn501694n; Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j; DEBLOIS RW, 1977, J COLLOID INTERF SCI, V61, P323, DOI 10.1016/0021-9797(77)90395-2; DEBLOIS RW, 1977, J VIROL, V23, P227, DOI 10.1128/JVI.23.2.227-233.1977; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Farimani AB, 2014, ACS NANO, V8, P7914, DOI 10.1021/nn5029295; German SR, 2013, J PHYS CHEM C, V117, P703, DOI 10.1021/jp310513v; Gong XQ, 2014, ANAL CHEM, V86, P835, DOI 10.1021/ac403391q; Graham MD, 2003, JALA J ASS LAB AUTOM, V8, P72, DOI [DOI 10.1016/S1535-5535(03)00023-6, 10.1016/s1535-5535-03-00023-6, DOI 10.1016/S1535-5535-03-00023-6]; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; Gu Z, 2015, SOFT MATTER; Heerema SJ, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/7/074001; Kowalczyk SW, 2012, NANOPORES FOR BIOANA; Kuan AT, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921620; Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Min Jun K, 2007, NANOTECHNOLOGY, V18; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Sischka A, 2015, ANALYST, V140, P4843, DOI 10.1039/c4an02319f; Smeets RMM, 2008, P NATL ACAD SCI USA, V105, P417, DOI 10.1073/pnas.0705349105; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Soni GV, 2012, NANO LETT, V12, P3180, DOI 10.1021/nl301163m; Steinbock LJ, 2013, NANO LETT, V13, P1717, DOI 10.1021/nl400304y; Steinbock LJ, 2013, ACS NANO, V7, P11255, DOI 10.1021/nn405029j; Steinbock LJ, 2012, ELECTROPHORESIS, V33, P3480, DOI 10.1002/elps.201100663; Steinbock LJ, 2010, NANO LETT, V10, P2493, DOI 10.1021/nl100997s; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Wendell D, 2009, NAT NANOTECHNOL, V4, P765, DOI [10.1038/NNANO.2009.259, 10.1038/nnano.2009.259]; Yanagi I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14656; Zhang B, 2007, ANAL CHEM, V79, P4778, DOI 10.1021/ac070609j	44	21	22	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157399	10.1371/journal.pone.0157399	http://dx.doi.org/10.1371/journal.pone.0157399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285088	Green Published, gold			2022-12-26	WOS:000377564000064
J	Duan, C; Li, CW; Zhao, L; Subramaniam, S; Yu, XM; Li, YY; Chen, DH; Li, TY; Shen, L; Shi, L; Wang, DY				Duan, Chen; Li, Chun Wei; Zhao, Li; Subramaniam, Somasundaram; Yu, Xue Min; Li, Ying Ying; Chen, De Hua; Li, Tian Ying; Shen, Liang; Shi, Li; Wang, De Yun			Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; GENE-EXPRESSION; IN-VITRO; INTRACELLULAR DOMAIN; GOBLET CELLS; REPAIR; LIGANDS; INFLAMMATION; ASTHMA	Epidermal growth factor receptors play an important role in airway epithelial cell growth and differentiation. The current study investigates the expression profiles of EGF, EGFR and ERBB4 in patients with nasal polyps (NP), and their response to glucocorticosteroid (GC) treatment. Fifty patients with NP (40 without GC treatment and 10 with oral GC) and 20 control subjects with septal deviation were recruited into the study. Protein levels of EGF, EGFR, and ERBB4 were evaluated by immune-staining. In healthy nasal epithelium, EGF and EGFR localized within p63(+) basal cells, while ERBB4 localized within ciliated cells. GC-naive NP epithelium showed weak expression of EGF in 90% of samples versus 5% of controls. EGFR was significantly increased in the epithelium with basal cell hyperplasia from GC-naive NPs (78%, 31/40) compared to controls (23%, 4/17). EGFR was also found in some degranulating goblet cells. ERBB4 expression was significantly higher in hyperplastic epithelium from GC-naive NPs (65%, 26/40) than in controls (6%, 1/17). GC treatment restored the EGF expression and normalized the EGFR and ERBB4 expression in NPs. Differential expression patterns of EGF, EGFR, and ERBB4 are essential in epithelial restitution and remodeling in nasal epithelium.	[Duan, Chen; Zhao, Li; Shi, Li] Shandong Univ, Hosp 2, Dept Otolaryngol, Jinan 250100, Peoples R China; [Duan, Chen; Li, Chun Wei; Li, Ying Ying; Wang, De Yun] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Otolaryngol, Singapore 117548, Singapore; [Li, Chun Wei; Chen, De Hua; Li, Tian Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Subramaniam, Somasundaram] Ng Teng Fong Gen Hosp, Dept Otolaryngol, Singapore, Singapore; [Yu, Xue Min] Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Peoples R China; [Shen, Liang] Natl Univ Singapore, Natl Univ Hlth Syst, Biostat Unit, Singapore 117548, Singapore	Shandong University; National University of Singapore; Sun Yat Sen University; Shandong University; National University of Singapore	Shi, L (corresponding author), Shandong Univ, Hosp 2, Dept Otolaryngol, Jinan 250100, Peoples R China.; Wang, DY (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Dept Otolaryngol, Singapore 117548, Singapore.	shili126@sina.com; entwdy@nus.edu.sg			National Medical Research Council (NMRC) [IRG10may086, CIRG12Nov033]; Singapore Immunology Network (SIgN) of Singapore [SIgN 10-028]; National Nature Science Foundation of China [81170897, 81441028]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Singapore Immunology Network (SIgN) of Singapore; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Medical Research Council (NMRC, IRG10may086, CIRG12Nov033) and from Singapore Immunology Network (SIgN, SIgN 10-028) of Singapore; and the National Nature Science Foundation of China (Grant awarded number 81170897, 81441028).	Burgel PR, 2000, J ALLERGY CLIN IMMUN, V106, P705, DOI 10.1067/mai.2000.109823; Cho HY, 2000, AM J RESP CRIT CARE, V162, P629, DOI 10.1164/ajrccm.162.2.9811078; Fiaturi N, 2014, J CELL COMMUN SIGNAL, V8, P105, DOI 10.1007/s12079-014-0233-y; Frey MR, 2014, PEDIATR RES, V75, P127, DOI 10.1038/pr.2013.210; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Holgate ST, 2000, CLIN EXP ALLERGY, V30, P37; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Lee HM, 2001, J ALLERGY CLIN IMMUN, V107, P1046, DOI 10.1067/mai.2001.115140; Li CW, 2009, THORAX, V64, P306, DOI 10.1136/thx.2008.106096; Li CW, 2011, J ALLERGY CLIN IMMUN, V127, P765, DOI 10.1016/j.jaci.2010.12.011; Li YY, 2014, J ALLERGY CLIN IMMUN, V134, P1282, DOI 10.1016/j.jaci.2014.07.038; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Polosa R, 2002, J ALLERGY CLIN IMMUN, V109, P75, DOI 10.1067/mai.2002.120274; Polosa R, 2000, J ALLERGY CLIN IMMUN, V106, P1124; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Schneider MR, 2009, TRENDS ENDOCRIN MET, V20, P517, DOI 10.1016/j.tem.2009.06.008; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Turner J, 2011, AM J RESP CELL MOL, V44, P276, DOI 10.1165/rcmb.2009-0304OC; Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004; Wadsworth SJ, 2006, J CLIN IMMUNOL, V26, P376, DOI 10.1007/s10875-006-9029-z; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Yu XM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04619; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	30	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156949	10.1371/journal.pone.0156949	http://dx.doi.org/10.1371/journal.pone.0156949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285994	gold, Green Submitted, Green Published			2022-12-26	WOS:000377564000032
J	Huang, V; Peck, K; Mallya, S; Lupien, SJ; Fiocco, AJ				Huang, Vivian; Peck, Katlyn; Mallya, Sasha; Lupien, Sonia J.; Fiocco, Alexandra J.			Subjective Sleep Quality as a Possible Mediator in the Relationship between Personality Traits and Depressive Symptoms in Middle-Aged Adults	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; MAJOR DEPRESSION; ANXIETY DISORDERS; HIGHER-ORDER; NEUROTICISM; INSOMNIA; POPULATION; CONSCIENTIOUSNESS; DISTURBANCE; PREDICTORS	This study explored the mediating role of sleep in the relationship between personality traits and depressive symptoms in a group of community-dwelling men and women (M-age = 57.92, SD = 4.00). Participants completed the short form NEO Five Factor Inventory (NEO-FFI), Pittsburgh Sleep Quality Index (PSQI), and the Center for Epidemiologic Studies Depression Scale (CES-D). High neuroticism and low conscientiousness was associated with poor sleep, as well as greater depressive symptom severity. Partial indirect mediation effects were found between personality traits (i.e., neuroticism and conscientiousness) and depressive symptoms through self-report sleep measures. An alternative model was also explored, entering depression as the mediator; however a smaller portion of the variance was explained by this model, compared with the hypothesized model. The current study provides preliminary information regarding the mechanisms that influence the relationship between personality traits, sleep, and depression among a group of community-dwelling middle-aged adults. Implications and future directions are discussed.	[Huang, Vivian; Peck, Katlyn; Mallya, Sasha; Fiocco, Alexandra J.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Lupien, Sonia J.] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada	Toronto Metropolitan University; Universite de Montreal	Fiocco, AJ (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	afiocco@psych.ryerson.ca		Fiocco, Alexandra/0000-0002-9353-476X				Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Barbui C, 2006, EPIDEMIOL PSICHIAT S, V15, P276, DOI 10.1017/S1121189X00002165; Bartley CE, 2011, PERS INDIV DIFFER, V50, P79, DOI 10.1016/j.paid.2010.08.027; Bienvenu OJ, 2004, DEPRESS ANXIETY, V20, P92, DOI 10.1002/da.20026; BM Corp, IBM SPSS STATISTICS; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calkins AW, 2013, BEHAV SLEEP MED, V11, P133, DOI 10.1080/15402002.2011.643968; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Cho HJ, 2008, AM J PSYCHIAT, V165, P1543, DOI 10.1176/appi.ajp.2008.07121882; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; COSTA PT, 1991, PERS INDIV DIFFER, V12, P887, DOI 10.1016/0191-8869(91)90177-D; Costa PT, 2007, REVISED NEO PERSONAL; Danielsson NS, 2010, PERS INDIV DIFFER, V48, P463, DOI 10.1016/j.paid.2009.11.023; de Graaf R, 2002, ACTA PSYCHIAT SCAND, V106, P303, DOI 10.1034/j.1600-0447.2002.01397.x; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Duggan KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090628; Fanous AH, 2007, PSYCHOL MED, V37, P1163, DOI 10.1017/S0033291707000244; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Friedman EM, 2007, PSYCHOSOM MED, V69, P682, DOI 10.1097/PSY.0b013e31814ceada; Gelfand LA, 2009, J GEN PSYCHOL, V136, P153, DOI 10.3200/GENP.136.2.153-178; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Gray EK, 2002, J PERS, V70, P177; Hall M, 2000, PSYCHOSOM MED, V62, P227, DOI 10.1097/00006842-200003000-00014; Harman JS, 2004, PSYCHIAT SERV, V55, P1379, DOI 10.1176/appi.ps.55.12.1379; Harvey AG, 2001, CLIN PSYCHOL REV, V21, P1037, DOI 10.1016/S0272-7358(00)00083-0; Harvey CJ, 2014, SLEEP MED REV, V18, P237, DOI 10.1016/j.smrv.2013.11.004; Hayes A. F., 2013, INTRODUCTION TO MEDI; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hintsanen M, 2014, HEALTH PSYCHOL, V33, P1214, DOI 10.1037/hea0000105; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Kessler R., 2010, J LIFELONG LEARNING, V8, P459, DOI DOI 10.1176/FOC.8.3.FOC459; Klein DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI 10.1146/annurev-clinpsy-032210-104540; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Lee E, 2013, SLEEP, V36, P1685, DOI 10.5665/sleep.3128; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Mallinckrodt B, 2006, J COUNS PSYCHOL, V53, P372, DOI 10.1037/0022-0167.53.3.372; Manber R, 2009, CURR PSYCHIAT REP, V11, P437, DOI 10.1007/s11920-009-0066-1; MCCRAE RR, 1995, EUR J PERSONALITY, V9, P231, DOI 10.1002/per.2410090402; McCrae RR, 2005, HANDBOOK OF PERSONAL, P159; McHugh JE, 2011, AGING MENT HEALTH, V15, P749, DOI 10.1080/13607863.2011.562180; Meeks TW, 2011, J AFFECT DISORDERS, V129, P126, DOI 10.1016/j.jad.2010.09.015; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Muris P, 2005, PERS INDIV DIFFER, V39, P1105, DOI 10.1016/j.paid.2005.04.005; Naragon-Gainey K, 2014, ASSESSMENT, V21, P387, DOI 10.1177/1073191114528030; Nyer M, 2013, DEPRESS ANXIETY, V30, P873, DOI 10.1002/da.22064; O'Connor DB, 2009, ANN BEHAV MED, V37, P184, DOI 10.1007/s12160-009-9087-6; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P990, DOI 10.1001/archpsyc.61.10.990; Pandi-Perumal SR, 2009, PROG NEUROBIOL, V88, P264, DOI 10.1016/j.pneurobio.2009.04.007; Pek J, 2016, SOC PERSONAL PSYCHOL, V10, P150, DOI 10.1111/spc3.12237; Perlis Michael L, 2006, Behav Sleep Med, V4, P104, DOI 10.1207/s15402010bsm0402_3; Perlman CA, 2006, BIPOLAR DISORD, V8, P271, DOI 10.1111/j.1399-5618.2006.00330.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Quilty LC, 2008, J AFFECT DISORDERS, V108, P241, DOI 10.1016/j.jad.2007.10.022; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Randler C, 2008, PERS INDIV DIFFER, V45, P191, DOI 10.1016/j.paid.2008.03.007; REYNER A, 1995, SLEEP, V18, P127; Roberts BW, 2004, J PERS, V72, P325, DOI 10.1111/j.0022-3506.2004.00264.x; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Roelofs J, 2008, BEHAV RES THER, V46, P1283, DOI 10.1016/j.brat.2008.10.002; SAKLOFSKE DH, 1995, PERS INDIV DIFFER, V18, P27, DOI 10.1016/0191-8869(94)00128-F; Sbarra DA, 2009, J ABNORM PSYCHOL, V118, P171, DOI 10.1037/a0014375; Schneider TR, 2012, STRESS HEALTH, V28, P102, DOI 10.1002/smi.1409; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; van de Laar M, 2010, SLEEP MED REV, V14, P61, DOI 10.1016/j.smrv.2009.07.007; Vincent N, 2009, COMPR PSYCHIAT, V50, P158, DOI 10.1016/j.comppsych.2008.07.007; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Weber K, 2012, AGING MENT HEALTH, V16, P472, DOI 10.1080/13607863.2011.630375; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Williams PG, 2009, PERS INDIV DIFFER, V46, P598, DOI 10.1016/j.paid.2008.12.017; Yoon KL, 2013, ANXIETY STRESS COPIN, V26, P558, DOI 10.1080/10615806.2012.734810; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	84	18	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157238	10.1371/journal.pone.0157238	http://dx.doi.org/10.1371/journal.pone.0157238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285159	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000046
J	Abram, NK; MacMillan, DC; Xofis, P; Ancrenaz, M; Tzanopoulos, J; Ong, R; Goossens, B; Koh, LP; Del Valle, C; Peter, L; Morel, AC; Lackman, I; Chung, R; Kler, H; Ambu, L; Baya, W; Knight, AT				Abram, Nicola K.; MacMillan, Douglas C.; Xofis, Panteleimon; Ancrenaz, Marc; Tzanopoulos, Joseph; Ong, Robert; Goossens, Benoit; Koh, Lian Pin; Del Valle, Christian; Peter, Lucy; Morel, Alexandra C.; Lackman, Isabelle; Chung, Robin; Kler, Harjinder; Ambu, Laurentius; Baya, William; Knight, Andrew T.			Identifying Where REDD plus Financially Out-Competes Oil Palm in Floodplain Landscapes Using a Fine-Scale Approach	PLOS ONE			English	Article							ECOSYSTEM SERVICES; FOREST DEGRADATION; CARBON STOCKS; CONSERVATION; DEFORESTATION; EMISSIONS; PAYMENTS; BIODIVERSITY; WILLINGNESS; MANAGEMENT	Reducing Emissions from Deforestation and forest Degradation (REDD+) aims to avoid forest conversion to alternative land-uses through financial incentives. Oil-palm has high opportunity costs, which according to current literature questions the financial competitiveness of REDD+ in tropical lowlands. To understand this more, we undertook regional fine-scale and coarse-scale analyses (through carbon mapping and economic modelling) to assess the financial viability of REDD+ in safeguarding unprotected forest (30,173 ha) in the Lower Kinabatangan floodplain in Malaysian Borneo. Results estimate 4.7 million metric tons of carbon (MgC) in unprotected forest, with 64% allocated for oil-palm cultivations. Through fine-scale mapping and carbon accounting, we demonstrated that REDD+ can outcompete oil-palm in regions with low suitability, with low carbon prices and low carbon stock. In areas with medium oil-palm suitability, REDD+ could outcompete oil palm in areas with: very high carbon and lower carbon price; medium carbon price and average carbon stock; or, low carbon stock and high carbon price. Areas with high oil palm suitability, REDD+ could only outcompete with higher carbon price and higher carbon stock. In the coarse-scale model, oil-palm outcompeted REDD+ in all cases. For the fine-scale models at the landscape level, low carbon offset prices (US $3 MgCO(2)e) would enable REDD+ to outcompete oil-palm in 55% of the unprotected forests requiring US $27 million to secure these areas for 25 years. Higher carbon offset price (US $30 MgCO(2)e) would increase the competitiveness of REDD+ within the landscape but would still only capture between 69%-74% of the unprotected forest, requiring US $380-416 million in carbon financing. REDD+ has been identified as a strategy to mitigate climate change by many countries (including Malaysia). Although REDD+ in certain scenarios cannot outcompete oil palm, this research contributes to the global REDD+ debate by: highlighting REDD+ competitiveness in tropical floodplain landscapes; and, providing a robust approach for identifying and targeting limited REDD+ funds.	[Abram, Nicola K.] Living Landscape Alliance, 110 Maui Court,Jalan Aru, Kota Kinabalu 88100, Sabah, Malaysia; [Abram, Nicola K.; Knight, Andrew T.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Abram, Nicola K.; Ancrenaz, Marc; Lackman, Isabelle; Kler, Harjinder] HUTAN Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu 88874, Sabah, Malaysia; [Abram, Nicola K.; MacMillan, Douglas C.; Tzanopoulos, Joseph] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Marlowe Bldg, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc] Borneo Futures Initiat, Jakarta 15412, Indonesia; [Xofis, Panteleimon] Technol Educ Inst Kavala, Dept Forestry & Management Nat Environm, GR-61100 Drama, Greece; [Ancrenaz, Marc] North England Zool Soc, Chester, Cheshire, England; [Ancrenaz, Marc; Goossens, Benoit; Baya, William] Sabah Wildlife Dept, Kota Kinabalu 88100, Sabah, Malaysia; [Ong, Robert] Sabah Forestry Dept, Forest Res Ctr, POB 1407, Sandakan 90715, Sabah, Malaysia; [Goossens, Benoit; Peter, Lucy] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu 88100, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales; [Koh, Lian Pin] Univ Adelaide Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Del Valle, Christian] Ecosphere Capital Ltd, Althelia Ecosphere, 1 Lumley St, London W1K 6TT, England; [Morel, Alexandra C.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Chung, Robin] CH Williams Talhar & Wong Sabah Sdn Bhd, Sandakan 90715, Sabah, Malaysia; [Ambu, Laurentius] Borneo Conservat Trust, 5th Floor,Block B, Kota Kinabalu 88100, Sabah, Malaysia; [Knight, Andrew T.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England; [Knight, Andrew T.] Nelson Mandela Metropolitan Univ, Dept Bot, POB 77000, ZA-6031 Port Elizabeth, Eastern Cape, South Africa	University of Queensland; University of Kent; Pusat Penyelidikan Hutan; Cardiff University; University of Adelaide; University of Oxford; Imperial College London; Nelson Mandela University	Abram, NK (corresponding author), Living Landscape Alliance, 110 Maui Court,Jalan Aru, Kota Kinabalu 88100, Sabah, Malaysia.; Abram, NK (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia.; Abram, NK (corresponding author), HUTAN Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu 88874, Sabah, Malaysia.; Abram, NK (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Marlowe Bldg, Canterbury, Kent, England.; Abram, NK (corresponding author), Borneo Futures Initiat, Jakarta 15412, Indonesia.	nicola_abram@hotmail.com	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Xofis, Panteleimon/AAG-9513-2019; Morel, Alexandra/J-4071-2019; Koh, Lian Pin/A-5794-2010; Knight, Andrew Thomas/C-8394-2009; Abram, Nicola/K-2060-2014	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Xofis, Panteleimon/0000-0003-0528-3073; Morel, Alexandra/0000-0002-0905-8079; Koh, Lian Pin/0000-0001-8152-3871; Knight, Andrew Thomas/0000-0002-6563-0500; Abram, Nicola/0000-0003-1886-7297	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London (UK); ARC Centre of Excellence in Environmental Decisions; University of Queensland (Australia); HUTAN/Kinabatangan Orangutan Conservation Programme; Althelia ecosphere; C H Williams, Talhar and Wong; Sabah Biodiversity Centre (SaBC); Economic Planning Unit (EPU); Ecosphere Capital Limited	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London (UK); ARC Centre of Excellence in Environmental Decisions(Australian Research Council); University of Queensland (Australia)(University of Queensland); HUTAN/Kinabatangan Orangutan Conservation Programme; Althelia ecosphere; C H Williams, Talhar and Wong; Sabah Biodiversity Centre (SaBC); Economic Planning Unit (EPU); Ecosphere Capital Limited	NKA would like to thank RICS Research Trust, U.S. Fish and Wildlife Service's Great Ape Fund and The Arcus Foundation (part of a larger study for the Borneo Futures initiative) for financial support; Planet Action and Trimble for providing satellite imagery and the Definiens eCognition Licence. These funders provided support either financial or in-kind support in the form of a PhD stipend, and/or project costs for lead author NKA, or software licenses/satellite imagery for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ATK acknowledges support from the Department of Life Sciences at Imperial College London (UK), and ARC Centre of Excellence in Environmental Decisions, University of Queensland (Australia) for salary contribution. The specific roles of authors are articulated in the 'author contributions' section. HUTAN/Kinabatangan Orangutan Conservation Programme [MA, HK, IL], Althelia ecosphere, Ecosphere Capital Limited [CDV] and C H Williams, Talhar and Wong [RC] provided support in the form of salaries for authors, but did not have any additional role in the study design, da collection and analysis, decision to publish, or preparation of the manuscript. These affiliations did not fund this study. CDV and RC provided guidance on this research outside of their commercial affiliation and provisioned some data. The specific roles of these authors are articulated in the 'author contributions' section.; Thanks to Sabah Biodiversity Centre (SaBC) and the Economic Planning Unit (EPU) for supporting this project. Thank you to HUTAN/KOCP staff especially Abdul Rajak Bin Saharon for his botanical expertise.	Abram NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095388; Abram NK, 2014, ECOSYST SERV, V7, P116, DOI 10.1016/j.ecoser.2013.11.004; Abram NK, 2013, UNDERSTANDING INVEST; Abram NK, 2013, SPATIAL PLANNING CON; Ancrenaz M, 2015, ORYX, V49, P465, DOI 10.1017/S0030605313001270; Angelsen A, 2008, VINNV PROGR REN MOV; [Anonymous], 2009, JAKARTA POST; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Borrego A, 2014, ECOL ECON, V101, P1, DOI 10.1016/j.ecolecon.2014.02.005; Bottrill MC, 2009, TRENDS ECOL EVOL, V24, P183, DOI 10.1016/j.tree.2008.11.007; Broch SW, 2013, ECOL ECON, V92, P78, DOI 10.1016/j.ecolecon.2011.12.017; Brown S., 1997, FAO Forestry Paper; Burnett C, 2003, ECOL MODEL, V168, P233, DOI 10.1016/S0304-3800(03)00139-X; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Cacho OJ, 2014, ECOL ECON, V107, P321, DOI 10.1016/j.ecolecon.2014.09.012; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Caro-Borrero A, 2015, LAND USE POLICY, V43, P138, DOI 10.1016/j.landusepol.2014.11.008; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; CRIST EP, 1984, PHOTOGRAMM ENG REM S, V50, P343; de Koning GHJ, 2007, LANDSCAPE URBAN PLAN, V83, P255, DOI 10.1016/j.landurbplan.2007.04.010; Delacote P, 2014, RESOUR ENERGY ECON, V36, P508, DOI 10.1016/j.reseneeco.2013.07.002; den Besten JW, 2014, ENVIRON SCI POLICY, V35, P40, DOI 10.1016/j.envsci.2013.03.009; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Ebeling J, 2008, GENERATING CARBON FI, P1917; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601; Estrada M., 2010, TRADING CARBON MAGAZ, V4, ps6; Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Fosci M, 2013, ECOL ECON, V89, P196, DOI 10.1016/j.ecolecon.2012.11.022; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Giam X, 2011, BIOL CONSERV, V144, P3149, DOI 10.1016/j.biocon.2011.10.001; Grainger A, 2011, ENVIRON SCI POLICY, V14, P127, DOI 10.1016/j.envsci.2010.10.006; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Heumann BW, 2011, REMOTE SENS-BASEL, V3, P2440, DOI 10.3390/rs3112440; IPCC, 2007, CLIMATE CHANGE 2007; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Larson AM, 2013, GLOBAL ENVIRON CHANG, V23, P678, DOI 10.1016/j.gloenvcha.2013.02.014; Lee JSH, 2014, AGRON SUSTAIN DEV, V34, P501, DOI 10.1007/s13593-013-0159-4; Leventon J, 2014, FOREST POLICY ECON, V44, P10, DOI 10.1016/j.forpol.2014.03.005; Levin J., 2012, ANAL INCREMENTAL FIN; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Matsuda I, 2009, INT J PRIMATOL, V30, P313, DOI 10.1007/s10764-009-9344-3; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; McMorrow J, 2001, GLOBAL ENVIRON CHANG, V11, P217, DOI 10.1016/S0959-3780(00)00059-5; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Hoang MH, 2013, LAND USE POLICY, V31, P48, DOI 10.1016/j.landusepol.2011.09.013; Molenaar JW, 2010, ANAL AGRONOMIC I CON; Monserud RA, 1990, METHOD COMP GLOBAL V, P90; Morel AC, 2011, FOREST ECOL MANAG, V262, P1786, DOI 10.1016/j.foreco.2011.07.008; MPOB, 2010, PALM OIL COST PRODUC; NRE UNDP, 2013, MAL REDD READ PROJ N; Pagiola S, 2009, ESIMATING COSTS REED; Parolin P, 2004, FOLIA GEOBOT, V39, P371, DOI 10.1007/BF02803209; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Permandu, 2010, EC TRANSF PROGR ROAD; Peters-Stanley M., 2013, MANEUVERING MOSAIC S; Peters-Stanley M, 2013, COVERING NEW GROUNDS; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Vo QT, 2012, ECOL INDIC, V23, P431, DOI 10.1016/j.ecolind.2012.04.022; Reinhardt ED, 2008, FOREST ECOL MANAG, V256, P1997, DOI 10.1016/j.foreco.2008.09.016; Rowling M, 2013, PALM OIL EXPASION TH; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sabah Forestry Department, 2007, VEGETATION ASSESSMEN; Saner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029642; Schalatek Liane, 2010, WHERES MONEY STATUS; Skutsch M, 2011, ENVIRON SCI POLICY, V14, P140, DOI 10.1016/j.envsci.2010.12.005; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Somorin OA, 2014, ENVIRON SCI POLICY, V35, P87, DOI 10.1016/j.envsci.2013.02.004; Stark D. J., 2012, Endangered Species Research, V16, P31, DOI 10.3354/esr00385; Tauli-Corpuz V., 2009, GUIDE CLIMATE CHANGE; Teoh CH, 2000, LAND USE OIL PALM IN; Tockner K., 2011, Ecohydrology and Hydrobiology, V11, P167; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; UNDP-GEF, 2013, PROJ INC WORKSH JUL; UNFCCC, 2005, RED EM DEF DEV COUNT; UNFCCC, 2009, COP ACC; Vancutsem C, 2009, INT J APPL EARTH OBS, V11, P62, DOI 10.1016/j.jag.2008.08.001; Veloo R, 2015, NJAS-WAGEN J LIFE SC, V72-73, P33, DOI 10.1016/j.njas.2014.11.001; Venter O, 2012, ANN NY ACAD SCI, V1249, P137, DOI 10.1111/j.1749-6632.2011.06306.x; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wells JA, 2013, FOREST FLOODS PEOPLE; Wertz-Kanounnikoff S., 2009, 46 CIFOR; Wich SA, 2014, CURR BIOL, V24, P1659, DOI 10.1016/j.cub.2014.05.077; Yuen JQ, 2013, FOREST ECOL MANAG, V310, P915, DOI 10.1016/j.foreco.2013.09.042; Ziegler AD, 2012, GLOBAL CHANGE BIOL, V18, P3087, DOI 10.1111/j.1365-2486.2012.02747.x	91	18	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156481	10.1371/journal.pone.0156481	http://dx.doi.org/10.1371/journal.pone.0156481			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276218	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000377561700025
J	Levitsky, J; Miller, J; Huang, XM; Gallon, L; Leventhal, JR; Mathew, JM				Levitsky, Josh; Miller, Joshua; Huang, Xuemei; Gallon, Lorenzo; Leventhal, Joseph R.; Mathew, James M.			Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses	PLOS ONE			English	Article							REGULATORY T-CELLS; LIVER-TRANSPLANT RECIPIENTS; RENAL-FUNCTION; MAMMALIAN TARGET; CYCLOSPORINE-A; RAPAMYCIN; CALCINEURIN; TACROLIMUS; INHIBITION; GENERATION	Everolimus (EVL) is a novel mTOR-inhibitor similar to sirolimus (SRL) that is used in organ transplant recipients, often in combination with tacrolimus (TAC) or mycophenolate (MPA). The current study aims to determine its effects on regulatory T cells. Increasing concentrations of EVL, MPA and TAC alone or in combination were added to MLRs of healthy volunteers. Lymphoproliferation by H-3-TdR incorporation and the percentage of newly generated CD4(+)CD127(-)CD25(+)FOXP3(+) (total Treg) and CD4(+)CD127(-)CD25(High)FOXP3(+) (natural Treg) in CFSE labeled responder cells were assessed by flow cytometry. In comparison to medium controls, EVL and other agents dose-dependently inhibited H-3-TdR incorporation in HLA-2DR-matched and HLA-mismatched MLRs (n = 3-10). However, EVL significantly amplified newly generated total and natural Tregs in CFSE labeled responder cells (p<0.05) at all concentrations, while MPA and SRL did this only at sub-therapeutic concentrations and inhibited at therapeutic levels. In contrast, TAC inhibited newly generated Tregs at all concentrations. When tested in combination with TAC, EVL failed to reverse TAC inhibition of Treg generation. Combinations of EVL and low concentrations of MPA inhibited proliferation and amplified Treg generation in an additive manner when compared to medium controls or each drug tested alone (p<0.05). The relative tolerogenic effect from high to low was EVL > SRL > MPA > TAC. If the results from these in vitro studies are extrapolated to clinical transplantation, it would suggest EVL plus low concentrations of MPA may be the most tolerogenic combination.	[Levitsky, Josh] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA; [Levitsky, Josh; Miller, Joshua; Huang, Xuemei; Gallon, Lorenzo; Leventhal, Joseph R.; Mathew, James M.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Gallon, Lorenzo] Northwestern Univ, Dept Med, Div Nephrol, Feinberg Sch Med, Chicago, IL 60611 USA; [Mathew, James M.] Northwestern Univ, Dept Immunol Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Mathew, JM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA.; Mathew, JM (corresponding author), Northwestern Univ, Dept Immunol Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA.	James-mathew@northwestern.edu	Levitsky, Josh/AAF-8662-2019	Levitsky, Josh/0000-0001-7527-6093	Novartis [CRAD001AUSNC10T]; National Institutes of Health [2R01DK25243-25A2]	Novartis(Novartis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Novartis (CRAD001AUSNC10T; https://www.novartis.com/;JL; JM & JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the funders approved the publication of the results. This work was supported by the National Institutes of Health (2R01DK25243-25A2; http://www.niddk.nih.gov; JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrani SK, 2014, AM J TRANSPLANT, V14, P356, DOI 10.1111/ajt.12543; Baan CC, 2005, TRANSPLANTATION, V80, P110, DOI 10.1097/01.TP.0000164142.98167.4B; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Benitez C, 2013, HEPATOLOGY, V58, P1824, DOI 10.1002/hep.26426; Bohne F, 2012, J CLIN INVEST, V122, P368, DOI 10.1172/JCI59411; Daniel C, 2010, P NATL ACAD SCI USA, V107, P16246, DOI 10.1073/pnas.1007422107; De Simone P, 2012, AM J TRANSPLANT, V12, P3008, DOI 10.1111/j.1600-6143.2012.04212.x; Demirkiran A, 2008, TRANSPLANTATION, V85, P783, DOI 10.1097/TP.0b013e318166910b; Fourtounas C, 2010, AM J NEPHROL, V32, P1, DOI 10.1159/000313940; Gallon L, 2015, TRANSPLANTATION, V99, P1774, DOI 10.1097/TP.0000000000000717; Game DS, 2005, AM J TRANSPLANT, V5, P454, DOI 10.1111/j.1600-6143.2005.00758.x; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Jin YP, 2014, AM J TRANSPLANT, V14, P806, DOI 10.1111/ajt.12669; Levitsky J, 2013, TRANSPLANTATION, V96, P689, DOI 10.1097/TP.0b013e31829f1607; Levitsky J, 2013, HEPATOLOGY, V57, P239, DOI 10.1002/hep.25579; Levitsky J, 2012, HUM IMMUNOL, V73, P141, DOI 10.1016/j.humimm.2011.11.008; Levitsky J, 2011, LIVER TRANSPLANT, V17, pS60, DOI 10.1002/lt.22385; Levitsky J, 2011, TRANSPLANTATION, V91, P199, DOI 10.1097/TP.0b013e318200e97; Levitsky J, 2009, TRANSPLANTATION, V88, P1303, DOI 10.1097/TP.0b013e3181bbee98; Levitsky J, 2009, HUM IMMUNOL, V70, P146, DOI 10.1016/j.humimm.2008.12.008; Merino D, 2016, IMMUNOLOGY, V148, P206, DOI 10.1111/imm.12603; Mittal SK, 2009, TRANSPLANTATION, V88, P435, DOI 10.1097/TP.0b013e3181af20fd; Mjornstedt L, 2012, AM J TRANSPLANT, V12, P2744, DOI 10.1111/j.1600-6143.2012.04162.x; Roat E, 2012, CYTOM PART A, V81A, P303, DOI 10.1002/cyto.a.22019; Sabbatini M, 2015, CLIN EXP IMMUNOL, V182, P230, DOI 10.1111/cei.12669; Saliba F, 2013, AM J TRANSPLANT, V13, P1734, DOI 10.1111/ajt.12280; Saliba F, 2011, LIVER TRANSPLANT, V17, P905, DOI 10.1002/lt.22292; San Segundo D, 2010, TRANSPL P, V42, P2871, DOI 10.1016/j.transproceed.2010.07.045; Szabo G, 2001, J INVEST MED, V49, P442, DOI 10.2310/6650.2001.33789; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Yamashita K, 2014, AM J TRANSPLANT, V14, P6; Yu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022450; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156535	10.1371/journal.pone.0156535	http://dx.doi.org/10.1371/journal.pone.0156535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275747	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561700027
J	Ferreira, RB; Beard, KH; Crump, ML				Ferreira, Rodrigo B.; Beard, Karen H.; Crump, Martha L.			Breeding Guild Determines Frog Distributions in Response to Edge Effects and Habitat Conversion in the Brazil's Atlantic Forest	PLOS ONE			English	Article							FRAGMENTATION; ABUNDANCE; SOUTHEASTERN; AMPHIBIANS; DIVERSITY; MATRIX; SPLIT; ISLAND; LIFE; MAP	Understanding the response of species with differing life-history traits to habitat edges and habitat conversion helps predict their likelihood of persistence across changing landscape. In Brazil's Atlantic Forest, we evaluated frog richness and abundance by breeding guild at four distances from the edge of a reserve: i) 200 m inside the forest, ii) 50 m inside the forest, iii) at the forest edge, and iv) 50 m inside three different converted habitats (coffee plantation, non-native Eucalyptus plantation, and abandoned pastures, hereafter matrix types). By sampling a dry and a wet season, we recorded 622 individual frogs representing 29 species, of which three were undescribed. Breeding guild (i.e. bromeliad, leaf-litter, and water-body breeders) was the most important variable explaining frog distributions in relation to edge effects and matrix types. Leaf-litter and bromeliad breeders decreased in richness and abundance from the forest interior toward the matrix habitats. Water-body breeders increased in richness toward the matrix and remained relatively stable in abundance across distances. Number of large trees (i.e. DBH > 15 cm) and bromeliads best explained frog richness and abundance across distances. Twenty species found in the interior of the forest were not found in any matrix habitat. Richness and abundance across breeding guilds were higher in the rainy season but frog distributions were similar across the four distances in the two seasons. Across matrix types, leaf-litter species primarily used Eucalyptus plantations, whereas water-body species primarily used coffee plantations. Bromeliad breeders were not found inside any matrix habitat. Our study highlights the importance of primary forest for bromeliad and leaf-litter breeders. We propose that water-body breeders use edge and matrix habitats to reach breeding habitats along the valleys. Including life-history characteristics, such as breeding guild, can improve predictions of frog distributions in response to edge effect and matrix types, and can guide more effective management and conservation actions.	[Ferreira, Rodrigo B.; Beard, Karen H.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Ferreira, Rodrigo B.; Beard, Karen H.; Crump, Martha L.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Ferreira, Rodrigo B.] Univ Vila Velha, Lab Ecol Populacoes & Conservacao, Vila Velha, ES, Brazil; [Crump, Martha L.] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Centro Universitario Vila Velha; Utah System of Higher Education; Utah State University	Ferreira, RB (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.; Ferreira, RB (corresponding author), Utah State Univ, Ctr Ecol, Logan, UT 84322 USA.; Ferreira, RB (corresponding author), Univ Vila Velha, Lab Ecol Populacoes & Conservacao, Vila Velha, ES, Brazil.	rodrigoecologia@yahoo.com.br	Beard, Karen/B-7177-2011	Beard, Karen/0000-0003-4997-2495; Ferreira, Rodrigo/0000-0001-6099-5116	Herpetologists' League; Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [231020/2013-9]; Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES); Utah Agricultural Experiment Station, Utah State University	Herpetologists' League; Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES); Utah Agricultural Experiment Station, Utah State University	RBF received funding from The Herpetologists' League, Ecology Center at Utah State University, Dr. Dinesh and Kalpana Patel Fellowship, IdeaWild, Jack Berryman Institute, the Rufford Foundation, Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 231020/2013-9), Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES). This research was supported by the Utah Agricultural Experiment Station, Utah State University, and approved as journal paper number 8876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Antonio de Padua, 2011, Check List, V7, P542; Almeida-Gomes M, 2015, BIOTROPICA, V47, P113, DOI 10.1111/btp.12168; American Veterinary Medical Association, 2013, GUID EUTH AN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Becker CG, 2010, CONSERV BIOL, V24, P287, DOI 10.1111/j.1523-1739.2009.01324.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Both C, 2008, J NAT HIST, V42, P205, DOI 10.1080/00222930701847923; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CEBEA/CFMV CdEBeB-EA, 2013, GUIA BRAS BOAS PRAT; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Dixo M, 2008, J TROP ECOL, V24, P551, DOI 10.1017/S0266467408005282; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058093; Ferreira RB, 2012, IHERINGIA SER ZOOL, V102, P163, DOI 10.1590/S0073-47212012000200008; Fletcher RJ, 2005, J ANIM ECOL, V74, P342, DOI 10.1111/j.1365-2656.2005.00930.x; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Fundacao SOS Mata Atlantica & Instituto Nacional de Pesquisas Espaciais, 2013, ATL REM FLOR MAT ATL; Gardner TA, 2007, CONSERV BIOL, V21, P775, DOI 10.1111/j.1523-1739.2007.00659.x; Giaretta AA, 1999, BIOTROPICA, V31, P669, DOI 10.1111/j.1744-7429.1999.tb00416.x; Haddad CFB, 2013, GUIA ANTIBIOS MATA A; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Kurz DJ, 2014, BIOL CONSERV, V170, P246, DOI 10.1016/j.biocon.2013.12.027; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lion MB, 2014, DIVERS DISTRIB, V20, P1245, DOI 10.1111/ddi.12228; Marsh DM, 1997, CONSERV BIOL, V11, P1323, DOI 10.1046/j.1523-1739.1997.95519.x; Mendes Sergio L., 2000, Boletim do Museu de Biologia Mello Leitao, V11-12, P7; Mendiburu F, 2014, AGRICOLAE STAT PROCE; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Roedder Dennis, 2007, Salamandra, V43, P91; Santos-Pereire M, 2011, ZOOLOGIA-CURITIBA, V28, P755, DOI 10.1590/S1984-46702011000600008; Thomaz L. D., 1997, B MUSEU BIOL MELLO L, V7, P3; Tocher M., 2002, LESSONS AMAZONIA ECO, P235; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X; Venables WN., 2002, MODERN APPL STAT S, V4; Watanabe S, 2005, J TROP ECOL, V21, P85, DOI 10.1017/S0266467404002068; Wright K, 2014, CORRGRAM PLOT CORREL; Zimmerman BL, 1996, J BIOGEOGR, V23, P27, DOI 10.1046/j.1365-2699.1996.d01-218.x; Zuur Alain F., 2009, P1	50	25	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156781	10.1371/journal.pone.0156781	http://dx.doi.org/10.1371/journal.pone.0156781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272328	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000036
J	Arai, M; Nakamura, C				Arai, Manabu; Nakamura, Chie			It's Harder to Break a Relationship When you Commit Long	PLOS ONE			English	Article							EYE-MOVEMENTS; SENTENCE; PLAUSIBILITY; EXPECTATION; CONSTRAINTS; INFORMATION; ATTACHMENT; RECOVERY	Past research has produced evidence that parsing commitments strengthen over the processing of additional linguistic elements that are consistent with the commitments and undoing strong commitments takes more time than undoing weak commitments. It remains unclear, however, whether this so-called digging-in effect is exclusively due to the length of an ambiguous region or at least partly to the extra cost of processing these additional phrases. The current study addressed this issue by testing Japanese relative clause structure, where lexical content and sentence meaning were controlled for. The results showed evidence for a digging-in effect reflecting the strengthened commitment to an incorrect analysis caused by the processing of additional adjuncts. Our study provides strong support for the dynamical, self-organizing models of sentence processing but poses a problem for other models including serial two-stage models as well as frequency-based probabilistic models such as the surprisal theory.	[Arai, Manabu] Seijo Univ, Dept Econ, Tokyo, Japan; [Nakamura, Chie] MIT, Dept Linguist & Philosophy, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nakamura, Chie] Univ Tokyo, Dept Language & Informat Sci, Tokyo, Japan; [Nakamura, Chie] Japan Soc Promot Sci, Tokyo, Japan	Massachusetts Institute of Technology (MIT); University of Tokyo; Japan Society for the Promotion of Science	Arai, M (corresponding author), Seijo Univ, Dept Econ, Tokyo, Japan.	manabu-arai@seijo.ac.jp	Nakamura, Chie/AAX-8788-2021	Nakamura, Chie/0000-0003-4534-7385	Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [26770134]	Japan Society for the Promotion of Science (JSPS KAKENHI Grant)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers 26770134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Farmer TA, 2014, P 36 ANN M COGN SCI, V1, P2181; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FERREIRA F, 1991, J MEM LANG, V30, P725, DOI 10.1016/0749-596X(91)90034-H; FERREIRA F, 1993, CAN J EXP PSYCHOL, V47, P247, DOI 10.1037/h0078819; Frazier L, 1997, J PSYCHOLINGUIST RES, V26, P277, DOI 10.1023/A:1025024524133; Frazier L., 1996, CONSTRUAL; Frazier Lyn, 1998, REANALYSIS SENTENCE, P143, DOI DOI 10.1007/978-94-015-9070-9_5; Garnsey SM, 1997, J MEM LANG, V37, P58, DOI 10.1006/jmla.1997.2512; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Kamide Y, 1999, LANG COGNITIVE PROC, V14, P631, DOI 10.1080/016909699386211; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Koizumi M, 1993, JAPANESE KOREAN LING, P409; Koizumi M, 2006, NINTI KAGAKU, V13, P392; Konieczny Lars., JOINT INT C COGN SCI, P13; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Levy RP, 2013, J MEM LANG, V68, P199, DOI 10.1016/j.jml.2012.02.005; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Miyamoto ET, 2002, J PSYCHOLINGUIST RES, V31, P307, DOI 10.1023/A:1019540324040; Nakamura C, 2016, COGNITIVE SCI, V40, P909, DOI 10.1111/cogs.12266; Namba E, P 6 CORP JAP SCI WOR, P165; OSAKA N, 1992, J OPT SOC AM A, V9, P5, DOI 10.1364/JOSAA.9.000005; Pickering MJ, 1998, J EXP PSYCHOL LEARN, V24, P940, DOI 10.1037/0278-7393.24.4.940; PRITCHETT BL, 1991, J PSYCHOLINGUIST RES, V20, P251, DOI 10.1007/BF01067218; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K., 1994, HDB PSYCHOLINGUISTIC, P57; Sturt P, 1999, J MEM LANG, V40, P136, DOI 10.1006/jmla.1998.2606; Tabor W, 2004, J EXP PSYCHOL LEARN, V30, P431, DOI 10.1037/0278-7393.30.2.431; Tabor W, 1997, LANG COGNITIVE PROC, V12, P211, DOI 10.1080/016909697386853; Traxler MJ, 1998, J MEM LANG, V39, P558, DOI 10.1006/jmla.1998.2600; Van Gompel RPG, 2001, J MEM LANG, V45, P283; WARNER J, 1987, J MEM LANG, V26, P714, DOI 10.1016/0749-596X(87)90111-2; Yamashita H, 1997, J PSYCHOLINGUIST RES, V26, P163, DOI 10.1023/A:1025009615473	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156482	10.1371/journal.pone.0156482	http://dx.doi.org/10.1371/journal.pone.0156482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1SU	27271881	Green Submitted, gold, Green Published			2022-12-26	WOS:000377560200011
J	Fekry, B; Jeffries, KA; Esmaeilniakooshkghazi, A; Ogretmen, B; Krupenko, SA; Krupenko, NI				Fekry, Baharan; Jeffries, Kristen A.; Esmaeilniakooshkghazi, Amin; Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.			CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; CERAMIDE SYNTHASES; 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; P53-INDUCIBLE REGULATOR; BIOPHYSICAL PROPERTIES; METABOLIC-REGULATION; GLUCOSE-METABOLISM; FOLATE-DEPLETION; UP-REGULATION; EXPRESSION	Our previous study suggested that ceramide synthase 6 (CerS6), an enzyme in sphingolipid biosynthesis, is regulated by p53: CerS6 was elevated in several cell lines in response to transient expression of p53 or in response to folate stress, which is known to activate p53. It was not clear, however, whether CerS6 gene is a direct transcriptional target of p53 or whether this was an indirect effect through additional regulatory factors. In the present study, we have shown that the CerS6 promoter is activated by p53 in luciferase assays, whereas transcriptionally inactive R175H p53 mutant failed to induce the luciferase expression from this promoter. In vitro immunoprecipitation assays and gel shift analyses have further demonstrated that purified p53 binds within the CerS6 promoter sequence spanning 91 bp upstream and 60 bp downstream of the transcription start site. The Promo 3.0.2 online tool for the prediction of transcription factor binding sites indicated the presence of numerous putative non-canonical p53 binding motifs in the CerS6 promoter. Luciferase assays and gel shift analysis have identified a single motif upstream of the transcription start as a key p53 response element. Treatment of cells with Nutlin-3 or low concentrations of actinomycin D resulted in a strong elevation of CerS6 mRNA and protein, thus demonstrating that CerS6 is a component of the non-genotoxic p53-dependent cellular stress response. This study has shown that by direct transcriptional activation of CerS6, p53 can regulate specific ceramide biosynthesis, which contributes to the pro-apoptotic cellular response.	[Fekry, Baharan; Jeffries, Kristen A.; Esmaeilniakooshkghazi, Amin; Krupenko, Sergey A.; Krupenko, Natalia I.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Ogretmen, Besim] Med Univ South Carolina, Dept Biochem, Charleston, SC 29425 USA; [Ogretmen, Besim] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Krupenko, Sergey A.; Krupenko, Natalia I.] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Krupenko, NI (corresponding author), Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA.; Krupenko, NI (corresponding author), Univ N Carolina, Dept Nutr, Kannapolis, NC 28081 USA.	Natalia_krupenko@unc.edu	Fekry, Baharan/GLT-6510-2022	Fekry, Baharan/0000-0003-1218-4161	National Institutes of Health [CA193782, CA88932, CA97165, DE16572, DK54388]; NATIONAL CANCER INSTITUTE [R01CA193782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA193782 (to N. I. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the National Institutes of Health Grants CA88932, CA97165, and DE16572.r Supported by the National Institutes of Health Grant DK54388.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Choong ML, 2009, CELL CYCLE, V8, P2810, DOI 10.4161/cc.8.17.9503; Colombini Marco, 2013, Handb Exp Pharmacol, P109, DOI 10.1007/978-3-7091-1368-4_6; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Crott JW, 2007, MUTAT RES-GEN TOX EN, V626, P171, DOI 10.1016/j.mrgentox.2006.10.001; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fekry B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146618; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heffernan-Stroud LA, 2011, ADV ENZYME REGUL, V51, P219, DOI 10.1016/j.advenzreg.2010.10.003; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoeferlin LA, 2013, J BIOL CHEM, V288, P12880, DOI 10.1074/jbc.M113.461798; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; KRUPENKO SA, 1995, PROTEIN EXPRES PURIF, V6, P457, DOI 10.1006/prep.1995.1061; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; Menendez D, 2010, DISCOV MED, V10, P94; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyers-Needham M, 2012, EMBO MOL MED, V4, P78, DOI 10.1002/emmm.201100189; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Oleinik Natalia V, 2011, Genes Cancer, V2, P130, DOI 10.1177/1947601911405841; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Ou Y, 2015, J BIOL CHEM, V290, P457, DOI 10.1074/jbc.M114.616359; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinn JL, 2011, TRENDS CELL BIOL, V21, P344, DOI 10.1016/j.tcb.2011.04.002; Saddoughi SA, 2013, ADV CANCER RES, V117, P37, DOI 10.1016/B978-0-12-394274-6.00002-9; Sanchez-Macedo N, 2013, CELL DEATH DIFFER, V20, P659, DOI 10.1038/cdd.2012.168; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Sinha AU, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-88; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Suzuki M, 2016, J CLIN INVEST, V126, P254, DOI 10.1172/JCI79775; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; TISHLER RB, 1993, CANCER RES, V53, P2212; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Wang SJ, 2013, CELL CYCLE, V12, P753, DOI 10.4161/cc.23597; Wegner MS, 2014, BIOCHEM PHARMACOL, V92, P577, DOI 10.1016/j.bcp.2014.10.007; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhang X, 2015, MOL CELL, V59, P243, DOI 10.1016/j.molcel.2015.05.036	59	30	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16586	16596		10.1074/jbc.M116.716902	http://dx.doi.org/10.1074/jbc.M116.716902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302066	hybrid, Green Published			2022-12-26	WOS:000380826700018
J	Hicks, KC; Patel, TB				Hicks, Kristin C.; Patel, Tarun B.			Sprouty2 Protein Regulates Hypoxia-inducible Factor-alpha (HIF alpha) Protein Levels and Transcription of HIF alpha-responsive Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HUMAN ERYTHROPOIETIN GENE; FACTOR-I; HEPATOCELLULAR-CARCINOMA; KINASE PATHWAY; FACTOR 1-ALPHA; PROSTATE-CANCER; DOWN-REGULATION; ERK ACTIVATION; UP-REGULATION	The alpha-subunits of hypoxia-inducible factors (HIF1 alpha and HIF2 alpha) promote transcription of genes that regulate glycolysis and cell survival and growth. Sprouty2 (Spry2) is a modulator of receptor tyrosine kinase signaling and inhibits cell proliferation by a number of different mechanisms. Because of the seemingly opposite actions of HIF alpha subunits and Spry2 on cellular processes, we investigated whether Spry2 regulates the levels of HIF1 alpha and HIF2 alpha proteins. In cell lines from different types of tumors in which the decreased protein levels of Spry2 have been associated with poor prognosis, silencing of Spry2 elevated HIF1 alpha protein levels. Increases in HIF1 alpha and HIF2 alpha protein levels due to silencing of Spry2 also up-regulated HIF alpha target genes. Using HIF1 alpha as a prototype, we show that Spry2 decreases HIF1 alpha stability and enhances the ubiquitylation of HIF1 alpha by a von Hippel-Lindau protein (pVHL)-dependent mechanism. Spry2 also exists in a complex with HIF1 alpha. Because Spry2 can also associate with pVHL, using a mutant form of Spry2 (3P/3A-Spry2) that binds HIF1 alpha, but not pVHL, we show that WT-Spry2, but not the 3P/3A-Spry2 decreases HIF1 alpha protein levels. In accordance, expression of WT-Spry2, but not 3P/3A-Spry2 results in a decrease in HIF1 alpha-sensitive glucose uptake. Together our data suggest that Spry2 acts as a scaffold to bring more pVHL/associated E3 ligase in proximity of HIF1 alpha and increase its ubiquitylation and degradation. This represents a novel action for Spry2 in modulating biological processes regulated by HIF alpha subunits.	[Hicks, Kristin C.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Patel, Tarun B.] Albany Coll Pharm & Hlth Sci, OBrien Bldg,Ste 104G,106 New Scotland Ave, Albany, NY 12208 USA	Loyola University Chicago; Albany College of Pharmacy & Health Sciences	Patel, TB (corresponding author), Albany Coll Pharm & Hlth Sci, OBrien Bldg,Ste 104G,106 New Scotland Ave, Albany, NY 12208 USA.	tarun.patel@acphs.edu		Hicks, Kristin/0000-0001-9192-875X	Schmitt fellowship; Veterans Affairs Merit Review Award [5IBX002355]; Veterans Affairs [I01BX002355] Funding Source: NIH RePORTER	Schmitt fellowship; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Schmitt fellowship (to K. H.) and Veterans Affairs Merit Review Award 5IBX002355 (to T. B. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; Gao ML, 2012, EMBO MOL MED, V4, P776, DOI 10.1002/emmm.201100944; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hopfer U, 2006, J BIOL CHEM, V281, P8645, DOI 10.1074/jbc.M513751200; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim BY, 2008, EXP MOL MED, V40, P71, DOI 10.3858/emm.2008.40.1.71; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu X., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1007/S11033-014-3506-X; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Macia A, 2012, ONCOGENE, V31, P3961, DOI 10.1038/onc.2011.556; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Mastrogiannaki M, 2012, HAEMATOL-HEMATOL J, V97, P827, DOI 10.3324/haematol.2011.056119; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Perl AKT, 2003, DEV BIOL, V258, P154, DOI 10.1016/S0012-1606(03)00106-4; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ravi R, 2000, GENE DEV, V14, P34; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sirivatanauksorn Y, 2012, J SURG ONCOL, V105, P273, DOI 10.1002/jso.22095; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song K, 2012, HEPATOB PANCREAT DIS, V11, P177, DOI 10.1016/S1499-3872(12)60145-3; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Taniguchi K, 2009, CANCER SCI, V100, P1648, DOI 10.1111/j.1349-7006.2009.01214.x; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Wang CM, 2012, J HEPATOL, V57, P577, DOI 10.1016/j.jhep.2012.04.026; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3; Zhong H, 2000, CANCER RES, V60, P1541; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	94	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16787	16801		10.1074/jbc.M116.714139	http://dx.doi.org/10.1074/jbc.M116.714139			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27281823	Green Published, hybrid			2022-12-26	WOS:000380826700035
J	Vartun, A; Flo, K; Widnes, C; Acharya, G				Vartun, Ase; Flo, Kari; Widnes, Christian; Acharya, Ganesh			Static and Functional Hemodynamic Profiles of Women with Abnormal Uterine Artery Doppler at 22-24 Weeks of Gestation	PLOS ONE			English	Article							THORACIC ELECTRICAL BIOIMPEDANCE; CARDIAC-OUTPUT; IMPEDANCE CARDIOGRAPHY; DIASTOLIC FUNCTION; NORMAL-PREGNANCY; BLOOD-FLOW; PREECLAMPSIA; TERM; ECHOCARDIOGRAPHY; COMPLICATIONS	Objective To compare cardiac function, systemic hemodynamics and preload reserve of women with increased (cases) and normal (controls) uterine artery (UtA) pulsatility index (PI) at 22-24 weeks of gestation. Materials and Methods A prospective cross-sectional study of 620 pregnant women. UtA blood flow velocities were measured using Doppler ultrasonography, and PI was calculated. Mean UtA PI >= 1.16 (90th percentile) was considered abnormal. Maternal hemodynamics was investigated at baseline and during passive leg raising (PLR) using impedance cardiography (ICG). Preload reserve was defined as percent increase in stroke volume (SV) 90 seconds after passive leg raising compared to baseline. Results Mean UtA PI was 1.49 among cases (n = 63) and 0.76 among controls (n = 557) (p < 0.0001). Eighteen (28.6%) cases and 53 (9.5%) controls developed pregnancy complications (p < 0.0001). The mean arterial pressure and systemic vascular resistance were 83 mmHg and 1098.89 +/- 293.87 dyne s/cm(5) among cases and 79 mmHg and 1023.95 +/- 213.83 dyne s/cm(5) among controls (p = 0.007 and p = 0.012, respectively). Heart rate, SV and cardiac output were not different between the groups. Both cases and controls responded with a small (4-5%) increase in SV in response to PLR, but the cardiac output remained unchanged. The preload reserve was not significantly different between two groups. Conclusion Pregnant women with abnormal UtA PI had higher blood pressure and systemic vascular resistance, but similar functional hemodynamic profile at 22-24 weeks compared to controls. Further studies are needed to clarify whether functional hemodynamic assessment using ICG can be useful in predicting pregnancy complications.	[Vartun, Ase; Flo, Kari; Widnes, Christian; Acharya, Ganesh] UiT Arctic Univ Norway, Womens Hlth & Perinatol Res Grp, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Vartun, Ase; Flo, Kari; Widnes, Christian; Acharya, Ganesh] Univ Hosp Northern Norway, Dept Obstet & Gynaecol, Tromso, Norway; [Acharya, Ganesh] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Karolinska Institutet	Vartun, A (corresponding author), UiT Arctic Univ Norway, Womens Hlth & Perinatol Res Grp, Dept Clin Med, Fac Hlth Sci, Tromso, Norway.; Vartun, A (corresponding author), Univ Hosp Northern Norway, Dept Obstet & Gynaecol, Tromso, Norway.	ase.vartun@uit.no			Regional Health Authority of Northern Norway (Helse-Nord) [SFP873/ID1646]; Northern Norway Regional Health Authority	Regional Health Authority of Northern Norway (Helse-Nord); Northern Norway Regional Health Authority	This study was funded by the Regional Health Authority of Northern Norway (Helse-Nord), Grant No. SFP873/ID1646, GA.; This study was supported by a grant from the Northern Norway Regional Health Authority. We want to thank the midwives at the antenatal clinic for their help in recruiting participants for the study.	Albaiges G, 2000, OBSTET GYNECOL, V96, P559, DOI 10.1016/S0029-7844(00)00946-7; Barnett S B, 2001, J Matern Fetal Med, V10, P75, DOI 10.1080/714904312; Brun C, 2013, INTENS CARE MED, V39, P593, DOI 10.1007/s00134-012-2770-2; Burlingame J, 2013, J PERINATOL, V33, P675, DOI 10.1038/jp.2013.35; Cavallaro F, 2010, INTENS CARE MED, V36, P1475, DOI 10.1007/s00134-010-1929-y; Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; CLARK SL, 1994, OBSTET GYNECOL, V83, P669; DUVEKOT JJ, 1993, AM J OBSTET GYNECOL, V169, P1382, DOI 10.1016/0002-9378(93)90405-8; Estensen ME, 2013, ULTRASOUND OBST GYN, V41, P659, DOI 10.1002/uog.12296; Flo K, 2011, ULTRASOUND OBST GYN, V37, P538, DOI 10.1002/uog.8907; Flo K, 2010, BJOG-INT J OBSTET GY, V117, P837, DOI 10.1111/j.1471-0528.2010.02548.x; Gallo DM, 2013, FETAL DIAGN THER, V34, P241, DOI 10.1159/000356171; Gomez O, 2006, ULTRASOUND OBST GYN, V28, P802, DOI 10.1002/uog.2814; Hartgill TW, 2011, ACTA PHYSIOL, V201, P467, DOI 10.1111/j.1748-1716.2010.02228.x; HUNTER S, 1992, BRIT HEART J, V68, P540; HYTTEN FE, 1963, J OBSTET GYN BR COMM, V70, P402; Khalil A, 2014, ULTRASOUND OBST GYN, V43, P541, DOI 10.1002/uog.13257; Kingma Boris Rm, 2014, Temperature (Austin), V1, P142, DOI 10.4161/temp.29702; Li H, 2005, ULTRASOUND OBST GYN, V25, P459, DOI 10.1002/uog.1895; Liu LX, 2014, CARDIOVASC RES, V101, P545, DOI 10.1093/cvr/cvu009; MASAKI DI, 1989, AM J OBSTET GYNECOL, V161, P680, DOI 10.1016/0002-9378(89)90379-7; Melchiorre K, 2013, BJOG-INT J OBSTET GY, V120, P496, DOI 10.1111/1471-0528.12068; Melchiorre K, 2011, HYPERTENSION, V57, P85, DOI 10.1161/HYPERTENSIONAHA.110.162321; Monnet X, 2008, INTENS CARE MED, V34, P659, DOI 10.1007/s00134-008-0994-y; Paelinck B P, 2003, Eur J Echocardiogr, V4, P196, DOI 10.1016/S1525-2167(02)00167-1; Papageorghiou A T, 2002, J Matern Fetal Neonatal Med, V12, P78, DOI 10.1080/713605620; Papageorghiou AT, 2005, BJOG-INT J OBSTET GY, V112, P703, DOI 10.1111/j.1471-0528.2005.00519.x; Papageorghiou AT, 2004, BEST PRACT RES CL OB, V18, P383, DOI 10.1016/j.bpobgyn.2004.02.003; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; RUBLER S, 1977, AM J CARDIOL, V40, P534, DOI 10.1016/0002-9149(77)90068-6; Scardo JA, 2000, AM J OBSTET GYNECOL, V183, P911, DOI 10.1067/mob.2000.108892; Simmons LA, 2002, AM J PHYSIOL-HEART C, V283, pH1627, DOI 10.1152/ajpheart.00966.2001; Staelens A, 2013, EXPERT REV MED DEVIC, V10, P765, DOI 10.1586/17434440.2013.853466; Tomsin K, 2012, J OBSTET GYNAECOL, V32, P630, DOI 10.3109/01443615.2012.673036; Valensise H, 2000, ULTRASOUND OBST GYN, V15, P487, DOI 10.1046/j.1469-0705.2000.00135.x; Valensise H, 2001, ULTRASOUND OBST GYN, V18, P450, DOI 10.1046/j.0960-7692.2001.00576.x; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Vartun A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135300; Vartun A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094629; Vasapollo B, 2008, HYPERTENSION, V51, P1020, DOI 10.1161/HYPERTENSIONAHA.107.105858; Ventura W, 2015, PRENATAL DIAG, V35, P294, DOI 10.1002/pd.4542; Wang Y, 1992, J Clin Anesth, V4, P4, DOI 10.1016/0952-8180(92)90111-D; WONG DH, 1989, CRIT CARE MED, V17, P979, DOI 10.1097/00003246-198910000-00002	43	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157916	10.1371/journal.pone.0157916	http://dx.doi.org/10.1371/journal.pone.0157916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308858	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800143
J	Cao, JF; Cui, HY; Shi, H; Jiao, LJ				Cao, Jianfang; Cui, Hongyan; Shi, Hao; Jiao, Lijuan			Big Data: A Parallel Particle Swarm Optimization-Back-Propagation Neural Network Algorithm Based on MapReduce	PLOS ONE			English	Article							GENETIC ALGORITHM; PREDICTION; MODEL	A back-propagation (BP) neural network can solve complicated random nonlinear mapping problems; therefore, it can be applied to a wide range of problems. However, as the sample size increases, the time required to train BP neural networks becomes lengthy. Moreover, the classification accuracy decreases as well. To improve the classification accuracy and runtime efficiency of the BP neural network algorithm, we proposed a parallel design and realization method for a particle swarm optimization (PSO)-optimized BP neural network based on MapReduce on the Hadoop platform using both the PSO algorithm and a parallel design. The PSO algorithm was used to optimize the BP neural network's initial weights and thresholds and improve the accuracy of the classification algorithm. The MapReduce parallel programming model was utilized to achieve parallel processing of the BP algorithm, thereby solving the problems of hardware and communication overhead when the BP neural network addresses big data. Datasets on 5 different scales were constructed using the scene image library from the SUN Database. The classification accuracy of the parallel PSO-BP neural network algorithm is approximately 92%, and the system efficiency is approximately 0.85, which presents obvious advantages when processing big data. The algorithm proposed in this study demonstrated both higher classification accuracy and improved time efficiency, which represents a significant improvement obtained from applying parallel processing to an intelligent algorithm on big data.	[Cao, Jianfang; Cui, Hongyan; Jiao, Lijuan] Xinzhou Teachers Univ, Comp Sci & Technol Dept, Xinzhou, Peoples R China; [Shi, Hao] Taiyuan Univ Sci & Technol, Coll Comp Sci & Technol, Taiyuan, Peoples R China	Xinzhou Teachers University; Taiyuan University of Science & Technology	Cui, HY (corresponding author), Xinzhou Teachers Univ, Comp Sci & Technol Dept, Xinzhou, Peoples R China.	cuihy16@yeah.net			College Students' Innovative and Entrepreneurial Training Project in universities and colleges in Shanxi Province [2014383]; Natural Science Foundation of Shanxi Province [2013011017-2]; key discipline project of Xinzhou Teachers University [XK201308, XK201404]; Youth Foundation Project of Xinzhou Teachers University [201209]	College Students' Innovative and Entrepreneurial Training Project in universities and colleges in Shanxi Province; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); key discipline project of Xinzhou Teachers University; Youth Foundation Project of Xinzhou Teachers University	This study was supported by the College Students' Innovative and Entrepreneurial Training Project in universities and colleges in Shanxi Province (2014383), the Natural Science Foundation of Shanxi Province (2013011017-2), the key discipline project of Xinzhou Teachers University (XK201308, XK201404), and the Youth Foundation Project of Xinzhou Teachers University (201209).	Cao JW, 2016, MULTIMED TOOLS APPL, V75, P2839, DOI 10.1007/s11042-014-2424-1; Chen C, 2013, IEEE T INTELL TRANSP, V14, P22, DOI 10.1109/TITS.2012.2205144; Cheng C, 2015, COMPUT BIOL MED, V66, P103, DOI 10.1016/j.compbiomed.2015.08.018; Chiroma H, 2014, PROCEEDINGS OF THE 1; Chiroma H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136140; Chiroma H, 2015, APPL ENERG, V142, P266, DOI 10.1016/j.apenergy.2014.12.045; Chung IH, 2014, INT CONF HIGH PERFOR, P745, DOI 10.1109/SC.2014.66; Ding SF, 2011, ARTIF INTELL REV, V36, P153, DOI 10.1007/s10462-011-9208-z; Doulkeridis C, 2014, VLDB J, V23, P355, DOI 10.1007/s00778-013-0319-9; Elsebakhi E, 2015, J COMPUT SCI-NETH, V11, P69, DOI 10.1016/j.jocs.2015.09.008; Feng JQ, 2014, APPL MECH MATER, V614, P521, DOI 10.4028/www.scientific.net/AMM.614.521; Gao Yu-ming, 2014, Computer Engineering, V40, P187, DOI 10.3969/j.issn.1000-3428.2014.04.036; Guo YH, 2013, APPL MECH MATER, V239-240, P1541, DOI 10.4028/www.scientific.net/AMM.239-240.1541; Guo ZH, 2011, KNOWL-BASED SYST, V24, P1048, DOI 10.1016/j.knosys.2011.04.019; Hu Ming-xia, 2012, Computer Engineering, V38, P148, DOI 10.3969/j.issn.1000-3428.2012.06.048; Hu Y, 2003, THE PARALLELISM AND; Jia WK, 2015, APPL INTELL, V43, P176, DOI 10.1007/s10489-014-0618-x; Jing GL, 2012, DESALINATION, V291, P78, DOI 10.1016/j.desal.2012.02.002; Kim Y, 2014, INFORM SYST, V42, P15, DOI 10.1016/j.is.2013.11.002; Liu J, 2012, J GUANGDONG U PETROC, V12, P34; Liu M. L., 2012, J SYSTEMS SCI, V20, P88; Liu Y, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/297672; Mohamed H, 2013, PARALLEL COMPUT, V39, P851, DOI 10.1016/j.parco.2013.08.010; Nawi NM, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/868375; Pan RR, 2011, J TEXT I, V102, P19, DOI 10.1080/00405000903430255; Qian J, 2015, KNOWL-BASED SYST, V73, P18, DOI 10.1016/j.knosys.2014.09.001; Ren C, 2014, KNOWL-BASED SYST, V56, P226, DOI 10.1016/j.knosys.2013.11.015; Roberge V, 2013, IEEE T IND INFORM, V9, P132, DOI 10.1109/TII.2012.2198665; Rong Gu, 2013, 2013 IEEE International Conference on Big Data, P376, DOI 10.1109/BigData.2013.6691598; Saadi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144371; Scardapane S., 2015, NEURAL NETWORKS; Shen H, 2014, INT CONF CLOUD COMPU, P499, DOI 10.1109/CCIS.2014.7175787; Stateczny A, 2014, LECT NOTES COMPUT SC, V8537, P335, DOI 10.1007/978-3-319-08729-0_34; Wang GG, 2014, INFORM SCIENCES, V274, P17, DOI 10.1016/j.ins.2014.02.123; Wang GG, 2014, APPL MATH MODEL, V38, P2454, DOI 10.1016/j.apm.2013.10.052; Wang Gai-ge, 2013, Journal of Jilin University (Engineering and Technology Edition), V43, P1064, DOI 10.7964/jdxbgxb201304035; Wang GG, 2014, J COMPUT THEOR NANOS, V11, P477, DOI 10.1166/jctn.2014.3383; Wang HS, 2013, EXPERT SYST APPL, V40, P418, DOI 10.1016/j.eswa.2012.01.166; Wang YB, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/830869; [徐黎明 Xu Liming], 2013, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V43, P186; Yan J, 2014, J HENAN NORM UNIV, V42, P152; Yu F, 2014, APPL ENERG, V134, P102, DOI 10.1016/j.apenergy.2014.07.104; Zhang F, 2012, NEUROCOMPUTING, V78, P139, DOI 10.1016/j.neucom.2011.05.033; Zhang JianHua, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P161; Zheng Xiao-wei, 2014, Journal of Chinese Computer Systems, V35, P1348; Zhu Weisheng, 2014, Journal of Computer Applications, V34, P695; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	49	55	60	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157551	10.1371/journal.pone.0157551	http://dx.doi.org/10.1371/journal.pone.0157551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304987	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800071
J	Huik, K; Avi, R; Pauskar, M; Kallas, E; Jogeda, EL; Karki, T; Ruutel, K; Talu, A; Abel-Ollo, K; Uuskula, A; Carrillo, A; Ahuja, SK; He, WJ; Lutsar, I				Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jogeda, Ene-Ly; Karki, Tonis; Ruutel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uuskula, Anneli; Carrillo, Andrew; Ahuja, Sunil K.; He, Weijing; Lutsar, Irja			A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RANTES GENE VARIANTS; CD4(+) T-CELLS; CHEMOKINES; EXPRESSION; IL28B; LIVER; TRANSMISSION; POLYMORPHISM; LYMPHOCYTES	Objective The role of CC chemokine receptor 5 (CCR5) and its ligand CCL5 on the pathogenesis of HIV infection has been well studied but not for HCV infection. Here, we investigated whether CCL5 haplotypes influence HIV and HCV seropositivity among 373 Caucasian people who inject drugs (PWID) from Estonia. Methods Study included 373 PWID; 56% were HIV seropositive, 44% HCV seropositive and 47% coinfected. Four CCL5 haplotypes (A-D) were derived from three CCL5 polymorphisms (rs2107538/rs2280788/rs2280789) typed by Taqman allelic discrimination assays. The data of CCR5 haplotypes were used from our previous study. The association between CCL5 haplotypes with HIV and/or HCV seropositivity was determined using logistic regression analysis. Results Possessing CCL5 haplotype D (defined by rs2107538A/rs2280788G/rs2280789C) decreased the odds of HCV seropositivity compared to those not possessing it (OR = 0.19; 95% CI 0.09-0.40), which remained significant after adjustment to co-variates (OR = 0.08; 95% CI 0.02-0.29). An association of this haplotype with HIV seropositivity was not found. In step-wise logistic regression with backward elimination CCL5 haplotype D and CCR5 HHG*1 had reduced odds for HCV seropositivity (OR = 0.28 95% CI 0.09-0.92; OR = 0.23 95% CI 0.08-0.68, respectively) compared to those who did not possess these haplotypes, respectively. Conclusions Our results suggest that among PWID CCL5 haplotype D and CCR5 HHG*1 independently protects against HCV. Our findings highlight the importance of CCL5 genetic variability and CCL5-CCR5 axis on the susceptibility to HCV.	[Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jogeda, Ene-Ly; Karki, Tonis; Lutsar, Irja] Univ Tartu, Inst Biomed & Translat Med, Dept Microbiol, EE-50411 Tartu, Estonia; [Ruutel, Kristi; Abel-Ollo, Katri] Natl Inst Hlth Dev, EE-11619 Tallinn, Estonia; [Talu, Ave; Uuskula, Anneli] Univ Tartu, Inst Family Med & Publ Hlth, EE-50411 Tartu, Estonia; [Carrillo, Andrew; Ahuja, Sunil K.; He, Weijing] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Carrillo, Andrew; Ahuja, Sunil K.; He, Weijing] South Texas Vet Hlth Care Syst, Vet Adm Ctr Personalized Med, San Antonio, TX 78229 USA	University of Tartu; National Institute for Health Development - Estonia; University of Tartu; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Huik, K (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Microbiol, EE-50411 Tartu, Estonia.	kristi.huik@ut.ee	Talu, Ave/D-7677-2014; Uusküla, Anneli/H-3303-2015; Huik, Kristi/AGY-9109-2022	Talu, Ave/0000-0003-3543-483X; Uusküla, Anneli/0000-0002-4036-3856; Huik, Kristi/0000-0002-1569-8830; Avi, Radko/0000-0002-9640-8427	European Union through the European Regional Development Fund; Basic Financing; Target Financing [SF0180004s12]; Institutional research funding of Estonian Ministry of Education and Research [IUT34-24, IUT34-17]; European Commission - project Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population [2005305]; Global Fund; Tuberculosis and Malaria Program "Scaling up the response to HIV in Estonia"; National HIV/AIDS Strategy; US Civilian Research Development Foundation [ESX0-2722-TA-06]; US National Institutes of Health; National Institute on Drug Abuse [R01DA03574]; Archimedes Foundation and Norwegian Financial Mechanism/EEA [EE0016]; Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health MERIT grant [R37AI046326]; Doris Duke Distinguished Clinical Scientist Award; VA MERIT award; Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326] Funding Source: NIH RePORTER	European Union through the European Regional Development Fund(European Commission); Basic Financing; Target Financing; Institutional research funding of Estonian Ministry of Education and Research; European Commission - project Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population; Global Fund; Tuberculosis and Malaria Program "Scaling up the response to HIV in Estonia"; National HIV/AIDS Strategy; US Civilian Research Development Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Archimedes Foundation and Norwegian Financial Mechanism/EEA; Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health MERIT grant; Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); VA MERIT award(US Department of Veterans Affairs); Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Study was supported by: European Union through the European Regional Development Fund; Basic Financing and the Target Financing (SF0180004s12) and Institutional research funding (IUT34-24, IUT34-17) of Estonian Ministry of Education and Research; European Commission funded project Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population Nr. 2005305 (ENCAP); Global Fund to Fight HIV, Tuberculosis and Malaria Program "Scaling up the response to HIV in Estonia" for 2003-2007; National HIV/AIDS Strategy for 2006-2015; US Civilian Research Development Foundation (grant ESX0-2722-TA-06); US National Institutes of Health, National Institute on Drug Abuse (grant R01DA03574); the Archimedes Foundation and Norwegian Financial Mechanism/EEA (grant EE0016); the Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System, a National Institutes of Health MERIT grant (R37AI046326), and the Doris Duke Distinguished Clinical Scientist Award to S.K.A. S.K.A. is also supported by a VA MERIT award, the Elizabeth Glaser Pediatric AIDS Foundation, the Burroughs Welcome Clinical Scientist Award in Translational Research and the Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund.	Abad-Molina C, 2012, CLIN VACCINE IMMUNOL, V19, P223, DOI 10.1128/CVI.05305-11; An P, 2002, P NATL ACAD SCI USA, V99, P10002, DOI 10.1073/pnas.142313799; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; Broadhead RS, 1999, PUBLIC HEALTH REP, V114, P439, DOI 10.1093/phr/114.5.439; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Furci L, 1997, J EXP MED, V186, P455, DOI 10.1084/jem.186.3.455; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Huik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070561; Huik K, 2010, J INFECT DIS, V201, P730, DOI 10.1086/650491; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; Kase K, 2015, 25 EUR C CLIN MICR I; Kusano F, 2000, LAB INVEST, V80, P415, DOI 10.1038/labinvest.3780046; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Nattermann J, 2004, J VIRAL HEPATITIS, V11, P519, DOI 10.1111/j.1365-2893.2004.00545.x; Pauskar M, 2015, 25 EUR C CLIN MICR I; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Rathore A, 2008, J MED VIROL, V80, P1133, DOI 10.1002/jmv.21201; Shields PL, 1999, J IMMUNOL, V163, P6236; Solari R, 1997, J BIOL CHEM, V272, P9617; Soo HM, 2002, VIROLOGY, V303, P253, DOI 10.1006/viro.2002.1617; Tallo T, 2007, J MED VIROL, V79, P374, DOI 10.1002/jmv.20828; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Team RDC, 2019, R LANG ENV STAT COMP; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Wasmuth HE, 2004, HEPATOLOGY, V40, P327, DOI 10.1002/hep.20322; Woitas RP, 1997, J IMMUNOL, V159, P1012	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156850	10.1371/journal.pone.0156850	http://dx.doi.org/10.1371/journal.pone.0156850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304910	Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800026
J	Song, LP; Ding, XQ; Feng, LP; Shi, Q				Song, Li-Peng; Ding, Xiao-Qiang; Feng, Li-Ping; Shi, Qiong			Hopf Bifurcation of an Epidemic Model with Delay	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; BRUCELLOSIS MODEL; GLOBAL STABILITY; TIME-DELAY; DISEASE; POPULATION; BEHAVIOR; MEASLES; SYSTEM	A spatiotemporal epidemic model with nonlinear incidence rate and Neumann boundary conditions is investigated. On the basis of the analysis of eigenvalues of the eigenpolynomial, we derive the conditions of the existence of Hopf bifurcation in one dimension space. By utilizing the normal form theory and the center manifold theorem of partial functional differential equations (PFDs), the properties of bifurcating periodic solutions are analyzed. Moreover, according to numerical simulations, it is found that the periodic solutions can emerge in delayed epidemic model with spatial diffusion, which is consistent with our theoretical results. The obtained results may provide a new viewpoint for the recurrent outbreak of disease.	[Song, Li-Peng; Ding, Xiao-Qiang; Feng, Li-Ping; Shi, Qiong] North Univ China, Dept Comp Sci & Technol, Taiyuan 030051, Shanxi, Peoples R China	North University of China	Song, LP (corresponding author), North Univ China, Dept Comp Sci & Technol, Taiyuan 030051, Shanxi, Peoples R China.	slp880nuc@sina.com			National Natural Science foundation of China [61379125]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science foundation of China under Grant No. 61379125.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; [Anonymous], 2012, ELECT J DIFFER EQU; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563; BUSENBERG S, 1980, J MATH BIOL, V10, P13, DOI 10.1007/BF00276393; Capasso, 1993, LECT NOTES BIOMATHEM; CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; FARIA T, 1995, J DIFFER EQUATIONS, V122, P181, DOI 10.1006/jdeq.1995.1144; Hale J., 1977, THEORY FUNCTIONAL DI; Hethcote H.W., 1989, APPL MATH ECOLOGY; HOPPENSTEADT F, 1971, Mathematical Biosciences, V12, P133, DOI 10.1016/0025-5564(71)90078-2; Huo X, 2016, VACCINE, V34, P1767, DOI 10.1016/j.vaccine.2016.02.046; Kadder A., 2009, ELECT JDE, V1, P1; Klinkenberg D, 2011, J THEOR BIOL, V284, P52, DOI 10.1016/j.jtbi.2011.06.015; Korobeinikov A, 2007, B MATH BIOL, V69, P1871, DOI 10.1007/s11538-007-9196-y; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; LIU WM, 1986, J MATH BIOL, V23, P187, DOI 10.1007/BF00276956; LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; McCluskey CC, 2010, NONLINEAR ANAL-REAL, V11, P3106, DOI 10.1016/j.nonrwa.2009.11.005; Song LP, 2011, J BIOL PHYS, V37, P133, DOI 10.1007/s10867-010-9204-6; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; Sun CJ, 2006, CHAOS SOLITON FRACT, V30, P204, DOI 10.1016/j.chaos.2005.08.167; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun GQ, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08011; Sun G, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/11/P11011; White MC, 2012, PUBLIC HEALTH, V126, P752, DOI 10.1016/j.puhe.2012.04.009; Wu J, 1996, THEORY AND APPLICATI; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Yan XP, 2007, APPL MATH COMPUT, V192, P552, DOI 10.1016/j.amc.2007.03.033; Zhang JZ, 2009, NONLINEAR ANAL-THEOR, V70, P658, DOI 10.1016/j.na.2008.01.002; Zhang J, 2012, J APPL ANAL COMPUT, V2, P111; Zhang J, 2012, B MATH BIOL, V74, P1226, DOI 10.1007/s11538-012-9720-6; Zuo WJ, 2011, NONLINEAR ANAL-REAL, V12, P1998, DOI 10.1016/j.nonrwa.2010.12.016	45	2	2	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157367	10.1371/journal.pone.0157367	http://dx.doi.org/10.1371/journal.pone.0157367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304674	gold, Green Published, Green Submitted			2022-12-26	WOS:000377824800056
J	Wills, C; Harms, KE; Wiegand, T; Punchi-Manage, R; Gilbert, GS; Erickson, D; Kress, WJ; Hubbell, SP; Gunatilleke, CVS; Gunatilleke, IAUN				Wills, Christopher; Harms, Kyle E.; Wiegand, Thorsten; Punchi-Manage, Ruwan; Gilbert, Gregory S.; Erickson, David; Kress, W. John; Hubbell, Stephen P.; Gunatilleke, C. V. Savitri; Gunatilleke, I. A. U. Nimal			Persistence of Neighborhood Demographic Influences over Long Phylogenetic Distances May Help Drive Post-Speciation Adaptation in Tropical Forests	PLOS ONE			English	Article							DEPENDENT SEEDLING MORTALITY; NEGATIVE DENSITY-DEPENDENCE; NEOTROPICAL FOREST; RAIN-FOREST; REPRODUCTIVE ISOLATION; PLANT DIVERSITY; HABITAT ASSOCIATIONS; SPECIES COEXISTENCE; DIPTEROCARP FOREST; TREE RECRUITMENT	Studies of forest dynamics plots (FDPs) have revealed a variety of negative density-dependent (NDD) demographic interactions, especially among conspecific trees. These interactions can affect growth rate, recruitment and mortality, and they play a central role in the maintenance of species diversity in these complex ecosystems. Here we use an equal area annulus (EAA) point-pattern method to comprehensively analyze data from two tropical FDPs, Barro Colorado Island in Panama and Sinharaja in Sri Lanka. We show that these NDD interactions also influence the continued evolutionary diversification of even distantly related tree species in these FDPs. We examine the details of a wide range of these interactions between individual trees and the trees that surround them. All these interactions, and their cumulative effects, are strongest among conspecific focal and surrounding tree species in both FDPs. They diminish in magnitude with increasing phylogenetic distance between heterospecific focal and surrounding trees, but do not disappear or change the pattern of their dependence on size, density, frequency or physical distance even among the most distantly related trees. The phylogenetic persistence of all these effects provides evidence that interactions between tree species that share an ecosystem may continue to promote adaptive divergence even after the species' gene pools have become separated. Adaptive divergence among taxa would operate in stark contrast to an alternative possibility that has previously been suggested, that distantly related species with dispersal-limited distributions and confronted with unpredictable neighbors will tend to converge on common strategies of resource use. In addition, we have also uncovered a positive density-dependent effect: growth rates of large trees are boosted in the presence of a smaller basal area of surrounding trees. We also show that many of the NDD interactions switch sign rapidly as focal trees grow in size, and that their cumulative effect can strongly influence the distributions and species composition of the trees that surround the focal trees during the focal trees' lifetimes.	[Wills, Christopher] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA; [Harms, Kyle E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Wiegand, Thorsten] UFZ Helmholtz Ctr Environm Res GmbH UFZ, Dept Ecol Modeling, D-04318 Leipzig, Germany; [Wiegand, Thorsten] German Ctr Integrat Biodivers Res iDiv, Biodivers Synth, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Punchi-Manage, Ruwan] Univ Gottingen, Dept Ecosyst Modelling, Busgenweg 4, D-37077 Gottingen, Germany; [Gilbert, Gregory S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Gilbert, Gregory S.; Erickson, David; Kress, W. John; Hubbell, Stephen P.] Smithsonian Trop Res Inst, Balboa 084303092, Ancon, Panama; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Gunatilleke, C. V. Savitri; Gunatilleke, I. A. U. Nimal] Univ Peradeniya, Dept Bot, Fac Sci, Peradeniya 20400, Sri Lanka	University of California System; University of California San Diego; Louisiana State University System; Louisiana State University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles; University of Peradeniya	Wills, C (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA.	cwills@ucsd.edu	Wiegand, Thorsten/AAP-9709-2021; Wiegand, Thorsten/H-5877-2016	Wiegand, Thorsten/0000-0002-3721-2248; Wiegand, Thorsten/0000-0002-3721-2248; Punchi-Manage, Ruwan/0000-0002-4753-4996	ERC advanced grant [233066-SPATIODIVERSITY]; National Science Foundation; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; Direct For Biological Sciences [1545761, 1354741] Funding Source: National Science Foundation	ERC advanced grant(European Research Council (ERC)); National Science Foundation(National Science Foundation (NSF)); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Thorsten Wiegand and Ruwan Punchi-Manage acknowledge funding from ERC advanced grant 233066-SPATIODIVERSITY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge assistance from Cam Webb in the phylogenetic analysis, for the advice of Andreas Huth, Livio Fenga and Rick Condit, and for help in data analysis from Jerry Greenberg, Ron Hawkins and Paul Rodriguez of the San Diego Supercomputer Center. The detailed and constructive comments by reviewers of earlier versions of the manuscript were of great assistance in refining both the data analysis and its presentation. The BCI forest dynamics research project is supported by the National Science Foundation, the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation, the Small World Institute Fund, and numerous private individuals, and through the hard work of over 100 people from 10 countries over the past three decades. We thank the University of Peradeniya, Postgraduate Institute of Science and the Forest Department of Sri Lanka for administrative support, and the field staff who contributed to the censuses of the Sinharaja plot. These plot projects are part of the Center for Tropical Forest Science, a global network of large-scale demographic tree plots. BCI plot data are available from http://ctfs.arnarb.harvard.edu/webatlas/datasets/bci/. The Sinharaja Forest Monitoring Plot data belongs to the plot PIs and is managed by the CTFS-ForestGEO network. Data are available under request at http://ctfs.si.edu/Public/plotdataaccess/SiteDescription.php?plotname=sinharaja&typedata=tree. Thorsten Wiegand and Ruwan Punchi-Manage acknowledge funding from ERC advanced grant 233066-SPATIODIVERSITY. Programs for EAA analysis are available from C. Wills, cwills@ucsd.edu	Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; [Anonymous], 2004, TROPICAL FOREST DIVE; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bagchi R, 2010, ECOL LETT, V13, P1262, DOI 10.1111/j.1461-0248.2010.01520.x; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Canham CD, 2006, ECOL APPL, V16, P62, DOI 10.1890/04-0657; Chen YX, 2016, ECOLOGY, V97, P776, DOI 10.1890/15-0625.1; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1998, TROPICAL FOREST CENS; CONNELL J H, 1971, P298; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Danner JE, 2011, AM NAT, V178, P53, DOI 10.1086/660283; Diggle P., 2003, STAT ANAL SPATIAL PO; Ediriweera S, 2008, FOREST ECOL MANAG, V256, P1339, DOI 10.1016/j.foreco.2008.06.035; Endara MJ, 2015, J ECOL, V103, P1107, DOI 10.1111/1365-2745.12431; Fricke EC, 2014, ECOL LETT, V17, P593, DOI 10.1111/ele.12261; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilbert GS, 2012, EVOL APPL, V5, P869, DOI 10.1111/j.1752-4571.2012.00265.x; Green PT, 2014, P NATL ACAD SCI USA, V111, P18649, DOI 10.1073/pnas.1321892112; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell S.P., 1986, BIOL CHANCE HIST STR, P314; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Illian J, 2008, STAT ANAL MODELLING; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson DJ, 2014, ECOLOGY, V95, P2493, DOI 10.1890/13-2098.1; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Lebrija-Trejos E, 2014, ECOLOGY IN PRESS; Lebrija-Trejos E, 2014, ECOLOGY, V95, P940, DOI 10.1890/13-0623.1; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Marhaver KL, 2013, ECOLOGY, V94, P146, DOI 10.1890/12-0985.1; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Packer A, 2004, P ROY SOC B-BIOL SCI, V271, P317, DOI 10.1098/rspb.2003.2583; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; Paine CET, 2012, ECOL LETT, V15, P34, DOI 10.1111/j.1461-0248.2011.01705.x; Palma-Silva C, 2011, MOL ECOL, V20, P3185, DOI 10.1111/j.1365-294X.2011.05143.x; Parker IM, 2015, NATURE, V520, P542, DOI 10.1038/nature14372; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Punchi-Manage R, 2013, J ECOL, V101, P149, DOI 10.1111/1365-2745.12017; Rabosky DL, 2013, P NATL ACAD SCI USA, V110, P15354, DOI 10.1073/pnas.1305529110; SHELLY TE, 1985, OECOLOGIA, V67, P57, DOI 10.1007/BF00378452; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Surget-Groba Y, 2013, MOL ECOL, V22, P4931, DOI 10.1111/mec.12442; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Uriarte Maria, 2005, P89, DOI 10.1017/CBO9780511541971.005; Velho N, 2012, OECOLOGIA, V169, P995, DOI 10.1007/s00442-012-2252-9; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wendt T, 2008, PLANT SYST EVOL, V275, P31, DOI 10.1007/s00606-008-0054-7; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yamazaki M, 2009, PLANT ECOL, V201, P181, DOI 10.1007/s11258-008-9531-x; Zhu K, 2015, ECOLOGY, V96, P2319, DOI 10.1890/14-1780.1; Zhu Y, 2015, J ECOLOGY	72	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156913	10.1371/journal.pone.0156913	http://dx.doi.org/10.1371/journal.pone.0156913			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305092	Green Published, gold			2022-12-26	WOS:000377824800029
J	Byeon, B; Kovalchuk, I				Byeon, Boseon; Kovalchuk, Igor			Pattern Recognition on Read Positioning in Next Generation Sequencing	PLOS ONE			English	Article							ALIGNMENT; BIAS	The usefulness and the utility of the next generation sequencing (NGS) technology are based on the assumption that the DNA or cDNA cleavage required to generate short sequence reads is random. Several previous reports suggest the existence of sequencing bias of NGS reads. To address this question in greater detail, we analyze NGS data from four organisms with different GC content, Plasmodium falciparum (19.39%), Arabidopsis thaliana (36.03%), Homo sapiens (40.91%) and Streptomyces coelicolor (72.00%). Using machine learning techniques, we recognize the pattern that the NGS read start is positioned in the local region where the nucleotide distribution is dissimilar from the global nucleotide distribution. We also demonstrate that the mono-nucleotide distribution underestimates sequencing bias, and the recognized pattern is explained largely by the distribution of multi-nucleotides (di-, tri-, and tetra-nucleotides) rather than mono-nucleotides. This implies that the correction of sequencing bias needs to be performed on the basis of the multi-nucleotide distribution. Providing companion software to quantify the effect of the recognized pattern on read positioning, we exemplify that the bias correction based on the mono-nucleotide distribution may not be sufficient to clean sequencing bias.	[Byeon, Boseon; Kovalchuk, Igor] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Kovalchuk, I (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	igor.kovalchuk@uleth.ca			Natural Sciences and Engineering Research Council of Canada Discovery grant; NSERC Create grant	Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Create grant	This work was funded by a Natural Sciences and Engineering Research Council of Canada Discovery grant to IK and NSERC Create grant to BB.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Awad M., 2015, EFFICIENT LEARNING M, P67, DOI [10.1007/978-1-4302-5990-9, DOI 10.1007/978-1-4302-5990-9_4]; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bouckaert R., 2010, 1 U WAIK; Byeon B, 2010, P IASTED INT C COMP, P593; Darwiche A, 2009, MODELING AND REASONING WITH BAYESIAN NETWORKS, P1, DOI 10.1017/CBO9780511811357; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Gabadinho A, 2011, J STAT SOFTW, V40, P1; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Korpelainen E., 2014, RNA SEQ DATA ANAL PR; Kryukov K, 2012, GENOME BIOL EVOL, V4, P501, DOI 10.1093/gbe/evs026; Kubat M, 1997, P 14 INT C MACH LEAR, V97; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Mitchell T.M, 2003, MACH LEARN; Neapolitan RE, 2009, PROBABILISTIC METHODS FOR BIOINFORMATICS WITH AN INTRODUCTION TO BAYESIAN NETWORKS, P1; Pages H, BIOSTRINGS STRING OB; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Venables WN., 2002, MODERN APPL STAT S 4; Wang X., 2016, NEXT GENERATION SEQU; Witten IH, 2011, MOR KAUF D, P1; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	29	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157033	10.1371/journal.pone.0157033	http://dx.doi.org/10.1371/journal.pone.0157033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299343	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200024
J	Wei, Q; Wang, XC; Gao, J; Li, J; Li, J; Qi, CS; Li, YY; Li, ZW; Shen, L				Wei, Qing; Wang, Xicheng; Gao, Jing; Li, Jian; Li, Jie; Qi, Changsong; Li, Yanyan; Li, Zhongwu; Shen, Lin			Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component	PLOS ONE			English	Article							CARCINOMA; CANCER; COLON; SUSCEPTIBILITY; POLYPOSIS; SURVIVAL; MUTATION; CARRIERS; AGE	Background We performed a retrospective study to assess the clinicopathological characters, molecular alterations and multigene mutation profiles in colorectal cancer patients with signet-ring cell component. Methods Between November 2008 and January 2015, 61 consecutive primary colorectal carcinomas with signet-ring cell component were available for pathological confirmation. RAS/BRAF status was performed by direct sequencing. 14 genes associated with hereditary cancer syndromes were analyzed by targeted gene sequencing. Results A slight male predominance was detected in these patients (59.0%). Colorectal carcinomas with signet-ring cell component were well distributed along the large intestine. A frequently higher TNM stage at the time of diagnosis was observed, compared with the conventional adenocarcinoma. Family history of malignant tumor was remarkable with 49.2% in 61 cases. The median OS time of stage IV patients in our study was 14 months. RAS mutations were detected in 22.2% (12/54) cases with KRAS mutations in 16.7% (9/54) cases and Nras mutations in 5.4%(3/54) cases. BRAF V600E mutation was detected in 3.7% (2/54) cases. As an exploration, we analyzed 14 genes by targeted gene sequencing. These genes were selected based on their biological role in association with hereditary cancer syndromes. 79.6% cases carried at least one pathogenic mutation. Finally, the patients were classified by the percentage of signet-ring cell. 39 (63.9%) cases were composed of >= 50% signet-ring cells; 22 (36.1%) cases were composed of <50% signet-ring cells. Wecompared clinical parameters, molecular and genetic alterations between the two groups and found no significant differences. Conclusions Colorectal adenocarcinoma with signet-ring cell component is characterized by advanced stage at diagnosis with remarkable family history of malignant tumor. It is likely a negative prognostic factor and tends to affect male patients with low rates of RAS/BRAF mutation. Colorectal patients with any component of signet-ring cells, regardless of the extent, shared similar clinicopathological characteristics, molecular alterations and genetic profiles.	[Wei, Qing; Wang, Xicheng; Gao, Jing; Li, Jian; Li, Jie; Qi, Changsong; Li, Yanyan; Shen, Lin] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, Beijing 100871, Peoples R China; [Li, Zhongwu] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Shen, L (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, Beijing 100871, Peoples R China.; Li, ZW (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing 100871, Peoples R China.	zhwuli@hotmail.com; lin100@medmail.com.cn						Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Anthony T, 1996, ANN SURG ONCOL, V3, P344, DOI 10.1007/BF02305663; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; Borger ME, 2007, J PATHOL, V212, P278, DOI 10.1002/path.2181; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Burt R, 2005, GASTROENTEROLOGY, V128, P1696, DOI 10.1053/j.gastro.2005.03.036; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Kakar S, 2012, MODERN PATHOL, V25, P1040, DOI 10.1038/modpathol.2012.44; Kang HJ, 2005, DIS COLON RECTUM, V48, P1161, DOI 10.1007/s10350-004-0932-1; Lang K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-227; Lee S, 2008, PATHOL INT, V58, P104, DOI 10.1111/j.1440-1827.2007.02197.x; MALLORY SB, 1995, DERMATOL CLIN, V13, P27, DOI 10.1016/S0733-8635(18)30103-7; MESSERINI L, 1995, DIS COLON RECTUM, V38, P1189, DOI 10.1007/BF02048335; Mizushima T, 2010, SURG TODAY, V40, P234, DOI 10.1007/s00595-009-4057-y; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ooi BS, 2001, ANZ J SURG, V71, P703, DOI 10.1046/j.1445-1433.2001.02269.x; Pande R, 2008, DIS COLON RECTUM, V51, P50, DOI 10.1007/s10350-007-9073-7; Perea J, 2011, ANN SURG ONCOL, V18, P3285, DOI 10.1245/s10434-011-1782-4; Phelan CM, 2014, BRIT J CANCER, V110, P530, DOI 10.1038/bjc.2013.741; Psathakis D, 1999, DIS COLON RECTUM, V42, P1618, DOI 10.1007/BF02236218; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Rowley PT, 2005, ANNU REV MED, V56, P539, DOI 10.1146/annurev.med.56.061704.135235; Schreibman IR, 2005, AM J GASTROENTEROL, V100, P476, DOI 10.1111/j.1572-0241.2005.40237.x; Song W, 2009, CHINESE MED J-PEKING, V122, P1486, DOI 10.3760/cma.j.issn.0366-6999.2009.13.002; Stoffel EM, 2014, CLIN GASTROENTEROL H, V12, P1059, DOI 10.1016/j.cgh.2013.08.015; Sung CO, 2008, MODERN PATHOL, V21, P1533, DOI 10.1038/modpathol.2008.170; Tan Y, 2015, CHINA PLOS ONE, V10, DOI [10. 1371/ journal. pone. 0121944, DOI 10.1371/J0URNAL.P0NE.0121944]; Tung SY, 1996, AM J GASTROENTEROL, V91, P2195; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yanyan Li, 2016, CHIN CLIN ONCOL, V21, P27	36	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156659	10.1371/journal.pone.0156659	http://dx.doi.org/10.1371/journal.pone.0156659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300552	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200012
J	Sliwoski, G; Schubert, M; Stichel, J; Weaver, D; Beck-Sickinger, AG; Meiler, J				Sliwoski, Gregory; Schubert, Mario; Stichel, Jan; Weaver, David; Beck-Sickinger, Annette G.; Meiler, Jens			Discovery of Small-Molecule Modulators of the Human Y-4 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; PANCREATIC-POLYPEPTIDE; NEUROPEPTIDE-Y; FOOD-INTAKE; ALLOSTERIC MODULATION; BODY-WEIGHT; PEPTIDE YY; GUT HORMONES; CHALLENGES; BINDING	The human neuropeptide Y-4 receptor (Y4R) and its native ligand, pancreatic polypeptide, are critically involved in the regulation of human metabolism by signaling satiety and regulating food intake, as well as increasing energy expenditure. Thus, this receptor represents a putative target for treatment of obesity. With respect to new approaches to treat complex metabolic disorders, especially in multi-receptor systems, small molecule allosteric modulators have been in the focus of research in the last years. However, no positive allosteric modulators or agonists of the Y4R have been described so far. In this study, small molecule compounds derived from the Niclosamide scaffold were identified by high-throughput screening to increase Y4R activity. Compounds were characterized for their potency and their effects at the human Y4R and as well as their selectivity towards Y1R, Y2R and Y5R. These compounds provide a structure-activity relationship profile around this common scaffold and lay the groundwork for hit-to-lead optimization and characterization of positive allosteric modulators of the Y4R.	[Sliwoski, Gregory; Schubert, Mario; Stichel, Jan; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04109 Leipzig, Germany; [Sliwoski, Gregory; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN USA; [Weaver, David] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	Leipzig University; Vanderbilt University; Vanderbilt University	Beck-Sickinger, AG (corresponding author), Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04109 Leipzig, Germany.; Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN USA.	abeck-sickinger@uni-leipzig.de; jens@meilerlab.org		Schubert, Mario/0000-0002-8375-8233	National Institutes of Health [R01 DK097376]; Deutsche Forschungsgemeinschaft (DFG) [Be1264-16]; European Union; Free State of Saxony [100148835, 1423213128452]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; Division Of Chemistry [1305874] Funding Source: National Science Foundation; Office Of The Director [1157751] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); Free State of Saxony; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by National Institutes of Health [R01 DK097376 to JM], by the Deutsche Forschungsgemeinschaft (DFG) [Grant Be1264-16 to ABS], and by the European Union and the Free State of Saxony [Grants 100148835 and 1423213128452 to ABS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Asakawa A, 1999, PEPTIDES, V20, P1445, DOI 10.1016/S0196-9781(99)00155-2; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; BERNTSON GG, 1993, PEPTIDES, V14, P497, DOI 10.1016/0196-9781(93)90138-7; Brunicardi FC, 1996, J CLIN ENDOCR METAB, V81, P3566, DOI 10.1210/jc.81.10.3566; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; Cho HP, 2014, ACS CHEM BIOL, V9, P2334, DOI 10.1021/cb500560h; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; Cox HM, 2007, AUTON NEUROSCI-BASIC, V133, P76, DOI 10.1016/j.autneu.2006.10.005; Davey AE, 2012, ENDOCRINOLOGY, V153, P1232, DOI 10.1210/en.2011-1426; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Ershow Abby G, 2009, J Diabetes Sci Technol, V3, P727; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Heppner KM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00092; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Inui A, 2000, PHARMACOL REV, V52, P35; Jesudason DR, 2007, BRIT J NUTR, V97, P426, DOI 10.1017/S0007114507336799; Kaiser A, 2015, ANGEW CHEM INT EDIT, V54, P7446, DOI 10.1002/anie.201411688; Katsuura G, 2002, PEPTIDES, V23, P323, DOI 10.1016/S0196-9781(01)00604-0; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kissler HJ, 2013, SEMIN NEPHROL, V33, P75, DOI 10.1016/j.semnephrol.2012.12.004; Kojima S, 2007, PEPTIDES, V28, P459, DOI 10.1016/j.peptides.2006.09.024; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Made V, 2014, CHEMMEDCHEM, V9, P2463, DOI 10.1002/cmdc.201402235; Makris A, 2011, PSYCHIAT CLIN N AM, V34, P813, DOI 10.1016/j.psc.2011.08.004; Misra S, 2004, J PHARMACOL EXP THER, V311, P1154, DOI 10.1124/jpet.104.071415; Moreno-Herrera A, 2014, MINIREVIEWS MED CHEM; Pedragosa-Badia X, 2014, J BIOL CHEM, V289, P5846, DOI 10.1074/jbc.M113.502021; Pedragosa-Badia Xavier, 2013, Front Endocrinol (Lausanne), V4, P5, DOI 10.3389/fendo.2013.00005; Sato N, 2009, EXPERT OPIN THER PAT, V19, P1401, DOI 10.1517/13543770903251722; Seymour NE, 1996, J SURG RES, V65, P1, DOI 10.1006/jsre.1996.9999; Shonberg J, 2014, MED RES REV, V34, P1286, DOI 10.1002/med.21318; Smith BR, 2008, ENDOCRIN METAB CLIN, V37, P943, DOI 10.1016/j.ecl.2008.08.001; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Troke RC, 2014, THER ADV CHRONIC DIS, V5, P4, DOI 10.1177/2040622313506730; Ueno N, 1999, GASTROENTEROLOGY, V117, P1427, DOI 10.1016/S0016-5085(99)70293-3; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Yulyaningsih E, 2011, BRIT J PHARMACOL, V163, P1170, DOI 10.1111/j.1476-5381.2011.01363.x; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157146	10.1371/journal.pone.0157146	http://dx.doi.org/10.1371/journal.pone.0157146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294784	Green Submitted, gold, Green Published			2022-12-26	WOS:000377821300024
J	Asakawa-Haas, K; Schiestl, M; Bugnyar, T; Massen, JJM				Asakawa-Haas, Kenji; Schiestl, Martina; Bugnyar, Thomas; Massen, Jorg J. M.			Partner Choice in Raven (Corvus corax) Cooperation	PLOS ONE			English	Article							CHIMPANZEES; COGNITION; BEHAVIOR; FISH	Although social animals frequently make decisions about when or with whom to cooperate, little is known about the underlying mechanisms of partner choice. Most previous studies compared different dyads' performances, though did not allow an actual choice among partners. We tested eleven ravens, Corvus corax, in triads, giving them first the choice to cooperate with either a highly familiar or a rather unfamiliar partner and, second, with either a friend or a non-friend using a cooperative string-pulling task. In either test, the ravens had a second choice and could cooperate with the other partner, given that this one had not pulled the string in the meantime. We show that during the experiments, these partner ravens indeed learn to wait and inhibit pulling, respectively. Moreover, the results of these two experiments show that ravens' preferences for a specific cooperation partner are not based on familiarity. In contrast, the ravens did show a preference based on relationship quality, as they did choose to cooperate significantly more with friends than with non-friends and they were also more proficient when cooperating with a friend. In order to further identify the proximate mechanism of this preference, we designed an open-choice experiment for the whole group where all birds were free to cooperate on two separate apparatuses. This setup allowed us to distinguish between preferences for close proximity and preferences to cooperate. The results revealed that friends preferred staying close to each other, but did not necessarily cooperate with one another, suggesting that tolerance of proximity and not relationship quality as a whole may be the driving force behind partner choice in raven cooperation. Consequently, we stress the importance of experiments that allow such titrations and, suggest that these results have important implications for the interpretations of cooperation studies that did not include open partner choice.	[Asakawa-Haas, Kenji; Schiestl, Martina; Bugnyar, Thomas; Massen, Jorg J. M.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Schiestl, Martina; Bugnyar, Thomas] Univ Vienna, Haidlhof Res Stn, Bad Voslau, Austria; [Schiestl, Martina; Bugnyar, Thomas] Univ Vet Med Vienna, Bad Voslau, Austria	University of Vienna; University of Vienna	Massen, JJM (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	jorgmassen@gmail.com	Asakawa-Haas, Kenji/GQI-1119-2022; Massen, Jorg/F-1190-2011	Massen, Jorg/0000-0002-1630-9606	Stand-Alone grant of the Austrian Science Fund (FWF) [M 1351, P 26806]; Austrian Science Fund (FWF) [P 26806] Funding Source: researchfish	Stand-Alone grant of the Austrian Science Fund (FWF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was funded by a Lise Meitner- and a Stand-Alone grant of the Austrian Science Fund (FWF, grant nos: M 1351 & P 26806) to JJMM.; We thank the whole Haidlhof personnel for their help and especially Andras Peter for the technical support, and Kerstin Polzl and Judith Schmidt for their help with coding videos. We are grateful for comments and suggestions of Angel Sanchez and two anonymous reviewers to an earlier version of this paper. This research was funded by a Lise Meitner- and a Stand-Alone grant of the Austrian Science Fund (FWF, grant nrs.: M 1351 & P 26806) to JJMM.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BEDNARZ JC, 1988, SCIENCE, V239, P1525, DOI 10.1126/science.239.4847.1525; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Boeckle M, 2012, CURR BIOL, V22, P801, DOI 10.1016/j.cub.2012.03.023; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; BROWN JA, 1986, BEHAV ECOL SOCIOBIOL, V19, P373, DOI 10.1007/BF00295711; Bugnyar T, 2008, CURR BIOL, V18, pR530, DOI 10.1016/j.cub.2008.04.057; Bugnyar T, 2013, COMP COGN BEHAV REV, V8, P1, DOI 10.3819/ccbr.2013.80001; Chalmeau R, 1997, INT J PRIMATOL, V18, P23, DOI 10.1023/A:1026337006136; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Cronin KA, 2005, ANIM BEHAV, V69, P133, DOI 10.1016/j.anbehav.2004.02.024; de Waal FBM, 2003, NEUROPSYCHOLOGIA, V41, P221, DOI 10.1016/S0028-3932(02)00152-5; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; Drea CM, 2009, ANIM BEHAV, V78, P967, DOI 10.1016/j.anbehav.2009.06.030; DUGATKIN LA, 1992, ANIM BEHAV, V44, P223, DOI 10.1016/0003-3472(92)90028-8; Engelmann JM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2803; Fraser ON, 2012, ANIM BEHAV, V83, P171, DOI 10.1016/j.anbehav.2011.10.023; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Hammerstein P, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0101; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Hendricks P, 1998, CAN FIELD NAT, V112, P702; Hirata S., 2003, HATTATSU, V95, P103; Loretto MC, 2016, J ORNITHOL, V157, P439, DOI 10.1007/s10336-015-1289-z; MAGURRAN AE, 1994, J FISH BIOL, V45, P401, DOI 10.1111/j.1095-8649.1994.tb01322.x; Majolo B, 2006, BEHAVIOUR, V143, P1383, DOI 10.1163/156853906778987506; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; Massen JJM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15021; Massen JJM, 2014, CURR BIOL, V24, P2733, DOI 10.1016/j.cub.2014.09.073; Massen JJM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4679; Massen JJM, 2011, PRIMATES, V52, P237, DOI 10.1007/s10329-011-0244-8; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Molesti S, 2016, ANIM COGN, V19, P133, DOI 10.1007/s10071-015-0919-4; Ostojic L, 2014, ANIM COGN, V17, P445, DOI 10.1007/s10071-013-0676-1; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Schino G, GROOMING COALITIONS; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Schmelz M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0067; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; STANDER PE, 1992, BEHAV ECOL SOCIOBIOL, V29, P445; Suchak M, 2014, PEERJ, V2, DOI 10.7717/peerj.417; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vail AL, 2014, CURR BIOL, V24, pR791, DOI 10.1016/j.cub.2014.07.033; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; Werdenich D, 2002, ANIM BEHAV, V64, P771, DOI 10.1006/anbe.2002.9001	53	37	38	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156962	10.1371/journal.pone.0156962	http://dx.doi.org/10.1371/journal.pone.0156962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286247	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000033
J	Lester, J; Paige, S; Chapman, CA; Gibson, M; Jones, JH; Switzer, WM; Ting, N; Goldberg, TL; Frost, SDW				Lester, James; Paige, Sarah; Chapman, Colin A.; Gibson, Mhairi; Jones, James Holland; Switzer, William M.; Ting, Nelson; Goldberg, Tony L.; Frost, Simon D. W.			Assessing Commitment and Reporting Fidelity to a Text Message-Based Participatory Surveillance in Rural Western Uganda	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; DISEASE; HEALTH	Syndromic surveillance, the collection of symptom data from individuals prior to or in the absence of diagnosis, is used throughout the developed world to provide rapid indications of outbreaks and unusual patterns of disease. However, the low cost of syndromic surveillance also makes it highly attractive for the developing world. We present a case study of electronic participatory syndromic surveillance, using participant-mobile phones in a rural region of Western Uganda, which has a high infectious disease burden, and frequent local and regional outbreaks. Our platform uses text messages to encode a suite of symptoms, their associated durations, and household disease burden, and we explore the ability of participants to correctly encode their symptoms, with an average of 75.2% of symptom reports correctly formatted between the second and 11th reporting timeslots. Concomitantly we identify divisions between participants able to rapidly adjust to this unusually participatory style of data collection, and those few for whom the study proved more challenging. We then perform analyses of the resulting syndromic time series, examining the clustering of symptoms by time and household to identify patterns such as a tendency towards the within-household sharing of respiratory illness.	[Lester, James; Frost, Simon D. W.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Paige, Sarah; Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Paige, Sarah; Goldberg, Tony L.] Univ Wisconsin, Global Hlth Inst, Madison, WI USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Gibson, Mhairi] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Jones, James Holland] Stanford Univ, Woods Inst Environm, Dept Anthropol, Stanford, CA 94305 USA; [Switzer, William M.] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA; [Ting, Nelson] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA	University of Cambridge; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; McGill University; McGill University; Wildlife Conservation Society; University of Bristol; Stanford University; Centers for Disease Control & Prevention - USA; University of Oregon	Frost, SDW (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	sdf22@cam.ac.uk	Gibson, Mhairi A/D-4726-2009; Chapman, Colin/S-1911-2019; Frost, Simon/F-3648-2010	Gibson, Mhairi A/0000-0001-7963-4759; Chapman, Colin/0000-0002-8827-8140; Frost, Simon/0000-0002-5207-9879; Jones, James/0000-0003-1680-6757; Lester, James/0000-0002-4102-8662	National Institute of Health [TW009237]; UK Economic and Social Research Council [ES/J011266/1]; NIH as part of the joint NIH-NSF Ecology of Infectious Disease program [TW009237]; Economic and Social Research Council [ES/J011266/1, 1227381] Funding Source: researchfish; ESRC [ES/J011266/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R01TW009237] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NIH as part of the joint NIH-NSF Ecology of Infectious Disease program; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institute of Health grant TW009237 (http://www.nih.gov/, TG), and UK Economic and Social Research Council grant ES/J011266/1 (http://www.esrc.ac.uk/, MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant TW009237 as part of the joint NIH-NSF Ecology of Infectious Disease program and the UK Economic and Social Research Council (grant ES/J011266/1). We thank Annet Abwooki Nyamwija, Bashil Araali Musabe, and James Amooti Tuhaise for their field work, and Geoffrey Weny for his logistical assistance. We also thank two anonymous reviewers for their valuable comments. Use of trade names is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services, the Public Health Service, or the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention, or any of the authors' affiliated institutions.	Cayce R, 2014, INT J INTEGR PEDIAT, V1, P27, DOI DOI 10.6000/IJIPEM/2014/4; Centers for Disease Control and Prevention, 2013, PHIN MESS GUID SYNDR; Central Intelligence Agency, 2014, WORLD FACTB MAJ INF; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; Ciha M., GAMMU PROJECT; Cox J, 2007, EMERG INFECT DIS, V13, P779, DOI 10.3201/eid1305.061410; Drumright LN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0789-z; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goldberg T., KIBALE ECOHEALTH PRO; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; International Telecommunication Union, 2013, MEASURING INFORM SOC; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Lamunu M, 2004, INT J INFECT DIS, P1; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Mutebi JP, 2012, J MED ENTOMOL, V49, P1289, DOI 10.1603/ME12111; Organization WH, 2014, UG STAT SUMM 2002 PR; Paige SB, 2014, ECOHEALTH, V11, P534, DOI 10.1007/s10393-014-0942-y; Paterson BJ, 2012, GLOB PUBLIC HEALTH, V7, P682, DOI 10.1080/17441692.2012.699713; Rosewell A, 2013, EMERG INFECT DIS, V19, P1811, DOI 10.3201/eid1911.121843; Sawford K, 2012, J BIOTERRORISM BIODE, V01, P1; Shoemaker T, 2012, EMERG INFECT DIS, V18, P1480, DOI 10.3201/eid1809.111536; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; Tuarob S, 2014, J BIOMED INFORM, V49, P255, DOI 10.1016/j.jbi.2014.03.005; Uganda Bureau of Statistics (UBOS) ICF Macro, 2010, TECHNICAL REPORT; Uganda Communications Commission, 2013, TECHNICAL REPORT; Velardi P, 2014, ARTIF INTELL MED, V61, P153, DOI 10.1016/j.artmed.2014.01.002; Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525; Wojcik OP, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-7; Yan WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062749	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155971	10.1371/journal.pone.0155971	http://dx.doi.org/10.1371/journal.pone.0155971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281020	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000010
J	Narayanan, S; Nieh, AH; Kenwood, BM; Davis, CA; Tosello-Trampont, AC; Elich, TD; Breazeale, SD; Ward, E; Anderson, RJ; Caldwell, SH; Hoehn, KL; Hahn, YS				Narayanan, Sowmya; Nieh, Albert H.; Kenwood, Brandon M.; Davis, Christine A.; Tosello-Trampont, Annie-Carole; Elich, Tedd D.; Breazeale, Steven D.; Ward, Eric; Anderson, Richard J.; Caldwell, Stephen H.; Hoehn, Kyle L.; Hahn, Young S.			Distinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; FATTY-ACID SYNTHASE; CORE PROTEIN; HIGH-CARBOHYDRATE; RNA REPLICATION; PALMITOYLATION; HCV; TRIGLYCERIDE; METABOLISM; SOFOSBUVIR	Hepatitis C is a chronic liver disease that contributes to progressive metabolic dysfunction. Infection of hepatocytes by hepatitis C virus (HCV) results in reprogramming of hepatic and serum lipids. However, the specific contribution of these distinct pools of lipids to HCV infection remains ill defined. In this study, we investigated the role of hepatic lipogenesis in HCV infection by targeting the rate-limiting step in this pathway, which is catalyzed by the acetylCoA carboxylase (ACC) enzymes. Using two structurally unrelated ACC inhibitors, we determined that blockade of lipogenesis resulted in reduced viral replication, assembly, and release. Supplementing exogenous lipids to cells treated with ACC inhibitors rescued HCV assembly with no effect on viral replication and release. Intriguingly, loss of viral RNA was not recapitulated at the protein level and addition of 2-bromopalmitate, a competitive inhibitor of protein palmitoylation, mirrored the effects of ACC inhibitors on reduced viral RNA without a concurrent loss in protein expression. These correlative results suggest that newly synthesized lipids may have a role in protein palmitoylation during HCV infection.	[Narayanan, Sowmya; Nieh, Albert H.; Tosello-Trampont, Annie-Carole; Hahn, Young S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA USA; [Narayanan, Sowmya; Hahn, Young S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Kenwood, Brandon M.; Hoehn, Kyle L.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Davis, Christine A.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Elich, Tedd D.; Breazeale, Steven D.; Ward, Eric; Anderson, Richard J.] Cropsolution Inc, Morrisville, NY USA; [Caldwell, Stephen H.] Univ Virginia, Div Gastroenterol & Hepatol, Charlottesville, VA USA; [Kenwood, Brandon M.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Hoehn, Kyle L.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Virginia; University of Virginia; University of Virginia; University of Richmond; University of Virginia; University System of Georgia; Georgia Institute of Technology; University of New South Wales Sydney	Hahn, YS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA USA.; Hahn, YS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA.	ysh5e@virginia.edu		NARAYANAN, SOWMYA/0000-0002-0725-9731; Hoehn, Kyle/0000-0002-0214-3238	Cropsolution, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098126, T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK104562, R01DK101803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM007055] Funding Source: NIH RePORTER	Cropsolution, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Cropsolution, Inc. provided support in the form of the salaries for authors TDE, SDB, EW, and RJA, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anania VG, 2011, J VIROL, V85, P2288, DOI 10.1128/JVI.01961-10; Anderson R, 2012, MODULATORS ACETYLCOE; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Castera L, 2005, AM J GASTROENTEROL, V100, P711, DOI 10.1111/j.1572-0241.2005.40898.x; Castera L, 2004, GUT, V53, P420, DOI 10.1136/gut.2002.009936; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Chen SL, 2013, ELECTROPHORESIS, V34, P2848, DOI 10.1002/elps.201200629; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; DIENES HP, 1982, HEPATOLOGY, V2, P562; Diraison F, 1998, AM J PHYSIOL-ENDOC M, V274, pE321, DOI 10.1152/ajpendo.1998.274.2.E321; Elkrief L, 2014, HEPATOLOGY, V60, P823, DOI 10.1002/hep.27228; Etienne L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137182; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Fukasawa M, 2006, BIOL PHARM BULL, V29, P1958, DOI 10.1248/bpb.29.1958; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Lambert JE, 2013, HEPATOLOGY, V57, P1697, DOI 10.1002/hep.25990; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Liefhebber JMP, 2014, J BIOL CHEM, V289, P21276, DOI 10.1074/jbc.M114.582999; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Majeau N, 2009, J BIOL CHEM, V284, P33915, DOI 10.1074/jbc.M109.018549; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; MOENCH SJ, 1994, BIOCHEMISTRY-US, V33, P5783, DOI 10.1021/bi00185a016; Muir AJ, 2015, CLIN GASTROENTEROL H, V13, P2166, DOI 10.1016/j.cgh.2015.07.015; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Ng CG, 2008, P NATL ACAD SCI USA, V105, P16326, DOI 10.1073/pnas.0808720105; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Paul D, 2015, J GEN VIROL, V96, P1696, DOI 10.1099/vir.0.000111; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Singaravelu R, 2015, ACS INFECT DIS, V1, P130, DOI 10.1021/acsinfecdis.5b00019; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Taddeo EP, 2014, MOL METAB, V3, P124, DOI 10.1016/j.molmet.2013.11.003; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; VAHLENSIECK HF, 1994, CURR GENET, V25, P95, DOI 10.1007/BF00309532; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Visser BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-442; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang XF, 2011, J VIROL, V85, P5494, DOI 10.1128/JVI.02031-10; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011; Wei XC, 2011, J BIOL CHEM, V286, P2933, DOI 10.1074/jbc.M110.193037; Wu LY, 2014, METABOLISM, V63, P1469, DOI 10.1016/j.metabol.2014.08.010; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Yu GY, 2006, J VIROL, V80, P6013, DOI 10.1128/JVI.00053-06; Zhu YZ, 2012, VIROLOGY, V429, P112, DOI 10.1016/j.virol.2012.03.002	79	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156996	10.1371/journal.pone.0156996	http://dx.doi.org/10.1371/journal.pone.0156996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280294	gold, Green Submitted, Green Published			2022-12-26	WOS:000377563000063
J	Erickson, DL; Lew, CS; Kartchner, B; Porter, NT; McDaniel, SW; Jones, NM; Mason, S; Wu, E; Wilson, E				Erickson, David L.; Lew, Cynthia S.; Kartchner, Brittany; Porter, Nathan T.; McDaniel, S. Wade; Jones, Nathan M.; Mason, Sara; Wu, Erin; Wilson, Eric			Lipopolysaccharide Biosynthesis Genes of Yersinia pseudotuberculosis Promote Resistance to Antimicrobial Chemokines	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; SIGNATURE-TAGGED MUTAGENESIS; O-ANTIGEN; FUNCTIONAL-CHARACTERIZATION; TRANSPOSON MUTAGENESIS; CELL ACCUMULATION; MUCOSAL TISSUES; MAMMARY-GLAND; PESTIS; INFECTION	Antimicrobial chemokines (AMCs) are a recently described family of host defense peptides that play an important role in protecting a wide variety of organisms from bacterial infection. Very little is known about the bacterial targets of AMCs or factors that influence bacterial susceptibility to AMCs. In an effort to understand how bacterial pathogens resist killing by AMCs, we screened Yersinia pseudotuberculosis transposon mutants for those with increased binding to the AMCs CCL28 and CCL25. Mutants exhibiting increased binding to AMCs were subjected to AMC killing assays, which revealed their increased sensitivity to chemokine-mediated cell death. The majority of the mutants exhibiting increased binding to AMCs contained transposon insertions in genes related to lipopolysaccharide biosynthesis. A particularly strong effect on susceptibility to AMC mediated killing was observed by disruption of the hldD/waaF/waaC operon, necessary for ADP-L-glycero-D-manno-heptose synthesis and a complete lipopolysaccharide core oligosaccharide. Periodate oxidation of surface carbohydrates also enhanced AMC binding, whereas enzymatic removal of surface proteins significantly reduced binding. These results suggest that the structure of Y. pseudotuberculosis LPS greatly affects the antimicrobial activity of AMCs by shielding a protein ligand on the bacterial cell surface.	[Erickson, David L.; Lew, Cynthia S.; Kartchner, Brittany; Porter, Nathan T.; McDaniel, S. Wade; Jones, Nathan M.; Mason, Sara; Wu, Erin; Wilson, Eric] Brigham Young Univ, Dept Microbiol & Mol Biol, 4007 LSB, Provo, UT 84602 USA; [Porter, Nathan T.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Brigham Young University; University of Michigan System; University of Michigan	Erickson, DL (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, 4007 LSB, Provo, UT 84602 USA.	david_erickson@byu.edu	Porter, Nathan/AAV-9098-2020	Porter, Nathan/0000-0001-8523-6909; Erickson, David/0000-0001-6149-273X; Mason, Sara/0000-0002-0684-2714	NIH grant [R0102057]	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R0102057 to DLE and E. Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi KL, 2015, MICROBIOL-SGM, V161, P628, DOI 10.1099/mic.0.000018; Berri M, 2008, MOL IMMUNOL, V45, P271, DOI 10.1016/j.molimm.2007.04.026; Berri M, 2014, DEV COMP IMMUNOL, V44, P286, DOI 10.1016/j.dci.2014.01.005; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; Dai C, 2015, J IMMUNOL, V194, P5980, DOI 10.4049/jimmunol.1402634; Dentovskaya SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P808, DOI 10.1134/S0006297911070121; Distelhorst K, 2010, VET IMMUNOL IMMUNOP, V138, P134, DOI 10.1016/j.vetimm.2010.07.008; Durand EA, 2010, CELL MICROBIOL, V12, P1064, DOI 10.1111/j.1462-5822.2010.01451.x; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Felek S, 2010, INFECT IMMUN, V78, P1163, DOI 10.1128/IAI.00997-09; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Guo JT, 2011, MICROB PATHOGENESIS, V51, P121, DOI 10.1016/j.micpath.2011.04.010; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Ho N, 2008, MOL MICROBIOL, V68, P424, DOI 10.1111/j.1365-2958.2008.06163.x; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Karlyshev AV, 2001, INFECT IMMUN, V69, P7810, DOI 10.1128/IAI.69.12.7810-7819.2001; Kiljunen S, 2011, J BACTERIOL, V193, P4963, DOI 10.1128/JB.00339-11; Klein KA, 2012, J BACTERIOL, V194, P653, DOI 10.1128/JB.06237-11; Knirel YA, 2008, ADV SCI LETT, V1, P192, DOI 10.1166/asl.2008.020; Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Langereis JD, 2014, MBIO, V5, DOI 10.1128/mBio.01478-14; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Liu B, 2010, EUR J IMMUNOL, V40, P186, DOI 10.1002/eji.200939819; Logsdon LK, 2006, INFECT IMMUN, V74, P1516, DOI 10.1128/IAI.74.3.1516-1527.2006; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2157, DOI 10.1007/s00018-011-0709-3; Marceau M, 2004, MICROBIOL-SGM, V150, P3947, DOI 10.1099/mic.0.27426-0; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; Morteau O, 2008, J IMMUNOL, V181, P6309, DOI 10.4049/jimmunol.181.9.6309; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Otvos L, 2005, J PEPT SCI, V11, P697, DOI 10.1002/psc.698; Pallister KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138084; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Prior JL, 2001, FEMS MICROBIOL LETT, V197, P229, DOI 10.1111/j.1574-6968.2001.tb10608.x; QADRI F, 1988, J CLIN MICROBIOL, V26, P1343, DOI 10.1128/JCM.26.7.1343-1348.1988; Rebeil R, 2006, J BACTERIOL, V188, P1381, DOI 10.1128/JB.188.4.1381-1388.2006; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Reid-Yu SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004648; Reines M, 2012, J BACTERIOL, V194, P3173, DOI 10.1128/JB.00308-12; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	54	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157092	10.1371/journal.pone.0157092	http://dx.doi.org/10.1371/journal.pone.0157092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275606	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700068
J	Modur, V; Joshi, P; Nie, DT; Robbins, KT; Khan, AU; Rao, K				Modur, Vishnu; Joshi, Pooja; Nie, Daotai; Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna			CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; PROGNOSTIC MARKER; POOR-PROGNOSIS; OVARIAN-CANCER; IDENTIFICATION	Platinum-based therapy is most often used to treat advanced cases of head and neck cancers, but only a small fraction of the patient population responds to cisplatin, with a median survival time of less than a year. Although gene signatures and molecular etiology of head and neck cancers have been previously described, none of them are predictive indicators of cisplatin treatment response in particular. Therefore, currently, there is a lack of clinically employable predictive indicators of the disease beyond HPV status to specifically predict patients' response to platinum-based therapy. It beckons a substantial effort to look for predictive indicators of cisplatin treatment response. In this regard, CD24 expression level appears to be a significant molecular phenotype of cisplatin-resistant residual cells in laryngeal carcinoma lines. CD24 expression level directly affects cisplatin sensitivity and affects the expression of critical apoptotic, stem and drug resistance genes. A relatively small retrospective patient tumor analysis suggests that CD24 high tumors go on to show an unfavorable response to cisplatin treatment. Overall, based on the strength of further analysis, CD24 presents a strong rationale to be utilized as a predictive indicator to stratify head and neck cancer patients for platinum-based therapy. It also provides a rationale for using CD24 as a therapeutic adjuvant target along with standard cisplatin therapy.	[Modur, Vishnu; Joshi, Pooja; Nie, Daotai; Rao, Krishna] SIU, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA; [Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna] SIU, Div Hematol & Oncol, Dept Internal Med, Springfield, IL 62794 USA; [Robbins, K. Thomas; Khan, Aziz U.] SIU, Dept ENT Otolaryngol, Springfield, IL 62794 USA; [Nie, Daotai; Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna] So Illinois Univ, Sch Med, Springfield, IL USA; [Nie, Daotai; Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna] SIU, Simmons Canc Inst, POB 19678, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Rao, K (corresponding author), SIU, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA.; Rao, K (corresponding author), SIU, Div Hematol & Oncol, Dept Internal Med, Springfield, IL 62794 USA.; Rao, K (corresponding author), So Illinois Univ, Sch Med, Springfield, IL USA.; Rao, K (corresponding author), SIU, Simmons Canc Inst, POB 19678, Springfield, IL 62794 USA.	krao@siumed.edu			SCI Chair in Oncology Fund	SCI Chair in Oncology Fund	Funding was received from the SCI Chair in Oncology Fund.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Brockstein BE, 2011, DRUGS, V71, P1551, DOI 10.2165/11592540-000000000-00000; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gourin CG, 2006, LARYNGOSCOPE, V116, P1093, DOI 10.1097/01.mlg.0000224939.61503.83; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Johnsson A, 2000, BRIT J CANCER, V83, P1047, DOI 10.1054/bjoc.2000.1420; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kristiansen G, 2004, PROSTATE, V58, P183, DOI 10.1002/pros.10324; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Lee HJ, 2010, J THORAC ONCOL, V5, P649, DOI 10.1097/JTO.0b013e3181d5e554; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; PIRRUCCELLO SJ, 1986, J IMMUNOL, V136, P3779; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Shi Y, 2012, ORL-J OTO-RHIN-LARYN, V74, P78, DOI 10.1159/000335584; Surowiak P, 2006, ANTICANCER RES, V26, P629; Wang M, 2011, INT J CANCER, V128, P72, DOI 10.1002/ijc.25317; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156651	10.1371/journal.pone.0156651	http://dx.doi.org/10.1371/journal.pone.0156651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276062	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700031
J	Salim, T; Sershen, CL; May, EE				Salim, Taha; Sershen, Cheryl L.; May, Elebeoba E.			Investigating the Role of TNF-alpha and IFN-gamma Activation on the Dynamics of iNOS Gene Expression in LPS Stimulated Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; HIGH-AFFINITY RECEPTOR; INTERFERON-GAMMA; KAPPA-B; CYTOKINE PRODUCTION; T-CELLS; PERITONEAL-MACROPHAGES; TRANSCRIPTION FACTORS; PRIMED MACROPHAGES	Macrophage produced inducible nitric oxide synthase (iNOS) is known to play a critical role in the proinflammatory response against intracellular pathogens by promoting the generation of bactericidal reactive nitrogen species. Robust and timely production of nitric oxide (NO) by iNOS and analogous production of reactive oxygen species are critical components of an effective immune response. In addition to pathogen associated lipopolysaccharides (LPS), iNOS gene expression is dependent on numerous proinflammatory cytokines in the cellular microenvironment of the macrophage, two of which include interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha). To understand the synergistic effect of IFN-gamma and TNF-alpha activation, and LPS stimulation on iNOS expression dynamics and NO production, we developed a systems biology based mathematical model. Using our model, we investigated the impact of pre-infection cytokine exposure, or priming, on the system. We explored the essentiality of IFN-gamma priming to the robustness of initial proinflammatory response with respect to the ability of macrophages to produce reactive species needed for pathogen clearance. Results from our theoretical studies indicated that IFN-gamma and subsequent activation of IRF1 are essential in consequential production of iNOS upon LPS stimulation. We showed that IFN-gamma priming at low concentrations greatly increases the effector response of macrophages against intracellular pathogens. Ultimately the model demonstrated that although TNF-alpha contributed towards a more rapid response time, measured as time to reach maximum iNOS production, IFN-gamma stimulation was significantly more significant in terms of the maximum expression of iNOS and the concentration of NO produced.	[Salim, Taha; Sershen, Cheryl L.; May, Elebeoba E.] Univ Houston, Dept Biomed Engn, Houston, TX USA	University of Houston System; University of Houston	May, EE (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX USA.	eemay@central.uh.edu			Defense Threat Reduction Agency grant [FA8650-10-2-6062, 2381]; Sandia National Laboratories' Laboratory Directed Research and Development grant [151348]	Defense Threat Reduction Agency grant(United States Department of DefenseDefense Threat Reduction Agency); Sandia National Laboratories' Laboratory Directed Research and Development grant	Research supported in part by Defense Threat Reduction Agency grant# FA8650-10-2-6062 subaward #2381 to EEM and Sandia National Laboratories' Laboratory Directed Research and Development grant #151348 to EEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2014, MULTILEVEL PARALLEL; Afford SC, 1998, J PATHOL, V186, P82, DOI 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D; Ahlers JD, 2001, INT IMMUNOL, V13, P897, DOI 10.1093/intimm/13.7.897; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Aksan I, 2003, J RECEPT SIG TRANSD, V23, P197, DOI 10.1081/RRS-120025203; Arroyo-Espliguero R, 2004, HEART, V90, P983, DOI 10.1136/hrt.2002.001297; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Bartee E, 2013, CYTOKINE, V63, P237, DOI 10.1016/j.cyto.2013.04.036; Bedoui Sammy, 2005, J Inflamm (Lond), V2, P2, DOI 10.1186/1476-9255-2-2; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bocek P, 2004, J EXP MED, V199, P1619, DOI 10.1084/jem.20032014; Bokhari SM, 2008, INFECT IMMUN, V76, P1379, DOI 10.1128/IAI.00745-07; Butchar JP, 2008, FEBS LETT, V582, P1044, DOI 10.1016/j.febslet.2008.02.058; Casals-Casas C, 2009, EUR J IMMUNOL, V39, P1902, DOI 10.1002/eji.200839037; Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Conradi C, 2012, J MATH BIOL, V65, P107, DOI 10.1007/s00285-011-0453-1; DAMAS P, 1989, CRIT CARE MED, V17, P975, DOI 10.1097/00003246-198910000-00001; De Lean A, KINETICS COOPERATIVE; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Frigo DE, 2004, CARCINOGENESIS, V25, P249, DOI 10.1093/carcin/bgh009; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Guo H, 2008, J BIOL CHEM, V283, P25209, DOI 10.1074/jbc.M804062200; Gutierrez J, 2010, THEORETICAL BIOL MED; Gutierrez J, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-7; Haldorsen Helge H., 1990, STOCHASTIC MODELING, V42; HAN JH, 1994, J BIOL CHEM, V269, P8172; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; HAYES MP, 1995, CYTOKINE, V7, P427, DOI 10.1006/cyto.1995.0058; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Herman Friedman, 2012, MICROBIAL INFECT ROL; Hirata N, 2008, MOL IMMUNOL, V45, P2734, DOI 10.1016/j.molimm.2008.02.010; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu XY, 2005, J IMMUNOL, V175, P3637, DOI 10.4049/jimmunol.175.6.3637; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jablonska E, 2002, MELANOMA RES, V12, P123; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Klipp E, 2009, SYSTEMS BIOL; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kwon H, 2001, EUR J BIOCHEM, V268, P565, DOI 10.1046/j.1432-1327.2001.01897.x; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Bedran TBL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106766; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Mustafa SB, 1998, J BIOL CHEM, V273, P5073, DOI 10.1074/jbc.273.9.5073; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; Nelson G, 2002, J CELL SCI, V115, P1137; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Procyk KJ, 2000, BLOOD, V96, P2592; Quaiser T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-30; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; REIN T, 1994, NUCLEIC ACIDS RES, V22, P3033, DOI 10.1093/nar/22.15.3033; RENIER G, 1994, J LIPID RES, V35, P1413; Robert-Gangneux F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033413; Ryser S, 2004, BIOCHEM J, V378, P473, DOI 10.1042/BJ20031022; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schoffelen T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00093; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seguin R, 1997, INFECT IMMUN, V65, P2522; Sharp GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070180; Shin HJ, 2007, MOL CELLS, V24, P119; SODHI A, 1992, CLIN EXP IMMUNOL, V88, P350; Tan RST, 2013, IMMUNOL CELL BIOL, V91, P377, DOI 10.1038/icb.2013.13; Taniguchi S, 1997, EXP HEMATOL, V25, P193; ten Hagen TL, 1998, LIVER, V18, P299; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; UTSUMI T, 1992, ARCH BIOCHEM BIOPHYS, V294, P271, DOI 10.1016/0003-9861(92)90168-V; VANLOON APGM, 1991, J LEUKOCYTE BIOL, V49, P462, DOI 10.1002/jlb.49.5.462; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; WILLIAMS JG, 1992, J LEUKOCYTE BIOL, V52, P579, DOI 10.1002/jlb.52.6.579; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5; Yoon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004560; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511	94	93	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0153289	10.1371/journal.pone.0153289	http://dx.doi.org/10.1371/journal.pone.0153289			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276061	gold, Green Published			2022-12-26	WOS:000377561700002
J	Wei, HM; Lin, LC; Wang, CF; Lee, YJ; Chen, YT; Liao, YD				Wei, Hung-Mu; Lin, Li-Chih; Wang, Chiu-Feng; Lee, Yi-Jang; Chen, Yuan-Tsong; Liao, You-Di			Antimicrobial Properties of an Immunomodulator-15 kDa Human Granulysin	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; MEMBRANE-PERMEABILITY; PROTEINS; EXPRESSION; MECHANISM; MOLECULE; CELLS; TRANSPLANTATION; HYDROPHOBICITY; DIVERSITY	Granulysin, a cationic protein expressed by human natural killer cells and cytotoxic T lymphocytes, is a mediator for drug-induced Stevens-Johnson syndrome and graft-versus-host disease. Some 15 kDa granulysin are processed into 9 kDa forms and sequestered in cytolytic granules, while others are constitutively secreted into body fluids. Both 9 and 15 kDa granulysin have been shown to be a serum marker for cell-mediated immunity. Furthermore, 15 kDa is able to activate monocyte differentiation. However, its antimicrobial properties have not been clearly addressed. Here, we report a novel method to prepare both the soluble 9 and 15 kDa granulysin and show that the 15 kDa form is more effective than the 9 kDa form in exerting specific antimicrobial activity against Pseudomonas aeruginosa within a range of few micromolars. We also show that the 15 kDa granulysin is able to hyperpolarize the membrane potential and increase membrane permeability of treated bacteria. Interestingly, the bactericidal activity and membrane permeability of the granulysins were markedly reduced at lower pH (pH 5.4) as a result of probable increase in hydrophobicity of the granulysins. Additionally, we've also shown the granulysin to inhibit biofilm formation by P. aeruginosa. These results suggest that the 15 kDa granulysin exhibits a novel mechanism in bacteria killing in a way that's different from most antimicrobial peptides. Our novel granulysin preparation methodology will be useful for further study of action mechanisms of other antimicrobial, cytotoxic and immunomodulating properties in granulysin-mediated diseases.	[Wei, Hung-Mu; Lee, Yi-Jang] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lin, Li-Chih; Wang, Chiu-Feng; Liao, You-Di] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Wei, Hung-Mu; Liao, You-Di] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Wei, Hung-Mu; Liao, You-Di] Acad Sinica, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Liao, YD (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.; Liao, YD (corresponding author), Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan.; Liao, YD (corresponding author), Acad Sinica, Taipei, Taiwan.	ydliao@ibms.sinica.edu.tw	Liao, You-Di/S-7018-2018	Liao, You-Di/0000-0001-5527-4736	Academia Sinica Thematic Research Program [AS-102-TP-B04]; Ministry of Science and Technology, Taiwan [104-0210-01-09-02]; Academia Sinica, Taiwan	Academia Sinica Thematic Research Program(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by a grant from the Academia Sinica Thematic Research Program (AS-102-TP-B04), and funds from Academia Sinica and Ministry of Science and Technology (104-0210-01-09-02), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; [Anonymous], 2011, TXB MED PHYSL; Ashokkumar C, 2011, AM J PATHOL, V179, P1929, DOI 10.1016/j.ajpath.2011.06.040; Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chang TW, 2015, ANTIMICROB AGENTS CH, V59, P6210, DOI 10.1128/AAC.01406-15; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; Chen HL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003425; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Clayberger C, 2012, J IMMUNOL, V188, P6119, DOI 10.4049/jimmunol.1200570; Deng AM, 2005, J IMMUNOL, V174, P5243, DOI 10.4049/jimmunol.174.9.5243; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Finn MW, 2011, PROTEIN EXPRES PURIF, V75, P70, DOI 10.1016/j.pep.2010.07.009; Gammon K, 2014, NATURE, V509, pS10, DOI 10.1038/509S10a; Guo YG, 2013, APPL MICROBIOL BIOT, V97, P7669, DOI 10.1007/s00253-012-4602-2; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Kaspar AA, 2001, J IMMUNOL, V167, P350, DOI 10.4049/jimmunol.167.1.350; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Krensky AM, 2005, AM J TRANSPLANT, V5, P1789, DOI 10.1111/j.1600-6143.2005.00970.x; Nagasawa M, 2006, AM J HEMATOL, V81, P340, DOI 10.1002/ajh.20570; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Okada S, 2003, J IMMUNOL, V171, P2556, DOI 10.4049/jimmunol.171.5.2556; Pardo J, 2001, J IMMUNOL, V167, P1222, DOI 10.4049/jimmunol.167.3.1222; Pena S V, 1997, Semin Immunol, V9, P117, DOI 10.1006/smim.1997.0061; Pena SV, 1997, J IMMUNOL, V158, P2680; Rasamiravaka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132791; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Saini RV, 2011, J IMMUNOL, V186, P3497, DOI 10.4049/jimmunol.1003409; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Sarwal MM, 2001, HUM IMMUNOL, V62, P21, DOI 10.1016/S0198-8859(00)00228-7; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Vanhauteghem D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060328; Wang Z, 2000, J IMMUNOL, V165, P1486, DOI 10.4049/jimmunol.165.3.1486; Waugh A, 2010, ROSS WILSON ANATOMY; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502; Zhu X, 2015, ANTIMICROB AGENTS CH, V59, P3008, DOI 10.1128/AAC.04830-14	50	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156321	10.1371/journal.pone.0156321	http://dx.doi.org/10.1371/journal.pone.0156321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276051	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700023
J	Kanzi, AM; Wingfield, BD; Steenkamp, ET; Naidoo, S; van der Merwe, NA				Kanzi, Aquillah Mumo; Wingfield, Brenda Diana; Steenkamp, Emma Theodora; Naidoo, Sanushka; van der Merwe, Nicolaas Albertus			Intron Derived Size Polymorphism in the Mitochondrial Genomes of Closely Related Chrysoporthe Species	PLOS ONE			English	Article							HOMING ENDONUCLEASE GENES; OPHIOSTOMA-NOVO-ULMI; ELM DISEASE FUNGUS; OPEN READING FRAME; GROUP-II INTRONS; CRYPHONECTRIA-CUBENSIS; FUSARIUM-OXYSPORUM; EVOLUTION; SEQUENCES; EUCALYPTUS	In this study, the complete mitochondrial (mt) genomes of Chrysoporthe austroafricana (190,834 bp), C. cubensis (89,084 bp) and C. deuterocubensis (124,412 bp) were determined. Additionally, the mitochondrial genome of another member of the Cryphonectriaceae, namely Cryphonectria parasitica (158,902 bp), was retrieved and annotated for comparative purposes. These genomes showed high levels of synteny, especially in regions including genes involved in oxidative phosphorylation and electron transfer, unique open reading frames (uORFs), ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs), as well as intron positions. Comparative analyses revealed signatures of duplication events, intron number and length variation, and varying intronic ORFs which highlighted the genetic diversity of mt genomes among the Cryphonectriaceae. These mt genomes showed remarkable size polymorphism. The size polymorphism in the mt genomes of these closely related Chrysoporthe species was attributed to the varying number and length of introns, coding sequences and to a lesser extent, intergenic sequences. Compared to publicly available fungal mt genomes, the C. austroafricana mt genome is the second largest in the Ascomycetes thus far.	[Kanzi, Aquillah Mumo; Wingfield, Brenda Diana; Naidoo, Sanushka; van der Merwe, Nicolaas Albertus] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag x20, ZA-0028 Pretoria, South Africa; [Steenkamp, Emma Theodora] Univ Pretoria, Dept Microbiol & Plant Pathol, Forestry & Agr Biotechnol Inst, Private Bag x20, ZA-0028 Pretoria, South Africa	University of Pretoria; University of Pretoria	van der Merwe, NA (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag x20, ZA-0028 Pretoria, South Africa.	albe.vdmerwe@up.ac.za	Van der Merwe, Nicolaas A/A-9096-2008; Naidoo, Sanushka/B-2844-2010; Wingfield, Brenda D./B-1376-2008; Steenkamp, Emma T/B-7958-2009	Wingfield, Brenda D./0000-0002-6189-1519; Steenkamp, Emma T/0000-0003-0217-8219; van der Merwe, Albe/0000-0003-3185-348X; Kanzi, Aquillah/0000-0001-6081-9438	Genomics Research Institute (GRI) University of Pretoria; University of Pretoria Research Development Programme; DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria); National Research Foundation (NRF) [87332]	Genomics Research Institute (GRI) University of Pretoria; University of Pretoria Research Development Programme; DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria); National Research Foundation (NRF)	This work was co-funded by the Genomics Research Institute (GRI) University of Pretoria, the University of Pretoria Research Development Programme, the DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria), and the National Research Foundation (NRF) (grant number 87332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was co-funded by the Genomics Research Institute (GRI) University of Pretoria, the University of Pretoria Research Development Programme, the DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria), and the National Research Foundation (NRF) (Grant number 87332).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Al-Reedy RM, 2012, FUNGAL GENET BIOL, V49, P2, DOI 10.1016/j.fgb.2011.11.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2015, IMA FUNGUS, V6, P493, DOI 10.5598/imafungus.2015.06.02.13; [Anonymous], WROTE PAPER AMK BDW; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Beaudet D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060768; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bullerwell CE, 2004, CURR OPIN MICROBIOL, V7, P528, DOI 10.1016/j.mib.2004.08.008; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Capella- Gutierrez S., 2009, BIOINFORMATICS, V25; Chungu D, 2010, MYCOL PROG, V9, P379, DOI 10.1007/s11557-009-0646-9; Cole TE, 2000, VIROLOGY, V268, P239, DOI 10.1006/viro.1999.0097; Cunnington JH, 2009, SYDOWIA, V61, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ferandon C, 2013, FUNGAL GENET BIOL, V55, P85, DOI 10.1016/j.fgb.2013.01.009; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Fourie G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-605; Gilmore SR, 2009, MOL ECOL RESOUR, V9, P90, DOI 10.1111/j.1755-0998.2009.02636.x; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gryzenhout M, 2006, MYCOLOGIA, V98, P239, DOI 10.3852/mycologia.98.2.239; Gryzenhout M, 2005, FUNGAL DIVERS, V20, P39; Gryzenhout M, 2004, STUD MYCOL, P119; Gryzenhout M, 2006, MYCOL RES, V110, P833, DOI 10.1016/j.mycres.2006.02.010; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Hausner G, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 3, P101; Hausner G, 1999, CURR GENET, V35, P109, DOI 10.1007/s002940050439; Hausner G, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P329, DOI 10.1007/978-3-642-22380-8_13; Himmelstrand K, 2014, CURR GENET, V60, P303, DOI 10.1007/s00294-014-0436-z; HODGES C S, 1976, Fitopatologia Brasileira, V1, P129; HODGES CS, 1979, PLANT DIS REP, V63, P216; Hong YG, 1999, VIROLOGY, V258, P118, DOI 10.1006/viro.1999.9691; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kouvelis VN, 2008, MYCOL RES, V112, P829, DOI 10.1016/j.mycres.2008.01.016; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lin RM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0341-8; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; Mardanov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107536; Monteiro-Vitorello CB, 2009, FUNGAL GENET BIOL, V46, P837, DOI 10.1016/j.fgb.2009.07.005; Myburg H, 2002, CAN J BOT, V80, P590, DOI [10.1139/b02-039, 10.1139/B02-039]; Pantou MP, 2008, GENE, V419, P7, DOI 10.1016/j.gene.2008.04.009; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Pramateftaki PV, 2006, PLOS ONE; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Salavirta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097141; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Shimko N, 2001, NUCLEIC ACIDS RES, V29, P128, DOI 10.1093/nar/29.1.128; Stamatakis A, 2014, BIOINFORMATICS; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stone CL, 2010, MYCOLOGIA, V102, P887, DOI 10.3852/09-198; Torriani SFF, 2014, FUNGAL GENET BIOL, V62, P34, DOI 10.1016/j.fgb.2013.11.001; Tuller T, 2011, NUCL ACIDS RES; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; Van der Merwe NA, 2010, FUNGAL BIOL-UK, V114, P966, DOI 10.1016/j.funbio.2010.09.007; Wingfield BD, 2015, IMA FUNGUS, V6, P233, DOI 10.5598/imafungus.2015.06.01.15; WINGFIELD M J, 1989, Phytophylactica, V21, P311; Wu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-238; Yin LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049096; Youssar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074792	71	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156104	10.1371/journal.pone.0156104	http://dx.doi.org/10.1371/journal.pone.0156104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27272523	Green Submitted, Green Published, gold			2022-12-26	WOS:000377560200005
J	Hershey, DM; Browne, PJ; Iavarone, AT; Teyra, J; Lee, EH; Sidhu, SS; Komeili, A				Hershey, David M.; Browne, Patrick J.; Iavarone, Anthony T.; Teyra, Joan; Lee, Eun H.; Sidhu, Sachdev S.; Komeili, Arash			Magnetite Biomineralization in Magnetospirillum magneticum Is Regulated by a Switch-like Behavior in the HtrA Protease MamE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; biomineralization; iron; metal; serine protease; HtrA protease; MamE; magnetite; magnetosome; magnetotactic bacteria	PDZ DOMAINS; SUBSTRATE-SPECIFICITY; FUNCTIONAL-ANALYSIS; GENETIC DISSECTION; CRYSTAL-STRUCTURE; STRESS SENSOR; DEGS; REVEALS; MAGNETOCHROME; PROTEOLYSIS	Magnetotactic bacteria are aquatic organisms that produce subcellular magnetic particles in order to orient in the earth's geomagnetic field. MamE, a predicted HtrA protease required to produce magnetite crystals in the magnetotactic bacterium Magnetospirillum magneticum AMB-1, was recently shown to promote the proteolytic processing of itself and two other biomineralization factors in vivo. Here, we have analyzed the in vivo processing patterns of three proteolytic targets and used this information to reconstitute proteolysis with a purified form of MamE. MamE cleaves a custom peptide substrate with positive cooperativity, and its autoproteolysis can be stimulated with exogenous substrates or peptides that bind to either of its PDZ domains. A misregulated form of the protease that circumvents specific genetic requirements for proteolysis causes biomineralization defects, showing that proper regulation of its activity is required during magnetite biosynthesis in vivo. Our results represent the first reconstitution of the proteolytic activity of MamE and show that its behavior is consistent with the previously proposed checkpoint model for biomineralization.	[Hershey, David M.; Browne, Patrick J.; Komeili, Arash] Univ Calif Berkeley, Dept Plant & Microbial Biol, 261 Koshland Hall, Berkeley, CA 94720 USA; [Lee, Eun H.; Komeili, Arash] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Iavarone, Anthony T.; Komeili, Arash] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; [Teyra, Joan; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Terrance Donnelly Ctr Cellular & Biomed Res, Toronto, ON M5S 3E1, Canada	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Toronto	Komeili, A (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 261 Koshland Hall, Berkeley, CA 94720 USA.	komeili@berkeley.edu	Hamid Reza, Komeili/A-7818-2017	Hamid Reza, Komeili/0000-0002-6665-6462	National Institutes of Health [1S10OD020062-01]; Direct For Mathematical & Physical Scien [1504681] Funding Source: National Science Foundation; Division Of Physics [1504610] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084122] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The QB3/Chemistry Mass Spectrometry Facility at the University of California (Berkeley, CA) is supported by National Institutes of Health Grant 1S10OD020062-01.	Arita Y, 2016, BIOCHEM BIOPH RES CO, V473, P370, DOI 10.1016/j.bbrc.2016.01.050; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; BALKWILL DL, 1980, J BACTERIOL, V141, P1399, DOI 10.1128/JB.141.3.1399-1408.1980; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Cornejo E, 2016, MBIO, V7, DOI 10.1128/mBio.01898-15; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Held HA, 2004, J MOL BIOL, V340, P587, DOI 10.1016/j.jmb.2004.04.060; Hershey DM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002402; Ivarsson Y, 2014, P NATL ACAD SCI USA, V111, P2542, DOI 10.1073/pnas.1312296111; Jones SR, 2015, P NATL ACAD SCI USA, V112, P3904, DOI 10.1073/pnas.1417614112; Kashyap S, 2014, ACS NANO, V8, P9097, DOI 10.1021/nn502551y; Kim S, 2014, GENE DEV, V28, P902, DOI 10.1101/gad.238394.114; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Kley J, 2011, NAT STRUCT MOL BIOL, V18, P728, DOI 10.1038/nsmb.2055; Kolinko I, 2014, NAT NANOTECHNOL, V9, P193, DOI [10.1038/nnano.2014.13, 10.1038/NNANO.2014.13]; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Lohse I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021486; Lohsse A, 2014, J BACTERIOL, V196, P2658, DOI 10.1128/JB.01716-14; Londer YY, 2006, PROTEIN EXPRES PURIF, V47, P241, DOI 10.1016/j.pep.2005.11.017; Mauldin RV, 2013, NAT CHEM BIOL, V9, P90, DOI [10.1038/nchembio.1135, 10.1038/NCHEMBIO.1135]; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Quinlan A, 2011, MOL MICROBIOL, V80, P1075, DOI 10.1111/j.1365-2958.2011.07631.x; Rahn-Lee L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004811; Rawlings AE, 2014, P NATL ACAD SCI USA, V111, P16094, DOI 10.1073/pnas.1409256111; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Siponen MI, 2013, NATURE, V502, P681, DOI 10.1038/nature12573; Siponen MI, 2012, BIOCHEM SOC T, V40, P1319, DOI 10.1042/BST20120104; Small JL, 2013, J BIOL CHEM, V288, P12489, DOI 10.1074/jbc.M113.456541; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wolff A, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1161-5; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Yang W, 2010, RES MICROBIOL, V161, P701, DOI [10.1016/J.resmic.2010.07.002, 10.1016/j.resmic.2010.07.002]; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207	49	13	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17941	17952		10.1074/jbc.M116.731000	http://dx.doi.org/10.1074/jbc.M116.731000			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27302060	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000383241300037
J	Basagiannis, D; Christoforidis, S				Basagiannis, Dimitris; Christoforidis, Savvas			Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR-2; AMYLOID-BETA-PROTEIN; MEDIATED ENDOCYTOSIS; ENDOTHELIAL-CELLS; VASCULAR FUNCTION; EPSIN DEFICIENCY; TUMOR-GROWTH; DYNAMIN; ANGIOGENESIS; TRAFFICKING	VEGFR2 plays a fundamental role in blood vessel formation and in life threatening diseases, such as cancer angiogenesis and cardiovascular disorders. Although inactive growth factor receptors are mainly localized at the plasma membrane, VEGFR2 undergoes constitutive endocytosis (in the absence of ligand) and recycling. Intriguingly, the significance of these futile transport cycles of VEGFR2 remains unclear. Here we found that, unexpectedly, the function of constitutive endocytosis of VEGFR2 is to protect the receptor against plasma membrane cleavage (shedding), thereby preserving the functional state of the receptor until the time of activation by VEGF. Inhibition of constitutive endocytosis of VEGFR2, by interference with the function of clathrin, dynamin, or Rab5, increases dramatically the cleavage/shedding of VEGFR2. Shedding of VEGFR2 produces an N-terminal soluble fragment (100 kDa, s100), which is released in the extracellular space, and a residual C-terminal part (130 kDa, p130) that remains integrated at the plasma membrane. The released soluble fragment (s100) co-immunoprecipitates with VEGF, in line with the topology of the VEGF-binding domain at the N terminus of VEGFR2. Increased shedding of VEGFR2 (via inhibition of constitutive endocytosis) results in reduced response to VEGF, consistently with the loss of the VEGF-binding domain from the membrane remnant of VEGFR2. These data suggest that constitutive internalization of VEGFR2 protects the receptor against shedding and provides evidence for an unprecedented mechanism via which endocytosis can regulate the fate and activity of growth factor receptors.	[Basagiannis, Dimitris; Christoforidis, Savvas] Fdn Res & Technol, Inst Mol Biol & Biotechnol Biomed Res, Ioannina 45110, Greece; [Basagiannis, Dimitris; Christoforidis, Savvas] Univ Ioannina, Sch Hlth Sci, Biol Chem Lab, Dept Med, GR-45110 Ioannina, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Ioannina	Christoforidis, S (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol Biomed Res, Ioannina 45110, Greece.	savvas_christoforidis@imbb.forth.gr		Basagiannis, Dimitris/0000-0002-3932-5051; Christoforidis, Savvas/0000-0002-0210-0713	EMBO Young Investigator Program; Integrated Project "PULMOTENSION" (EU, FP6); Integrated Project "ENDOTRACK" (EU, FP6); European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning"	EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Integrated Project "PULMOTENSION" (EU, FP6); Integrated Project "ENDOTRACK" (EU, FP6); European Union (European Social Fund)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning"	This work was supported by the EMBO Young Investigator Program and the Integrated Projects "PULMOTENSION" and "ENDOTRACK" (EU, FP6), grants "ARISTEIA II" (SecrEndo), Heracleitus II, Synergasia (NOISEPLUS), and KRIPIS, co-funded by the European Union (European Social Fund), and Greek national funds through the Operational Program "Education and Lifelong Learning" (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Bruns AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048539; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Domigan CK, 2014, CELL, V159, P473, DOI 10.1016/j.cell.2014.10.008; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fukuda S, 2012, BIOCHEM BIOPH RES CO, V420, P315, DOI 10.1016/j.bbrc.2012.02.156; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gonzalez-Jamett Arlek M, 2013, Front Endocrinol (Lausanne), V4, P126, DOI 10.3389/fendo.2013.00126; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; HOPKINS CR, 1985, J CELL SCI, P173; Huang YW, 2009, J BIOL CHEM, V284, P29644, DOI 10.1074/jbc.M109.045682; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Ivanov AI, 2014, METHODS MOL BIOL, V1174, P3, DOI 10.1007/978-1-4939-0944-5_1; Ivanov Andrei I, 2008, Methods Mol Biol, V440, pv; Jin YX, 2013, MOL CELL BIOL, V33, P4181, DOI 10.1128/MCB.00650-13; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Koch S, 2014, DEV CELL, V28, P633, DOI 10.1016/j.devcel.2014.02.010; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lee MY, 2014, DEVELOPMENT, V141, P1465, DOI 10.1242/dev.104539; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Numrich J, 2014, BIOL CHEM, V395, P327, DOI 10.1515/hsz-2013-0258; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Papanikolaou A, 2011, TRAFFIC, V12, P1148, DOI 10.1111/j.1600-0854.2011.01224.x; Park SY, 2013, ARTERIOSCL THROM VAS, V33, P737, DOI 10.1161/ATVBAHA.112.300386; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pasula S, 2012, J CLIN INVEST, V122, P4424, DOI 10.1172/JCI64537; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Robinson DG, 2014, TRENDS PLANT SCI, V19, P134, DOI 10.1016/j.tplants.2013.10.008; Rodman JS, 2000, J CELL SCI, V113, P183; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Smith GA, 2016, TRAFFIC, V17, P53, DOI 10.1111/tra.12341; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Tessneer KL, 2014, ARTERIOSCL THROM VAS, V34, P331, DOI 10.1161/ATVBAHA.113.302586; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Zografou S, 2012, J CELL SCI, V125, P4780, DOI 10.1242/jcs.104174	70	37	38	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16892	16903		10.1074/jbc.M116.730309	http://dx.doi.org/10.1074/jbc.M116.730309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298320	hybrid, Green Published			2022-12-26	WOS:000380826700045
J	Herrendorff, R; Faleschini, MT; Stiefvater, A; Erne, B; Wiktorowicz, T; Kern, F; Hamburger, M; Potterat, O; Kinter, J; Sinnreich, M				Herrendorff, Ruben; Faleschini, Maria Teresa; Stiefvater, Adeline; Erne, Beat; Wiktorowicz, Tatiana; Kern, Frances; Hamburger, Matthias; Potterat, Olivier; Kinter, Jochen; Sinnreich, Michael			Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myotonic dystrophy; natural product; RNA splicing; RNA-protein interaction; trinucleotide repeat disease; MBNL1; alkaloids; non-coding RNA	3 UNTRANSLATED REGION; TRIPLET REPEAT RNA; PRE-MESSENGER-RNA; SMALL MOLECULES; CUG REPEATS; TRINUCLEOTIDE REPEAT; MUSCLEBLIND PROTEINS; CHLORIDE CHANNEL; NATURAL-PRODUCTS; PATHOGENIC RNAS	Myotonic dystrophy type I (DM1) is a disabling neuromuscular disease with no causal treatment available. This disease is caused by expanded CTG trinucleotide repeats in the 3 UTR of the dystrophia myotonica protein kinase gene. On the RNA level, expanded (CUG)(n) repeats form hairpin structures that sequester splicing factors such as muscleblind-like 1 (MBNL1). Lack of available MBNL1 leads to misregulated alternative splicing of many target pre-mRNAs, leading to the multisystemic symptoms in DM1. Many studies aiming to identify small molecules that target the (CUG)(n)-MBNL1 complex focused on synthetic molecules. In an effort to identify new small molecules that liberate sequestered MBNL1 from (CUG)(n) RNA, we focused specifically on small molecules of natural origin. Natural products remain an important source for drugs and play a significant role in providing novel leads and pharmacophores for medicinal chemistry. In a new DM1 mechanism-based biochemical assay, we screened a collection of isolated natural compounds and a library of over 2100 extracts from plants and fungal strains. HPLC-based activity profiling in combination with spectroscopic methods were used to identify the active principles in the extracts. The bioactivity of the identified compounds was investigated in a human cell model and in a mouse model of DM1. We identified several alkaloids, including the -carboline harmine and the isoquinoline berberine, that ameliorated certain aspects of the DM1 pathology in these models. Alkaloids as a compound class may have potential for drug discovery in other RNA-mediated diseases.	[Herrendorff, Ruben; Stiefvater, Adeline; Erne, Beat; Wiktorowicz, Tatiana; Kern, Frances; Kinter, Jochen; Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Res Grp, Dept Neurol, Klingelbergstr 50, CH-4056 Basel, Switzerland; [Herrendorff, Ruben; Stiefvater, Adeline; Erne, Beat; Wiktorowicz, Tatiana; Kern, Frances; Kinter, Jochen; Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Res Grp, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland; [Faleschini, Maria Teresa; Hamburger, Matthias; Potterat, Olivier] Univ Basel, Dept Pharmaceut Sci, Div Pharmaceut Biol, Klingelbergstr 50, CH-4056 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Kinter, J; Sinnreich, M (corresponding author), Univ Basel Hosp, Neuromuscular Res Grp, Dept Neurol, Klingelbergstr 50, CH-4056 Basel, Switzerland.; Kinter, J; Sinnreich, M (corresponding author), Univ Basel Hosp, Neuromuscular Res Grp, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.	j.kinter@unibas.ch; michael.sinnreich@unibas.ch		Sinnreich, Michael/0000-0002-9835-1276	Neuromuscular Research Association Basel; Swiss National Science Foundation; Myosuisse	Neuromuscular Research Association Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Myosuisse	This work was funded by the Neuromuscular Research Association Basel, Swiss National Science Foundation, and by Myosuisse. The authors declare that they have no conflicts of interest with the contents of this article.	Arambula JF, 2009, P NATL ACAD SCI USA, V106, P16068, DOI 10.1073/pnas.0901824106; Berg J, 2004, NEUROLOGY, V63, P2371, DOI 10.1212/01.WNL.0000148482.40683.88; BROOK, 1992, CELL, V69, P385; Cetinkol OP, 2009, NUCLEIC ACIDS RES, V37, P611, DOI 10.1093/nar/gkn977; Chaouch S, 2009, HUM GENE THER, V20, P784, DOI 10.1089/hum.2008.163; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen CZ, 2012, ANAL BIOANAL CHEM, V402, P1889, DOI 10.1007/s00216-011-5604-0; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P856, DOI 10.1021/cb200408a; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Gareiss PC, 2008, J AM CHEM SOC, V130, P16254, DOI 10.1021/ja804398y; Guan YB, 2001, J TOXICOL ENV HEAL A, V64, P645, DOI 10.1080/152873901753246241; Herraiz T, 2010, FOOD CHEM TOXICOL, V48, P839, DOI 10.1016/j.fct.2009.12.019; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hoskins JW, 2014, NUCLEIC ACIDS RES, V42, P6591, DOI 10.1093/nar/gku275; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729; Kumar GS, 2012, J BIOSCIENCES, V37, P539, DOI 10.1007/s12038-012-9217-3; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Lee SS, 1999, MED SCI RES, V27, P749; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Nafisi S, 2010, DNA CELL BIOL, V29, P753, DOI 10.1089/dna.2010.1087; Ofori LO, 2012, NUCLEIC ACIDS RES, V40, P6380, DOI 10.1093/nar/gks298; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Potterat O, 2014, PLANTA MED, V80, P1171, DOI 10.1055/s-0034-1382900; Pushechnikov A, 2009, J AM CHEM SOC, V131, P9767, DOI 10.1021/ja9020149; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	45	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17165	17177		10.1074/jbc.M115.710616	http://dx.doi.org/10.1074/jbc.M115.710616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27298317	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000382643800021
J	Li, C; Li, XY; Deng, C; Guo, CB				Li, Chun; Li, Xiaoyu; Deng, Chun; Guo, Chunbao			Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia	PLOS ONE			English	Article							ATTENUATES BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE ASTHMA; DIFFERENTIATION; INFLAMMATION; TRAFFICKING; MIGRATION; FIBROSIS; ACTIVATION; LUNGS	Background Bronchopulmonary dysplasia (BPD) is characterized by the aberrant remodeling of the lung parenchyma, resulting from accumulation of fibroblasts or myofibroblasts. Circulating fibrocytes are implied in pulmonary fibrosis, but whether these cells are associated with the development of BPD or the progressive fibrosis is unknown. The aim of the present study was to investigate the occurrence of fibrocytes in peripheral venous blood and explore whether these cells might be associated with severity of BPD. Methods We investigated circulating fibrocytes in 66 patients with BPD, 23 patients with acute respiratory distress syndrome(ARDS) and 11 normal subjects. Circulating fibrocytes were defined and quantified as cells positive for CD45 andcollagen-1 by flow cytometry. Furthermore, serum SDF-1/CXCL12 and TGF-beta 1 were evaluated using ELISA methods. We also investigated the clinical value of fibrocyte counts by comparison with standard clinical parameters. Results The patients with BPD had significantly increased numbers of fibrocytes compared to the controls (p < 0.01). Patients with ARDS were not different from healthy control subjects. There was a correlation between the number of fibrocytes and pulmonary hypertension or oxygen saturation (p < 0.05). Fibrocyte numbers were not correlated with other clinical or functional variables or radiologic severity scores. The fibrocyte attractant chemokine CXCL12 increased in plasma (p < 0.05) and was detectable in the bronchoalveolar lavage fluid of 40% of the patients but not in controls. Conclusion These findings indicate that circulating fibrocytes are increased in patients with BPD and may contribute to pulmonary fibrosis in BPD. Circulating fibrocytes, likely recruited through the CXCR4/CXCL12 axis, might contribute to the production of TGF-beta 1 for the expansion of fibroblast/myofibroblast population in BPD.	[Guo, Chunbao] Chongqing Med Univ, Childrens Hosp, Dept Pediat Gen Surg & Liver Transplantat, Chongqing 400014, Peoples R China; [Li, Chun; Li, Xiaoyu; Deng, Chun] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Deng, Chun; Guo, Chunbao] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Guo, CB (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Pediat Gen Surg & Liver Transplantat, Chongqing 400014, Peoples R China.; Deng, C (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Deng, C; Guo, CB (corresponding author), Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China.	dengcgcb@163.com; guochunbao@cqmu.edu.cn			National Natural Science Foundation of China [81270058, 30770950]; Chongqing Natural Science Foundation (CSTC) [2009BB6072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This research was supported by the National Natural Science Foundation of China (No. 81270058, 30770950) and by the Chongqing Natural Science Foundation (CSTC, 2009BB6072).	Alhamad EH, 2015, ANN THORAC MED, V10, P279, DOI 10.4103/1817-1737.157294; Aono Y, 2014, AM J RESP CELL MOL, V51, P793, DOI 10.1165/rcmb.2013-0455OC; Borie R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053736; Negrete-Garcia MC, 2010, CHEST, V138, P100, DOI 10.1378/chest.09-2104; de Alba CG, 2015, AM J RESP CRIT CARE, V191, P427, DOI 10.1164/rccm.201407-1334OC; Dupin I, 2015, J ALLERGY CLINIMMUNO; Fu XY, 2015, CELL PHYSIOL BIOCHEM, V35, P489, DOI 10.1159/000369714; Gillen JR, 2013, ANN THORAC SURG, V95, P1768, DOI 10.1016/j.athoracsur.2013.02.021; Han WL, 2015, CELL TISSUE RES, V359, P589, DOI 10.1007/s00441-014-2035-1; Harris DA, 2013, J THORAC CARDIOV SUR, V145, P854, DOI 10.1016/j.jtcvs.2012.03.079; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Inomata M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-16; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kitamura H, 2011, J CLIN INVEST, V121, P2863, DOI 10.1172/JCI45589; LaPar DJ, 2011, ANN THORAC SURG, V92, P470, DOI 10.1016/j.athoracsur.2011.04.065; Lo CY, 2015, J ALLERGY CLIN IMMUN, V135, P1186, DOI 10.1016/j.jaci.2014.10.031; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Madala SK, 2014, AM J RESP CELL MOL, V50, P777, DOI 10.1165/rcmb.2013-0042OC; Maharaj S, 2013, EUR RESPIR REV, V22, P552, DOI 10.1183/09059180.00007713; Shipe R, 2015, J ALLERGY CLINIMMUNO; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Torchin H, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2163; Trimble A, 2014, AM J RESP CRIT CARE, V190, P1395, DOI 10.1164/rccm.201407-1287OC; Velten M, 2010, J APPL PHYSIOL, V108, P1347, DOI 10.1152/japplphysiol.01392.2009; Wang CH, 2015, J ALLERGY CLIN IMMUN, V135, P1154, DOI 10.1016/j.jaci.2014.09.011; Wang CH, 2012, J ALLERGY CLIN IMMUN, V129, P1367, DOI 10.1016/j.jaci.2012.01.038; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008	28	7	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157181	10.1371/journal.pone.0157181	http://dx.doi.org/10.1371/journal.pone.0157181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309347	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800040
J	Bashford, L; Mehring, C				Bashford, Luke; Mehring, Carsten			Ownership and Agency of an Independent Supernumerary Hand Induced by an Imitation Brain-Computer Interface	PLOS ONE			English	Article							RUBBER HAND; ILLUSION; LIMB; AMPUTEES; THREAT; CORTEX; SHIFTS; TOUCH; OWN	To study body ownership and control, illusions that elicit these feelings in non-body objects are widely used. Classically introduced with the Rubber Hand Illusion, these illusions have been replicated more recently in virtual reality and by using brain-computer interfaces. Traditionally these illusions investigate the replacement of a body part by an artificial counterpart, however as brain-computer interface research develops it offers us the possibility to explore the case where non-body objects are controlled in addition to movements of our own limbs. Therefore we propose a new illusion designed to test the feeling of ownership and control of an independent supernumerary hand. Subjects are under the impression they control a virtual reality hand via a brain-computer interface, but in reality there is no causal connection between brain activity and virtual hand movement but correct movements are observed with 80% probability. These imitation brain-computer interface trials are interspersed with movements in both the subjects' real hands, which are in view throughout the experiment. We show that subjects develop strong feelings of ownership and control over the third hand, despite only receiving visual feedback with no causal link to the actual brain signals. Our illusion is crucially different from previously reported studies as we demonstrate independent ownership and control of the third hand without loss of ownership in the real hands.	[Bashford, Luke] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Bashford, Luke; Mehring, Carsten] Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany	Imperial College London; University of Freiburg	Bashford, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.; Bashford, L (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	luke.bashford11@imperial.ac.uk	Mehring, Carsten/R-8986-2019	Mehring, Carsten/0000-0001-8125-5205; Bashford, Luke/0000-0003-4391-2491	German Federal Ministry of Education and Research (BMBF) [01GQ0830]; German Research Foundation (DFG); University of Freiburg	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This work was supported by the German Federal Ministry of Education and Research (BMBF) grant 01GQ0830 to BFNT Freiburg and Tubingen (http://www.bmbf.de/en/), received by CM. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134501; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Di Pino G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00109; Ehrsson HH, 2009, PERCEPTION, V38, P310, DOI 10.1068/p6304; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Evans N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130019; Folegatti A, 2012, CONSCIOUS COGN, V21, P799, DOI 10.1016/j.concog.2012.02.008; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Giummarra MJ, 2011, CORTEX, V47, P998, DOI 10.1016/j.cortex.2011.02.010; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Guterstam A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017208; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Kanayama N, 2007, PSYCHOPHYSIOLOGY, V44, P392, DOI 10.1111/j.1469-8986.2007.00511.x; Limanowski J, 2014, NEUROIMAGE, V86, P514, DOI 10.1016/j.neuroimage.2013.10.035; Ma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00604; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Ninaus M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00914; Orsborn AL, 2014, NEURON, V82, P1380, DOI 10.1016/j.neuron.2014.04.048; Parietti F, 2014, IEEE INT CONF ROBOT, P141, DOI 10.1109/ICRA.2014.6906601; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Schaefer M, 2009, HUM BRAIN MAPP, V30, P1413, DOI 10.1002/hbm.20609; Shokur S, 2013, P NATL ACAD SCI USA, V110, P15121, DOI 10.1073/pnas.1308459110; Thompson SC, 2007, BASIC APPL SOC PSYCH, V29, P75, DOI 10.1080/01973530701331189; Yokosaka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06201	27	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156591	10.1371/journal.pone.0156591	http://dx.doi.org/10.1371/journal.pone.0156591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303808	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800019
J	Baylis, AMM; Kowalski, GJ; Voigt, CC; Orben, RA; Trillmich, F; Staniland, IJ; Hoffman, JI				Baylis, Alastair M. M.; Kowalski, Gabriele J.; Voigt, Christian C.; Orben, Rachael A.; Trillmich, Fritz; Staniland, Iain J.; Hoffman, Joseph I.			Pup Vibrissae Stable Isotopes Reveal Geographic Differences in Adult Female Southern Sea Lion Habitat Use during Gestation	PLOS ONE			English	Article							MARINE PREDATOR; PATTERNS; ECOLOGY; DIET	Individuals within populations often differ substantially in habitat use, the ecological consequences of which can be far reaching. Stable isotope analysis provides a convenient and often cost effective means of indirectly assessing the habitat use of individuals that can yield valuable insights into the spatiotemporal distribution of foraging specialisations within a population. Here we use the stable isotope ratios of southern sea lion (Otaria flavescens) pup vibrissae at the Falkland Islands, in the South Atlantic, as a proxy for adult female habitat use during gestation. A previous study found that adult females from one breeding colony (Big Shag Island) foraged in two discrete habitats, inshore (coastal) or offshore (outer Patagonian Shelf). However, as this species breeds at over 70 sites around the Falkland Islands, it is unclear if this pattern is representative of the Falkland Islands as a whole. In order to characterize habitat use, we therefore assayed carbon (delta C-13) and nitrogen (delta N-15) ratios from 65 southern sea lion pup vibrissae, sampled across 19 breeding colonies at the Falkland Islands. Model-based clustering of pup isotope ratios identified three distinct clusters, representing adult females that foraged inshore, offshore, and a cluster best described as intermediate. A significant difference was found in the use of inshore and offshore habitats between West and East Falkland and between the two colonies with the largest sample sizes, both of which are located in East Falkland. However, habitat use was unrelated to the proximity of breeding colonies to the Patagonian Shelf, a region associated with enhanced biological productivity. Our study thus points towards other factors, such as local oceanography and its influence on resource distribution, playing a prominent role in inshore and offshore habitat use.	[Baylis, Alastair M. M.] South Atlantic Environm Res Inst, Stanley FIQQ1ZZ, Falkland Isl, England; [Baylis, Alastair M. M.] Falklands Conservat, Stanley FIQQ1ZZ, Falkland Isl, England; [Baylis, Alastair M. M.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Kowalski, Gabriele J.; Trillmich, Fritz; Hoffman, Joseph I.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Kowalski, Gabriele J.] Univ Potsdam, Dept Anim Ecol, Potsdam, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Alfred Kowalke Str 17, D-10315 Berlin, Germany; [Orben, Rachael A.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Staniland, Iain J.] British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England	Macquarie University; University of Bielefeld; University of Potsdam; Leibniz Institut fur Zoo und Wildtierforschung; Oregon State University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	joseph.hoffman@uni-bielefeld.de	Hoffman, Joseph i/K-7725-2012; Orben, Rachael A./H-9460-2019	Hoffman, Joseph i/0000-0001-5895-8949; Orben, Rachael A./0000-0002-0802-407X; Staniland, Iain/0000-0003-2736-9134	Marie Curie FP7-Reintegration Grant within the 7th European Community Framework Programme [PCIG-GA-2011-303618]; NERC [bas0100035] Funding Source: UKRI; Natural Environment Research Council [bas0100035] Funding Source: researchfish	Marie Curie FP7-Reintegration Grant within the 7th European Community Framework Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Field work was supported by the Shackleton Scholarship Fund (Centenary Award), Rufford Small Grants, Sea World and Busch Gardens Conservation Fund, Joint Nature Conservation Council, National Geographic, Winifred Violet Scott and the Falkland Islands Government (to AMMB). Laboratory work was supported by a Marie Curie FP7-Reintegration Grant within the 7th European Community Framework Programme PCIG-GA-2011-303618 (to JIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Arkhipkin A, 2012, J FISH BIOL, V81, P882, DOI 10.1111/j.1095-8649.2012.03359.x; Arkhipkin Alexander, 2012, Arquipelago-Life and Marine Sciences, P19; Arkhipkin A, 2010, FISH RES, V105, P156, DOI 10.1016/j.fishres.2010.03.022; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Baylis AMM, 2015, OECOLOGIA, V179, P1053, DOI 10.1007/s00442-015-3421-4; Baylis AMM, 2015, ECOLOGY, V96, P2834, DOI 10.1890/14-1948.1.sm; Baylis AMM, 2015, MAR BIOL, V162, P99, DOI 10.1007/s00227-014-2561-0; Baylis AMM, 2015, MAR MAMMAL SCI, V31, P322, DOI 10.1111/mms.12148; Baylis AMM, 2008, MAR ECOL PROG SER, V361, P279, DOI 10.3354/meps07258; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Cherel Y, 2000, OECOLOGIA, V122, P155, DOI 10.1007/PL00008843; Drago M, 2010, SCI MAR, V74, P589, DOI 10.3989/scimar.2010.74n3589; Drago M, 2010, MAR MAMMAL SCI, V26, P309, DOI 10.1111/j.1748-7692.2009.00321.x; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fraley C., 2007, MCLUST VERSION 4 R N; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Jeglinski JWE, 2015, OECOLOGIA, V179, P1041, DOI 10.1007/s00442-015-3424-1; Jeglinski JWE, 2012, MAR ECOL PROG SER, V453, P279, DOI 10.3354/meps09649; Kernaleguen L, 2016, OECOLOGIA, V180, P657, DOI 10.1007/s00442-015-3407-2; Lowther AD, 2011, MAR MAMMAL SCI, V27, P567, DOI 10.1111/j.1748-7692.2010.00425.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; RCore Team, 2020, R LANG ENV STAT COMP; Rea LD, 2015, MAR MAMMAL SCI, V31, P1213, DOI 10.1111/mms.12221; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Scherer RD, 2015, MAR ECOL PROG SER, V527, P261, DOI 10.3354/meps11255; Sepulveda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134926; Stephens D.W., 1986, pi; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Thompson D, 1998, J ZOOL, V246, P135, DOI 10.1111/j.1469-7998.1998.tb00142.x; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077	34	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157394	10.1371/journal.pone.0157394	http://dx.doi.org/10.1371/journal.pone.0157394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304855	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000377824800057
J	Drymala, SM; Zanno, LE				Drymala, Susan M.; Zanno, Lindsay E.			Osteology of Carnufex carolinensis (Archosauria: Psuedosuchia) from the Pekin Formation of North Carolina and Its Implications for Early Crocodylomorph Evolution	PLOS ONE			English	Article							ORIGIN; REVISION; ANATOMY; REPTILE; SUCHIA; PSEUDOSUCHIA; POSTOSUCHUS; RADIATION; SKELETON; GERMANY	Crocodylomorphs originated in the Late Triassic and were the only crocodile-line archosaurs to survive the end-Triassic extinction. Recent phylogenetic analyses suggest that the closest relatives of these generally gracile, small-bodied taxa were a group of robust, large-bodied predators known as rauisuchids implying a problematic morphological gap between early crocodylomorphs and their closest relatives. Here we provide a detailed osteological description of the recently named early diverging crocodylomorph Carnufex carolinensis from the Upper Triassic Pekin Formation of North Carolina and assess its phylogenetic position within the Paracrocodylomorpha. Carnufex displays a mosaic of crocodylomorph, rauisuchid, and dinosaurian characters, as well as highly laminar cranial elements and vertebrae, ornamented dermal skull bones, a large, subtriangular antorbital fenestra, and a reduced forelimb. A phylogenetic analysis utilizing a comprehensive dataset of early paracrocodylomorphs and including seven new characters and numerous modifications to characters culled from the literature recovers Carnufex carolinensis as one of the most basal members of Crocodylomorpha, in a polytomy with two other large bodied taxa ( CM 73372 and Redondavenator). The analysis also resulted in increased resolution within Crocodylomorpha and a monophyletic clade containing the holotype and two referred specimens of Hesperosuchus as well as Dromicosuchus. Carnufex occupies a key transition at the origin of Crocodylomorpha, indicating that the morphology typifying early crocodylomorphs appeared before the shift to small body size.	[Drymala, Susan M.; Zanno, Lindsay E.] North Carolina Museum Nat Sci, Res & Collect, Raleigh, NC USA; [Drymala, Susan M.; Zanno, Lindsay E.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Drymala, SM (corresponding author), North Carolina Museum Nat Sci, Res & Collect, Raleigh, NC USA.; Drymala, SM (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	sdrymal@ncsu.edu		Zanno, Lindsay/0000-0002-1654-1990; Drymala, Susan/0000-0002-6736-965X	Dorris O. and Samuel P. Welles Research Fund through University of California Museum of Paleontology; Ernst Mayr Travel Grant in Animal Systematics through Harvard Museum of Comparative Zoology; Jackson School of Geosciences Student Travel Grant through Society of Vertebrate Paleontology	Dorris O. and Samuel P. Welles Research Fund through University of California Museum of Paleontology; Ernst Mayr Travel Grant in Animal Systematics through Harvard Museum of Comparative Zoology; Jackson School of Geosciences Student Travel Grant through Society of Vertebrate Paleontology	SMD received travel grants from the following sources: The Dorris O. and Samuel P. Welles Research Fund through the University of California Museum of Paleontology (http://www.ucmp.berkeley.edu/museum/wellesfund/), an Ernst Mayr Travel Grant in Animal Systematics through the Harvard Museum of Comparative Zoology (http://www.mcz.harvard.edu/grants_and_funding/ernstmayr-travel.html), and a Jackson School of Geosciences Student Travel Grant through the Society of Vertebrate Paleontology (http://vertpaleo.org/Awards/Award-%2814%29.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie JW, 2008, SYST ZOOL, V34, P326; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Brusatte SL, 2008, BIOL LETTERS, V4, P733, DOI 10.1098/rsbl.2008.0441; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Brusatte SL, 2009, ACTA PALAEONTOL POL, V54, P221, DOI 10.4202/app.2008.0065; Butler RJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-128; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Campbell MR, 1923, N CAROLINA GEOLOGICA, V33, P1; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Clark JM, 2004, NATURE, V430, P1021, DOI 10.1038/nature02802; Clark JM, 2002, ZOOL J LINN SOC-LOND, V136, P77, DOI 10.1046/j.1096-3642.2002.00026.x; Clark JM, 2000, J VERTEBR PALEONTOL, V20, P683, DOI 10.1671/0272-4634(2000)020[0683:ANSOHA]2.0.CO;2; CODDINGTON J, 1994, CLADISTICS, V10, P415; COLBERT EDWIN H., 1952, BULL AMER MUS NAT HIST, V99, P561; Cope E.D., 1869, T AM PHIL SOC, V14, P1; CRUSH PJ, 1984, PALAEONTOLOGY, V27, P131; De Franca MAG, 2013, GEOL SOC SPEC PUBL, V379, P469, DOI 10.1144/SP379.8; DEBUFFRENIL V, 1982, ZOOMORPHOLOGY, V99, P155, DOI 10.1007/BF00310307; Drumheller SK, 2014, NATURWISSENSCHAFTEN, V101, P975, DOI 10.1007/s00114-014-1238-3; Drymala S., 2015, THESIS; Emmons E., 1856, GEOLOGICAL REPORT MI; Ezcurra MD, 2011, 4 C LAT PAL VERT; FAITH DP, 1991, CLADISTICS, V7, P1, DOI 10.1111/j.1096-0031.1991.tb00020.x; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; Galton PM, STUTTGARTER BEITRAGE, V116, P1; Gauthier J., 1985, P185; Gower DJ, 2009, J VERTEBR PALEONTOL, V29, P103, DOI 10.1080/02724634.2009.10010365; Gower David J., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V280, P1; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Irmis RB, 2013, GEOL SOC SPEC PUBL, V379, P275, DOI 10.1144/SP379.24; Jalil NE, 2007, PALAEONTOLOGY, V50, P417, DOI 10.1111/j.1475-4983.2007.00640.x; Kitching I.J., 1998, SYSTEMATICS ASS PUBL; KREBS B, 1974, NATURWISSENSCHAFTEN, V61, P17, DOI 10.1007/BF00602887; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; LITWIN RJ, 1993, REV PALAEOBOT PALYNO, V77, P75, DOI 10.1016/0034-6667(93)90057-2; Maddison W. P, 2014, MESQUITE MODULAR SYS; Merrem B., 1820, VERSUCH SYSTEMS AMPH; Muttoni G, 2004, GEOL SOC AM BULL, V116, P1043, DOI 10.1130/B25326.1; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt Sterling J., 2005, Palaeontologische Zeitschrift, V79, P471; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Olsen P. E., 1978, NEWSL STRATIGR, V7, P90, DOI DOI 10.1127/NOS/7/1978/90; Olsen PE, 2010, EARTH ENV SCI T R SO, V101, P201, DOI 10.1017/S1755691011020032; OLSEN PE, 1982, AM J SCI, V282, P1, DOI 10.2475/ajs.282.1.1; Parker WG, 2013, GEOL SOC SPEC PUBL, V379, P503, DOI 10.1144/SP379.3; Parrish J.M., 1991, Journal of Vertebrate Paleontology, V11, P198; Parrish J. Michael, 1993, Journal of Vertebrate Paleontology, V13, P287; Peyer K, 2008, J VERTEBR PALEONTOL, V28, P363, DOI 10.1671/0272-4634(2008)28[363:ANSAFT]2.0.CO;2; Pol D, 2013, BIOL REV, V88, P862, DOI 10.1111/brv.12030; Reinemund JA, 1955, 246 US GEOL SURV PRO; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Sues HD, 2013, ZOOL J LINN SOC-LOND, V168, P859, DOI 10.1111/zoj.12038; Sulej T, 2005, J VERTEBR PALEONTOL, V25, P78, DOI 10.1671/0272-4634(2005)025[0078:ANRRDA]2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TRAVERSE A, 1987, SCIENCE, V236, P1469, DOI 10.1126/science.236.4807.1469; Traverse A, 1986, 3 ANN MID M; Turner AH, 2013, GEOL SOC SPEC PUBL, V379, P573, DOI 10.1144/SP379.15; WALKER AD, 1990, PHILOS T ROY SOC B, V330, P1, DOI 10.1098/rstb.1990.0185; WALKER AD, 1968, GEOL MAG, V105, P1, DOI 10.1017/S0016756800046434; Ward LF, 1899, US GEOLOGICAL SURVEY; Weinbaum JC, 2007, PALAEONTOL Z, V81, P131, DOI 10.1007/BF02988388; Weinbaum JC, 2013, GEOL SOC SPEC PUBL, V379, P525, DOI 10.1144/SP379.7; Weinbaum Jonathan C., 2011, Paleobios, V30, P18; Whiteside JH, 2011, P NATL ACAD SCI USA, V108, P8972, DOI 10.1073/pnas.1102473108; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wu Xiao-Chun, 1993, Journal of Vertebrate Paleontology, V13, P58; Zanno LE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09276	74	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157528	10.1371/journal.pone.0157528	http://dx.doi.org/10.1371/journal.pone.0157528			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304665	Green Submitted, gold, Green Published			2022-12-26	WOS:000377824800067
J	Huang, YH; Lien, Y; Huang, CC; Huang, CY				Huang, Yen-Hua; Lien, Yi; Huang, Chien-Chih; Huang, Cheng-Yang			Characterization of Staphylococcus aureus Primosomal DnaD Protein: Highly Conserved C-Terminal Region Is Crucial for ssDNA and PriA Helicase Binding but Not for DnaA Protein-Binding and Self-Tetramerization	PLOS ONE			English	Article							BACILLUS-SUBTILIS DNAD; STALLED REPLICATION FORKS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MECHANISMS; INITIATION; RESTART; RECOGNITION; REVEALS; OLIGOMERIZATION	The role of DnaD in the recruitment of replicative helicase has been identified. However, knowledge of the DNA, PriA, and DnaA binding mechanism of this protein for the DnaA-and PriA-directed replication primosome assemblies is limited. We characterized the DNA-binding properties of DnaD from Staphylococcus aureus (SaDnaD) and analyzed its interactions with SaPriA and SaDnaA. The gel filtration chromatography analysis of purified SaDnaD and its deletion mutant proteins (SaDnaD1-195, SaDnaD1-200 and SaDnaD1-204) showed a stable tetramer in solution. This finding indicates that the C-terminal region aa 196-228 is not crucial for SaDnaD oligomerization. SaDnaD forms distinct complexes with ssDNA of different lengths. In fluorescence titrations, SaDnaD bound to ssDNA with a binding-site size of approximately 32 nt. A stable complex of SaDnaD1-195, SaDnaD1-200, and SaDnaD1-204 with ssDNA dT40 was undetectable, indicating that the C-terminal region of SaDnaD (particularly aa 205-228) is crucial for ssDNA binding. The SPR results revealed that SaDnaD1-195 can interact with SaDnaA but not with SaPriA, which may indicate that DnaD has different binding sites for PriA and DnaA. Both SaDnaD and SaDna-DY176A mutant proteins, but not SaDnaD1-195, can significantly stimulate the ATPase activity of SaPriA. Hence, the stimulation effect mainly resulted from direct contact within the protein-protein interaction, not via the DNA-protein interaction. Kinetic studies revealed that the SaDnaD-SaPriA interaction increases the V-max of the SaPriA ATPase fivefold without significantly affecting the K-m. These results indicate that the conserved C-terminal region is crucial for ssDNA and PriA helicase binding, but not for DnaA protein-binding and self-tetramerization.	[Huang, Yen-Hua; Lien, Yi; Huang, Chien-Chih; Huang, Cheng-Yang] Chung Shan Med Univ, Sch Biomed Sci, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan; [Huang, Cheng-Yang] Chung Shan Med Univ Hosp, Dept Med Res, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Huang, CY (corresponding author), Chung Shan Med Univ, Sch Biomed Sci, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan.; Huang, CY (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan.	cyhuang@csmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2320-B-040-018-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	i This research was supported by a grant from the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-040-018-MY2 to C.Y. Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Bonilla CY, 2012, J BACTERIOL, V194, P5110, DOI 10.1128/JB.00958-12; Briggs GS, 2012, J BACTERIOL, V194, P5162, DOI 10.1128/JB.00865-12; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Carneiro MJVM, 2006, MOL MICROBIOL, V60, P917, DOI 10.1111/j.1365-2958.2006.05152.x; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Huang CY, 2008, BIOCHEM BIOPH RES CO, V375, P220, DOI 10.1016/j.bbrc.2008.07.160; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Huang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127634; Huang YH, 2015, PROTEIN J, V34, P169, DOI 10.1007/s10930-015-9609-y; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/195162; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P837, DOI 10.1111/gtc.12001; Ishigo-oka D, 2001, J BACTERIOL, V183, P2148, DOI 10.1128/JB.183.6.2148-2150.2001; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Koyama N, 2013, MOLECULES, V18, P204, DOI 10.3390/molecules18010204; Leonard AC, 2011, ANNU REV MICROBIOL, V65, P19, DOI 10.1146/annurev-micro-090110-102934; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Marston FY, 2010, NUCLEIC ACIDS RES, V38, P6930, DOI 10.1093/nar/gkq465; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Mizukoshi T, 2003, J BIOL CHEM, V278, P42234, DOI 10.1074/jbc.C300285200; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Peng WF, 2014, BIOCHIMIE, V101, P113, DOI 10.1016/j.biochi.2014.01.001; Sandler SJ, 2000, GENETICS, V155, P487; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; SCHEKMAN R, 1974, SCIENCE, V186, P987, DOI 10.1126/science.186.4168.987; Schneider S, 2008, J MOL BIOL, V376, P1237, DOI 10.1016/j.jmb.2007.12.045; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P966, DOI 10.1093/nar/30.4.966; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Szymanski MR, 2010, J MOL BIOL, V398, P8, DOI 10.1016/j.jmb.2010.02.009; Tanaka T, 2002, J BIOL CHEM, V277, P38062, DOI 10.1074/jbc.M204397200; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; Thompson AB, 2011, ACS APPL MATER INTER, V3, P2979, DOI 10.1021/am200459a; Turner IJ, 2004, FEBS LETT, V577, P460, DOI 10.1016/j.febslet.2004.10.051; Wang CC, 2010, PROTEIN J, V29, P445, DOI 10.1007/s10930-010-9272-2; Zhang W, 2008, J MOL BIOL, V377, P706, DOI 10.1016/j.jmb.2008.01.067; Zhang WK, 2006, J BACTERIOL, V188, P5487, DOI 10.1128/JB.00339-06; Zhang WK, 2005, J MOL BIOL, V351, P66, DOI 10.1016/j.jmb.2005.05.065	57	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157593	10.1371/journal.pone.0157593	http://dx.doi.org/10.1371/journal.pone.0157593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304067	Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800075
J	Kotlarek, D; Worch, R				Kotlarek, Daria; Worch, Remigiusz			New Insight into Metal Ion-Driven Catalysis of Nucleic Acids by Influenza PA-Nter	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; A VIRUS POLYMERASE; RNA-POLYMERASE; ENDONUCLEASE DOMAIN; HOST ADAPTATION; SUBSTRATE-SPECIFICITY; VIRAL TRANSCRIPTION; CRYSTAL-STRUCTURE; SUBUNIT; MECHANISM	PA subunit of influenza RNA-dependent RNA polymerase deserves constantly increasing attention due to its essential role in influenza life cycle. N-terminal domain of PA (PA-Nter) harbors endonuclease activity, which is indispensable in viral transcription and replication. Interestingly, existing literature reports on in vitro ion preferences of the enzyme are contradictory. Some show PA-Nter activity exclusively with Mn2+, whereas others report Mg2+ as a natural cofactor. To clarify it, we performed a series of experiments with varied ion concentrations and substrate type. We observed cleavage in the presence of both ions, with a slight preference for manganese, however PA-Nter activity highly depended on the amount of residual, co-purified ions. Furthermore, to quantify cleavage reaction rate, we applied fluorescence cross-correlation spectroscopy (FCCS), providing highly sensitive and real-time monitoring of single molecules. Using nanomolar ssDNA in the regime of enzyme excess, we estimated the maximum reaction rate at 0.81 +/- 0.38 and 1.38 +/- 0.34 nM/min for Mg2+ and Mn2+, respectively. However, our calculations of PA-Nter ion occupancy, based on thermodynamic data, suggest Mg2+ to be a canonical metal in PA-Nter processing of RNA in vivo. Presented studies constitute a step toward better understanding of PA-Nter ion-dependent activity, which will possibly contribute to new successful inhibitor design in the future.	[Kotlarek, Daria; Worch, Remigiusz] Polish Acad Sci, Inst Phys, Phys Biol Lab, Warsaw, Poland; [Kotlarek, Daria] AIT Austrian Inst Technol GmbH, BioSensor Technol, Vienna, Austria	Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Austrian Institute of Technology (AIT)	Worch, R (corresponding author), Polish Acad Sci, Inst Phys, Phys Biol Lab, Warsaw, Poland.	remiwo@ifpan.edu.pl		Worch, Remigiusz/0000-0002-3222-4821	National Science Centre [2012/07/D/NZ1/04255]; Foundation for Polish Science [123/UD/SKILLS/2013]	National Science Centre(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported by the National Science Centre, 2012/07/D/NZ1/04255 (https://www.ncn.gov.pl/?language=en) and the Foundation for Polish Science, 123/UD/SKILLS/2013 (http://www.fnp.org.pl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla NR, 2012, FEBS J, V279, P4492, DOI 10.1111/febs.12035; Bacia K, 2012, CHEMPHYSCHEM, V13, P1221, DOI 10.1002/cphc.201100801; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Crepin T, 2010, J VIROL, V84, P9096, DOI 10.1128/JVI.00995-10; Datta K, 2013, NUCLEIC ACIDS RES, V41, P8289, DOI 10.1093/nar/gkt603; De Clereq E, 2007, TRENDS PHARMACOL SCI, V28, P280, DOI 10.1016/j.tips.2007.04.005; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Doan L, 1999, BIOCHEMISTRY-US, V38, P5612, DOI 10.1021/bi9828932; DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830; Eyers S, 2010, J ROY SOC MED, V103, P403, DOI 10.1258/jrsm.2010.090441; Fedor MJ, 2002, CURR OPIN STRUC BIOL, V12, P289, DOI 10.1016/S0959-440X(02)00324-X; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Hu J, 2015, MED MICROBIOL IMMUN, V204, P137, DOI 10.1007/s00430-014-0349-y; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Jefferson T, 2014, SAO PAULO MED J, V132, P256, DOI 10.1590/1516-3180.20141324T2; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Klumpp K, 2000, J BIOL CHEM, V275, P6181, DOI 10.1074/jbc.275.9.6181; Koppstein D, 2015, NUCLEIC ACIDS RES, V43, P5052, DOI 10.1093/nar/gkv333; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Liu YF, 2009, SCI CHINA SER C, V52, P450, DOI 10.1007/s11427-009-0060-1; Noble E, 2012, VIROLOGY, V433, P27, DOI 10.1016/j.virol.2012.07.008; Palermo G, 2015, ACCOUNTS CHEM RES, V48, P220, DOI 10.1021/ar500314j; Parkes KEB, 2003, J MED CHEM, V46, P1153, DOI 10.1021/jm020334u; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Preaud E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-813; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Stevaert A, 2015, MOL PHARMACOL, V87, P323, DOI 10.1124/mol.114.095588; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Treanor JJ, 2010, VIRAL INFECT HUMANS, P2265; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xiao SY, 2014, J PHYS CHEM B, V118, P873, DOI 10.1021/jp408383g; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	43	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156972	10.1371/journal.pone.0156972	http://dx.doi.org/10.1371/journal.pone.0156972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300442	Green Published, gold			2022-12-26	WOS:000377822200021
J	Lu, XK; Chen, XG; Mu, M; Wang, JJ; Wang, XG; Wang, DL; Yin, ZJ; Fan, WL; Wang, S; Guo, LX; Ye, WW				Lu, Xuke; Chen, Xiugui; Mu, Min; Wang, Junjuan; Wang, Xiaoge; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Guo, Lixue; Ye, Wuwei			Genome-Wide Analysis of Long Noncoding RNAs and Their Responses to Drought Stress in Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; FIBER DEVELOPMENT; REVEALS; PROTEIN; EXPRESSION; SEQUENCE; PROVIDES; IDENTIFICATION; EVOLUTION	Recent researches on long noncoding RNAs (lncRNAs) have expanded our horizon of gene regulation and the cellular complexity. However, the number, characteristics and expression patterns of lncRNAs remain poorly characterized and how these lncRNAs biogenesis are regulated in response to drought stress in cotton are still largely unclear. In the study, using a reproducibility-based RNA-sequencing and bioinformatics strategy to analyze the lncRNAs of 9 samples under three different environment stresses (control, drought stress and re-watering, three replications), we totally identified 10,820 lncRNAs of high-confidence through five strict steps filtration, of which 9,989 were lincRNAs, 153 were inronic lncRNAs, 678 were anti-sense lncRNAs. Coding function analysis showed 6,470 lncRNAs may have the ability to code proteins. Small RNAs precursor analysis revealed that 196 lncRNAs may be the precursors to small RNAs, most of which (35.7%, 70) were miRNAs. Expression patterns analysis showed that most of lncRNAs were expressed at a low level and most inronic lncRNAs (75.95%) had a consistent expression pattern with their adjacent protein-coding genes. Further analysis of transcriptome data uncovered that lncRNAs XLOC_063105 and XLOC_115463 probably function in regulating two adjacent coding genes CotAD_37096 and CotAD_12502, respectively. Investigations of the content of plant hormones and proteomics analysis under drought stress also complemented the prediction. We analyzed the characteristics and the expression patterns of lncRNAs under drought stress and re-watering treatment, and found lncRNAs may be likely to involve in regulating plant hormones pathway in response to drought stress.	[Chen, Xiugui; Mu, Min; Wang, Junjuan; Wang, Xiaoge; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Guo, Lixue; Ye, Wuwei] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China; [Lu, Xuke; Ye, Wuwei] Xinjiang Agr Univ, Coll Agron, Urumqi 830052, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Xinjiang Agricultural University	Ye, WW (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.; Ye, WW (corresponding author), Xinjiang Agr Univ, Coll Agron, Urumqi 830052, Peoples R China.	yew158@163.com			Genetically modified organisms breeding [2014 ZX0800504B]	Genetically modified organisms breeding	This project was supported by grants from the Genetically modified organisms breeding (2014 ZX0800504B).	Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Boerner S, 2012, PLOS ONE, P7; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Charon C, 2010, MOL PLANT, V3, P729, DOI 10.1093/mp/ssq037; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cramer GR, 2001, AUST J PLANT PHYSIOL, V28, P101, DOI 10.1071/PP00101; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Dong YP, 2014, FUNCT INTEGR GENOMIC, V14, P479, DOI 10.1007/s10142-014-0373-4; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gong L, 2013, GENOME BIOL EVOL, V5, P2449, DOI 10.1093/gbe/evt196; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Kapusta A, 2014, TRENDS GENET, V30, P439, DOI 10.1016/j.tig.2014.08.004; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Pandey DM, 2003, BIOL PLANTARUM, V47, P535, DOI 10.1023/B:BIOP.0000041058.65442.41; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Wang MJ, 2015, NEW PHYTOL, V207, P1181, DOI 10.1111/nph.13429; Wang XJ, 2005, GENOME BIOL, P6; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Werner A, 2005, PHYSIOL GENOMICS, V23, P125, DOI 10.1152/physiolgenomics.00124.2005; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; Zhao L, 2012, PHYTOCHEM ANALYSIS, V23, P647, DOI 10.1002/pca.2368; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	51	70	76	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156723	10.1371/journal.pone.0156723	http://dx.doi.org/10.1371/journal.pone.0156723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294517	Green Published, gold			2022-12-26	WOS:000377821300010
J	Hao, Y; Yu, FF; Lv, RT; Ma, CX; Zhang, ZT; Rui, YK; Liu, LM; Cao, WD; Xing, BS				Hao, Yi; Yu, Feifan; Lv, Ruitao; Ma, Chuanxin; Zhang, Zetian; Rui, Yukui; Liu, Liming; Cao, Weidong; Xing, Baoshan			Carbon Nanotubes Filled with Different Ferromagnetic Alloys Affect the Growth and Development of Rice Seedlings by Changing the C:N Ratio and Plant Hormones Concentrations	PLOS ONE			English	Article							SILVER NANOPARTICLES EXPOSURE; OXIDE NANOPARTICLES; ABSCISIC-ACID; CERIA NANOPARTICLES; SEED-GERMINATION; HIGH-TEMPERATURE; SALICYLIC-ACID; WHEAT; ARABIDOPSIS; TOXICITY	The aim of this study was to investigate the phytotoxicity of thin-walled carbon nanotubes (CNTs) to rice (Oryza sativa L.) seedlings. Three different CNTs, including hollow multi-walled carbon nanotubes (MWCNTs), Fe-filled carbon nanotubes (Fe-CNTs), and Fe-Cofilled carbon nanotubes (FeCo-CNTs), were evaluated. The CNTs significantly inhibited rice growth by decreasing the concentrations of endogenous plant hormones. The carbon to nitrogen ratio (C:N ratio) significantly increased in rice roots after treatments with CNTs, and all three types of CNTs had the same effects on the C:N ratio. Interestingly, the increase in the C:N ratio in roots was largely because of decreased N content, indicating that the CNTs significantly decreased N assimilation. Analyses of the Fe and Co contents in plant tissues, transmission electron microscope (TEM) observations and energy dispersive X-ray spectroscopy (EDS) analysis proved that the CNTs could penetrate the cell wall and the cell membrane, and then enter the root cells. According to the author's knowledge, this is the first time to study the relationship between carbon nanotubes and carbon nitrogen ratio and plant hormones.	[Hao, Yi; Zhang, Zetian; Rui, Yukui; Liu, Liming] China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China; [Yu, Feifan; Lv, Ruitao] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Ma, Chuanxin; Rui, Yukui; Xing, Baoshan] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Cao, Weidong] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing 100081, Peoples R China	China Agricultural University; Tsinghua University; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Rui, YK (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China.; Rui, YK (corresponding author), Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA.	ruiyukui@163.com	Ma, Chuanxin/AFO-5267-2022; Xing, Baoshan/AAE-7826-2019; Lv, Ruitao/P-2557-2014	Ma, Chuanxin/0000-0001-5125-7322; Lv, Ruitao/0000-0001-9967-263X	Key National Natural Science Foundation of China [41130526]; National Natural Science Foundation of China [41371471, 51372131]; NSFC-Guangdong Joint Fund [U1401234]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Joint Fund	This work was supported by the Key National Natural Science Foundation of China (No. 41130526), National Natural Science Foundation of China (No. 41371471), NSFC-Guangdong Joint Fund (U1401234), and National Natural Science Foundation of China (No. 51372131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by the Key National Natural Science Foundation of China (No. 41130526), the National Natural Science Foundation of China (No. 41371471) and the NSFC-Guangdong Joint Fund (U1401234). The authors gratefully acknowledge Ouyang Li for technical assistance with ICP-MS. We also acknowledged the support from the National Natural Science Foundation of China (No. 51372131).	Agami RA, 2013, ECOTOX ENVIRON SAFE, V94, P164, DOI 10.1016/j.ecoenv.2013.04.013; Anjum SA, 2011, J AGRON CROP SCI, V197, P177, DOI 10.1111/j.1439-037X.2010.00459.x; Clarke SM, 2009, NEW PHYTOL, V182, P175, DOI 10.1111/j.1469-8137.2008.02735.x; Cools N, 2014, FOREST ECOL MANAG, V311, P3, DOI 10.1016/j.foreco.2013.06.047; Corral-Diaz B, 2014, PLANT PHYSIOL BIOCH, V84, P277, DOI 10.1016/j.plaphy.2014.09.018; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dong W, 2013, PLANT PHYSIOL, V161, P1217, DOI 10.1104/pp.112.211854; Erb M, 2009, THE UNDERESTIMATED R, P653; Garcia-Sanchez S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1530-4; Gawronska H, 2003, PLANT PHYSIOL BIOCH, V41, P605, DOI 10.1016/S0981-9428(03)00059-7; Ghosh M, 2015, MUTAT RES-FUND MOL M, V774, P49, DOI 10.1016/j.mrfmmm.2015.03.004; Gomez LM, 2009, NANO LETT, V9, P3592, DOI 10.1021/nl901802m; Gui X, 2015, RSC ADV, V5, P4554, DOI 10.1039/c4ra13915a; Herrero-Latorre C, 2015, ANAL CHIM ACTA, V853, P77, DOI 10.1016/j.aca.2014.10.008; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Hu YJ, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-42; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Jackson P, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-154; Jain A, 2014, PLANT PHYSIOL BIOCH, V84, P189, DOI 10.1016/j.plaphy.2014.09.013; Ji J, 2011, CHEM ENG J, V170, P525, DOI 10.1016/j.cej.2010.11.026; Khodakovskaya MV, 2013, SMALL, V9, P115, DOI 10.1002/smll.201201225; Khodakovskaya MV, 2012, ACS NANO, V6, P2128, DOI 10.1021/nn204643g; Kim J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00020; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lahiani MH, 2013, ACS APPL MATER INTER, V5, P7965, DOI 10.1021/am402052x; Lam SK, 2012, GLOBAL CHANGE BIOL, V18, P2853, DOI 10.1111/j.1365-2486.2012.02758.x; Lanone S, 2013, ADV DRUG DELIVER REV, V65, P2063, DOI 10.1016/j.addr.2013.07.019; Larue C, 2012, J HAZARD MATER, V227, P155, DOI 10.1016/j.jhazmat.2012.05.033; Nhan LV, 2015, SCI REP-UK, V5, DOI 10.1038/srep11618; Li BQ, 2012, AMINO ACIDS, V43, P2469, DOI 10.1007/s00726-012-1327-6; Li XG, 2014, J HAZARD MATER, V274, P173, DOI 10.1016/j.jhazmat.2014.04.025; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Liu SJ, 2015, PHYSIOL PLANTARUM, V154, P142, DOI 10.1111/ppl.12292; Liu Z, 2015, RICE, V8, DOI 10.1186/s12284-015-0042-9; Lv RT, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3042099; Ma YH, 2015, NANOTOXICOLOGY, V9, P262, DOI 10.3109/17435390.2014.921344; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Mansouri H, 2009, J INTEGR PLANT BIOL, V51, P553, DOI 10.1111/j.1744-7909.2009.00833.x; Miralles P, 2012, J R SOC INTERFACE, V9, P3514, DOI 10.1098/rsif.2012.0535; Mittal G, 2015, J IND ENG CHEM, V21, P11, DOI 10.1016/j.jiec.2014.03.022; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Mondal A, 2011, J NANOPART RES, V13, P4519, DOI 10.1007/s11051-011-0406-z; Mukherjee A, 2014, CHEM ENG J, V258, P394, DOI 10.1016/j.cej.2014.06.112; Nair PMG, 2014, CHEMOSPHERE, V112, P105, DOI 10.1016/j.chemosphere.2014.03.056; PATEL V, 2011, NANOTECH INSIGHTS, V2, P31; Peralta-Videa JR, 2014, PLANT PHYSIOL BIOCH, V80, P128, DOI 10.1016/j.plaphy.2014.03.028; Poborilova Z, 2013, ENVIRON EXP BOT, V91, P1, DOI 10.1016/j.envexpbot.2013.03.002; Royer M, 2013, PHYTOCHEMISTRY, V88, P25, DOI 10.1016/j.phytochem.2012.12.003; Rui YK, 2015, ENVIRON POLLUT, V198, P8, DOI 10.1016/j.envpol.2014.12.017; Savchenko T, 2014, PLANT PHYSIOL, V164, P1151, DOI 10.1104/pp.113.234310; Serag MF, 2011, ACS NANO, V5, P493, DOI 10.1021/nn102344t; Shaw AK, 2014, ENVIRON EXP BOT, V102, P37, DOI 10.1016/j.envexpbot.2014.02.016; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Shu HM, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1823-x; Shukla D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00652; Singh S, 2015, PLANT GROWTH REGUL, V77, P87, DOI 10.1007/s10725-015-0039-9; Song J, 2014, BIOTECHNOL LETT, V36, P1043, DOI 10.1007/s10529-013-1436-7; Srivastava V, 2015, IND ENG CHEM RES, V54, P6209, DOI 10.1021/acs.iecr.5b01610; Syu YY, 2014, PLANT PHYSIOL BIOCH, V83, P57, DOI 10.1016/j.plaphy.2014.07.010; Thuesombat P, 2014, ECOTOX ENVIRON SAFE, V104, P302, DOI 10.1016/j.ecoenv.2014.03.022; Tripathi S, 2011, NANOSCALE, V3, P1176, DOI 10.1039/c0nr00722f; Le VN, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0050-8; Vannini C, 2014, J PLANT PHYSIOL, V171, P1142, DOI 10.1016/j.jplph.2014.05.002; Wang WX, 2007, CARBON, V45, P1127, DOI 10.1016/j.carbon.2006.12.029; Wang XP, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0841-5; Wang Y, 2002, CHEM PHYS LETT, V364, P568, DOI 10.1016/S0009-2614(02)01384-2; Yan SH, 2013, J HAZARD MATER, V246, P110, DOI 10.1016/j.jhazmat.2012.12.013; Yang Y, 2011, PLANT SOIL, V346, P215, DOI 10.1007/s11104-011-0811-1; Zhai GS, 2015, ENVIRON SCI TECHNOL, V49, P7380, DOI 10.1021/acs.est.5b01145; Zhang P, 2015, NANOTOXICOLOGY, V9, P1, DOI 10.3109/17435390.2013.855829; Zhang Q, 2013, SMALL, V9, P1237, DOI 10.1002/smll.201203252; Zhang Q, 2011, CHEMSUSCHEM, V4, P864, DOI 10.1002/cssc.201100177; Zhang X, 2014, J INTEGR AGR, V13, P82, DOI 10.1016/S2095-3119(13)60348-2; Zhao XC, 2012, ENVIRON INT, V40, P244, DOI 10.1016/j.envint.2011.12.003; Zhu Y, 2015, PLANT CELL PHYSIOL, V56, P1442, DOI 10.1093/pcp/pcv061	75	40	42	9	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157264	10.1371/journal.pone.0157264	http://dx.doi.org/10.1371/journal.pone.0157264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284692	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000052
J	Saikkonen, K; Phillips, TD; Faeth, SH; McCulley, RL; Saloniemi, I; Helander, M				Saikkonen, Kari; Phillips, Timothy D.; Faeth, Stanley H.; McCulley, Rebecca L.; Saloniemi, Irma; Helander, Marjo			Performance of Endophyte Infected Tall Fescue in Europe and North America	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; PLANT INVASIONS; DIVERSITY; GRASS; ALKALOIDS; RANGE; RESISTANCE; EVOLUTION; SYMBIOSIS; ECOLOGY	Human assisted plant invasions from Europe to North America have been more common than the reverse. We tested endophyte-mediated performance of tall fescue in parallel three year experiments in Europe and the USA using endophyte infected and uninfected wild and cultivated plants. Experimental plants were subjected to nutrient and water treatments. Whereas endophyte infection increased tall fescue performance in general, the effects of endophytes on plant growth and reproduction varied among plant origins under different environmental conditions. Naturally endophyte-free Finnish cultivar 'Retu' performed equally well as 'Kentucky-31' in both geographic locations. All Eurasian origin plants performed well in the US. In Finland, plants established well and both cultivars survived over the first winter. However, winter mortality of 'Kentucky-31' plants was higher, particularly in fertilized soils in the subsequent winters. Our results suggest that tall fescue ecotype 'Kentucky-31' that flourishes in North America is poorly adapted to Northern European conditions.	[Saikkonen, Kari; Helander, Marjo] Nat Resources Inst Finland Luke, Turku, Finland; [Phillips, Timothy D.; McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Faeth, Stanley H.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Saloniemi, Irma; Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland	Natural Resources Institute Finland (Luke); University of Kentucky; University of North Carolina; University of North Carolina Greensboro; University of Turku	Saikkonen, K (corresponding author), Nat Resources Inst Finland Luke, Turku, Finland.	kari.saikkonen@luke.fi	Saloniemi, Irma/C-8893-2011	Helander, Marjo/0000-0002-9759-4321				Afkhami ME, 2014, ECOL LETT, V17, P1265, DOI 10.1111/ele.12332; ARECHAVALETA M, 1992, APPL ENVIRON MICROB, V58, P857, DOI 10.1128/AEM.58.3.857-861.1992; BACON CW, 1977, APPL ENVIRON MICROB, V34, P576, DOI 10.1128/AEM.34.5.576-581.1977; BALL DM, 1993, AM SCI, V81, P370; Belesky DP, 1997, ANN BOT-LONDON, V79, P259, DOI 10.1006/anbo.1996.0342; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bhamidimarri S, 2012, CROP SCI, V52, P413, DOI 10.2135/cropsci2010.11.0660; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Clay K, 2005, P NATL ACAD SCI USA, V102, P12465, DOI 10.1073/pnas.0503059102; Clay K, 2009, MYCOL SER, V27, P9; DARWIN C, 1872, ORIGIN SPECIES, V1; Elton C. S., 1958, ECOLOGY INVASIONS AN; Firn J, 2011, ECOL LETT, V14, P274, DOI 10.1111/j.1461-0248.2010.01584.x; Hand ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-303; HOVELAND CS, 1993, AGR ECOSYST ENVIRON, V44, P3, DOI 10.1016/0167-8809(93)90036-O; Lehtonen P, 2005, ECOL LETT, V8, P1256, DOI 10.1111/j.1461-0248.2005.00834.x; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Mack R. N., 1989, BIOL INVASIONS GLOBA, P155; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Malinowski DP, 2008, AUST J AGR RES, V59, P1092, DOI 10.1071/AR08084; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; MARX DH, 1977, CAN J MICROBIOL, V23, P217, DOI 10.1139/m77-033; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Murray J. J., 1979, Agronomy, P293; Niemela P, 1996, BIOSCIENCE, V46, P741, DOI 10.2307/1312850; Pringle A, 2009, MOL ECOL, V18, P817, DOI 10.1111/j.1365-294X.2008.04030.x; R Core Team, 2012, R LANG ENV STAT COMP; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Saari S, 2010, MICROB ECOL, V60, P928, DOI 10.1007/s00248-010-9749-8; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2000, SCIENCE, V287, P1887; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Saikkonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011395; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saxena P, 2014, CROP SCI, V54, P1205, DOI 10.2135/cropsci2013.08.0565; Seastedt TR, 2011, ANNU REV ECOL EVOL S, V42, P133, DOI 10.1146/annurev-ecolsys-102710-145057; STEVENS GC, 1991, ANNU REV ECOL SYST, V22, P177, DOI 10.1146/annurev.es.22.110191.001141; Takach JE, 2012, APPL ENVIRON MICROB, V78, P5501, DOI 10.1128/AEM.01084-12; VANSANTEN E, 1991, PLANT BREEDING, V107, P210, DOI 10.1111/j.1439-0523.1991.tb01208.x; Winter M, 2010, GLOBAL ECOL BIOGEOGR, V19, P332, DOI 10.1111/j.1466-8238.2010.00520.x; Young CA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00095	50	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157382	10.1371/journal.pone.0157382	http://dx.doi.org/10.1371/journal.pone.0157382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284909	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000062
J	Wu, XC; Zhao, LL; Chen, Z; Ji, X; Qiao, XF; Jin, YP; Liu, W				Wu, Xiaochun; Zhao, Lingling; Chen, Zhi; Ji, Xin; Qiao, Xianfeng; Jin, Yaping; Liu, Wei			FLCN Maintains the Leucine Level in Lysosome to Stimulate mTORC1	PLOS ONE			English	Article							BIRT-HOGG-DUBE; AMINO-ACID TRANSPORTERS; TUMOR-SUPPRESSOR; RAG GTPASES; CELL-LINE; BHD GENE; COMPLEX; FOLLICULIN; ACTIVATION; INTERACTS	The intracellular amino acid pool within lysosome is a signal that stimulates the nutrient-sensing mTORC1 signalling pathway. The signal transduction cascade has garnered much attention, but little is known about the sequestration of the signalling molecules within the lysosome. Using human HEK293 cells as a model, we found that suppression of the BHD syndrome gene FLCN reduced the leucine level in lysosome, which correlated with decreased mTORC1 activity. Both consequences could be reversed by supplementation with high levels of leucine, but not other tested amino acids. Conversely, overexpressed FLCN could sequester lysosomal leucine and stimulate mTORC1 in an amino acid limitation environment. These results identify a novel function of FLCN: it controls mTORC1 by modulating the leucine signal in lysosome. Furthermore, we provided evidence that FLCN exerted this role by inhibiting the accumulation of the amino acid transporter PAT1 on the lysosome surface, thereby maintaining the signal level within the organelle.	[Wu, Xiaochun; Zhao, Lingling; Chen, Zhi; Ji, Xin; Qiao, Xianfeng; Jin, Yaping; Liu, Wei] Northwest Agr & Forest Univ, Minist Agr, Coll Vet Med, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Jin, YP; Liu, W (corresponding author), Northwest Agr & Forest Univ, Minist Agr, Coll Vet Med, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	yapingjin@163.com; wliucn150@yahoo.com			NWAF [Z111021005]; National Natural Science Foundation of China [31372256]	NWAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in whole or part by a NWAF grant [http://www.nwsuaf.edu.cn/ (Z111021005) and a National Natural Science Foundation of China [http://www.nsfc.gov.cn/] (31372256) to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Berra E, 2006, ANN LIMNOL-INT J LIM, V42, P79, DOI 10.1051/limn/2006012; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cash TP, 2011, ONCOGENE, V30, P2534, DOI 10.1038/onc.2010.628; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Dunlop EA, 2014, AUTOPHAGY, V10, P1749, DOI 10.4161/auto.29640; Fiandra L, 2010, J INSECT PHYSIOL, V56, P165, DOI 10.1016/j.jinsphys.2009.09.015; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Goncharova EA, 2014, CELL REP, V7, P412, DOI 10.1016/j.celrep.2014.03.025; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Khabibullin D, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12107; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Liu B, 2012, SCIENCE, V337, P351, DOI 10.1126/science.1220281; Liu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065869; Luijten MNH, 2013, HUM MOL GENET, V22, P4383, DOI 10.1093/hmg/ddt288; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Neufeld TP, 2003, CURR TOP MICROBIOL, V279, P139; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nookala RK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120071; Ogmundsdottir MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036616; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Possik E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004273; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Roberg KJ, 1997, GENETICS, V147, P1569; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt LS, 2013, FAM CANCER, V12, P357, DOI 10.1007/s10689-012-9574-y; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Tee AR, 2013, FAM CANCER, V12, P367, DOI 10.1007/s10689-012-9576-9; Thwaites DT, 2011, BRIT J PHARMACOL, V164, P1802, DOI 10.1111/j.1476-5381.2011.01438.x; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wreden CC, 2003, J NEUROSCI, V23, P1265, DOI 10.1523/JNEUROSCI.23-04-01265.2003; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	49	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157100	10.1371/journal.pone.0157100	http://dx.doi.org/10.1371/journal.pone.0157100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280402	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000084
J	Nguyen, DT; Gomez-Zurita, J				Nguyen, Dinh T.; Gomez-Zurita, Jesus			Subtle Ecological Gradient in the Tropics Triggers High Species-Turnover in a Local Geographical Scale	PLOS ONE			English	Article							GEOMETRID MOTHS LEPIDOPTERA; BETA-DIVERSITY PATTERNS; COMMUNITY COMPOSITION; ELEVATIONAL PATTERNS; DIVERGENCE TIMES; SPATIAL SCALE; R PACKAGE; RICHNESS; CHRYSOMELIDAE; ASSEMBLAGES	Our perception of diversity, including both alpha- and beta-diversity components, depends on spatial scale. Studies of spatial variation of the latter are just starting, with a paucity of research on beta-diversity patterns at smaller scales. Understanding these patterns and the processes shaping the distribution of diversity is critical to describe this diversity, but it is paramount in conservation too. Here, we investigate the diversity and structure of a tropical community of herbivorous beetles at a reduced local scale of some 10 km(2), evaluating the effect of a small, gradual ecological change on this structure. We sampled leaf beetles in the Nui Chua National Park (S Vietnam), studying changes in alpha-and beta-diversity across an elevation gradient up to 500 m, encompassing the ecotone between critically endangered lowland dry deciduous forest and mixed evergreen forest at higher elevations. Leaf beetle diversity was assessed using several molecular tree-based species delimitation approaches (with mtDNA cox1 data), species richness using rarefaction and incidence-based diversity indexes, and beta-diversity was investigated decomposing the contribution of species turnover and nestedness. We documented 155 species in the area explored and species-richness estimates 1.5-2.0x higher. Species diversity was similar in both forest types and changes in alpha-diversity along the elevation gradient showed an expected local increase of diversity in the ecotone. Beta-diversity was high among forest paths (average Sorensen's dissimilarity = 0.694) and, tentatively fixing at 300 m the boundary between otherwise continuous biomes, demonstrated similarly high beta-diversity (Sorensen's dissimilarity = 0.581), with samples clustering according to biome/elevation. Highly relevant considering the local scale of the study, beta-diversity had a high contribution of species replacement among locales (54.8%) and between biomes (79.6%), suggesting environmental heterogeneity as the dominant force shaping diversity at such small scale, directly and indirectly on the plant communities. Protection actions in the Park, especially these addressed at the imperative conservation of dry forest, must ponder the small scale at which processes shape species diversity and community structure for inconspicuous, yet extraordinarily diverse organisms such as the leaf beetles.	[Nguyen, Dinh T.; Gomez-Zurita, Jesus] CSIC Univ Pompeu Fabra, Inst Evolutionary Biol, Anim Biodivers & Evolut, Barcelona, Spain; [Nguyen, Dinh T.] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, 18 Hoang Quoc Viet, Hanoi, Vietnam	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Vietnam Academy of Science & Technology (VAST)	Gomez-Zurita, J (corresponding author), CSIC Univ Pompeu Fabra, Inst Evolutionary Biol, Anim Biodivers & Evolut, Barcelona, Spain.	j.gomez-zurita@csic.es	Gomez-Zurita, Jesus/C-4248-2008; Nguyen, Dinh/AAU-2573-2021	Gomez-Zurita, Jesus/0000-0001-7337-6541; Nguyen, Dinh/0000-0002-2706-8166	Grup de Recerca Consolidad en Biologia Animal i Evolucio [2014SGR1532]; Spanish Ministry of Economy and Competitiveness	Grup de Recerca Consolidad en Biologia Animal i Evolucio; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work results from the activity in the "Grup de Recerca Consolidad en Biologia Animal i Evolucio" (project 2014SGR1532) and was possible thanks to funds from the Spanish Ministry of Economy and Competitiveness to promote a Scientific Cooperation Agreement between the Spanish High Research Council (CSIC) and the Vietnamese Academy of Sciences and Technology (VAST). These funds allowed a three-year predoctoral training period for NTD in the lab of the senior author.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2021, SPLITS SPECIES LIMIT; Gomez-Anaya JA, 2011, REV BIOL TROP, V59, P1559; Axmacher JC, 2004, DIVERS DISTRIB, V10, P293, DOI 10.1111/j.1366-9516.2004.00101.x; Aynekulu E, 2012, BIODIVERS CONSERV, V21, P2691, DOI 10.1007/s10531-012-0328-9; Bach K, 2007, DIVERS DISTRIB, V13, P863, DOI 10.1111/j.1472-4642.2007.00357.x; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Brehm G, 2004, J TROP ECOL, V20, P165, DOI 10.1017/S0266467403001184; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Charles E, 2005, J TROP ECOL, V21, P329, DOI 10.1017/S0266467405002300; Colwell RK, 2013, ESTIMATES STAT ESTIM; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dossa GGO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067720; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunn RR, 2007, GLOBAL ECOL BIOGEOGR, V16, P305, DOI 10.1111/j.1466-8238.2006.00284.x; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; Escobar F, 2006, J BIOGEOGR, V33, P1793, DOI 10.1111/j.1365-2699.2006.01528.x; Flowers R. Wills, 2003, International Congress of Entomology Proceedings, V21, P25; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Lopez A, 2013, J BIOGEOGR, V40, P2134, DOI 10.1111/jbi.12148; Garcia-Lopez A, 2012, DIVERS DISTRIB, V18, P543, DOI 10.1111/j.1472-4642.2011.00846.x; Gomez-Hernandez M, 2012, BIODIVERS CONSERV, V21, P2247, DOI 10.1007/s10531-011-0180-3; Gomez-Zurita J, 2012, ZOOL SCR, V41, P47, DOI 10.1111/j.1463-6409.2011.00500.x; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Jamoneau A, 2012, ECOGRAPHY, V35, P124, DOI 10.1111/j.1600-0587.2011.06900.x; Jankowski JE, 2009, J ANIM ECOL, V78, P315, DOI 10.1111/j.1365-2656.2008.01487.x; Sanchez-Reyes UJ, 2014, ZOOKEYS, P103, DOI 10.3897/zookeys.417.7551; Keil P, 2012, J BIOGEOGR, V39, P1473, DOI 10.1111/j.1365-2699.2012.02701.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; KIMOTO S, 1989, Esakia, P1; KIMOTO S, 1981, PAC INSECTS, V23, P286; Kimoto S, 1982, ESAKIA, V18, P1; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Lloyd H, 2012, AUSTRAL ECOL, V37, P470, DOI 10.1111/j.1442-9993.2011.02308.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Mohamedsaid MS, 2004, CATALOGUE MALAYSIAN; Molina-Martinez A, 2013, J INSECT CONSERV, V17, P1169, DOI 10.1007/s10841-013-9598-0; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Novotny V, 2005, ANN ZOOL FENN, V42, P463; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Ochoa-Ochoa LM, 2014, REV MEX BIODIVERS, V85, P918, DOI 10.7550/rmb.38737; Odegaard F., 2006, BIODIVERS CONSERV, V15, P69; Olivier PI, 2014, J BIOGEOGR, V41, P1428, DOI 10.1111/jbi.12303; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; R Development Core Team, 2014, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rambaut A., 2014, TRACER V1 6; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Tello JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121458; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sorensen T., 1948, BIOL SKAR, V5, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Szava-Kovats RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110485; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Thormann B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148268; Voda R, 2015, ECOGRAPHY, V38, P405, DOI 10.1111/ecog.00762; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; Wang SP, 2014, ECOL LETT, V17, P891, DOI 10.1111/ele.12292; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	82	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156840	10.1371/journal.pone.0156840	http://dx.doi.org/10.1371/journal.pone.0156840			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276228	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700039
J	Yue, YJ; Guo, TT; Yuan, C; Liu, JB; Guo, J; Feng, RL; Niu, CN; Sun, XP; Yang, BH				Yue, Yaojing; Guo, Tingting; Yuan, Chao; Liu, Jianbin; Guo, Jian; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui			Integrated Analysis of the Roles of Long Noncoding RNA and Coding RNA Expression in Sheep (Ovis aries) Skin during Initiation of Secondary Hair Follicle	PLOS ONE			English	Article							COLLAGEN-VI CHAINS; DIFFERENTIAL EXPRESSION; MORPHOGENESIS; BIOLOGY; IDENTIFICATION; REVEALS; TRANSCRIPTOMES; ANNOTATION; MECHANISMS; GENOMICS	Initiation of hair follicle (HF) is the first and most important stage of HF morphogenesis. However the precise molecular mechanism of initiation of hair follicle remains elusive. Meanwhile, in previous study, the more attentions had been paid to the function of genes, while the roles of non-coding RNAs (such as long noncoding RNA and microRNA) had not been described. Therefore, the roles of long noncoding RNA(LncRNA) and coding RNA in sheep skin during the initiation of sheep secondary HF were integrated and analyzed, by using strand-specific RNA sequencing (ssRNA-seq). A total of 192 significant differentially expressed genes were detected, including 67 up-regulated genes and 125 down-regulated genes between stage 0 and stage 1 of HF morphogenesis during HF initiation. Only Wnt2, FGF20 were just significant differentially expressed among Wnt, Shh, Notch and BMP signaling pathways. Further expression profile analysis of lncRNAs showed that 884 novel lncRNAs were discovered in sheep skin expression profiles. A total of 15 lncRNAs with significant differential expression were detected, 6 up-regulated and 9 down-regulated. Among of differentially expressed genes and LncRNA, XLOC002437 lncRNA and potential target gene COL6A6 were all significantly down-regulated in stage 1. Furthermore, by using RNA-hybrid, XLOC005698 may be as a competing endogenous RNA "sponges" oar-miR-39555p activity. Gene Ontology and KEGG pathway analyses indicated that the significantly enriched pathway was peroxisome proliferator-activated receptors (PPARs) pathway (corrected P-value < 0.05), indicating that PPAR pathway is likely to play significant roles during the initiation of secondary HF. Results suggest that the key differentially expressed genes and LncRNAs may be considered as potential candidate genes for further study on the molecular mechanisms of HF initiation, as well as supplying some potential values for understanding human hair disorders.	[Yue, Yaojing; Guo, Tingting; Yuan, Chao; Liu, Jianbin; Guo, Jian; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Yang, BH (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China.	lzyangbohui@163.com			Central Level, Scientific Research Institutes for Basic R & D Special Fund Business [1610322015014]; Earmarked Fund for Modern China Wool & Cashmere Technology Research System [nycytx-40-3]; National Natural Science Foundation for Young Scholars of China [31402057]	Central Level, Scientific Research Institutes for Basic R & D Special Fund Business; Earmarked Fund for Modern China Wool & Cashmere Technology Research System; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This study was supported by the Central Level, Scientific Research Institutes for Basic R & D Special Fund Business (Grant No. 1610322015014), the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (Grant No. nycytx-40-3), and the National Natural Science Foundation for Young Scholars of China (Grant No. 31402057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Central Level, Scientific Research Institutes for Basic R & D Special Fund Business (Grant No. 1610322015014), the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (Grant No. nycytx-40-3), and the National Natural Science Foundation for Young Scholars of China (Grant No. 31402057).	Al-Nuaimi Y, 2010, EXP DERMATOL, V19, P707, DOI 10.1111/j.1600-0625.2010.01114.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Botchkarev VA, 2006, J INVEST DERMATOL, V126, P1719, DOI 10.1038/sj.jid.5700270; Botchkareva NV, 2006, J INVEST DERMATOL, V126, P258, DOI 10.1038/sj.jid.5700007; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Bushby KMD, 2014, ADV EXP MED BIOL, V802, P185, DOI 10.1007/978-94-007-7893-1_12; Cadau S, 2013, EUR J DERMATOL, V23, P4, DOI 10.1684/ejd.2013.1972; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Fu J, 2013, J INVEST DERMATOL, V133, P890, DOI 10.1038/jid.2012.407; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Hanley K, 1999, J INVEST DERMATOL, V113, P788, DOI 10.1046/j.1523-1747.1999.00743.x; HARDY MARGARET H., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P423; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Huh SH, 2013, GENE DEV, V27, P450, DOI 10.1101/gad.198945.112; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kamberov YG, 2015, P NATL ACAD SCI USA, V112, P9932, DOI 10.1073/pnas.1511680112; Khorkova O, 2014, HUM MOL GENET, V23, pR54, DOI 10.1093/hmg/ddu207; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Liang WC, 2015, ONCOTARGET; Lim X, 2013, COLD SPRING HARBOR P, V5, DOI DOI 10.1101/CSHPERSPECTA008029; Lin CM, 2014, BIOCHEM BIOPH RES CO, V453, P508, DOI 10.1016/j.bbrc.2014.09.119; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Nishizawa M, 2015, FRONT BIOSCI-LANDMRK, V20, P1, DOI 10.2741/4297; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rippa A, 2015, HISTOCHEM CELL BIOL, V143, P481, DOI 10.1007/s00418-014-1291-1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers GE, 2006, EXP DERMATOL, V15, P931, DOI 10.1111/j.1600-0625.2006.00512.x; Sabatelli P, 2011, J INVEST DERMATOL, V131, P99, DOI 10.1038/jid.2010.284; Sen R, 2014, SCI WORLD J, DOI 10.1155/2014/896206; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tagliavini F, 2014, BBA-MOL BASIS DIS, V1842, P1604, DOI 10.1016/j.bbadis.2014.05.033; Thiboutot D, 2004, J INVEST DERMATOL, V123, P1, DOI 10.1111/j.1523-1747.2004.t01-2-.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wan DC, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015404; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; [吴瑜瑜 Wu Yuyu], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1923; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yue Y, 2015, PLOS ONE, V10, DOI [10.1371/tournal.pone.0129249, DOI 10.1371/TOURNAL.PONE.0129249]; Zhao LX, 2011, MOL BIOL REP, V38, P3495, DOI 10.1007/s11033-010-0460-0	73	31	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156890	10.1371/journal.pone.0156890	http://dx.doi.org/10.1371/journal.pone.0156890			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276011	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700044
J	Demares, FJ; Crous, KL; Pirk, CWW; Nicolson, SW; Human, H				Demares, Fabien J.; Crous, Kendall L.; Pirk, Christian W. W.; Nicolson, Susan W.; Human, Hannelie			Sucrose Sensitivity of Honey Bees Is Differently Affected by Dietary Protein and a Neonicotinoid Pesticide	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; APIS-MELLIFERA; RESPONSE THRESHOLDS; FORAGING BEHAVIOR; COLONY LOSSES; NUTRITION; EXPOSURE; SURVIVAL; HISTOCHEMISTRY; CURRENTS	Over a decade, declines in honey bee colonies have raised worldwide concerns. Several potentially contributing factors have been investigated, e.g. parasites, diseases, and pesticides. Neonicotinoid pesticides have received much attention due to their intensive use in crop protection, and their adverse effects on many levels of honey bee physiology led the European Union to ban these compounds. Due to their neuronal target, a receptor expressed throughout the insect nervous system, studies have focused mainly on neuroscience and behaviour. Through the Geometric Framework of nutrition, we investigated effects of the neonicotinoid thiamethoxam on survival, food consumption and sucrose sensitivity of honey bees (Apis mellifera). Thiamethoxam did not affect protein and carbohydrate intake, but decreased responses to high concentrations of sucrose. Interestingly, when bees ate fixed unbalanced diets, dietary protein facilitated better sucrose detection. Both thiamethoxam and dietary protein influenced survival. These findings suggest that, in the presence of a pesticide and unbalanced food, honey bee health may be severely challenged. Consequences for foraging efficiency and colony activity, cornerstones of honey bee health, are also discussed.	[Demares, Fabien J.; Crous, Kendall L.; Pirk, Christian W. W.; Nicolson, Susan W.; Human, Hannelie] Univ Pretoria, Dept Zool & Entomol, Social Res Insect Grp, Private Bag X20, ZA-0028 Pretoria, South Africa	University of Pretoria	Demares, FJ (corresponding author), Univ Pretoria, Dept Zool & Entomol, Social Res Insect Grp, Private Bag X20, ZA-0028 Pretoria, South Africa.	fabien.demares@zoology.up.ca.za	Pirk, Christian/E-4180-2010; Demares, Fabien/I-6679-2016	Pirk, Christian/0000-0001-6821-7044; Demares, Fabien/0000-0002-2638-4247; Human, Hannelie/0000-0002-3887-1202; Nicolson, Susan/0000-0001-6024-9383	University of Pretoria	University of Pretoria	FJD is supported by a postdoctoral fellowship from the University of Pretoria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Altaye SZ, 2010, J EXP BIOL, V213, P3311, DOI 10.1242/jeb.046953; Archer CR, 2014, FUNCT ECOL, V28, P913, DOI 10.1111/1365-2435.12226; Arganda S, 2014, J INSECT PHYSIOL, V69, P19, DOI 10.1016/j.jinsphys.2014.04.002; Armengaud C, 2000, BRAIN RES, V859, P390, DOI 10.1016/S0006-8993(00)02016-3; Barbara GS, 2005, J COMP PHYSIOL A, V191, P823, DOI 10.1007/s00359-005-0007-3; Bazazi S, 2011, P ROY SOC B-BIOL SCI, V278, P356, DOI 10.1098/rspb.2010.1447; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Cutler GC, 2015, PEST MANAG SCI, V71, P1368, DOI 10.1002/ps.4042; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Demares F, 2014, PHARMACOL BIOCHEM BE, V124, P137, DOI 10.1016/j.pbb.2014.05.025; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Dupuis JP, 2011, J NEUROPHYSIOL, V106, P1604, DOI 10.1152/jn.00126.2011; Dussutour A, 2012, P ROY SOC B-BIOL SCI, V279, P2402, DOI 10.1098/rspb.2012.0051; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Fewell J, 1992, BEHAV ECOL SOCIOBIOL, V30; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Henry M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2110; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Human H, 2014, J INSECT PHYSIOL, V69, P74, DOI 10.1016/j.jinsphys.2014.03.012; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Kohler A, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.03; Kohler A, 2012, J INSECT PHYSIOL, V58, P918, DOI 10.1016/j.jinsphys.2012.04.007; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lihoreau M, 2014, J INSECT PHYSIOL, V69, P2, DOI 10.1016/j.jinsphys.2014.03.004; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Nicodemo D, 2014, ENVIRON TOXICOL CHEM, V33, P2070, DOI 10.1002/etc.2655; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P387, DOI 10.1007/BF00177334; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pirk CWW, 2016, APIDOLOGIE, V47, P276, DOI 10.1007/s13592-015-0406-6; Pirk CWW, 2014, J APICULT RES, V53, P35, DOI 10.3896/IBRA.1.53.1.03; Ponton F, 2013, J INSECT PHYSIOL, V59, P130, DOI 10.1016/j.jinsphys.2012.10.011; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Simpson SJ, 2012, NATURE NUTR UNIFYING; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; SMIRLE MJ, 1993, PHYSIOL ENTOMOL, V18, P420, DOI 10.1111/j.1365-3032.1993.tb00616.x; Stabler D, 2015, J EXP BIOL, V218, P793, DOI 10.1242/jeb.114249; Stanley DA, 2015, NATURE, V528, P548, DOI 10.1038/nature16167; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wolschin F, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-10	69	26	28	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156584	10.1371/journal.pone.0156584	http://dx.doi.org/10.1371/journal.pone.0156584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272274	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000020
J	Eslami-Mossallam, B; Schram, RD; Tompitak, M; van Noort, J; Schiessel, H				Eslami-Mossallam, Behrouz; Schram, Raoul D.; Tompitak, Marco; van Noort, John; Schiessel, Helmut			Multiplexing Genetic and Nucleosome Positioning Codes: A Computational Approach	PLOS ONE			English	Article							IN-VITRO; MOLECULAR-DYNAMICS; CORE PARTICLE; DNA; ORGANIZATION; CHROMATIN; BINDING; MAP	Eukaryotic DNA is strongly bent inside fundamental packaging units: the nucleosomes. It is known that their positions are strongly influenced by the mechanical properties of the underlying DNA sequence. Here we discuss the possibility that these mechanical properties and the concomitant nucleosome positions are not just a side product of the given DNA sequence, e.g. that of the genes, but that a mechanical evolution of DNA molecules might have taken place. We first demonstrate the possibility of multiplexing classical and mechanical genetic information using a computational nucleosome model. In a second step we give evidence for genome-wide multiplexing in Saccharomyces cerevisiae and Schizosacharomyces pombe. This suggests that the exact positions of nucleosomes play crucial roles in chromatin function.	[Eslami-Mossallam, Behrouz; Schram, Raoul D.; Tompitak, Marco; Schiessel, Helmut] Leiden Univ, Inst Lorentz Theoret Phys, Niels Bohrweg 2, Leiden, Netherlands; [Eslami-Mossallam, Behrouz; van Noort, John] Leiden Univ, Huygens Kamerlingh Onnes Lab, Biol & Soft Matter Phys, Niels Bohrweg 2, NL-2333 CA Leiden, Netherlands; [Eslami-Mossallam, Behrouz] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Delft University of Technology	Schiessel, H (corresponding author), Leiden Univ, Inst Lorentz Theoret Phys, Niels Bohrweg 2, Leiden, Netherlands.	schiessel@lorentz.leidenuniv.nl	van Noort, John/B-1242-2008	van Noort, John/0000-0002-9094-5598; Tompitak, Marco/0000-0003-4275-2262	NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) - Dutch Ministry of Education, Culture and Science (OCW); research programme of the Foundation for Fundamental Research on Matter (FOM) - NWO; NWO-VICI program; National Science Foundation [NSF PHY11-25915]	NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) - Dutch Ministry of Education, Culture and Science (OCW); research programme of the Foundation for Fundamental Research on Matter (FOM) - NWO; NWO-VICI program; National Science Foundation(National Science Foundation (NSF))	This research is supported by the NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) that is funded by the Dutch Ministry of Education, Culture and Science (OCW) and by the research programme of the Foundation for Fundamental Research on Matter (FOM), which is financially supported by NWO; and by the NWO-VICI program (JN). HS thanks the KITP at Santa Barbara for hospitality where part of this work has been performed and the National Science Foundation under Grant No. NSF PHY11-25915 for support.; This study has been inspired by the work of the late Jonathan Widom. We would like to acknowledge Arman Fathizadeh for fruitful discussions. This research is supported by the NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) that is funded by the Dutch Ministry of Education, Culture and Science (OCW); by the research programme of the Foundation for Fundamental Research on Matter (FOM), which is financially supported by NWO; and by the NWO-VICI program. HS thanks the KITP at Santa Barbara for hospitality where part of this work has been performed and the National Science Foundation under Grant No. NSF PHY11-25915 for support.	Becker NB, 2006, NUCLEIC ACIDS RES, V34, P5638, DOI 10.1093/nar/gkl683; Becker NB, 2009, STRUCTURE, V17, P579, DOI 10.1016/j.str.2009.01.013; Bettecken T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-273; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; CALLADINE CR, 1984, J MOL BIOL, V178, P773, DOI 10.1016/0022-2836(84)90251-1; Coleman BD, 2003, J CHEM PHYS, V118, P7127, DOI 10.1063/1.1559690; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Diament A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6876; Fathizadeh A, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13021-4; Freeman GS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.168101; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Jin H, 2016, NUCLEIC ACIDS RES, V44, P2047, DOI 10.1093/nar/gkw101; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kodgire P, 2012, MOL CELL BIOL, V32, P2030, DOI 10.1128/MCB.06722-11; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Liu H, 2014, BRIEF BIOINFORM, V15, P1014, DOI 10.1093/bib/bbt062; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; Moyle-Heyrman G, 2013, P NATL ACAD SCI USA, V110, P20158, DOI 10.1073/pnas.1315809110; Nalabothula N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-391; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Rosanio G, 2015, BIOPOLYMERS, V103, P303, DOI 10.1002/bip.22608; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Teif VB, 2016, BRIEF BIOINFORM, V17, P745, DOI 10.1093/bib/bbv086; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; TRIFONOV EN, 1989, B MATH BIOL, V51, P417, DOI 10.1007/BF02460081; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Vaillant C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.218103; van Loenhout MTJ, 2012, SCIENCE, V338, P94, DOI 10.1126/science.1225810; Widom J, 2011, KITP C SOFT MATT PHY; Yazdi PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136574; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018	37	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156905	10.1371/journal.pone.0156905	http://dx.doi.org/10.1371/journal.pone.0156905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272176	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000045
J	Kostereva, NV; Wang, Y; Fletcher, DR; Unadkat, JV; Schnider, JT; Komatsu, C; Yang, Y; Stolz, DB; Davis, MR; Plock, JA; Gorantla, VS				Kostereva, Nataliya V.; Wang, Yong; Fletcher, Derek R.; Unadkat, Jignesh V.; Schnider, Jonas T.; Komatsu, Chiaki; Yang, Yang; Stolz, Donna B.; Davis, Michael R.; Plock, Jan A.; Gorantla, Vijay S.			IGF-1 and Chondroitinase ABC Augment Nerve Regeneration after Vascularized Composite Limb Allotransplantation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MUSCLE REINNERVATION; AXONAL REGENERATION; PROTEOGLYCANS; EXPRESSION; SYSTEM; GLYCOSAMINOGLYCANS; CELLS; FK506	Impaired nerve regeneration and inadequate recovery of motor and sensory function following peripheral nerve repair remain the most significant hurdles to optimal functional and quality of life outcomes in vascularized tissue allotransplantation (VCA). Neurotherapeutics such as Insulin-like Growth Factor-1 (IGF-1) and chondroitinase ABC (CH) have shown promise in augmenting or accelerating nerve regeneration in experimental models and may have potential in VCA. The aim of this study was to evaluate the efficacy of low dose IGF-1, CH or their combination (IGF-1+CH) on nerve regeneration following VCA. We used an allogeneic rat hind limb VCA model maintained on low-dose FK506 (tacrolimus) therapy to prevent rejection. Experimental animals received neurotherapeutics administered intraoperatively as multiple intraneural injections. The IGF-1 and IGF-1+CH groups received daily IGF-1 (intramuscular and intraneural injections). Histomorphometry and immunohistochemistry were used to evaluate outcomes at five weeks. Overall, compared to controls, all experimental groups showed improvements in nerve and muscle (gastrocnemius) histomorphometry. The IGF-1 group demonstrated superior distal regeneration as confirmed by Schwann cell (SC) immunohistochemistry as well as some degree of extrafascicular regeneration. IGF-1 and CH effectively promote nerve regeneration after VCA as confirmed by histomorphometric and immunohistochemical outcomes.	[Kostereva, Nataliya V.; Wang, Yong; Fletcher, Derek R.; Unadkat, Jignesh V.; Schnider, Jonas T.; Komatsu, Chiaki; Yang, Yang; Plock, Jan A.; Gorantla, Vijay S.] Univ Pittsburgh, Dept Plast Surg, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA; [Kostereva, Nataliya V.; Plock, Jan A.; Gorantla, Vijay S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Wang, Yong] East Hosp Shanghai, Dept Trauma Surg, Shanghai, Peoples R China; [Stolz, Donna B.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA; [Davis, Michael R.] US Army, Inst Surg Res, San Antonio Mil Med Ctr, 3698 Chambers Rd, San Antonio, TX USA; [Fletcher, Derek R.] Univ Penn, Div Plast Surg, Philadelphia, PA 19104 USA; [Schnider, Jonas T.] Univ Hosp Bern, Inselspital, Dept Plast & Hand Surg, CH-3010 Bern, Switzerland; [Yang, Yang] Fourth Mil Med Univ, Xijing Hosp, Dept Plast & Reconstruct Surg, Xian 710032, Xincheng, Peoples R China; [Plock, Jan A.] Univ Zurich Hosp, Div Plast & Hand Surg, CH-8091 Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; San Antonio Military Medical Center; University of Pennsylvania; University of Bern; University Hospital of Bern; Air Force Military Medical University; University of Zurich; University Zurich Hospital	Gorantla, VS (corresponding author), Univ Pittsburgh, Dept Plast Surg, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA.; Gorantla, VS (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.	gorantlavs@upmc.edu	Plock, Jan/ABE-9876-2020; Plock, Jan A./I-2451-2017	Plock, Jan A./0000-0002-9495-6198; Unadkat, Jashvant/0000-0002-4820-8455	Department of Defense (Congressionally Directed Medical Research Programs) [W81XWH-11-2-0215]	Department of Defense (Congressionally Directed Medical Research Programs)(United States Department of Defense)	The study was supported by a generous grant by the Department of Defense (Congressionally Directed Medical Research Programs)- Grant # W81XWH-11-2-0215, PI: Vijay Gorantla (URL: http://cdmrp.army.mil). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahori Y, 1997, NEUROREPORT, V8, P2265, DOI 10.1097/00001756-199707070-00034; AMIR R, 1993, BRAIN RES, V630, P283, DOI 10.1016/0006-8993(93)90667-C; Apel PJ, 2010, MUSCLE NERVE, V41, P335, DOI 10.1002/mus.21485; Brenner MJ, 2008, MICROSURG, V28, P265, DOI 10.1002/micr.20483; Brenner MJ, 2005, RESTOR NEUROL NEUROS, V23, P237; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; Fansa H, 2002, MUSCLE NERVE, V26, P87, DOI 10.1002/mus.10165; GILLERY P, 1992, J CELL PHYSIOL, V152, P389, DOI 10.1002/jcp.1041520221; Gorantla VS, 2011, HAND CLIN, V27, P511, DOI 10.1016/j.hcl.2011.08.008; Gorio A, 1998, NEUROSCIENCE, V82, P1029; Graham JB, 2007, EXP NEUROL, V203, P185, DOI 10.1016/j.expneurol.2006.08.004; Hansen M, 2012, SCAND J MED SCI SPOR, P1; Hattori T, 2008, J CLIN NEUROSCI, V15, P185, DOI 10.1016/j.jocn.2006.12.009; HENDERSON N, 1988, CR ACAD SCI III-VIE, V307, P403; Ishii DN, 1993, PHARMACOL THERAPEUT, V62, P125; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Nachemson AK, 1990, GROWTH FACTORS, V3, P309, DOI 10.3109/08977199009003673; NOTTERPEK LM, 1994, NEURON, V13, P473, DOI 10.1016/0896-6273(94)90361-1; Ono A, 1998, J SPINAL DISORD, V11, P253; Park SE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-12; Puglianiello A, 2000, J ENDOCRINOL, V165, P123, DOI 10.1677/joe.0.1650123; Rabinovsky ED, 2004, NEUROL RES, V26, P204, DOI 10.1179/016164104225013851; Soleman S, 2012, BRAIN, V135, P1210, DOI 10.1093/brain/aws027; Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199; Thiebot B, 1997, BBA-MOL CELL RES, V1358, P127, DOI 10.1016/S0167-4889(97)00070-0; Tuffaha S, 2011, J HAND SURG-AM, V36A, P1447, DOI 10.1016/j.jhsa.2011.06.007; TYLER JA, 1989, BIOCHEM J, V260, P543, DOI 10.1042/bj2600543; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Vergani L, 1998, J NEUROSCI RES, V54, P840, DOI 10.1002/(SICI)1097-4547(19981215)54:6<840::AID-JNR12>3.3.CO;2-C; Yang RK, 2003, PLAST RECONSTR SURG, V112, P1832, DOI 10.1097/01.PRS.0000091167.27303.18	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156149	10.1371/journal.pone.0156149	http://dx.doi.org/10.1371/journal.pone.0156149			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272754	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000008
J	Covarrubias-Pazaran, G				Covarrubias-Pazaran, Giovanny			Genome-Assisted Prediction of Quantitative Traits Using the R Package sommer	PLOS ONE			English	Article							AVERAGE INFORMATION REML; LINEAR MIXED MODELS; RIDGE-REGRESSION; SELECTION; ASSOCIATION; VARIANCE; PERFORMANCE; PEDIGREE; HYBRIDS; NUMBER	Most traits of agronomic importance are quantitative in nature, and genetic markers have been used for decades to dissect such traits. Recently, genomic selection has earned attention as next generation sequencing technologies became feasible for major and minor crops. Mixed models have become a key tool for fitting genomic selection models, but most current genomic selection software can only include a single variance component other than the error, making hybrid prediction using additive, dominance and epistatic effects unfeasible for species displaying heterotic effects. Moreover, Likelihood-based software for fitting mixed models with multiple random effects that allows the user to specify the variance-covariance structure of random effects has not been fully exploited. A new open-source R package called sommer is presented to facilitate the use of mixed models for genomic selection and hybrid prediction purposes using more than one variance component and allowing specification of covariance structures. The use of sommer for genomic prediction is demonstrated through several examples using maize and wheat genotypic and phenotypic data. At its core, the program contains three algorithms for estimating variance components: Average information (AI), Expectation-Maximization (EM) and Efficient Mixed Model Association (EMMA). Kernels for calculating the additive, dominance and epistatic relationship matrices are included, along with other useful functions for genomic analysis. Results from sommer were comparable to other software, but the analysis was faster than Bayesian counterparts in the magnitude of hours to days. In addition, ability to deal with missing data, combined with greater flexibility and speed than other REML-based software was achieved by putting together some of the most efficient algorithms to fit models in a gentle environment such as R.	[Covarrubias-Pazaran, Giovanny] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Covarrubias-Pazaran, G (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	covarrubiasp@wisc.edu		COVARRUBIAS-PAZARAN, GIOVANNY/0000-0002-7194-3837	CONACYT (Mexico)	CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT (Mexico) funded PhD studies of GCP, but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir D, 2015, EMMREML FITTING MIXE; [Anonymous], 2021, LANG ENV STAT COMP; BERNARDO R, 1994, CROP SCI, V34, P20, DOI 10.2135/cropsci1994.0011183X003400010003x; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Bernardo R, 2006, CROP SCI, V46, P1972, DOI 10.2135/cropsci2006.01-0057; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; David Clifford PM, 2006, R NEWS, P6; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Gianola D, 2015, ANNU REV ANIM BIOSCI, V3, P19, DOI 10.1146/annurev-animal-022114-110733; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Henderson C.R., 1963, STAT GENETICS PLANT, V982, P141, DOI DOI 10.17226/20264; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Lee SH, 2016, BIOINFORMATICS, V32, P1420, DOI 10.1093/bioinformatics/btw012; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meuwissen THE, 2001, GENETICS, V157, P1819; Munoz PR, 2014, GENETICS, V198, P1759, DOI 10.1534/genetics.114.171322; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Rosyara UR, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0073; Sax K, 1923, GENETICS, V8, P301; Searle S. R., 2006, VARIANCE COMPONENTS; Searle SR, PAPER INVITED FOR TH; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Technow F, 2014, GENETICS, V197, P1343, DOI 10.1534/genetics.114.165860; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao YS, 2015, PLANT BREEDING, V134, P1, DOI 10.1111/pbr.12231; Zhong SQ, 2007, GENETICS, V177, P567, DOI 10.1534/genetics.107.075358; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	36	210	217	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156744	10.1371/journal.pone.0156744	http://dx.doi.org/10.1371/journal.pone.0156744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271781	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200014
J	Walinda, E; Morimoto, D; Sugase, K; Shirakawa, M				Walinda, Erik; Morimoto, Daichi; Sugase, Kenji; Shirakawa, Masahiro			Dual Function of Phosphoubiquitin in E3 Activation of Parkin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE GENE-PRODUCT; UBIQUITIN LIGASE; CONFORMATIONAL ENTROPY; PINK1-DEPENDENT PHOSPHORYLATION; MOLECULAR RECOGNITION; AUTOINHIBITED STATE; DYNAMIC ACTIVATION; NMR-SPECTROSCOPY; RING DOMAIN; PROTEIN	Mutations in the gene encoding parkin, an auto-inhibited E3 ubiquitin ligase that functions in the clearance of damaged mitochondria, are the most common cause of autosomal recessive juvenile Parkinsonism. The mechanism regulating parkin activation remains poorly understood. Here we show, by using isothermal titration calorimetry, solution NMR, and fluorescence spectroscopy, that parkin can bind ubiquitin and phosphomimetic ubiquitin by recognizing the canonical hydrophobic patch and C terminus of ubiquitin. The affinity of parkin for both phosphomimetic and unmodified ubiquitin is markedly enhanced upon removal of the ubiquitin-like (UBL) domain of parkin. This suggests that the agonistic binding of ubiquitin to parkin in trans is counterbalanced by the antagonistic activity of the parkin UBL domain in cis. Intriguingly, UBL binding is enthalpy-driven, whereas ubiquitin binding is driven by an increase in the total entropy of the system. These thermodynamic differences are explained by different chemistry in the ubiquitin-and UBL-binding pockets of parkin and, as shown by molecular dynamics simulations, are not a consequence of changes in protein conformational entropy. Indeed, comparison of conformational fluctuations reveals that the RING1-IBR element becomes considerably more rigid upon complex formation. A model of parkin activation is proposed in which E2 similar to Ub binding triggers large scale diffusional motion of the RING2 domain toward the ubiquitin-stabilized RING1-IBR assembly to complete formation of the active parkin-E2 similar to Ub transfer complex. Thus, ubiquitin plays a dual role in parkin activation by competing with the inhibitory UBL domain and stabilizing the active form of parkin.	[Walinda, Erik] Kyoto Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Kyoto 6068501, Japan; [Morimoto, Daichi; Sugase, Kenji; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan	Kyoto University; Kyoto University	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp	Sugase, Kenji/S-3132-2016; Sugase, Kenji/AAF-4552-2021	Sugase, Kenji/0000-0001-8623-7743; Sugase, Kenji/0000-0001-8623-7743; Morimoto, Daichi/0000-0002-7672-2136	Japan Society for the Promotion of Science KAKENHI Grant [15H04342]; Grants-in-Aid for Scientific Research [15H04342, 16K18503] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 15H04342. The authors declare that they have no conflicts of interest with the contents of this article.	Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Craft JW, 2005, J BIOMOL NMR, V33, P15, DOI 10.1007/s10858-005-1199-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Hedrich K, 2002, NEUROLOGY, V58, P1239, DOI 10.1212/WNL.58.8.1239; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Macedo MG, 2009, MOVEMENT DISORD, V24, P196, DOI 10.1002/mds.22287; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Munoz E, 2002, J NEUROL NEUROSUR PS, V73, P582, DOI 10.1136/jnnp.73.5.582; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; TORDA AE, 1989, CHEM PHYS LETT, V157, P289, DOI 10.1016/0009-2614(89)87249-5; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; TROPP J, 1980, J CHEM PHYS, V72, P6035, DOI 10.1063/1.439059; Tzeng SR, 2013, NAT CHEM BIOL, V9, P462, DOI [10.1038/NCHEMBIO.1250, 10.1038/nchembio.1250]; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966	64	10	10	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16879	16891		10.1074/jbc.M116.728600	http://dx.doi.org/10.1074/jbc.M116.728600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27284007	hybrid, Green Published			2022-12-26	WOS:000380826700044
J	Sankari, S; O'Brian, MR				Sankari, Siva; O'Brian, Mark R.			The Bradyrhizobium japonicum Ferrous Iron Transporter FeoAB Is Required for Ferric Iron Utilization in Free Living Aerobic Cells and for Symbiosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOYBEAN ROOT-NODULES; RESPONSE REGULATOR IRR; SIDEROPHORE-UPTAKE; RHIZOBIUM-LEGUMINOSARUM; UPTAKE SYSTEM; MAJOR ROLE; HEME; BACTERIA; PROTEIN; ACQUISITION	The bacterium Bradyrhizobium japonicum USDA110 does not synthesize siderophores for iron utilization in aerobic environments, and the mechanism of iron uptake within symbiotic soybean root nodules is unknown. An mbfA bfr double mutant defective in iron export and storage activities cannot grow aerobically in very high iron medium. Here, we found that this phenotype was suppressed by loss of function mutations in the feoAB operon encoding ferrous (Fe2+) iron uptake proteins. Expression of the feoAB operon genes was elevated under iron limitation, but mutants defective in either gene were unable to grow aerobically over a wide external ferric (Fe3+) iron (FeCl3) concentration range. Thus, FeoAB accommodates iron acquisition under iron limited and iron replete conditions. Incorporation of radiolabel from either Fe-55(2+) or Fe-59(3+) into cells was severely defective in the feoA and feoB strains, suggesting Fe3+ reduction to Fe2+ prior to traversal across the cytoplasmic membrane by FeoAB. The feoA or feoB deletion strains elicited small, ineffective nodules on soybean roots, containing few bacteria and lacking nitrogen fixation activity. A feoA(E40K) mutant contained partial iron uptake activity in culture that supported normal growth and established an effective symbiosis. The feoA(E40K) strain had partial iron uptake activity in situ within nodules and in isolated cells, indicating that FeoAB is the iron transporter in symbiosis. We conclude that FeoAB supports iron acquisition under limited conditions of soil and in the iron-rich environment of a symbiotic nodule.	[Sankari, Siva; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY USA.	mrobrian@buffalo.edu	sankaran, Siva Sankari iyer mani/AAB-5222-2020		National Institutes of Health [R01 GM099667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099667 (to M. R. O.) The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Benson HP, 2005, MOL PLANT MICROBE IN, V18, P950, DOI 10.1094/MPMI-18-0950; Brear EM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00359; Brickman TJ, 2012, MOL MICROBIOL, V86, P580, DOI 10.1111/mmi.12003; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Elhassanny AEM, 2013, MOL MICROBIOL, V88, P1070, DOI 10.1111/mmi.12242; Escamilla-Hernandez R, 2012, J BACTERIOL, V194, P3137, DOI 10.1128/JB.00071-12; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; GUERINOT ML, 1990, J BACTERIOL, V172, P3298, DOI 10.1128/jb.172.6.3298-3303.1990; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Jaggavarapu S, 2014, MOL MICROBIOL, V92, P609, DOI 10.1111/mmi.12584; Kaiser BN, 2003, PLANT J, V35, P295, DOI 10.1046/j.1365-313X.2003.01802.x; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; LeVier K, 1996, PLANT PHYSIOL, V111, P893, DOI 10.1104/pp.111.3.893; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; Mathew A, 2014, MOL MICROBIOL, V91, P805, DOI 10.1111/mmi.12499; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Nienaber A, 2001, MOL MICROBIOL, V41, P787, DOI 10.1046/j.1365-2958.2001.02555.x; Noya F, 1997, J BACTERIOL, V179, P3076, DOI 10.1128/jb.179.9.3076-3078.1997; OBRIAN MR, 1987, J BACTERIOL, V169, P1089, DOI 10.1128/jb.169.3.1089-1094.1987; PERSMARK M, 1993, J AM CHEM SOC, V115, P3950, DOI 10.1021/ja00063a014; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; PLESSNER O, 1993, APPL ENVIRON MICROB, V59, P1688, DOI 10.1128/AEM.59.5.1688-1690.1993; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; REGENSBURGER B, 1986, ARCH MICROBIOL, V144, P355, DOI 10.1007/BF00409885; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Sankari S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157250; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Small SK, 2011, J BACTERIOL, V193, P4088, DOI 10.1128/JB.05064-11; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; SO JS, 1987, MOL GEN GENET, V207, P15, DOI 10.1007/BF00331485; Stevens JB, 1999, MICROBIOL-UK, V145, P593, DOI 10.1099/13500872-145-3-593; Su YC, 2010, ACTA CRYSTALLOGR F, V66, P636, DOI 10.1107/S1744309110013941; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wittenberg JB, 1996, PLANT SOIL, V178, P161, DOI 10.1007/BF00011579; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yeoman KH, 2000, MICROBIOL-SGM, V146, P829, DOI 10.1099/00221287-146-4-829	42	15	16	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15653	15662		10.1074/jbc.M116.734129	http://dx.doi.org/10.1074/jbc.M116.734129			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27288412	hybrid, Green Published			2022-12-26	WOS:000380584200020
J	Kim, J; Jones, CAR; Groves, NS; Sun, B				Kim, Jihan; Jones, Christopher A. R.; Groves, Nicholas Scott; Sun, Bo			Three-Dimensional Reflectance Traction Microscopy	PLOS ONE			English	Article							CELLS; MATRIX; MICROMECHANICS; INVASION; STRESSES; ROLES	Cells in three-dimensional (3D) environments exhibit very different biochemical and biophysical phenotypes compared to the behavior of cells in two-dimensional (2D) environments. As an important biomechanical measurement, 2D traction force microscopy can not be directly extended into 3D cases. In order to quantitatively characterize the contraction field, we have developed 3D reflectance traction microscopy which combines confocal reflection imaging and partial volume correlation postprocessing. We have measured the deformation field of collagen gel under controlled mechanical stress. We have also characterized the deformation field generated by invasive breast cancer cells of different morphologies in 3D collagen matrix. In contrast to employ dispersed tracing particles or fluorescently-tagged matrix proteins, our methods provide a label-free, computationally effective strategy to study the cell mechanics in native 3D extracellular matrix.	[Kim, Jihan; Jones, Christopher A. R.; Groves, Nicholas Scott; Sun, Bo] Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA	Oregon State University	Sun, B (corresponding author), Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA.	sunb@physics.oregonstate.edu	Kim, Jihan/AAE-6280-2021					Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Bashour KT, 2014, P NATL ACAD SCI USA, V111, P2241, DOI 10.1073/pnas.1315606111; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Brown RA, 2013, EXP CELL RES, V319, P2460, DOI 10.1016/j.yexcr.2013.07.001; Brugues A, 2014, NAT PHYS, V10, P684, DOI [10.1038/nphys3040, 10.1038/NPHYS3040]; Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Elson E. L., 1999, P299; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Garcia D, 2011, EXP FLUIDS, V50, P1247, DOI 10.1007/s00348-010-0985-y; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Gjorevski N, 2012, BIOPHYS J, V103, P152, DOI 10.1016/j.bpj.2012.05.048; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; HOPWOOD D, 1995, GUT, V37, P598, DOI 10.1136/gut.37.5.598; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Huang H, 1997, MEAS SCI TECHNOL, V8, P1427, DOI 10.1088/0957-0233/8/12/007; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Jawerth LM, 2010, BIOPHYS J, V98, pL1, DOI 10.1016/j.bpj.2009.09.065; Jones CAR, 2015, P NATL ACAD SCI USA, V112, pE5117, DOI 10.1073/pnas.1509663112; Jones CAR, 2014, SOFT MATTER, V10, P8855, DOI 10.1039/c4sm01772b; KEANE RD, 1992, APPL SCI RES, V49, P191, DOI 10.1007/BF00384623; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Lang NR, 2013, BIOPHYS J, V105, P1967, DOI 10.1016/j.bpj.2013.09.038; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004; Lombardi ML, 2007, J CELL SCI, V120, P1624, DOI 10.1242/jcs.002527; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Notbohm J, 2015, INTEGR BIOL-UK, V7, P1186, DOI 10.1039/c5ib00013k; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrie RJ, 2013, J CELL SCI, V125, P1; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x; Roesgen T, 2003, EXP FLUIDS, V35, P252, DOI 10.1007/s00348-003-0627-8; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Steinwachs J, 2016, NAT METHODS, V13, P171, DOI [10.1038/NMETH.3685, 10.1038/nmeth.3685]; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thielicke W., 2014, J OPEN RES STW, V2, P30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Thievessen I, 2015, FASEB J, V14; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109	50	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156797	10.1371/journal.pone.0156797	http://dx.doi.org/10.1371/journal.pone.0156797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304456	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800022
J	Thompson, GN; McArthur, J; Doupe, M				Thompson, Genevieve N.; McArthur, Jennifer; Doupe, Malcolm			Identifying Markers of Dignity-Conserving Care in Long-Term Care: A Modified Delphi Study	PLOS ONE			English	Article							QUALITY INDICATORS; HEALTH-CARE; PALLIATIVE CARE; OLDER-PEOPLE; CAREGIVERS; PERCEPTIONS; RESIDENTS; AUTONOMY; FAMILY; EXPERIENCES	Ensuring that people living in nursing homes (NHs) are afforded with dignity in their daily lives is an essential and humane concern. Promoting dignity-conserving care is fundamentally important. By nature, however, this care is all-encompassing and holistic, and from current knowledge it is challenging to create explicit strategies for measuring dignity-conserving care. In practice the majority of current NH indicators of quality care are derived from information that is routinely collected on NH residents using the RAI-Minimum Data Set (MDS). In this regard, issues that are more tangible to resident dignity such as being treated with respect, compassion, and having opportunities to engage with others are not adequately captured in current NH quality of care indicators. An initial set of markers was created by conducting an integrative literature review of existing markers and indicators of dignity in the NH setting. A modified Delphi process was used to prioritize essential dignity-conserving care markers for use by NH providers, based on factors such as the importance to fostering a culture of dignity, the impact it may have on the residents, and how achievable it is in practice. Through this consensus building technique, we were able to develop a comprehensive set of markers that capture the range and diversity of important dignity-conserving care strategies for use in NHs. The final 10 markers were judged as having high face validity by experts in the field and have explicit implications for enhancing the provision of daily dignified care to NH residents. These markers make an important addition to the traditional quality indicators used in the NH setting and as such, bridge an important gap in addressing the psychosocial and the less easily quantified needs of NH residents.	[Thompson, Genevieve N.] Univ Manitoba, Rady Fac Hlth Sci, Coll Nursing, Winnipeg, MB, Canada; [Thompson, Genevieve N.] CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB, Canada; [McArthur, Jennifer] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Doupe, Malcolm] Univ Manitoba, Rady Fac Hlth Sci, Coll Med, Winnipeg, MB, Canada	University of Manitoba; CancerCare Manitoba Foundation; University of Alberta; University of Manitoba	Thompson, GN (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Coll Nursing, Winnipeg, MB, Canada.; Thompson, GN (corresponding author), CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB, Canada.	Genevieve.thompson@umanitoba.ca		Thompson, Genevieve/0000-0003-2558-9926	Government of Manitoba	Government of Manitoba	This project was funded by the Government of Manitoba. There is no funding number allocated for this project as it was done by contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg P, 2007, J ADV NURS, V59, P635, DOI 10.1111/j.1365-2648.2007.04375.x; Asselin M, 2014, J NURSES PROF DEV, V30, P11, DOI 10.1097/01.NND.0000434028.30432.34; Boisaubin EV, 2007, J MED PHILOS, V32, P447, DOI 10.1080/03605310701626414; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Campbell SM, 1999, MED CARE, V37, P964, DOI 10.1097/00005650-199909000-00012; Carinci F, 2015, INT J QUAL HEALTH C, V27, P137, DOI 10.1093/intqhc/mzv004; Chochinov Harvey Max, 2005, J Palliat Med, V8 Suppl 1, pS103; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 2004, J CLIN ONCOL, V22, P1336, DOI 10.1200/JCO.2004.12.095; Coventry ML, 2006, J GERONTOL NURS, V32, P42, DOI 10.3928/00989134-20060501-08; Doupe M, 2012, JAMDA, V12, P467; Dwyer LL, 2009, INT J OLDER PEOPLE N, V4, P185, DOI 10.1111/j.1748-3743.2008.00153.x; Enes SPD, 2003, PALLIATIVE MED, V17, P263, DOI 10.1191/0269216303pm699oa; Franklin LL, 2006, NURS ETHICS, V13, P130, DOI 10.1191/0969733006ne851oa; Gallagher A, 2004, NURS ETHICS, V11, P587, DOI 10.1191/0969733004ne744oa; Gallagher A, 2008, BMC NURS, V7, DOI 10.1186/1472-6955-7-11; Haddock J, 1996, J ADV NURS, V24, P924, DOI 10.1111/j.1365-2648.1996.tb02927.x; Hall S, 2009, AGE AGEING, V38, P411, DOI 10.1093/ageing/afp069; Heggestad AKT, 2013, NURS ETHICS, V20, P881, DOI 10.1177/0969733013484484; Jacelon CS, 2004, J ADV NURS, V48, P76, DOI 10.1111/j.1365-2648.2004.03170.x; Jacobson N, 2009, QUAL HEALTH RES, V19, P1536, DOI 10.1177/1049732309349809; Johnstone DE, 2012, CAN J CARDIOL, V28, P599, DOI 10.1016/j.cjca.2012.01.024; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; Lin YP, 2013, NURS ETHICS, V20, P168, DOI 10.1177/0969733012458609; Lobchuk MM, 2007, J PAIN SYMPTOM MANAG, V33, P130, DOI 10.1016/j.jpainsymman.2006.07.015; Lothian K, 2001, BRIT MED J, V322, P668, DOI 10.1136/bmj.322.7287.668; Magee H., 2008, MEASURING DIGNITY CA; McClement SE, 2006, TXB PALLIATIVE MED, P100; McClement Susan E, 2004, Int J Palliat Nurs, V10, P173; Naden D, 2013, NURS ETHICS, V20, P748, DOI 10.1177/0969733012475253; Nekolaichuk Cheryl L, 2004, Palliat Support Care, V2, P243; Oosterveld-Vlug MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073822; Oosterveld-Vlug MG, 2014, J ADV NURS, V70, P97, DOI 10.1111/jan.12171; Periyakoil VS, 2013, J AM GERIATR SOC, V61, P440, DOI 10.1111/jgs.12145; Pleschberger S, AGE AGEING, V36, P197; Proulx Kathryn, 2004, Am J Hosp Palliat Care, V21, P116, DOI 10.1177/104990910402100209; Puchalski CM, 2014, J PALLIAT MED, V17, P105, DOI [10.1089/jpm.2014.9427, 10.1089/jpm.2013.9458]; Pullman D, 2004, J PALLIAT CARE, V20, P171, DOI 10.1177/082585970402000309; Shaw KL, 2014, PALLIATIVE MED, V28, P501, DOI 10.1177/0269216314521852; Zhai X, 2007, J MED PHILOS, V32, P425, DOI 10.1080/03605310701631695	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156816	10.1371/journal.pone.0156816	http://dx.doi.org/10.1371/journal.pone.0156816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304853	Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800024
J	Gandley, RE; Althouse, A; Jeyabalan, A; Bregand-White, JM; McGonigal, S; Myerski, AC; Gallaher, M; Powers, RW; Hubel, CA				Gandley, Robin E.; Althouse, Andrew; Jeyabalan, Arundhathi; Bregand-White, Julia M.; McGonigal, Stacy; Myerski, Ashley C.; Gallaher, Marcia; Powers, Robert W.; Hubel, Carl A.			Low Soluble Syndecan-1 Precedes Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GLYCOCALYX; VASCULAR-PERMEABILITY; PLACENTAL SYNDECAN-1; EXPRESSION; PREGNANCY; COMPONENTS	Introduction Syndecan-1 (Sdc1; CD138) is a major transmembrane heparan sulfate proteoglycan expressed on the extracellular, luminal surface of epithelial cells and syncytiotrophoblast, thus comprising a major component of the glycocalyx of these cells. The "soluble" (shed) form of Sdc1 has paracrine and autocrine functions and is normally produced in a regulated fashion. We compared plasma soluble Sdc1 concentrations, in relation to placental Sdc1 expression, in uncomplicated (control) and preeclamptic pregnancies. Methods We evaluated soluble Sdc1 across uncomplicated pregnancy, and between preeclamptic, gestational hypertensive and control patients at mid-pregnancy (20 weeks) and 3rd trimester by ELISA. Placental expression level of Sdc1 was compared between groups in relation to pre-delivery plasma soluble Sdc1. Participants were recruited from Magee-Womens Hospital. Results In uncomplicated pregnancy, plasma soluble Sdc1 rose significantly in the 1st trimester, and reached an approximate 50-fold increase at term compared to post pregnancy levels. Soluble Sdc1 was lower at mid-pregnancy in women who later developed preeclampsia (P<0.05), but not gestational hypertension, compared to controls, and remained lower at late pregnancy in preeclampsia (P<0.01) compared to controls. Sdc1 was prominently expressed on syncytiotrophoblast of microvilli. Syncytiotrophoblast Sdc1 immunostaining intensities, and mRNA content in villous homogenates, were lower in preeclampsia vs. controls (P<0.05). Soluble Sdc1 and Sdc1 immunostaining scores were inversely associated with systolic blood pressures, and positively correlated with infant birth weight percentile. Conclusion Soluble Sdc1 is significantly lower before the clinical onset of preeclampsia, with reduced expression of Sdc1 in the delivered placenta, suggesting a role for glycocalyx disturbance in preeclampsia pathophysiology.	[Gandley, Robin E.; Althouse, Andrew; Jeyabalan, Arundhathi; McGonigal, Stacy; Myerski, Ashley C.; Gallaher, Marcia; Powers, Robert W.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA; [Gandley, Robin E.; Jeyabalan, Arundhathi; Bregand-White, Julia M.; Powers, Robert W.; Hubel, Carl A.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, Pittsburgh, PA USA; [Jeyabalan, Arundhathi] Univ Pittsburgh, Clin & Translat Res Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hubel, CA (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, Pittsburgh, PA USA.	chubel@mwri.magee.edu	Althouse, Andrew/AAF-4836-2019; Althouse, Andrew/AAF-5053-2019	Althouse, Andrew/0000-0002-8654-5014	State of Pennsylvania Health Research Formula Fund; National Institutes of Health [R21HD083659, P01HD030367, UL1RR024153, UL1TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD030367, R21HD083659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	State of Pennsylvania Health Research Formula Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by the State of Pennsylvania Health Research Formula Fund (CAH) (portal.state.pa.us), and National Institutes of Health Grants R21HD083659 (REG and CAH), P01HD030367 (CAH, REG, AJ, SM, ACM, RWP), and UL1RR024153 and UL1TR000005 (University of Pittsburgh Clinical and Translational Science Institute)(nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annecke T, 2011, BRIT J ANAESTH, V107, P679, DOI 10.1093/bja/aer269; Becker BF, 2015, BRIT J CLIN PHARMACO, V80, P389, DOI 10.1111/bcp.12629; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; BRADBURY S, 1970, Histochemical Journal, V2, P263, DOI 10.1007/BF01004995; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Burke-Gaffney A, 2012, CRIT CARE, V16, DOI 10.1186/cc11239; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; CHESLEY LC, 1980, KIDNEY INT, V18, P234, DOI 10.1038/ki.1980.131; Chui A, 2012, GYNECOL OBSTET INVES, V73, P277, DOI 10.1159/000333262; Chui A, 2012, AM J PATHOL, V180, P693, DOI 10.1016/j.ajpath.2011.10.023; Crescimanno C, 1999, J PATHOL, V189, P600; Deng YP, 2012, HEPATOLOGY, V55, P277, DOI 10.1002/hep.24626; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gunatillake T, 2013, J GLYCOBIOL, V2, P105, DOI [10.4172/2168-958X.1000105, DOI 10.4172/2168-958X.1000105]; Heyer-Chauhan N, 2014, J PERINAT MED, V42, P329, DOI 10.1515/jpm-2013-0097; Hofmann-Kiefer KF, 2013, REPROD SCI, V20, P1237, DOI 10.1177/1933719113483011; Hofmann-Kiefer KF, 2013, REPROD SCI, V20, P318, DOI 10.1177/1933719112453508; Jansson Thomas, 2009, Curr Vasc Pharmacol, V7, P521; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Jokimaa V, 1998, PLACENTA, V19, P157, DOI 10.1016/S0143-4004(98)90004-2; Jokimaa VIS, 2000, AM J OBSTET GYNECOL, V183, P1495, DOI 10.1067/mob.2000.107320; Lamorte S, 2012, LEUKEMIA, V26, P1081, DOI 10.1038/leu.2011.290; Lanoix D, 2012, PLACENTA, V33, P151, DOI 10.1016/j.placenta.2011.12.008; Lemkes BA, 2012, DIABETES TECHNOL THE, V14, pS3, DOI 10.1089/dia.2012.0011; Leonova EI, 2015, ADV EXPT MED BIOL, P241; Maksimenko AV, 2012, BIOCH RES INT, V2012, P1; Manon-Jensen T, 2013, FEBS J, V280, P2320, DOI 10.1111/febs.12174; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; NELSON DM, 1976, ANAT REC, V184, P159, DOI 10.1002/ar.1091840204; Nussbaum C, 2014, J PEDIATR-US, V164, P584, DOI 10.1016/j.jpeds.2013.11.016; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P316, DOI 10.1111/j.1399-6576.2011.02578.x; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stepp MA, 2015, ADV WOUND CARE, V4, P235, DOI 10.1089/wound.2014.0555; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Szabo S, 2013, VIRCHOWS ARCH, V463, P445, DOI 10.1007/s00428-013-1426-0; Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Weissgerber TL, 2014, J CLIN ENDOCR METAB, V99, P978, DOI 10.1210/jc.2013-3277	44	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157608	10.1371/journal.pone.0157608	http://dx.doi.org/10.1371/journal.pone.0157608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299886	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200067
J	Zahn, D; Duchstein, P				Zahn, Dirk; Duchstein, Patrick			Multi-Scale Modelling of Deformation and Fracture in a Biomimetic Apatite-Protein Composite: Molecular-Scale Processes Lead to Resilience at the mu m-Scale	PLOS ONE			English	Article							COLLAGEN; SIMULATION	Fracture mechanisms of an enamel-like hydroxyapatite-collagen composite model are elaborated by means of molecular and coarse-grained dynamics simulation. Using fully atomistic models, we uncover molecular-scale plastic deformation and fracture processes initiated at the organic-inorganic interface. Furthermore, coarse-grained models are developed to investigate fracture patterns at the mu m-scale. At the meso-scale, micro-fractures are shown to reduce local stress and thus prevent material failure after loading beyond the elastic limit. On the basis of our multi-scale simulation approach, we provide a molecular scale rationalization of this phenomenon, which seems key to the resilience of hierarchical biominerals, including teeth and bone.	[Zahn, Dirk; Duchstein, Patrick] Univ Erlangen Nurnberg, Lehrstuhl Theoret Chem, Comp Chem Ctr, Nagelsbachstr 25, D-91052 Erlangen, Germany	University of Erlangen Nuremberg	Zahn, D (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Theoret Chem, Comp Chem Ctr, Nagelsbachstr 25, D-91052 Erlangen, Germany.	dirk.zahn@chemie.uni-erlangen.de	Duchstein, Patrick/H-3243-2017	Duchstein, Patrick/0000-0002-9925-8639; Zahn, Dirk/0000-0002-4303-3422	Deutsche Forschungsgemeinschaft [ZA 420-7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors gratefully acknowledge Deutsche Forschungsgemeinschaft for funding within the grant ZA 420-7. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almora-Barrios N, 2012, CRYST GROWTH DES, V12, P756, DOI 10.1021/cg201092s; Duchstein P, 2011, J MOL MODEL, V17, P73, DOI 10.1007/s00894-010-0707-7; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Fratzl P., 2008, COLLAGEN STRUCTURE M; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; He LH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2450649; He LH, 2007, J DENT, V35, P431, DOI 10.1016/j.jdent.2006.12.002; He LH, 2009, J BIOMED MATER RES A, V91A, P352, DOI 10.1002/jbm.a.32223; Kawska A, 2008, ANGEW CHEM, V120, P5060; Kniep R, 2008, ANGEW CHEM INT EDIT, V47, P1405, DOI 10.1002/anie.200702532; Kniep R, 2007, TOP CURR CHEM, V270, P73, DOI 10.1007/128_053; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Zahn D, 2007, J MATER SCI, V42, P8966, DOI 10.1007/s10853-007-1586-x; Zahn D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093309; Zahn D, 2010, ANGEW CHEM INT EDIT, V49, P9405, DOI 10.1002/anie.201002663	16	2	2	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157241	10.1371/journal.pone.0157241	http://dx.doi.org/10.1371/journal.pone.0157241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300748	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200033
J	Tan, TY; Dong, S; Huang, YW; Liu, J; Le, J; Liu, KP				Tan, Tianyuan; Dong, Shuan; Huang, Yingwei; Liu, Jian; Le, Jian; Liu, Kaipei			Improved Active Harmonic Current Elimination Based on Voltage Detection	PLOS ONE			English	Article								With the increasing penetration of power electronic equipment in modern residential distribution systems, harmonics mitigation through the distributed generation (DG) interfacing converters has received significant attention. Among recently proposed methods, the so-called active resonance damper (ARD) and harmonic voltage compensator (HVC) based on voltage detection can effectively reduce the harmonic distortions in selected areas of distribution systems. However, it is found out that when traditional ARD algorithm is used to eliminate harmonic current injected by non-linear loads, its performance is constrained by stability problems and can at most eliminate half of the load harmonic currents. Thus, inspired by the duality between ARD and HVC, this paper presents a novel improved resistive active power filter (R-APF) algorithm based on integral-decoupling control. The design guideline for its parameters is then investigated through carefully analyzing the closed-loop poles' trajectory. Computer studies demonstrate that the proposed algorithm can effectively mitigate the load harmonic currents and its performance is much better than traditional ARD based on proportional control.	[Tan, Tianyuan; Liu, Jian; Le, Jian; Liu, Kaipei] Wuhan Univ, Sch Elect Engn, Wuhan 430072, Hubei, Peoples R China; [Dong, Shuan; Huang, Yingwei] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [Tan, Tianyuan] 3312-8 South East Lake Rd, Wuhan 430072, Peoples R China; [Dong, Shuan] 3085-2332 Main Mall, Vancouver, BC V6T 1Z4, Canada	Wuhan University; University of British Columbia	Tan, TY (corresponding author), Wuhan Univ, Sch Elect Engn, Wuhan 430072, Hubei, Peoples R China.; Tan, TY (corresponding author), 3312-8 South East Lake Rd, Wuhan 430072, Peoples R China.	tty@whu.edu.cn	Huang, Yingwei/T-7363-2019	Huang, Yingwei/0000-0002-5162-6420	National Science Foundation for Young Scientists of China; NSFC (National Science Foundation of China) [51307127]	National Science Foundation for Young Scientists of China; NSFC (National Science Foundation of China)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation for Young Scientists of China (https://isisn.nsfc.gov.cn/egrantweb/). The Grand No. is 51307127 and the receipt is TT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thanks NSFC (National Science Foundation of China) for their fund supporting to this research under Grant No. 51307127.	Akagi H, 1997, IEEE T POWER DELIVER, V12, P354, DOI 10.1109/61.568259; Bagheri P, 2014, IEEE T POWER DELIVER, V29, P215, DOI 10.1109/TPWRD.2013.2291866; Blaabjerg F, 2004, IEEE T POWER ELECTR, V19, P1184, DOI 10.1109/TPEL.2004.833453; Desmet J., 2010, ICHQP2010; El-Samahy I, 2005, IEEE POWER ENG SOC, P2969; He JW, 2012, IEEE T IND ELECTRON, V59, P444, DOI 10.1109/TIE.2011.2141098; He Jinwei, 2010, IPEC2010; Lasseter RH, 2011, P IEEE, V99, P1074, DOI 10.1109/JPROC.2011.2114630; Carrasco JM, 2006, IEEE T IND ELECTRON, V53, P1002, DOI 10.1109/TIE.2006.878356; McBee KD, 2014, IEEE T IND APPL, V50, P2142, DOI 10.1109/TIA.2013.2288606; Menniti D, 2011, ELECTR POW SYST RES, V81, P798, DOI 10.1016/j.epsr.2010.11.010; Tan Tianyuan, 2007, Automation of Electric Power Systems, V31, P81; Tan Tianyuan, 2006, POWERCON2006; Wang YF, 2013, IEEE T POWER ELECTR, V28, P2204, DOI 10.1109/TPEL.2012.2214445; Yuan ZH, 2004, PROCEEDINGS OF THE 2004 IEEE INTERNATIONAL CONFERENCE ON ELECTRIC UTILITY DEREGULATION, RESTRUCTURING AND POWER TECHNOLOGIES, VOLS 1 AND 2, P763, DOI 10.1109/DRPT.2004.1338085	15	0	0	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157057	10.1371/journal.pone.0157057	http://dx.doi.org/10.1371/journal.pone.0157057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295213	Green Published, Green Submitted, gold			2022-12-26	WOS:000377821300017
J	Yazawa, S; Takahashi, R; Yokobori, T; Sano, R; Mogi, A; Saniabadi, AR; Kuwano, H; Asao, T				Yazawa, Shin; Takahashi, Ryo; Yokobori, Takehiko; Sano, Rie; Mogi, Akira; Saniabadi, Abby R.; Kuwano, Hiroyuki; Asao, Takayuki			Fucosylated Glycans in alpha 1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients	PLOS ONE			English	Article							ALPHA(1)-ACID GLYCOPROTEIN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL-ANTIBODY; TUMOR-MARKERS; HUMAN ADENOCARCINOMA; SERUM; GLYCOSYLATION; PLASMA; LUNG; IDENTIFICATION	One standard treatment option for advanced-stage cancer is surgical resection of malignant tumors following by adjuvant chemotherapy and chemoradiotherapy. Additionally, neoadjuvant chemotherapy may be applied if required. During the time course of treatments, patients are generally followed by computed tomography (CT) surveillance, and by tumor marker diagnosis. However, currently, early evidence of recurrence and/or metastasis of tumors with a clinically relevant biomarker remains a major therapeutic challenge. In particular, there has been no validated biomarker for predicting treatment outcomes in therapeutic settings. Recently, we have looked at glycoforms of serum alpha(1)-acid glycoprotein (AGP) by using a crossed affinoimmunoelectrophoresis with two lectins and an anti-AGP antibody. The primary glycan structures of AGP were also analyzed by a mass spectrometer and a novel software in a large number of patients with various cancers. Accordingly, the relative abundance of alpha 1,3fucosylated glycans in AGP (FUCAGP) was found to be significantly high in cancer patients as compared with the healthy controls. Further, strikingly elevated levels of FUCAGP were found in patients with poor prognosis but not in patients with good prognosis. In the current study, levels of FUCAGP in serum samples from various cancer patients were analyzed and 17 patients including 13 who had undergone chemotherapy were followed for several years post operation. FUCAGP level determined diligently by using a mass spectrometer was found to change along with disease prognosis as well as with responses to treatments, in particular, to various chemotherapies. Therefore, FUCAGP levels measured during following-up of the patients after operation appeared to be clinically relevant biomarker of treatment intervention.	[Yazawa, Shin; Takahashi, Ryo; Mogi, Akira; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan; [Yokobori, Takehiko] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol, Maebashi, Gunma 371, Japan; [Sano, Rie] Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gunma 371, Japan; [Saniabadi, Abby R.] Hamamatsu Univ, Sch Med, Dept Pharmacol, Hamamatsu, Shizuoka 4312102, Japan; [Asao, Takayuki] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma 371, Japan; [Asao, Takayuki] Gunma Univ Initiat Adv Res, Big Data Ctr Integrat Anal, Maebashi, Gunma, Japan	Gunma University; Gunma University; Gunma University; Hamamatsu University School of Medicine; Gunma University	Yazawa, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan.	syazawa@gunma-u.ac.jp						Abelev G I, 1971, Adv Cancer Res, V14, P295, DOI 10.1016/S0065-230X(08)60523-0; Ahn YH, 2014, J PROTEOMICS, V106, P221, DOI 10.1016/j.jprot.2014.04.031; Ahn YH, 2012, J PROTEOMICS, V75, P5507, DOI 10.1016/j.jprot.2012.06.027; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; ASAO T, 1989, CANCER, V64, P2541, DOI 10.1002/1097-0142(19891215)64:12<2541::AID-CNCR2820641222>3.0.CO;2-7; Asao T, 2001, CLIN EXP METASTAS, V18, P605; Asao T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/834790; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; BORIES PN, 1990, INFLAMMATION, V14, P315, DOI 10.1007/BF00915815; BrinkmanVanderLinden ECM, 1996, J BIOL CHEM, V271, P14492, DOI 10.1074/jbc.271.24.14492; BrinkmanVanderLinden ECM, 1996, GLYCOBIOLOGY, V6, P407, DOI 10.1093/glycob/6.4.407; Chavan MM, 2005, GLYCOBIOLOGY, V15, P838, DOI 10.1093/glycob/cwi067; CHIU KM, 1977, IMMUNOLOGY, V32, P997; Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c; Dobryszycka W, 1992, AFFINITY ELECTROPHOR, P211; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ferens-Sieczkowska M, 2013, POSTEP HIG MED DOSW, V67, P828; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Fukuda M, 1996, CANCER RES, V56, P2237; FUKUDA MN, 1989, BLOOD, V73, P84; FUKUSHI Y, 1985, CANCER RES, V45, P3711; FUKUSHI Y, 1984, J BIOL CHEM, V259, P4681; Gaspar MJ, 2008, ANTICANCER RES, V28, P2947; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; Gu JG, 2012, GLYCOCONJUGATE J, V29, P599, DOI 10.1007/s10719-012-9386-1; HADA T, 1995, GLYCOCONJUGATE J, V12, P627, DOI 10.1007/BF00731257; Hakomori S, 1996, CANCER RES, V56, P5309; HAKOMORI S, 1983, JNCI-J NATL CANCER I, V71, P231; HAKOMORI S, 1984, J BIOL CHEM, V259, P4672; HAKOMORI SI, 1986, CHEM PHYS LIPIDS, V42, P209, DOI 10.1016/0009-3084(86)90054-X; HANSEN JES, 1984, CLIN CHIM ACTA, V138, P41, DOI 10.1016/0009-8981(84)90352-8; HANSEN JES, 1987, CANCER, V60, P1630, DOI 10.1002/1097-0142(19871001)60:7<1630::AID-CNCR2820600735>3.0.CO;2-X; Hashimoto S, 2004, CANCER, V15, P2825; Haston JL, 2003, BIOMED CHROMATOGR, V17, P361, DOI 10.1002/bmc.251; HRYCAJ P, 1993, J RHEUMATOL, V20, P2020; INOUE M, 1990, OBSTET GYNECOL, V75, P1032; ITZKOWITZ SH, 1990, CANCER-AM CANCER SOC, V66, P1960, DOI 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X; KANNAGI R, 1986, CANCER RES, V46, P2619; Klug TL, 1981, CANCER RES, V44, P1048; KOPROWSKI H, 1982, LANCET, V1, P1332; KOPROWSKI H, 1979, SOMAT CELL GENET, V5, P957, DOI 10.1007/BF01542654; Kratz E, 2003, CLIN CHIM ACTA, V331, P87, DOI 10.1016/S0009-8981(03)00084-6; KREMER JMH, 1988, PHARMACOL REV, V40, P1; KUBUSHIRO K, 1995, JPN J CANCER RES, V86, P361, DOI 10.1111/j.1349-7006.1995.tb03065.x; Kushner I, 1993, MOL BIOL BIOCH CLIN, P4; Lai H, 2014, TUMOR BIOL, V35, P10547, DOI 10.1007/s13277-014-2355-5; Levander L, 2009, SCAND J IMMUNOL, V69, P412, DOI 10.1111/j.1365-3083.2009.02240.x; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Litvak A, 2014, J NATL COMPR CANC NE, V12, P907, DOI 10.6004/jnccn.2014.0085; Liu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052287, 10.1371/journal.pone.0061188, 10.1371/journal.pone.0083052]; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; MADIYALAKAN R, 1986, ANAL BIOCHEM, V152, P22, DOI 10.1016/0003-2697(86)90112-0; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; MOLLICONE R, 1994, J BIOL CHEM, V269, P12662; Mondal G, 2009, GLYCOCONJUGATE J, V26, P1225, DOI 10.1007/s10719-009-9241-1; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; NICHOLS EJ, 1985, J IMMUNOL, V135, P1911; Olewicz-Gawlik A, 2007, CLIN RHEUMATOL, V26, P1679, DOI 10.1007/s10067-007-0572-7; Ongay S, 2010, ELECTROPHORESIS, V31, P3314, DOI 10.1002/elps.201000244; Poland DCW, 2005, J LEUKOCYTE BIOL, V78, P453, DOI 10.1189/jlb.1004566; Poland DCW, 2003, GLYCOCONJUGATE J, V20, P99, DOI 10.1023/B:GLYC.0000018584.66712.2c; Schutter EMJ, 2002, AM J OBSTET GYNECOL, V187, P385, DOI 10.1067/mob.2002.123768; Selvaraju S, 2013, PROTEOMICS, V13, P1701, DOI 10.1002/pmic.201200524; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shiyan SD, 1997, GLYCOCONJUGATE J, V14, P631, DOI 10.1023/A:1018544711767; Sobin L, 2009, TNM CLASSIFICATION M; STENMAN UH, 1981, J IMMUNOL METHODS, V46, P337, DOI 10.1016/0022-1759(81)90319-7; TACHIKAWA T, 1991, CLIN CHEM, V37, P2081; Tanaka S, 2001, EXP CLIN IMMUNOGENET, V18, P1, DOI 10.1159/000049082; Tsuboi K, 2007, ANN SURG ONCOL, V14, P1880, DOI 10.1245/s10434-007-9363-2; Van Dijk W, 1998, TRENDS GLYCOSCI GLYC, V10, P235, DOI 10.4052/tigg.10.235; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Wu J, 2012, J PROTEOME RES, V11, P4541, DOI 10.1021/pr300330z; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688; Yang AP, 2014, CLIN CHIM ACTA, V437, P183, DOI 10.1016/j.cca.2014.07.034; Yazawa S, 1999, EXP CLIN IMMUNOGENET, V16, P125, DOI 10.1159/000019104; Yazawa S, 1998, GLYCOCONJUGATE J, V15, P863, DOI 10.1023/A:1006954915102; YAZAWA S, 1990, ANAL BIOCHEM, V187, P374, DOI 10.1016/0003-2697(90)90472-L; Yazawa S, 2002, GLYCOBIOLOGY, V12, P545, DOI 10.1093/glycob/cwf070; YAZAWA S, 1988, JPN J CANCER RES, V79, P538, DOI 10.1111/j.1349-7006.1988.tb01624.x; YAZAWA S, 1984, J BIOCHEM-TOKYO, V96, P1737, DOI 10.1093/oxfordjournals.jbchem.a135006; YAZAWA S, 1989, Journal of Tumor Marker Oncology, V4, P355; YAZAWA S, 1989, J CANCER RES CLIN, V115, P451, DOI 10.1007/BF00393336; YAZAWA S, 1995, CANCER RES, V55, P1473; YAZAWA S, 1990, IMMUNOL INVEST, V19, P319, DOI 10.3109/08820139009050773; YAZAWA S, 1993, JPN J CANCER RES, V84, P989, DOI 10.1111/j.1349-7006.1993.tb00190.x; YAZAWA S, 1988, CANCER, V62, P516, DOI 10.1002/1097-0142(19880801)62:3<516::AID-CNCR2820620313>3.0.CO;2-4; Zimmermann-Belsing T, 2002, AUTOIMMUNITY, V35, P441, DOI 10.1080/0891693021000038721	89	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156277	10.1371/journal.pone.0156277	http://dx.doi.org/10.1371/journal.pone.0156277			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295180	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300004
J	Deepthi, BV; Rao, KP; Chennapa, G; Naik, MK; Chandrashekara, KT; Sreenivasa, MY				Deepthi, B. V.; Rao, K. Poornachandra; Chennapa, G.; Naik, M. K.; Chandrashekara, K. T.; Sreenivasa, M. Y.			Antifungal Attributes of Lactobacillus plantarum MYS6 against Fumonisin Producing Fusarium proliferatum Associated with Poultry Feeds	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; IN-VITRO; FERMENTATIVE BACTERIA; STRAINS; CONTAMINATION; AFLATOXIN; BINDING; COMPONENTS; COMPOUND; SPOILAGE	Fumonisins, being common in occurrence in maize-based feeds, pose a great threat to animal and human health. The present study is aimed at determining the antifungal activity of Lactobacillus plantarum MYS6 against a fumonisin producing fungus, Fusarium proliferatum MYS9. The isolate was subjected to standard tests for determining its probiotic attributes and antifungal properties. L. plantarum MYS6 thrived well at pH 3.0 and 6.0, and exhibited strong resistance up to 3% bile. The isolate showed a high degree of cell surface hydrophobicity corresponding to its strong adhesion to chicken crop epithelial cells. Co-inoculation with the fungus on modified de Man Rogosa Sharpe medium revealed the inhibitory effect of L. plantarum MYS6 on fungal growth and biomass. Observation using scanning electron microscopy showed distortion of hyphal structures, swollen tips and disrupted conidia. Conidia germination inhibition assay restrained germination and showed deformed hyphae. The bioprotective feature of the isolate was evident by the inhibition of fungal development in maize-kernel treated with the cell free supernatant of L. plantarum MYS6. Both the isolate and its extracellular metabolites lowered fumonisin content in feed model up to 0.505 mg/Kg of feed and 0.3125 mg/Kg of feed respectively when compared to the level of 0.870 mg/Kg of feed in control. The major antifungal compounds produced by the isolate were 10-Octadecenoic acid, methyl ester; palmitic acid, methyl ester; heptadecanoic acid, 16-methyl ester; stearic acid and lauric acid. L. plantarum MYS6 reduced 61.7% of fumonisin possibly by a binding mechanism. These findings suggest the application of L. plantarum MYS6 as an efficient probiotic additive and biocontrol agent in feed used in poultry industry. Additionally, the antifungal metabolites pose a conspicuous inhibition of Fusarium growth and fumonisin production.	[Deepthi, B. V.; Rao, K. Poornachandra; Chennapa, G.; Sreenivasa, M. Y.] Univ Mysore, Dept Studies Microbiol, Mysuru, Karnataka, India; [Naik, M. K.] UAS, Coll Agr Sci, Dept Plant Pathol, Raichur, Karnataka, India; [Chandrashekara, K. T.] Univ Mysore, Inst Excellence, Vijnana Bhavan, Mysuru, Karnataka, India	University of Mysore; University of Mysore	Sreenivasa, MY (corresponding author), Univ Mysore, Dept Studies Microbiol, Mysuru, Karnataka, India.	sreenivasamy@gmail.com	Gurikar, Chennappa/AAF-7707-2019; Y, Sreenivasa M/F-7220-2011; K, Poornachandra Rao/AAT-3027-2021	Gurikar, Chennappa/0000-0001-5664-2393; 	University Grants Commission	University Grants Commission(University Grants Commission, India)	B V Deepthi acknowledges University Grants Commission for the award of RGNF research fellowship. The authors also thank Central Instrumentation Facility, Institute of Excellence (IOE), University with Potential for Excellence-Centre with Potential for Excellence in Particular Area (UPE-CPEPA), University of Mysore for providing timely assistance in LC/MS analysis, Fluorescent Microscopy and Scanning Electron Microscopy. We also thank Dr. Sadashiva MP, Department of Chemistry, University of Mysore, for his valuable guidance in analysis and interpretation of GCMS analysis.	Agoramoorthy G, 2007, BRAZ J MICROBIOL, V38, P739, DOI 10.1590/S1517-83822007000400028; Arasu MV, 2013, J APPL MICROBIOL, V115, P1172, DOI 10.1111/jam.12319; CHANDEL U, 2014, INDIAN J SCI RES, V4, P70; CLSI, 2012, PERF STAND ANT SUSC; Dalie D, 2012, FOOD CONTROL, V23, P405, DOI 10.1016/j.foodcont.2011.08.008; Davidson M., 2001, FOOD MICROBIOLOGY FU, P593; Ehrmann MA, 2002, J APPL MICROBIOL, V92, P966, DOI 10.1046/j.1365-2672.2002.01608.x; El-Nezami H, 2002, APPL ENVIRON MICROB, V68, P3545, DOI 10.1128/AEM.68.7.3545-3549.2002; El-Nezami HS, 2002, FOOD ADDIT CONTAM, V19, P680, DOI 10.1080/02652030210134236; Fandohan P, 2005, INT J FOOD MICROBIOL, V99, P173, DOI 10.1016/j.ijfoodmicro.2004.08.012; Gong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116871; Haskard C, 2000, CHEM-BIOL INTERACT, V128, P39, DOI 10.1016/S0009-2797(00)00186-1; Hassan YI, 2008, INT J FOOD MICROBIOL, V121, P112, DOI 10.1016/j.ijfoodmicro.2007.11.038; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; IARC, 2002, SOM TRAD HERB MED SO, V82; Jakava-Vijanen M, 2007, VET MICROBIOL, V124, P264, DOI 10.1016/j.vetmic.2007.04.029; Jurado M, 2006, SYST APPL MICROBIOL, V29, P681, DOI 10.1016/j.syapm.2006.01.014; Kim PI, 2007, APPL MICROBIOL BIOT, V74, P1103, DOI 10.1007/s00253-006-0741-7; Koch E, 2009, J PHYTOPATHOL, V157, P235, DOI 10.1111/j.1439-0434.2008.01484.x; Lahtinen SJ, 2004, FOOD ADDIT CONTAM A, V21, P158, DOI [10.1080/02652030310001639521, 10.1080/02646830020032300]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee H, 2011, INT J FOOD MICROBIOL, V145, P155, DOI 10.1016/j.ijfoodmicro.2010.12.003; Leslie J.F., 2006, FUSARIUM LAB MANUAL, P224; Gerez CL, 2009, FOOD CONTROL, V20, P144, DOI 10.1016/j.foodcont.2008.03.005; Magnusson J, 2003, FEMS MICROBIOL LETT, V219, P129, DOI 10.1016/S0378-1097(02)01207-7; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Maragkoudakis PA, 2006, INT DAIRY J, V16, P189, DOI 10.1016/j.idairyj.2005.02.009; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; MASUI H, 1989, PHYTOCHEMISTRY, V28, P2613, DOI 10.1016/S0031-9422(00)98051-8; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Morgavi DP, 2007, ANIM FEED SCI TECH, V137, P201, DOI 10.1016/j.anifeedsci.2007.06.002; Musikasang H, 2009, WORLD J MICROB BIOT, V25, P1337, DOI 10.1007/s11274-009-0020-8; Narasimharao Bhogireddy, 2015, Advances in Biological Research, V9, P109; Niderkorn V, 2009, J APPL MICROBIOL, V106, P977, DOI 10.1111/j.1365-2672.2008.04065.x; Niderkorn V, 2007, FOOD ADDIT CONTAM A, V24, P406, DOI 10.1080/02652030601101110; Niderkorn V, 2006, J APPL MICROBIOL, V101, P849, DOI 10.1111/j.1365-2672.2006.02958.x; Park SC, 2006, WORLD J MICROB BIOT, V22, P35, DOI 10.1007/s11274-005-4856-2; Pearson TC, 2004, CEREAL CHEM, V81, P490, DOI 10.1094/CCHEM.2004.81.4.490; Pohl C. H., 2011, ANTIFUNGAL FREE FATT; Proctor RH, 2004, MYCOL RES, V108, P815, DOI 10.1017/S0953756204000577; Rao KP, 2015, PROBIOTICS ANTIMICRO, V7, P146, DOI 10.1007/s12602-015-9186-6; Rouse S, 2008, J APPL MICROBIOL, V104, P915, DOI 10.1111/j.1365-2672.2007.03619.x; Salah R.B., 2012, ANAEROBE, V18, P436, DOI DOI 10.1016/J.ANAEROBE.2012.05.001; Sangmanee P, 2014, FOOD CONTROL, V40, P224, DOI 10.1016/j.foodcont.2013.12.005; Sathe SJ, 2007, J APPL MICROBIOL, V103, P2622, DOI 10.1111/j.1365-2672.2007.03525.x; Sreenivasa MY, 2008, FOOD BIOTECHNOL, V22, P160, DOI 10.1080/08905430802043206; Strom K, 2005, FEMS MICROBIOL LETT, V246, P119, DOI 10.1016/j.femsle.2005.03.047; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Yang EJ, 2010, INT J FOOD MICROBIOL, V139, P56, DOI 10.1016/j.ijfoodmicro.2010.02.012	50	40	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155122	10.1371/journal.pone.0155122	http://dx.doi.org/10.1371/journal.pone.0155122			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285317	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000377564000002
J	Hey, F; Giblett, S; Forrest, S; Herbert, C; Pritchard, C				Hey, Fiona; Giblett, Susan; Forrest, Stephanie; Herbert, Chelsea; Pritchard, Catrin			Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3 alpha/beta Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine	PLOS ONE			English	Article							EPITHELIAL STEM-CELL; POLYPOSIS-COLI APC; BETA-CATENIN; PROTEIN-KINASE; CYCLIN D1; EXPRESSION; GSK3; PATHWAY; INSULIN; TARGET	The WNT signalling pathway controls many developmental processes and plays a key role in maintenance of intestine renewal and homeostasis. Glycogen Synthase Kinase 3 (GSK3) is an important component of the WNT pathway and is involved in regulating beta-catenin stability and expression of WNT target genes. The mechanisms underpinning GSK3 regulation in this context are not completely understood, with some evidence suggesting this occurs through inhibitory N-terminal serine phosphorylation in a similar way to GSK3 inactivation in insulin signaling. To investigate this in a physiologically relevant context, we have analysed the intestinal phenotype of GSK3 knockin mice in which N-terminal serines 21/9 of GSK3 alpha/beta have been mutated to non-phosphorylatable alanine residues. We show that these knockin mutations have very little effect on overall intestinal integrity, cell lineage commitment, beta-catenin localization or WNT target gene expression although a small increase in apoptosis at villi tips is observed. Our results provide in vivo evidence that GSK3 is regulated through mechanisms independent of N-terminal serine phosphorylation in order for beta-catenin to be stabilised.	[Hey, Fiona; Giblett, Susan; Forrest, Stephanie; Herbert, Chelsea; Pritchard, Catrin] Univ Leicester, Dept Mol Cell Biol, Henry Wellcome Bldg, Leicester, Leics, England; [Pritchard, Catrin] Univ Leicester, Dept Canc Studies, Robert Kilpatrick Clin Sci Bldg, Leicester, Leics, England	University of Leicester; University of Leicester	Pritchard, C (corresponding author), Univ Leicester, Dept Mol Cell Biol, Henry Wellcome Bldg, Leicester, Leics, England.; Pritchard, C (corresponding author), Univ Leicester, Dept Canc Studies, Robert Kilpatrick Clin Sci Bldg, Leicester, Leics, England.	cap8@le.ac.uk		Pritchard, Catrin/0000-0003-1859-4487	Cancer Research UK Programme grant [A13083]; Royal Society-Wolfson Research Merit Award; Cancer Research UK [13083] Funding Source: researchfish	Cancer Research UK Programme grant(Cancer Research UK); Royal Society-Wolfson Research Merit Award(Royal Society of London); Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK Programme grant (Ref A13083), and CP was the recipient of a Royal Society-Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Cancer Research UK Programme grant (Ref A13083) and CP was the recipient of a Royal Society-Wolfson Research Merit Award. We are extremely grateful to Dario Alessi for providing the GSK3 mutant mice. We are also indebted to the Department of Biomedical Services for their invaluable help throughout this project and the Genomic Services within Core Biotechnology Services at Leicester for help with qRT-PCR. Furthermore we acknowledge Mr David Brown for all mouse genotyping carried out for this project.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Beurel E., 2014, PHARM THER; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gao XJ, 2014, BIOCHEM CELL BIOL, V92, P349, DOI 10.1139/bcb-2014-0065; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; HALL PA, 1994, J CELL SCI, V107, P3569; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419	51	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156877	10.1371/journal.pone.0156877	http://dx.doi.org/10.1371/journal.pone.0156877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284979	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000027
J	Jee, D; Kim, EC; Cho, E; Arroyo, JG				Jee, Donghyun; Kim, Eun Chul; Cho, Eunyoung; Arroyo, Jorge G.			Positive Association between Blood 25-Hydroxyvitamin D Levels and Pterygium after Control for Sunlight Exposure	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; VITAMIN-D STATUS; NATIONAL-HEALTH; ULTRAVIOLET-RADIATION; MACULAR DEGENERATION; RISK-FACTOR; PATHOGENESIS; METABOLISM; P450SCC; PATHWAY	Purpose To investigate the association between blood 25-hydroxyvitamin D levels and pterygium. Methods Korean National Health and Nutrition Examination Survey 2008-2011 were used for the present epidemiologic study. A total of 19,178 participants aged >= 30 years were evaluated for blood 25-hydroxyvitamin D levels and performed ophthalmic slit lamp examinations. Pterygium was considered as a growth of fibrovascular tissue over the cornea. Results The average blood 25-hydroxyvitamin D levels were 18.6 ng/mL, and prevalence of pterygium was 6.5%. The odds of pterygium significantly increased across blood 25-hydroxyvitamin D quintiles after controlling sun exposure time as well as other confounders such as sex, age, smoking, diabetes, hypertension (P < 0.001). The odds ratios (OR) for pterygium was 1.51 (95% Confidence Interval[95% CI]; 1.19-1.92) in the highest blood vitamin D quintile. Stratified analysis by sex showed a positive association between blood 25-hydroxyvitamin D levels and pterygium in both men (quintile 5 versus 1, OR; 1.68, 95% CI; 1.19-2.37) and women (quintile 5 versus 1, OR; 1.37, 95% CI; 1.00-1.88). Conclusions Even after controlling sun light exposure time, we found a positive association between blood 25-hydroxyvitamin D levels and pterygium in a representative Korean population. The mechanism underlying this association is unknown.	[Jee, Donghyun] Catholic Univ Korea, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Kim, Eun Chul] Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Ophthalmol & Visual Sci, Bucheon, South Korea; [Cho, Eunyoung] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA; [Arroyo, Jorge G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA	Catholic University of Korea; Catholic University of Korea; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, EC (corresponding author), Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Ophthalmol & Visual Sci, Bucheon, South Korea.	doj087@mail.harvard.edu	Cho, Eunyoung/AAV-4469-2020	Cho, Eunyoung/0000-0001-6594-2582; Arroyo, Jorge/0000-0001-9812-296X	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1A1A1A05028023]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1A1A1A05028023).	Alvarez JA, 2014, CLIN ENDOCRINOL, V81, P458, DOI 10.1111/cen.12449; Chalam KV, 2011, EYE CONTACT LENS, V37, P225, DOI 10.1097/ICL.0b013e31821fbd3e; Choi HS, 2011, J CLIN ENDOCR METAB, V96, P643, DOI 10.1210/jc.2010-2133; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Coroneo M T, 1999, Curr Opin Ophthalmol, V10, P282, DOI 10.1097/00055735-199908000-00011; CORONEO MT, 1993, BRIT J OPHTHALMOL, V77, P734, DOI 10.1136/bjo.77.11.734; Di Girolamo N, 2006, INVEST OPHTH VIS SCI, V47, P2430, DOI 10.1167/iovs.05-1130; Eum KD, 2008, SCI TOTAL ENVIRON, V407, P147, DOI 10.1016/j.scitotenv.2008.08.037; Fang CL, 2013, INVEST OPHTH VIS SCI, V54, P4563, DOI 10.1167/iovs.13-11604; Grant W B, 2003, J Cosmet Dermatol, V2, P86, DOI 10.1111/j.1473-2130.2004.00041.x; Jee D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149294; Jee D, 2015, J CATARACT REFR SURG, V41, P1705, DOI 10.1016/j.jcrs.2014.12.052; Jee DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115199; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Lee MS, 2011, ENVIRON RES, V111, P171, DOI 10.1016/j.envres.2010.10.006; Lee YA, 2014, PUBLIC HEALTH NUTR, V17, P764, DOI 10.1017/S1368980013000438; Liu T, 2013, CURR EYE RES, V38, P1191, DOI 10.3109/02713683.2013.823212; Lucas RM, 2011, EYE CONTACT LENS, V37, P168, DOI 10.1097/ICL.0b013e31821cb0cf; Mangge H, 2013, CURRENT VASCULAR PHA; Parekh N, 2007, ARCH OPHTHALMOL-CHIC, V125, P661, DOI 10.1001/archopht.125.5.661; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Patrick PA, 2012, ARCH OPHTHALMOL-CHIC, V130, P756, DOI 10.1001/archophthalmol.2011.2749; Payne JF, 2012, ENDOCR PRACT, V18, P185, DOI 10.4158/EP11147.OR; Riau AK, 2009, MOL VIS, V15, P335; Rim THT, 2013, CORNEA, V32, P962, DOI 10.1097/ICO.0b013e3182801668; Roberts JE, 2011, EYE CONTACT LENS, V37, P246, DOI 10.1097/ICL.0b013e31821cbcc9; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, INT J BIOCHEM CELL B, V44, P2003, DOI 10.1016/j.biocel.2012.07.027; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Smith M, 2010, BIOSCI HORIZ, V3, P124; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Tan DTH, 2000, INVEST OPHTH VIS SCI, V41, P1684; Uberti F, 2014, J CLIN ENDOCR METAB, V99, P1367, DOI 10.1210/jc.2013-2103	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157501	10.1371/journal.pone.0157501	http://dx.doi.org/10.1371/journal.pone.0157501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286036	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000069
J	Colombatti, R; Lucchetta, M; Montanaro, M; Rampazzo, P; Ermani, M; Talenti, G; Baracchini, C; Favaro, A; Basso, G; Manara, R; Sainati, L				Colombatti, Raffaella; Lucchetta, Marta; Montanaro, Maria; Rampazzo, Patrizia; Ermani, Mario; Talenti, Giacomo; Baracchini, Claudio; Favaro, Angela; Basso, Giuseppe; Manara, Renzo; Sainati, Laura			Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study	PLOS ONE			English	Article							SILENT CEREBRAL INFARCTS; INTELLECTUAL FUNCTION; RISK-FACTORS; ANEMIA; BRAIN; CONNECTIVITY; SCHIZOPHRENIA; HEMOGLOBIN; STROKE; CORTEX	Cerebrovascular complications are frequent events in children with sickle cell disease, yet routinely used techniques such as Transcranial Doppler (TCD), Magnetic Resonance (MRI) and Angiography (MRA), insufficiently explain the cause of poor cognitive performances. Forty children with SS-S beta degrees (mean age 8 years) underwent neurocognitive evaluation and comprehensive brain imaging assessment with TCD, MRI, MRA, Resting State (RS) Functional MRI with evaluation of the Default Mode Network (DMN). Sixteen healthy age-matched controls underwent MRI, MRA and RS functional MRI. Children with SCD display increased brain connectivity in the DMN even in the absence of alterations in standard imaging techniques. Patients with low neurocognitive scores presented higher brain connectivity compared to children without cognitive impairment or controls, suggesting an initial compensatory mechanism to maintain performances. In our cohort steady state haemoglobin level was not related to increased brain connectivity, but SatO2<97% was. Our findings provide novel evidence that SCD is characterized by a selective disruption of connectivity among relevant regions of the brain, potentially leading to reduced cognition and altered functional brain dynamics. RS functional MRI could be used as a useful tool to evaluate cognition and cerebral damage in SCD in longitudinal trials.	[Colombatti, Raffaella; Montanaro, Maria; Basso, Giuseppe; Sainati, Laura] Azienda Osped Univ Padova, Dept Maternal & Child Hlth, Clin Pediat Hematol Oncol, Padua, Italy; [Lucchetta, Marta; Rampazzo, Patrizia; Ermani, Mario; Talenti, Giacomo; Baracchini, Claudio; Favaro, Angela] Azienda Osped Univ Padova, Dept Neurosci, Padua, Italy; [Manara, Renzo] Univ Salerno, Neuroradiol Unit, Dept Neurosci, I-84100 Salerno, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Salerno	Colombatti, R (corresponding author), Azienda Osped Univ Padova, Dept Maternal & Child Hlth, Clin Pediat Hematol Oncol, Padua, Italy.	rcolombatti@gmail.com	Colombatti, Raffaella/D-2910-2017	Colombatti, Raffaella/0000-0001-9797-0457; BASSO, GIUSEPPE/0000-0002-2634-9302	Fondazione Citta della Speranza [07/04, 11/04, 14/02]	Fondazione Citta della Speranza	The research was performed with funding from Fondazione Citta della Speranza Grants 07/04, 11/04, 14/02. www.cittadellasperanza.org.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Bernaudin F, 2000, J CHILD NEUROL, V15, P333, DOI 10.1177/088307380001500510; Bernaudin F, 2015, BLOOD, V125, P1653, DOI 10.1182/blood-2014-09-599852; Bernaudin F, 2011, BLOOD, V117, P1130, DOI 10.1182/blood-2010-06-293514; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bohlken MM, 2016, JAMA PSYCHIAT, V73, P11, DOI 10.1001/jamapsychiatry.2015.1925; Brousse V, 2015, BRIT J HAEMATOL, V170, P615, DOI 10.1111/bjh.13477; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Colombatti R, 2015, BRIT J HAEMATOL, V169, P597, DOI 10.1111/bjh.13232; Colombatti R, 2012, PEDIATR BLOOD CANCER, V59, P1275, DOI 10.1002/pbc.24110; CONNES P, 2000, BRIT J HAEMATOL, V161, P484; Darbari DS, 2015, J PAIN, V16, P1077, DOI 10.1016/j.jpain.2015.07.005; Debaun M.R., 2016, BLOOD; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Droby A, 2015, BRAIN IMAGING BEHAV; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldin PR, 2013, JAMA PSYCHIAT, V70, P1048, DOI 10.1001/jamapsychiatry.2013.234; Gorges M, 2015, NEUROBIOL AGING, V36, P1727, DOI 10.1016/j.neurobiolaging.2014.12.026; Hijmans CT, 2011, PEDIATR BLOOD CANCER, V57, P297, DOI 10.1002/pbc.22892; Hogan AM, 2006, DEVELOPMENTAL SCI, V9, P379, DOI 10.1111/j.1467-7687.2006.00503.x; Hollocks MJ, 2012, J INT NEUROPSYCH SOC, V18, P168, DOI 10.1017/S1355617711001469; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; Kawadler JM, 2015, STROKE, V46, P1793, DOI 10.1161/STROKEAHA.115.008721; Kawadler JM, 2013, BRIT J HAEMATOL, V163, P373, DOI 10.1111/bjh.12496; Kim DS, 2014, J LIPID RES, V55, P1173, DOI 10.1194/jlr.P049247; King AA, 2014, AM J HEMATOL, V89, pE188, DOI 10.1002/ajh.23805; King AA, 2014, AM J HEMATOL, V89, P162, DOI 10.1002/ajh.23604; Kirk GR, 2009, CEREB CORTEX, V19, P1549, DOI 10.1093/cercor/bhn193; Kloppel S, 2015, EBIOMEDICINE, V2, P1420, DOI 10.1016/j.ebiom.2015.08.002; Kwiatkowski JL, 2009, BRIT J HAEMATOL, V146, P300, DOI 10.1111/j.1365-2141.2009.07753.x; Lanzkron S, 2015, HEMATOL-AM SOC HEMAT, P420, DOI 10.1182/asheducation-2015.1.420; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marshall MJ, 2009, HAEMATOL-HEMATOL J, V94, P1006, DOI 10.3324/haematol.2008.005215; Montanaro M, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-36; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Ohene-Frempong K, 1998, BLOOD, V91, P288; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Orsini A, 1996, WPPSI R CONTRIBUTO T; Orsini A., 2006, WISC 3 CONTRIBUTO TA; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Schatz J, 2002, J CHILD NEUROL, V17, P891, DOI 10.1177/08830738020170122401; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Steen RG, 2003, AM J NEURORADIOL, V24, P382; van der Land V, 2015, CEREBROVASC DIS, V39, P181, DOI 10.1159/000373917; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	50	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157090	10.1371/journal.pone.0157090	http://dx.doi.org/10.1371/journal.pone.0157090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281287	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000081
J	Hayat, T; Hussain, Z; Alsaedi, A; Farooq, M				Hayat, T.; Hussain, Zakir; Alsaedi, A.; Farooq, M.			Magnetohydrodynamic Flow by a Stretching Cylinder with Newtonian Heating and Homogeneous-Heterogeneous Reactions	PLOS ONE			English	Article							STAGNATION POINT FLOW; BOUNDARY-LAYER-FLOW; EYRING-POWELL FLUID; MELTING HEAT; NANOFLUID; MHD; SURFACE; MODEL	This article examines the effects of homogeneous-heterogeneous reactions and Newtonian heating in magnetohydrodynamic (MHD) flow of Powell-Eyring fluid by a stretching cylinder. The nonlinear partial differential equations of momentum, energy and concentration are reduced to the nonlinear ordinary differential equations. Convergent solutions of momentum, energy and reaction equations are developed by using homotopy analysis method (HAM). This method is very efficient for development of series solutions of highly nonlinear differential equations. It does not depend on any small or large parameter like the other methods i. e., perturbation method, delta-perturbation expansion method etc. We get more accurate result as we increase the order of approximations. Effects of different parameters on the velocity, temperature and concentration distributions are sketched and discussed. Comparison of present study with the previous published work is also made in the limiting sense. Numerical values of skin friction coefficient and Nusselt number are also computed and analyzed. It is noticed that the flow accelerates for large values of Powell-Eyring fluid parameter. Further temperature profile decreases and concentration profile increases when Powell-Eyring fluid parameter enhances. Concentration distribution is decreasing function of homogeneous reaction parameter while opposite influence of heterogeneous reaction parameter appears.	[Hayat, T.; Hussain, Zakir] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, POB 80257, Jeddah 21589, Saudi Arabia; [Farooq, M.] Riphah Int Univ, Dept Math, Islamabad 44000, Pakistan	Quaid I Azam University; King Abdulaziz University	Hussain, Z (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	zakir.qamar@yahoo.com	Alsaedi, Ahmed/A-2094-2013; Farooq, Muhammad/AAX-3841-2020; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; Farooq, Muhammad/0000-0002-5481-6393; 				Ara A, 2014, AIN SHAMS ENG J, V5, P1337, DOI 10.1016/j.asej.2014.06.002; Ellahi R, 2015, COMMUN THEOR PHYS, V63, P353, DOI 10.1088/0253-6102/63/3/353; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2012, INT J NUMER METHOD H, V22, P24, DOI 10.1108/09615531211188775; Fang TG, 2009, COMMUN NONLINEAR SCI, V14, P3731, DOI 10.1016/j.cnsns.2009.02.012; Farooq M, 2015, APPL MATH MECH-ENGL, V36, P1319, DOI 10.1007/s10483-015-1981-9; Fathizadeh M., 2013, J KING SAUD UNIV SCI, V25, P107, DOI [10.1016/j.jksus.2011.08.003, DOI 10.1016/j.jksus.2011.08.003]; Hayat T, 2016, J MOL LIQ, V220, P49, DOI 10.1016/j.molliq.2016.04.032; Hayat T, 2016, J MOL LIQ, V220, P200, DOI 10.1016/j.molliq.2016.04.012; Hayat T, 2016, J MOL LIQ, V215, P749, DOI 10.1016/j.molliq.2015.12.109; Hayat T, 2015, J MAGN MAGN MATER, V385, P222, DOI 10.1016/j.jmmm.2015.02.046; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4908602; Hayat T, 2015, APPL MATH MECH-ENGL, V36, P61, DOI 10.1007/s10483-015-1895-9; Hayat T, 2014, INT J NONLIN SCI NUM, V15, P77, DOI 10.1515/ijnsns-2013-0069; Hayat T, 2013, J THERMOPHYS HEAT TR, V27, P761, DOI 10.2514/1.T4059; Hayat T, 2012, INT J HEAT MASS TRAN, V55, P1817, DOI 10.1016/j.ijheatmasstransfer.2011.10.046; Hayat T., 2013, J EGYPTIAN MATH SOC, V21, P379, DOI [10.1016/j.joems.2013.02.009, DOI 10.1016/J.JOEMS.2013.02.009]; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148662; Javed T, 2013, CHEM ENG COMMUN, V200, P327, DOI 10.1080/00986445.2012.703151; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Kumar JP, 2012, J APPL FLUID MECH, V5, P13; Liao S., 2012, HOMOTOPY ANAL METHOD; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Rashidi S, 2015, J MAGN MAGN MATER, V378, P128, DOI 10.1016/j.jmmm.2014.11.020; Salleh MZ, 2012, MECCANICA, V47, P1261, DOI 10.1007/s11012-011-9510-5; Salleh MZ, 2010, ACTA APPL MATH, V112, P263, DOI 10.1007/s10440-010-9567-5; Shaw S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-77; Waqas M, 2016, J MOL LIQ, V220, P642, DOI 10.1016/j.molliq.2016.04.086; Zeeshan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14261-5; Zeeshan A, 2013, APPL MATH INFORM SCI, V7, P257, DOI 10.12785/amis/070132	31	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156955	10.1371/journal.pone.0156955	http://dx.doi.org/10.1371/journal.pone.0156955			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280883	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000059
J	Jiang, WD; Qu, B; Feng, L; Jiang, J; Kuang, SY; Wu, P; Tang, L; Tang, WN; Zhang, YA; Zhou, XQ; Liu, Y				Jiang, Wei-Dan; Qu, Biao; Feng, Lin; Jiang, Jun; Kuang, Sheng-Yao; Wu, Pei; Tang, Ling; Tang, Wu-Neng; Zhang, Yong-An; Zhou, Xiao-Qiu; Liu, Yang			Histidine Prevents Cu-Induced Oxidative Stress and the Associated Decreases in mRNA from Encoding Tight Junction Proteins in the Intestine of Grass Carp (Ctenopharyngodon idella)	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ANTIOXIDANT GENE-EXPRESSION; TROUT ONCORHYNCHUS-MYKISS; DIETARY COPPER EXPOSURE; MUCOSAL IMMUNE-SYSTEM; SALMON SALMO-SALAR; FRESH-WATER FISH; RAINBOW-TROUT; OREOCHROMIS-NILOTICUS; ENZYME-ACTIVITIES	Copper (Cu) is a common heavy metal pollutant in aquatic environments that originates from natural as well as anthropogenic sources. The present study investigated whether Cu causes oxidative damage and induces changes in the expression of genes that encode tight junction (TJ) proteins, cytokines and antioxidant-related genes in the intestine of the grass carp (Ctenopharyngodon idella). We demonstrated that Cu decreases the survival rate of fish and increases oxidative damage as measured by increases in malondialdehyde and protein carbonyl contents. Cu exposure significantly decreased the expression of genes that encode the tight junction proteins, namely, claudin (CLDN)-c, -3 and -15 as well as occludin and zonula occludens-1, in the intestine of fish. In addition, Cu exposure increases the mRNA levels of the pro-inflammatory cytokines, specifically, IL-8, TNF-alpha and its related signalling factor (nuclear factor kappa B, NF-kappa B), which was partly correlated to the decreased mRNA levels of NF-kappa B inhibitor protein (I kappa B). These changes were associated with Cu-induced oxidative stress detected by corresponding decreases in glutathione (GSH) content, as well as decreases in the copper, zinc-superoxide dismutase (SOD1) and glutathione peroxidase (GPx) activities and mRNA levels, which were associated with the down-regulated antioxidant signalling factor NF-E2-related factor-2 (Nrf2) mRNA levels, and the Kelch-like-ECH-associated protein1 (Keap1) mRNA levels in the intestine of fish. Histidine supplementation in diets (3.7 up to 12.2 g/kg) blocked Cu-induced changes. These results indicated that Cu-induced decreases in intestinal TJ proteins and cytokine mRNA levels might be partially mediated by oxidative stress and are prevented by histidine supplementation in fish diet.	[Jiang, Wei-Dan; Qu, Biao; Feng, Lin; Jiang, Jun; Wu, Pei; Zhou, Xiao-Qiu; Liu, Yang] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China; [Jiang, Wei-Dan; Feng, Lin; Wu, Pei; Zhou, Xiao-Qiu; Liu, Yang] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China; [Jiang, Wei-Dan; Feng, Lin; Wu, Pei; Zhou, Xiao-Qiu; Liu, Yang] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu 611130, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu 610066, Peoples R China; [Zhang, Yong-An] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhou, XQ; Liu, Y (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.; Zhou, XQ; Liu, Y (corresponding author), Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China.; Zhou, XQ; Liu, Y (corresponding author), Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu 611130, Sichuan, Peoples R China.	xqzhouqq@tom.com; kyckgk@hotmail.com	jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022; liu, yang/HHY-8583-2022		National Basic Research Program of China (973 Program) [2014CB138600]; Science and Technology Support Program of Sichuan Province of China [2014NZ0003]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007, 2013NC0045]; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2015CC0011]; Natural Science Foundation for Young Scientists of Sichuan Province [2014JQ0007]; Sichuan Province Research Foundation for Basic Research [2013JY0082]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Support Program of Sichuan Province of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Natural Science Foundation for Young Scientists of Sichuan Province; Sichuan Province Research Foundation for Basic Research	This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600), Science and Technology Support Program of Sichuan Province of China (2014NZ0003), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007, 2013NC0045), the Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011), Natural Science Foundation for Young Scientists of Sichuan Province (2014JQ0007), and Sichuan Province Research Foundation for Basic Research (2013JY0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2005, AQUACULT NUTR, V11, P359, DOI 10.1111/j.1365-2095.2005.00358.x; Al-Bairuty GA, 2013, AQUAT TOXICOL, V126, P104, DOI 10.1016/j.aquatox.2012.10.005; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; Bakke S, 2010, COMP BIOCHEM PHYS B, V156, P48, DOI 10.1016/j.cbpb.2010.02.002; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bopp SK, 2008, AQUAT TOXICOL, V86, P197, DOI 10.1016/j.aquatox.2007.10.014; Castro-Gonzalez MI, 2008, ENVIRON TOXICOL PHAR, V26, P263, DOI 10.1016/j.etap.2008.06.001; Cereijido M, 2004, PHYSIOL REV, V84, P1229, DOI 10.1152/physrev.00001.2004; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; Cifarelli V, 2008, ATHEROSCLEROSIS, V201, P248, DOI 10.1016/j.atherosclerosis.2007.12.060; Corridoni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042067; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Dreger H, 2009, CARDIOVASC RES, P107; Fatima RA, 2005, SCI TOTAL ENVIRON, V346, P256, DOI 10.1016/j.scitotenv.2004.12.004; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Garcia-Hernandez V, 2015, J CELL PHYSIOL, V230, P105, DOI 10.1002/jcp.24687; Glover CN, 2008, J MEMBRANE BIOL, V221, P87, DOI 10.1007/s00232-007-9088-y; Glover CN, 2008, J COMP PHYSIOL B, V178, P101, DOI 10.1007/s00360-007-0203-2; Gonzalez-Mariscal L, 1999, EXP CELL RES, V248, P97, DOI 10.1006/excr.1999.4392; Grosell M, 2004, AQUAT TOXICOL, V68, P249, DOI 10.1016/j.aquatox.2004.03.006; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hoyle I, 2007, AQUAT TOXICOL, V83, P62, DOI 10.1016/j.aquatox.2007.03.014; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jacquillet G, 2006, AM J PHYSIOL-RENAL, V290, pF127, DOI 10.1152/ajprenal.00366.2004; Jiang WD, 2014, AQUAT TOXICOL, V155, P301, DOI 10.1016/j.aquatox.2014.07.003; Jiang WD, 2013, AQUAT TOXICOL, V132, P100, DOI 10.1016/j.aquatox.2013.02.005; Jiang WD, 2011, AQUAT TOXICOL, V105, P543, DOI 10.1016/j.aquatox.2011.08.012; Jing G, 2006, COMP BIOCHEM PHYS C, V144, P184, DOI 10.1016/j.cbpc.2006.08.005; KADIISKA MB, 1993, MOL PHARMACOL, V44, P222; Kamunde C, 2002, AM J PHYSIOL-REG I, V283, pR69, DOI 10.1152/ajpregu.00016.2002; Khan MA, 2004, AQUAC RES, V35, P1277, DOI 10.1111/j.1365-2109.2004.01150.x; Larsson T, 2014, AQUACULTURE, V426, P288, DOI 10.1016/j.aquaculture.2014.01.034; Lee MH, 2002, FISH SHELLFISH IMMUN, V13, P259, DOI 10.1006/fsim.2001.0401; Li HT, 2013, AQUAT TOXICOL, V126, P169, DOI 10.1016/j.aquatox.2012.11.005; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Lin YH, 2008, AQUACULTURE, V284, P207, DOI 10.1016/j.aquaculture.2008.07.049; Liu DS, 2013, FOOD CHEM, V140, P105, DOI 10.1016/j.foodchem.2013.02.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVINGSTONE DR, 1990, FUNCT ECOL, V4, P415, DOI 10.2307/2389604; LLAMES CR, 1994, J AOAC INT, V77, P1362; Lu Z, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24978; Luo JB, 2014, FISH SHELLFISH IMMUN, V40, P197, DOI 10.1016/j.fsi.2014.07.003; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; McCarthy MP, 2013, AQUAT TOXICOL, V138, P123, DOI 10.1016/j.aquatox.2013.04.015; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Nadella SR, 2006, J COMP PHYSIOL B, V176, P793, DOI 10.1007/s00360-006-0101-z; Niklasson L, 2011, FISH SHELLFISH IMMUN, V31, P1072, DOI 10.1016/j.fsi.2011.09.011; Ning L, 2010, EUR J PHARM SCI, V40, P1, DOI 10.1016/j.ejps.2010.02.001; OECD, 1994, OECD GUIDELINES TEST; Oner M, 2008, ENVIRON TOXICOL CHEM, V27, P360, DOI 10.1897/07-281R.1; Pandey S, 2008, CHEM-BIOL INTERACT, V174, P183, DOI 10.1016/j.cbi.2008.05.014; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rau MA, 2004, COMP BIOCHEM PHYS C, V137, P335, DOI 10.1016/j.cca.2004.03.001; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Rincon-Heredia R, 2014, EXP CELL RES, V320, P108, DOI 10.1016/j.yexcr.2013.10.008; ROBBINS KR, 1979, J NUTR, V109, P1710, DOI 10.1093/jn/109.10.1710; Sampaio FG, 2008, COMP BIOCHEM PHYS C, V147, P43, DOI 10.1016/j.cbpc.2007.07.009; Sandrini JZ, 2009, AQUAT TOXICOL, V95, P285, DOI 10.1016/j.aquatox.2009.02.016; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Sevgili H, 2012, AQUACULTURE, V344, P126, DOI 10.1016/j.aquaculture.2012.03.030; Shaw BJ, 2006, AQUAT TOXICOL, V76, P111, DOI 10.1016/j.aquatox.2005.10.002; Shiau SY, 2003, ANIM SCI, V77, P287, DOI 10.1017/S1357729800059026; Shiau SY, 2002, AQUACULTURE, V210, P335, DOI 10.1016/S0044-8486(01)00853-5; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Subudhi U, 2012, MOL BIOL REP, V39, P9849, DOI 10.1007/s11033-012-1851-1; Syakuri H, 2013, FISH SHELLFISH IMMUN, V34, P305, DOI 10.1016/j.fsi.2012.11.010; Tan BP, 2001, AQUACULTURE, V192, P67, DOI 10.1016/S0044-8486(00)00435-X; Tang QQ, 2013, BIOL TRACE ELEM RES, V155, P370, DOI 10.1007/s12011-013-9785-6; Tantikitti C, 2001, AQUAC RES, V32, P135, DOI 10.1046/j.1355-557x.2001.00011.x; Wachtel M, 2001, J NEUROCHEM, V78, P155, DOI 10.1046/j.1471-4159.2001.00399.x; Wade AM, 1998, J NUTR BIOCHEM, V9, P308, DOI 10.1016/S0955-2863(98)00022-9; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wu CL, 2010, COMP BIOCHEM PHYS C, V152, P121, DOI 10.1016/j.cbpc.2010.03.007; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Ye P, 2012, AUST DENT J, V57, P11, DOI 10.1111/j.1834-7819.2011.01651.x; Yruela Inmaculada, 2005, Braz. J. Plant Physiol., V17, P145, DOI 10.1590/S1677-04202005000100012; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996; Zhao J, 2012, AQUACULTURE, V368, P117, DOI 10.1016/j.aquaculture.2012.09.019; Zhen-Yu D, 2006, CTENOPHARYNGODON IDE, P247	85	57	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157001	10.1371/journal.pone.0157001	http://dx.doi.org/10.1371/journal.pone.0157001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280406	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000064
J	Jouffroy-Bapicot, I; Vanniere, B; Iglesias, V; Debret, M; Delarras, JF				Jouffroy-Bapicot, Isabelle; Vanniere, Boris; Iglesias, Virginia; Debret, Maxime; Delarras, Jean-Francois			2000 Years of Grazing History and the Making of the Cretan Mountain Landscape, Greece	PLOS ONE			English	Article							EASTERN MEDITERRANEAN REGION; CLIMATE-CHANGE; FIRE HISTORY; PALYNOLOGICAL RICHNESS; CENTRAL TURKEY; POLLEN DATA; HOLOCENE; VEGETATION; SEDIMENTS; LAKE	Understanding the processes that led to the recent evolution of Mediterranean landscapes is a challenging question that can be addressed with paleoecological data. Located in the White Mountains of Crete, Asi Gonia peat bog constitutes an exceptional 2000-years-long sedimentary archive of environmental change. In this study, we document the making of the White Mountains landscape and assess human impact on ecosystem trajectories. The paleoenvironmental reconstruction is based on high-resolution analyses of sediment, pollen, dung fungal spores and charcoal obtained from a 6-m core collected from the bog. Multiproxy analyses and a robust chronological control have shed light on anthropogenic and natural processes that have driven ecological changes, giving rise to the present-day Mediterranean ecosystem. Our results suggest that sediment accumulation began during the transition from the Hellenistic to the Roman period, likely due to watershed management. The evolution of the peat bog as well as vegetation dynamics in the surrounding area were linked to past climate changes but were driven by human activities, among which breeding was of great importance. Charcoal analysis reveals that fire was largely used for the construction and maintenance of sylvo-agropastoral areas. Pollen data allow the identification of three main vegetation assemblages: 1) evergreen oak forest (before ca. 850 AD), 2) heather maquis (ca. 850 to 1870 AD), 3) phrygana/steppe landscape. Rapid changes between phases in vegetation development are associated with tipping-points in ecosystem dynamics resulting from anthropogenic impact. The modern ecosystem did not get established until the 20th century, and it is characterized by biodiversity loss along with a dramatic drying of the peat bog.	[Jouffroy-Bapicot, Isabelle; Vanniere, Boris; Iglesias, Virginia; Delarras, Jean-Francois] Univ Bourgogne Franche Comte, Lab Chronoenvironm, UMR 6249, CNRS, F-25000 Besancon, France; [Jouffroy-Bapicot, Isabelle; Vanniere, Boris; Iglesias, Virginia] Univ Bourgogne Franche Comte, Maison Sci Homme & Environm, USR 3124, CNRS, F-25000 Besancon, France; [Debret, Maxime] Univ Rouen, Morphodynam Continentale & Cotiere, UMR 6143, CNRS, F-76821 Mont St Aignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rouen Normandie	Jouffroy-Bapicot, I (corresponding author), Univ Bourgogne Franche Comte, Lab Chronoenvironm, UMR 6249, CNRS, F-25000 Besancon, France.; Jouffroy-Bapicot, I (corresponding author), Univ Bourgogne Franche Comte, Maison Sci Homme & Environm, USR 3124, CNRS, F-25000 Besancon, France.	isabelle.jouffroy@univ-fcomte.fr	Vannière, Boris C/E-4002-2010; Debret, Maxime/L-4236-2017	Vannière, Boris C/0000-0002-6779-6053; Debret, Maxime/0000-0002-8852-0152; Jouffroy-Bapicot, Isabelle/0000-0001-5920-7565; Iglesias, Virginia/0000-0001-5732-3714	PALEOMEX/ARCHEOMED-MISTRALS project (CNRS, France)	PALEOMEX/ARCHEOMED-MISTRALS project (CNRS, France)	The research leading to these results was funded by the PALEOMEX/ARCHEOMED-MISTRALS project (CNRS, France) and conducted in the framework of the Pole 2 "Environnement: ressources et paysages" of the MSHE Ledoux, through the laboratory facilities of the UMR Chrono-environnement (Besancon, France). The Greek Institute of Geology and Mineral Exploration (I.G.M.E.) authorized fieldwork and core analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez-Saez JA, 2014, QUATERN INT, V353, P98, DOI 10.1016/j.quaint.2013.06.034; Atherden MA, 1999, HOLOCENE, V9, P183, DOI 10.1191/095968399673523574; Atherden MA, 2000, LANDSCAPE LAND USE P; Baker AG, 2013, QUATERNARY SCI REV, V62, P21, DOI 10.1016/j.quascirev.2012.11.018; Bakker J, 2013, CLIM PAST, V9, P57, DOI 10.5194/cp-9-57-2013; Balsam W.L, 1997, OCEAN DRILLING PRO S, V155s, P193, DOI DOI 10.2973/0DP.PR0C.SR.155.210.1997; Beug H.J, 2004, LEITFADEN POLLENBEST; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Blondel J, 2010, MEDITERRANEAN REGION; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Bottema S, 2003, HOLOCENE, V13, P733, DOI 10.1191/0959683603hl659rp; Carrion Y, 2010, HOLOCENE, V20, P53, DOI 10.1177/0959683609348849; Chaniotis A., 1999, MINOAN FARMERS ROMAN, P181; Charman D.J., 2002, J CHEM ENG; Chester PI, 2012, GRANA, V46, P299; CLARK J.S., 1997, SEDIMENT RECORDS BIO, P23, DOI DOI 10.1007/978-3-642-59171-6_3; Clark JS, 1996, ECOLOGY, V77, P2148, DOI 10.2307/2265709; Clark RL, 1988, HOLOCENE, V8, P113; CRUISE GM, 1990, REV PALAEOBOT PALYNO, V63, P173, DOI 10.1016/0034-6667(90)90097-3; Cugny C, 2010, VEG HIST ARCHAEOBOT, V19, P391, DOI 10.1007/s00334-010-0242-6; Dean JR, 2015, QUATERNARY SCI REV, V124, P162, DOI 10.1016/j.quascirev.2015.07.023; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dearing JA, 2015, ANTHROPOCENE REV; Debret M, 2011, EARTH-SCI REV, V109, P1, DOI 10.1016/j.earscirev.2011.07.002; Eastwood WJ, 2007, J QUATERNARY SCI, V22, P327, DOI 10.1002/jqs.1062; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Enache MD, 2007, J PALEOLIMNOL, V38, P347, DOI 10.1007/s10933-006-9084-8; England A, 2008, HOLOCENE, V18, P1229, DOI 10.1177/0959683608096598; Etienne D, 2014, VEG HIST ARCHAEOBOT, V23, P743, DOI 10.1007/s00334-014-0439-1; Fielding J., 2005, FLOWERS OF CRETE; Finne M, 2011, J ARCHAEOL SCI, V38, P3153, DOI 10.1016/j.jas.2011.05.007; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Giesecke T, 2014, VEG HIST ARCHAEOBOT, V23, P217, DOI 10.1007/s00334-014-0435-5; Grimm E.C., 1991, TILIA TILIA GRAPH; Harris VV.V., 1999, MINOAN FARMERS ROMAN, P353; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; ISPIKOUDIS I, 1993, LANDSCAPE URBAN PLAN, V24, P259, DOI 10.1016/0169-2046(93)90105-M; Iversen J, 1989, J BIOGEOGR; Kaniewski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102090; Kouli K, 2012, VEG HIST ARCHAEOBOT, V21, P267, DOI 10.1007/s00334-011-0336-9; Kouli K, 2009, GEOBIOS-LYON, V42, P43, DOI 10.1016/j.geobios.2008.07.004; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Macklin MG, 2010, GLOBAL PLANET CHANGE, V70, P35, DOI 10.1016/j.gloplacha.2009.11.006; Magny M, 2013, HOLOCENE CHANGES ENV; Marlon J, 2006, HOLOCENE, V16, P1059, DOI 10.1177/0959683606069396; Mercuri AM, 2013, QUATERN INT, V303, P24, DOI 10.1016/j.quaint.2013.01.005; Mix A. C., 1992, P ODP INIT REP, V138, P67, DOI DOI 10.2973/0DP.PR0C.IR.138.104.1992; Nixon L., 2009, MEDIEVAL POSTMEDIEVA, P395; Odgaard B, 2001, DIVERSITY DISTRIBUTI, V7, P197; Rackham O., 1996, MAKING CRETAN LANDSC; Reille M., 1992, POLLEN SPORES EUROPE; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rhodes AN, 1998, HOLOCENE, V8, P113, DOI 10.1191/095968398671104653; Roberts N, 2001, HOLOCENE, V11, P721, DOI 10.1191/09596830195744; ROBERTS N, 1990, MANS ROLE IN THE SHAPING OF THE EASTERN MEDITERRANEAN LANDSCAPE, P53; Roberts N, 2012, GLOBAL PLANET CHANGE, V84-85, P23, DOI 10.1016/j.gloplacha.2011.11.002; RULL V, 1987, Pollen et Spores, V29, P471; Sadori L, 2016, QUATERNARY SCI REV, V136, P173, DOI 10.1016/j.quascirev.2015.09.020; Stallsmith AB, 2007, VENICE ISTANBUL COLO, P151; Stockmarr J, 1971, POLLEN SPORES, V13, P614; Van Geel B., 2001, TRACKING ENV CHANGE, V3, P99, DOI DOI 10.1007/0-306-47668-1_6; VANGEEL B, 1983, REV PALAEOBOT PALYNO, V38, P269, DOI 10.1016/0034-6667(83)90026-X; VANGEEL B, 1989, REV PALAEOBOT PALYNO, V60, P25, DOI 10.1016/0034-6667(89)90072-9; VANGEEL B, 1981, REV PALAEOBOT PALYNO, V31, P367; Vanniere B, 2008, QUATERNARY SCI REV, V27, P1181, DOI 10.1016/j.quascirev.2008.02.011; Vanniere B, 2016, QUATERNARY SCI REV, V132, P206, DOI 10.1016/j.quascirev.2015.11.012; Vanniere B, 2011, HOLOCENE, V21, P53, DOI 10.1177/0959683610384164; Walsh K., 2014, HUMAN ENV INTERACTIO; Weng CY, 2006, DIVERS DISTRIB, V12, P310, DOI 10.1111/j.1366-9516.2006.00230.x; Whitlock C, 1996, HOLOCENE, V6, P7, DOI 10.1177/095968369600600102; Whitlock C, 2001, TRACKING ENV CHANGE, P75, DOI DOI 10.1007/0-306-47668-1_5; Wolfe AP, 2006, J PALEOLIMNOL, V36, P91, DOI 10.1007/s10933-006-0006-6; Zanchetta G, 2013, QUATERN INT, V303, P1, DOI 10.1016/j.quaint.2013.05.009	75	22	22	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156875	10.1371/journal.pone.0156875	http://dx.doi.org/10.1371/journal.pone.0156875			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280287	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000053
J	Koduvayur, SP; Su, Y; Kay, BK; Lavie, A				Koduvayur, Sujatha P.; Su, Ying; Kay, Brian K.; Lavie, Arnon			Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine	PLOS ONE			English	Article							CANCER-THERAPY; PICOMOLAR AFFINITY; AFFIBODY MOLECULES; TRASTUZUMAB; ANTICANCER; MECHANISM; PROTEINS; 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE; PHARMACOKINETICS; PHOSPHORYLATION	Cytotoxic drugs, such as nucleoside analogs and toxins, commonly suffer from off-target effects. One approach to mitigate this problem is to deliver the cytotoxic drug selectively to the intended site. While for toxins this can be achieved by conjugating the cell-killing moiety to a targeting moiety, it is not an option for nucleoside analogs, which rely on intracellular enzymes to convert them to their active triphosphorylated form. To overcome this limitation, and achieve site-targeted activation of nucleoside analogs, we fused the coding region of a prodrug-activating enzyme, deoxycytidine kinase (dCK), to affinity reagents that bind to the Her2 cell surface protein. We evaluated dCK fusions to an anti-Her2 affibody and Designed Ankyrin Repeat Protein (DARPin) for their ability to kill cancer cells by promoting the activation of the nucleoside analog fludarabine. Cell staining and flow cytometry experiments with three Her2 positive cancer cell lines (BT-474-JB, JIMT-1 and SK-OV-3) indicate dCK fusions binding and cellular internalization. In contrast, these reagents bind only weakly to the Her2 negative cell line, MCF-7. Cell proliferation assays indicate that SK-OV-3 and BT-474-JB cell lines exhibit significantly reduced proliferation rates when treated with targeting-module fused dCK and fludarabine, compared to fludarabine alone. These findings demonstrate that we have succeeded in delivering active dCK into the Her2-positive cells, thereby increasing the activation of fludarabine, which ultimately reduces the dose of nucleoside analog needed for cell killing. This strategy may help establish the therapeutic index required to differentiate between healthy tissues and cancer cells.	[Koduvayur, Sujatha P.; Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Su, Ying; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Lavie, Arnon] Jesse Brown VA Med Ctr, Chicago, IL USA; [Koduvayur, Sujatha P.] Stevens Inst Technol, Dept Elect & Comp Engn, Hoboken, NJ 07030 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Stevens Institute of Technology	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.; Lavie, A (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL USA.	Lavie@uic.edu		Lavie, Arnon/0000-0001-5591-8722	National Institutes of Health [R21 CA155424]; NATIONAL CANCER INSTITUTE [R21CA155424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R21 CA155424 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; AVRAMIS VI, 1982, CANCER RES, V42, P2587; BARRUECO JR, 1987, CANCER RES, V47, P700; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Burris HA, 2013, AM SOC CLIN ONCOL ED; Campbell DO, 2012, J BIOL CHEM, V287, P446, DOI 10.1074/jbc.M111.314666; Canonici A, 2013, ONCOTARGET, V4, P1592, DOI 10.18632/oncotarget.1148; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Friedman M, 2007, PROTEIN ENG DES SEL, V20, P189, DOI 10.1093/protein/gzm011; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Koduvayur SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087964; Koshkaryev A, 2013, ADV DRUG DELIVER REV, V65, P24, DOI 10.1016/j.addr.2012.08.009; Lambert JM, 2005, CURR OPIN PHARMACOL, V5, P543, DOI 10.1016/j.coph.2005.04.017; Lambert JM, 2013, BRIT J CLIN PHARMACO, V76, P248, DOI 10.1111/bcp.12044; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Leal M, 2014, ANN NY ACAD SCI, V1321, P41, DOI 10.1111/nyas.12499; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; PLUNKETT W, 1993, SEMIN ONCOL, V20, P2; Ricci Francesca, 2009, Ther Clin Risk Manag, V5, P187; ROSS SR, 1993, DRUGS, V45, P737, DOI 10.2165/00003495-199345050-00009; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Singh Y, 2008, CURR MED CHEM, V15, P1802, DOI 10.2174/092986708785132997; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Steiner M, 2011, CLIN CANCER RES, V17, P6406, DOI 10.1158/1078-0432.CCR-11-0483; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tanner M, 2004, MOL CANCER THER, V3, P1585; Vlashi E, 2009, MOL PHARMACEUT, V6, P1868, DOI 10.1021/mp900158d; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	42	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157114	10.1371/journal.pone.0157114	http://dx.doi.org/10.1371/journal.pone.0157114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280468	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000086
J	Sinnott, SJ; Brick, A; Layte, R; Cunningham, N; Turner, MJ				Sinnott, Sarah-Jo; Brick, Aoife; Layte, Richard; Cunningham, Nathan; Turner, Michael J.			National Variation in Caesarean Section Rates: A Cross Sectional Study in Ireland	PLOS ONE			English	Article							DELIVERY RATES; MATERNAL MORTALITY; RISK; BIRTH; MORBIDITY; QUALITY	Objective Internationally, caesarean section (CS) rates are rising. However, mean rates of CS across providers obscure extremes of CS provision. We aimed to quantify variation between all maternity units in Ireland. Methods Two national databases, the National Perinatal Reporting System and the Hospital Inpatient Enquiry Scheme, were used to analyse data for all women delivering singleton births weighing >= 500g. We used multilevel models to examine variation between hospitals in Ireland for elective and emergency CS, adjusted for individual level sociodemographic, clinical and organisational variables. Analyses were subsequently stratified for nullipara and multipara with and without prior CS. Results The national CS rate was 25.6% (range 18.2% - 35.1%). This was highest in multipara with prior CS at 86.1%(range 6.9% - 100%). The proportion of variation in CS that was attributable to the hospital of birth was 11.1% (95% CI, 6.0 - 19.4) for elective CS and 2.9% (95% CI, 1.4 - 5.6) for emergency CS, after adjustment. Stratifying across parity group, variation between hospitals was greatest for multipara with prior CS. Both types of CS were predicted by increasing age, prior history of miscarriage or stillbirth, prior CS, antenatal complications and private model of care. Conclusion The proportion of variation attributable to the hospital was higher for elective CS than emergency CS suggesting that variation is more likely influenced by antenatal decision making than intrapartum decision making. Multipara with prior CS were particularly subject to variability, highlighting a need for consensus on appropriate care in this group.	[Sinnott, Sarah-Jo; Brick, Aoife; Layte, Richard; Cunningham, Nathan] Econ & Social Res Inst, Whitaker Sq, Dublin 2, Ireland; [Brick, Aoife] Trinity Coll Dublin, Dublin, Ireland; [Layte, Richard] Univ Dublin Trinity Coll, Dept Sociol, Dublin 2, Ireland; [Turner, Michael J.] Coombe Women & Infants Univ Hosp, UCD Ctr Human Reprod, Dublin 8, Ireland	Economic & Social Research Institute (ESRI); Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Sinnott, SJ (corresponding author), Econ & Social Res Inst, Whitaker Sq, Dublin 2, Ireland.	sarah-jo.sinnott@esri.ie		Turner, Michael/0000-0003-0064-5098; Brick, Aoife/0000-0002-5046-8336	Health Research Board in Ireland [HRA_HSR/2012/8]	Health Research Board in Ireland	This work was supported by the Health Research Board in Ireland under grant no. HRA_HSR/2012/8. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baicker K, 2006, HEALTH AFFAIR, V25, pW355, DOI 10.1377/hlthaff.25.w355; Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Bramley Michelle, 2005, Health Inf Manag, V34, P40, DOI 10.1177/183335830503400205; Caceres IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057817; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Chaillet N, 2015, NEW ENGL J MED, V372, P1710, DOI 10.1056/NEJMoa1407120; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Edmonds JK, 2014, BIRTH-ISS PERINAT C, V41, P290, DOI 10.1111/birt.12108; Fitzmaurice G, 2000, NUTRITION, V16, P313, DOI 10.1016/S0899-9007(99)00293-2; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; Healthcare Pricing Office, 2014, ACT AC PUBL HOSP IR; Healthcare Pricing Office, 2013, NAT PER STAT REP 201; Higgins JR, 2013, ESTABLISHMENT HOSP G, V2013; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Kozhimannil KB, 2013, HEALTH AFFAIR, V32, P527, DOI 10.1377/hlthaff.2012.1030; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Lobel M, 2007, SOC SCI MED, V64, P2272, DOI 10.1016/j.socscimed.2007.02.028; Macfarlane A, 2015, BJOG INT J OBSTET GY; Mohammed MA, 2016, STAT METHODS MED RES, V25, P706, DOI 10.1177/0962280212465165; Murphy DJ, BRIT MED J OPEN; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; O'Neill SM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001670; Organisation for Economic Co-operation and Development, 2015, OECD HLTH STAT 2015; Paranjothy S, 2005, BJOG-INT J OBSTET GY, V112, P658, DOI 10.1111/j.1471-0528.2005.00501.x; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Potter JE, 2001, UNWANTED CAESAREAN S; Scott JR, 2011, OBSTET GYNECOL, V118, P342, DOI 10.1097/AOG.0b013e3182245b39; Sebastiao YV, 2015, AM J OBSTET GYNECOLO; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Turner MJ, 2011, INT J GYNECOL OBSTET, V113, P175, DOI 10.1016/j.ijgo.2011.01.012; WHO, 2010, WOR HEALT REP, P1; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zich K., 2012, KAISERSCHNITTGEBURTE	34	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156172	10.1371/journal.pone.0156172	http://dx.doi.org/10.1371/journal.pone.0156172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280848	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000377563000019
J	Maekawa, N; Konnai, S; Okagawa, T; Nishimori, A; Ikebuchi, R; Izumi, Y; Takagi, S; Kagawa, Y; Nakajima, C; Suzuki, Y; Kato, Y; Murata, S; Ohashi, K				Maekawa, Naoya; Konnai, Satoru; Okagawa, Tomohiro; Nishimori, Asami; Ikebuchi, Ryoyo; Izumi, Yusuke; Takagi, Satoshi; Kagawa, Yumiko; Nakajima, Chie; Suzuki, Yasuhiko; Kato, Yukinari; Murata, Shiro; Ohashi, Kazuhiko			Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; MAST-CELL TUMORS; BREAST-CANCER; B7-H1 PD-L1; DOGS; OSTEOSARCOMA; PROGNOSIS; HEMANGIOSARCOMA; CARCINOMA; BLOCKADE	Spontaneous cancers are common diseases in dogs. Among these, some malignant cancers such as oral melanoma, osteosarcoma, hemangiosarcoma, and mast cell tumor are often recognized as clinical problems because, despite their high frequencies, current treatments for these cancers may not always achieve satisfying outcomes. The absence of effective systemic therapies against these cancers leads researchers to investigate novel therapeutic modalities, including immunotherapy. Programmed death 1 (PD-1) is a costimulatory receptor with immunosuppressive function. When it binds its ligands, PD-ligand 1 (PD-L1) or PD-L2, PD-1 on T cells negatively regulates activating signals from the T cell receptor, resulting in the inhibition of the effector function of cytotoxic T lymphocytes. Aberrant PD-L1 expression has been reported in many human cancers and is considered an immune escape mechanism for cancers. In clinical trials, anti-PD-1 or anti-PD-L1 antibodies induced tumor regression for several malignancies, including advanced melanoma, non-small cell lung carcinoma, and renal cell carcinoma. In this study, to assess the potential of the PD-1/PD-L1 axis as a novel therapeutic target for canine cancer immunotherapy, immunohistochemical analysis of PD-L1 expression in various malignant cancers of dogs was performed. Here, we show that dog oral melanoma, osteosarcoma, hemangiosarcoma, mast cell tumor, mammary adenocarcinoma, and prostate adenocarcinoma expressed PD-L1, whereas some other types of cancer did not. In addition, PD-1 was highly expressed on tumor-infiltrating lymphocytes obtained from oral melanoma, showing that lymphocytes in this cancer type might have been functionally exhausted. These results strongly encourage the clinical application of PD-1/PD-L1 inhibitors as novel therapeutic agents against these cancers in dogs.	[Maekawa, Naoya; Konnai, Satoru; Okagawa, Tomohiro; Nishimori, Asami; Ikebuchi, Ryoyo; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Izumi, Yusuke; Takagi, Satoshi] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kagawa, Yumiko] North Lab, Sapporo, Hokkaido, Japan; [Kagawa, Yumiko] Hokkaido Univ, Dept Diagnost Pathol, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Nakajima, Chie; Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Kato, Yukinari] Tohoku Univ, Dept Reg Innovat, Grad Sch Med, Sendai, Miyagi 980, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Tohoku University	Ohashi, K (corresponding author), Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	okazu@vetmed.hokudai.ac.jp	Ikebuchi, Ryoyo/AAG-1138-2019; Suzuki, Yasuhiko/F-6890-2012; Nakajima, Chie/A-5020-2012; Okagawa, Tomohiro/AAX-1284-2021	Ikebuchi, Ryoyo/0000-0003-0231-7733; TAKAGI, Satoshi/0000-0001-6653-5890; Kato, Yukinari/0000-0001-5385-8201; Satoru, Konnai/0000-0002-3230-7109	Japan Society for the Promotion of Science (JSPS) [16K15042, 15J01989]; Platform for Drug Discovery, Informatics, and Structural Life Science from Japan Agency for Medical Research and Development (AMED) [2157]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-in-Aid for Scientific Research (Grant Number 16K15042) and Grant-in-aid for JSPS Fellows (Grant Number 15J01989) from Japan Society for the Promotion of Science (JSPS). This research is (partially) supported by the Platform for Drug Discovery, Informatics, and Structural Life Science (Proposal No. 2157) from Japan Agency for Medical Research and Development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; BOSTOCK DE, 1989, BRIT J CANCER, V59, P915, DOI 10.1038/bjc.1989.193; Brahmer JR, 2012, NEW ENGL J MED, P1; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; D'Angelo SP, 2015, HUM PATHOL, V46, P357, DOI 10.1016/j.humpath.2014.11.001; Dickerson EB, 2005, VET PATHOL, V42, P618, DOI 10.1354/vp.42-5-618; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Ikebuchi R, 2014, IMMUNOLOGY, V142, P551, DOI 10.1111/imm.12243; Kanae Y, 2006, AM J VET RES, V67, P127, DOI 10.2460/ajvr.67.1.127; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082870; Koenig A, 2002, VET PATHOL, V39, P458, DOI 10.1354/vp.39-4-458; Levine RA, 2002, VET PATHOL, V39, P372, DOI 10.1354/vp.39-3-372; Lussier DM, 2015, J IMMUNOTHER, V38, P96, DOI 10.1097/CJI.0000000000000065; MACEWEN EG, 1986, CANCER INVEST, V4, P397, DOI 10.3109/07357908609017520; MACVEAN DW, 1978, VET PATHOL, V15, P700, DOI 10.1177/030098587801500602; Maekawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098415; Massari F, 2015, TARGET ONCOL; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Mittendorf EA, 2014, CANCER IMMUNOL RES, V2, P361, DOI 10.1158/2326-6066.CIR-13-0127; Murphy S, 2005, Vet Comp Oncol, V3, P222, DOI 10.1111/j.1476-5810.2005.00082.x; Ogilvie GK, 1996, J VET INTERN MED, V10, P379, DOI 10.1111/j.1939-1676.1996.tb02085.x; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; PATNAIK AK, 1984, VET PATHOL, V21, P469, DOI 10.1177/030098588402100503; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Smith SH, 2002, VET PATHOL, V39, P651, DOI 10.1354/vp.39-6-651; Sorenmo K U, 2004, Vet Comp Oncol, V2, P13, DOI 10.1111/j.1476-5810.2004.00035.x; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; Szewczyk M, 2015, VET RES COMMUN, V39, P61, DOI 10.1007/s11259-014-9623-0; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Topalian SL, 2012, NEW ENGL J MED, V366, P1, DOI DOI 10.1056/NEJM0A1200690; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Wood CA, 1998, J AM ANIM HOSP ASSOC, V34, P417, DOI 10.5326/15473317-34-5-417; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003	44	58	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157176	10.1371/journal.pone.0157176	http://dx.doi.org/10.1371/journal.pone.0157176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276060	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700080
J	Potenza, N; Castiello, F; Panella, M; Colonna, G; Ciliberto, G; Russo, A; Costantini, S				Potenza, Nicoletta; Castiello, Filomena; Panella, Marta; Colonna, Giovanni; Ciliberto, Gennaro; Russo, Aniello; Costantini, Susan			Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; REGULATES EXPRESSION; LIVER-CANCER; IN-VITRO; SELENOPROTEINS; MICRORNAS; PROMOTES; ETIOLOGY; TARGETS	Hepatocellular carcinoma (HCC) is a multi-factorial cancer with a very poor prognosis; therefore, there are several investigations aimed at the comprehension of the molecular mechanisms leading to development and progression of HCC and at the definition of new therapeutic strategies. We have recently evaluated the expression of selenoproteins in HCC cell lines in comparison with normal hepatocytes. Recent results have shown that some of them are down- and others up-regulated, including the selenoprotein K (SELK), whose expression was also induced by sodium selenite treatment on cells. However, so far very few studies have been dedicated to a possible effect of microRNAs on the expression of selenoproteins and their implication in HCC. In this study, the analysis of SELK 3'UTR by bioinformatics tools led to the identification of eight sites potentially targeted by human microRNAs. They were then subjected to a validation test based on luciferase reporter constructs transfected in HCC cell lines. In this functional screening, miR-544a was able to interact with SELK 3'UTR suppressing the reporter activity. Transfection of a miR-544a mimic or inhibitor was then shown to decrease or increase, respectively, the translation of the endogenous SELK mRNA. Intriguingly, miR-544a expression was found to be modulated by selenium treatment, suggesting a possible role in SELK induction by selenium.	[Potenza, Nicoletta; Castiello, Filomena; Panella, Marta; Russo, Aniello] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy; [Colonna, Giovanni] Univ Naples 2, Azienda Osped Univ, Serv Informat Med, Naples, Italy; [Ciliberto, Gennaro] Ist Nazl Tumori Fdn G Pascale IRCCS, Direttore Sci, Naples, Italy; [Costantini, Susan] Ist Nazl Tumori Fdn G Pascale IRCCS, CROM, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Potenza, N (corresponding author), Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy.; Costantini, S (corresponding author), Ist Nazl Tumori Fdn G Pascale IRCCS, CROM, Naples, Italy.	nicoletta.potenza@unina2.it; s.costantini@istitutotumori.na.it	Colonna, Giovanni/AAY-3568-2021; Ciliberto, Gennaro/J-4131-2017; Costantini, Susan/J-9914-2018	Ciliberto, Gennaro/0000-0003-2851-8605; Colonna, Giovanni/0000-0002-0473-1455; Potenza, Nicoletta/0000-0002-9736-792X; Costantini, Susan/0000-0002-7538-4657				Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Bronte F, 2016, CRIT REV ONCOL HEMAT, V97, P312, DOI 10.1016/j.critrevonc.2015.09.007; Capone F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134594; DAEMER RJ, 1980, INFECT IMMUN, V30, P607; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Diamond AM, 2015, NUTRIENTS, V7, P3938, DOI 10.3390/nu7053938; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Guariniello S, 2015, ANAL CELL PATHOL AMS, V2015; Haga CL, 2015, ACS CHEM BIOL, V10, P2267, DOI 10.1021/acschembio.5b00265; He XX, 2016, TUMOR BIOL, V37, P807, DOI 10.1007/s13277-015-3857-5; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee JH, 2015, J BIOL CHEM, V290, P29941, DOI 10.1074/jbc.M115.680215; Liu J, 2014, FEBS LETT, V588, P3311, DOI 10.1016/j.febslet.2014.07.037; Maciel-Dominguez A, 2013, MOL NUTR FOOD RES, V57, P2195, DOI 10.1002/mnfr.201300168; Mao LY, 2015, AM J CANCER RES, V5, P1939; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meplan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048709; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mo XM, 2014, ONCOL LETT, V8, P1731, DOI 10.3892/ol.2014.2387; Mo XM, 2014, ONCOTARGETS THER, V7, P895, DOI 10.2147/OTT.S61695; Morishita A, 2015, HEPATOL RES, V45, P128, DOI 10.1111/hepr.12386; Mosca N, 2014, BIOCHEM BIOPH RES CO, V449, P141, DOI 10.1016/j.bbrc.2014.05.009; Mukhopadhyay B, 2015, HEPATOLOGY, V61, P1615, DOI 10.1002/hep.27686; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Rusolo F, 2013, MOLECULES, V18, P2549, DOI 10.3390/molecules18032549; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Stiuso P, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.8; Sun J, 2013, SCI WORLD J, V2013, P14; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106; Yang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149227; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	40	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156908	10.1371/journal.pone.0156908	http://dx.doi.org/10.1371/journal.pone.0156908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275761	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700048
J	Romek, KM; Remaud, GS; Silvestre, V; Paneth, P; Robins, RJ				Romek, Katarzyna M.; Remaud, Gerald S.; Silvestre, Virginie; Paneth, Piotr; Robins, Richard J.			Non-statistical C-13 Fractionation Distinguishes Co-incident and Divergent Steps in the Biosynthesis of the Alkaloids Nicotine and Tropine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ISOTOPE FRACTIONATION; DATURA-STRAMONIUM; NATURAL-ABUNDANCE; ACID; OXIDASE; ASPARTATE; SYNTHASE; REVEALS; PATHWAY	During the biosynthesis of natural products, isotopic fractionation occurs due to the selectivity of enzymes for the heavier or lighter isotopomers. As only some of the positions in the molecule are implicated in a given reaction mechanism, position-specific fractionation occurs, leading to a non-statistical distribution of isotopes. This can be accessed by isotope ratio monitoring C-13 NMR spectrometry. The solanaceous alkaloids S-(-)-nicotine and hyoscyamine (atropine) are related in having a common intermediate, but downstream enzymatic steps diverge, providing a relevant test case to: (a) elucidate the isotopic affiliation between carbon atoms in the alkaloids and those in the precursors; (b) obtain information about the kinetic isotope effects of as yet undescribed enzymes, thus to make predictions as to their possible mechanism(s). We show that the position-specific C-13/C-12 ratios in the different moieties of these compounds can satisfactorily be related to their known precursors and to the known kinetic isotope effects of enzymes involved in their biosynthesis, or to similar reaction mechanisms. Thus, the pathway to the common intermediate, N-methyl-Delta(1)-pyrrolinium, is seen to introduce similar isotope distribution patterns in the two alkaloids independent of plant species, whereas the remaining atoms of each target compound, which are of different origins, reflect their specific metabolic ancestry. We further demonstrate that the measured 13C distribution pattern can be used to deduce aspects of the reaction mechanism of enzymes still to be identified.	[Romek, Katarzyna M.; Remaud, Gerald S.; Silvestre, Virginie; Robins, Richard J.] Univ Nantes, CNRS,UMR6230, Elucidat Biosynth Isotop Spectrometry Grp, Interdisciplinary Chem Synth,Anal,Modeling, F-44322 Nantes, France; [Romek, Katarzyna M.; Paneth, Piotr] Lodz Univ Technol, Fac Chem, Inst Appl Radiat Chem, Ul Stefana Zeromskiego 116, PL-90924 Lodz, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; Lodz University of Technology	Robins, RJ (corresponding author), Univ Nantes, CNRS, Elucidat Biosynth Isotop Spectrometry Grp, CEISAM,UMR6230, 2 Rue Houssiniere, F-44322 Nantes, France.	richard.robins@univ-nantes.fr		Robins, Richard/0000-0002-5325-8983; Paneth, Piotr/0000-0002-3091-8387	French Research Ministry; CNRS	French Research Ministry(Ministry of Research, France); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the French Research Ministry (to K. M. R.) and the CNRS (to R. J. R.). The authors declare that they have no conflicts of interest within the contents of this article.	BALDWIN IT, 1988, OECOLOGIA, V77, P378, DOI 10.1007/BF00378046; Bayle K, 2015, J BIOL CHEM, V290, P4118, DOI 10.1074/jbc.M114.621441; Bayle K, 2014, ANAL CHIM ACTA, V846, P1, DOI 10.1016/j.aca.2014.07.018; Biastoff S, 2009, PHYTOCHEMISTRY, V70, P1708, DOI 10.1016/j.phytochem.2009.06.012; Botosoa EP, 2009, ANAL BIOCHEM, V393, P182, DOI 10.1016/j.ab.2009.06.031; Chaintreau A, 2013, ANAL CHIM ACTA, V788, P108, DOI 10.1016/j.aca.2013.06.004; Cherrier MV, 2014, J AM CHEM SOC, V136, P5253, DOI 10.1021/ja501431b; CHESTERS NCJE, 1994, J CHEM SOC PERK T 1, P1159, DOI 10.1039/p19940001159; Dalton HL, 2016, J EXP BOT, V67, P3367, DOI 10.1093/jxb/erw166; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P10, DOI 10.1016/j.phytochem.2013.06.002; Diomande DG, 2015, ANAL CHEM, V87, P6600, DOI 10.1021/acs.analchem.5b00559; Drager B, 2006, PHYTOCHEMISTRY, V67, P327, DOI 10.1016/j.phytochem.2005.12.001; FRIESEN JB, 1990, TETRAHEDRON LETT, V31, P6295; Gilbert A, 2011, PLANT CELL ENVIRON, V34, P1104, DOI 10.1111/j.1365-3040.2011.02308.x; Greule M, 2011, ISOT ENVIRON HEALT S, V47, P470, DOI 10.1080/10256016.2011.616270; JACKANICZ TM, 1966, J BIOL CHEM, V241, P1296; Katoh A, 2006, PLANT PHYSIOL, V141, P851, DOI 10.1104/pp.106.081091; KIM JM, 1993, J AM CHEM SOC, V115, P10591, DOI 10.1021/ja00076a017; LEETE E, 1967, J AM CHEM SOC, V89, P7081, DOI 10.1021/ja01002a042; Lewis RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117273; Li R, 2006, CHEM BIOL, V13, P513, DOI 10.1016/j.chembiol.2006.03.005; Melander L., 1980, REACTION RATES ISOTO; MELZER E, 1988, BIOCHEM J, V252, P913, DOI 10.1042/bj2520913; MONSON KD, 1982, J BIOL CHEM, V257, P5568; Naconsie M, 2014, PLANT CELL PHYSIOL, V55, P436, DOI 10.1093/pcp/pct179; O'Hagan D, 1998, CHEM SOC REV, V27, P207, DOI 10.1039/a827207z; ROBINS RJ, 1994, RECENT ADV PHYTOCHEM, V28, P1; Robins RJ, 1997, J AM CHEM SOC, V119, P10929, DOI 10.1021/ja964461p; ROBINS RJ, 1994, J CHEM SOC PERK T 1, P615, DOI 10.1039/p19940000615; Robins RJ, 1993, ALKALOIDS, V44, P115; Romek KM, 2015, P NATL ACAD SCI USA, V112, P8296, DOI 10.1073/pnas.1506011112; Schmidt H, 1998, STABLE ISOTOPES INTE, P13; Schmidt HL, 2015, ISOT ENVIRON HEALT S, V51, P155, DOI 10.1080/10256016.2015.1014355; Schmidt HL, 2003, NATURWISSENSCHAFTEN, V90, P537, DOI 10.1007/s00114-003-0485-5; SCHMIDT HL, 1995, SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1994, P869; Schultes R.E., 1992, PLANTS GODS THEIR SA; Shoji T, 2015, PHYTOCHEMISTRY, V113, P41, DOI 10.1016/j.phytochem.2014.05.017; Silvestre V, 2009, J PHARMACEUT BIOMED, V50, P336, DOI 10.1016/j.jpba.2009.04.030; Tenailleau E, 2007, J MAGN RESON, V185, P50, DOI 10.1016/j.jmr.2006.11.007; Waldhauser SSM, 1997, PHYTOCHEMISTRY, V44, P853, DOI 10.1016/S0031-9422(96)00662-0; Weilacher T, 1996, PHYTOCHEMISTRY, V41, P1073, DOI 10.1016/0031-9422(95)00757-1; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258	42	11	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16620	16629		10.1074/jbc.M116.734087	http://dx.doi.org/10.1074/jbc.M116.734087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288405	Green Published, hybrid			2022-12-26	WOS:000380826700021
J	Tagami, T; Miyano, E; Sadahiro, J; Okuyama, M; Iwasaki, T; Kimura, A				Tagami, Takayoshi; Miyano, Eri; Sadahiro, Juri; Okuyama, Masayuki; Iwasaki, Tomohito; Kimura, Atsuo			Two Novel Glycoside Hydrolases Responsible for the Catabolism of Cyclobis-(1 -> 6)-alpha-nigerosyl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRASACCHARIDE-SYNTHESIZING ENZYMES; BACILLUS-GLOBISPORUS C-11; LONG-CHAIN SUBSTRATE; SP NRRL B-21195; CYCLIC TETRASACCHARIDE; ALPHA-GLUCOSIDASE; GLUCOAMYLASE; GLUCOSYLTRANSFERASE; OLIGOSACCHARIDES; CYCLOALTERNAN	The actinobacterium Kribbella flavida NBRC 14399(T) produces cyclobis-(1 -> 6)-alpha-nigerosyl (CNN), a cyclic glucotetraose with alternate alpha-(1 -> 6)- and alpha-(1 -> 3)-glucosidic linkages, from starch in the culture medium. We identified gene clusters associated with the production and intracellular catabolism of CNN in the K. flavida genome. One cluster encodes 6-alpha-glucosyl-transferase and 3-alpha-isomaltosyltransferase, which are known to coproduce CNN from starch. The other cluster contains four genes annotated as a transcriptional regulator, sugar transporter, glycoside hydrolase family (GH) 31 protein (Kfla1895), and GH15 protein (Kfla1896). Kfla1895 hydrolyzed the alpha-(1 -> 3)-glucosidic linkages of CNN and produced isomaltose via a possible linear tetrasaccharide. The initial rate of hydrolysis of CNN (11.6 s(-1)) was much higher than that of panose (0.242 s(-1)), and hydrolysis of isomaltotriose and nigerose was extremely low. Because Kfla1895 has a strong preference for the alpha-(1 -> 3)-isomaltosyl moiety and effectively hydrolyzes the alpha-(1 -> 3)-glucosidic linkage, it should be termed 1,3-alpha-isomaltosidase. Kfla1896 effectively hydrolyzed isomaltose with liberation of beta-glucose, but displayed low or no activity toward CNN and the general GH15 enzyme substrates such as maltose, soluble starch, or dextran. The k(cat)/K-m for isomaltose (4.81 +/- 0.18 s(-1) mM(-1)) was 6.9- and 19-fold higher than those for panose and isomaltotriose, respectively. These results indicate that Kfla1896 is a new GH15 enzyme with high substrate specificity for isomaltose, suggesting the enzyme should be designated an isomaltose glucohydrolase. This is the first report to identify a starch-utilization pathway that proceeds via CNN.	[Tagami, Takayoshi; Iwasaki, Tomohito] Rakuno Gakuen Univ, Coll Agr Food & Environm Sci, Ebetsu, Hokkaido 0698501, Japan; [Miyano, Eri; Sadahiro, Juri; Okuyama, Masayuki; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Rakuno Gakuen University; Hokkaido University	Tagami, T (corresponding author), Rakuno Gakuen Univ, 582 Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.; Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	t-tagami@rakuno.ac.jp; kimura@abs.agr.hokudai.ac.jp	Tagami, Takayoshi/Q-3953-2019; Okuyama, Masayuki/D-8739-2012	Okuyama, Masayuki/0000-0001-7013-6032; Tagami, Takayoshi/0000-0002-4004-1558	Northern Advancement Center for Science AMP; Technology of Hokkaido Japan	Northern Advancement Center for Science AMP; Technology of Hokkaido Japan	This work was supported in part by Grants-in-Aid for Regional R&D Proposal-based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Aga H, 2003, J BIOSCI BIOENG, V95, P215, DOI 10.1263/jbb.95.215; Aga H, 2002, BIOSCI BIOTECH BIOCH, V66, P1057, DOI 10.1271/bbb.66.1057; COTE GL, 1994, EUR J BIOCHEM, V226, P641, DOI 10.1111/j.1432-1033.1994.tb20091.x; Cote GL, 2001, CARBOHYD RES, V332, P373, DOI 10.1016/S0008-6215(01)00106-9; COUTINHO PM, 1994, PROTEIN ENG, V7, P393, DOI 10.1093/protein/7.3.393; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Hodge JE, 1962, METHODS CARBOHYDRATE, DOI DOI 10.1371/JOURNAL.PONE.0065418; Kazanov MD, 2013, NUCLEIC ACIDS RES, V41, P790, DOI 10.1093/nar/gks1184; Kim YK, 2004, CARBOHYD RES, V339, P1179, DOI 10.1016/j.carres.2004.02.008; Kim YK, 2003, CARBOHYD RES, V338, P2213, DOI 10.1016/S0008-6215(03)00375-6; Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P1267, DOI 10.1007/s00253-010-3034-0; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Miyazaki T, 2015, BIOCHEM J, V469, P145, DOI 10.1042/BJ20150261; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; Mukai K, 2004, BIOSCI BIOTECH BIOCH, V68, P2529, DOI 10.1271/bbb.68.2529; Nishimoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P1806, DOI 10.1271/bbb.66.1806; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pukall R, 2010, STAND GENOMIC SCI, V2, P186, DOI 10.4056/sigs.731321; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; Sakaguchi M, 2015, APPL ENVIRON MICROB, V81, P4920, DOI 10.1128/AEM.00956-15; Sauer J, 2000, BBA-PROTEIN STRUCT M, V1543, P275, DOI 10.1016/S0167-4838(00)00232-6; Tagami T, 2015, J BIOL CHEM, V290, P1796, DOI 10.1074/jbc.M114.606939; Uotsu-Tomita R, 2001, APPL MICROBIOL BIOT, V56, P465, DOI 10.1007/s002530100609	33	8	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16438	16447		10.1074/jbc.M116.727305	http://dx.doi.org/10.1074/jbc.M116.727305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302067	hybrid, Green Published			2022-12-26	WOS:000380826700003
J	Bock, A; Bermudez, M; Krebs, F; Matera, C; Chirinda, B; Sydow, D; Dallanoce, C; Holzgrabe, U; De Amici, M; Lohse, MJ; Wolber, G; Mohr, K				Bock, Andreas; Bermudez, Marcel; Krebs, Fabian; Matera, Carlo; Chirinda, Brian; Sydow, Dominique; Dallanoce, Clelia; Holzgrabe, Ulrike; De Amici, Marco; Lohse, Martin J.; Wolber, Gerhard; Mohr, Klaus			Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSIGHTS; ALLOSTERIC LIGANDS; CONFORMATIONAL DYNAMICS; AMINO-ACIDS; SITE; MODULATION; AFFINITY	G protein-coupled receptors constitute the largest family of membrane receptors and modulate almost every physiological process in humans. Binding of agonists to G protein-coupled receptors induces a shift from inactive to active receptor conformations. Biophysical studies of the dynamic equilibrium of receptors suggest that a portion of receptors can remain in inactive states even in the presence of saturating concentrations of agonist and G protein mimetic. However, the molecular details of agonist-bound inactive receptors are poorly understood. Here we use the model of bitopic orthosteric/allosteric (i.e. dualsteric) agonists for muscarinic M-2 receptors to demonstrate the existence and function of such inactive agonist.receptor complexes on a molecular level. Using all-atom molecular dynamics simulations, dynophores (i.e. a combination of static three-dimensional pharmacophores and molecular dynamics-based conformational sampling), ligand design, and receptor mutagenesis, we show that inactive agonist.receptor complexes can result from agonist binding to the allosteric vestibule alone, whereas the dualsteric binding mode produces active receptors. Each agonist forms a distinct ligand binding ensemble, and different agonist efficacies depend on the fraction of purely allosteric (i.e. inactive) versus dualsteric (i.e. active) binding modes. We propose that this concept may explain why agonist.receptor complexes can be inactive and that adopting multiple binding modes may be generalized also to small agonists where binding modes will be only subtly different and confined to only one binding site.	[Bock, Andreas; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany; [Bermudez, Marcel; Sydow, Dominique; Wolber, Gerhard] Free Univ Berlin, Inst Pharm, Konigin Luise Str 2 & 4, D-14195 Berlin, Germany; [Krebs, Fabian; Chirinda, Brian; Mohr, Klaus] Univ Bonn, Inst Pharm, Pharmacol & Toxicol Sect, Gerhard Domagk Str 3, D-53121 Bonn, Germany; [Matera, Carlo; Dallanoce, Clelia; De Amici, Marco] Univ Milan, Dipartimento Sci Farmaceut, Sez Chim Farmaceut Pietro Pratesi, Via Mangiagalli 25, I-20133 Milan, Italy; [Holzgrabe, Ulrike] Univ Wurzburg, Inst Pharm, D-97074 Wurzburg, Germany; [Krebs, Fabian] Univ Bonn, Res Training Grp GRK 1873, Bonn, Germany	University of Wurzburg; Free University of Berlin; University of Bonn; University of Milan; University of Wurzburg; University of Bonn	Bock, A (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.; Bermudez, M (corresponding author), Free Univ Berlin, Inst Pharm, Konigin Luise Str 2 & 4, D-14195 Berlin, Germany.; Mohr, K (corresponding author), Univ Bonn, Inst Pharm, Pharmacol & Toxicol Sect, Gerhard Domagk Str 3, D-53121 Bonn, Germany.	andreas.bock@uni-wuerzburg.de; m.bermudez@fu-berlin.de	Matera, Carlo/G-3808-2015; Lohse, Martin J/A-7160-2012; Wolber, Gerhard/C-7133-2008; Bermudez, Marcel/D-5449-2015; Wolber, Gerhard/ABD-4955-2020; De Amici, Marco/F-9684-2015	Matera, Carlo/0000-0001-6939-3859; Lohse, Martin J/0000-0002-0599-3510; Wolber, Gerhard/0000-0002-5344-0048; Bermudez, Marcel/0000-0002-7421-3282; Wolber, Gerhard/0000-0002-5344-0048; De Amici, Marco/0000-0002-0236-0662; Holzgrabe, Ulrike/0000-0002-0364-7278; Bock, Andreas/0000-0002-6344-6494; Sydow, Dominique/0000-0003-4205-8705	international doctoral program (Elite Network of Bavaria) "Receptor Dynamics: Emerging Paradigms for Novel Drugs"	international doctoral program (Elite Network of Bavaria) "Receptor Dynamics: Emerging Paradigms for Novel Drugs"	Supported by the international doctoral program (Elite Network of Bavaria) "Receptor Dynamics: Emerging Paradigms for Novel Drugs."	Anami Y, 2014, J MED CHEM, V57, P4351, DOI 10.1021/jm500392t; [Anonymous], 2010, Drug Discov Today Technol, V7, pe203, DOI 10.1016/j.ddtec.2010.11.004; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Bermudez M, 2015, MOL INFORM, V34, P526, DOI 10.1002/minf.201500025; Bermudez M, 2015, BIOORGAN MED CHEM, V23, P3907, DOI 10.1016/j.bmc.2015.03.026; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bock A, 2014, TRENDS PHARMACOL SCI, V35, P630, DOI 10.1016/j.tips.2014.10.002; Bock A, 2014, NAT CHEM BIOL, V10, P18, DOI 10.1038/nchembio.1384; Bock Andreas, 2013, Drug Discov Today Technol, V10, pe245, DOI 10.1016/j.ddtec.2012.12.003; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Burgmer U, 1998, N-S ARCH PHARMACOL, V357, P363, DOI 10.1007/PL00005180; Chen X, 2015, J MED CHEM, V58, P560, DOI 10.1021/jm500860w; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christopoulos A, 2014, PHARMACOL REV, V66, P918, DOI 10.1124/pr.114.008862; Dallanoce C, 1999, BIOORGAN MED CHEM, V7, P1539, DOI 10.1016/S0968-0896(99)00107-8; Disingrini T, 2006, J MED CHEM, V49, P366, DOI 10.1021/jm050769s; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kaur D, 2011, COMPUT THEOR CHEM, V963, P71, DOI 10.1016/j.comptc.2010.09.011; Kenakin T, 2002, TRENDS PHARMACOL SCI, V23, P275, DOI 10.1016/S0165-6147(02)02036-9; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kloeckner J, 2010, TETRAHEDRON LETT, V51, P3470, DOI 10.1016/j.tetlet.2010.04.130; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mohr K, 2013, ANGEW CHEM INT EDIT, V52, P508, DOI 10.1002/anie.201205315; Mortier J, 2015, DRUG DISCOV TODAY, V20, P686, DOI 10.1016/j.drudis.2015.01.003; Muth M, 2003, J MED CHEM, V46, P1031, DOI 10.1021/jm021017q; Nwachukwu JC, 2014, ELIFE, V3, DOI 10.7554/eLife.02057; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Olofsson L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6206; Onaran HO, 1997, ANN NY ACAD SCI, V812, P98, DOI 10.1111/j.1749-6632.1997.tb48150.x; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PAGE KM, 1995, EUR J PHARM-MOLEC PH, V289, P429, DOI 10.1016/0922-4106(95)90151-5; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rakers C, 2016, J BIOL CHEM, V291, P58, DOI 10.1074/jbc.M115.685610; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schmitz J, 2014, J MED CHEM, V57, P6739, DOI 10.1021/jm500790x; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Srinivasan S, 2013, NAT CHEM BIOL, V9, P326, DOI [10.1038/NCHEMBIO.1214, 10.1038/nchembio.1214]; Vafabakhsh R, 2015, NATURE, V524, P497, DOI 10.1038/nature14679; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Werner C, 2007, CHEM-EUR J, V13, P9462, DOI 10.1002/chem.200700827; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7	73	53	53	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16375	16389		10.1074/jbc.M116.735431	http://dx.doi.org/10.1074/jbc.M116.735431			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27298318	Green Published, hybrid			2022-12-26	WOS:000380585400040
J	Bawah, A; Houle, B; Alam, N; Razzaque, A; Streatfield, PK; Debpuur, C; Welaga, P; Oduro, A; Hodgson, A; Tollman, S; Collinson, M; Kahn, K; Toan, TK; Phuc, HD; Chuc, NTK; Sankoh, O; Clark, SJ				Bawah, Ayaga; Houle, Brian; Alam, Nurul; Razzaque, Abdur; Streatfield, Peter Kim; Debpuur, Cornelius; Welaga, Paul; Oduro, Abraham; Hodgson, Abraham; Tollman, Stephen; Collinson, Mark; Kahn, Kathleen; Tran Khan Toan; Ho Dang Phuc; Nguyen Thi Kim Chuc; Sankoh, Osman; Clark, Samuel J.			The Evolving Demographic and Health Transition in Four Low- and Middle-Income Countries: Evidence from Four Sites in the INDEPTH Network of Longitudinal Health and Demographic Surveillance Systems	PLOS ONE			English	Article							EPIDEMIOLOGIC TRANSITION; NONCOMMUNICABLE DISEASES; POPULATION; MORTALITY; COVERAGE; AFRICA; POOR	This paper contributes evidence documenting the continued decline in all-cause mortality and changes in the cause of death distribution over time in four developing country populations in Africa and Asia. We present levels and trends in age-specific mortality (all-cause and cause-specific) from four demographic surveillance sites: Agincourt (South Africa), Navrongo (Ghana) in Africa; Filabavi (Vietnam), Matlab (Bangladesh) in Asia. We model mortality using discrete time event history analysis. This study illustrates how data from INDEPTH Network centers can provide a comparative, longitudinal examination of mortality patterns and the epidemiological transition. Health care systems need to be reconfigured to deal simultaneously with continuing challenges of communicable disease and increasing incidence of non-communicable diseases that require long-term care. In populations with endemic HIV, long-term care of HIV patients on ART will add to the chronic care needs of the community.	[Bawah, Ayaga] Univ Ghana, RIPS, Legon, Ghana; [Houle, Brian] Australian Natl Univ, Sch Demog, Canberra, ACT, Australia; [Houle, Brian; Tollman, Stephen; Collinson, Mark; Kahn, Kathleen; Clark, Samuel J.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, MRC Wits Rural Publ Hlth Transit Res Unit Agincou, Johannesburg, South Africa; [Houle, Brian; Clark, Samuel J.] Univ Colorado, Inst Behav Sci, CU Populat Ctr, Boulder, CO 80309 USA; [Alam, Nurul; Razzaque, Abdur; Streatfield, Peter Kim] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh; [Debpuur, Cornelius; Welaga, Paul; Oduro, Abraham; Hodgson, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Tollman, Stephen; Collinson, Mark; Kahn, Kathleen] Umea Univ, Div Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, Umea, Sweden; [Bawah, Ayaga; Tollman, Stephen; Collinson, Mark; Kahn, Kathleen; Sankoh, Osman; Clark, Samuel J.] INDEPTH Network, Accra, Ghana; [Tran Khan Toan; Ho Dang Phuc; Nguyen Thi Kim Chuc] Filabavi Hlth & Demog Surveillance Site, Hanoi, Vietnam; [Clark, Samuel J.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Clark, Samuel J.] London Sch Hyg & Trop Med, ALPHA Network, London WC1, England; [Bawah, Ayaga] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Ghana; Australian National University; University of Witwatersrand; University of Colorado System; University of Colorado Boulder; International Centre for Diarrhoeal Disease Research (ICDDR); Navrongo Health Research Center; Umea University; INDEPTH Network; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; Columbia University	Houle, B (corresponding author), Australian Natl Univ, Sch Demog, Canberra, ACT, Australia.; Houle, B (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, MRC Wits Rural Publ Hlth Transit Res Unit Agincou, Johannesburg, South Africa.; Houle, B (corresponding author), Univ Colorado, Inst Behav Sci, CU Populat Ctr, Boulder, CO 80309 USA.	brian.houle@anu.edu.au	Clark, Samuel J/A-8419-2009; Tran, Toan K/O-7671-2017; Sankoh, Osman/ABB-3755-2020	Clark, Samuel J/0000-0002-4929-6231; Tran, Toan K/0000-0002-5902-749X; Sankoh, Osman/0000-0003-4405-9808; Alam, Nurul/0000-0002-1202-4451; Kahn, Kathleen/0000-0003-3339-3931; Tollman, Stephen/0000-0003-0744-7588; Houle, Brian/0000-0003-2157-3118; Debpuur, Cornelius/0000-0003-0968-5280; ODURO, ABRAHAM/0000-0002-4191-7419	Canadian International Development Research Center [IDRC: 105727-001]	Canadian International Development Research Center	This work has been funded by a grant from the Canadian International Development Research Center (IDRC: 105727-001) made to the INDEPTH Network and administrative support from the INDEPTH Network Secretariat.	Allison P.D., 1984, EVENT HIST ANAL REGR; Byass P, 2014, GLOBAL HEALTH ACTION, V7, P158, DOI 10.3402/gha.v7.23359; CALDWELL JC, 1986, POPUL DEV REV, V12, P171, DOI 10.2307/1973108; Defo BK, 2014, GLOBAL HEALTH ACTION, V7, P17, DOI 10.3402/gha.v7.22443; Gwatkin DR, 1997, BRIT MED J, V315, P497, DOI 10.1136/bmj.315.7107.497; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Kahn K, 2006, AGING SUBSAHARAN AFR, P166; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kowal P, 2010, GLOBAL HEALTH ACTION, V3, P11, DOI 10.3402/gha.v3i0.5302; Long N, 2002, FILABAVI DEMOGRAPHIC, P305; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCKEOWN T, 1972, POP STUD-J DEMOG, V26, P345, DOI 10.2307/2173815; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nyarko P, 2002, NAVRONGO DEMOGRAPHIC, P247; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Preston S. H., 1991, FATAL YEARS CHILD MO; Razzaque A, 2002, MATLAB DEMOGRAPHIC S, P287; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Sankoh O, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23286; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The World Bank Group, 2015, WORLD BANK ANN REP 2; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Unwin N, 2001, B WORLD HEALTH ORGAN, V79, P947; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5	28	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157281	10.1371/journal.pone.0157281	http://dx.doi.org/10.1371/journal.pone.0157281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304429	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800044
J	Che, LQ; Hu, L; Liu, Y; Yan, C; Peng, X; Xu, Q; Wang, R; Cheng, YF; Chen, H; Fang, ZF; Lin, Y; Xu, SY; Feng, B; Chen, DW; Wu, D				Che, Lianqiang; Hu, Liang; Liu, Yan; Yan, Chuan; Peng, Xie; Xu, Qin; Wang, Ru; Cheng, Yuanfang; Chen, Hong; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Feng, Bin; Chen, Daiwen; Wu, De			Dietary Nucleotides Supplementation Improves the Intestinal Development and Immune Function of Neonates with Intra-Uterine Growth Restriction in a Pig Model	PLOS ONE			English	Article							FORMULA-FED INFANTS; TOLL-LIKE RECEPTORS; NECROTIZING ENTEROCOLITIS; EXOGENOUS NUCLEOTIDES; GUT STRUCTURE; PERFORMANCE; IUGR; PROLIFERATION; RETARDATION; DIFFERENTIATION	The current study aimed to determine whether dietary nucleotides supplementation could improve growth performance, intestinal development and immune function of intra-uterine growth restricted (IUGR) neonate using pig as animal model. A total of 14 pairs of normal birth weight (NBW) and IUGR piglets (7 days old) were randomly assigned to receive a milk-based control diet (CON diet) or diet supplemented with nucleotides (NT diet) for a period of 21 days. Blood samples, intestinal tissues and digesta were collected at necropsy and analyzed for morphology, digestive enzyme activities, microbial populations, peripheral immune cells, expression of intestinal innate immunity and barrier-related genes and proteins. Compared with NBW piglets, IUGR piglets had significantly lower average daily dry matter intake and body weight gain (P<0.05). Moreover, IUGR markedly decreased the villous height and villi: crypt ratio in duodenum (P<0.05), as well as the maltase activity in jejunum (P<0.05). In addition, IUGR significantly decreased the serum concentrations of IgA, IL-1 beta and IL-10 (P<0.05), as well as the percentage of peripheral lymphocytes (P<0.05). Meanwhile, the down-regulation of innate immunity-related genes such as TOLLIP (P<0.05), TLR-9 (P = 0.08) and TLR-2 (P = 0.07) was observed in the ileum of IUGR relative to NBW piglets. Regardless of birth weight, however, feeding NT diet markedly decreased (P<0.05) feed conversion ratio, increased the villous height in duodenum(P<0.05), activities of lactase and maltase in jejunum (P<0.05), count of peripheral leukocytes (P<0.05), serum concentrations of IgA and IL-1 beta as well as gene expressions of TLR-9, TLR-4 and TOLLIP in ileum (P<0.05). In addition, expressions of tight junction proteins (Claudin-1 and ZO-1) in ileum were markedly increased by feeding NT diet relative to CON diet (P<0.05). These results indicated that IUGR impaired growth performance, intestinal and immune function, but dietary nucleotides supplementation improved nutrients utilization, intestinal function and immunity.	[Che, Lianqiang; Hu, Liang; Liu, Yan; Yan, Chuan; Peng, Xie; Xu, Qin; Wang, Ru; Cheng, Yuanfang; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Feng, Bin; Chen, Daiwen; Wu, De] Sichuan Agr Univ, Inst Anim Nutr, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China; [Chen, Hong] Sichuan Agr Univ, Coll Food Sci, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China; [Cheng, Yuanfang] Tongwei Grp Co Ltd, Inst Livestock Nutr, 588 Tianfu Rd, Chengdu 610041, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Che, LQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.	clianqiang@hotmail.com	Xu, Shengyu/AFN-8288-2022	Xu, Shengyu/0000-0002-4415-8542	National Natural Science Foundation of China [31101727]; International Cooperation in Science and Technology Project of Sichuan Province [2014HH0034]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Development Plan for Sichuan Strategically New Products [2015GZX0011]; Tongwei group Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation in Science and Technology Project of Sichuan Province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Development Plan for Sichuan Strategically New Products; Tongwei group Co., Ltd.	The present study was supported by the National Natural Science Foundation of China (31101727), the International Cooperation in Science and Technology Project of Sichuan Province (2014HH0034), the Program for Changjiang Scholars and Innovative Research Team in University (IRT13083), and the Development Plan for Sichuan Strategically New Products (2015GZX0011). Tongwei group Co., Ltd., partly provided support in the form of salaries for YC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Yuanfang Cheng are articulated in the 'author contributions' section.	Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Aly H, 2013, J MATERN-FETAL NEO M, V26, P388, DOI 10.3109/14767058.2012.733767; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Andres-Elias N, 2007, LIVEST SCI, V108, P280, DOI 10.1016/j.livsci.2007.01.080; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; CARVER JD, 1994, J NUTR, V124, pS144, DOI 10.1093/jn/124.suppl_1.144S; Castaneda-Gutierrez E, 2014, ACTA PHYSIOL, V210, P161, DOI 10.1111/apha.12145; Che LQ, 2010, PEDIATR RES, V67, P54, DOI 10.1203/PDR.0b013e3181c1b15e; Chen L, 2016, J DEV ORIG HLTH DIS, V7, P91, DOI 10.1017/S2040174415007242; Chen Y, 2012, BRIT J NUTR, V108, P1069, DOI 10.1017/S0007114511006350; Chiesa C, 2008, CLIN CHEM, V54, P550, DOI 10.1373/clinchem.2007.095299; Cicalese L, 2016, J GASTROINTEST SURG, V20, P34, DOI 10.1007/s11605-015-2974-1; Cortes-Barberena E, 2013, CELL PROLIFERAT, V46, P164, DOI 10.1111/cpr.12019; Cosgrove M, 1996, ARCH DIS CHILD-FETAL, V74, pF122, DOI 10.1136/fn.74.2.F122; D'Inca R, 2011, NEONATOLOGY, V99, P208, DOI 10.1159/000314919; Dancey CP, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-16; Dourmad JY, 1998, J ANIM SCI, V76, P542; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Gil A, 2002, EUR J CLIN NUTR, V56, pS1, DOI 10.1038/sj.ejcn.1601475; Hackam DJ, 2013, SEMIN PEDIATR SURG, V22, P76, DOI 10.1053/j.sempedsurg.2013.01.003; Han F, 2013, BRIT J NUTR, V110, P1819, DOI 10.1017/S0007114513001232; Hawkes JS, 2006, EUR J CLIN NUTR, V60, P254, DOI 10.1038/sj.ejcn.1602310; He JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136848; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Hu L, 2015, BRIT J NUTR, V114, P53, DOI 10.1017/S0007114515001579; Jamin A, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/545341; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Lee DN, 2007, J ANIM PHYSIOL AN N, V91, P508, DOI 10.1111/j.1439-0396.2007.00684.x; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansoori B, 2009, ANIM FEED SCI TECH, V148, P301, DOI 10.1016/j.anifeedsci.2008.04.009; Mateo CD, 2004, J ANIM SCI, V82, P1339; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Neumann CG, 1998, NUTR RES, V18, P201, DOI 10.1016/S0271-5317(98)00013-X; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Rosero DS, 2015, BRIT J NUTR, V114, P1985, DOI 10.1017/S000711451500392X; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Sangild PT, 2006, EXP BIOL MED, V231, P1695, DOI 10.1177/153537020623101106; Sanz-Cortes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080121; Sato N, 1999, J NUTR SCI VITAMINOL, V45, P107, DOI 10.3177/jnsv.45.107; Sauer N, 2012, J ANIM SCI, V90, P3126, DOI 10.2527/jas.2011-4417; Sauer N, 2011, NUTR RES REV, V24, P46, DOI 10.1017/S0954422410000326; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Singhal A, 2008, AM J CLIN NUTR, V87, P1785, DOI 10.1093/ajcn/87.6.1785; Singhal A, 2010, PEDIATRICS, V126, pE946, DOI 10.1542/peds.2009-2609; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tanaka M, 1996, J NUTR, V126, P424, DOI 10.1093/jn/126.2.424; Thureen P, 2005, PEDIATR RES, V57, p95R, DOI 10.1203/01.PDR.0000160434.69916.34; TSUJINAKA T, 1993, NUTRITION, V9, P532; Tzschoppe A, 2011, CLIN ENDOCRINOL, V74, P459, DOI 10.1111/j.1365-2265.2010.03943.x; Wang T, 2005, BIOL NEONATE, V88, P66, DOI 10.1159/000084645; Wu BangYuan, 2012, Health, V4, P32, DOI 10.4236/health.2012.41007; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; YANG SL, 1983, OBSTET GYNECOL, V62, P561; Zanardo V, 2015, J MATERN-FETAL NEO M, V28, P362, DOI 10.3109/14767058.2014.916684; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033	60	32	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157314	10.1371/journal.pone.0157314	http://dx.doi.org/10.1371/journal.pone.0157314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304828	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800046
J	Choi, Y; Kim, HR; Lim, EJ; Park, M; Yoon, JA; Kim, YS; Kim, EK; Shin, JE; Kim, JH; Kwon, H; Song, H; Choi, DH				Choi, Youngsok; Kim, Hye-Ryun; Lim, Eun Jin; Park, Miseon; Yoon, Jung Ah; Kim, Yeon Sun; Kim, Eun-Kyung; Shin, Ji-Eun; Kim, Ji Hyang; Kwon, Hwang; Song, Haengseok; Choi, Dong-Hee			Integrative Analyses of Uterine Transcriptome and MicroRNAome Reveal Compromised LIF-STAT3 Signaling and Progesterone Response in the Endometrium of Patients with Recurrent/Repeated Implantation Failure (RIF)	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; CALCIUM-BINDING PROTEIN; EMBRYO IMPLANTATION; BLASTOCYST IMPLANTATION; GROWTH-FACTORS; EXPRESSION; WOMEN; RECEPTIVITY; PREGNANCY; RECEPTOR	Intimate two-way interactions between the implantation-competent blastocyst and receptive uterus are prerequisite for successful embryo implantation. In humans, recurrent/repeated implantation failure (RIF) may occur due to altered uterine receptivity with aberrant gene expression in the endometrium as well as genetic defects in embryos. Several studies have been performed to understand dynamic changes of uterine transcriptome during menstrual cycles in humans. However, uterine transcriptome of the patients with RIF has not been clearly investigated yet. Here we show that several signaling pathways as well as many genes and microRNAs are dysregulated in the endometrium of patients with RIF (RIFE). Whereas unsupervised hierarchical clustering showed that overall mRNA and microRNA profiles of RIFE were similar to those of endometria of healthy women, many genes were significantly dysregulated in RIFE (cut off at 1.5 fold change). The majority (similar to 75%) of differentially expressed genes in RIFE including S100 calcium binding protein P (S100P), Chemokine (C-X-C motif) ligand 13 (CXCL13) and SIX homeobox 1 (SIX1) were down-regulated, suggesting that reduced uterine expression of these genes is associated with RIF. Gene Set Enrichment analyses (GSEA) for mRNA microarrays revealed that various signaling pathways including Leukemia inhibitory factor (LIF) signaling and a P-4 response were dysregulated in RIFE although expression levels of Estrogen receptor alpha (ER alpha) and Progesterone receptor (PR) were not significantly altered in RIFE. Furthermore, expression and phosphorylation of Signal transducer and activator of transcription 3 (STAT3) are reduced and a gene set associated with Janus kinase (JAK)-STAT signaling pathway is systemically down-regulated in these patients. Pairwise analyses of microRNA arrays with prediction of dysregulated microRNAs based on mRNA expression datasets demonstrated that 6 microRNAs are aberrantly regulated in RIFE. Collectively, we here suggest that dysregulation of several major signaling pathways and genes critical for uterine biology and embryo implantation may lead to uterine abnormalities in patients with RIF.	[Choi, Youngsok; Kim, Hye-Ryun; Lim, Eun Jin; Kim, Yeon Sun; Song, Haengseok] CHA Univ, Dept Biomed Sci, Seongnam, South Korea; [Park, Miseon; Yoon, Jung Ah] CHA Univ, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Kim, Eun-Kyung; Shin, Ji-Eun; Kim, Ji Hyang; Kwon, Hwang; Song, Haengseok; Choi, Dong-Hee] CHA Univ, CHA Bundang Med Ctr, Fertil Ctr, Seongnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Song, H (corresponding author), CHA Univ, Dept Biomed Sci, Seongnam, South Korea.; Song, H; Choi, DH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Fertil Ctr, Seongnam, South Korea.	hssong@cha.ac.kr; dhchoimc@cha.ac.kr		Song, Haengseok/0000-0002-5027-7310; Choi, Youngsok/0000-0002-3862-4105	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [NRF-2015R1A2A2A01006714, NRF-2014R1A1A2059980]	National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work was supported in part by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MEST)(NRF-2015R1A2A2A01006714 to HS and NRF-2014R1A1A2059980 to DHC).	Aghajanova L, 2009, FERTIL STERIL, V91, P2602, DOI 10.1016/j.fertnstert.2008.04.010; Arck P, 2007, AM J REPROD IMMUNOL, V58, P268, DOI 10.1111/j.1600-0897.2007.00512.x; Bae S, 2016, BIOCHEM BIOPH RES CO, V472, P489, DOI 10.1016/j.bbrc.2016.02.116; Bhurke AS, 2016, AM J REPROD IMMUNOL, V75, P237, DOI 10.1111/aji.12473; Bissonnette L, 2016, CELL ADHES MIGR, V10, P282, DOI 10.1080/19336918.2015.1128623; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; Casper RF, 2016, FERTIL STERIL, V105, P867, DOI 10.1016/j.fertnstert.2016.01.006; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Fox C, 2016, FERTIL STERIL, V105, P873, DOI 10.1016/j.fertnstert.2016.02.018; Franasiak JM, 2015, REPROD SCI, V22, P442, DOI 10.1177/1933719114542011; Granot I, 2012, REPRODUCTION, V144, P661, DOI 10.1530/REP-12-0217; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Horcajadas JA, 2008, J CLIN ENDOCR METAB, V93, P4500, DOI 10.1210/jc.2008-0588; JOTTI GS, 1994, J CLIN PATHOL, V47, P900; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kim JY, 2009, J CLIN ENDOCR METAB, V94, P1416, DOI 10.1210/jc.2008-1612; Kim YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20242; Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Liu XM, 2012, J CLIN ENDOCR METAB, V97, P3672, DOI 10.1210/jc.2012-2075; Mariee N, 2012, HUM REPROD, V27, P1946, DOI 10.1093/humrep/des134; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Nastri CO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009517.pub3; Polanski LT, 2014, REPROD BIOMED ONLINE, V28, P409, DOI 10.1016/j.rbmo.2013.12.006; Potdar N, 2012, REPROD BIOMED ONLINE, V25, P561, DOI 10.1016/j.rbmo.2012.08.005; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Sharkey A, 1998, REV REPROD, V3, P52, DOI 10.1530/revreprod/3.1.52; Shohayeb A, 2012, EUR J OBSTET GYN R B, V164, P176, DOI 10.1016/j.ejogrb.2012.06.029; Song H, 2007, REPRODUCTION, V133, P487, DOI 10.1530/REP-06-0330; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Stewart CL, 1997, DEV GENET, V21, P91, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;91::AID-DVG11&gt;3.0.CO;2-D; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Subramani E, 2016, FERTIL STERIL, V105, P1076, DOI 10.1016/j.fertnstert.2015.12.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tan BK, 2005, BJOG-INT J OBSTET GY, V112, P773, DOI 10.1111/j.1471-0528.2005.00523.x; Tapia A, 2008, HUM REPROD, V23, P340, DOI 10.1093/humrep/dem319; Tapia-Pizarro A, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-92; Thouas GA, 2015, ENDOCR REV, V36, P92, DOI 10.1210/er.2014-1046; Tong XM, 2010, FERTIL STERIL, V94, P1510, DOI 10.1016/j.fertnstert.2009.07.1667; Vasquez YM, 2013, SEMIN CELL DEV BIOL, V24, P724, DOI 10.1016/j.semcdb.2013.08.004; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Yoshioka S, 2006, HUM REPROD, V21, P3290, DOI 10.1093/humrep/del312; Yu N, 2014, AM J REPROD IMMUNOL, V71, P24, DOI 10.1111/aji.12150; Zhang RX, 2017, REPRODUCTION, V154, pZ1, DOI 10.1530/REP-15-0381	48	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157696	10.1371/journal.pone.0157696	http://dx.doi.org/10.1371/journal.pone.0157696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304912	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800081
J	Li, H; Zhou, GY; Liu, JA; Xu, JP				Li, He; Zhou, Guo-Ying; Liu, Jun-Ang; Xu, Jianping			Population Genetic Analyses of the Fungal Pathogen Colletotrichum fructicola on Tea-Oil Trees in China	PLOS ONE			English	Article							1ST REPORT; CRYPTOCOCCUS-NEOFORMANS; GLOEOSPORIOIDES; RECOMBINATION; SOFTWARE; SEQUENCE; HYBRIDIZATION; DISPERSAL; PATTERNS; ORIGINS	The filamentous fungus Colletotrichum fructicola is found in all five continents and is capable of causing severe diseases in a number of economically important plants such as avocado, fig, cocoa, pear, and tea-oil trees. However, almost nothing is known about its patterns of genetic variation and epidemiology on any of its host plant species. Here we analyzed 167 isolates of C. fructicola obtained from the leaves of tea-oil tree Camellia oleifera at 15 plantations in seven Chinese provinces. Multilocus sequence typing was conducted for all isolates based on DNA sequences at fragments of four genes: the internal transcribed spacers of the nuclear ribosomal RNA gene cluster (539 bp), calmodulin (633 bp), glutamine synthetase (711 bp), and glyceraldehyde-3-phosphate dehydrogenase (190 bp), yielding 3.52%, 0.63%, 8.44%, and 7.89% of single nucleotide polymorphic sites and resulting in 15, 5, 12 and 11 alleles respectively at the four gene fragments in the total sample. The combined allelic information from all four loci identified 53 multilocus genotypes with the most frequent represented by 21 isolates distributed in eight tea-oil plantations in three provinces, consistent with long-distance clonal dispersal. However, despite evidence for clonal dispersal, statistically significant genetic differentiation among geographic populations was detected. In addition, while no evidence of recombination was found within any of the four gene fragments, signatures of recombination were found among the four gene fragments in most geographic populations, consistent with sexual mating of this species in nature. Our study provides the first insights into the population genetics and epidemiology of the important plant fungal pathogen C. fructicola.	[Li, He; Zhou, Guo-Ying; Liu, Jun-Ang; Xu, Jianping] Cent South Univ Forestry & Technol, Minist Educ, Key Lab Nonwood Forest Cultivat & Conservat, Changsha, Hunan, Peoples R China; [Li, He; Zhou, Guo-Ying; Liu, Jun-Ang; Xu, Jianping] Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Central South University of Forestry & Technology; Central South University of Forestry & Technology; McMaster University	Xu, JP (corresponding author), Cent South Univ Forestry & Technol, Minist Educ, Key Lab Nonwood Forest Cultivat & Conservat, Changsha, Hunan, Peoples R China.; Xu, JP (corresponding author), Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China.; Xu, JP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca			National Science Foundation of China [31100479]; Natural Sciences and Engineering Research Council of Canada; Lotus Scholar Visiting Professorship program of Hunan Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lotus Scholar Visiting Professorship program of Hunan Province	This work was supported by grants from National Science Foundation of China (grant numbers: 31100479), Natural Sciences and Engineering Research Council of Canada, and the Lotus Scholar Visiting Professorship program of Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Science Foundation of China (grant numbers: 31100479), Natural Sciences and Engineering Research Council of Canada, and the Lotus Scholar Visiting Professorship program of Hunan Province. We thank Liao Yu for helping with sample collections.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; BROWN AHD, 1980, GENETICS, V96, P523; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Cai L, 2009, FUNGAL DIVERS, V39, P183; Campbell FT, 2001, BIOSCIENCE, V51, P148, DOI 10.1641/0006-3568(2001)051[0148:TSORAF]2.0.CO;2; Cannon PF, 2008, MYCOTAXON, V104, P189; CISAR CR, 1994, CURR GENET, V25, P330, DOI 10.1007/BF00351486; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Diao YZ, 2015, EVOL APPL, V8, P108, DOI 10.1111/eva.12233; DICKENS JSW, 1989, PLANT PATHOL, V38, P75, DOI 10.1111/j.1365-3059.1989.tb01430.x; Dilmaghani A, 2012, MOL ECOL, V21, P2519, DOI 10.1111/j.1365-294X.2012.05535.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; He Fang, 2002, Scientia Silvae Sinicae, V38, P64; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang YL, 2010, JIANGXI FORESTRY TEC, V2, P24; Liu Wei, 2012, THESIS; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Phoulivong S, 2010, FUNGAL DIVERS, V44, P33, DOI 10.1007/s13225-010-0046-0; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; Pritchard JK, 2000, GENETICS, V155, P945; Qing AX, 2009, CHINESE FOREST PATHO, V28, P27; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanders GM, 2003, MICROBIOL RES, V158, P143, DOI 10.1078/0944-5013-00186; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Silva DN, 2012, MOL ECOL, V21, P2655, DOI 10.1111/j.1365-294X.2012.05557.x; Snowdon AL, 1991, VEGETABLES, V2; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Sun S, 2006, MICROBIOL-SGM, V152, P3245, DOI 10.1099/mic.0.29170-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TEBEEST DO, 1988, PLANT DIS, V72, P16, DOI 10.1094/PD-72-0016; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Berkum P, 2010, APPL ENVIRON MICROB, V76, P3967, DOI 10.1128/AEM.00251-10; VON ARX J. A., 1970, A revision of the fungi classified as Gloeosporium.; Wang XX, 2010, PLANT DIS, V94, P1508, DOI 10.1094/PDIS-08-10-0556; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Weir BS, 1996, GENETICS DATA ANAL; Xie Liu, 2010, Mycology - An International Journal on Fungal Biology, V1, P242, DOI 10.1080/21501203.2010.526644; Xu J, 2010, MICROBIAL POPULATION GENETICS, P1; Xu J., 2005, EVOLUTIONARY GENETIC; Xu JP, 2009, MOL ECOL, V18, P2628, DOI 10.1111/j.1365-294X.2009.04227.x; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; XU JP, 1994, TRENDS GENET, V10, P226, DOI 10.1016/0168-9525(94)90158-9; Xu JP, 2002, MICROBIOL-SGM, V148, P203, DOI 10.1099/00221287-148-1-203; Yan J, 2011, PLANT DIS, V95, P880, DOI 10.1094/PDIS-03-11-0186; Yang SY, 2011, PLANT DIS, V95, P1314, DOI 10.1094/PDIS-04-11-0269; Zhang RQ, 2010, NONWOOD FOREST RES, V28, P146	54	44	51	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156841	10.1371/journal.pone.0156841	http://dx.doi.org/10.1371/journal.pone.0156841			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299731	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200016
J	Moscicki, AB; Yao, TJ; Ryder, MI; Russell, JS; Dominy, SS; Patel, K; McKenna, M; Van Dyke, RB; Seage, GR; Hazra, R; Shiboski				Moscicki, Anna-Barbara; Yao, Tzy-Jyun; Ryder, Mark I.; Russell, Jonathan S.; Dominy, Stephen S.; Patel, Kunjal; McKenna, Matt; Van Dyke, Russell B.; Seage, George R., III; Hazra, Rohan; Shiboski			The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth	PLOS ONE			English	Article							EARLY ENAMEL CARIES; DENTAL-CARIES; ANTIRETROVIRAL TREATMENT; US CHILDREN; PREVALENCE; PREDICTORS; BACTERIA; THERAPY; LESIONS; HUMANS	Objective To compare oral health parameters in perinatally HIV-infected (PHIV) and perinatally HIV-exposed but uninfected youth (PHEU). Methods In a cross-sectional substudy within the Pediatric HIV/AIDS Cohort Study, participants were examined for number of decayed teeth (DT), Decayed, Missing, and Filled Teeth (DMFT), oral mucosal disease, and periodontal disease (PD). Covariates for oral health parameters were examined using zero-inflated negative binomial regression and ordinal logistic regression models. Results Eleven sites enrolled 209 PHIV and 126 PHEU. Higher DT scores were observed in participants who were PHIV [ Adjusted Mean Ratio (aMR) = 1.7 (95% CI 1.2-2.5)], female [ aMR = 1.4 (1.0-1.9)], had no source of regular dental care [aMR = 2.3 (1.5-3.4)], and had a high frequency of meals/snacks [>= 5 /day vs 0-3, aMR = 1.9 (1.1-3.1)] and juice/soda [>= 5 /day vs 0-3, aMR = 1.6 (1.1-2.4)]. Higher DMFT scores were observed in participants who were older [>= 19, aMR = 1.9 (1.2-2.9)], had biological parent as caregiver [ aMR = 1.2 (1.0-1.3)], had a high frequency of juice/soda [>= 5 /day vs 0-3, aMR = 1.4 (1.1-1.7)] and a low salivaflow rate [mL/min, aMR = 0.8 per unit higher (0.6-1.0)]. Eighty percent had PD; no differences were seen by HIV status using the patient-based classifications of health, gingivitis or mild, moderate, or severe periodontitis. No associations were observed of CD4 count and viral load with oral health outcomes after adjustment. Conclusions Oral health was poor in PHIV and PHEU youth. This was dismaying since most HIV infected children in the U.S. are carefully followed at medical health care clinics. This data underscore the need for regular dental care. As PHIV youth were at higher risk for cavities, it will be important to better understand this relationship in order to develop targeted interventions.	[Moscicki, Anna-Barbara] Univ Calif Los Angeles, Dept Pediat, Div Adolescent Med, Los Angeles, CA 90024 USA; [Yao, Tzy-Jyun; Russell, Jonathan S.; McKenna, Matt] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Ryder, Mark I.; Shiboski] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA USA; [Dominy, Stephen S.] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Patel, Kunjal] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Van Dyke, Russell B.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Seage, George R., III] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hazra, Rohan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Maternal & Pediat Infect Dis Branch, NIH, Bethesda, MD USA	University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Tulane University; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Moscicki, AB (corresponding author), Univ Calif Los Angeles, Dept Pediat, Div Adolescent Med, Los Angeles, CA 90024 USA.	amoscicki@mednet.ucla.edu	Moscicki, Anna-Barbara/AAP-3806-2021		National Institute of Dental and Craniofacial Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; Office of AIDS Research; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; National Heart Lung and Blood Institute; National Institute on Alcohol Abuse and Alcoholism; Harvard T. H. Chan School of Public Health [HD052102, 3 U01 HD052102-05S1, 3 U01 HD052102-06S3]; Tulane University School of Medicine [HD052104, 3U01 HD052104-06S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD052102, U01HD052104] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Harvard T. H. Chan School of Public Health; Tulane University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institute of Dental and Craniofacial Research and Eunice Kennedy Shriver National Institute of Child Health and Human Development with cofunding from the National Institute on Drug Abuse, the National Institute of Allergy and Infectious Diseases, the Office of AIDS Research, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Deafness and Other Communication Disorders, the National Heart Lung and Blood Institute, and the National Institute on Alcohol Abuse and Alcoholism, through cooperative agreements with the Harvard T. H. Chan School of Public Health (HD052102, 3 U01 HD052102-05S1, and 3 U01 HD052102-06S3) (PI: George Seage; Project Director: Julie Alperen) and the Tulane University School of Medicine (HD052104, 3U01 HD052104-06S1) (PI: Russell Van Dyke; Co-PI: Kenneth Rich; Project Director: Patrick Davis). Data management services were provided by Frontier Science and Technology Research Foundation (PI: Suzanne Siminski), and regulatory services and logistical support were provided by Westat, Inc (PI: Julie Davidson). The funders NICHD have a significant role in study design, data collection, decision to publish and preparation of manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Westat, Inc. provided regulatory services, protocol development support and logistical support but had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperen J, 2014, J ADOLESCENT HEALTH, V54, P341, DOI 10.1016/j.jadohealth.2013.09.003; American Academy of Pediatric Dentistry, 2014, PEDIAT DENT, V36, P171; [Anonymous], 2014, PEDIATRICS, V134, P1224, DOI 10.1542/peds.2014-2984; Armitage GC, 1996, PERIODONTOL 2000, V12, P33, DOI 10.1111/j.1600-0757.1996.tb00078.x; Beil H, 2014, AM J PUBLIC HEALTH, V104, P1979, DOI 10.2105/AJPH.2013.301325; Boyce WT, 2010, SOC SCI MED, V71, P1644, DOI 10.1016/j.socscimed.2010.07.045; Centers for Disease Control and Prevention, 2009, DATA 2010 HLTH PEOPL; Sales-Peres SHD, 2012, CIENC SAUDE COLETIVA, V17, P55, DOI 10.1590/S1413-81232012000100008; Dye Bruce A, 2015, NCHS Data Brief, P1; Ebersole JL, 2003, PERIODONTOL 2000, V31, P135, DOI 10.1034/j.1600-0757.2003.03109.x; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; General Surgeon, 2000, OR HLTH AM REP SURG; Jeganathan S, 2012, SPEC CARE DENT, V32, P130, DOI 10.1111/j.1754-4505.2012.00247.x; KLEIN H., 1938, Public Health Reports, V53, P751, DOI 10.2307/4582532; Lingstrom P, 2000, J DENT RES, V79, P770, DOI 10.1177/00220345000790021101; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Masiga MA, 2013, J CLIN PEDIATR DENT, V38, P83, DOI 10.17796/jcpd.38.1.62l1q94650j5l815; Massarente DB, 2009, ORAL HLTH PREV DENT, V7, P403; Meless D, 2014, TROP MED INT HEALTH, V19, P246, DOI 10.1111/tmi.12253; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Nelson-Filho Paulo, 2013, Braz. Dent. J., V24, P415, DOI 10.1590/0103-6440201302266; Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220; Okunseri C, 2003, AIDS PATIENT CARE ST, V17, P5, DOI 10.1089/108729103321042863; Oladokun Regina E, 2013, Oral Health Dent Manag, V12, P200; Pari Arul, 2014, J Clin Diagn Res, V8, pZE01, DOI 10.7860/JCDR/2014/9004.4957; Preisser JS, 2012, CARIES RES, V46, P413, DOI 10.1159/000338992; Ramos-Gomez F J, 1999, J Clin Pediatr Dent, V23, P85; Rwenyonyi Charles Mugisha, 2011, Eur J Dent, V5, P291; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Shiboski CH, 2009, J ORAL PATHOL MED, V38, P481, DOI 10.1111/j.1600-0714.2009.00749.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Subramaniam P, 2014, SPEC CARE DENT, V34, P127, DOI 10.1111/scd.12041; Tassiopoulos K, 2013, CLIN INFECT DIS, V56, P283, DOI 10.1093/cid/cis816; Tinanoff N, 2009, ACAD PEDIATR, V9, P396, DOI 10.1016/j.acap.2009.08.006; Tomar SL, 2009, ACAD PEDIATR, V9, P388, DOI 10.1016/j.acap.2009.09.018; Van Dyke RB, 2011, JAIDS-J ACQ IMM DEF, V57, P165, DOI 10.1097/QAI.0b013e318215c7b1; van Ruyven FOJ, 2000, J DENT RES, V79, P778, DOI 10.1177/00220345000790021201	38	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156459	10.1371/journal.pone.0156459	http://dx.doi.org/10.1371/journal.pone.0156459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299992	gold, Green Submitted, Green Published			2022-12-26	WOS:000377822200008
J	Wu, DQ; Xu, LW; Tang, SX; Guan, LL; He, ZX; Guan, YJ; Tan, ZL; Han, XF; Zhou, CS; Kang, JH; Wang, M				Wu, Duanqin; Xu, Liwei; Tang, Shaoxun; Guan, Leluo; He, Zhixiong; Guan, Yongjuan; Tan, Zhiliang; Han, Xuefeng; Zhou, Chuanshe; Kang, Jinhe; Wang, Min			Influence of Oleic Acid on Rumen Fermentation and Fatty Acid Formation In Vitro	PLOS ONE			English	Article							RUMINAL FERMENTATION; GAS-PRODUCTION; ANAEROBIC FUNGUS; LINOLEIC ACIDS; SUNFLOWER OIL; COCONUT OIL; FISH-OIL; SUPPLEMENTATION; METHANE; BIOHYDROGENATION	A series of batch cultures were conducted to investigate the effects of oleic acid (OA) on in vitro ruminal dry matter degradability (IVDMD), gas production, methane (CH4) and hydrogen (H-2) production, and proportion of fatty acids. Rumen fluid was collected from fistulated goats, diluted with incubation buffer, and then incubated with 500 mg Leymus chinensis meal supplemented with different amounts of OA (0, 20, 40, and 60 mg for the CON, OA20, OA40 and OA60 groups, respectively). Incubation was carried out anaerobically at 39 degrees C for 48 h, and the samples were taken at 12, 24 and 48 h and subjected to laboratory analysis. Supplementation of OA decreased IVDMD, the cumulative gas production, theoretical maximum of gas production and CH4 production, but increased H-2 production. However, no effect was observed on any parameters of rumen fermentation pH, ammonia, production of acetate, propionate and butyrate and total volatile fatty acid production). The concentrations of some beneficial fatty acids, such as cis monounsaturated fatty acids and conjugated linoleic acid (CLA) were higher (P < 0.05) from OA groups than those from the control group at 12 h incubation. In summary, these results suggest that the OA supplementation in diet can reduce methane production and increase the amount of some beneficial fatty acids in vitro.	[Wu, Duanqin; Xu, Liwei; Tang, Shaoxun; He, Zhixiong; Tan, Zhiliang; Han, Xuefeng; Zhou, Chuanshe; Kang, Jinhe; Wang, Min] Chinese Acad Sci, Inst Subtrop Agr, Changsha 410125, Hunan, Peoples R China; [Wu, Duanqin] Chinese Acad Agricultrial Sci, Inst Bast Fiber Crops, Changsha 410205, Hunan, Peoples R China; [Guan, Leluo] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Guan, Yongjuan] Univ Western Australia, UWA Inst Agr M082, 35 Stirling Highway, Crawley, WA 6009, Australia	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; University of Alberta; University of Western Australia	Tan, ZL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Changsha 410125, Hunan, Peoples R China.	zltan@isa.ac.cn	Wu, Duanqin/GLR-0201-2022	He, Zhixiong/0000-0002-4802-3506	Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues [XDA05020700]; National Natural Science Foundation of China [31320103917]; CAS Visiting Professorship for Senior International Scientists [2010T2S13, 2012T1S0009]; Hunan Provincial Creation Development Project [2013TF3006]	Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Visiting Professorship for Senior International Scientists; Hunan Provincial Creation Development Project	The authors express their appreciation for "Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues" (Grant No. XDA05020700), the National Natural Science Foundation of China (Grant No. 31320103917), "CAS Visiting Professorship for Senior International Scientists" (Grant No. 2010T2S13, 2012T1S0009), and Hunan Provincial Creation Development Project (2013TF3006).; We express our appreciation to "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" (Grant No. XDA05020700), the National Natural Science Foundation of China (Grant No. 31320103917), "CAS Visiting Professorship for Senior International Scientists" (Grant No. 2010T2S13, 2012T1S0009), and Hunan Provincial Creation Development Project (2013TF3006) for suppling this work.	Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058386; Armando J, 2012, REV MEX CIENC PECU, V3, P215; Beauchemin KA, 2007, CAN J ANIM SCI, V87, P431, DOI 10.4141/CJAS07011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buccioni A, 2012, ANIM FEED SCI TECH, V174, P1, DOI 10.1016/j.anifeedsci.2012.02.009; Ding XZ, 2012, TROP ANIM HEALTH PRO, V44, P1541, DOI 10.1007/s11250-012-0103-7; Goering HK, 1970, AGR HDB, V379, P13; Harfoot C. G., 1988, The rumen microbial ecosystem., P285; Hook SE, 2010, ARCHAEA, V2010, DOI 10.1155/2010/945785; Hristov AN, 2011, J DAIRY SCI, V94, P4057, DOI 10.3168/jds.2011-4283; Hristov AN, 2009, J DAIRY SCI, V92, P5561, DOI 10.3168/jds.2009-2383; Hwang IH, 2001, ASIAN AUSTRAL J ANIM, V14, P501, DOI 10.5713/ajas.2001.501; Ichihara K, 1996, LIPIDS, V31, P535, DOI 10.1007/BF02522648; Immig I, 1996, ENVIRON MONIT ASSESS, V42, P57, DOI 10.1007/BF00394042; Jalc D, 2007, VET MED-CZECH, V52, P87, DOI 10.17221/2012-VETMED; Jalc D, 2002, FOLIA MICROBIOL, V47, P171, DOI 10.1007/BF02817677; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Jenkins TC, 2006, J NUTR, V136, P926, DOI 10.1093/jn/136.4.926; Kim CH, 2008, ANAEROBE, V14, P19, DOI 10.1016/j.anaerobe.2007.08.005; Laverroux S, 2011, LIPIDS, V46, P843, DOI 10.1007/s11745-011-3584-7; Lee SS, 2001, ASIAN AUSTRAL J ANIM, V14, P1110, DOI 10.5713/ajas.2001.1110; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; McKain N, 2010, MICROBIOL-SGM, V156, P579, DOI 10.1099/mic.0.036442-0; Mosley EE, 2002, J LIPID RES, V43, P290; Mosley EE, 2006, LIPIDS, V41, P513, DOI 10.1007/s11745-006-5125-3; O'Brien M, 2014, ANIM PROD SCI, V54, P141, DOI 10.1071/AN12204; Pilajun R, 2011, LIVEST SCI, V141, P148, DOI 10.1016/j.livsci.2011.05.013; Shingfield KJ, 2008, ADV EXP MED BIOL, V606, P3, DOI 10.1007/978-0-387-74087-4_1; Shingfield KJ, 2006, J DAIRY SCI, V89, P714, DOI 10.3168/jds.S0022-0302(06)72134-8; Tang SX, 2008, J ANIM SCI, V86, P1164, DOI 10.2527/jas.2007-0438; Toral PG, 2010, J DAIRY SCI, V93, P1604, DOI 10.3168/jds.2009-2530; Wanapat M, 2011, LIVEST SCI, V135, P32, DOI 10.1016/j.livsci.2010.06.006; Wang M, 2011, ANIM FEED SCI TECH, V165, P137, DOI 10.1016/j.anifeedsci.2010.09.016; Wang M., 2013, ANIMAL, V1, P1; Wang M, 2008, LIVEST SCI, V117, P233, DOI 10.1016/j.livsci.2007.12.016; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Wu DQ, 2015, EUR J LIPID SCI TECH, V117, P945, DOI 10.1002/ejlt.201400370; Wu DQ, 2013, J FOOD AGRIC ENVIRON, V11, P464; Zhang CM, 2008, ANIM FEED SCI TECH, V146, P259, DOI 10.1016/j.anifeedsci.2008.01.005	40	15	17	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156835	10.1371/journal.pone.0156835	http://dx.doi.org/10.1371/journal.pone.0156835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299526	gold, Green Submitted, Green Published			2022-12-26	WOS:000377822200015
J	Hincke, AJC; Broere, T; Kurschner, WM; Donders, TH; Wagner-Cremer, F				Hincke, Alexandra J. C.; Broere, Tom; Kurschner, Wolfram M.; Donders, Timme H.; Wagner-Cremer, Friederike			Multi-Year Leaf-Level Response to Sub-Ambient and Elevated Experimental CO2 in Betula nana	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; STOMATAL FREQUENCY; CLIMATE-CHANGE; QUERCUS-ROBUR; RISING CO2; WATER-USE; CONDUCTANCE; FUTURE; LEAVES; INCREASE	The strong link between stomatal frequency and CO2 in woody plants is key for understanding past CO2 dynamics, predicting future change, and evaluating the significant role of vegetation in the hydrological cycle. Experimental validation is required to evaluate the long-term adaptive leaf response of C3 plants to CO2 conditions; however, studies to date have only focused on short-term single-season experiments and may not capture (1) the full ontogeny of leaves to experimental CO2 exposure or (2) the true adjustment of structural stomatal properties to CO2, which we postulate is likely to occur over several growing seasons. We conducted controlled growth chamber experiments at 150 ppmv, 450 ppmv and 800 ppmv CO2 with woody C3 shrub Betula nana (dwarf birch) over two successive annual growing seasons and evaluated the structural stomatal response to atmospheric CO2 conditions. We find that while some adjustment of leaf morphological and stomatal parameters occurred in the first growing season where plants are exposed to experimental CO2 conditions, amplified adjustment of non-plastic stomatal properties such as stomatal conductance occurred in the second year of experimental CO2 exposure. We postulate that the species response limit to CO2 of B. nana may occur around 400-450 ppmv. Our findings strongly support the necessity for multi-annual experiments in C3 perennials in order to evaluate the effects of environmental conditions and provide a likely explanation of the contradictory results between historical and palaeobotanical records and experimental data.	[Hincke, Alexandra J. C.; Broere, Tom; Donders, Timme H.; Wagner-Cremer, Friederike] Univ Utrecht, Fac Geosci, Dept Phys Geog, Palaeoecol, Utrecht, Netherlands; [Kurschner, Wolfram M.] Univ Oslo, Dept Geosci, Oslo, Norway	Utrecht University; University of Oslo	Hincke, AJC; Wagner-Cremer, F (corresponding author), Univ Utrecht, Fac Geosci, Dept Phys Geog, Palaeoecol, Utrecht, Netherlands.	A.J.C.Hincke@gmail.com; F.Wagner-Cremer@uu.nl	Kürschner, Wolfram Michael/B-4724-2009; Kürschner, Wolfram Michael/AAC-7769-2020; Wagner-Cremer, Friederike/B-4225-2009	Kürschner, Wolfram Michael/0000-0001-6883-6486; Kürschner, Wolfram Michael/0000-0001-6883-6486; Wagner-Cremer, Friederike/0000-0002-8119-3558; Donders, Timme/0000-0003-4698-3463	Darwin Centre for Biogeosciences; Utrecht University Botanische Tuinen	Darwin Centre for Biogeosciences; Utrecht University Botanische Tuinen	This project was funded by the Darwin Centre for Biogeosciences (http://www.darwincenter.nl/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We greatly appreciate the support from the Utrecht University Botanische Tuinen, particularly the assistance of Gerard van Buiten. Thank you to Rob Welschen for technical assistance in the Fytotron.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Andrews T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043991; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; BEERLING DJ, 1993, ANN BOT-LONDON, V71, P231, DOI 10.1006/anbo.1993.1029; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Cao L, 2010, P NATL ACAD SCI USA, V107, P9513, DOI 10.1073/pnas.0913000107; de Boer HJ, 2011, P NATL ACAD SCI USA, V108, P4041, DOI 10.1073/pnas.1100555108; England JR, 2011, TREES-STRUCT FUNCT, V25, P987, DOI 10.1007/s00468-011-0573-7; Epron D, 1996, TREE PHYSIOL, V16, P425; Ferris R, 2001, PLANT CELL ENVIRON, V24, P305, DOI 10.1046/j.1365-3040.2001.00684.x; Finsinger W, 2009, HOLOCENE, V19, P757, DOI 10.1177/0959683609105300; Franks PJ, 2014, NEW PHYTOL, V201, P1079, DOI 10.1111/nph.12673; Franks PJ, 2012, PHILOS T R SOC B, V367, P537, DOI 10.1098/rstb.2011.0270; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Gagen M, 2011, GLOBAL CHANGE BIOL, V17, P1064, DOI 10.1111/j.1365-2486.2010.02273.x; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Kurschner WM, 1997, GEOL RUNDSCH, V86, P512, DOI 10.1007/s005310050158; Lake JA, 2001, NATURE, V411, P154, DOI 10.1038/35075660; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; Li YY, 2014, J EXP BOT, V65, P3657, DOI 10.1093/jxb/eru193; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; MORISON JIL, 1984, AUST J PLANT PHYSIOL, V11, P361, DOI 10.1071/PP9840361; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pettersson R, 1992, PLANT CELL ENVIRON, V15, P1115; RADOGLOU KM, 1990, ANN BOT-LONDON, V65, P627, DOI 10.1093/oxfordjournals.aob.a087979; Reid CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017775; Rico C, 2013, NEW PHYTOL, V199, P956, DOI 10.1111/nph.12339; Roth-Nebelsick A, 2013, PLANT CELL ENVIRON, V36, P579, DOI 10.1111/j.1365-3040.2012.02597.x; Roth-Nebelsick A, 2012, REV PALAEOBOT PALYNO, V174, P106, DOI 10.1016/j.revpalbo.2012.01.001; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; Salisbury EJ, 1928, PHILOS T R SOC LON B, V216, P1, DOI 10.1098/rstb.1928.0001; Temme AA, 2015, ECOL EVOL, V5, P4949, DOI 10.1002/ece3.1687; TICHA I, 1982, PHOTOSYNTHETICA, V16, P375; van Hoof TB, 2006, PLANT ECOL, V183, P237, DOI 10.1007/s11258-005-9021-3; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Wagner F, 2005, AM J BOT, V92, P690, DOI 10.3732/ajb.92.4.690; Wagner F, 2004, QUATERNARY SCI REV, V23, P1947, DOI 10.1016/j.quascirev.2004.04.003; Wagner F, 1996, P NATL ACAD SCI USA, V93, P11705, DOI 10.1073/pnas.93.21.11705; Wagner F, 1999, SCIENCE, V284, P1971, DOI 10.1126/science.284.5422.1971; Wagner F, 1998, EFFECTS NITROGEN DEF, P102; Wagner F, 2007, COUR FOR SEKENBG, V258, P183	43	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157400	10.1371/journal.pone.0157400	http://dx.doi.org/10.1371/journal.pone.0157400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285314	Green Published, gold			2022-12-26	WOS:000377564000065
J	Liew, TS; Schilthuizen, M				Liew, Thor-Seng; Schilthuizen, Menno			A Method for Quantifying, Visualising, and Analysing Gastropod Shell Form	PLOS ONE			English	Article							GEOMETRIC ANALYSIS; SECTORIAL-EXPANSION; MOLLUSCAN SHELL; COILED-SHELL; GROWTH; SHAPE; MORPHOGENESIS; 3D; REPRESENTATION; PLECTOSTOMA	Quantitative analysis of organismal form is an important component for almost every branch of biology. Although generally considered an easily-measurable structure, the quantification of gastropod shell form is still a challenge because many shells lack homologous structures and have a spiral form that is difficult to capture with linear measurements. In view of this, we adopt the idea of theoretical modelling of shell form, in which the shell form is the product of aperture ontogeny profiles in terms of aperture growth trajectory that is quantified as curvature and torsion, and of aperture form that is represented by size and shape. We develop a workflow for the analysis of shell forms based on the aperture ontogeny profile, starting from the procedure of data preparation (retopologising the shell model), via data acquisition (calculation of aperture growth trajectory, aperture form and ontogeny axis), and data presentation (qualitative comparison between shell forms) and ending with data analysis (quantitative comparison between shell forms). We evaluate our methods on representative shells of the genera Opisthostoma and Plectostoma, which exhibit great variability in shell form. The outcome suggests that our method is a robust, reproducible, and versatile approach for the analysis of shell form. Finally, we propose several potential applications of our methods in functional morphology, theoretical modelling, taxonomy, and evolutionary biology.	[Liew, Thor-Seng; Schilthuizen, Menno] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia; [Liew, Thor-Seng; Schilthuizen, Menno] Leiden Univ, Inst Biol Leiden, POB 9516, NL-2300 RA Leiden, Netherlands; [Liew, Thor-Seng; Schilthuizen, Menno] Nat Biodivers Ctr, POB 9517, NL-2300 RA Leiden, Netherlands	Universiti Malaysia Sabah; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center	Liew, TS (corresponding author), Univ Malaysia Sabah, Inst Trop Biol & Conservat, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.; Liew, TS (corresponding author), Leiden Univ, Inst Biol Leiden, POB 9516, NL-2300 RA Leiden, Netherlands.; Liew, TS (corresponding author), Nat Biodivers Ctr, POB 9517, NL-2300 RA Leiden, Netherlands.	thorsengliew@gmail.com	Liew, Thor-Seng/AHC-0363-2022	Liew, Thor-Seng/0000-0002-9437-5924	Research Council for Earth and Life Sciences (ALW-NWO) [819.01.012]	Research Council for Earth and Life Sciences (ALW-NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by project 819.01.012 of Research Council for Earth and Life Sciences (ALW-NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2012, PALAEONTOL ELECTRON, V15, P1, DOI DOI 10.26879/284; ACKERLY S C, 1989, Palaios, V4, P374, DOI 10.2307/3514561; ACKERLY SC, 1989, PALEOBIOLOGY, V15, P147, DOI 10.1017/S0094837300009337; Andrei RM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S16; Atwood JW, 2012, J PALEONTOL, V86, P813, DOI 10.1666/12-003.1; Bayer U., 1978, ABHANDLUNGEN, V156, P226; Boettiger A, 2009, P NATL ACAD SCI USA, V106, P6837, DOI 10.1073/pnas.0810311106; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1980, AM ZOOL, V20, P627; BOOKSTEIN FL, 1977, MATH BIOSCI, V34, P177, DOI 10.1016/0025-5564(77)90101-8; Brandmaier AM, 2015, J STAT SOFTWARE, V65, DOI 10.18637/jss.v067.i05; Brandmaier AM, 2012, PERMUTATION DISTRIBU; CAIN AJ, 1977, PHILOS T ROY SOC B, V277, P377, DOI 10.1098/rstb.1977.0026; CAMERON RAD, 1981, BIOL J LINN SOC, V16, P157, DOI 10.1111/j.1095-8312.1981.tb01648.x; Cardini A, 2013, HYSTRIX, V24, P1, DOI 10.4404/hystrix-24.1-8749; Cassola VF, 2010, PHYS MED BIOL, V55, P133, DOI 10.1088/0031-9155/55/1/009; Chacon R, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412300054; Chaplin TA, 2013, J COMP NEUROL, V521, P1001, DOI 10.1002/cne.23215; CHECA A, 1992, PALAEONTOLOGY, V35, P913; CHECA A, 1991, LETHAIA, V24, P97, DOI 10.1111/j.1502-3931.1991.tb01183.x; Cignoni P., 2008, ERCIM NEWS, V73, P45, DOI DOI 10.2312/L0CALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPC0NF2008/129-136; Clarke RK, 1999, J ZOOL, V247, P145, DOI 10.1111/j.1469-7998.1999.tb00978.x; Claude J, 2008, MORPHOMETRICS R; CORTIE MB, 1993, COMPUT GRAPH, V17, P79, DOI 10.1016/0097-8493(93)90054-D; CORTIE MB, 1989, S AFR J SCI, V85, P454; Costa C, 2008, J ZOOL, V276, P71, DOI 10.1111/j.1469-7998.2008.00469.x; Davoli E, 1974, B SOC PALEONTOLOGICA, V13, P108; Dera G, 2008, PALEOBIOLOGY, V34, P301, DOI 10.1666/07070.1; EKARATNE SUK, 1983, J MAR BIOL ASSOC UK, V63, P777, DOI 10.1017/S0025315400071216; EMBERTON KC, 1994, BIOL J LINN SOC, V52, P241, DOI 10.1111/j.1095-8312.1994.tb00989.x; Evans AR, 2013, HYSTRIX ITALIAN J MA, V24, P8; FOOTE M, 1988, EVOLUTION, V42, P396, DOI 10.1111/j.1558-5646.1988.tb04143.x; FOWLER DR, 1992, COMP GRAPH, V26, P379, DOI 10.1145/142920.134096; Galbraith C, 2002, VISUAL COMPUT, V18, P70, DOI 10.1007/s003710100136; Godefroy JE, 2012, CR BIOL, V335, P205, DOI 10.1016/j.crvi.2011.12.004; GOODFRIED G A, 1983, Malacological Review, V16, P79; GRAUS RR, 1974, LETHAIA, V7, P303, DOI 10.1111/j.1502-3931.1974.tb00906.x; Harary G, 2011, COMPUT GRAPH FORUM, V30, P237, DOI 10.1111/j.1467-8659.2011.01855.x; Hardy OJ, 2012, EVOLUTION, V66, P2614, DOI 10.1111/j.1558-5646.2012.01623.x; Haug C., 2012, PALAEONTOL ELECTRON, V15, P2; Haug JT, 2010, ARTHROPOD STRUCT DEV, V39, P154, DOI 10.1016/j.asd.2010.01.005; Haug JT, 2009, PALAEONTOGR ABT A, V289, P1; HUTCHINSON JMC, 1999, TRENDS ECOL EVOL, V14, P414; ILLERT C, 1983, MATH BIOSCI, V63, P21, DOI 10.1016/0025-5564(83)90049-4; ILLERT C, 1992, IEEE COMPUT GRAPH, V12, P18, DOI 10.1109/38.135910; Im CH, 2012, PHYS MED BIOL, V57, P2137, DOI 10.1088/0031-9155/57/8/2137; JOHNSTON MR, 1991, PALEOBIOLOGY, V17, P19, DOI 10.1017/S0094837300010320; KAESLER RL, 1972, GEOL SOC AM BULL, V83, P1169, DOI 10.1130/0016-7606(1972)83[1169:FAOTOM]2.0.CO;2; Kawaguchi K., 1982, Computer Graphics, V16, P223, DOI 10.1145/965145.801284; Klingenberg CP, 2013, HYSTRIX ITALIAN J MA, V24, P10; KOHN AJ, 1975, SYST ZOOL, V24, P346, DOI 10.2307/2412720; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Lewiner T, 2005, COMPUT GRAPH-UK, V29, P641, DOI 10.1016/j.cag.2005.08.004; Liew TS, 2014, PEERJ, V2, DOI 10.7717/peerj.383; Liew TS, 2014, PEERJ, V2, DOI 10.7717/peerj.329; Liew TS, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.393.6717; LOVTRUP S, 1974, B MATH BIOL, V36, P567, DOI 10.1016/S0092-8240(74)80051-0; Lv ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057990; Mayer G, 2012, Z ANZEIGER A J COMP, V252, P536; MCGHEE GR, 1978, LETHAIA, V11, P315, DOI 10.1111/j.1502-3931.1978.tb01889.x; McGhee GR., 2007, GEOMETRY EVOLUTION A; McGhee GR, 1999, PERS PALEOB; Meinhardt H., 2009, ALGORITHMIC BEAUTY S; Monnet C, 2009, PALAEONTOL ELECTRON, V12; Moseley H., 1838, PHILOS T ROY SOC LON, V128, P351; Moulton DE, 2012, J THEOR BIOL, V311, P69, DOI 10.1016/j.jtbi.2012.07.009; Moulton DE, 2012, J MATH BIOL, P1; NEWKIRK GF, 1975, MAR BIOL, V30, P227, DOI 10.1007/BF00390745; Noshita K, 2016, J THEOR BIOL, V389, P11, DOI 10.1016/j.jtbi.2015.10.011; Noshita K, 2014, J THEOR BIOL, V363, P93, DOI 10.1016/j.jtbi.2014.08.010; Noshita Koji, 2010, Geoscience Reports of Shizuoka University, V37, P57; Okajima R, 2013, EVOLUTION, V67, P429, DOI 10.1111/j.1558-5646.2012.01772.x; Okajima R, 2011, AM NAT, V178, P801, DOI 10.1086/662674; OKAMOTO T, 1988, PALAEONTOLOGY, V31, P35; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pappas JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077551; PICADO J., 2009, MAA MATH SCI DIGITAL, P1; Pyka M, 2010, NEUROINFORMATICS, V8, P21, DOI 10.1007/s12021-009-9060-3; R Core Team, 2021, R LANGUAGE ENV STAT; Raup D. M., 1967, Journal of Paleontology, V41, P43; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; RAUP DM, 1961, P NATL ACAD SCI USA, V47, P602, DOI 10.1073/pnas.47.4.602; Raup DM, 1972, MATH GEOL, V4, P307; Rice SH, 1998, PALEOBIOLOGY, V24, P133, DOI 10.1017/S0094837300020017; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; RStudio, 2012, RSTUDIO INT DEV ENV; Samadi S, 2000, EVOLUTION, V54, P492, DOI 10.1111/j.0014-3820.2000.tb00052.x; Sarkar D, 2008, USE R, P1; SAUNDERS WB, 1986, PALEOBIOLOGY, V12, P64, DOI 10.1017/S0094837300002980; SAVAZZI E, 1992, PALAEOGEOGR PALAEOCL, V99, P349, DOI 10.1016/0031-0182(92)90022-W; SAVAZZI E, 1990, LETHAIA, V23, P195, DOI 10.1111/j.1502-3931.1990.tb01360.x; SAVAZZI E, 1993, COMPUT GEOSCI, V19, P931, DOI 10.1016/0098-3004(93)90003-N; SAVAZZI E, 1985, COMPUT GEOSCI, V11, P521, DOI 10.1016/0098-3004(85)90083-4; Savazzi E, 1995, ABHANDLUNGEN, V195, P229; Schindel D.E., 1990, P270; Shojaei MF, 2012, J MECH BEHAV BIOMED, V16, P38, DOI 10.1016/j.jmbbm.2012.08.006; Stepien C, 2009, COMPUT GRAPH-UK, V33, P576, DOI 10.1016/j.cag.2009.02.003; Stone JR, 1997, LETHAIA, V30, P213; Thompson D.W, 1917, GROWTH FORM; TISSOT BN, 1988, EVOLUTION, V42, P103, DOI 10.1111/j.1558-5646.1988.tb04111.x; Ubukata Takao, 2001, Historical Biology, V15, P303, DOI 10.1080/0891296021000024475; Urdy S, 2010, J EXP ZOOL PART B, V314B, P280, DOI 10.1002/jez.b.21337; Van Bocxlaer B, 2010, PALEOBIOLOGY, V36, P497, DOI 10.1666/08068.1; Verduin A., 1982, Basteria, V45, P127; VERMEIJ GJ, 1971, J ZOOL, V163, P15; Vermeulen JJ, 1994, BASTERIA, V58, P73; WARBURTON K, 1979, J NAT HIST, V13, P385, DOI 10.1080/00222937900770301	108	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157069	10.1371/journal.pone.0157069	http://dx.doi.org/10.1371/journal.pone.0157069			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280463	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000075
J	Sheaffer, AK; Lee, MS; Qi, HL; Chaniewski, S; Zheng, XF; Farr, GA; Esposito, K; Harden, D; Lei, M; Schweizer, L; Friborg, J; Agler, M; McPhee, F; Gentles, R; Beno, BR; Chupak, L; Mason, S				Sheaffer, Amy K.; Lee, Min S.; Qi, Huilin; Chaniewski, Susan; Zheng, Xiaofan; Farr, Glen A.; Esposito, Kim; Harden, David; Lei, Ming; Schweizer, Liang; Friborg, Jacques; Agler, Michele; McPhee, Fiona; Gentles, Robert; Beno, Brett R.; Chupak, Lou; Mason, Stephen			A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-16 E6 PROTEIN; CERVICAL-CARCINOMA CELLS; FASL-MEDIATED APOPTOSIS; CANCER-CELLS; E7 PROTEIN; CASPASE 8; TYPE-16; GENE; DNA; KERATINOCYTES	A phenotypic high-throughput cell culture screen was performed to identify compounds that prevented proliferation of the human Papilloma virus type 16 (HPV-16) transformed cell line Ca Ski. A series of quinoxaline compounds exemplified by Compound 1 was identified. Testing against a panel of cell lines demonstrated that Compound 1 selectively inhibited replication of all HPV-16, HPV-18, and HPV-31 transformed cell lines tested with 50% Inhibitory Concentration (IC50) values of 2 to 8 mu M relative to IC50 values of 28 to 73 mu M in HPV-negative cell lines. Treatment with Compound 1 resulted in a cascade of multiple apoptotic events, including selective activation of effector caspases 3 and 7, fragmentation of cellular DNA, and PARP (poly(ADP-ribose) polymerase) cleavage in HPV-positive cells relative to HPV-negative cells. Unregulated proliferation of HPV transformed cells is dependent on the viral oncogenes, E6 and E7. Treatment with Compound 1 resulted in a decrease in HPV E7 protein in Ca Ski cells. However, the timing of this reduction relative to other effects of compound treatment suggests that this was a consequence, rather than a cause, of the apoptotic cascade. Likewise, compound treatment resulted in no obvious effects on the E6- and E7-mediated down regulation of p53 and Rb, or their downstream effectors, p21 or PCNA. Further investigation of apoptotic signals induced by Compound 1 revealed cleavage of Caspase-8 in HPV-positive cells as early as 2 hours post-treatment, suggesting the compound initiates apoptosis through the extrinsic, death receptor-mediated, pathway of cell death. These studies provide proof of concept that cells transformed by oncogenic Papillo-maviruses can be selectively induced to undergo apoptosis by compound treatment.	[Sheaffer, Amy K.; Lee, Min S.; Qi, Huilin; Chaniewski, Susan; Zheng, Xiaofan; Farr, Glen A.; Esposito, Kim; Harden, David; Lei, Ming; Schweizer, Liang; Friborg, Jacques; Agler, Michele; McPhee, Fiona; Gentles, Robert; Beno, Brett R.; Chupak, Lou; Mason, Stephen] Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA; [Farr, Glen A.] Regeneron, Tarrytown, NY USA; [Agler, Michele] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA; [Lei, Ming] Bristol Myers Squibb Co, Res & Dev, Hopewell, NJ USA; [Schweizer, Liang] Sanofi Oncol, Shanghai, Peoples R China; [Friborg, Jacques] Merck Res Labs, N Wales, PA USA; [Mason, Stephen] SWM Consulting, Wallingford, CT USA	Bristol-Myers Squibb; Regeneron; Boehringer Ingelheim; Bristol-Myers Squibb; Merck & Company	Sheaffer, AK (corresponding author), Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA.	amy.sheaffer@bms.com		Sheaffer, Amy/0000-0002-4776-4679; Mason, Stephen/0000-0002-6662-9624; Farr, Glen/0000-0002-5651-7995	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	Bristol-Myers Squibb Company provided support in the form of salaries for all the authors at the time this work was carried out, and the authors designed, collected and analyzed data, and prepared the manuscript as employees of Bristol-Myers Squibb. Bristol-Myers Squibb Company approved the decision to disclose this work. The specific roles of the authors are articulated in the 'author contributions' section.	BOSCH FX, 1992, INT J CANCER, V52, P750, DOI 10.1002/ijc.2910520514; Boyer SN, 1996, CANCER RES, V56, P4620; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Darus CJ, 2013, CLIN OBSTET GYNECOL, V56, P10, DOI 10.1097/GRF.0b013e31827af770; DELVECCHIO AM, 1992, J VIROL, V66, P5949, DOI 10.1128/JVI.66.10.5949-5958.1992; DiMaio D, 2013, VIROLOGY, V445, P99, DOI 10.1016/j.virol.2013.05.006; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fehrmann Frauke, 2005, Methods Mol Biol, V292, P317; Filippova M, 2005, CELL DEATH DIFFER, V12, P1622, DOI 10.1038/sj.cdd.4401678; Filippova M, 2004, J BIOL CHEM, V279, P25729, DOI 10.1074/jbc.M401172200; Filippova M, 2002, J BIOL CHEM, V277, P21730, DOI 10.1074/jbc.M200113200; Filippova M, 2007, J VIROL, V81, P4116, DOI 10.1128/JVI.01924-06; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Garnett TO, 2006, ARCH VIROL, V151, P2321, DOI 10.1007/s00705-006-0821-0; Garnett TO, 2006, CELL DEATH DIFFER, V13, P1915, DOI 10.1038/sj.cdd.4401886; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hu Z, 2015, J CLIN INVEST, V125, P425, DOI 10.1172/JCI78206; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kabsch K, 2004, INTERVIROLOGY, V47, P48, DOI 10.1159/000076642; Kabsch K, 2002, J VIROL, V76, P12162, DOI 10.1128/JVI.76.23.12162-12172.2002; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Li CY, 2013, CELL CYCLE, V12, P923, DOI 10.4161/cc.23882; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Magaldi TG, 2012, VIROLOGY, V422, P114, DOI 10.1016/j.virol.2011.10.012; Manzo-Merino J, 2014, VIROLOGY, V450, P146, DOI 10.1016/j.virol.2013.12.013; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Morozov A, 1997, J VIROL, V71, P3451, DOI 10.1128/JVI.71.5.3451-3457.1997; MUNGER K, 1989, J VIROL, V63, P4417; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; POMMIER Y, 1995, MUTAT RES-DNA REPAIR, V337, P135, DOI 10.1016/0921-8777(95)00019-G; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Reesink-Peters N, 2005, GYNECOL ONCOL, V96, P705, DOI 10.1016/j.ygyno.2004.10.046; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Samson SLA, 2005, OBSTET GYNECOL, V105, P325, DOI 10.1097/01.AOG.0000151991.09124.bb; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SEDMAN SA, 1991, J VIROL, V65, P4860, DOI 10.1128/JVI.65.9.4860-4866.1991; Stoppler MC, 1996, VIROLOGY, V223, P251, DOI 10.1006/viro.1996.0475; Wang Y, 2004, J BIOL CHEM, V279, P6976, DOI 10.1074/jbc.M311376200; White PW, 2005, ANTIMICROB AGENTS CH, V49, P4834, DOI 10.1128/AAC.49.12.4834-4842.2005; Yuan CH, 2012, BIOORG MED CHEM LETT, V22, P2125, DOI 10.1016/j.bmcl.2011.12.145; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014	49	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155909	10.1371/journal.pone.0155909	http://dx.doi.org/10.1371/journal.pone.0155909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280728	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000008
J	Wenzel, M; Zahn, D; Rowland, Z; Kubiak, T				Wenzel, Mario; Zahn, Daniela; Rowland, Zarah; Kubiak, Thomas			The Benefits of Self-Set Goals: Is Ego Depletion Really a Result of Self-Control Failure?	PLOS ONE			English	Article							POSITIVE AFFECT; MODEL; RESOURCE; TASK	Research on ego depletion aims at explaining self-control failures in daily life. Both resource models and motivational accounts have been proposed for explanation. The aim of the present research was to test the different assumptions in two dual-task experiments where we operationalized ego depletion as a performance deviation from a self-set goal. In two experiments, we found evidence for this deviation contradicting motivational accounts of ego depletion: Participants experiencing ego depletion set themselves a stricter instead of a more lenient goal than controls, in that they chose to eat less cookies or wanted to perform better. Moreover, only participants without an initial self-control task could adhere to their self-set goal, whereas participants in the ego depletion condition in both experiments could not follow through with their more ambitious intentions. Taken together, our findings demonstrate the importance of goals in ego depletion research.	[Wenzel, Mario; Zahn, Daniela; Rowland, Zarah; Kubiak, Thomas] Johannes Gutenberg Univ Mainz, Inst Psychol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Wenzel, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Psychol, D-55122 Mainz, Germany.	wenzelma@uni-mainz.de	Kubiak, Thomas/D-4655-2009	Kubiak, Thomas/0000-0003-0095-9265; Zahn, Daniela/0000-0002-0477-1369; Wenzel, Mario/0000-0003-2839-9482	Internal University Research Funding	Internal University Research Funding	The study was funded by the Internal University Research Funding (https://www.uni-mainz.de/forschung/140_ENG_HTML.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Baumeister RF, 2002, SELF IDENTITY, V1, P129, DOI 10.1080/152988602317319302; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Carter EC, 2015, J EXP PSYCHOL GEN, V144, P796, DOI 10.1037/xge0000083; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Carter EC, 2013, BEHAV BRAIN SCI, V36, P683, DOI 10.1017/S0140525X13000952; Converse PD, 2009, J APPL PSYCHOL, V94, P1318, DOI 10.1037/a0014604; Dewitte S, 2009, J CONSUM RES, V36, P394, DOI 10.1086/598615; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Fishbach A, 2010, J EXP SOC PSYCHOL, V46, P29, DOI 10.1016/j.jesp.2009.09.008; Hagger M. S., 2016, PERSPECTIVE IN PRESS; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hofmann W, 2009, PERSPECT PSYCHOL SCI, V4, P162, DOI 10.1111/j.1745-6924.2009.01116.x; Huberts JCD, 2014, PERS SOC PSYCHOL REV, V18, P119, DOI 10.1177/1088868313507533; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Moller AC, 2006, PERS SOC PSYCHOL B, V32, P1024, DOI 10.1177/0146167206288008; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Schmeichel BJ, 2010, J PERS SOC PSYCHOL, V99, P162, DOI 10.1037/a0019797; Shamosh NA, 2007, COGNITION EMOTION, V21, P1833, DOI 10.1080/02699930701273658; Wenzel M, 2014, COGNITION EMOTION, V28, P747, DOI 10.1080/02699931.2013.851069; Wenzel M, 2013, EUR J SOC PSYCHOL, V43, P175, DOI 10.1002/ejsp.1936	25	4	4	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157009	10.1371/journal.pone.0157009	http://dx.doi.org/10.1371/journal.pone.0157009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280531	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000066
J	Bakshi, MV; Azimzadeh, O; Merl-Pham, J; Verreet, T; Hauck, SM; Benotmane, MA; Atkinson, MJ; Tapio, S				Bakshi, Mayur V.; Azimzadeh, Omid; Merl-Pham, Juliane; Verreet, Tine; Hauck, Stefanie M.; Benotmane, Mohammed A.; Atkinson, Michael J.; Tapio, Soile			In-Utero Low-Dose Irradiation Leads to Persistent Alterations in the Mouse Heart Proteome	PLOS ONE			English	Article							IONIZING-RADIATION; SHOCK-PROTEIN; DILATED CARDIOMYOPATHY; MICE; EXPOSURE; CELLS; ATHEROSCLEROSIS; IDENTIFICATION; CYTOSKELETAL; SURVIVORS	Prenatal exposure to stress such as increased level of reactive oxygen species or antiviral therapy are known factors leading to adult heart defects. The risks following a radiation exposure during fetal period are unknown, as are the mechanisms of any potential cardiac damage. The aim of this study was to gather evidence for possible damage by investigating long-term changes in the mouse heart proteome after prenatal exposure to low and moderate radiation doses. Pregnant C57Bl/6J mice received on embryonic day 11 (E11) a single total body dose of ionizing radiation that ranged from 0.02 Gy to 1.0 Gy. The offspring were sacrificed at the age of 6 months or 2 years. Quantitative proteomic analysis of heart tissue was performed using Isotope Coded Protein Label technology and tandem mass spectrometry. The proteomics data were analyzed by bioinformatics and key changes were validated by immunoblotting. Persistent changes were observed in the expression of proteins representing mitochondrial respiratory complexes, redox and heat shock response, and the cytoskeleton, even at the low dose of 0.1 Gy. The level of total and active form of the kinase MAP4K4 that is essential for the embryonic development of mouse heart was persistently decreased at the radiation dose of 1.0 Gy. This study provides the first insight into the molecular mechanisms of cardiac impairment induced by ionizing radiation exposure during the prenatal period.	[Bakshi, Mayur V.; Azimzadeh, Omid; Atkinson, Michael J.; Tapio, Soile] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Radiat Biol, D-85764 Neuherberg, Germany; [Merl-Pham, Juliane; Hauck, Stefanie M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Prot Sci, D-80939 Munich, Germany; [Atkinson, Michael J.] Tech Univ Munich, Chair Radiat Biol, D-80333 Munich, Germany; [Verreet, Tine; Benotmane, Mohammed A.] CEN SCK, Belgian Nucl Res Ctr, Radiobiol Unit, B-2400 Mol, Belgium; [Verreet, Tine] Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol Sect, Lab Neural Circuit Dev & Regenerat, B-3000 Leuven, Belgium	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Belgian Nuclear Research Centre (SCK-CEN); KU Leuven	Tapio, S (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Radiat Biol, D-85764 Neuherberg, Germany.	soile.tapio@helmholtz-muenchen.de	Tapio, Soile/CAJ-5871-2022; Atkinson, Michael/AAU-5127-2020; Atkinson, Michael J/E-5537-2011; Tapio, Soile/M-7358-2014; Merl-Pham, Juliane/N-7258-2014; Hauck, Stefanie/B-3300-2013	Atkinson, Michael/0000-0003-3358-2089; Atkinson, Michael J/0000-0003-3358-2089; Tapio, Soile/0000-0001-9860-3683; Merl-Pham, Juliane/0000-0002-3422-4083; Hauck, Stefanie/0000-0002-1630-6827; Benotmane, Rafi/0000-0002-8985-1578; Verreet, Tine/0000-0001-7810-6102; Azimzadeh, Omid/0000-0001-8984-0388	European Community's Seventh Framework Program (EURATOM) [295823];  [295552]	European Community's Seventh Framework Program (EURATOM); 	The research leading to these results is supported by a grant from the European Community's Seventh Framework Program (EURATOM), Contract No. 295823 (PROCARDIO) and Contract No. 295552 (CEREBRAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, OBSTET GYNECOL, V104, P647; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Bakshi MV, 2015, J PROTEOME RES, V14, P366, DOI 10.1021/pr500890n; Bakshi MV, 2013, RADIAT ENVIRON BIOPH, V52, P451, DOI 10.1007/s00411-013-0483-8; Banmeyer I, 2005, FEBS LETT, V579, P2327, DOI 10.1016/j.febslet.2005.03.027; Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Beqqali A, 2010, J CELL SCI, V123, P1141, DOI 10.1242/jcs.063859; Beutner G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113330; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapple SJ, 2015, FREE RADIC BIOL MED; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; Fattibene P, 1999, ACTA PAEDIATR, V88, P693; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Fuller SJ, 2015, CARDIOVASC RES, V108, P87, DOI 10.1093/cvr/cvv210; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Kempf SJ, 2015, J PROTEOME RES; Kempf SJ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-57; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2009, J BIOL CHEM, V284, P23602, DOI 10.1074/jbc.M109.024323; Li ZH, 2010, CIRC-ARRHYTHMIA ELEC, V3, P646, DOI 10.1161/CIRCEP.109.929240; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; OTAKE M, 1991, J RADIAT RES, V32, P249, DOI 10.1269/jrr.32.SUPPLEMENT_249; Protection IICoR. ICRP, 2000, ICRP PUBL, V30; Qian J, 2011, CIRC RES, V108, P1429, DOI 10.1161/CIRCRESAHA.110.237644; Raddatz E., 2006, Annales de Cardiologie et d'Angeiologie, V55, P79, DOI 10.1016/j.ancard.2006.02.007; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sarioglu H, 2006, PROTEOMICS, V6, P2407, DOI 10.1002/pmic.200500680; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Talmud PJ, 2003, ARTERIOSCL THROM VAS, V23, P644, DOI 10.1161/01.ATV.0000065196.61663.8D; Tatsukawa Y, 2008, RADIAT RES, V170, P269, DOI 10.1667/RR1434.1; van Eldik W, 2011, INT J DEV BIOL, V55, P649, DOI 10.1387/ijdb.103207wv; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Wang DM, 2011, EXP LUNG RES, V37, P291, DOI 10.3109/01902148.2011.554599; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Williams PM, 2010, AM FAM PHYSICIAN, V82, P488; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200; Zhou Y, 2000, BIOCHEM BIOPH RES CO, V268, P921, DOI 10.1006/bbrc.2000.2231	52	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156952	10.1371/journal.pone.0156952	http://dx.doi.org/10.1371/journal.pone.0156952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276052	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700051
J	Kopp, M; Morisset, R; Koehler, P; Rychlik, M				Kopp, Markus; Morisset, Rosalie; Koehler, Peter; Rychlik, Michael			Stable Isotope Dilution Assays for Clinical Analyses of Folates and Other One-Carbon Metabolites: Application to Folate-Deficiency Studies	PLOS ONE			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; TANDEM MASS-SPECTROMETRY; SMALL-VESSEL DISEASE; NEURAL-TUBE DEFECTS; FOLIC-ACID; LC-MS/MS; TISSUE DISTRIBUTION; TOTAL HOMOCYSTEINE; ADENOSYLMETHIONINE; PLASMA	Folate deficiency is generally accepted as a potential direct or indirect risk factor for diseases including spina bifida, coronary heart diseases, malfunctions of the central nervous system, and cancer. The direct inclusion of folates in the methylation cycle, including the remethylation of homocysteine and regeneration of S-adenosylmethionine, underlines the importance of these vitamins and other components of one-carbon metabolism. Therefore, the aim of the present study was to develop a multiple stable isotope dilution assay (SIDA) for the respective analytes in plasma and tissue samples to allow for a closer look at the interaction between a severe folate deficiency and local folate status, as well as further interactions with circulating S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine. The analytical methods were based on SIDAs coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis using the deuterated folates [H-2(4)]-5-methyltetrahydrofolic acid, [H-2(4)]-5-formyltetrahydrofolic acid, [H-2(4)]-tetrahydrofolic acid, [H-2(4)]-10-formylfolic acid, and [H-2(4)]-folic acid and the deuterated one-carbon metabolites [H-2(4)]-homocysteine, [H-2(4)]-S-adenosylhomocysteine, and [H-2(3)]-S-adenosylmethionine as internal standards. Three analytical methods have been developed for the analysis of homocysteine, S-adenosylmethionine, S-adenosylhomocysteine, and six folate vitamers. Validation data for the analysis of C-1-metabolites in plasma and tissue samples or folate analysis in tissue samples revealed excellent sensitivity, precision, and recovery for all analytes studied. The miniaturized methods using sample volumes as low as 50 mu L and weighed portions of 5-25 mg will allow the assessment of the status of folates and additional biomarkers of impaired one-carbon metabolism during folate deficiency.	[Kopp, Markus; Rychlik, Michael] Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany; [Kopp, Markus; Morisset, Rosalie] Tech Univ Munich, Inst Food & Hlth ZIEL, Weihenstephaner Berg 1, D-85354 Freising Weihenstephan, Germany; [Morisset, Rosalie] Tech Univ Munich, Chair Nutr Physiol, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany; [Koehler, Peter] Deutsch Forschungsanstalt Lebensmittelchem, Leibniz Inst, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Leibniz-Institute for Food Systems Biology at the Technical University of Munich	Rychlik, M (corresponding author), Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany.	michael.rychlik@tum.de	Rychlik, Michael/G-6064-2015	Rychlik, Michael/0000-0002-5826-6288; Kopp, Markus/0000-0003-2166-3164	TUM; DFG; TUM Open Access Publishing Fund; TUM Graduate School	TUM; DFG(German Research Foundation (DFG)); TUM Open Access Publishing Fund; TUM Graduate School	This work was funded by TUM, DFG (https://www.ub.tum.de/en/publishing-fund), TUM Open Access Publishing Fund, and TUM Graduate School (https://www.gs.tum.de/en/about-tum-gs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcot J, 2005, TRENDS FOOD SCI TECH, V16, P253, DOI 10.1016/j.tifs.2005.03.013; Baggott JE, 2000, BIOCHEMISTRY-US, V39, P14647, DOI 10.1021/bi001362m; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; BENESCH R, 1982, BIOCHEM BIOPH RES CO, V106, P1359, DOI 10.1016/0006-291X(82)91263-3; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; Bottiglieri T, 2002, AM J CLIN NUTR, V76, p1151S, DOI 10.1093/ajcn/76.5.1151S; Caudill M, 2004, J FOOD SCI, V69, pS55, DOI 10.1111/j.1365-2621.2004.tb17887.x; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; CLIFFORD AJ, 1990, J NUTR, V120, P1633, DOI 10.1093/jn/120.12.1633; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dahlhoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057387; EISENGA BH, 1992, J NUTR, V122, P977, DOI 10.1093/jn/122.4.977; ELORANTA TO, 1976, BIOCHEM J, V160, P287, DOI 10.1042/bj1600287; ELORANTA TO, 1977, BIOCHEM J, V166, P521, DOI 10.1042/bj1660521; Finkelstein JD, 2007, CLIN CHEM LAB MED, V45, P1694, DOI 10.1515/CCLM.2007.341; Freisleben A, 2002, J AGR FOOD CHEM, V50, P4760, DOI 10.1021/jf025571k; Fu WY, 2000, BIOCHEM BIOPH RES CO, V271, P47, DOI 10.1006/bbrc.2000.2587; Gardner LA, 2013, ELECTROPHORESIS, V34, P1710, DOI 10.1002/elps.201200536; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; HELLAND S, 1983, CANCER RES, V43, P1847; HELLAND S, 1983, CANCER RES, V43, P4142; Hinterberger M, 2013, J NEURAL TRANSM, V120, P211, DOI 10.1007/s00702-012-0822-y; HOPPNER K, 1980, AM J CLIN NUTR, V33, P862, DOI 10.1093/ajcn/33.4.862; Inoue-Choi M, 2012, INT J MOL EPIDEMIOL, V3, P160; Jakubowski H., 2013, HOMOCYSTEINE PROTEIN; Jeon SB, 2014, NEUROLOGY, V83, P695, DOI 10.1212/WNL.0000000000000720; Kirsch SH, 2009, J CHROMATOGR B, V877, P3865, DOI 10.1016/j.jchromb.2009.09.039; Kloppenborg RP, 2014, NEUROLOGY, V82, P777, DOI 10.1212/WNL.0000000000000168; Kopp M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143639; Korinek M, 2013, BIOMED CHROMATOGR, V27, P111, DOI 10.1002/bmc.2755; Krijt J, 2009, J CHROMATOGR B, V877, P2061, DOI 10.1016/j.jchromb.2009.05.039; LADJIMI H, 1992, ARCH INT PHYSIOL BIO, V100, P67, DOI 10.3109/13813459209035261; Li SJ, 2008, J CHROMATOGR B, V870, P63, DOI 10.1016/j.jchromb.2008.06.003; Luippold G, 1999, J CHROMATOGR B, V724, P231, DOI 10.1016/S0378-4347(98)00580-5; Mari M, 2004, J CLIN INVEST, V113, P895, DOI 10.1172/JCI200419852; McNeil CJ, 2012, MOL NUTR FOOD RES, V56, P1122, DOI 10.1002/mnfr.201100694; Monch S, 2015, FOOD FUNCT, V6, P242, DOI 10.1039/c4fo00658e; Monch S, 2010, ANAL BIOCHEM, V398, P150, DOI 10.1016/j.ab.2009.11.007; Nakata R, 2000, J NUTR SCI VITAMINOL, V46, P215, DOI 10.3177/jnsv.46.215; Neha Rastogi, 2012, PRACTICAL PEDIAT HEM, P41; Nelson BC, 2005, ANAL CHEM, V77, P3586, DOI 10.1021/ac050235z; Nelson BC, 2003, ANAL CHEM, V75, P775, DOI 10.1021/ac0204799; Obeid R, 2015, REPROD TOXICOL, V56, P30, DOI DOI 10.1016/J.REPR0T0X.2015.07.073; Persichilli S, 2010, J SEP SCI, V33, P3119, DOI 10.1002/jssc.201000399; REED LS, 1980, J AGR FOOD CHEM, V28, P801, DOI 10.1021/jf60230a044; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Ringling C, 2013, EUR FOOD RES TECHNOL, V236, P17, DOI 10.1007/s00217-012-1849-x; Robinson K, 2000, HEART, V83, P127, DOI 10.1136/heart.83.2.127; Rychlik M, 2003, J CHROMATOGR B, V792, P167, DOI 10.1016/S1570-0232(03)00254-X; Satterfield MB, 2006, ANAL BIOANAL CHEM, V385, P612, DOI 10.1007/s00216-006-0434-1; Shane B., 2010, FOLATE HLTH DIS, V2nd, P1; Shane B, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013367; Snowdon DA, 2000, AM J CLIN NUTR, V71, P993; Souci SW, 2009, KLEINE SOUCI FACHMAN; Thomas AH, 2000, J PHOTOCH PHOTOBIO A, V135, P147, DOI 10.1016/S1010-6030(00)00304-X; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234; Wang ZG, 2010, J LIPID RES, V51, P3158, DOI 10.1194/jlr.M007948; Wilcken DEL, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P1; Wild CP, 2001, BRIT J NUTR, V86, pS37, DOI 10.1079/BJN2001338; Zhang HY, 2008, EXP NEUROL, V212, P515, DOI 10.1016/j.expneurol.2008.04.044; 2014, EFSA J, V12	63	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156610	10.1371/journal.pone.0156610	http://dx.doi.org/10.1371/journal.pone.0156610			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276031	gold, Green Published			2022-12-26	WOS:000377561700030
J	Wang, Y; Wang, R; Jin, F; Liu, Y; Yu, JY; Fu, XM; Chang, ZY				Wang, Yan; Wang, Rui; Jin, Feng; Liu, Yang; Yu, Jiayu; Fu, Xinmiao; Chang, Zengyi			A Supercomplex Spanning the Inner and Outer Membranes Mediates the Biogenesis of beta-Barrel Outer Membrane Proteins in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; IN-VIVO; CHAPERONE; COMPLEX; SURA; SHOCK; BAMA; TRANSLOCON; RELEASE; ACID	beta-barrel outer membrane proteins (OMPs) are ubiquitously present in Gram-negative bacteria, mitochondria and chloroplasts, and function in a variety of biological processes. The mechanism by which the hydrophobic nascent beta-barrel OMPs are transported through the hydrophilic periplasmic space in bacterial cells remains elusive. Here, mainly via unnatural amino acid-mediated in vivo photo-crosslinking studies, we revealed that the primary periplasmic chaperone SurA interacts with nascent beta-barrel OMPs largely via its N-domain but with beta-barrel assembly machine protein BamA mainly via its satellite P2 domain, and that the nascent beta-barrel OMPs interact with SurA via their N- and C-terminal regions. Additionally, via dual in vivo photo-crosslinking, we demonstrated the formation of a ternary complex involving beta-barrel OMP, SurA, and BamA in cells. More importantly, we found that a supercomplex spanning the inner and outer membranes and involving the BamA, BamB, SurA, PpiD, SecY, SecE, and SecA proteins appears to exist in living cells, as revealed by a combined analyses of sucrose-gradient ultra-centrifugation, Blue native PAGE and mass spectrometry. We propose that this supercomplex integrates the translocation, transportation, and membrane insertion events for beta-barrel OMP biogenesis.	[Wang, Yan; Wang, Rui; Jin, Feng; Liu, Yang; Yu, Jiayu; Fu, Xinmiao; Chang, Zengyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Fu, Xinmiao; Chang, Zengyi] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Jin, Feng] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Fu, XM; Chang, ZY (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Fu, XM; Chang, ZY (corresponding author), Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China.	fuxinmiao@pku.edu.cn; changzy@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904	National Basic Research Program of China (973 Program) [2012CB917300]; National Natural Science Foundation of China [31470766, 31270804, 31570778]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grant 2012CB917300 (to Z. Y. C. and X. M. F.) from the National Basic Research Program of China (973 Program) and Research Grants 31470766 (to Z. Y. C.) and 31270804 and 31570778 (to X. M. F.) from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Chen YC, 2005, J CHIN INST CHEM ENG, V36, P527; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Fu XM, 2013, J BIOL CHEM, V288, P11897, DOI 10.1074/jbc.M113.450437; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Ge X, 2014, FEBS J, V281, P1226, DOI 10.1111/febs.12701; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011; NEU HC, 1965, J BIOL CHEM, V240, P3685; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Sachelaru I, 2014, J BIOL CHEM, V289, P21706, DOI 10.1074/jbc.M114.577916; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sinnige T, 2014, J MOL BIOL, V426, P2009, DOI 10.1016/j.jmb.2014.02.007; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	32	37	38	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16720	16729		10.1074/jbc.M115.710715	http://dx.doi.org/10.1074/jbc.M115.710715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298319	hybrid, Green Published			2022-12-26	WOS:000380826700029
J	Lira, RMM; Flores, AYL; Carmona, MCS; Stern, AO				Mifuji Lira, Roque M.; Limon Flores, Alberto Yairh; Salinas Carmona, Mario Cesar; Ortiz Stern, Alejandro			Experimental Granulomatous Pulmonary Nocardiosis in BALB/C Mice	PLOS ONE			English	Article							DELTA T-LYMPHOCYTES; ASTEROIDES; INFECTION; BRASILIENSIS; ACTINOMYCETOMA; MACROPHAGE; GAMMA; CLEARANCE; DIAGNOSIS; MODEL	Pulmonary nocardiosis is a granulomatous disease with high mortality that affects both immunosuppressed and immunocompetent patients. The mechanisms leading to the establishment and progression of the infection are currently unknown. An animal model to study these mechanisms is sorely needed. We report the first in vivo model of granulomatous pulmonary nocardiosis that closely resembles human pathology. BALB/c mice infected intranasally with two different doses of GFP-expressing Nocardia brasiliensis ATCC700358 (NbGFP), develop weight loss and pulmonary granulomas. Mice infected with 10(9) CFUs progressed towards death within a week while mice infected with 10(8) CFUs died after five to six months. Histological examination of the lungs revealed that both the higher and lower doses of NbGFP induced granulomas with NbGFP clearly identifiable at the center of the lesions. Mice exposed to 10(8) CFUs and subsequently to 10(9) CFUs were not protected against disease severity but had less granulomas suggesting some degree of protection. Attempts to identify a cellular target for the infection were unsuccessful but we found that bacterial microcolonies in the suspension used to infect mice were responsible for the establishment of the disease. Small microcolonies of NbGFP, incompatible with nocardial doubling times starting from unicellular organisms, were identified in the lung as early as six hours after infection. Mice infected with highly purified unicellular preparations of NbGFP did not develop granulomas despite showing weight loss. Finally, intranasal delivery of nocardial microcolonies was enough for mice to develop granulomas with minimal weight loss. Taken together these results show that Nocardia brasiliensis microcolonies are both necessary and sufficient for the development of granulomatous pulmonary nocardiosis in mice.	[Mifuji Lira, Roque M.; Limon Flores, Alberto Yairh; Salinas Carmona, Mario Cesar; Ortiz Stern, Alejandro] Univ Autonoma Nuevo Leon, Fac Med, Dept Inmunol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Stern, AO (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Inmunol, Monterrey, Nuevo Leon, Mexico.	alejandro.ortizst@uanl.edu.mx	Salinas-Carmona, Mario C/Y-2456-2019; Ortiz-Stern, Alejandro/C-3048-2013	Salinas-Carmona, Mario C/0000-0002-4239-7363; Ortiz-Stern, Alejandro/0000-0002-4468-4817; Limon-Flores, Alberto Yairh/0000-0003-4718-4356				Baracco Gio J., 2001, Curr Infect Dis Rep, V3, P286, DOI 10.1007/s11908-001-0032-5; BEAMAN BL, 1978, INFECT IMMUN, V22, P867, DOI 10.1128/IAI.22.3.867-877.1978; BEAMAN BL, 1977, INFECT IMMUN, V15, P925, DOI 10.1128/IAI.15.3.925-937.1977; Brown-Elliott B. A., 2015, Clinical Microbiology Newsletter, V37, P25, DOI 10.1016/j.clinmicnews.2015.01.; BYRON PR, 1986, J PHARM SCI-US, V75, P433, DOI 10.1002/jps.2600750502; Cakir E, 2013, PEDIATR PULM, V48, P1144, DOI 10.1002/ppul.22740; Dominguez DC, 1999, J NATL MED ASSOC, V91, P35; Ellis TN, 2002, J LEUKOCYTE BIOL, V72, P373; Gama JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002503; Hui CH, 2003, RESP MED, V97, P709, DOI 10.1053/rmed.2003.1505; Trevino-Villarreal JH, 2012, INFECT IMMUN, V80, P3587, DOI 10.1128/IAI.00446-12; Martinez R, 2008, CURR OPIN PULM MED, V14, P219, DOI 10.1097/MCP.0b013e3282f85dd3; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Menendez R, 1997, EUR RESPIR J, V10, P1542, DOI 10.1183/09031936.97.10071542; Mihai MM, 2015, CURR TOP MED CHEM; MISHRA SK, 1973, INFECT IMMUN, V7, P123, DOI 10.1128/IAI.7.2.123-129.1973; Moore TA, 2000, J IMMUNOL, V164, P908, DOI 10.4049/jimmunol.164.2.908; Munoz-Hernandez B, 2009, MYCOPATHOLOGIA, V168, P37, DOI 10.1007/s11046-009-9189-5; Negi Amita, 2013, J Oral Maxillofac Pathol, V17, P363, DOI 10.4103/0973-029X.125199; Salinas-Carmona MC, 2011, PLASMID, V65, P25, DOI 10.1016/j.plasmid.2010.09.005; Salinas-Carmona MC, 1999, INFECT IMMUN, V67, P2428, DOI 10.1128/IAI.67.5.2428-2432.1999; SILVA CL, 1992, INFECT IMMUN, V60, P3566, DOI 10.1128/IAI.60.9.3566-3570.1992; Tam S, 2001, INFECT IMMUN, V69, P6165, DOI 10.1128/IAI.69.10.6165-6171.2001; Tam S, 2012, MICROBES INFECT, V14, P1133, DOI 10.1016/j.micinf.2012.05.008; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Zehra Y, 2014, CASE REPORTS PULMONO, DOI [10.1155/2014/963482, DOI 10.1155/2014/963482]	27	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157475	10.1371/journal.pone.0157475	http://dx.doi.org/10.1371/journal.pone.0157475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303806	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000377824800063
J	Painting, CJ; Splinter, W; Callander, S; Maricic, T; Peso, M; Backwell, PRY				Painting, Christina J.; Splinter, William; Callander, Sophia; Maricic, Tim; Peso, Marianne; Backwell, Patricia R. Y.			Ladies First: Coerced Mating in a Fiddler Crab	PLOS ONE			English	Article							FEMALE RESISTANCE BEHAVIOR; MATE CHOICE; FORCED COPULATION; UCA; COURTSHIP; DECAPODA; CONSTRAINTS; PREFERENCE; BURROWS; SYSTEM	In some species males increase their reproductive success by forcing females to copulate with them, usually by grasping the female or pinning her to the ground to prevent her from escaping. Here we report an example of males coercing copulation by trapping a female in a confined space. During mate-searching, female Uca mjoebergi fiddler crabs visit males and choose whether or not to enter their burrow for inspection. Males typically enter the burrow first and we found that 71% of females will follow him down and 54% decide to stay and mate. However, some males use an alternative tactic where he will wait for the female to enter the burrow first, after which he traps her inside. Although a significantly lower percentage of females will enter a burrow following this behaviour (41%), upon entry 79% females that enter will become trapped and almost all of these females (90%) produce a clutch of eggs. Our observations suggest that males are able to gain fertilisations from females that may not have remained in the burrow by trapping them and coercing them to mate.	[Painting, Christina J.; Splinter, William; Callander, Sophia; Maricic, Tim; Peso, Marianne; Backwell, Patricia R. Y.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Painting, Christina J.] Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1, New Zealand; [Peso, Marianne] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Australian National University; University of Auckland; Macquarie University	Painting, CJ (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.; Painting, CJ (corresponding author), Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1, New Zealand.	chrissiepainting@gmail.com	Backwell, Patricia RY/C-8883-2009	Painting, Christina/0000-0003-0701-2648	Australian Research Council [DP 120101427]	Australian Research Council(Australian Research Council)	This study was supported by an Australian Research Council Discovery Grant (DP 120101427) to PRYB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 1996, ANIM BEHAV, V52, P737, DOI 10.1006/anbe.1996.0218; Andersson Malte, 1994; [Anonymous], 2014, R LANG ENV STAT COMP; ARNQVIST G, 1992, ANIM BEHAV, V43, P559, DOI 10.1016/S0003-3472(05)81016-4; Backwell PRY, 1996, BEHAV ECOL SOCIOBIOL, V38, P407, DOI 10.1007/s002650050258; Bates D, 2012, R PACKAGE VERSION 09; Beinlich B., 2006, Zoologische Mededelingen (Leiden), V80, P9; Bisazza A, 2001, BEHAV ECOL, V12, P59, DOI 10.1093/oxfordjournals.beheco.a000379; Callander S, 2011, BEHAV ECOL SOCIOBIOL, V65, P2071, DOI 10.1007/s00265-011-1216-0; Castro I, 1996, IBIS, V138, P765, DOI 10.1111/j.1474-919X.1996.tb08834.x; Chang ES, 2005, NATURAL HIST CRUSTAC, V4; CHRISTY JH, 1983, BEHAV ECOL SOCIOBIOL, V12, P169, DOI 10.1007/BF00343209; CHRISTY JH, 1987, B MAR SCI, V41, P177; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Conroy LP, 2014, BEHAV ECOL SOCIOBIOL, V68, P1431, DOI 10.1007/s00265-014-1750-7; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Curran E, 2008, FEMALE MATE CHOICE F; Derivera CE, 2005, ANIM BEHAV, V70, P289, DOI 10.1016/j.anbehav.2004.10.027; Detto T, 2009, ANIM BEHAV, V78, P407, DOI 10.1016/j.anbehav.2009.05.014; Dukas R, 2012, ANIM BEHAV, V84, P1177, DOI 10.1016/j.anbehav.2012.08.021; Eberhard WG, 2002, REV BIOL TROP, V50, P485; Gowaty PA, 1998, AM ZOOL, V38, P207; HENMI Y, 1993, J CRUSTACEAN BIOL, V13, P736, DOI 10.2307/1549104; How MJ, 2008, J COMP PHYSIOL A, V194, P1053, DOI 10.1007/s00359-008-0376-5; Kasatani A, 2012, J ETHOL, V30, P69, DOI 10.1007/s10164-011-0296-7; McKinney Frank, 1998, Ornithological Monographs, V49, P163; MITANI JC, 1985, ANIM BEHAV, V33, P392, DOI 10.1016/S0003-3472(85)80063-4; Morrell LJ, 2005, ANIM BEHAV, V70, P653, DOI 10.1016/j.anbehav.2004.11.014; MURAI M, 1995, J CRUSTACEAN BIOL, V15, P655, DOI 10.2307/1548814; Murai M, 1996, J CRUSTACEAN BIOL, V16, P522, DOI 10.2307/1548742; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakasone Y, 1998, J CRUSTACEAN BIOL, V18, P70, DOI 10.2307/1549522; OLSSON M, 1995, HERPETOLOGICA, V51, P19; Reaney LT, 2008, CURR BIOL, V18, pR62, DOI 10.1016/j.cub.2007.11.047; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Reaney LT, 2012, BEHAV ECOL SOCIOBIOL, V66, P1017, DOI 10.1007/s00265-012-1349-9; Reaney LT, 2009, ANIM BEHAV, V77, P139, DOI 10.1016/j.anbehav.2008.09.019; SAKALUK SK, 1995, P ROY SOC B-BIOL SCI, V261, P65, DOI 10.1098/rspb.1995.0118; SALMON M, 1984, Transactions of the Zoological Society of London, V37, P1; Seeley C, 2011, ANIM BEHAV, V81, P595, DOI 10.1016/j.anbehav.2010.12.003; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; VONHAGEN HO, 1993, ETHOLOGY, V93, P3; WADA K, 1984, J ETHOL, V2, P7, DOI DOI 10.1007/BF02348201; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; ZUCKER N, 1983, MAR BEHAV PHYSIOL, V10, P57, DOI 10.1080/10236248309378606	45	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155707	10.1371/journal.pone.0155707	http://dx.doi.org/10.1371/journal.pone.0155707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303816	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800008
J	Meng, JA; Saberi, K; Hsieh, IH				Meng, Jhao-An; Saberi, Kourosh; Hsieh, I-Hui			Velocity Selective Networks in Human Cortex Reveal Two Functionally Distinct Auditory Motion Systems	PLOS ONE			English	Article							AUDIBLE MOVEMENT ANGLE; SPATIAL SEPARATION; SIGNAL FREQUENCY; HORIZONTAL PLANE; APPARENT MOTION; PARIETAL CORTEX; VISUAL-SYSTEM; EYE-MOVEMENTS; SOUND SOURCE; NO EVIDENCE	The auditory system encounters motion cues through an acoustic object's movement or rotation of the listener's head in a stationary sound field, generating a wide range of naturally occurring velocities from a few to several hundred degrees per second. The angular velocity of moving acoustic objects relative to a listener is typically slow and does not exceed tens of degrees per second, whereas head rotations in a stationary acoustic field may generate fast-changing spatial cues in the order of several hundred degrees per second. We hypothesized that these two types of systems (i.e., encoding slow movements of an object or fast head rotations) may engage functionally distinct substrates in processing spatially dynamic auditory cues, with the latter potentially involved in maintaining perceptual constancy in a stationary field during head rotations and therefore possibly involving corollary-discharge mechanisms in premotor cortex. Using fMRI, we examined cortical response patterns to sound sources moving at a wide range of velocities in 3D virtual auditory space. We found a significant categorical difference between fast and slow moving sounds, with stronger activations in response to higher velocities in the posterior superior temporal regions, the planum temporale, and notably the premotor ventral-rostral (PMVr) area implicated in planning neck and head motor functions.	[Meng, Jhao-An; Hsieh, I-Hui] Natl Cent Univ, Inst Cognit Neurosci, Jhongli 32001, Taiwan; [Saberi, Kourosh] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92697 USA	National Central University; University of California System; University of California Irvine	Saberi, K (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92697 USA.	saberi@uci.edu	Saberi, Kourosh/GXG-0944-2022	Hsieh, I-Hui/0000-0003-4001-4274	National Institutes of Health [R01 DC03681, R01 DC009659]; National Science Foundation [BCS-1329255]; National Science Council, Taiwan [NSC 98-2410-H-008-081]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health R01 DC03681 (KS); National Science Foundation BCS-1329255 (KS); National Institutes of Health R01 DC009659 (KS); and National Science Council, Taiwan NSC 98-2410-H-008-081 (IH).	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ANDERSON DC, 1964, AM J PSYCHOL, V77, P502, DOI 10.2307/1421029; Barton B, 2012, P NATL ACAD SCI USA, V109, P20738, DOI 10.1073/pnas.1213381109; BERNARDIN AC, 1957, AM J PSYCHOL, V70, P133, DOI 10.2307/1419249; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Burtt HE, 1917, J EXP PSYCHOL, V2, P63, DOI 10.1037/h0070778; DAVIDSON ML, 1973, PERCEPT PSYCHOPHYS, V14, P110, DOI 10.3758/BF03198624; DeValois RL, 1988, SPATIAL VISION; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Flight MH, 2013, NAT REV NEUROSCI, V14, P669, DOI 10.1038/nrn3590; Gibson JJ, 1950, PERCEPTION VISUAL WO; GRANTHAM DW, 1986, J ACOUST SOC AM, V79, P1939, DOI 10.1121/1.393201; GRANTHAM DW, 1984, J ACOUST SOC AM, V76, P71, DOI 10.1121/1.391009; Grantham DW, 1989, C P NATL ACAD SCI US, P35; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 2008, INTELLIGENT MOVEMENT; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; IRWIN DE, 1983, PERCEPT PSYCHOPHYS, V34, P49, DOI 10.3758/BF03205895; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; MOISEFF A, 1992, J NEUROPHYSIOL, V67, P1428, DOI 10.1152/jn.1992.67.6.1428; Nelson A, 2013, J NEUROSCI, V33, P14342, DOI 10.1523/JNEUROSCI.2275-13.2013; Ocklenburg S, 2010, BRAIN COGNITION, V72, P210, DOI 10.1016/j.bandc.2009.08.013; Pavani F, 2005, CORTEX, V41, P181, DOI 10.1016/S0010-9452(08)70892-X; PERROTT D R, 1981, Journal of Auditory Research, V21, P287; PERROTT DR, 1977, J ACOUST SOC AM, V62, P1463, DOI 10.1121/1.381675; PERROTT DR, 1990, PERCEPT PSYCHOPHYS, V48, P214, DOI 10.3758/BF03211521; PERROTT DR, 1989, J ACOUST SOC AM, V85, P1773, DOI 10.1121/1.397968; PERROTT DR, 1969, PSYCHON SCI, V17, P207; PERROTT DR, 1988, J ACOUST SOC AM, V83, P1522, DOI 10.1121/1.395908; PERROTT DR, 1990, J ACOUST SOC AM, V87, P1728, DOI 10.1121/1.399421; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Reichardt W, 1961, SENS COMMUN, P303; RUSSELL G, 1974, J EXP PSYCHOL, V103, P173, DOI 10.1037/h0036797; Saberi K, 2002, HEARING RES, V174, P149, DOI 10.1016/S0378-5955(02)00652-4; SABERI K, 1990, J ACOUST SOC AM, V88, P2639, DOI 10.1121/1.399984; Saberi K., 1997, BINAURAL SPATIAL HEA, P315; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; SHAW EAG, 1974, J ACOUST SOC AM, V56, P1848, DOI 10.1121/1.1903522; Smith KR, 2007, BRAIN RES, V1150, P94, DOI 10.1016/j.brainres.2007.03.003; Smith KR, 2010, J COGNITIVE NEUROSCI, V22, P632, DOI 10.1162/jocn.2009.21196; Smith KR, 2004, NEUROREPORT, V15, P1523, DOI 10.1097/01.wnr.0000130233.43788.4b; SPITZER MW, 1991, SCIENCE, V254, P721, DOI 10.1126/science.1948053; STRYBEL TZ, 1990, PERCEPT PSYCHOPHYS, V47, P439, DOI 10.3758/BF03208177; Strybel TZ, 1998, PERCEPT PSYCHOPHYS, V60, P1441, DOI 10.3758/BF03208004; Warren JE, 2005, TRENDS NEUROSCI, V28, P636, DOI 10.1016/j.tins.2005.09.010; WAUGH W, 1979, Journal of Auditory Research, V19, P103; WESTHEIMER G, 1977, VISION RES, V17, P941, DOI 10.1016/0042-6989(77)90069-4; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wolbers T, 2011, NEUROIMAGE, V56, P681, DOI 10.1016/j.neuroimage.2010.04.266; Zwicker E, 1952, ACUSTICA          S3, V2, P125	56	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157131	10.1371/journal.pone.0157131	http://dx.doi.org/10.1371/journal.pone.0157131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294673	Green Published, Green Submitted, gold			2022-12-26	WOS:000377821300023
J	Zuo, W; Sun, W; Zhao, DY; Gao, FQ; Su, YM; Li, ZR				Zuo, Wei; Sun, Wei; Zhao, Dingyan; Gao, Fuqiang; Su, Yangming; Li, Zirong			Investigating Clinical Failure of Bone Grafting through a Window at the Femoral Head Neck Junction Surgery for the Treatment of Osteonecrosis of the Femoral Head	PLOS ONE			English	Article							TERM-FOLLOW-UP; CORE DECOMPRESSION; AVASCULAR NECROSIS; SURVIVORSHIP ANALYSIS	Aims This study aimed to analyze the clinical factors related to the failure of bone grafting through a window at the femoral head-neck junction. Methods In total, 119 patients (158 hips) underwent bone grafting for treatment of avascular necrosis of the femoral head. The patients were classified by their ARCO staging and CJFH classification. All patients were clinically and radiographically followed up every three months during the first year and every six months in the following year. The clinical follow-up comprised determination of pre- and postoperative Harris hip scores, while serial AP, frog lateral radiographs, and CT scan were used for the radiographic follow-up. Results The clinical failure of bone grafting was observed in 40 patients. The clinical failure rates in patients belonging to ARCO stage II period, IIIa, and III (b + c) were 25.9%, 16.2%, and 61.5%, respectively, while those in patients belonging to (C + M + L1) type and L2, L3 type disease groups were 1.7%, 38.9%, and 39%, respectively. The clinical failure rates in patients aged below 40 and those aged 40 and over were 20.5% and 39.0%, respectively (all P < 0.05). Conclusion Disease type, disease stage, and patient age are risk factors for failure of bone graft surgery. Patients belonging to ARCO stage II and IIIa showed a good overall response rate, while patients belonging to ARCO stage IIIb and IIIc and those with necrotic lesions involving the lateral pillar (L2 and L3 type) showed high surgical failure rates.	[Zuo, Wei] Peking Univ, Hlth Sci Ctr, China Japan Friendship Med Sch, Dept Orthopaed Surg, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Sun, Wei; Zhao, Dingyan; Gao, Fuqiang; Li, Zirong] China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, 2 Yingdong Rd, Beijing 100029, Peoples R China; [Su, Yangming] Beijing Univ Chinese Med, 2 Yingdong Rd, Beijing 100029, Peoples R China	Peking University; China-Japan Friendship Hospital; Beijing University of Chinese Medicine	Sun, W (corresponding author), China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, 2 Yingdong Rd, Beijing 100029, Peoples R China.	sun887@163.com			National Natural Science Foundation of China [81372013]; China-Japan Friendship Hospital Youth Science and Technology Excellence Project [2014-QNYC-A-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-Japan Friendship Hospital Youth Science and Technology Excellence Project	This study was supported by the National Natural Science Foundation of China (81372013), and China-Japan Friendship Hospital Youth Science and Technology Excellence Project (2014-QNYC-A-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozic KJ, 1999, J BONE JOINT SURG AM, V81A, P200, DOI 10.2106/00004623-199902000-00007; Chang Y, 2009, SURG INNOV, V16, P63, DOI 10.1177/1553350608330398; Chen CC, 2009, J BONE JOINT SURG AM, V91A, P2390, DOI 10.2106/JBJS.H.01814; Classen T, 2015, J TISSUE ENG REGEN M; Israelite C, 2005, CLIN ORTHOP RELAT R, P285, DOI 10.1097/01.blo.0000192365.58958.84; Kawate K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-78; Landgraeber S, 2015, ARCH ORTHOP TRAUM SU, V135, P1357, DOI 10.1007/s00402-015-2287-6; Lieberman JR, 2012, CLIN ORTHOP RELAT R, V470, P525, DOI 10.1007/s11999-011-2050-4; Marker DR, 2008, CLIN ORTHOP RELAT R, V466, P1093, DOI 10.1007/s11999-008-0184-9; Mont MA, 1998, J BONE JOINT SURG BR, V80B, P56, DOI 10.1302/0301-620X.80B1.7989; Mont MA, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000096826.67494.38; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Mont MA, 2004, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000150128.57777.8e; Mont MA, 2010, J BONE JOINT SURG AM, V92A, P2165, DOI 10.2106/JBJS.I.00575; ROSENWASSER MP, 1994, CLIN ORTHOP RELAT R, P17; Simank HG, 1999, INT ORTHOP, V23, P154, DOI 10.1007/s002640050335; Wang BL, 2010, INT ORTHOP, V34, P635, DOI 10.1007/s00264-009-0822-1; Yoo MC, 2008, CLIN ORTHOP RELAT R, V466, P1133, DOI 10.1007/s11999-008-0204-9; Yoon TR, 2001, INT ORTHOP, V24, P316, DOI 10.1007/s002640000186	19	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156903	10.1371/journal.pone.0156903	http://dx.doi.org/10.1371/journal.pone.0156903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285821	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000031
J	Carver, LM; Perlaky, P; Cressler, A; Zigler, KS				Carver, Linnea M.; Perlaky, Patricia; Cressler, Alan; Zigler, Kirk S.			Reproductive Seasonality in Nesticus (Araneae: Nesticidae) Cave Spiders	PLOS ONE			English	Article							LIFE-HISTORY; META-MENARDI; TETRAGNATHIDAE; CRAYFISH; ECOLOGY; FAUNA	Spiders of the family Nesticidae are members of cave communities around the world with cave-obligate (troglobiotic) species known from North America, Europe, Asia and the Indo-Pacific. A radiation of Nesticus (Araneae: Nesticidae) in the southern Appalachians includes ten troglobiotic species. Many of these species are of conservation interest due to their small ranges, with four species being single-cave endemics. Despite conservation concerns and their important role as predators in cave communities, we know little about reproduction and feeding in this group. We addressed this knowledge gap by examining populations of two species on a monthly basis for one year. We made further observations on several other species and populations, totaling 671 individual spider observations. This more than doubled the reported observations of reproduction and feeding in troglobiotic Nesticus. Female Nesticus carry egg sacs, facilitating the determination of the timing and frequency of reproduction. We found that Nesticus exhibit reproductive seasonality. Females carried egg sacs from May through October, with a peak in frequency in June. These spiders were rarely observed with prey; only 3.3% (22/671) of individuals were observed with prey items. The frequency at which prey items were observed did not vary by season. Common prey items were flies, beetles and millipedes. Troglobiotic species constituted approximately half of all prey items observed. This result represents a greater proportion of troglobiotic prey than has been reported for various troglophilic spiders. Although our findings shed light on the life history of troglobiotic Nesticus and on their role in cave ecosystems, further work is necessary to support effective conservation planning for many of these rare species.	[Carver, Linnea M.; Zigler, Kirk S.] Sewanee Univ South, Dept Biol, Sewanee, TN 37375 USA; [Perlaky, Patricia] Raccoon Mt Caverns, Chattanooga, TN USA	Sewanee: University of the South	Zigler, KS (corresponding author), Sewanee Univ South, Dept Biol, Sewanee, TN 37375 USA.	kzigler@sewanee.edu	Zigler, Kirk S./GZM-2049-2022		Cave Conservancy Foundation; Sewanee: The University of the South; Raccoon Mountain Caverns	Cave Conservancy Foundation; Sewanee: The University of the South; Raccoon Mountain Caverns	LMC received a Fellowship in Karst Studies from the Cave Conservancy Foundation (http://www.caveconservancyfoundation.org/). The Cave Conservancy Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KSZ received research support from Sewanee: The University of the South (http://www.sewanee.edu/). The University of the South had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Raccoon Mountain Caverns provided support in the form of salary for one author [PP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR T C JR, 1971, Annales de Speleologie, V26, P47; BARR TC, 1967, AM NAT, V101, P475, DOI 10.1086/282512; Benjamin SP., REV SUISSE ZOOLOGIE, V111, P303; Buhlmann Kurt A., 2001, Journal of Cave and Karst Studies, V63, P91; Cokendolpher James, 2001, Texas Memorial Museum Speleological Monograph, V5, P25; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; GERTSCH WJ, 1984, TEX MEM MUS B, V31, P1; Harvey MS, 2011, INVERTEBR SYST, V25, P1, DOI 10.1071/IS11011; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Hedin M, 2005, ZOOTAXA, P1; Hedin MC, 1997, EVOLUTION, V51, P1929, DOI 10.1111/j.1558-5646.1997.tb05115.x; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; IVES J. D., 1935, JOUR ELISHA MITCHELL SCI SOC, V51, P297; Ives JD, 1947, BREEDING HABITS CAVE, V63, P215; JEGLA TC, 1966, BIOL BULL, V130, P345, DOI 10.2307/1539741; JEGLA TC, 1970, COMP BIOCHEM PHYSIOL, V33, P347, DOI 10.1016/0010-406X(70)90355-5; Kane T.C., 1975, International J Speleol, V7, P45; Lopez-Pancorbo A, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.89.921; Mammola S, 2014, INT J SPELEOL, V43, P343, DOI 10.5038/1827-806X.43.3.11; Mays JD, 2002, THESIS; Nakamura H., 1973, B AKIYOSHI DAI MUSEU, V9, P29; Niemiller ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064177; Niemiller ML, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P169, DOI 10.1201/EBK1578086702-c7; Novak T, 2010, ACTA OECOL, V36, P522, DOI 10.1016/j.actao.2010.07.005; PECK SB, 1986, EVOLUTION, V40, P1021, DOI 10.1111/j.1558-5646.1986.tb00569.x; Reddell JR, 2012, ENCY CAVES, P787; Reeves Will, 1999, Insecta Mundi, V13, P93; Ribera C, 2014, ZOOKEYS, P87, DOI 10.3897/zookeys.419.5739; Slay Michael E., 2009, Speleobiology Notes, V1, P3; Smithers P, 2005, J ARACHNOL, V33, P243, DOI 10.1636/CT-05-2.1; Snowman CV, 2010, J ARACHNOL, V38, P49, DOI 10.1636/A09-057.1; Weary DJ, 20141156 US GEOL SUR, P1; Zhang YY, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-183; Zigler Kirk S., 2011, Speleobiology Notes, V3, P1	36	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156751	10.1371/journal.pone.0156751	http://dx.doi.org/10.1371/journal.pone.0156751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280416	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000044
J	Gayek, AS; Ohi, R				Gayek, A. Sophia; Ohi, Ryoma			CDK-1 Inhibition in G2 Stabilizes Kinetochore-Microtubules in the following Mitosis	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; SPINDLE ASSEMBLY CHECKPOINT; MITOTIC KINESIN EG5; REGULATED PROTEIN; CELLS; HURP; ACTIVATION; DYNAMICS; PHASE; PROGRESSION	Cell proliferation is driven by cyclical activation of cyclin-dependent kinases (CDKs), which produce distinct biochemical cell cycle phases. Mitosis (M phase) is orchestrated by CDK-1, complexed with mitotic cyclins. During M phase, chromosomes are segregated by a bipolar array of microtubules called the mitotic spindle. The essential bipolarity of the mitotic spindle is established by the kinesin-5 Eg5, but factors influencing the maintenance of spindle bipolarity are not fully understood. Here, we describe an unexpected link between inhibiting CDK-1 before mitosis and bipolar spindle maintenance. Spindles in human RPE-1 cells normally collapse to monopolar structures when Eg5 is inhibited at metaphase. However, we found that inhibition of CDK-1 in the G2 phase of the cell cycle improved the ability of RPE-1 cells to maintain spindle bipolarity without Eg5 activity in the mitosis immediately after release from CDK-1 inhibition. This improved bipolarity maintenance correlated with an increase in the stability of kinetochore-microtubules, the subset of microtubules that link chromosomes to the spindle. The improvement in bipolarity maintenance after CDK-1 inhibition in G2 required both the kinesin-12 Kif15 and increased stability of kinetochore-microtubules. Consistent with increased kinetochore-microtubule stability, we find that inhibition of CDK-1 in G2 impairs mitotic fidelity by increasing the incidence of lagging chromosomes in anaphase. These results suggest that inhibition of CDK-1 in G2 causes unpredicted effects in mitosis, even after CDK-1 inhibition is relieved.	[Gayek, A. Sophia; Ohi, Ryoma] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA	Vanderbilt University	Ohi, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA.	ryoma.ohi@vanderbilt.edu			National Institutes of Health [R01 GM086610]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health R01 GM086610 (https://www.nigms.nih.gov/Pages/default.aspx) to RO, and the Leukemia and Lymphoma Society (http://www.lls.org/) Scholar Career Development Award to RO.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; El-Nassan HB, 2013, EUR J MED CHEM, V62, P614, DOI 10.1016/j.ejmech.2013.01.031; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gayek AS, 2014, MOL BIOL CELL, V25, P2051, DOI 10.1091/mbc.E14-03-0785; Hardwick LJA, 2014, TRENDS GENET, V30, P254, DOI 10.1016/j.tig.2014.04.001; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Ly T, 2015, ELIFE, V4, DOI 10.7554/eLife.04534; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Peco E, 2012, DEVELOPMENT, V139, P1095, DOI 10.1242/dev.068569; Pines J, 2011, PHILOS T R SOC B, V366, P3625, DOI 10.1098/rstb.2011.0080; Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3; Sacristan C, 2015, TRENDS CELL BIOL, V25, P21, DOI 10.1016/j.tcb.2014.08.006; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; SHERWOOD SW, 1994, EXP CELL RES, V211, P275, DOI 10.1006/excr.1994.1087; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sturgill EG, 2013, CURR BIOL, V23, P1280, DOI 10.1016/j.cub.2013.05.043; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; van Heesbeen RGHP, 2014, CELL REP, V8, P948, DOI 10.1016/j.celrep.2014.07.015; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yasutis KM, 2013, CELL CYCLE, V12, P1501, DOI 10.4161/cc.24637; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	57	6	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157491	10.1371/journal.pone.0157491	http://dx.doi.org/10.1371/journal.pone.0157491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281342	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000122
J	Liu, YF; Ren, J; Wang, XR; Fan, ZQ				Liu, Yafeng; Ren, Jing; Wang, Xiangrong; Fan, Zhengqiu			Mechanism and Reaction Pathways for Microcystin-LR Degradation through UV/H2O2 Treatment	PLOS ONE			English	Article							ULTRASONICALLY INDUCED DEGRADATION; DRINKING-WATER; PHOTOCATALYTIC OXIDATION; HYDROXYL RADICALS; AQUEOUS-SOLUTION; UV; CYANOBACTERIA; PHOTODEGRADATION; DETOXIFICATION; DECOMPOSITION	Microcystin-LR (MCLR) is the most common cyanotoxin in contaminated aquatic systems. MCLR inhibits protein phosphatases 1 and 2A, leading to liver damage and tumor formation. MCLR is relatively stable owing to its cyclic structures. The combined UV/H2O2 technology can degrade MCLR efficiently. The second-order rate constant of the reaction between MCLR and hydroxyl radical (center dot OH) is 2.79(+/- 0.23)x10(10) M-1 s(-1) based on the competition kinetics model using nitrobenzene as reference compound. The probable degradation pathway was analyzed through liquid chromatography mass spectrometry. Results suggested that the major destruction pathways of MCLR were initiated by center dot OH attack on the benzene ring and diene of the Adda side chain. The corresponding aldehyde or ketone peptide residues were formed through further oxidation. Another minor destruction pathway involved center dot OH attack on the methoxy group of the Adda side chain, followed by complete removal of the methoxy group. The combined UV/H2O2 system is a promising technology for MCLR removal in contaminated aquatic systems.	[Liu, Yafeng; Ren, Jing; Wang, Xiangrong; Fan, Zhengqiu] Fudan Univ, Dept Environm Engn Sci, Shanghai 200433, Peoples R China	Fudan University	Fan, ZQ (corresponding author), Fudan Univ, Dept Environm Engn Sci, Shanghai 200433, Peoples R China.	zhqfan@fudan.edu.cn	Fan, zhengqiu/AAF-8705-2021		Key Laboratory Open Fund of Fishery Ecology Environment, Ministry of Agriculture, China	Key Laboratory Open Fund of Fishery Ecology Environment, Ministry of Agriculture, China	This work was supported by a grant from the Key Laboratory Open Fund of Fishery Ecology Environment, Ministry of Agriculture, China.	AN JS, 1994, TOXICON, V32, P1495, DOI 10.1016/0041-0101(94)90308-5; Antoniou MG, 2008, TOXICON, V51, P1103, DOI 10.1016/j.toxicon.2008.01.018; Antoniou MG, 2008, ENVIRON SCI TECHNOL, V42, P8877, DOI 10.1021/es801637z; Antoniou MG, 2005, J ENVIRON ENG, V131, P1239, DOI 10.1061/(ASCE)0733-9372(2005)131:9(1239); Bandala ER, 2004, TOXICON, V43, P829, DOI 10.1016/j.toxicon.2004.03.013; BARFORD D, 1994, J MOL BIOL, V235, P763, DOI 10.1006/jmbi.1994.1027; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; FALCONER IR, 1989, J AM WATER WORKS ASS, V81, P102; Feitz AJ, 2003, ENVIRON SCI TECHNOL, V37, P561, DOI 10.1021/es0256010; Gajdek P, 2001, TOXICON, V39, P1575, DOI 10.1016/S0041-0101(01)00139-8; Gao NY, 2009, J HAZARD MATER, V164, P640, DOI 10.1016/j.jhazmat.2008.08.038; Kaya K, 1998, CHEM RES TOXICOL, V11, P159, DOI 10.1021/tx970132e; Keijola AM, 1988, TOXICOL ASSESS, V81, P102; Lawton LA, 1999, ENVIRON SCI TECHNOL, V33, P771, DOI 10.1021/es9806682; Lee J, 2006, ENVIRON SCI TECHNOL, V40, P7336, DOI 10.1021/es060352r; Lei L, 2009, J ZHEJIANG UNIBERS A, V11, P1666; Linda IL, 2003, ENVIRON SCI TECHNOL, V37, P3214; Liu I, 2002, J PHOTOCH PHOTOBIO A, V148, P349, DOI 10.1016/S1010-6030(02)00062-X; McMurray J., 1995, ORGANIC CHEM, P1243; Onstad GD, 2007, ENVIRON SCI TECHNOL, V41, P4397, DOI 10.1021/es0625327; Qiao RP, 2005, TOXICON, V45, P745, DOI 10.1016/j.toxicon.2005.01.012; Rafael OR, 2010, TOXICON, V56, P1342, DOI [10.1016/j.toxicon.2010.07.020, DOI 10.1016/J.TOXICON.2010.07.020]; RINEHART KL, 1994, J APPL PHYCOL, V6, P159, DOI 10.1007/BF02186070; Rosenfeldt EJ, 2004, ENVIRON SCI TECHNOL, V38, P5476, DOI 10.1021/es035413p; Schwarzenbach RP, 1993, ENV ORGANIC CHEM, P134; Song W, 2006, ENVIRON SCI TECHNOL, V40, P3941, DOI 10.1021/es0521730; Song WH, 2009, ENVIRON SCI TECHNOL, V43, P1487, DOI 10.1021/es802282n; Song WH, 2005, ENVIRON SCI TECHNOL, V39, P6300, DOI 10.1021/es048350z; Tsuji K, 1995, TOXICON, V33, P1619, DOI 10.1016/0041-0101(95)00101-8; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; Vogna D, 2004, CHEMOSPHERE, V54, P497, DOI 10.1016/S0045-6535(03)00757-4; Wu CL, 2007, J AGR FOOD CHEM, V55, P4059, DOI 10.1021/jf0635762; Wu CL, 2008, WATER RES, V42, P4780, DOI 10.1016/j.watres.2008.08.023; YOSHIZAWA S, 1990, J CANCER RES CLIN, V116, P609, DOI 10.1007/BF01637082	35	7	8	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156236	10.1371/journal.pone.0156236	http://dx.doi.org/10.1371/journal.pone.0156236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281173	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000021
J	Tourino, LFPG; Correa-Faria, P; Ferreira, RC; Bendo, CB; Zarzar, PM; Vale, MP				Padua Goncalves Tourino, Luciana Fonseca; Correa-Faria, Patricia; Ferreira, Raquel Conceciao; Bendo, Cristiane Baccin; Zarzar, Patricia Maria; Vale, Miriam Pimenta			Association between Molar Incisor Hypomineralization in Schoolchildren and Both Prenatal and Postnatal Factors: A Population-Based Study	PLOS ONE			English	Article							ETIOLOGIC FACTORS; DEMARCATED OPACITIES; ENAMEL DEFECTS; PREVALENCE; CHILDREN	Background Although studies throughout the world have investigated potential factors involved in the occurrence of molar incisor hypomineralization (MIH), the findings are varied and inconclusive. Objective The aim of the present study was to evaluate the prevalence of MIH and identify associated prenatal, perinatal and postnatal factors among Brazilian schoolchildren aged 8 and 9 years. Methods A cross-sectional study was conducted with a randomly selected population-based sample of 1181 schoolchildren. Information on demographic and socioeconomic characteristics as well as prenatal, perinatal and postnatal aspects was obtained through questionnaires. The clinical examination included the investigation of MIH based on the criteria of the European Academy of Paediatric Dentistry. Dental caries in the permanent dentition and developmental defects of enamel (DDE) on the primary second molars were also recorded. Data analysis involved descriptive statistics, bivariate tests and Poisson regression with robust variance. Results The prevalence of MIH was 20.4%. MIH was more frequent among children with dental caries in the permanent dentition (PR: 2.67; 95% CI: 1.98-3.61), those with DDE on the primary second molars (PR: 2.54; 95% CI: 1.87-3.45) and those who experienced asthma/bronchitis in the first four years of life (PR: 1.93; 95% CI: 1.45-2.56). Conclusions The prevalence of MIH was high and was associated with dental caries, the presence of DDE on primary second molars and the experience of asthma/bronchitis in early life. These findings could be useful in the identification of children in need of shorter recall intervals to prevent the consequences of MIH, such as enamel breakdown dental caries.	[Padua Goncalves Tourino, Luciana Fonseca] Ctr Univ Lavras, Dept Pediat Dent, Lavras, MG, Brazil; [Correa-Faria, Patricia; Bendo, Cristiane Baccin; Zarzar, Patricia Maria; Vale, Miriam Pimenta] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Ferreira, Raquel Conceciao] Univ Fed Minas Gerais, Sch Dent, Dept Publ Oral Hlth, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Tourino, LFPG (corresponding author), Ctr Univ Lavras, Dept Pediat Dent, Lavras, MG, Brazil.	lucianapaduatourino@yahoo.com	de Faria, Patricia Corrêa/N-9428-2013; Bendo, Cristiane Baccin/H-5835-2012; de Araújo Zarzar, Patricia Maria Pereira/H-9534-2012; de araujo zarzar, patricia maria pereira/F-4237-2018; Ferreira, Raquel Conceição/J-5236-2015	de Faria, Patricia Corrêa/0000-0002-0528-1425; Bendo, Cristiane Baccin/0000-0003-4849-8779; de Araújo Zarzar, Patricia Maria Pereira/0000-0002-6952-5767; Ferreira, Raquel Conceição/0000-0001-8897-9345; Tourino, Luciana/0000-0002-3640-036X				Alaluusua S, 2010, EUR ARCH PAEDIATR DE, V11, P53, DOI 10.1007/BF03262713; [Anonymous], 1992, Int Dent J, V42, P411; Arrow P, 2009, COMMUNITY DENT ORAL, V37, P405, DOI 10.1111/j.1600-0528.2009.00480.x; Beentjes V E, 2002, Eur J Paediatr Dent, V3, P9; Brogardh-Roth S, 2011, EUR J ORAL SCI, V119, P33, DOI 10.1111/j.1600-0722.2011.00792.x; Casanova-Rosado AJ, 2011, EUR J PAEDIATR DENT, V12, P155; Cho SY, 2008, INT J PAEDIATR DENT, V18, P348, DOI 10.1111/j.1365-263X.2008.00927.x; Crombie F, 2009, INT J PAEDIATR DENT, V19, P73, DOI 10.1111/j.1365-263X.2008.00966.x; da Costa-Silva CM, 2010, INT J PAEDIATR DENT, V20, P426, DOI 10.1111/j.1365-263X.2010.01097.x; Fagrell TG, 2008, INT J PAEDIATR DENT, V18, P333, DOI 10.1111/j.1365-263X.2007.00908.x; Garcia-Margarit M, 2014, INT J PAEDIATR DENT, V24, P14, DOI 10.1111/ipd.12020; Ghanim A, 2013, INT J PAEDIATR DENT, V23, P197, DOI 10.1111/j.1365-263X.2012.01244.x; Ghanim A, 2013, INT J PAEDIATR DENT, V23, P48, DOI 10.1111/j.1365-263X.2012.01223.x; Guergolette RP, 2009, J BRAS PNEUMOL, V35, P295, DOI 10.1590/S1806-37132009000400002; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Harju M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1357-6; Jalevik B, 2010, EUR ARCH PAEDIATR DE, V11, P59; Jalevik B, 2001, EUR J ORAL SCI, V109, P230, DOI 10.1034/j.1600-0722.2001.00047.x; Jeremias F, 2013, ACTA ODONTOL SCAND, V71, P870, DOI 10.3109/00016357.2012.734412; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Petrou MA, 2014, INT J PAEDIATR DENT, V24, P434, DOI 10.1111/ipd.12089; Pitiphat W, 2014, EUR J ORAL SCI, V122, P265, DOI 10.1111/eos.12136; Souza JF, 2012, EUR ARCH PAEDIATR DE, V13, P164, DOI 10.1007/BF03262865; Soviero V, 2009, ACTA ODONTOL SCAND, V67, P170, DOI 10.1080/00016350902758607; Suga S, 1989, Adv Dent Res, V3, P188; Tung K, 2006, ARCH ORAL BIOL, V51, P464, DOI 10.1016/j.archoralbio.2005.12.001; VANAMERONGEN WE, 1995, J DENT CHILD, V62, P266; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Weerheijm K L, 2004, Dent Update, V31, P9; Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P110; Weerheijm K L, 2003, Int J Paediatr Dent, V13, P411, DOI 10.1046/j.1365-263X.2003.00498.x; Whatling R, 2008, INT J PAEDIATR DENT, V18, P155, DOI 10.1111/j.1365-263X.2007.00901.x; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	33	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156332	10.1371/journal.pone.0156332	http://dx.doi.org/10.1371/journal.pone.0156332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280451	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000025
J	Rosso, MC; Badino, P; Ferrero, G; Costa, R; Cordero, F; Steidler, S				Rosso, Marilena Caterina; Badino, Paola; Ferrero, Giulio; Costa, Roberto; Cordero, Francesca; Steidler, Stephanie			Biologic Data of Cynomolgus Monkeys Maintained under Laboratory Conditions	PLOS ONE			English	Article							MACAQUES MACACA-FASCICULARIS; CLINICAL-CHEMISTRY; NONHUMAN-PRIMATES; BASE-LINE; STRESS; HEMATOLOGY; PARAMETERS; VALUES; CORTISOL; BLOOD	The cynomolgus monkey (Macaca fascicularis) is a well-known non-human primate species commonly used in non-clinical research. It is important to know basal clinical pathology parameters in order to have a reference for evaluating any potential treatment-induced effects, maintaining health status among animals and, if needed, evaluating correct substantiative therapies. In this study, data from 238 untreated cynomolgus monkeys (119 males and 119 females of juvenile age, 2.5 to 3.5 years) kept under laboratory conditions were used to build up a reference database of clinical pathology parameters. Twenty-two hematology markers, 24 clinical chemistry markers and two blood coagulation parameters were analyzed. Gender-related differences were evaluated using statistical analyses. To assess the possible effects of stress induced by housing or handling involved in treatment procedures, 78 animals (35 males and 35 females out of 238 juvenile monkeys and four adult males and four adult females) were used to evaluate cortisol, corticosterone and behavioral assessment over time. Data were analyzed using a non-parametric statistical test and machine learning approaches. Reference clinical pathology data obtained from untreated animals may be extremely useful for investigators employing cynomolgus monkeys as a test system for non-clinical safety studies.	[Rosso, Marilena Caterina; Badino, Paola] Univ Turin, Dept Vet Sci, Grugliasco, TO, Italy; [Rosso, Marilena Caterina; Costa, Roberto; Steidler, Stephanie] RBM SpA Merck Serono, Ivrea, Italy; [Ferrero, Giulio; Cordero, Francesca] Univ Turin, Dept Comp Sci, Turin, Italy; [Ferrero, Giulio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Ferrero, Giulio; Cordero, Francesca] Univ Turin, Ctr Mol Syst Biol, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Cordero, F (corresponding author), Univ Turin, Dept Comp Sci, Turin, Italy.; Cordero, F (corresponding author), Univ Turin, Ctr Mol Syst Biol, Turin, Italy.	fcordero@di.unito.it	Cordero, Francesca/AAB-3655-2019; Badino, Paola/AAC-5779-2019; Ferrero, Giulio/K-9508-2019; Steidler, Stephanie/AAE-8099-2022; Steidler, Stephanie/AAC-6369-2022	Cordero, Francesca/0000-0002-3143-3330; Ferrero, Giulio/0000-0002-4580-0680; Steidler, Stephanie/0000-0002-4441-7962; BADINO, Paola/0000-0002-2716-8853	Merck KGaA-Merck Serono [489]	Merck KGaA-Merck Serono	This research was supported and granted by Merck KGaA-Merck 489 Serono. The funder provided support in the form of salaries for authors MCR, RC and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson KSP, 2005, IN VIVO, V19, P815; Andrade MCR, 2004, MEM I OSWALDO CRUZ, V99, P581, DOI 10.1590/S0074-02762004000600009; [Anonymous], 1990, Lab Anim, V24, P97; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Bailey Jarrod, 2005, Biogenic Amines, V19, P235, DOI 10.1163/156939105774647385; Bonfanti U, 2009, J MED PRIMATOL, V38, P228, DOI 10.1111/j.1600-0684.2009.00345.x; Bourges-Abella N, 2014, J MED PRIMATOL, V43, P1, DOI 10.1111/jmp.12077; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Field AE, 2015, J AM ASSOC LAB ANIM, V54, P59; Gauvin David V., 2008, Journal of Pharmacological and Toxicological Methods, V58, P88, DOI 10.1016/j.vascn.2008.05.002; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall Robert L., 2003, Toxicologic Pathology, V31, P6, DOI 10.1080/01926230309765; Herodin F, 2005, EUR CYTOKINE NETW, V16, P104; *I LAB AN RES, 2000, ILAR J, V41, P59; Joshi Girish P, 2005, Anesthesiol Clin North Am, V23, P21, DOI 10.1016/j.atc.2004.11.013; Kim CY, 2005, J MED PRIMATOL, V34, P188, DOI 10.1111/j.1600-0684.2005.00116.x; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee JI, 2013, J MED PRIMATOL, V42, P10, DOI 10.1111/jmp.12023; Liu YW, 2008, EXP ANIM TOKYO, V57, P139, DOI 10.1538/expanim.57.139; Malisch JL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P146, DOI 10.1086/508828; Maninger N, 2010, PSYCHONEUROENDOCRINO, V35, P1055, DOI 10.1016/j.psyneuen.2010.01.006; MATSUZAWA T, 1994, COMP HAEMATOL INT, V4, P43, DOI 10.1007/BF00368266; McCarthy C.R., 1999, ILAR J, V40, P1, DOI [10.1093/ilar.40.1.1, DOI 10.1093/ILAR.40.1.1]; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Ogawa LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-748; PERRETTA G, 1991, J MED PRIMATOL, V20, P345; Perry P, 2007, ILAR J, V48, P42, DOI 10.1093/ilar.48.1.42; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Ruys JD, 2004, PHYSIOL BEHAV, V82, P205, DOI 10.1016/j.physbeh.2004.02.031; Schuurman HJ, 2005, XENOTRANSPLANTATION, V12, P72, DOI 10.1111/j.1399-3089.2004.00186.x; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Stockman SL, 2002, FUNDAMENTALS VET CLI, P443; SUGIMOTO Y, 1986, EXP ANIM TOKYO, V35, P443, DOI 10.1538/expanim1978.35.4_443; Suzuki J, 2002, J MED PRIMATOL, V31, P340, DOI 10.1034/j.1600-0684.2002.01011.x; Wang H, 2012, VET MED-CZECH, V57, P233, DOI 10.17221/5953-VETMED; Weatherall D., 2006, USE NONHUMAN PRIMATE; Westlund K, 2012, LAB ANIM-UK, V46, P51, DOI 10.1258/la.2011.011040; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892; Zhou Q, 2014, TRENDS GENET, V30, P476, DOI 10.1016/j.tig.2014.09.005	39	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157003	10.1371/journal.pone.0157003	http://dx.doi.org/10.1371/journal.pone.0157003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280447	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000065
J	Armengot, L; Caldarella, E; Marques-Bueno, MM; Martinez, MC				Armengot, Laia; Caldarella, Eleonora; Mar Marques-Bueno, Maria; Carmen Martinez, M.			The Protein Kinase CK2 Mediates Cross-Talk between Auxin- and Salicylic Acid-Signaling Pathways in the Regulation of PINOID Transcription	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; TRANSPORT; POLARITY; NPR1; PHOSPHORYLATION; EXPRESSION; INSIGHTS; SURVIVAL; MOTIFS	The protein kinase CK2 is a ubiquitous and highly conserved enzyme, the activity of which is vital for eukaryotic cells. We recently demonstrated that CK2 modulates salicylic acid (SA) homeostasis in Arabidopsis thaliana, and that functional interplay between CK2 and SA sustains transcriptional expression of PIN-FORMED (PIN) genes. In this work, we show that CK2 also plays a key role in the transcriptional regulation of PINOID (PID), an AGC protein kinase that modulates the apical/basal localization of auxin-efflux transporters. We show that PID transcription is up-regulated by auxin and by SA and that CK2 is involved in both pathways. On the one hand, CK2 activity is required for proteosome-dependent degradation of AXR3, a member of the AUX/IAA family of auxin transcriptional repressors that must be degraded to activate auxin-responsive gene expression. On the other hand, the role of CK2 in SA homeostasis and, indirectly, in SA-driven PID transcription, was confirmed by using Arabidopsis NahG transgenic plants, which cannot accumulate SA. In conclusion, our results evidence a role for CK2 as a functional link in the negative cross-talk between auxin- and SA-signaling.	[Armengot, Laia; Caldarella, Eleonora; Mar Marques-Bueno, Maria; Carmen Martinez, M.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Barcelona, Spain; [Armengot, Laia] Univ Lyon, Lab Reprod & Dev Plantes, UCB Lyon 1, ENS Lyon,CNRS,INRA, F-69342 Lyon, France	Autonomous University of Barcelona; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Martinez, MC (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Barcelona, Spain.	carmen.martinez@uab.es	Marques-Bueno, Mar/Q-7111-2018; Armengot, Laia/AAI-7650-2021; Armengot, Laia/AAI-6684-2021	Armengot, Laia/0000-0002-3790-9838; Martinez, M. Carmen/0000-0002-7472-4349	Ministerio de Educacion, Cultura y Deporte; Fondos FEDER [BFU2010-15090, BFU2013-42695-P]; Ministerio de Economia y Competitividad; Departament d'Universitats, Recerca i Societat de la Informacio [2009SGR-795]	Ministerio de Educacion, Cultura y Deporte(Spanish Government); Fondos FEDER(European Commission); Ministerio de Economia y Competitividad(Spanish Government); Departament d'Universitats, Recerca i Societat de la Informacio	This work was supported by: Ministerio de Educacion, Cultura y Deporte (www.mecd.gob.es/) and Fondos FEDER, Grant nr: BFU2010-15090 (MCM); Ministerio de Economia y Competitividad (www.mineco.gob.es/) and fondos FEDER, Grant nr: BFU2013-42695-P (MCM); Departament d'Universitats, Recerca i Societat de la Informacio (www.gencat.es/dursi), Grant nr. 2009SGR-795 (MCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Armengot L, 2014, PLANT J, V78, P411, DOI 10.1111/tpj.12481; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Blakeslee JJ, 2004, PLANT PHYSIOL, V134, P28, DOI 10.1104/pp.103.031690; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Chen ZY, 2007, P NATL ACAD SCI USA, V104, P20131, DOI 10.1073/pnas.0704901104; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Davies P.J., 2004, PLANT HORMONES BIOSY; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; Espunya MC, 1999, PLANT J, V19, P655, DOI 10.1046/j.1365-313x.1999.00563.x; Feraru E, 2008, PLANT PHYSIOL, V147, P1553, DOI 10.1104/pp.108.121756; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; Hosek P, 2012, J EXP BOT, V63, P3815, DOI 10.1093/jxb/ers074; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Leyser O, 2005, CELL, V121, P819, DOI 10.1016/j.cell.2005.06.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marques-Bueno MM, 2011, PLANT J, V67, P169, DOI 10.1111/j.1365-313X.2011.04585.x; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Moreno-Romero J, 2012, PLANT J, V71, P627, DOI 10.1111/j.1365-313X.2012.05019.x; Moreno-Romero J, 2011, MOL CELL BIOCHEM, V356, P233, DOI 10.1007/s11010-011-0970-7; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SHUGAR D, 1994, CELL MOL BIOL RES, V40, P411; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; Stomp A-M., 1992, GUS PROTOCOLS GUS PR, DOI [10.1016/B978-0-12-274010-7.50013-6, DOI 10.1016/13978-0-12-274010-7.500133-6]; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Willemsen V, 2003, PLANT CELL, V15, P612, DOI 10.1105/tpc.008433; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; Zegzouti H, 2006, J BIOL CHEM, V281, P35520, DOI 10.1074/jbc.M605167200; Zhang J, 2010, P NATL ACAD SCI USA, V107, P918, DOI 10.1073/pnas.0909460107; Zheng ZY, 2013, NAT CHEM BIOL, V9, P244, DOI [10.1038/nchembio.1178, 10.1038/NCHEMBIO.1178]; Zourelidou M, 2014, ELIFE, V3, DOI 10.7554/eLife.02860	53	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157168	10.1371/journal.pone.0157168	http://dx.doi.org/10.1371/journal.pone.0157168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275924	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700078
J	Baba, W; Kalaji, HM; Kompala-Baba, A; Goltsev, V				Baba, Wojciech; Kalaji, Hazem M.; Kompala-Baba, Agnieszka; Goltsev, Vasilij			Acclimatization of Photosynthetic Apparatus of Tor Grass (Brachypodium pinnatum) during Expansion	PLOS ONE			English	Article							A FLUORESCENCE INDUCTION; TRITICUM-AESTIVUM L; CHLOROPHYLL-A; GENETIC DIVERSITY; PHOTOSYSTEM-II; CHALK GRASSLAND; IN-VIVO; ELECTRON-TRANSPORT; PSII CENTERS; LIGHT	The aim of this study was to understand the acclimatization mechanisms of photosynthetic apparatus in Brachypodium pinnatum (L.) P. Beauv grass during its expansion. Twelve populations differentiated by age: young (30-50 years old), intermediate age (ca. 100 y) and old (> 300 y) were studied. It was confirmed that the decrease of the number of genotypes as a result of environmental stress and competition were reflected in changes in chlorophyll fluorescence (ChlF) parameters. The old stands were dominated by a few genotypes which seem to be the best acclimatized to the self-shading/competition by lowering their photosynthetic performance during light-phase of photosynthesis. On the other hand, the 'high-speed' photosynthetic rate observed in the young populations can be seen as acclimatization to very adverse conditions. Our results clearly confirm that ChlF is a powerful method of inferring physiological mechanisms of the expansion of tor grass. The Principal Component and Redundancy Analyses, followed with k-means classification, allowed to find the differentiation of groups of distinct ChlF parameters and enabled us to relate them to changes in genotypic diversity of populations. We conclude that the plastic morphological and physiological response to changeable habitat light conditions with its optimum in half-shade refers to its forest-steppe origin.	[Baba, Wojciech] Jagiellonian Univ, Inst Bot, Dept Plant Ecol, Lubicz 46, PL-31512 Krakow, Poland; [Kalaji, Hazem M.] Warsaw Univ Life Sci SGGW, Dept Plant Physiol, Nowoursynowska 159, PL-02776 Warsaw, Poland; [Kompala-Baba, Agnieszka] Silesian Univ, Dept Bot & Nat Protect, Jagiellonska 28, PL-40032 Katowice, Poland; [Goltsev, Vasilij] St Kliment Ohridski Univ Sofia, Fac Biol, Dept Biophys & Radiobiol, 8 Dr Tzankov Blvd, Sofia 1164, Bulgaria	Jagiellonian University; Warsaw University of Life Sciences; University of Silesia in Katowice; Bulgarian Academy of Sciences; Medical University Sofia; University of Sofia	Baba, W (corresponding author), Jagiellonian Univ, Inst Bot, Dept Plant Ecol, Lubicz 46, PL-31512 Krakow, Poland.	wojciech.baba12@gmail.com	Kalaji, Mohamed Hazem/E-8086-2012; Goltsev, Vasilij N/H-7423-2012; Bąba, Wojciech/AFX-4233-2022	Kalaji, Mohamed Hazem/0000-0002-3833-4917; Goltsev, Vasilij N/0000-0003-4338-6671; Baba, Wojciech/0000-0001-7428-0429; Kompala-Baba, Agnieszka/0000-0002-4736-4704				Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Baba W, 2004, BIOLOGIA, V59, P447; Baba W, 2003, ACTA SOC BOT POL, V72, P61, DOI 10.5586/asbp.2003.008; Baba W, 2012, FLORA, V207, P346, DOI 10.1016/j.flora.2012.01.011; Baba W, 2012, POL J ECOL, V60, P31; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; BOBBINK R, 1987, BIOL CONSERV, V40, P301, DOI 10.1016/0006-3207(87)90122-4; Bobbink R, 1998, NEW PHYTOL, V139, P161, DOI 10.1046/j.1469-8137.1998.00175.x; BOBBINK R, 1991, BIOL CONSERV, V56, P1, DOI 10.1016/0006-3207(91)90085-N; Brestic M, 2012, PLANT PHYSIOL BIOCH, V57, P93, DOI 10.1016/j.plaphy.2012.05.012; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; DEKROON H, 1990, OIKOS, V59, P39, DOI 10.2307/3545120; Doorduin LJ, 2010, BASIC APPL ECOL, V11, P244, DOI 10.1016/j.baae.2009.12.007; Dujardin G, 2011, FLORA, V206, P1030, DOI 10.1016/j.flora.2011.05.012; Falbel TG, 1996, PLANT PHYSIOL, V112, P821, DOI 10.1104/pp.112.2.821; Falinska K, 2010, POL J ECOL, V58, P27; Farmer A.M., 1998, J PRACT ECOL CONSERV, V2, P9; Force L, 2003, PHOTOSYNTH RES, V78, P17, DOI 10.1023/A:1026012116709; Forsman A, 2014, P NATL ACAD SCI USA, V111, P302, DOI 10.1073/pnas.1317745111; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Fuzy A, 2014, J PLANT PHYSIOL, V171, P1, DOI 10.1016/j.jplph.2013.11.002; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Holderegger R, 2006, LANDSCAPE ECOL, V21, P797, DOI 10.1007/s10980-005-5245-9; Hurst A, 1999, BIOL CONSERV, V89, P261, DOI 10.1016/S0006-3207(99)00005-1; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Jacquemyn H, 2010, CONSERV GENET, V11, P1979, DOI 10.1007/s10592-010-0089-5; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; JOLIOT P, 2005, DISCOVERIES PHOTOSYN, P187; Kahlert BR, 2005, J VEG SCI, V16, P433, DOI 10.1111/j.1654-1103.2005.tb02383.x; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Kalaji HM, 2014, PLANT PHYSIOL BIOCH, V81, P16, DOI 10.1016/j.plaphy.2014.03.029; Kalaji HM, 2012, J PHOTOCH PHOTOBIO B, V112, P1, DOI 10.1016/j.jphotobiol.2012.03.009; Kalaji HM, 2014, EMERGING TECHNOLOGIE, P347, DOI DOI 10.1016/B978-0-12-800875-1.00015-6; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Khan MA, 1999, NORD J BOT, V19, P257, DOI 10.1111/j.1756-1051.1999.tb01108.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Mathis P, 1995, PHOTOSYNTHESIS FROM, DOI [10.1007/978-94-009-0173-5, DOI 10.1007/978-94-009-0173-5]; Mojzes A, 2003, FLORA, V198, P304, DOI 10.1078/0367-2530-00102; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Murchie EH, 1997, PLANT CELL ENVIRON, V20, P438, DOI 10.1046/j.1365-3040.1997.d01-95.x; Nishiyama Y, 2014, APPL MICROBIOL BIOT, V98, P8777, DOI 10.1007/s00253-014-6020-0; Oukarroum A, 2007, ENVIRON EXP BOT, V60, P438, DOI 10.1016/j.envexpbot.2007.01.002; Papageorgiou GC, 2007, PHOTOSYNTH RES, V94, P275, DOI 10.1007/s11120-007-9193-x; Pattanayak GK, 2005, BIOCHEM BIOPH RES CO, V326, P466, DOI 10.1016/j.bbrc.2004.11.049; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pogan M, 1991, ACTA BIOL CRACOV BOT, V32, P1; R Core Team, 2008, LANG ENV STAT COMP; Rapacz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134820; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Sapek A, 1997, METODY ANALIZY CHEM; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Schansker G, 2006, BBA-BIOENERGETICS, V1757, P787, DOI 10.1016/j.bbabio.2006.04.019; Schansker G, 2011, BBA-BIOENERGETICS, V1807, P1032, DOI 10.1016/j.bbabio.2011.05.022; Schlapfer F, 1998, ECOGRAPHY, V21, P351, DOI 10.1111/j.1600-0587.1998.tb00400.x; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Stirbet A, 2013, PHOTOSYNTH RES, V116, P189, DOI 10.1007/s11120-013-9863-9; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser RJ, 2004, ACTA PHYSIOL PLANT, V26, P94; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Strasser RJ, 2001, MATH COMPUT SIMULAT, V56, P451, DOI 10.1016/S0378-4754(01)00314-7; Stroch M, 2004, PHOTOSYNTHETICA, V42, P323, DOI 10.1023/B:PHOT.0000046149.97220.18; Sutkowska A, 2015, SURTSEY RES, V13, P17; Tanaka R., 2000, PORPHYRINS, V9, P240; Tikkanen M, 2011, TRENDS PLANT SCI, V16, P126, DOI 10.1016/j.tplants.2010.11.006; Tsimilli-Michael M, 2004, ACTA PHYSIOL PLANT, V26, P176; Way DA, 2012, TREE PHYSIOL, V32, P1066, DOI 10.1093/treephys/tps064; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Zivcak M, 2008, PLANT SOIL ENVIRON, V54, P133, DOI 10.17221/392-PSE; Zivcak M, 2014, PHOTOSYNTH RES, V119, P339, DOI 10.1007/s11120-014-9969-8; Zurek G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091475	80	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156201	10.1371/journal.pone.0156201	http://dx.doi.org/10.1371/journal.pone.0156201			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275605	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700019
J	Rayl, M; Truitt, M; Held, A; Sargeant, J; Thorsen, K; Hay, JC				Rayl, Mariah; Truitt, Mishana; Held, Aaron; Sargeant, John; Thorsen, Kevin; Hay, Jesse C.			Penta-EF-Hand Protein Peflin Is a Negative Regulator of ER-To-Golgi Transport	PLOS ONE			English	Article							RETICULUM EXIT SITES; COPII VESICLE FUSION; ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; (ER)-TO-GOLGI TRANSPORT; CA2+-DEPENDENT MANNER; SECRETORY PATHWAY; MAMMALIAN-CELLS; CALCIUM; ALG-2	Luminal calcium regulates vesicle transport early in the secretory pathway. In ER-to-Golgi transport, depletion of luminal calcium leads to significantly reduced transport and a buildup of budding and newly budded COPII vesicles and vesicle proteins. Effects of luminal calcium on transport may be mediated by cytoplasmic calcium sensors near ER exits sites (ERES). The penta-EF-hand (PEF) protein apoptosis-linked gene 2 (ALG-2) stabilizes sec31A at ER exit sites (ERES) and promotes the assembly of inner and outer shell COPII components. However, in vitro and intact cell approaches have not determined whether ALG-2 is a negative or positive regulator, or a regulator at all, under basal physiological conditions. ALG-2 interacts with another PEF protein, peflin, to form cytosolic heterodimers that dissociate in response to calcium. However, a biological function for peflin has not been demonstrated and whether peflin and the ALG-2/peflin interaction modulates transport has not been investigated. Using an intact, single cell, morphological assay for ER-to-Golgi transport in normal rat kidney (NRK) cells, we found that depletion of peflin using siRNA resulted in significantly faster transport of the membrane cargo VSV-G. Double depletion of peflin and ALG-2 blocked the increased transport resulting from peflin depletion, demonstrating a role for ALG-2 in the increased transport. Furthermore, peflin depletion caused increased targeting of ALG-2 to ERES and increased ALG-2/sec31A interactions, suggesting that peflin may normally inhibit transport by preventing ALG-2/sec31A interactions. This work identifies for the first time a clear steady state role for a PEF protein in ER-to-Golgi transport-peflin is a negative regulator of transport.	[Hay, Jesse C.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Thorsen, Kevin] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY USA	University of Montana System; University of Montana; University of Montana System; University of Montana; Cornell University	Hay, JC (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	jesse.hay@umontana.edu			National Institutes of Health [GM106323]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a grant from the National Institutes of Health (GM106323) to JCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Cao Q, 2015, J CELL BIOL, V209, P879, DOI 10.1083/jcb.201409071; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Kitaura Y, 2002, ARCH BIOCHEM BIOPHYS, V399, P12, DOI 10.1006/abbi.2001.2736; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Micaroni M, 2010, TRAFFIC COPENHAGEN D; Micaroni M, 2012, ADV EXP MED BIOL, V740, P439, DOI 10.1007/978-94-007-2888-2_18; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Parkinson K, 2014, NAT CELL BIOL, V16, P87, DOI 10.1038/ncb2887; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Tabata K, 2009, EMBO J; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; von Blume J, 2012, J CELL BIOL, V199, P1057, DOI 10.1083/jcb.201207180; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yoshibori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040765; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	40	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157227	10.1371/journal.pone.0157227	http://dx.doi.org/10.1371/journal.pone.0157227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276012	gold, Green Submitted, Green Published			2022-12-26	WOS:000377561700085
J	Kang, MJ; Kang, JW				Kang, Min-Joo; Kang, Je-Won			Intrusion Detection System Using Deep Neural Network for In-Vehicle Network Security	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; MEMORY	A novel intrusion detection system (IDS) using a deep neural network (DNN) is proposed to enhance the security of in-vehicular network. The parameters building the DNN structure are trained with probability-based feature vectors that are extracted from the in-vehicular network packets. For a given packet, the DNN provides the probability of each class discriminating normal and attack packets, and, thus the sensor can identify any malicious attack to the vehicle. As compared to the traditional artificial neural network applied to the IDS, the proposed technique adopts recent advances in deep learning studies such as initializing the parameters through the unsupervised pre-training of deep belief networks (DBN), therefore improving the detection accuracy. It is demonstrated with experimental results that the proposed technique can provide a real-time response to the attack with a significantly improved detection ratio in controller area network (CAN) bus.	[Kang, Min-Joo; Kang, Je-Won] Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea	Ewha Womans University	Kang, JW (corresponding author), Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea.	jewonk@ewha.ac.kr	Kang, Jewon/AAU-9722-2020	Kang, Jewon/0000-0002-1637-9479	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2056587]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2056587).	BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bengio Y., 2009, FDN TRENDS MACH LEAR; Bengio Y, 2012, ADV NEURAL INFORM PR, V25; Biswas S, 2006, IEEE SIGNAL PROCESSI, V44, P82; Borazjani P, 2014, P EMB SEC CARS C 201; Charlie M, 2013, ADVENTURES AUTOMOTIV; Checkoway S., 2011, P USENIX SEC 2011; Chen WH, 2005, COMPUTERS OPERATIONS; Dan C, 2012, NEURAL NETWORKS; Deepa AJ, 2012, PROCEDIA ENGINEER, V38, P2063, DOI 10.1016/j.proeng.2012.06.248; Deng L, 2011, APSIPA; Erhan D., 2010, J MACHINE LEARNING R; Fan Y, 2008, VEH POW PROP C 2008; Farsi M, 1999, COMPUTING CONTROL EN, V10; Geiger A, 2012, IEEE T INTELL TRANSP, V13, P1018; Golovko V, 2005, INTRUSION RECOGNITIO; Hinton G, 2012, COMMUNICATIONS MAGAZ; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hoppe T, 2008, P 27 INT C SAFECOMP; Hu W, 2003, INT C MACH LEARN; Jin WL, 2006, TRANSP RES B, P3; Johansson K. H., 2005, HDB NETWORKED EMBEDD; Kemmerer D, 2002, COMPUTER, P27, DOI 10.1109/MC.2002.1012428; Kesting A, 2010, IEEE T INTELL TRANSP, V11, P172, DOI 10.1109/TITS.2009.2037924; Kleberger P, 2011, INT VEH S IV 2011; Koscher K, 2010, P IEEE S SECUR PRIV, P447, DOI 10.1109/SP.2010.34; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Larson E, 2008, IEEE INT VEH S GOLD; Lenz H, 1999, EUR PHYS J B, V7, P331, DOI 10.1007/s100510050618; Lidstrom K, 2012, IEEE T INTELL TRANSP, V13, P1050, DOI 10.1109/TITS.2012.2204877; Lv Y., 2015, IEEE T INTELLIGENT T; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Muter M, 2010, 6 INT C INF ASS SEC; Park TJ, 2005, MECHATRONICS, V15, P899, DOI 10.1016/j.mechatronics.2005.05.002; Patsakis C, 2014, COMPUT SECUR, V40, P60, DOI 10.1016/j.cose.2013.11.003; Sun XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139513; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2014, NONLINEAR DYNAM, V76, P2017, DOI 10.1007/s11071-014-1265-9; Tsai CF, 2009, EXPERT SYST APPL, V36, P11994, DOI 10.1016/j.eswa.2009.05.029; Tsugawa S., 2002, IEEE INT VEH S 2002; Tuohy S, 2015, IEEE T INTELL TRANSP, V16, P534, DOI 10.1109/TITS.2014.2320605; Tyagi P, 2014, ADV COMPUTING COMMUN; van Nunen E, 2012, IEEE T INTELL TRANSP, V13, P1018, DOI 10.1109/TITS.2012.2200475; Woo S, 2015, IEEE T INTELLIGENT T; Wu JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120976; Yu SW, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215500848; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Yu SW, 2014, PHYSICA A, V407, P152, DOI 10.1016/j.physa.2014.03.081; Zhang JP, 2011, IEEE T INTELL TRANSP, V12, P1624, DOI 10.1109/TITS.2011.2158001; Zhang Z, 2001, IEEE WORKSH INF ASS; Zhou SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107122	52	293	302	16	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0155781	10.1371/journal.pone.0155781	http://dx.doi.org/10.1371/journal.pone.0155781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271802	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000004
J	Reepalu, A; Balcha, TT; Skogmar, S; Guner, N; Sturegard, E; Bjorkman, P				Reepalu, Anton; Balcha, Taye Tolera; Skogmar, Sten; Guner, Nuray; Sturegard, Erik; Bjorkman, Per			Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; DEATH; INDIVIDUALS; INITIATION; PROGRAMS; SEX	Introduction Despite increasing access to antiretroviral treatment (ART) in low-income countries, HIV-related mortality is high, especially in the first months following ART initiation. We aimed to evaluate the impact of TB coinfection on early mortality and to assess gender-specific predictors of mortality in a cohort of Ethiopian adults subjected to intensified casefinding for active TB before starting ART. Material and Methods Prospectively recruited ART-eligible adults (n = 812, 58.6% female) at five Ethiopian health centers were followed for 6 months. At inclusion sputum culture, Xpert MTB/RIF, and smear microscopy were performed (158/812 [19.5%] had TB). Primary outcome was all-cause mortality. We used multivariate Cox models to identify predictors of mortality. Results In total, 37/812 (4.6%) participants died, 12 (32.4%) of whom had TB. Karnofsky performance score (KPS) and mid-upper arm circumference (MUAC) were associated with mortality in the whole population. However, the associations were different in men and women. In men, only MUAC remained associated with mortality (adjusted hazard ratio [aHR] 0.71 [95% CI 0.57-0.88]). In women, KPS <80% was associated with mortality (aHR 10.95 [95% CI 2.33-51.49]), as well as presence of cough (aHR 3.98 [95% CI 1.10-14.36]). Cough was also associated with mortality for TB cases (aHR 8.30 [95% CI 1.06-65.14]), but not for non-TB cases. Conclusions In HIV-positive Ethiopian adults managed at health centers, mortality was associated with reduced performance score and malnutrition, with different distribution with regard to gender and TB coinfection. These robust variables could be used at clinic registration to identify persons at increased risk of early mortality.	[Reepalu, Anton; Balcha, Taye Tolera; Skogmar, Sten; Bjorkman, Per] Lund Univ, Dept Clin Sci, Fac Med, Infect Dis Res Unit, Malmo, Sweden; [Balcha, Taye Tolera] Minist Hlth, Addis Ababa, Ethiopia; [Guner, Nuray] Skane Univ Hosp, Reg Skane Competence Ctr, Lund, Sweden; [Sturegard, Erik] Malmo Lund Univ, Dept Lab Med, Med Microbiol, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University	Reepalu, A (corresponding author), Lund Univ, Dept Clin Sci, Fac Med, Infect Dis Res Unit, Malmo, Sweden.	anton.reepalu@med.lu.se	MIZEKA, PANU/A-3952-2017	Reepalu, Anton/0000-0003-1690-8921	Swedish Civil Contingency Agency; Swedish International Development Cooperation Agency; Swedish Medical Society; Crafoord Foundation	Swedish Civil Contingency Agency; Swedish International Development Cooperation Agency; Swedish Medical Society; Crafoord Foundation	This work was supported by the Swedish Civil Contingency Agency (www.msb.se), the Swedish International Development Cooperation Agency (www.sida.se), the Swedish Medical Society (www.sls.se), and the Crafoord Foundation (www.crafoord.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Balcha TT, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu095; Balcha TT, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27048; Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402; Cornell M, 2014, J ACQ IMMUN DEF SYND, P67; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Cox JA, 2010, AIDS REV, V12, P183; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Federal Ministry of Health, 2012, GUID CLIN PROGR MAN; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hosseinipour MC, 2015, 8 INT AIDS SOC C HIV; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Ministry of Health of Ethiopia, 2008, GUID MAN OPP INF ANT; Reepalu A, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu039; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Van Rie A, 2014, INT J TUBERC LUNG D, V18, P1340, DOI 10.5588/ijtld.14.0153; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, GUIDELINE ON WHEN TO; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197	35	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156602	10.1371/journal.pone.0156602	http://dx.doi.org/10.1371/journal.pone.0156602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272622	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000022
J	Saini, U; Naidu, S; ElNaggar, AC; Bid, HK; Wallbillich, JJ; Bixel, K; Bolyard, C; Suarez, AA; Kaur, B; Kuppusamy, P; Hays, J; Goodfellow, PJ; Cohn, DE; Selvendiran, K				Saini, U.; Naidu, S.; ElNaggar, A. C.; Bid, H. K.; Wallbillich, J. J.; Bixel, K.; Bolyard, C.; Suarez, A. A.; Kaur, B.; Kuppusamy, P.; Hays, J.; Goodfellow, P. J.; Cohn, D. E.; Selvendiran, K.			Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target	ONCOGENE			English	Article							SIGNAL TRANSDUCER; CURCUMIN ANALOG; ANTITUMOR; CELLS; HO-3867; INHIBITOR; ACTIVATION; APOPTOSIS; MODEL; PHOSPHORYLATION	Although activation of the STAT3 pathway has been associated with tumor progression in a wide variety of cancer types (including ovarian cancer), the precise mechanism of invasion and metastasis due to STAT3 are not fully delineated in ovarian cancer. We found that pSTAT3 Tyr705 is constitutively activated in patient ascites and ascites-derived ovarian cancer cells (ADOCCs), and the range of STAT3 expression could be very high to low. In vivo transplantation of ADOCCs with high pSTAT3 expression into the ovarian bursa of mice resulted in a large primary tumor and widespread peritoneal metastases. In contrast, ADOCCs with low STAT3 expression or ADOCCs with STAT3 expression knockdown, led to reduced tumor growth and an absence of metastases in vivo. Cytokines derived from the ADOCC culture medium activate the interleukin (IL)-6/STAT pathway in the STAT3 knockout (KO) cells, compensating for the absence of inherent STAT3 in the cells. Treatment with HO-3867 (a novel STAT3 inhibitor at 100 p.p.m. in an orthotopic murine model) significantly suppressed ovarian tumor growth, angiogenesis and metastasis by targeting STAT3 and its downstream proteins. HO-3867 was found to have cytotoxic effects in ex vivo cultures of freshly collected human ovarian cancers, including those resistant to platinum-based chemotherapy. Our results show that STAT3 is necessary for ovarian tumor progression/metastasis and highlight the potential for targeting STAT3 by HO-3867 as a therapeutic strategy for ovarian cancer.	[Saini, U.; Naidu, S.; ElNaggar, A. C.; Bid, H. K.; Wallbillich, J. J.; Bixel, K.; Suarez, A. A.; Hays, J.; Goodfellow, P. J.; Cohn, D. E.; Selvendiran, K.] Ohio State Univ, Wexner Med Ctr, Ctr Comprehens Canc, Div Gynecol Oncol, Columbus, OH 43210 USA; [Bolyard, C.; Kaur, B.] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Kuppusamy, P.] Dartmouth Med Sch, Dept Radiol, Hanover, NH USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Dartmouth College	Cohn, DE; Selvendiran, K (corresponding author), Ohio State Univ, Wexner Med Ctr, Ctr Comprehens Canc, Div Gynecol Oncol, Columbus, OH 43210 USA.	david.cohn@osumc.edu; selvendiran.karuppaiyah@osumc.edu	Hays, John/H-3968-2012; ElNaggar, Adam/V-6999-2019	ElNaggar, Adam/0000-0003-3409-583X; Cohn, David/0000-0002-3036-6172; Wallbillich, John/0000-0001-5913-8088	Ovarian Cancer Research Fund (OCRF); NCI [RO1-CA176078]; Drug Development Institute pilot grant; OSU CCC Internal grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD085817] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA163205, R01CA176078, R01CA150153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064607] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund (OCRF); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Drug Development Institute pilot grant; OSU CCC Internal grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr John Hays for his willingness to pre-review this manuscript and provide valuable comments and suggestions. We also thank Dr Vinay Puduvalli and his lab members (including Jihong Xu) for providing access to their vibrating microtome. We extend additional thanks to Dr Mitch Phelps and Dr Yonghua Ling of the Pharmacoanalytical Shared Resource (PhASR), for LC MS analysis of drug bioabsorption and metabolism. The authors are also thankful to the undergraduate students Ross Wanner, Riley Maria, Roman Zingarelli and Jack Fowler for the cell culture and basic assay help. This work was funded by Ovarian Cancer Research Fund (OCRF), NCI RO1-CA176078 grant and Drug Development Institute pilot grant (KS and DEC), and OSU CCC Internal grant to DEC.	Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Bill MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-165; Bolyard C, 2014, CLIN CANCER RES, V20, P6479, DOI 10.1158/1078-0432.CCR-14-0463; Cheng XL, 2010, BIOORGAN MED CHEM, V18, P4509, DOI 10.1016/j.bmc.2010.04.066; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Dayton A, 2010, CANCER BIOL THER, V10, P1027, DOI 10.4161/cbt.10.10.13250; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Goff BA, 2015, GYNECOL ONCOL, V136, P1, DOI 10.1016/j.ygyno.2014.12.008; Greten FR, 2010, NAT MED, V16, P1085, DOI 10.1038/nm1010-1085; Gritsina G, 2015, MOL CANCER THER, V14, P1035, DOI 10.1158/1535-7163.MCT-14-0800; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P2970, DOI 10.1002/cncr.25869; Huang F, 2008, ACTA BIOCH BIOPH SIN, V40, P519, DOI 10.1111/j.1745-7270.2008.00424.x; Kalai T, 2011, J MED CHEM, V54, P5414, DOI 10.1021/jm200353f; Kim D, 2014, CANCER RES, V74, P2144, DOI 10.1158/0008-5472.CAN-13-2187; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kroon P, 2013, CANCER RES, V73, P5288, DOI 10.1158/0008-5472.CAN-13-0874; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Latifi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046858; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee MY, 2006, BREAST, V15, P187, DOI 10.1016/j.breast.2005.05.005; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Matte I, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-288; McCann Georgia A, 2014, Oncoscience, V1, P216; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Pedranzini L, 2004, J CLIN INVEST, V114, P619, DOI 10.1172/JCI200422800; Pirnia F, 2006, ANTICANCER RES, V26, P1765; Pradeep S, 2015, CANCER CELL, V28, P610, DOI 10.1016/j.ccell.2015.09.008; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Rath KS, 2014, CANCER RES, V74, P2316, DOI 10.1158/0008-5472.CAN-13-2433; Selvendiran K, 2006, CANCER RES, V66, P4826, DOI 10.1158/0008-5472.CAN-05-4062; Selvendiran K, 2010, MOL CANCER RES, V8, P1188, DOI 10.1158/1541-7786.MCR-10-0201; Selvendiran K, 2010, MOL CANCER THER, V9, P1169, DOI 10.1158/1535-7163.MCT-09-1207; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Seo JM, 2012, J BIOL CHEM, V287, P13840, DOI 10.1074/jbc.M111.317131; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tierney BJ, 2014, GYNECOL ONCOL, V135, P133, DOI 10.1016/j.ygyno.2014.07.087; Tierney BJ, 2012, CANCER BIOL THER, V13, P766, DOI 10.4161/cbt.20559; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; Venkatesh S, 2000, J PHARM SCI-US, V89, P145, DOI 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6; Wen W, 2014, MOL CANCER THER, V13, P3037, DOI 10.1158/1535-7163.MCT-14-0077; Yoo JY, 2014, CLIN CANCER RES, V20, P3787, DOI 10.1158/1078-0432.CCR-14-0553; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	49	74	78	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					168	181		10.1038/onc.2016.197	http://dx.doi.org/10.1038/onc.2016.197			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27292260	Green Accepted			2022-12-26	WOS:000393938100003
J	Hresko, RC; Kraft, TE; Quigley, A; Carpenter, EP; Hruz, PW				Hresko, Richard C.; Kraft, Thomas E.; Quigley, Andrew; Carpenter, Elisabeth P.; Hruz, Paul W.			Mammalian Glucose Transporter Activity Is Dependent upon Anionic and Conical Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transport; glucose transporter type 4 (GLUT4); liposome; membrane transporter reconstitution; phospholipid; phospholipid vesicle; protein-lipid interaction; glucose transport kinetics; glucose transporter type 3 (GLUT3)	FUNCTIONAL-CHARACTERIZATION; LIPID-COMPOSITION; MEMBRANE-LIPIDS; PHOSPHATIDYLETHANOLAMINE; BINDING; MECHANISM; EXPRESSION; CURVATURE; LIPOSOMES; CARNITINE	The regulated movement of glucose across mammalian cell membranes is mediated by facilitative glucose transporters (GLUTs) embedded in lipid bilayers. Despite the known importance of phospholipids in regulating protein structure and activity, the lipid-induced effects on the GLUTs remain poorly understood. We systematically examined the effects of physiologically relevant phospholipids on glucose transport in liposomes containing purified GLUT4 and GLUT3. The anionic phospholipids, phosphatidic acid, phosphatidylserine, phosphatidylglycerol, and phosphatidylinositol, were found to be essential for transporter function by activating it and stabilizing its structure. Conical lipids, phosphatidylethanolamine and diacylglycerol, enhanced transporter activity up to 3-fold in the presence of anionic phospholipids but did not stabilize protein structure. Kinetic analyses revealed that both lipids increase the k(cat) of transport without changing the K-m values. These results allowed us to elucidate the activation of GLUT by plasma membrane phospholipids and to extend the field of membrane protein-lipid interactions to the family of structurally and functionally related human solute carriers.	[Hresko, Richard C.; Kraft, Thomas E.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Quigley, Andrew; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	Washington University (WUSTL); Washington University (WUSTL); University of Oxford	Kraft, TE (corresponding author), Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev, Penzberg, Germany.; Hruz, PW (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	thomas_kraft@gmx.net; hruz_p@kids.wustl.edu		Quigley, Andrew/0000-0002-5022-9845; Carpenter, Liz/0000-0001-9138-2937; Kraft, Thomas/0000-0002-5528-3197; Hruz, Paul/0000-0002-1478-3355	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; American Heart Association; Structural Genomics Consortium from AbbVie [1097737]; Bayer; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z, 106169]	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; American Heart Association(American Heart Association); Structural Genomics Consortium from AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Predoctoral Fellowship from the American Heart Association. To whom correspondence may be addressed: Roche Pharma Research and Early Development, Roche Innovation Center Munich, Nonnenwald, Penzberg, Germany. E-mail: thomas_kraft@gmx.net.; Supported by the Structural Genomics Consortium, which is a registered charity (number 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust Grant 092809/Z/10/Z.; Supported by Wellcome Trust Grant 106169.	Ansell G.V., 1973, FORM FUNCTION PHOSPH; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Barnes K, 2004, BIOCHEM J, V378, P343, DOI 10.1042/BJ20031186; Bechara C, 2015, NAT CHEM, V7, P255, DOI [10.1038/NCHEM.2172, 10.1038/nchem.2172]; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Brown MF, 2012, BIOCHEMISTRY-US, V51, P9782, DOI 10.1021/bi301332v; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dawaliby R, 2016, J BIOL CHEM, V291, P3658, DOI 10.1074/jbc.M115.706523; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Escriba PV, 2015, PROG LIPID RES, V59, P38, DOI 10.1016/j.plipres.2015.04.003; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Kim KH, 2003, BIOCHEMISTRY-US, V42, P15377, DOI 10.1021/bi035280k; Kobayashi D, 2005, REPRODUCTION, V130, P931, DOI 10.1530/rep.1.00737; Kraft TE, 2015, PROTEIN SCI, V24, P2008, DOI 10.1002/pro.2812; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee S.-J., 2013, NAT COMMUN, V4, P1; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Neale C, 2015, BIOPHYS J, V109, P1652, DOI 10.1016/j.bpj.2015.08.028; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Nowis D, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000017; Oppedisano F, 2007, BBA-BIOMEMBRANES, V1768, P291, DOI 10.1016/j.bbamem.2006.09.002; Parrish CC, 1997, BBA-BIOMEMBRANES, V1323, P253, DOI 10.1016/S0005-2736(96)00192-7; Pliotas C, 2015, NAT STRUCT MOL BIOL, V22, P991, DOI 10.1038/nsmb.3120; Pochini L, 2004, BBA-BIOMEMBRANES, V1661, P78, DOI 10.1016/j.bbamem.2003.12.001; RAY TK, 1969, J BIOL CHEM, V244, P5528; Rog T, 2014, CHEM PHYS LIPIDS, V184, P82, DOI 10.1016/j.chemphyslip.2014.10.004; Rosenhouse-Dantsker A, 2012, COMPR PHYSIOL, V2, P31, DOI 10.1002/cphy.c110001; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; TEFFT RE, 1986, BIOCHEMISTRY-US, V25, P3709, DOI 10.1021/bi00360a035; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vitrac H, 2013, J BIOL CHEM, V288, P5873, DOI 10.1074/jbc.M112.442988; Weijers RNM, 2012, CURR DIABETES REV, V8, P390, DOI 10.2174/157339912802083531; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; Yeagle PL, 2014, BBA-BIOMEMBRANES, V1838, P1548, DOI 10.1016/j.bbamem.2013.11.009	52	40	41	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17271	17282		10.1074/jbc.M116.730168	http://dx.doi.org/10.1074/jbc.M116.730168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27302065	Green Published, hybrid			2022-12-26	WOS:000382643800028
J	Aly, HH; Suzuki, J; Watashi, K; Chayama, K; Hoshino, S; Hijikata, M; Kato, T; Wakita, T				Aly, Hussein H.; Suzuki, Junya; Watashi, Koichi; Chayama, Kazuaki; Hoshino, Shin-ichi; Hijikata, Makoto; Kato, Takanobu; Wakita, Takaji			RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C VIRUS; GENOME REPLICATION; ANTIVIRAL FACTOR; LIVER-DISEASE; VIRAL GENOME; HBX PROTEIN; CELL-LINE; EXPRESSION; INFECTION; HELICASE	Hepatitis B virus (HBV) is a stealth virus, minimally inducing the interferon system required for efficient induction of both innate and adaptive immune responses. However, 90% of acutely infected adults can clear the virus, suggesting the presence of other, interferon-independent pathways leading to viral clearance. Given the known ability of helicases to bind viral nucleic acids, we performed a functional screening assay to identify helicases that regulate HBV replication. We identified the superkiller viralicidic activity 2-like (SKIV2L) RNA helicase (a homolog of the Saccharomyces cerevisiae Ski2 protein) on the basis of its direct and preferential interaction with HBV X-mRNA. This interaction was essential for HBVX-mRNA degradation at the RNA exosome. The degradation of HBV X-mRNA at the RNA exosome was also mediated by HBS1L (HBS1-like translational GTPase) protein, a known component of the host RNA quality control system. We found that the redundant HBV-precore translation initiation site present at the 3'-end of HBV X-mRNA (3'precore) is translationally active. The initiation of translation from this site without a proper stop codon was identified by the non-stop-mediated RNA decay mechanism leading to its degradation. Although 3'-precore is present in the five main HBV-RNA transcripts, only X-mRNA lacks the presence of an upstream start codons for large, middle, and small (L, M, and S) HBV surface proteins. These upstream codons are in-frame with 3'-precore translation initiation site, blocking its translation from the other HBV-mRNA transcripts. To our knowledge, this is the first demonstration of the anti-viral function of the non-stop-mediated RNA decay mechanism.	[Aly, Hussein H.; Suzuki, Junya; Watashi, Koichi; Kato, Takanobu; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Watashi, Koichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Saitama 3320012, Japan; [Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan; [Hijikata, Makoto] Kyoto Univ, Inst Virus Res, Lab Human Tumor Viruses, Kyoto 6068507, Japan	National Institute of Infectious Diseases (NIID); Tokyo University of Science; Japan Science & Technology Agency (JST); Hiroshima University; Nagoya City University; Kyoto University	Aly, HH; Wakita, T (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan.	ahussein@nih.go.jp; wakita@nih.go.jp	Aly, Hussein Hassan/GWV-0669-2022	Aly, Hussein H/0000-0002-2455-0694; Chayama, Kazuaki/0000-0002-5530-5341; Hoshino, Shinichi/0000-0001-6135-7896	Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED) Japan; Miyakawa memorial research fund	Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED) Japan(Japan Agency for Medical Research and Development (AMED)); Miyakawa memorial research fund	This study was supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED) Japan and the Miyakawa memorial research fund. The authors declare that they have no conflicts of interest with the contents of this article.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Cullen BR, 2014, J VIROL, V88, P12934, DOI 10.1128/JVI.01179-14; DANGEL AW, 1995, NUCLEIC ACIDS RES, V23, P2120, DOI 10.1093/nar/23.12.2120; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Garcia D, 2014, CELL HOST MICROBE, V16, P391, DOI 10.1016/j.chom.2014.08.001; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Leupin O, 2005, J VIROL, V79, P4238, DOI 10.1128/JVI.79.7.4238-4245.2005; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Michitaka K, 2010, J GASTROENTEROL, V45, P86, DOI 10.1007/s00535-009-0128-5; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; NAOUMOV NV, 1992, GASTROENTEROLOGY, V102, P538, DOI 10.1016/0016-5085(92)90101-4; Ogura N, 2014, BIOCHEM BIOPH RES CO, V452, P315, DOI 10.1016/j.bbrc.2014.08.029; Orzalli MH, 2014, ANNU REV MICROBIOL, V68, P477, DOI 10.1146/annurev-micro-091313-103409; PUGH JC, 1988, J VIROL, V62, P3513, DOI 10.1128/JVI.62.9.3513-3516.1988; Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001; Saito S, 2013, J BIOL CHEM, V288, P17832, DOI 10.1074/jbc.M112.448977; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Tsuge M, 2010, J GEN VIROL, V91, P1854, DOI 10.1099/vir.0.019224-0; Tsukuda S, 2015, J BIOL CHEM, V290, P5673, DOI 10.1074/jbc.M114.602540; ULRICH PP, 1990, J MED VIROL, V32, P109, DOI 10.1002/jmv.1890320208; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200; Watashi Koichi, 2013, J Biol Chem, V288, P31715, DOI 10.1074/jbc.M113.501122; WIDNER WR, 1993, MOL CELL BIOL, V13, P4331, DOI 10.1128/MCB.13.7.4331; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yokosuka O, 2011, HEPATOL RES, V41, P1, DOI 10.1111/j.1872-034X.2010.00739.x; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	46	18	18	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15958	15974		10.1074/jbc.M116.724641	http://dx.doi.org/10.1074/jbc.M116.724641			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27281821	Green Published, hybrid			2022-12-26	WOS:000380585400004
J	Bird, TG; Dimitropoulou, P; Turner, RM; Jenks, SJ; Cusack, P; Hey, SY; Blunsum, A; Kelly, S; Sturgeon, C; Hayes, PC; Bird, SM				Bird, Thomas G.; Dimitropoulou, Polyxeni; Turner, Rebecca M.; Jenks, Sara J.; Cusack, Pearce; Hey, Shiying; Blunsum, Andrew; Kelly, Sarah; Sturgeon, Catharine; Hayes, Peter C.; Bird, Sheila M.			Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SURVEILLANCE TEST; PROGNOSTIC ROLE; MANAGEMENT; CIRRHOSIS; TRIAL; ASIA	Detection of hepatocellular carcinoma (HCC) through screening can improve outcomes. However, HCC surveillance remains costly, cumbersome and suboptimal. We tested whether and how serum Alpha-Fetoprotein (AFP) should be used in HCC surveillance. Record linkage, dedicated pathways for management and AFP data-storage identified i) consecutive highly characterised cases of HCC diagnosed in 2009-14 and ii) a cohort of ongoing HCC-free patients undergoing regular HCC surveillance from 2009. These two well-defined Scottish patient cohorts enabled us to test the utility of AFP surveillance. Of 304 cases of HCC diagnosed over 6 years, 42% (129) were identified by a dedicated HCC surveillance programme. Of these 129, 47% (61) had a detectable lesion first identified by screening ultrasound (US) but 38% (49) were prompted by elevated AFP. Despite pre-HCC diagnosis AFP >20kU/L being associated with poor outcome, 'AFP-detected' tumours were offered potentially curative management as frequently as 'US-detected' HCCs; and had comparable survival. Linearity of serial log10-transformed AFPs in HCC cases and in the screening 'HCC-free' cohort (n = 1509) provided indicators of high-risk AFP behaviour in HCC cases. An algorithm was devised in static mode, then tested dynamically. A case/control series in hepatitis C related disease demonstrated highly significant detection (p<1.72*10(-5)) of patients at high risk of developing HCC. These data support the use of AFP in HCC surveillance. We show proof-of-principle that an automated and further refineable algorithmic interpretation of AFP can identify patients at higher risk of HCC. This approach could provide a cost-effective, user-friendly and much needed addition to US surveillance.	[Bird, Thomas G.; Cusack, Pearce; Hey, Shiying; Blunsum, Andrew; Kelly, Sarah; Hayes, Peter C.] Royal Infirm Edinburgh NHS Trust, Ctr Liver & Digest Disorders, Edinburgh EH16 4SA, Midlothian, Scotland; [Bird, Thomas G.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Dimitropoulou, Polyxeni; Turner, Rebecca M.; Bird, Sheila M.] MRC Biostat Unit, Cambridge CB2 0SR, England; [Jenks, Sara J.; Sturgeon, Catharine] Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh EH16 4SA, Midlothian, Scotland; [Bird, Sheila M.] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; Beatson Institute; MRC Biostatistics Unit; Royal Infirmary of Edinburgh; University of Edinburgh; University of Strathclyde	Bird, TG (corresponding author), Royal Infirm Edinburgh NHS Trust, Ctr Liver & Digest Disorders, Edinburgh EH16 4SA, Midlothian, Scotland.; Bird, TG (corresponding author), Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.	t.bird@beatson.gla.ac.uk	Bird, Tom/H-3840-2019	Bird, Tom/0000-0002-6120-1581	Academy of Medical Science Starter Grant for Clinical Lecturers; Wellcome Trust [107492/z/15/z]; Medical Research Council (MRC) programme [MC_U105260794]; MRC programme [MC_U105260558]; Medical Research Council [MC_U105260558, MC_U105260794] Funding Source: researchfish; MRC [MC_U105260558, MC_U105260794] Funding Source: UKRI	Academy of Medical Science Starter Grant for Clinical Lecturers; Wellcome Trust(Wellcome Trust); Medical Research Council (MRC) programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TGB is supported by an Academy of Medical Science Starter Grant for Clinical Lecturers and a Wellcome Trust Intermediate Fellowship (107492/z/15/z). SMB and PD were supported by Medical Research Council (MRC) programme MC_U105260794, RT by MRC programme MC_U105260558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal EW, 2014, J SURG ONCOL, V110, P967, DOI 10.1002/jso.23765; Biselli M, 2015, BRIT J CANCER, V112, P69, DOI 10.1038/bjc.2014.536; Bruce MG, 2008, J VIRAL HEPATITIS, V15, P179, DOI 10.1111/j.1365-2893.2007.00928.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang TS, 2015, AM J GASTROENTEROL, V110, P836, DOI 10.1038/ajg.2015.100; Chen TM, 2007, J GASTROEN HEPATOL, V22, P669, DOI 10.1111/j.1440-1746.2007.04898.x; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Dalton-Fitzgerald E, 2015, CLIN GASTROENTEROL H, V13, P791, DOI 10.1016/j.cgh.2014.06.031; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; El-Serag HB, 2013, CLIN GASTROENTEROL H, V11, P441, DOI 10.1016/j.cgh.2012.12.046; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Fong ZV, 2014, CANCER-AM CANCER SOC, V120, P2824, DOI 10.1002/cncr.28730; Giannini EG, 2012, HEPATOLOGY, V56, P1371, DOI 10.1002/hep.25814; Gupta S, 2003, ANN INTERN MED, V139, P46, DOI 10.7326/0003-4819-139-1-200307010-00012; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones AL, 1994, GRADUATE SCH MED PAP, P237; Joshi K, 2014, DIGEST DIS SCI, V59, P3073, DOI 10.1007/s10620-014-3256-6; Khalili M, 2011, DIGEST DIS SCI, V56, P1516, DOI 10.1007/s10620-010-1439-3; Kim GA, 2015, LIVER INT, V35, P232, DOI 10.1111/liv.12516; Lee E, 2013, CLIN GASTROENTEROL H, V11, P437, DOI 10.1016/j.cgh.2012.11.029; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Ma WJ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-212; McGowan CE, 2015, CLIN GASTROENTEROL H, V13, P799, DOI 10.1016/j.cgh.2014.07.056; McMahon BJ, 2000, HEPATOLOGY, V32, P842, DOI 10.1053/jhep.2000.17914; Nguyen MH, 2002, HEPATOLOGY, V36, P410, DOI 10.1053/jhep.2002.34744; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Richardson P, 2012, CLIN GASTROENTEROL H, V10, P428, DOI 10.1016/j.cgh.2011.11.025; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624; Singal AG, 2013, AM J GASTROENTEROL, V108, P425, DOI 10.1038/ajg.2012.449; Sinn DH, 2015, HEPATO-GASTROENTEROL, V62, P327, DOI 10.5754/hge11951; Tayob N, 2016, CLIN GASTROENTEROL H, V14, P469, DOI 10.1016/j.cgh.2015.07.049; Trevisani F, 2004, AM J GASTROENTEROL, V99, P1470, DOI 10.1111/j.1572-0241.2004.30137.x; van Meer S, 2015, J HEPATOL, V63, P1156, DOI 10.1016/j.jhep.2015.06.012; Wong GLH, 2014, HEPATOLOGY, V59, P986, DOI 10.1002/hep.26739; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050919; Zhou L, 2012, HEPATO-GASTROENTEROL, V59, P840, DOI 10.5754/hge10404	42	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156801	10.1371/journal.pone.0156801	http://dx.doi.org/10.1371/journal.pone.0156801			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308823	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000378029800013
J	Barbier, M; Jaensch, S; Cornelissen, F; Vidic, S; Gjerde, K; de Hoogt, R; Graeser, R; Gustin, E; Chong, YT				Barbier, Michael; Jaensch, Steffen; Cornelissen, Frans; Vidic, Suzana; Gjerde, Kjersti; de Hoogt, Ronald; Graeser, Ralph; Gustin, Emmanuel; Chong, Yolanda T.		IMI PREDECT Consortium	Ellipsoid Segmentation Model for Analyzing Light-Attenuated 3D Confocal Image Stacks of Fluorescent Multi-Cellular Spheroids	PLOS ONE			English	Article							CANCER; PLATFORM; DRUG	In oncology, two-dimensional in-vitro culture models are the standard test beds for the discovery and development of cancer treatments, but in the last decades, evidence emerged that such models have low predictive value for clinical efficacy. Therefore they are increasingly complemented by more physiologically relevant 3D models, such as spheroid microtumor cultures. If suitable fluorescent labels are applied, confocal 3D image stacks can characterize the structure of such volumetric cultures and, for example, cell proliferation. However, several issues hamper accurate analysis. In particular, signal attenuation within the tissue of the spheroids prevents the acquisition of a complete image for spheroids over 100 micrometers in diameter. And quantitative analysis of large 3D image data sets is challenging, creating a need for methods which can be applied to large-scale experiments and account for impeding factors. We present a robust, computationally inexpensive 2.5D method for the segmentation of spheroid cultures and for counting proliferating cells within them. The spheroids are assumed to be approximately ellipsoid in shape. They are identified from information present in the Maximum Intensity Projection (MIP) and the corresponding height view, also known as Z-buffer. It alerts the user when potential bias-introducing factors cannot be compensated for and includes a compensation for signal attenuation.	[Barbier, Michael; Jaensch, Steffen; Vidic, Suzana; Gjerde, Kjersti; de Hoogt, Ronald; Gustin, Emmanuel; Chong, Yolanda T.] Janssen Pharmaceut Co Johnson & Johnson, Discovery Sci, Beerse, Belgium; [Cornelissen, Frans] Janssen Pharmaceut Co Johnson & Johnson, Pharma R&D IT, Beerse, Belgium; [Vidic, Suzana; Gjerde, Kjersti] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [Vidic, Suzana] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia; [Graeser, Ralph] Boehringer Ingelheim KG, Translat Med & Clin Pharmacol, Ingelheim, Germany	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Erasmus University Rotterdam; Erasmus MC; University of Primorska; Boehringer Ingelheim	Gustin, E; Chong, YT (corresponding author), Janssen Pharmaceut Co Johnson & Johnson, Discovery Sci, Beerse, Belgium.	egustin@its.jnj.com; ychong4@its.jnj.com	; Smalley, Matthew/M-7000-2015; Mauricio Brito Ataide Montes, Ana Catarina/A-2389-2009	Gustin, Emmanuel/0000-0002-7606-1075; Smalley, Matthew/0000-0001-9540-1146; Mauricio Brito Ataide Montes, Ana Catarina/0000-0002-8926-279X	Janssen Pharmaceutical Companies of Johnson Johnson; Innovative Medicines Initiative Joint Undertaking [115188]; European Union's Seventh Framework Programme (FP7)	Janssen Pharmaceutical Companies of Johnson Johnson; Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7)	Authors MB, SJ, FC, RH, RG, EG, and YTC were funded by Janssen Pharmaceutical Companies of Johnson & Johnson. Authors SV and KG were supported by Innovative Medicines Initiative Joint Undertaking under Grant agreement no 115188, the resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and contributions in kind from the European Federation of Pharmaceutical Industries and Associations. The funders provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aljitawi OS, 2014, LEUKEMIA LYMPHOMA, V55, P378, DOI 10.3109/10428194.2013.793323; Chen WJ, 2014, JOVE-J VIS EXP, DOI 10.3791/51639; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harma V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096426; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hickman JA, 2013, INT INNOV, P80; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hodneland E, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-16; Jiglaire CJ, 2014, EXP CELL RES, V321, P99, DOI 10.1016/j.yexcr.2013.12.010; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Koshkin V, 2016, J CELL BIOCHEM, V117, P59, DOI 10.1002/jcb.25247; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Levinger I, 2014, ADV CANCER RES, V121, P383, DOI 10.1016/B978-0-12-800249-0.00009-3; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Lou XH, 2014, STEM CELL REP, V2, P382, DOI 10.1016/j.stemcr.2014.01.010; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Pampaloni F, 2013, CELL TISSUE RES, V352, P161, DOI 10.1007/s00441-013-1589-7; Parker DL, 2000, JMRI-J MAGN RESON IM, V11, P378, DOI 10.1002/(SICI)1522-2586(200004)11:4<378::AID-JMRI5>3.3.CO;2-R; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Piccinini F, 2015, COMPUT METH PROG BIO, V119, P43, DOI 10.1016/j.cmpb.2015.02.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Strasters K. C., 1994, Bioimaging, V2, P78, DOI 10.1002/1361-6374(199406)2:2<78::AID-BIO2>3.3.CO;2-4; Strasters KC, 1994, THESIS; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Trinh A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0442-y; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wrzesinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106973	33	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156942	10.1371/journal.pone.0156942	http://dx.doi.org/10.1371/journal.pone.0156942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303813	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000377824800030
J	Costion, CM; Kress, WJ; Crayn, DM				Costion, Craig M.; Kress, W. John; Crayn, Darren M.			DNA Barcodes Confirm the Taxonomic and Conservation Status of a Species of Tree on the Brink of Extinction in the Pacific	PLOS ONE			English	Article							PHYLOGENY; RUBIACEAE; EVOLUTION; FAMILY; SEQUENCE; SPACER; RBCL	The taxonomic status of a single island, narrow range endemic plant species from Palau, Micronesia (Timonius salsedoi) was assessed using DNA barcode markers, additional plastid loci, and morphology in order to verify its conservation status. DNA barcode loci distinguished T. salsedoi from all other Timonius species sampled from Palau, and were supported by sequence data from the atpB-rbcL intergenic spacer region. Timonius salsedoi was only known from two mature individual trees in 2012. Due to its extremely narrow range and population size, it had previously been recommended to be listed as Critically Endangered Status under three separate IUCN Criteria. In 2014 a second survey of the population following a typhoon revealed that the only two known trees had died suggesting that this species may now be extinct. Comprehensive follow up surveys of suitable habitat for this species are urgently required.	[Costion, Craig M.; Kress, W. John] Smithsonian Inst, MRC 166, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Costion, Craig M.; Crayn, Darren M.] James Cook Univ, Australian Trop Herbarium, Cairns Campus, Cairns, Qld, Australia; [Crayn, Darren M.] James Cook Univ, Ctr Trop Environm Sustainabil Sci, Cairns Campus, Cairns, Qld, Australia	Smithsonian Institution; Smithsonian National Museum of Natural History; James Cook University; James Cook University	Costion, CM (corresponding author), Smithsonian Inst, MRC 166, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA.; Costion, CM (corresponding author), James Cook Univ, Australian Trop Herbarium, Cairns Campus, Cairns, Qld, Australia.	costionc@si.edu	Crayn, Darren M/A-7386-2011	Crayn, Darren M/0000-0001-6614-4216	Critical Ecosystem Partnership Fund - Threatened Endemic Plants of Palau, University of Adelaide, EF-Critical Ecosystem Partnership Fund [56276]; Polynesia-Micronesia (Polynesia-Micronesia), Strategic Category: Safeguard and restore threatened species	Critical Ecosystem Partnership Fund - Threatened Endemic Plants of Palau, University of Adelaide, EF-Critical Ecosystem Partnership Fund; Polynesia-Micronesia (Polynesia-Micronesia), Strategic Category: Safeguard and restore threatened species	Funding was provided by Critical Ecosystem Partnership Fund: http://www.cepf.net/Pages/default.aspx - Threatened Endemic Plants of Palau, University of Adelaide, EF-Critical Ecosystem Partnership Fund, Grant #56276 (Status: Closed, CI Funds: $36,025.17, Period: May 1, 2010-Apr 30, 2012), Polynesia-Micronesia (Polynesia-Micronesia), Strategic Category: Safeguard and restore threatened species. CMC received funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achille F, 2006, ANN MO BOT GARD, V93, P103, DOI 10.3417/0026-6493(2006)93[103:PIGLRG]2.0.CO;2; Athens J. Stephen, 2002, Archaeology in Oceania, V37, P57; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BAILLIE JEM, 2004, IUCN RED LIST THREAT; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Costion CM, 2009, PLANT ENDEMISM RARIT, P131; Costion CM, 2012, BIOL CONSERV, V147, P153, DOI 10.1016/j.biocon.2011.12.026; Crayn DM, 2000, MOL PHYLOGENET EVOL, V16, P238, DOI 10.1006/mpev.2000.0794; Darwin SP, 2010, CANDOLLEA, V65, P217, DOI 10.15553/c2010v652a5; Duchene D, 2013, BMC EVOLUTIONARY BIO, V13, P11; FOSBERG F R, 1987, Micronesica, V20, P157; Fosberg FR, 1993, SMITHSONIAN CONTRIBU, V0, P1, DOI DOI 10.5479/SI.0081024X.81; Guo X, 2011, J SYST EVOL, V49, P203, DOI 10.1111/j.1759-6831.2011.00130.x; HOLDAWAY RN, 1989, NEW ZEAL J ECOL, V12, P11; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; Manns U, 2010, MOL PHYLOGENET EVOL, V56, P21, DOI 10.1016/j.ympev.2010.04.002; Miller SE, 2013, P ENTOMOL SOC WASH, V115, P107, DOI 10.4289/0013-8797.115.1.107; Moynihan J, 2001, INT J PLANT SCI, V162, P393, DOI 10.1086/319583; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M, 2000, MOL EVOLUTION PHYLOG, Vi-xiv, P1; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Porch N, 2007, QUATERNARY INT S, V328, P167; Porch N, 2007, QUATERNARY INT S, V327, P167; Prebble M, 2007, QUATERNARY INT S, V330, P167; Pregill GK, 2004, J HERPETOL, V38, P15, DOI 10.1670/73-03A; Rova JHE, 2002, AM J BOT, V89, P145, DOI 10.3732/ajb.89.1.145; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Smith CW, 1983, SOIL SURVEY ISLANDS; Steadman David W., 2006, P1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155118	10.1371/journal.pone.0155118	http://dx.doi.org/10.1371/journal.pone.0155118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304905	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000377824800004
J	Xu, WX; Yu, HY; Li, WH; Gao, W; Guo, LJ; Wang, GS				Xu, Weixian; Yu, Haiyi; Li, Weihong; Gao, Wei; Guo, Lijun; Wang, Guisong			Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia	PLOS ONE			English	Article							CHROMOGRANIN-A; CATECHOLAMINE RELEASE; EARLY DECLINE; GENETIC RISK; PEPTIDE; HYPERTENSION; INFARCTION; MIGRATION; HEART; ANGIOGENESIS	Backgrounds Catestatin is an endogenous multifunctional neuroendocrinepeptide. Recently, catestatin was discovered as a novel angiogenic cytokine. The study was to investigate the associations between endogenous catestatin and coronary collateral development among the patients with chronic myocardial ischemia. Methods Thirty-eight patients with coronary artery chronic total occlusions (CTO) (CTO group) and 38 patients with normal coronary arteries (normal group) were enrolled in the series. Among the patients with CTO, coronary collateral development was graded according to the Rentrop score method. Rentrop score 0-1 collateral development was regarded as poor collateral group and 2-3 collateral development was regarded as good collateral group. Plasma catestatin level and vascular endothelial growth factor (VEGF) were measured by ELISA kits. Results The plasma catestatin levels in CTO group were significantly higher than that in normal group (1.97 +/- 1.01 vs 1.36 +/- 0.97ng/ml, p = 0.009). In the CTO group, the patients with good collateral development had significantly higher catestatin and VEGF levels than those with poor collateral development (2.36 +/- 0.73 vs 1.61 +/- 1.12 ng/ml, p = 0.018; 425.23 +/- 140.10 vs 238.48 +/- 101.00pg/mL, p<0.001). There is a positive correlation between plasma catestatin levels and Rentrop scores (r = 0.40, p = 0.013) among the patients with CTO. However, there is no correlations between plasma catestatin levels and VEGF (r = -0.06, p = 0.744). In the multiple linear regression models, plasma catestatin level was one of the independent factors of coronary collateral development after adjustment for confounders. Conclusions Plasma catestatin was associated with coronary collateral developments. It may be a useful biomarker for coronary collateral development and potential target for therapeutic angiogenesis in patients with CTO.	[Xu, Weixian; Yu, Haiyi; Li, Weihong; Gao, Wei; Guo, Lijun; Wang, Guisong] Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100191, Peoples R China	Peking University	Xu, WX (corresponding author), Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100191, Peoples R China.	xwxbird05@163.com		Gao, Wei/0000-0003-3541-9568	Scientific Research Foundation for the Returned Overseas Scholars of Peking University Third Hospital [Y78504-1]; National Natural Science Foundation of China [NNSFC 81400319]	Scientific Research Foundation for the Returned Overseas Scholars of Peking University Third Hospital(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The Scientific Research Foundation for the Returned Overseas Scholars of Peking University Third Hospital (Xu WX. Y78504-1) and The National Natural Science Foundation of China(NNSFC 81400319, Xu WX).	Aung G, 2011, IMMUNOLOGY, V132, P527, DOI 10.1111/j.1365-2567.2010.03395.x; Avolio E, 2014, NEUROSCIENCE, V270, P48, DOI 10.1016/j.neuroscience.2014.04.001; Belloni D, 2007, FASEB J, V21, P3052, DOI 10.1096/fj.06-6829com; Biswas N, 2012, HYPERTENSION, V60, P1552, DOI 10.1161/HYPERTENSIONAHA.112.202127; Crippa L, 2013, BLOOD, V121, P392, DOI 10.1182/blood-2012-05-430314; Egger M, 2008, EUR J PHARMACOL, V598, P104, DOI 10.1016/j.ejphar.2008.09.016; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Gayen JR, 2009, ENDOCRINOLOGY, V150, P5027, DOI 10.1210/en.2009-0429; Goetze JP, 2014, BIOMARK MED, V8, P133, DOI 10.2217/bmm.13.102; Helle KB, 2014, CELL MOL LIFE SCI; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Liu L, 2013, PEPTIDES, V46, P20, DOI 10.1016/j.peptides.2013.05.003; Liu L, 2013, SCAND CARDIOVASC J, V47, P217, DOI 10.3109/14017431.2013.794951; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mahata SK, 2010, REGUL PEPTIDES, V162, P33, DOI 10.1016/j.regpep.2010.01.006; Martin-Yuste V, 2012, REV ESP CARDIOL, V65, P334, DOI [10.1016/j.recesp.2011.11.009, 10.1016/j.rec.2011.11.008]; Mazza R, 2012, NITRIC OXIDE-BIOL CH, V27, P40, DOI 10.1016/j.niox.2012.04.003; Meng L, 2013, POSTGRAD MED J, V89, P193, DOI 10.1136/postgradmedj-2012-131060; O'Connor DT, 2002, ANN NY ACAD SCI, V971, P533, DOI 10.1111/j.1749-6632.2002.tb04520.x; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Pei ZQ, 2014, PEPTIDES, V55, P131, DOI 10.1016/j.peptides.2014.02.016; Penna C, 2012, CURR MED CHEM, V19, P4074, DOI 10.2174/092986712802429966; Perrelli MG, 2013, PFLUG ARCH EUR J PHY, V465, P1031, DOI 10.1007/s00424-013-1217-0; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Tota B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00064; Wang XY, 2011, BIOMARKERS, V16, P372, DOI 10.3109/1354750X.2011.578260; Werner GS, 2003, CIRCULATION, V107, P1972, DOI 10.1161/01.CIR.0000061953.72662.3A; Xu WX, 2013, BIOMARKERS, V18, P343, DOI 10.3109/1354750X.2013.787459	28	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0149062	10.1371/journal.pone.0149062	http://dx.doi.org/10.1371/journal.pone.0149062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304618	gold, Green Submitted, Green Published			2022-12-26	WOS:000377824800001
J	Gelaye, B; Sumner, SJ; McRitchie, S; Carlson, JE; Ananth, CV; Enquobahrie, DA; Qiu, CF; Sorensen, TK; Williams, MA				Gelaye, Bizu; Sumner, Susan J.; McRitchie, Susan; Carlson, James E.; Ananth, Cande V.; Enquobahrie, Daniel A.; Qiu, Chunfang; Sorensen, Tanya K.; Williams, Michelle A.			Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study	PLOS ONE			English	Article							RISK-FACTORS; ALPHA-FETOPROTEIN; PRETERM DELIVERY; FATTY-ACID; PERFORMANCE; DEFICIENCY; METABOLISM; DIAGNOSIS; BIOMARKER; STORAGE	Background & Objective Placental abruption, an ischemic placental disorder, complicates about 1 in 100 pregnancies, and is an important cause of maternal and perinatal morbidity and mortality worldwide. Metabolomics holds promise for improving the phenotyping, prediction and understanding of pathophysiologic mechanisms of complex clinical disorders including abruption. We sought to evaluate maternal early pregnancy pre-diagnostic serum metabolic profiles and abnormal vaginal bleeding as predictors of abruption later in pregnancy. Methods Maternal serum was collected in early pregnancy (mean 16 weeks, range 15 to 22 weeks) from 51 abruption cases and 51 controls. Quantitative targeted metabolic profiles of serum were acquired using electrospray ionization liquid chromatography-mass spectrometry (ESI-LC-MS/MS) and the Absolute IDQ (R) p180 kit. Maternal sociodemographic characteristics and reproductive history were abstracted from medical records. Stepwise logistic regression models were developed to evaluate the extent to which metabolites aid in the prediction of abruption. We evaluated the predictive performance of the set of selected metabolites using a receiver operating characteristics (ROC) curve analysis and area under the curve (AUC). Results Early pregnancy vaginal bleeding, dodecanoylcarnitine/dodecenoylcarnitine (C12 / C12:1), and phosphatidylcholine acyl-alkyl C 38:1 (PC ae C38:1) strongly predict abruption risk.The AUC for these metabolites alone was 0.68, for early pregnancy vaginal bleeding alone was 0.65, and combined the AUC improved to 0.75 with the addition of quantitative metabolite data (P = 0.003). Conclusion Metabolomic profiles of early pregnancy maternal serum samples in addition to the clinical symptom, vaginal bleeding, may serve as important markers for the prediction of abruption. Larger studies are necessary to corroborate and validate these findings in other cohorts.	[Gelaye, Bizu; Williams, Michelle A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Sumner, Susan J.; McRitchie, Susan; Carlson, James E.] RTI Int, Discovery Sci, Res Triangle Pk, NC USA; [Ananth, Cande V.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Ananth, Cande V.] Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Enquobahrie, Daniel A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Enquobahrie, Daniel A.; Qiu, Chunfang; Sorensen, Tanya K.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA	Harvard University; Harvard T.H. Chan School of Public Health; Research Triangle Institute; Columbia University; Columbia University; University of Washington; University of Washington Seattle; Swedish Medical Center	Gelaye, B (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu		Gelaye, Bizu/0000-0001-7934-548X	National Institutes of Health [R01-HD059827, U24 DK097193]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by awards from the National Institutes of Health (R01-HD059827 and U24 DK097193). The NIH had no further role in study design; in the collection, analysis and interpretation of data; in drafting of the report; and in the decision to submit the paper for publication.; This research was supported by awards from the National Institutes of Health (R01-HD059827 and U24 DK097193). The NIH had no further role in study design; in the collection, analysis and interpretation of data; in drafting of the report; and in the decision to submit the paper for publication.	Ananth CV, 2004, OBSTET GYNECOL, V104, P71, DOI 10.1097/01.AOG.0000128172.71408.a0; Arnold DL, 2009, J OBSTET GYNAECOL RE, V35, P446, DOI 10.1111/j.1447-0756.2008.00980.x; Austdal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091923; Denis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116346; Enquobahrie DA, 2015, J CLIN ENDOCR METAB, V100, P4348, DOI 10.1210/jc.2015-2862; Hebels DGAJ, 2013, ENVIRON HEALTH PERSP, V121, P480, DOI 10.1289/ehp.1205657; Horgan RP, 2010, PLACENTA, V31, P893, DOI 10.1016/j.placenta.2010.07.002; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Kistin N, 1996, PAEDIATR PERINAT EP, V10, P269, DOI 10.1111/j.1365-3016.1996.tb00050.x; Koster MPH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/857108; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Kramer MS, 1997, OBSTET GYNECOL, V89, P221, DOI 10.1016/S0029-7844(96)00478-4; Lord R.S., 2008, LAB EVALUATIONS INTE; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Nilsen RM, 2008, AM J EPIDEMIOL, V167, P867, DOI 10.1093/aje/kwm373; Onalan R, 2006, GYNECOL OBSTET INVES, V61, P142, DOI 10.1159/000090432; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Qiu Chunfang, 2015, BMC Res Notes, V8, P447, DOI 10.1186/s13104-015-1340-4; Qiu CF, 2014, DIABETES RES CLIN PR, V104, P393, DOI 10.1016/j.diabres.2014.03.001; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Sanchez SE, 2006, AM J OBSTET GYNECOL, V194, P225, DOI 10.1016/j.ajog.2005.05.013; Seibel BA, 2002, J EXP BIOL, V205, P297; Signore C, 2008, PRENATAL DIAG, V28, P852, DOI 10.1002/pd.2065; Signore C, 2006, OBSTET GYNECOL, V108, P338, DOI 10.1097/01.AOG.0000216014.72503.09; Tikkanen M, 2007, PRENATAL DIAG, V27, P240, DOI 10.1002/pd.1654; VANHOVE JLK, 1993, AM J HUM GENET, V52, P958; Vaswani K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/850471; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wikoff WR, 2015, J CLIN ONCOL, V33, P3880, DOI 10.1200/JCO.2015.61.7779; WILLIAMS MA, 1991, AM J EPIDEMIOL, V134, P965, DOI 10.1093/oxfordjournals.aje.a116181; WILLIAMS MA, 1992, AM J OBSTET GYNECOL, V167, P1032, DOI 10.1016/S0002-9378(12)80033-0; WILLIAMS MA, 1993, OBSTET GYNECOL, V82, P808; Williams MA, 2013, INT J MOL EPIDEMIOL, V4, P120; Workalemahu T, 2013, INT J MOL EPIDEMIOL, V4, P128; Xiao R, 2002, PAEDIATR PERINAT EP, V16, P297, DOI 10.1046/j.1365-3016.2002.00448.x; Yaron Y, 2002, PRENATAL DIAG, V22, P778, DOI 10.1002/pd.407; Zukunft S, 2013, CHROMATOGRAPHIA, V76, P1295, DOI 10.1007/s10337-013-2429-3	37	12	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156755	10.1371/journal.pone.0156755	http://dx.doi.org/10.1371/journal.pone.0156755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300725	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200013
J	Woolnough, JL; Atwood, BL; Liu, Z; Zhao, R; Giles, KE				Woolnough, Jessica L.; Atwood, Blake L.; Liu, Zhong; Zhao, Rui; Giles, Keith E.			The Regulation of rRNA Gene Transcription during Directed Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; CHROMATIN; PLURIPOTENCY; METHYLATION; EXPRESSION; RRN3; COMPLEX; BINDING	It has become increasingly clear that proper cellular control of pluripotency and differentiation is related to the regulation of rRNA synthesis. To further our understanding of the role that the regulation of rRNA synthesis has in pluripotency we monitored rRNA synthesis during the directed differentiation of human embryonic stem cells (hESCs). We discovered that the rRNA synthesis rate is reduced similar to 50% within 6 hours of ACTIVIN A treatment. This precedes reductions in expression of specific stem cell markers and increases in expression of specific germ layer markers. The reduction in rRNA synthesis is concomitant with dissociation of the Pol I transcription factor, UBTF, from the rRNA gene promoter and precedes any increase to heterochromatin throughout the rRNA gene. To directly investigate the role of rRNA synthesis in pluripotency, hESCs were treated with the Pol I inhibitor, CX-5461. The direct reduction of rRNA synthesis by CX-5461 induces the expression of markers for all three germ layers, reduces the expression of pluripotency markers, and is overall similar to the ACTIVIN A induced changes. This work indicates that the dissociation of UBTF from the rRNA gene, and corresponding reduction in transcription, represent early regulatory events during the directed differentiation of pluripotent stem cells.	[Woolnough, Jessica L.; Atwood, Blake L.; Liu, Zhong; Zhao, Rui; Giles, Keith E.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Stem Cell Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Giles, KE (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Stem Cell Inst, Birmingham, AL 35294 USA.	kegiles@uab.edu		Makofske, Jessica/0000-0002-6547-6451	State of Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	State of Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by start up funds, State of Alabama.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; [Anonymous], 2014, Cancer Discov, V4, pOF5, DOI 10.1158/2159-8290.CD-NB2014-154; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; BIRD AP, 1981, J MOL BIOL, V152, P1, DOI 10.1016/0022-2836(81)90092-9; Boles NC, 2014, CELL REP, V6, P724, DOI 10.1016/j.celrep.2014.01.026; Cavanaugh AH, 2008, GENE EXPRESSION, V14, P131; CLOS J, 1986, P NATL ACAD SCI USA, V83, P604, DOI 10.1073/pnas.83.3.604; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Hayashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098586; Hou J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-92; Ikonomou L, 2015, J CELL PHYSIOL, V230, P246, DOI 10.1002/jcp.24771; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lee HJ, 2011, IMMUNOL LETT, V140, P92, DOI 10.1016/j.imlet.2011.07.001; Li FM, 2011, J CELL BIOCHEM, V112, P1022, DOI 10.1002/jcb.22962; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MCKNIGHT SL, 1976, CELL, V8, P305, DOI 10.1016/0092-8674(76)90014-3; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Moorefield B, 2000, P NATL ACAD SCI USA, V97, P4724, DOI 10.1073/pnas.080063997; MORGAN GT, 1983, P NATL ACAD SCI-BIOL, V80, P6490, DOI 10.1073/pnas.80.21.6490; Negi SS, 2015, ONCOTARGET; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; Savic N, 2014, CELL STEM CELL, V15, P720, DOI 10.1016/j.stem.2014.10.005; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stefanovsky V, 2006, CELL CYCLE, V5, P735, DOI 10.4161/cc.5.7.2633; Strohner R, 2004, MOL CELL BIOL, V24, P1791, DOI 10.1128/MCB.24.4.1791-1798.2004; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Watanabe-Susaki K, 2014, STEM CELLS, V32, P3099, DOI 10.1002/stem.1825; Woolnough JL, 2015, MOL CELL BIOL, V35, P2278, DOI 10.1128/MCB.00076-15; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zentner GE, 2014, G3-GENES GENOM GENET, V4, P243, DOI 10.1534/g3.113.009290; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	58	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157276	10.1371/journal.pone.0157276	http://dx.doi.org/10.1371/journal.pone.0157276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299313	gold, Green Submitted, Green Published			2022-12-26	WOS:000377822200034
J	Bolsterlee, B; Gandevia, SC; Herbert, RD				Bolsterlee, Bart; Gandevia, Simon C.; Herbert, Robert D.			Effect of Transducer Orientation on Errors in Ultrasound Image-Based Measurements of Human Medial Gastrocnemius Muscle Fascicle Length and Pennation	PLOS ONE			English	Article							ARCHITECTURE; CURVATURE; CHILDREN; ANGLE	Ultrasound imaging is often used to measure muscle fascicle lengths and pennation angles in human muscles in vivo. Theoretically the most accurate measurements are made when the transducer is oriented so that the image plane aligns with muscle fascicles and, for measurements of pennation, when the image plane also intersects the aponeuroses perpendicularly. However this orientation is difficult to achieve and usually there is some degree of misalignment. Here, we used simulated ultrasound images based on three-dimensional models of the human medial gastrocnemius, derived from magnetic resonance and diffusion tensor images, to describe the relationship between transducer orientation and measurement errors. With the transducer oriented perpendicular to the surface of the leg, the error in measurement of fascicle lengths was about 0.4 mm per degree of misalignment of the ultrasound image with the muscle fascicles. If the transducer is then tipped by 20 degrees, the error increases to 1.1 mm per degree of misalignment. For a given degree of misalignment of muscle fascicles with the image plane, the smallest absolute error in fascicle length measurements occurs when the transducer is held perpendicular to the surface of the leg. Misalignment of the transducer with the fascicles may cause fascicle length measurements to be underestimated or overestimated. Contrary to widely held beliefs, it is shown that pennation angles are always overestimated if the image is not perpendicular to the aponeurosis, even when the image is perfectly aligned with the fascicles. An analytical explanation is provided for this finding.	[Bolsterlee, Bart; Gandevia, Simon C.; Herbert, Robert D.] Neurosci Res Australia, Sydney, NSW, Australia; [Bolsterlee, Bart; Gandevia, Simon C.; Herbert, Robert D.] Univ New S Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Bolsterlee, B (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Bolsterlee, B (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	b.bolsterlee@neura.edu.au	; Gandevia, Simon/D-5009-2011	Bolsterlee, Bart/0000-0001-8277-5026; Gandevia, Simon/0000-0002-1345-3821; Herbert, Rob/0000-0003-4188-9195	Australian NHMRC (National Health and Medical Research Council) [APP1055084]	Australian NHMRC (National Health and Medical Research Council)	The study was supported by the Australian NHMRC (National Health and Medical Research Council) (Program Grant APP1055084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SKEKETAL MUSCLE STRU; Benard MR, 2011, J ANAT, V219, P388, DOI 10.1111/j.1469-7580.2011.01402.x; Benard MR, 2009, MUSCLE NERVE, V39, P652, DOI 10.1002/mus.21287; Bolsterlee B, 2016, J BIOMECH, V49, P1002, DOI 10.1016/j.jbiomech.2016.02.014; Bolsterlee B, 2015, J BIOMECH, V48, P1133, DOI 10.1016/j.jbiomech.2015.01.012; Cronin NJ, 2013, GAIT POSTURE, V37, P305, DOI 10.1016/j.gaitpost.2012.07.024; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Darby J, 2013, IEEE T BIO-MED ENG, V60, P1935, DOI 10.1109/TBME.2013.2245328; Diong JHL, 2012, MUSCLE NERVE, V46, P237, DOI 10.1002/mus.23356; Heemskerk AM, 2010, NMR BIOMED, V23, P294, DOI 10.1002/nbm.1463; Herbert RD, 2015, J PHYSIOL-LONDON, V593, P441, DOI 10.1113/jphysiol.2014.279166; HERBERT RD, 1995, J PHYSIOL-LONDON, V484, P523, DOI 10.1113/jphysiol.1995.sp020683; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740, DOI 10.1152/jappl.1993.74.6.2740; Kellis E, 2009, J BIOMECH, V42, P2549, DOI 10.1016/j.jbiomech.2009.07.011; Klimstra M, 2007, J ELECTROMYOGR KINES, V17, P504, DOI 10.1016/j.jelekin.2006.04.011; Lee D, 2015, COMPUT METHOD BIOMEC, V18, P1474, DOI 10.1080/10255842.2014.917294; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129, DOI 10.1152/jappl.2002.92.1.129; Narici MV, 1996, J PHYSIOL-LONDON, V496, P287, DOI 10.1113/jphysiol.1996.sp021685; Rana M, 2014, J APPL PHYSIOL, V117, P1388, DOI 10.1152/japplphysiol.00109.2013; Shortland AP, 2002, DEV MED CHILD NEUROL, V44, P158, DOI 10.1017/S0012162201001864; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhong H, 2008, LECT NOTES COMPUT SC, V5242, P485, DOI 10.1007/978-3-540-85990-1_58	24	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157273	10.1371/journal.pone.0157273	http://dx.doi.org/10.1371/journal.pone.0157273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294280	gold, Green Published, Green Submitted			2022-12-26	WOS:000377821300031
J	Lee, HW; Park, SY; Kim, SU; Jang, JY; Park, H; Kim, JK; Lee, CK; Chon, YE; Han, KH				Lee, Hye Won; Park, Soo Young; Kim, Seung Up; Jang, Jae Young; Park, Hana; Kim, Ja Kyung; Lee, Chun Kyon; Chon, Young Eun; Han, Kwang-Hyub			Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; HEPATIC STEATOSIS; NONINVASIVE ASSESSMENT; SAMPLING VARIABILITY; SCORING SYSTEM; FIBROSIS SCORE; BIOPSY; NAFLD; VALIDATION; PREDICTORS	Background/aims The accuracy of noninvasive markers to discriminate nonalcoholic steatohepatitis (NASH) is unsatisfactory. We investigated whether transient elastography (TE) could discriminate patients with NASH from those with nonalcoholic fatty liver disease (NAFLD). Methods The patients suspected of NAFLD who underwent liver biopsy and concomitant TE were recruited from five tertiary centers between November 2011 and December 2013. Results The study population (n = 183) exhibited a mean age of 40.6 years and male predominance (n = 111, 60.7%). Of the study participants, 89 (48.6%) had non-NASH and 94 (51.4%) had NASH. The controlled attenuation parameter (CAP) and liver stiffness (LS) were significantly correlated with the degrees of steatosis (r = 0.656, P<0.001) and fibrosis (r = 0.714, P<0.001), respectively. The optimal cut-off values for steatosis were 247 dB/m for S1, 280 dB/m for S2, and 300 dB/m for S3. Based on the independent predictors derived from multivariate analysis [P = 0.044, odds ratio (OR) 4.133, 95% confidence interval (CI) 1.037-16.470 for CAP>250 dB/m; P = 0.013, OR 3.399, 95% CI 1.295-8.291 for LS>7.0 kPa; and P<0.001, OR 7.557, 95% CI 2.997-19.059 for Alanine aminotransferase>60 vertical bar U/L], we developed a novel CLA model for discriminating patients with NASH. The CLA model showed good discriminatory capability, with an area under the receiver operating characteristic curve (AUROC) of 0.812 (95% CI 0.724-0.880). To assess discriminatory power, the AUROCs, as determined by the bootstrap method, remained largely unchanged between iterations, with an average value of 0.833 (95% CI 0.740-0.893). Conclusion This novel TE-based CLA model showed acceptable accuracy in discriminating NASH from simple steatosis. However, further studies are required for external validation.	[Lee, Hye Won; Kim, Seung Up; Kim, Ja Kyung; Chon, Young Eun; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea; [Park, Soo Young] Kyungpook Natl Univ, Coll Med, Kyungpook Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Jang, Jae Young] Soonchunhyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Hana] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Bundang, South Korea; [Lee, Chun Kyon] Ilsan Hosp, Natl Hlth Insurance Cooperat, Ilsan, South Korea	Yonsei University; Yonsei University Health System; Kyungpook National University; Kyungpook National University Hospital; Soonchunhyang University; Pochon Cha University; NHIS Ilsan Hospital	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea.; Jang, JY (corresponding author), Soonchunhyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	ksukorea@yuhs.ac; jyjaung@schmc.ac.kr		Han, Kwang-Hyub/0000-0003-3960-6539; KIM, JA KYUNG/0000-0001-5025-6846; Kim, Seung Up/0000-0002-9658-8050	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R&D project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R&D project, Ministry of Health and Welfare, Republic of Korea	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare Technology R&D project, the Ministry of Health and Welfare, Republic of Korea (no. HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2015, CLIN GASTROENTEROL H, V13, P772, DOI 10.1016/j.cgh.2014.12.014; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Aykut UE, 2014, SCAND J GASTROENTERO, V49, P1343, DOI 10.3109/00365521.2014.958099; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cholongitas E, 2006, AM J CLIN PATHOL, V125, P710, DOI 10.1309/W3XCNT4HKFBN2G0B; Chon YE, 2015, DIGEST DIS SCI, V60, P234, DOI 10.1007/s10620-014-3293-1; Chon YE, 2014, LIVER INT, V34, P102, DOI 10.1111/liv.12282; Cordeiro A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/839253; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hyysalo J, 2014, J HEPATOL, V60, P839, DOI 10.1016/j.jhep.2013.12.009; Jia JD, 2015, J GASTROEN HEPATOL, V30, P756, DOI 10.1111/jgh.12840; Jung KS, 2012, CLIN MOL HEPATOL, V18, P163, DOI 10.3350/cmh.2012.18.2.163; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Kwok R, 2016, GUT, V65, P1359, DOI 10.1136/gutjnl-2015-309265; Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007; Lupsor-Platon M, 2015, J GASTROINTEST LIVER, V24, P35, DOI 10.15403/jgld.2014.1121.mlp; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Marcos A, 2000, TRANSPLANTATION, V69, P2410, DOI 10.1097/00007890-200006150-00034; Masaki K, 2013, HEPATOL RES, V43, P1182, DOI 10.1111/hepr.12094; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Ong JP, 2005, OBES SURG, V15, P310, DOI 10.1381/0960892053576820; Pathik P, 2015, ANN GASTROENTEROL, V28, P281; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ratziu V, 2009, BIOMARK MED, V3, P353, DOI 10.2217/BMM.09.36; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Seo YS, 2015, LIVER INT, V35, P2246, DOI 10.1111/liv.12808; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sharma P, 2014, INDIAN J GASTROENTER, V33, P445, DOI 10.1007/s12664-014-0491-x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vuppalanchi R, 2009, CLIN GASTROENTEROL H, V7, P481, DOI 10.1016/j.cgh.2008.12.015; Yamazaki H, 2015, DIABETES CARE, V38, P1673, DOI 10.2337/dc15-0140	45	45	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157358	10.1371/journal.pone.0157358	http://dx.doi.org/10.1371/journal.pone.0157358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284700	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000061
J	Schiffer, JT; Swan, DA; Magaret, A; Schacker, TW; Wald, A; Corey, L				Schiffer, Joshua T.; Swan, David A.; Magaret, Amalia; Schacker, Timothy W.; Wald, Anna; Corey, Lawrence			Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CD8(+) T-CELLS; RAPIDLY CLEARED EPISODES; REACTIVATION; INFECTION; TYPE-2; SKIN; ACTIVATION; VACCINE; HIV	A signature feature of HIV infection is poor control of herpes virus infections, which reactivate from latency and cause opportunistic infections. While the general mechanism underlying this observation is deficient CD4+ T-cell function, it is unknown whether increased severity of herpes virus infections is due primarily to poor immune control in latent or lytic sites of infection, or whether CD4+ immunodeficiency leads to more critical downstream deficits in humoral or cell-mediated immunologic responses. Here we compare genital shedding patterns of herpes simplex virus-2 (HSV-2) in 98 HIV infected and 98 HIV uninfected men matched on length of infection, HSV-1 serostatus and nationality. We demonstrate that high copy HSV-2 shedding is more frequent in HIV positive men, particularly in participants with CD4+ T-cell count < 200/mu L. Genital shedding is more frequent due to higher rate of shedding episodes, as well as a higher proportion of prolonged shedding episodes. Peak episode viral load was not found to differ between HIV infected and uninfected participants regardless of CD4+ T-cell count. We simulate a mathematical model which recapitulates these findings and identifies that rate of HSV-2 release from neural tissue increases, duration of mucosal cytolytic immune protection decreases, and cell-free viral lifespan increases in HIV infected participants. These results suggest that increased HSV-2 shedding in HIV infected persons may be caused by impaired immune function in both latent and lytic tissue compartments, with deficits in clearance of HSV-2 infected cells and extracellular virus.	[Schiffer, Joshua T.; Swan, David A.; Magaret, Amalia; Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Schiffer, Joshua T.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Schiffer, Joshua T.; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Magaret, Amalia; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Magaret, Amalia] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Schacker, Timothy W.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	Schiffer, JT (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Schiffer, JT (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Schiffer, JT (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.	jschiffe@fredhutch.org	Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438	National Institute of Allergy and Infectious Diseases [P01 AI030731, K23 AI087206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042528, K24AI071113, P01AI030731] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grant P01 AI030731 to JTS, AM, and AW and grant K23 AI087206 to JTS. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; Dhankani V, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003922; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gilbert PB, 2014, J INFECT DIS, V210, P1573, DOI 10.1093/infdis/jiu279; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Iversen MB, 2015, IMMUNOBIOLOGY, V220, P762, DOI 10.1016/j.imbio.2014.12.019; Johnson KE, 2009, AIDS, V23, P1807, DOI 10.1097/QAD.0b013e32832efdf1; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Lubinski JM, 2011, J VIROL, V85, P3239, DOI 10.1128/JVI.02509-10; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Mark KE, 2010, JAIDS-J ACQ IMM DEF, V54, P482, DOI 10.1097/QAI.0b013e3181d91322; Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251; NG VL, 1989, BLOOD, V74, P2471; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Posavad CM, 1997, P NATL ACAD SCI USA, V94, P10289, DOI 10.1073/pnas.94.19.10289; Posavad CM, 2004, J INFECT DIS, V190, P693, DOI 10.1086/422755; SACKS SL, 1989, ANN INTERN MED, V111, P893, DOI 10.7326/0003-4819-111-11-893; SAFRIN S, 1991, NEW ENGL J MED, V325, P551, DOI 10.1056/NEJM199108223250805; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schiffer JT, 2013, ANTIMICROB AGENTS CH, V57, P5820, DOI 10.1128/AAC.01114-13; Schiffer JT, 2013, ELIFE, V2, DOI 10.7554/eLife.00288; Schiffer JT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00209; Schiffer JT, 2011, J ANTIMICROB CHEMOTH, V66, P2593, DOI 10.1093/jac/dkr346; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stock AT, 2011, IMMUNOL CELL BIOL, V89, P143, DOI 10.1038/icb.2010.66; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155124	10.1371/journal.pone.0155124	http://dx.doi.org/10.1371/journal.pone.0155124			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285483	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000003
J	Wang, D; Lin, HD; Xia, MF; Aleteng, QQG; Li, XM; Ma, H; Pan, BS; Gao, J; Gao, X				Wang, Dan; Lin, Huandong; Xia, Mingfeng; Aleteng, Qiqige; Li, Xiaoming; Ma, Hui; Pan, Baishen; Gao, Jian; Gao, Xin			Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study	PLOS ONE			English	Article							METABOLIC SYNDROME; 25-HYDROXYVITAMIN D; INSULIN-RESISTANCE; D DEFICIENCY; ULTRASOUND; STEATOSIS; INCREASES; DIAGNOSIS; HISTOLOGY; RECEPTOR	Background/Objectives Vitamin D exerts metabolic activities. We investigated whether the 25-hydroxy vitamin D [25(OH)D] is associated with liver fat content (LFC) and non-alcoholic fatty liver disease (NAFLD) in a middle-aged, elderly Chinese population. Subject/Methods A total of 2,960 participants (954 men and 2,006 women) aged over 45 years old were enrolled. Each participant underwent a standard interview, anthropometric measurements and laboratory examinations. Vitamin D deficiency and insufficiency was diagnosed when serum 25(OH)D level was < 50 and 50-75nmol/L. An ultrasound quantitative method was used to assess the LFC. Results Among the 2,960 participants, 1,982 (67.0%) subjects had vitamin D deficiency, 769 (26.0%) had vitamin D insufficiency, and 209 (7%) had normal vitamin D. Male subjects with vitamin D deficiency and insufficiency had significantly higher LFC than those with normal 25(OH)D (P = 0.034), while the LFC values showed no significant difference among the female subjects with vitamin D sufficiency, insufficiency and deficiency (P = 0.396). Univariate correlation analysis showed that 25(OH)D had a significantly negative association with LFC in men (r = -0.085, P = 0.009), but not in women. After adjusting for age, cigarette smoking, examination season, serum calcium, PTH and all possible confounders that displayed significant associations with LFC in univariate correlation analysis, serum 25(OH)D remained associated with LFC in middle-aged and elderly Chinese men. Conclusion Serum 25(OH)D level was inversely associated with LFC in middle-aged and elderly Chinese men.	[Wang, Dan; Lin, Huandong; Xia, Mingfeng; Aleteng, Qiqige; Li, Xiaoming; Ma, Hui; Gao, Xin] Fudan Univ, Dept Endocrinol & Metab, Shanghai Zhongshan Hosp, Inst Chron Metab Dis, Shanghai 200032, Peoples R China; [Pan, Baishen] Fudan Univ, Zhongshan Hosp, Dept Lab Med, Shanghai 200032, Peoples R China; [Gao, Jian] Fudan Univ, Zhongshan Hosp, Dept Clin Nutr, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Gao, X (corresponding author), Fudan Univ, Dept Endocrinol & Metab, Shanghai Zhongshan Hosp, Inst Chron Metab Dis, Shanghai 200032, Peoples R China.	zhongshan_endo@126.com	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gao, Xin/0000-0003-1864-7796	National Key Basic Research Program of China [2012CB524906]; Shanghai Municipal Health Project Grant [2013ZYJB0802]; Shanghai Health and Family Planning Commission Foundation [12GWZX0103, 2013SY005]; Shanghai Hospital Development Center Foundation [SHDC12012201]	National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Health Project Grant; Shanghai Health and Family Planning Commission Foundation; Shanghai Hospital Development Center Foundation	This work was supported by grants from the National Key Basic Research Program of China (grant no. 2012CB524906 to X. Gao), URL www.973.gov.cn/Default_3.aspx; the Shanghai Municipal Health Project Grant (grant no. 2013ZYJB0802 to X. Gao); the Shanghai Health and Family Planning Commission Foundation (Grant Nos. 12GWZX0103 and 2013SY005 to X. Gao); the Shanghai Hospital Development Center Foundation (SHDC12012201 to X. Gao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Barchetta I, 2012, HEPATOLOGY, V56, P2180, DOI 10.1002/hep.25930; Bhatt SP, 2013, ATHEROSCLEROSIS, V230, P157, DOI 10.1016/j.atherosclerosis.2013.07.006; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Eliades M, 2013, ALIMENT PHARM THER, V38, P246, DOI 10.1111/apt.12377; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Feldman D, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Gao X, 2010, EUR J EPIDEMIOL, V25, P885, DOI 10.1007/s10654-010-9525-6; Jafari T, 2016, CLIN NUTR; Kayaniyil S, 2011, J CLIN ENDOCR METAB, V96, P168, DOI 10.1210/jc.2010-1439; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Kim MK, 2010, CLIN ENDOCRINOL, V73, P330, DOI 10.1111/j.1365-2265.2010.03798.x; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065210; Li XM, 2012, ATHEROSCLEROSIS, V224, P480, DOI 10.1016/j.atherosclerosis.2012.07.002; Lin SC, 2015, CLIN GASTROENTEROL H, V13, P1337, DOI 10.1016/j.cgh.2014.11.027; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Musso G, 2013, TRENDS MOL MED, V19, P522, DOI 10.1016/j.molmed.2013.05.006; Nelson JE, 2016, AM J GASTROENTEROL, V111, P852, DOI 10.1038/ajg.2016.51; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Pilz S, 2016, NAT REV CARDIOL, V13, P404, DOI 10.1038/nrcardio.2016.73; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Sundstrom J, 2008, HEART, V94, P874, DOI 10.1136/hrt.2007.121020; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Verdoia M, 2015, NUTR METAB CARDIOVAS, V25, P464, DOI 10.1016/j.numecd.2015.01.009; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xia MF, 2016, ALIMENT PHARM THER, V43, P631, DOI 10.1111/apt.13521; Xia MF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0766-3; Xia MF, 2015, OBESITY, V23, P1929, DOI 10.1002/oby.21182; Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhai H. L., 2016, BR J NUTR, V115, P1; Zhou QG, 2008, DIABETES-METAB RES, V24, P459, DOI 10.1002/dmrr.873	41	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157515	10.1371/journal.pone.0157515	http://dx.doi.org/10.1371/journal.pone.0157515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284686	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000070
J	Junqueira, VS; Peixoto, LD; Laviola, BG; Bhering, LL; Mendonca, S; Costa, TDA; Antoniassi, R				Junqueira, Vinicius Silva; Peixoto, Leonardo de Azevedo; Laviola, Bruno Galveas; Bhering, Leonardo Lopes; Mendonca, Simone; Agostini Costa, Tania da Silveira; Antoniassi, Rosemar			Bayesian Multi-Trait Analysis Reveals a Useful Tool to Increase Oil Concentration and to Decrease Toxicity in Jatropha curcas L.	PLOS ONE			English	Article							GENETIC-PARAMETERS; MOLECULAR MARKERS; SELECTION; VARIABILITY; BIOFUEL; COLLECTION; MODELS; VALUES; PLANT; SEEDS	The biggest challenge for jatropha breeding is to identify superior genotypes that present high seed yield and seed oil content with reduced toxicity levels. Therefore, the objective of this study was to estimate genetic parameters for three important traits (weight of 100 seed, oil seed content, and phorbol ester concentration), and to select superior genotypes to be used as progenitors in jatropha breeding. Additionally, the genotypic values and the genetic parameters estimated under the Bayesian multi-trait approach were used to evaluate different selection indices scenarios of 179 half-sib families. Three different scenarios and economic weights were considered. It was possible to simultaneously reduce toxicity and increase seed oil content and weight of 100 seed by using index selection based on genotypic value estimated by the Bayesian multi-trait approach. Indeed, we identified two families that present these characteristics by evaluating genetic diversity using the Ward clustering method, which suggested nine homogenous clusters. Future researches must integrate the Bayesian multi- trait methods with realized relationship matrix, aiming to build accurate selection indices models.	[Junqueira, Vinicius Silva] Univ Fed Vicosa, Dept Anim Sci, BR-36570000 Vicosa, MG, Brazil; [Peixoto, Leonardo de Azevedo; Bhering, Leonardo Lopes] Univ Fed Vicosa, Dept Biol, BR-36570000 Vicosa, MG, Brazil; [Laviola, Bruno Galveas; Mendonca, Simone] Embrapa Agroenergia, Empresa Brasileira Pesquisa Agr, Parque Estacao Biol PqEB S-N, BR-70770901 Brasilia, DF, Brazil; [Agostini Costa, Tania da Silveira] Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Recursos Genet & Biotecnol, Final PqEB, PqEB, Parque Estacao Biol,W5 Norte, BR-70770917 Brasilia, DF, Brazil; [Antoniassi, Rosemar] Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Tecnol Agroind Alimentos, Ave Amer 29501 Guaratiba, BR-23020470 Rio De Janeiro, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Peixoto, LD (corresponding author), Univ Fed Vicosa, Dept Biol, BR-36570000 Vicosa, MG, Brazil.	leoazevedop@gmail.com	Laviola, Bruno Galvêas/AAK-8551-2020; Bhering, Leonardo/AAK-9548-2020; Laviola, Bruno G/F-5855-2010	Laviola, Bruno/0000-0002-6360-1204; Bhering, Leonardo/0000-0002-6072-0996; Antoniassi, Rosemar/0000-0002-0795-9877	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Cnpq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Cnpq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior http://www.capes.gov.br/ and Cnpq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico http://cnpq.br/.	ADOLF W, 1984, PHYTOCHEMISTRY, V23, P129, DOI 10.1016/0031-9422(84)83091-5; Akintayo ET, 2004, BIORESOURCE TECHNOL, V92, P307, DOI 10.1016/S0960-8524(03)00197-4; Alves AA, 2015, BIOTECHNOL J, V10, P505, DOI 10.1002/biot.201400201; [Anonymous], 1991, EVALUATING ACCURACY; Bahadur B., 2012, JATROPHA CHALLENGES; Bailis R, 2011, GCB BIOENERGY, V3, P449, DOI 10.1111/j.1757-1707.2011.01100.x; Basha SD, 2007, EUPHYTICA, V156, P375, DOI 10.1007/s10681-007-9387-5; Bhering LL, 2015, IND CROP PROD, V74, P898, DOI 10.1016/j.indcrop.2015.06.004; Bhering LL, 2013, IND CROP PROD, V41, P260, DOI 10.1016/j.indcrop.2012.04.026; Bhering LL, 2012, PESQUI AGROPECU BRAS, V47, P402, DOI 10.1590/S0100-204X2012000300012; Carels N, 2013, JATROPHA CHALLENGES; DIAS L. A. S., 2007, CULTIVO PINHAOMANSO; Franco J, 2001, THEOR APPL GENET, V103, P944, DOI 10.1007/s001220100641; Gomes RA, 2014, IND CROP PROD, V52, P512, DOI 10.1016/j.indcrop.2013.10.036; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Gupta P, 2012, MOL BREEDING, V30, P1325, DOI 10.1007/s11032-012-9719-6; Hayashi T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-34; Hazel LN, 1943, GENETICS, V28, P476; Laviola BG, 2012, CIENC RURAL, V42, P429, DOI 10.1590/S0103-84782012000300008; Laviola BG, 2010, PESQUI AGROPECU BRAS, V45, P1117, DOI 10.1590/S0100-204X2010001000010; LIBERALINO AAA, 1988, ARQ BIOL TECNOL, V31, P539; Makkar HPS, 1998, FOOD CHEM, V62, P207, DOI 10.1016/S0308-8146(97)00183-0; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MISZTAL I., 2002, WORLD C GEN APPL LIV, V7; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; Nithiyanantham S, 2012, J AM OIL CHEM SOC, V89, P961, DOI 10.1007/s11746-012-2012-3; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Peixoto LD, 2016, IND CROP PROD, V80, P70, DOI 10.1016/j.indcrop.2015.10.034; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Resende JCF, 2013, PINHAO MANSO; Rolf MM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0106-8; Rosado TB, 2010, CROP SCI, V50, P2372, DOI 10.2135/cropsci2010.02.0112; Singh P, 2010, GENES GENOMES GENOMI, V4, P1, DOI DOI 10.1007/S11033-009-9712-2; Smith BJ, 2007, J STAT SOFTW, V21, P1; Spinelli VM, 2015, IND CROP PROD, V69, P355, DOI 10.1016/j.indcrop.2015.02.024; Team RC, 2012, R LANG ENV STAT COMP; Ventura HT, 2015, LIVEST SCI, V176, P47, DOI 10.1016/j.livsci.2015.03.030	38	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157038	10.1371/journal.pone.0157038	http://dx.doi.org/10.1371/journal.pone.0157038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281340	Green Published, gold			2022-12-26	WOS:000377563000072
J	Yang, CC; Chen, FL; Lo, YC				Yang, Ching-Ching; Chen, Fong-Lin; Lo, Yeh-Chi			Improving Image Quality of On-Board Cone-Beam CT in Radiation Therapy Using Image Information Provided by Planning Multi-Detector CT: A Phantom Study	PLOS ONE			English	Article							X-RAY SCATTER; RADIOTHERAPY; NECK; HEAD	Purpose The aim of this study was to improve the image quality of cone-beam computed tomography (CBCT) mounted on the gantry of a linear accelerator used in radiation therapy based on the image information provided by planning multi-detector CT (MDCT). Methods MDCT-based shading correction for CBCT and virtual monochromatic CT (VMCT) synthesized using the dual-energy method were performed. In VMCT, the high-energy data were obtained from CBCT, while the low-energy data were obtained from MDCT. An electron density phantom was used to investigate the efficacy of shading correction and VMCT on improving the target detectability, Hounsfield unit (HU) accuracy and variation, which were quantified by calculating the contrast-to-noise ratio (CNR), the percent difference (%Diff) and the standard deviation of the CT numbers for tissue equivalent background material, respectively. Treatment plan studies for a chest phantom were conducted to investigate the effects of image quality improvement on dose planning. Results For the electron density phantom, the mean value of CNR was 17.84, 26.78 and 34.31 in CBCT, shading-corrected CBCT and VMCT, respectively. The mean value of %Diff was 152.67%, 11.93% and 7.66% in CBCT, shading-corrected CBCT and VMCT, respectively. The standard deviation within a uniform background of CBCT, shading-corrected CBCT and VMCT was 85, 23 and 15 HU, respectively. With regards to the chest phantom, the monitor unit (MU) difference between the treatment plan calculated using MDCT and those based on CBCT, shading corrected CBCT and VMCT was 6.32%, 1.05% and 0.94%, respectively. Conclusions Enhancement of image quality in on-board CBCT can contribute to daily patient setup and adaptive dose delivery, thus enabling higher confidence in patient treatment accuracy in radiation therapy. Based on our results, VMCT has the highest image quality, followed by the shading corrected CBCT and the original CBCT. The research results presented in this study should be able to provide a route to reach a high level of image quality for CBCT imaging in radiation oncology.	[Yang, Ching-Ching] Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan; [Chen, Fong-Lin] Koo Fdn Sun Yat Sen Canc Ctr, Dept Med Phys, Taipei, Taiwan; [Lo, Yeh-Chi] Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY USA	Tzu Chi University of Science & Technology; Icahn School of Medicine at Mount Sinai	Yang, CC (corresponding author), Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan.	cyang@tcust.edu.tw		Yang, Ching-Ching/0000-0002-9420-3102				Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Boda-Heggemann J, 2011, STRAHLENTHER ONKOL, V187, P284, DOI 10.1007/s00066-011-2236-4; Chen GTY, 2009, RADIOL PHYS TECHNOL, V2, P1, DOI 10.1007/s12194-008-0045-y; Chuanyong B, 2003, NUCL SCI IEEE T, V50, P1510, DOI [10.1109/tns.2003.817281, DOI 10.1109/TNS.2003.817281]; Elstrom UV, 2011, ACTA ONCOL, V50, P908, DOI 10.3109/0284186X.2011.590525; Endo M, 2001, MED PHYS, V28, P469, DOI 10.1118/1.1357457; Glide-Hurst C, 2013, MED PHYS, V40, DOI 10.1118/1.4805102; Goldman LW, 2007, J NUCL MED TECHNOL, V35, DOI 10.2967/jnmt.106.037846; Guckenberger M, 2007, STRAHLENTHER ONKOL, V183, P307, DOI 10.1007/s00066-007-1695-0; Hsieh J, 2000, MED PHYS, V27, P23, DOI 10.1118/1.598853; Li H, 2012, MED PHYS, V39, P6056, DOI 10.1118/1.4752212; Marchant TE, 2008, PHYS MED BIOL, V53, P5719, DOI 10.1088/0031-9155/53/20/010; Miracle AC, 2009, AM J NEURORADIOL, V30, P1088, DOI 10.3174/ajnr.A1653; Oldham M, 2005, RADIOTHER ONCOL, V75, P271, DOI 10.1016/j.radonc.2005.03.026; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Siewerdsen JH, 2006, MED PHYS, V33, P187, DOI 10.1118/1.2148916; Siewerdsen JH, 2001, MED PHYS, V28, P220, DOI 10.1118/1.1339879; Srinivasan K, 2014, POL J RADIOL, V79, P181, DOI 10.12659/PJR.890745; Steinke MF, 2008, AUSTRALAS PHYS ENG S, V31, P167, DOI 10.1007/BF03179341; van Zijtvetd M, 2007, RADIOTHER ONCOL, V85, P195, DOI 10.1016/j.radonc.2007.08.010; Wagenaar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127932; Yang Y, 2007, PHYS MED BIOL, V52, P685, DOI 10.1088/0031-9155/52/3/011; Yoo S, 2006, INT J RADIAT ONCOL, V66, P1553, DOI 10.1016/j.ijrobp.2006.08.031; Yu HY, 2007, ACAD RADIOL, V14, P495, DOI 10.1016/j.acra.2006.12.015	24	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157072	10.1371/journal.pone.0157072	http://dx.doi.org/10.1371/journal.pone.0157072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280593	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000076
J	Bal, NC; Maurya, SK; Singh, S; Wehrens, XHT; Periasamy, M				Bal, Naresh C.; Maurya, Santosh K.; Singh, Sushant; Wehrens, Xander H. T.; Periasamy, Muthu			Increased Reliance on Muscle-based Thermogenesis upon Acute Minimization of Brown Adipose Tissue Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium transport; mitochondria; mitochondrial metabolism; sarcoplasmic reticulum (SR); skeletal muscle; cold adaptation; core body temperature; mitochondrial dynamics; brown adipose tissue	ADAPTIVE NONSHIVERING THERMOGENESIS; COLD-ACCLIMATED DUCKLINGS; SKELETAL-MUSCLE; RYANODINE RECEPTOR; CA2+ TRANSPORT; CALCIUM-UPTAKE; SARCOLIPIN; MITOCHONDRIAL; MICE; PROTEIN	Skeletal muscle has been suggested as a site of nonshivering thermogenesis (NST) besides brown adipose tissue (BAT). Studies in birds, which do not contain BAT, have demonstrated the importance of skeletal muscle-based NST. However, muscle-based NST in mammals remains poorly characterized. We recently reported that sarco/endoplasmic reticulum Ca2+ cycling and that its regulation by SLN can be the basis for muscle NST. Because of the dominant role of BAT-mediated thermogenesis in rodents, the role of muscle-based NST is less obvious. In this study, we investigated whether muscle will become an important site of NST when BAT function is conditionally minimized in mice. We surgically removed interscapular BAT (iBAT, which constitutes approximate to 70% of total BAT) and exposed the mice to prolonged cold (4 degrees C) for 9 days. The iBAT-ablated mice were able to maintain optimal body temperature (approximate to 35-37 degrees C) during the entire period of cold exposure. After 4 days in the cold, both sham controls and iBAT-ablated mice stopped shivering and resumed routine physical activity, indicating that they are cold-adapted. The iBAT-ablated mice showed higher oxygen consumption and decreased body weight and fat mass, suggesting an increased energy cost of cold adaptation. The skeletal muscles in these mice underwent extensive remodeling of both the sarcoplasmic reticulum and mitochondria, including alteration in the expression of key components of Ca2+ handling and mitochondrial metabolism. These changes, along with increased sarcolipin expression, provide evidence for the recruitment of NST in skeletal muscle. These studies collectively suggest that skeletal muscle becomes the major site of NST when BAT activity is minimized.	[Bal, Naresh C.; Maurya, Santosh K.; Singh, Sushant; Periasamy, Muthu] Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL 32827 USA; [Bal, Naresh C.; Maurya, Santosh K.; Singh, Sushant; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bal, Naresh C.] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Odisha, India; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Cardiovasc Res Inst, Houston, TX 77030 USA; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Med, Cardiovasc Res Inst, Houston, TX 77030 USA; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Pediat, Cardiovasc Res Inst, Houston, TX 77030 USA	Sanford Burnham Prebys Medical Discovery Institute; University System of Ohio; Ohio State University; Kalinga Institute of Industrial Technology (KIIT); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bal, NC (corresponding author), Sanford Burnham Preby Med Discovery Inst, 6400 Sanger Rd, Orlando, FL 32827 USA.	nbal@sbpdiscovery.org	Maurya, Santosh/O-9066-2017; Singh, Sushant/AAQ-7930-2021; Wehrens, Xander/AAQ-9574-2020; Singh, Sushant/AAP-3860-2020	Maurya, Santosh/0000-0002-7610-2463; Singh, Sushant/0000-0002-0858-4405; Wehrens, Xander/0000-0001-5044-672X; 	National Institutes of Health [R01-HL 088555, R01 DK098240-01, R01-HL089598, R01-HL091947, R01-HL117641]; NIDDK, National Institutes of Health [DK102772]; American Heart Association [13EIA14560061]; Department of Biotechnology, India; American Physiological Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555, R01HL089598, R01HL117641, R01HL091947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240, K01DK102772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); Department of Biotechnology, India(Department of Biotechnology (DBT) India); American Physiological Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01-HL 088555 and R01 DK098240-01 (to M. P.) and R01-HL089598, R01-HL091947, and R01-HL117641 (to X. H. T. W.). The research reported in this publication was supported in part by the NIDDK, National Institutes of Health under Award DK102772 (to N. C. B.) and by American Heart Association Grant 13EIA14560061 (to X. H. T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a Ramalingaswamy Re-entry Fellowship from the Department of Biotechnology, India. Supported by a postdoctoral fellowship in physiological genomics from the American Physiological Society. To whom correspondence should be addressed: 6400 Sanger Rd., Sanford Burnham Preby Medical Discovery Institute, Lake Nona, Orlando, FL 32827. Fax: 407-745-2001. E-mail: nbal@sbpdiscovery.org or naresh.bal@kiitbiotech.ac.in.	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Arruda AP, 2008, ENDOCRINOLOGY, V149, P6262, DOI 10.1210/en.2008-0564; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Blondin DP, 2015, J PHYSIOL-LONDON, V593, P701, DOI 10.1113/jphysiol.2014.283598; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS TRA, 1967, AM J PHYSIOL, V213, P1423, DOI 10.1152/ajplegacy.1967.213.6.1423; DUCHAMP C, 1991, AM J PHYSIOL, V261, pR1438, DOI 10.1152/ajpregu.1991.261.6.R1438; DUCHAMP C, 1993, AM J PHYSIOL, V265, pR1076, DOI 10.1152/ajpregu.1993.265.5.R1076; DUMONTEIL E, 1993, AM J PHYSIOL, V265, pC507, DOI 10.1152/ajpcell.1993.265.2.C507; DUMONTEIL E, 1995, AM J PHYSIOL-CELL PH, V269, pC955, DOI 10.1152/ajpcell.1995.269.4.C955; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Gamu D, 2014, EXERC SPORT SCI REV, V42, P136, DOI 10.1249/JES.0000000000000016; Garcia-Perez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011; Gehlert S, 2015, INT J MOL SCI, V16, P1066, DOI 10.3390/ijms16011066; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; GRAV HJ, 1979, SCIENCE, V204, P87, DOI 10.1126/science.219477; GRAV HJ, 1988, J COMP PHYSIOL B, V158, P513, DOI 10.1007/BF00692558; GREENWAY DC, 1978, AM J PHYSIOL, V234, pC7, DOI 10.1152/ajpcell.1978.234.1.C7; HELDMAIER G, 1985, J COMP PHYSIOL B, V156, P237, DOI 10.1007/BF00695778; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; JANSKY L, 1973, BIOL REV, V48, P85; JANSKY L, 1973, PHYSIOL BOHEMOSLOV, V22, P125; Louzada RA, 2014, AM J PHYSIOL-ENDOC M, V307, pE1020, DOI 10.1152/ajpendo.00637.2013; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; Maurya SK, 2015, PHARMACOL RES, V102, P270, DOI 10.1016/j.phrs.2015.10.020; McKay WP, 2013, APPL PHYSIOL NUTR ME, V38, P227, DOI 10.1139/apnm-2011-0358; MILNER RE, 1989, AM J PHYSIOL, V256, pR42, DOI 10.1152/ajpregu.1989.256.1.R42; Mineo PM, 2012, COMP BIOCHEM PHYS A, V161, P395, DOI 10.1016/j.cbpa.2011.12.012; NEDERGAARD J, 1984, AM J PHYSIOL, V247, pR506, DOI 10.1152/ajpregu.1984.247.3.R506; Nedergaard J, 2001, BIOCHEM SOC T, V29, P756; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Pant M, 2015, J EXP BIOL, V218, P2321, DOI 10.1242/jeb.119164; Paran CW, 2015, OBESITY, V23, P1440, DOI 10.1002/oby.21123; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Rowland LA, 2015, BIOL REV, V90, P1279, DOI 10.1111/brv.12157; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Shaikh SA, 2016, J MOL CELL CARDIOL, V91, P81, DOI 10.1016/j.yjmcc.2015.12.030; Shum A Y, 1991, Chin J Physiol, V34, P427; Song MS, 2015, CELL METAB, V21, P195, DOI 10.1016/j.cmet.2014.12.019; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Teets NM, 2013, P NATL ACAD SCI USA, V110, P9154, DOI 10.1073/pnas.1306705110; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2	53	52	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17247	17257		10.1074/jbc.M116.728188	http://dx.doi.org/10.1074/jbc.M116.728188			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27298322	Green Published, hybrid			2022-12-26	WOS:000382643800026
J	Akabane, S; Matsuzaki, K; Yamashita, S; Arai, K; Okatsu, K; Kanki, T; Matsuda, N; Oka, T				Akabane, Shiori; Matsuzaki, Kohei; Yamashita, Shun-ichi; Arai, Kana; Okatsu, Kei; Kanki, Tomotake; Matsuda, Noriyuki; Oka, Toshihiko			Constitutive Activation of PINK1 Protein Leads to Proteasome-mediated and Non-apoptotic Cell Death Independently of Mitochondrial Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE PARKIN; MEMBRANE PERMEABILIZATION; DAMAGED MITOCHONDRIA; OXIDATIVE STRESS; OUTER-MEMBRANE; CYTOCHROME-C; RECRUITMENT; IDENTIFICATION; DEGRADATION; MITOPHAGY	Phosphatase and tensin homolog-induced putative kinase 1 (PINK1), a Ser/Thr kinase, and PARKIN, a ubiquitin ligase, are causal genes for autosomal recessive early-onset parkinsonism. Multiple lines of evidence indicate that PINK1 and PARKIN cooperatively control the quality of the mitochondrial population via selective degradation of damaged mitochondria by autophagy. Here, we report that PINK1 and PARKIN induce cell death with a 12-h delay after mitochondrial depolarization, which differs from the time profile of selective autophagy of mitochondria. This type of cell death exhibited definite morphologic features such as plasma membrane rupture, was insensitive to a pan-caspase inhibitor, and did not involve mitochondrial permeability transition. Expression of a constitutively active form of PINK1 caused cell death in the presence of a pan-caspase inhibitor, irrespective of the mitochondrial membrane potential. PINK1-mediated cell death depended on the activities of PARKIN and proteasomes, but it was not affected by disruption of the genes required for autophagy. Furthermore, fluorescence and electron microscopic analyses revealed that mitochondria were still retained in the dead cells, indicating that PINK1-mediated cell death is not caused by mitochondrial loss. Our findings suggest that PINK1 and PARKIN play critical roles in selective cell death in which damaged mitochondria are retained, independent of mitochondrial autophagy.	[Akabane, Shiori; Matsuzaki, Kohei; Arai, Kana; Oka, Toshihiko] Rikkyo Univ, Dept Life Sci, Toshima Ku, 34-1 Nishi Ikebukuro, Tokyo 1718501, Japan; [Yamashita, Shun-ichi; Kanki, Tomotake] Niigata Univ, Inst Nephrol, Dept Cellular Physiol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Okatsu, Kei; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Tokyo 1568506, Japan; [Okatsu, Kei] Univ Tokyo, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan	Rikkyo University; Niigata University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo	Oka, T (corresponding author), Rikkyo Univ, Dept Life Sci, Toshima Ku, 34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	toka@rikkyo.ac.jp	Matsuda, Noriyuki/AAI-3156-2020; Kanki, Tomotake/H-7250-2012	Matsuda, Noriyuki/0000-0001-8199-952X; Kanki, Tomotake/0000-0001-9646-5379; Okatsu, Kei/0000-0001-8949-3750	Japan Society for the Promotion of Science; CREST grant from the Japan Science and Technology Corp.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST grant from the Japan Science and Technology Corp.	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and a CREST grant from the Japan Science and Technology Corp. (to T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Aki T, 2015, TOXICOLOGY, V333, P118, DOI 10.1016/j.tox.2015.04.003; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kazlauskaite A, 2015, FEBS J, V282, P215, DOI 10.1111/febs.13127; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Okatsu K, 2015, J CELL SCI, V128, P964, DOI 10.1242/jcs.161000; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zhu H, 2007, BBA-MOL CELL RES, V1773, P593, DOI 10.1016/j.bbamcr.2007.01.008	45	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16162	16174		10.1074/jbc.M116.714923	http://dx.doi.org/10.1074/jbc.M116.714923			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27302064	Green Published, hybrid			2022-12-26	WOS:000380585400021
J	Bellan, V; Wallwork, SB; Stanton, TR; Reverberi, C; Gallace, A; Moseley, GL				Bellan, Valeria; Wallwork, Sarah B.; Stanton, Tasha R.; Reverberi, Carlo; Gallace, Alberto; Moseley, G. Lorimer			No Telescoping Effect with Dual Tendon Vibration	PLOS ONE			English	Article							PROPRIOCEPTIVE ILLUSIONS; MUSCLE VIBRATION; LIMB POSITION; PHANTOM-LIMB; BODY SHAPE; ONE ARM; MOVEMENT; REPRESENTATION; CONTRACTION; PERCEPTION	The tendon vibration illusion has been extensively used to manipulate the perceived position of one's own body part. However, findings from previous research do not seem conclusive sregarding the perceptual effect of the concurrent stimulation of both agonist and antagonist tendons over one joint. On the basis of recent data, it has been suggested that this paired stimulation generates an inconsistent signal about the limb position, which leads to a perceived shrinkage of the limb. However, this interesting effect has never been replicated. The aim of the present study was to clarify the effect of a simultaneous and equal vibration of the biceps and triceps tendons on the perceived location of the hand. Experiment 1 replicated and extended the previous findings. We compared a dual tendon stimulation condition with single tendon stimulation conditions and with a control condition ( no vibration) on both 'upward-downward' and 'towards-away from the elbow' planes. Our results show a mislocalisation towards the elbow of the position of the vibrated arm during dual vibration, in line with previous results; however, this did not clarify whether the effect was due to arm representation contraction (i.e., a 'telescoping' effect). Therefore, in Experiment 2 we investigated explicitly and implicitly the perceived arm length during the same conditions. Our results clearly suggest that in all the vibration conditions there was a mislocalisation of the entire arm (including the elbow), but no evidence of a contraction of the perceived arm length.	[Bellan, Valeria; Wallwork, Sarah B.; Stanton, Tasha R.; Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Bellan, Valeria; Wallwork, Sarah B.; Stanton, Tasha R.; Moseley, G. Lorimer] PainAdelaide, Adelaide, SA, Australia; [Bellan, Valeria; Reverberi, Carlo; Gallace, Alberto] Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy; [Bellan, Valeria; Reverberi, Carlo; Gallace, Alberto] NeuroMI Milan Ctr Neurosci, Milan, Italy; [Stanton, Tasha R.; Moseley, G. Lorimer] Neurosci Res Australia, Randwick, NSW 2031, Australia	University of South Australia; University of Milano-Bicocca; Neuroscience Research Australia	Moseley, GL (corresponding author), Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.; Moseley, GL (corresponding author), PainAdelaide, Adelaide, SA, Australia.; Moseley, GL (corresponding author), Neurosci Res Australia, Randwick, NSW 2031, Australia.	Lorimer.Moseley@unisa.edu.au	Moseley, Lorimer/A-7095-2009; Bellan, Valeria/J-4490-2018; Stanton, Tasha/F-4038-2013; Wallwork, Sarah/CAJ-0955-2022	Moseley, Lorimer/0000-0002-3750-4945; Bellan, Valeria/0000-0002-8512-5288; Stanton, Tasha/0000-0001-7106-4456; Wallwork, Sarah/0000-0003-1170-6263; GALLACE, ALBERTO/0000-0002-4561-8926	National Health & Medical Research Council of Australia [1008017]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was funded by a project grant from the National Health & Medical Research Council of Australia (ID 1008017) (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo DE, 2012, NEUROSCI LETT, V516, P188, DOI 10.1016/j.neulet.2012.03.077; Bellan V, 2015, EXP BRAIN RES, V233, P1689, DOI 10.1007/s00221-015-4242-8; Calvin-Figuiere S, 1999, EXP BRAIN RES, V124, P342, DOI 10.1007/s002210050631; Cody FWJ, 2008, NEUROSCI LETT, V433, P103, DOI 10.1016/j.neulet.2007.12.054; CORDO P, 1993, ELECTROEN CLIN NEURO, V89, P45, DOI 10.1016/0168-5597(93)90084-3; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; EKLUND G, 1972, J NEUROL NEUROSUR PS, V35, P606, DOI 10.1136/jnnp.35.5.606; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Fuentes CT, 2012, EUR J NEUROSCI, V36, P3709, DOI 10.1111/ejn.12004; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; GILHODES JC, 1986, EXP BRAIN RES, V61, P395; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Hakuta N, 2014, EXP BRAIN RES, V232, P2197, DOI 10.1007/s00221-014-3911-3; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Longo MR, 2009, CURR BIOL, V19, pR727, DOI 10.1016/j.cub.2009.07.024; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; Moseley GL, 2009, P NATL ACAD SCI USA, V106, P18798, DOI 10.1073/pnas.0907151106; Newport R, 2011, CURR BIOL, V21, pR804, DOI 10.1016/j.cub.2011.08.044; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Schofield JS, 2015, TECHNOL HEALTH CARE, V23, P129, DOI 10.3233/THC-140879; Stanton TR, 2016, PHYS THER, V96, P876, DOI 10.2522/ptj.20150241; Tidoni E, 2015, EXP BRAIN RES, V233, P375, DOI 10.1007/s00221-014-4121-8; Tsuge M, 2012, EXP BRAIN RES, V223, P541, DOI 10.1007/s00221-012-3281-7; Winter JA, 2005, J PHYSIOL-LONDON, V568, P1035, DOI 10.1113/jphysiol.2005.092619	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157351	10.1371/journal.pone.0157351	http://dx.doi.org/10.1371/journal.pone.0157351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305112	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000377824800051
J	Mansouri, S; Lietzau, G; Lundberg, M; Nathanson, D; Nystrom, T; Patrone, C				Mansouri, Shiva; Lietzau, Grazyna; Lundberg, Mathias; Nathanson, David; Nystrom, Thomas; Patrone, Cesare			Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; COGNITIVE FUNCTION; NEURODEGENERATIVE DISEASES; VASCULAR-DISEASE; RECEPTOR AGONIST; GLYCEMIC CONTROL; NEURONAL DEATH; CYCLOSPORINE-A; IN-VITRO; NEUROGENESIS	Hypoglycaemia is a common side-effect of glucose-lowering therapies for type-2 diabetic patients, which may cause cognitive/neurological impairment. Although the effects of hypoglycaemia in the brain have been extensively studied in neurons, how hypoglycaemia impacts the viability of adult neural stem cells (NSCs) has been poorly investigated. In addition, the cellular and molecular mechanisms of how hypoglycaemia regulates NSCs survival have not been characterized. Recent work others and us have shown that the pituitary adenylate cyclase-activating polypeptide (PACAP) and the glucagon-like peptide-1 receptor (GLP-1R) agonist Exendin-4 stimulate NSCs survival against glucolipoapoptosis. The aim of this study was to establish an in vitro system where to study the effects of hypoglycaemia on NSC survival. Furthermore, we determine the potential role of PACAP and Exendin-4 in counteracting the effect of hypoglycaemia. A hypoglycaemic in vitro milieu was mimicked by exposing subventricular zone-derived NSC to low levels of glucose. Moreover, we studied the potential involvement of apoptosis and endoplasmic reticulum stress by quantifying protein levels of Bcl-2, cleaved caspase-3 and mRNA levels of CHOP. We show that PACAP via PAC-1 receptor and PKA activation counteracts impaired NSC viability induced by hypoglycaemia. The protective effect induced by PACAP correlated with endoplasmic reticulum stress, Exendin-4 was ineffective. The results show that hypoglycaemia decreases NSC viability and that this effect can be substantially counteracted by PACAP via PAC-1 receptor activation. The data supports a potential therapeutic role of PAC-1 receptor agonists for the treatment of neurological complications, based on neurogenesis impairment by hypoglycaemia.	[Mansouri, Shiva; Lietzau, Grazyna; Lundberg, Mathias; Nathanson, David; Nystrom, Thomas; Patrone, Cesare] Karolinska Inst, Dept Clin Sci & Educ, Internal Med, Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital	Mansouri, S (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Internal Med, Sodersjukhuset, Stockholm, Sweden.	shiva.mansouri@ki.se		Lietzau, Grazyna/0000-0001-5119-3082	Novo Nordisk foundation [5421]; Diabetesfonden [DIA2013-010]; Swedish Heart and Lung Foundation [20130523]; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; foundations Magnus Bergvalls; Syskonen Svensson; Ahlen; STROKE Riksforbundet; Gamla Tjanarinnor	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Diabetesfonden; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; foundations Magnus Bergvalls; Syskonen Svensson; Ahlen; STROKE Riksforbundet; Gamla Tjanarinnor	This work was supported by Novo Nordisk foundation [Grant number 5421], (http://www.novonordiskfonden.dk/en/grantrecipients?field_date_value%5Bvalue%5D&field_date_value_1%5Bvalue%5D&field_related_center_tid=All&keys=&page=1), Diabetesfonden [Grant number DIA2013-010], (http://www.diabetesfonden.se/Forskning/Beviljade-projekt/), The Swedish Heart and Lung Foundation [grant number: 20130523, (http://www.hjartlungfonden.se/Forskning/), The fighting stroke project (Uppdrag Besegra Stroke). This work has also been supported by grants from: Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, The foundations Magnus Bergvalls, Syskonen Svensson, Ahlen, STROKE Riksforbundet, Gamla Tjanarinnor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago Y, 2011, NEUROSCIENCE, V172, P554, DOI 10.1016/j.neuroscience.2010.10.044; Ahren B, 2013, VASC HEALTH RISK MAN, V9, P155, DOI 10.2147/VHRM.S33934; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; AUER RN, 1986, STROKE, V17, P699, DOI 10.1161/01.STR.17.4.699; AUER RN, 1993, BAILLIERE CLIN ENDOC, V7, P611, DOI 10.1016/S0950-351X(05)80210-1; Aung PP, 2012, DIABETIC MED, V29, P328, DOI 10.1111/j.1464-5491.2011.03505.x; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7921; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Buse JB, 2010, DIABETES CARE, V33, P1255, DOI 10.2337/dc09-1914; Cavaliere F, 2006, EXP NEUROL, V201, P66, DOI 10.1016/j.expneurol.2006.03.020; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; Darsalia V, 2014, REV ENDOCR METAB DIS, V15, P233, DOI 10.1007/s11154-014-9285-9; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; Dave KR, 2011, STROKE, V42, P1404, DOI 10.1161/STROKEAHA.110.594937; de Galan BE, 2009, DIABETOLOGIA, V52, P2328, DOI 10.1007/s00125-009-1484-7; Dey J, 1997, DIABETES CARE, V20, P32, DOI 10.2337/diacare.20.1.32; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Estrada FS, 2009, NEUROSCI LETT, V459, P109, DOI 10.1016/j.neulet.2009.05.016; Fanelli CG, 2004, DIABETES-METAB RES, V20, pS32, DOI 10.1002/dmrr.514; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Frier BM, 2011, DIABETES CARE, V34, pS132, DOI 10.2337/dc11-s220; Fujioka M, 1997, STROKE, V28, P584, DOI 10.1161/01.STR.28.3.584; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Hershey T, 2010, DIABETES, V59, P236, DOI 10.2337/db09-1117; Holt Paula, 2011, Br J Community Nurs, V16, P246; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Jang BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076466; Jauch-Chara K, 2014, NEUROSCIENCE, V283, P202, DOI 10.1016/j.neuroscience.2014.04.059; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee CW, 2013, CURR ALZHEIMER RES, V10, P298, DOI 10.2174/1567205011310030009; Lee DA, 2012, INT J DEV NEUROSCI, V30, P615, DOI 10.1016/j.ijdevneu.2012.07.003; Leyton J, 1998, CANCER LETT, V125, P131, DOI 10.1016/S0304-3835(97)00525-9; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654; Mansouri S, 2013, J NEUROCHEM, V127, P209, DOI 10.1111/jnc.12396; Mansouri S, 2012, J NEUROSCI RES, V90, P759, DOI 10.1002/jnr.22803; Mansouri Shiva D V, 2014, J DIABETES METABOLIS, V5; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McNay EC, 2010, PHYSIOL BEHAV, V100, P234, DOI 10.1016/j.physbeh.2010.01.004; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monnier L, 2009, DIABETES-METAB RES, V25, P393, DOI 10.1002/dmrr.962; Ogata K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120526; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Persson K, 2002, ACTA PHYSIOL SCAND, V175, P25, DOI 10.1046/j.1365-201X.2002.00977.x; Punthakee Z, 2012, DIABETES CARE, V35, P787, DOI 10.2337/dc11-1855; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rosenstock J, 2014, DIABETES CARE, V37, P2317, DOI 10.2337/dc14-0001; Ruan LH, 2014, PROG NEUROBIOL, V115, P116, DOI 10.1016/j.pneurobio.2013.12.006; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sander D, 2009, J NEUROL, V256, P1603, DOI 10.1007/s00415-009-5143-1; Snell-Bergeon JK, 2012, DIABETES TECHNOL THE, V14, pS51, DOI 10.1089/dia.2012.0031; Soares MBP, 1998, J IMMUNOL, V160, P1811; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2005, DIABETES, V54, P500, DOI 10.2337/diabetes.54.2.500; Suh SW, 2003, J NEUROSCI, V23, P10681; Tong L, 1998, J NEURAL TRANSM, V105, P905, DOI 10.1007/s007020050101; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Xu YY, 2011, BRAIN RES, V1375, P49, DOI 10.1016/j.brainres.2010.12.029; Yamada KA, 2004, PEDIATR RES, V55, P372, DOI 10.1203/01.PDR.0000110523.07240.C1; Yang Y.J., 2013, ABSTR APPL ANAL, V2013, P7, DOI DOI 10.1016/J.NEUR0SCIENCE.2013.07.009	72	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156867	10.1371/journal.pone.0156867	http://dx.doi.org/10.1371/journal.pone.0156867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305000	Green Submitted, gold, Green Published			2022-12-26	WOS:000377824800028
J	Roberts, GC; Morris, PG; Moss, MA; Maltby, SL; Palmer, CA; Nash, CE; Smart, E; Holliday, DL; Speirs, V				Roberts, Grace C.; Morris, Paul G.; Moss, Marcus A.; Maltby, Sarah L.; Palmer, Chelsea A.; Nash, Claire E.; Smart, Emily; Holliday, Deborah L.; Speirs, Valerie			An Evaluation of Matrix-Containing and Humanised Matrix-Free 3-Dimensional Cell Culture Systems for Studying Breast Cancer	PLOS ONE			English	Article							IN-VITRO MODEL; FRAGMENTATION; MORPHOGENESIS; EXPRESSION; CASPASE-3; ADHESION; INVASION; INDUCE; TISSUE; ASSAYS	Background 3D cell cultures are emerging as more physiologically meaningful alternatives to monolayer cultures for many biological applications. They are attractive because they more closely mimic in vivo morphology, especially when co-cultured with stromal fibroblasts. Methodology/Principal Findings We compared the efficacy of 3 different 3D cell culture systems; collagen I, low attachment culture vessels and a modification of Fibrolife (R), a specialised humanised cell culture medium devoid of animal-derived components, using breast cancer cell lines representative of the different molecular subtypes of breast cancer, cultured alone or with human mammary fibroblasts with a view to developing matrix-free humanised systems. 3D collagen I culture supported the growth of a range of breast cancer cell lines. By modifying the composition of Fibrolife (R) to epiFL, matrix-free cell culture was possible. During sequential transfer to epiFL breast cancer cells gradually detached from the flask, growing progressively as spheroids. Phenotype was stable and reversible with cells remaining actively proliferating and easily accessible throughout culture. They could also be revived from frozen stocks. To achieve co-culture with fibroblasts in epiFL required use of low attachment culture vessels instead of standard plastic as fibroblasts remained adherent in epiFL. Here, cancer cell spheroids were allowed to form before adding fibroblasts. Immunohistochemical examination showed fibroblasts scattered throughout the epithelial spheroid, not dissimilar to the relationship of tumour stroma in human breast cancer. Conclusions Because of its ease of handling, matrix-free 3D cell culture may be a useful model to study the influence of fibroblasts on breast cancer epithelial cells with use of epiFL culture medium taking this a step further towards a fully humanised 3D model. This methodology could be applied to other types of cancer cell lines, making this a versatile technique for cancer researchers wishing to use in vitro systems that better reflect cancer in vivo.	[Roberts, Grace C.; Morris, Paul G.; Moss, Marcus A.; Maltby, Sarah L.; Palmer, Chelsea A.; Nash, Claire E.; Smart, Emily; Holliday, Deborah L.; Speirs, Valerie] Univ Leeds, Leeds Inst Canc & Pathol, Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England	University of Leeds	Speirs, V (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England.	v.speirs@leeds.ac.uk	Speirs, Valerie/ABE-7377-2021	Speirs, Valerie/0000-0002-0602-4666; Roberts, Grace Charlotte/0000-0003-4687-6940; Morris, Paul George/0000-0002-4554-2132	Breast Cancer Now [2008NovPr04]; Lord Dowding Fund; Pathological Society of Great Britain Ireland [PHD2011/13]; CRUK [C16708/A18080]; Dr Hadwen Trust	Breast Cancer Now; Lord Dowding Fund; Pathological Society of Great Britain Ireland; CRUK(Cancer Research UK); Dr Hadwen Trust	This work was supported by Breast Cancer Now (formerly Breast Cancer Campaign; http://breastcancernow.org/) Grant number 2008NovPr04; Lord Dowding Fund (http://www.ldf.org.uk/) No specific grant number; Pathological Society of Great Britain & Ireland (http://www.pathsoc.org/) Grant number PHD2011/13; CRUK (http://www.cancerresearchuk.org/) Grant number C16708/A18080; Dr Hadwen Trust (GB) (http://www.drhadwentrust.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NATURE, V424, P861, DOI 10.1038/424861b; Bissell MJ, 2003, BREAST CANCER RES, V5, P117, DOI 10.1186/bcr579; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Guzman A, 2014, BIOMATERIALS, V35, P6954, DOI 10.1016/j.biomaterials.2014.04.086; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Holliday DL, 2010, ATLA-ALTERN LAB ANIM, V38, P41, DOI 10.1177/026119291003801S13; Holliday DL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2218; Ivascu A, 2007, INT J ONCOL, V31, P1403; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Kundu B, 2013, BIOMATERIALS, V34, P9462, DOI 10.1016/j.biomaterials.2013.08.047; Leeper AD, 2012, BIOMATERIALS, V33, P907, DOI 10.1016/j.biomaterials.2011.10.028; Li LY, 2011, J CANCER, V2, P458, DOI 10.7150/jca.2.458; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Lovitt CJ, 2015, J CANCER RES CLIN, V141, P951, DOI 10.1007/s00432-015-1950-1; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; Nash CE, 2015, DEV CHARACTERISATION; Nash CE, 2015, ONCOTARGET, V6, P13731, DOI 10.18632/oncotarget.3803; Offterdinger M, 2003, J CELL PHYSIOL, V195, P260, DOI 10.1002/jcp.10237; Olsen CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-444; Pervez Shahid, 2007, J Med Case Rep, V1, P83, DOI 10.1186/1752-1947-1-83; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pinto MP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-735; Russ A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047734; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Sommers CL, 1996, J MAMMARY GLAND BIOL, V1, P219, DOI 10.1007/BF02013645; Speirs V, 1998, BRIT J CANCER, V78, P1421, DOI 10.1038/bjc.1998.702; Stuelten CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060919; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Vaillant F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2851; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang XL, 2010, BIOMATERIALS, V31, P3920, DOI 10.1016/j.biomaterials.2010.01.118; Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001; Wu YH, 2011, BREAST CANCER RES TR, V127, P397, DOI 10.1007/s10549-010-1013-x	43	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157004	10.1371/journal.pone.0157004	http://dx.doi.org/10.1371/journal.pone.0157004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300768	Green Submitted, gold, Green Published			2022-12-26	WOS:000377822200023
J	Yang, SK; Yang, Q; Xu, XY; Lu, D; Li, DQ				Yang Shunkun; Yang Qian; Xu Xiaoyun; Lu Dan; Li Daqing			Observability Transitions in Networks with Betweenness Preference	PLOS ONE			English	Article							OPTIMAL PMU PLACEMENT; GENETIC ALGORITHM	A network is considered observable if its current state can be determined in finite time from knowledge of the observed states. The observability transitions in networks based on random or degree-correlated sensor placement have recently been studied. However, these placement strategies are predominantly based on local information regarding the network. In this paper, to understand the phase transition process of network observability, we analyze the network observability transition for a betweenness-based sensor placement strategy, in which sensors are placed on nodes according to their betweenness. Using numerical simulations, we compute the size of the network's largest observable component (LOC) and compare the observability transitions for different sensor placements. We find that betweenness-based sensor placement can generate a larger LOC in the observability transition than the random or degree-based placement strategy in both model and real networks. This finding may help to understand the relationship between network observability and the topological properties of the network.	[Yang Shunkun; Yang Qian; Xu Xiaoyun; Lu Dan; Li Daqing] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China; [Xu Xiaoyun; Li Daqing] Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China	Beihang University	Xu, XY; Li, DQ (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.; Xu, XY; Li, DQ (corresponding author), Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China.	xuxiaoyun0216@gmail.com; daqingl@buaa.edu.cn						Alinejad-Beromi Y, 2008, 2008 PROCEEDINGS OF THE 43RD INTERNATIONAL UNIVERSITIES POWER ENGINEERING CONFERENCE, VOLS 1-3, P589; BALDWIN TL, 1993, IEEE T POWER SYST, V8, P707, DOI 10.1109/59.260810; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V., 2006, PAJEK DATASETS; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; El-Zonkoly A, 2006, EXPERT SYST APPL, V31, P193, DOI 10.1016/j.eswa.2005.09.016; Hasegawa T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042809; Havlin S, 2010, COMPLEX NETWORKS STR; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Li DQ, 2014, NAT SCI REP, V4, P5381; Milosevic B, 2003, IEEE T POWER SYST, V18, P69, DOI 10.1109/TPWRS.2002.807064; MONTICELLI A, 1985, IEEE T POWER AP SYST, V104, P1035, DOI 10.1109/TPAS.1985.323453; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Peng JN, 2006, INT J ELEC POWER, V28, P223, DOI 10.1016/j.ijepes.2005.05.005; Phadke AG, 2008, POWER ELECTRON POWER, P3, DOI 10.1007/978-0-387-76537-2_1; Rakpenthai C, 2007, IEEE T POWER DELIVER, V22, P101, DOI 10.1109/TPWRD.2006.881425; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.258701	18	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156764	10.1371/journal.pone.0156764	http://dx.doi.org/10.1371/journal.pone.0156764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299338	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200014
J	Gullberg, M; Lohse, L; Botner, A; McInerney, GM; Burman, A; Jackson, T; Polacek, C; Belsham, GJ				Gullberg, Maria; Lohse, Louise; Botner, Anette; McInerney, Gerald M.; Burman, Alison; Jackson, Terry; Polacek, Charlotta; Belsham, Graham J.			A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; EXPRESSION SYSTEM; IMPROVED VACCINES; MAMMALIAN-CELLS; FMD VACCINES; PROTEIN; RNA; REPLICATION; CHALLENGE; ALPHA-V-BETA-6	Foot-and-mouth disease (FMD) remains one of the most economically important infectious diseases of production animals globally. Vaccination can successfully control this disease, however, current vaccines are imperfect. They are made using chemically inactivated FMD virus (FMDV) that is produced in large-scale mammalian cell culture under high containment conditions. Here, we have expressed the FMDV capsid protein precursor (P1-2A) of strain O1 Manisa alone or with the FMDV 3C protease (3C(pro)) using a "single cycle" packaged alphavirus self-replicating RNA based on Semliki Forest virus (SFV). When the FMDV P1-2A was expressed with 3C(pro) then processing of the FMDV capsid precursor protein is observed within cells and the proteins assemble into empty capsid particles. The products interact with anti-FMDV antibodies in an ELISA and bind to the integrin alpha(v)beta(6) (a cellular receptor for FMDV). In cattle vaccinated with these rSFV-FMDV vectors alone, anti-FMDV antibodies were elicited but the immune response was insufficient to give protection against FMDV challenge. However, the prior vaccination with these vectors resulted in a much stronger immune response against FMDV post-challenge and the viremia observed was decreased in level and duration. In subsequent experiments, cattle were sequentially vaccinated with a rSFV-FMDV followed by recombinant FMDV empty capsid particles, or vice versa, prior to challenge. Animals given a primary vaccination with the rSFV-FMDV vector and then boosted with FMDV empty capsids showed a strong anti-FMDV antibody response prior to challenge, they were protected against disease and no FMDV RNA was detected in their sera post-challenge. Initial inoculation with empty capsids followed by the rSFV-FMDV was much less effective at combating the FMDV challenge and a large post-challenge boost to the level of anti-FMDV antibodies was observed. This prime-boost system, using reagents that can be generated outside of high-containment facilities, offers significant advantages to achieve control of FMD by vaccination.	[Gullberg, Maria; Lohse, Louise; Botner, Anette; Polacek, Charlotta; Belsham, Graham J.] Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark; [McInerney, Gerald M.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Burman, Alison; Jackson, Terry] Pirbright, Pirbright Inst, Woking, Surrey, England	Technical University of Denmark; Karolinska Institutet; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Belsham, GJ (corresponding author), Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark.	grbe@vet.dtu.dk	Belsham, Graham J./H-8589-2019; Belsham, Graham/J-3132-2019; McInerney, Gerald/G-5344-2012; Ibrahim, Essam Hassan/G-1960-2018	Belsham, Graham J./0000-0003-1187-4873; Belsham, Graham/0000-0003-1187-4873; McInerney, Gerald/0000-0003-2257-7241; Ibrahim, Essam Hassan/0000-0003-0130-2257; Polacek, Charlotta/0000-0003-0297-5672; Lohse, Louise/0000-0002-6769-5447	Danish Council for Independent Research \ Technology and Production Sciences (FTP grant) [09-070549]; plus Defra (UK) [SE1127]; DTU National Veterinary Institute	Danish Council for Independent Research \ Technology and Production Sciences (FTP grant); plus Defra (UK); DTU National Veterinary Institute	This work was supported by the Danish Council for Independent Research vertical bar Technology and Production Sciences (FTP grant 09-070549) to CP and GJB, plus Defra (UK) project number SE1127 to TJ and internal funding from DTU National Veterinary Institute to GJB.	ABRAMS CC, 1995, J GEN VIROL, V76, P3089, DOI 10.1099/0022-1317-76-12-3089; ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; ANSARDI DC, 1992, J VIROL, V66, P4556, DOI 10.1128/JVI.66.7.4556-4563.1992; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; Belsham GJ, 2005, CURR TOP MICROBIOL, V288, P43; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; Belsham GJ, 2015, VIRUS ADAPTATION TRE, V7, P1; Botner A, 2011, J GEN VIROL, V92, P1141, DOI 10.1099/vir.0.029710-0; Caridi F, 2015, J VIROL, V89, P5633, DOI 10.1128/JVI.03358-14; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; Defra, 2004, AN HLTH WELF FMD DAT; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; DONALDSON AI, 1989, RES VET SCI, V46, P9, DOI 10.1016/S0034-5288(18)31109-3; Ellard FM, 1999, J GEN VIROL, V80, P1911, DOI 10.1099/0022-1317-80-8-1911; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gullberg M, 2013, J VIROL, V87, P11591, DOI 10.1128/JVI.01863-13; Gullberg M, 2013, J GEN VIROL, V94, P1769, DOI 10.1099/vir.0.054122-0; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; Karlsson GB, 2003, METH MOLEC MED, V87, P69; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Kotecha A, 2015, NAT STRUCT MOL BIOL, V22, P788, DOI 10.1038/nsmb.3096; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Mateo R, 2008, J VIROL, V82, P12232, DOI 10.1128/JVI.01553-08; Mayr GA, 2001, VACCINE, V19, P2152, DOI 10.1016/S0264-410X(00)00384-4; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; Moraes MP, 2011, VACCINE, V29, P9431, DOI 10.1016/j.vaccine.2011.10.037; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; Nayak A, 2006, J VIROL, V80, P9865, DOI 10.1128/JVI.00561-06; OIE, 2012, FOOT AND MOUTH DIS M; Polacek C, 2013, J GEN VIROL, V94, P1249, DOI 10.1099/vir.0.050492-0; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Porta C, 2013, J VIROL METHODS, V187, P406, DOI 10.1016/j.jviromet.2012.11.011; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; Rincon V, 2014, STRUCTURE, V22, P1560, DOI 10.1016/j.str.2014.08.019; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; RWEYEMAMU MM, 1979, ARCH VIROL, V59, P69, DOI 10.1007/BF01317896; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; Stenfeldt C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-66; Sweeney TR, 2007, J VIROL, V81, P115, DOI 10.1128/JVI.01587-06	42	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157435	10.1371/journal.pone.0157435	http://dx.doi.org/10.1371/journal.pone.0157435			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294397	Green Submitted, gold, Green Published			2022-12-26	WOS:000377821300045
J	Blaha, I; Recio, P; Martinez, MP; Lopez-Oliva, ME; Ribeiro, ASF; Agis-Torres, A; Martinez, AC; Benedito, S; Garcia-Sacristan, A; Fernandes, VS; Hernandez, M				Blaha, Igor; Recio, Paz; Pilar Martinez, Maria; Elvira Lopez-Oliva, Maria; Ribeiro, Ana S. F.; Agis-Torres, Angel; Cristina Martinez, Ana; Benedito, Sara; Garcia-Sacristan, Albino; Fernandes, Vitor S.; Hernandez, Medardo			Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors	PLOS ONE			English	Article							METABOLIC SYNDROME; OXIDATIVE STRESS; TRACT SYMPTOMS; DIABETIC-RATS; DYSFUNCTION; OVERACTIVITY; NERVE; MOUSE; EXPRESSION; AGONISTS	Metabolic syndrome (MS) is a known risk factor for lower urinary tract symptoms. This study investigates whether functional and expression changes of cannabinoid CB1 and CB2 receptors are involved in the bladder dysfunction in an obese rat model with insulin resistance. Bladder samples from obese Zucker rat (OZR) and their respective controls lean Zucker rat (LZR) were processed for immunohistochemistry and western blot for studying the cannabinoid receptors expression. Detrusor smooth muscle (DSM) strips from LZR and OZR were also mounted in myographs for isometric force recordings. Neuronal and smooth muscle CB1 and CB2 receptor expression and the nerve fiber density was diminished in the OZR bladder. Electrical field stimulation (EFS) and acetylcholine (ACh) induced frequency-and concentration-dependent contractions of LZR and OZR DSM. ACh contractile responses were similar in LZR and OZR. EFS-elicited contractions, however, were reduced in OZR bladder. Cannabinoid receptor agonists and antagonists failed to modify the DSM basal tension in LZR and OZR In LZR bladder, EFS responses were inhibited by ACEA and SER-601, CB1 and CB2 receptor agonists, respectively, these effects being reversed by ACEA plus the CB1 antagonist, AM-251 or SER-601 plus the CB2 antagonist, AM-630. In OZR bladder, the inhibitory action of ACEA on nerve-evoked contractions was diminished, whereas that SER-601 did not change EFS responses. These results suggest that a diminished function and expression of neuronal cannabinoid CB1 and CB2 receptors, as well as a lower nerve fiber density is involved in the impaired excitatory neurotransmission of the urinary bladder from the OZR.	[Blaha, Igor] Hosp Gen Univ Gregorio Maranon, Dept Urol, Madrid 28007, Spain; [Recio, Paz; Elvira Lopez-Oliva, Maria; Ribeiro, Ana S. F.; Agis-Torres, Angel; Cristina Martinez, Ana; Benedito, Sara; Garcia-Sacristan, Albino; Fernandes, Vitor S.; Hernandez, Medardo] Univ Complutense Madrid, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain; [Pilar Martinez, Maria] Univ Complutense Madrid, Fac Vet, Dept Anat & Anat Patol Comparadas, E-28040 Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; Complutense University of Madrid	Hernandez, M (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain.	medardo@ucm.es	López-Oliva, Elvira ELO/L-1660-2014; Pilar Martinez, P Martinez/E-8591-2016; Ribeiro, Ana Sofia F/F-3428-2013; Martinez, Ana Cristina/H-9795-2015; Fernandes, Vitor Samuel/F-3437-2013; BENEDITO, SARA/H-9730-2015	López-Oliva, Elvira ELO/0000-0002-0615-9149; Pilar Martinez, P Martinez/0000-0001-9063-3191; Ribeiro, Ana Sofia F/0000-0003-3913-7859; Martinez, Ana Cristina/0000-0002-2829-0914; Fernandes, Vitor Samuel/0000-0001-6060-9035; AGIS TORRES, ANGEL/0000-0002-3548-7264; BENEDITO, SARA/0000-0001-9660-2409				Aizawa N, 2014, J UROLOGY, V192, P956, DOI 10.1016/j.juro.2014.04.008; Azadzoi KM, 2003, J UROLOGY, V169, P1885, DOI 10.1097/01.ju.0000048668.97821.f4; Bakali E, 2016, INT UROGYNECOL J, V27, P129, DOI 10.1007/s00192-015-2802-x; Bozkurt TE, 2016, EUR J PHARMACOL, V776, P132, DOI 10.1016/j.ejphar.2016.02.045; Changolkar AK, 2005, J UROLOGY, V173, P309, DOI 10.1097/01.ju.0000141583.31183.7a; Chung SD, 2013, EUR J NUTR, V52, P347, DOI 10.1007/s00394-012-0342-4; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fullhase C, 2014, BJU INT, V113, P144, DOI 10.1111/bju.12350; Gasbarro G, 2010, AM J PHYSIOL-RENAL, V298, pF72, DOI 10.1152/ajprenal.00309.2009; Gratzke C, 2010, EUR UROL, V57, P1093, DOI 10.1016/j.eururo.2010.02.027; Gratzke C, 2009, J UROLOGY, V181, P1939, DOI 10.1016/j.juro.2008.11.079; GuerreMillo M, 1997, BIOMED PHARMACOTHER, V51, P318, DOI 10.1016/S0753-3322(97)88048-1; Hedlund P, 2014, NEUROUROL URODYNAM, V33, P46, DOI 10.1002/nau.22442; Huang YC, 2010, J UROLOGY, V183, P1232, DOI 10.1016/j.juro.2009.11.012; Irwin DE, 2010, EUR UROL, V58, P532, DOI 10.1016/j.eururo.2010.06.007; Izzo AA, 2015, HANDB EXP PHARMACOL, V231, P423, DOI 10.1007/978-3-319-20825-1_15; Juan YS, 2009, INT UROL NEPHROL, V41, P513, DOI 10.1007/s11255-008-9492-y; Kendig DM, 2016, AM J PHYSIOL-RENAL, V310, pF909, DOI 10.1152/ajprenal.00511.2015; Kupelian V, 2009, J UROLOGY, V182, P616, DOI 10.1016/j.juro.2009.04.025; Lee WC, 2008, J UROLOGY, V179, P2470, DOI 10.1016/j.juro.2008.01.086; Lee WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045578; Lee WC, 2011, J UROLOGY, V186, P318, DOI 10.1016/j.juro.2011.03.037; Liu GM, 2008, NEUROUROL URODYNAM, V27, P429, DOI 10.1002/nau.20543; Marini P, 2013, BRIT J PHARMACOL, V169, P887, DOI 10.1111/bph.12191; Martin RS, 2000, BRIT J PHARMACOL, V129, P1707, DOI 10.1038/sj.bjp.0703229; Nobe K, 2008, J PHARMACOL EXP THER, V324, P631, DOI 10.1124/jpet.107.131334; Park HK, 2008, UROLOGY, V72, P556, DOI 10.1016/j.urology.2008.03.043; Pasquini S, 2008, J MED CHEM, V51, P5075, DOI 10.1021/jm800552f; Shen GX, 2010, CAN J PHYSIOL PHARM, V88, P241, DOI 10.1139/Y10-018; Shenfeld OZ, 2005, UROLOGY, V65, P181, DOI 10.1016/j.urology.2004.08.055; Tai HC, 2010, J CLIN ENDOCR METAB, V95, P1143, DOI 10.1210/jc.2009-1492; Tong YC, 2007, J UROLOGY, V178, P1537, DOI 10.1016/j.juro.2007.05.114; Torimoto K, 2004, J UROLOGY, V171, P1959, DOI 10.1097/01.ju.0000121283.92963.05; Tyagi V, 2009, J UROLOGY, V181, P1932, DOI 10.1016/j.juro.2008.11.078	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157424	10.1371/journal.pone.0157424	http://dx.doi.org/10.1371/journal.pone.0157424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285468	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000066
J	Meyer, M; Dhamne, SC; LaCoursiere, CM; Tambunan, D; Poduri, A; Rotenberg, A				Meyer, Michaela; Dhamne, Sameer C.; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna; Rotenberg, Alexander			Microarray Noninvasive Neuronal Seizure Recordings from Intact Larval Zebrafish	PLOS ONE			English	Article							EPILEPTIC SEIZURES; IDENTIFY; COMPLEX; SCREEN; MODEL	Zebrafish epilepsy models are emerging tools in experimental epilepsy. Zebrafish larvae, in particular, are advantageous because they can be easily genetically altered and used for developmental and drug studies since agents applied to the bath penetrate the organism easily. Methods for electrophysiological recordings in zebrafish are new and evolving. We present a novel multi-electrode array method to non-invasively record electrical activity from up to 61 locations of an intact larval zebrafish head. This method enables transcranial non-invasive recording of extracellular field potentials (which include multi-unit activity and EEG) to identify epileptic seizures. To record from the brains of zebrafish larvae, the dorsum of the head of an intact larva was secured onto a multi-electrode array. We recorded from individual electrodes for at least three hours and quantified neuronal firing frequency, spike patterns (continuous or bursting), and synchrony of neuronal firing. Following 15 mM potassium chloride-or pentylenetetrazole-infusion into the bath, spike and burst rate increased significantly. Additionally, synchrony of neuronal firing across channels, a hallmark of epileptic seizures, also increased. Notably, the fish survived the experiment. This non-invasive method complements present invasive zebrafish neurophysiological techniques: it affords the advantages of high spatial and temporal resolution, a capacity to measure multiregional activity and neuronal synchrony in seizures, and fish survival for future experiments, such as studies of epileptogenesis and development.	[Meyer, Michaela; Dhamne, Sameer C.; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna; Rotenberg, Alexander] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Epilepsy & Clin Neurophysiol,Dept Neurol, Boston, MA 02163 USA; [Meyer, Michaela; Dhamne, Sameer C.; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna; Rotenberg, Alexander] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02163 USA; [Meyer, Michaela; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna] Harvard Univ, Sch Med, Boston Childrens Hosp, Epilepsy Genet Program,Neurogenet Program,Dept Ne, Boston, MA 02163 USA; [Meyer, Michaela; Dhamne, Sameer C.; Rotenberg, Alexander] Harvard Univ, Sch Med, Boston Childrens Hosp, Neuromodulat Program,Dept Neurol, Boston, MA 02163 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Epilepsy & Clin Neurophysiol,Dept Neurol, Boston, MA 02163 USA.; Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02163 USA.; Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Neuromodulat Program,Dept Neurol, Boston, MA 02163 USA.	Alexander.Rotenberg@childrens.harvard.edu			Richard A. and Susan F. Smith President's Innovation Award; Boston Children's Hospital Translational Research Program; NIH NINDS [R01NS088583]; NIMH [R01100186]; Sage Therapeutics; Massachusetts Life Sciences Foundation; Autism Speaks; Assimon Family Fund; National Institute of Neurological Disorders and Stroke [NINDS K23NS069784]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS069784, R01NS088583] Funding Source: NIH RePORTER	Richard A. and Susan F. Smith President's Innovation Award; Boston Children's Hospital Translational Research Program; NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sage Therapeutics; Massachusetts Life Sciences Foundation; Autism Speaks; Assimon Family Fund; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Richard A. and Susan F. Smith President's Innovation Award, and the Boston Children's Hospital Translational Research Program (AP, AR). Related research in Dr. Rotenberg's laboratory includes support from the NIH NINDS R01NS088583 and NIMH R01100186, Sage Therapeutics, Massachusetts Life Sciences Foundation, Autism Speaks and the Assimon Family Fund. A.P. was supported by the National Institute of Neurological Disorders and Stroke (NINDS K23NS069784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0; Baraban SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50104; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hortopan GA, 2010, DIS MODEL MECH, V3, P144, DOI 10.1242/dmm.002139; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Moorman S J, 2001, ILAR J, V42, P292; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; RAMANJANEYULU R, 1984, EUR J PHARMACOL, V98, P337, DOI 10.1016/0014-2999(84)90282-6; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Zdebik AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079765; Zhang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125898	25	18	18	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156498	10.1371/journal.pone.0156498	http://dx.doi.org/10.1371/journal.pone.0156498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281339	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000032
J	Varet, H; Brillet-Gueguen, L; Coppee, JY; Dillies, MA				Varet, Hugo; Brillet-Gueguen, Loraine; Coppee, Jean-Yves; Dillies, Marie-Agnes			SARTools: A DESeq2-and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data	PLOS ONE			English	Article								Background Several R packages exist for the detection of differentially expressed genes from RNA-Seq data. The analysis process includes three main steps, namely normalization, dispersion estimation and test for differential expression. Quality control steps along this process are recommended but not mandatory, and failing to check the characteristics of the dataset may lead to spurious results. In addition, normalization methods and statistical models are not exchangeable across the packages without adequate transformations the users are often not aware of. Thus, dedicated analysis pipelines are needed to include systematic quality control steps and prevent errors from misusing the proposed methods. Results SARTools is an R pipeline for differential analysis of RNA-Seq count data. It can handle designs involving two or more conditions of a single biological factor with or without a blocking factor (such as a batch effect or a sample pairing). It is based on DESeq2 and edgeR and is composed of an R package and two R script templates (for DESeq2 and edgeR respectively). Tuning a small number of parameters and executing one of the R scripts, users have access to the full results of the analysis, including lists of differentially expressed genes and a HTML report that (i) displays diagnostic plots for quality control and model hypotheses checking and (ii) keeps track of the whole analysis process, parameter values and versions of the R packages used. Conclusions SARTools provides systematic quality controls of the dataset as well as diagnostic plots that help to tune the model parameters. It gives access to the main parameters of DESeq2 and edgeR and prevents untrained users from misusing some functionalities of both packages. By keeping track of all the parameters of the analysis process it fits the requirements of reproducible research.	[Varet, Hugo; Coppee, Jean-Yves; Dillies, Marie-Agnes] Inst Pasteur, Ctr Innovat & Rech Technol Citech, Plate Forme Transcriptome & Epigenome, Paris, France; [Varet, Hugo; Dillies, Marie-Agnes] Inst Pasteur, Hub Bioinformat & Biostat, Ctr Bioinformat Biostat & Biol Integrat C3BI, USR 3756,IP,CNRS, Paris, France; [Brillet-Gueguen, Loraine] UPMC, CNRS, FR2424, ABiMS,Stn Biol, Roscoff, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Dillies, MA (corresponding author), Inst Pasteur, Ctr Innovat & Rech Technol Citech, Plate Forme Transcriptome & Epigenome, Paris, France.; Dillies, MA (corresponding author), Inst Pasteur, Hub Bioinformat & Biostat, Ctr Bioinformat Biostat & Biol Integrat C3BI, USR 3756,IP,CNRS, Paris, France.	marie-agnes.dillies@pasteur.fr			France Genomique National infrastructure as part of the "Investissements d'Avenir" [ANR-10-INBS-09]	France Genomique National infrastructure as part of the "Investissements d'Avenir"(French National Research Agency (ANR))	This work was supported by the France Genomique National infrastructure, funded as part of the "Investissements d'Avenir" program managed by the Agence Nationale pour la Recherche (contract ANR-10-INBS-09).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Girke T., 2014, SYSTEMPIPER NGS WORK; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Patro R, 2015, BIORXIV PREPRINT; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russo F, 2014, BIOINFORMATICS, V30, P2514, DOI 10.1093/bioinformatics/btu308; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Soneson C, 2016, F1000RESEARCH, DOI 10.12688/f1000research.7563.2; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Zhou X, 2013, RNA	20	392	397	12	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157022	10.1371/journal.pone.0157022	http://dx.doi.org/10.1371/journal.pone.0157022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280887	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000069
J	Bakhshi, B; Fard, EM; Nikpay, N; Ebrahimi, MA; Bihamta, MR; Mardi, M; Salekdeh, GH				Bakhshi, Behnam; Fard, Ehsan Mohseni; Nikpay, Nava; Ebrahimi, Mohammad Ali; Bihamta, Mohammad Reza; Mardi, Mohsen; Salekdeh, Ghasem Hosseini			MicroRNA Signatures of Drought Signaling in Rice Root	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; CLASS IIIHD-ZIP; ARABIDOPSIS-THALIANA; PLANT MICRORNA; RESPONSIVE MICRORNAS; EXPRESSION PROFILES; POPULUS-TRICHOCARPA; WIDE IDENTIFICATION; SEED-GERMINATION; ABSCISIC-ACID	Background Drought stress is one of the most important abiotic stresses and the main constraint to rice agriculture. MicroRNA-mediated post-transcriptional gene regulation is one of the ways to establish drought stress tolerance in plants. MiRNAs are 20-24-nt regulatory RNAs that play an important role in regulating plant gene expression upon exposure to biotic and abiotic stresses. Methodology/Principal Findings In this study, we applied a partial root drying system as well as a complete root drying system to identify miRNAs involved in conditions of drought stress, drought signaling and wet signaling using high-throughput sequencing. To this end, we produced four small RNA libraries: (1) fully-watered (WW), (2) fully-droughted (WD), and split-root systems where (3) one-half was well watered (SpWW) and (4) the other half was water-deprived (SpWD). Our analysis revealed 10,671 and 783 unique known and novel miRNA reads in all libraries, respectively. We identified, 65 (52 known + 13 novel), 72 (61 known + 11 novel) and 51 (38 known + 13 novel) miRNAs that showed differential expression under conditions of drought stress, drought signaling and wet signaling, respectively. The results of quantitative real-time PCR showed expression patterns similar to the high-throughput sequencing results. Furthermore, our target prediction led to the identification of 244, 341 and 239 unique target genes for drought-stress-, drought-signaling-and wet-signaling-responsivemiRNAs, respectively. Conclusions/Significance Our results suggest that miRNAs that are responsive under different conditions could play different roles in the regulation of abscisic acid signaling, calcium signaling, detoxification and lateral root formation.	[Bakhshi, Behnam; Nikpay, Nava; Mardi, Mohsen; Salekdeh, Ghasem Hosseini] Agr Res Educ & Extens Org, Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran; [Bakhshi, Behnam] Islamic Azad Univ, Sci & Res Branch, Dept Plant Breeding, Tehran, Iran; [Fard, Ehsan Mohseni] Univ Zanjan, Fac Agr, Dept Agron & Plant Breeding, Zanjan, Iran; [Ebrahimi, Mohammad Ali] Payame Noor Univ, Dept Biotechnol, Tehran, Iran; [Bihamta, Mohammad Reza] Univ Tehran, Fac Agr Sci & Engn, Dept Agron & Plant Breeding, Coll Agr & Nat Resources, Karaj, Iran; [Salekdeh, Ghasem Hosseini] Royan Inst Stem Cell Biol & Technol, Dept Mol Syst Biol, Cell Sci Res Ctr, ACECR, Tehran, Iran	Islamic Azad University; University Zanjan; Payame Noor University; University of Tehran; Academic Center for Education, Culture & Research (ACECR)	Salekdeh, GH (corresponding author), Agr Res Educ & Extens Org, Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran.; Salekdeh, GH (corresponding author), Royan Inst Stem Cell Biol & Technol, Dept Mol Syst Biol, Cell Sci Res Ctr, ACECR, Tehran, Iran.	h_salekdeh@abrii.ac.ir	Bakhshi, Behnam/N-2159-2016; Mardi, Mohsen/M-5829-2017; Salekdeh, Ghasem Hosseini/E-4198-2012; Ebrahimi, Mohammad Ali/AFL-4657-2022	Bakhshi, Behnam/0000-0001-6099-6565; Mardi, Mohsen/0000-0002-4718-7701; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Ebrahimi, Mohammad Ali/0000-0002-2610-9018	Agricultural Biotechnology Research Institute of Iran; Iran National Science Foundation	Agricultural Biotechnology Research Institute of Iran; Iran National Science Foundation(Iran National Science Foundation (INSF))	This project was partially funded by grants from the Agricultural Biotechnology Research Institute of Iran and Iran National Science Foundation to GHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bhardwaj AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092456; Bologna NG, 2013, BRIEF FUNCT GENOMICS, V12, P37, DOI 10.1093/bfgp/els050; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Boudsocq M, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P75, DOI 10.1007/978-90-481-3112-9_4; Budak H, 2011, OMICS, V15, P791, DOI 10.1089/omi.2011.0073; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castaings L, 2011, J EXP BOT, V62, P1391, DOI 10.1093/jxb/erq375; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Close TJ, 1993, PLANT RESPONSES CELL; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Ding YF, 2013, J EXP BOT, V64, P3077, DOI 10.1093/jxb/ert164; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Ehya F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066372; Gleeson M, 2014, J PLANT BIOCHEM BIOT, P1; GOLLAN T, 1986, FUNCT PLANT BIOL, V13, P459; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Jian XY, 2010, GENOMICS, V95, P47, DOI 10.1016/j.ygeno.2009.08.017; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Khan GA, 2011, PLANT MOL BIOL, V77, P47, DOI 10.1007/s11103-011-9793-x; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liang MX, 2006, PLANTA, V224, P1185, DOI 10.1007/s00425-006-0300-6; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu Q, 2009, BIOCHEM BIOPH RES CO, V384, P1, DOI 10.1016/j.bbrc.2009.04.028; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Mirzaei M, 2014, J PROTEOME RES, V13, P517, DOI 10.1021/pr400696u; Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779; Pandey S., 2008, DROUGHT FRONTIERS RI, P3, DOI DOI 10.1142/9789814280013_0001; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Qibin L., 2008, MIREAP MICRORNA DISC; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shinozaki K, 1999, MOL RESPONSES DROUGH; Shuai P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-233; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wei LY, 2009, INT J PLANT SCI, V170, P979, DOI 10.1086/605122; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	82	35	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156814	10.1371/journal.pone.0156814	http://dx.doi.org/10.1371/journal.pone.0156814			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276090	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700038
J	Stommel, C; Hofer, H; East, ML				Stommel, Claudia; Hofer, Heribert; East, Marion L.			The Effect of Reduced Water Availability in the Great Ruaha River on the Vulnerable Common Hippopotamus in the Ruaha National Park, Tanzania	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD ANALYSIS; GENERALIZED LINEAR-MODELS; RAINFALL; ECOLOGY; AFRICA	In semi-arid environments, 'permanent' rivers are essential sources of surface water for wildlife during 'dry' seasons when rainfall is limited or absent, particularly for species whose resilience to water scarcity is low. The hippopotamus (Hippopotamus amphibius) requires submersion in water to aid thermoregulation and prevent skin damage by solar radiation; the largest threat to its viability are human alterations of aquatic habitats. In the Ruaha National Park (NP), Tanzania, the Great Ruaha River (GRR) is the main source of surface water for wildlife during the dry season. Recent, large-scale water extraction from the GRR by people upstream of Ruaha NP is thought to be responsible for a profound decrease in dry season water-flow and the absence of surface water along large sections of the river inside the NP. We investigated the impact of decreased water flow on daytime hippo distribution using regular censuses at monitoring locations, transects and camera trap records along a 104km section of the GRR within the Ruaha NP during two dry seasons. The minimum number of hippos per monitoring location increased with the expanse of surface water as the dry seasons progressed, and was not affected by water quality. Hippo distribution significantly changed throughout the dry season, leading to the accumulation of large numbers in very few locations. If surface water loss from the GRR continues to increase in future years, this will have serious implications for the hippo population and other water dependent species in Ruaha NP.	[Stommel, Claudia; Hofer, Heribert; East, Marion L.] Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung	Stommel, C (corresponding author), Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany.	stommel@izw-berlin.de	Hofer, Heribert/AAF-7854-2021	Hofer, Heribert/0000-0002-2813-7442	Leibniz Institute for Zoo and Wildlife Research IZW institutional budget; German Academic Exchange Service (DAAD) [D/11/44168]; Leibniz Association	Leibniz Institute for Zoo and Wildlife Research IZW institutional budget; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Leibniz Association	Funding for this study came from the Leibniz Institute for Zoo and Wildlife Research IZW institutional budget and the German Academic Exchange Service (DAAD), https://www.daad.de, grant number: D/11/44168, to CS. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2013, CATEGORICAL DATA ANA; Aitkin M, 1999, BIOMETRICS, V55, P117, DOI 10.1111/j.0006-341X.1999.00117.x; Aitkin M, 1996, STAT COMPUT, V6, P251, DOI 10.1007/BF00140869; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; BARNES RFW, 1983, AFR J ECOL, V21, P185, DOI 10.1111/j.1365-2028.1983.tb01180.x; Bates D., PACKAGE LME4; Bobbink R, 2006, ECOL STUD-ANAL SYNTH, V191, P1; Cerioli A, 1997, BIOMETRICS, V53, P619, DOI 10.2307/2533962; Cerling TE, 2008, J ZOOL, V276, P204, DOI 10.1111/j.1469-7998.2008.00450.x; Chen CJ, 2015, INT J CLIMATOL, V35, P2698, DOI 10.1002/joc.4165; Dudley JP, 2016, MAMMAL REV, V46, P191, DOI 10.1111/mam.12056; East ML, 2015, BEHAV ECOL SOCIOBIOL, V69, P805, DOI 10.1007/s00265-015-1897-x; Eltringham S. K., 1999, HIPPOS NATURAL HIST; Eltringham SK, 1993, PIGS PECCARIES HIPPO, P161; FESTABIANCHET M, 1989, J ANIM ECOL, V58, P785, DOI 10.2307/5124; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Harrison ME, 2008, AFR J ECOL, V46, P507, DOI 10.1111/j.1365-2028.2007.00887.x; Hijmans R., 2005, DIVA GIS VERSION 7 5; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Hofer H, 2012, NEW DIRECTIONS CONSE, P82; Hosmer D. W., 2013, APPL LOGISTIC REGRES; JACOBSEN NHG, 1993, WATER SA, V19, P301; KARSTAD EL, 1986, MAMMALIA, V50, P153, DOI 10.1515/mamm.1986.50.2.153; Klingel H., 2013, MAMMALS OF AFRICA, P68; KLINGEL H, 1991, AFRICAN WILDLIFE RES, P73; LEIVESTAD H, 1973, RESP PHYSIOL, V19, P19, DOI 10.1016/0034-5687(73)90086-8; Lewison R, 1998, ETHOL ECOL EVOL, V10, P277, DOI 10.1080/08927014.1998.9522857; Lewison R, 2015, IUCN RED LIST THREAT; Lewison R, 2007, AFR J ECOL, V45, P407, DOI 10.1111/j.1365-2028.2006.00747.x; LOCK JM, 1972, J ECOL, V60, P445, DOI 10.2307/2258356; Lyon B, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050337; Mtahiko M. G. G., 2006, Wetlands Ecology and Management, V14, P489, DOI 10.1007/s11273-006-9002-x; OLIVIER R C D, 1974, East African Wildlife Journal, V12, P249; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Rowell DP, 2015, J CLIMATE, V28, P9768, DOI 10.1175/JCLI-D-15-0140.1; Saikawa Y, 2004, NATURE, V429, P363, DOI 10.1038/429363a; SMUTS G.L., 1981, KOEDOE, V24, P169, DOI DOI 10.4102/koedoe.v24i1.626; Stommel C, 2016, MAMM BIOL, V81, P21, DOI 10.1016/j.mambio.2015.08.005; Tanzania Wildlife Research Institute, 2006, TECHNICAL REPORT; Tanzania Wildlife Research Institute, 2009, TECHNICAL REPORT; Team R core, 2015, R LANG ENV STAT COMP; Timbuka CD, 2012, THESIS U E ANGLIA; Venables WN., 2002, MODERN APPL STAT S 4; Viljoen P. C., 1995, Koedoe, V38, P115; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wafula MM, 2008, AFR J ECOL, V46, P24, DOI 10.1111/j.1365-2028.2007.00796.x	48	16	16	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157145	10.1371/journal.pone.0157145	http://dx.doi.org/10.1371/journal.pone.0157145			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276362	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561700074
J	Kadipasaoglu, CM; Conner, CR; Whaley, ML; Baboyan, VG; Tandon, N				Kadipasaoglu, Cihan Mehmet; Conner, Christopher Richard; Whaley, Meagan Lee; Baboyan, Vatche George; Tandon, Nitin			Category-Selectivity in Human Visual Cortex Follows Cortical Topology: A Grouped icEEG Study	PLOS ONE			English	Article							HUMAN FACE PERCEPTION; WORD FORM AREA; VENTRAL TEMPORAL CORTEX; HUMAN BRAIN; INFEROTEMPORAL CORTEX; OCCIPITOTEMPORAL CORTEX; FUNCTIONAL ARCHITECTURE; ELECTRICAL-STIMULATION; OBJECT RECOGNITION; GAMMA-OSCILLATIONS	Neuroimaging studies suggest that category-selective regions in higher-order visual cortex are topologically organized around specific anatomical landmarks: the mid-fusiform sulcus (MFS) in the ventral temporal cortex (VTC) and lateral occipital sulcus (LOS) in the lateral occipital cortex (LOC). To derive precise structure-function maps from direct neural signals, we collected intracranial EEG (icEEG) recordings in a large human cohort (n = 26) undergoing implantation of subdural electrodes. A surface-based approach to grouped icEEG analysis was used to overcome challenges from sparse electrode coverage within subjects and variable cortical anatomy across subjects. The topology of category-selectivity in bilateral VTC and LOC was assessed for five classes of visual stimuli-faces, animate non-face (animals/ body-parts), places, tools, and words-using correlational and linear mixed effects analyses. In the LOC, selectivity for living (faces and animate non-face) and non-living (places and tools) classes was arranged in a ventral-to-dorsal axis along the LOS. In the VTC, selectivity for living and non-living stimuli was arranged in a latero-medial axis along the MFS. Written word-selectivity was reliably localized to the intersection of the left MFS and the occipito-temporal sulcus. These findings provide direct electrophysiological evidence for topological information structuring of functional representations within higher-order visual cortex.	[Kadipasaoglu, Cihan Mehmet; Conner, Christopher Richard; Whaley, Meagan Lee; Baboyan, Vatche George; Tandon, Nitin] Univ Texas Houston, Sch Med, Vivian Smith Dept Neurosurg, Houston, TX USA; [Tandon, Nitin] Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Tandon, N (corresponding author), Univ Texas Houston, Sch Med, Vivian Smith Dept Neurosurg, Houston, TX USA.; Tandon, N (corresponding author), Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA.	Nitin.tandon@uth.tmc.edu	; Kadipasaoglu, Cihan/G-6077-2016	Baboyan, Vatche/0000-0001-9025-591X; Kadipasaoglu, Cihan/0000-0001-5390-372X	National Center for Advancing Translational Sciences of the National Institutes of Health [5TL1TR000369-08]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB006350]; National Institute for Deafness and communication disorders [NIDCD - R01DC014589]; National Science Foundation [NSF-FO 1533664]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014589] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute for Deafness and communication disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (5TL1TR000369-08 to CMK), the National Institute of Biomedical Imaging and Bioengineering (NIBIB; T32EB006350 to CRC), National Institute for Deafness and communication disorders (NIDCD - R01DC014589 to NT) and partially by the National Science Foundation (NSF-FO 1533664 to NT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Andrews TJ, 2010, NEUROIMAGE, V49, P703, DOI 10.1016/j.neuroimage.2009.08.046; Anticevic A, 2008, NEUROIMAGE, V41, P835, DOI 10.1016/j.neuroimage.2008.02.052; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baldassi C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003167; Barton Jason J S, 2014, Continuum (Minneap Minn), V20, P922, DOI 10.1212/01.CON.0000453311.29519.67; Bastin J, 2013, J NEUROSCI, V33, P10123, DOI 10.1523/JNEUROSCI.4646-12.2013; Bates D., 2015, LME4 LINEAR MIXED EF; Bates D, 2015, J STAT SOFTWARE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Brants M, 2011, NEUROIMAGE, V56, P1372, DOI 10.1016/j.neuroimage.2011.02.079; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Caspers J, 2015, BRAIN STRUCT FUNCT, V220, P205, DOI 10.1007/s00429-013-0646-z; Caspers J, 2013, BRAIN STRUCT FUNCT, V218, P511, DOI 10.1007/s00429-012-0411-8; Chan AM, 2011, J NEUROSCI, V31, P18119, DOI 10.1523/JNEUROSCI.3122-11.2011; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Conner CR, 2014, CEREB CORTEX, V24, P2741, DOI 10.1093/cercor/bht130; Conner CR, 2011, J NEUROSCI, V31, P12855, DOI 10.1523/JNEUROSCI.1457-11.2011; Connolly AC, 2012, J NEUROSCI, V32, P2608, DOI 10.1523/JNEUROSCI.5547-11.2012; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Davidenko N, 2012, HUM BRAIN MAPP, V33, P2334, DOI 10.1002/hbm.21367; Davidesco I, 2014, CEREB CORTEX, V24, P1879, DOI 10.1093/cercor/bht038; Davidesco I, 2013, J NEUROSCI, V33, P1228, DOI 10.1523/JNEUROSCI.3181-12.2013; Dehaene S., 2009, READING BRAIN NEW SC; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Dilks DD, 2013, J NEUROSCI, V33, P1331, DOI 10.1523/JNEUROSCI.4081-12.2013; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Drane DL, 2008, NEUROPSYCHOLOGIA, V46, P1242, DOI 10.1016/j.neuropsychologia.2007.11.034; Dubois J, 2015, J NEUROSCI, V35, P2791, DOI 10.1523/JNEUROSCI.4037-14.2015; Dykstra AR, 2012, NEUROIMAGE, V59, P3563, DOI 10.1016/j.neuroimage.2011.11.046; Ellmore TM, 2009, J NEUROSURG, V111, P755, DOI 10.3171/2009.3.JNS081427; Engell AD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00642; Engell AD, 2012, NEUROIMAGE, V59, P2600, DOI 10.1016/j.neuroimage.2011.08.079; Engell AD, 2011, CEREB CORTEX, V21, P1213, DOI 10.1093/cercor/bhq206; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Esposito F, 2013, NEUROIMAGE, V66, P457, DOI 10.1016/j.neuroimage.2012.10.080; Falk EB, 2015, P NATL ACAD SCI USA, V112, P1977, DOI 10.1073/pnas.1500247112; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Ghuman AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6672; Gomez J, 2015, NEURON, V85, P216, DOI 10.1016/j.neuron.2014.12.027; Green DM, 1966, SIGNAL DETECTION THE; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Haxby JV, 2012, NEUROIMAGE, V62, P852, DOI 10.1016/j.neuroimage.2012.03.016; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hermes D, 2015, CEREB CORTEX, V25, P2951, DOI 10.1093/cercor/bhu091; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Jacques C, 2016, NEUROPSYCHOLOGIA, V83, P14, DOI 10.1016/j.neuropsychologia.2015.07.024; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Jonas J, 2012, NEUROSCIENCE, V222, P281, DOI 10.1016/j.neuroscience.2012.07.021; Kadipasaoglu CM, 2014, NEUROIMAGE, V101, P215, DOI 10.1016/j.neuroimage.2014.07.006; Kadipasaoglu CM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01008; Kaiser D, 2016, J NEUROPHYSIOL, V115, P2246, DOI 10.1152/jn.01074.2015; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Kojima K, 2013, CLIN NEUROPHYSIOL, V124, P2368, DOI 10.1016/j.clinph.2013.05.030; Konkle T, 2013, J NEUROSCI, V33, P10235, DOI 10.1523/JNEUROSCI.0983-13.2013; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kujovic M, 2013, BRAIN STRUCT FUNCT, V218, P157, DOI 10.1007/s00429-012-0390-9; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lehky SR, 2016, CURR OPIN NEUROBIOL, V37, P23, DOI 10.1016/j.conb.2015.12.001; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lingnau A, 2015, TRENDS COGN SCI, V19, P268, DOI 10.1016/j.tics.2015.03.006; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Lorenz S, 2017, CEREB CORTEX, V27, P373, DOI 10.1093/cercor/bhv225; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Majaj NJ, 2015, J NEUROSCI, V35, P13402, DOI 10.1523/JNEUROSCI.5181-14.2015; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Marr D., 1982, VISION; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Matsuo T, 2013, CEREB CORTEX, DOI [10.1093/cercor/bht319, DOI 10.1093/CERC0R/BHT319]; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Mendola JD, 1999, J NEUROSCI, V19, P8560; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Miller KJ, 2014, NEUROIMAGE, V85, P711, DOI 10.1016/j.neuroimage.2013.08.070; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mukamel R, 2012, ANNU REV PSYCHOL, V63, P511, DOI 10.1146/annurev-psych-120709-145401; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Oosterhof NN, 2011, NEUROIMAGE, V56, P593, DOI 10.1016/j.neuroimage.2010.04.270; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Orlov T, 2010, NEURON, V68, P586, DOI 10.1016/j.neuron.2010.09.032; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pieters TA, 2013, J NEUROSURG, V118, P1086, DOI 10.3171/2013.2.JNS121450; Pourtois G, 2007, NEUROPSYCHOLOGIA, V45, P2621, DOI 10.1016/j.neuropsychologia.2007.04.005; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Privman E, 2007, J NEUROSCI, V27, P6234, DOI 10.1523/JNEUROSCI.4627-06.2007; Privman E, 2011, CEREB CORTEX, V21, P616, DOI 10.1093/cercor/bhq128; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Pyles JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061611; R Core Team, 2012, R LANG ENV STAT COMP; Rice GE, 2014, J NEUROSCI, V34, P8837, DOI 10.1523/JNEUROSCI.5265-13.2014; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Rossion Bruno, 2014, Front Biosci (Elite Ed), V6, P258; Rouse AG, 2013, J NEUROSCI, V33, P1326, DOI 10.1523/JNEUROSCI.0271-12.2013; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sha L, 2015, J COGNITIVE NEUROSCI, V27, P665, DOI 10.1162/jocn_a_00733; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tandon N, 2008, TXB EPILEPSY SURG, P1001, DOI DOI 10.3109/9780203091708-129; Tang HL, 2014, NEURON, V83, P736, DOI 10.1016/j.neuron.2014.06.017; Vidal JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00195; Vinberg J, 2008, J NEUROPHYSIOL, V99, P1380, DOI 10.1152/jn.01223.2007; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108; Wandell BA, 2012, ANNU REV PSYCHOL, V63, P31, DOI 10.1146/annurev-psych-120710-100434; Weiner KS, 2014, NEUROIMAGE, V84, P453, DOI 10.1016/j.neuroimage.2013.08.068; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Weiner KS, 2011, NEUROIMAGE, V56, P2183, DOI 10.1016/j.neuroimage.2011.03.041; Weiner KS, 2010, NEUROIMAGE, V52, P1559, DOI 10.1016/j.neuroimage.2010.04.262; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winawer J, 2013, CURR BIOL, V23, P1145, DOI 10.1016/j.cub.2013.05.001; Yamins DLK, 2016, CURR OPIN NEUROBIOL, V37, P114, DOI 10.1016/j.conb.2016.02.001; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yeatman JD, 2014, P NATL ACAD SCI USA, V111, pE5214, DOI 10.1073/pnas.1418503111; Yeatman JD, 2013, BRAIN LANG, V125, P146, DOI 10.1016/j.bandl.2012.04.010; Yoshor D, 2007, CEREB CORTEX, V17, P2293, DOI 10.1093/cercor/bhl138	164	25	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157109	10.1371/journal.pone.0157109	http://dx.doi.org/10.1371/journal.pone.0157109			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272936	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000065
J	Chang, CY; Chien, CI; Chang, CP; Lin, BC; Wang, CC				Chang, Chih-Yao; Chien, Chin-, I; Chang, Chia-Pei; Lin, Bo-Chun; Wang, Chien-Chia			A WHEP Domain Regulates the Dynamic Structure and Activity of Caenorhabditis elegans Glycyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; THERMUS-THERMOPHILUS; GENE ENCODES; MITOCHONDRIAL; MUTATIONS; PROTEIN; TRANSLATION; DUPLICATION; DIVERGENCE; EXPRESSION	WHEP domains exist in certain eukaryotic aminoacyl-tRNA synthetases and play roles in tRNA or protein binding. We present evidence herein that cytoplasmic and mitochondrial forms of Caenorhabditis elegans glycyl-tRNA synthetase (CeGlyRS) are encoded by the same gene (CeGRS1) through alternative initiation of translation. The cytoplasmic form possessed an N-terminal WHEP domain, whereas its mitochondrial isoform possessed an extra N-terminal sequence consisting of an mitochondrial targeting signal and an appended domain. Cross-species complementation assays showed that CeGRS1 effectively rescued the cytoplasmic and mitochondrial defects of a yeast GRS1 knock-out strain. Although both forms of CeGlyRS efficiently charged the cytoplasmic tRNAs(Gly) of C. elegans, the mitochondrial form was much more efficient than its cytoplasmic counterpart in charging the mitochondrial tRNA(Gly) isoacceptor, which carries a defective T psi C hairpin. Despite the WHEP domain per se lacking tRNA binding activity, deletion of this domain reduced the catalytic efficiency of the enzyme. Most interestingly, the deletion mutant possessed a higher thermal stability and a somewhat lower structural flexibility. Our study suggests a role for the WHEP domain as a regulator of the dynamic structure and activity of the enzyme.	[Chang, Chih-Yao; Chien, Chin-, I; Chang, Chia-Pei; Lin, Bo-Chun; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan	National Central University	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan.	dukewang@cc.ncu.edu.tw		Wang, Chien-Chia/0000-0002-7104-1307	Ministry of Science and Technology [MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, NSC 102-2311-B-008-004-MY3]; National Central University; Landseed Hospital Joint Research Program Grant [NCU-LSH-103-A-003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Central University; Landseed Hospital Joint Research Program Grant	This work was supported by Ministry of Science and Technology Grants MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, and NSC 102-2311-B-008-004-MY3 (to C.-C. W.) and National Central University and Landseed Hospital Joint Research Program Grant NCU-LSH-103-A-003 (to C.-C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang CP, 2015, MOL CELL BIOL, V35, P2242, DOI 10.1128/MCB.00018-15; Chang CP, 2012, NUCLEIC ACIDS RES, V40, P314, DOI 10.1093/nar/gkr724; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chien CI, 2015, FUNGAL GENET BIOL, V76, P47, DOI 10.1016/j.fgb.2015.02.004; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Grice SJ, 2015, HUM MOL GENET, V24, P4397, DOI 10.1093/hmg/ddv176; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516; Ladror US, 1998, PROTEIN SCI, V7, P2595, DOI 10.1002/pro.5560071213; Liao CC, 2012, NUCLEIC ACIDS RES, V40, P9171, DOI 10.1093/nar/gks689; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; Mazauric MH, 1998, EUR J BIOCHEM, V251, P744, DOI 10.1046/j.1432-1327.1998.2510744.x; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; NADA S, 1993, J BIOL CHEM, V268, P7660; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; OSTREM DL, 1970, P NATL ACAD SCI USA, V67, P1967, DOI 10.1073/pnas.67.4.1967; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Turner RJ, 2000, J BIOL CHEM, V275, P27681	35	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16567	16575		10.1074/jbc.M116.730812	http://dx.doi.org/10.1074/jbc.M116.730812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298321	Green Published, hybrid			2022-12-26	WOS:000380826700016
J	Lucon-Xiccato, T; Dadda, M				Lucon-Xiccato, Tyrone; Dadda, Marco			Guppies Show Behavioural but Not Cognitive Sex Differences in a Novel Object Recognition Test	PLOS ONE			English	Article							FEMALE MATE CHOICE; SPATIAL MEMORY; WATER MAZE; COLOR; SIZE; DISCRIMINATION; EXPLORATION; PERFORMANCE; MALES; RATS	The novel object recognition (NOR) test is a widely-used paradigm to study learning and memory in rodents. NOR performance is typically measured as the preference to interact with a novel object over a familiar object based on spontaneous exploratory behaviour. In rats and mice, females usually have greater NOR ability than males. The NOR test is now available for a large number of species, including fish, but sex differences have not been properly tested outside of rodents. We compared male and female guppies (Poecilia reticulata) in a NOR test to study whether sex differences exist also for fish. We focused on sex differences in both performance and behaviour of guppies during the test. In our experiment, adult guppies expressed a preference for the novel object as most rodents and other species do. When we looked at sex differences, we found the two sexes showed a similar preference for the novel object over the familiar object, suggesting that male and female guppies have similar NOR performances. Analysis of behaviour revealed that males were more inclined to swim in the proximity of the two objects than females. Further, males explored the novel object at the beginning of the experiment while females did so afterwards. These two behavioural differences are possibly due to sex differences in exploration. Even though NOR performance is not different between male and female guppies, the behavioural sex differences we found could affect the results of the experiments and should be carefully considered when assessing fish memory with the NOR test.	[Lucon-Xiccato, Tyrone; Dadda, Marco] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Padua	Lucon-Xiccato, T (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	tyrone.luconxiccato@studenti.unipd.it	DADDA, Marco/ABI-7266-2020; Lucon-Xiccato, Tyrone/AAG-9221-2020	DADDA, Marco/0000-0001-7944-4058; Lucon-Xiccato, Tyrone/0000-0002-1017-9230	"Progetto di Ateneo" from University of Padova [CPDA 131092/13]	"Progetto di Ateneo" from University of Padova	Funding was provided by "Progetto di Ateneo" from University of Padova to MD (CPDA 131092/13).	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Barchard KA, 2015, ANAL SOC ISS PUB POL, V15, P418, DOI 10.1111/asap.12095; Barkley CL, 2007, ANIM BEHAV, V73, P321, DOI 10.1016/j.anbehav.2006.07.009; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Beiko J, 2004, BEHAV BRAIN RES, V151, P239, DOI 10.1016/j.bbr.2003.08.019; Bettis T, 2012, BEHAV BRAIN RES, V233, P288, DOI 10.1016/j.bbr.2012.04.028; Bettis TJ, 2013, ANIM COGN, V16, P873, DOI 10.1007/s10071-013-0619-x; Bettis TJ, 2009, BEHAV PROCESS, V82, P249, DOI 10.1016/j.beproc.2009.07.004; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blaser R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00183; Braida D, 2014, PROG NEURO-PSYCHOPH, V55, P80, DOI 10.1016/j.pnpbp.2014.03.010; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Brown C., 2008, FISH COGNITION BEHAV, DOI DOI 10.1098/rsbl.2017.0002; Burns JG, 2008, J COMP PSYCHOL, V122, P344, DOI 10.1037/0735-7036.122.4.344; Callahan H, 2000, PROG NEURO-PSYCHOPH, V24, P693, DOI 10.1016/S0278-5846(00)00102-0; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; Eakley AL, 2004, P ROY SOC B-BIOL SCI, V271, pS299, DOI 10.1098/rsbl.2004.0165; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Gasparini C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3072; Ghi P, 1999, PHARMACOL BIOCHEM BE, V64, P761, DOI 10.1016/S0091-3057(99)00143-4; Gori S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06443; Harris S, 2010, OIKOS, V119, P1711, DOI 10.1111/j.1600-0706.2010.18028.x; Heyser CJ, 2012, BEHAV PROCESS, V89, P232, DOI 10.1016/j.beproc.2011.12.004; Hodgson ZG, 2005, ANIM COGN, V8, P211, DOI 10.1007/s10071-004-0249-4; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; Irving E, 2013, J FISH BIOL, V83, P311, DOI 10.1111/jfb.12165; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; Jeffreys H., 1998, THEORY PROBABILITY; Kinzler KD, 2007, PROG BRAIN RES, V164, P257, DOI 10.1016/S0079-6123(07)64014-X; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; LONG KD, 1989, ETHOLOGY, V82, P316; Lucon-Xiccato T, 2016, ANIM COGN, V19, P733, DOI 10.1007/s10071-016-0969-2; Lucon-Xiccato T, 2016, ETHOLOGY, V122, P481, DOI 10.1111/eth.12498; Lucon-Xiccato T, 2015, ANIM BEHAV, V107, P183, DOI 10.1016/j.anbehav.2015.06.019; Lucon-Xiccato T, 2014, BEHAV PROCESS, V106, P1, DOI 10.1016/j.beproc.2014.03.010; Lucon-Xiccato T, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0206; Magurran AE, 2000, J FISH BIOL, V57, P839, DOI [10.1006/jfbi.2000.1391, 10.1111/j.1095-8649.2000.tb02196.x]; Malkova L, 2003, J NEUROSCI, V23, P1956; May Z, 2016, BEHAV BRAIN RES, V296, P199, DOI 10.1016/j.bbr.2015.09.016; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Muller CA, 2011, BIOL LETTERS, V7, P689, DOI 10.1098/rsbl.2011.0287; O'Hara M, 2015, ANIM BEHAV, V101, P51, DOI 10.1016/j.anbehav.2014.12.022; Okujava V, 2005, ACTA NEUROBIOL EXP, V65, P205; Oliveira J, 2015, ZEBRAFISH, V12, P166, DOI 10.1089/zeb.2014.1019; Petrazzini MEM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15497; Petrazzini MEM, 2012, BEHAV BRAIN RES, V233, P443, DOI 10.1016/j.bbr.2012.05.044; Reader SM, 2000, ANIM BEHAV, V60, P175, DOI 10.1006/anbe.2000.1450; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2008, ANIM COGN, V11, P129, DOI 10.1007/s10071-007-0096-1; Sava S, 2005, HORM BEHAV, V48, P23, DOI 10.1016/j.yhbeh.2005.01.011; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silverman I, 2007, ARCH SEX BEHAV, V36, P261, DOI 10.1007/s10508-006-9168-6; Sokal R.R., 2012, BIOMETRY; Sovrano VA, 2008, ANIM COGN, V11, P161, DOI 10.1007/s10071-007-0100-9; Sovrano VA, 2009, PERCEPTION, V38, P579, DOI 10.1068/p6121; Steckler T, 1998, PROG NEUROBIOL, V54, P289, DOI 10.1016/S0301-0082(97)00060-9; Stowe M, 2006, BEHAV PROCESS, V73, P68, DOI 10.1016/j.beproc.2006.03.015; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Tello-Ramos MC, 2014, ANIM BEHAV, V93, P129, DOI 10.1016/j.anbehav.2014.04.036; THINUSBLANC C, 1992, BEHAV PROCESS, V26, P43, DOI 10.1016/0376-6357(92)90031-8; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; Vallortigara G, 1996, BEHAV PROCESS, V36, P289, DOI 10.1016/0376-6357(95)00063-1; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; WARREN EW, 1976, BEHAV BIOL, V18, P499, DOI 10.1016/S0091-6773(76)92524-4; WARREN EW, 1975, J FISH BIOL, V7, P105, DOI 10.1111/j.1095-8649.1975.tb04580.x; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	69	30	30	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156589	10.1371/journal.pone.0156589	http://dx.doi.org/10.1371/journal.pone.0156589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305102	gold, Green Published, Green Submitted			2022-12-26	WOS:000377824800018
J	Okada, M; Ishikawa, T; Ikegaya, Y				Okada, Mami; Ishikawa, Tomoe; Ikegaya, Yuji			A Computationally Efficient Filter for Reducing Shot Noise in Low S/N Data	PLOS ONE			English	Article							ACTION-POTENTIALS; NEURONAL POPULATIONS; CALCIUM	Functional multineuron calcium imaging (fMCI) provides a useful experimental platform to simultaneously capture the spatiotemporal patterns of neuronal activity from a large cell population in situ. However, fMCI often suffers from low signal-to-noise ratios (S/N). The main factor that causes the low S/N is shot noise that arises from photon detectors. Here, we propose a new denoising procedure, termed the Okada filter, which is designed to reduce shot noise under low S/N conditions, such as fMCI. The core idea of the Okada filter is to replace the fluorescence intensity value of a given frame time with the average of two values at the preceding and following frames unless the focused value is the median among these three values. This process is iterated serially throughout a time-series vector. In fMCI data of hippocampal neurons, the Okada filter rapidly reduces background noise and significantly improves the S/N. The Okada filter is also applicable for reducing shot noise in electrophysiological data and photographs. Finally, the Okada filter can be described using a single continuous differentiable equation based on the logistic function and is thus mathematically tractable.	[Okada, Mami; Ishikawa, Tomoe; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Ikegaya, Yuji] Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks, Suita, Osaka 5650871, Japan	University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.; Ikegaya, Y (corresponding author), Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks, Suita, Osaka 5650871, Japan.	yuji@ikegaya.jp		Ikegaya, Yuji/0000-0003-2260-8191	 [22115003]		This work was supported by Grants-in-Aid for Science Research on Innovative Areas, "Mesoscopic Neurocircuitry" (22115003).	Arias-Castro E, 2009, ANN STAT, V37, P1172, DOI 10.1214/08-AOS604; Fiore L, 1996, J NEUROSCI METH, V70, P177, DOI 10.1016/S0165-0270(96)00116-1; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Ishikawa T, 2015, INT J PHARMACOL, V11, P318, DOI 10.3923/ijp.2015.318.326; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Little MA, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0546; Mizunuma M, 2014, NAT NEUROSCI, V17, P503, DOI 10.1038/nn.3674; Namiki S, 2009, BIOL PHARM BULL, V32, P1, DOI 10.1248/bpb.32.1; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Szymanska AF, J NEUROSCI IN PRESS; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Takahashi Naoya, 2011, Curr Protoc Neurosci, VChapter 2, DOI 10.1002/0471142301.ns0214s57; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157595	10.1371/journal.pone.0157595	http://dx.doi.org/10.1371/journal.pone.0157595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304217	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800076
J	Chan, IH; Van Hoof, D; Abramova, M; Bilardello, M; Mar, E; Jorgensen, B; McCauley, S; Bal, H; Oft, M; Van Vlasselaer, P; Mumm, JB				Chan, Ivan H.; Van Hoof, Dennis; Abramova, Marina; Bilardello, Melissa; Mar, Elliot; Jorgensen, Brett; McCauley, Scott; Bal, Harminder; Oft, Martin; Van Vlasselaer, Peter; Mumm, John B.			PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; RECOMBINANT HUMAN INTERLEUKIN-10; REVERSE CHOLESTEROL TRANSPORT; ACUTE MYELOGENOUS LEUKEMIA; NECROSIS-FACTOR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; NEGATIVE REGULATION; MESSENGER-RNA; GENE-TRANSFER; LIVER-CELLS	Interleukin-10 (IL-10) is a multifunctional cytokine that exerts potent context specific immunostimulatory and immunosuppressive effects. We have investigated the mechanism by which PEGylated rIL-10 regulates plasma cholesterol in mice and humans. In agreement with previous work on rIL-10, we report that PEGylated rIL-10 harnesses the myeloid immune system to control total plasma cholesterol levels. We have discovered that PEG-NrMuIL-10's dramatic lowering of plasma cholesterol is dependent on phagocytotic cells. In particular, PEG-rHuIL-10 enhances cholesterol uptake by Kupffer cells. In addition, removal of phagocytotic cells dramatically increases plasma cholesterol levels, suggesting for the first time that immunological cells are implicitly involved in regulating total cholesterol levels. These data suggest that treatment with PEG-rIL-10 potentiates endogenous cholesterol regulating cell populations not currently targeted by standard of care therapeutics. Furthermore, we show that IL-10's increase of Kupffer cell cholesterol phagocytosis is concomitant with decreases in liver cholesterol and triglycerides. This leads to the reversal of early periportal liver fibrosis and facilitates the restoration of liver health. These data recommend PEG-rIL-10 for evaluation in the treatment of fatty liver disease and preventing its progression to non-alcoholic steatohepatitis. In direct confirmation of our in vivo findings in the treatment of hypercholesterolemic mice with PEG-rMuIL-10, we report that treatment of hypercholesterolemic cancer patients with PEG-rHuIL-10 lowers total plasma cholesterol by up to 50%. Taken together these data suggest that PEG-rIL-10's cholesterol regulating biology is consistent between mice and humans.	[Chan, Ivan H.; Van Hoof, Dennis; Abramova, Marina; Bilardello, Melissa; Mar, Elliot; Jorgensen, Brett; McCauley, Scott; Bal, Harminder; Oft, Martin; Van Vlasselaer, Peter; Mumm, John B.] ARMO BioSci Inc, 575 Chesapeake Dr, Redwood City, CA 94063 USA; [Van Hoof, Dennis] Becton Dickinson Biosci, 2350 Qume Dr, San Jose, CA 95131 USA; [Abramova, Marina] Kaiser Permanente, 128 Locust Ave, Larkspur, CA 94939 USA; [Mar, Elliot] Soundninja, 415 Middlefield Rd, Belmont, CA 94002 USA	Becton Dickinson; Kaiser Permanente	Mumm, JB (corresponding author), ARMO BioSci Inc, 575 Chesapeake Dr, Redwood City, CA 94063 USA.	john.mumm@armobio.com	Abramova, Marina/AAA-8459-2020; Chan, Ivan/B-7922-2010	Chan, Ivan/0000-0003-2834-2574; McCauley, Scott/0000-0003-4549-5599	Kleiner Perkins Caufield Byers; Orbimed; ARMO BioSciences Inc.	Kleiner Perkins Caufield Byers; Orbimed; ARMO BioSciences Inc.	ARMO BioSciences is 100% financed by venture funding. At the time this work was conducted the following venture capital firms had provided funds: Kleiner Perkins Caufield Byers, http://www.kpcb.com/; Orbimed, http://www.orbimed.com/. ARMO BioSciences will not conduct clinical trials for the purposes of testing PEG-rHuIL-10's capacity to control cholesterol. ARMO BioSciences is developing PEG-rHuIL-10 only in immunoncology. The funders did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ARMO BioSciences Inc. provided support in the form of salaries for authors [IHC, DVH, MA, MB, EM, BJ, SM, HB, MO, PVV, JBM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Bell DA, 2011, EXPERT OPIN INV DRUG, V20, P265, DOI 10.1517/13543784.2011.547471; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; BUDD D, 1986, CANCER, V58, P1361, DOI 10.1002/1097-0142(19860915)58:6<1361::AID-CNCR2820580630>3.0.CO;2-S; Chan IH, 2015, J INTERF CYTOK RES, V35, P948, DOI 10.1089/jir.2014.0221; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; de Fost M, 2009, ATHEROSCLEROSIS, V204, P267, DOI 10.1016/j.atherosclerosis.2008.08.027; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; GINSBERG H, 1984, CLIN GENET, V26, P109; Halvorsen B, 2005, J LIPID RES, V46, P211, DOI 10.1194/jlr.M400324-JLR200; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; HARKES L, 1984, BIOCHIM BIOPHYS ACTA, V794, P340, DOI 10.1016/0005-2760(84)90165-6; HARKES L, 1984, BIOCHEM J, V224, P21, DOI 10.1042/bj2240021; Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ichimura M, 2015, HEPATOL RES, V45, P458, DOI 10.1111/hepr.12358; Infante JR, 2015, ASCO M S, V33, P3017; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; KAMPS JAAM, 1991, BIOCHEM J, V276, P135, DOI 10.1042/bj2760135; Kimball AB, 2002, ARCH DERMATOL, V138, P1341, DOI 10.1001/archderm.138.10.1341; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Martel C, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0354-4; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; MILLER GJ, 1975, LANCET, V1, P16; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; NENSETER MS, 1992, J LIPID RES, V33, P867; NIMER SD, 1988, JAMA-J AM MED ASSOC, V260, P3297, DOI 10.1001/jama.260.22.3297; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Peterson AS, 2008, J LIPID RES, V49, P1595, DOI 10.1194/jlr.CX00001-JLR200; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Reich K, 2001, J INVEST DERMATOL, V116, P319, DOI 10.1046/j.1523-1747.2001.01248.x; REVERTER JC, 1988, EUR J HAEMATOL, V41, P317; Ritchlin C, 2001, J RHEUMATOL, V28, P698; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; Santucci L, 1996, GASTROENTEROLOGY, V111, P736, DOI 10.1053/gast.1996.v111.pm8780580; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Steib CJ, 2011, GUT, V60, P1307, DOI 10.1136/gut.2011.242560; Tatidis L, 2001, CANCER LETT, V170, P169, DOI 10.1016/S0304-3835(01)00592-4; Thomas GS, 2013, J AM COLL CARDIOL, V62, P2178, DOI 10.1016/j.jacc.2013.07.081; Tilg H, 2002, GUT, V50, P191, DOI 10.1136/gut.50.2.191; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; von der Thusen JH, 2001, FASEB J, V15, P2730, DOI 10.1096/fj.01-0483fje; Wang XZ, 2004, WORLD J GASTROENTERO, V10, P2706, DOI 10.3748/wjg.v10.i18.2706; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Yoshioka T, 2004, GENE THER, V11, P1772, DOI 10.1038/sj.gt.3302348; Zhang LJ, 2007, HEPATO-GASTROENTEROL, V54, P2092	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156229	10.1371/journal.pone.0156229	http://dx.doi.org/10.1371/journal.pone.0156229			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299860	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200007
J	Kaye, DR; Pinto, PA; Cecchi, F; Reilly, J; Semerjian, A; Rabe, DC; Gupta, G; Choyke, PL; Bottaro, DP				Kaye, Deborah R.; Pinto, Peter A.; Cecchi, Fabiola; Reilly, Joseph; Semerjian, Alice; Rabe, Daniel C.; Gupta, Gopal; Choyke, Peter L.; Bottaro, Donald P.			Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; BONE METASTASES; ANTIGEN LEVEL; PROGRESSION; EXPRESSION; RECEPTOR; CABOZANTINIB; CARCINOMA; LOCATION	Objective To measure Met protein content in prostate biopsies guided by fused magnetic resonance and ultrasound imaging, and to measure soluble Met (sMet) protein concentration in plasma samples from patients presenting evidence of prostate cancer. Patients and Methods 345 patients had plasma samples drawn prior to image-guided biopsy of the prostate. Of these, 32% had benign biopsies. Of the 236 that were positive for prostate adenocarcinoma (PCa), 132 treated by total prostatectomy had Gleason scores of 6 (17%), 7, (55%), 8 (16%), or 9-10 (12%). 23% had evidence of local invasion. Plasma samples were also obtained from 80 healthy volunteers. Tissue Met and plasma sMet were measured by two-site immunoassay; values were compared among clinically defined groups using non-parametric statistical tests to determine significant differences or correlations. Results PCa tumor Met correlated significantly with plasma sMet, but median values were similar among benign and malignant groups. Median plasma sMet values were also similar among those groups, although both medians were significantly above normal. Median Met content in primary PCa tumors and sMet concentrations were independent of Gleason score, final pathologic stage and age. Conclusion Plasma sMet is not predictive of PCa or its severity in patients with organ-confined or locally invasive disease. Quantitative analysis of Met protein content and activation state in PCa tumor biopsy samples was highly feasible and may have value in follow-up to genomic and/or transcriptomic-based screens that show evidence of oncogenically relevant MET gene features that occur at relatively low frequency in non-metastatic PCa.	[Kaye, Deborah R.; Pinto, Peter A.; Cecchi, Fabiola; Reilly, Joseph; Semerjian, Alice; Rabe, Daniel C.; Gupta, Gopal; Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Choyke, Peter L.] NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Kaye, Deborah R.] Johns Hopkins Univ, James Buchanan Brady Urol Inst, 600 N Wolfe St, Baltimore, MD 21287 USA; [Cecchi, Fabiola; Reilly, Joseph] NantOmics, 9600 Med Ctr Dr,Suite 300, Rockville, MD 20850 USA; [Semerjian, Alice] George Washington Univ Med Fac Associates, 2150 Penn Ave NW, Washington, DC 20037 USA; [Rabe, Daniel C.] Univ Chicago, Div Biol Sci, BSLC, 924 E 57th St,Suite 104, Chicago, IL 60637 USA; [Gupta, Gopal] Loyola Univ, Med Ctr, Dept Urol, 2160 S First Ave,Bldg 54,Room 237A, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University of Chicago; Loyola University Chicago	Bottaro, DP (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	dbottaro@helix.nih.gov	Bottaro, Donald P/AAF-3853-2020; Rabe, Daniel/F-2420-2018; Bottaro, Donald P/F-8550-2010	Bottaro, Donald P/0000-0002-5057-5334; Rabe, Daniel/0000-0001-6126-2280; Bottaro, Donald P/0000-0002-5057-5334	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research [ZIA BC011124]; NATIONAL CANCER INSTITUTE [ZIABC011081, ZIABC011124] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research, awarded to DPB, ZIA BC011124: http://fundedresearch.cancer.gov/nciportfolio/search/detailsaction=abstract&grantNum=ZIA%20BC%20011124&grantID=34045&grtSCDC=FY%202013&absID=34045&absSCDC=PUB2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. We thank Alessio Giubellino for contributions to Met measurements reported here.	AIHARA M, 1994, J UROLOGY, V151, P1558, DOI 10.1016/S0022-5347(17)35302-8; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Basch E, 2015, EUR UROL, V67, P310, DOI 10.1016/j.eururo.2014.02.013; Bensalah K, 2008, PROSTATE CANCER P D, V11, P112, DOI 10.1038/sj.pcan.4501026; Cecchi F, 2012, CANCER CELL, V22, P250, DOI 10.1016/j.ccr.2012.06.029; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clyne Melanie, 2014, Nat Rev Urol, V11, P188, DOI 10.1038/nrurol.2014.57; Fall K, 2007, JNCI-J NATL CANCER I, V99, P526, DOI 10.1093/jnci/djk110; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gartrell BA, 2014, NAT REV CLIN ONCOL, V11, P335, DOI 10.1038/nrclinonc.2014.70; Graham TJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju033; Gupta A, 2008, CLIN CANCER RES, V14, P7385, DOI 10.1158/1078-0432.CCR-07-5110; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Humphrey PA, 2006, CLIN GENITOURIN CANC, V4, P269, DOI 10.3816/CGC.2006.n.006; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Knudsen BS, 2002, UROLOGY, V60, P1113, DOI 10.1016/S0090-4295(02)01954-4; Lee RJ, 2013, CLIN CANCER RES, V19, P3088, DOI 10.1158/1078-0432.CCR-13-0319; Leibovici D, 2007, CANCER, V109, P198, DOI 10.1002/cncr.22372; Naughton M, 2001, J UROLOGY, V165, P1325, DOI 10.1016/S0022-5347(01)69893-8; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Russo AL, 2009, CLIN CANCER RES, V15, P4292, DOI 10.1158/1078-0432.CCR-09-0599; Sandblom G, 2008, CANCER, V112, P813, DOI 10.1002/cncr.23235; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Turkbey B, 2011, CANCER IMAGING, V11, P31, DOI 10.1102/1470-7330.2011.0007; Turkbey B, 2011, BJU INT, V107, P53, DOI 10.1111/j.1464-410X.2010.09483.x; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Watanabe M, 1999, CANCER LETT, V141, P173, DOI 10.1016/S0304-3835(99)00102-0	28	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157130	10.1371/journal.pone.0157130	http://dx.doi.org/10.1371/journal.pone.0157130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300295	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200030
J	Kelsey, TW; Ginbey, E; Chowdhury, MM; Bath, LE; Anderson, RA; Wallace, WHB				Kelsey, Thomas W.; Ginbey, Eleanor; Chowdhury, Moti M.; Bath, Louise E.; Anderson, Richard A.; Wallace, W. Hamish B.			A Validated Normative Model for Human Uterine Volume from Birth to Age 40 Years	PLOS ONE			English	Article							CENTRAL PRECOCIOUS PUBERTY; PELVIC ULTRASONOGRAPHY; HEALTHY GIRLS; EARLY DIFFERENTIATION; ULTRASOUND EVALUATION; POSTMENOPAUSAL WOMEN; PREMATURE THELARCHE; REPLACEMENT THERAPY; TURNER-SYNDROME; OVARIAN	Transabdominal pelvic ultrasound and/or pelvic Magnetic Resonance Imaging are safe, accurate and non-invasive means of determining the size and configuration of the internal female genitalia. The assessment of uterine size and volume is helpful in the assessment of many conditions including disorders of sex development, precocious or delayed puberty, infertility and menstrual disorders. Using our own data from the assessment of MRI scans in healthy young females and data extracted from four studies that assessed uterine volume using transabdominal ultrasound in healthy females we have derived and validated a normative model of uterine volume from birth to age 40 years. This shows that uterine volume increases across childhood, with a faster increase in adolescence reflecting the influence of puberty, followed by a slow but progressive rise during adult life. The model suggests that around 84% of the variation in uterine volumes in the healthy population up to age 40 is due to age alone. The derivation of a validated normative model for uterine volume from birth to age 40 years has important clinical applications by providing age-related reference values for uterine volume.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews KY16 9SX, Fife, Scotland; [Ginbey, Eleanor] Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Chowdhury, Moti M.] Royal Hosp Sick Children, Dept Paediat Radiol, Edinburgh EH9 1LF, Midlothian, Scotland; [Bath, Louise E.] Royal Hosp Sick Children, Dept Endocrinol & Diabet, Edinburgh EH9 1LF, Midlothian, Scotland; [Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Wallace, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458				Abbassi V, 1998, PEDIATRICS, V102, P507; Albertsson-Wikland K, 2014, HORM RES PAEDIAT, V82, P158, DOI 10.1159/000363106; Badouraki M, 2008, J CLIN ULTRASOUND, V36, P539, DOI 10.1002/jcu.20522; Bath LE, 1999, BRIT J OBSTET GYNAEC, V106, P1265, DOI 10.1111/j.1471-0528.1999.tb08180.x; Bridges NA, 1996, ARCH DIS CHILD, V75, P330, DOI 10.1136/adc.75.4.330; Buzi F, 1998, ACTA PAEDIATR, V87, P1138; Cagnacci A, 2000, MENOPAUSE, V7, P117, DOI 10.1097/00042192-200007020-00008; Christodoulacos G, 2002, MATURITAS, V42, P77, DOI 10.1016/S0378-5122(02)00027-0; Critchley Hilary O D, 2005, J Natl Cancer Inst Monogr, P64; Da Costa AG, 2004, ULTRASOUND MED BIOL, V30, P7, DOI 10.1016/j.ultrasmedbio.2003.09.009; de Vries L, 2006, EUR J ENDOCRINOL, V154, P891, DOI 10.1530/eje.1.02151; Elsedfy HH, 2012, J PEDIATR ENDOCR MET, V25, P441, DOI 10.1515/jpem-2012-0040; HABER HP, 1995, EUR J PEDIATR, V154, P182, DOI 10.1007/BF01954267; Haber HP, 1999, J ULTRAS MED, V18, P271; HABER HP, 1994, PEDIATR RADIOL, V24, P11, DOI 10.1007/BF02017650; Hagen CP, 2015, FERTIL STERIL, V104, P452, DOI 10.1016/j.fertnstert.2015.04.042; Hauth EAM, 2007, EUR RADIOL, V17, P734, DOI 10.1007/s00330-006-0313-3; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Herter LD, 2002, J ULTRAS MED, V21, P1237, DOI 10.7863/jum.2002.21.11.1237; HOLM K, 1995, ULTRASOUND OBST GYN, V6, P175, DOI 10.1046/j.1469-0705.1995.06030175.x; HRA, 2013, DOES MY PROJ REQ REV; Kelsey TW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153843; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Kelsey TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071465; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Merz E, 1996, ULTRASOUND OBST GYN, V7, P38, DOI 10.1046/j.1469-0705.1996.07010038.x; Nella AA, 2014, J PEDIATR ENDOCR MET, V27, P821, DOI 10.1515/jpem-2013-0415; Razzaghy-Azar M, 2011, J CLIN ULTRASOUND, V39, P64, DOI 10.1002/jcu.20723; RIGSBY CK, 1994, J COMPUT ASSIST TOMO, V18, P72, DOI 10.1097/00004728-199401000-00016; Rohatgi A., 2015, WEBPLOTDIGITIZER; SALARDI S, 1988, J PEDIATR-US, V112, P880, DOI 10.1016/S0022-3476(88)80208-7; SALARDI S, 1985, ARCH DIS CHILD, V60, P120, DOI 10.1136/adc.60.2.120; SORNES T, 1989, ACTA OBSTET GYN SCAN, V68, P439, DOI 10.3109/00016348909021017; TSE WY, 1989, ACTA PAEDIATR SCAND, P38; Verguts J, 2013, ULTRASOUND OBST GYN, V42, P713, DOI 10.1002/uog.12538; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772	37	18	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157375	10.1371/journal.pone.0157375	http://dx.doi.org/10.1371/journal.pone.0157375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295032	Green Published, Green Submitted, gold			2022-12-26	WOS:000377821300038
J	Marmesat, E; Soriano, L; Mazzoni, CJ; Sommer, S; Godoy, JA				Marmesat, Elena; Soriano, Laura; Mazzoni, Camila J.; Sommer, Simone; Godoy, Jose A.			PCR Strategies for Complete Allele Calling in Multigene Families Using High-Throughput Sequencing Approaches	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TAQ DNA-POLYMERASE; MHC; MISMATCH; AMPLIFICATION; POLYMORPHISM; GENE; DISCRIMINATION; POPULATION; EXPRESSION	The characterization of multigene families with high copy number variation is often approached through PCR amplification with highly degenerate primers to account for all expected variants flanking the region of interest. Such an approach often introduces PCR biases that result in an unbalanced representation of targets in high-throughput sequencing libraries that eventually results in incomplete detection of the targeted alleles. Here we confirm this result and propose two different amplification strategies to alleviate this problem. The first strategy (called pooled-PCRs) targets different subsets of alleles in multiple independent PCRs using different moderately degenerate primer pairs, whereas the second approach (called pooled-primers) uses a custom-made pool of non-degenerate primers in a single PCR. We compare their performance to the common use of a single PCR with highly degenerate primers using the MHC class I of the Iberian lynx as a model. We found both novel approaches to work similarly well and better than the conventional approach. They significantly scored more alleles per individual (11.33 +/- 1.38 and 11.72 +/- 0.89 vs 7.94 +/- 1.95), yielded more complete allelic profiles (96.28 +/- 8.46 and 99.50 +/- 2.12 vs 63.76 +/- 15.43), and revealed more alleles at a population level (13 vs 12). Finally, we could link each allele's amplification efficiency with the primer-mismatches in its flanking sequences and show that ultra-deep coverage offered by high-throughput technologies does not fully compensate for such biases, especially as real alleles may reach lower coverage than artefacts. Adopting either of the proposed amplification methods provides the opportunity to attain more complete allelic profiles at lower coverages, improving confidence over the downstream analyses and subsequent applications.	[Marmesat, Elena; Soriano, Laura; Godoy, Jose A.] CSIC, Dept Integrat Ecol, Estn Biol Donana, E-41080 Seville, Spain; [Mazzoni, Camila J.] Berlin Ctr Genom Biodivers Res BeGenDiv, Berlin, Germany; [Mazzoni, Camila J.] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany; [Sommer, Simone] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Leibniz Institut fur Zoo und Wildtierforschung; Ulm University	Godoy, JA (corresponding author), CSIC, Dept Integrat Ecol, Estn Biol Donana, E-41080 Seville, Spain.	godoy@ebd.csic.es	Mazzoni, Camila/AAJ-9702-2020; Marmesat, Elena/AAC-4300-2020; Godoy, José Antonio/B-9288-2008	Mazzoni, Camila/0000-0001-6758-5427; Marmesat, Elena/0000-0002-3007-4284; Godoy, José Antonio/0000-0001-7502-9471	Direccion General de Investigacion Cinetifica y Tecnica, Spanish Science and Innovation Ministry [CGL2010-21540/BOS, CGL2013-47755-P]; CSIC (Spanish National Research Council); CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI); Life project [LIFE10NAT/ES/570]; Spanish Direccion General de Investigacion Cientifica y Tecnica [CGL2013-47755-P, CCGL2010-21540/BOS]; ESF activity on 'Conservation Genomics: Amalgamation of Conservation Genetics and Ecological and Evolutionary Genomics'	Direccion General de Investigacion Cinetifica y Tecnica, Spanish Science and Innovation Ministry; CSIC (Spanish National Research Council); CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI); Life project; Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government); ESF activity on 'Conservation Genomics: Amalgamation of Conservation Genetics and Ecological and Evolutionary Genomics'	Funding for this project was provided by the Direccion General de Investigacion Cinetifica y Tecnica, Spanish Science and Innovation Ministry, through grants CGL2010-21540/BOS and CGL2013-47755-P. Elena Marmesat received a JAE predoctoral grant from CSIC (Spanish National Research Council) and a short stay grant within the framework of the ESF activity on 'Conservation Genomics: Amalgamation of Conservation Genetics and Ecological and Evolutionary Genomics'. The authors acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Ana Piriz and Maria Mendez for support with laboratory work and to P. James Macaluso for his proofreading services. Thanks to the Junta de Andalucia, the Iberian lynx Captive Breeding Program and the Life project LIFE10NAT/ES/570 for kindly providing the samples used in this study. Logistical support was provided by Laboratorio de Ecologia Molecular, Estacion Biologica de Donana, CSIC (LEM-EBD). This study was funded by the Spanish Direccion General de Investigacion Cientifica y Tecnica through projects CCGL2010-21540/BOS and CGL2013-47755-P. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Burri R, 2014, MOL ECOL RESOUR, V14, P778, DOI 10.1111/1755-0998.12234; Casas-Marce M, 2013, MOL ECOL, V22, P5503, DOI 10.1111/mec.12498; Castro-Prieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049129; Castro-Prieto A, 2011, MOL BIOL EVOL, V28, P1455, DOI 10.1093/molbev/msq330; Christopherson C, 1997, NUCLEIC ACIDS RES, V25, P654, DOI 10.1093/nar/25.3.654; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Day JP, 1999, NUCLEIC ACIDS RES, V27, P1810, DOI 10.1093/nar/27.8.1810; Denovo.cnag.cat, 2016, JBROWSE; DRESSLER GR, 1988, TRENDS GENET, V4, P214, DOI 10.1016/S0168-9525(88)80003-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Herdegen M, 2014, J EVOLUTION BIOL, V27, P2347, DOI 10.1111/jeb.12476; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim UK, 2004, J DENT RES, V83, P448, DOI 10.1177/154405910408300603; KLEIN J, 1986, NATURAL HIST MAJOR H; Lamaze FC, 2014, MOL ECOL, V23, P1730, DOI 10.1111/mec.12684; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lighten J, 2014, MOL ECOL, V23, P3957, DOI 10.1111/mec.12843; Lighten J, 2014, MOL ECOL RESOUR, V14, P753, DOI 10.1111/1755-0998.12225; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Oomen RA, 2013, MOL ECOL RESOUR, V13, P103, DOI 10.1111/1755-0998.12027; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Pokorny I, 2010, IMMUNOGENETICS, V62, P667, DOI 10.1007/s00251-010-0475-7; R Core Team, 2008, LECT NOTE PHYS, V739, P2673, DOI [10.1007/978-3-540-74686-7, DOI 10.1007/978-3-540-74686-7]; R Development Core Team, 2014, R LANG ENV STAT COMP; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sachdev M, 2005, TISSUE ANTIGENS, V66, P9, DOI 10.1111/j.1399-0039.2005.00432.x; Sambrook J., 2001, MOL CLONING LAB MANU; SARKAR G, 1990, ANAL BIOCHEM, V186, P64, DOI 10.1016/0003-2697(90)90573-R; Sebastian A, 2016, MOL ECOL RESOUR, V16, P498, DOI 10.1111/1755-0998.12453; Sepil I, 2013, MOL ECOL, V22, P384, DOI 10.1111/mec.12123; Shum J, 2009, ANAL BIOCHEM, V388, P266, DOI 10.1016/j.ab.2009.02.033; Sommer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-542; Stutz WE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100587; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wegner KM, 2009, MOL ECOL, V18, P1818, DOI 10.1111/j.1365-294X.2009.04173.x; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; YANAGI S, 1975, LIFE SCI, V17, P1411, DOI 10.1016/0024-3205(75)90161-7; Yuhki N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002674; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395	53	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157402	10.1371/journal.pone.0157402	http://dx.doi.org/10.1371/journal.pone.0157402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294261	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300043
J	Niendorf, S; Klemm, U; Marques, AM; Bock, CT; Hohne, M				Niendorf, Sandra; Klemm, Uwe; Marques, Andreas Mas; Bock, C. -Thomas; Hoehne, Marina			Infection with the Persistent Murine Norovirus Strain MNV-S99 Suppresses IFN-Beta Release and Activation of Stat1 In Vitro	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HEPATITIS-C VIRUS; REGULATORY FACTOR-3; GAMMA-INTERFERON; REPLICATION; PROTEIN; CELLS; DEGRADATION; IRF-3; GASTROENTERITIS	Norovirus infection is the main cause of epidemic non-bacterial gastroenteritis in humans. Although human norovirus (HuNoV) infection is self-limiting, it can persist for extended periods of time in immune deficient patients. Due to the lack of robust cell culture and small animal systems, little is known about HuNoV pathogenicity. However, murine norovirus (MNV) can be propagated in cell culture and is used as a model to study norovirus infection. Several MNV are known to persist in mice. In this study, we show that the MNV strain MNV-S99 persists in wild type inbred (C57BL/6J) mice over a period of at least 5 weeks post infection. Viral RNA was detectable in the jejunum, ileum, cecum, and colon, with the highest titers in the colon and cecum. To characterize the effect of MNV-S99 on the innate immune response, Stat1 phosphorylation and IFN-beta production were analyzed and compared to the non-persistent strain MNV-1. CW3. While MNV-S99 and MNV-1. CW3 showed comparable growth characteristics in vitro, Stat1 phosphorylation and IFN-beta release is strongly decreased after infection with MNV-S99 compared to MNV-1. CW3. In conclusion, our results show that unlike MNV-1. CW3, MNV-S99 establishes a persistent infection in mice, possibly due to interfering with the innate immune response.	[Niendorf, Sandra; Marques, Andreas Mas; Bock, C. -Thomas; Hoehne, Marina] Robert Koch Inst, Dept Viral Gastroenteritis & Hepatitis Pathogens, Berlin, Germany; [Klemm, Uwe] Max Planck Inst Infect Biol, Berlin, Germany	Robert Koch Institute; Max Planck Society	Niendorf, S (corresponding author), Robert Koch Inst, Dept Viral Gastroenteritis & Hepatitis Pathogens, Berlin, Germany.	NiendorfS@rki.de	Bock, C.-Thomas/A-3518-2012	Bock, C.-Thomas/0000-0002-2773-486X; Mas Marques, Andreas/0000-0001-8112-8054				Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Arias A, 2012, J GEN VIROL, V93, P1432, DOI 10.1099/vir.0.042176-0; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Capizzi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-131; Chang KO, 2004, P NATL ACAD SCI USA, V101, P8733, DOI 10.1073/pnas.0401126101; Changotra H, 2009, J VIROL, V83, P5683, DOI 10.1128/JVI.00231-09; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Hsu CC, 2006, COMPARATIVE MED, V56, P247; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kim JR, 2011, J VET MED SCI, V73, P687, DOI 10.1292/jvms.10-0226; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Ludwig A, 2008, J MED VIROL, V80, P1461, DOI 10.1002/jmv.21217; Maloney NS, 2012, J VIROL, V86, P12655, DOI 10.1128/JVI.01564-12; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Perdue KA, 2007, J AM ASSOC LAB ANIM, V46, P39; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schorn R, 2010, CLIN INFECT DIS, V51, P307, DOI 10.1086/653939; Shortland A, 2014, J GEN VIROL, V95, P413, DOI 10.1099/vir.0.059188-0; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12; Tian J, 2015, INFECT GENET EVOL, V34, P352, DOI 10.1016/j.meegid.2015.06.003; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Waugh E, 2014, VIRUS RES, V181, P27, DOI 10.1016/j.virusres.2013.12.025; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Xu RH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002475; Yumiketa Y, 2016, VET MICROBIOL, V185, P62, DOI 10.1016/j.vetmic.2016.02.005	42	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156898	10.1371/journal.pone.0156898	http://dx.doi.org/10.1371/journal.pone.0156898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294868	gold, Green Published, Green Submitted			2022-12-26	WOS:000377821300013
J	Ceccarelli, DM; Emslie, MJ; Richards, ZT				Ceccarelli, Daniela M.; Emslie, Michael J.; Richards, Zoe T.			Post-Disturbance Stability of Fish Assemblages Measured at Coarse Taxonomic Resolution Masks Change at Finer Scales	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE PROTECTED AREAS; CORAL-REEFS; TROPICAL CYCLONE; TERRITORIAL DAMSELFISHES; COMMUNITY STRUCTURE; HABITAT; CLIMATE; RECOVERY; IMPACT	Quantifying changes to coral reef fish assemblages in the wake of cyclonic disturbances is challenging due to spatial variability of damage inherent in such events. Often, fish abundance appears stable at one spatial scale (e.g. reef-wide), but exhibits substantial change at finer scales (e.g. site-specific decline or increase). Taxonomic resolution also plays a role; overall stability at coarse taxonomic levels (e.g. family) may mask species-level turnover. Here we document changes to reef fish communities after severe Tropical Cyclone Ita crossed Lizard Island, Great Barrier Reef. Coral and reef fish surveys were conducted concurrently before and after the cyclone at four levels of exposure to the prevailing weather. Coral cover declined across all exposures except sheltered sites, with the largest decline at exposed sites. There was no significant overall reduction in the total density, biomass and species richness of reef fishes between 2011 and 2015, but individual fish taxa (families and species) changed in complex and unpredictable ways. For example, more families increased in density and biomass than decreased following Cyclone Ita, particularly at exposed sites whilst more fish families declined at lagoon sites even though coral cover did not decline. All sites lost biomass of several damselfish species, and at most sites there was an increase in macroinvertivores and grazers. Overall, these results suggest that the degree of change measured at coarse taxonomic levels masked high species-level turnover, although other potential explanations include that there was no impact of the storm, fish assemblages were impacted but underwent rapid recovery or that there is a time lag before the full impacts become apparent. This study confirms that in high-complexity, high diversity ecosystems such as coral reefs, species level analyses are essential to adequately capture the consequences of disturbance events.	[Ceccarelli, Daniela M.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Emslie, Michael J.] Australian Inst Marine Sci, TMC, PMB 3, Townsville, Qld 4810, Australia; [Richards, Zoe T.] Western Australian Museum, Dept Aquat Zool, 49 Kew St, Perth, WA 6016, Australia	James Cook University; Australian Institute of Marine Science; Western Australian Museum	Ceccarelli, DM (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	dmcecca@gmail.com	Ceccarelli, Daniela/AAN-3577-2020; Ceccarelli, Daniela/AGO-7628-2022		John and Laurie Proud Foundation; Hermon Slade Raiatea Foundation; Isobel Bennett Fellowships; Australian Museum	John and Laurie Proud Foundation; Hermon Slade Raiatea Foundation; Isobel Bennett Fellowships; Australian Museum	The 2015 study was undertaken with support from the John and Laurie Proud Foundation, the Hermon Slade Raiatea Foundation and Isobel Bennett Fellowships awarded to DMC and ZTR. The 2011 study was supported and funded from a research grant by the Australian Museum to ZTR. The funders provided support in the form of salaries for authors (Z. Richards in 2011, Z. Richards and D. Ceccarelli in 2015), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adam TC, 2014, OECOLOGIA, V176, P285, DOI 10.1007/s00442-014-3011-x; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P29, DOI 10.3354/meps320029; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bellwood DR, 2012, OECOLOGIA, V170, P567, DOI 10.1007/s00442-012-2306-z; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Cheal AJ, 2002, CORAL REEFS, V21, P131, DOI 10.1007/s00338-002-0227-8; Coker DJ, 2009, BEHAV ECOL, V20, P1204, DOI 10.1093/beheco/arp113; De'ath G, 2012, P NATL ACAD SCI US; DONE TJ, 1986, GREAT BARRIER REEF M, V7, P50; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emslie MJ, 2011, CORAL REEFS, V30, P461, DOI 10.1007/s00338-011-0730-x; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Emslie MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105384; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; FENNER DP, 1991, B MAR SCI, V48, P719; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Glynn PW, 1998, CORAL REEFS, V17, P368, DOI 10.1007/s003380050140; Gochfeld DJ, 2010, MAR ECOL PROG SER, V398, P137, DOI 10.3354/meps08302; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P1045, DOI 10.1071/MF02063; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Johansen JL, 2013, ECOL APPL, V23, P1504, DOI 10.1890/12-0704.1; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kaufman L.S., 1983, Coral Reefs, V2, P43, DOI 10.1007/BF00304731; KLUMPP DW, 1987, MAR ECOL PROG SER, V40, P41, DOI 10.3354/meps040041; KNOWLTON N, 1981, NATURE, V294, P251, DOI 10.1038/294251a0; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kulbicki M, 2005, CYBIUM, V29, P235; LASSIG BR, 1983, ENVIRON BIOL FISH, V9, P55, DOI 10.1007/BF00001058; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Perry CT, 2014, GEOMORPHOLOGY, V222, P92, DOI 10.1016/j.geomorph.2014.03.012; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Pratchett MS, 2006, J FISH BIOL, V69, P1269, DOI 10.1111/j.1095-8649.2006.01161.x; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; SANO M, 1984, PAC SCI, V38, P51; VANWOESIK R, 1991, J COASTAL RES, V7, P551; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Wyatt ASJ, 2012, CORAL REEFS, V31, P1029, DOI 10.1007/s00338-012-0923-y	55	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156232	10.1371/journal.pone.0156232	http://dx.doi.org/10.1371/journal.pone.0156232			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285160	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000377564000010
J	Yasuoka, T; Kuwahara, M; Yamada, T; Maruyama, S; Suzuki, J; Taniguchi, M; Yasukawa, M; Yamashita, M				Yasuoka, Toshiaki; Kuwahara, Makoto; Yamada, Takeshi; Maruyama, Saho; Suzuki, Junpei; Taniguchi, Masaru; Yasukawa, Masaki; Yamashita, Masakatsu			The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1-and NKT2-Type iNKT Cells	PLOS ONE			English	Article							V-ALPHA-14I NKT CELLS; KILLER T-CELLS; LYMPHOCYTE DEVELOPMENT; TERMINAL MATURATION; EFFECTOR FUNCTIONS; ROR-GAMMA; TGF-BETA; DIFFERENTIATION; HOMEOSTASIS; EXPRESSION	Gfi1 plays an important role in the development and maintenance of many hematopoietic linage cells. However, the impact of Gfi1-deficiency on the iNKT cell differentiation remains unclear. We herein demonstrate a critical role of Gfi1 in regulating the development of iNKT cell subsets. In the thymus of T cell-specific Gfi1-deficient mice, iNKT cells normally developed up to stage 2, while the number of stage 3 NK1.1(pos) iNKT cells was significantly reduced. Furthermore, CD4(pos) iNKT cells were selectively reduced in the peripheral organs of T cell-specific Gfi1-deficient mice. The alpha-GalCer-dependent production of IFN-gamma and Th2 cytokines, but not IL-17A, was severely reduced in T cell-specific Gfi1-deficient mice. In addition, a reduction of the alpha-GalCer-induced anti-tumor activity was observed in Gfi1-deficient mice. These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.	[Yasuoka, Toshiaki] Ehime Univ, Grad Sch Med, Dept Obstet & Gynecol, Toon, Ehime, Japan; [Yasuoka, Toshiaki; Kuwahara, Makoto; Maruyama, Saho; Yamashita, Masakatsu] Ehime Univ, Grad Sch Med, Dept Immunol, Toon, Ehime, Japan; [Kuwahara, Makoto; Suzuki, Junpei; Yamashita, Masakatsu] Ehime Univ Hosp, Translat Res Ctr, Toon, Ehime, Japan; [Kuwahara, Makoto; Yamashita, Masakatsu] Ehime Univ, Div Immune Regulat, Dept Proteoinovat, Proteosci Ctr, Toon, Ehime, Japan; [Yamada, Takeshi] Ehime Univ, Dept Infect & Host Def, Grad Sch Med, Toon, Ehime, Japan; [Suzuki, Junpei; Yasukawa, Masaki] Ehime Univ, Dept Hematol Clin Immunol & Infect Dis, Grad Sch Med, Toon, Ehime, Japan; [Taniguchi, Masaru] RIKEN, Ctr Integrat Med Sci, Lab Immune Regulat, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan	Ehime University; Ehime University; Ehime University; Ehime University; Ehime University; Ehime University; RIKEN	Yamashita, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Immunol, Toon, Ehime, Japan.; Yamashita, M (corresponding author), Ehime Univ Hosp, Translat Res Ctr, Toon, Ehime, Japan.; Yamashita, M (corresponding author), Ehime Univ, Div Immune Regulat, Dept Proteoinovat, Proteosci Ctr, Toon, Ehime, Japan.	yamamasa@m.ehime-u.ac.jp			Japan Society for Promotion of Science KAKENHI [15K20149, 15K19133, 25860376, 23390075]; Naito Foundation Natural Science Scholarship	Japan Society for Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation Natural Science Scholarship	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Numbers 15K20149, 15K19133, 25860376, 23390075, and the Naito Foundation Natural Science Scholarship.	Anderson BL, 2013, MOLECULES, V18, P15662, DOI 10.3390/molecules181215662; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Chang CL, 2011, J IMMUNOL, V187, P1235, DOI 10.4049/jimmunol.1100270; Chowdhury AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053666; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Ichiyama K, 2009, INT IMMUNOL, V21, P881, DOI 10.1093/intimm/dxp054; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Khandanpour C, 2013, CANCER CELL, V23, P200, DOI 10.1016/j.ccr.2013.01.011; Khandanpour C, 2011, STEM CELLS, V29, P376, DOI 10.1002/stem.575; Kim EY, 2015, SEMIN IMMUNOL, V27, P26, DOI 10.1016/j.smim.2015.02.005; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Miller SA, 2010, IMMUNOL REV, V238, P233, DOI 10.1111/j.1600-065X.2010.00952.x; Miyake Sachiko, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P315, DOI 10.2174/1568008054863772; Monteiro M, 2014, CRIT REV IMMUNOL, V34, P81, DOI 10.1615/CritRevImmunol.2014010088; Montoya-Durango DE, 2008, J BIOL CHEM, V283, P32056, DOI 10.1074/jbc.M802320200; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shinnakasu R, 2008, J BIOL CHEM, V283, P28216, DOI 10.1074/jbc.M804174200; Suzuki J, 2016, IMMUNOLOGY, V147, P476, DOI 10.1111/imm.12580; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Webster KE, 2014, MUCOSAL IMMUNOL, V7, P1058, DOI 10.1038/mi.2013.122; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zajonc DM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00400; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666; Zornig M, 1996, ONCOGENE, V12, P1789	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157395	10.1371/journal.pone.0157395	http://dx.doi.org/10.1371/journal.pone.0157395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284976	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000063
J	Balaguera-Reina, SA; Venegas-Anaya, M; Sanchez, A; Arbelaez, I; Lessios, HA; Densmore, LD				Balaguera-Reina, Sergio A.; Venegas-Anaya, Miryam; Sanchez, Andres; Arbelaez, Italo; Lessios, Harilaos A.; Densmore, Llewellyn D., III			Spatial Ecology of the American Crocodile in a Tropical Pacific Island in Central America	PLOS ONE			English	Article							CROCODYLUS-POROSUS; HOME RANGES; GROWTH-RATES; ARNHEM-LAND; MOVEMENTS; ACUTUS; RIVER; DISPERSAL; PATTERNS	Conservation of large predators has long been a challenge for biologists due to the limited information we have about their ecology, generally low numbers in the wild, large home ranges and the continuous expansion of human settlements. The American crocodile (Crocodylus acutus) is a typical apex predator, that has suffered from all of these characteristic problems, especially the latter one. Humans have had a major impact on the recovery of this species throughout its range, even though most of the countries it inhabits have banned hunting. The last decade has made it clear that in order to implement sound conservation and management programs, we must increase our understanding of crocodile spatial ecology. However, in only two countries where American crocodiles have telemetry studies even been published. Herein we have characterized the spatial ecology of C. acutus on Coiba Island, Panama, by radio-tracking (VHF transmitters) 24 individuals between 2010 and 2013, to determine movement patterns, home range, and habitat use. We have then compared our findings with those of previous studies to develop the most comprehensive assessment of American crocodile spatial ecology to date. Females showed a higher average movement distance (AMD) than males; similarly, adults showed a higher AMD than sub-adults and juveniles. However, males exhibited larger home ranges than females, and concomitantly sub-adults had larger home ranges than juveniles, hatchlings, and adults. There was an obvious relationship between seasonal precipitation and AMD, with increased AMD in the dry and "low-wet" seasons, and reduced AMD during the "true" wet season. We found disaggregate distributions according to age groups throughout the 9 habitat types in the study area; adults and hatchlings inhabited fewer habitat types than juveniles and sub-adults. These sex-and age-group discrepancies in movement and habitat choice are likely due to the influences of reproductive biology and Coiba's precipitation cycle. Juveniles also showed distinct movement patterns and home ranges; however, with sexual maturation and development, these behaviors became more characteristic of adults and sub-adults. Ours is one of a very small number of studies that will allow future management and conservation planning to be based on the comprehensive integration of the spatial ecology of a Neotropical crocodylian apex predator.	[Balaguera-Reina, Sergio A.; Densmore, Llewellyn D., III] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Venegas-Anaya, Miryam; Lessios, Harilaos A.] Smithsonian Trop Res Inst, Apartado Postal 0843-03092, Balboa, Ancon, Panama; [Sanchez, Andres] Univ Quindio, Fac Biol, Armenia, Colombia; [Arbelaez, Italo] Univ Bogota Jorge Tadeo Lozano, Fac Biol Marina, Bogota, Colombia	Texas Tech University System; Texas Tech University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad del Quindio; Universidad de Bogota Jorge Tadeo Lozano	Balaguera-Reina, SA (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	sergio.balaguera-reina@ttu.edu	Balaguera-Reina, Sergio A./I-9102-2019	Balaguera-Reina, Sergio A./0000-0002-5153-0031; Lessios, Harilaos/0000-0003-4726-1382; Venegas-Anaya, Miryam/0000-0003-4287-0162	Panamanian Environmental Agency (ANAM); Panamanian National Secretariat of Science, Technology, and Innovation (SENACYT) [APB11-004, PNCOIBA08]; Texas Tech University [10086-01]	Panamanian Environmental Agency (ANAM); Panamanian National Secretariat of Science, Technology, and Innovation (SENACYT); Texas Tech University	This research project was approved and supported by the Panamanian Environmental Agency (ANAM), the Panamanian National Secretariat of Science, Technology, and Innovation (SENACYT; project number ID APB11-004, permit number PNCOIBA08), and the Texas Tech University (animal care ACUC permit 10086-01) to capture, mark, and tag American crocodiles inside the CNP. All procedures followed ethical practices for animals approved by the Panamanian Environmental Agency and the Smithsonian Tropical Research Institute (STRI).	Alroy J, 2015, P NATL ACAD SCI USA, V112, P13003, DOI 10.1073/pnas.1508681112; Anam, 2009, PLAN MAN PARQ NAC CO; [Anonymous], 1970, P ANN C SE ASS GAM F; Balaguera-Reina S. A., 2008, HERPETOTROPICOS, V4, P59; Balaguera-Reina Sergio A., 2015, Mesoamerican Herpetology, V2, P566; Balaguera-Reina SA, 2015, J HERPETOL, V49, P200, DOI 10.1670/13-065; Balaguera-Reina SA, 2015, S AM J HERPETOL, V10, P10, DOI 10.2994/SAJH-D-14-00024.1; Bonke R, 2014, SALAMANDRA, V50, P40; Brien ML, 2008, WILDLIFE RES, V35, P140, DOI 10.1071/WR06116; Britton ARC, 2012, CROCODILIAN BIOL DAT; Campos Z, 2004, B PESQUISA DESENVOLV, V57, P1; Campos Z, 2006, HERPETOL J, V16, P123; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chabreck Robert H., 1966, P 20 ANN C SE ASS GA, P105; CMNUDS (Cumbre Mundial de las Naciones Unidas para el Desarrollo Sostenible), 2002, CORR MAR CONS DESS S; CSG (Crocodile Specialist Group), 1996, IUCN RED LIST THREAT; Di Rienzo, 2014, INFOSTAT; Ding Y., 2004, CROC P 17 WORK M CRO, P109; Espinal M, 2011, SOUTHWEST NAT, V56, P212, DOI 10.1894/F10-PAS-13.1; ESRI (Environmental Systems Research Institute), 2014, ARC GISVERS 10 2 2; ETESA, 2015, HIDROMETEOROLOGIA; Fergusson R.A., 1992, P98; GABY R, 1985, J HERPETOL, V19, P189, DOI 10.2307/1564172; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; GOODWIN TM, 1979, J HERPETOL, V13, P157, DOI 10.2307/1563922; Green TW, 2014, WETLANDS, V34, pS213, DOI 10.1007/s13157-012-0370-0; Gross B, 2014, TECHNICAL REPORT; Hagan JMI, 1982, THESIS; Hernandez-Hurtado H, 2011, REV MEX BIODIVERS, V82, P887; HUTTON J, 1989, AM ZOOL, V29, P1033; Hutton JM., 1982, CROCODILES, P100; Kay Winston R., 2004, Herpetological Review, V35, P354; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; KUSHLAN JA, 1989, J HERPETOL, V23, P7, DOI 10.2307/1564310; MAGNUSSON WE, 1991, J HERPETOL, V25, P41, DOI 10.2307/1564793; Martin AR, 1998, MAR TECHNOL SOC J, V32, P82; Mazzotti FJ, 1983, THESIS; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; Medem F., 1981, CROCODYLIA AM CROCOD; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morea CR, 1999, THESIS; MUNGER JC, 1984, ECOLOGY, V65, P1077, DOI 10.2307/1938315; Munoz M., 1997, CIENCIA CONSERVACION, P161; Munoz MD, 2000, J HERPETOL, V34, P397; Platt SG, 2000, BIOL CONSERV, V96, P13, DOI 10.1016/S0006-3207(00)00038-0; Ponce-Campos P., 2012, IUCN RED LIST THREAT; R Development Core Team, 2012, R LANG ENV STAT COMP; Read M, 2004, CROC P 17 WORK M IUC, P386; RODDA GH, 1984, HERPETOLOGICA, V40, P444; ROOTES WL, 1993, J HERPETOL, V27, P121, DOI 10.2307/1564926; SAMUEL MD, 1992, J WILDLIFE MANAGE, V56, P725, DOI 10.2307/3809466; Seijas A. E, 1988, THESIS; Signer J, 2015, WILDLIFE SOC B; SPRINGER JT, 1979, J WILDLIFE MANAGE, V43, P926, DOI 10.2307/3808276; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; Swihart Robert K., 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P48, DOI 10.2307/1400640; Targarona RR, 1996, IUCN RED LIST THREAT; Thorbjarnarson J., 2010, CHINESE ALLIGATOR EC; Thorbjarnarson J.B., 2010, CROCODILES STATUS SU, P46; Tucker AD, 1997, WILDLIFE RES, V24, P379, DOI 10.1071/WR95073; Venegas-Anaya M, 2013, CSG NEWSLETTER, V32, P10; Venegas-Anaya M, 2015, J HERPETOL, V49, P349, DOI 10.1670/13-193; Wall J., 2014, MOVEMENT ECOLOGY TOO; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P263, DOI 10.1071/WR9780263; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured]	70	11	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157152	10.1371/journal.pone.0157152	http://dx.doi.org/10.1371/journal.pone.0157152			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280554	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000096
J	Enomoto, K; Aoki, S; Toma, R; Fujiwara, K; Sakamaki, K; Hirahara, F				Enomoto, Kimiko; Aoki, Shigeru; Toma, Rie; Fujiwara, Kana; Sakamaki, Kentaro; Hirahara, Fumiki			Pregnancy Outcomes Based on Pre-Pregnancy Body Mass Index in Japanese Women	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; SPONTANEOUS PRETERM BIRTH; WEIGHT-GAIN; FETAL-GROWTH	Objective To verify whether body mass index (BMI) classification proposed by the Institute of Medicine (IOM) is valid in Japanese women. Method A study was conducted in 97,157 women with singleton pregnancies registered in the Japan Society of Obstetrics and Gynecology (JSOG) Successive Pregnancy Birth Registry System between January 2013 and December 2013, to examine pregnancy outcomes in four groups stratified by pre-pregnancy BMI category according to the 2009 criteria recommended by the Institute of Medicine (IOM). The groups comprised 17,724 underweight women with BMI <18.5, 69,126 normal weight women with BMI 18.5-24.9, 7,502 overweight women with BMI 25-29.9, and 2,805 obese women with BMI >= 30. The pregnancy outcomes were also compared among subgroups stratified by a gestational weight gain below, within, and above the optimal weight gain. Results The higher the pre-pregnancy BMI, the higher the incidences of pregnancy-induced hypertension, gestational diabetes mellitus, macrosomia, cesarean delivery, postpartum hemorrhage, and post-term birth, but the lower the incidence of small for gestational age (SGA). In all pre-pregnancy BMI category groups, excess gestational weight gain was associated with a higher frequency of large for gestational age and macrosomia; poor weight gain correlated with a higher frequency of SGA, preterm birth, preterm premature rupture of membranes, and spontaneous preterm birth; and optimal weight gain within the recommended range was associated with a better outcome. Conclusion The BMI classification by the IOM was demonstrated to be valid in Japanese women.	[Enomoto, Kimiko; Aoki, Shigeru; Toma, Rie; Fujiwara, Kana] Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonate, Yokohama, Kanagawa 232, Japan; [Sakamaki, Kentaro] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Sakamaki, Kentaro] Univ Med Ctr, Yokohama, Kanagawa, Japan; [Hirahara, Fumiki] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Aoki, S (corresponding author), Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonate, Yokohama, Kanagawa 232, Japan.	smyyaoki@yahoo.co.jp						[Anonymous], 2015, PROM COUNC HLTH PAR, V21; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Challis JRG, 2004, AM J OBSTET GYNECOL, V191, P1059, DOI 10.1016/j.ajog.2004.06.071; de la Torre L, 2011, AM J PERINAT, V28, P285, DOI 10.1055/s-0030-1271211; Fujiwara K, 2014, J OBSTET GYNAECOL RE, V40, P988, DOI 10.1111/jog.12283; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; JOHNSON JWC, 1992, AM J OBSTET GYNECOL, V167, P353, DOI 10.1016/S0002-9378(11)91414-8; Li CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136850; Masho SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-120; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Stotland N, 2006, OBSTET GYNECOL, V108; Takimoto H, 2011, J OBSTET GYNAECOL RE, V37, P553, DOI 10.1111/j.1447-0756.2010.01396.x; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070	17	91	95	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157081	10.1371/journal.pone.0157081	http://dx.doi.org/10.1371/journal.pone.0157081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280958	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000079
J	Meca, O; Cruz, MJ; Sanchez-Ortiz, M; Gonzalez-Barcala, FJ; Ojanguren, I; Munoz, X				Meca, Olga; Cruz, Maria-Jesus; Sanchez-Ortiz, Monica; Gonzalez-Barcala, Francisco-Javier; Ojanguren, Inigo; Munoz, Xavier			Do Low Molecular Weight Agents Cause More Severe Asthma than High Molecular Weight Agents?	PLOS ONE			English	Article							DIAGNOSING OCCUPATIONAL ASTHMA; EXPOSURE; CHALLENGE; POPULATION; MECHANISMS; MANAGEMENT; CESSATION; HISTORY	Introduction The aim of this study was to analyse whether patients with occupational asthma (OA) caused by low molecular weight (LMW) agents differed from patients with OA caused by high molecular weight (HMW) with regard to risk factors, asthma presentation and severity, and response to various diagnostic tests. Methods Seventy-eight patients with OA diagnosed by positive specific inhalation challenge (SIC) were included. Anthropometric characteristics, atopic status, occupation, latency periods, asthma severity according to the Global Initiative for Asthma (GINA) control classification, lung function tests and SIC results were analysed. Results OA was induced by an HMW agent in 23 patients (29%) and by an LMW agent in 55 (71%). A logistic regression analysis confirmed that patients with OA caused by LMW agents had a significantly higher risk of severity according to the GINA classification after adjusting for potential confounders (OR = 3.579, 95% CI 1.136-11.280; p = 0.029). During the SIC, most patients with OA caused by HMW agents presented an early reaction (82%), while in patients with OA caused by LMW agents the response was mainly late (73%) (p = 0.0001). Similarly, patients with OA caused by LMW agents experienced a greater degree of bronchial hyperresponsiveness, measured as the difference in the methacholine dose-response ratio (DRR) before and after SIC (1.77, range 0-16), compared with patients with OA caused by HMW agents (0.87, range 0-72), (p = 0.024). Conclusions OA caused by LMW agents may be more severe than that caused by HMW agents. The severity of the condition may be determined by the different mechanisms of action of these agents.	[Meca, Olga] Hosp Gen Univ Morales Messeguer, Serv Neumol, Murcia, Spain; [Cruz, Maria-Jesus; Sanchez-Ortiz, Monica; Ojanguren, Inigo; Munoz, Xavier] Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Catalonia, Spain; [Cruz, Maria-Jesus; Sanchez-Ortiz, Monica; Ojanguren, Inigo; Munoz, Xavier] ISCIII, Ctr Invest Red Enfermedades Resp CIBERES, Barcelona, Spain; [Gonzalez-Barcala, Francisco-Javier] Clin Univ Hosp, Resp Dept, Santiago De Compostela, Spain; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Catalonia, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Autonomous University of Barcelona	Cruz, MJ (corresponding author), Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Catalonia, Spain.; Cruz, MJ (corresponding author), ISCIII, Ctr Invest Red Enfermedades Resp CIBERES, Barcelona, Spain.	mj.cruz@vhir.org	Meca Birlanga, Olga/ABE-4440-2021; Cruz, Maria Jesus/I-9073-2014	Ojanguren, Inigo/0000-0003-1270-5772; Munoz, Xavier/0000-0002-8693-022X; Cruz, Maria Jesus/0000-0001-9759-5466; Gonzalez-Barcala, Francisco-Javier/0000-0001-5847-4784	Miguel Servet programme from Instituto de Salud Carlos III [CP12/03101]	Miguel Servet programme from Instituto de Salud Carlos III(Instituto de Salud Carlos III)	MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101). The funders had no role in the study design, the data collection or analysis, the decision to publish, or the preparation of the manuscript. Competing	Baur X, 2012, EUR RESPIR J, V39, P529, DOI 10.1183/09031936.00096111; Baur X, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-15; Bernstein DI, 2013, TOXICOL SCI, V131, P242, DOI 10.1093/toxsci/kfs272; Bernstein IL, 2013, ASTHMA WORKPLACE, P1; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; CHANYEUNG M, 1982, J ALLERGY CLIN IMMUN, V70, P32, DOI 10.1016/0091-6749(82)90198-1; Chester DA, 2005, AM J IND MED, V48, P78, DOI 10.1002/ajim.20183; COTE J, 1990, AM REV RESPIR DIS, V141, P373, DOI 10.1164/ajrccm/141.2.373; Cruz MJ, 2012, CURR OPIN ALLERGY CL, V12, P119, DOI 10.1097/ACI.0b013e328351137c; Descatha A, 2007, ALLERGY, V62, P795, DOI 10.1111/j.1398-9995.2007.01424.x; Dufour MH, 2009, EUR RESPIR J, V33, P734, DOI 10.1183/09031936.00120407; Girard F, 2004, AM J RESP CRIT CARE, V170, P845, DOI 10.1164/rccm.200403-380OC; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Hox V, 2013, AM J RESP CRIT CARE, V187, P486, DOI 10.1164/rccm.201208-1358OC; Hur GY, 2009, J CLIN IMMUNOL, V29, P786, DOI 10.1007/s10875-009-9314-8; Jones MG, 2004, CLIN EXP ALLERGY, V34, P812, DOI 10.1111/j.1365-2222.2004.1956.x; Le Moual N, 2005, AM J RESP CRIT CARE, V172, P440, DOI 10.1164/rccm.200501-111OC; Le Moual N, 2014, EUR RESPIR J, V43, P374, DOI 10.1183/09031936.00034913; Lemiere C, 2013, J ALLERGY CLIN IMMUN, V131, P704, DOI 10.1016/j.jaci.2012.08.024; Maestrelli P, 2013, ASTHMA WORKPLACE, P40; Maestrelli P, 2009, J ALLERGY CLIN IMMUN, V123, P531, DOI 10.1016/j.jaci.2009.01.057; Malo JL, 2005, AM J RESP CRIT CARE, V172, P406, DOI 10.1164/rccm.2506006; Malo JL, 1997, EUR RESPIR J, V10, P1513, DOI 10.1183/09031936.97.10071513; MALO JL, 1991, AM REV RESPIR DIS, V143, P528, DOI 10.1164/ajrccm/143.3.528; MALO JL, 1992, J ALLERGY CLIN IMMUN, V90, P937, DOI 10.1016/0091-6749(92)90466-F; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ortega HG, 2002, AM J IND MED, V42, P50, DOI 10.1002/ajim.10088; PAGGIARO PL, 1984, CLIN ALLERGY, V14, P463, DOI 10.1111/j.1365-2222.1984.tb02230.x; Tordera MP, 2013, ARCH BRONCONEUMOL, V49, P432, DOI 10.1016/j.arbres.2013.05.001; Rachiotis G, 2007, THORAX, V62, P147, DOI 10.1136/thx.2006.061952; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Tarlo SM, 2008, CHEST, V134, p1S, DOI 10.1378/chest.08-0201; Vandenplas O, 1997, EUR RESPIR J, V10, P2612, DOI 10.1183/09031936.97.10112612; Vandenplas O, 2011, EUR RESPIR J, V38, P804, DOI 10.1183/09031936.00177510; Vandenplas O, 2014, EUR RESPIR J, V43, P1573, DOI 10.1183/09031936.00180313; Vandenplas O, 2013, CHEST, V143, P1261, DOI 10.1378/chest.12-1983; Vandenplas O, 2011, ALLERGY ASTHMA IMMUN, V3, P157, DOI 10.4168/aair.2011.3.3.157; Wisnewski AV, 2008, CLIN EXP ALLERGY, V38, P957, DOI 10.1111/j.1365-2222.2008.02982.x	39	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156141	10.1371/journal.pone.0156141	http://dx.doi.org/10.1371/journal.pone.0156141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280473	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000016
J	Zhou, H; Zhang, L; Ye, F; Wang, HJ; Huntington, D; Huang, YJ; Wang, AQ; Liu, SQ; Wang, Y				Zhou, Hong; Zhang, Long; Ye, Fang; Wang, Hai-jun; Huntington, Dale; Huang, Yanjie; Wang, Anqi; Liu, Shuiqing; Wang, Yan			The Effect of Maternal Death on the Health of the Husband and Children in a Rural Area of China: A Prospective Cohort Study	PLOS ONE			English	Article							SHORT SCREENING SCALE; FEEDING PATTERNS; MORTALITY; IMPACTS; INFANT; MALNUTRITION; SURVIVAL; FAMILIES; BUTAJIRA; COUNTIES	Objective To examine the effects of maternal death on the health of the index child, the health and educational attainment of the older children, and the mental health and quality of life of the surviving husband. Methods A cohort study including 183 households that experienced a maternal death matched to 346 households that experienced childbirth but not a maternal death was conducted prospectively between June 2009 and October 2011 in rural China. Data on household sociodemographic characteristics, physical and mental health were collected using a quantitative questionnaire and medical examination at baseline and follow-up surveys. Multivariate linear regression, logistic regression models and difference-in-difference (DID) were used to compare differences of outcomes between two groups. Findings The index children who experienced the loss of a mother had a significantly higher likelihood of dying, abandonment and malnutrition compared to children whose mothers survived at the follow-up survey. The risk of not attending school on time and dropping out of school among older children in the affected group was higher than those in the control group during the follow-up. Husbands whose wife died had significantly lower EQ-5D index and EQ-VAS both at baseline and at follow-up surveys compared to those without experiencing a wife's death, suggesting an immediate and sustained poorer mental health quality of life among the surviving husbands. Also the prevalence of posttraumatic stress disorder (PTSD) was 72.6% at baseline and 56.2% at follow-up among husbands whose wife died. Conclusions Maternal death has multifaceted and spillover effects on the physical and mental health of family members that are sustained over time. Programmes that reduce maternal mortality will mitigate repercussions on surviving family members are critical and needed.	[Zhou, Hong; Wang, Anqi; Liu, Shuiqing; Wang, Yan] Peking Univ, Div Maternal & Child Hlth, Sch Publ Hlth, 38 Xueyuan Rd Haidian Dist, Beijing 100871, Peoples R China; [Zhang, Long] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ye, Fang] China Japan Friendship Hosp, Dept Prevent Hlth Care, 38 Xueyuan Rd Haidian Dist, Beijing, Peoples R China; [Wang, Hai-jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, 38 Xueyuan Rd Haidian Dist, Beijing 100871, Peoples R China; [Huntington, Dale] World Hlth Org Western Pacific Reg Off, Asia Pacific Observ Hlth Syst & Policies, Manila, Philippines; [Huang, Yanjie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; China-Japan Friendship Hospital; Peking University; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, Y (corresponding author), Peking Univ, Div Maternal & Child Hlth, Sch Publ Hlth, 38 Xueyuan Rd Haidian Dist, Beijing 100871, Peoples R China.	wangyan@bjmu.edu.cn	huang, yan/GWM-4747-2022; Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland [A65403]; Chinese Ministry of Health and Provincial Health Offices	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland; Chinese Ministry of Health and Provincial Health Offices	This study was supported by a grant from the UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland (http://www.who.int/reproductivehealth/en/). The grant number is A65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank research teams from Hebei, Henan, and Yunnan provinces for their hard work in orchestrating the field work and the support from the Chinese Ministry of Health and Provincial Health Offices in assistance with identifying study population through the registration system. We also want to thank all of family members who participated in this study and expressed our condolences to those who experienced the loss of their loved one. We are grateful for endeavors from each member in Economic Impact of Maternal Deaths study, including Yan Wang (principal investigator), Hai-Jun Wang, Fang Ye, Hong Zhou, Chu-Yun Kang, Shan-Shan Hou, Du Wang, Deng Ao, Yao Feng, Yi-Chong Xu (Division of Maternal and Child Health, School of Public Health, Peking University), Jin-Hua Li, Hai-Ying Ma (Hebei Women and Children Health Center) in Hebei; Mei-Lin Yao, Feng-Zhi You, Wei-jie Zhang, Hui-Min Qu, Xiao-Hui Xu, Rui Wang, Jian Liu, Wen-Bin Jia, De-Qi Du, Jie Deng (Women's healthcare section, Zheng-zhou University 3rd Affiliated Hospital) in Henan; Yan Li, Wen-Long Cui, Ying Huang, Jing Long, Hai-Mei Hu, Shi-Hong Xu, Jun-Ying Wang, Hai-Xia Yang, Ying Tan, Gui-Cun Chen, Xi-Ying Luo (School of Public Health, Kunming Medical College); Ya-Ping Zhu, Hong Zhou, Tao Zhao, Wei Li, Guang-Ping Guo (Maternal and Child Health Hospital of Yunnan) in Yunnan. We acknowledge Robert Black for providing intellectual suggestions on the revision of manuscript.	Ang M, 2013, OPTOMETRY VISION SCI, V90, P861, DOI 10.1097/OPX.0000000000000004; Bazile J, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S1; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Case A, 2006, DEMOGRAPHY, V43, P401, DOI 10.1353/dem.2006.0022; China . NHaFPCo, 2016, CHIN HLTH STAT YB; Dalen N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-321; de Souza Orivaldo Florencio, 2012, Rev Bras Epidemiol, V15, P211, DOI 10.1590/S1415-790X2012000100019; Ferdous F, 2013, AM J TROP MED HYG, V89, P223, DOI 10.4269/ajtmh.12-0743; Finlay JE, 2015, MATERN CHILD HLTH J, V19, P2393, DOI 10.1007/s10995-015-1758-2; Fujikawa Ai, 2011, Environmental Health and Preventive Medicine, V16, P25, DOI 10.1007/s12199-010-0162-1; Hauksdottir A, 2013, PSYCHO-ONCOLOGY, V22, P352, DOI 10.1002/pon.2096; Houle B, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S7; Karakartal D., 2012, INT ONLINE J PRIMARY, V1, P37; Kimerling R, 2006, J GEN INTERN MED, V21, P65, DOI 10.1111/j.1525-1497.2005.00292.x; Knight L, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S5; Mihrshahi S, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-28; Molla M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S6; Moucheraud C, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S4; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Ratti ML, 2011, I HAVE GO EFFECT MOT; RISMAN BJ, 1986, FAM RELAT, V35, P95, DOI 10.2307/584288; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; Tessema M, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.75.1630; Tremblay GC, 1998, CLIN PSYCHOL-SCI PR, V5, P424, DOI 10.1111/j.1468-2850.1998.tb00165.x; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Unicef, 2014, TRENDS MAT MORT 1990; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076624; Wang YP, 2016, LANCET, V387, P273, DOI 10.1016/S0140-6736(15)00554-1; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Ye F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134756; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038467; Zhou H, 2012, ASIA PAC J CLIN NUTR, V21, P234	33	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157122	10.1371/journal.pone.0157122	http://dx.doi.org/10.1371/journal.pone.0157122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280717	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000088
J	Nahvijou, A; Daroudi, R; Tahmasebi, M; Hashemi, FA; Hemami, MR; Sari, AA; Marenani, AB; Zendehdel, K				Nahvijou, Azin; Daroudi, Rajabali; Tahmasebi, Mamak; Hashemi, Farnaz Amouzegar; Hemami, Mohsen Rezaei; Sari, Ali Akbari; Marenani, Ahmad Barati; Zendehdel, Kazem			Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; NATURAL-HISTORY; HPV; CYTOLOGY; INFECTION; WOMEN; ABNORMALITIES; PREVENTION; MANAGEMENT; FREQUENCY	Objective Invasive cervical cancer (ICC) is the fourth most common cancer among women worldwide. Cervical screening programs have reduced the incidence and mortality rates of ICC. We studied the cost-effectiveness of different cervical screening strategies in the Islamic Republic of Iran, a Muslim country with a low incidence rate of ICC. Methods We constructed an 11-state Markov model, in which the parameters included regression and progression probabilities, test characteristics, costs, and utilities; these were extracted from primary data and the literature. Our strategies included Pap smear screening and human papillomavirus (HPV) DNA testing plus Pap smear triaging with different starting ages and screening intervals. Model outcomes included lifetime costs, life years gained, quality-adjusted life years (QALY), and incremental cost-effectiveness ratios (ICERs). One-way sensitivity analysis was performed to examine the stability of the results. Results We found that the prevented mortalities for the 11 strategies compared with no screening varied from 26% to 64%. The most cost-effective strategy was HPV screening, starting at age 35 years and repeated every 10 years. The ICER of this strategy was $ 8,875 per QALY compared with no screening. We found that screening at 5-year intervals was also costeffective based on GDP per capita in Iran. Conclusion We recommend organized cervical screening with HPV DNA testing for women in Iran, beginning at age 35 and repeated every 10 or 5 years. The results of this study could be generalized to other countries with low incidence rates of cervical cancer.	[Nahvijou, Azin; Tahmasebi, Mamak; Hashemi, Farnaz Amouzegar] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran; [Daroudi, Rajabali; Sari, Ali Akbari] Univ Tehran Med Sci, Dept Hlth Management & Econ, Sch Publ Hlth, Tehran, Iran; [Hemami, Mohsen Rezaei] Univ Glasgow, Inst Hlth & Wellbeing Hlth Econ & Hlth Technol As, Glasgow G12 8QQ, Lanark, Scotland; [Marenani, Ahmad Barati] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Dept Hlth Serv Management, Tehran, Iran; [Zendehdel, Kazem] Univ Tehran Med Sci, Canc Inst Iran, Canc Model Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Glasgow; Iran University of Medical Sciences; Tehran University of Medical Sciences	Zendehdel, K (corresponding author), Univ Tehran Med Sci, Canc Inst Iran, Canc Model Res Ctr, Tehran, Iran.	kzendeh@tums.ac.ir	Nahvijou, Azin/O-5612-2017; Nahvijou, Azin/AAL-4117-2020	Nahvijou, Azin/0000-0003-1973-7638; Nahvijou, Azin/0000-0003-1973-7638; Daroudi, Rajabali/0000-0002-0487-4114; Zendehdel, Kazem/0000-0002-0269-4945	Iran University of Medical Sciences [IUMS/SHMIS-1391/128]	Iran University of Medical Sciences	This work was part of a PhD dissertation supported by Iran University of Medical Sciences (Grant No.: IUMS/SHMIS-1391/128).	Andres-Gamboa O, 2008, SALUD PUBLICA MEXICO, V50, P276, DOI 10.1590/s0036-36342008000400005; [Anonymous], 2016, NETW ICS ORG CERV CA; [Anonymous], 2014, FDA OKS HPV DNA TEST; Anttila A, 2004, BRIT J CANCER, V91, P935, DOI 10.1038/sj.bjc.6602069; Anttila A, 2009, EUR J CANCER, V45, P2649, DOI 10.1016/j.ejca.2009.07.020; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Behtash N., 2008, Research Journal of Biological Sciences, V3, P627; Bergeron C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju423; Berkhof J, 2010, INT J CANCER, V127, P2147, DOI 10.1002/ijc.25211; BOFFETTA P, 1994, CA-CANCER J CLIN, V44, P81, DOI 10.3322/canjclin.44.2.81; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Burger E, 2012, BRIT J CANC; Center for Disease Control & prevention Noncomunicable Diseases Unit Cancer Office, 2012, IR ANN NAT CANC REG; Chow IHI, 2010, BRIT J CANCER, V103, P1773, DOI 10.1038/sj.bjc.6605974; Cox JT, 2009, J CLIN VIROL, V45, pS3, DOI 10.1016/S1386-6532(09)70002-2; Cuzick J, 2000, BRIT J CANCER, V83, P561, DOI 10.1054/bjoc.2000.1375; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Daroudi A, 2014, REV METHODS ESTIMATI; Denny L, 2015, INT J GYNECOLOGY OBS; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Garber AM, 2010, HEALTH AFFAIR, V29, P1805, DOI 10.1377/hlthaff.2010.0647; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hadji M, 2015, BASIC CLIN CANC RES, V7, P9; Huh WK, 2015, GYNECOLOGIC ONCOLOGY; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Khaksar N KF, 2014, SURVIVAL AN IN PRESS; Khodakarami N, 2012, INT J CANCER, V131, pE156, DOI 10.1002/ijc.26488; Khorasanizadeh F, 2013, GYNECOL ONCOL, V128, P277, DOI 10.1016/j.ygyno.2012.11.032; Kim JJ, 2005, JNCI-J NATL CANCER I, V97, P888, DOI 10.1093/jnci/dji162; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Kulasingam SL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-69; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; LAARA E, 1987, LANCET, V1, P1247; Levin CE, 2010, INT J CANCER, V127, P1404, DOI 10.1002/ijc.25150; Macroeconomics W, 2001, HLTH INV HLTH EC DEV; Majidi A, 2015, INT J HLTH POLICY MA; Malloy C., 2000, HPV DNA TESTING TECH; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Melnikow J, 2010, OBSTET GYNECOL, V116, P1158, DOI 10.1097/AOG.0b013e3181f88e72; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nahar K N, 2011, Mymensingh Med J, V20, P528; Nahvijou A, 2014, ASIAN PAC J CANCER P, V15, P8209, DOI 10.7314/APJCP.2014.15.19.8209; Nahvijou A, 2014, ASIAN PAC J CANCER P, V15, P8229, DOI 10.7314/APJCP.2014.15.19.8229; Nessa A, 2013, ASIAN PAC J CANCER P, V14, P7607, DOI 10.7314/APJCP.2013.14.12.7607; Organization W.H, 2013, GLOB HLTH OBS DAT RE; Park Y, 2012, J CLIN MICROBIOL, V50, P2359, DOI 10.1128/JCM.00337-12; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Ronco G, 2007, EUR J CANCER, V43, P476, DOI 10.1016/j.ejca.2006.11.013; Sankaranarayanan R, 2012, CERVICAL CANC SCREEN, P3; Sawaya GF, 2007, NEW ENGL J MED, V356, P1991, DOI 10.1056/NEJMe078060; Sawaya GF, 2000, OBSTET GYNECOL, V96, P219, DOI 10.1016/S0029-7844(00)00882-6; Sroczynski G, 2011, EUR J CANCER, V47, P1633, DOI 10.1016/j.ejca.2011.03.006; Sroczynski G., 2010, GMS HLTH TECHNOL ASS, V6, P05; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Szende A, 2007, EQ 5D VALUE SETS INV; Tanprasertkul C, 2010, THAMMASAT MED J, V9, P15; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; Vijayaraghavan A, 2009, GYNECOL ONCOL, V112, P377, DOI 10.1016/j.ygyno.2008.08.030; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Zarchi MK, 2010, ASIAN PAC J CANCER P, V11, P1289	67	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156705	10.1371/journal.pone.0156705	http://dx.doi.org/10.1371/journal.pone.0156705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276093	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000377561700032
J	Joanisse, S; Nederveen, JP; Baker, JM; Snijders, T; Iacono, C; Parise, G				Joanisse, Sophie; Nederveen, Joshua P.; Baker, Jeff M.; Snijders, Tim; Iacono, Carlo; Parise, Gianni			Exercise conditioning in old mice improves skeletal muscle regeneration	FASEB JOURNAL			English	Article						exercise; aging; cardiotoxin; satellite cells	SATELLITE-CELL POOL; RAT PLANTARIS MUSCLE; ANGIOGENESIS; YOUNG; RESPONSES; VEGF; IMMOBILIZATION; EXPANSION; ATROPHY; MODEL	Skeletal muscle possesses the ability to regenerate after injury, but this ability is impaired or delayed with aging. Regardless of age, muscle retains the ability to positively respond to stimuli, such as exercise. We examined whether exercise is able to improve regenerative response in skeletal muscle of aged mice. Twenty-two-month-old male C57Bl/6J mice (n = 20) underwent an 8-wk progressive exercise training protocol [old exercised (O-Ex) group]. An old sedentary (O-Sed) and a sedentary young control (Y-Ctl) group were included. Animals were subjected to injections of cardiotoxin into the tibialis anterior muscle. The tibialis anterior were harvested before [O-Ex/O-Sed/Y-Ctl control (CTL); n = 6], 10 d (O-Ex/O-Sed/Y-Ctl d 10; n = 8), and 28 d (O-Ex/O-Sed/Y-Ctl d 28; n = 6) postinjection. Average fiber cross-sectional area was reduced in all groups at d 10 (CTL: O-Ex: 2499 +/- 140; O-Sed: 2320 +/- 165; Y-Ctl: 2474 +/- 269; d 10: O-Ex: 1191 +/- 100; O-Sed: 1125 +/- 99; Y-Ctl: 1481 +/- 167 mu m(2); P < 0.05), but was restored to control values in O-Ex and Y-Ctl groups at d 28 (O-Ex: 2257 +/- 181; Y-Ctl: 2398 +/- 171 mu m(2); P > 0.05). Satellite cell content was greater at CTL in O-Ex (2.6 +/- 0.4 satellite cells/100 fibers) compared with O-Sed (1.0 +/- 0.1% satellite cells/100 fibers; P < 0.05). Exercise conditioning appears to improve ability of skeletal muscle to regenerate after injury in aged mice.Joanisse, S., Nederveen, J. P., Baker, J. M., Snijders, T., Iacono, C., Parise, G. Exercise conditioning in old mice improves skeletal muscle regeneration.	[Joanisse, Sophie; Nederveen, Joshua P.; Baker, Jeff M.; Snijders, Tim; Iacono, Carlo; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada; [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada.; Parise, G (corresponding author), McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4L8, Canada.	pariseg@mcmaster.ca	Snijders, Tim/U-4155-2017	Snijders, Tim/0000-0002-5874-1245; Joanisse, Sophie/0000-0001-9983-9401	Natural Sciences and Engineering Research Council of Canada Discovery; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development	Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an Natural Sciences and Engineering Research Council of Canada Discovery grant to G.P. Pax7 hybridoma cells developed by Dr. A. Kawakami (Tokyo Institute of Technology, Tokyo, Japan) were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and maintained by The University of Iowa, Department of Biology (Iowa City, IA, USA). Author contributions: S. Joanisse, J. M. Baker, and G. Parise conceived and designed the experiments; S. Joanisse, J. P. Nederveen, C. Iacono, and G. Parise performed the experiments; S. Joanisse analyzed the data; S. Joanisse, J. P. Nederveen, T. Snijders, and G. Parise interpreted results of experiments; S. Joanisse and G. Parise drafted the manuscript; and S. Joanisse, J. P. Nederveen, J. M. Baker, T. Snijders, C. Iacono, and G. Parise approved the final version of manuscript.	Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002; Amaral SL, 2001, AM J PHYSIOL-HEART C, V281, pH1163, DOI 10.1152/ajpheart.2001.281.3.H1163; Ambrose C, 2015, AGEING RES REV, V23, P139, DOI 10.1016/j.arr.2015.03.005; BODINEFOWLER S, 1994, J VOICE, V8, P53, DOI 10.1016/S0892-1997(05)80319-4; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Davidson YS, 1999, J GERONTOL A-BIOL, V54, pB448, DOI 10.1093/gerona/54.10.B448; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Gavin TP, 2006, ACTA PHYSIOL, V188, P113, DOI 10.1111/j.1748-1716.2006.01609.x; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Hepple RT, 2001, J APPL PHYSIOL, V91, P2150, DOI 10.1152/jappl.2001.91.5.2150; Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010; Johnston APW, 2011, AM J PHYSIOL-REG I, V301, pR363, DOI 10.1152/ajpregu.00766.2010; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1401, DOI 10.1152/jappl.1989.67.4.1401; Kurosaka M, 2012, ACTA PHYSIOL, V205, P159, DOI 10.1111/j.1748-1716.2011.02381.x; Kurosaka M, 2009, J SPORT SCI MED, V8, P51; Lee Antonio S J, 2013, Bioarchitecture, V3, P25, DOI 10.4161/bioa.24966; Liu XH, 2015, INT J BIOL SCI, V11, P156, DOI 10.7150/ijbs.10283; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; SADEH M, 1988, J NEUROL SCI, V87, P67, DOI 10.1016/0022-510X(88)90055-X; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; SHEFER G, 2013, FEBS J, V280, P4063, DOI DOI 10.1111/FEBS.12228; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Snijders T, 2009, AGEING RES REV, V8, P328, DOI 10.1016/j.arr.2009.05.003; Suetta C, 2013, J PHYSIOL-LONDON, V591, P3789, DOI 10.1113/jphysiol.2013.257121; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127	45	41	42	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3256	3268		10.1096/fj.201600143RR	http://dx.doi.org/10.1096/fj.201600143RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27306336	Green Accepted			2022-12-26	WOS:000382816300024
J	Carrara, VI; Darakomon, MC; Thin, NWW; Paw, NTK; Wah, N; Wah, HG; Helen, N; Keereecharoen, S; Paw, NTM; Jittamala, P; Nosten, FH; Ricci, D; McGready, R				Carrara, Verena I.; Darakomon, Mue Chae; Thin, Nant War War; Paw, Naw Ta Kaw; Wah, Naw; Wah, Hser Gay; Helen, Naw; Keereecharoen, Suporn; Paw, Naw Ta Mlar; Jittamala, Podjanee; Nosten, Francois H.; Ricci, Daniela; McGready, Rose			Evaluation and Acceptability of a Simplified Test of Visual Function at Birth in a Limited-Resource Setting	PLOS ONE			English	Article							THIAMINE-DEFICIENCY; MATURATION; PREGNANCY; REFUGEES; MALARIA; BORDER; WOMEN	Neurological examination, including visual fixation and tracking of a target, is routinely performed in the Shoklo Malaria Research Unit postnatal care units on the Thailand-Myanmar border. We aimed to evaluate a simple visual newborn test developed in Italy and performed by non-specialized personnel working in neonatal care units. An intensive training of local health staff in Thailand was conducted prior to performing assessments at 24, 48 and 72 hours of life in healthy, low-risk term singletons. The 48 and 72 hours results were then compared to values obtained to those from Italy. Parents and staff administering the test reported on acceptability. One hundred and seventy nine newborns, between June 2011 and October 2012, participated in the study. The test was rapidly completed if the infant remained in an optimal behavioral stage (7 +/- 2 minutes) but the test duration increased significantly (12 +/- 4 minutes, p < 0.001) if its behavior changed. Infants were able to fix a target and to discriminate a colored face at 24 hours of life. Horizontal tracking of a target was achieved by 96% (152/159) of the infants at 48 hours. Circular tracking, stripe discrimination and attention to distance significantly improved between each 24-hour test period. The test was easily performed by non-specialized local staff and well accepted by the parents. Healthy term singletons in this limited-resource setting have a visual response similar to that obtained to gestational age matched newborns in Italy. It is possible to use these results as a reference set of values for the visual assessment in Karen and Burmese infants in the first 72 hours of life. The utility of the 24 hours test should be pursued.	[Carrara, Verena I.; Darakomon, Mue Chae; Thin, Nant War War; Paw, Naw Ta Kaw; Wah, Naw; Wah, Hser Gay; Helen, Naw; Keereecharoen, Suporn; Paw, Naw Ta Mlar] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Jittamala, Podjanee] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Nosten, Francois H.; McGready, Rose] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand; [Nosten, Francois H.; McGready, Rose] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Ricci, Daniela] Catholic Univ, Paediat Neurol Unit, Rome, Italy	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Carrara, VI (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand.	verena@shoklo-unit.com	McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019; Carrara, Verena/R-6492-2019; Ricci, Daniela/AAC-3415-2022	McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Carrara, Verena/0000-0002-2758-0872; ricci, daniela/0000-0002-3547-7592	Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP	Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP	The study was funded by the Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The study was funded by the Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boel M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000887; BRONSON G, 1974, CHILD DEV, V45, P873, DOI 10.1111/j.1467-8624.1974.tb00683.x; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Dubowitz L, 1977, GESTATIONAL AGE NEWB; DUBOWITZ LMS, 1986, LANCET, V1, P1139, DOI 10.1016/S0140-6736(86)91847-7; Fowkes FJI, 2013, CLIN INFECT DIS, V56, P749, DOI 10.1093/cid/cis979; McGready R, 2003, ANN TROP PAEDIATR, V23, P193, DOI 10.1179/027249303322296510; McGready R, 2000, ANN TROP PAEDIATR, V20, P323, DOI 10.1080/02724936.2000.11748154; McGready R, 2001, AM J CLIN NUTR, V74, P808; McGready R, 2015, F1000RESEARCH, V3, P123, DOI 10.12688/f1000research.4190.2; McGready R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040244; Ricci D, 2008, EARLY HUM DEV, V84, P107, DOI 10.1016/j.earlhumdev.2007.03.010; Ricci D, 2008, EARLY HUM DEV, V84, P277, DOI 10.1016/j.earlhumdev.2007.10.002; Ricci D, 2010, EARLY HUM DEV, V86, P29, DOI 10.1016/j.earlhumdev.2009.11.004; Ricci D, 2008, PEDIATRICS, V122, pE1193, DOI 10.1542/peds.2008-1888; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Russell-Eggitt I, 1998, DEV MED CHILD NEUROL, V40, P130; Stuetz W, 2006, SCI TOTAL ENVIRON, V363, P78, DOI 10.1016/j.scitotenv.2005.06.032; Stuetz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036280; Stuetz W, 2012, EUR J NUTR, V51, P425, DOI 10.1007/s00394-011-0226-z; Teeyapant P, 2014, J TOXICOL SCI, V39, P121, DOI 10.2131/jts.39.121; Turner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072721; Turner C, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-93; White AL, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-19; YAGI N, 1979, J ENVIRON PATHOL TOX, V2, P1119	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157087	10.1371/journal.pone.0157087	http://dx.doi.org/10.1371/journal.pone.0157087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300137	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200029
J	Herrera, C; Klokk, TI; Cole, R; Sandvig, K; Mantis, NJ				Herrera, Cristina; Klokk, Tove Irene; Cole, Richard; Sandvig, Kirsten; Mantis, Nicholas J.			A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking	PLOS ONE			English	Article							PASSIVELY PROTECTS MICE; RETROGRADE TRANSPORT; ENDOPLASMIC-RETICULUM; NEUTRALIZING AGENT; BINDING; MACROPINOCYTOSIS; MECHANISM; CHAIN; RETROTRANSLOCATION; NANOPARTICLES	JJX12 is an engineered bispecific antibody against ricin, a member of the medically important A-B family of toxins that exploits retrograde transport as means to gain entry into the cytosol of target cells. JJX12 consists of RTA-D10, a camelid single variable domain (VHH) antibody directed against an epitope on ricin's enzymatic subunit (RTA), linked via a 15-mer peptide to RTB-B7, a VHH against ricin's bivalent galactose binding subunit (RTB). We previously reported that JJX12, but not an equimolar mixture of RTA-D10 and RTB-B7 monomers, was able to passively protect mice against a lethal dose ricin challenge, demonstrating that physically linking RTB-B7 and RTA-D10 is critical for toxin-neutralizing activity in vivo. We also reported that JJX12 promotes aggregation of ricin in solution, presumably through the formation of intermolecular crosslinking. In the current study, we now present evidence that JJX12 affects the dynamics of ricin uptake and trafficking in human epithelial cells. Confocal microscopy, as well as live cell imaging coupled with endocytosis pathway-specific inhibitors, revealed that JJX12-toxin complexes are formed on the surfaces of mammalian cells and internalized via a pathway sensitive to amiloride, a known inhibitor of macropinocytosis. Moreover, in the presence of JJX12, retrograde transport of ricin to the trans-Golgi network was significantly reduced, while accumulation of the toxin in late endosomes was significantly enhanced. In summary, we propose that JJX12, by virtue of its ability to crosslink ricin toxin, alters the route of toxin uptake and trafficking within cells.	[Herrera, Cristina; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Herrera, Cristina; Cole, Richard; Mantis, Nicholas J.] Univ Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Klokk, Tove Irene; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0450 Oslo, Norway; [Klokk, Tove Irene; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed, N-0450 Oslo, Norway; [Klokk, Tove Irene; Sandvig, Kirsten] Univ Oslo, Dept Biosci, Oslo, Norway; [Cole, Richard] New York State Dept Hlth, Wadsworth Ctr, Div Translat Med, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Oslo; University of Oslo; University of Oslo; State University of New York (SUNY) System; Wadsworth Center	Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA.; Mantis, NJ (corresponding author), Univ Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA.	nicholas.mantis@health.ny.gov		Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (USA) [HHSN272201400021C]; South-Eastern Norway Regional Health Authority; Norwegian Cancer Society; Norwegian Research Council through its Centers of Excellence funding scheme [179571]	National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (USA); South-Eastern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council through its Centers of Excellence funding scheme	This work was supported by contract HHSN272201400021C (PI-Mantis) from the National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (USA): https://www.fbo.gov/index?s=opportunity&mode=form&tab=core&id=977f0135ae02cab0bdb4e84e35bf9b18. TIK and KS were supported by grants from the South-Eastern Norway Regional Health Authority, the Norwegian Cancer Society and the Norwegian Research Council through its Centers of Excellence funding scheme, project number 179571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Herrera C, 2015, J BIOL CHEM, V290, P27880, DOI 10.1074/jbc.M115.658070; Herrera C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099788; Hu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045595; Iversen TG, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-33; Klokk TI, 2016, CELL MOL LIFE SCI, V73, P1301, DOI 10.1007/s00018-015-2049-1; Klokk TI, 2011, TOXINS, V3, P1203, DOI 10.3390/toxins3091203; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Moayeri M, 2016, CLIN VACCINE IMMUNOL, V23, P213, DOI 10.1128/CVI.00611-15; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheoran AS, 2015, INFECT IMMUN, V83, P286, DOI 10.1128/IAI.02360-14; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Sully EK, 2014, TOXICON, V92, P36, DOI 10.1016/j.toxicon.2014.09.006; Sully EK, 2014, CLIN VACCINE IMMUNOL, V21, P777, DOI 10.1128/CVI.00003-14; Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Unger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07850; Vance D, 2009, ADV DRUG DELIVER REV, V61, P931, DOI 10.1016/j.addr.2009.06.002; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Wolfe DN, 2013, HUM VACC IMMUNOTHER, V9, P1591, DOI 10.4161/hv.24063; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yermakova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22721; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156893	10.1371/journal.pone.0156893	http://dx.doi.org/10.1371/journal.pone.0156893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300140	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200019
J	Mikkelsen, S; Brauer, C; Pedersen, EB; Alkjaer, T; Koblauch, H; Simonsen, EB; Helweg-Larsen, K; Thygesen, LC				Mikkelsen, Sigurd; Brauer, Charlotte; Pedersen, Ellen Botker; Alkjaer, Tine; Koblauch, Henrik; Simonsen, Erik Bruun; Helweg-Larsen, Karin; Thygesen, Lau Caspar			A Cohort Study on Meniscal Lesions among Airport Baggage Handlers	PLOS ONE			English	Article							RISK-FACTORS; KNEE DISORDERS; FLOOR LAYERS; POPULATION; REGISTERS; PATHOLOGY; HEALTH; TEARS; MRI	Meniscal lesions are common and may contribute to the development of knee arthrosis. A few case-control and cross-sectional studies have identified knee-straining work as risk factors for meniscal lesions, but exposure-response relations and the role of specific exposures are uncertain, and previous results may be sensitive to reporting and selection bias. We examined the relation between meniscal lesions and cumulative exposure to heavy lifting in a prospective register-based study with complete follow-up and independent information on exposure and outcome. We established a cohort of unskilled men employed at Copenhagen Airport or in other companies in the metropolitan Copenhagen area from 1990 to 2012 (the Copenhagen Airport Cohort). The cohort at risk included 3,307 airport baggage handlers with heavy lifting and kneeling or squatting work tasks and 63,934 referents with a similar socioeconomic background and less knee-straining work. Baggage handlers lifted suitcases with an average weight of approximately 15 kg, in total approximately five tonnes during a 9-hour workday. The cohort was followed in the National Patient Register and Civil Registration System. The outcome was a first time hospital diagnosis or surgery of a meniscal lesion. Baggage handlers had a higher incidence of meniscal lesions than the referents. Within baggage handlers spline regression showed that the incidence rate ratio was 1.91 (95% confidence interval: 1.29-2.84) after five years as a baggage handler and then decreased slowly to reach unity after approximately 30 years, adjusted for effects of potential confounders. This relation between baggage handling and meniscal lesions was present for work on the apron which involves lifting in a kneeling or squatting position, but not in the baggage hall, which only involves lifting in standing positions. The results support that long-term heavy lifting in a kneeling or squatting position is a risk factor for the development of symptomatic meniscal lesions.	[Mikkelsen, Sigurd; Brauer, Charlotte; Pedersen, Ellen Botker] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Alkjaer, Tine; Koblauch, Henrik; Simonsen, Erik Bruun] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Helweg-Larsen, Karin; Thygesen, Lau Caspar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Southern Denmark	Mikkelsen, S (corresponding author), Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	sigurd.mikkelsen.01@regionh.dk	Thygesen, Lau/W-9096-2019	Thygesen, Lau/0000-0001-8375-5211; Alkjaer, Tine/0000-0002-9105-3882; Brauer, Charlotte/0000-0002-2109-3264; Simonsen, Erik Bruun/0000-0002-6378-6595	Danish Working Environment Research Fund [24-2011-03]; Danish Rheumatism Association [R101-A2003]	Danish Working Environment Research Fund; Danish Rheumatism Association	The study was funded by The Danish Working Environment Research Fund (grant number 24-2011-03) (( http://arbejdstilsynet.dk/da/om%20arbejdstilsynet/arbejdsmiljoforskningsfonden.aspx) and The Danish Rheumatism Association (grant number R101-A2003) (https://www.gigtforeningen.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Baker P, 2003, OCCUP ENVIRON MED, V60, P794, DOI 10.1136/oem.60.10.794; Baker P, 2002, J RHEUMATOL, V29, P557; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2012, NAT REV RHEUMATOL, V8, P412, DOI 10.1038/nrrheum.2012.69; Englund M, 2011, ANN RHEUM DIS, V70, P1733, DOI 10.1136/ard.2011.150052; Englund M, 2009, J RHEUMATOL, V36, P1362, DOI 10.3899/jrheum.090335; Hardin G T, 1992, Orthop Rev, V21, P1311; Jensen LK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001109; Jensen LK, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-188; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Katz JN, 2009, ARTHRITIS RHEUM, V60, P633, DOI 10.1002/art.24363; KIVIMAKI J, 1992, SCAND J WORK ENV HEA, V18, P310, DOI 10.5271/sjweh.1571; Lass Preben, 2006, Ugeskr Laeger, V168, P4212; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rytter Soren, 2009, J Occup Med Toxicol, V4, P19, DOI 10.1186/1745-6673-4-19; Rytter S, 2009, J RHEUMATOL, V36, P1512, DOI 10.3899/jrheum.081150; SHARRARD WJ, 1962, BRIT J IND MED, V19, P195; Snoeker BAM, 2013, J ORTHOP SPORT PHYS, V43, P352, DOI 10.2519/jospt.2013.4295; The Danish Data Protection Agency, 2008, STAND TERMS RES PROJ; The National Committee on Health Research Ethics (DNVK) Copenhagen, 2011, GUID NOT ETC BIOM RE; Thorlund JB, 2014, ACTA ORTHOP, V85, P287, DOI 10.3109/17453674.2014.919558; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157336	10.1371/journal.pone.0157336	http://dx.doi.org/10.1371/journal.pone.0157336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299861	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200037
J	Benhalima, K; Jegers, K; Devlieger, R; Verhaeghe, J; Mathieu, C				Benhalima, Katrien; Jegers, Katleen; Devlieger, Roland; Verhaeghe, Johan; Mathieu, Chantal			Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN SENSITIVITY; PREGNANCY OUTCOMES; WOMEN; MELLITUS; POSTPARTUM; TOLERANCE; RESISTANCE; COHORT	Aims Uncertainty exists on the prevalence of glucose intolerance in women with a recent diagnosis of gestational diabetes (GDM) based on a two-step screening strategy and the 2013 World Health Organization (WHO) criteria. Our aim was to evaluate the uptake of postpartum screening, the prevalence and the risk factors for glucose intolerance in women with a recent history of GDM. Methods Retrospective analysis of the medical records of women with a recent history of GDM diagnosed in a universal two-step screening strategy with the 2013 WHO criteria. All women with a history of GDM are advised to undergo a 75g oral glucose tolerance test (OGTT) around 12 weeks postpartum. Indices of insulin sensitivity (the Matsuda index and the reciprocal of the homeostasis model assessment of insulin resistance, 1/HOMA-IR) and an index of beta-cell function, the Insulin Secretion-Sensitivity Index-2 (ISSI-2) were calculated based on the OGTT postpartum. Multivariable logistic regression was used to adjust for confounders such as age, BMI, ethnicity and breastfeeding. Results Of the 191 women with GDM, 29.3%(56) did not attend the scheduled postpartum OGTT. These women had a higher BMI (28.6 +/- 6.8 vs. 26.2 +/- 5.6, p = 0.015), were more often from an ethnic minority (EM) background (41.1% vs. 25.2%, p = 0.029) and smoked more often during pregnancy (14.3% vs. 2.2%, p = 0.001) than women who attended the OGTT postpartum. Of all women (135) who received an OGTT postpartum, 42.2% (57) had prediabetes (11.9% impaired fasting glucose, 24.4% impaired glucose tolerance and 5.9% both impaired fasting and impaired glucose tolerance) and 1.5% (2) had overt diabetes. Compared to women with a normal OGTT postpartum, women with glucose intolerance were older (32.5 +/- 4.3 vs. 30.8 +/- 4.8 years, p = 0.049), were more often obese (34.5% vs. 17.3%, p = 0.023), were more often from an EM background (33.9% vs. 18.4%, p = 0.040), less often breastfed (69.5% vs. 84.2%, p = 0.041) and had more often an abnormal fasting glycaemia at the time of the OGTT in pregnancy (55.6% vs. 37.3%, p = 0.040). In the multivariable logistic regression, an EM background [OR = 2.76 (1.15-6.62), p = 0.023] and the HbA1c level at the time of the OGTT in pregnancy [OR = 4.78 (1.19-19.20), p = 0.028] remained significant predictors for glucose intolerance postpartum. Women with glucose intolerance postpartum had a similar insulin sensitivity [Matsuda index 0.656 (0.386-1.224) vs. 0.778 (0.532-1.067), p = 0.709; 1/HOMA-IR 0.004 (0.002-0.009) vs. (0.004-0.003-0.007), p = 0.384] but a lower beta-cell function compared to women with a normal OGTT postpartum, remaining significant after adjustment for confounders [ISSI-2 1.6 (1.2-2.1) vs. 1.9 (1.7-2.4), p = 0.002]. Conclusions Glucose intolerance is very frequent in early postpartum in women with GDM based on the 2013 WHO criteria in a two-step screening strategy and these women have an impaired beta-cell function. Nearly one third of women did not attend the scheduled OGTT postpartum and these women have an adverse risk profile. More efforts are needed to engage and stimulate women with GDM to attend the postpartum OGTT.	[Benhalima, Katrien; Jegers, Katleen; Mathieu, Chantal] Katholieke Univ Leuven, UZ Gasthuisberg, Dept Endocrinol, Leuven, Belgium; [Devlieger, Roland; Verhaeghe, Johan] Katholieke Univ Leuven, Dept Obstet & Gynecol, UZ Gasthuisberg, Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Benhalima, K (corresponding author), Katholieke Univ Leuven, UZ Gasthuisberg, Dept Endocrinol, Leuven, Belgium.	katrien.benhalima@uzleuven.be	Devlieger, Roland/AAS-9181-2020; Benhalima, Katrien/K-5800-2017; mathieu, chantal/ABD-5505-2021	Devlieger, Roland/0000-0001-7837-4684; Benhalima, Katrien/0000-0002-3325-0263; mathieu, chantal/0000-0002-4055-5233				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2013, DIAGNOSTIC CRITERIA; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Benhalima K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0706-x; Benhalima K, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/727652; Benhalima K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-226; Benhalima K, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-66; Bihan H, 2014, DIABETES METAB, V40, P151, DOI 10.1016/j.diabet.2013.12.002; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Duran A, 2014, DIABETES CARE, V37, P2442, DOI 10.2337/dc14-0179; Gunderson EP, 2012, DIABETES CARE, V35, P50, DOI 10.2337/dc11-1409; International Diabetes Federation, 2013, DIABETES E ATLAS; Picon MJ, 2012, DIABETES CARE, V35, P1648, DOI 10.2337/dc11-2111; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kirwan JP, 2001, DIABETES CARE, V24, P1602, DOI 10.2337/diacare.24.9.1602; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Kramer CK, 2014, DIABETES CARE, V37, P3262, DOI 10.2337/dc14-1529; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Leuridan L, 2015, PRIM CARE DIABETES, V9, P244, DOI 10.1016/j.pcd.2015.03.007; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Noctor E, 2013, EUR J ENDOCRINOL, V169, P681, DOI 10.1530/EJE-13-0491; O'Reilly MW, 2011, EUR J ENDOCRINOL, V165, P953, DOI 10.1530/EJE-11-0663; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Retnakaran R, 2008, DIABETES CARE, V31, P2026, DOI 10.2337/dc08-0972; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; Shah BR, 2011, BJOG-INT J OBSTET GY, V118, P1484, DOI 10.1111/j.1471-0528.2011.03083.x; The National Institute for Health and Care Excellence (NICE), 2015, UPDATED GUIDELINES O	32	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157272	10.1371/journal.pone.0157272	http://dx.doi.org/10.1371/journal.pone.0157272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285104	Green Published, gold			2022-12-26	WOS:000377564000055
J	Bergler, T; Jung, B; Bourier, F; Kuhne, L; Banas, MC; Rummele, P; Wurm, S; Banas, B				Bergler, Tobias; Jung, Bettina; Bourier, Felix; Kuehne, Louisa; Banas, Miriam C.; Ruemmele, Petra; Wurm, Simone; Banas, Bernhard			Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation	PLOS ONE			English	Article							HUMAN RENAL-ALLOGRAFTS; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODIES; ADHESION MOLECULES; BIOPSIES; DYSFUNCTION; EXPRESSION; MONOCYTES; INJURY; C4D	Objective Despite substantial progress in recent years, graft survival beyond the first year still requires improvement. Since modern immunosuppression addresses mainly T-cell activation and proliferation, we studied macrophage infiltration into the allografts of 103 kidney transplant recipients during acute antibody and T-cell mediated rejection. Macrophage infiltration was correlated with both graft function and graft survival until month 36 after transplantation. Results Macrophage infiltration was significantly elevated in antibody-mediated and T-cell mediated rejection, but not in kidneys with established IFTA. Treatment of rejection with steroids was less successful in patients with more prominent macrophage infiltration into the allografts. Macrophage infiltration was accompanied by increased cell proliferation as well as antigen presentation. With regard to the compartmental distribution severity of T-cell-mediated rejection was correlated to the amount of CD68(+) cells especially in the peritubular and perivascular compartment, whereas biopsies with ABMR showed mainly peritubular CD68 infiltration. Furthermore, severity of macrophage infiltration was a valid predictor of resulting creatinine values two weeks as well as two and three years after renal transplantation as illustrated by multivariate analysis. Additionally performed ROC curve analysis showed that magnitude of macrophage infiltration (below vs. above the median) was a valid predictor for the necessity to restart dialysis. Having additionally stratified biopsies in accordance to the magnitude of macrophage infiltration, differential CD68+ cell infiltration was reflected by striking differences in overall graft survival. Conclusion The differences in acute allograft rejection have not only been reflected by different magnitudes of macrophage infiltration, but also by compartment-specific infiltration pattern and subsequent impact on resulting allograft function as well as need for dialysis initiation. There is a robust relationship between macrophage infiltration, accompanying antigen-presentation and resulting allograft function.	[Bergler, Tobias; Jung, Bettina; Bourier, Felix; Kuehne, Louisa; Banas, Miriam C.; Wurm, Simone; Banas, Bernhard] Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany; [Ruemmele, Petra] Univ Regensburg, Dept Pathol, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Bergler, T (corresponding author), Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany.	tobias.bergler@ukr.de	Steines, Louisa/AAD-3347-2022	Steines, Louisa/0000-0002-6027-2986; Bourier, Felix/0000-0003-4861-6595; Bergler, Tobias/0000-0002-3875-6730; Banas, Bernhard/0000-0003-2076-2195	Else Kroner-Fresenius-Stiftung	Else Kroner-Fresenius-Stiftung	This work was supported by the Else Kroner-Fresenius-Stiftung to BT.	AXELSEN RA, 1985, CLIN NEPHROL, V23, P1; Bajwa A, 2009, CURR DRUG TARGETS, V10, P1196, DOI 10.2174/138945009789753174; BISHOP GA, 1986, KIDNEY INT, V29, P708, DOI 10.1038/ki.1986.56; BURKHARDT K, 1995, TRANSPLANT P, V27, P890; Chadban SJ, 2010, SEMIN NEPHROL, V30, P278, DOI 10.1016/j.semnephrol.2010.03.009; Copin M C, 1995, Transpl Immunol, V3, P229, DOI 10.1016/0966-3274(95)80029-8; DIAMOND JR, 1992, TRANSPLANTATION, V54, P710, DOI 10.1097/00007890-199210000-00028; DOOPER IMM, 1994, TRANSPLANTATION, V58, P820, DOI 10.1097/00007890-199410150-00013; Girlanda R, 2008, AM J TRANSPLANT, V8, P600, DOI 10.1111/j.1600-6143.2007.02109.x; Guillen-Gomez E, 2014, CLIN EXP IMMUNOL, V175, P323, DOI 10.1111/cei.12228; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; HABIB R, 1993, KIDNEY INT, V44, pS104; HANCOCK WH, 1993, TRANSPLANTATION, V56, P643, DOI 10.1097/00007890-199309000-00028; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; HARRY TR, 1984, TRANSPLANTATION, V37, P70, DOI 10.1097/00007890-198401000-00019; HEEMANN UW, 1994, TRANSPLANT INT, V7, P349, DOI 10.1007/BF00336711; Hoffmann U, 2006, NEPHROL DIAL TRANSPL, V21, P1373, DOI 10.1093/ndt/gfk075; Hoffmann U, 2013, TRANSPL IMMUNOL, V28, P24, DOI 10.1016/j.trim.2012.12.001; Ikezumi Y, 2015, PEDIATR NEPHROL, V30, P1007, DOI 10.1007/s00467-014-3023-0; Kirk AD, 1999, TRANSPLANTATION, V68, P1578, DOI 10.1097/00007890-199911270-00024; Mannon RB, 2012, CURR OPIN ORGAN TRAN, V17, P20, DOI 10.1097/MOT.0b013e32834ee5b6; MATHEW TH, 1975, AM J MED, V59, P177, DOI 10.1016/0002-9343(75)90352-6; MATHEW TH, 1988, AM J KIDNEY DIS, V12, P85, DOI 10.1016/S0272-6386(88)80001-5; Matoza JRA, 2008, TRANSPL P, V40, P2303, DOI 10.1016/j.transproceed.2008.07.004; Mauiyyedi S, 2001, J AM SOC NEPHROL, V12, P574, DOI 10.1681/ASN.V123574; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Messias NC, 2001, TRANSPLANTATION, V72, P655, DOI 10.1097/00007890-200108270-00016; Nankivell BJ, 2006, AM J TRANSPLANT, V6, P2006, DOI 10.1111/j.1600-6143.2006.01436.x; Nankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01; OM A, 1987, TRANSPLANT P, V19, P1618; RAFTERY MJ, 1989, TRANSPLANTATION, V48, P238, DOI 10.1097/00007890-198908000-00011; RAMOS EL, 1995, TRANSPLANTATION, V59, P490; Regele H, 2002, J AM SOC NEPHROL, V13, P2371, DOI 10.1097/01.ASN.0000025780.03790.0F; RICHARDSON WP, 1981, NEW ENGL J MED, V305, P57, DOI 10.1056/NEJM198107093050201; Rowshani AT, 2012, TRANSPLANTATION, V94, P309, DOI 10.1097/TP.0b013e318250c10f; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; SERON D, 1989, TRANSPLANTATION, V47, P811, DOI 10.1097/00007890-198905000-00013; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Tinckam KJ, 2005, KIDNEY INT, V68, P1866, DOI 10.1111/j.1523-1755.2005.00606.x; Toki D, 2014, AM J TRANSPLANT, V14, P2126, DOI 10.1111/ajt.12803; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20	41	47	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156900	10.1371/journal.pone.0156900	http://dx.doi.org/10.1371/journal.pone.0156900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285579	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000030
J	Menon, VK; George, S; Sarkar, R; Giri, S; Samuel, P; Vivek, R; Saravanabavan, A; Liakath, FB; Ramani, S; Iturriza-Gomara, M; Gray, JJ; Brown, DW; Estes, MK; Kang, G				Menon, Vipin Kumar; George, Santosh; Sarkar, Rajiv; Giri, Sidhartha; Samuel, Prasanna; Vivek, Rosario; Saravanabavan, Anuradha; Liakath, Farzana Begum; Ramani, Sasirekha; Iturriza-Gomara, Miren; Gray, James J.; Brown, David W.; Estes, Mary K.; Kang, Gagandeep			Norovirus Gastroenteritis in a Birth Cohort in Southern India	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NORWALK VIRUS; GENETIC DIVERSITY; ACUTE DIARRHEA; MOLECULAR CHARACTERIZATION; HUMAN CALICIVIRUSES; NONSENSE MUTATION; CHILDREN; ROTAVIRUS; INFECTIONS	Background Noroviruses are an important cause of gastroenteritis but little is known about disease and re-infection rates in community settings in Asia. Methods Disease, re-infection rates, strain prevalence and genetic susceptibility to noroviruses were investigated in a birth cohort of 373 Indian children followed up for three years. Stool samples from 1856 diarrheal episodes and 147 vomiting only episodes were screened for norovirus by RT-PCR. Norovirus positivity was correlated with clinical data, secretor status and ABO blood group. Results Of 1856 diarrheal episodes, 207 (11.2%) were associated with norovirus, of which 49(2.6%) were norovirus GI, 150(8.1%) norovirus GII, and 8 (0.4%) were mixed infections with both norovirus GI and GII. Of the 147 vomiting only episodes, 30 (20.4%) were positive for norovirus in stool, of which 7 (4.8%) were norovirus GI and 23 (15.6%) GII. At least a third of the children developed norovirus associated diarrhea, with the first episode at a median age of 5 and 8 months for norovirus GI and GII, respectively. Norovirus GI. 3 and GII. 4 were the predominant genotypes (40.3% and 53.0%) with strain diversity and change in the predominant sub-cluster over time observed among GII viruses. A second episode of norovirus gastroenteritis was documented in 44/174 (25.3%) ever-infected children. Children with the G428A homozygous mutation for inactivation of the FUT2 enzyme (se(428)se(428)) were at a significantly lower risk (48/190) of infection with norovirus (p = 0.01). Conclusions This is the first report of norovirus documenting disease, re-infection and genetic susceptibility in an Asian birth cohort. The high incidence and apparent lack of genogroupII specific immunity indicate the need for careful studies on further characterization of strains, asymptomatic infection and shedding and immune response to further our understanding of norovirus infection and disease.	[Menon, Vipin Kumar; George, Santosh; Sarkar, Rajiv; Giri, Sidhartha; Vivek, Rosario; Saravanabavan, Anuradha; Liakath, Farzana Begum; Ramani, Sasirekha; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Samuel, Prasanna] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Iturriza-Gomara, Miren; Gray, James J.; Brown, David W.] Hlth Protect Agcy, Ctr Infect, Virus Reference Dept, London, England; [Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Menon, Vipin Kumar] Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Ramani, Sasirekha] Baylor Coll Med, Houston, TX 77030 USA; [Iturriza-Gomara, Miren] Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Gray, James J.] Norwich Med Sch, Norwich, Norfolk, England	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Health Protection Agency; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Liverpool; University of East Anglia	Kang, G (corresponding author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India.	gkang@cmcvellore.ac.in	Sarkar, Rajiv/AAU-7203-2021; George, Santosh/AAX-4797-2021; Gomara, Miren Iturriza/B-4351-2013; Giri, Sidhartha/Y-9516-2018; Menon, Vipin Kumar/J-7451-2019; George, Santosh/F-2054-2018	Sarkar, Rajiv/0000-0003-0616-3129; Gomara, Miren Iturriza/0000-0001-5816-6423; Giri, Sidhartha/0000-0003-3927-7392; George, Santosh/0000-0003-0886-9766; Menon, Vipin/0000-0001-7404-678X	Indian Council of Medical Research (ICMR) [18/11/23/2006-ECD-I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057788] Funding Source: NIH RePORTER	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Indian Council of Medical Research (ICMR), award number: 18/11/23/2006-ECD-I, grant recipient: Gagandeep Kang (http://icmr.nic.in/projects/projectsanc07-09.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; Al-Mashhadani MN, 2008, J MED VIROL, V80, P506, DOI 10.1002/jmv.21099; Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589; Arness MK, 2000, EMERG INFECT DIS, V6, P204; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Banerjee I, 2007, J MED VIROL, V79, P1768, DOI 10.1002/jmv.20988; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brick T, 2004, INT J HYG ENVIR HEAL, V207, P473, DOI 10.1078/1438-4639-00318; Brookhart MA, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-67; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Cheng WX, 2010, ARCH VIROL, V155, P553, DOI 10.1007/s00705-010-0592-5; Chhabra P, 2008, J CLIN VIROL, V42, P429, DOI 10.1016/j.jcv.2008.03.014; Chhabra P, 2010, VIRUS RES, V147, P242, DOI 10.1016/j.virusres.2009.11.007; Chhabra P, 2009, J MED VIROL, V81, P922, DOI 10.1002/jmv.21458; Chung JY, 2010, J MED VIROL, V82, P146, DOI 10.1002/jmv.21650; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Estevez A, 2013, J MED VIROL, V85, P1293, DOI 10.1002/jmv.23578; Gladstone BP, 2008, ARCH DIS CHILD, V93, P479, DOI 10.1136/adc.2006.114546; Gladstone BP, 2010, J TROP PEDIATRICS, V56, P221, DOI 10.1093/tropej/fmp116; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; GREEN J, 1995, J MED VIROL, V47, P392, DOI 10.1002/jmv.1890470416; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Hassine-Zaafrane M, 2013, J MED VIROL, V85, P1100, DOI 10.1002/jmv.23552; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Knipe DM, 2007, FIELDS VIROLOGY; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lukkarinen H, 2009, PEDIATR INFECT DIS J, V28, P847, DOI 10.1097/INF.0b013e31819d1cd9; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Murata T, 2007, PEDIATR INFECT DIS J, V26, P46, DOI 10.1097/01.inf.0000247102.04997.e0; Nakagomi T, 2008, ARCH VIROL, V153, P957, DOI 10.1007/s00705-008-0060-7; Nataraju SM, 2010, EPIDEMIOL INFECT, V19, P1; Nguyen TA, 2007, J MED VIROL, V79, P582, DOI 10.1002/jmv.20857; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; O'Ryan ML, 2010, PEDIATR INFECT DIS J, V29, P855, DOI 10.1097/INF.0b013e3181e8b346; O'Ryan ML, 2009, PEDIATR INFECT DIS J, V28, P879, DOI 10.1097/INF.0b013e3181a4bb60; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Parashar UD, 2004, J INFECT DIS, V190, P1088, DOI 10.1086/423324; Rachakonda G, 2008, J CLIN VIROL, V43, P42, DOI 10.1016/j.jcv.2008.05.006; Ramani S, 2009, CURR OPIN INFECT DIS, V22, P477, DOI 10.1097/QCO.0b013e328330662f; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Ribeiro LR, 2008, MEM I OSWALDO CRUZ, V103, P201, DOI 10.1590/S0074-02762008000200013; Rockx BHG, 2005, J INFECT DIS, V191, P749, DOI 10.1086/427779; Saito M, 2013, CLIN INFECT DIS; Shioda K, 2015, VACCINE, V33, P4065, DOI 10.1016/j.vaccine.2015.05.051; Shirato H, 2011, JPN J INFECT DIS, V64, P95; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; Trainor E, 2013, J MED VIROL, V85, P1299, DOI 10.1002/jmv.23589; Yori PP, 2009, PEDIATR INFECT DIS J, V28, P844, DOI 10.1097/INF.0b013e3181a24730	62	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157007	10.1371/journal.pone.0157007	http://dx.doi.org/10.1371/journal.pone.0157007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284939	gold, Green Published, Green Submitted			2022-12-26	WOS:000377564000035
J	Liu, D; Xu, M; Niu, DX; Wang, SK; Liang, S				Liu, Da; Xu, Ming; Niu, Dongxiao; Wang, Shoukai; Liang, Sai			Forecast Modelling via Variations in Binary Image-Encoded Information Exploited by Deep Learning Neural Networks	PLOS ONE			English	Article								Traditional forecasting models fit a function approximation from dependent invariables to independent variables. However, they usually get into trouble when date are presented in various formats, such as text, voice and image. This study proposes a novel image-encoded forecasting method that input and output binary digital two-dimensional (2D) images are transformed from decimal data. Omitting any data analysis or cleansing steps for simplicity, all raw variables were selected and converted to binary digital images as the input of a deep learning model, convolutional neural network (CNN). Using shared weights, pooling and multiple-layer back-propagation techniques, the CNN was adopted to locate the nexus among variations in local binary digital images. Due to the computing capability that was originally developed for binary digital bitmap manipulation, this model has significant potential for forecasting with vast volume of data. The model was validated by a power loads predicting dataset from the Global Energy Forecasting Competition 2012.	[Liu, Da; Niu, Dongxiao; Wang, Shoukai] North China Elect Power Univ, Sch Econ & Management, Beijing, Peoples R China; [Xu, Ming; Liang, Sai] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	North China Electric Power University; University of Michigan System; University of Michigan	Liu, D (corresponding author), North China Elect Power Univ, Sch Econ & Management, Beijing, Peoples R China.	liuda315@163.com	Xu, Ming/F-3653-2010; Liu, Da/G-9784-2014	Xu, Ming/0000-0002-7106-8390; Liu, Da/0000-0003-0816-1901; Liang, Sai/0000-0002-6306-5800	National Natural Science Foundation of China (NSFC) [70901025]; Social Science Funding Project of Beijing [13JDJGC055]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Social Science Funding Project of Beijing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (NSFC) (70901025), the Social Science Funding Project of Beijing (13JDJGC055) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Baldi P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5308; Ben Taieb S, 2014, INT J FORECASTING, V30, P382, DOI 10.1016/j.ijforecast.2013.07.005; Charlton N, 2014, INT J FORECASTING, V30, P364, DOI 10.1016/j.ijforecast.2013.07.003; Chouard T, 2015, NATURE, V521, P435, DOI 10.1038/521435a; Ciresan D.C., 2011, PROC 22 INT JOINT C, P1237; Gandomi A, 2015, INT J INFORM MANAGE, V35, P137, DOI 10.1016/j.ijinfomgt.2014.10.007; Hahn H, 2009, EUR J OPER RES, V199, P902, DOI 10.1016/j.ejor.2009.01.062; Hippert HS, 2001, IEEE T POWER SYST, V16, P44, DOI 10.1109/59.910780; Hong T, 2014, INT J FORECASTING, V30, P357, DOI 10.1016/j.ijforecast.2013.07.001; Jones N, 2014, NATURE, V505, P146, DOI 10.1038/505146a; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Kang HW, 2015, ADV SOC SCI EDUC HUM, V41, P638; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lloyd JR, 2014, INT J FORECASTING, V30, P369, DOI 10.1016/j.ijforecast.2013.07.002; Meade N, 1986, J OPER RES SOC, V5; Niu DX, 2010, APPL SOFT COMPUT, V10, P868, DOI 10.1016/j.asoc.2009.10.004; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Silva L, 2014, INT J FORECASTING, V30, P395, DOI 10.1016/j.ijforecast.2013.07.007; Taylor JW, 2007, IEEE T POWER SYST, V22, P2213, DOI 10.1109/TPWRS.2007.907583; Tufekci P, 2014, INT J ELEC POWER, V60, P126, DOI 10.1016/j.ijepes.2014.02.027; Yann LeCun, 2015, Nature, V521, P436, DOI 10.1038/nature14539	25	1	1	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157028	10.1371/journal.pone.0157028	http://dx.doi.org/10.1371/journal.pone.0157028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281032	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000070
J	Mosquera, T; Alvarez, MF; Jimenez-Gomez, JM; Muktar, MS; Paulo, MJ; Steinemann, S; Li, JQ; Draffehn, A; Hofmann, A; Lubeck, J; Strahwald, J; Tacke, E; Hofferbert, HR; Walkemeier, B; Gebhardt, C				Mosquera, Teresa; Fernanda Alvarez, Maria; Jimenez-Gomez, Jose M.; Muktar, Meki Shehabu; Paulo, Maria Joao; Steinemann, Sebastian; Li, Jinquan; Draffehn, Astrid; Hofmann, Andrea; Luebeck, Jens; Strahwald, Josef; Tacke, Eckhard; Hofferbert, Hans-Reinhardt; Walkemeier, Birgit; Gebhardt, Christiane			Targeted and Untargeted Approaches Unravel Novel Candidate Genes and Diagnostic SNPs for Quantitative Resistance of the Potato (Solanum tuberosum L.) to Phytophthora infestans Causing the Late Blight Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BROAD-SPECTRUM RESISTANCE; A REDUCTASE GENES; ARABIDOPSIS-THALIANA; FIELD-RESISTANCE; TRAIT LOCI; R-GENE; PATHOGEN RESISTANCE; CULTIVATED POTATO; TETRAPLOID POTATO	The oomycete Phytophthora infestans causes late blight of potato, which can completely destroy the crop. Therefore, for the past 160 years, late blight has been the most important potato disease worldwide. The identification of cultivars with high and durable field resistance to P. infestans is an objective of most potato breeding programs. This type of resistance is polygenic and therefore quantitative. Its evaluation requires multi-year and location trials. Furthermore, quantitative resistance to late blight correlates with late plant maturity, a negative agricultural trait. Knowledge of the molecular genetic basis of quantitative resistance to late blight not compromised by late maturity is very limited. It is however essential for developing diagnostic DNA markers that facilitate the efficient combination of superior resistance alleles in improved cultivars. We used association genetics in a population of 184 tetraploid potato cultivars in order to identify single nucleotide polymorphisms (SNPs) that are associated with maturity corrected resistance (MCR) to late blight. The population was genotyped for almost 9000 SNPs from three different sources. The first source was candidate genes specifically selected for their function in the jasmonate pathway. The second source was novel candidate genes selected based on comparative transcript profiling (RNA-Seq) of groups of genotypes with contrasting levels of quantitative resistance to P. infestans. The third source was the first generation 8.3k SolCAP SNP genotyping array available in potato for genome wide association studies (GWAS). Twenty seven SNPs from all three sources showed robust association with MCR. Some of those were located in genes that are strong candidates for directly controlling quantitative resistance, based on functional annotation. Most important were: a lipoxygenase (jasmonate pathway), a 3-hydroxy- 3-methylglutaryl coenzyme A reductase (mevalonate pathway), a P450 protein (terpene biosynthesis), a transcription factor and a homolog of a major gene for resistance to P. infestans from the wild potato species Solanum venturii. The candidate gene approach and GWAS complemented each other as they identified different genes. The results of this study provide new insight in the molecular genetic basis of quantitative resistance in potato and a toolbox of diagnostic SNP markers for breeding applications.	[Mosquera, Teresa; Fernanda Alvarez, Maria; Jimenez-Gomez, Jose M.; Muktar, Meki Shehabu; Steinemann, Sebastian; Li, Jinquan; Draffehn, Astrid; Walkemeier, Birgit; Gebhardt, Christiane] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Mosquera, Teresa; Fernanda Alvarez, Maria] Univ Nacl Colombia, Fac Agr Sci, Bogota, Colombia; [Paulo, Maria Joao] Wageningen Univ, Biometris, NL-6700 AP Wageningen, Netherlands; [Hofmann, Andrea] Univ Bonn, Inst Human Genet, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Luebeck, Jens; Strahwald, Josef] SaKa Pflanzenzucht GmbH & Co KG, D-24340 Windeby, Germany; [Tacke, Eckhard] Bioplant GmbH, Ebstorf, Germany; [Hofferbert, Hans-Reinhardt] Bohm Nordkartoffel Agrarprod GbR, Ebstorf, Germany; [Jimenez-Gomez, Jose M.] Univ Paris Saclay, AgroParis Tech, CNRS, Inst Jean Pierre Bourgin,INRA, Versailles, France	Max Planck Society; Universidad Nacional de Colombia; Wageningen University & Research; University of Bonn; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gebhardt, C (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany.	gebhardt@mpipz.mpg.de	Gebhardt, Chris/HGD-6090-2022; Muktar, Meki/AAJ-1732-2020; Alvarez, Maria/GZH-1345-2022	Muktar, Meki/0000-0003-4750-8031; Mosquera, Teresa/0000-0003-4854-1079; Caldas Paulo, Maria Joao/0000-0002-4180-0763; Jimenez-Gomez, Jose M/0000-0002-5033-7192	German Federal Ministry of Education and Research [0315065]; International Development Research Centre (IDRC); Department of Foreign Affairs, Trade and Development (DFATD) from Canada through the Canadian International Food Security Research Fund; Max-Planck Society	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); International Development Research Centre (IDRC); Department of Foreign Affairs, Trade and Development (DFATD) from Canada through the Canadian International Food Security Research Fund; Max-Planck Society(Max Planck Society)	This work was funded by the German Federal Ministry of Education and Research under the GABI (_g_enome_a_nalysis in the_bi_ological system plant) program (grant No. 0315065, PAPATOMICS), by the International Development Research Centre (IDRC) and Department of Foreign Affairs, Trade and Development (DFATD) from Canada through the Canadian International Food Security Research Fund, and the Max-Planck Society. The breeding companies SaKa-Pflanzenzucht GmbH & Co. KG, Windeby, Germany, Bohm-Nordkartoffel Agrarproduktion GbR, Ebstorf, Germany, and Bioplant GmbH, Ebstorf, Germany, were partners in a collaborative research project that was funded by a public institution (The German Federal Ministry for Education and Research). The role of the companies in the project was the provision of plant material and phenotypic data from field experiments. The companies contributions were in part funded by the public institution (The German Federal Ministry for Education and Research) and in part by themselves, but not including salaries of JS, JL, H-RH and ET. The funders provided support in the form of salaries for authors MFA and AD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Ballvora A, 2001, MOL PLANT MICROBE IN, V14, P629, DOI 10.1094/MPMI.2001.14.5.629; Basso B, 1996, PLANT PHYSIOL, V110, P714; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Beketova MP, 2006, RUSS J PLANT PHYSL+, V53, P384, DOI 10.1134/S1021443706030149; Bogdanova EA, 2008, MOL BIOSYST, V4, P205, DOI 10.1039/b715110c; Bormann CA, 2004, MOL PLANT MICROBE IN, V17, P1126, DOI 10.1094/MPMI.2004.17.10.1126; Boutanaev AM, 2015, P NATL ACAD SCI USA, V112, pE81, DOI 10.1073/pnas.1419547112; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradshaw JE, 2004, GENETICS, V168, P983, DOI 10.1534/genetics.104.030056; Bradshaw JE, 2006, THEOR APPL GENET, V113, P943, DOI 10.1007/s00122-006-0353-8; Brenner ED, 1998, PLANT PHYSIOL, V118, P237, DOI 10.1104/pp.118.1.237; Brouwer DJ, 2004, GENOME, V47, P475, DOI 10.1139/G04-001; Brouwer DJ, 2004, THEOR APPL GENET, V108, P628, DOI 10.1007/s00122-003-1469-8; Chen KM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-43; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; CHOI D, 1992, PLANT CELL, V4, P1333, DOI 10.1105/tpc.4.10.1333; Collins A, 1999, MOL BREEDING, V5, P387, DOI 10.1023/A:1009601427062; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; COLON LT, 1995, EUR J PLANT PATHOL, V101, P387, DOI 10.1007/BF01874852; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; Mondego JMC, 2011, PLANTA, V233, P123, DOI 10.1007/s00425-010-1284-9; Costanzo S, 2005, THEOR APPL GENET, V111, P609, DOI 10.1007/s00122-005-2053-1; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; Danan S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-16; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dhaubhadel S, 2005, J EXP BOT, V56, P2335, DOI 10.1093/jxb/eri226; Diaz M, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue1-fulltext-3; Douches D, 2014, POTATO RES, V57, P215, DOI 10.1007/s11540-014-9267-z; Draffehn AM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00423; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ECKES P, 1986, MOL GEN GENET, V205, P14, DOI 10.1007/BF02428027; El-Kasmi F, 2011, PLANT J, V66, P268, DOI 10.1111/j.1365-313X.2011.04487.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing EE, 2000, MOL BREEDING, V6, P25, DOI 10.1023/A:1009648408198; Farmaki T, 2007, J EXP BOT, V58, P555, DOI 10.1093/jxb/erl230; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Fidantsef AL, 1998, PHYSIOL PLANTARUM, V102, P257, DOI 10.1034/j.1399-3054.1998.1020214.x; Fischer M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-113; Foster SJ, 2009, MOL PLANT MICROBE IN, V22, P589, DOI 10.1094/MPMI-22-5-0589; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; FRY WE, 1978, PHYTOPATHOLOGY, V68, P1650, DOI 10.1094/Phyto-68-1650; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; Ghislain M, 2001, THEOR APPL GENET, V103, P433, DOI 10.1007/s00122-001-0545-1; Glaczinski H, 2002, POTATO RES, V45, P163, DOI 10.1007/BF02736112; Gunnewich N, 2013, PHYTOCHEMISTRY, V91, P93, DOI 10.1016/j.phytochem.2012.07.019; Gyetvai G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031526; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HERMANS J, 1988, PLANT MOL BIOL, V10, P323, DOI 10.1007/BF00029882; Hrmova M, 2001, PLANT MOL BIOL, V47, P73, DOI 10.1023/A:1010619128894; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Jo KR, 2015, THEOR APPL GENET, V128, P931, DOI 10.1007/s00122-015-2480-6; Jo KR, 2011, THEOR APPL GENET, V123, P1331, DOI 10.1007/s00122-011-1670-0; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Kollas AK, 2002, FEBS LETT, V532, P432, DOI 10.1016/S0014-5793(02)03725-0; Kolomiets MV, 2000, PLANT PHYSIOL, V124, P1121, DOI 10.1104/pp.124.3.1121; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Kushalappa AC, 2013, TRENDS PLANT SCI, V18, P522, DOI 10.1016/j.tplants.2013.05.002; Lascombe MB, 2008, PROTEIN SCI, V17, P1522, DOI 10.1110/ps.035972.108; LEONARDSSCHIPPERS C, 1994, GENETICS, V137, P67; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li JC, 2012, THEOR APPL GENET, V124, P1339, DOI 10.1007/s00122-012-1791-0; Li L, 2005, GENETICS, V170, P813, DOI 10.1534/genetics.104.040006; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2008, THEOR APPL GENET, V116, P1167, DOI 10.1007/s00122-008-0746-y; Lindqvist-Kreuze H, 2014, PHYTOPATHOLOGY, V104, P624, DOI 10.1094/PHYTO-10-13-0270-R; Lokossou AA, 2009, MOL PLANT MICROBE IN, V22, P630, DOI 10.1094/MPMI-22-6-0630; Lu W, 2012, GENE, V503, P65, DOI 10.1016/j.gene.2012.04.042; Madsen DK, 2006, AM J POTATO RES, V83, P349, DOI 10.1007/BF02871596; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Marcos R, 2015, PLANT PHYSIOL, V169, P2324, DOI 10.1104/pp.15.00992; MASON HS, 1988, PLANT MOL BIOL, V11, P845, DOI 10.1007/BF00019524; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Miernyk JA, 2001, CELL STRESS CHAPERON, V6, P209, DOI 10.1379/1466-1268(2001)006<0209:TJDPOA>2.0.CO;2; Muktar MS, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00294; MUSGROVE JE, 1986, PHILOS T ROY SOC B, V313, P419, DOI 10.1098/rstb.1986.0048; Oberhagemann P, 1999, MOL BREEDING, V5, P399, DOI 10.1023/A:1009623212180; Odeny DA, 2010, PLANT CELL ENVIRON, V33, P2149, DOI 10.1111/j.1365-3040.2010.02213.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pajerowska KM, 2005, MOL PLANT MICROBE IN, V18, P1107, DOI 10.1094/MPMI-18-1107; Pajerowska-Mukhtar K, 2009, GENETICS, V181, P1115, DOI 10.1534/genetics.108.094268; Pajerowska-Mukhtar KM, 2008, PLANTA, V228, P293, DOI 10.1007/s00425-008-0737-x; Park TH, 2005, MOL PLANT MICROBE IN, V18, P722, DOI 10.1094/MPMI-18-0722; Pel MA, 2009, MOL PLANT MICROBE IN, V22, P601, DOI 10.1094/MPMI-22-5-0601; Pritchard JK, 2000, GENETICS, V155, P945; Qiao Y, 2009, MOL PLANT MICROBE IN, V22, P1523, DOI 10.1094/MPMI-22-12-1523; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Rapala-Kozik M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-2; Rauscher G, 2010, THEOR APPL GENET, V121, P1553, DOI 10.1007/s00122-010-1410-x; Revenkova E, 1999, INVOLVEMENT ARABIDOP, P490; Rickert AM, 2003, PLANT BIOTECHNOL J, V1, P399, DOI 10.1046/j.1467-7652.2003.00036.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Royo J, 1996, J BIOL CHEM, V271, P21012, DOI 10.1074/jbc.271.35.21012; Sade D, 2015, METABOLOMICS, V11, P81, DOI 10.1007/s11306-014-0670-x; Sandbrink JM, 2000, MOL BREEDING, V6, P215, DOI 10.1023/A:1009697318518; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; SCHWARTZ E, 1991, PLANT MOL BIOL, V17, P923, DOI 10.1007/BF00037074; Sharma R, 2014, SCI HORTIC-AMSTERDAM, V179, P204, DOI 10.1016/j.scienta.2014.09.018; Sharma SK, 2013, G3-GENES GENOM GENET, V3, P2031, DOI 10.1534/g3.113.007153; Simko I, 2006, PLANT BREEDING, V125, P385, DOI 10.1111/j.1439-0523.2006.01232.x; Singh B, 2013, GENE, V532, P177, DOI 10.1016/j.gene.2013.09.078; Sliwka J, 2007, THEOR APPL GENET, V115, P101, DOI 10.1007/s00122-007-0546-9; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Sorensen KK, 2006, PLANT BREEDING, V125, P268, DOI 10.1111/j.1439-0523.2006.01219.x; Stich B, 2013, PLANT BREEDING, V132, P718, DOI 10.1111/pbr.12102; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tamburrini M, 2005, PROTEIN J, V24, P423, DOI 10.1007/s10930-005-7638-7; Tchorzewski M, 2000, BBA-MOL CELL RES, V1499, P63, DOI 10.1016/S0167-4889(00)00108-7; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Urbany C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-7; Vadassery J, 2009, PLANT SIGNAL BEHAV, V4, P1024, DOI 10.4161/psb.4.11.9800; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; Van Lijsebettens M, 2014, TRENDS PLANT SCI, V19, P717, DOI 10.1016/j.tplants.2014.07.002; Vazquez-Flota FA, 1998, PLANT PHYSIOL, V117, P1351, DOI 10.1104/pp.117.4.1351; Villamon FG, 2005, THEOR APPL GENET, V111, P1201, DOI 10.1007/s00122-005-0053-9; Visker MHPW, 2005, EUPHYTICA, V143, P189, DOI 10.1007/s10681-005-3444-8; Visker MHPW, 2003, THEOR APPL GENET, V106, P317, DOI 10.1007/s00122-002-1021-2; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; VSN INTERNATIONAL, 2014, GENSTAT WINDOWS; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; Wastie R., 1991, ADV PLANT PATHOL, V7, P193; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; YANG ZB, 1991, PLANT CELL, V3, P397, DOI 10.1105/tpc.3.4.397; Yin Y, 2010, GLYCOSYLTRANSFERASES, P167; Yogendra KN, 2015, J EXP BOT, V66, P7377, DOI 10.1093/jxb/erv434; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhang CZ, 2014, THEOR APPL GENET, V127, P1353, DOI 10.1007/s00122-014-2303-1; Zhang ZW, 2009, BRIEF BIOINFORM, V10, P664, DOI 10.1093/bib/bbp050; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	145	36	40	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156254	10.1371/journal.pone.0156254	http://dx.doi.org/10.1371/journal.pone.0156254			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281327	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000022
J	Davido, B; Saleh-Mghir, A; Laurent, F; Danel, C; Couzon, F; Gatin, L; Vandenesch, F; Rasigade, JP; Cremieux, AC				Davido, Benjamin; Saleh-Mghir, Azzam; Laurent, Frederic; Danel, Claire; Couzon, Florence; Gatin, Laure; Vandenesch, Francois; Rasigade, Jean-Philippe; Cremieux, Anne-Claude			Phenol-Soluble Modulins Contribute to Early Sepsis Dissemination Not Late Local USA300-Osteomyelitis Severity in Rabbits	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; VIRULENCE DETERMINANTS; JOINT INFECTIONS; OSTEOMYELITIS; MODEL; BONE; CHILDREN; SURVIVAL	Introduction In bone and joint infections (BJIs), bacterial toxins are major virulence factors: Panton-Valentine leukocidin (PVL) expression leads to severe local damage, including bone distortion and abscesses, while alpha-hemolysin (Hla) production is associated with severe sepsis-related mortality. Recently, other toxins, namely phenol-soluble modulins (PSMs) expressed by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain USA300 (LAC WT) were shown to have ex vivo intracellular cytotoxic activity after S. aureus invasion of osteoblasts, but their in vivo contribution in a relatively PVL-sensitive osteomyelitis model remains poorly elucidated. Materials and Methods We compared the outcomes of experimental rabbit osteomyelitises induced with pvl(+)hla(+-) psms(+) LAC WT and its isogenic Delta psm derivatives (LAC Delta psm alpha and LAC Delta psm alpha beta hld) using an inoculum of 3 x 10(8) CFUs. Mortality, hematogenous spread (blood culture, spleen and kidney), lung and bone involvements were assessed in two groups (non-survivors of severe sepsis and survivors sacrificed on day (D) 14). Results Severe sepsis-related mortality tended to be lower for Delta psm derivatives (Kaplan-Meier curves, P =.06). Non-survivors' bone LAC-Delta psm alpha (6.9 log(10) CFUs/g of bone, P =.04) or -Delta psm alpha beta hld (6.86 log(10) CFUs/g of bone, P =.014) densities were significantly higher than LAC WT (6.43 log(10) CFUs/g of bone). Conversely, lung Delta psm alpha beta hld CFUs were significantly lower than LAC WT (P =.04). LAC Delta psm alpha, Delta psm alpha beta hld and WT induced similar bone damage in D14 survivors, with comparable bacterial densities (respectively: 5.89, 5.91, and 6.15 log(10) CFUs/g of bone). Meanwhile, pulmonary histological scores of inflammation were significantly higher for LAC Delta psm alpha- and Delta psm alpha beta hld-infected rabbits compared to LAC WT (P =.04 and .01, respectively) but with comparable lung bacterial densities. Conclusion Our experimental results showed that deactivating PSM peptides significantly limited bacterial dissemination from bone during the early phase of infection, but did not affect local severity of USA300 rabbit osteomyelitis.	[Davido, Benjamin; Saleh-Mghir, Azzam; Gatin, Laure; Cremieux, Anne-Claude] Hop Raymond Poincare, AP HP, Dept Med Aigue Specialisee, Garches, France; [Davido, Benjamin; Saleh-Mghir, Azzam; Gatin, Laure; Cremieux, Anne-Claude] Univ Versailles St Quentin, Fac Med Paris Ile de France Ouest, EA 3647, Versailles, France; [Laurent, Frederic; Couzon, Florence; Vandenesch, Francois; Rasigade, Jean-Philippe] Univ Lyon 1, Int Ctr Infectiol Res, Inserm U1111, ENS Lyon,CNRS UMR5308,Hosp Civils Lyon,CIRI, F-69365 Lyon, France; [Danel, Claire] UFR Med Paris 7, Dept Pathol, Site Bichat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Davido, B (corresponding author), Hop Raymond Poincare, AP HP, Dept Med Aigue Specialisee, Garches, France.; Davido, B (corresponding author), Univ Versailles St Quentin, Fac Med Paris Ile de France Ouest, EA 3647, Versailles, France.	benjamin.davido@aphp.fr	Crémieux, A/AAP-9147-2020; LAURENT, Frederic/AGM-0706-2022; Rasigade, Jean-Philippe/AAE-1667-2021; Vandenesch, Francois/C-7209-2014; Rasigade, Jean-Philippe/L-9320-2014	Vandenesch, Francois/0000-0001-9412-7106; Rasigade, Jean-Philippe/0000-0002-8264-0452; laurent, frederic/0000-0003-0609-9091	Raymond Poincare University Hospital; Raymond Poincare University Hospital and Infectious Diseases	Raymond Poincare University Hospital; Raymond Poincare University Hospital and Infectious Diseases	The authors thank the Raymond Poincare University Hospital and Infectious Diseases Colleagues: Aurore Lagrange and Aurelien Dinh for their support and Janet Jacobson for editorial assistance.	Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; Cassat JE, 2013, CELL HOST MICROBE, V13, P759, DOI 10.1016/j.chom.2013.05.003; Chen Y, 2015, J INFECT DIS, V211, P472, DOI 10.1093/infdis/jiu462; Cremieux AC, 2014, J INFECT DIS, V209, P1773, DOI 10.1093/infdis/jit840; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Deplanche M, 2015, FASEB J, V29, P1950, DOI 10.1096/fj.14-260513; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Horewicz VV, 2015, EUR J PHARMACOL, V746, P267, DOI 10.1016/j.ejphar.2014.11.026; Hua L, 2015, ANTIMICROB AGENTS CH, V59, P4526, DOI 10.1128/AAC.00510-15; Iwamoto M, 2013, PEDIATRICS, V132, pE817, DOI 10.1542/peds.2013-1112; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Periasamy Saravanan, 2012, Commun Integr Biol, V5, P275, DOI 10.4161/cib.19420; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Rasigade JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063176; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Spaulding AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00018; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; Valentino MD, 2014, MBIO, V5, DOI 10.1128/mBio.01729-14; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Vardakas KZ, 2013, EUR J CLIN MICROBIOL, V32, P711, DOI 10.1007/s10096-012-1807-3; Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wilde AD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005341	35	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157133	10.1371/journal.pone.0157133	http://dx.doi.org/10.1371/journal.pone.0157133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275944	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700071
J	Jakob, RP; Schmidpeter, PAM; Koch, JR; Schmid, FX; Maier, T				Jakob, Roman P.; Schmidpeter, Philipp A. M.; Koch, Johanna R.; Schmid, Franz X.; Maier, Timm			Structural and Functional Characterization of a Novel Family of Cyclophilins, the AquaCyps	PLOS ONE			English	Article							PEPTIDYL-PROLYL ISOMERASE; CIS-TRANS ISOMERASES; ACTIVE-SITE MUTANTS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CIS/TRANS ISOMERASES; BINDING-PROTEIN; CHAPERONE; SEQUENCE; VIRULENCE	Cyclophilins are ubiquitous cis-trans-prolyl isomerases (PPIases) found in all kingdoms of life. Here, we identify a novel family of cyclophilins, termed AquaCyps, which specifically occurs in marine Alphaproteobacteria, but not in related terrestric species. In addition to a canonical PPIase domain, AquaCyps contain large extensions and insertions. The crystal structures of two representatives from Hirschia baltica, AquaCyp293 and AquaCyp300, reveal the formation of a compact domain, the NIC domain, by the N- and C-terminal extensions together with a central insertion. The NIC domain adopts a novel mixed alpha-helical, beta-sheet fold that is linked to the cyclophilin domain via a conserved disulfide bond. In its overall fold, AquaCyp293 resembles AquaCyp300, but the two proteins utilize distinct sets of active site residues, consistent with differences in their PPIase catalytic properties. While AquaCyp293 is a highly active general PPIase, AquaCyp300 is specific for hydrophobic substrate peptides and exhibits lower overall activity.	[Jakob, Roman P.; Maier, Timm] Univ Basel, Dept Biozentrum, CH-4056 Basel, Switzerland; [Schmidpeter, Philipp A. M.; Koch, Johanna R.; Schmid, Franz X.] Univ Bayreuth, Biochem Lab, POB 101251, D-95440 Bayreuth, Germany; [Schmidpeter, Philipp A. M.; Koch, Johanna R.; Schmid, Franz X.] Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, POB 101251, D-95440 Bayreuth, Germany	University of Basel; University of Bayreuth; University of Bayreuth	Jakob, RP; Maier, T (corresponding author), Univ Basel, Dept Biozentrum, CH-4056 Basel, Switzerland.	roman.jakob@unibas.ch; timm.maier@unibas.ch	Schmidpeter, Philipp/Q-5540-2019	Schmidpeter, Philipp/0000-0003-2871-9706; Jakob, Roman/0000-0002-6451-8656	Swiss National Science Foundation [R'EQUIP 145023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (R'EQUIP 145023).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andreeva L, 1999, INT J EXP PATHOL, V80, P305, DOI 10.1046/j.1365-2613.1999.00128.x; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Budiman C, 2011, PROTEIN SCI, V20, P1755, DOI 10.1002/pro.714; Chakraborty A, 2002, J BIOL CHEM, V277, P47451, DOI 10.1074/jbc.M204827200; Chen MM, 2011, MOL PLANT PATHOL, V12, P239, DOI 10.1111/j.1364-3703.2010.00665.x; Chertkov O, 2011, STAND GENOMIC SCI, V5, P287, DOI 10.4056/sigs.2205004; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; COMPTON LA, 1992, EUR J BIOCHEM, V206, P927, DOI 10.1111/j.1432-1033.1992.tb17002.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Edwards KJ, 1997, J MOL BIOL, V271, P258, DOI 10.1006/jmbi.1997.1151; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; HACKER J, 1993, MOL MICROBIOL, V10, P445, DOI 10.1111/j.1365-2958.1993.tb00917.x; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; Hoffmann H, 2014, BIOL CHEM, V395, P721, DOI 10.1515/hsz-2014-0125; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ivery MTG, 2000, MED RES REV, V20, P452, DOI 10.1002/1098-1128(200011)20:6<452::AID-MED2>3.0.CO;2-6; Jackson SE, 2013, TOP CURR CHEM, V328, P35, DOI 10.1007/128_2011_151; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jakob RP, 2015, J BIOL CHEM, V290, P3278, DOI 10.1074/jbc.M114.622910; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KE HM, 1991, P NATL ACAD SCI USA, V88, P9483, DOI 10.1073/pnas.88.21.9483; KE HM, 1992, J MOL BIOL, V228, P539, DOI 10.1016/0022-2836(92)90841-7; Kim IS, 2010, J MICROBIOL BIOTECHN, V20, P974, DOI 10.4014/jmb.0911.11005; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Marin-Menendez A, 2011, PROTEIN EXPRES PURIF, V78, P225, DOI 10.1016/j.pep.2011.04.012; Mayr LM, 1996, BIOCHEMISTRY-US, V35, P5550, DOI 10.1021/bi953035y; MAYR LM, 1993, J MOL BIOL, V231, P897, DOI 10.1006/jmbi.1993.1336; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mok D, 2006, FEBS LETT, V580, P2761, DOI 10.1016/j.febslet.2006.04.039; Moparthi SB, 2009, PROTEIN SCI, V18, P475, DOI 10.1002/pro.28; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Phadke ND, 2001, PROTEOMICS, V1, P705, DOI 10.1002/1615-9861(200104)1:5<705::AID-PROT705>3.3.CO;2-E; RAHFELD JU, 1994, FEBS LETT, V352, P180, DOI 10.1016/0014-5793(94)00932-5; Reffuveille F, 2012, INFECT IMMUN, V80, P1728, DOI 10.1128/IAI.06251-11; Riboldi-Tunnicliffe A, 2001, NAT STRUCT BIOL, V8, P779, DOI 10.1038/nsb0901-779; Saphire ACS, 2000, IMMUNOL RES, V21, P211, DOI 10.1385/IR:21:2-3:211; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schiene-Fischer C, 2015, BBA-GEN SUBJECTS, V1850, P2005, DOI 10.1016/j.bbagen.2014.11.012; SCHLESNER H, 1990, INT J SYST BACTERIOL, V40, P443, DOI 10.1099/00207713-40-4-443; Schmid FX, 1996, BIOL CHEM, V377, P417; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Scholz C, 1997, FEBS LETT, V414, P69, DOI 10.1016/S0014-5793(97)00979-4; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P1634, DOI 10.1128/AEM.02512-07; Taylor P, 2001, STRUCTURE, V9, P431, DOI 10.1016/S0969-2126(01)00603-7; Viaud MC, 2002, PLANT CELL, V14, P917, DOI 10.1105/tpc.010389; Wang P, 2001, EMBO REP, V2, P511, DOI 10.1093/embo-reports/kve109; WEBER C, 1991, BIOCHEMISTRY-US, V30, P6563, DOI 10.1021/bi00240a029; Zhang XC, 2013, FEBS LETT, V587, P666, DOI 10.1016/j.febslet.2013.01.028; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	79	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157070	10.1371/journal.pone.0157070	http://dx.doi.org/10.1371/journal.pone.0157070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276069	Green Published, Green Accepted, gold			2022-12-26	WOS:000377561700066
J	Perland, E; Lekholm, E; Eriksson, MM; Bagchi, S; Arapi, V; Fredriksson, R				Perland, Emelie; Lekholm, Emilia; Eriksson, Mikaela M.; Bagchi, Sonchita; Arapi, Vasiliki; Fredriksson, Robert			The Putative SLC Transporters Mfsd5 and Mfsd11 Are Abundantly Expressed in the Mouse Brain and Have a Potential Role in Energy Homeostasis	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; AMINO-ACID; GENE-EXPRESSION; PROTEINS; SYSTEM; IDENTIFICATION; AMYGDALA; NEURONS; GROWTH; SENSOR	Background Solute carriers (SLCs) are membrane bound transporters responsible for the movement of soluble molecules such as amino acids, ions, nucleotides, neurotransmitters and oligopeptides over cellular membranes. At present, there are 395 SLCs identified in humans, where about 40% are still uncharacterized with unknown expression and/or function(s). Here we have studied two uncharacterized atypical SLCs that belong to the Major Facilitator Superfamily Pfam clan, Major facilitator superfamily domain 5 (MFSD5) and Major facilitator superfamily domain 11 (MFSD11). We provide fundamental information about the histology in mice as well as data supporting their disposition to regulate expression levels to keep the energy homeostasis. Results In mice subjected to starvation or high-fat diet, the mRNA expression of Mfsd5 was significantly down-regulated (P<0.001) in food regulatory brain areas whereas Mfsd11 was significantly up-regulated in mice subjected to either starvation (P<0.01) or high-fat diet (P< 0.001). qRT-PCR analysis on wild type tissues demonstrated that both Mfsd5 and Mfsd11 have a wide central and peripheral mRNA distribution, and immunohistochemistry was utilized to display the abundant protein expression in the mouse embryo and the adult mouse brain. Both proteins are expressed in excitatory and inhibitory neurons, but not in astrocytes. Conclusions Mfsd5 and Mfsd11 are both affected by altered energy homeostasis, suggesting plausible involvement in the energy regulation. Moreover, the first histological mapping of MFSD5 and MFSD11 shows ubiquitous expression in the periphery and the central nervous system of mice, where the proteins are expressed in excitatory and inhibitory mouse brain neurons.	[Perland, Emelie; Lekholm, Emilia] Uppsala Univ, Dept Neurosci, Unit Funct Pharmacol, Uppsala, Sweden; [Eriksson, Mikaela M.; Bagchi, Sonchita; Arapi, Vasiliki; Fredriksson, Robert] Uppsala Univ, Dept Pharmaceut Biosci, Unit Mol Neuropharmacol, Uppsala, Sweden	Uppsala University; Uppsala University	Fredriksson, R (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Unit Mol Neuropharmacol, Uppsala, Sweden.	Robert.Fredriksson@farmbio.uu.se		Fredriksson, Robert/0000-0002-2810-3226; Lekholm, Emilia/0000-0001-8135-9127; Ceder, Mikaela/0000-0002-9681-5129; Perland, Emelie/0000-0001-6672-2442	Swedish Research Council; Swedish Brain Foundation; Swedish Society for Medical Research; Novo Nordisk foundation; Ahlens foundation; Engkvist Foundation; Thurings Foundation for metabolic research; Gunvor and Josef Aners foundation; Tore Nilssons foundation; Science for Life Lab BioVis Platform, Uppsala	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Swedish Society for Medical Research; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Ahlens foundation; Engkvist Foundation; Thurings Foundation for metabolic research; Gunvor and Josef Aners foundation; Tore Nilssons foundation; Science for Life Lab BioVis Platform, Uppsala	This study was supported by the Swedish Research Council, The Swedish Brain Foundation, The Swedish Society for Medical Research, The Novo Nordisk foundation, Ahlens foundation, Engkvist Foundation, Thurings Foundation for metabolic research, Gunvor and Josef Aners foundation and Tore Nilssons foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have received funding from the Novo Nordisk Fondation, which is not a commercial source, but a non-profit foundation.; We wish to express special thanks to Mona Bushra and Johanna Lundgren for their assistance with preparations of the experiments and to Matyas Molnar for his microscopy expertise. Imaging was performed with support of the Science for Life Lab BioVis Platform, Uppsala. Further, we wish to thank Michael J. Williams for critically reading the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Bagchi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095438; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; BioParadigms, 2016, SLC TABL; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Cellier Mathieu F M, 2013, Biology (Basel), V2, P233, DOI 10.3390/biology2010233; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hellsten SV, 2016, THESIS ACTA U UPSALI; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KIZER JS, 1976, BRAIN RES, V108, P363, DOI 10.1016/0006-8993(76)90192-X; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Liao XH, 2008, AMINO ACIDS, V35, P761, DOI 10.1007/s00726-008-0100-3; Manns ID, 2001, NEUROSCIENCE, V107, P249, DOI 10.1016/S0306-4522(01)00302-5; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palii SS, 2009, AMINO ACIDS, V37, P79, DOI 10.1007/s00726-008-0199-2; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paxinos G., 2007, MOUSE BRAIN STEREOTA, V3rd Edn; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Qian ZHANG, 2011, [Frontiers in Biology, 生物学前沿], V6, P82; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taka S, 2013, INFECT GENET EVOL, V17, P8, DOI 10.1016/j.meegid.2013.03.033; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Van der Gucht E, 2003, BRAIN RES, V988, P29, DOI 10.1016/S0006-8993(03)03332-8; van Zessen R, 2012, P NUTR SOC, V71, P435, DOI 10.1017/S0029665112000614; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	51	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156912	10.1371/journal.pone.0156912	http://dx.doi.org/10.1371/journal.pone.0156912			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272503	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561000047
J	Ristivojevic, P; Dimkic, I; Trifkovic, J; Beric, T; Vovk, I; Milojkovic-Opsenica, D; Stankovic, S				Ristivojevic, Petar; Dimkic, Ivica; Trifkovic, Jelena; Beric, Tanja; Vovk, Irena; Milojkovic-Opsenica, Dusanka; Stankovic, Slavisa			Antimicrobial Activity of Serbian Propolis Evaluated by Means of MIC, HPTLC, Bioautography and Chemometrics	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; CHEMICAL-COMPOSITION; PHENOLIC-COMPOUNDS; IMAGE-ANALYSIS; BACTERIA; GROWTH; REGIONS; ACIDS	New information has come to light about the biological activity of propolis and the quality of natural products which requires a rapid and reliable assessment method such as High Performance Thin-Layer Chromatography (HPTLC) fingerprinting. This study investigates chromatographic and chemometric approaches for determining the antimicrobial activity of propolis of Serbian origin against various bacterial species. A linear multivariate calibration technique, using Partial Least Squares, was used to extract the relevant information from the chromatographic fingerprints, i.e. to indicate peaks which represent phenolic compounds that are potentially responsible for the antimicrobial capacity of the samples. In addition, direct bioautography was performed to localize the antibacterial activity on chromatograms. The biological activity of the propolis samples against various bacterial species was determined by a minimum inhibitory concentration assay, confirming their affiliation with the European poplar type of propolis and revealing the existence of two types (blue and orange) according to botanical origin. The strongest antibacterial activity was exhibited by sample 26 against Staphylococcus aureus, with a MIC value of 0.5 mg/mL, and Listeria monocytogenes, with a MIC as low as 0.1 mg/mL, which was also the lowest effective concentration observed in our study. Generally, the orange type of propolis shows higher antimicrobial activity compared to the blue type. PLS modelling was performed on the HPTLC data set and the resulting models might qualitatively indicate compounds that play an important role in the activity exhibited by the propolis samples. The most relevant peaks influencing the antimicrobial activity of propolis against all bacterial strains were phenolic compounds at RF values of 0.37, 0.40, 0.45, 0.51, 0.60 and 0.70. The knowledge gained through this study could be important for attributing the antimicrobial activity of propolis to specific chemical compounds, as well as the verification of HPTLC fingerprinting as a reliable method for the identification of compounds that are potentially responsible for antimicrobial activity. This is the first report on the activity of Serbian propolis as determined by several combined methods, including the modelling of antimicrobial activity by HPTLC fingerprinting.	[Ristivojevic, Petar] Univ Belgrade, Innovat Ctr, Fac Chem Ltd, Belgrade, Serbia; [Dimkic, Ivica; Beric, Tanja; Stankovic, Slavisa] Univ Belgrade, Fac Biol, Dept Microbiol, Belgrade, Serbia; [Trifkovic, Jelena; Milojkovic-Opsenica, Dusanka] Univ Belgrade, Fac Chem, Dept Analyt Chem, Belgrade, Serbia; [Vovk, Irena] Natl Inst Chem, Food Chem Lab, Ljubljana, Slovenia	University of Belgrade; University of Belgrade; University of Belgrade; National Institute of Chemistry - Slovenia	Stankovic, S (corresponding author), Univ Belgrade, Fac Biol, Dept Microbiol, Belgrade, Serbia.	slavisas@bio.bg.ac.rs	Stanković, Slaviša/S-6273-2018; Dimkić, Ivica/AAE-1508-2019; Milojkovic-Opsenica, Dusanka/M-5726-2013; Trifković, Jelena/Q-3985-2016; Ristivojevic, Petar/R-6512-2016; Beric, Tanja/GLR-4901-2022; Dimkic, Ivica/GWR-2445-2022	Stanković, Slaviša/0000-0003-0527-8741; Milojkovic-Opsenica, Dusanka/0000-0001-6274-4222; Trifković, Jelena/0000-0002-8866-1991; Ristivojevic, Petar/0000-0001-6106-1454; Dimkic, Ivica/0000-0002-0425-5938; Beric, Tanja/0000-0002-4860-2225	Ministry of Education, Science and Technological Development of Serbia [172017, 173026]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia, Grants No. 172017 and 173026, http://www.mpn.gov.rs/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisard S, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/319240; Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244; Choma IM, 2011, J CHROMATOGR A, V1218, P2684, DOI 10.1016/j.chroma.2010.12.069; D'Souza L, 2010, INDIAN J MAR SCI, V39, P294; Darwish RM, 2010, AFR J BIOTECHNOL, V9, P5966; Drago L, 2000, J CHEMOTHERAPY, V12, P390, DOI 10.1179/joc.2000.12.5.390; Du Toit K, 2009, S AFR J SCI, V105, P470; Dumarey M, 2008, J CHROMATOGR A, V1192, P81, DOI 10.1016/j.chroma.2008.03.052; Gatto MT, 2002, BIOORGAN MED CHEM, V10, P269, DOI 10.1016/S0968-0896(01)00275-9; Gomez-Caravaca AM, 2006, J PHARMACEUT BIOMED, V41, P1220, DOI 10.1016/j.jpba.2006.03.002; Kalogeropoulos N, 2009, FOOD CHEM, V116, P452, DOI 10.1016/j.foodchem.2009.02.060; Kareem AA, 2015, J CONTEMP MED SCI, V1, P6; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; Lou ZX, 2012, FOOD CONTROL, V25, P550, DOI 10.1016/j.foodcont.2011.11.022; Lu Jing, 2013, Acta Hydrobiologica Sinica, V37, P1128; Mercan N, 2006, ANN MICROBIOL, V56, P373, DOI 10.1007/BF03175035; Merkl R, 2010, CZECH J FOOD SCI, V28, P275, DOI 10.17221/132/2010-CJFS; Mirzoeva OK, 1997, MICROBIOL RES, V152, P239, DOI 10.1016/S0944-5013(97)80034-1; Morlock GE, 2014, J CHROMATOGR A, V1328, P104, DOI 10.1016/j.chroma.2013.12.053; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Nikaido H., 1996, ESCHERICHIA COLI SAL, P29; Pepeljnjak S, 2004, FEMS MICROBIOL LETT, V240, P111, DOI 10.1016/j.femsle.2004.09.018; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; Prasad VGNV, 2014, ASIAN PAC J TROP DIS, V4, P326, DOI DOI 10.1016/S2222-1808(14)60464-3; Ristivojevic P, 2015, NAT PROD COMMUN, V10, P1869; Ristivojevic P, 2015, PHYTOCHEM ANALYSIS, V26, P127, DOI 10.1002/pca.2544; Ristivojevic P, 2014, J CHEMOMETR, V28, P301, DOI 10.1002/cem.2592; Vaquero MJR, 2007, FOOD CONTROL, V18, P587, DOI 10.1016/j.foodcont.2006.02.005; Vaquero MJR, 2011, FOOD TECHNOL BIOTECH, V49, P83; Salatino A, 2011, NAT PROD REP, V28, P925, DOI 10.1039/c0np00072h; Sanpa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126886; Sarbu C, 2011, TALANTA, V85, P1112, DOI 10.1016/j.talanta.2011.05.030; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Shan SM, 2014, J PHARMACEUT BIOMED, V89, P76, DOI 10.1016/j.jpba.2013.10.030; Stepanovic S, 2003, MICROBIOL RES, V158, P353, DOI 10.1078/0944-5013-00215; Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08; Temiz A, 2011, TURK J BIOL, V35, P503, DOI 10.3906/biy-0908-22; Tistaert C, 2009, ANAL CHIM ACTA, V652, P189, DOI 10.1016/j.aca.2009.08.024; Tiwari BK, 2009, J AGR FOOD CHEM, V57, P5987, DOI 10.1021/jf900668n; Tukmechi A, 2010, BRAZ J MICROBIOL, V41, P1086, DOI [10.1590/S1517-83822010000400030, 10.1590/S1517-838220100004000030]; Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034; Vijay Kothari, 2011, Research in Biotechnology, V2, P20	43	49	49	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157097	10.1371/journal.pone.0157097	http://dx.doi.org/10.1371/journal.pone.0157097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272728	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000064
J	Kralova, J; Fabisik, M; Pokorna, J; Skopcova, T; Malissen, B; Brdicka, T				Kralova, Jarmila; Fabisik, Matej; Pokorna, Jana; Skopcova, Tereza; Malissen, Bernard; Brdicka, Tomas			The Transmembrane Adaptor Protein SCIMP Facilitates Sustained Dectin-1 Signaling in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; TOLL-LIKE RECEPTORS; FUNGAL-INFECTIONS; ANTIFUNGAL IMMUNITY; PATTERN-RECOGNITION; CANDIDA-ALBICANS; ERK ACTIVATION; MICE; INNATE	Transmembrane adaptor proteins are molecules specialized in recruiting cytoplasmic proteins to the proximity of the cell membrane as part of the signal transduction process. A member of this family, SLP65/SLP76, Csk-interacting membrane protein (SCIMP), recruits a complex of SLP65/SLP76 and Grb2 adaptor proteins, known to be involved in the activation of PLC gamma 1/2, Ras, and other pathways. SCIMP expression is restricted to antigen-presenting cells. In a previous cell line-based study, it was shown that, in B cells, SCIMP contributes to the reverse signaling in the immunological synapse, downstream of MHCII glycoproteins. There it mainly facilitates the activation of ERK MAP kinases. However, its importance for MHCII glycoprotein-dependent ERK signaling in primary B cells has not been analyzed. Moreover, its role in macrophages and dendritic cells has remained largely unknown. Here we present the results of our analysis of SCIMP-deficient mice. In these mice, we did not observe any defects in B cell signaling and B cell-dependent responses. On the other hand, we found that, in dendritic cells and macrophages, SCIMP expression is up-regulated after exposure to GM-CSF or the Dectin-1 agonist zymosan. Moreover, we found that SCIMP is strongly phosphorylated after Dectin-1 stimulation and that it participates in signal transduction downstream of this important pattern recognition receptor. Our analysis of SCIMP-deficient dendritic cells revealed that SCIMP specifically contributes to sustaining long-term MAP kinase signaling and cytokine production downstream of Dectin-1 because of an increased expression and sustained phosphorylation lasting at least 24 h after signal initiation.	[Kralova, Jarmila; Fabisik, Matej; Skopcova, Tereza; Brdicka, Tomas] Acad Sci Czech Republ, Lab Leukocyte Signaling, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic; [Pokorna, Jana] Acad Sci Czech Republ, Lab Mol Immunol, Inst Mol Genet, Prague 14220, Czech Republic; [Malissen, Bernard] Aix Marseille Univ UM2, INSERM US012, CNRS UMS3367, Ctr Immunophenom,PHENOMIN CIPHE, F-13288 Marseille, France	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Brdicka, T (corresponding author), Acad Sci Czech Republ, Lab Leukocyte Signaling, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic.	tomas.brdicka@img.cas.cz	Brdicka, Tomas/G-6205-2014; Fabisik, Matej/V-7224-2017; Kralova, Jarmila/G-3834-2014; Malissen, Bernard/AAK-4659-2020	Brdicka, Tomas/0000-0002-1560-4398; Fabisik, Matej/0000-0003-2347-245X; Kralova, Jarmila/0000-0003-3017-2666; Kralova, Jarmila/0000-0002-4735-8857; Malissen, Bernard/0000-0003-1340-9342	Czech Science Foundation (GACR) [P302/12/1712]; IMG ASCR [RVO 68378050]; Faculty of Science, Charles University, Prague; PHENOMIN CIPHE	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); IMG ASCR; Faculty of Science, Charles University, Prague; PHENOMIN CIPHE	This work was supported by Czech Science Foundation (GACR, Project P302/12/1712) and received institutional funding from IMG ASCR (RVO 68378050). The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by the Faculty of Science, Charles University, Prague.r Supported by PHENOMIN CIPHE.	Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; ANDRE P, 1994, J EXP MED, V179, P763, DOI 10.1084/jem.179.2.763; Barreto-Bergter E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00145; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Chatterjee P, 2012, J IMMUNOL, V188, P2695, DOI 10.4049/jimmunol.1101527; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Draber P, 2011, MOL CELL BIOL, V31, P4550, DOI 10.1128/MCB.05817-11; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Filler SG, 2005, CLIN INFECT DIS, V41, pS208, DOI 10.1086/430000; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jia XM, 2014, J EXP MED, V211, P2307, DOI 10.1084/jem.20132349; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Seo Beom-Seok, 2013, Immune Netw, V13, P205, DOI 10.4110/in.2013.13.5.205; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stepanek O, 2014, CELL SIGNAL, V26, P895, DOI 10.1016/j.cellsig.2014.01.007; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vallabhaneni S, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0572-1; Van Enckevort FHJ, 1999, MED MYCOL, V37, P419, DOI 10.1046/j.1365-280X.1999.00247.x; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Wu YJ, 2015, J IMMUNOL, V195, P2612, DOI 10.4049/jimmunol.1402944; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	47	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16530	16540		10.1074/jbc.M116.717157	http://dx.doi.org/10.1074/jbc.M116.717157			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288407	Green Published, hybrid			2022-12-26	WOS:000380826700013
J	Yang, DL; Frego, L; Lasaro, M; Truncali, K; Kroe-Barrett, R; Singh, S				Yang, Danlin; Frego, Lee; Lasaro, Marcio; Truncali, Kristopher; Kroe-Barrett, Rachel; Singh, Sanjaya			Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; HUMAN MONOCLONAL-ANTIBODIES; LINKED-IMMUNOSORBENT-ASSAY; MEMORY B-CELLS; THERAPEUTIC ANTIBODIES; VACCINE DEVELOPMENT; ELISA; IMMUNIZATION; SERUM; STRATEGIES	To determine the effectiveness of immunization strategies used in therapeutic antibody or vaccine development, it is critical to assess the quality of immunization-induced polyclonal antibody responses. Here, we developed a workflow that uses sensitive methods to quantitatively and qualitatively assess immune responses against foreign antigens with regard to antibody binding affinity and epitope diversity. The application of such detailed assessments throughout an immunization campaign can significantly reduce the resources required to generate highly specific antibodies. Our workflow consists of the following two steps: 1) the use of surface plasmon resonance to quantify antigen-specific antibodies and evaluate their apparent binding affinities, and 2) the recovery of serum IgGs using an automated small scale purification system, followed by the determination of their epitope diversity using hydrogen deuterium exchange coupled with mass spectrometry. We showed that these methods were sensitive enough to detect antigen-specific IgGs in the nanogram/mu l range and that they provided information for differentiating the antibody responses of the various immunized animals that could not be obtained by conventional methods. We also showed that this workflow can guide the selection of an animal that produces high affinity antibodies with a desired epitope coverage profile, resulting in the generation of potential therapeutic monoclonal antibody clones with desirable functional profiles. We postulate that this workflow will be an important tool in the development of effective vaccines to combat the highly sophisticated evasion mechanisms of pathogens.	[Yang, Danlin; Frego, Lee; Lasaro, Marcio; Truncali, Kristopher; Kroe-Barrett, Rachel; Singh, Sanjaya] Boehringer Ingelheim Pharmaceut Inc, Dept Biotherapeut Discovery Immune Modulat & Biot, 900 Ridgebury Rd, Ridgefield, CT 06877 USA	Boehringer Ingelheim	Singh, S (corresponding author), Boehringer Ingelheim Pharmaceut Inc, Dept Biotherapeut Discovery Immune Modulat & Biot, 900 Ridgebury Rd, Ridgefield, CT 06877 USA.	sanjaya.singh@boehringer-ingelheim.com		Yang, Danlin/0000-0002-5085-5950; Kroe-Barrett, Rachel/0000-0003-1413-1223; Singh, Sanjaya/0000-0002-9119-7966				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; An ZQ, 2010, PROTEIN CELL, V1, P319, DOI 10.1007/s13238-010-0052-8; Awasthi S, 2011, J VIROL, V85, P10472, DOI 10.1128/JVI.00849-11; Benjamin, 1996, Methods, V9, P508; Burns Robert, 2009, V508, P27, DOI 10.1007/978-1-59745-062-1_3; Campagnolo C, 2004, J BIOCHEM BIOPH METH, V61, P283, DOI 10.1016/j.jbbm.2004.05.006; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cho HS, 2007, J VET DIAGN INVEST, V19, P414, DOI 10.1177/104063870701900414; Cho HS, 2006, J VET MED SCI, V68, P1327, DOI 10.1292/jvms.68.1327; Deantonio C, 2014, METHODS MOL BIOL, V1060, P277, DOI 10.1007/978-1-62703-586-6_14; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Gan SD, 2013, J INVEST DERMATOL, V133, pE10, DOI 10.1038/jid.2013.287; Hanly W. Carey, 1995, ILAR J, V37, P93; Hauge S, 2007, CLIN VACCINE IMMUNOL, V14, P978, DOI 10.1128/CVI.00033-07; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Hoa XD, 2007, BIOSENS BIOELECTRON, V23, P151, DOI 10.1016/j.bios.2007.07.001; Kamata T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066096; Kaufmann SHE, 2014, CURR OPIN IMMUNOL, V28, P18, DOI 10.1016/j.coi.2014.01.009; KOHLER G, 1985, EMBO J, V4, P1359, DOI 10.1002/j.1460-2075.1985.tb03787.x; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269; Masch A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4_13; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; MORI H, 1989, INT J IMMUNOPHARMACO, V11, P597, DOI 10.1016/0192-0561(89)90144-6; Moy FJ, 2001, J MOL BIOL, V310, P219, DOI 10.1006/jmbi.2001.4764; NOSSAL GJV, 1992, CELL, V68, P1, DOI 10.1016/0092-8674(92)90198-L; Obungu VH, 2009, BIOCHEMISTRY-US, V48, P7251, DOI 10.1021/bi900296g; Petrakou E, 1998, ANTICANCER RES, V18, P4419; Pirrone GF, 2015, ANAL CHEM, V87, P99, DOI 10.1021/ac5040242; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Wang H, 2000, P NATL ACAD SCI USA, V97, P847, DOI 10.1073/pnas.97.2.847; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	39	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16361	16374		10.1074/jbc.M116.736660	http://dx.doi.org/10.1074/jbc.M116.736660			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27288409	hybrid, Green Published			2022-12-26	WOS:000380585400039
J	Chou, PS; Hsu, CY; Wu, MN; Liou, LM; Lu, SR; Liu, CK; Lai, CL				Chou, Ping-Song; Hsu, Chung-Yao; Wu, Meng-Ni; Liou, Li-Min; Lu, Shinag-Ru; Liu, Ching-Kuan; Lai, Chiou-Lian			Action-Monitoring Dysfunction in Obstructive Sleep Apnea - A Pilot Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; NEUROCOGNITIVE FUNCTION; METABOLIC SYNDROME; DEPRIVATION; PERFORMANCE; TASK; IMPAIRMENT	Obstructive sleep apnea (OSA) is associated with a broad range of frontal lobe dysfunctions. However, no study has investigated action monitoring, a crucial domain of frontal cognitive functions, in patients with OSA. By using the modified Flanker task, we tested the hypothesis that patients with OSA have an impaired action monitoring function. We recruited 25 untreated patients with moderate-severe OSA and 12 control participants who were matched for age, sex, apolipoprotein E4, and education level. Every enrolled participant underwent a standard overnight laboratory-based polysomnography and completed a modified Flanker task. Compared with the controls, the patients with OSA presented a significantly lower correct response rate in all trials (78.9% vs 95.9%, P = .008), congruent trials (84.7% vs 98.3%, P = .016), and incongruent trials (77.4% vs 94.7%, P = .009). The post-error correction rate was significantly lower in the patients with OSA than in the controls (74.9% vs 93.8%, P = .005). Furthermore, strong significant correlations were observed between the arousal index and correct rate in all trials (r = -0.390, P < .05) and in the incongruent trials (r = -0.429, P < .01), as well as between the arousal index and rate of post-error correction (r = -0.435, P < .01). We concluded that the action monitoring function was impaired in the patients with OSA. Sleep fragmentation was a major determinant of impaired action monitoring in these patients.	[Chou, Ping-Song; Hsu, Chung-Yao; Wu, Meng-Ni; Liou, Li-Min; Lu, Shinag-Ru; Liu, Ching-Kuan; Lai, Chiou-Lian] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chou, Ping-Song] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsu, Chung-Yao; Liou, Li-Min; Lu, Shinag-Ru; Liu, Ching-Kuan; Lai, Chiou-Lian] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Neurol, Kaohsiung, Taiwan; [Lai, Chiou-Lian] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Neurol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Lai, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.; Lai, CL (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Neurol, Kaohsiung, Taiwan.; Lai, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Neurol, Kaohsiung, Taiwan.	cllai@kmu.edu.tw		Chou, Ping-Song/0000-0003-3693-3323; Hsu, Chung-Yao/0000-0002-9880-5944	Ministry of Science and Technology, Taiwan [NSC-101-2314-B-037-067]; Kaohsiung Medical University Hospital [KMUH101-1R54]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This study was supported by grants from the Ministry of Science and Technology, Taiwan (NSC-101-2314-B-037-067) and Kaohsiung Medical University Hospital (KMUH101-1R54). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalon L, 2009, SLEEP, V32, P373, DOI 10.1093/sleep/32.3.373; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Henderson H, 2006, BRAIN COGNITION, V61, P96, DOI 10.1016/j.bandc.2005.12.009; Hsieh S, 2007, J SLEEP RES, V16, P137, DOI 10.1111/j.1365-2869.2007.00583.x; Hsieh S, 2009, J SLEEP RES, V18, P159, DOI 10.1111/j.1365-2869.2008.00730.x; Iber C., 2007, AASM MANUAL SCORING; Ko CH, 2015, BIOL PSYCHOL, V104, P163, DOI 10.1016/j.biopsycho.2014.12.008; Lal C, 2012, CHEST, V141, P1601, DOI 10.1378/chest.11-2214; Lam B, 2007, INT J TUBERC LUNG D, V11, P2; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Lim DC, 2014, SLEEP MED REV, V18, P35, DOI 10.1016/j.smrv.2012.12.003; Liu HC, 2002, DEMENT GERIATR COGN, V13, P244, DOI 10.1159/000057703; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; McCall WV, 2006, J CLIN SLEEP MED, V2, P424; Murphy TI, 2006, J SLEEP RES, V15, P15, DOI 10.1111/j.1365-2869.2006.00503.x; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Rabbitt, 1966, J EXP PSYCHOL, V71, P264; Renn RP, 2013, INT J PSYCHOPHYSIOL, V88, P64, DOI 10.1016/j.ijpsycho.2013.01.013; Rodgers Rabbitt, 1977, J EXP PSYCHOL, V29, P727; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Tulek B, 2013, J SLEEP RES, V22, P422, DOI 10.1111/jsr.12038; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Zhang X, 2011, SLEEP MED, V12, P335, DOI 10.1016/j.sleep.2010.08.015	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157575	10.1371/journal.pone.0157575	http://dx.doi.org/10.1371/journal.pone.0157575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300504	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200061
J	Li, JJ; Liu, YR; Jiang, YZ; Shao, ZM				Li, Junjie; Liu, Yirong; Jiang, Yizhou; Shao, Zhimin			Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods	PLOS ONE			English	Article							OVARIAN SUPPRESSION; ADJUVANT TAMOXIFEN; RECURRENCE; DIAGNOSIS; SURVIVAL; THERAPY; CONSENSUS; EFFICACY; OUTCOMES; MODELS	Purpose To determine whether and how the patterns of breast cancer-specific mortality (BCSM) changed along with time periods. Methods We used the Surveillance, Epidemiology and End Results registry to identify 228209 female patients diagnosed with invasive breast cancer between 1990 and 2000 (cohort 1 [C1], 112981) and between 2001 and 2005 (cohort 2 [C2], 115228). BCSM was compared in two cohorts using Cox proportional hazard regression models. We analysed the relative hazard ratios (HRs) and absolute BCSM rates by flexible parametric survival modelling. Results The patterns of BCSM were similar between the two cohorts, with the peak of mortality presenting in the first 2-3 years after diagnosis, and mortality rate significantly decreased in C2 in all cases. In C2, the annual BCSM rate of all cases was 9.64 (per 1000 persons per year) in year 10 with a peak rate of 23.34 in year 2. In ER-negative and high-risk patients, marked survival improvements were achieved mostly in the first 5 years, while in ER-positive and low-risk patients, survival improvements were less but constant up to 10 years. Conclusion There has been a significant improvement of BCSM with substantially decreased mortality within 5 years. The current pattern of BCSM and its changing feature differs according to ER status. Our findings have some clinical implications both for treatment decisions and adjuvant treatment trial design.	[Li, Junjie; Liu, Yirong; Jiang, Yizhou; Shao, Zhimin] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Li, Junjie; Liu, Yirong; Jiang, Yizhou; Shao, Zhimin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.; Shao, ZM (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com		Liu, Yirong/0000-0003-4019-6901				Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Cardoso F, 2014, ANN ONCOL, V25, P1871, DOI 10.1093/annonc/mdu385; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Cossetti RJD, 2015, J CLIN ONCOL, V33, P65, DOI 10.1200/JCO.2014.57.2461; Cuzick J, 2013, ONCOLOGY-NY, V27, P1224; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; International Agency for Research on Cancer (IARC), 2002, IARC HDB CANC PREV, V7; Jatoi I, 2011, J CLIN ONCOL, V29, P2301, DOI 10.1200/JCO.2010.32.3550; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Muss HB, 2008, J CLIN ONCOL, V26, P1956, DOI 10.1200/JCO.2007.12.6334; National Cancer Institute, CANC DRUGS APPR FOOD; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Park JH, 2015, J CLIN ONCOL, V33, P2870, DOI 10.1200/JCO.2014.59.9191; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Ribelles N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3559; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Rutqvist LE, 1996, J NATL CANCER I, V88, P1543; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Savci-Heijink CD, 2015, BREAST CANCER RES TR, V150, P547, DOI 10.1007/s10549-015-3352-0; Surveillance Epidemiology and End Results (SEER) Program, 2014, SEER STAT DAT INC SE; Ufen MP, 2014, ANN ONCOL, V25, P95, DOI 10.1093/annonc/mdt429; Yu KD, 2012, J CLIN ENDOCR METAB, V97, pE2201, DOI 10.1210/jc.2012-2423	30	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157322	10.1371/journal.pone.0157322	http://dx.doi.org/10.1371/journal.pone.0157322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299729	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200036
J	Eden, A; Marcotte, TD; Heaton, RK; Nilsson, S; Zetterberg, H; Fuchs, D; Franklin, D; Price, RW; Grant, I; Letendre, SL; Gisslen, M				Eden, Arvid; Marcotte, Thomas D.; Heaton, Robert K.; Nilsson, Staffan; Zetterberg, Henrik; Fuchs, Dietmar; Franklin, Donald; Price, Richard W.; Grant, Igor; Letendre, Scott L.; Gisslen, Magnus			Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment	PLOS ONE			English	Article							CEREBROSPINAL-FLUID NEOPTERIN; CENTRAL-NERVOUS-SYSTEM; ANTIRETROVIRAL THERAPY; NEUROFILAMENT PROTEIN; HIV-1 INFECTION; DEFICIT SCORES; DISORDERS; CSF; PREVALENCE; BIOMARKERS	Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). Design and Methods We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Results Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Conclusions Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.	[Eden, Arvid; Gisslen, Magnus] Univ Gothenburg, Dept Infect Dis, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Marcotte, Thomas D.; Heaton, Robert K.; Franklin, Donald; Grant, Igor; Letendre, Scott L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Nilsson, Staffan] Chalmers, Math Sci, S-41296 Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London, England; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria; [Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of Gothenburg; University of California System; University of California San Diego; Chalmers University of Technology; University of Gothenburg; University of London; University College London; Medical University of Innsbruck; University of California System; University of California San Francisco	Eden, A (corresponding author), Univ Gothenburg, Dept Infect Dis, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	arvid.eden@vgregion.se	Letendre, Scott L./GLU-6874-2022; Fuchs, Dietmar/AAL-8011-2021; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Gisslen, Magnus/0000-0002-2357-1020; Nilsson, Staffan/0000-0003-4748-0446	US National Institutes of Health [N01MH22005, P30MH62512, U24MH100928, P50DA026306, HHSN271201000036C, K24MH097673]; Swedish Research Council [K2011-58P-20931-01-4, K2010-63P-21562-01-4, K2011-61X-20401-05-6, 2013-2546, K2013-61X-14002-13-5]; Sahlgrenska University Hospital [ALFGBG-430271, ALFGBG-441051, ALFGBG-139671]; Knut and Alice Wallenberg Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107345, P30MH062512, K24MH097673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health [awards N01MH22005 (IG), P30MH62512 (RKH), U24MH100928 (IG), P50DA026306 (IG), HHSN271201000036C (IG), K24MH097673 (SLL)]; The Swedish Research Council [K2011-58P-20931-01-4, K2010-63P-21562-01-4, K2011-61X-20401-05-6, 2013-2546, K2013-61X-14002-13-5] (MG); the Sahlgrenska University Hospital [ALFGBG-430271, ALFGBG-441051, ALFGBG-139671] (MG); and the Knut and Alice Wallenberg Foundation (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulle S, 2007, J NEUROLOGY; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; BOGNER JR, 1992, CLIN INVESTIGATOR, V70, P665; Brew BJ, 1996, J INFECT DIS, V174, P294, DOI 10.1093/infdis/174.2.294; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cysique LA, 2011, J NEUROVIROL, V17, P176, DOI 10.1007/s13365-011-0021-x; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Dahl V, 2014, AIDS, V28, P2251, DOI 10.1097/QAD.0000000000000400; Eden A, 2007, J INFECT DIS, V196, P1779, DOI 10.1086/523648; Gelman BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046178; Gisslen M, 2007, J NEUROIMMUNE PHARM, V2, P112, DOI 10.1007/s11481-006-9035-1; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Grant I, 2014, NEUROLOGY, V82, P2055, DOI 10.1212/WNL.0000000000000492; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2014, NEUROCOGNITIVE CHANG, DOI [10.1093/cid/ciu862, DOI 10.1093/CID/CIU862]; Krut JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088591; Krut JJ, 2013, J NEUROL, V260, P620, DOI 10.1007/s00415-012-6688-y; Lescure FX, 2011, CLIN INFECT DIS, V52, P235, DOI 10.1093/cid/ciq041; Mellgren A, 2007, NEUROLOGY, V69, P1536, DOI 10.1212/01.wnl.0000277635.05973.55; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Peterson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116081; Price RW, 2007, NEUROLOGY, V69, P1781, DOI 10.1212/01.wnl.0000278457.55877.eb; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Sattler FR, 2015, JAIDS-J ACQ IMM DEF, V68, P281, DOI 10.1097/QAI.0000000000000458; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Torti C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-138; Yilmaz A, 2008, JAIDS-J ACQ IMM DEF, V47, P168, DOI 10.1097/QAI.0b013e31815ace97; Yilmaz A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-62	31	72	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157160	10.1371/journal.pone.0157160	http://dx.doi.org/10.1371/journal.pone.0157160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295036	Green Published, gold			2022-12-26	WOS:000377821300026
J	Pani, G; Dessi, A; Dallocchio, R; Scherm, B; Azara, E; Delogu, G; Migheli, Q				Pani, Giovanna; Dessi, Alessandro; Dallocchio, Roberto; Scherm, Barbara; Azara, Emanuela; Delogu, Giovanna; Migheli, Quirico			Natural Phenolic Inhibitors of Trichothecene Biosynthesis by the Wheat Fungal Pathogen Fusarium culmorum: A Computational Insight into the Structure-Activity Relationship	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; GRAMINEARUM; MECHANISMS; RESISTANCE; MOLECULES; DERIVATIVES; SYSTEM; GENES; ACID; FOOD	A model of the trichodiene synthase (TRI5) of the wheat fungal pathogen and type-B trichothecene producer Fusarium culmorum was developed based on homology modelling with the crystallized protein of F. sporotrichioides. Eight phenolic molecules, namely ferulic acid 1, apocynin 2, propyl gallate 3, eugenol 4, Me-dehydrozingerone 5, eugenol dimer 6, magnolol 7, and ellagic acid 8, were selected for their ability to inhibit trichothecene production and/or fungal vegetative growth in F. culmorum. The chemical structures of phenols were constructed and partially optimised based on Molecular Mechanics (MM) studies and energy minimisation by Density Functional Theory (DFT). Docking analysis of the phenolic molecules was run on the 3D model of F. culmorum TRI5. Experimental biological activity, molecular descriptors and interacting-structures obtained from computational analysis were compared. Besides the catalytic domain, three privileged sites in the interaction with the inhibitory molecules were identified on the protein surface. The TRI5-ligand interactions highlighted in this study represent a powerful tool to the identification of new Fusarium-targeted molecules with potential as trichothecene inhibitors.	[Pani, Giovanna; Scherm, Barbara; Migheli, Quirico] Univ Sassari, Dipartimento Agr, Viale Italia 39, I-07100 Sassari, Italy; [Pani, Giovanna; Scherm, Barbara; Migheli, Quirico] Univ Sassari, Ist Nazl Biostrutture & Biosistemi, Unita Ric, Viale Italia 39, I-07100 Sassari, Italy; [Dessi, Alessandro; Dallocchio, Roberto; Azara, Emanuela; Delogu, Giovanna] Ist CNR Chim Biomol, Traversa La Crucca 3, I-07100 Sassari, Italy	University of Sassari; University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR)	Migheli, Q (corresponding author), Univ Sassari, Dipartimento Agr, Viale Italia 39, I-07100 Sassari, Italy.; Migheli, Q (corresponding author), Univ Sassari, Ist Nazl Biostrutture & Biosistemi, Unita Ric, Viale Italia 39, I-07100 Sassari, Italy.; Delogu, G (corresponding author), Ist CNR Chim Biomol, Traversa La Crucca 3, I-07100 Sassari, Italy.	giovanna.delogu@icb.cnr.it; qmigheli@uniss.it	Migheli, Quirico/B-7203-2009; Migheli, Quirico/K-7065-2019; Dessì, Alessandro/B-8021-2015	Migheli, Quirico/0000-0002-2459-5833; Migheli, Quirico/0000-0002-2459-5833; Dessì, Alessandro/0000-0001-8258-7332; Azara, Emanuela/0000-0001-9199-9398; Dallocchio, Roberto Nico/0000-0003-4626-4792	Ministry of University and Research; P.O.R. SARDEGNA F.S.E. - Obiettivo competitivita regionale e occupazione, Asse IV Capitale umano, Linea di Attivita l. 3.1 (research project: "Ide	Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); P.O.R. SARDEGNA F.S.E. - Obiettivo competitivita regionale e occupazione, Asse IV Capitale umano, Linea di Attivita l. 3.1 (research project: "Ide	Research was funded by the Ministry of University and Research (PRIN 2011: "Cell wall determinants to improve durum wheat resistance to Fusarium diseases"). BS acknowledges support by P.O.R. SARDEGNA F.S.E. 2007-2013 - Obiettivo competitivita regionale e occupazione, Asse IV Capitale umano, Linea di Attivita l. 3.1 (research project: "Identification of natural and natural-like molecules inhibiting mycotoxin biosynthesis by Fusaria pathogenic on cereals"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; Altomare C, 2004, J AGR FOOD CHEM, V52, P2997, DOI 10.1021/jf035233z; Arunachalam C, 2013, TOXICOL LETT, V217, P149, DOI 10.1016/j.toxlet.2012.12.003; Bakan B, 2003, J AGR FOOD CHEM, V51, P2826, DOI 10.1021/jf020957g; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Becher R, 2010, PHYTOPATHOLOGY, V100, P444, DOI 10.1094/PHYTO-100-5-0444; Bhat R, 2010, COMPR REV FOOD SCI F, V9, P57, DOI 10.1111/j.1541-4337.2009.00094.x; Boutigny AL, 2008, EUR J PLANT PATHOL, V121, P411, DOI 10.1007/s10658-007-9266-x; Boutigny AL, 2010, EUR J PLANT PATHOL, V127, P275, DOI 10.1007/s10658-010-9592-2; Boutigny AL, 2009, MYCOL RES, V113, P746, DOI 10.1016/j.mycres.2009.02.010; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; da Silva JKR, 2014, MOLECULES, V19, P17926, DOI 10.3390/molecules191117926; Dambolena JS, 2012, FOOD CONTROL, V28, P163, DOI 10.1016/j.foodcont.2012.05.008; Dennington R., 2009, GAUSS VIEW VERSION 5; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Dettori MA, 2015, LETT DRUG DES DISCOV, V12, P131; Eriksson ARB, 2002, EMBL GENBANK D UNPUB; Frisch G. W., 2013, GAUSSIAN 09; Fujisawa S, 2007, IN VIVO, V21, P181; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunnaiah R, 2014, PLANT PHYSIOL BIOCH, V83, P40, DOI 10.1016/j.plaphy.2014.07.002; Hajduk PJ, 2000, J MED CHEM, V43, P3443, DOI 10.1021/jm000164q; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lowe RGT, 2010, MOL PLANT MICROBE IN, V23, P1605, DOI 10.1094/MPMI-04-10-0092; Marchiani A, 2013, AMINO ACIDS, V45, P327, DOI 10.1007/s00726-013-1503-3; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Menke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063077; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Pan JZ, 2014, LETT DRUG DES DISCOV, V11, P27; Pani G, 2014, J AGR FOOD CHEM, V62, P4969, DOI 10.1021/jf500647h; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prandini A, 2009, FOOD CHEM TOXICOL, V47, P927, DOI 10.1016/j.fct.2008.06.010; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sagrera G, 2011, BIOORGAN MED CHEM, V19, P3060, DOI 10.1016/j.bmc.2011.04.010; Sakuda S, 2016, BIOSCI BIOTECH BIOCH, V80, P43, DOI 10.1080/09168451.2015.1086261; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Scherm B, 2011, MOL PLANT PATHOL, V12, P759, DOI 10.1111/J.1364-3703.2011.00709.X; Shiina I, 2008, BIOCHEM PHARMACOL, V75, P1014, DOI 10.1016/j.bcp.2007.11.005; Vedula LS, 2007, ARCH BIOCHEM BIOPHYS, V466, P260, DOI 10.1016/j.abb.2007.06.016; Vedula LS, 2008, ARCH BIOCH BIOPHYS, V469; Vogel H.J., 1956, MICROB GENET B, V13, P42; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Wu HS, 2010, SCI HORTIC-AMSTERDAM, V124, P448, DOI 10.1016/j.scienta.2010.02.007	50	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157316	10.1371/journal.pone.0157316	http://dx.doi.org/10.1371/journal.pone.0157316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294666	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300035
J	Dobing, S; Frolova, N; McAlister, F; Ringrose, J				Dobing, Selina; Frolova, Natalia; McAlister, Finlay; Ringrose, Jennifer			Sleep Quality and Factors Influencing Self-Reported Sleep Duration and Quality in the General Internal Medicine Inpatient Population	PLOS ONE			English	Article								Background Sleep quality in hospitalized Canadian General Internal Medicine patients is not well characterized. Our goals were to characterize hospital sleep quality in this population and identify potentially modifiable barriers to good sleep. Methods GIM inpatients at a quaternary centre in Edmonton, Canada completed a survey, including the Verran-Snyder Halpern (VSH) questionnaire, to characterize the previous night's sleep within 48 hours prior to discharge. A chart review was also completed to assess comorbidities, discharge diagnoses, and pharmaceutical sleep aid use. Results Patients reported significantly worse nighttime sleep duration in hospital compared with home (mean 5.5 versus 7.0 hours per night, p < 0.0001). Sleep quality was poor, as measured by the VSH disturbance (mean 371), effectiveness (190), and supplementation (115) subscales. Variables independently associated with poorer sleep duration in multivariable regression include prior diagnosis of sleep disorder and multi-patient occupancy rooms. Age, sex, admitting diagnosis, length of stay, frequency of vital checks, and use of sleep pharmaceuticals during the index hospitalization were not associated with sleep duration. The most frequently reported reasons for poor sleep included noise (59%), nursing interruptions (30%), uncomfortable beds (18%), bright lights (16%), unfamiliar surroundings (14%), and pain (9%). Conclusions Sleep quality for GIM inpatients is significantly worse in hospital than at home. There is a need to test non-pharmacologic interventions to address the most frequently identified factors causing poor sleep hygiene for GIM inpatients.	[Dobing, Selina] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Frolova, Natalia; McAlister, Finlay; Ringrose, Jennifer] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada	University of Alberta; University of Alberta	Ringrose, J (corresponding author), Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada.	jennifer.ringrose@ualberta.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341	Alberta Health Services Quality Improvement Grant; Alberta Health Services	Alberta Health Services Quality Improvement Grant; Alberta Health Services	Funded by Alberta Health Services Quality Improvement Grant 2014 (JR SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank nursing staff at the University of Alberta Hospital for support of this project, and Erik Youngson for statistical assistance. Funding for this study was generously provided by Alberta Health Services.	Arora VM, 2011, J AM GERIATR SOC, V59, P2185, DOI 10.1111/j.1532-5415.2011.03644.x; Bartick Melissa C, 2010, J Hosp Med, V5, pE20, DOI 10.1002/jhm.549; Bonnet MH, 2006, SLEEP MED CLIN, V1, P351, DOI 10.1016/j.jsmc.2006.06.004; Calev H, 2015, J HOSP MED, V10, P439, DOI 10.1002/jhm.2364; Frighetto L, 2010, HLTH QUAL LIFE OUT, V24, P2; Hoey LM, 2014, INT J NURS STUD, V51, P1281, DOI 10.1016/j.ijnurstu.2014.02.001; Knauert MP, 2014, SEMIN RESP CRIT CARE, V35, P582, DOI 10.1055/s-0034-1390080; Kokras N, 2011, GEN HOSP PSYCHIAT, V33, P78, DOI 10.1016/j.genhosppsych.2010.12.003; Missildine K, 2010, GERIATR NURS, V31, P263, DOI 10.1016/j.gerinurse.2010.02.013; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; SNYDERHALPERN R, 1987, RES NURS HEALTH, V10, P155, DOI 10.1002/nur.4770100307; Tranmer Joan E, 2003, Clin Nurs Res, V12, P159, DOI 10.1177/1054773803012002004; Young JS, 2009, J HOSP MED, V4, P50, DOI 10.1002/jhm.397	14	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156735	10.1371/journal.pone.0156735	http://dx.doi.org/10.1371/journal.pone.0156735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280292	Green Submitted, gold, Green Published			2022-12-26	WOS:000377563000043
J	Papin-Michault, C; Bonnetaud, C; Dufour, M; Almairac, F; Coutts, M; Patouraux, S; Virolle, T; Darcourt, J; Burel-Vandenbos, F				Papin-Michault, Caroline; Bonnetaud, Christelle; Dufour, Maxime; Almairac, Fabien; Coutts, Mickael; Patouraux, Stephanie; Virolle, Thierry; Darcourt, Jacques; Burel-Vandenbos, Fanny			Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers	PLOS ONE			English	Article							TRANSPORTER 1 EXPRESSION; PROGNOSTIC-SIGNIFICANCE; RADIATION NECROSIS; CD98 EXPRESSION; F-18-FDOPA PET; LUNG-CANCER; HEAVY-CHAIN; LIGHT-CHAIN; TUMOR; RECURRENT	Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be promising in distinguishing between recurrent tumour and radionecrosis in the follow-up of brain metastasis (BM). The amino acid transporter LAT1 and its cofactor CD98, which are involved in AA uptake, have never been investigated in BM. The aim of our study was to determine and compare the expression of LAT1 and CD98 in BM and in non-tumoral brain tissue (NT). The expression of LAT1 and CD98 were studied by immunohistochemistry in 67 BM, including 18 BM recurrences after radiotherapy, in 53 NT, and in 13 cases of patients with previously irradiated brain tumor and investigated by [18F] FDOPA-PET. LAT1 and CD98 expression were detected in 98.5% and 59.7% of BM respectively and were significantly associated with BM tissue as compared to NT (p<0.001). LAT1 expression in recurrent BM was significantly increased as compared to newly occurring BM. Ten cases investigated by [18F] FDOPA-PET corresponding to recurrent BM displayed significant [18F] FDOPA uptake and LAT1 overexpression whereas three cases corresponding to radionecrosis showed no or low uptake and LAT1 expression. LAT1 expression level and [18F] FDOPA uptake were significantly correlated. In conclusion, we hypothesized that BM may overexpress the AA transporter LAT1. We have shown that LAT1 overexpression was common in BM and was specific for BM as compared to healthy brain. These results could explain the specific BM uptake on PET-AA.	[Papin-Michault, Caroline; Coutts, Mickael; Patouraux, Stephanie; Burel-Vandenbos, Fanny] Univ Hosp, Dept Pathol, Nice, France; [Bonnetaud, Christelle] Univ Hosp, Dept Expt Pathol, Nice, France; [Dufour, Maxime; Darcourt, Jacques] Ctr Antoine Lacassagne, Dept Nucl Med, 36 Voie Romaine, F-06054 Nice, France; [Dufour, Maxime; Darcourt, Jacques] Univ Med, TIRO UMR E 4320, Nice, France; [Almairac, Fabien] Univ Hosp, Dept Neurosurg, Nice, France; [Virolle, Thierry; Burel-Vandenbos, Fanny] Univ Sci, Inst Biol Valrose, UMR CNRS 7277, UMR INSERM 1091, Nice, France	CHU Nice; CHU Nice; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Burel-Vandenbos, F (corresponding author), Univ Hosp, Dept Pathol, Nice, France.; Burel-Vandenbos, F (corresponding author), Univ Sci, Inst Biol Valrose, UMR CNRS 7277, UMR INSERM 1091, Nice, France.	burel-vandenbos.f@chu-nice.fr	Virolle, Thierry/E-5838-2016	patouraux, stephanie/0000-0001-6004-7685				Campbell WA, 2001, J BIOL CHEM, V276, P16877, DOI 10.1074/jbc.M008248200; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Chen W, 2006, J NUCL MED, V47, P904; Cicone F, 2015, EUR J NUCL MED MOL I, V42, P103, DOI 10.1007/s00259-014-2886-4; Ebara T, 2010, ANTICANCER RES, V30, P4223; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Galldiks N, 2012, J NUCL MED, V53, P1367, DOI 10.2967/jnumed.112.103325; Gulyas B, 2012, Q J NUCL MED MOL IM, V56, P173; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Imai H, 2009, HISTOPATHOLOGY, V54, P804, DOI 10.1111/j.1365-2559.2009.03300.x; Kageyama T, 2000, NEUROREPORT, V11, P3663, DOI 10.1097/00001756-200011270-00015; Kageyama T, 2000, BRAIN RES, V879, P115, DOI 10.1016/S0006-8993(00)02758-X; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2007, CLIN CANCER RES, V13, P6369, DOI 10.1158/1078-0432.CCR-07-1294; Kaira K, 2011, ANTICANCER RES, V31, P3775; Kaira K, 2010, EXP THER MED, V1, P799, DOI 10.3892/etm.2010.117; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kickingereder P, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-52; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Li J, 2013, TUMOR BIOL, V34, P2977, DOI 10.1007/s13277-013-0861-5; Lizarraga KJ, 2014, J NUCL MED, V55, P30, DOI 10.2967/jnumed.113.121418; Nussbaum ES, 1996, CANCER-AM CANCER SOC, V78, P1781, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.3.CO;2-Z; Ohkame H, 2001, J SURG ONCOL, V78, P265, DOI 10.1002/jso.1165; Oka S, 2014, MOL IMAGING BIOL, V16, P322, DOI 10.1007/s11307-013-0693-0; Ono M, 2013, BRAIN RES, V1535, P24, DOI 10.1016/j.brainres.2013.08.037; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Terakawa Y, 2008, J NUCL MED, V49, P694, DOI 10.2967/jnumed.107.048082; Tsuyuguchi N, 2003, J NEUROSURG, V98, P1056, DOI 10.3171/jns.2003.98.5.1056; Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Xu G, 2012, J NUCL MED; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yanagisawa N, 2012, J CLIN PATHOL, V65, P1019, DOI 10.1136/jclinpath-2012-200826; Youland RS, 2013, J NEURO-ONCOL, V111, P11, DOI 10.1007/s11060-012-0986-1; Yu WP, 2015, NUCL MED BIOL, V42, P8, DOI 10.1016/j.nucmedbio.2014.07.002; Yu WP, 2010, J MED CHEM, V53, P876, DOI 10.1021/jm900556s	37	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157139	10.1371/journal.pone.0157139	http://dx.doi.org/10.1371/journal.pone.0157139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276226	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700073
J	Vejrik, L; Matejickova, I; Sed'a, J; Blabolil, P; Juza, T; Vasek, M; Ricard, D; Matena, J; Frouzova, J; Kubecka, J; Riha, M; Cech, M				Vejrik, Lukas; Matejickova, Ivana; Sed'a, Jaromir; Blabolil, Petr; Juza, Tomas; Vasek, Mojmir; Ricard, Daniel; Matena, Josef; Frouzova, Jaroslava; Kubecka, Jan; Riha, Milan; Cech, Martin			Who Is Who: An Anomalous Predator-Prey Role Exchange between Cyprinids and Perch	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; CORMORANT PHALACROCORAX-CARBO; BLEAK ALBURNUS-ALBURNUS; UPPER NIAGARA RIVER; SCARDINIUS-ERYTHROPHTHALMUS; ABRAMIS-BRAMA; ZOOPLANKTON CONSUMPTION; FORAGING EFFICIENCY; EUROPEAN RESERVOIR; INVASIVE CYPRINID	Piscivory in cyprinids (Cyprinidae) is extremely rare. Specifically, common bream (Abramis brama) and common carp (Cyprinus carpio) are zooplanktivorous fish in deep lentic waters. Nevertheless, we observed predation by these two cyprinids under natural conditions in the Vir Reservoir, Czech Republic. We conducted diet analysis for cyprinids caught by trawling and gillnets and the large amount of young-of-the-year (YOY) perch (Perca fluviatilis), with sizes of 37-52 mm standard length, were found in their digestive tracts. In 2010, a large amount of YOY perch caused a significant decrease in Daphnia spp. size and abundance in the reservoir. Hence, a food deficit was induced for the cyprinids, apparent also from the poor nutritional condition of common bream which was much worse than the condition of those in similar reservoirs. Common carp and common bream shifted to forced piscivory, and they utilized the YOY perch as an alternative food source. In contrast, smaller species, such as roach (Rutilus rutilus) and bleak (Alburnus alburnus), widely utilized planktonic cyanobacteria. In the following year, YOY perch occurred in significantly lower numbers and conversely, Daphnia spp. size and abundance were significantly higher. The forced piscivory was not observed. Our results indicate a switch to forced piscivory by cyprinids, which was caused by a shortage of their natural food source. Moreover, this phenomenon presents an effective mechanism for reduction in the numbers of YOY perch, ensuring the stability of the ecosystem.	[Vejrik, Lukas; Matejickova, Ivana; Sed'a, Jaromir; Blabolil, Petr; Juza, Tomas; Vasek, Mojmir; Ricard, Daniel; Matena, Josef; Frouzova, Jaroslava; Kubecka, Jan; Riha, Milan; Cech, Martin] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Na Sadkach 7, Ceske Budejovice 37005, Czech Republic; [Vejrik, Lukas; Matejickova, Ivana; Blabolil, Petr] Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Ricard, Daniel] Fisheries & Oceans Canada, Gulf Fisheries Ctr, 343 Ave Univ,CP 5030, Moncton, NB E1C 9B6, Canada	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Fisheries & Oceans Canada	Vejrik, L (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Na Sadkach 7, Ceske Budejovice 37005, Czech Republic.; Vejrik, L (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	vejrik.lukas@seznam.cz	Riha, Milan/G-1065-2014; Juza, Tomas/G-3159-2014; Ricard, Daniel/G-1814-2014; Seda, Jaromir/F-9072-2014; Frouzova, Jaroslava/F-8518-2014; Vejřík, Lukáš/E-1607-2017; Kubecka, Jan/A-8230-2011; Vejříková, Ivana/K-4697-2016; Riha, Milan/AAF-9819-2019; Blabolil, Petr/N-8719-2019; Vasek, Mojmir/C-5839-2014; Blabolil, Petr/K-9548-2015; Čech, Martin/C-5797-2014; Vejříková, Ivana/E-1624-2017	Riha, Milan/0000-0002-3930-420X; Frouzova, Jaroslava/0000-0003-4876-4985; Vejřík, Lukáš/0000-0001-8911-9128; Kubecka, Jan/0000-0001-9203-4854; Blabolil, Petr/0000-0003-1344-9627; Vasek, Mojmir/0000-0001-6386-4015; Čech, Martin/0000-0003-1350-4286; Vejříková, Ivana/0000-0001-9113-2815	Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0204]; Czech Science Foundation [206/09/P266, 15-24309S]; Grant Agency of University of South Bohemia [159/2013/P]; Postdok BIOGLOBE - European Social Fund [CZ.1.07/2.3.00/30.0032]; state budget of the Czech Republic; Norwegian Financial Mechanism [7F14316, MSMT-28477/2014]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of University of South Bohemia; Postdok BIOGLOBE - European Social Fund; state budget of the Czech Republic; Norwegian Financial Mechanism	The study was supported by projects no. CZ.1.07/2.3.00/20.0204 (CEKOPOT) of the Ministry of Education, Youth and Sports (http://www.msmt.cz/), 7F14316 of the Norwegian Financial Mechanism 2009-2014 under contract number MSMT-28477/2014 (http://nfm.mjs.bg/NFMs/EN/SitePages/Home.aspx), 206/09/P266 and 15-24309S of the Czech Science Foundation (http://www.udu.cas.cz/en/), and 159/2013/P of the Grant Agency of University of South Bohemia (http://www.jcu.cz/). D. Ricard was supported by project no. CZ.1.07/2.3.00/30.0032 of the Postdok BIOGLOBE co-financed by the European Social Fund and the state budget of the Czech Republic (http://alfa.bc.cas.cz/Postdok-BIOGLOBE/ (http://alfa.bc.cas.cz/Postdok-BIOGLOBE/)).	[Anonymous], 2005, EN14757; Auguie B, 2017, GRIDEXTRA MISCELLANE; Benzie AH, 2005, GUIDES IDENTIFICATIO, V21, P1; Borcherding J, 2000, ECOL FRESHW FISH, V9, P236, DOI 10.1111/j.1600-0633.2000.eff090406.x; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031707; Britton JR, 2010, BIOL INVASIONS, V12, P1533, DOI 10.1007/s10530-009-9566-5; Cech M, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012026; Cech M, 2008, WATERBIRDS, V31, P438; Cech M, 2011, FOLIA ZOOL, V60, P129; CERNY K, 1973, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V37, P1; de Graaf M, 2008, MAR FRESHWATER RES, V59, P391, DOI 10.1071/MF07123; de Graaf M, 2010, AFR ZOOL, V45, P32, DOI 10.3377/004.045.0117; DIEHL S, 1988, OIKOS, V53, P207, DOI 10.2307/3566064; Eklov P, 1997, J FISH AQUAT SCI, V7, P1520; Flossner D, 2000, HAPLOPODA CALDOCERA; Frankiewicz P, 1996, ANN ZOOL FENN, V33, P321; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Garcia-Berthou E, 2001, AQUAT SCI, V63, P466, DOI 10.1007/s00027-001-8045-6; Guinan ME, 2015, AQUAT INVASIONS, V10, P217, DOI 10.3391/ai.2015.10.2.10; HARTMAN KJ, 1993, J FISH BIOL, V43, P109, DOI 10.1006/jfbi.1993.1113; Jarolim O, 2010, HYDROBIOLOGIA, V654, P253, DOI 10.1007/s10750-010-0398-1; Johansson L., 1986, P237; Juza T, 2007, FISH RES, V85, P285, DOI 10.1016/j.fishres.2007.03.001; Juza T, 2015, HYDROBIOLOGIA, V762, P169, DOI 10.1007/s10750-015-2346-6; Kapuscinski KL, 2012, HYDROBIOLOGIA, V693, P169, DOI 10.1007/s10750-012-1106-0; Kratochvil M, 2010, J LIMNOL, V69, P305, DOI 10.4081/jlimnol.2010.305; McCauley E., 1984, IBP HDB, P228; Mehner T, 1999, ENVIRON BIOL FISH, V56, P169, DOI 10.1023/A:1007532720226; Mittelbach GG, 1998, CAN J FISH AQUAT SCI, V55, P1454, DOI 10.1139/f98-041; MULLER M, 1984, Transactions of the Zoological Society of London, V37, P51; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Okun N, 2005, ECOL FRESHW FISH, V14, P139, DOI 10.1111/j.1600-0633.2005.00087.x; Olin M, 2010, J FISH BIOL, V76, P1277, DOI 10.1111/j.1095-8649.2010.02559.x; Olin M, 2002, J FISH BIOL, V60, P593, DOI 10.1006/jfbi.2002.1876; OLSON MH, 1995, ECOLOGY, V76, P1758, DOI 10.2307/1940708; Persson A, 1999, CAN J FISH AQUAT SCI, V56, P70, DOI 10.1139/cjfas-56-1-70; Persson A, 2002, OIKOS, V97, P271, DOI 10.1034/j.1600-0706.2002.970213.x; Persson L., 1988, P203; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; PERSSON L, 1991, BEHAV ECOL SOCIOBIOL, V28, P101; PERSSON L, 1993, OIKOS, V68, P12, DOI 10.2307/3545304; Petrusek A, 2008, PHILOS T R SOC B, V363, P2931, DOI 10.1098/rstb.2008.0026; Petrusek A, 2012, LIMNOL OCEANOGR, V57, P1838, DOI 10.4319/lo.2012.57.6.1838; Prchalova M, 2011, FISH RES, V107, P201, DOI 10.1016/j.fishres.2010.10.021; Rahman MM, 2010, ECOL RES, V25, P303, DOI 10.1007/s11284-009-0657-7; RINGELBERG J, 1991, ARCH HYDROBIOL, V121, P129; Ringelberg J, 2010, DIEL VERTICAL MIGRATION OF ZOOPLANKTON IN LAKES AND OCEANS: CAUSAL EXPLANATIONS AND ADAPTIVE SIGNIFICANCES, P1, DOI 10.1007/978-90-481-3093-1; RINGELBERG J, 1991, J PLANKTON RES, V13, P17, DOI 10.1093/plankt/13.1.17; Seda J, 2007, HYDROBIOLOGIA, V594, P47, DOI 10.1007/s10750-007-9075-4; Seda J, 2007, J PLANKTON RES, V29, P619, DOI 10.1093/plankt/fbm044; Sibbing FA, 2001, REV FISH BIOL FISHER, V10, P393; Smejkal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122437; Specziar A, 1998, ITAL J ZOOL, V65, P331, DOI 10.1080/11250009809386842; Specziar A, 2009, J FISH BIOL, V75, P247, DOI 10.1111/j.1095-8649.2009.02283.x; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Tesch FW., 1971, METHODS ASSESSMENT F, V1, P98; Van Wassenbergh S, 2011, ZOOLOGY, V114, P46, DOI 10.1016/j.zool.2010.10.001; Vasek M, 2016, ECOL INDIC, V63, P219, DOI 10.1016/j.ecolind.2015.11.061; Vasek M, 2004, FOLIA ZOOL, V53, P203; Vasek M, 2011, J FISH BIOL, V78, P953, DOI 10.1111/j.1095-8649.2011.02901.x; Vasek M, 2008, FOLIA ZOOL, V57, P324; Vasek M, 2006, INT REV HYDROBIOL, V91, P178, DOI 10.1002/iroh.200510835; Vejrik L, 2016, FRESHWATER BIOL, V61, P899, DOI 10.1111/fwb.12753; VOLLESTAD LA, 1985, HOLARCTIC ECOL, V8, P88; WINEMILLER KO, 1994, J FISH BIOL, V45, P211; WINFIELD IJ, 1986, J FISH BIOL, V29, P37, DOI 10.1111/j.1095-8649.1986.tb04997.x	67	5	5	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156430	10.1371/journal.pone.0156430	http://dx.doi.org/10.1371/journal.pone.0156430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276078	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700024
J	Tiveron, MC; Beurrier, C; Ceni, C; Andriambao, N; Combes, A; Koehl, M; Maurice, N; Gatti, E; Abrous, DN; Kerkerian-Le Goff, L; Pierre, P; Cremer, H				Tiveron, Marie-Catherine; Beurrier, Corinne; Ceni, Claire; Andriambao, Naly; Combes, Alexis; Koehl, Muriel; Maurice, Nicolas; Gatti, Evelina; Abrous, Dhoher Nora; Kerkerian-Le Goff, Lydia; Pierre, Philippe; Cremer, Harold			LAMP5 Fine-Tunes GABAergic Synaptic Transmission in Defined Circuits of the Mouse Brain	PLOS ONE			English	Article							CLATHRIN-COATED VESICLES; PLUS-MAZE; BAD-LAMP; NEUROGENESIS; ANXIETY; TRANSPORTER; NEURONS; CELLS; MODEL	LAMP5 is member of the LAMP family of membrane proteins. In contrast to the canonical members of this protein family, LAMP1 and LAMP2, which show widespread expression in many tissues, LAMP 5 is brain specific in mice. In C. elegans, the LAMP5 ortholog UNC-46 has been suggested to act a trafficking chaperone, essential for the correct targeting of the nematode vesicular GABA-transporter UNC-47. We show here that in the mouse brain LAMP5 is expressed in subpopulations of GABAergic forebrain neurons in the striato-nigral system and the olfactory bulb. The protein was present at synaptic terminals, overlapping with the mammalian vesicular GABA-transporter VGAT. In LAMP5-deficient mice localization of the transporter was unaffected arguing against a conserved role in VGAT trafficking. Electrophysiological analyses in mutants showed alterations in short term synaptic plasticity suggesting that LAMP5 is involved in controlling the dynamics of evoked GABAergic transmission. At the behavioral level, LAMP5 mutant mice showed decreased anxiety and deficits in olfactory discrimination. Altogether, this work implicates LAMP5 function in GABAergic neurotransmission in defined neuronal subpopulations.	[Tiveron, Marie-Catherine; Beurrier, Corinne; Ceni, Claire; Andriambao, Naly; Maurice, Nicolas; Kerkerian-Le Goff, Lydia; Cremer, Harold] Aix Marseille Univ, CNRS, IBDM, Dev Biol Inst Marseille,UMR 7288, F-13009 Marseille, France; [Combes, Alexis; Gatti, Evelina; Pierre, Philippe] Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy, INSERM, U1104,CNRS UMR7280, F-13288 Marseille, France; [Koehl, Muriel; Abrous, Dhoher Nora] NeuroCtr Magendie, INSERM, U862, Neurogenesis & Physiopathol Grp, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Tiveron, MC (corresponding author), Aix Marseille Univ, CNRS, IBDM, Dev Biol Inst Marseille,UMR 7288, F-13009 Marseille, France.	marie-catherine.tiveron@univ-amu.fr	Koehl, Muriel/ABI-2043-2020; Abrous, Nora-Djoher/N-6977-2017; Koehl, Muriel/C-3698-2011; Gatti, Evelina/B-7941-2012; TIVERON, Marie-Catherine/AAR-1142-2020	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; Gatti, Evelina/0000-0002-0667-0799; pierre, philippe/0000-0003-0863-8255; Kerkerian-Le Goff, Lydia/0000-0002-7951-3479; Combes, Alexis/0000-0002-9110-6542; abrous, nora/0000-0002-8589-305X; Cremer, Harold/0000-0002-8673-5176	Agence National pour la Recherche (ANR BadLampLayers); ARC Subvention libre "BAD-LAMP function in multiple myeloma"; A*MIDEX project - "Investissements d'Avenir" French government program [ANR-11-IDEX-0001-02]; France-BioImaging/PICsL infrastructure facility [ANR-10-INSB-04-01]; IBDM animal facility	Agence National pour la Recherche (ANR BadLampLayers)(French National Research Agency (ANR)); ARC Subvention libre "BAD-LAMP function in multiple myeloma"; A*MIDEX project - "Investissements d'Avenir" French government program(French National Research Agency (ANR)); France-BioImaging/PICsL infrastructure facility(French National Research Agency (ANR)); IBDM animal facility	HC and PP received funding from Agence National pour la Recherche (ANR BadLampLayers), and EG from ARC Subvention libre "BAD-LAMP function in multiple myeloma" and A*MIDEX project ANR-11-IDEX-0001-02 funded by the "Investissements d'Avenir" French government program.; The authors thank C. Beclin, and A. de Chevigny for critical reading of the manuscript. V. Camosseto, P. Delage and A. Defays for expert technical assistance, B. Gasnier for anti VGAT antibody. We acknowledge support by the the France-BioImaging/PICsL infrastructure (ANR-10-INSB-04-01) and the IBDM animal facilities.	Beurrier C, 2009, NEUROSCIENCE, V158, P1608, DOI 10.1016/j.neuroscience.2008.11.018; Beurrier C, 2009, FASEB J, V23, P3619, DOI 10.1096/fj.09-131789; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Boulay D, 2000, EUR J PHARMACOL, V391, P63, DOI 10.1016/S0014-2999(99)00916-4; Boulay D, 2000, PROG NEURO-PSYCHOPH, V24, P39, DOI 10.1016/S0278-5846(99)00079-2; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Burk K, 2012, J NEUROSCI, V32, P3759, DOI 10.1523/JNEUROSCI.4906-11.2012; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; David A, 2007, J CELL SCI, V120, P353, DOI 10.1242/jcs.03316; Defays A, 2011, BLOOD, V118, P609, DOI 10.1182/blood-2010-11-319699; Dumoulin A, 1999, J CELL SCI, V112, P811; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Poudel KR, 2014, CURR OPIN CELL BIOL, V26, P28, DOI 10.1016/j.ceb.2013.09.001; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Saftig P, 2001, TRENDS MOL MED, V7, P37, DOI 10.1016/S1471-4914(00)01868-2; Saheki A, 2012, INT J PHARMACEUT, V422, P489, DOI 10.1016/j.ijpharm.2011.10.060; Saheki T, 2012, MOL GENET METAB, V107, P322, DOI 10.1016/j.ymgme.2012.07.021; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Schuske K, 2007, NAT NEUROSCI, V10, P846, DOI 10.1038/nn1920; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SUDHOF T, 2011, COLD SPRING HARB PER, V3; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	33	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157052	10.1371/journal.pone.0157052	http://dx.doi.org/10.1371/journal.pone.0157052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272053	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000059
J	Eyking, A; Reis, H; Frank, M; Gerken, G; Schmid, KW; Cario, E				Eyking, Annette; Reis, Henning; Frank, Magdalena; Gerken, Guido; Schmid, Kurt W.; Cario, Elke			MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; DIFFERENTIATION; MICRORNA; PROLIFERATION; INFLAMMATION; PROGNOSIS; ADENOCARCINOMA; MODULATION; CARCINOMA	Mucinous adenocarcinoma (MAC) represents a distinct histopathological entity of colorectal cancer (CRC), which is associated with disease progression and poor prognosis. Here, we found that expression levels of miR-205 and miR-373 were specifically upregulated only in patients with mucinous colon cancers, but not in CRC that lack mucinous components. To investigate the effects of miR-205 and miR-373 on intestinal epithelial cell (IEC) biology by gain-and loss-of-function experiments in a proof-of-concept approach, we chose previously established in-vitro human Caco-2-based models of differentiated, non-invasive (expressing TLR4 wild-type; termed Caco-2[WT]) versus undifferentiated, invasive (expressing TLR4 mutant D299G; termed Caco-2[D299G]) IEC. Enterocyte-like Caco-2[WT] showed low levels of miR-205 and miR-373 expression, while both miRNAs were significantly upregulated in colorectal carcinoma-like Caco-2[D299G], thus resembling the miRNA expression pattern of paired normal versus tumor samples from MAC patients. Using stable transfection, we generated miR-205-or miR-373-expressing and miR-205-or miR-373-inhibiting subclones of these IEC lines. We found that introduction of miR-205 into Caco-2 [WT] led to expansion of mucus-secreting goblet cell-like cells, which was associated with induction of KLF4, MUC2 and TGF beta 1 expression. Activation of miR-205 in Caco-2[WT] induced chemoresistance, while inhibition of miR-205 in Caco-2[D299G] promoted chemosensitivity. Caco-2[WT] overexpressing miR-373 showed mitotic abnormalities and underwent morphologic changes (loss of epithelial polarity, cytoskeletal reorganization, and junctional disruption) associated with epithelial-mesenchymal transition and progression to inflammation-associated colonic carcinoma, which correlated with induction of phosphorylated STAT3 and N-CADHERIN expression. Functionally, introduction of miR-373 into Caco-2[WT] mediated loss of cell-cell adhesion and increased proliferation and invasion. Reversely, inhibition of miR-373 allowed mesenchymal IEC to regain epithelial properties, which correlated with absence of neoplastic progression. Using xenografts in mice demonstrated miR-373-mediated acceleration of malignant intestinal tumor growth. In conclusion, our results provide first evidence that miR-205 and miR-373 may differentially contribute to the aggressive phenotype of MAC in CRC.	[Eyking, Annette; Frank, Magdalena; Gerken, Guido; Cario, Elke] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Reis, Henning; Schmid, Kurt W.] Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Cario, E (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany.	elke.cario@uni-due.de	Reis, Henning/AAX-9545-2020	Reis, Henning/0000-0003-1373-5295	Deutsche Forschungsgemeinschaft [CA226/4-3]; Interne Forschungsforderung Essen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interne Forschungsforderung Essen	This study was supported by the Deutsche Forschungsgemeinschaft (Grant CA226/4-3 to E.C.) and intramural funding (Interne Forschungsforderung Essen to E.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson AM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-336; Bosman F. T., 2010, WHO CLASSIFICATION O; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cario E, 2006, J IMMUNOL, V176, P4258, DOI 10.4049/jimmunol.176.7.4258; Cario E, 2013, CURR OPIN GASTROEN, V29, P85, DOI 10.1097/MOG.0b013e32835a670e; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Chao CH, 2014, J CLIN INVEST, V124, P3093, DOI 10.1172/JCI73351; Chen D, 2015, ONCOTARGET, V6, P32701, DOI 10.18632/oncotarget.4702; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; DAHIYA R, 1992, CANCER RES, V52, P4655; Debunne H, 2013, ACTA CHIR BELG, V113, P385, DOI 10.1080/00015458.2013.11680951; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Farmer DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076634; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; HANSKI C, 1995, BRIT J CANCER, V72, P1350, DOI 10.1038/bjc.1995.514; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; Hugen N, 2016, NAT REV CLIN ONCOL, V13, P361, DOI 10.1038/nrclinonc.2015.140; Hugen N, 2014, ANN SURG ONCOL, V21, P2963, DOI 10.1245/s10434-014-3706-6; Ivanov AI, 2008, J CELL SCI, V121, P1803, DOI 10.1242/jcs.015842; Kara M, 2015, GENE, V567, P81, DOI 10.1016/j.gene.2015.04.065; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kelemen LE, 2011, LANCET ONCOL, V12, P1071, DOI 10.1016/S1470-2045(11)70058-4; Klaewsongkram J, 2007, J IMMUNOL, V179, P4679, DOI 10.4049/jimmunol.179.7.4679; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leowardi C, 2015, ANN SURG ONCOL, V14, P14; Low D, 2015, ONCOTARGET, V6, P36535, DOI 10.18632/oncotarget.5440; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; Mekenkamp LJM, 2012, EUR J CANCER, V48, P501, DOI 10.1016/j.ejca.2011.12.004; Melis M, 2010, DIS COLON RECTUM, V53, P936, DOI 10.1007/DCR.0b013e3181d320c4; Orang AV, 2014, ASIAN PAC J CANCER P, V15, P4033, DOI 10.7314/APJCP.2014.15.9.4033; Park JS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000658; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sierko E, 2010, THROMB HAEMOSTASIS, V103, P198, DOI 10.1160/TH09-06-0416; Song GA, 2005, INT J ONCOL, V26, P745; Stewart BW, 2014, WORLD CANCER REPORT; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tanaka T, 2011, ONCOL REP, V26, P1329, DOI 10.3892/or.2011.1401; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TIBBETTS LM, 1988, CANCER RES, V48, P3751; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Vosgha H, 2014, CURR CANCER DRUG TAR, V14, P621, DOI 10.2174/156800961407140926105634; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Walsh MD, 2013, MODERN PATHOL, V26, P1642, DOI 10.1038/modpathol.2013.101; Wang DM, 2013, NAT CELL BIOL, V15, P1153, DOI 10.1038/ncb2827; Wei FR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0523-z; Xuan Y, 2015, CANCER LETT, V360, P89, DOI 10.1016/j.canlet.2014.11.051; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou AD, 2012, ONCOGENE, V31, P2968, DOI 10.1038/onc.2011.461; Zhou YN, 2014, MOL BIOL CELL, V25, P2882, DOI 10.1091/mbc.E14-05-0998	58	54	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156871	10.1371/journal.pone.0156871	http://dx.doi.org/10.1371/journal.pone.0156871			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271572	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200024
J	Velusamy, P; Su, CH; Kumar, GV; Adhikary, S; Pandian, K; Gopinath, SCB; Chen, Y; Anbu, P				Velusamy, Palaniyandi; Su, Chia-Hung; Kumar, Govindarajan Venkat; Adhikary, Shritama; Pandian, Kannaiyan; Gopinath, Subash C. B.; Chen, Yeng; Anbu, Periasamy			Biopolymers Regulate Silver Nanoparticle under Microwave Irradiation for Effective Antibacterial and Antibiofilm Activities	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; AG NANOPARTICLES; SODIUM ALGINATE; GREEN SYNTHESIS; PARTICLES; CELLULOSE; TOXICITY	In the current study, facile synthesis of carboxymethyl cellulose (CMC) and sodium alginate capped silver nanoparticles (AgNPs) was examined using microwave radiation and aniline as a reducing agent. The biopolymer matrix embedded nanoparticles were synthesized under various experimental conditions using different concentrations of biopolymer (0.5, 1, 1.5, 2%), volumes of reducing agent (50, 100, 150 mu L), and duration of heat treatment (30 s to 240 s). The synthesized nanoparticles were analyzed by scanning electron microscopy, UV-Vis spectroscopy, X-ray diffraction, and Fourier transform infrared spectroscopy for identification of AgNPs synthesis, crystal nature, shape, size, and type of capping action. In addition, the significant antibacterial efficacy and antibiofilm activity of biopolymer capped AgNPs were demonstrated against different bacterial strains, Staphylococcus aureus MTCC 740 and Escherichia coli MTCC 9492. These results confirmed the potential for production of biopolymer capped AgNPs grown under microwave irradiation, which can be used for industrial and biomedical applications.	[Velusamy, Palaniyandi; Kumar, Govindarajan Venkat; Adhikary, Shritama] SRM Univ, Dept Biotechnol, Sch Bioengn, Kancheepuram, Tamil Nadu, India; [Su, Chia-Hung] Ming Chi Univ Technol, Dept Chem Engn, Taipei, Taiwan; [Pandian, Kannaiyan] Univ Madras, Dept Inorgan Chem, Guindy Campus, Madras, Tamil Nadu, India; [Gopinath, Subash C. B.] Univ Malaysia, Inst Nano Elect Engn, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Arau, Perlis, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur, Malaysia; [Anbu, Periasamy] Inha Univ, Coll Engn, Dept Biol Engn, Inchon, South Korea	SRM Institute of Science & Technology Chennai; Ming Chi University of Technology; University of Madras; Universiti Malaysia Perlis; Universiti Malaya; Inha University	Velusamy, P (corresponding author), SRM Univ, Dept Biotechnol, Sch Bioengn, Kancheepuram, Tamil Nadu, India.	velusamy.p@ktr.srmuniv.ac.in	Chen, Yeng -/A-6873-2011; Gopinath, Subash/D-2953-2015; Velusamy, Palaniyandi/AAA-6517-2022; pandian, Kannaiyan/AAZ-3539-2020; Kumar, G. Venkat/AAL-7001-2020; Govindarajan, Venkat Kumar/N-9424-2016; Su, Chia-Hung/C-2807-2008	Chen, Yeng -/0000-0002-0064-7678; Gopinath, Subash/0000-0002-8347-4687; Velusamy, Palaniyandi/0000-0002-6551-979X; Kumar, G. Venkat/0000-0001-6137-774X; Govindarajan, Venkat Kumar/0000-0001-6137-774X; Velusamy, Palaniyandi/0000-0002-9238-7390; Anbiu, Periasamy/0000-0003-4519-5254; Su, Chia-Hung/0000-0002-4203-5143	High Impact Research grant-"MoE Grant" [UM.C/625/1/HIR/MOE/DENT/09]; High Impact Research grant-"UM-MoHE HIR" [UM.C/625/1/HIR/MOHE/MED/16/5]; Inha University, Republic of Korea	High Impact Research grant-"MoE Grant"; High Impact Research grant-"UM-MoHE HIR"; Inha University, Republic of Korea	YC thanks the support from High Impact Research grants-"MoE Grant UM.C/625/1/HIR/MOE/DENT/09" and "UM-MoHE HIR UM.C/625/1/HIR/MOHE/MED/16/5". PA thanks Inha University, Republic of Korea, for providing a research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank the Nanotechnology Research Centre, Interdisciplinary School of Indian System of Medicine and Department of Physics and Nanotechnology of SRM University for performing SEM, FTIR, and XRD analysis, respectively. We also thank the School of Bioengineering, SRM University for providing the facilities for conduct of these studies. The author would like to thank Inha University Research grant for proof reading support.	Abdel-Halim ES, 2011, CARBOHYD POLYM, V86, P1615, DOI 10.1016/j.carbpol.2011.06.072; Ali K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131178; Avasthi DK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/12/125604; Bankura K, 2014, CARBOHYD POLYM, V107, P151, DOI 10.1016/j.carbpol.2014.02.047; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bhui DK, 2011, J MOL LIQ, V158, P170, DOI 10.1016/j.molliq.2010.11.014; Bonnemann H, 2001, EUR J INORG CHEM, P2455; Campi G, 2011, NANOSCALE, V3, P3774, DOI 10.1039/c1nr10474h; Carneiro-Da-Cunha MG, 2010, CARBOHYD POLYM, V82, P153, DOI 10.1016/j.carbpol.2010.04.043; Darroudi M, 2011, INT J NANOMED, V6, P569, DOI 10.2147/IJN.S16867; Deepika H, 2013, ACS SUSTAIN CHEM ENG, V1, P703; Dipak KB, 2012, CARBOHYD POLYM, V89, P830, DOI [10.1016/j.carbpol.2012.04.017, DOI 10.1016/J.CARBP0L.2012.04.017]; Dwivedi S, 2015, COLLOID SURFACE B, V132, P290, DOI 10.1016/j.colsurfb.2015.05.034; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Fard JK, 2015, ADV PHARM BULL, V5, P447, DOI 10.15171/apb.2015.061; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gopinath SCS, 2009, ANAL CHEM, V81, P4963, DOI 10.1021/ac802757z; Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007; Hebeish AA, 2010, CARBOHYD POLYM, V82, P933, DOI 10.1016/j.carbpol.2010.06.020; Hebeish A, 2013, CARBOHYD POLYM, V92, P407, DOI 10.1016/j.carbpol.2012.08.094; Hsueh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144306; Kou JH, 2013, CHEM COMMUN, V49, P692, DOI 10.1039/c2cc37696b; Kumar M, 2016, PLASMONICS, V11, P261, DOI 10.1007/s11468-015-0044-x; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2010, PHYSICA E, V42, P1940, DOI 10.1016/j.physe.2010.03.002; Kumar M, 2009, PHYS STATUS SOLIDI B, V246, P2232, DOI 10.1002/pssb.200844464; Le Ouay B, 2015, NANO TODAY, V10, P339, DOI 10.1016/j.nantod.2015.04.002; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Li S, 2011, BIOMACROMOLECULES, V12, P2864, DOI 10.1021/bm2001439; Li SM, 2011, CARBOHYD POLYM, V86, P441, DOI 10.1016/j.carbpol.2011.04.060; Li SM, 2011, CARBOHYD POLYM, V83, P422, DOI 10.1016/j.carbpol.2010.08.003; Lin N, 2012, NANOSCALE, V4, P3274, DOI 10.1039/c2nr30260h; Liu K, 2013, J AGR FOOD CHEM, V61, P6562, DOI 10.1021/jf4010065; Lunhong A, 2013, BIORESOURCE TECHNOL, V132, P374, DOI [10.1016/j.biortech.2012.10.161, DOI 10.1016/J.BIORTECH.2012.10.161]; Mishra YK, 2007, SCRIPTA MATER, V56, P629, DOI 10.1016/j.scriptamat.2006.12.008; Mohan YM, 2007, J APPL POLYM SCI, P3375; Mohapatra S, 2008, J NANOSCI NANOTECHNO, V8, P4285, DOI 10.1166/jnn.2008.AN30; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Moulton MC, 2010, NANOSCALE, V2, P763, DOI 10.1039/c0nr00046a; Nadagouda MN, 2011, ACCOUNTS CHEM RES, V44, P469, DOI 10.1021/ar1001457; Pandey S, 2012, INT J BIOL MACROMOL, V51, P583, DOI 10.1016/j.ijbiomac.2012.06.033; Parlak O, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400136; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Rao YN, 2010, RADIAT PHYS CHEM, V79, P1240, DOI 10.1016/j.radphyschem.2010.07.004; Rastogi PK, 2012, MATER SCI ENG B-ADV, V177, P456, DOI 10.1016/j.mseb.2012.02.012; Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j; Sarmast MK, 2016, MOL BIOTECHNOL; Seo SY, 2012, CARBOHYD POLYM, V90, P109, DOI 10.1016/j.carbpol.2012.05.002; Shankar S, 2015, CARBOHYD POLYM, V130, P353, DOI 10.1016/j.carbpol.2015.05.018; Sharma S, 2012, RSC ADV, V2, P5837, DOI 10.1039/c2ra00006g; Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Velusamy P, 2016, J TAIWAN INST CHEM E, V59, P450, DOI 10.1016/j.jtice.2015.07.018; Velusamy P, 2015, IND CROP PROD, V66, P103, DOI 10.1016/j.indcrop.2014.12.042; Vishvanath T, 2014, J NANOMED NANOTECHNO, V5, P6; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wei DW, 2009, CARBOHYD RES, V344, P2375, DOI 10.1016/j.carres.2009.09.001; Yang JS, 2012, ACTA MATER, V60, P4753, DOI 10.1016/j.actamat.2012.05.037; Yang LB, 2007, J PHYS CHEM C, V111, P5300, DOI 10.1021/jp067010s; Zhao XH, 2014, COLLOID SURFACE A, V444, P180, DOI 10.1016/j.colsurfa.2013.12.008	61	47	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157612	10.1371/journal.pone.0157612	http://dx.doi.org/10.1371/journal.pone.0157612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304672	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800078
J	Chen, YC; Liu, CS; Parker, WD; Chen, HY; Beach, TG; Liu, XH; Serrano, GE; Lu, YF; Huang, JJ; Yang, KF; Wang, CM				Chen, Yucai; Liu, Changsheng; Parker, William Davis; Chen, Hongyi; Beach, Thomas G.; Liu, Xinhua; Serrano, Geidy E.; Lu, Yanfen; Huang, Jianjun; Yang, Kunfang; Wang, Chunmei			Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer's Disease: Analysis of 13 Cases	PLOS ONE			English	Article							KEARNS-SAYRE SYNDROME; DONATION PROGRAM; RIBOSOMAL-RNA; MUTATIONS; TRANSCRIPTION; PROTEIN; CELLS; DYSFUNCTION; DEFICIENCY; DELETIONS	Background Mitochondrial dysfunction may play a central role in the pathologic process of Alzheimer's disease (AD), but there is still a scarcity of data that directly links the pathology of AD with the alteration of mitochondrial DNA. This study aimed to provide a comprehensive assessment of mtDNA rearrangement events in AD brain tissue. Patients and Methods Postmortem frozen human brain cerebral cortex samples were obtained from the Banner Sun Health Research Institute Brain and Body Donation Program, Sun City, AZ. Mitochondria were isolated and direct sequence by using MiSeq (R), and analyzed by relative software. Results Three types of mitochondrial DNA (mtDNA) rearrangements have been seen in post mortem human brain tissue from patients with AD and age matched control. These observed rearrangements include a deletion, F-type rearrangement, and R-type rearrangement. We detected a high level of mtDNA rearrangement in brain tissue from cognitively normal subjects, as well as the patients with Alzheimer's disease (AD). The rate of rearrangements was calculated by dividing the number of positive rearrangements by the coverage depth. The rearrangement rate was significantly higher in AD brain tissue than in control brain tissue (17.9% versus 6.7%; p = 0.0052). Of specific types of rearrangement, deletions were markedly increased in AD (9.2% versus 2.3%; p = 0.0005). Conclusions Our data showed that failure of mitochondrial DNA in AD brain might be important etiology of AD pathology.	[Chen, Yucai; Lu, Yanfen; Huang, Jianjun; Yang, Kunfang; Wang, Chunmei] Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China; [Chen, Yucai; Parker, William Davis; Chen, Hongyi] Univ Illinois, Dept Pediat, Peoria, IL USA; [Liu, Changsheng; Liu, Xinhua] SoftGenetics LLC, State Coll, PA USA; [Beach, Thomas G.; Serrano, Geidy E.] Banner Sun Hlth Res Inst, Sun City, AZ USA	Shanghai Jiao Tong University; University of Illinois System; University of Illinois Peoria; Banner Research; Banner Health; Banner Sun Health Research Institute	Chen, YC (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China.; Chen, YC (corresponding author), Univ Illinois, Dept Pediat, Peoria, IL USA.	chenyucaiphd@hotmail.com			Pediatrics Department, University of Illinois College of Medicine at Peoria; Shanghai Children's Hospital, Shanghai Jiao Tong University; National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-90, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	Pediatrics Department, University of Illinois College of Medicine at Peoria; Shanghai Children's Hospital, Shanghai Jiao Tong University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported funding from Pediatrics Department, University of Illinois College of Medicine at Peoria, and funding from Shanghai Children's Hospital, Shanghai Jiao Tong University. The authors are grateful to the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona for the provision of human brain tissue. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011,05-90 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. Changsheng Liu and Xinhua Liu from SoftGenetics LLC played a role in sequence data analysis by using modified NextGENe software. Changsheng Liu also played a role in preparation of the manuscript.; We thank the individual brain donors and their families for their extremely generous gift. We thank the scientists of SoftGenetics LLC for modifying NextGENe software for this project. We thank Peggy Mankin for her assistance with the preparation of this manuscript. This work was supported funding from Pediatrics Department, University of Illinois College of Medicine at Peoria, and funding from Shanghai Children's Hospital, Shanghai Jiao Tong University. We are grateful to the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona for the provision of human brain tissue. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011,05-90and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. Changsheng Liu and Xinhua Liu from SoftGenetics LLC play a role in sequence data analysis by using modified NextGENe software. Changsheng Liu also plays a role in preparation of the manuscript.	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982; Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Hyman B. T., 1997, EXP NEUROL, V56, P1095, DOI [10.1097/00005072-199710000-00002, DOI 10.1097/00005072-199710000-00002]; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021; Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; NAKASE H, 1990, AM J HUM GENET, V46, P418; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Sulijoadikusumo I, 2001, BIOCHEMISTRY-US, V40, P11559, DOI 10.1021/bi015526q; WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0154582	10.1371/journal.pone.0154582	http://dx.doi.org/10.1371/journal.pone.0154582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299301	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200004
J	Heydarchi, B; Center, RJ; Gonelli, C; Muller, B; Mackenzie, C; Khoury, G; Lichtfuss, M; Rawlin, G; Purcell, DFJ				Heydarchi, Behnaz; Center, Rob J.; Gonelli, Christopher; Muller, Brian; Mackenzie, Charlene; Khoury, Georges; Lichtfuss, Marit; Rawlin, Grant; Purcell, Damian F. J.			Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response	PLOS ONE			English	Article							HYPERIMMUNE BOVINE COLOSTRUM; PREEXPOSURE PROPHYLAXIS; BROAD NEUTRALIZATION; ENVELOPE PROTEIN; VIRUS; TRIMERS; SITE; POTENT; GP120; TRANSMISSION	An important feature of a potential vaccine against HIV is the production of broadly neutralising antibodies (BrNAbs) capable of potentially blocking infectivity of a diverse array of HIV strains. BrNAbs naturally arise in some HIV infected individuals after several years of infection and their serum IgG can neutralise various HIV strains across different subtypes. We previously showed that vaccination of cows with HIV gp140 AD8 trimers resulted in a high titre of serum IgG against HIV envelope (Env) that had strong BrNAb activity. These polyclonal BrNAbs concentrated into the colostrum during the late stage of pregnancy and can be harvested in vast quantities immediately after calving. In this study, we investigated the effect of prolonged HIV gp140 vaccination on bovine colostrum IgG HIV Env-binding and BrNAb activity over subsequent pregnancies. Repeated immunisation led to a maintained high titre of HIV Env specific IgG in the colostrum batches, but this did not increase through repeated cycles. Colostrum IgG from all batches also strongly competed with sCD4 binding to gp140 Env trimer and with human-derived monoclonal VRC01 and b12 BrNAbs that bind the CD4 binding site (CD4bs). Furthermore, competition neutralisation assays using RSC3 Env gp120 protein core and a derivative CD4bs mutant, RSC3 Delta 371I/P363N, showed that CD4bs neutralising antibodies contribute to the neutralising activity of all batches of purified bovine colostrum IgG. This result indicates that the high IgG titre/avidity of anti-CD4bs antibodies with BrNAb activity was achieved during the first year of vaccination and was sustained throughout the years of repeated vaccinations in the cow tested. Although IgG of subsequent colostrum batches may have a higher avidity towards the CD4bs, the overall breadth in neutralisation was not enhanced. This implies that the boosting vaccinations over 4 years elicited a polyclonal antibody response that maintained the proportion of both neutralising and non-neutralising CD4bs antibodies.	[Heydarchi, Behnaz; Center, Rob J.; Gonelli, Christopher; Muller, Brian; Mackenzie, Charlene; Khoury, Georges; Lichtfuss, Marit; Rawlin, Grant; Purcell, Damian F. J.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Center, Rob J.] Burnet Inst, Ctr Biomed Res, Prahran, Vic, Australia	University of Melbourne; Burnet Institute	Purcell, DFJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	dfjp@unimelb.edu.au	Purcell, Damian F/G-5068-2011; Khoury, Georges/AGZ-0672-2022; Khoury, Georges/AGY-8421-2022	Khoury, Georges/0000-0002-2136-2487; HEYDARCHI, BEHNAZ/0000-0003-3043-1322; Gonelli, Christopher/0000-0002-7521-8528	Immuron Ltd; AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH [12042, 12362]	Immuron Ltd; AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Immuron Ltd funded the animal husbandry and veterinarian support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ian Gill and Noel Russell for Veterinary care of the cows and Victor Wong and Gerhardt Rank for technical assistance. RSC3 (catalog no. 12042) and RSC3 Delta 371I/P363N (catalog no. 12362) were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH, from Zhi-Yong Yang, Peter Kwong, and Gary Nabel.	Beddows S, 1999, J VIROL, V73, P1740, DOI 10.1128/JVI.73.2.1740-1745.1999; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bower JF, 2004, J VIROL, V78, P4710, DOI 10.1128/JVI.78.9.4710-4719.2004; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Center RJ, 2009, VACCINE, V27, P6605, DOI 10.1016/j.vaccine.2009.08.016; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; EARL PL, 1989, AIDS RES HUM RETROV, V5, P23, DOI 10.1089/aid.1989.5.23; Goo L, 2012, J VIROL, V86, P9566, DOI 10.1128/JVI.00953-12; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; HAIGWOOD NL, 1990, AIDS RES HUM RETROV, V6, P855, DOI 10.1089/aid.1990.6.855; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaushik AK, 2009, VET IMMUNOL IMMUNOP, V127, P106, DOI 10.1016/j.vetimm.2008.09.024; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kramski M, 2012, EUR J IMMUNOL, V42, P2771, DOI 10.1002/eji.201242469; Kramski M, 2012, ANTIMICROB AGENTS CH, V56, P4310, DOI 10.1128/AAC.00453-12; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mayer KH, 2001, CLIN INFECT DIS, V32, P476, DOI 10.1086/318496; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Rademeyer C, 2007, VIROLOGY, V368, P172, DOI 10.1016/j.virol.2007.06.013; Ramjee G, 2010, AIDS, V24, pS40, DOI 10.1097/01.aids.0000390706.81383.f3; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhao YF, 2006, DEV COMP IMMUNOL, V30, P175, DOI 10.1016/j.dci.2005.06.012; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157353	10.1371/journal.pone.0157353	http://dx.doi.org/10.1371/journal.pone.0157353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300145	Green Published, gold			2022-12-26	WOS:000377822200039
J	Garonzik, SM; Lenhard, JR; Forrest, A; Holden, PN; Bulitta, JB; Tsuji, BT				Garonzik, Samira M.; Lenhard, Justin R.; Forrest, Alan; Holden, Patricia N.; Bulitta, Jurgen B.; Tsuji, Brian T.			Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach	PLOS ONE			English	Article							PARTICULARLY TISSUE PENETRATION; PROTEIN-BINDING; BACTERICIDAL ACTIVITY; PSEUDOMONAS-AERUGINOSA; BETA-LACTAMS; MODEL; VANCOMYCIN; SUSCEPTIBILITY; CIPROFLOXACIN; CEFTAZIDIME	Our objective was to study the pharmacodynamics of daptomycin in the presence of varying concentrations of human serum (HS) in vitro to quantify the fraction of daptomycin that is 'active'. Time kill experiments were performed with daptomycin (0 to 256 mg/L) against two MRSA strains at log-phase growth, in the presence of HS (0%, 10%, 30%, 50%, 70%) combined with Mueller-Hinton broth. Daptomycin >= 2 mg/L achieved 99.9% kill within 8 h at all HS concentrations; early killing activity was slightly attenuated at higher HS concentrations. After 1 h, bacterial reduction of USA300 upon exposure to daptomycin 4 mg/L ranged from -3.1 to -0.5 log(10)CFU/mL in the presence of 0% to 70% HS, respectively. Bactericidal activity was achieved against both strains at daptomycin >= 4 mg/L for all fractions of HS exposure. A mechanism-based mathematical model (MBM) was developed to estimate the active daptomycin fraction at each %HS, comprising 3 bacterial subpopulations differing in daptomycin susceptibility. Time-kill data were fit with this MBM with excellent precision (r(2) > 0.95). The active fraction of daptomycin was estimated to range from 34.6% to 25.2% at HS fractions of 10% to 70%, respectively. Despite the reported low unbound fraction of daptomycin, the impact of protein binding on the activity of daptomycin was modest. The active fraction approach can be utilized to design in vitro experiments and to optimize therapeutic regimens of daptomycin in humans.	[Garonzik, Samira M.; Lenhard, Justin R.; Forrest, Alan; Holden, Patricia N.; Bulitta, Jurgen B.; Tsuji, Brian T.] Sch Pharm & Pharmaceut Sci Buffalo, Lab Antimicrobial Pharmacodynam, Buffalo, NY USA; [Lenhard, Justin R.; Holden, Patricia N.; Tsuji, Brian T.] Univ Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA; [Forrest, Alan] Univ N Carolina, Sch Pharm, Dept Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Bulitta, Jurgen B.] Univ Florida, Coll Pharm, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA; [Garonzik, Samira M.] Bristol Myers Squibb Co, Jersey City, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; Bristol-Myers Squibb	Tsuji, BT (corresponding author), Sch Pharm & Pharmaceut Sci Buffalo, Lab Antimicrobial Pharmacodynam, Buffalo, NY USA.; Tsuji, BT (corresponding author), Univ Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA.	btsuji@buffalo.edu	Lenhard, Justin/M-6681-2018; Bulitta, Jurgen B/P-3355-2018	Lenhard, Justin/0000-0002-2570-7593; Bulitta, Jurgen B/0000-0001-7352-3097	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI111990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111990] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Cubist Pharmaceuticals provided the daptomycin for the experiments; however, Cubist Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BT's and JL's participation was supported by research grants from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI111990 (description at: http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8826683). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. NIH did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulitta JB, 2010, ANTIMICROB AGENTS CH, V54, P2051, DOI 10.1128/AAC.00881-09; Bulitta JB, 2009, ANTIMICROB AGENTS CH, V53, P46, DOI 10.1128/AAC.00489-08; Cafini E, 2007, J ANTIMICROB CHEMOTH, V59, P1185, DOI 10.1093/jac/dkm078; Cha R, 2004, J ANTIMICROB CHEMOTH, V54, P259, DOI 10.1093/jac/dkh259; CRAIG WA, 1977, CLIN PHARMACOKINET, V2, P252, DOI 10.2165/00003088-197702040-00002; DUDLEY MN, 1987, AM J MED, V82, P363; Eisenstein BI, 2004, EXPERT OPIN INV DRUG, V13, P1159, DOI 10.1517/13543784.13.9.1159; GARRISON MW, 1990, ANTIMICROB AGENTS CH, V34, P1925, DOI 10.1128/AAC.34.10.1925; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Jung D, 2008, CHEM PHYS LIPIDS, V154, P120, DOI 10.1016/j.chemphyslip.2008.04.004; Meagher AK, 2004, ANTIMICROB AGENTS CH, V48, P2061, DOI 10.1128/AAC.48.6.2061-2068.2004; Moise PA, 2009, LANCET INFECT DIS, V9, P617, DOI 10.1016/S1473-3099(09)70200-2; Mouton JW, 1997, ANTIMICROB AGENTS CH, V41, P733, DOI 10.1128/AAC.41.4.733; Smith PF, 2006, DIAGN MICR INFEC DIS, V56, P379, DOI 10.1016/j.diagmicrobio.2006.06.019; Treyaprasert W, 2007, INT J ANTIMICROB AG, V29, P263, DOI 10.1016/j.ijantimicag.2006.08.049; Tsuji BT, 2008, DIAGN MICR INFEC DIS, V60, P441, DOI 10.1016/j.diagmicrobio.2007.11.011; Tsuji BT, 2008, ANTIMICROB AGENTS CH, V52, P1533, DOI 10.1128/AAC.01254-07; WISE R, 1983, J ANTIMICROB CHEMOTH, V12, P1, DOI 10.1093/jac/12.1.1; WISE R, 1983, J ANTIMICROB CHEMOTH, V12, P105, DOI 10.1093/jac/12.2.105; WISE R, 1978, LANCET, V2, P431; WISE R, 1985, J ANTIMICROB CHEMOTH, V15, P77, DOI 10.1093/jac/15.suppl_A.77; WISE R, 1986, CLIN PHARMACOKINET, V11, P470, DOI 10.2165/00003088-198611060-00004; Zeitlinger MA, 2011, ANTIMICROB AGENTS CH, V55, P3067, DOI 10.1128/AAC.01433-10	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156131	10.1371/journal.pone.0156131	http://dx.doi.org/10.1371/journal.pone.0156131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284923	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000008
J	Shapira, S; Pleban, S; Kazanov, D; Tirosh, P; Arber, N				Shapira, Shiran; Pleban, Shlomo; Kazanov, Diana; Tirosh, Peter; Arber, Nadir			Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers	PLOS ONE			English	Article							TEA TREE OIL; PERILLYL ALCOHOL; GENE-THERAPY; CD24; COMPONENT; CELLS; L.	Background Terpinen-4-ol, a naturally occurring monoterpene is the main bioactive component of tea-tree oil and has been shown to have many biological activities. Aim To study the antitumor effects of terpinen-4-ol and its mechanism of action in prostate and GI malignancies, alone and in combination with chemotherapeutic and biological agents. Methods Terpinen-4-ol was administrated alone or combined with standard chemotherapy (Oxaliplatin, Fluorouracil, Gemcitabine, Tarceva) and biological agent (Cetuximab). It was also combined with humanized anti-CD24 mAbs (was developed by us). Killing effects were measured qualitatively by light microscopy and quantitatively using the MTT and FACS analysis, following treatment of colorectal, pancreatic, gastric and prostate cancer cells. Terpinen-4-ol effect on tumor development was evaluated in xenograft model. Results Terpinen-4-ol induces a significant growth inhibition of colorectal, pancreatic, prostate and gastric cancer cells in a dose-dependent manner (10-90% in 0.005-0.1%). Terpinen-4-ol and various anti-cancer agents (0.2 mu M oxaliplatin and 0.5 mu M fluorouracil) demonstrated a synergistic inhibitory effect (83% and 91%, respectively) on cancer cell proliferation. In KRAS mutated colorectal cancer cells, which are resistant to anti-EGFR therapy, combining of terpinen-4-ol with cetuximab (1 mu M) resulted in impressive efficacy of 80-90% growth inhibition. Sub-toxic concentrations of terpinen-4-ol potentiate anti-CD24 mAb (150 mu g/ml)-induced growth inhibition (90%). Considerable reduction in tumor volume was seen following terpinen-4-ol (0.2%) treatment alone and with cetuximab (10mg/kg) (40% and 63%, respectively) as compare to the control group. Conclusion Terpinen-4-ol significantly enhances the effect of several chemotherapeutic and biological agents. The possible molecular mechanism for its activity involves induction of cell-death rendering this compound as a potential anti-cancer drug alone and in combination in the treatment of numerous malignancies. Terpinen-4-ol restores the activity of cetuximab in cancers with mutated KRAS.	[Shapira, Shiran; Kazanov, Diana; Arber, Nadir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Mol Biol,Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel; [Pleban, Shlomo; Tirosh, Peter] EMERALD BIO LABS LTD, Netanya, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Arber, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Mol Biol,Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel.	nadir@tlvmc.gov.il		Arber, Nadir/0000-0001-5283-6991	EMERALD BIO-LABS LTD	EMERALD BIO-LABS LTD	EMERALD BIO-LABS LTD provided support in the form of salaries for authors SP & PT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arweiler N B, 2000, Clin Oral Investig, V4, P70, DOI 10.1007/s007840050118; Astani A, 2010, PHYTOTHER RES, V24, P673, DOI 10.1002/ptr.2955; Barra A, 2007, J AGR FOOD CHEM, V55, P7093, DOI 10.1021/jf071129w; Calcabrini A, 2004, J INVEST DERMATOL, V122, P349, DOI 10.1046/j.0022-202X.2004.22236.x; Cha JD, 2007, PHYTOTHER RES, V21, P295, DOI 10.1002/ptr.1864; Da Fonseca CO, 2006, SURG NEUROL, V66, P611, DOI 10.1016/j.surneu.2006.02.034; da Fonseca CO, 2008, SURG NEUROL, V70, P259, DOI 10.1016/j.surneu.2007.07.040; Dryden MS, 2004, J HOSP INFECT, V56, P283, DOI 10.1016/j.jhin.2004.01.008; Dvory-Sobol H, 2005, BIOMED PHARMACOTHER, V59, pS370, DOI 10.1016/S0753-3322(05)80081-2; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gould MN, 1997, ENVIRON HEALTH PERSP, V105, P977, DOI 10.2307/3433313; Greay SJ, 2010, CANCER CHEMOTH PHARM, V65, P877, DOI 10.1007/s00280-009-1093-7; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lim SC, 2005, PATHOL RES PRACT, V201, P479, DOI 10.1016/j.prp.2005.05.004; Lisiansky V, 2012, CANCER GENE THER, V19, P862, DOI 10.1038/cgt.2012.73; Loughlin R, 2008, LETT APPL MICROBIOL, V46, P428, DOI 10.1111/j.1472-765X.2008.02334.x; Martin KW, 2004, MYCOSES, V47, P87, DOI 10.1046/j.1439-0507.2003.00951.x; Mertas A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/590470; Mondello F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-158; Naumov I, 2012, EXP CELL RES, V318, P160, DOI 10.1016/j.yexcr.2011.09.015; Pino JA, 2003, J AGR FOOD CHEM, V51, P3836, DOI 10.1021/jf020733y; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Sagiv Eyal, 2008, Expert Rev Gastroenterol Hepatol, V2, P125, DOI 10.1586/17474124.2.1.125; Shapira S, 2011, GASTROENTEROLOGY, V140, P935, DOI 10.1053/j.gastro.2010.12.004; Sobral Marianna Vieira X AL, 2014, SCI WORLD J, V2014; Suzuki T, 2001, J IMMUNOL, V166, P5567, DOI 10.4049/jimmunol.166.9.5567; Wagner KH, 2003, ANN NUTR METAB, V47, P95, DOI 10.1159/000070030; Wu CS, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/818261	28	44	47	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156540	10.1371/journal.pone.0156540	http://dx.doi.org/10.1371/journal.pone.0156540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275783	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700028
J	Tiruneh, YM; Galarraga, O; Genberg, B; Wilson, IB				Tiruneh, Yordanos M.; Galarraga, Omar; Genberg, Becky; Wilson, Ira B.			Retention in Care among HIV-Infected Adults in Ethiopia, 2005-2011: A Mixed-Methods Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PATIENT RETENTION; TREATMENT PROGRAM; HERBAL MEDICINE; EARLY MORTALITY; FOLLOW-UP; ADHERENCE; BARRIERS; PREDICTORS; INITIATION	Background Poor retention in HIV care challenges the success of antiretroviral therapy (ART). This study assessed how well patients stay in care and explored factors associated with retention in the context of an initial ART rollout in Sub-Saharan Africa. Methods We conducted a mixed-methods study at a teaching hospital in Addis Ababa, Ethiopia. A cohort of 385 patients was followed for a median of 4.6 years from ART initiation to lost-to-follow- up (LTFU-missing appointments for more than three months after last scheduled visit or administrative censoring). We used Kaplan-Meier plots to describe LTFU over time and Cox-regression models to identify factors associated with being LTFU. We held six focus group discussions, each with 6-11 patients enrolled in care; we analyzed data inductively informed by grounded theory. Results Patients in the cohort were predominantly female (64%) and the median age was 34 years. Thirty percent were LTFU by study's end; the median time to LTFU was 1,675 days. Higher risk of LTFU was associated with baseline CD4 counts <100 and >200 cells/mu L (HR = 1.62; 95% CI: 1.03-2.55; and HR = 2.06; 95% CI: 1.15-3.70, respectively), compared with patients with baseline CD4 counts of 100-200 cells/mu L. Bedridden participants at ART initiation (HR = 2.05; 95% CIs [1.11-3.80]) and those with no or only primary education (HR = 1.50; 95% CIs [1.00-2.24]) were more likely to be LTFU. Our qualitative data revealed that fear of stigma, care dissatisfaction, use of holy water, and economic constraints discouraged retention in care. Social support and restored health and functional ability motivated retention. Conclusion Complex socio-cultural, economic, and health-system factors inhibit optimum patient retention. Better tracking, enhanced social support, and regular adherence counseling addressing stigma and alternative healing options are needed. Intervention strategies aimed at changing clinic routines and improving patient-provider communication could address many of the identified barriers.	[Tiruneh, Yordanos M.; Galarraga, Omar; Genberg, Becky; Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA	Brown University	Tiruneh, YM (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.	yordanos_tiruneh@brown.edu	Galarraga, Omar/N-1622-2019	Galarraga, Omar/0000-0002-9985-9266; Genberg, Becky/0000-0002-9450-5311; Tiruneh, Yordanos/0000-0001-9296-9908	department of Sociology; Graduate School of Northwestern University; Agency for Healthcare Research and Quality [T32HS000011]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH092242, K01MH099966] Funding Source: NIH RePORTER	department of Sociology; Graduate School of Northwestern University; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the department of Sociology and The Graduate School of Northwestern University, and by grant number T32HS000011 from the Agency for Healthcare Research and Quality.	Abdulwadud O, 2011, ETHIOP J HEALTH DEV, V25, P110; Ahmed I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-867; Alvarez-Uria G, 2013, FACTORS ASS ATTRITIO, P6; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Assefa Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-45; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Balcha TT, 2011, J INT ASS PHYS AIDS; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Bezabhe WM, 2014, BARRIERS FACILITATOR; Bhatta L, 2006, BMC INFECT DIS; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Buchberg MK, 2015, AIDS PATIENT CARE ST, V29, P126, DOI 10.1089/apc.2014.0227; Catz SL, 1999, AIDS CARE, V11, P361, DOI 10.1080/09540129947983; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; Dessalegn M., 2015, J AIDS HIV RES, V7, P1, DOI DOI 10.5897/JAHR2014.0315; Edwards JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102305; Federal Ministry of Health, 2007, GUID PREV MOTH TO CH; Federal Ministry of Health, 2008, GUID MAN OPP INF ANT; Federal Ministry of Health (F-MOH), 2007, GUID IMPL ANT THER P; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Holtzman CW, 2015, AIDS CARE, V27, P817, DOI 10.1080/09540121.2015.1009362; Hsiao AF, 2003, JAIDS-J ACQ IMM DEF, V33, P157, DOI 10.1097/00126334-200306010-00007; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jones DL, 2013, J ASSOC NURSE AIDS C, V24, pE1, DOI 10.1016/j.jana.2012.06.009; Kalichman SC, 2011, ANN BEHAV MED, V42, P111, DOI 10.1007/s12160-011-9271-3; Kloos H, 2013, ETHIOP J HEALTH DEV, V27, P141; Kulkarni S, 2015, J INT ASS PROVIDERS; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Levinson W, 2010, HEALTH AFFAIR, V29, P1310, DOI 10.1377/hlthaff.2009.0450; Lifson Alan R, 2013, J Int Assoc Provid AIDS Care, V12, P32, DOI 10.1177/1545109712456428; Mallinson RK, 2007, AIDS PATIENT CARE ST, V21, pS77, DOI 10.1089/apc.2007.9984; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mugisha V, 2014, PLOS ONE, V9; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Namuddu B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-855; Rao Kavitha C, 2013, J Int Assoc Provid AIDS Care, V12, P178, DOI 10.1177/2325957412472058; Rathert C, 2012, MED CARE RES REV; Relf MV, 2015, J ASSOC NURSE AIDS C, V26, P36, DOI 10.1016/j.jana.2014.03.003; Robinson JH, 2008, J AM ACAD NURSE PRAC, V20, P600, DOI 10.1111/j.1745-7599.2008.00360.x; Sabin LL, 2008, AIDS CARE, V20, P1242, DOI 10.1080/09540120801918651; Schoni-Affolter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027919; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Strauss A., 1998, BASICS QUALITATIVE R; Tadele A., 2014, J AIDS CLIN RES; Tiruneh YM., 2012, INTERNATIONAL PUBLIC, V4, P403; Tsegaye E, 2011, ETHIOPIAN J HLTH DEV, V25; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629; WUBSHET M, 2012, AIDS, V2012, P1, DOI DOI 10.5402/2012/721720; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197; Yang GLL, 2015, ASIA-PAC J PUBLIC HE, V27, p86S, DOI 10.1177/1010539514548758; Yehia BR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0990-0	67	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156619	10.1371/journal.pone.0156619	http://dx.doi.org/10.1371/journal.pone.0156619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272890	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000024
J	Atwood, BL; Woolnough, JL; Lefevre, GM; Ribeiro, MS; Felsenfeld, G; Giles, KE				Atwood, Blake L.; Woolnough, Jessica L.; Lefevre, Gaelle M.; Ribeiro, Mariana Saint Just; Felsenfeld, Gary; Giles, Keith E.			Human Argonaute 2 Is Tethered to Ribosomal RNA through MicroRNA Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; ChIP-sequencing (ChIP-seq); Dicer; microRNA (miRNA); ribosomal ribonucleic acid (rRNA) (ribosomal RNA); miRNA; par-clip; rRNA	HUMAN-CELLS; GENE-EXPRESSION; BINDING-SITES; POLYMERASE I; PAR-CLIP; TARGET; NUCLEOLUS; PROTEIN; HETEROCHROMATIN; DICER	The primary role of the RNAi machinery is to promote mRNA degradation within the cytoplasm in a microRNA-dependent manner. However, both Dicer and the Argonaute protein family have expanded roles in gene regulation within the nucleus. To further our understanding of this role, we have identified chromatin binding sites for AGO2 throughout the 45S region of the human rRNA gene. The location of these sites was mirrored by the positions of AGO2 cross-linking sites identified via PAR-CLIP-seq. AGO2 binding to the rRNA within the nucleus was confirmed by RNA immunoprecipitation and quantitative-PCR. To explore a possible mechanism by which AGO2 could be recruited to the rRNA, we identified 1174 regions within the 45S rRNA transcript that have the ability to form a perfect duplex with position 2-6 (seed sequence) of each microRNA expressed in HEK293T cells. Of these potential AGO2 binding sites, 479 occurred within experimentally verified AGO2-rRNA cross-linking sites. The ability of AGO2 to cross-link to rRNA was almost completely lost in a DICER knock-out cell line. The transfection of miR-92a-2-3p into the noDICE cell line facilitated AGO2 cross-linking at a region of the rRNA that has a perfect seed match at positions 3-8, including a single G-U base pair. Knockdown of AGO2 within HEK293T cells causes a slight, but statistically significant increase in the overall rRNA synthesis rate but did not impact the ratio of processing intermediates or the recruitment of the Pol I transcription factor UBTF.	[Atwood, Blake L.; Woolnough, Jessica L.; Ribeiro, Mariana Saint Just; Giles, Keith E.] Univ Alabama Birmingham, UAB Stem Cell Inst, Dept Biochem & Mol Genet, Birmingham, AL 35209 USA; [Lefevre, Gaelle M.; Felsenfeld, Gary] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Giles, KE (corresponding author), Univ Alabama Birmingham, UAB Stem Cell Inst, Dept Biochem & Mol Genet, Birmingham, AL 35209 USA.	kegiles@uab.edu		Makofske, Jessica/0000-0002-6547-6451	National Institutes of Health, NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health, NIDDK Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allo M, 2014, P NATL ACAD SCI USA, V111, P15622, DOI 10.1073/pnas.1416858111; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; [Anonymous], 2014, Cancer Discov, V4, pOF5, DOI 10.1158/2159-8290.CD-NB2014-154; Bai BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107519; Bai BY, 2014, FEBS OPEN BIO, V4, P441, DOI 10.1016/j.fob.2014.04.010; Bailey T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003326; Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hein N, 2013, TRENDS MOL MED, V19, P643, DOI 10.1016/j.molmed.2013.07.005; Huang V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003821; Ierusalimsky VN, 2016, BRAIN RES, V1633, P139, DOI 10.1016/j.brainres.2015.12.049; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joseph TT, 2012, PROTEINS, V80, P1283, DOI 10.1002/prot.24025; Kanellopoulou C, 2009, P NATL ACAD SCI USA, V106, P1122, DOI 10.1073/pnas.0812210106; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Klinghoffer RA, 2010, RNA, V16, P879, DOI 10.1261/rna.1977810; KRAMER B, 1980, J ANAT, V130, P809; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Li ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070869; Liang XH, 2011, NUCLEIC ACIDS RES, V39, P4875, DOI 10.1093/nar/gkr076; MCELHONE MJ, 1971, BIOCHEM J, V125, P821, DOI 10.1042/bj1250821; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pickering BF, 2011, J BIOL CHEM, V286, P44095, DOI 10.1074/jbc.M111.265439; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roberts TC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.40; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Woolnough JL, 2015, MOL CELL BIOL, V35, P2278, DOI 10.1128/MCB.00076-15; Yang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4818; Yilmazel B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-192; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; ZATSEPINA OV, 1993, CHROMOSOMA, V102, P599, DOI 10.1007/BF00352307; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17919	17928		10.1074/jbc.M116.725051	http://dx.doi.org/10.1074/jbc.M116.725051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27288410	hybrid, Green Published			2022-12-26	WOS:000383241300035
J	Li, TZ; Tong, X; Yang, Q; Giddens, JP; Wang, LX				Li, Tiezheng; Tong, Xin; Yang, Qiang; Giddens, John P.; Wang, Lai-Xi			Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; EFFICIENT CHEMOENZYMATIC SYNTHESIS; DEPENDENT CELLULAR CYTOTOXICITY; MONOCLONAL-ANTIBODY; ANTIINFLAMMATORY ACTIVITY; THERAPEUTIC ACTIVITY; IGG FC; IMMUNOGLOBULIN-G; GLYCANS; GLYCOPROTEINS	Glycosylation can exert a profound impact on the structures and biological functions of antibodies. Glycosylation remodeling using the endoglycosidase-catalyzed deglycosylation and transglycosylation approach is emerging as a promising platform to produce homogeneous glycoforms of antibodies, but the broad application of this method will require the availability of highly efficient glycosynthase mutants. We describe in this paper a systematic site-directed mutagenesis of an endoglycosidase from Streptococcus pyogenes of serotype M49 (Endo-S2) and the evaluation of the resulting mutants for their hydrolysis and transglycosylation activities. We found that mutations at the Asp-184 residue gave mutants that demonstrated significantly different properties, some possessed potent transglycosylation activity with diminished hydrolysis activity but others did not, which would be otherwise difficult to predict without the comparative study. In contrast to the previously reported Endo-S mutants that are limited to action on complex type N-glycans, the Endo-S2 glycosynthases described here, including D184M and D184Q, were found to have remarkably relaxed substrate specificity and were capable of transferring three major types (complex, high-mannose, and hybrid type) of N-glycans for antibody glycosylation remodeling. In addition, the Endo-S2 glycosynthase mutants were found to be much more active in general than the Endo-S mutants for transglycosylation. The usefulness of these Endo-S2 glycosynthase mutants was exemplified by an efficient glycosylation remodeling of two therapeutic monoclonal antibodies, rituximab and trastuzumab (Herceptin).	[Li, Tiezheng; Tong, Xin; Yang, Qiang; Giddens, John P.; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA.	wang518@umd.edu	Wang, Lai-Xi/E-8790-2019; Wang, Lai-Xi/E-8755-2019; Tong, Xin/AAP-7528-2020; Wang, Xin/GYU-1129-2022; wang, xiao/HGB-7081-2022; wang, xl/Y-8251-2019; Wang, Xin/AAN-8435-2021	Wang, Lai-Xi/0000-0003-4293-5819; wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Giddens, John/0000-0001-8123-8704	National Institutes of Health [R01 GM080374, R01 GM096973]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096973, R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM080374 and R01 GM096973 (to L. X. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Aggarwal SR, 2014, NAT BIOTECHNOL, V32, P323, DOI 10.1038/nbt.2864; Aggarwal S, 2012, NAT BIOTECHNOL, V30, P1191, DOI 10.1038/nbt.2437; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Giddens JP, 2016, J BIOL CHEM, V291, P9356, DOI 10.1074/jbc.M116.721597; Giddens JP, 2015, METHODS MOL BIOL, V1321, P375, DOI 10.1007/978-1-4939-2760-9_25; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Illidge T, 2014, EXPERT OPIN BIOL TH, V14, P1507, DOI 10.1517/14712598.2014.948414; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Lin CW, 2015, P NATL ACAD SCI USA, V112, P10611, DOI 10.1073/pnas.1513456112; Liu RP, 2016, MABS-AUSTIN, V8, P340, DOI 10.1080/19420862.2015.1113361; Le NPL, 2016, BBA-GEN SUBJECTS, V1860, P1655, DOI 10.1016/j.bbagen.2016.04.016; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Park JE, 2002, J BIOCHEM MOL BIOL, V35, P330; Parsons TB, 2016, ANGEW CHEM INT EDIT, V55, P2361, DOI 10.1002/anie.201508723; Quast I, 2015, J CLIN INVEST, V125, P4160, DOI 10.1172/JCI82695; Rodriguez-Diaz J, 2011, APPL ENVIRON MICROB, V77, P703, DOI 10.1128/AEM.01906-10; Saribas AS, 2007, BIOCHEM BIOPH RES CO, V362, P381, DOI 10.1016/j.bbrc.2007.07.199; Schwab I, 2014, EUR J IMMUNOL, V44, P1444, DOI 10.1002/eji.201344230; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Sjogren J, 2015, GLYCOBIOLOGY, V25, P1053, DOI 10.1093/glycob/cwv047; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Stanley P, 2005, GLYCOBIOLOGY, V15, P43, DOI 10.1093/glycob/cwh136; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; van de Bovenkamp FS, 2016, J IMMUNOL, V196, P1435, DOI 10.4049/jimmunol.1502136; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	46	76	83	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16508	16518		10.1074/jbc.M116.738765	http://dx.doi.org/10.1074/jbc.M116.738765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288408	Green Published, hybrid			2022-12-26	WOS:000380826700011
J	Orton, S; Coleman, T; Lewis, S; Cooper, S; Jones, LL				Orton, Sophie; Coleman, Tim; Lewis, Sarah; Cooper, Sue; Jones, Laura L.			"I Was a Full Time Proper Smoker": A Qualitative Exploration of Smoking in the Home after Childbirth among Women Who Relapse Postpartum	PLOS ONE			English	Article							PREGNANCY; CHILDREN; CESSATION; BEHAVIOR; MAINTENANCE; PREDICTORS; COTININE; MOTHERS; TRENDS; RISK	Background Many women stop smoking during pregnancy but relapse shortly afterwards, potentially putting their infants at risk of secondhand smoke (SHS) exposure. Women who were able to stop during pregnancy may be a motivated group, receptive to making behaviour changes postpartum to protect their infant from SHS exposure. Understanding more about their experiences of relapse, and if this influences home smoking behaviours and children's exposure to SHS in the home may help to inform intervention development to prevent infant SHS exposure. Methods Guided by interpretative phenomenological methodology we conducted and analysed nine semi-structured interviews with women who quit smoking during pregnancy, but relapsed <= 3 months postpartum. Findings Central to mothers' accounts of their smoking behaviours during pregnancy and postpartum was their desire to be a 'responsible mother'. Mothers described using strategies to protect their infant from SHS exposure, and held strong negative attitudes towards other smoking parents. After relapsing, mothers appeared to reposition themselves as 'social' or 'occasional' smokers rather than 'regular' smokers. Conclusions Findings suggest that interventions to prevent/reduce infants' home SHS exposure should build on mothers' intentions to be responsible parents. As mothers who relapse principally view themselves as 'social' or 'occasional' smokers, interventions that are highlighted as relevant for women with these types of smoking patterns may be more likely to be responded to, and, ultimately, be effective.	[Orton, Sophie; Coleman, Tim; Lewis, Sarah; Cooper, Sue; Jones, Laura L.] Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England; [Orton, Sophie; Coleman, Tim; Cooper, Sue] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Lewis, Sarah] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Jones, Laura L.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Birmingham	Orton, S (corresponding author), Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England.; Orton, S (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	Sophie.orton@nottingham.ac.uk	Jones, Laura/AAY-6159-2020; Cooper, Sue/A-7471-2011	Jones, Laura/0000-0002-4018-3855; Orton, Sophie/0000-0002-8577-216X; Cooper, Sue/0000-0002-1994-6395; Coleman, Tim/0000-0002-7303-4805	National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR); NIHR under the Programme Grants for Applied Research programme [RP-PG-0109-10020]; Medical Research Council [MR/K023195/1] Funding Source: researchfish; National Institute for Health Research [SPCR-041, RP-PG-0109-10020] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR)(National Institute for Health Research (NIHR)); NIHR under the Programme Grants for Applied Research programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	SO is funded by the National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR). The NIHR SPCR is a partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham, Oxford, Southampton and University College London. This article presents independent research funded by the NIHR under the Programme Grants for Applied Research programme (RP-PG-0109-10020). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Abrahamsson A, 2005, HEALTH EDUC RES, V20, P367, DOI 10.1093/her/cyg127; Ashford KB, 2009, PUBLIC HEALTH REP, V124, P515, DOI 10.1177/003335490912400408; Baldwin AS, 2006, HEALTH PSYCHOL, V25, P626, DOI 10.1037/0278-6133.25.5.626; Baxter S, 2011, HEALTH EDUC RES, V26, P265, DOI 10.1093/her/cyq092; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Bull L, 2007, J NEONATAL NURS, V13, P100, DOI DOI 10.1016/J.JNN.2007.01.002; Businelle MS, 2013, ANN BEHAV MED, V45, P180, DOI 10.1007/s12160-012-9434-x; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Colman GJ, 2003, AM J PREV MED, V24, P29, DOI 10.1016/S0749-3797(02)00574-3; Coxhead L, 2006, SOCIOL HEALTH ILL, V28, P98, DOI 10.1111/j.1467-9566.2005.00484.x; Dwyer SC., 2009, INT J QUAL METHODS, V8, P54, DOI 10.1177/160940690900800105; FINGERHUT LA, 1990, AM J PUBLIC HEALTH, V80, P541, DOI 10.2105/AJPH.80.5.541; Flemming K, 2013, J ADV NURS, V69, P1023, DOI 10.1111/jan.12066; Godin G, 2005, BRIT J SOC PSYCHOL, V44, P497, DOI 10.1348/014466604X17452; Hajek P, 2001, ADDICTION, V96, P485, DOI 10.1046/j.1360-0443.2001.96348511.x; Harmer C, 2013, NICOTINE TOB RES, V15, P904, DOI 10.1093/ntr/nts221; Haslam C, 2004, HEALTH PSYCHOL, V23, P486, DOI 10.1037/0278-6133.23.5.486; Heppner WL, 2011, HEALTH PSYCHOL, V30, P736, DOI 10.1037/a0025132; Hill L, 2003, HEALTH PROMOT J AUST, V14, P196; Holdsworth C, 2008, SOCIOL HEALTH ILL, V30, P1086, DOI 10.1111/j.1467-9566.2008.01102.x; Holdsworth C, 2007, SOCIOLOGY, V41, P401, DOI 10.1177/0038038507076614; Kahn RS, 2002, AM J PUBLIC HEALTH, V92, P1801, DOI 10.2105/AJPH.92.11.1801; Leas EC, 2014, SMOKERS WHO REPORT S; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2012, PREV TOB UYOUTH YO; Nichter M, 2008, QUAL HEALTH RES, V18, P1184, DOI 10.1177/1049732308321738; Notley C, 2015, ADDICTION, V110, P1712, DOI 10.1111/add.13062; Office for National Statistics, 2014, AD SMOK HAB GREAT BR, V2013; Orton S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004915; Pickett KE, 2009, J EPIDEMIOL COMMUN H, V63, P474, DOI 10.1136/jech.2008.082594; Poland B., 2009, Critical Public Health, V19, P203, DOI 10.1080/09581590802395416; Polanska K, 2011, MATERN CHILD HLTH J, V15, P579, DOI 10.1007/s10995-010-0639-y; Prady SL, 2012, MATERN CHILD HLTH J, V16, P1364, DOI 10.1007/s10995-011-0899-1; Reid K, 2005, PSYCHOLOGIST, V18, P20; Robinson J, 2008, INT REV QUAL RES, V1, P173; Robinson J, 2009, HEALTH EDUC RES, V24, P11, DOI 10.1093/her/cym080; Robinson J, 2007, HEALTH PLACE, V13, P894, DOI 10.1016/j.healthplace.2007.03.001; Robinson Jude, 2013, Contemp Drug Probl, V40, P47; Robinson J, 2011, SOCIOL HEALTH ILL, V33, P66, DOI 10.1111/j.1467-9566.2010.01273.x; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Smith J., 2008, DOING SOCIAL PSYCHOL, P229; Smith JA, 2009, QUAL RES PSYCHOL; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wakefield M, 2000, AM J PREV MED, V19, P188, DOI 10.1016/S0749-3797(00)00197-5; Wilson IS, 2013, HEALTH EDUC RES, V28, P165, DOI 10.1093/her/cys082; Woodby LL, 1999, ADDICTION, V94, P283, DOI 10.1046/j.1360-0443.1999.94228311.x	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157525	10.1371/journal.pone.0157525	http://dx.doi.org/10.1371/journal.pone.0157525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27308829	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000378029800091
J	Savage, JR; Pulsipher, A; Rao, NV; Kennedy, TP; Prestwich, GD; Ryan, ME; Lee, WY				Savage, Justin R.; Pulsipher, Abigail; Rao, Narayanam V.; Kennedy, Thomas P.; Prestwich, Glenn D.; Ryan, Maria E.; Lee, Won Yong			A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; ANTIBIOTIC-RESISTANCE; INFLAMMATORY RESPONSE; OSTEOCLAST FORMATION; TREPONEMA-DENTICOLA; BONE-RESORPTION; HYALURONIC-ACID; DECOY RECEPTOR	Background Periodontitis is characterized by microbial infection, inflammation, tissue breakdown, and accelerated loss of alveolar bone matrix. Treatment targeting these multiple stages of the disease provides ways to treat or prevent periodontitis. Certain glycosaminoglycans (GAGs) block multiple inflammatory mediators as well as suppress bacterial growth, suggesting that these GAGs may be exploited as a therapeutic for periodontitis. Methods We investigated the effects of a synthetic GAG, GM-0111, on various molecular events associated with periodontitis: growth of Porphyromonas gingivalis (P. gingivalis) and Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) pathogenic bacteria associated with periodontitis; activation of pro-inflammatory signaling through TLR2 and TLR4 in mouse macrophage RAW 264.7 cells and heterologously expressed HEK 293 cells; osteoclast formation and bone matrix resorption in cultured mouse pre-osteoclasts. Results (1) GM-0111 suppressed the growth of P. gingivalis and A. actinomycetemcomitans even at 1% (w/v) solution. The antibacterial effects of GM-0111 were stronger than hyaluronic acid (HA) or xylitol in P. gingivalis at all concentrations and comparable to xylitol in A. actinomycetemcomitans at >= 2% (w/v) solution. We also observed that GM-0111 suppressed biofilm formation of P. gingivalis and these effects were much stronger than HA. (2) GM-0111 inhibited TLR-mediated pro-inflammatory cellular signaling both in macrophage and HEK 293 cells with higher selectivity for TLR2 than TLR4 (IC50 of 1-10 ng/mL vs. > 100 mu g/mL, respectively). (3) GM-0111 blocked RANKL-induced osteoclast formation (as low as 300 ng/mL) and bone matrix resorption. While GM-0111 showed high affinity binding to RANKL, it did not interfere with RANKL/RANK/NF-kappa B signaling, suggesting that GM-0111 inhibits osteoclast formation by a RANKL-RANK-independent mechanism. Conclusions We report that GM-0111 inhibits multiple molecular events involved in periodontitis, spanning from the early pro-inflammatory TLR signaling, to pathways activated at the later stage component of bone loss.	[Savage, Justin R.; Pulsipher, Abigail; Rao, Narayanam V.; Kennedy, Thomas P.; Prestwich, Glenn D.; Lee, Won Yong] GlycoMira Therapeut Inc, Salt Lake City, UT 84108 USA; [Kennedy, Thomas P.] Tulane Univ, Sch Med, Pulm Dis Crit Care & Environm Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; [Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT 84108 USA; [Ryan, Maria E.] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	Tulane University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lee, WY (corresponding author), GlycoMira Therapeut Inc, Salt Lake City, UT 84108 USA.	lee.wonyong@glycomira.com		Lee, Won Yong/0000-0001-7915-1829	National Institute of Dental and Craniofacial Research [5R44DE022216, 1R43DE024024]; GlycoMira Therapeutics, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R43DE024024, R44DE022216, R44DE024024] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); GlycoMira Therapeutics, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant numbers 5R44DE022216 (WYL, GDP, MER) and 1R43DE024024 (WYL) from the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlycoMira Therapeutics, Inc. provided support in the form of salaries for authors [JRS, AP, WYL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acharya A, 2013, AM J EPIDEMIOL, V177, P700, DOI 10.1093/aje/kws293; Alatalo SL, 2000, CLIN CHEM, V46, P1751; Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; [Anonymous], 2015, STATSREF STAT ANAL H; Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Ardila CM, 2010, J PERIODONTAL RES, V45, P557, DOI 10.1111/j.1600-0765.2010.01274.x; Ardizzoni A, 2011, J MATER SCI-MATER M, V22, P2329, DOI 10.1007/s10856-011-4408-2; Ariyoshi W, 2005, J BIOL CHEM, V280, P18967, DOI 10.1074/jbc.M412740200; Ariyoshi W, 2008, J CELL BIOCHEM, V103, P1707, DOI 10.1002/jcb.21559; Bodet C, 2007, PATHOL BIOL, V55, P154, DOI 10.1016/j.patbio.2006.07.045; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202; Campo GM, 2009, ARCH BIOCHEM BIOPHYS, V491, P7, DOI 10.1016/j.abb.2009.09.017; Chen B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731039; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chhina Shivjot, 2015, J Contemp Dent Pract, V16, P474; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Crotti T, 2003, J PERIODONTAL RES, V38, P380, DOI 10.1034/j.1600-0765.2003.00615.x; Deo Vikas, 2010, Dent Today, V29, P60; Di Paola R, 2007, J CLIN PERIODONTOL, V34, P95, DOI 10.1111/j.1600-051X.2006.01016.x; Ebid Rainer, 2014, ISRN Nephrol, V2014, P714081, DOI 10.1155/2014/714081; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Endo Y, 2010, J PERIODONTOL, V81, P520, DOI 10.1902/jop.2009.090574; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Giannopoulou C, 2012, ACTA ODONTOL SCAND, V70, P629, DOI 10.3109/00016357.2011.645064; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gunasekera TS, 2000, APPL ENVIRON MICROB, V66, P1228, DOI 10.1128/AEM.66.3.1228-1232.2000; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hasan M, 1999, J IMMUNOL, V162, P1064; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; Iwamoto K, 2004, BIOCHEM BIOPH RES CO, V325, P229, DOI 10.1016/j.bbrc.2004.10.024; Jeganathan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104498; Jung SM, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/137468; Jungermann GB, 2011, J ENDODONT, V37, P1337, DOI 10.1016/j.joen.2011.06.028; Kelk P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.6; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Khan G, 2016, AAPS PHARMSCITECH, V17, P1312, DOI 10.1208/s12249-015-0466-y; Kim KW, 2007, IMMUNOL LETT, V110, P54, DOI 10.1016/j.imlet.2007.03.004; Krajewski AC, 2009, APMIS, V117, P746, DOI 10.1111/j.1600-0463.2009.02532.x; KREMER M, 1995, J CELL BIOCHEM, V57, P271, DOI 10.1002/jcb.240570211; Kumar PS, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00035; Lee WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077854; Ling L, 2010, J CELL BIOCHEM, V109, P1222, DOI 10.1002/jcb.22506; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Maezono H, 2011, ANTIMICROB AGENTS CH, V55, P5887, DOI 10.1128/AAC.05169-11; Makimura Y, 2006, CLIN EXP IMMUNOL, V146, P159, DOI 10.1111/j.1365-2249.2006.03182.x; Mombelli A, 2016, J PERIODONTOL, V87, P539, DOI 10.1902/jop.2015.150494; Mori Y, 2003, ORAL MICROBIOL IMMUN, V18, P54, DOI 10.1034/j.1399-302X.2003.180109.x; Muia C, 2006, EUR J PHARMACOL, V539, P205, DOI 10.1016/j.ejphar.2006.03.072; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Myneni SR, 2013, IMMUNOL INVEST, V42, P519, DOI 10.3109/08820139.2013.822761; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nibali L, 2013, J DENT RES, V92, P868, DOI 10.1177/0022034513501878; Noguchi N, 2005, APPL ENVIRON MICROB, V71, P8738, DOI 10.1128/AEM.71.12.8738-8743.2005; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Page RC, 2007, ORAL MICROBIOL IMMUN, V22, P162, DOI 10.1111/j.1399-302X.2007.00337.x; Paquette DW, 2000, PERIODONTOL 2000, V24, P239, DOI 10.1034/j.1600-0757.2000.2240112.x; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pirnazar P, 1999, J PERIODONTOL, V70, P370, DOI 10.1902/jop.1999.70.4.370; Pollari S, 2012, MOL CANCER RES, V10, P597, DOI 10.1158/1541-7786.MCR-11-0482; Prestwich GD, 2012, Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof, Patent No. [US 8329673 B2, 8329673]; Priyanka N, 2015, J Int Acad Periodontol, V17, P42; Raja M, 2014, J CLIN DIAGN RES, V8, pZE13, DOI 10.7860/JCDR/2014/9845.4766; ROSETT W, 1980, J CLIN MICROBIOL, V11, P30, DOI 10.1128/JCM.11.1.30-34.1980; Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028; Scapoli Luca, 2012, Dent Res J (Isfahan), V9, pS202, DOI 10.4103/1735-3327.109755; Scheres N, 2011, MICROB PATHOGENESIS, V51, P149, DOI 10.1016/j.micpath.2011.04.006; Serrano Carlos, 2009, Acta odontol. latinoam., V22, P99; Siddiqui H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00947-14; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Ukai T, 2008, INFECT IMMUN, V76, P812, DOI 10.1128/IAI.01241-07; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002; Zhang JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016658; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhang WJ, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-89; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	91	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157310	10.1371/journal.pone.0157310	http://dx.doi.org/10.1371/journal.pone.0157310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308827	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800052
J	D'Ambrosio, R; Degasperi, E; Aghemo, A; Fraquelli, M; Lampertico, P; Rumi, MG; Facchetti, F; Grassi, E; Casazza, G; Rosenberg, W; Bedossa, P; Colombo, M				D'Ambrosio, Roberta; Degasperi, Elisabetta; Aghemo, Alessio; Fraquelli, Mirella; Lampertico, Pietro; Rumi, Maria Grazia; Facchetti, Floriana; Grassi, Eleonora; Casazza, Giovanni; Rosenberg, William; Bedossa, Pierre; Colombo, Massimo			Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon	PLOS ONE			English	Article							SERUM MARKER PANELS; LIVER FIBROSIS; FOLLOW-UP; LONG-TERM; TRANSIENT ELASTOGRAPHY; ESOPHAGEAL-VARICES; ACCURATE MARKER; ELF SCORE; CIRRHOSIS; THERAPY	Background and Aim Liver biopsy (LB) has lost popularity to stage liver fibrosis in the era of highly effective anti-hepatitis C virus (HCV) therapy, yet diagnosis of persistent cirrhosis may have important implications following HCV eradication. As performance of serological non-invasive tests (NITs) to predict residual fibrosis in non-viremic HCV patients is unknown, we investigated accuracy of NITs to predict residual fibrosis in cirrhotics after a sustained virological response (SVR) to interferon (IFN). Methods Thirty-eight patients with a pre-treatment histological diagnosis of cirrhosis and a 48-104 months post-SVR LB were tested with APRI, CDS, FIB-4, FibroQ, Forns Score, GUCI Index, King Score, Lok Index, PLF, ELF. In 23 (61%) patients, cirrhosis had histologically regressed. Results All NITs values declined after SVR without any significant difference between regressors and non-regressors (AUROC 0.52-0.75). Using viremic cut-offs, PPV ranged from 34% to 100%, with lower NPV (63% - 68%). NITs performance did not improve using derived cutoffs (PPV: 40% - 80%; NPV: 66% - 100%). PLF, which combines several NITs with transient elastography, had the best diagnostic performance (AUROC 0.75, Sn 61%, Sp 90%, PPV 80%, NPV 78%). After treatment, none of the NITs resulted significantly associated with any of the histological features (activity grade, fibrosis stage, area of fibrosis). Conclusions The diagnostic estimates obtained using both viremic and derived cut-off values of NITs were suboptimal, indicating that none of these tests helps predicting residual fibrosis and that LB remains the gold standard for this purpose.	[D'Ambrosio, Roberta; Degasperi, Elisabetta; Aghemo, Alessio; Lampertico, Pietro; Facchetti, Floriana; Grassi, Eleonora; Colombo, Massimo] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Hepatol, Milan, Italy; [Fraquelli, Mirella] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Endoscopy, Milan, Italy; [Rumi, Maria Grazia] Univ Milan, Osped San Giuseppe, Div Hepatol, Milan, Italy; [Casazza, Giovanni] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Rosenberg, William] UCL, Ctr Hepatol, Div Med, London, England; [Bedossa, Pierre] Univ Paris Diderot, Hop Beaujon, Dept Pathol, Clichy, France; [Bedossa, Pierre] Univ Paris Diderot, Hop Beaujon, INSERM U773, Clichy, France	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	D'Ambrosio, R (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Hepatol, Milan, Italy.	roberta.dambrosio@unimi.it	Aghemo, Alessio/ABE-5976-2021; Rosenberg, William/ABA-1071-2021; Lampertico, Pietro/J-8463-2018; D'Ambrosio, Roberta/K-3078-2016; Casazza, Giovanni/G-3661-2012	Aghemo, Alessio/0000-0003-0941-3226; Rosenberg, William/0000-0002-2732-2304; Lampertico, Pietro/0000-0002-1026-7476; D'Ambrosio, Roberta/0000-0003-0019-1153; Casazza, Giovanni/0000-0003-3718-1784; RUMI, MARIAGRAZIA/0000-0002-5876-8528; Bedossa, Pierre/0000-0002-8487-7322	Siemens	Siemens(Siemens AG)	Prof. William Rosenberg has been paid by Siemens for providing lectures on ELF marker. He is named inventor on a patent wholly owned by Siemens. He has no financial or non-financial competing relevant interests to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Arif A, 2003, DIGEST DIS SCI, V48, P1425, DOI 10.1023/A:1024196201684; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Bota S, 2011, HEPAT MON, V11, P548; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Colli A, 2005, WORLD J GASTROENTERO, V11, P7318, DOI 10.3748/wjg.v11.i46.7318; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; D'Ambrosio R, 2013, J HEPATOL, V59, P251, DOI 10.1016/j.jhep.2013.03.013; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; D'Ambrosio R, 2011, ANTIVIR THER, V16, P677, DOI 10.3851/IMP1807; Everson GT, 2008, ALIMENT PHARM THERAP, V27, P542, DOI 10.1111/j.1365-2036.2008.03620.x; Fontana RJ, 2009, CLIN GASTROENTEROL H, V7, P219, DOI 10.1016/j.cgh.2008.10.034; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Guechot J, 2012, CLIN CHEM LAB MED, V50, P693, DOI 10.1515/cclm-2011-0858; Hsieh YY, 2012, WORLD J GASTROENTERO, V18, P746, DOI 10.3748/wjg.v18.i8.746; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; MAHARAJ B, 1986, LANCET, V1, P523; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Pol S, 2004, HUM PATHOL, V35, P107, DOI 10.1016/j.humpath.2003.08.012; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Reichard O, 1999, J HEPATOL, V30, P783, DOI 10.1016/S0168-8278(99)80129-9; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Tachi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133515; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	50	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155967	10.1371/journal.pone.0155967	http://dx.doi.org/10.1371/journal.pone.0155967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304619	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800012
J	Cerman, E; Akkoc, T; Eraslan, M; Sahin, O; Ozkara, S; Aker, FV; Subasi, C; Karaoz, E; Akkoc, T				Cerman, Eren; Akkoc, Tolga; Eraslan, Muhsin; Sahin, Ozlem; Ozkara, Selvinaz; Aker, Fugen Vardar; Subasi, Cansu; Karaoz, Erdal; Akkoc, Tunc			Retinal Electrophysiological Effects of Intravitreal Bone Marrow Derived Mesenchymal Stem Cells in Streptozotocin Induced Diabetic Rats	PLOS ONE			English	Article							ELECTRORETINOGRAPHIC OSCILLATORY POTENTIALS; MULLER CELL; DYSFUNCTION; RETINOPATHY; MODEL; TRANSPLANTATION; REGENERATION; PROGENITORS; NEUROPROTECTION; DIFFERENTIATION	Diabetic retinopathy is the most common cause of legal blindness in developed countries at middle age adults. In this study diabetes was induced by streptozotocin (STZ) in male Wistar albino rats. After 3 months of diabetes, rights eye were injected intravitreally with green fluorescein protein (GFP) labelled bone marrow derived stem cells (BMSC) and left eyes with balanced salt solution (Sham). Animals were grouped as Baseline (n = 51), Diabetic (n = 45), Diabetic+BMSC (n = 45 eyes), Diabetic+Sham (n = 45 eyes), Healthy+BMSC (n = 6 eyes), Healthy+Sham (n = 6 eyes). Immunohistology analysis showed an increased retinal gliosis in the Diabetic group, compared to Baseline group, which was assessed with GFAP and vimentin expression. In the immunofluorescence analysis BMSC were observed to integrate mostly into the inner retina and expressing GFP. Diabetic group had prominently lower oscillatory potential wave amplitudes than the Baseline group. Three weeks after intravitreal injection Diabetic+BMSC group had significantly better amplitudes than the Diabetic+Sham group. Taken together intravitreal BMSC were thought to improve visual function.	[Cerman, Eren; Eraslan, Muhsin; Sahin, Ozlem] Marmara Univ, Sch Med, Dept Ophthalmol, Istanbul, Turkey; [Akkoc, Tolga] Sci & Technol Res Council Turkey, Genet Engn & Biotechnol Inst, Kocaeli, Turkey; [Ozkara, Selvinaz; Aker, Fugen Vardar] Haydarpasa Numune Educ & Res Hosp, Dept Pathol, Istanbul, Turkey; [Subasi, Cansu; Karaoz, Erdal] Kocaeli Univ, Ctr Stem Cell & Gene Therapies, Kocaeli, Turkey; [Akkoc, Tunc] Marmara Univ, Sch Med, Dept Pediat Allergy & Immunol, Istanbul, Turkey	Marmara University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Istanbul Haydarpasa Numune Training & Research Hospital; Kocaeli University; Marmara University	Cerman, E (corresponding author), Marmara Univ, Sch Med, Dept Ophthalmol, Istanbul, Turkey.	erencerman@yahoo.com	Karaoz, Erdal/AAO-1470-2020; Cerman, Eren/S-7203-2016	Cerman, Eren/0000-0002-8681-9214	Marmara University, BAPKO (Scientific Research Project Commission) [SAG-A-090512-0126, SAG-B-131113-0421, SAG-D-100615-0265]	Marmara University, BAPKO (Scientific Research Project Commission)	The study was granted by Marmara University, BAPKO (Scientific Research Project Commission) with the project numbers SAG-A-090512-0126, SAG-B-131113-0421 and SAG-D-100615-0265.	Akbarzadeh A, 2007, INDIAN J CLIN BIOCHE, V22, P60, DOI 10.1007/BF02913315; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Baydas G, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1001, DOI 10.1023/B:BIRY.0000043542.39691.95; Bogdanov P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097302; BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P929, DOI 10.1001/archopht.1987.01060070065030; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Bui Bang Viet, 2002, Documenta Ophthalmologica, V104, P17, DOI 10.1023/A:1014401502915; Bunce C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-58; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chang HM, 2015, J CHIN MED ASSOC, V78, P169, DOI 10.1016/j.jcma.2014.08.017; Chung K H, 1994, Korean J Ophthalmol, V8, P1; Coorey NJ, 2012, CLIN EXP OPTOM, V95, P266, DOI 10.1111/j.1444-0938.2012.00741.x; Cronk SM, 2015, STEM CELL TRANSL MED, V4, P459, DOI 10.5966/sctm.2014-0108; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Deliyanti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134392; DiCicco RM, 2014, INVEST OPHTH VIS SCI, V55, P6281, DOI 10.1167/iovs.14-14724; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Forte JD, 2008, J NEUROSCI METH, V169, P191, DOI 10.1016/j.jneumeth.2007.12.007; Friedlander Martin, 2007, Angiogenesis, V10, P89, DOI 10.1007/s10456-007-9070-4; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Hamilton R, 2007, VISION RES, V47, P2968, DOI 10.1016/j.visres.2007.04.020; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; JUEN S, 1990, ARCH OPHTHALMOL-CHIC, V108, P372, DOI 10.1001/archopht.1990.01070050070033; Katsman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050417; Kicic A, 2003, J NEUROSCI, V23, P7742; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kong JH, 2015, INT J OPHTHALMOL-CHI, V8, P257, DOI 10.3980/j.issn.2222-3959.2015.02.08; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Li Q, 2002, INVEST OPHTH VIS SCI, V43, P3109; Li TQ, 2013, CELL RES, V23, P788, DOI 10.1038/cr.2013.48; LI XX, 1992, DOC OPHTHALMOL, V81, P173, DOI 10.1007/BF00156006; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Mead B, 2015, STEM CELL RES, V14, P243, DOI 10.1016/j.scr.2015.02.003; Mead B, 2015, NEURAL REGEN RES, V10, P371, DOI 10.4103/1673-5374.153681; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Pardue MT, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.3.6; Park SS, 2015, INVEST OPHTH VIS SCI, V56, P81, DOI 10.1167/iovs.14-15415; Park TS, 2014, CIRCULATION, V129, P359, DOI 10.1161/CIRCULATIONAHA.113.003000; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Rajashekhar G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00059; Rajashekhar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084671; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Ramsey DJ, 2006, INVEST OPHTH VIS SCI, V47, P5116, DOI 10.1167/iovs.06-0364; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Scalinci SZ, 2011, CLIN OPHTHALMOL, V5, P691, DOI 10.2147/OPTH.S21161; Schraermeyer U, 2001, CELL TRANSPLANT, V10, P673, DOI 10.3727/000000001783986215; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; SEVERNS ML, 1993, DOC OPHTHALMOL, V85, P135, DOI 10.1007/BF01371129; Tan SM, 2015, EXP EYE RES, V136, P1, DOI 10.1016/j.exer.2015.04.015; Tian B, 2010, CHINESE MED J-PEKING, V123, P2265, DOI 10.3760/cma.j.issn.0366-6999.2010.16.020; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Tucker BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125947; Vadala M, 2002, ACTA OPHTHALMOL SCAN, V80, P305, DOI 10.1034/j.1600-0420.2002.800314.x; Vujosevic S, 2015, INVEST OPHTH VIS SCI, V56, P3913, DOI 10.1167/iovs.15-16554; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Weerasekera LY, 2015, INVEST OPHTH VIS SCI, V56, P3721, DOI 10.1167/iovs.14-16289; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Wong Vickie H Y, 2011, J Ocul Biol Dis Infor, V4, P42, DOI 10.1007/s12177-011-9069-3; Yang ZK, 2010, GRAEF ARCH CLIN EXP, V248, P1415, DOI 10.1007/s00417-010-1384-z; YOSHIDA A, 1991, OPHTHALMOLOGY, V98, P1266; Yoshii C, 2007, DEV BIOL, V303, P45, DOI 10.1016/j.ydbio.2006.11.024; Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314; Zhao XJ, 2015, INVEST OPHTH VIS SCI, V56, P2773, DOI 10.1167/iovs.14-16104; Zou H, 2010, BIOCHEM BIOPH RES CO, V391, P1268, DOI 10.1016/j.bbrc.2009.12.057	74	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156495	10.1371/journal.pone.0156495	http://dx.doi.org/10.1371/journal.pone.0156495			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300133	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200009
J	Dores, MR; Grimsey, NJ; Mendez, F; Trejo, J				Dores, Michael R.; Grimsey, Neil J.; Mendez, Francisco; Trejo, JoAnn			ALIX Regulates the Ubiquitin-Independent Lysosomal Sorting of the P2Y(1) Purinergic Receptor via a YPX3L Motif	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ESCRT-III; GROWTH-FACTOR; MULTIVESICULAR ENDOSOMES; MEDIATES UBIQUITINATION; ENDOCYTIC TRAFFICKING; DOWN-REGULATION; COMPLEX; HRS; CELLS	Endocytic sorting and lysosomal degradation are integral to the regulation of G protein-coupled receptor (GPCR) function. Upon ligand binding, classical GPCRs are activated, internalized and recycled or sorted to lysosomes for degradation, a process that requires receptor ubiquitination. However, recent studies have demonstrated that numerous GPCRs are sorted to lysosomes independent of receptor ubiquitination. Here, we describe an ubiquitin-independent lysosomal sorting pathway for the purinergic GPCR P2Y(1). After activation, P2Y(1) sorts to lysosomes for degradation independent of direct ubiquitination that is mediated by a YPX3L motif within the second intracellular loop that serves as a binding site for the adaptor protein ALIX. Depletion of ALIX or site-directedmutation of the YPX3L motif inhibits P2Y(1) sorting into the lumen of multivesicular endosomes/lysosomes and degradation. These findings confirm the function of YPX3L motifs as lysosomal targeting sequences for GPCRs and demonstrate that ALIX mediates the ubiquitin-independent degradation of certain GPCRs.	[Dores, Michael R.; Grimsey, Neil J.; Mendez, Francisco; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Dores, Michael R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA	University of California System; University of California San Diego; Hofstra University	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health/National Institute of General Medical Sciences [R01 GM090689]; National Institutes of Health [K12 GM06852]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689, K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM090689 (to JT): National Institutes of Health/National Institute of General Medical Sciences: https://www.nigms.nih.gov/Pages/default.aspx. K12 GM06852 (MRD): National Institutes of Health: https://www.nigms.nih.gov/Training/CareerDev/Pages/TWDInstRes.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dores MR, 2015, METHOD CELL BIOL, V130, P319, DOI 10.1016/bs.mcb.2015.05.006; Dores MR, 2015, MOL BIOL CE IN PRESS; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Freeman CL, 2014, J CELL SCI, V127, P2053, DOI 10.1242/jcs.144659; Govindan S, 2010, BRIT J PHARMACOL, V160, P1953, DOI 10.1111/j.1476-5381.2010.00763.x; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Ko T, 2012, PANCREAS, V41, P797, DOI 10.1097/MPA.0b013e31823ba3b3; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lu Q, 2003, P NATL ACAD SCI US; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Nisar S, 2010, TRAFFIC, V11, P508, DOI 10.1111/j.1600-0854.2010.01035.x; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Reiner S, 2009, MOL PHARMACOL, V76, P1162, DOI 10.1124/mol.109.060467; Sachse M, 2004, J CELL SCI, V117, P1699, DOI 10.1242/jcs.00998; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shinozaki Y, 2006, GLIA, V54, P606, DOI 10.1002/glia.20408; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; van Weering JRT, 2012, EMBO J, V31, P4466, DOI 10.1038/emboj.2012.283; Wei Q, 2011, BIOCHEM PHARMACOL, V82, P418, DOI 10.1016/j.bcp.2011.05.013; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319	56	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157587	10.1371/journal.pone.0157587	http://dx.doi.org/10.1371/journal.pone.0157587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27301021	Green Published, gold			2022-12-26	WOS:000377822200063
J	Tago, D; Hammitt, JK; Thomas, A; Raboisson, D				Tago, Damian; Hammitt, James K.; Thomas, Alban; Raboisson, Didier			The Impact of Farmers' Strategic Behavior on the Spread of Animal Infectious Diseases	PLOS ONE			English	Article							CATTLE; EPIDEMIC; NETWORKS; FRANCE; POLICY; VIRUS	One of the main strategies to control the spread of infectious animal diseases is the implementation of movement restrictions. This paper shows a loss in efficiency of the movement restriction policy (MRP) when behavioral responses of farmers are taken into account. Incorporating the strategic behavior of farmers in an epidemiologic model reveals that the MRP can trigger premature animal sales by farms at high risk of becoming infected that significantly reduce the efficacy of the policy. The results are validated in a parameterized network via Monte Carlo simulations and measures to mitigate the loss of efficiency of the MRP are discussed. Financial aid to farmers can be justified by public health concerns, not only for equity. This paper contributes to developing an interdisciplinary analytical framework regarding the expansion of infectious diseases combining economic and epidemiologic dimensions.	[Tago, Damian] CMAEE, CIRAD, UMR, Petit Bourg, Guadeloupe, France; [Tago, Damian] CMAEE, INRA, UMR1309, F-34398 Montpellier, France; [Hammitt, James K.; Thomas, Alban] Univ Toulouse, INRA, Toulouse Sch Econ Rech, F-31000 Toulouse, France; [Hammitt, James K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02215 USA; [Hammitt, James K.] Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02215 USA; [Raboisson, Didier] Univ Toulouse, INRA, ENVT, IHAP, Toulouse, France	CIRAD; INRAE; INRAE; Universite de Toulouse; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Tago, D (corresponding author), CMAEE, CIRAD, UMR, Petit Bourg, Guadeloupe, France.; Tago, D (corresponding author), CMAEE, INRA, UMR1309, F-34398 Montpellier, France.	damian.tago_pacheco@cirad.fr	Raboisson, Didier/AAL-4025-2020; THOMAS, Alban/X-8092-2019; THOMAS, Alban/AAW-7849-2020	Raboisson, Didier/0000-0003-1630-6218; THOMAS, Alban/0000-0002-8730-2487; Tago Pacheco, Damian/0000-0001-7251-9408	INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [609642]; INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [609642]	INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant; INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant	This work was partially sponsored by an INRA Scientific Package and by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement number 609642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was partially sponsored by an INRA Scientific Package and by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement number 609642.	ANDERSON R M, 1991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; Bosman KJ, 2013, TRANSBOUND EMERG DIS, V60, P303, DOI 10.1111/j.1865-1682.2012.01348.x; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; GLOSTER J, 1981, VET REC, V108, P370, DOI 10.1136/vr.108.17.370; Hennessy DA, 2007, AM J AGR ECON, V89, P1226, DOI 10.1111/j.1467-8276.2007.01088.x; Hennessy DA, 2007, AM J AGR ECON, V89, P698, DOI 10.1111/j.1467-8276.2007.01001.x; Jin H.J., 2004, EFFECTS BSE OUTBREAK; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Muchnik L., 2013, COMPLEX NETWORKS PAC; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pioz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085444; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Rautureau S, 2011, TRANSBOUND EMERG DIS, V58, P110, DOI 10.1111/j.1865-1682.2010.01187.x; Sahneh FD, 2012, SCI REP, P2; Shirley MDF, 2005, EPIDEMIOL INFECT, V133, P1023, DOI 10.1017/S095026880500453X; Sinn HW, 2008, INT TAX PUBLIC FINAN, V15, P360, DOI 10.1007/s10797-008-9082-z; Tago D, 2014, PREV VET MED, V117, P577, DOI 10.1016/j.prevetmed.2014.10.010; Turner J, 2012, SCI REP, P2; Volchenkov D, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046137; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Wismans WMG, 1999, COMPUT ELECTRON AGR, V24, P99, DOI 10.1016/S0168-1699(99)00040-X; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014; Zar JH, 1998, ENCY BIOSTATISTICS, P4191	31	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157450	10.1371/journal.pone.0157450	http://dx.doi.org/10.1371/journal.pone.0157450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300368	Green Published, gold			2022-12-26	WOS:000377822200051
J	Hong, JY; Sunwoo, MK; Oh, JS; Kim, JS; Sohn, YH; Lee, PH				Hong, Jin Yong; Sunwoo, Mun Kyung; Oh, Jungsu S.; Kim, Jae Seung; Sohn, Young H.; Lee, Phil Hyu			Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CLINICAL-FEATURES; TYROSINE-HYDROXYLASE; I-123-FP-CIT SPECT; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; HALOPERIDOL; DYSKINESIA; PET; ACCURACY	Functional neuroimaging for the dopamine transporter (DAT) is used to distinguish drug-induced parkinsonism (DIP) from subclinical Parkinson's disease (PD). Although DIP patients who show a normal DAT image are expected to recover completely, some do not. We investigated whether these patients showed changes in striatal DAT activity using semi-quantitative analysis of F-18-FP-CIT PET data. DIP patients with visually normal DAT images were selected from medical records. The subjects were classified as patients who recovered partially (PR) or completely within 12 months (CR). The F-18-FP-CIT uptake in each striatal subregion was compared between the CR and the PR groups. In total, 41 and 9 patients of the CR and PR groups were assessed, respectively. The two patient groups were comparable in terms of clinical characteristics including age, sex, and severity of parkinsonism. From semi-quantitative analysis of the PET image, the PR patients showed a relatively lower ligand uptake in the ventral striatum, the anterior putamen and the posterior putamen compared with the CR patients. This result suggests that persistent DIP in patients with visually normal DAT imaging may be associated with subtle decrement of DAT activity.	[Hong, Jin Yong] Yonsei Univ Wonju, Coll Med, Dept Neurol, Wonju, South Korea; [Sunwoo, Mun Kyung] Bundang Jesaeng Gen Hosp, Dept Neurol, Songnam, South Korea; [Oh, Jungsu S.; Kim, Jae Seung] Univ Ulsan, Coll Med, Dept Nucl Med, Asan Med Ctr, Seoul, South Korea; [Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Lee, Phil Hyu] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; University of Ulsan; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Hong, JY (corresponding author), Yonsei Univ Wonju, Coll Med, Dept Neurol, Wonju, South Korea.	mlunoilu@hanmail.net		Lee, Phil Hyu/0000-0001-9931-8462; Sohn, Young H./0000-0001-6533-2610	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014M3C7A1064752]	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Korean government (MSIP)	This research was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (no. 2014M3C7A1064752). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa MT, 2006, MOVEMENT DISORD, V21, P800, DOI 10.1002/mds.20806; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Bishnoi M, 2007, PHARMACOLOGY, V79, P171, DOI 10.1159/000100924; BURN DJ, 1993, NEUROLOGY, V43, P552, DOI 10.1212/WNL.43.3_Part_1.552; Chiba S, 2012, NEUROBIOL AGING, V33, P2491, DOI 10.1016/j.neurobiolaging.2011.11.002; Cuberas-Borros G, 2011, CLIN NUCL MED, V36, P991, DOI 10.1097/RLU.0b013e3182291a7b; Diaz-Corrales FJ, 2010, EUR J NUCL MED MOL I, V37, P556, DOI 10.1007/s00259-009-1289-4; Eerola J, 2005, J NEUROL NEUROSUR PS, V76, P1211, DOI 10.1136/jnnp.2004.045237; Erro R, 2015, MOVEMENT DISORD, V30, P780, DOI 10.1002/mds.26209; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Foubert-Samier A, 2012, NEUROLOGY, V79, P1615, DOI 10.1212/WNL.0b013e31826e25ce; GOETZ CG, 1983, ARCH NEUROL-CHICAGO, V40, P325, DOI 10.1001/archneur.1983.04050050093019; HARDIE RJ, 1988, J NEUROL NEUROSUR PS, V51, P850, DOI 10.1136/jnnp.51.6.850; Hong JY, 2014, NEUROLOGY, V82, P1597, DOI 10.1212/WNL.0000000000000385; Horvath J, 2014, J ALZHEIMERS DIS, V39, P115, DOI 10.3233/JAD-131289; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jimenez-Jimenez F J, 1996, Parkinsonism Relat Disord, V2, P145, DOI 10.1016/1353-8020(96)00013-2; Kim JS, 2013, ARCH GERONTOL GERIAT, V56, P124, DOI 10.1016/j.archger.2012.05.001; Levinson AJ, 1998, NEUROSCIENCE, V84, P201, DOI 10.1016/S0306-4522(97)00447-8; Lorberboym M, 2006, MOVEMENT DISORD, V21, P510, DOI 10.1002/mds.20748; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; Meredith GE, 2004, BRAIN RES, V995, P14, DOI 10.1016/j.brainres.2003.09.040; Oh JS, 2014, NEUROREPORT, V25, P1198, DOI 10.1097/WNR.0000000000000247; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Romero JO, 2013, NEUROLOGIA, V28, P276, DOI 10.1016/j.nrl.2012.05.005; RAJPUT AH, 1982, ARCH NEUROL-CHICAGO, V39, P644, DOI 10.1001/archneur.1982.00510220042009; Rinne JO, 2002, NEUROLOGY, V58, P1489, DOI 10.1212/WNL.58.10.1489; Rinne JO, 1998, NEUROLOGY, V50, P152, DOI 10.1212/WNL.50.1.152; ROLLEMA H, 1994, J PHARMACOL EXP THER, V268, P380; Shin HW, 2015, NEUROL SCI, V36, P269, DOI 10.1007/s10072-014-1945-8; Shin HW, 2012, J CLIN NEUROL, V8, P15, DOI 10.3988/jcn.2012.8.1.15; Shuaib UA, 2016, MOVEMENT DISORD, V31, P360, DOI 10.1002/mds.26467; STEPHEN PJ, 1984, LANCET, V2, P1082; Tinazzi M, 2008, MOVEMENT DISORD, V23, P1825, DOI 10.1002/mds.22098; Tinazzi M, 2012, SCHIZOPHR RES, V139, P40, DOI 10.1016/j.schres.2012.06.003; Tsai GC, 1998, AM J PSYCHIAT, V155, P1207, DOI 10.1176/ajp.155.9.1207; Vlaar AMM, 2008, EUR NEUROL, V59, P258, DOI 10.1159/000115640	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157410	10.1371/journal.pone.0157410	http://dx.doi.org/10.1371/journal.pone.0157410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294367	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300044
J	Zein, JG; Udeh, BL; Teague, WG; Koroukian, SM; Schlitz, NK; Bleecker, ER; Busse, WB; Calhoun, WJ; Castro, M; Comhair, SA; Fitzpatrick, AM; Israel, E; Wenzel, SE; Holguin, F; Gaston, BM; Erzurum, SC				Zein, Joe G.; Udeh, Belinda L.; Teague, W. Gerald; Koroukian, Siran M.; Schlitz, Nicholas K.; Bleecker, Eugene R.; Busse, William B.; Calhoun, William J.; Castro, Mario; Comhair, Suzy A.; Fitzpatrick, Anne M.; Israel, Elliot; Wenzel, Sally E.; Holguin, Fernando; Gaston, Benjamin M.; Erzurum, Serpil C.		Severe Asthma Res Program	Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012	PLOS ONE			English	Article							SECONDARY DATABASES; NATIONAL HEART; EXACERBATIONS; PREVALENCE; CHILDHOOD; SEVERITY; SYMPTOMS; LUNG; BIAS	Background Worldwide, asthma is a leading cause of morbidity, mortality and economic burden, with significant gender and racial disparities. However, little attention has been given to the independent role of age on lifetime asthma severity and hospitalization. We aimed to assess the effect of age, gender, race and ethnicity on indicators of asthma severity including asthma related hospitalization, mortality, hospital cost, and the rate of respiratory failure. Methods We analyzed the 2011 and 2012 Healthcare Cost and Utilization Project-National Inpatient Sample (NIS). We validated and extended those results using the National Heart, Lung, and Blood Institute-Severe Asthma Research Program (SARP; 2002-2011) database. Severe asthma was prospectively defined using the stringent American Thoracic Society (ATS) definition. Results Hospitalization for asthma was reported in 372,685 encounters in 2012 and 368,528 in 2011. The yearly aggregate cost exceeded $2 billion. There were distinct bimodal distributions for hospitalization age, with an initial peak at 5 years and a second at 50 years. Likewise, this bimodal age distribution of patients with severe asthma was identified using SARP. Males comprised the majority of individuals in the first peak, but women in the second. Aggregate hospital cost mirrored the bimodal peak distribution. The probability of respiratory failure increased with age until the age of 60, after which it continued to increase in men, but not in women. Conclusions Severe asthma is primarily a disease of young boys and middle age women. Greater understanding of the biology of lung aging and influence of sex hormones will allow us to plan for targeted interventions during these times in order to reduce the personal and societal burdens of asthma.	[Zein, Joe G.; Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Zein, Joe G.; Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Udeh, Belinda L.] Cleveland Clin, Inst Anesthesiol, Dept Outcomes Res, Cleveland, OH 44106 USA; [Teague, W. Gerald] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Koroukian, Siran M.; Schlitz, Nicholas K.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Bleecker, Eugene R.] Wake Forest Univ, Sch Med, Ctr Genom & Personalized Med, Winston Salem, NC 27109 USA; [Busse, William B.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Calhoun, William J.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Castro, Mario] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Israel, Elliot] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm, Boston, MA 02115 USA; [Wenzel, Sally E.; Holguin, Fernando] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Gaston, Benjamin M.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Virginia; Case Western Reserve University; Wake Forest University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Zein, JG (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.; Zein, JG (corresponding author), Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA.	zeinj@ccf.org	Koroukian, Siran/S-9127-2019	Koroukian, Siran/0000-0002-8106-9581; Fitzpatrick, Anne/0000-0002-2933-5926; Wenzel, Sally/0000-0002-4242-0164; Calhoun, William/0000-0001-7075-712X	National Institute of Health-National Heart, Lung, and Blood Institute [HL109250, HL081064, HL69170, HL103453, U10 HL109250, UL1TR000439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, P01HL081064, U10HL109250] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SCE received funding from the National Institute of Health-National Heart, Lung, and Blood Institute: HL109250, HL081064, HL69170, HL103453, U10 HL109250, and UL1TR000439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; *CDC, NAT HLTH INT SURV; Ciccone G, 1997, EUR RESPIR J, V10, P1780; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; Department of Health and Human Services, INT CLASS DIS, V1; DODGE RR, 1980, AM REV RESPIR DIS, V122, P567; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Jenkins MA, 2006, CLIN EXP ALLERGY, V36, P609, DOI 10.1111/j.1365-2222.2006.02475.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Krishnan V, 2006, AM J RESP CRIT CARE, V174, P633, DOI 10.1164/rccm.200601-007OC; Mandhane PJ, 2005, AM J RESP CRIT CARE, V172, P45, DOI 10.1164/rccm.200412-1738OC; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moorman JE, 2012, VITAL HLTH STAT, V35, P1; NORMAN GR, 1985, J MED EDUC, V60, P925; Pfuntner A, 2011, MOST FREQUENT CONDIT MOST FREQUENT CONDIT; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Rao CK, 2013, CHEST, V143, P984, DOI 10.1378/chest.12-0973; RETHANS JJ, 1994, BRIT J GEN PRACT, V44, P153; Schneeweiss S, 2004, J CLIN PSYCHOPHARM, V24, P632, DOI 10.1097/01.jcp.0000145344.76288.39; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P648, DOI 10.1016/j.jclinepi.2006.10.019; SENNHAUSER FH, 1995, PEDIATR PULM, V19, P161, DOI 10.1002/ppul.1950190304; Serra-Batlles J, 1998, EUR RESPIR J, V12, P1322, DOI 10.1183/09031936.98.12061322; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; Terris DD, 2007, J CLIN EPIDEMIOL, V60, P734, DOI 10.1016/j.jclinepi.2006.08.012; Tsai CL, 2012, J ALLERGY CLIN IMMUN, V129, P1252, DOI 10.1016/j.jaci.2012.01.061; United Nations, 2 WORLD ASS AG; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wilchesky M, 2004, J CLIN EPIDEMIOL, V57, P131, DOI 10.1016/S0895-4356(03)00246-4; Zein J, 2016, AM THOR SOC INT C AM, pA1436; Zein JG, 2015, PLOS ONE IN PRESS	36	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157301	10.1371/journal.pone.0157301	http://dx.doi.org/10.1371/journal.pone.0157301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294365	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000377821300032
J	Cabinian, A; Sinsimer, D; Tang, M; Zumba, O; Mehta, H; Toma, A; Sant'Angelo, D; Laouar, Y; Laouar, A				Cabinian, Allison; Sinsimer, Daniel; Tang, May; Zumba, Osvaldo; Mehta, Hetali; Toma, Annmarie; Sant'Angelo, Derek; Laouar, Yasmina; Laouar, Amale			Transfer of Maternal Immune Cells by Breastfeeding: Maternal Cytotoxic T Lymphocytes Present in Breast Milk Localize in the Peyer's Patches of the Nursed Infant	PLOS ONE			English	Article							INTESTINAL-ABSORPTION; GASTROINTESTINAL-TRACT; MEDIATED-IMMUNITY; THYMIC EMIGRANTS; MAMMARY-GLAND; PLASMA-CELLS; ANTIBODY; ANTIGEN; CYTOKINE; PROTECTION	Despite our knowledge of the protective role of antibodies passed to infants through breast milk, our understanding of immunity transfer via maternal leukocytes is still limited. To emulate the immunological interface between the mother and her infant while breast-feeding, we used murine pups fostered after birth onto MHC-matched and MHC-mismatched dams. Overall, data revealed that: 1) Survival of breast milk leukocytes in suckling infants is possible, but not significant after the foster-nursing ceases; 2) Most breast milk lymphocytes establish themselves in specific areas of the intestine termed Peyer's patches (PPs); 3) While most leukocytes in the milk bolus were myeloid cells, the majority of breast milk leukocytes localized to PPs were T lymphocytes, and cytotoxic T cells (CTLs) in particular; 4) These CTLs exhibit high levels of the gut-homing molecules alpha 4 beta 7 and CCR9, but a reduced expression of the systemic homing marker CD62L; 5) Under the same activation conditions, transferred CD8 T cells through breast milk have a superior capacity to produce potent cytolytic and inflammatory mediators when compared to those generated by the breastfed infant. It is therefore possible that maternal CTLs found in breast milk are directed to the PPs to compensate for the immature adaptive immune system of the infant in order to protect it against constant oral infectious risks during the postnatal phase.	[Cabinian, Allison; Sinsimer, Daniel; Tang, May; Zumba, Osvaldo; Mehta, Hetali; Toma, Annmarie; Sant'Angelo, Derek; Laouar, Amale] Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08903 USA; [Laouar, Yasmina] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan	Laouar, A (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08903 USA.; Laouar, Y (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	ylaouar@umich.edu; laouaram@rwjms.rutgers.edu	Laouar, Amale/AAO-2903-2020	Laouar, Amale/0000-0002-3714-4628	Robert Wood Johnson Foundation [67038, 581534]; NIH NIAID [R01 AI083988, R01AI083642]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge the support of the Robert Wood Johnson Foundation (grant # 67038) for the Child Health Institute of New Jersey, NIH NIAID R01 AI083988 to DSA, NIH NIAID R01AI083642 to YL, and Robert Wood Johnson Foundation (grant # 581534) to AL.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Arnardottir H, 2015, MUCOSAL IMMUNOLOGY; Arvola M, 2000, BIOL REPROD, V63, P1817, DOI 10.1095/biolreprod63.6.1817; Autengruber A, 2012, EUR J MICROBIOL IMMU, V2, P112, DOI 10.1556/EuJMI.2.2012.2.3; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Beyer K, 2002, J ALLERGY CLIN IMMUN, V109, P707, DOI 10.1067/mai.2002.122503; Alves JGB, 2012, BREASTFEED MED, V7, P25, DOI 10.1089/bfm.2011.0009; BOASS A, 1963, AM J PHYSIOL, V204, P101, DOI 10.1152/ajplegacy.1963.204.1.101; BOORMAN KE, 1958, ARCH DIS CHILD, V33, P24, DOI 10.1136/adc.33.167.24; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; CRUZ JR, 1988, ACTA PAEDIATR SCAND, V77, P658, DOI 10.1111/j.1651-2227.1988.tb10726.x; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; DAHLGREN UIH, 1987, J IMMUNOL, V138, P1397; Ebsen H, 2015, MOL IMMUNOL, V65, P416, DOI 10.1016/j.molimm.2015.02.008; EGLINTON BA, 1994, IMMUNOL CELL BIOL, V72, P306, DOI 10.1038/icb.1994.46; Eidelman AI, 2012, BREASTFEED MED, V7, P323, DOI 10.1089/bfm.2012.0067; Faucher JL, 2007, CYTOM PART A, V71A, P934, DOI 10.1002/cyto.a.20457; Gasparoni A, 2003, BIOL NEONATE, V84, P297, DOI 10.1159/000073638; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; GLASS RI, 1983, NEW ENGL J MED, V308, P1389, DOI 10.1056/NEJM198306093082304; GOLD E, 1964, PEDIATRICS, V33, P541; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Hanson L A, 1978, Adv Exp Med Biol, V107, P165; Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4; HANSON LA, 1961, INT ARCH ALLER A IMM, V18, P241, DOI 10.1159/000229177; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; HEAD JR, 1977, TRANSPLANT P, V9, P1465; HIRANO S, 1986, ARCH HISTOL CYTOL, V49, P333, DOI 10.1679/aohc.49.333; Houston EG, 2011, P NATL ACAD SCI USA, V108, P5366, DOI 10.1073/pnas.1015286108; HUGHES A, 1988, IMMUNOLOGY, V64, P213; Ichikawa M, 2003, IMMUNOLOGY, V108, P189, DOI 10.1046/j.1365-2567.2003.01572.x; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; Jakaitis BM, 2014, CLIN PERINATOL, V41, P423, DOI 10.1016/j.clp.2014.02.011; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kim SH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.165; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; Laouar A, 2007, J IMMUNOL, V178, P652, DOI 10.4049/jimmunol.178.2.652; Laouar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004089; Li XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105314; Li XY, 2004, IMMUNOLOGY, V113, P44, DOI 10.1111/j.1365-2567.2004.01928.x; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lohman-Payne B, 2012, AIDS, V26, P2007, DOI 10.1097/QAD.0b013e328359b7e0; Lonnerdal B, 2000, NUTRITION, V16, P509, DOI 10.1016/S0899-9007(00)00363-4; Losonsky G A, 1981, Prog Clin Biol Res, V70, P171; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Ma L, 2008, FIFTH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY, VOL 3, PROCEEDINGS, P3, DOI 10.1109/FSKD.2008.17; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; MANDALAPU P, 1995, CELL IMMUNOL, V162, P178, DOI 10.1006/cimm.1995.1067; MANNING LS, 1980, J IMMUNOL, V125, P2508; Marild S, 2004, ACTA PAEDIATR, V93, P164, DOI 10.1080/08035250310007402; MILLER SC, 1981, J REPROD IMMUNOL, V3, P187, DOI 10.1016/0165-0378(81)90060-7; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; PALACIOS R, 1986, EUR J IMMUNOL, V16, P12, DOI 10.1002/eji.1830160104; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; PARMELY MJ, 1977, J DAIRY SCI, V60, P655, DOI 10.3168/jds.S0022-0302(77)83915-5; Pearson T, 2008, CURRENT PROTOCOLS IM; Persson LA, 2002, ADV EXP MED BIOL, V503, P115; RIVAS RA, 1994, BIOL NEONATE, V66, P195, DOI 10.1159/000244108; Roederer M, 1997, J CLIN INVEST, V99, P1555, DOI 10.1172/JCI119318; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; ROUX ME, 1981, CELL IMMUNOL, V61, P141, DOI 10.1016/0008-8749(81)90361-0; RUDLOFF HE, 1992, PEDIATR RES, V31, P29, DOI 10.1203/00006450-199201000-00005; RUIZPALACIOS GM, 1990, J PEDIATR-US, V116, P707, DOI 10.1016/S0022-3476(05)82652-6; Sabbaj S, 2005, J IMMUNOL, V174, P2951, DOI 10.4049/jimmunol.174.5.2951; Sabbaj S, 2002, J VIROL, V76, P7365, DOI 10.1128/JVI.76.15.7365-7373.2002; Salmon H, 2000, ADV EXP MED BIOL, V480, P279; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; SEELIG LL, 1981, TRANSPLANT P, V13, P1245; SHELDRAKE RF, 1985, RES VET SCI, V39, P10, DOI 10.1016/S0034-5288(18)31762-4; Shiou SR, 2013, J BIOL CHEM, V288, P34757, DOI 10.1074/jbc.M113.503946; SILVERS WK, 1975, J IMMUNOL, V115, P1117; Slavica L, 2013, J LEUKOCYTE BIOL, V94, P1003, DOI 10.1189/jlb.1212617; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; STOLIAR OA, 1976, LANCET, V1, P1258; Strand TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036436; Tanneau GM, 1999, J HISTOCHEM CYTOCHEM, V47, P1581, DOI 10.1177/002215549904701210; TATEMATSU M, 1975, CELL DIFFER DEV, V4, P285, DOI 10.1016/0045-6039(75)90013-5; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; THORPE LW, 1986, PEDIATR RES, V20, P373, DOI 10.1203/00006450-198604000-00023; Tobin NH, 2013, IMMUNOL REV, V254, P143, DOI 10.1111/imr.12074; Torow N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8725; Tourneur E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/270301; Tuboly S, 2002, ADV EXP MED BIOL, V503, P107; TUBOLY S, 1995, ACTA VET HUNG, V43, P105; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; WARREN RJ, 1964, PEDIATRICS, V34, P4; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; WEISZCARRINGTON P, 1979, J IMMUNOL, V123, P1705; WOLF JL, 1984, ANNU REV MED, V35, P95, DOI 10.1146/annurev.med.35.1.95; Xu RJ, 1996, REPROD FERT DEVELOP, V8, P35, DOI 10.1071/RD9960035; Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x	99	73	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156762	10.1371/journal.pone.0156762	http://dx.doi.org/10.1371/journal.pone.0156762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285085	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000019
J	Hsu, YH; Yu, HY; Chen, HJ; Li, TC; Hsu, CC; Kao, CH				Hsu, Yueh-Han; Yu, Hui-Yi; Chen, Hsuan-Ju; Li, Tsai-Chung; Hsu, Chih-Cheng; Kao, Chia-Hung			The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANKLE-BRACHIAL INDEX; HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; SECONDARY HYPERPARATHYROIDISM; CARDIOVASCULAR-DISEASE; BONE TURNOVER; VITAMIN-D; HORMONE; CALCIFICATION	Purpose The changes of the risk of peripheral arterial disease (PAD) in patients with end-stage renal disease after parathyroidectomy are scant. Methods We used a nationwide health insurance claims database to select all dialysis-dependent patients with end-stage renal disease aged 18 years and older for the study population in 2000 to 2006. Of the patients with end-stage renal disease, we selected 947 patients who had undergone parathyroidectomy as the parathyroidectomy group and frequency matched 3746 patients with end-stage renal disease by sex, age, years since the disease diagnosis, and the year of index date as the non-parathyroidectomy group. We used a multivariate Cox proportional hazards regression analysis with the use of a robust sandwich covariance matrix estimate, accounting for the intra-cluster dependence of hospitals or clinics, to measure the risk of peripheral arterial disease for the parathyroidectomy group compared with the non-parathyroidectomy group after adjusting for sex, age, premium-based income, urbanization, and comorbidity. Results The mean post-op follow-up periods were 5.08 and 4.52 years for the parathyroidectomy and non-parathyroidectomy groups, respectively; the incidence density rate of PAD in the PTX group was 12.26 per 1000 person-years, significantly lower than the data in the non-PTX group (24.09 per 1000 person-years, adjusted HR = 0.66, 95% CI = 0.46-0.94). Conclusion Parathyroidectomy is associated with reduced risk of peripheral arterial disease in patients with end-stage renal disease complicated with severe secondary hyperparathyroidism.	[Hsu, Yueh-Han; Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Yueh-Han] Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Hsu, Yueh-Han] Min Hwei Jr Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Yu, Hui-Yi] Ditmanson Med Fdn Chia Yi Christian Hosp, Div Endocrinol & Metab, Dept Internal Med, Chia Yiy, Taiwan; [Yu, Hui-Yi] Chia Nan Univ Pharm & Sci, Dept Sports Management, Tainan, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.	10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abou-Hassan N, 2015, KIDNEY INT, V87, P195, DOI 10.1038/ki.2014.187; Anderson JL, 2011, AM HEART J, V162, P331, DOI 10.1016/j.ahj.2011.05.005; Bleyer AJ, 2005, AM J KIDNEY DIS, V46, P464, DOI 10.1053/j.ajkd.2005.04.035; Bover J, 2014, SEMIN NEPHROL, V34, P626, DOI 10.1016/j.semnephrol.2014.09.008; Chang TI, 2016, J HUM HYPERTENS, V30, P204, DOI 10.1038/jhh.2015.56; Chen YJ, 2014, ANGIOLOGY, V65, P396, DOI 10.1177/0003319713480842; Coen G, 2007, NEPHROL DIAL TRANSPL, V22, P3262, DOI 10.1093/ndt/gfm370; Conzo G, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S4; Eggers PW, 1999, KIDNEY INT, V56, P1524, DOI 10.1046/j.1523-1755.1999.00668.x; Eguchi M, 2000, AM J NEPHROL, V20, P278, DOI 10.1159/000013601; FOWKES FGR, 1992, AM J EPIDEMIOL, V135, P331; Fukagawa M, 2013, EXPERT OPIN PHARMACO, V14, P863, DOI 10.1517/14656566.2013.783017; Ghimire M, 2014, Kathmandu Univ Med J (KUMJ), V12, P181; Goldenstein PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068870; Hojs R, 2000, ARTIF ORGANS, V24, P691, DOI 10.1046/j.1525-1594.2000.06466.x; Hsu YH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000936; Hsu YH, 2015, J HEPATOL, V62, P519, DOI 10.1016/j.jhep.2014.09.022; Hyun Suzanne, 2014, J Vasc Surg, V60, P390, DOI 10.1016/j.jvs.2014.02.008; Ishani A, 2015, CLIN J AM SOC NEPHRO, V10, P90, DOI 10.2215/CJN.03520414; Ishii H, 2012, DIABETOLOGIA, V55, P1304, DOI 10.1007/s00125-012-2473-9; Iwamoto N, 2012, J NEPHROL, V25, P755, DOI 10.5301/jn.5000056; Jiajue R, 2014, OSTEOPOROSIS INT, V25, P1999, DOI 10.1007/s00198-014-2714-5; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Komaba H, 2015, KIDNEY INT, V88, P350, DOI 10.1038/ki.2015.72; Kuwahara M, 2014, THER APHER DIAL, V18, P9, DOI 10.1111/1744-9987.12055; LAZARUS JM, 1975, KIDNEY INT, V7, pS167; Lee MY, 2010, KIDNEY BLOOD PRESS R, V33, P352, DOI 10.1159/000317524; Lepantalo M, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2233; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; London GM, 2015, J AM SOC NEPHROL, V26, P476, DOI 10.1681/ASN.2014020169; Lorenzo V, 2001, AM J KIDNEY DIS, V37, P1260, DOI 10.1053/ajkd.2001.24532; Ma TL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/639587; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497; Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x; Otsubo S, 2012, INT UROL NEPHROL, V44, P569, DOI 10.1007/s11255-010-9883-8; Rostand SG, 1999, KIDNEY INT, V56, P383, DOI 10.1046/j.1523-1755.1999.00575.x; Selvin E, 2004, CIRCULATION; Sharma J, 2012, J AM COLL SURGEONS, V214, P400, DOI 10.1016/j.jamcollsurg.2011.12.046; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tsuchihashi K, 2000, NEPHRON, V84, P13, DOI 10.1159/000045533; Usdin TB, 1996, ENDOCRINOLOGY, V137, P4285, DOI 10.1210/en.137.10.4285	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156863	10.1371/journal.pone.0156863	http://dx.doi.org/10.1371/journal.pone.0156863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284924	gold, Green Published, Green Submitted			2022-12-26	WOS:000377564000026
J	Silberstein, E; Ulitzky, L; Lima, LA; Cehan, N; Teixeira-Carvalho, A; Roingeard, P; Taylor, DR				Silberstein, Erica; Ulitzky, Laura; Lima, Livia Alves; Cehan, Nicoleta; Teixeira-Carvalho, Andrea; Roingeard, Philippe; Taylor, Deborah R.			HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; LIVER FIBROSIS; CELL-DEATH; SMMC-7721 CELLS; GAMBOGIC ACID; INFECTION; REPLICATION; CASPASE	Chronic Hepatitis C Virus (HCV) infection is associated with progressive liver injury and subsequent development of fibrosis and cirrhosis. The death of hepatocytes results in the release of cytokines that induce inflammatory and fibrotic responses. The mechanism of liver damage is still under investigation but both apoptosis and immune-mediated processes may play roles. By observing the changes in gene expression patterns in HCV-infected cells, both markers and the causes of HCV-associated liver injury may be elucidated. HCV genotype 1b virus from persistently infected VeroE6 cells induced a strong cytopathic effect when used to infect Huh7.5 hepatoma cells. To determine if this cytopathic effect was a result of apoptosis, ultrastructural changes were observed by electron microscopy and markers of programmed cell death were surveyed. Screening of a human PCR array demonstrated a gene expression profile that contained upregulated markers of apoptosis, including tumor necrosis factor, caspases and caspase activators, Fas, Bcl2-interacting killer (BIK) and tumor suppressor protein, p53, as a result of HCV genotype 1b infection. The genes identified in this study should provide new insights into understanding viral pathogenesis in liver cells and may possibly help to identify novel antiviral and antifibrotic targets.	[Silberstein, Erica; Ulitzky, Laura; Lima, Livia Alves; Cehan, Nicoleta; Teixeira-Carvalho, Andrea; Taylor, Deborah R.] CBER FDA, Off Blood Res & Review, Div Emerging Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20903 USA; [Roingeard, Philippe] Univ Tours, INSERM U966, Tours, France; [Roingeard, Philippe] CHRU Tours, Tours, France; [Lima, Livia Alves] Univ Fed Mato Grosso do Sul, Campo Grande, Brazil; [Cehan, Nicoleta] EMLab P&K, Fairfax, VA 22030 USA; [Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Fundacao Lab Biomarcadores Diagnost & Monitoracao, Grp Integrado Pesquisas Biomarcadores, Belo Horizonte, MG, Brazil	US Food & Drug Administration (FDA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universidade Federal de Mato Grosso do Sul; Fundacao Oswaldo Cruz	Taylor, DR (corresponding author), CBER FDA, Off Blood Res & Review, Div Emerging Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20903 USA.	Deborah.Taylor@fda.hhs.gov	Guedes, Livia Stêfania Alves Lima/U-8748-2017	Guedes, Livia Stêfania Alves Lima/0000-0002-1071-0351				Ahmad W, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-41; Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Aizaki H, 2002, HEPATOLOGY, V36, P1431, DOI 10.1053/jhep.2002.36937; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Aweya JJ, 2015, VIROLOGY, V474, P41, DOI 10.1016/j.virol.2014.10.027; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartenschlager R, 2010, J HEPATOL, V53, P583, DOI 10.1016/j.jhep.2010.04.015; Basu A, 2006, VIROLOGY, V349, P347, DOI 10.1016/j.virol.2006.02.023; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Chu VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028551; Ciccaglione AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-309; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Duan DZ, 2014, FREE RADICAL BIO MED, V69, P15, DOI 10.1016/j.freeradbiomed.2013.12.027; El-Bassiouni A, 2006, APMIS, V114, P420, DOI 10.1111/j.1600-0463.2006.apm_323.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Ferraris P, 2013, CELL MOL LIFE SCI, V70, P1297, DOI 10.1007/s00018-012-1213-0; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Ghavami S, 2005, MED SCI MONITOR, V11, pRA337; Gogela NA, 2015, CURR HIV-AIDS REP, V12, P68, DOI 10.1007/s11904-014-0243-7; Guo QL, 2006, LIFE SCI, V78, P1238, DOI 10.1016/j.lfs.2005.06.046; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lee MH, 2014, INT J CANCER, V135, P1119, DOI 10.1002/ijc.28753; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Ma Yan-bin, 2011, Virologica Sinica, V26, P366, DOI 10.1007/s12250-011-3218-5; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Poenisch M, 2010, SEMIN LIVER DIS, V30, P333, DOI 10.1055/s-0030-1267535; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roingeard P, 2013, J VIRAL HEPATITIS, V20, P77, DOI 10.1111/jvh.12035; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sebastiani G, 2014, WORLD J GASTROENTERO, V20, P11033, DOI 10.3748/wjg.v20.i32.11033; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Silberstein E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000910; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wang Y, 2012, EUR REV MED PHARMACO, V16, P995; Zekri ARN, 2007, J VIRAL HEPATITIS, V14, P468, DOI 10.1111/j.1365-2893.2006.00832.x; Zekri Abdel-Rahman N, 2011, Comp Hepatol, V10, P4, DOI 10.1186/1476-5926-10-4; Zhao P, 2012, VIRUS RES	53	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155708	10.1371/journal.pone.0155708	http://dx.doi.org/10.1371/journal.pone.0155708			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280444	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000005
J	Visioli, G; Galieni, A; Stagnari, F; Bonas, U; Speca, S; Faccini, A; Pisante, M; Marmiroli, N				Visioli, Giovanna; Galieni, Angelica; Stagnari, Fabio; Bonas, Urbana; Speca, Stefano; Faccini, Andrea; Pisante, Michele; Marmiroli, Nelson			Proteomics of Durum Wheat Grain during Transition to Conservation Agriculture	PLOS ONE			English	Article							STORAGE PROTEIN-COMPOSITION; WINTER-WHEAT; NITROGEN-FERTILIZATION; HIGH-TEMPERATURE; QUALITY; YIELD; SOIL; TILLAGE; STRESS; EFFICIENCY	Nitrogen management in combination with sustainable agronomic techniques can have a great impact on the wheat grain proteome influencing its technological quality. In this study, proteomic analyses were used to document changes in the proportion of prolamins in mature grains of the newly released Italian durum wheat cv Achille. Such an approach was applied to wheat fertilized with urea (UREA) and calcium nitrate (NITRATE), during the transition to no-till Conservation Agriculture (CA) practice in a Mediterranean environment. Results obtained in a two-years field experiment study suggest low molecular weight glutenins (LMW-GS) as the fraction particularly inducible regardless of the N-form. Quantitative analyses of LMW-GS by 2D-GE followed by protein identification by LC-ESI-MS/MS showed that the stable increase was principally due to C-type LMW-GS. The highest accumulation resulted from a physiologically healthier state of plants treated with UREA and NITRATE. Proteomic analysis on the total protein fraction during the active phase of grain filling was also performed. For both N treatments, but at different extent, an up-regulation of different classes of proteins was observed: i) enzymes involved in glycolysis and citric acid cycles which contribute to an enhanced source of energy and carbohydrates, ii) stress proteins like heat shock proteins (HSPs) and antioxidant enzymes, such as peroxidases and superoxide dismutase which protect the grain from abiotic stress during starch and storage protein synthesis. In conclusion N inputs, which combined rate with N form gave high yield and improved quality traits in the selected durum wheat cultivar. The specific up-regulation of some HSPs, antioxidant enzymes and defense proteins in the early stages of grain development and physiological indicators related to fitness traits, could be useful bio-indicators, for wheat genotype screening under more sustainable agronomic conditions, like transition phase to no-till CA in Mediterranean environments.	[Visioli, Giovanna; Bonas, Urbana; Marmiroli, Nelson] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Galieni, Angelica; Stagnari, Fabio; Speca, Stefano; Pisante, Michele] Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Teramo, Italy; [Faccini, Andrea] Univ Parma, Interdept Measure Ctr Giuseppe Casnati, I-43100 Parma, Italy; [Marmiroli, Nelson] Reg Emilia Romagna SITEIA, PARMA Technopole, Parma, Italy	University of Parma; University of Teramo; University of Parma	Visioli, G (corresponding author), Univ Parma, Dept Life Sci, I-43100 Parma, Italy.	giovanna.visioli@unipr.it	visioli, giovanna/C-1016-2015; PISANTE, MICHELE/J-4589-2019	visioli, giovanna/0000-0001-9712-3223; PISANTE, MICHELE/0000-0001-5851-3704; Galieni, Angelica/0000-0002-0971-796X	Progetto AGER [2010-C21J10000660002]; Regione Emilia-Romagna (IT) SITEIA. PARMA Technopole (POR FESR)	Progetto AGER; Regione Emilia-Romagna (IT) SITEIA. PARMA Technopole (POR FESR)	This work was supported by Progetto AGER, grant n.2010-C21J10000660002, and by Regione Emilia-Romagna (IT) SITEIA. PARMA Technopole (POR FESR 2007-2013).	Almeselmani M., 2009, Acta Agronomica Hungarica, V57, P1, DOI 10.1556/AAgr.57.2009.1.1; Altenbach SB, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-46; Apan A., 2006, INT J GEOINFORMATICS, V2, P93; Barraclough PB, 2010, EUR J AGRON, V33, P1, DOI 10.1016/j.eja.2010.01.005; Bencze S, 2004, CEREAL RES COMMUN, V32, P75; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; De Sanctis G, 2012, EUR J AGRON, V40, P18, DOI 10.1016/j.eja.2012.02.002; Derpsch R, 2008, NO TILL FARMING SYST, V3, P7; Dupont FM, 2003, J CEREAL SCI, V38, P133, DOI 10.1016/S0733-5210(03)00030-4; Farooq M, 2011, SOIL TILL RES, V117, P172, DOI 10.1016/j.still.2011.10.001; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galieni A, 2016, ITAL J AGRON, V11, P12, DOI 10.4081/ija.2016.662; Gallardo K, 2003, PLANT PHYSIOL, V133, P664, DOI 10.1104/pp.103.025254; Garrido-Lestache E, 2004, FIELD CROP RES, V85, P213, DOI 10.1016/S0378-4290(03)00167-9; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P494, DOI 10.1016/S0176-1617(96)80284-7; Grahmann K, 2014, FIELD CROP RES, V164, P166, DOI 10.1016/j.fcr.2014.05.002; Gruber S, 2011, SOIL TILL RES, V115, P80, DOI 10.1016/j.still.2011.07.001; Hurkman WJ, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-8; Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7; Jiang SS, 2012, INT J MOL SCI, V13, P16065, DOI 10.3390/ijms131216065; Johansson E, 2001, CEREAL CHEM, V78, P19, DOI 10.1094/CCHEM.2001.78.1.19; Kihara A, 2011, BIOSCI BIOTECH BIOCH, V75, P1740, DOI 10.1271/bbb.110285; Kindred DR, 2008, J CEREAL SCI, V48, P46, DOI 10.1016/j.jcs.2007.07.010; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Lemaire G, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P171, DOI 10.1016/B978-0-12-374431-9.00008-6; Marcus JP, 1999, PLANT J, V19, P699, DOI 10.1046/j.1365-313x.1999.00569.x; Matsunaka T, 1997, SOIL SCI PLANT NUTR, V43, P127, DOI 10.1080/00380768.1997.10414721; Melero S, 2011, SOIL TILL RES, V114, P97, DOI 10.1016/j.still.2011.04.007; Muccilli V, 2010, J CEREAL SCI, V51, P134, DOI 10.1016/j.jcs.2009.11.003; Osipova SV, 2012, J AGR FOOD CHEM, V60, P12065, DOI 10.1021/jf303513m; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; Penuelas J, 1997, INT J REMOTE SENS, V18, P2869, DOI 10.1080/014311697217396; PENUELAS J, 1995, NEW PHYTOL, V131, P291, DOI 10.1111/j.1469-8137.1995.tb03064.x; Pimstein A, 2011, FIELD CROP RES, V121, P125, DOI 10.1016/j.fcr.2010.12.001; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; R Core Team, 2021, R LANGUAGE ENV STAT; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Saint Pierre C, 2008, J CEREAL SCI, V47, P407, DOI 10.1016/j.jcs.2007.05.007; Sassa H, 2000, GENE, V250, P61, DOI 10.1016/S0378-1119(00)00190-6; Schleicher TD, 2001, 2001 ASAE ANN INT M; SINGH NK, 1991, J CEREAL SCI, V14, P203, DOI 10.1016/S0733-5210(09)80039-8; Skylas DJ, 2002, J CEREAL SCI, V35, P175, DOI 10.1006/jcrs.2001.0410; Stagnari F, 2013, PLANT BREEDING, V132, P266, DOI 10.1111/pbr.12044; Tang L, 2008, TRANSGENIC RES, V17, P705, DOI 10.1007/s11248-007-9155-2; Tea I, 2004, CEREAL CHEM, V81, P759, DOI 10.1094/CCHEM.2004.81.6.759; Tenuta M, 2003, CAN J SOIL SCI, V83, P521, DOI 10.4141/S02-062; Velthof GL, 2003, BIOL FERT SOILS, V37, P221, DOI 10.1007/s00374-003-0589-2; Vensel WH, 2005, PROTEOMICS, V5, P1594, DOI 10.1002/pmic.200401034; Vinje MA, 2011, PLANTA, V233, P1001, DOI 10.1007/s00425-011-1348-5; Visioli G, 2016, FOOD ANAL METHOD, V9, P469, DOI 10.1007/s12161-015-0218-3; Wan YF, 2013, J EXP BOT, V64, P161, DOI 10.1093/jxb/ers318; Wang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102914; Wang ZJ, 2004, FIELD CROP RES, V90, P311, DOI 10.1016/j.fcr.2004.04.004; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang JH, 2010, SCI CHINA TECHNOL SC, V53, P1159, DOI 10.1007/s11431-010-0131-3; Zhang N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00735; Zhao CX, 2009, CR BIOL, V332, P759, DOI 10.1016/j.crvi.2009.03.003; Zhao H, 2008, J AGRON CROP SCI, V194, P47, DOI 10.1111/j.1439-037X.2007.00283.x	60	15	15	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156007	10.1371/journal.pone.0156007	http://dx.doi.org/10.1371/journal.pone.0156007			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281174	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000011
J	Walitt, B; Katz, RS; Bergman, MJ; Wolfe, F				Walitt, Brian; Katz, Robert S.; Bergman, Martin J.; Wolfe, Frederick			Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview Survey	PLOS ONE			English	Article							DISTRESS	Objectives Although fibromyalgia criteria have been in effect for decades, little is known about how the fibromyalgia diagnosis is applied and understood by clinicians and patients. We used the National Health Interview Survey (NHIS) to determine the prevalence of self-reported clinician diagnosed fibromyalgia and then compared demographics, symptoms, disability and medical utilization measures of persons with a clinical diagnosis of fibromyalgia that did not meet diagnostic criteria (false-positive or prior [F/P] fibromyalgia) to persons with and without criteria-positive fibromyalgia. Methods The National Health Interview Survey (NHIS) collected information about both clinical diagnosis and symptoms of fibromyalgia that was appropriately weighted to represent 225,726,257 US adults. Surrogate NHIS diagnostic criteria for fibromyalgia were developed based on the level of polysymptomatic distress (PSD) as characterized in the 2011 modified American College of Rheumatology criteria (ACR) for fibromyalgia. Persons with F/P fibromyalgia were compared with persons who do not have fibromyalgia and those meeting surrogate NHIS fibromyalgia criteria. Results Of the 1.78% of persons reporting a clinical diagnosis, 73.5% did not meet NHIS fibromyalgia criteria. The prevalence of F/P fibromyalgia is 1.3%. F/P fibromyalgia is associated with a mild degree of polysymptomatic distress (NHIS PSD score 6.2) and characterized by frequent but not widespread pain and insomnia. Measures of work disability and medical utilization in F/P fibromyalgia were equal to that seen with NHIS criteria positive fibromyalgia and were 6-7x greater in F/P fibromyalgia than in non-fibromyalgia persons. F/P fibromyalgia was best predicted by being female (Odds Ratio [OR] 8.81), married (OR 3.27), and white (OR 1.96). In contrast, being a white, married woman was only modestly predictive of NHIS (criteria positive) fibromyalgia (OR 2.1). Conclusions The majority of clinically diagnosed fibromyalgia cases in the US do not reach levels of severity necessary and sufficient for diagnosis. The clinical diagnosis of fibromyalgia is disproportionally dependent on demographic and social factors rather than the symptoms themselves. Diagnostic criteria for fibromyalgia appear to be used as a vague guide by clinicians and patients, and allow for substantial diagnostic expansion of fibromyalgia.	[Walitt, Brian] Georgetown Univ, Washington, DC USA; [Katz, Robert S.] Rush Univ, Med Ctr, Dept Rheumatol, Chicago, IL 60612 USA; [Bergman, Martin J.] Drexel Univ, Coll Med, Dept Rheumatol, Philadelphia, PA 19104 USA; [Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS USA	Georgetown University; Rush University; Drexel University; National Data Bank for Rheumatic Diseases	Walitt, B (corresponding author), Georgetown Univ, Washington, DC USA.	Brian.walitt@nih.gov		Wolfe, Frederick/0000-0002-2801-6413				Association A. P., 2013, DIAGN STAT MAN MENT, V5th, P991; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; CDC, 2013, VIT SIGNS PRESCR PAI; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Conrad P, 2010, SOC SCI MED, V70, P1943, DOI 10.1016/j.socscimed.2010.02.019; Corporation S., 2013, STAT STAT SOFTW REL; Furedi F, 2006, SOCIETY, V43, P14, DOI 10.1007/BF02698479; GARFIELD SR, 1970, SCI AM, V222, P15, DOI 10.1038/scientificamerican0470-15; Gupta A, 2007, RHEUMATOLOGY, V46, P666, DOI 10.1093/rheumatology/kel363; Hauser W, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4441; Hauser W, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010292; Mease P, 2009, J RHEUMATOL, V36, P2318, DOI 10.3899/jrheum.090367; Nakamura I, 2014, ARTHRIT CARE RES, V66, P1093, DOI 10.1002/acr.22277; National Condidential Enquiry into Patient Outcome and Death (UK), 2013, MOD SHAL GAS DEV US, P1; Petzke F, 2003, J RHEUMATOL, V30, P567; Robinson RL, 2013, PAIN MED, V14, P1400, DOI 10.1111/pme.12168; Skaer TL, 2014, PHARMACOECONOMICS, V32, P457, DOI 10.1007/s40273-014-0137-y; SMYTHE H A, 1977, Bulletin on the Rheumatic Diseases, V28, P928; Szabo RM, 2000, J BONE JOINT SURG AM, V82A, P1314, DOI 10.2106/00004623-200009000-00012; Uceyler N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010782; Walitt B, 2015, PREVALENCE CHARACTER; Walitt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138024; Walitt B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011735; Walitt B, 2011, J RHEUMATOL, V38, P2238, DOI 10.3899/jrheum.110026; Wolfe F, 1997, ANN RHEUM DIS, V56, P268, DOI 10.1136/ard.56.4.268; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2015, J RHEUMATOL, V42, P1494, DOI 10.3899/jrheum.141519; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolinsky H, 2005, EMBO REP, V6, P612, DOI 10.1038/sj.embor.7400476	32	51	51	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157235	10.1371/journal.pone.0157235	http://dx.doi.org/10.1371/journal.pone.0157235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281286	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000112
J	Davis, MP; Sparks, JS; Smith, WL				Davis, Matthew P.; Sparks, John S.; Smith, W. Leo			Repeated and Widespread Evolution of Bioluminescence in Marine Fishes	PLOS ONE			English	Article							PONYFISHES TELEOSTEI LEIOGNATHIDAE; DEEP-SEA; DIVERSIFICATION; PHYLOGENY; AULOPIFORMES; RADIATIONS; DIVERSITY; LIGHT	Bioluminescence is primarily a marine phenomenon with 80% of metazoan bioluminescent genera occurring in the world's oceans. Here we show that bioluminescence has evolved repeatedly and is phylogenetically widespread across ray-finned fishes. We recover 27 independent evolutionary events of bioluminescence, all among marine fish lineages. This finding indicates that bioluminescence has evolved many more times than previously hypothesized across fishes and the tree of life. Our exploration of the macroevolutionary patterns of bioluminescent lineages indicates that the present day diversity of some inshore and deep-sea bioluminescent fish lineages that use bioluminescence for communication, feeding, and reproduction exhibit exceptional species richness given clade age. We show that exceptional species richness occurs particularly in deep-sea fishes with intrinsic bioluminescent systems and both shallow water and deep-sea lineages with luminescent systems used for communication.	[Davis, Matthew P.] St Cloud State Univ, St Cloud, MN 56301 USA; [Sparks, John S.] Amer Museum Nat Hist, New York, NY 10024 USA; [Smith, W. Leo] Univ Kansas, Lawrence, KS 66045 USA	Minnesota State Colleges & Universities; Saint Cloud State University; American Museum of Natural History (AMNH); University of Kansas	Davis, MP (corresponding author), St Cloud State Univ, St Cloud, MN 56301 USA.	mpdavis@stcloudstate.edu			National Science Foundation grants (DEB) [1543654, 1258141, 0444842, 1257555, 1060869]; Dalio Family Foundation; KU; SCSU; Direct For Biological Sciences [1543654] Funding Source: National Science Foundation	National Science Foundation grants (DEB); Dalio Family Foundation; KU; SCSU; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by National Science Foundation grants (DEB) to M.P.D. (1543654, 1258141), J.S.S. (0444842, 1257555), and W.L.S. (1060869, 1258141), with support from the Dalio Family Foundation, KU, and SCSU.; We thank the following people and institutions for providing specimens and tissue loans: A. Bentley (KU), H.J. Walker (SIO), K. Hartel and A. Williston (MCZ), C. McMahan, S. Mochel, and K. Swagel (FMNH), C. Baldwin (USNM), A. Graham (CSIRO), and M. Miya (CBM). Financial support was provided by National Science Foundation grants (DEB) to M.P.D. (1543654, 1258141), J.S.S. (0444842, 1257555), and W.L.S. (1060869, 1258141), with support from the Dalio Family Foundation, KU, and SCSU.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Branham MA, 1996, NATURE, V381, P745, DOI 10.1038/381745b0; Chakrabarty P, 2011, MOL ECOL, V20, P2818, DOI 10.1111/j.1365-294X.2011.05112.x; Chakrabarty P, 2011, J MORPHOL, V272, P704, DOI 10.1002/jmor.10941; Claes JM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150219; Davis MP, 2014, MAR BIOL, V161, P1139, DOI 10.1007/s00227-014-2406-x; Davis MP, 2010, MOL PHYLOGENET EVOL, V57, P1194, DOI 10.1016/j.ympev.2010.09.003; DeVaney SC, 2008, THESIS U KANSAS; Dikow RB, 2011, CLADISTICS, V27, P9, DOI 10.1111/j.1096-0031.2010.00312.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunlap PV, 2007, CLADISTICS, V23, P507, DOI 10.1111/j.1096-0031.2007.00157.x; Eschmeyer W. N., 2014, CATALOG FISHES; Gerlach T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0787; Ghedotti MJ, 2015, J MORPHOL, V276, P310, DOI 10.1002/jmor.20341; Haddock SHD, 2001, P NATL ACAD SCI USA, V98, P11148, DOI 10.1073/pnas.201329798; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASTINGS JW, 1971, SCIENCE, V173, P1016, DOI 10.1126/science.173.4001.1016; Herring P.J., 1987, Journal of Bioluminescence and Chemiluminescence, V1, P147, DOI 10.1002/bio.1170010303; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kronstrom J, 2010, ACTA ZOOL-STOCKHOLM, V91, P474, DOI 10.1111/j.1463-6395.2009.00438.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2012, MOL PHYLOGENET EVOL, V63, P388, DOI 10.1016/j.ympev.2012.01.011; Niemiller ML, 2013, EVOLUTION, V67, P732, DOI 10.1111/j.1558-5646.2012.01822.x; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sparks JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083259; Straube N, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0446-6; Straube N, 2010, MOL PHYLOGENET EVOL, V56, P905, DOI 10.1016/j.ympev.2010.04.042; Thacker CE, 2009, MOL PHYLOGENET EVOL, V52, P735, DOI 10.1016/j.ympev.2009.05.017; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Wiley EO, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.2946.1.4; Zwickl DJ., 2006, THESIS	38	59	59	13	225	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155154	10.1371/journal.pone.0155154	http://dx.doi.org/10.1371/journal.pone.0155154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276229	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561700004
J	Jiang, T; Nogales, A; Baker, SF; Martinez-Sobrido, L; Turner, DH				Jiang, Tian; Nogales, Aitor; Baker, Steven F.; Martinez-Sobrido, Luis; Turner, Douglas H.			Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture	PLOS ONE			English	Article							SECONDARY STRUCTURE; COAXIAL STACKING; AVIAN INFLUENZA; UNITED-STATES; VIRUS-VACCINE; NS1 PROTEIN; SEQUENCE; DOMAIN; CHILDREN; EFFICACY	Influenza A virus is a significant public health threat, but little is understood about the viral RNA structure and function. Current vaccines and therapeutic options to control influenza A virus infections are mostly protein-centric and of limited effectiveness. Here, we report using an ensemble defect approach to design mutations to misfold regions of conserved mRNA structures in influenza A virus segments 7 and 8. Influenza A mutant viruses inhibit pre-mRNA splicing and attenuate viral replication in cell culture, thus providing evidence for functions of the targeted regions. Targeting these influenza A viral RNA regions provides new possibilities for designing vaccines and therapeutics against this important human respiratory pathogen. The results also demonstrate that the ensemble defect approach is an efficient way to test for function of RNA sequences.	[Jiang, Tian; Turner, Douglas H.] Univ Rochester, Dept Chem, Rochester, NY USA; [Nogales, Aitor; Baker, Steven F.; Martinez-Sobrido, Luis] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA	University of Rochester; University of Rochester	Turner, DH (corresponding author), Univ Rochester, Dept Chem, Rochester, NY USA.	turner@chem.rochester.edu	NOGALES, AITOR/AAY-1590-2020; Martinez-Sobrido, Luis/ACJ-7853-2022; NOGALES, AITOR/W-3948-2017	NOGALES, AITOR/0000-0002-2424-7900; Martinez-Sobrido, Luis/0000-0001-7084-0804; Baker, Steven/0000-0001-8379-283X	National Institutes of Health [GM22939]; University of Rochester Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM22939 (DHT) and a 2014 University of Rochester Research Award (LMS) (http://www.nih.gov/) (http://www.rochester.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2012, EUR J CLIN MICROBIOL, V31, P2549, DOI 10.1007/s10096-012-1595-9; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Belshe RB, 2008, VACCINE, V26, pD10, DOI 10.1016/j.vaccine.2008.06.083; Belshe RB, 2007, VACCINE, V25, P6755, DOI 10.1016/j.vaccine.2007.06.066; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Carrillo B, 2014, J VIROL, V88, P4113, DOI 10.1128/JVI.03692-13; CDC, 2015, LIV ATT INFL VACC LA; CDC, 2015, IN INFL VACC INF STA; Chen JL, 2012, BIOCHEMISTRY-US, V51, P3508, DOI 10.1021/bi3002709; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Cho KJ, 2015, J VIROL, V89, P3700, DOI 10.1128/JVI.02576-14; Cox A, 2015, J VIROL, V89, P3421, DOI 10.1128/JVI.02636-14; COX NJ, 1988, VIROLOGY, V167, P554, DOI 10.1016/S0042-6822(88)90118-3; Cross TA, 2012, CURR OPIN VIROL, V2, P128, DOI 10.1016/j.coviro.2012.01.005; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Govorkova EA, 2013, CURR TOP MICROBIOL, V370, P273, DOI 10.1007/82_2011_198; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; Gu M, 2012, J VIROL, V86, P12463, DOI 10.1128/JVI.02315-12; Gultyaev AP, 2007, BIOINFORMATICS, V23, P272, DOI 10.1093/bioinformatics/btl559; Gultyaev AP, 2014, RNA BIOL, V11, P942, DOI 10.4161/rna.29730; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Jiang T, 2014, BIOCHEMISTRY-US, V53, P5236, DOI 10.1021/bi500611j; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lommer BS, 2002, J BIOL CHEM, V277, P7108, DOI 10.1074/jbc.M109045200; MAASSAB HF, 1967, NATURE, V213, P612, DOI 10.1038/213612a0; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Martinez-Sobrido L, 2010, J VISUALIZED EXPT; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Moss WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038323; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Safo MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109510; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; SNYDER MH, 1988, J VIROL, V62, P488, DOI 10.1128/JVI.62.2.488-495.1988; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Tyagi R, 2007, RNA, V13, P939, DOI 10.1261/rna.305307; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; WALTER AE, 1994, BIOCHEMISTRY-US, V33, P12715, DOI 10.1021/bi00208a024; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786	55	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156906	10.1371/journal.pone.0156906	http://dx.doi.org/10.1371/journal.pone.0156906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272307	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000046
J	Sotolongo, A; Monica, FZ; Kots, A; Xiao, HJ; Liu, J; Seto, E; Bian, K; Murad, F				Sotolongo, Alex; Monica, Fabiola Zakia; Kots, Alex; Xiao, Haijie; Liu, Jun; Seto, Edward; Bian, Ka; Murad, Ferid			Epigenetic regulation of soluble guanylate cyclase (sGC) 1 in breast cancer cells	FASEB JOURNAL			English	Article						histone acetyltransferase; histone deacetylase; inhibitors	HISTONE DEACETYLASE INHIBITORS; NITRIC-OXIDE SYNTHASE; MESENCHYMAL TRANSITION; PROTEIN ACETYLATION; TRICHOSTATIN-A; EXPRESSION; GENE; DIFFERENTIATION; STIMULATION; REPRESSION	Soluble guanylate cyclase (sGC) is a heterodimer composed of and subunits. The loss of sGC1 has been implicated in several vascular and nonvascular diseases. Our analysis showed that higher levels of sGC1 in breast cancer tissues are correlated with greater survival probability than lower sGC1 levels. However, there is no information on sGC regulation by epigenetic mechanisms. We examined the role of histone deacetylase (HDAC) inhibitors in regulating sGC1 and -1 expression in human breast cancer MDA-MB-231 and MDA-MB-468 cell lines. The class I HDAC inhibitors increased the expression of sGC1 more than sGC1. Transient overexpression of HDAC3, but not HDAC1 or HDAC2, significantly reduced sGC1 mRNA. Chromatin immunoprecipitation assay confirmed an enhanced binding of HDAC3 to the sGC1 proximal promoter, which could be reversed by panobinostat (LBH-589) treatment. Mutations at the CCAAT binding sequence, a major element regulating sGC1 expression, markedly reduced the efficacy of LBH-589 in augmenting sGC1 promoter activity. LBH-589 markedly enhanced the binding of nuclear transcription factor Y, subunit , to the sGC1 promoter (CCAAT binding sequence). In summary, HDAC3 is an endogenous antagonist of sGC1 expression. Inhibition of HDAC3 with targeted therapy could benefit treatment of the diseases associated with sGC1 down-regulation and/or deficiency such as cancer and several vascular-related diseases.Sotolongo, A., Monica, F. Z., Kots, A., Xiao, H., Liu, J., Seto, E., Bian, K., Murad, F. Epigenetic regulation of soluble guanylate cyclase (sGC) 1 in breast cancer cells.	[Sotolongo, Alex; Monica, Fabiola Zakia; Kots, Alex; Xiao, Haijie; Liu, Jun; Seto, Edward; Bian, Ka; Murad, Ferid] George Washington Univ, Dept Biochem & Mol Med, Washington, DC USA; [Seto, Edward] George Washington Univ, Ctr Canc, Washington, DC USA; [Monica, Fabiola Zakia] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil	George Washington University; George Washington University; Universidade Estadual de Campinas	Bian, K (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Med, 2300 Eye St NW, Washington, DC 20037 USA.	bcmkxb@gwu.edu	Kots, Alexander/AAF-5404-2020; Monica, Fabiola Zakia/B-4191-2013	Kots, Alexander/0000-0002-5278-5888; Monica, Fabiola Zakia/0000-0002-8449-6677	SAo Paulo Research Foundation (FAPESP) [2013/02246-7]; Coordination for the Improvement of Higher Education Personnel Foundation (CAPES) [BEX 6718-14]; State University of Campinas (UNICAMP); George Washington University	SAo Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel Foundation (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); State University of Campinas (UNICAMP); George Washington University	F.Z.M. acknowledges the SAo Paulo Research Foundation (FAPESP; 2013/02246-7), the Coordination for the Improvement of Higher Education Personnel Foundation (CAPES; BEX 6718-14), the State University of Campinas (UNICAMP), and George Washington University for research support. The authors thank Kleber Fertrin (University of Campinas) for valuable discussion of the experimental methods and results. Author contributions: A. Sotolongo and H. Xiao performed the experiments and analyzed the data; F. Z. Monica analyzed the data and wrote the manuscript; A. Kots analyzed the data; J. Liu perfomed the experiments; E. Seto supported the experiments and corrected the manuscript; K. Bian designed the experiments, analyzed the data and wrote the manuscript; and F. Murad conceived and supported the experiments, contributed reagents, sourced materials, provided analysis tools, and wrote the paper.	Alexandre EC, 2014, J PHARMACOL EXP THER, V349, P2, DOI 10.1124/jpet.113.211029; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bian K, 2014, NITRIC OXIDE-BIOL CH, V43, P3, DOI 10.1016/j.niox.2014.08.006; Bian K, 2012, IUBMB LIFE, V64, P676, DOI 10.1002/iub.1057; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Campanero MR, 2008, ONCOGENE, V27, P1263, DOI 10.1038/sj.onc.1210735; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Gan YH, 2005, J BIOL CHEM, V280, P16467, DOI 10.1074/jbc.M412960200; Glaser KB, 2004, BIOCHEM BIOPH RES CO, V325, P683, DOI 10.1016/j.bbrc.2004.10.082; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Kang JH, 2008, J CELL BIOCHEM, V104, P1192, DOI 10.1002/jcb.21697; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; Kourea Helen P, 2014, Curr Mol Pharmacol, V7, P4; Leiria LO, 2014, J UROLOGY, V191, P539, DOI 10.1016/j.juro.2013.09.020; Li Y, 2015, ONCOTARGET, V6, P4345, DOI 10.18632/oncotarget.2999; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Marro ML, 2008, J BIOL CHEM, V283, P20027, DOI 10.1074/jbc.M801223200; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Monica F. Z., 2014, OA BIOCH, V2, P3; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Muller BM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-215; Mujoo K, 2010, NITRIC OXIDE-BIOL CH, V22, P43, DOI 10.1016/j.niox.2009.11.007; MURAD F, 1988, COLD SPRING HARB SYM, V53, P1005, DOI 10.1101/SQB.1988.053.01.115; Nakane M, 1994, Adv Pharmacol, V26, P7, DOI 10.1016/S1054-3589(08)60048-4; Nielsen TO, 2015, CLIN CANCER RES, V21, P1779, DOI 10.1158/1078-0432.CCR-14-2552; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Peng Lirong, 2011, Handb Exp Pharmacol, V206, P39, DOI 10.1007/978-3-642-21631-2_3; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; RIBEIRO MO, 1992, HYPERTENSION, V20, P298, DOI 10.1161/01.HYP.20.3.298; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Shailubhai K, 2000, CANCER RES, V60, P5151; Sharina IG, 2003, P NATL ACAD SCI USA, V100, P11523, DOI 10.1073/pnas.1934338100; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Silva FH, 2014, J SEX MED, V11, P2661, DOI 10.1111/jsm.12682; Suzuki J, 2009, CLIN CANCER RES, V15, P3163, DOI 10.1158/1078-0432.CCR-08-2319; Weissmann N, 2014, AM J RESP CRIT CARE, V189, P1359, DOI 10.1164/rccm.201311-2037OC; Wen HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125518; Wilson C, 2014, CANCER EPIDEM BIOMAR, V23, P2328, DOI 10.1158/1055-9965.EPI-14-0440; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhu HF, 2011, MOL PHARMACOL, V80, P1076, DOI 10.1124/mol.111.073585; Zuzga DS, 2012, INT J CANCER, V130, P2539, DOI 10.1002/ijc.26257	55	7	7	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3171	3180		10.1096/fj.201600339R	http://dx.doi.org/10.1096/fj.201600339R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27279362				2022-12-26	WOS:000382816300017
J	Malmos, KG; Bjerring, M; Jessen, CM; Nielsen, EHT; Poulsen, ET; Christiansen, G; Vosegaard, T; Skrydstrup, T; Enghild, JJ; Pedersen, JS; Otzen, DE				Malmos, Kirsten Gade; Bjerring, Morten; Jessen, Christian Moestrup; Nielsen, Erik Holm Toustrup; Poulsen, Ebbe T.; Christiansen, Gunna; Vosegaard, Thomas; Skrydstrup, Troels; Enghild, Jan J.; Pedersen, Jan Skov; Otzen, Daniel E.			How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATED GLYCOSAMINOGLYCANS; PEPTIDE; IDENTIFICATION; ENHANCEMENT; PROLACTIN; OLIGOMERS; MECHANISM; GRANULES; PLAQUES; BINDING	Glycosaminoglycans (GAGs) bind all known amyloid plaques and help store protein hormones in (acidic) granular vesicles, but the molecular mechanisms underlying these important effects are unclear. Here we investigate GAG interactions with the peptide hormone salmon calcitonin (sCT). GAGs induce fast sCT fibrillation at acidic pH and only bind monomeric sCT at acidic pH, inducing sCT helicity. Increasing GAG sulfation expands the pH range for binding. Heparin, the most highly sulfated GAG, binds sCT in the pH interval 3-7. Small angle x-ray scattering indicates that sCT monomers densely decorate and pack single heparin chains, possibly via hydrophobic patches on helical sCT. sCT fibrillates without GAGs, but heparin binding accelerates the process by decreasing the otherwise long fibrillation lag times at low pH and accelerates fibril growth rates at neutral pH. sCT center dot heparin complexes form beta-sheet-rich heparin-covered fibrils. Solid-state NMR reveals that heparin does not alter the sCT fibrillary core around Lys(11) but makes changes to Val(8) on the exterior side of the beta-strand, possibly through contacts to Lys(18). Thus GAGs significantly modulate sCT fibrillation in a pH-dependent manner by interacting with both monomeric and aggregated sCT.	[Malmos, Kirsten Gade; Bjerring, Morten; Jessen, Christian Moestrup; Nielsen, Erik Holm Toustrup; Vosegaard, Thomas; Skrydstrup, Troels; Pedersen, Jan Skov; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Malmos, Kirsten Gade; Bjerring, Morten; Jessen, Christian Moestrup; Nielsen, Erik Holm Toustrup; Vosegaard, Thomas; Skrydstrup, Troels; Pedersen, Jan Skov; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Malmos, Kirsten Gade; Poulsen, Ebbe T.; Enghild, Jan J.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus, Denmark; [Bjerring, Morten; Vosegaard, Thomas; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.	dao@inano.au.dk	Pedersen, Jan Skov/A-8346-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Christiansen, Gunna/0000-0003-0540-1367; Enghild, Jan Johannes/0000-0001-9292-9172; Gade Malmos, Kirsten/0000-0002-4035-9048; Nielsen, Erik Nguyen/0000-0002-8810-1046; Skrydstrup, Troels/0000-0001-8090-5050; Vosegaard, Thomas/0000-0001-5414-4550; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431	Danish Research Foundation inSPIN Grant [DNRF59]; Danish Ministry of Higher Education and Science [AU-2010-612-181]; Novo Nordisk Fonden [NNF14OC0012953] Funding Source: researchfish	Danish Research Foundation inSPIN Grant; Danish Ministry of Higher Education and Science; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Danish Research Foundation inSPIN Grant DNRF59 and Danish Ministry of Higher Education and Science Grant AU-2010-612-181. The authors declare that they have no conflicts of interest with the contents of this article.	Andreasen M, 2014, BIOCHEMISTRY-US, V53, P6968, DOI 10.1021/bi500674u; Andreotti G, 2004, J BIOL CHEM, V279, P6364, DOI 10.1074/jbc.M310882200; Andreotti G, 2011, J BIOL CHEM, V286, P2707, DOI 10.1074/jbc.M110.182014; Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; BEATY NB, 1987, J CHROMATOGR-BIOMED, V418, P187, DOI 10.1016/0378-4347(87)80009-9; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Bruinsma IB, 2010, ACTA NEUROPATHOL, V119, P211, DOI 10.1007/s00401-009-0577-1; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chan C., 2000, FMOC SOLID PHASE PEP; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; CUDD A, 1995, J PHARM SCI, V84, P717, DOI 10.1002/jps.2600840610; Dannies PS, 2012, ENDOCR REV, V33, P254, DOI 10.1210/er.2011-1002; De Carufel CA, 2013, BIOPOLYMERS, V100, P645, DOI 10.1002/bip.22243; Diociaiuti M, 2006, BIOPHYS J, V91, P2275, DOI 10.1529/biophysj.105.079475; Diociaiuti M, 2014, BBA-MOL BASIS DIS, V1842, P1622, DOI 10.1016/j.bbadis.2014.06.006; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GALANTE L, 1971, CLIN SCI, V40, pP9; Gallagher JT, 2000, PROTEOGLYCANS STRUCT, P27; GIANNATTASIO G, 1980, J CELL BIOL, V86, P273, DOI 10.1083/jcb.86.1.273; Iannuzzi C, 2015, MOLECULES, V20, P2510, DOI 10.3390/molecules20022510; Iozzo R. V., 2000, PROTEOGLYCANS STRUCT, P1; Kamihira M, 2000, PROTEIN SCI, V9, P867, DOI 10.1110/ps.9.5.867; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lehri-Boufala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116641; Madine J, 2012, ANGEW CHEM INT EDIT, V51, P13140, DOI 10.1002/anie.201204459; Madine J, 2009, ORG BIOMOL CHEM, V7, P2414, DOI 10.1039/b820808e; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Malmos K.G., 2014, BIONANOIMAGING PROTE, P281; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Motamedi-Shad N, 2012, NAT STRUCT MOL BIOL, V19, P547, DOI 10.1038/nsmb.2286; NAGASAWA K, 1978, BIOCHIM BIOPHYS ACTA, V544, P430, DOI 10.1016/0304-4165(78)90110-1; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Saridaki T, 2012, J MOL BIOL, V421, P616, DOI 10.1016/j.jmb.2012.02.007; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shi T, 2002, BIOORG MED CHEM LETT, V12, P2237, DOI 10.1016/S0960-894X(02)00344-X; SNOW AD, 1990, LAB INVEST, V63, P601; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Virchow R., 1855, ARCH PATHOL ANAT PH, V8, P140, DOI [10.1007/BF01935322, DOI 10.1007/BF01935322]; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	51	16	16	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16849	16862		10.1074/jbc.M116.715466	http://dx.doi.org/10.1074/jbc.M116.715466			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27281819	hybrid, Green Published			2022-12-26	WOS:000380826700040
J	Guest, SK; Ribas, R; Pancholi, S; Nikitorowicz-Buniak, J; Simigdala, N; Dowsett, M; Johnston, SR; Martin, LA				Guest, Stephanie K.; Ribas, Ricardo; Pancholi, Sunil; Nikitorowicz-Buniak, Joanna; Simigdala, Nikiana; Dowsett, Mitch; Johnston, Stephen R.; Martin, Lesley-Ann			Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation	PLOS ONE			English	Article							ER-ALPHA PHOSPHORYLATION; TAMOXIFEN-RESISTANT; ANTITUMOR-ACTIVITY; MOLECULAR MARKERS; DASATINIB THERAPY; PATIENT SELECTION; KINASE INHIBITOR; GENE-EXPRESSION; MCF-7 CELLS; PATHWAYS	Despite the effectiveness of endocrine therapies in estrogen receptor positive (ER+) breast cancer, approximately 40% of patients relapse. Previously, we identified the Focal-adhesion kinase canonical pathway as a major contributor of resistance to estrogen deprivation and cellular-sarcoma kinase (c-src) as a dominant gene in this pathway. Dasatinib, a pansrc inhibitor, has recently been used in clinical trials to treat ER+ patients but has shown mixed success. In the following study, using isogenic cell line models, we provide a potential explanation for these findings and suggest a sub-group that may benefit. A panel of isogenic cell lines modelling resistance to aromatase inhibitors (LTED) and tamoxifen (TAMR) were assessed for response to dasatinib +/- endocrine therapy. Dasatinib caused a dose-dependent decrease in proliferation in MCF7-TAMR cells and resensitized them to tamoxifen and fulvestrant but not in HCC1428-TAMR. In contrast, in estrogen-deprived conditions, dasatinib increased the proliferation rate of parental-MCF7 cells and had no effect on MCF7-LTED or HCC1428-LTED. Treatment with dasatinib caused a decrease in src-phosphorylation and inhibition of downstream pathways, including AKT and ERK1/2 in all cell lines tested, but only the MCF7-TAMR showed a concomitant decrease in markers of cell cycle progression. Inhibition of src also caused a significant decrease in cell migration in both MCF7-LTED and MCF7-TAMR cells. Finally, we showed that, in MCF7-TAMR cells, in contrast to tamoxifen sensitive cell lines, ER is expressed throughout the cell rather than being restricted to the nucleus and that treatment with dasatinib resulted in nuclear shuttling of ER, which was associated with an increase in ER-mediated transcription. These data suggest that src has differential effects in endocrine-resistant cell lines, particularly in tamoxifen resistant models, with low ER genomic activity, providing further evidence of the importance of patient selection for clinical trials testing dasatinib utility in ER+ breast cancer.	[Guest, Stephanie K.; Ribas, Ricardo; Pancholi, Sunil; Nikitorowicz-Buniak, Joanna; Simigdala, Nikiana; Dowsett, Mitch; Martin, Lesley-Ann] Inst Canc Res, Breast Canc Now & Toby Robins Res Ctr, London SW3 6JB, England; [Dowsett, Mitch; Johnston, Stephen R.] Royal Marsden Hosp, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Martin, LA (corresponding author), Inst Canc Res, Breast Canc Now & Toby Robins Res Ctr, London SW3 6JB, England.	lesley-ann.martin@icr.ac.uk	Martin, Lesley-Ann/AAA-1841-2020	Ribas, Ricardo/0000-0002-8134-0036; Dowsett, Mitch/0000-0003-4122-744X; Pancholi, Sunil/0000-0002-0880-1588; Nikitorowicz-Buniak, Joanna/0000-0002-7510-3843	Breast Cancer Now; NHS funding to the Royal Marsden Hospital's NIHR Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10122] Funding Source: researchfish	Breast Cancer Now; NHS funding to the Royal Marsden Hospital's NIHR Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge Breast Cancer Now and NHS funding to the Royal Marsden Hospital's NIHR Biomedical Research Centre for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; [Anonymous], 2014, CANC DISCOV, V4, P138; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Beliakoff J, 2003, CLIN CANCER RES, V9, P4961; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brann DW, 2008, MOL CELL ENDOCRINOL, V290, P2, DOI 10.1016/j.mce.2008.04.019; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Castoria G, 2012, ONCOGENE, V31, P4868, DOI 10.1038/onc.2011.642; Ceppi P, 2009, MOL CANCER THER, V8, P3066, DOI 10.1158/1535-7163.MCT-09-0151; Chakravarty D, 2010, IUBMB LIFE, V62, P163, DOI 10.1002/iub.287; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; Eastman BM, 2012, CELL SIGNAL, V24, P1847, DOI 10.1016/j.cellsig.2012.05.011; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Konecny GE, 2009, BRIT J CANCER, V101, P1699, DOI 10.1038/sj.bjc.6605381; Llombart A, 2012, CANC RES S, V71; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Mayer EL, 2011, CLIN CANCER RES, V17, P6897, DOI 10.1158/1078-0432.CCR-11-0070; Moulder S, 2010, MOL CANCER THER, V9, P1120, DOI 10.1158/1535-7163.MCT-09-1117; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Pancholi S, 2008, ENDOCR-RELAT CANCER, V15, P985, DOI 10.1677/ERC-07-0240; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Paul D, 2014, CANC RES S, V73; Pusztai L, 2014, CLIN CANCER RES, V20, P5265, DOI 10.1158/1078-0432.CCR-14-0800; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Sun J, 2012, MOL ENDOCRINOL, V26, P1567, DOI 10.1210/me.2012-1140; Thomas NBP, 2010, BREAST CANCER RES TR, V119, P575, DOI 10.1007/s10549-009-0355-8; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Weigel MT, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3191; Wright G, 2012, CANC RES, V71	42	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157397	10.1371/journal.pone.0157397	http://dx.doi.org/10.1371/journal.pone.0157397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308830	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800065
J	Jazi, MM; Khorzoghi, EG; Botanga, C; Seyedi, SM				Jazi, Maryam Moazzam; Khorzoghi, Effat Ghadirzadeh; Botanga, Christopher; Seyedi, Seyed Mahdi			Identification of Reference Genes for Quantitative Gene Expression Studies in a Non-Model Tree Pistachio (Pistacia vera L.)	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; NORMALIZATION; VALIDATION; SELECTION; QPCR; RNA; STRESS	The tree species, Pistacia vera (P. vera) is an important commercial product that is salt-tolerant and long-lived, with a possible lifespan of over one thousand years. Gene expression analysis is an efficient method to explore the possible regulatory mechanisms underlying these characteristics. Therefore, having the most suitable set of reference genes is required for transcript level normalization under different conditions in P. vera. In the present study, we selected eight widely used reference genes, ACT, EF1 alpha, alpha-TUB, beta-TUB, GAPDH, CYP2, UBQ10, and 18S rRNA. Using qRT-PCR their expression was assessed in 54 different samples of three cultivars of P. vera. The samples were collected from different organs under various abiotic treatments (cold, drought, and salt) across three time points. Several statistical programs (geNorm, NormFinder, and BestKeeper) were applied to estimate the expression stability of candidate reference genes. Results obtained from the statistical analysis were then exposed to Rank aggregation package to generate a consensus gene rank. Based on our results, EF1 alpha was found to be the superior reference gene in all samples under all abiotic treatments. In addition to EF1 alpha, ACT and beta-TUB were the second best reference genes for gene expression analysis in leaf and root. We recommended beta-TUB as the second most stable gene for samples under the cold and drought treatments, while ACT holds the same position in samples analyzed under salt treatment. This report will benefit future research on the expression profiling of P. vera and other members of the Anacardiaceae family.	[Jazi, Maryam Moazzam; Khorzoghi, Effat Ghadirzadeh; Seyedi, Seyed Mahdi] Natl Inst Genet Engn & Biotechnol, Dept Plant Biotechnol, Tehran, Iran; [Botanga, Christopher] Chicago State Univ, Dept Biol Sci, Chicago, IL USA	Chicago State University	Seyedi, SM (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Plant Biotechnol, Tehran, Iran.	Seyedi@nigeb.ac.ir			Iran National Science Foundation (INSF); Iran National Science Foundation (INSF), Tehran, Iran	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Iran National Science Foundation (INSF), Tehran, Iran(Iran National Science Foundation (INSF))	This work was supported by the Iran National Science Foundation (INSF).; The authors appreciate the financial support for this work provided by the Iran National Science Foundation (INSF), Tehran, Iran.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arabnezhad H, 2011, SCI HORTIC-AMSTERDAM, V128, P249, DOI 10.1016/j.scienta.2011.01.028; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dubrovina AS, 2013, J PLANT PHYSIOL, V170, P1491, DOI 10.1016/j.jplph.2013.06.014; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Faostat F., 2009, STAT DATABASES; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; HABIBI G, 2014, PROG BIOL SCI, V4, P189; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ishitani R, 1996, J NEUROCHEM, V66, P928; Jazi MM, 2015, PHYSIOL MOL BIOL PLA, V21, P597, DOI 10.1007/s12298-015-0319-x; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Lim FH, 2014, J OIL PALM RES, V26, P170; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Niu X, 2015, FRONT PLANT SCI, P6; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-648; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Sun M, 2015, PLOS ONE, P10; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H., 2015, SCI REP, P5; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Zhang LJ, 2014, INT J MOL SCI, V15, P21825, DOI 10.3390/ijms151221825; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3	51	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157467	10.1371/journal.pone.0157467	http://dx.doi.org/10.1371/journal.pone.0157467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308855	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800078
J	Calabrese, SK; Magnus, M; Mayer, KH; Krakower, DS; Eldahan, AI; Hawkins, LAG; Hansen, NB; Kershaw, TS; Underhill, K; Betancourt, JR; Dovidio, JF				Calabrese, Sarah K.; Magnus, Manya; Mayer, Kenneth H.; Krakower, Douglas S.; Eldahan, Adam I.; Hawkins, Lauren A. Gaston; Hansen, Nathan B.; Kershaw, Trace S.; Underhill, Kristen; Betancourt, Joseph R.; Dovidio, John F.			Putting PrEP into Practice: Lessons Learned from Early-Adopting US Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care	PLOS ONE			English	Article							UNITED-STATES; ATTITUDES; KNOWLEDGE; WILLINGNESS; ADULTS; RISK; SEX	Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource, requires expanding healthcare providers' adoption of PrEP into clinical practice. This qualitative study explored PrEP providers' firsthand experiences relative to six commonly-cited barriers to prescription-financial coverage, implementation logistics, eligibility determination, adherence concerns, side effects, and anticipated behavior change (risk compensation)-as well as their recommendations for training PrEP-inexperienced providers. U.S.-based PrEP providers were recruited via direct outreach and referral from colleagues and other participants (2014-2015). One-on-one interviews were conducted in person or by phone, transcribed, and analyzed. The sample (n = 18) primarily practiced in the Northeastern (67%) or Southern (22%) U.S. Nearly all (94%) were medical doctors (MDs), most of whom self-identified as infectious disease specialists. Prior experience prescribing PrEP ranged from 2 to 325 patients. Overall, providers reported favorable experiences with PrEP implementation and indicated that commonly anticipated problems were minimal or manageable. PrEP was covered via insurance or other programs for most patients; however, pre-authorization requirements, laboratory/service provision costs, and high deductibles sometimes presented challenges. Various models of PrEP care and coordination with other providers were utilized, with several providers highlighting the value of clinical staff support. Eligibility was determined through joint decision-making with patients; CDC guidelines were commonly referenced but not considered absolute. Patient adherence was variable, with particularly strong adherence noted among patients who had actively sought PrEP (self-referred). Providers observed minimal adverse effects or increases in risk behavior. However, they identified several barriers with respect to accessing and engaging PrEP candidates. Providers offered a wide range of suggestions regarding content, strategy, and logistics surrounding PrEP training, highlighting sexual history-taking and sexual minority competence as areas to prioritize. These insights from early-adopting PrEP providers may facilitate adoption of PrEP into clinical practice by PrEP-inexperienced providers, thereby improving access for individuals at risk for HIV.	[Calabrese, Sarah K.; Eldahan, Adam I.; Hawkins, Lauren A. Gaston; Kershaw, Trace S.; Dovidio, John F.] Yale Univ, Dept Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT USA; [Calabrese, Sarah K.; Hansen, Nathan B.; Kershaw, Trace S.; Underhill, Kristen; Dovidio, John F.] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA; [Magnus, Manya] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA; [Mayer, Kenneth H.; Krakower, Douglas S.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.; Krakower, Douglas S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Hansen, Nathan B.] Univ Georgia, Dept Hlth Promot & Behav, Coll Publ Hlth, Athens, GA 30602 USA; [Underhill, Kristen] Yale Univ, Sch Law, New Haven, CT 06520 USA; [Betancourt, Joseph R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dispar Solut Ctr, Boston, MA USA; [Dovidio, John F.] Yale Univ, Dept Psychol, New Haven, CT USA	Yale University; Yale University; George Washington University; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Georgia; University of Georgia; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University	Calabrese, SK (corresponding author), Yale Univ, Dept Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT USA.; Calabrese, SK (corresponding author), Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA.	sarah.calabrese@yale.edu		Dovidio, John/0000-0002-6110-8344; Gaston-Hawkins, Lauren/0000-0003-0786-8892	National Institute of Mental Health (NIMH) [K01-MH103080, K01-MH093273, K23-MH098795]; Yale University Center for Interdisciplinary Research on AIDS [P30-MH062294]; Harvard University Center for AIDS Research [P30-AI060354]; National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH098795, K01MH103080] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Yale University Center for Interdisciplinary Research on AIDS; Harvard University Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding and resources for this research were provided by the National Institute of Mental Health (NIMH; www.nimh.nih.gov) via Award Number K01-MH103080 (SKC) and the Yale University Center for Interdisciplinary Research on AIDS (P30-MH062294). The efforts of SKC, KU, and DSK were supported by the NIMH via Award Numbers K01-MH103080 (SKC), K01-MH093273 (KU), and K23-MH098795 (DSK). Additional support was provided through the Harvard University Center for AIDS Research (P30-AI060354), funded by the National Institutes of Health (http://www.nih.gov). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2015, HIV SPECIALIST, V7, P18; Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Cohen SE, 2015, JAIDS-J ACQ IMM DEF, V68, P439, DOI 10.1097/QAI.0000000000000479; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Grant RM, 2016, CURR OPIN HIV AIDS, V11, P3, DOI 10.1097/COH.0000000000000216; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower DS, 2016, CLIN INFECT DIS, V62, P99, DOI 10.1093/cid/civ736; Krakower DS, 2016, CURR OPIN HIV AIDS, V11, P41, DOI 10.1097/COH.0000000000000206; Mayer KH, 2015, CURR OPIN HIV AIDS, V10, P226, DOI 10.1097/COH.0000000000000170; Mullins TLK, 2015, AIDS PATIENT CARE ST, V29, P193, DOI 10.1089/apc.2014.0273; Schneider J, 2015, ANN M AM PUBL HLTH A; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Spector AY, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/1747-597X-10-1; Stein M, 2014, AIDS BEHAV, V18, P1694, DOI 10.1007/s10461-014-0778-z; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; U. S. Centers for Disease Control and Prevention, 2014, HIV SURV REP DIAGN H, P26; Underhill K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112425; US Public Health Service, 2014, PREEXP PROPH PREV HI; White House Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030	23	81	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157324	10.1371/journal.pone.0157324	http://dx.doi.org/10.1371/journal.pone.0157324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304883	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800047
J	Carr, D; Sanchez-Alvarez, L; Imai, JH; Slatculescu, C; Noblett, N; Mao, L; Beese, L; Colavita, A				Carr, David; Sanchez-Alvarez, Leticia; Imai, Janice H.; Slatculescu, Cristina; Noblett, Nathaniel; Mao, Lei; Beese, Lorena; Colavita, Antonio			A Farnesyltransferase Acts to Inhibit Ectopic Neurite Formation in C. elegans	PLOS ONE			English	Article							PLANAR CELL POLARITY; PRICKLE; PROTEIN; FARNESYLATION; LOCALIZATION; STRABISMUS; MIGRATION	Genetic pathways that regulate nascent neurite formation play a critical role in neuronal morphogenesis. The core planar cell polarity components VANG-1/Van Gogh and PRKL-1/Prickle are involved in blocking inappropriate neurite formation in a subset of motor neurons in C. elegans. A genetic screen for mutants that display supernumerary neurites was performed to identify additional factors involved in this process. This screen identified mutations in fntb-1, the beta subunit of farnesyltransferase. We show that fntb-1 is expressed in neurons and acts cell-autonomously to regulate neurite formation. Prickle proteins are known to be post-translationally modified by farnesylation at their C-terminal CAAX motifs. We show that PRKL-1 can be recruited to the plasma membrane in both a CAAX-dependent and CAAX-independent manner but that PRKL-1 can only inhibit neurite formation in a CAAX-dependent manner.	[Carr, David; Sanchez-Alvarez, Leticia; Imai, Janice H.; Slatculescu, Cristina; Noblett, Nathaniel; Colavita, Antonio] Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada; [Carr, David; Sanchez-Alvarez, Leticia; Noblett, Nathaniel; Colavita, Antonio] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Mao, Lei; Beese, Lorena] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Colavita, Antonio] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Duke University; University of Ottawa	Colavita, A (corresponding author), Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada.; Colavita, A (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Colavita, A (corresponding author), Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada.	colavita@uottawa.ca		Colavita, Antonio/0000-0001-9391-5282	Canadian Institutes of Health Research [123513]; Natural Sciences and Engineering Research Council of Canada [312460-2012]; National Institutes of Health [GM052362]; CIHR [123513]; NSERC [312460-2012]; NIH Office of Research Infrastructure Programs [P40 OD010440]; C. elegans Gene Knockout Consortium (University of British Columbia and the University of Oklahoma); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C. elegans Gene Knockout Consortium (University of British Columbia and the University of Oklahoma); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Canadian Institutes of Health Research Grant 123513 and Natural Sciences and Engineering Research Council of Canada Discovery Grant 312460-2012 to AC and by National Institutes of Health Grant GM052362 to LB (http://www.cihr-irsc.gc.ca/e/193.html; http://www.nserc-crsng.gc.ca/index_eng.asp; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by CIHR Grant 123513 and NSERC Discovery Grant 312460-2012 to A.C. Some strains were provided by the Caenorhabditis Genetics Center (University of Minnesota), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), Shohei Mitani (National Bioresource Project, Japan) and the C. elegans Gene Knockout Consortium (University of British Columbia and the University of Oklahoma). We thank Wormbase.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BRENNER S, 1974, GENETICS, V77, P71; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Colavita A, 2003, SCIENCE, V302, P293, DOI 10.1126/science.1089163; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lin YY, 2009, DEV BIOL, V325, P386, DOI 10.1016/j.ydbio.2008.10.042; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Mapp OM, 2011, DEVELOPMENT, V138, P2121, DOI 10.1242/dev.060442; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Randlett O, 2011, NEURON, V70, P266, DOI 10.1016/j.neuron.2011.03.013; Saengsawang W, 2012, CURR BIOL, V22, P494, DOI 10.1016/j.cub.2012.01.038; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; Sebti SM, 2005, CANCER CELL, V7, P297, DOI 10.1016/j.ccr.2005.04.005; Shen MY, 2015, DRUG DISCOV TODAY, V20, P267, DOI 10.1016/j.drudis.2014.10.002; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Strutt H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003654; Tank EMH, 2011, J NEUROSCI, V31, P9279, DOI 10.1523/JNEUROSCI.6606-10.2011; Tao H, 2012, DEV BIOL, V364, P138, DOI 10.1016/j.ydbio.2012.01.025; Tissir F, 2013, NAT REV NEUROSCI, V14, P525, DOI 10.1038/nrn3525; van Beuningen SFB, 2015, NEURON, V88, P1208, DOI 10.1016/j.neuron.2015.11.012; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157537	10.1371/journal.pone.0157537	http://dx.doi.org/10.1371/journal.pone.0157537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300162	gold, Green Published, Green Submitted			2022-12-26	WOS:000377822200059
J	Castro, R; Ribeiro-Alves, M; Correa, RG; Derrico, M; Lemos, K; Grangeiro, JR; de Jesus, B; Pires, D; Veloso, VG; Grinsztejn, B				Castro, Rodolfo; Ribeiro-Alves, Marcelo; Correa, Renato Girade; Derrico, Monica; Lemos, Katia; Grangeiro, Jose Roberto; de Jesus, Beto; Pires, Denise; Veloso, Valdilea G.; Grinsztejn, Beatriz			The Men Who Have Sex with Men HIV Care Cascade in Rio de Janeiro, Brazil	PLOS ONE			English	Article							MEDICAL-CARE; INFECTION; STIGMA; EPIDEMIOLOGY; RETENTION; HEALTH; MSM; TRANSMISSION; ENGAGEMENT; CONTINUUM	Brazil has a concentrated HIV epidemic and men who have sex with men (MSM) are disproportionately affected. Yet, no data is available on the HIV care cascade for this population. This study aimed to assess the HIV care cascade among MSM newly diagnosed through innovative testing strategies in Rio de Janeiro. Data from 793 MSM and travestites/transgender women (transwomen) tested for HIV at a non-governmental LGBT organization and a mobile testing unit located at a gay friendly venue were analyzed. A 12-month-after-HIV-diagnosis- censored cohort was established using CD4, viral load and combination antiretro-viral therapy (cART) longitudinal data from those diagnosed with HIV. A cross-sectional HIV care cascade was built using this data. The relative risks of achieving each cascade-stage were estimated using generalized linear models according to age, self-declared skin-color, education, history of sexually transmitted diseases (STD), drug use and prior HIV testing. From Jan-2013 to Jan-2014, 793 MSM and transwomen were tested, 131 (16.5%) were HIV-infected. As of January 2015, 95 (72.5%) were linked to HIV care, 90 (68.7%) were retained in HIV care, 80 (61.1%) were on cART, and 50 (38.2%) were virally suppressed one year after HIV diagnosis. Being non-white (Relative risk [lower bound; upper bound of 95% confidence interval] = 1.709 [1.145; 2.549]) and having a prior HIV-test (1.954 [1.278; 2.986]) were associated with an HIV-positive diagnosis. A higher linkage (2.603 [1.091; 6.211]) and retention in care (4.510 [1.880; 10.822]) were observed among those who were older than 30 years of age. Using community-based testing strategies, we were able to access a high-risk MSM population and a small sample of transwomen. Despite universal care coverage and the test-and-treat policy adopted in Brazil, the MSM cascade of care indicates that strategies to increase linkage to care and prompt cART initiation targeted to these populations are critically needed. Interventions targeting non-white and young MSM should be prioritized.	[Castro, Rodolfo; Ribeiro-Alves, Marcelo; Derrico, Monica; Lemos, Katia; Grangeiro, Jose Roberto; Veloso, Valdilea G.; Grinsztejn, Beatriz] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil; [Castro, Rodolfo] Univ Fed Estado Rio de Janeiro, Inst Saude Colet, Rio De Janeiro, RJ, Brazil; [Correa, Renato Girade] Minist Saude, Dept DST Aids & Hepatites Virais, Brasilia, DF, Brazil; [Lemos, Katia; Pires, Denise] Secretaria Estado Saude Sao Paulo, Gerrncia DST Aids Sangue & Hemoderivados, Rio De Janeiro, RJ, Brazil; [Grangeiro, Jose Roberto] Grp Arco Iris, Rio De Janeiro, RJ, Brazil; [de Jesus, Beto] Assoc Int Lesbicas Gays Bissexuais Transexuais &, Buenos Aires, DF, Argentina	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro	Castro, R (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.	rodolfo.castro@ini.fiocruz.br	Castro, Rodolfo/D-4231-2013	Castro, Rodolfo/0000-0002-0701-2528; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	NIAID NIH HHS [UM1 AI069476] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agwu AL, 2015, J ADOLESCENT HEALTH, V56, P345, DOI 10.1016/j.jadohealth.2014.11.009; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], 2014, R LANG ENV STAT COMP; Ayala G., 2014, Journal of AIDS and Clinical Research, V5, P331; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Blashill AJ, 2013, ANN BEHAV MED, V46, P149, DOI [10.1007/s12160-013-9527-1, 10.1007/s12160-013-9489-3]; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, B EP AIDS DST ANO 3; Brito AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130445; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; De Boni R, 2014, CURR OPIN HIV AIDS, V9, P192, DOI 10.1097/COH.0000000000000031; Veras MADM, 2015, AIDS BEHAV, V19, P1589, DOI 10.1007/s10461-014-0944-3; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; Dowshen N, 2009, AIDS PATIENT CARE ST, V23, P371, DOI 10.1089/apc.2008.0256; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Giordano TR, 2009, HIV CLIN TRIALS, V10, P299, DOI 10.1310/hct1005-299; Grangeiro A, 2009, REV SAUDE PUBL, V43, DOI 10.1590/S0034-89102009000300006; Grangeiro A, 2009, CAD SAUDE PUBLICA, V25, P2053, DOI 10.1590/S0102-311X2009000900019; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; Hoenigl M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0458-5; Instituto Nacional de Estudos e Pesquisas Educacionais Anisio Teixeira, 2014, SIN EST ED SUP GRAD; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Lorente N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061225; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacCarthy S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1313; Magidson JF, 2016, AIDS BEHAV, V20, P699, DOI 10.1007/s10461-015-1142-7; Mello A, 2008, ASSESSMENT RISK FACT; Mimiaga MJ, 2009, AIDS PATIENT CARE ST, V23, P825, DOI 10.1089/apc.2009.0086; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Nachega JB, 2014, CLIN INFECT DIS, V59, pS21, DOI 10.1093/cid/ciu299; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Pachankis JE, 2015, AIDS, V29, P1239, DOI 10.1097/QAD.0000000000000724; Peretti-Watel P, 2006, AIDS CARE, V18, P254, DOI 10.1080/09540120500456193; Peretti-Watel P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000411; Pines HA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010388; Puljic VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093734; Rodger ABT., 2014, C RETR OPP INF 2014; Mota RMS, 2011, JAIDS-J ACQ IMM DEF, V57, pS153, DOI 10.1097/QAI.0b013e31821e9c10; Shivaji T, 2014, J INT AIDS SOC, V17, P129, DOI 10.7448/IAS.17.4.19690; Silva DS, 2016, AIDS BEHAV, V20, P1039, DOI 10.1007/s10461-015-1235-3; Tripathi A, 2011, AIDS RES HUM RETROV, V27, P751, DOI [10.1089/aid.2010.0268, 10.1089/AID.2010.0268]; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; UNAIDS, 2014, GLOB AIDS RESP PROGR; WHO, 2015, CONSOLIDATED GUIDELI	49	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157309	10.1371/journal.pone.0157309	http://dx.doi.org/10.1371/journal.pone.0157309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299524	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200035
J	Subburaj, S; Cao, SH; Xia, XC; He, ZH				Subburaj, Saminathan; Cao, Shuanghe; Xia, Xianchun; He, Zhonghu			Phylogenetic Analysis, Lineage-Specific Expansion and Functional Divergence of seed dormancy 4-Like Genes in Plants	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; POSITIVE SELECTION; GENOME; EXPRESSION; DUPLICATION; ARABIDOPSIS; MECHANISMS; CLONING; FAMILY; SUBFUNCTIONALIZATION	The rice gene seed dormancy 4 (OsSdr4) functions in seed dormancy and is a major factor associated with pre-harvest sprouting (PHS). Although previous studies of this protein family were reported for rice and other species, knowledge of the evolution of genes homologous to OsSdr4 in plants remains inadequate. Fifty four Sdr4-like (hereafter designated Sdr4L) genes were identified in nine plant lineages including 36 species. Phylogenetic analysis placed these genes in eight subfamilies (I-VIII). Genes from the same lineage clustered together, supported by analysis of conserved motifs and exon-intron patterns. Segmental duplications were present in both dicot and monocot clusters, while tandemly duplicated genes occurred only in monocot clusters indicating that both tandem and segmental duplications contributed to expansion of the grass I and II subfamilies. Estimation of the approximate ages of the duplication events indicated that ancestral Sdr4 genes evolved from a common angiosperm ancestor, about 160 million years ago (MYA). Moreover, diversification of Sdr4L genes in mono and dicot plants was mainly associated with genome-wide duplication and speciation events. Functional divergence was observed in all subfamily pairs, except IV/VIIIa. Further analysis indicated that functional constraints between subfamily pairs I/II, I/VIIIb, II/VI, II/VIIIb, II/IV, and VI/VIIIb were statistically significant. Site and branch-site model analyses of positive selection suggested that these genes were under strong adaptive selection pressure. Critical amino acids detected for both functional divergence and positive selection were mostly located in the loops, pointing to functional importance of these regions in this protein family. In addition, differential expression studies by transcriptome atlas of 11 Sdr4L genes showed that the duplicated genes may have undergone divergence in expression between plant species. Our findings showed that Sdr4L genes are functionally divergent and positively selected. These may contribute to further functional analysis and molecular evolution of Sdr4L gene families in land plants.	[Subburaj, Saminathan; Cao, Shuanghe; Xia, Xianchun; He, Zhonghu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, 12 Zhongguancun South St, Beijing 100081, Peoples R China; [He, Zhonghu] Int Maize & Wheat Improvement Ctr CIMMYT China Of, 12 Zhongguancun South St, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	He, ZH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, 12 Zhongguancun South St, Beijing 100081, Peoples R China.; He, ZH (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT China Of, 12 Zhongguancun South St, Beijing, Peoples R China.	zhhecaas@163.com	He, Zhonghu/E-1625-2015	CAO, SHUANGHE/0000-0002-2905-0728; He, Zhonghu/0000-0003-1384-3712; SUBBURAJ, SAMINATHAN/0000-0002-9660-7661	International Science & Technology Cooperation Programs of China [2012DFA32290, 2013DFG30530, 2014DFG31690]; China Agriculture Research System [CARS-3-1-3]	International Science & Technology Cooperation Programs of China; China Agriculture Research System	This work was supported by International Science & Technology Cooperation Programs of China, grant numbers 2012DFA32290, 2013DFG30530, and 2014DFG31690 (Zhonghu He); and China Agriculture Research System, grant number CARS-3-1-3 (Zhonghu He).; The authors are grateful to Prof. R. A. McIntosh, Plant Breeding Institute, University of Sydney, for review of this manuscript. This study was supported by the International Science & Technology Cooperation Programs of China (2012DFA32290, 2013DFG30530, 2014DFG31690), and China Agriculture Research System (CARS-3-1-3).	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Ashikawa I, 2013, PLANT SCI, V208, P1, DOI 10.1016/j.plantsci.2013.03.011; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Frugoli JA, 1998, GENETICS, V149, P355; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu QP, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-256; Liu QP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-313; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Monke G, 2012, NUCLEIC ACIDS RES, V40, P8240, DOI 10.1093/nar/gks594; Moon HD, 2016, BIOL PLANTARUM, V60, P105, DOI 10.1007/s10535-015-0567-1; Muhlhausen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-202; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Nonogaki H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00233; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Song WL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-124; Sugimoto K, 2010, P NATL ACAD SCI USA, V107, P5792, DOI 10.1073/pnas.0911965107; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Suzuki M, 2005, PLANT PHYSIOL, V139, P437, DOI 10.1104/pp.104.058412; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wagner A, 1998, BIOESSAYS, V20, P785, DOI 10.1002/(SICI)1521-1878(199810)20:10<785::AID-BIES2>3.3.CO;2-D; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wu NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0373-5; Yang ZF, 2008, GENOMICS, V92, P246, DOI 10.1016/j.ygeno.2008.06.001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YJ, 2014, THEOR APPL GENET, V127, P855, DOI 10.1007/s00122-014-2262-6; Zheng Y, 2007, J EXP ZOOL PART B, V308B, P85, DOI 10.1002/jez.b.21140	68	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0153717	10.1371/journal.pone.0153717	http://dx.doi.org/10.1371/journal.pone.0153717			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300553	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200002
J	Campagna, G; Zampetti, S; Gallozzi, A; Giansanti, S; Chiesa, C; Pacifico, L; Buzzetti, R				Campagna, Giuseppe; Zampetti, Simona; Gallozzi, Alessia; Giansanti, Sara; Chiesa, Claudio; Pacifico, Lucia; Buzzetti, Raffaella			Excellent Intra and Inter-Observer Reproducibility of Wrist Circumference Measurements in Obese Children and Adolescents	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; NECK CIRCUMFERENCE; RATIO; VARIABILITY; RELIABILITY; HEIGHT; INDEX; TOOLS; FAT	In a previous study, we found that wrist circumference, in particular its bone component, was associated with insulin resistance in a population of overweight/obese children. The aim of the present study was to evaluate the intra- and inter-operator variability in wrist circumference measurement in a population of obese children and adolescents. One hundred and two (54 male and 48 female) obese children and adolescents were consecutively enrolled. In all subjects wrist circumferences were measured by two different operators two times to assess intra- and inter-operator variability. Statistical analysis was performed using SAS v. 9.4 and JMP v. 12. Measurements of wrist circumference showed excellent inter-operator reliability with Intra class Correlation Coefficients (ICC) of 0.96 and ICC of 0.97 for the first and the second measurement, respectively. The intra- operator reliability was, also, very strong with a Concordance Correlation Coefficient (CCC) of 0.98 for both operators. The high reproducibility demonstrated in our results suggests that wrist circumference measurement, being safe, non-invasive and repeatable can be easily used in out-patient settings to identify youths with increased risk of insulin-resistance. This can avoid testing the entire population of overweight/obese children for insulin resistance parameters.	[Campagna, Giuseppe; Zampetti, Simona; Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Gallozzi, Alessia; Giansanti, Sara; Pacifico, Lucia] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Chiesa, Claudio] CNR, Inst Translat Pharmacol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Buzzetti, R (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	raffaella.buuzzetti@uniroma1.it	CAMPAGNA, GIUSEPPE/AAT-2796-2020; Pacifico, Lucia/S-4662-2019; Buzzetti, Raffaella/K-3090-2016	CAMPAGNA, GIUSEPPE/0000-0002-1884-9171; Buzzetti, Raffaella/0000-0003-1490-6041				Ashwell M, 1996, BRIT MED J, V312, P377; Ben-Noun Liubov Louba, 2006, Exp Clin Cardiol, V11, P14; Berg RL, 1992, P 17 ANN SAS US GROU, P1521; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Bridger T, 2009, PAED CHILD HEALT-CAN, V14, P177, DOI 10.1093/pch/14.3.177; Capizzi M, 2011, CIRCULATION, V123, P1757, DOI 10.1161/CIRCULATIONAHA.110.012898; Chiarelli F, 2008, EUR J ENDOCRINOL, V159, pS67, DOI 10.1530/EJE-08-0245; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Silva Cleliani de Cassia da, 2014, Rev. paul. pediatr., V32, P221, DOI 10.1590/0103-0582201432210713; Ferrante E, 1993, Minerva Pediatr, V45, P289; GRANT JP, 1981, SURG CLIN N AM, V61, P437; Hazani Ron, 2008, Eplasty, V8, pe53; Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740; Kahn HS, 2005, J PEDIATR-US, V146, P482, DOI 10.1016/j.jpeds.2004.12.028; LaBerge RC, 2009, PEDIATR PULM, V44, P64, DOI 10.1002/ppul.20944; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LINDNER P, 1973, ASSESS DEGREES FATNE; Magalhães Elma Izze da Silva, 2014, Rev. paul. pediatr., V32, P273, DOI 10.1590/0103-0582201432320; MILLER JZ, 1991, BONE MINER, V14, P137, DOI 10.1016/0169-6009(91)90091-D; Mitrea A, 2013, ROM J DIABETES NUTR, V20, P323; Mueller NT, 2013, AM J HUM BIOL, V25, P581, DOI 10.1002/ajhb.22416; Nadas J, 2008, MED SCI MONITOR, V14, pCR15; Noudeh YJ, 2013, J CLIN ENDOCR METAB, V98, P777, DOI 10.1210/jc.2012-2416; Nyland J, 2006, CLIN IMAG, V30, P335, DOI 10.1016/j.clinimag.2006.02.004; Panoulas VF, 2008, POSTGRAD MED J, V84, P344, DOI 10.1136/pgmj.2008.068825; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Reddy RS, 2005, CURR ORTHOPAED, V19, P171, DOI 10.1016/j.cuor.2005.02.008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stabe C, 2013, CLIN ENDOCRINOL, V78, P874, DOI 10.1111/j.1365-2265.2012.04487.x; Strobel MJ, 2002, MANUAL ARTHROSCOPIC, P97, DOI [10.1007/978-3-540-87410-2_2, DOI 10.1007/978-3-540-87410-2_2]; Sung RYT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-324; Taylor RW, 2000, AM J CLIN NUTR, V72, P490	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156646	10.1371/journal.pone.0156646	http://dx.doi.org/10.1371/journal.pone.0156646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294398	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300009
J	Saad, A; Hegde, S; Kechichian, T; Gamble, P; Rahman, M; Stutz, SJ; Anastasio, NC; Alshehri, W; Lei, J; Mori, S; Kajs, B; Cunningham, KA; Saade, G; Burd, I; Costantine, M				Saad, Antonio; Hegde, Shruti; Kechichian, Talar; Gamble, Phyllis; Rahman, Mahbubur; Stutz, Sonja J.; Anastasio, Noelle C.; Alshehri, Wael; Lei, Jun; Mori, Susumu; Kajs, Bridget; Cunningham, Kathryn A.; Saade, George; Burd, Irina; Costantine, Maged			Is There a Causal Relation between Maternal Acetaminophen Administration and ADHD?	PLOS ONE			English	Article							PREGNANCY; HYPERACTIVITY; TOXICITY	Objective Recent epidemiological studies reported an association between maternal intake of acetaminophen (APAP) and attention deficit hyperactivity disorder (ADHD) in their children. However, none of these studies demonstrated causality. Our objective was to determine whether exposure to APAP during pregnancy result in hyperkinetic dysfunctions in offspring, using a murine model. Material and Methods Pregnant CD1 mice (N = 8/group) were allocated to receive by gavage either APAP (150 mg/kg/day, equivalent to the FDA-approved maximum human clinical dose), or 0.5% carboxymethylcellulose (control group), starting on embryonic day 7 until delivery. Maternal serum APAP and alanine transaminase (ALT) concentrations were determined by ELISA and kinetic colorimetric assays, respectively. Open field locomotor activity (LMA) in the 30-day old mouse offspring was quantified using Photobeam Activity System. Mouse offspring were then sacrificed, whole brains processed for magnetic resonance imaging (MRI; 11.7 Tesla magnet) and for neuronal quantification using Nissl stain. The association between APAP exposure and LMA in mouse offspring was analyzed using a mixed effects Poisson regression model that accounted for mouse offspring weight, gender, random selection, and testing time and day. We corrected for multiple comparisons and considered P<0.008 as statistically significant. Results Maternal serum APAP concentration peaked 30 minutes after gavage, reaching the expected mean of 117 mu g/ml. Serum ALT concentrations were not different between groups. There were no significant differences in vertical (rearing), horizontal, or total locomotor activity between the two rodent offspring groups at the P level fixed to adjust for multiple testing. In addition, no differences were found in volumes of 29 brain areas of interest on MRI or in neuronal quantifications between the two groups. Conclusion This study refutes that hypothesis that prenatal exposure to APAP causes hyperkinetic dysfunction in mouse offspring. Due to lack of accurate assessment of ADHD in murine models, our results should be taken with caution when compared to the reported clinical data.	[Saad, Antonio; Hegde, Shruti; Kechichian, Talar; Gamble, Phyllis; Rahman, Mahbubur; Stutz, Sonja J.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Saade, George; Costantine, Maged] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA; [Lei, Jun; Kajs, Bridget; Burd, Irina] Johns Hopkins Univ, Dept Gynecol & Obstet, Div Maternal Fetal Med, Integrated Res Ctr Fetal Med, Baltimore, MD USA; [Alshehri, Wael; Mori, Susumu] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA	University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Johns Hopkins University	Saad, A (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA.	afsaad@utmb.edu		Cunningham, Kathryn A./0000-0002-4257-1739; Saad, Antonio/0000-0003-0034-3567; Alshehri, Wael/0000-0002-6347-7848	NIDA NIH HHS [K05 DA020087] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020087] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BOYD EM, 1966, BRIT J PHARM CHEMOTH, V26, P606, DOI 10.1111/j.1476-5381.1966.tb01841.x; Brust V, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S17; Carver AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100873; Chau V, 2013, NEUROLOGY, V81, P2082, DOI 10.1212/01.wnl.0000437298.43688.b9; Colborn T, 2004, ENVIRON HEALTH PERSP, V112, P944, DOI 10.1289/ehp.6601; HYND GW, 1993, J CHILD NEUROL, V8, P339, DOI 10.1177/088307389300800409; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; LARREY D, 1986, J PHARMACOL EXP THER, V237, P283; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; Nagaraju K, 2010, TREAT NMD SOP; Pastor Patricia N, 2008, Vital Health Stat 10, P1; REEL JR, 1992, FUND APPL TOXICOL, V18, P233, DOI 10.1016/0272-0590(92)90051-I; Schug TT, 2015, ENDOCRINOLOGY; Thiele K, 2013, J REPROD IMMUNOL, V97, P128, DOI 10.1016/j.jri.2012.10.014; Thompson JMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108210; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; WHITEHOUSE LW, 1977, J PHARM SCI, V66, P1399, DOI 10.1002/jps.2600661012; Yang X, 2013, J PHARMACOL EXP THER, V344, P286, DOI 10.1124/jpet.112.199067; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	20	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157380	10.1371/journal.pone.0157380	http://dx.doi.org/10.1371/journal.pone.0157380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295086	gold, Green Submitted, Green Published			2022-12-26	WOS:000377821300039
J	Wulaningsih, W; Holmberg, L; Abeler-Doner, L; Ng, T; Rohrmann, S; Van Hemelrijck, M				Wulaningsih, Wahyu; Holmberg, Lars; Abeler-Doner, Lucie; Ng, Tony; Rohrmann, Sabine; Van Hemelrijck, Mieke			Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women	PLOS ONE			English	Article							COLORECTAL-CANCER; PROGNOSTIC ROLE; RISK; SURVIVAL; CELLS; METAANALYSIS; INTERLEUKIN-6; RECRUITMENT; NEUTROPHIL; BIOMARKERS	Inflammation may play a role in breast cancer, but evidence in the general population is lacking. We investigated the association between serum inflammatory markers (C-reactive protein (CRP), absolute granulocyte count (AGC) and granulocyte-to-lymphocyte (G/L) ratio) and breast cancer (BCa) mortality in American women while accounting for adiposity. From the Third National Health and Nutrition Examination Survey (NHANES III) we selected all women aged 20+ without any known history of cancer (n = 7,780). Multivariable Cox regression models were used to assess CRP, AGC and G/L ratio in relation to mortality from BCa, all cancer, cardiovascular disease and all causes. Stratification analyses by body mass index (BMI) and waist circumference were performed to investigate the effect of adiposity on this association. During a mean follow-up of 167 months, 44 women died from BCa. After adjustments for BMI and waist circumference, only G/L ratio was associated to risk of BCa death (e.g. HR: 2.35, 95% CI: 1.36-4.06 for the 3rd compared to the 1st tertile, P-trend = 0.01). Except for a borderline interaction between CRP categories and obesity by BMI, no statistically significant interaction between markers and categories of BMI or waist circumference was observed. All three markers were associated with mortality from cardiovascular disease and all causes. Our findings support a role of inflammation in BCa mortality which may involve mechanisms apart from obesity, and potential usefulness of GLR as a marker in assessing inflammation and cancer.	[Wulaningsih, Wahyu; Holmberg, Lars; Van Hemelrijck, Mieke] Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Wulaningsih, Wahyu] Univ Gadjah Mada, Div Haematol Oncol, Yogyakarta, Indonesia; [Holmberg, Lars] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Holmberg, Lars] Uppsala Univ, Reg Canc Ctr, Uppsala, Sweden; [Abeler-Doner, Lucie] Kings Coll London, Dept Immunobiol, London WC2R 2LS, England; [Ng, Tony] Kings Coll London, Richard Dimbleby Dept Canc Res, Randall Div, London WC2R 2LS, England; [Ng, Tony] Kings Coll London, Div Canc Studies, London WC2R 2LS, England; [Ng, Tony] UCL, Dept Med Oncol, Inst Canc, London, England; [Rohrmann, Sabine] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of London; King's College London; Gadjah Mada University; Uppsala University; Uppsala University; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London; University of Zurich	Wulaningsih, W (corresponding author), Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England.; Wulaningsih, W (corresponding author), Univ Gadjah Mada, Div Haematol Oncol, Yogyakarta, Indonesia.	wahyu.wulaningsih@kcl.ac.uk	Wulaningsih, Wahyu/AAW-4307-2020; Rohrmann, Sabine/D-2113-2012	Rohrmann, Sabine/0000-0002-2215-1200; Van Hemelrijck, Mieke/0000-0002-7317-0858; Ng, Tony/0000-0003-3894-5619	Cancer Research UK (CRUK); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London	Cancer Research UK (CRUK)(Cancer Research UK); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London	The research was funded/supported by Cancer Research UK (CRUK) and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the CRUK, the NHS, the NIHR or the Department of Health.	Allavena P, 2000, IMMUNOL REV, V177, P141, DOI 10.1034/j.1600-065X.2000.17714.x; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1994, J CLIN ONCOL, V12, P2471; [Anonymous], 2010, NHANES 3 LINK MORT F; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bronte V, 1999, J IMMUNOL, V162, P5728; Chen ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-539; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de la Cruz-Merino L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/785317; Dossus L, 2014, CANCER CAUSE CONTROL, V25, P533, DOI 10.1007/s10552-014-0355-9; Eklund CM, 2009, ADV CLIN CHEM, V48, P111, DOI 10.1016/S0065-2423(09)48005-3; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gunter EW, 1996, LAB PROCEDURES USED; Guo YZ, 2013, ASIAN PAC J CANCER P, V14, P243, DOI 10.7314/APJCP.2013.14.1.243; Gwilliam B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4920; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handin RI, 2003, BLOOD PRINCIPLES PRA; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Hu Q., 2014, UROL ONCOL, V32, pe51, DOI DOI 10.1016/J.UR0L0NC.2013.07.016; Jenkins P, 2009, ANN ONCOL, V20, P34, DOI 10.1093/annonc/mdn560; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; PETRIE HT, 1985, J IMMUNOL, V134, P230; Prizment AE, 2013, CANCER CAUSE CONTROL, V24, P2077, DOI 10.1007/s10552-013-0285-y; Rao SR, 2007, CIRCULATION, V115, P109, DOI 10.1161/CIRCULATIONAHA.106.614859; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Shimazaki J, 2013, ONCOLOGY-BASEL, V84, P356, DOI 10.1159/000350836; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wulaningsih W, 2015, CARCINOGENESIS, V36, P1121, DOI 10.1093/carcin/bgv096; Xiong H, 2013, INT J CANC; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157482	10.1371/journal.pone.0157482	http://dx.doi.org/10.1371/journal.pone.0157482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294662	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300047
J	Eckelman, MJ; Sherman, J				Eckelman, Matthew J.; Sherman, Jodi			Environmental Impacts of the US Health Care System and Effects on Public Health	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; AIR-POLLUTION; CLIMATE-CHANGE; BURDEN	The U.S. health care sector is highly interconnected with industrial activities that emit much of the nation's pollution to air, water, and soils. We estimate emissions directly and indirectly attributable to the health care sector, and potential harmful effects on public health. Negative environmental and public health outcomes were estimated through economic input-output life cycle assessment (EIOLCA) modeling using National Health Expenditures (NHE) for the decade 2003-2013 and compared to national totals. In 2013, the health care sector was also responsible for significant fractions of national air pollution emissions and impacts, including acid rain (12%), greenhouse gas emissions (10%), smog formation (10%) criteria air pollutants (9%), stratospheric ozone depletion (1%), and carcinogenic and non-carcinogenic air toxics (1-2%). The largest contributors to impacts are discussed from both the supply side (EIOLCA economic sectors) and demand side (NHE categories), as are trends over the study period. Health damages from these pollutants are estimated at 470,000 DALYs lost from pollution-related disease, or 405,000 DALYs when adjusted for recent shifts in power generation sector emissions. These indirect health burdens are commensurate with the 44,000-98,000 people who die in hospitals each year in the U.S. as a result of preventable medical errors, but are currently not attributed to our health system. Concerted efforts to improve environmental performance of health care could reduce expenditures directly through waste reduction and energy savings, and indirectly through reducing pollution burden on public health, and ought to be included in efforts to improve health care quality and safety.	[Eckelman, Matthew J.] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Sherman, Jodi] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA	Northeastern University; Yale University	Eckelman, MJ (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.	m.eckelman@neu.edu		sherman, jodi/0000-0003-4157-9728	Anesthesia Patient Safety Foundation	Anesthesia Patient Safety Foundation	MJE received no specific funding for this work. JS was supported by the Anesthesia Patient Safety Foundation, awarded in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andel Charles, 2012, J Health Care Finance, V39, P39; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], WRI CAIT 2 0 CLIM AN; Bare J, 2006, ENVIRON SCI TECHNOL, V40, P5108, DOI 10.1021/es052494b; Bare J, 2011, CLEAN TECHNOL ENVIR, V13, P687, DOI 10.1007/s10098-010-0338-9; BARE JC, 2003, J IND ECOLOGY, V0006; Berwick DM, 2008, HLTH AFF MILLWOOD, V27, P759; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Caiazzo F, 2013, ATMOS ENVIRON, V79, P198, DOI 10.1016/j.atmosenv.2013.05.081; Carnegie Mellon University Green Design Institute, EC INP OUTP LIF CYCL; Chung JW, 2009, JAMA-J AM MED ASSOC, V302, P1970, DOI 10.1001/jama.2009.1610; Connor A, 2011, HEMODIAL INT, V15, P39, DOI 10.1111/j.1542-4758.2010.00523.x; Eckelman M, 2012, ANESTH ANALG, V114, P1067, DOI 10.1213/ANE.0b013e31824f6959; Energy Information Administration, EL DAT; Energy Information Administration, 2012, 2012 COMM BUILD EN C; Fann N, 2013, ENVIRON SCI TECHNOL, V47, P3580, DOI 10.1021/es304831q; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361; Hendrickson CT, 2006, ENV LIFE CYCLE ASSES; Institute for Health Metrics and Evaluation, 2013, STAT US HLTH INN INS; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine Roundtable, 2013, PUBL HLTH LINK SUST; ISO, 2006, 140442006 ISO, DOI [10.1136/bmj.332.7550.1107, DOI 10.1016/J.ECOLIND.2011.01.007]; Jaramillo P, 2016, ENERG POLICY, V90, P202, DOI DOI 10.1016/J.ENP0L.2015.12.035; Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Lautier A, 2010, SCI TOTAL ENVIRON, V409, P33, DOI 10.1016/j.scitotenv.2010.09.016; Leffall L, 2010, REDUCING ENVIRONMENT; Mccoy D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2351; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; NHS Sustainable Development Unit, NHS ENGL CARB FOOTPR; OECD, 2015, HLTH STAT; Pizzol M, 2011, J CLEAN PROD, V19, P646, DOI 10.1016/j.jclepro.2010.05.007; Ryberg M, 2014, CLEAN TECHNOL ENVIR, V16, P329, DOI 10.1007/s10098-013-0629-z; Sherman J, 2012, ANESTH ANALG, V114, P1086, DOI 10.1213/ANE.0b013e31824f6940; Thiel CL, 2015, ENVIRON SCI TECHNOL, V49, P1779, DOI 10.1021/es504719g; US Environmental Protection Agency, NAT EM IN V NEI AIR; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2015, PROM HLTH WHIL MIT C; World Health Organization, 2014, BURD DIS AMB AIR POL	42	309	310	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157014	10.1371/journal.pone.0157014	http://dx.doi.org/10.1371/journal.pone.0157014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280706	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000067
J	Gao, JJ; Qiu, XP; Wang, XB; Peng, CY; Zheng, F				Gao, Jiajia; Qiu, Xueping; Wang, Xuebin; Peng, Chunyan; Zheng, Fang			Associations of ChREBP and Global DNA Methylation with Genetic and Environmental Factors in Chinese Healthy Adults	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; GENOMIC DNA; POLYMORPHISMS; MULTIPLE; TISSUE; RISK; AGE; METHYLTRANSFERASE; 5-METHYLCYTOSINE	Age, gender, diet, gene and lifestyle have been reported to affect metabolic status and disease susceptibility through epigenetic pathway. But it remains indistinct that which factors account for certain epigenetic modifications. Our aim was to identify the influencing factors on inter-individual DNA methylation variations of carbohydrate response element binding protein (ChREBP) and global genome in peripheral blood leucocytes (PBLs). ChREBP DNA methylation was determined by bisulfite sequencing, and genomic 5mdC contents were quantified by capillary hydrophilic-interaction liquid chromatography/in-source fragmentation/tandem mass spectrometry system in about 300 healthy individuals. Eleven single nucleotide polymorphisms (SNPs) spanning ChREBP and DNA methyltransferase 1 (DNMT1) were genotyped by high resolution melting or PCR-restriction fragment length polymorphism. DNMT1 mRNA expression was analyzed by quantitative PCR. We found ChREBP DNA methylation levels were statistically associated with age (Beta (B) = 0.028, p = 0.006) and serum total cholesterol concentrations (TC) (B = 0.815, p = 0.010), independent of sex, concentrations of triglyceride, high density lipoprotein cholesterol, low density lipoprotein cholesterol (LDL-C), fasting blood glucose and systolic blood pressure, diastolic blood pressure, PBLs counts and classifications. The DNMT1 haplotypes were related to ChREBP (odds ratio (OR) = 0.668, p = 0.029) and global (OR = 0.450, p = 0.015) DNA methylation as well as LDL-C, but not DNMT1 expression. However, only the relation to LDL-C was robust to correction for multiple testing (ORFDR = 1.593, p(FDR) = 0.013). These results indicated that the age and TC were independent influential factors of ChREBP methylation and DNMT1 variants could probably influence LDLC to further modify ChREBP DNA methylation. Certainly, sequential comprehensive analysis of the interactions between genetic variants and blood lipid levels on ChREBP and global DNA methylation was required.	[Gao, Jiajia; Qiu, Xueping; Wang, Xuebin; Peng, Chunyan; Zheng, Fang] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China; [Gao, Jiajia] Huazhong Univ Sci & Technol, Tongji Med Coll, Clin Immunol Lab, Wuhan Hosp 1, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Zheng, F (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China.	zhengfang@whu.edu.cn			National Natural Science Foundation of China [81270365, 81071420]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China with grants 81270365 and 81071420 (http://www.nsfc.gov.cn/).	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2014, NUTRIENTS, V6, P4625, DOI 10.3390/nu6104625; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Chettier R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117708; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Fang MZ, 2003, CANCER RES, V63, P7563; Fiorito G, 2014, NUTR METAB CARDIOVAS, V24, P483, DOI 10.1016/j.numecd.2013.10.026; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gillberg L, 2014, METABOLISM, V63, P263, DOI 10.1016/j.metabol.2013.10.003; Guo SR, 2011, CLIN CHIM ACTA, V412, P1854, DOI 10.1016/j.cca.2011.06.024; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kim SO, 2013, INT J ONCOL, V42, P349, DOI 10.3892/ijo.2012.1686; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Lakshmi SVV, 2013, MOL CELL BIOCHEM, V374, P203, DOI 10.1007/s11010-012-1520-7; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Maestri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139681; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Peng CY, 2014, INT J MOL SCI, V15, P22694, DOI 10.3390/ijms151222694; Potter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076506; Saad MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131960; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; Sauder KA, 2015, METABOLISM, V64, P1521, DOI 10.1016/j.metabol.2015.07.021; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Singal R, 2005, ONCOL REP, V14, P569; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Sun JL, 2008, PROSTATE, V68, P1257, DOI 10.1002/pros.20793; Tra J, 2002, MECH AGEING DEV, V123, P1487, DOI 10.1016/S0047-6374(02)00080-5; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yang N, 2014, CLIN LAB, V60, P125, DOI 10.7754/Clin.Lab.2013.130108; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	45	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157128	10.1371/journal.pone.0157128	http://dx.doi.org/10.1371/journal.pone.0157128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281235	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000092
J	Hesketh, KR; Law, C; Bedford, H; Hope, S				Hesketh, Kathryn R.; Law, Catherine; Bedford, Helen; Hope, Steven			Co-Occurrence of Health Conditions during Childhood: Longitudinal Findings from the UK Millennium Cohort Study (MCS)	PLOS ONE			English	Article							COMORBIDITY; CHILDREN; STRENGTHS; EDUCATION; RHINITIS; ECZEMA; ASTHMA	Aims To identify patterns of stability and change in co-occurrence in children between 5-11 years, and to assess if they vary by socio-demographic factors. Methods Data from 9548 singleton children from the UK Millennium Cohort Study (MCS) were assessed for co-occurrence of five common adverse conditions: wheeze; longstanding illness; unfavorable weight; injury; and socio-emotional difficulties. We summed adverse conditions (0-5) for each child at ages 5, 7, and 11 and identified co-occurrence (>= 2 conditions). Using multinomial regression, we explored associations between co-occurrence trajectories and child's sex and ethnicity, maternal education, and income quintile. Results 45.6% of children experienced co-occurrence between 5-11 years (7% experienced constant co-occurrence). More children moved into co-occurrence than moved out (16.9 vs. 11.9%). Mutually-adjusted relative risk ratios (aRRR) showed a gradient by maternal education: compared to children with no co-occurrence whose mothers had a higher/degree, children whose mothers had no qualifications were more likely to move into (aRRR = 1.32(95% CI: 1.02,1.70)), out of (1.74(1.34,2.26)), have fluctuating (1.52(1.09,2.10)) or constant co-occurrence (2.58(1.76,3.80)). The same gradient (high vs. low) was evident for income quintiles. Girls were less likely to experience co-occurrence. Conclusions Co-occurrence of adverse conditions is common during childhood, and trajectories are socially patterned. Child-focused care for lower-income children and boys early in life may prevent and reduce co-occurrence in later childhood.	[Hesketh, Kathryn R.; Law, Catherine; Bedford, Helen; Hope, Steven] UCL Inst Child Hlth, Guilford St, London, England	University of London; University College London	Hesketh, KR (corresponding author), UCL Inst Child Hlth, Guilford St, London, England.	Kathryn.hesketh@ucl.ac.uk		Law, Catherine/0000-0002-1777-9386; Hesketh, Kathryn/0000-0003-3963-9189; Hope, Steven/0000-0001-6759-6927	Department of Health through Children's Policy Research Unit [10090001]; Department of Health; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Economic and Social Research Council	Department of Health through Children's Policy Research Unit; Department of Health; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	All authors have support from a grant from the Department of Health (funded through the Children's Policy Research Unit; funder reference 10090001) for the submitted work. This is an independent piece of research commissioned and funded by the Department of Health. The views expressed are not necessarily those of the Department. Research at the UCL Institute of Child Health and Great Ormond Street Hospital for Children receives a proportion of the funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The Millennium Cohort Study is funded by grants to former and current directors of the study from the Economic and Social Research Council (Professor Heather Joshi, Professor Lucinda Platt and Professor Emla Fitzsimons) and a consortium of government funders. The study sponsors played no part in the design, data analysis and interpretation of this study; the writing of the manuscript or the decision to submit the paper for publication, and the authors' work was independent of their funders.	Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Case A, 2006, FUTURE CHILD, V16, P151, DOI 10.1353/foc.2006.0014; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Connelly R, 2014, INT J EPIDEMIOL, P1; Cummings P, 2005, INJURY PREV, V11, P43, DOI 10.1136/ip.2004.006833; Department of Health, 2013, ANN REP CHIEF MED OF; Department of Health, 2013, NHS OUTC FRAM 2014 2; Department of Health, 1999, SAV LIV OUR HLTH NAT; Department of Health, 2004, CHOOS HLTH MAK HLTH; FOWLER MG, 1992, PEDIATRICS, V90, P939; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Griffiths LJ, 2011, INT J PEDIATR OBES, V6, pE423, DOI 10.3109/17477166.2010.526221; Hale DR, 2015, PEDIATRICS, V136, P128, DOI 10.1542/peds.2014-2105; Hargreaves DS, 2013, ARCH DIS CHILD, V98, P850, DOI 10.1136/archdischild-2012-303403; Hillemeier MM, 2013, MATERN CHILD HLTH J, V17, P1852, DOI 10.1007/s10995-012-1205-6; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Lewis I., 2012, REPORT CHILDREN YOUN; McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Plewis I., 2007, MILLENNIUM COHORT ST; Public Health England, 2012, PUBL HLTH OUTC FRAM; Public Health England, 2012, HLTH LIV HLTH PEOPL; Public Health England, 2014, CHILDR YOUNG PEOPL H; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sidora-Arcoleo K, 2005, INJURY VIOLENCE AM M; StataCorp LP, 2013, STATA 13 SE; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sweeting H, 1998, ARCH DIS CHILD, V78, P427, DOI 10.1136/adc.78.5.427; The Marmot Review Team, 2011, STRAT REV HLTH IN EN; von Mutius E, 2011, J ALLERGY CLIN IMMUN, V127, P1513, DOI 10.1016/j.jaci.2011.04.026; West P, 1997, SOC SCI MED, V44, P833, DOI 10.1016/S0277-9536(96)00188-8	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156868	10.1371/journal.pone.0156868	http://dx.doi.org/10.1371/journal.pone.0156868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281228	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000051
J	Stanifer, JW; Turner, EL; Egger, JR; Thielman, N; Karia, F; Maro, V; Kilonzo, K; Patel, UD; Yeates, K				Stanifer, John W.; Turner, Elizabeth L.; Egger, Joseph R.; Thielman, Nathan; Karia, Francis; Maro, Venance; Kilonzo, Kajiru; Patel, Uptal D.; Yeates, Karen			Knowledge, Attitudes, and Practices Associated with Chronic Kidney Disease in Northern Tanzania: A Community-Based Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SUB-SAHARAN AFRICA; DIABETES-MELLITUS; MEDICINAL-PLANTS; HEALTH LITERACY; BURDEN; EPIDEMIOLOGY; RISK	Background Non-communicable diseases (NCDs) are a leading cause of death among adults in sub-Saharan Africa, and chronic kidney disease (CKD) is a growing public health threat. Understanding knowledge, attitudes, and practices associated with NCDs is vital to informing optimal policy and public health responses in the region, but few community-based assessments have been performed for CKD. To address this gap, we conducted a cross-sectional survey of adults in northern Tanzania using a validated instrument. Methods Between January and June 2014, we administered a structured survey to a random sample of adults from urban and rural communities. The validated instrument consisted of 25 items designed to measure knowledge, attitudes, and practices associated with kidney disease. Participants were also screened for CKD, diabetes, hypertension, and human immunodeficiency virus. Results We enrolled 606 participants from 431 urban and rural households. Knowledge of the etiologies, symptoms, and treatments for kidney disease was low (mean score 3.28 out of 10; 95% CI 2.94, 3.63). There were no significant differences by CKD status. Living in an urban setting and level of education had the strongest independent associations with knowledge score. Attitudes were characterized by frequent concern about the health (27.3%; 20.2, 36.0%), economic (73.1%; 68.2, 77.5%), and social impact (25.4%; 18.6, 33.6%) of kidney disease. Practices included the use of traditional healers (15.2%; 9.1, 24.5%) and traditional medicines (33.8%; 25.0, 43.9%) for treatment of kidney disease as well as a willingness to engage with mobile-phone technology in CKD care (94.3%; 90.1, 96.8%). Conclusions Community-based adults in northern Tanzania have limited knowledge of kidney disease. However, there is a modest knowledge base upon which to build public health programs to expand awareness and understanding of CKD, but these programs must also consider the variety of means by which adults in this population meet their healthcare needs. Finally, our assessment of local attitudes suggested that such public health efforts would be well-received.	[Stanifer, John W.; Thielman, Nathan; Patel, Uptal D.] Duke Univ, Dept Med, DUMC Box 3182, Durham, NC 27710 USA; [Stanifer, John W.; Turner, Elizabeth L.; Egger, Joseph R.; Thielman, Nathan; Patel, Uptal D.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Stanifer, John W.; Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, DUMC Box 3646, Durham, NC 27710 USA; [Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, DUMC Box 2721, Durham, NC 27710 USA; [Karia, Francis; Maro, Venance; Kilonzo, Kajiru] Kilimanjaro Christian Med Coll, Sokoine Rd, Moshi, Tanzania; [Yeates, Karen] Queens Univ, Dept Med, 76 Stuart St, Kingston, ON K7L 2VL, Canada	Duke University; Duke University; Duke University; Duke University; Queens University - Canada	Stanifer, JW (corresponding author), Duke Univ, Dept Med, DUMC Box 3182, Durham, NC 27710 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Clin Res Inst, DUMC Box 3646, Durham, NC 27710 USA.	john.stanifer@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879	National Institutes of Health Research Training Grant - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER	National Institutes of Health Research Training Grant - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by an National Institutes of Health Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology Global Outreach Committee; and a Master's of Science research stipend from the Duke Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2013, 2012 POP HOUS CENS; Bagnis CI, 2004, AM J KIDNEY DIS, V44, P1, DOI 10.1053/j.ajkd.2004.02.009; Bloomfield GS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-49; Boaduo NKK, 2014, PHARM BIOL, V52, P756, DOI 10.3109/13880209.2013.869828; Booysen HL, 2016, J HYPERTENS, V34, P1178, DOI 10.1097/HJH.0000000000000924; Cavanaugh KL, 2010, J AM SOC NEPHROL, V21, P1979, DOI 10.1681/ASN.2009111163; Colson CRD, 2005, ADV CHRONIC KIDNEY D, V12, P261, DOI 10.1016/j.ackd.2005.03.006; DeVellis R., 2017, SCALE DEV THEORY APP, V4; Devraj R, 2009, AM J KIDNEY DIS, V53, P884, DOI 10.1053/j.ajkd.2008.12.028; GOLD CH, 1980, CLIN NEPHROL, V14, P128; Green JA, 2015, ADV CHRONIC KIDNEY D, V22, P24, DOI 10.1053/j.ackd.2014.07.004; Gurman TA, 2012, J HEALTH COMMUN, V17, P82, DOI 10.1080/10810730.2011.649160; Hoy W, 2005, ADV CHRONIC KIDNEY D, V12, P64, DOI 10.1053/j.ackd.2004.10.004; International Telecommunication Union, 2013, WORLD 2013 ICT FACTS; Karou SD, 2011, PHARM BIOL, V49, P1286, DOI 10.3109/13880209.2011.621959; Kokwaro J.O., 1976, MED PLANTS E AFRICA; Krenzke T, 2006, P AM SOC ASS SURV RE; Luyckx VA, 2002, AM J KIDNEY DIS, V39, DOI 10.1053/ajkd.2002.31424; Mani MK, 2005, KIDNEY INT, V67, pS75, DOI 10.1111/j.1523-1755.2005.09419.x; Musabayane CT, 2012, CARDIOVASC J AFR, V23, P462, DOI 10.5830/CVJA-2012-025; Naicker S, 2010, CLIN NEPHROL, V74, pS13; Sharma SK, 2010, AM J KIDNEY DIS, V56, P915, DOI 10.1053/j.ajkd.2010.06.022; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122638; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121722; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; United Republic of Tanzania, 2011, ED SECT PERF REP 201; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601	29	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156336	10.1371/journal.pone.0156336	http://dx.doi.org/10.1371/journal.pone.0156336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280584	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000026
J	Wei, CC; Yen, PL; Chang, ST; Cheng, PL; Lo, YC; Liao, VHC				Wei, Chia-Cheng; Yen, Pei-Ling; Chang, Shang-Tzen; Cheng, Pei-Ling; Lo, Yi-Chen; Liao, Vivian Hsiu-Chuan			Antioxidative Activities of Both Oleic Acid and Camellia tenuifolia Seed Oil Are Regulated by the Transcription Factor DAF-16/FOXO in Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; OLIVE OIL; MEDITERRANEAN DIET; BETA-SITOSTEROL; LONGEVITY; RESISTANCE; GENE; IDENTIFICATION; COMPONENTS	Background Tea seed oil is a high quality edible oil, yet lacking sufficient scientific evidences to support the nutritional and medical purposes. We identified major and minor components in Camellia tenuifolia seed oil and investigated the antioxidative activity and its underlying mechanisms in Caenorhabditis elegans. Principal Findings The results showed that the major constitutes in C. tenuifolia seed oil were unsaturated fatty acids (similar to 78.4%). Moreover, two minor compounds, beta-amyrin and beta-sitosterol, were identified and their antioxidative activity was examined. We found that oleic acid was the major constitute in C. tenuifolia seed oil and plays a key role in the antioxidative activity of C. tenuifolia seed oil in C. elegans. Conclusions This study found evidences that the transcription factor DAF-16/FOXO was involved in both oleic acid- and C. tenuifolia seed oil-mediated oxidative stress resistance in C. elegans. This study suggests the potential of C. tenuifolia seed oil as nutrient or functional foods.	[Wei, Chia-Cheng; Liao, Vivian Hsiu-Chuan] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Yen, Pei-Ling; Chang, Shang-Tzen] Natl Taiwan Univ, Dept Forestry & Resource Conservat, Taipei 10764, Taiwan; [Cheng, Pei-Ling; Lo, Yi-Chen] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Liao, VHC (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	vivianliao@ntu.edu.tw		Wei, Chia-Cheng/0000-0002-0694-7284; Liao, Vivian/0000-0002-4676-9953	research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) - Taiwan Agriculture Research Institute, Council of Agriculture; NIH National Center for Research Resources	research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) - Taiwan Agriculture Research Institute, Council of Agriculture; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded in parts by the research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) supported by the Taiwan Agriculture Research Institute, Council of Agriculture (http://www.tari.gov.tw/) to VL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All nematodes strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources. This study was funded in parts by the research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) supported by the Taiwan Agriculture Research Institute, Council of Agriculture (http://www.tari.gov.tw/) to V. H.-C. Liao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BAST A, 1989, PHARM WEEKBLAD, V11, P199, DOI 10.1007/BF01959411; Boskou D., 2005, Current Topics in Nutraceutical Research, V3, P125; BRENNER S, 1974, GENETICS, V77, P71; Bulotta S, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0219-9; Carrillo C, 2012, NUTR HOSP, V27, P1860, DOI 10.3305/nh.2012.27.6.6010; Cheng SC, 2014, J AGR FOOD CHEM, V62, P4159, DOI 10.1021/jf500842v; Cicerale S, 2012, CURR OPIN BIOTECH, V23, P129, DOI 10.1016/j.copbio.2011.09.006; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Feas X, 2013, MOLECULES, V18, P4573, DOI 10.3390/molecules18044573; Frankel EN, 2011, J AGR FOOD CHEM, V59, P785, DOI 10.1021/jf103813t; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Guha S, 2013, AGE, V35, P1559, DOI 10.1007/s11357-012-9459-x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Horikawa M, 2010, MOL CELL ENDOCRINOL, V323, P183, DOI 10.1016/j.mce.2010.03.004; Johnston AD, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/546915; Kalua CM, 2007, FOOD CHEM, V100, P273, DOI 10.1016/j.foodchem.2005.09.059; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Krishnan K, 2014, INFLAMMOPHARMACOLOGY, V22, P373, DOI 10.1007/s10787-014-0218-8; Labuschagne CF, 2013, AGEING RES REV, V12, P918, DOI 10.1016/j.arr.2013.09.003; Li H, 2011, J MED PLANTS RES, V5, P485; Li WH, 2014, MOL NUTR FOOD RES, V58, P863, DOI 10.1002/mnfr.201300404; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Martelanc M, 2009, J CHROMATOGR A, V1216, P6662, DOI 10.1016/j.chroma.2009.07.038; Moreno JJ, 2003, FREE RADICAL BIO MED, V35, P1073, DOI 10.1016/S0891-5849(03)00465-9; Morgan KL, 2010, TOXICOL SCI, V118, P530, DOI 10.1093/toxsci/kfq273; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; OKEEFE SF, 1993, J AM OIL CHEM SOC, V70, P489, DOI 10.1007/BF02542581; Paniagua-Perez R, 2008, ARCH TOXICOL, V82, P615, DOI 10.1007/s00204-007-0277-3; Sahari MA, 2004, J AM OIL CHEM SOC, V81, P585, DOI 10.1007/s11746-006-0945-0; Saul N, 2008, MECH AGEING DEV, V129, P611, DOI 10.1016/j.mad.2008.07.001; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Shao P, 2015, EUR J LIPID SCI TECH, V117, P355, DOI 10.1002/ejlt.201400259; Shi YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039515; Shi YC, 2012, FREE RADICAL BIO MED, V52, P109, DOI 10.1016/j.freeradbiomed.2011.09.034; Sin O, 2014, BBA-MOL BASIS DIS, V1842, P1951, DOI 10.1016/j.bbadis.2014.01.015; Su MH, 2014, FOOD CHEM, V156, P369, DOI 10.1016/j.foodchem.2014.02.016; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sunil C, 2014, IND CROP PROD, V61, P510, DOI 10.1016/j.indcrop.2014.07.005; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Trichopoulou A, 2000, CANCER EPIDEM BIOMAR, V9, P869; Tripoli E, 2005, NUTR RES REV, V18, P98, DOI 10.1079/NRR200495; Uylaser V, 2014, CRIT REV FOOD SCI, V54, P1092, DOI 10.1080/10408398.2011.626874; Vivancos M, 2005, FREE RADICAL BIO MED, V39, P91, DOI 10.1016/j.freeradbiomed.2005.02.025; Wan Y, 2015, J SCI FOOD AGR, V95, P2571, DOI 10.1002/jsfa.7035; Wei CC, 2014, J AGR FOOD CHEM, V62, P10701, DOI 10.1021/jf503192x; Yu CW, 2014, J AGR FOOD CHEM, V62, P6159, DOI 10.1021/jf500417y	53	25	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157195	10.1371/journal.pone.0157195	http://dx.doi.org/10.1371/journal.pone.0157195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275864	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561700084
J	Porch, CE; Lauretta, MV				Porch, Clay E.; Lauretta, Matthew V.			On Making Statistical Inferences Regarding the Relationship between Spawners and Recruits and the Irresolute Case of Western Atlantic Bluefin Tuna (Thunnus thynnus)	PLOS ONE			English	Article							STOCK; FISH; AGE	Forecasts of the future abundance of western Atlantic bluefin tuna (Thunnus thynnus) have, for nearly two decades, been based on two competing views of future recruitment potential: (1) a "low" recruitment scenario based on hockey-stick (two-line) curve where the expected level of recruitment is set equal to the geometric mean of the recruitment estimates for the years after a supposed regime-shift in 1975, and (2) a "high" recruitment scenario based on a Beverton-Holt curve fit to the time series of spawner-recruit pairs beginning in 1970. Several investigators inferred the relative plausibility of these two scenarios based on measures of their ability to fit estimates of spawning biomass and recruitment derived from stock assessment outputs. Typically, these comparisons have assumed the assessment estimates of spawning biomass are known without error. It is shown here that ignoring error in the spawning biomass estimates can predispose model-choice approaches to favor the regime-shift hypothesis over the Beverton-Holt curve with higher recruitment potential. When the variance of the observation error approaches that which is typically estimated for assessment outputs, the same model-choice approaches tend to favor the single Beverton-Holt curve. For this and other reasons, it is argued that standard model-choice approaches are insufficient to make the case for a regime shift in the recruitment dynamics of western Atlantic bluefin tuna. A more fruitful course of action may be to move away from the current high/low recruitment dichotomy and focus instead on adopting biological reference points and management procedures that are robust to these and other sources of uncertainty.	[Porch, Clay E.; Lauretta, Matthew V.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA	Porch, CE (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA.	Clay.Porch@noaa.gov						Anonymous, 2015, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V71, P1863; [Anonymous], 2002, ICCAT REPORT BIENN 1, V2; Boettiger C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1631; Brooks EN, 2014, CAN J FISH AQUAT SCI, V72, P1; Brown Craig A., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P953; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Fromentin JM, 2014, FISH OCEANOGR, V23, P147, DOI 10.1111/fog.12050; Gilbert DJ, 1997, CAN J FISH AQUAT SCI, V54, P969, DOI 10.1139/cjfas-54-4-969; He X, 2014, FISH RES, V165, P54; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; ICCAT, 2013, INT COMM CONS ATL CO, V69, P1; Kehler DG, 2002, CAN J FISH AQUAT SCI, V59, P854, DOI 10.1139/F02-060; Kendall M.G., 1973, ADV THEORY STAT, V2; KERR LA, 2013, INT COMM CONS ATL CO, V69, P742; Klaer NL, 2015, FISH RES, V168, P49, DOI 10.1016/j.fishres.2015.03.021; LUDWIG D, 1981, CAN J FISH AQUAT SCI, V38, P711, DOI 10.1139/f81-094; Maunder MN, 2003, CAN J FISH AQUAT SCI, V60, P1204, DOI 10.1139/F03-104; McAllister M, 2001, COL VOL SCI PAP ICCA, V52, P1078; Myers RA, 1996, FISH B-NOAA, V94, P707; Porch CE, 2015, MAR COAST FISH, V7, P233, DOI 10.1080/19425120.2015.1040567; Porch CE, 2005, B MAR SCI, V76, P363; Porch CE, 2014, INT COMM CONS ATL CO, V70, P639; Porch Clay E., 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P1022; Report of the Meeting of the Standing Committee on Research and Statistics (SCRS), 1993, M STAND COMM RES S 2; Report of the Standing Committee on Research and Statistics (SCRS), 2014, ICCAT REPORT BIENN 1, V2; Rosenberg A, 2013, INT COMM CONS ATL CO, V69, P1016; SCRS, 2001, COL VOL SCI PAP ICCA, V54, P895; Su ZM, 2012, ECOL MODEL, V224, P76, DOI 10.1016/j.ecolmodel.2011.11.001; Szuwalski C, 2013, P NATL ACAD SCI USA, V110, pE1436, DOI 10.1073/pnas.1301759110; Szuwalski CS, 2015, FISH FISH, V16, P633, DOI 10.1111/faf.12083; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Vert Pre K. A, 2013, P NATL ACAD SCI USA, V110, P1779, DOI [10.1073/pnas.1214879110, DOI 10.1073/PNAS.1214879110]; 2015, COL VOL SCI PAP ICCA, V71, P692	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156767	10.1371/journal.pone.0156767	http://dx.doi.org/10.1371/journal.pone.0156767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272215	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000035
J	Machovina, MM; Usselman, RJ; DuBois, JL				Machovina, Melodie M.; Usselman, Robert J.; DuBois, Jennifer L.			Monooxygenase Substrates Mimic Flavin to Catalyze Cofactorless Oxygenations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; flavin; Gram-positive bacteria; oxidase; radical; monooxygenase; oxygen	SEQUENCE-ANALYSIS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; MOLECULAR-OXYGEN; HEME OXYGENASE; REDUCED FLAVIN; GENE-CLUSTER; BIOSYNTHESIS; ACTINORHODIN; DIOXYGENASES	Members of the antibiotic biosynthesis monooxygenase family catalyze O-2-dependent oxidations and oxygenations in the absence of any metallo- or organic cofactor. How these enzymes surmount the kinetic barrier to reactions between singlet substrates and triplet O-2 is unclear, but the reactions have been proposed to occur via a flavin-like mechanism, where the substrate acts in lieu of a flavin cofactor. To test this model, we monitored the uncatalyzed and enzymatic reactions of dithranol, a substrate for the nogalamycin monooxygenase (NMO) from Streptomyces nogalater. As with flavin, dithranol oxidation was faster at a higher pH, although the reaction did not appear to be base-catalyzed. Rather, conserved asparagines contributed to suppression of the substrate pK(a). The same residues were critical for enzymatic catalysis that, consistent with the flavoenzyme model, occurred via an O-2-dependent slow step. Evidence for a superoxide/substrate radical pair intermediate came from detection of enzyme-bound superoxide during turnover. Small molecule and enzymatic superoxide traps suppressed formation of the oxygenation product under uncatalyzed conditions, whereas only the small molecule trap had an effect in the presence of NMO. This suggested that NMO both accelerated the formation and directed the recombination of a superoxide/dithranyl radical pair. These catalytic strategies are in some ways flavin-like and stand in contrast to the mechanisms of urate oxidase and (1H)-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase, both cofactor-independent enzymes that surmount the barriers to direct substrate/O-2 reactivity via markedly different means.	[Machovina, Melodie M.; Usselman, Robert J.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, 221 Chem & Biochem Bldg, Bozeman, MT 59715 USA	Montana State University System; Montana State University Bozeman	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, 221 Chem & Biochem Bldg, Bozeman, MT 59715 USA.	jdubois@chemistry.montana.edu			National Institutes of Health [U54GM093342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM093342, R01GM090260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Garrett Moraski and Prof. David P. Ballou, University of Michigan, for helpful discussions. The Enzyme Function Initiative (funded by National Institutes of Health Grant U54GM093342) is gratefully acknowledged for sequence network analysis tools publicly available at the Enzyme Function Initiative website (enzymefunction.org).	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; BALLOU D, 1969, BIOCHEM BIOPH RES CO, V36, P898, DOI 10.1016/0006-291X(69)90288-5; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; CABALLERO JL, 1991, MOL GEN GENET, V230, P401, DOI 10.1007/BF00280297; Chung JY, 2002, J BACTERIOL, V184, P6115, DOI 10.1128/JB.184.22.6115-6122.2002; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Dikalov SI, 2011, FREE RADICAL RES, V45, P417, DOI 10.3109/10715762.2010.540242; Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Fischer F, 1999, J BACTERIOL, V181, P5725, DOI 10.1128/JB.181.18.5725-5733.1999; Frerichs-Deeken U, 2004, BIOCHEMISTRY-US, V43, P14485, DOI 10.1021/bi048735u; Frerichs-Deeken U, 2005, CURR MICROBIOL, V51, P344, DOI 10.1007/s00284-005-0065-3; Frey P.A., 2007, ENZYMATIC REACTION M, P1; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; GRAY B, 1992, BIOCHEM J, V281, P795, DOI 10.1042/bj2810795; Grocholski T, 2012, J BACTERIOL, V194, P2829, DOI 10.1128/JB.00228-12; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hernandez-Ortega A, 2015, J AM CHEM SOC, V137, P7474, DOI 10.1021/jacs.5b03836; Hernandez-Ortega A, 2014, J BIOL CHEM, V289, P8620, DOI 10.1074/jbc.M113.543033; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; KEMAL C, 1979, J AM CHEM SOC, V101, P1635, DOI 10.1021/ja00500a066; Kendrew SG, 2000, ACTA CRYSTALLOGR D, V56, P481, DOI 10.1107/S0907444900001189; Kendrew SG, 1997, J BACTERIOL, V179, P4305, DOI 10.1128/jb.179.13.4305-4310.1997; Koskiniemi H, 2009, ACTA CRYSTALLOGR F, V65, P256, DOI 10.1107/S1744309109001389; Kralj M, 2015, PHOTOCH PHOTOBIO SCI, V14, P1082, DOI 10.1039/c5pp00099h; MASSEY V, 1994, J BIOL CHEM, V269, P22459; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Muller K, 1996, GEN PHARMACOL-VASC S, V27, P1325, DOI 10.1016/S0306-3623(96)00075-4; MULLER K, 1986, ARCH PHARM, V319, P1009, DOI 10.1002/ardp.19863191109; Muller K, 1997, BIOCHEM PHARMACOL, V53, P1215, DOI 10.1016/S0006-2952(96)00732-0; MULLER K, 1987, ARCH PHARM, V320, P59, DOI 10.1002/ardp.19873200110; MULLER K, 1995, ARCH PHARM, V328, P359, DOI 10.1002/ardp.19953280412; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Palfey BA, 2000, BIOCHEMISTRY-US, V39, P1556; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Que L. Q., 2007, BIOL INORGANIC CHEM, P1; Rafanan ER, 2001, J NAT PROD, V64, P444; Rivera M, 2005, J INORG BIOCHEM, V99, P337, DOI 10.1016/j.jinorgbio.2004.09.016; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Roth JP, 2009, ACCOUNTS CHEM RES, V42, P399, DOI 10.1021/ar800169z; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Sellmer A, 1998, J PHOTOCH PHOTOBIO A, V116, P39, DOI 10.1016/S1010-6030(98)00277-9; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Steiner RA, 2010, P NATL ACAD SCI USA, V107, P657, DOI 10.1073/pnas.0909033107; Streit BR, 2016, J BIOL CHEM, V291, P862, DOI 10.1074/jbc.M115.666560; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Thierbach S, 2012, CHEMBIOCHEM, V13, P1125, DOI 10.1002/cbic.201200152; Ukpabi G, 2012, J BIOL CHEM, V287, P34179, DOI 10.1074/jbc.M112.393249; Usselman RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093065; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YE JS, 1994, J BACTERIOL, V176, P6270, DOI 10.1128/jb.176.20.6270-6280.1994; Ylihonko K, 1996, MOL GEN GENET, V251, P113; Zeng YH, 2005, J AM CHEM SOC, V127, P9794, DOI 10.1021/ja0425987	60	11	11	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17816	17828		10.1074/jbc.M116.730051	http://dx.doi.org/10.1074/jbc.M116.730051			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27307041	Green Published, hybrid			2022-12-26	WOS:000383241300028
J	Asad, AA; Seah, S; Baumgartner, R; Feng, D; Jensen, A; Manigbas, E; Henry, B; Houghton, A; Evelhoch, JL; Derbyshire, SWG; Chin, CL				Asad, Abu Bakar Ali; Seah, Stephanie; Baumgartner, Richard; Feng, Dai; Jensen, Andres; Manigbas, Elaine; Henry, Brian; Houghton, Andrea; Evelhoch, Jeffrey L.; Derbyshire, Stuart W. G.; Chin, Chih-Liang			Distinct BOLD fMRI Responses of Capsaicin-Induced Thermal Sensation Reveal Pain-Related Brain Activation in Nonhuman Primates	PLOS ONE			English	Article							LOW-BACK-PAIN; SECONDARY HYPERALGESIA; CENTRAL SENSITIZATION; CORTICAL REPRESENTATION; THERAPEUTIC-EFFICACY; MECHANICAL ALLODYNIA; ANESTHETIZED RATS; OPIOID RECEPTORS; RHESUS-MONKEYS; NOXIOUS HEAT	Background Approximately 20% of the adult population suffer from chronic pain that is not adequately treated by current therapies, highlighting a great need for improved treatment options. To develop effective analgesics, experimental human and animal models of pain are critical. Topically/intra-dermally applied capsaicin induces hyperalgesia and allodynia to thermal and tactile stimuli that mimics chronic pain and is a useful translation from preclinical research to clinical investigation. Many behavioral and self-report studies of pain have exploited the use of the capsaicin pain model, but objective biomarker correlates of the capsaicin augmented nociceptive response in nonhuman primates remains to be explored. Methodology Here we establish an aversive capsaicin-induced fMRI model using non-noxious heat stimuli in Cynomolgus monkeys (n = 8). BOLD fMRI data were collected during thermal challenge (ON: 20 s/42 degrees C; OFF: 40 s/35 degrees C, 4-cycle) at baseline and 30 min post-capsaicin (0.1 mg, topical, forearm) application. Tail withdrawal behavioral studies were also conducted in the same animals using 42 degrees C or 48 degrees C water bath pre-and post-capsaicin application (0.1 mg, subcutaneous, tail). Principal Findings Group comparisons between pre-and post-capsaicin application revealed significant BOLD signal increases in brain regions associated with the 'pain matrix', including somatosensory, frontal, and cingulate cortices, as well as the cerebellum (paired t-test, p<0.02, n = 8), while no significant change was found after the vehicle application. The tail withdrawal behavioral study demonstrated a significant main effect of temperature and a trend towards capsaicin induced reduction of latency at both temperatures. Conclusions These findings provide insights into the specific brain regions involved with aversive, 'painlike', responses in a nonhuman primate model. Future studies may employ both behavioral and fMRI measures as translational biomarkers to gain deeper understanding of pain processing and evaluate the preclinical efficacy of novel analgesics.	[Asad, Abu Bakar Ali; Seah, Stephanie; Chin, Chih-Liang] MSD, Merck Res Labs, Translat Biomarkers, Singapore, Singapore; [Baumgartner, Richard; Feng, Dai] Merck & Co Inc, Merck Res Labs, Biometr Res Biostat & Res Decis Sci, Rahway, NJ USA; [Jensen, Andres; Henry, Brian] MSD, Merck Res Labs, Early Discovery Pharmacol, Singapore, Singapore; [Manigbas, Elaine] Maccine Pte Ltd, Imaging, Singapore, Singapore; [Houghton, Andrea] Merck & Co Inc, Merck Res Labs, Early Discovery Pharmacol, West Point, PA USA; [Evelhoch, Jeffrey L.] Merck & Co Inc, Merck Res Labs, Translat Biomarkers, West Point, PA USA; [Derbyshire, Stuart W. G.] Natl Univ Singapore, Dept Psychol, Singapore 117570, Singapore; [Derbyshire, Stuart W. G.] A STAR NUS Clin Imaging Res Ctr, Singapore, Singapore; [Manigbas, Elaine] Natl Univ Singapore, Comparat Med Imaging Facil, Singapore 117570, Singapore	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; National University of Singapore; National University of Singapore	Asad, AA (corresponding author), MSD, Merck Res Labs, Translat Biomarkers, Singapore, Singapore.	asad.abu.bakar.ali@merck.com	Evelhoch, Jeffrey/R-2619-2019	Derbyshire, Stuart/0000-0002-2766-3424	Merck Co.	Merck Co.(Merck & Company)	This research was funded by Merck & Co. The authors would like to declare that the following individuals are current or former employees of the funder: Abu Bakar Ali Asad, Stephanie Seah, Richard Baumgartner, Dai Feng, Andres Jensen, Brian Henry, Andrea Houghton, Jeffrey L. Evelhoch and Chih-Liang Chin. The funder provided support in the form of salaries for authors ABAA, SS, RB, DF, AJ, BH, AH, JLE and CLC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson JLR, 1997, EXP BRAIN RES, V117, P192, DOI 10.1007/s002210050215; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Banks ML, 2010, J PHARMACOL EXP THER, V335, P497, DOI 10.1124/jpet.110.169276; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; Baron R, 2000, LANCET, V356, P785, DOI 10.1016/S0140-6736(00)02649-0; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Becerra L, 2013, J NEUROPHYSIOL, V110, P1221, DOI 10.1152/jn.00284.2013; Becerra L, 2011, NEUROIMAGE, V54, P1355, DOI 10.1016/j.neuroimage.2010.08.056; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Berge OG, 2011, BRIT J PHARMACOL, V164, P1195, DOI 10.1111/j.1476-5381.2011.01300.x; Bingel U, 2007, CURR OPIN NEUROL, V20, P424, DOI 10.1097/WCO.0b013e328259c34d; Borsook D, 2008, CEREBELLUM, V7, P252, DOI 10.1007/s12311-008-0011-6; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brooks JC, 2005, NEUROIMAGE, P27; Brooks JCW, 2002, NEUROIMAGE, V15, P293, DOI 10.1006/nimg.2001.0974; Burns David, 2006, BMC Anesthesiol, V6, P3, DOI 10.1186/1471-2253-6-3; Butelman ER, 2003, J PHARMACOL EXP THER, V306, P1106, DOI 10.1124/jpet.103.052381; Casey KL, 2003, EXP NEUROL, V184, pS80, DOI 10.1016/j.expneurol.2003.07.006; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen LM, 2012, PAIN, V153, P158, DOI 10.1016/j.pain.2011.10.006; Chizh BA, 2009, NEUROTHERAPEUTICS, V6, P749, DOI 10.1016/j.nurt.2009.08.005; Chizh BA, 2009, BRAIN RES REV, V60, P243, DOI 10.1016/j.brainresrev.2008.12.016; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Costigan M, 2012, CURR OPIN PHARMACOL, V12, P92, DOI 10.1016/j.coph.2011.10.019; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dirks J, 2000, ANESTH ANALG, V91, P967, DOI 10.1097/00000539-200010000-00037; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; DYKSTRA LA, 1986, J PHARMACOL METHOD, V15, P263, DOI 10.1016/0160-5402(86)90056-2; England S, 2009, BRIT J PHARMACOL, V158, P1413, DOI 10.1111/j.1476-5381.2009.00437.x; Field CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003928; Flor H, 1995, NATURE; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Gear RW, 1999, J NEUROSCI, V19, P7175, DOI 10.1523/JNEUROSCI.19-16-07175.1999; Governo RJM, 2006, PAIN, V126, P35, DOI 10.1016/j.pain.2006.06.012; Green BG, 2004, J NEUROBIOL, V61, P13, DOI 10.1002/neu.20081; Gyulai Ferenc E, 2004, Curr Opin Anaesthesiol, V17, P397, DOI 10.1097/00001503-200410000-00008; Harrison C, 2011, NAT REV DRUG DISCOV, V10, DOI 10.1038/nrd3396; Hood DD, 2003, ANESTH ANALG, V97, P810, DOI 10.1213/01.ANE.0000078811.80093.88; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Hu E, 2010, PAIN, V148, P107, DOI 10.1016/j.pain.2009.10.026; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016/0304-3959(95)00015-K; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; Iannetti GD, 2005, P NATL ACAD SCI USA, V102, P18195, DOI 10.1073/pnas.0506624102; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones Anthony K P, 2002, Curr Rheumatol Rep, V4, P329, DOI 10.1007/s11926-002-0042-9; Joshi SK, 2006, NEUROSCIENCE, V143, P587, DOI 10.1016/j.neuroscience.2006.08.005; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P1540; KARNI A, 1995, NATURE, V377, P155; KEEFE FJ, 1990, PAIN, V40, P153, DOI 10.1016/0304-3959(90)90066-M; Kissin I, 2010, ANESTH ANALG, V110, P780, DOI 10.1213/ANE.0b013e3181cde882; Klein T, 2005, PAIN, V115, P227, DOI 10.1016/j.pain.2005.03.021; Ko MC, 1999, J PHARMACOL EXP THER, V289, P378; Ko MC, 1998, J PHARMACOL EXP THER, V286, P150; Ko MC, 1999, PSYCHOPHARMACOLOGY, V143, P322, DOI 10.1007/s002130050955; Ko MC, 2009, NEUROPSYCHOPHARMACOL, V34, P2088, DOI 10.1038/npp.2009.33; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Lawrence J, 2008, DRUGS R&D, V9, P323, DOI 10.2165/00126839-200809050-00003; Lloyd D, 2008, SPINE, V33, P1372, DOI 10.1097/BRS.0b013e3181734a8a; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Maihofner C, 2005, NEUROIMAGE, V28, P996, DOI 10.1016/j.neuroimage.2005.06.049; Mainero C, 2007, NEUROIMAGE, V35, P1201, DOI 10.1016/j.neuroimage.2007.01.024; Malisza KL, 2003, MAGN RESON IMAGING, V21, P489, DOI 10.1016/S0730-725X(03)00074-2; Malisza KL, 2001, J MAGN RESON IMAGING, V14, P341, DOI 10.1002/jmri.1192; Mao JR, 2012, TRENDS PHARMACOL SCI, V33, P568, DOI 10.1016/j.tips.2012.08.001; Mathiesen O, 2006, J PAIN, V7, P565, DOI 10.1016/j.jpain.2006.02.004; May A, 1998, PAIN, V74, P61, DOI 10.1016/S0304-3959(97)00144-9; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mohr C, 2008, PAIN, V139, P416, DOI 10.1016/j.pain.2008.05.020; Mohr C, 2008, EUR J NEUROSCI, V27, P739, DOI 10.1111/j.1460-9568.2008.06036.x; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moulton EA, 2005, J NEUROPHYSIOL, V93, P2183, DOI 10.1152/jn.01025.2004; Moulton EA, 2007, NEUROIMAGE, V35, P1586, DOI 10.1016/j.neuroimage.2007.02.001; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Murphy KL, 2012, AM COLL LAB, P403, DOI 10.1016/B978-0-12-381365-7.00017-0; Negus SS, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/867067; Neubert JK, 2006, BEHAV BRAIN RES, V170, P308, DOI 10.1016/j.bbr.2006.03.008; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163; Olesen AE, 2012, PHARMACOL REV, V64, P722, DOI 10.1124/pr.111.005447; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 2004, NEUROLOGY, V63, P1838, DOI 10.1212/01.WNL.0000144177.61125.85; Popilskis SJ, 2008, AM COLL LAB, P335; Rempe T, 2014, J MAGN RESON IMAGING; Rempe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112325; SADATO N, 1995, ANN NEUROL, V37, P74, DOI 10.1002/ana.410370114; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Schenk LA, 2014, PAIN, V155, P150, DOI 10.1016/j.pain.2013.09.024; Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024; Scrivani S, 2010, PAIN MED, V11, P920, DOI 10.1111/j.1526-4637.2010.00859.x; Shenoy Ravikiran, 2011, J Pain Res, V4, P365, DOI 10.2147/JPR.S24810; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Svensson P, 1997, EVOKED POTENTIAL, V104, P343, DOI 10.1016/S0168-5597(97)00026-9; Symons KT, 2011, J PHARMACOL EXP THER, V336, P468, DOI 10.1124/jpet.110.172817; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tuor UI, 2000, PAIN, V87, P315, DOI 10.1016/S0304-3959(00)00293-1; Upadhyay J, 2011, NEUROPSYCHOPHARMACOL, V36, P2659, DOI 10.1038/npp.2011.156; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wang HS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001269; Watkinson P, 2013, PAIN, V154, P743, DOI 10.1016/j.pain.2013.01.016; Wey HY, 2010, NEUROIMAGE, V52, P1420, DOI 10.1016/j.neuroimage.2010.05.014; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Young SS, 1999, LAB ANIM, V33, P162, DOI 10.1258/002367799780578363; Zhao FQ, 2015, NEUROIMAGE, V106, P364, DOI 10.1016/j.neuroimage.2014.12.001; Zhao FQ, 2014, NEUROIMAGE, V84, P724, DOI 10.1016/j.neuroimage.2013.09.036	118	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156805	10.1371/journal.pone.0156805	http://dx.doi.org/10.1371/journal.pone.0156805			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309348	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800014
J	Murrison, LB; Ananthakrishnan, R; Sukumar, S; Augustine, S; Krishnan, N; Pai, M; Dowdy, DW				Murrison, Liza Bronner; Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini; Pai, Madhukar; Dowdy, David W.			Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing	PLOS ONE			English	Article							XPERT MTB/RIF; PULMONARY TUBERCULOSIS; SECTOR; PROVIDERS; ACCURACY; TANZANIA; IMPACT; DELAYS	Setting Private practitioners are frequently the first point of healthcare contact for patients with tuberculosis (TB) in India. As new molecular tests are developed for point-of-care (POC) diagnosis of TB, it is imperative to understand these individuals' practices and preferences for POC testing. Objective To evaluate rapid testing practices and identify priorities for novel POC TB tests among private practitioners in Chennai. Design We conducted a cross-sectional survey of 228 practitioners practicing in the private sector from January 2014 to February 2015 who saw at least one TB patient in the previous year. Practitioners were randomly selected from both the general community and a list of practitioners who referred patients to a public-private mix program for TB treatment. We used standardized questionnaires to collect data on current practices related to point-of-care diagnosis and interest in hypothetical POC tests. We used multivariable Poisson regression with robust estimates of standard error to calculate measures of association. Results Among 228 private practitioners, about half (48%) utilized any rapid testing in their current practice, most commonly for glucose (43%), pregnancy (21%), and malaria (5%). Providers using POC tests were more likely to work in hospitals (56% vs. 43%, P = 0.05) and less likely to be chest specialists (21% vs. 54%, P < 0.001). Only half (51%) of providers would use a hypothetical POC test for TB that was accurate, equipment-free, and took 20 minutes to complete. Chest specialists were half as likely to express interest in performing the hypothetical POC TB test in-house as other practitioners (aPR 0.5, 95% CI: 0.2-0.9). Key challenges to performing POC testing for TB in this study included time constraints, easy access to local private labs and lack of an attached lab facility. Conclusion As novel POC tests for TB are developed and scaled up, attention must be paid to integrating these diagnostics into healthcare providers' routine practice and addressing barriers for POC testing.	[Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini] REACH, Madras, Tamil Nadu, India; [Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; McGill University; McGill University	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.; Dowdy, DW (corresponding author), Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA.	ddowdy1@jhmi.edu	Murrison, Liza/AAE-7682-2019; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Bronner Murrison, Liza/0000-0002-8668-3898	Bill & Melinda Gates Foundation [OPP1061487]; Tier 1 Canada Research Chair from the Canadian Institutes of Health Research; B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Tier 1 Canada Research Chair from the Canadian Institutes of Health Research; B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health	This study was supported in part by a grant by the Bill & Melinda Gates Foundation (grant OPP1061487). MP is a recipient of a Tier 1 Canada Research Chair from the Canadian Institutes of Health Research. DD is supported in part by the B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Das J, 2015, LANCET INFECT DIS; Denkinger CM, 2012, LANCET INFECT DIS, V12, P169, DOI 10.1016/S1473-3099(11)70257-2; Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260; Diggle E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-502; Engel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135112; Government of India Ministry of Home Affairs Office of the Registrar General and Census Commissioner, 2011, PRIM CENS ABSTR CHEN; Jani IV, 2013, NEW ENGL J MED, V368, P2319, DOI 10.1056/NEJMsb1214197; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Murrison LB, 2016, INT J TUBERC LUNG D, V20, P544, DOI 10.5588/ijtld.15.0423; Murrison LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149862; Pai M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001805; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Qin ZZ, 2015, EUR RESPIR J, V45, P549, DOI 10.1183/09031936.00147714; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Satyanarayana S, 2014, PUBLIC HEALTH ACTION, V4, P249, DOI 10.5588/pha.14.0061; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Williams HA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-239; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, HIGH PRIOR TARG PROD; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	31	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155775	10.1371/journal.pone.0155775	http://dx.doi.org/10.1371/journal.pone.0155775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304061	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800009
J	Navarrete, E; Ortega-Bernal, JR; Trejo-Munoz, L; Diaz, G; Montufar-Chaveznava, R; Caldelas, I				Navarrete, Erika; Roberto Ortega-Bernal, Juan; Trejo-Munoz, Lucero; Diaz, Georgina; Montufar-Chaveznava, Rodrigo; Caldelas, Ivette			Participation of the Olfactory Bulb in Circadian Organization during Early Postnatal Life in Rabbits	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; MAMMARY PHEROMONE; LOCOMOTOR-ACTIVITY; BODY-TEMPERATURE; NEWBORN RABBITS; BULBECTOMIZED RATS; ACTIVITY RHYTHMS; YOUNG-RABBITS; PUPS	Experimental evidence indicates that during pre-visual stages of development in mammals, circadian regulation is still not under the control of the light-entrainable hypothalamic pacemaker, raising the possibility that the circadian rhythmicity that occurs during postnatal development is under the control of peripheral oscillators, such as the main olfactory bulb (MOB). We evaluated the outcome of olfactory bulbectomy on the temporal pattern of core body temperature and gross locomotor activity in newborn rabbits. From postnatal day 1 (P1), pups were randomly assigned to one of the following conditions: intact pups (INT), intact pups fed by enteral gavage (INT+ENT), sham operated pups (SHAM), pups with unilateral lesions of the olfactory bulb (OBx-UNI), and pups with bilateral lesions of the olfactory bulb (OBx-BI). At the beginning of the experiment, from P1-8, the animals in all groups were fed at 11:00, from P9-13 the feeding schedule was delayed 6 h (17:00), and finally, from P14-15 the animals were subjected to fasting conditions. The rabbit pups of the INT, INT+ENT, SHAM and OBx-UNI groups exhibited a clear circadian rhythmicity in body temperature and locomotor activity, with a conspicuous anticipatory rise hours prior to the nursing or feeding schedule, which persisted even during fasting conditions. In addition, phase delays in the nursing or feeding schedule induced a clear phase shift in both parameters. In contrast, the OBx-BI group exhibited atypical rhythmicity in both parameters under entrained conditions that altered the anticipatory component, as well as deficient phase control of both rhythms. The present results demonstrate that the expression of circadian rhythmicity at behavioral and physiological levels during early stages of rabbit development largely depends on the integrity of the main olfactory bulb.	[Navarrete, Erika; Roberto Ortega-Bernal, Juan; Trejo-Munoz, Lucero; Diaz, Georgina; Caldelas, Ivette] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Ciudad De Mexico, Mexico; [Montufar-Chaveznava, Rodrigo] Univ Nacl Autonoma Mexico, Fac Ingn, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Caldelas, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Ciudad De Mexico, Mexico.	caldelas@biomedicas.unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica from the Universidad Nacional Autonoma de Mexico [IN208513-3]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica from the Universidad Nacional Autonoma de Mexico	The grant IN208513-3 was provided by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica from the Universidad Nacional Autonoma de Mexico. http://dgapa.unam.mx/html/papiit/papit.html.	Albrecht U, 2004, FRONT BIOSCI-LANDMRK, V9, P48, DOI 10.2741/1196; Caldelas I, 2007, NEUROSCIENCE, V144, P395, DOI 10.1016/j.neuroscience.2006.09.020; Caldelas I, 2005, BIOL RHYTHM RES, V36, P23, DOI 10.1080/09291010400028500; Caldelas I., 2008, COMP ASPECTS CIRCADI, P143; Caldellas I, 2009, DEV NEUROBIOL, V69, P47, DOI 10.1002/dneu.20687; Coureaud G, 2004, CHEM SENSES, V29, P341, DOI 10.1093/chemse/bjh037; Coureaud G, 2008, CHEMOECOLOGY, V18, P53, DOI 10.1007/s00049-007-0392-x; Deutsch J. A., 1957, British Journal of Animal Behaviour, V5, P53, DOI 10.1016/S0950-5601(57)80026-4; Escobar C, 2000, J COMP PHYSIOL A, V186, P33, DOI 10.1007/s003590050004; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; Goel N, 1998, BRAIN RES, V792, P229, DOI 10.1016/S0006-8993(98)00134-6; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hernandez-Campos O, 2013, THESIS; HUDSON R, 1982, BEHAVIOUR, V79, P255, DOI 10.1163/156853982X00292; HUDSON R, 1987, BRAIN RES, V421, P85, DOI 10.1016/0006-8993(87)91278-9; Jilge B, 2000, J BIOL RHYTHM, V15, P329, DOI 10.1177/074873000129001431; JILGE B, 1993, J BIOL RHYTHM, V8, P247, DOI 10.1177/074873049300800307; Jilge B, 2001, LAB ANIM-UK, V35, P364, DOI 10.1258/0023677011911831; Jilge B, 2001, CHRONOBIOL INT, V18, P1, DOI 10.1081/CBI-100001275; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Marcilhac A, 1997, ARCH PHYSIOL BIOCHEM, V105, P552, DOI 10.1076/apab.105.6.552.3273; Marcilhac A, 1999, PHARMACOL BIOCHEM BE, V63, P599, DOI 10.1016/S0091-3057(99)00024-6; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Montufar-Chaveznava R, 2012, NEUROSCIENCE, V207, P198, DOI 10.1016/j.neuroscience.2012.01.025; Montufar-Chaveznava R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074048; NUESSLEINHILDESHEIM B, 1995, J COMP PHYSIOL B, V165, P13, DOI 10.1007/BF00264681; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; ONODA N, 1984, JPN J PHYSIOL, V34, P933, DOI 10.2170/jjphysiol.34.933; Perret M, 2003, J BIOL RHYTHM, V18, P392, DOI 10.1177/0748730403254248; PIEPER DR, 1990, J NEUROENDOCRINOL, V2, P707, DOI 10.1111/j.1365-2826.1990.tb00468.x; PIEPER DR, 1991, AM J PHYSIOL, V261, pR973, DOI 10.1152/ajpregu.1991.261.4.R973; Possidente B, 1996, BRAIN RES, V713, P108, DOI 10.1016/0006-8993(95)01490-X; POSSIDENTE B, 1990, BRAIN RES, V513, P325, DOI 10.1016/0006-8993(90)90475-Q; RAPISARDI SC, 1975, EXP BRAIN RES, V22, P295; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rivkees SA, 2000, SEMIN PERINATOL, V24, P232, DOI 10.1053/sper.2000.8598; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schley P, 1980, MUTTERLOSE AUFZUCHT; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; Tanida M, 2005, BRAIN RES, V1058, P44, DOI 10.1016/j.brainres.2005.07.048; Tanida M, 2008, NEUROSCI LETT, V439, P192, DOI 10.1016/j.neulet.2008.05.021; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Trejo-Munoz L, 2014, NEUROSCIENCE, V275, P170, DOI 10.1016/j.neuroscience.2014.06.007; Trejo-Munoz L, 2012, PHYSIOL BEHAV, V106, P587, DOI 10.1016/j.physbeh.2012.04.005; TUCKER GS, 1982, EXP BRAIN RES, V48, P263; VANRIEZEN H, 1990, PHARMACOL THERAPEUT, V47, P21, DOI 10.1016/0163-7258(90)90043-2; Vinkers CH, 2009, NEUROSCIENCE, V159, P39, DOI 10.1016/j.neuroscience.2008.12.009; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835	55	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156539	10.1371/journal.pone.0156539	http://dx.doi.org/10.1371/journal.pone.0156539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305041	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800017
J	Khoroshko, VA; Levitsky, VG; Zykova, TY; Antonenko, OV; Belyaeva, ES; Zhimulev, IF				Khoroshko, Varvara A.; Levitsky, Viktor G.; Zykova, Tatyana Yu.; Antonenko, Oksana V.; Belyaeva, Elena S.; Zhimulev, Igor F.			Chromatin Heterogeneity and Distribution of Regulatory Elements in the Late-Replicating Intercalary Heterochromatin Domains of Drosophila melanogaster Chromosomes	PLOS ONE			English	Article							POLYTENE CHROMOSOMES; GENUS DROSOPHILA; DNA-REPLICATION; GENOME; REVEALS; REGIONS; UNDERREPLICATION; IDENTIFICATION; CONSERVATION; ORGANIZATION	Late-replicating domains (intercalary heterochromatin) in the Drosophila genome display a number of features suggesting their organization is quite unique. Typically, they are quite large and encompass clusters of functionally unrelated tissue-specific genes. They correspond to the topologically associating domains and conserved microsynteny blocks. Our study aims at exploring further details of molecular organization of intercalary heterochromatin and has uncovered surprising heterogeneity of chromatin composition in these regions. Using the 4HMM model developed in our group earlier, intercalary heterochromatin regions were found to host chromatin fragments with a particular epigenetic profile. Aquamarine chromatin fragments (spanning 0.67% of late-replicating regions) are characterized as a class of sequences that appear heterogeneous in terms of their decompactization. These fragments are enriched with enhancer sequences and binding sites for insulator proteins. They likely mark the chromatin state that is related to the binding of cis-regulatory proteins. Malachite chromatin fragments (11% of late-replicating regions) appear to function as universal transitional regions between two contrasting chromatin states. Namely, they invariably delimit intercalary heterochromatin regions from the adjacent active chromatin of interbands. Malachite fragments also flank aquamarine fragments embedded in the repressed chromatin of latereplicating regions. Significant enrichment of insulator proteins CP190, SU(HW), and MOD2.2 was observed inmalachite chromatin. Neither aquamarine nor malachite chromatin types appear to correlate with the positions of highly conserved non-coding elements (HCNE) that are typically replete in intercalary heterochromatin. Malachite chromatin found on the flanks of intercalary heterochromatin regions tends to replicate earlier than the malachite chromatin embedded in intercalary heterochromatin. In other words, there exists a gradient of replication progressing from the flanks of intercalary heterochromatin regions center-wise. The peculiar organization and features of replication in large late-replicating regions are discussed as possible factors shaping the evolutionary stability of intercalary heterochromatin.	[Khoroshko, Varvara A.; Zykova, Tatyana Yu.; Antonenko, Oksana V.; Belyaeva, Elena S.; Zhimulev, Igor F.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Levitsky, Viktor G.; Zhimulev, Igor F.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Levitsky, Viktor G.] RAS, Inst Cytol & Genet SB, Novosibirsk, Russia	Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Khoroshko, VA (corresponding author), SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia.	vicerna@mcb.nsc.ru	Antonenko, Oksana/N-7471-2015; Khoroshko, Varvara A/N-5496-2015; Levitsky, Victor G/R-5696-2016; Zhimulev, Igor F/N-7978-2015; Zykova (Vatolina), Tatyana/I-3897-2014; Belyaeva, Elena S/N-8066-2015	Levitsky, Victor/0000-0002-4905-3088; Zhimulev, Igor/0000-0002-6220-3028	Russian Science Foundation [14-04-00934]; Federal Agency of Scientific Organizations of Russian Federation [0310-2014-0002]; Russian Science Foundation [14-14-00934] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Federal Agency of Scientific Organizations of Russian Federation; Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the grant 14-04-00934 from the Russian Science Foundation and the project 0310-2014-0002 from Federal Agency of Scientific Organizations of the Russian Federation.; The authors are grateful to Dr. Igor V. Makunin for stimulating discussions and help with the replication profiling analysis. This work was supported by the grant 14-04-00934 from the Russian Science Foundation and the project 0310-2014-0002 from the Federal Agency for Scientific Organizations of the Russian Federation.	Ahanger SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03917; Andreyenkova NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083319; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2006, CHROMOSOMA, V115, P355, DOI 10.1007/s00412-006-0063-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Boldyreva LV, 2017, CURR GENOMICS, V18, P214, DOI 10.2174/1389202917666160512164913; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Diaz-Castillo C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002475; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HAGELE K, 1971, CHROMOSOMA, V33, P297; Heitz E, 1932, PLANTA; Hiratani I, 2009, EPIGENETICS-US, V4, P93, DOI 10.4161/epi.4.2.7772; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kaufmann BP, 1939, P NATL ACAD SCI USA, V25, P571, DOI 10.1073/pnas.25.11.571; KEYL HG, 1958, CHROMOSOMA, V9, P441; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; LAMB MM, 1987, CHROMOSOMA, V95, P227, DOI 10.1007/BF00294779; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Makunin IV, 2014, GENOME BIOL EVOL, V6, P2050, DOI 10.1093/gbe/evu156; Makunin IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082362; Milon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-988; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Yang JP, 2012, CURR OPIN GENET DEV, V22, P86, DOI 10.1016/j.gde.2011.12.007; Yarosh W, 2014, GENE DEV, V28, P1840, DOI 10.1101/gad.245811.114; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631	56	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157147	10.1371/journal.pone.0157147	http://dx.doi.org/10.1371/journal.pone.0157147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300486	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200031
J	Ahmed, MN; Abdullah, AH; Kaiwartya, O				Ahmed, Malik N.; Abdullah, Abdul Hanan; Kaiwartya, Omprakash			FSM-F: Finite State Machine Based Framework for Denial of Service and Intrusion Detection in MANET	PLOS ONE			English	Article							IDS	Due to the continuous advancements in wireless communication in terms of quality of communication and affordability of the technology, the application area of Mobile Adhoc Networks (MANETs) significantly growing particularly in military and disaster management. Considering the sensitivity of the application areas, security in terms of detection of Denial of Service (DoS) and intrusion has become prime concern in research and development in the area. The security systems suggested in the past has state recognition problem where the system is not able to accurately identify the actual state of the network nodes due to the absence of clear definition of states of the nodes. In this context, this paper proposes a framework based on Finite State Machine (FSM) for denial of service and intrusion detection in MANETs. In particular, an Interruption Detection system for Adhoc On-demand Distance Vector (ID-AODV) protocol is presented based on finite state machine. The packet dropping and sequence number attacks are closely investigated and detection systems for both types of attacks are designed. The major functional modules of ID-AODV includes network monitoring system, finite state machine and attack detection model. Simulations are carried out in network simulator NS-2 to evaluate the performance of the proposed framework. A comparative evaluation of the performance is also performed with the state-of-the-art techniques: RIDAN and AODV. The performance evaluations attest the benefits of proposed framework in terms of providing better security for denial of service and intrusion detection attacks.	[Ahmed, Malik N.; Abdullah, Abdul Hanan; Kaiwartya, Omprakash] Univ Teknol Malaysia, Fac Comp, Johor Baharu 81310, Malaysia	Universiti Teknologi Malaysia	Ahmed, MN (corresponding author), Univ Teknol Malaysia, Fac Comp, Johor Baharu 81310, Malaysia.	mali7k@gmail.com	Kaiwartya, Omprakash/H-4782-2016; ABDULLAH, ABDUL HANAN/P-9181-2018	Kaiwartya, Omprakash/0000-0001-9669-8244; 				Ahmed A., 2011, Proceedings of the 2011 5th International Conference on Network and System Security (NSS 2011), P1, DOI 10.1109/ICNSS.2011.6059953; Damopoulos D, 2012, SECUR COMMUN NETW, V5, P3, DOI 10.1002/sec.341; Djahel S, 2011, IEEE COMMUN SURV TUT, V13, P658, DOI 10.1109/SURV.2011.072210.00026; ILGUN K, 1995, IEEE T SOFTWARE ENG, V21, P181, DOI 10.1109/32.372146; Jain AK, P INT C COMP INT COM, V1, P256; Joseph JFC, 2011, IEEE T DEPEND SECURE, V8, P233, DOI 10.1109/TDSC.2009.48; Kheyri D, 2012, COMPUTER INFORM SCI, V5, P132; Li W., 2004, P US DEP ENERGY CYBE, V1, P1; Mamatha G.S., 2010, INT J COMPUTER SCI S, V4, P275; Mutlu S, 2011, PROCEEDINGS OF ICNS 2011: THE SEVENTH INTERNATIONAL CONFERENCE ON NETWORKING AND SERVICES, P292; Nadeem A, 2009, INT C WIR COMM MOB C, P926, DOI DOI 10.1145/1582379; Nadeem A, 2013, IEEE COMMUN SURV TUT, V15, P2027, DOI 10.1109/SURV.2013.030713.00201; Panaousis EA, 2012, INFORM SYST FRONT, V14, P541, DOI 10.1007/s10796-010-9259-8; Perkins C, 2003, 3561 IETF RFC; Rafsanjani MK, 2009, INT C COMP ELEC ENG, P625, DOI 10.1109/ICCEE.2009.74; Stakhanova N, 2010, COMPUT SECUR, V29, P253, DOI 10.1016/j.cose.2009.08.007; Stamouli I, 2005, I S WORLD WIREL MOBI, P374, DOI 10.1109/WOWMOM.2005.85; Tamilselvan Latha, 2006, 2006 International Symposium on Ad Hoc and Ubiquitous Computing, P42, DOI 10.1109/ISAHUC.2006.4290645; Tseng CY, 2003, P WORKSH SEC AD HOC, V1, P125, DOI DOI 10.1145/986858.986876; Visumathi J, 2012, PROCEDIA ENGINEER, V38, P2816, DOI 10.1016/j.proeng.2012.06.330; Wu B, 2007, SIGNALS COMMUN TECHN, P103, DOI 10.1007/978-0-387-33112-6_5; Xenakis C, 2011, COMPUT SECUR, V30, P63, DOI 10.1016/j.cose.2010.10.008	22	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156885	10.1371/journal.pone.0156885	http://dx.doi.org/10.1371/journal.pone.0156885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285146	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000028
J	Ba, K; Thiaw, M; Lazar, N; Sarr, A; Brochier, T; Ndiaye, I; Faye, A; Sadio, O; Panfili, J; Thiaw, OT; Brehmer, P				Ba, Kamarel; Thiaw, Modou; Lazar, Najih; Sarr, Alassane; Brochier, Timothee; Ndiaye, Ismaila; Faye, Alioune; Sadio, Oumar; Panfili, Jacques; Thiaw, Omar Thiom; Brehmer, Patrice			Resilience of Key Biological Parameters of the Senegalese Flat Sardinella to Overfishing and Climate Change	PLOS ONE			English	Article							POINTE-NOIRE REGION; MADERENSIS LOWE; EBA VAL; MATURITY; LENGTH; AGE; AURITA; GROWTH; POPULATIONS; PATTERNS	The stock of the Senegalese flat sardinella, Sardinella maderensis, is highly exploited in Senegal, West Africa. Its growth and reproduction parameters are key biological indicators for improving fisheries management. This study reviewed these parameters using landing data from small-scale fisheries in Senegal and literature information dated back more than 25 years. Age was estimated using length-frequency data to calculate growth parameters and assess the growth performance index. With global climate change there has been an increase in the average sea surface temperature along the Senegalese coast but the length-weight parameters, sex ratio, size at first sexual maturity, period of reproduction and condition factor of S. maderensis have not changed significantly. The above parameters of S. maderensis have hardly changed, despite high exploitation and fluctuations in environmental conditions that affect the early development phases of small pelagic fish in West Africa. This lack of plasticity of the species regarding of the biological parameters studied should be considered when planning relevant fishery management plans.	[Ba, Kamarel; Thiaw, Modou; Brochier, Timothee; Brehmer, Patrice] ISRA, CRODT, Dakar, Senegal; [Ba, Kamarel; Sarr, Alassane; Ndiaye, Ismaila; Faye, Alioune; Thiaw, Omar Thiom] UCAD, IUPA, Dakar, Senegal; [Lazar, Najih] Univ Rhode Isl East Farm, Dept Fisheries, Kingston, RI USA; [Brochier, Timothee; Sadio, Oumar; Brehmer, Patrice] IRD, UMR Lemar 195, Dakar, Senegal; [Panfili, Jacques] Univ Montpellier 2, UMR Marbec, IRD, Montpellier 5, France	University Cheikh Anta Diop Dakar; University of Rhode Island; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Thiaw, OT (corresponding author), UCAD, IUPA, Dakar, Senegal.	thiawo@hotmail.com	Brehmer, Patrice/K-2285-2016; PANFILI, JACQUES/J-9397-2016	Brehmer, Patrice/0000-0001-8949-9095; PANFILI, JACQUES/0000-0003-0504-2384; SADIO, Oumar/0000-0002-6621-2490; Ba, Kamarel/0000-0002-2741-5148	USAID/COMFISH project	USAID/COMFISH project(United States Agency for International Development (USAID))	The study was supported by the USAID/COMFISH project, that was implemented by the University of Rhode Island in the United States and Senegalese partners including the University of Dakar (UCAD) within the Institute of Fisheries and Aquaculture of Senegal (Institut Universitaire de Peche et d'Aquaculture, IUPA).	[Anonymous], ICLARM FISHBYTE; [Anonymous], 2010, RESULTATS GENERAUX P; Belhabib D, 2014, FISH RES, V151, P1, DOI 10.1016/j.fishres.2013.12.006; Boely T., 1980, THESIS; Brochier T, 2014, 4 C MAR SCI JUN 11 1, P458; Camarena-Luhrs T., 1987, Oceanographie Tropicale, V21, P143; Conand F, 1971, CAHIER ORSTOM SERIE, V10, P293, DOI [10.1046/j.1439-0426.1999.00111.x, DOI 10.1046/J.1439-0426.1999.00111.X]; Cury P, 1988, AQUAT LIVING RESOUR, V1, P165, DOI 10.1051/alr:1988018; Demarcq H, 2000, OCEANOL ACTA, V23, P391, DOI 10.1016/S0399-1784(00)01113-0; DIOUF P.S., 1996, THESIS; Djama T, 1989, ICLARM FISHBYTE, V7, P13; Djama T, 1989, FISHBYTE, V7, P8; Dobo A., 2009, THESIS; Ecoutin JM, 2005, FISH RES, V72, P347, DOI 10.1016/j.fishres.2004.10.007; Ernande B, 2004, P ROY SOC B-BIOL SCI, V271, P415, DOI 10.1098/rspb.2003.2519; Etim L, 1998, FISH RES, V38, P211, DOI 10.1016/S0165-7836(98)00161-1; FAO, 1987, COPACE PACE SER, V86, P101; FAO, 2013, REP FAO WORK GROUP A; FAO, 1979, 791832 FAO COPACETEC; FAO, 1988, FAO FISHERIES REPORT; Faure V., 2002, POULPE OCTOPUS VULGA, P129; FONTANA A, 1969, CAH ORSTOM OCEANOGR, V7, P101; Freon P., 1986, REPONSES ADAPTATIONS; Froese R, 2004, FISH FISH, V5, P86, DOI 10.1111/j.1467-2979.2004.00144.x; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; GABCHE CE, 1995, FISH RES, V24, P331, DOI 10.1016/0165-7836(95)00371-7; Garcia S., 2012, FAO FISHERIES AQUACU, V18; GHENO Y, 1968, CAH ORSTOM OCEANOGR, V6, P69; Kromer JL, 1994, RIO GRANDE BUBA BIOE; Lawal H.S., 1988, CONTRIBUTION ETUDE R; Le Bec C., 1985, REV TRAVAUX I PECHES, V47, P181; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; MARCHAL E, 1993, ENV RESSOURCES AQUAT, V1, P237; Marcus O., 1989, J SCI, V23, P1; Mbaye BC, 2015, FISH OCEANOGR, V24, P69, DOI 10.1111/fog.12094; McDonald J.H., 2009, HDB BIOL STAT; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Pascual-Alayon P, 2012, SCI MANAGEMENT SMALL; PAULY D, 1995, FISH RES, V22, P197, DOI 10.1016/0165-7836(94)00323-O; Pauly D., 1983, FAO FISHERIES TECHNI, P52; Pineiro C, 2003, ICES J MAR SCI, V60, P1086, DOI 10.1016/S1054-3139(03)00086-9; Postel E., 1955, RESUME CONNAISSANCES, V137, P7; Quaatey SNK, 1999, J APPL ICHTHYOL, V15, P63, DOI 10.1046/j.1439-0426.1999.00111.x; Rossignol N., 1955, PREMIERE OBSERVATION, V137, P17; Roy C., 1989, Aquatic Living Resources, V2, P21, DOI 10.1051/alr:1989003; Rueda M, 1999, FISH RES, V42, P155, DOI 10.1016/S0165-7836(99)00033-8; Samb B., 1988, FAO FISHERIES REPORT, V389, P257; Showers PAT, 1996, NAGA ICLARM Q, V19, P42; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Somers I.F., 1988, FISHBYTE, V6, P8; Sow F, 2010, RESOURCES SCI, V32, P620; Thiaw M., 2010, THESIS; Valenzuela N, 2003, AM NAT, V161, P676, DOI 10.1086/368292; van der Lingen CD, 2010, AFRICAN J MARINE SCI, V32, P271, DOI [10.2989/1814232X.2010.501581, DOI 10.2989/1814232X.2010.501581]; Wetherall J. A., 1986, FISHBYTE, V4, P12; YOUMBI JT, 1991, J APPL ICHTHYOL, V7, P60, DOI 10.1111/j.1439-0426.1991.tb00595.x; Zar JH, 1999, BIOSTATISTICAL ANAL	59	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156143	10.1371/journal.pone.0156143	http://dx.doi.org/10.1371/journal.pone.0156143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280629	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000017
J	Hanski, L; Ausbacher, D; Tiirola, TM; Strom, MB; Vuorela, PM				Hanski, Leena; Ausbacher, Dominik; Tiirola, Terttu M.; Strom, Morten B.; Vuorela, Pia M.			Amphipathic beta(2,2)-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae	PLOS ONE			English	Article							IN-VITRO ACTIVITY; ANTIMICROBIAL PEPTIDES; CHLAMYDOPHILA-PNEUMONIAE; DEVELOPMENTAL CYCLE; TRACHOMATIS; PROTEINS; GROWTH; CHARGE; DRUGS; CELLS	We demonstrate in the current work that small cationic antimicrobial beta(2,2)-amino acid derivatives (Mw < 500 Da) are highly potent against Chlamydia pneumoniae at clinical relevant concentrations (< 5 mu M, i.e. < 3.4 mu g/mL). C. pneumoniae is an atypical respiratory pathogen associated with frequent treatment failures and persistent infections. This gram-negative bacterium has a biphasic life cycle as infectious elementary bodies and proliferating reticulate bodies, and efficient treatment is challenging because of its long and obligate intracellular replication cycle within specialized inclusion vacuoles. Chlamydicidal effect of the beta(2,2)-amino acid derivatives in infected human epithelial cells was confirmed by transmission electron microscopy. Images of infected host cells treated with our lead derivative A2 revealed affected chlamydial inclusion vacuoles 24 hours post infection. Only remnants of elementary and reticulate bodies were detected at later time points. Neither the EM studies nor resazurin-based cell viability assays showed toxic effects on uninfected host cells or cell organelles after A2 treatment. Besides the effects on early intracellular inclusion vacuoles, the ability of these beta(2,2)-amino acid derivatives to suppress Chlamydia pneumoniae infectivity upon treatment of elementary bodies suggested also a direct interaction with bacterial membranes. Synthetic beta(2,2)-amino acid derivatives that target C. pneumoniae represent promising lead molecules for development of antimicrobial agents against this hard-totreat intracellular pathogen.	[Hanski, Leena; Tiirola, Terttu M.; Vuorela, Pia M.] Univ Helsinki UHEL, Fac Pharm, Div Pharmaceut Biosci, Pharmaceut Design & Discovery Res Grp, Helsinki, Finland; [Ausbacher, Dominik; Strom, Morten B.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, Nat Prod & Med Chem Res Grp, Tromso, Norway	University of Helsinki; UiT The Arctic University of Tromso	Vuorela, PM (corresponding author), Univ Helsinki UHEL, Fac Pharm, Div Pharmaceut Biosci, Pharmaceut Design & Discovery Res Grp, Helsinki, Finland.	pia.vuorela@helsinki.fi	Hanski, Leena/AAD-5096-2019	Hanski, Leena/0000-0002-3121-8542; Strom, Morten B./0000-0003-1973-0778	Academy of Finland [252216, 272266]; Tor, Joe och Pentti Borgs minnesfond; Faculty of Health Sciences, UiT-The Arctic University of Norway; Research Council of Norway [214493/F20]	Academy of Finland(Academy of Finland); Tor, Joe och Pentti Borgs minnesfond; Faculty of Health Sciences, UiT-The Arctic University of Norway; Research Council of Norway(Research Council of Norway)	Academy of Finland (grant 252216 to LH and 272266 to PMV) and Tor, Joe och Pentti Borgs minnesfond are acknowledged for the financial support. The project was further supported by the transition grant of the Faculty of Health Sciences, UiT-The Arctic University of Norway (DA) and the Research Council of Norway, "Fellesloftet", Grant-214493/F20 (MBS). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Alvesalo J, 2006, BIOCHEM PHARMACOL, V71, P735, DOI 10.1016/j.bcp.2005.12.006; Ausbacher D, 2014, BIOFOULING, V30, P81, DOI 10.1080/08927014.2013.847924; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Chotikanatis K, 2014, ANTIMICROB AGENTS CH, V58, P1800, DOI 10.1128/AAC.02263-13; Chu HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126390; Donati M, 2005, ANTIMICROB AGENTS CH, V49, P1201, DOI 10.1128/AAC.49.3.1201-1202.2005; EKMAN MR, 1993, CLIN INFECT DIS, V17, P420, DOI 10.1093/clinids/17.3.420; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Hansen T, 2012, EUR J MED CHEM, V58, P22, DOI 10.1016/j.ejmech.2012.09.048; Hansen T, 2011, J MED CHEM, V54, P858, DOI 10.1021/jm101327d; Hanski L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115115; Hanski L, 2014, EXPERT OPIN DRUG DIS, V9, P791, DOI 10.1517/17460441.2014.915309; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hatch TP, 1996, J BACTERIOL, V178, P1; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Karlsson D, 2012, EUR J PHARM SCI, V47, P190, DOI 10.1016/j.ejps.2012.05.014; Kern JM, 2009, FEMS IMMUNOL MED MIC, V55, P131, DOI 10.1111/j.1574-695X.2008.00514.x; Kohlhoff SA, 2015, EXPERT OPIN PHARMACO, V16, P205, DOI 10.1517/14656566.2015.999041; Kohlhoff SA, 2014, ANTIMICROB AGENTS CH, V58, P7595, DOI 10.1128/AAC.03920-14; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; Kuo C-C, 1999, CHLAMYDIA PNEUMONIAE, P9; KUO CC, 1990, J INFECT DIS, V162, P755, DOI 10.1093/infdis/162.3.755; Lazarev VN, 2013, ARCH MICROBIOL, V195, P173, DOI 10.1007/s00203-012-0863-5; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Nguyen BD, 2011, P NATL ACAD SCI USA, V108, P10284, DOI 10.1073/pnas.1107478108; Park N, 2009, J ANTIMICROB CHEMOTH, V63, P115, DOI 10.1093/jac/dkn436; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Roblin PM, 2010, ANTIMICROB AGENTS CH, V54, P1358, DOI 10.1128/AAC.01343-09; Ronzone E, 2012, MANIPULATION HOST VE, P45; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Salin O, 2011, J AGR FOOD CHEM, V59, P12836, DOI 10.1021/jf2032473; Salin O, 2010, BIOCHEM PHARMACOL, V80, P1141, DOI 10.1016/j.bcp.2010.06.051; Siewert K, 2005, ANTIMICROB AGENTS CH, V49, P1852, DOI 10.1128/AAC.49.5.1852-1856.2005; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Vila-Corcoles A, 2009, RESP MED, V103, P309, DOI 10.1016/j.rmed.2008.08.006; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157306	10.1371/journal.pone.0157306	http://dx.doi.org/10.1371/journal.pone.0157306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280777	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000118
J	Tomar, RSS; Tiwari, S; Vinod; Naik, BK; Chand, S; Deshmukh, R; Mallick, N; Singh, S; Singh, NK; Tomar, SMS				Tomar, Ram Sewak Singh; Tiwari, Sushma; Vinod; Naik, Bhojaraja K.; Chand, Suresh; Deshmukh, Rupesh; Mallick, Niharika; Singh, Sanjay; Singh, Nagendra Kumar; Tomar, S. M. S.			Molecular and Morpho-Agronomical Characterization of Root Architecture at Seedling and Reproductive Stages for Drought Tolerance in Wheat	PLOS ONE			English	Article							GENETIC DIVERSITY; TRITICUM-AESTIVUM; GRAIN-YIELD; DURUM-WHEAT; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; TRAITS; WATER; GROWTH; POLYMORPHISM	Water availability is a major limiting factor for wheat (Triticum aestivum L.) production in rain-fed agricultural systems worldwide. Root architecture is important for water and nutrition acquisition for all crops, including wheat. A set of 158 diverse wheat genotypes of Australian (72) and Indian (86) origin were studied for morpho-agronomical traits in field under irrigated and drought stress conditions during 2010-11 and 2011-12. Out of these 31 Indian wheat genotypes comprising 28 hexaploid (Triticum aestivum L.) and 3 tetraploid (T. durum) were characterized for root traits at reproductive stage in polyvinyl chloride (PVC) pipes. Roots of drought tolerant genotypes grew upto137cm (C306) as compared to sensitive one of 63cm with a mean value of 94.8cm. Root architecture traits of four drought tolerant (C306, HW2004, HD2888 and NI5439) and drought sensitive (HD2877, HD2012, HD2851 and MACS2496) genotypes were also observed at 6 and 9 days old seedling stage. The genotypes did not show any significant variation for root traits except for longer coleoptiles and shoot and higher absorptive surface area in drought tolerant genotypes. The visible evaluation of root images using WinRhizo Tron root scanner of drought tolerant genotype HW2004 indicated compact root system with longer depth while drought sensitive genotype HD2877 exhibited higher horizontal root spread and less depth at reproductive stage. Thirty SSR markers were used to study genetic variation which ranged from 0.12 to 0.77 with an average value of 0.57. The genotypes were categorized into three subgroups as highly tolerant, sensitive, moderately sensitive and tolerant as intermediate group based on UPGMA cluster, STRUCTURE and principal coordinate analyses. The genotypic clustering was positively correlated to grouping based on root and morpho-agronomical traits. The genetic variability identified in current study demonstrated these traits can be used to improve drought tolerance and association mapping.	[Tomar, Ram Sewak Singh; Tiwari, Sushma; Singh, Nagendra Kumar] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi 110012, India; [Vinod; Naik, Bhojaraja K.; Mallick, Niharika; Tomar, S. M. S.] Indian Agr Res Inst, Div Genet, Pusa Campus, New Delhi 110012, India; [Chand, Suresh] Devi Ahilya Vishwa Vidyalaya, Sch Iife Sci, Khandwa Rd, Indore 452017, India; [Tomar, Ram Sewak Singh; Deshmukh, Rupesh] Univ Laval, Dept Phytol, Quebec City, PQ G1V0A6, Canada; [Singh, Sanjay] Directorate Wheat Res, Karnal 132001, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Devi Ahilya University; Laval University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research	Vinod (corresponding author), Indian Agr Res Inst, Div Genet, Pusa Campus, New Delhi 110012, India.	vinod.genetics@gmail.com	Deshmukh, Rupesh Kailasrao/C-6479-2012; TOMAR, RAM SEWAK SINGH/AAF-5619-2021; Mallick, Niharika/GVT-7629-2022; Singh, Nouratan/N-9377-2017	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; TOMAR, RAM SEWAK SINGH/0000-0001-9959-4395; Singh, Nouratan/0000-0002-8063-8375	Indian Council of Agricultural Research [NPTC 21/19-3008]	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	Funding for the current study was provided by Indian Council of Agricultural Research funded project "Transgenics in crops" (Grant number - NPTC 21/19-3008). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna TLB, 2007, PLANT SOIL, V301, P135, DOI 10.1007/s11104-007-9428-9; Ahmadizadeh M, 2011, AFR J BIOTECHNOL, V10, P19771, DOI 10.5897/AJB11.2371; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Atta B. M., 2013, Australian Journal of Crop Science, V7, P2108; Barrett BA, 1998, CROP SCI, V38, P1261, DOI 10.2135/cropsci1998.0011183X003800050025x; Bazzaz F. A., 2000, Seeds: the ecology of regeneration in plant communities, P1, DOI 10.1079/9780851994321.0001; Bharti S, 2014, INT J AGR SCI, V4, P214; Cane MA, 2014, MOL BREEDING, V34, P1629, DOI 10.1007/s11032-014-0177-1; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Cooper M, 2001, FIELD CROP RES, V69, P47, DOI 10.1016/S0378-4290(00)00131-3; Dadbakhsh A., 2011, Advances in Environmental Biology, V5, P1804; De Loose M, 1995, IDENTIFICATION METHO; Dhanda SS, 2004, J AGRON CROP SCI, V190, P6, DOI 10.1111/j.1439-037X.2004.00592.x; Dreisigacker S, 2004, CROP SCI, V44, P381, DOI 10.2135/cropsci2004.0381; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehdaie B, 2003, CROP SCI, V43, P710, DOI 10.2135/cropsci2003.0710; FAO & WFP, 2014, STAT FOOD INS WORLD; FISCHER RA, 1996, INCREASING YIELD POT, P150; Hai L, 2007, GENETICA, V130, P213, DOI 10.1007/s10709-006-9008-6; Hammer GL, 2005, AUST J AGR RES, V56, P947, DOI 10.1071/AR05157; Hao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024598; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; HURD EA, 1964, CAN J PLANT SCI, V44, P240, DOI 10.4141/cjps64-046; INNES P, 1985, J AGR SCI, V105, P543, DOI 10.1017/S0021859600059438; Kazemi M, 2009, 1 NAT C TOM PROD PRO; Khan AS, 2010, INT J AGRIC BIOL, V12, P247; Kinyua M. G., 2003, International Journal of Agriculture and Rural Development, V4, P9; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; Liao MT, 2006, AUST J AGR RES, V57, P1097, DOI 10.1071/AR05439; Liao MT, 2004, FUNCT PLANT BIOL, V31, P121, DOI 10.1071/FP03060; Liu K, 2004, POWER MARKER NEW GEN; LIU YG, 1991, JPN J GENET, V66, P617, DOI 10.1266/jjg.66.617; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; Manifesto MM, 2001, CROP SCI, V41, P682, DOI 10.2135/cropsci2001.413682x; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Manske G. G. B., 2002, Plant roots: the hidden half, P249; McDonald GK, 2012, CROP PASTURE SCI, V63, P1043, DOI 10.1071/CP12244; Mishra HS, 1999, IRRIGATION SCI, V18, P117, DOI 10.1007/s002710050052; MONYO JH, 1970, J AGR SCI-CAMBRIDGE, V74, P329, DOI 10.1017/S0021859600022954; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nezhadahmadi Arash, 2013, ScientificWorldJournal, V2013, P610721, DOI 10.1155/2013/610721; OBRIEN L, 1979, AUST J AGR RES, V30, P587, DOI 10.1071/AR9790587; OTOOLE JC, 1987, ADV AGRON, V41, P91, DOI 10.1016/S0065-2113(08)60803-2; Passioura J, 2006, AGR WATER MANAGE, V80, P176, DOI 10.1016/j.agwat.2005.07.012; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Placido DF, 2013, PLANT PHYSIOL, V161, P1806, DOI 10.1104/pp.113.214262; Plaut Z, 2004, FIELD CROP RES, V86, P185, DOI 10.1016/j.fcr.2003.08.005; Prasad M, 2000, THEOR APPL GENET, V100, P584, DOI 10.1007/s001229900102; Pritchard JK, 2000, GENETICS, V155, P945; Rebetzke GJ, 1999, AUST J AGR RES, V50, P291, DOI 10.1071/A98125; Reynolds M., 2001, APPL PHYSL WHEAT BRE; Richards RA, 2007, EUPHYTICA, V154, P409, DOI 10.1007/s10681-006-9286-1; Roder MS, 1998, GENOME, V41, P278, DOI 10.1139/gen-41-2-278; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Royo C, 2010, FIELD CROP RES, V119, P91, DOI 10.1016/j.fcr.2010.06.020; SADHU D, 1984, Z ACKER PFLANZENBAU, V153, P216; Sharma S, 2009, THEOR APPL GENET, V119, P783, DOI 10.1007/s00122-009-1088-0; SLAFER GA, 1991, EUPHYTICA, V58, P37, DOI 10.1007/BF00035338; Tahar Boutraa, 2010, Journal of Agronomy, V9, P1, DOI 10.3923/ja.2010.1.8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomar RS, 2012, INDIAN J GENET PL BR, V72, P195; Tomar RSS, 2014, PLANT BREEDING, V133, P12, DOI 10.1111/pbr.12116; Xue Q, 2003, PLANT SOIL, V257, P151, DOI 10.1023/A:1026230527597; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004; [No title captured]	68	13	13	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156528	10.1371/journal.pone.0156528	http://dx.doi.org/10.1371/journal.pone.0156528			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280445	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000035
J	Daniel, B; Wallner, S; Steiner, B; Oberdorfer, G; Kumar, P; van der Graaff, E; Roitsch, T; Sensen, CW; Gruber, K; Macheroux, P				Daniel, Bastian; Wallner, Silvia; Steiner, Barbara; Oberdorfer, Gustav; Kumar, Prashant; van der Graaff, Eric; Roitsch, Thomas; Sensen, Christoph W.; Gruber, Karl; Macheroux, Peter			Structure of a Berberine Bridge Enzyme-Like Enzyme with an Active Site Specific to the Plant Family Brassicaceae	PLOS ONE			English	Article							COVALENTLY ATTACHED FAD; OXIDATION; IDENTIFICATION; FLAVOPROTEINS; METABOLISM; SYNTHASE; GENES	Berberine bridge enzyme-like (BBE-like) proteins form a multigene family (pfam 08031), which is present in plants, fungi and bacteria. They adopt the vanillyl alcohol-oxidase fold and predominantly show bi-covalent tethering of the FAD cofactor to a cysteine and histidine residue, respectively. The Arabidopsis thaliana genome was recently shown to contain genes coding for 28 BBE-like proteins, while featuring four distinct active site compositions. We determined the structure of a member of the AtBBE-like protein family (termed AtBBE-like 28), which has an active site composition that has not been structurally and biochemically characterized thus far. The most salient and distinguishing features of the active site found in AtBBE-like 28 are a mono-covalent linkage of a histidine to the 8 alpha-position of the flavin-isoalloxazine ring and the lack of a second covalent linkage to the 6-position, owing to the replacement of a cysteine with a histidine. In addition, the structure reveals the interaction of a glutamic acid (Glu426) with an aspartic acid (Asp369) at the active site, which appear to share a proton. This arrangement leads to the delocalization of a negative charge at the active site that may be exploited for catalysis. The structure also indicates a shift of the position of the isoalloxazine ring in comparison to other members of the BBE-like family. The dioxygen surrogate chloride was found near the C(4a) position of the isoalloxazine ring in the oxygen pocket, pointing to a rapid reoxidation of reduced enzyme by dioxygen. A TDNA insertional mutant line for AtBBE-like 28 results in a phenotype, that is characterized by reduced biomass and lower salt stress tolerance. Multiple sequence analysis showed that the active site composition found in AtBBE-like 28 is only present in the Brassicaceae, suggesting that it plays a specific role in the metabolism of this plant family.	[Daniel, Bastian; Wallner, Silvia; Steiner, Barbara; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Oberdorfer, Gustav; Kumar, Prashant; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [van der Graaff, Eric; Roitsch, Thomas] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Roitsch, Thomas] Czech Globe AS CR, Global Change Res Ctr, Vvi, Drasov 470, CZ-66424 Drasov, Czech Republic; [Sensen, Christoph W.] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria	Graz University of Technology; University of Graz; University of Copenhagen; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Graz University of Technology	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Sensen, Christoph W./C-1798-2013; Macheroux, Peter/AAB-5157-2019; Gruber, Karl/GPP-6706-2022; Roitsch, Thomas/H-4347-2014	Sensen, Christoph W./0000-0001-9604-8962; Macheroux, Peter/0000-0002-0242-454X; Gruber, Karl/0000-0002-3485-9740; Roitsch, Thomas/0000-0001-7109-3134; Wallner, Silvia/0000-0002-3608-4029; Daniel, Bastian/0000-0001-9210-7136; Oberdorfer, Gustav/0000-0002-6144-9114	Austrian Science Foundation (FWF) [W908, P28678]; Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I) [LO1415]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Foundation (FWF) ( Doctoral program "Molecular Enzymology" W908 and P28678) to KG and PM; and the Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I), grant number LO1415, to T.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a grant from the Austrian Science Foundation (FWF) (Doctoral program "Molecular Enzymology" W908 and P28678) KG and PM and the Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I), grant number LO1415, to T.R.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V1000, P213, DOI DOI 10.1016/0926.6569(63)90227-X; Coram TE, 2010, FUNCT INTEGR GENOMIC, V10, P383, DOI 10.1007/s10142-009-0148-5; Daniel B, 2015, J BIOL CHEM, V290, P18770, DOI 10.1074/jbc.M115.659631; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; do Amaral AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049904; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gonzalez-Candelas L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-194; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hyun TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112946; Ishida M, 2014, BREEDING SCI, V64, P48, DOI 10.1270/jsbbs.64.48; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kopacz MM, 2014, BIOORGAN MED CHEM, V22, P5621, DOI 10.1016/j.bmc.2014.05.051; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Lin HC, 2015, ANGEW CHEM INT EDIT, V54, P3004, DOI 10.1002/anie.201411297; Liu YC, 2011, NAT CHEM BIOL, V7, P304, DOI 10.1038/nchembio.556; Lorenz N, 2010, APPL ENVIRON MICROB, V76, P1822, DOI 10.1128/AEM.00737-09; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; Massey V., 1992, CELL BIOCHEM FUNCT, DOI [10.1002/cbf.290100117, DOI 10.1002/CBF.290100117]; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rambaut A, 2009, FIGTREE V1 3 1; Schrittwieser JH, 2011, J ORG CHEM, V76, P6703, DOI 10.1021/jo201056f; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Winkler A, 2009, J BIOL CHEM, V284, P19993, DOI 10.1074/jbc.M109.015727; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zafred D, 2015, FEBS J, V282, P3060, DOI 10.1111/febs.13212; Zafred D, 2013, J ALLERGY CLIN IMMUN, V132, P696, DOI 10.1016/j.jaci.2013.03.021	51	20	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156892	10.1371/journal.pone.0156892	http://dx.doi.org/10.1371/journal.pone.0156892			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276217	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700046
J	Busa, MA; Lim, J; van Emmerik, REA; Hamill, J				Busa, Michael A.; Lim, Jongil; van Emmerik, Richard E. A.; Hamill, Joseph			Head and Tibial Acceleration as a Function of Stride Frequency and Visual Feedback during Running	PLOS ONE			English	Article							SHOCK ATTENUATION; IMPACT SHOCK; WALKING; LENGTH; PELVIS	Individuals regulate the transmission of shock to the head during running at different stride frequencies although the consequences of this on head-gaze stability remain unclear. The purpose of this study was to examine if providing individuals with visual feedback of their head-gaze orientation impacts tibial and head accelerations, shock attenuation and headgaze motion during preferred speed running at different stride frequencies. Fifteen strides from twelve recreational runners running on a treadmill at their preferred speed were collected during five stride frequencies (preferred, +/- 10% and +/- 20% of preferred) in two visual task conditions (with and without real-time visual feedback of head-gaze orientation). The main outcome measures were tibial and head peak accelerations assessed in the time and frequency domains, shock attenuation from tibia to head, and the magnitude and velocity of head-gaze motion. Decreasing stride frequency resulted in greater vertical accelerations of the tibia (p<0.01) during early stance and at the head (p<0.01) during early and late stance; however, for the impact portion the increase in head acceleration was only observed for the slowest stride frequency condition. Visual feedback resulted in reduced head acceleration magnitude (p<0.01) and integrated power spectral density in the frequency domain (p<0.01) in late stance, as well as overall of head-gaze motion (p<0.01). When running at preferred speed individuals were able to stabilize head acceleration within a wide range of stride frequencies; only at a stride frequency 20% below preferred did head acceleration increase. Furthermore, impact accelerations of the head and tibia appear to be solely a function of stride frequency as no differences were observed between feedback conditions. Increased visual task demands through head gaze feedback resulted in reductions in head accelerations in the active portion of stance and increased head-gaze stability.	[Busa, Michael A.; Lim, Jongil; Hamill, Joseph] Univ Massachusetts, Dept Kinesiol, Biomech Lab, Amherst, MA 01003 USA; [Busa, Michael A.; Lim, Jongil; van Emmerik, Richard E. A.] Univ Massachusetts, Dept Kinesiol, Motor Control Lab, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lim, J (corresponding author), Univ Massachusetts, Dept Kinesiol, Biomech Lab, Amherst, MA 01003 USA.; Lim, J (corresponding author), Univ Massachusetts, Dept Kinesiol, Motor Control Lab, Amherst, MA 01003 USA.	jongil@kin.umass.edu						Boyer KA, 2004, J BIOMECH, V37, P1583, DOI 10.1016/j.jbiomech.2004.01.002; CAVAGNA GA, 1963, J APPL PHYS, V18, P1; CAVANAGH PR, 1982, MED SCI SPORT EXER, V14, P30, DOI 10.1249/00005768-198201000-00006; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Derrick TR, 2004, MED SCI SPORT EXER, V36, P830, DOI 10.1249/01.MSS.0000125728.92536.54; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; Edwards WB, 2012, J APPL BIOMECH, V28, P502, DOI 10.1123/jab.28.5.502; Fajen BR, 2007, ECOL PSYCHOL, V19, P383, DOI 10.1080/10407410701557877; Fajen BR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00085; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Gibson J.J., 1966, SENSES CONSIDERED PE; Gruber AH, 2014, J SPORT HEALTH SCI, V3, P113, DOI 10.1016/j.jshs.2014.03.004; HAMILL J, 1995, HUM MOVEMENT SCI, V14, P45, DOI 10.1016/0167-9457(95)00004-C; HENNIG EM, 1991, INT J SPORT BIOMECH, V7, P303, DOI 10.1123/ijsb.7.3.303; HOLT KG, 1991, MED SCI SPORT EXER, V23, P491; HOLT KG, 1990, HUM MOVEMENT SCI, V9, P55, DOI 10.1016/0167-9457(90)90035-C; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Matthis JS, 2014, J EXP PSYCHOL HUMAN, V40, P106, DOI 10.1037/a0033101; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Mercer JA, 2003, MED SCI SPORT EXER, V35, P307, DOI 10.1249/01.MSS.0000048837.81430.E7; Mercer JA, 2002, EUR J APPL PHYSIOL, V87, P403, DOI 10.1007/s00421-002-0646-9; SHORTEN MR, 1992, INT J SPORT BIOMECH, V8, P288, DOI 10.1123/ijsb.8.4.288; Smeathers JE, 1981, P I MECH ENG H, V203, P181; Valiant GA., 1987, BIOMECHANICS X, P937; Warren WH, 2008, UNDERST COMPLEX SYST, P45, DOI 10.1007/978-3-540-74479-5_3; Wood CM, 2014, J BIOMECH, V47, P1739, DOI 10.1016/j.jbiomech.2014.03.008; WOSK J, 1981, J BIOMECH, V14, P261, DOI 10.1016/0021-9290(81)90071-3; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	28	16	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157297	10.1371/journal.pone.0157297	http://dx.doi.org/10.1371/journal.pone.0157297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271850	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000070
J	Foster, AC; Farnsworth, J; Lind, GE; Li, YX; Yang, JY; Dang, V; Penjwini, M; Viswanath, V; Staubli, U; Kavanaugh, MP				Foster, Alan C.; Farnsworth, Jill; Lind, Genevieve E.; Li, Yong-Xin; Yang, Jia-Ying; Dang, Van; Penjwini, Mahmud; Viswanath, Veena; Staubli, Ursula; Kavanaugh, Michael P.			D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures	PLOS ONE			English	Article							NEUROMODULATOR D-SERINE; D-ASPARTATE RECEPTOR; INTELLECTUAL DISABILITY; MOUSE-BRAIN; NEURONS; GLUTAMATE; RACEMASE; ASCT2; MUTATIONS; OXIDASE	N-methyl-D-aspartate (NMDA) receptors play critical roles in synaptic transmission and plasticity. Activation of NMDA receptors by synaptically released L-glutamate also requires occupancy of co-agonist binding sites in the tetrameric receptor by either glycine or D-serine. Although D-serine appears to be the predominant co-agonist at synaptic NMDA receptors, the transport mechanisms involved in D-serine homeostasis in brain are poorly understood. In this work we show that the SLC1 amino acid transporter family members SLC1A4 (ASCT1) and SLC1A5 (ASCT2) mediate homo-and hetero-exchange of D-serine with physiologically relevant kinetic parameters. In addition, the selectivity profile of D-serine uptake in cultured rat hippocampal astrocytes is consistent with uptake mediated by both ASCT1 and ASCT2. Together these data suggest that SLC1A4 (ASCT1) may represent an important route of Na-dependent D-serine flux in the brain that has the ability to regulate extracellular D-serine and thereby NMDA receptor activity.	[Foster, Alan C.; Li, Yong-Xin; Yang, Jia-Ying; Dang, Van; Penjwini, Mahmud; Viswanath, Veena; Staubli, Ursula] Allergan Pharmaceut Inc, Dept Biol Sci, 2525 Dupont Dr, Irvine, CA 92612 USA; [Farnsworth, Jill; Lind, Genevieve E.; Kavanaugh, Michael P.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	AbbVie; Allergan; University of Montana System; University of Montana	Foster, AC; Li, YX (corresponding author), Allergan Pharmaceut Inc, Dept Biol Sci, 2525 Dupont Dr, Irvine, CA 92612 USA.; Kavanaugh, MP (corresponding author), Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA.	AFoster@otonomy.com; li_yongxin@allergan.com; Michael.Kavanaugh@mso.umt.edu			NIH [R15 GM110690]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The following authors were employees of Allergan, Inc. at the time of the conduct of this study: ACF, Y-XL, JY, VD, MP, VV, and US. Allergan provided support in the form of salaries for authors ACF, Y-XL, JY, VD, MP, VV, and US, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JF,GEL, and MPK were supported by a grant from NIH (R15 GM110690).	ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 1999, J NEUROCHEM, V73, P2184; Damseh N, 2015, J MED GENET, V52, P541, DOI 10.1136/jmedgenet-2015-103104; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Gliddon CM, 2009, J NEUROCHEM, V108, P372, DOI 10.1111/j.1471-4159.2008.05767.x; Grewer C, 2004, J PHYSIOL-LONDON, V557, P747, DOI 10.1113/jphysiol.2004.062521; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; Heimer G, 2015, CLIN GENET, V88, P327, DOI 10.1111/cge.12637; Helboe L, 2003, EUR J NEUROSCI, V18, P2227, DOI 10.1046/j.1460-9568.2003.02966.x; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Kantrowitz JT, 2015, LANCET PSYCHIAT, V2, P403, DOI 10.1016/S2215-0366(15)00098-X; Kasai Y, 2011, J NEUROCHEM, V118, P304, DOI 10.1111/j.1471-4159.2011.07313.x; Martineau Magalie, 2014, Front Synaptic Neurosci, V6, P12, DOI 10.3389/fnsyn.2014.00012; Maucler C, 2013, ACS CHEM NEUROSCI, V4, P772, DOI 10.1021/cn4000549; Meunier CNJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151233; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyoshi Y, 2012, AMINO ACIDS, V43, P1919, DOI 10.1007/s00726-012-1398-4; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; O'Brien KB, 2005, NEUROSCI LETT, V385, P58, DOI 10.1016/j.neulet.2005.05.009; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panizzutti R, 2014, CURR PHARM DESIGN, V20, P5160, DOI 10.2174/1381612819666140110121139; Pinilia-Tenas J, 2003, J MEMBRANE BIOL, V195, P27, DOI 10.1007/s00232-003-2041-9; Potier B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.001.2010; Radzishevsky I, 2013, CURR OPIN CLIN NUTR, V16, P72, DOI 10.1097/MCO.0b013e32835a3466; Ribeiro CS, 2002, BRAIN RES, V929, P202, DOI 10.1016/S0006-8993(01)03390-X; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Sacchi S, 2012, AMINO ACIDS, V43, P1833, DOI 10.1007/s00726-012-1345-4; Sason H., 2016, CEREB CORTEX; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Shao ZJ, 2009, J NEUROSCI RES, V87, P2520, DOI 10.1002/jnr.22086; Smith Sean M, 2010, Open Med Chem J, V4, P3, DOI 10.2174/1874104501004020003; Srour M, 2015, CLIN GENET, V88, pE1, DOI 10.1111/cge.12605; Sun W, 2014, NEUROCHEM INT, V73, P146, DOI 10.1016/j.neuint.2014.04.007; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2013, BIOCHEM SOC T, V41, P1546, DOI 10.1042/BST20130220; Yamamori H, 2014, NEUROSCI LETT, V582, P93, DOI 10.1016/j.neulet.2014.08.052; Yamamoto T, 2004, NEUROSCI RES, V49, P101, DOI 10.1016/j.neures.2004.02.004; Yamamoto T, 2003, FEBS LETT, V548, P69, DOI 10.1016/S0014-5793(03)00742-7; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991	47	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156551	10.1371/journal.pone.0156551	http://dx.doi.org/10.1371/journal.pone.0156551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272177	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000019
J	Hanifa, Y; Fielding, KL; Chihota, VN; Adonis, L; Charalambous, S; Karstaedt, A; McCarthy, K; Nicol, MP; Ndlovu, NT; Sahid, F; Churchyard, GJ; Grant, AD				Hanifa, Yasmeen; Fielding, Katherine L.; Chihota, Violet N.; Adonis, Lungiswa; Charalambous, Salome; Karstaedt, Alan; McCarthy, Kerrigan; Nicol, Mark P.; Ndlovu, Nontobeko T.; Sahid, Faieza; Churchyard, Gavin J.; Grant, Alison D.			Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; SPUTUM	Background We assessed the diagnostic accuracy of Determine TB-LAM (LF-LAM) to screen for tuberculosis among ambulatory adults established in HIV care in South Africa. Methods A systematic sample of adults attending for HIV care, regardless of symptomatology, were enrolled in the XPHACTOR study, which tested a novel algorithm for prioritising investigation with Xpert MTB/RIF. In this substudy, restricted to participants with enrolment CD4<200x10(6)/l, urine was stored at enrolment for later testing with LF-LAM. Sputum was sent for immediate Xpert MTB/RIF if any of: current cough, fever >= 3 weeks, body mass index (BMI)<18.5kg/m(2), CD4<100x10(6)/l (or <200x10(6)/l if pre-ART), weight loss >= 10% or strong clinical suspicion were present; otherwise, sputum was stored for Xpert testing at study completion. Participants were reviewed monthly, with reinvestigation if indicated, to 3 months, when sputum and blood were taken for mycobacterial culture. We defined tuberculosis as "confirmed" if Xpert, line probe assay or culture for M. tuberculosis within six months of enrolment were positive, and "clinical" if tuberculosis treatment started without microbiological confirmation. Results Amongst 424 participants, 61% were female and 57% were taking ART (median duration 22 months); median age, CD4 and BMI were 39 years, 111x10(6)/l, and 23 kg/m(2). 56/424 (13%) participants had tuberculosis (40 confirmed, 16 clinical). 24/424 (5.7%) vs. 8/424 (1.9%) were LAM-positive using grade 1 vs. grade 2 cut-off. Using grade 1 cut-off, sensitivity for confirmed TB (all clinical TB excluded) was 12.5% (95% CI 4.2%, 26.8%) and in CD4<100x10(6)/l vs. CD4 >= 100x10(6)/l was 16.7% (95% CI 4.7%, 37.4%) vs. 6.3% (95% CI 0.2%, 30.2%). Specificity was > 95% irrespective of diagnostic reference standard, CD4 stratum, or whether grade 1 or grade 2 cut-off was used. Conclusion Sensitivity of LF-LAM is too low to recommend as part of intensified case finding in ambulatory patients established in HIV care.	[Hanifa, Yasmeen; Fielding, Katherine L.; Churchyard, Gavin J.; Grant, Alison D.] London Sch Hyg & Trop Med, London WC1, England; [Chihota, Violet N.; Charalambous, Salome; McCarthy, Kerrigan; Ndlovu, Nontobeko T.; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Chihota, Violet N.; Charalambous, Salome; Karstaedt, Alan; Sahid, Faieza; Churchyard, Gavin J.; Grant, Alison D.] Univ Witwatersrand, Johannesburg, South Africa; [Adonis, Lungiswa] Mamelodi Hosp, Pretoria, South Africa; [Karstaedt, Alan; Sahid, Faieza] Chris Hani Baragwanath Hosp, Dept Med, Johannesburg, South Africa; [Nicol, Mark P.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Nicol, Mark P.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Churchyard, Gavin J.] South African Med Res Council Collaborating Ctr H, Adv Care & Treatment ACT TB HIV, Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; National Health Laboratory Service; University of Cape Town	Hanifa, Y (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	yasmeen.hanifa@lshtm.ac.uk	Nicol, Mark/W-4149-2019; Chihota, Violet/DWH-9372-2022	Nicol, Mark/0000-0002-1366-4805; Charalambous, Salome/0000-0001-7143-1009; McCarthy, Kerrigan/0000-0001-8958-9795; HANIFA, YASMEEN/0000-0002-1677-0697; Fielding, Katherine/0000-0002-6524-3754; Chihota, Violet/0000-0003-1444-9266; Churchyard, Gavin/0000-0002-4269-3699	Bill and Melinda Gates Foundation [OPP1034523]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge funding from the Bill and Melinda Gates Foundation (Grant No. OPP1034523; http://www.gatesfoundation.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere Ltd, 2015, AL DET TB LAM PACK I; [Anonymous], 2015, US LAT FLOW UR LIP A; Balcha TT, 2014, TROP MED INT HEALTH, V19, P734, DOI 10.1111/tmi.12308; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Drain PK, 2015, JAIDS-J ACQ IMM DEF, V68, P274, DOI 10.1097/QAI.0000000000000436; Drain PK, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-110; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Manabe YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101459; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0967-z; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Shah M, 2014, AIDS, V28, P1307, DOI 10.1097/QAD.0000000000000264; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; World Health Organization, 2015, GLOB TUB REP 2014; World Health Organization, 2013, WHO POL COLL TB HIV	16	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156866	10.1371/journal.pone.0156866	http://dx.doi.org/10.1371/journal.pone.0156866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271432	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000377561000042
J	Li, WF; Liu, HZ; Yang, P; Xie, W				Li, Wenfa; Liu, Hongzhe; Yang, Peng; Xie, Wei			Supporting Regularized Logistic Regression Privately and Efficiently	PLOS ONE			English	Article							PRIVACY; GENE; ANONYMITY; NETWORK; SHARE	As one of the most popular statistical and machine learning models, logistic regression with regularization has found wide adoption in biomedicine, social sciences, information technology, and so on. These domains often involve data of human subjects that are contingent upon strict privacy regulations. Concerns over data privacy make it increasingly difficult to coordinate and conduct large-scale collaborative studies, which typically rely on cross-institution data sharing and joint analysis. Our work here focuses on safeguarding regularized logistic regression, a widely-used statistical model while at the same time has not been investigated from a data security and privacy perspective. We consider a common use scenario of multi-institution collaborative studies, such as in the form of research consortia or networks as widely seen in genetics, epidemiology, social sciences, etc. To make our privacy- enhancing solution practical, we demonstrate a non-conventional and computationally efficient method leveraging distributing computing and strong cryptography to provide comprehensive protection over individual-level and summary data. Extensive empirical evaluations on several studies validate the privacy guarantee, efficiency and scalability of our proposal. We also discuss the practical implications of our solution for large-scale studies and applications from various disciplines, including genetic and biomedical studies, smart grid, network analysis, etc.	[Li, Wenfa; Liu, Hongzhe; Yang, Peng] Beijing Union Univ, Beijing Key Lab Informat Serv Engn, Beijing 100101, Peoples R China; [Xie, Wei] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA	Beijing Union University; Vanderbilt University	Xie, W (corresponding author), Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA.	wei.xie@vanderbilt.edu		Xie, Wei/0000-0002-1871-6846; Liu, Hongzhe/0000-0003-2314-5272	National Nature Science Foundation of China [61300078]; The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD20130320, CITTCD201504039]; Funding Project for Academic Human Resources Development in Beijing Union University [Zk80201403, Rk100201510]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Funding Project for Academic Human Resources Development in Beijing Union University	This work was partly supported by The National Nature Science Foundation of China (No. 61300078), and The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD20130320, CIT&TCD201504039), and Funding Project for Academic Human Resources Development in Beijing Union University (Zk80201403, Rk100201510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe EA, 2012, AM ECON REV, V102, P65, DOI 10.1257/aer.102.3.65; Almquist ZW, 2014, SOCIOL METHODOL, V44, P273, DOI 10.1177/0081175013520159; [Anonymous], 2003, COMP NUMERICAL OPTIM; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Beimel Amos, 2011, Coding and Cryptology. Proceedings of the Third International Workshop, IWCC 2011, P11, DOI 10.1007/978-3-642-20901-7_2; boyd d., 2008, CONVERGENCE-US, V14, P13, DOI [DOI 10.1177/1354856507084416, 10.1177/1354856507084416]; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Chaudhuri K., 2009, ADV NEURAL INFORM PR, P289; Dai C, 2014, P VLDB ENDOWMENT, V7, DOI 10.14778/2733004.2733080; Daries JP, 2014, COMMUN ACM, V57, P56, DOI 10.1145/2643132; Dasgupta A, 2011, GENET EPIDEMIOL, V35, pS5, DOI 10.1002/gepi.20642; Du WL, 2004, SIAM PROC S, P222; Dwork, 2011, ENCY CRYPTOGRAPHY SE, P338, DOI DOI 10.1007/978-1-4419-5906-5_752; El Emam K, 2013, J AM MED INFORM ASSN, V20, P453, DOI 10.1136/amiajnl-2011-000735; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; Federal Trade Commission, PREL FTC STAFF REP P; Goldreich O., 2009, FDN CRYPTOGRAPHY, V2; GREEN PJ, 1984, J R STAT SOC B, V46, P149; Hall R, 2011, J OFF STAT, V27, P669; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kantarcioglu M, 2008, IEEE T INF TECHNOL B, V12, P606, DOI 10.1109/TITB.2007.908465; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lee S.-I., 2006, EFFICIENT L1 REGULAR, V1, P401; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Liu M, 2012, J AM MED INFORM ASSN, V19, pE28, DOI 10.1136/amiajnl-2011-000699; Liu Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-384; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Masuda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062262; McDaniel P, 2009, IEEE SECUR PRIV, V7, P75, DOI 10.1109/MSP.2009.76; Nardi Y, 2012, J PRIVACY CONFIDENTI, V4, P9; Nikolaenko V, 2013, P IEEE S SECUR PRIV, P334, DOI 10.1109/SP.2013.30; O'Keefe CM, 2013, INT STAT REV, V81, P426, DOI 10.1111/insr.12021; Office for Civil Rights HHS, 2002, Fed Regist, V67, P53181; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Richardson M., 2007, P 16 INT C WORLD WID, P521, DOI [DOI 10.1145/1242572.1242643, 10.1145/1242572.1242643]; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Shen X, 2013, GENETICS, V193, P1255, DOI 10.1534/genetics.112.146720; Sparks R, 2008, COMPUT METH PROG BIO, V91, P208, DOI 10.1016/j.cmpb.2008.04.001; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; van der Putten P., 2000, COIL CHALLENGE 2000; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wasserman L, 2011, ALL STAT; Wolfson M, 2010, INT J EPIDEMIOL; Wu Yuan, 2012, AMIA Annu Symp Proc, V2012, P1450; Xie W, 2014, BIOINFORMATICS, V30, P3334, DOI 10.1093/bioinformatics/btu561; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	50	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156479	10.1371/journal.pone.0156479	http://dx.doi.org/10.1371/journal.pone.0156479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271738	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200010
J	Huang, MY; Xuan, F; Liu, W; Cui, HJ				Huang, M-Y; Xuan, F.; Liu, W.; Cui, H-J			MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation	ONCOGENE			English	Article							MYC TARGET GENE; CHROMATIN MODIFICATIONS; COLON-CANCER; LUNG-CANCER; EXPRESSION; GROWTH; MDIG; NEUROBLASTOMA; CELLS	It is generally known that histone demethylases regulate gene transcription by altering the methylate status on histones, but their roles in cancers and the underlying molecular mechanisms still remain unclear. MYC-induced nuclear antigen (MINA) is reported to be a histone demethylase and highly expressed in many cancers. Here, for the first time, we show that MINA is involved in glioblastoma carcinogenesis and reveal the probable mechanisms of it in cell-cycle control. Kaplan-Meier analysis of progressionfree survival showed that high MINA expression was strongly correlated with poor outcome and advancing tumor stage. MINA knockdown significantly repressed the cell proliferation and tumorigenesis abilities of glioblastoma cells in vitro and in vivo that were rescued by overexpressing the full-length MINA afterwards. Microarray analysis after knockdown of MINA revealed that MINA probably regulated glioblastoma carcinogenesis through the predominant cell-cycle pathways. Further investigation showed that MINA deficiency led to a cell-cycle arrest in G1 and G2 phases. And among the downstream genes, we found that cyclins and cyclin-dependent kinases were directly activated by MINA via the demethylation of H3K9me3.	[Huang, M-Y; Xuan, F.; Liu, W.; Cui, H-J] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Cui, HJ (corresponding author), Southwest Univ, Dept Cell Biol, State Key Lab Silkworm Genome Biol, 2 Tianshenglu, Chongqing 400716, Peoples R China.	hongjuan.cui@gmail.com	Xuan, Fan/G-6580-2016	Xuan, Fan/0000-0002-8070-3309	National Basic Research Program of China [2012CB114603]; National Natural Science Foundation of China [31501100, 81502574]; Research Fund for the Doctoral Program of Higher Education of China [20130182110003]; Basal Research Fund of Central Higher Education Institutions [XDJK2016D003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Basal Research Fund of Central Higher Education Institutions	This work was supported by the National Basic Research Program of China (No. 2012CB114603), the National Natural Science Foundation of China (No. 31501100, 81502574), the Research Fund for the Doctoral Program of Higher Education of China (20130182110003) and the Basal Research Fund of Central Higher Education Institutions (XDJK2016D003).	Benjamin R, 2003, CANCER J, V9, P82, DOI 10.1097/00130404-200303000-00003; Chen BL, 2013, ONCOTARGET, V4, P1427, DOI 10.18632/oncotarget.1155; Chowdhury R, 2014, NATURE, V510, P422, DOI 10.1038/nature13263; Cohen Idan, 2011, Genes Cancer, V2, P631, DOI 10.1177/1947601911417176; Eilbracht J, 2005, EUR J CELL BIOL, V84, P279, DOI 10.1016/j.ejcb.2004.12.022; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Komiya K, 2010, LUNG CANCER, V69, P232, DOI 10.1016/j.lungcan.2009.10.010; Komiya K, 2010, J CANCER RES CLIN, V136, P465, DOI 10.1007/s00432-009-0679-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lin HQ, 2010, CELL RES, V20, P899, DOI 10.1038/cr.2010.84; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tan XP, 2014, CELL BIOCHEM BIOPHYS, V69, P619, DOI 10.1007/s12013-014-9841-7; Tan XP, 2012, ONCOL LETT, V3, P1037, DOI 10.3892/ol.2012.620; Teye K, 2004, AM J PATHOL, V164, P205, DOI 10.1016/S0002-9440(10)63111-2; Teye K, 2007, ONCOL REP, V18, P841; Toyokawa G, 2011, CANCER PREV RES, V4, P2051, DOI 10.1158/1940-6207.CAPR-11-0290; Tsuneoka M, 2004, CLIN CANCER RES, V10, P7347, DOI 10.1158/1078-0432.CCR-03-0543; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Wang M, 2015, ONCOTARGET, V6, P9517, DOI 10.18632/oncotarget.3367; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Xie Q, 2014, NEURO-ONCOLOGY, V16, P1575, DOI 10.1093/neuonc/nou147; Xing J, 2014, ONCOL REP, V31, P634, DOI 10.3892/or.2013.2918; Xuan F, 2016, NEURO-ONCOLOGY, V18, P819, DOI 10.1093/neuonc/nov281; Yang R, 2015, ONCOTARGET, V6, P7644, DOI 10.18632/oncotarget.3223; Yu M, 2014, PLOS ONE, V9; Zhang YD, 2005, ONCOGENE, V24, P4873, DOI 10.1038/sj.onc.1208668; Zhao EH, 2016, CELL REP, V14, P506, DOI 10.1016/j.celrep.2015.12.053	33	33	33	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					387	396		10.1038/onc.2016.208	http://dx.doi.org/10.1038/onc.2016.208			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27292258				2022-12-26	WOS:000394166000008
J	Banasavadi-Siddegowda, YK; Russell, L; Frair, E; Karkhanis, VA; Relation, T; Yoo, JY; Zhang, J; Sif, S; Imitola, J; Baiocchi, R; Kaur, B				Banasavadi-Siddegowda, Y. K.; Russell, L.; Frair, E.; Karkhanis, V. A.; Relation, T.; Yoo, J. Y.; Zhang, J.; Sif, S.; Imitola, J.; Baiocchi, R.; Kaur, B.			PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells	ONCOGENE			English	Article							RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; HUMAN BRAIN; STEM-CELL; SURVIVAL; GENE; PHOSPHATASE; EXPRESSION; INHIBITORS	Glioblastoma (GBM) represents the most common and aggressive histologic subtype among malignant astrocytoma and is associated with poor outcomes because of heterogeneous tumour cell population including mature non-stem-like cell and immature stem-like cells within the tumour. Thus, it is critical to find new target-specific therapeutic modalities. Protein arginine methyltransferase enzyme 5 (PRMT5) regulates many cellular processes through its methylation activity and its overexpression in GBM is associated with more aggressive disease. Previously, we have shown that silencing of PRMT5 expression in differentiated GBM cell lines results in apoptosis and reduced tumour growth in mice. Here, we report the critical role of PRMT5 in GBM differentiated cells (GBMDC) grown in serum and GBM neurospheres (GBMNS) grown as neurospheres in vitro. Our results uncover a very significant role for PRMT5 in GBMNS self-renewal capacity and proliferation. PRMT5 knockdown in GBMDC led to apoptosis, knockdown in GBMNS led to G1 cell cycle arrest through upregulation of p27 and hypophoshorylation of retinoblastoma protein, leading to senescence. Comparison of impact of PRMT5 on cellular signalling by the Human Phospho-Kinase Array and chromatin immunoprecipitation-PCR revealed that unlike GBMDC, PRMT5 regulates PTEN expression and controls Akt and ERk activity in GBMNS. In vivo transient depletion of PRMT5 decreased intracranial tumour size and growth rate in mice implanted with both primary tumour-derived GBMNS and GBMDC. This is the first study to identify PTEN as a potential downstream target of PRMT5 and PRMT5 is vital to support both mature and immature GBM tumour cell populations.	[Banasavadi-Siddegowda, Y. K.; Russell, L.; Frair, E.; Relation, T.; Yoo, J. Y.; Kaur, B.] Ohio State Univ, Coll Med, Dept Neurol Surg, 410W 12th Ave,CCC Room 385D, Columbus, OH 43210 USA; [Karkhanis, V. A.; Baiocchi, R.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, 400W 12th Ave,CCC 453, Columbus, OH 43210 USA; [Zhang, J.] Ctr Biostat, Dept Biomed Informat, Columbus, OH USA; [Sif, S.] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar; [Imitola, J.] Ohio State Univ, Coll Med, Dept Neurol, Lab Neural Stem Cells & Funct Neurogenet,Div Neur, Columbus, OH 43210 USA; [Imitola, J.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Qatar University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kaur, B (corresponding author), Ohio State Univ, Coll Med, Dept Neurol Surg, 410W 12th Ave,CCC Room 385D, Columbus, OH 43210 USA.; Baiocchi, R (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, 400W 12th Ave,CCC 453, Columbus, OH 43210 USA.	robert.baiocchi@osumc.edu; kaur.11@osu.edu	Sif, Said/AAE-5554-2019	/0000-0002-4730-6918; Sif, Said/0000-0001-6268-1145; Yoo, Ji Young/0000-0002-6767-1111	NIH RO1 [CA150153, NS064607]; NIH P01 [CA163205]; NIH P30 [NS045758]; NIH [R21 NS071346];  [IRG-67-003-50]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA163205, R01CA150153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071346, P30NS045758, R01NS064607] Funding Source: NIH RePORTER	NIH RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH P01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH P30; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was financially supported by: Kaur: NIH RO1 (CA150153), NIH P01 (CA163205), NIH P30 (NS045758), NIH RO1 (NS064607); Baiocchi: NIH R21 NS071346 and Yoo: IRG-67-003-50.	ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; CRISTOFALO VJ, 1989, J GERONTOL, V44, P55, DOI 10.1093/geronj/44.6.55; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Han XS, 2014, J NEURO-ONCOL, V118, P61, DOI 10.1007/s11060-014-1419-0; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Karberg S, 2009, CELL, V139, P1029, DOI 10.1016/j.cell.2009.11.038; KATO J, 1993, GENE DEV, V7, P331; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Masui K, 2012, NEUROPATH APPL NEURO, V38, P271, DOI 10.1111/j.1365-2990.2011.01238.x; McDowell KA, 2011, CURR PHARM DESIGN, V17, P2411; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; QIAN YY, 1992, MOL CELL BIOL, V12, P5363, DOI 10.1128/MCB.12.12.5363; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tan W, 2015, J CELL BIOCHEM, V116, P1583, DOI 10.1002/jcb.25112; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yen F, 2014, CANCER RES, V74, P1752; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	46	71	73	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					263	274		10.1038/onc.2016.199	http://dx.doi.org/10.1038/onc.2016.199			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27292259	Green Accepted			2022-12-26	WOS:000393938100011
J	Lin, JB; He, SL; Sun, XH; Franck, G; Deng, YH; Yang, DF; Haemmig, S; Wara, AKM; Icli, B; Li, DZ; Feinberg, MW				Lin, Jibin; He, Shaolin; Sun, Xinghui; Franck, Gregory; Deng, Yihuan; Yang, Dafeng; Haemmig, Stefan; Wara, A. K. M.; Icli, Basak; Li, Dazhu; Feinberg, Mark W.			MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10	FASEB JOURNAL			English	Article						endothelial cells; NF-B; Card10	NF-KAPPA-B; TISSUE FACTOR EXPRESSION; VASCULAR INFLAMMATION; CELLS; RECEPTORS; COAGULATION; MECHANISMS; ADHESION; ATHEROSCLEROSIS; PROMOTER	Thrombogenic and inflammatory mediators, such as thrombin, induce NF-B-mediated endothelial cell (EC) activation and dysfunction, which contribute to pathogenesis of arterial thrombosis. The role of anti-inflammatory microRNA-181b (miR-181b) on thrombosis remains unknown. Our previous study demonstrated that miR-181b inhibits downstream NF-B signaling in response to TNF-. Here, we demonstrate that miR-181b uniquely inhibits upstream NF-B signaling in response to thrombin. Overexpression of miR-181b inhibited thrombin-induced activation of NF-B signaling, demonstrated by reduction of phospho-IKK-, -IB-, and p65 nuclear translocation in ECs. MiR-181b also reduced expression of NF-B target genes VCAM-1, intercellular adhesion molecule-1, E-selectin, and tissue factor. Mechanistically, miR-181b targets caspase recruitment domain family member 10 (Card10), an adaptor protein that participates in activation of the IKK complex in response to signals transduced from protease-activated receptor-1. miR-181b reduced expression of Card10 mRNA and protein, but not protease-activated receptor-1. 3-Untranslated region reporter assays, argonaute-2 microribonucleoprotein immunoprecipitation studies, and Card10 rescue studies revealed that Card10 is a bona fide direct miR-181b target. Small interfering RNA-mediated knockdown of Card10 expression phenocopied effects of miR-181b on NF-B signaling and targets. Card10 deficiency did not affect TNF--induced activation of NF-B signaling, which suggested stimulus-specific regulation of NF-B signaling and endothelial responses by miR-181b in ECs. Finally, in response to photochemical injury-induced arterial thrombosis, systemic delivery of miR-181b reduced thrombus formation by 73% in carotid arteries and prolonged time to occlusion by 1.6-fold, effects recapitulated by Card10 small interfering RNA. These data demonstrate that miR-181b and Card10 are important regulators of thrombin-induced EC activation and arterial thrombosis. These studies highlight the relevance of microRNA-dependent targets in response to ligand-specific signaling in ECs.Lin, J., He, S., Sun, X., Franck, G., Deng, Y., Yang, D., Haemmig, S., Wara, A. K. M., Icli, B., Li, D., Feinberg, M. W. MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10.	[Lin, Jibin; Sun, Xinghui; Franck, Gregory; Deng, Yihuan; Yang, Dafeng; Haemmig, Stefan; Wara, A. K. M.; Icli, Basak; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA; [Lin, Jibin; He, Shaolin; Deng, Yihuan; Li, Dazhu] Huazhong Univ Sci & Technol, Inst Cardiovasc Dis, Union Hosp, Dept Cardiol,Tongji Med Coll, Wuhan, Peoples R China; [Yang, Dafeng] Cent S Univ, Xiangya Hosp, Dept Cardiol, Changsha, Hunan, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Huazhong University of Science & Technology; Central South University	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA.	mfeinberg@partners.org	Haemmig, Stefan/V-6585-2019; Yang, Dafeng/HIK-2106-2022	Haemmig, Stefan/0000-0001-5014-4393; Yang, Dafeng/0000-0002-8320-8215; Feinberg, Mark/0000-0001-9523-3859; FRANCK, Gregory/0000-0002-4288-9034	National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute) [HL115141, HL117994]; National Institutes of Health (NIH) (National Institute of General Medical Sciences) [GM115605]; A Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust, Bank of America, N.A. Trustee; State Scholarship Fund of the China Scholarship Council; Jonathan Levy Research Fund; American Heart Association (SDG) [15SDG25400012]; Boston Nutrition Obesity Research Center Pilot and Feasibility award under NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30KD046200]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115141, R01HL117994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115605] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); A Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust, Bank of America, N.A. Trustee; State Scholarship Fund of the China Scholarship Council(China Scholarship Council); Jonathan Levy Research Fund; American Heart Association (SDG)(American Heart Association); Boston Nutrition Obesity Research Center Pilot and Feasibility award under NIH National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Grants HL115141 and HL117994 (National Heart, Lung, and Blood Institute), and GM115605 (National Institute of General Medical Sciences) (all to M.W.F.); the Arthur K. Watson Charitable Trust (to M.W.F.); the Dr. Ralph and Marian Falk Medical Research Trust, Bank of America, N.A. Trustee (to M.W.F.); a State Scholarship Fund of the China Scholarship Council (to J.L.); a Jonathan Levy Research Fund (to M.W.F.), the American Heart Association (SDG#15SDG25400012) (to X.S.); and a Boston Nutrition Obesity Research Center Pilot and Feasibility award under NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant P30KD046200 (to X.S.). Author contributions: X. Sun and M. W. Feinberg designed research; J. Lin, S. He, X. Sun, Y. Deng, D. Yang, S. Haemmig, and M. W. Feinberg analyzed data; J. Lin, S. He, X. Sun, G. Franck, Y. Deng, S. D. Yang, and Haemmig performed research; J. Lin, X. Sun, and M. W. Feinberg wrote the paper; and X. Sun, A. K. M. Wara, B. Icli, D. Li, and M. W. Feinberg contributed to experimental design.	BARTHA K, 1993, J BIOL CHEM, V268, P421; Barua RS, 2013, ARTERIOSCL THROM VAS, V33, P1460, DOI 10.1161/ATVBAHA.112.300154; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Eisenreich A, 2014, TRENDS CARDIOVAS MED, V24, P128, DOI 10.1016/j.tcm.2013.09.005; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; HENRY PD, 1995, CURR OPIN LIPIDOL, V6, P190, DOI 10.1097/00041433-199508000-00002; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Li SF, 2014, ATHEROSCLEROSIS, V237, P514, DOI 10.1016/j.atherosclerosis.2014.09.033; Li SF, 2014, J MOL CELL CARDIOL, V75, P49, DOI 10.1016/j.yjmcc.2014.06.017; Li YD, 2009, J BIOL CHEM, V284, P4473, DOI 10.1074/jbc.M806010200; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; Medoff BD, 2009, AM J RESP CELL MOL, V40, P286, DOI 10.1165/rcmb.2008-0129OC; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612; Popovic M, 2012, MOL CELL BIOCHEM, V359, P301, DOI 10.1007/s11010-011-1024-x; Rahman A, 1999, J IMMUNOL, V162, P5466; Rezaie AR, 2014, THROMB HAEMOSTASIS, V112, P876, DOI 10.1160/TH14-02-0167; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Wang YM, 2014, J CLIN INVEST, V124, P2160, DOI 10.1172/JCI70966; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810	37	27	27	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3216	3226		10.1096/fj.201500163R	http://dx.doi.org/10.1096/fj.201500163R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27297585	Green Published			2022-12-26	WOS:000382816300021
J	Cazarim, MD; de Freitas, O; Penaforte, TR; Achcar, A; Pereira, LRL				Cazarim, Maurilio de Souza; de Freitas, Osvaldo; Penaforte, Thais Rodrigues; Achcar, Angela; Leira Pereira, Leonardo Regis			Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge	PLOS ONE			English	Article							PHARMACIST INTERVENTIONS; BLOOD-PRESSURE; PROGRAM; ENALAPRIL; OUTCOMES; DISEASE; BRAZIL	Introduction Almost 50% of the 17.5 million deaths worldwide from cardiovascular disease have been associated with systemic arterial hypertension (SAH). Into this scenario, Pharmaceutical Care (PC) has been inserted in order to improve the management of SAH and reduce its risks. Objective To evaluate the outcomes and healthcare assistance achieved after discharge of hypertension patients from the PC program. Methods This is a quasi-experimental study with historical controls. Retrospective data collection from 2006 to 2012 was begun in 2013 and included a PC program performed over one year. PC was performed in two basic units of the public health systemin Ribeirao Preto-SP, Brazil, where the pharmacist followed up 104 hypertensive patients. The clinical indicators of systolic (SBP) and diastolic blood pressure (DBP), triglycerides, total-cholesterol, high and low density lipoprotein cholesterol were collected, as well as care indicators related to the number of consultations (basic, specialized and emergency care) and antihypertensive drugs used. The coronary risk of patients by the Framingham risk score was also calculated. For the analysis, the data were divided into three periods, 2006-2008 as pre-PC, 2009 as PC and 2010-2012 as post-PC. Results In the pre-PC period, 54.4%, 79.0% and 27.3% of patients presented satisfactory levels of SBP, DBP and total-cholesterol, respectively. In the post-PC period, the percentages were 93.0% for SBP and DBP [p < 0.001] and 60.6% for total-cholesterol [p < 0.001]. The average number of consultations per patient/year in primary care was 1.66 +/- 1.43 and 2.36 +/- 1.73, [p = 0.012]; and for emergency care was 1.70 +/- 1.43 and 1.06 +/- 0.81, [p = 0.002] in the pre-PC and post-PC periods, respectively. The pre-PC Framingham risk in the last year was 14.3% +/- 10.6 and the average post-PC was 10.9% +/- 7.9. Conclusion PC was effective in the control of blood pressure and total-cholesterolafter discharge of the hypertensive patients from PC program.	[Cazarim, Maurilio de Souza; de Freitas, Osvaldo; Leira Pereira, Leonardo Regis] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Penaforte, Thais Rodrigues] Univ Fed Bahia, Sch Pharm, Dept Med, Salvador, BA, Brazil; [Achcar, Angela] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Social Med, BR-14049 Ribeirao Preto, SP, Brazil; [Leira Pereira, Leonardo Regis] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ctr Pesquisa Assistencia Farmaceut & Farm Clin CP, 23 Blc S,Av Cafe S-N, BR-14040903 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade de Sao Paulo; Universidade de Sao Paulo	Cazarim, MD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil.	maurilio.jf@gmail.com	de Freitas, Osvaldo/AAK-2913-2020; Freitas, Osvaldo/C-1440-2012; Pereira, Leonardo R L/J-9322-2012	de Freitas, Osvaldo/0000-0001-7055-2028; Pereira, Leonardo R L/0000-0002-8609-1390; Cazarim, Maurilio de Souza/0000-0002-2826-5903	Sao Paulo Research Foundation (FAPESP);  [2014/020879];  [07/06514-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	This work was supported by funding of Sao Paulo Research Foundation (FAPESP). This organization helped with scholarships for authors Maurilio Souza Cazarim [grant number 2014/020879], URL (http://bvs.fapesp.br/en/pesquisador/673633/maurilio-de-souza-cazarim/) and Thais Rodrigues Penaforte [grant number 07/06514-5], URL (http://www.bv.fapesp.br/en/pesquisador/77829/thaisrodrigues-penaforte/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, assumptions and conclusions or recommendations expressed in this article are responsibility of the authors and do not necessarily reflect the viewpoint of FAPESP.	Aguwa CN, 2008, PHARM WORLD SCI, V30, P107, DOI 10.1007/s11096-007-9151-x; Mazroui NR, 2009, BRIT J CLIN PHARMACO, V67, P547, DOI 10.1111/j.1365-2125.2009.03391.x; Almeida CM, 1995, CAD SAUDE PUBLICA, V11, P639, DOI [10.1590/S0102-311X1995000400020, DOI 10.1590/S0102-311X1995000400020]; Araujo A. L. A., 2005, Revista de Ciencias Farmaceuticas Basica e Aplicada, V26, P87; Borges APS, 2008, THESIS; Brazilian Institute of Geography and Statistics-IBGE, CONS EXP SURV BRAZ; Bruckert E, 2008, CARDIOVASC DRUG THER, V22, P495, DOI 10.1007/s10557-008-6137-4; Carter BL, 2009, ARCH INTERN MED, V169, P1748, DOI 10.1001/archinternmed.2009.316; Chinwong S, 2004, PHARM WORLD SCI, V26, P96, DOI 10.1023/B:PHAR.0000018599.47002.e7; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cipolle RJ, 1998, PHARM CARE PRACTICE; Coelho Eduardo Barbosa, 2005, Arq. Bras. Cardiol., V85, P157, DOI 10.1590/S0066-782X2005001600002; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; de Castro MS, 2007, ANN PHARMACOTHER, V41, P1486, DOI 10.1345/aph.1K080; Borges APD, 2011, ARQ BRAS ENDOCRINOL, V55, P686, DOI 10.1590/S0004-27302011000900003; De Souza WA, 2007, AM J HEALTH-SYST PH, V64, P1955, DOI 10.2146/ajhp060547; ELMANGOUSH M, 1990, POSTGRAD MED J, V66, P446, DOI 10.1136/pgmj.66.776.446; Fleury S, 2011, LANCET, V377, P1724, DOI 10.1016/S0140-6736(11)60318-8; Gale CR, 2014, AGE, V36, DOI 10.1007/s11357-014-9692-6; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Ivama AM, 2002, CONSENSO BRASILEIRO; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Pereira LRL, 2008, REV BRAS CIENC FARM, V44, P601, DOI 10.1590/S1516-93322008000400006; Lynch RL, 2009, FINANCIAL TIMES; Lyra Júnior Divaldo Pereira de, 2008, Rev. Bras. Cienc. Farm., V44, P451, DOI 10.1590/S1516-93322008000300015; Machado M, 2007, ANN PHARMACOTHER, V41, P1770, DOI 10.1345/aph.1K311; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Murabito J M, 1995, J Am Med Womens Assoc (1972), V50, P35; Obreli-Neto PR, 2011, INT J CLIN PHARM-NET, V33, P642, DOI 10.1007/s11096-011-9518-x; Paulos CP, 2005, ANN PHARMACOTHER, V39, P939, DOI 10.1345/aph.1E347; Penaforte TR, 2011, THESIS; Polgreen LA, 2015, HYPERTENSION, V66, P1145, DOI 10.1161/HYPERTENSIONAHA.115.06023; Pontes-Neto OM, 2008, STROKE, V39, P292, DOI 10.1161/STROKEAHA.107.493908; Roush G, 2014, J AM SOC HYPERTENS, V8, pe59, DOI DOI 10.1016/J.JASH.2014.03.132; Santschi V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000718; Silva-Castro M M, 2010, Farm Hosp, V34, P106, DOI 10.1016/j.farma.2009.09.007; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Tikkanen MJ, 1998, DIABETES CARE, V21, P477, DOI 10.2337/diacare.21.4.477; Von Muenster SJ, 2008, PHARM WORLD SCI, V30, P128, DOI 10.1007/s11096-007-9155-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2017, CARD DIS CVDS; Zanchetti A, 2001, AM J HYPERTENS, V14, P129, DOI 10.1016/S0895-7061(00)01240-1; Zubioli A, 2013, BRAZ J PHARM SCI, V49, P85, DOI 10.1590/S1984-82502013000100010	45	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155204	10.1371/journal.pone.0155204	http://dx.doi.org/10.1371/journal.pone.0155204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304922	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800005
J	Whittemore, K; Johnston, SA; Sykes, K; Shen, LH				Whittemore, Kurt; Johnston, Stephen Albert; Sykes, Kathryn; Shen, Luhui			A General Method to Discover Epitopes from Sera	PLOS ONE			English	Article							PHAGE-DISPLAY LIBRARIES; ANTIBODY EPITOPES; IDENTIFICATION; MIMOTOPES; IDENTIFY; ANTIGEN; LIGANDS	Antigen-antibody complexes are central players in an effective immune response. However, finding those interactions relevant to a particular disease state can be arduous. Nonetheless many paths to discovery have been explored since deciphering these interactions can greatly facilitate the development of new diagnostics, therapeutics, and vaccines. In silico B cell epitope mapping approaches have been widely pursued, though success has not been consistent. Antibody mixtures in immune sera have been used as handles for biologically relevant antigens, but these and other experimental approaches have proven resource intensive and time consuming. In addition, these methods are often tailored to individual diseases or a specific proteome, rather than providing a universal platform. Most of these methods are not able to identify the specific antibody's epitopes from unknown antigens, such as un-annotated neo antigens in cancer. Alternatively, a peptide library comprised of sequences unrestricted by naturally-found protein space provides for a universal search for mimotopes of an antibody's epitope. Here we present the utility of such a non-natural random sequence library of 10,000 peptides physically addressed on a microarray for mimotope discovery without sequence information of the specific antigen. The peptide arrays were probed with serum from an antigen-immunized rabbit, or alternatively probed with serum pre-absorbed with the same immunizing antigen. With this positive and negative screening scheme, we identified the library-peptides as the mimotopes of the antigen. The unique library peptides were successfully used to isolate antigen-specific antibodies from complete immune serum. Sequence analysis of these peptides revealed the epitopes in the immunized antigen. We present this method as an inexpensive, efficient method for identifying mimotopes of any antibody's targets. These mimotopes should be useful in defining both components of the antigen-antibody complex.	[Whittemore, Kurt; Johnston, Stephen Albert; Sykes, Kathryn; Shen, Luhui] Arizona State Univ, Biodesign Inst, Ctr Innovat Med, 1001 South McAllister Ave, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Shen, LH (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Innovat Med, 1001 South McAllister Ave, Tempe, AZ 85287 USA.	Luhui.Shen@asu.edu			Calviri, LLC	Calviri, LLC	This project was funded by unrestricted funds from Calviri, LLC to Center for Innovations in Medicine.	BILLINGS PB, 1983, P NATL ACAD SCI-BIOL, V80, P7104, DOI 10.1073/pnas.80.23.7104; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Coomber David W J, 2002, Methods Mol Biol, V178, P133; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Gao XL, 2004, MOL DIVERS, V8, P177, DOI 10.1023/B:MODI.0000036233.58271.25; Halperin RF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000786; Halperin RF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-1; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Hughes AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040201; Kukreja M, 2013, J PROTEOMICS BIOINFO; Lam Kit S., 1996, Methods (Orlando), V9, P482, DOI 10.1006/meth.1996.0056; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Legutki JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5785; Legutki JB, 2013, P NATL ACAD SCI USA, V110, P18614, DOI 10.1073/pnas.1309390110; Lim HS, 2009, BIOORG MED CHEM LETT, V19, P3866, DOI 10.1016/j.bmcl.2009.03.153; Reineke U, 2002, J IMMUNOL METHODS, V267, P37, DOI 10.1016/S0022-1759(02)00139-4; Restrepo L, 2013, J NEUROIMMUNOL, V254, P154, DOI 10.1016/j.jneuroim.2012.09.014; Richer J, 2015, MOL CELL PROTEOMICS, V14, P136, DOI 10.1074/mcp.M114.043513; Schimmele B, 2005, J MOL BIOL, V352, P229, DOI 10.1016/j.jmb.2005.06.073; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sykes KF, 2013, TRENDS BIOTECHNOL, V31, P45, DOI 10.1016/j.tibtech.2012.10.012; Usuda S, 1999, J VIROL METHODS, V80, P97, DOI 10.1016/S0166-0934(99)00039-7; Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668	24	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157462	10.1371/journal.pone.0157462	http://dx.doi.org/10.1371/journal.pone.0157462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300760	gold, Green Published, Green Submitted			2022-12-26	WOS:000377822200053
J	Yang, AW; Johnson, JD; Fronczak, CM; LaGrange, CA				Yang, Andy W.; Johnson, Justin D.; Fronczak, Carolyn M.; LaGrange, Chad A.			Lunar Phases and Emergency Department Visits for Renal Colic Due to Ureteral Calculus	PLOS ONE			English	Article								Background Urolithiasis affects an estimated 5% of the population and the lifetime risk of passing a stone in the urinary tract is estimated to be 8-10%. Urinary calculus formation is highly variable and while certain risk factors such as age, gender, seasonality, anatomic abnormality, and metabolic diseases have been identified, not much is known regarding the association of environmental factors such as lunar phases on renal colic. We conducted a retrospective study to test the hypothesis that full moon phase is an environmental factor associated for increased emergency department (ED) visits for renal colic due to ureteral calculus. Methods We analyzed 559 renal colic diagnoses by the ED at the University of Nebraska Medical Center in a 24-month period and compared them with corresponding lunar phases as well as supermoon events. The lunar phases were defined as full moon +/- two days, new moon +/- two days, and the days in-between as normal days according to the lunar calendar. Supermoon event dates were obtained from NASA. Results 90 cases (16.1%) were diagnosed during full moon phase, 89 cases (15.9%) were diagnosed during new moon phase, and 380 cases (68.0%) were diagnosed during normal days. The incidence of renal colic showed no statistically significant association with lunar phases or supermoon events. Conclusion In this retrospective longitudinal study with adequate power, neither full moon phase nor supermoon event exhibited an association with increased renal colic diagnoses due to ureteral calculus by the ED at the University of Nebraska Medical Center.	[Yang, Andy W.; Johnson, Justin D.; Fronczak, Carolyn M.; LaGrange, Chad A.] Univ Nebraska Med Ctr, Dept Surg, Div Urol Surg, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Yang, AW (corresponding author), Univ Nebraska Med Ctr, Dept Surg, Div Urol Surg, Omaha, NE USA.	ayang@unmc.edu			University of Nebraska Medical Center Department of Surgery's Summer Research Program	University of Nebraska Medical Center Department of Surgery's Summer Research Program	This study was supported in part by the University of Nebraska Medical Center Department of Surgery's Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arampatzis S, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/813460; Asplin JR, 1996, BRENNER RECTORS KIDN; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Barr W, 2000, J Psychosoc Nurs Ment Health Serv, V38, P28; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chauhan V, 2004, AM J EMERG MED, V22, P560, DOI 10.1016/j.ajem.2004.08.016; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Ghiandoni G, 1998, EUR J OBSTET GYN R B, V77, P47, DOI 10.1016/S0301-2115(97)00226-1; Hermida Perez Jose A., 2010, Archivos Espanoles de Urologia, V63, P173; Kazemi-Bajestani SMR, 2011, ASIAN J PSYCHIATR, V4, P45, DOI 10.1016/j.ajp.2010.12.002; LAW SP, 1986, ACTA OBSTET GYN SCAN, V65, P45, DOI 10.3109/00016348609158228; Molaee Govarchin Ghalae H, 2009, UROLOGY J, V8, P137; NASA, 2014, SOL SYST EXPL; Pamporaki C, 2014, EUR J ENDOCRINOL, V170, P349, DOI 10.1530/EJE-13-0673; Parmar MS, 2004, BMJ-BRIT MED J, V328, P1420, DOI 10.1136/bmj.328.7453.1420; Polychronopoulos P, 2006, NEUROLOGY, V66, P1442, DOI 10.1212/01.wnl.0000210482.75864.e8; Refinetti R, 2015, ANN MED, V47, P530, DOI 10.3109/07853890.2015.1085125; ROBERTSON WG, 1975, CLIN SCI MOL MED, V49, P597, DOI 10.1042/cs0490597; Torricelli FCM, 2014, UROLOGY, V84, P544, DOI 10.1016/j.urology.2014.02.074; Wake R, 2008, ENVIRON HEALTH INSIG, V1, P63	20	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157589	10.1371/journal.pone.0157589	http://dx.doi.org/10.1371/journal.pone.0157589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299307	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200064
J	Jain, V; Srivastava, I; Palchaudhuri, S; Goel, M; Sinha-Mahapatra, SK; Dhingra, NK				Jain, Varsha; Srivastava, Ipsit; Palchaudhuri, Shriya; Goel, Manvi; Sinha-Mahapatra, Sumit K.; Dhingra, Narender K.			Classical Photoreceptors Are Primarily Responsible for the Pupillary Light Reflex in Mouse	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; METHYL-N-NITROSOUREA; ROD-CONE INPUT; MORPHOLOGIC CHARACTERISTICS; SODIUM IODATE; RAT RETINA; MELANOPSIN; MICE; DEGENERATION; VISION	Pupillary light reflex (PLR) is an important clinical tool to assess the integrity of visual pathways. The available evidence suggests that melanopsin-expressing retinal ganglion cells (mRGCs) mediate PLR-driven by the classical photoreceptors (rods and cones) at low irradiances and by melanopsin activation at high irradiances. However, genetic or pharmacological elimination of melanopsin does not completely abolish PLR at high irradiances, raising the possibility that classical photoreceptors may have a role even at high irradiances. Using an inducible mouse model of photoreceptor degeneration, we asked whether classical photoreceptors are responsible for PLR at all irradiances, and found that the PLR was severely attenuated at all irradiances. Using multiple approaches, we show that the residual PLR at high irradiances in this mouse was primarily from the remnant rods and cones, with a minor contribution from melanopsin activation. In contrast, in rd1 mouse where classical photoreceptor degeneration occurs during development, the PLR was absent at low irradiances but intact at high irradiances, as reported previously. Since mRGCs receive inputs from classical photoreceptors, we also asked whether developmental loss of classical photoreceptors as in rd1 mouse leads to compensatory takeover of the high-irradiance PLR by mRGCs. Specifically, we looked at a distinct subpopulation of mRGCs that express Brn3b transcription factor, which has been shown to mediate PLR. We found that rd1 mouse had a significantly higher proportion of Brn3b-expressing M1 type of mRGCs than in the inducible model. Interestingly, inducing classical photoreceptor degeneration during development also resulted in a higher proportion of Brn3b-expressing M1 cells and partially rescued PLR at high irradiances. These results suggest that classical photoreceptors are primarily responsible for PLR at all irradiances, while melanopsin activation makes a minor contribution at very high irradiances.	[Jain, Varsha; Srivastava, Ipsit; Palchaudhuri, Shriya; Goel, Manvi; Sinha-Mahapatra, Sumit K.; Dhingra, Narender K.] Natl Brain Res Ctr, Gurgaon 122051, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dhingra, NK (corresponding author), Natl Brain Res Ctr, Gurgaon 122051, Haryana, India.	narender.dhingra@gmail.com	Goel, Manvi/T-3148-2019	Goel, Manvi/0000-0003-2049-5605; Palchaudhuri, Shriya/0000-0002-1537-0886; jain, varsha/0000-0002-1620-4177	National Brain Research Centre; Department of Biotechnology, Government of India [BT/PR6410/Med/14/801/2005]	National Brain Research Centre; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by National Brain Research Centre and a grant (BT/PR6410/Med/14/801/2005) from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Brain Research Centre and a grant (BT/PR6410/Med/14/801/2005) from the Department of Biotechnology, Government of India. The authors thank Noga Vardi and Michael Freed for their valuable comments on the manuscript; Kaushik Deka for his assistance in statistical analyses; and Ethiraj Ravindran and Sushma Dagar for their technical assistance.	Aleman TS, 2004, INVEST OPHTH VIS SCI, V45, P1259, DOI 10.1167/iovs.03-1230; Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Boudard DL, 2009, EUR J NEUROSCI, V30, P1527, DOI 10.1111/j.1460-9568.2009.06935.x; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Enzmann V, 2006, EXP EYE RES, V82, P441, DOI 10.1016/j.exer.2005.08.002; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gerlai R, 2001, BEHAV BRAIN RES, V125, P13, DOI 10.1016/S0166-4328(01)00282-0; Goel M, 2012, NEUROSCIENCE, V225, P152, DOI 10.1016/j.neuroscience.2012.08.066; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HERROLD KM, 1967, ARCH OPHTHALMOL-CHIC, V78, P650, DOI 10.1001/archopht.1967.00980030652017; Homma K, 2009, J NEUROSCI RES, V87, P2175, DOI 10.1002/jnr.22024; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jones KA, 2013, NAT CHEM BIOL, V9, P630, DOI [10.1038/NCHEMBIO.1333, 10.1038/nchembio.1333]; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; Kiuchi K, 2003, CURR EYE RES, V26, P355, DOI 10.1076/ceyr.26.5.355.15435; Kiuchi K, 2002, CURR EYE RES, V25, P373, DOI 10.1076/ceyr.25.6.373.14227; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Machalinska A, 2010, NEUROCHEM RES, V35, P1819, DOI 10.1007/s11064-010-0248-6; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Nambu H, 1997, PATHOL INT, V47, P377, DOI 10.1111/j.1440-1827.1997.tb04511.x; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Picciotto MR, 1998, PHYSIOL REV, V78, P1131, DOI 10.1152/physrev.1998.78.4.1131; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Ruggiero L, 2009, EUR J NEUROSCI, V29, P359, DOI 10.1111/j.1460-9568.2008.06589.x; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Semo M, 2016, INVEST OPHTH VIS SCI, V57, P115, DOI 10.1167/iovs.15-17609; SMITH SB, 1986, EXP EYE RES, V43, P791, DOI 10.1016/S0014-4835(86)80010-0; Szikra T, 2014, NAT NEUROSCI, V17, P1728, DOI 10.1038/nn.3852; Thompson S, 2008, INVEST OPHTH VIS SCI, V49, P2737, DOI 10.1167/iovs.07-1546; Thompson S, 2011, INVEST OPHTH VIS SCI, V52, P618, DOI 10.1167/iovs.10-6146; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Vugler A, 2015, NEUROSCIENCE, V286, P60, DOI 10.1016/j.neuroscience.2014.11.044; Wan J, 2006, NEUROSCI LETT, V400, P48, DOI 10.1016/j.neulet.2006.02.084; Weng SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066480; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Zhao XW, 2014, J PHYSIOL-LONDON, V592, P1619, DOI 10.1113/jphysiol.2013.262782	60	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157226	10.1371/journal.pone.0157226	http://dx.doi.org/10.1371/journal.pone.0157226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295136	gold, Green Published, Green Submitted			2022-12-26	WOS:000377821300028
J	Lopez-Villamizar, I; Cabezas, A; Pinto, RM; Canales, J; Ribeiro, JM; Cameselle, JC; Costas, MJ				Lopez-Villamizar, Iralis; Cabezas, Alicia; Maria Pinto, Rosa; Canales, Jose; Meireles Ribeiro, Joao; Carlos Cameselle, Jose; Jesus Costas, Maria			The Characterization of Escherichia coli CpdB as a Recombinant Protein Reveals that, besides Having the Expected 3 '-Nucleotidase and 2 ',3 '-Cyclic Mononucleotide Phosphodiesterase Activities, It Is Also Active as Cyclic Dinucleotide Phosphodiesterase	PLOS ONE			English	Article							C-DI-AMP; GMP-SPECIFIC PHOSPHODIESTERASE; DIPHOSPHATE-SUGAR HYDROLASE; ENTERICA SEROVAR PULLORUM; AFFECT BACTERIAL-GROWTH; MYCOBACTERIUM-TUBERCULOSIS; 3-NUCLEOTIDASE ACTIVITY; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; BACILLUS-SUBTILIS	Endogenous cyclic diadenylate phosphodiesterase activity was accidentally detected in lysates of Escherichia coli BL21. Since this kind of activity is uncommon in Gram-negative bacteria, its identification was undertaken. After partial purification and analysis by denaturing gel electrophoresis, renatured activity correlated with a protein identified by fingerprinting as CpdB (cpdB gene product), which is annotated as 3'-nucleotidase / 2',3'-cyclic-mononucleotide phosphodiesterase, and it is synthesized as a precursor protein with a signal sequence removable upon export to the periplasm. It has never been studied as a recombinant protein. The coding sequence of mature CpdB was cloned and expressed as a GST fusion protein. The study of the purified recombinant protein, separated from GST, confirmed CpdB annotation. The assay of catalytic efficiencies (kcat/Km) for a large substrate set revealed novel CpdB features, including very high efficiencies for 3'-AMP and 2',3'-cyclic mononucleotides, and previously unknown activities on cyclic and linear dinucleotides. The catalytic efficiencies of the latter activities, though low in relative terms when compared to the major ones, are far from negligible. Actually, they are perfectly comparable to those of the 'average' enzyme and the known, bona fide cyclic dinucleotide phosphodiesterases. On the other hand, CpdB differs from these enzymes in its extracytoplasmic location and in the absence of EAL, HD and DHH domains. Instead, it contains the domains of the 5'-nucleotidase family pertaining to the metallophosphoesterase superfamily, although CpdB lacks 5'-nucleotidase activity. The possibility that the extracytoplasmic activity of CpdB on cyclic dinucleotides could have physiological meaning is discussed.	[Lopez-Villamizar, Iralis; Cabezas, Alicia; Maria Pinto, Rosa; Canales, Jose; Meireles Ribeiro, Joao; Carlos Cameselle, Jose; Jesus Costas, Maria] Univ Extremadura, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Fac Med, Badajoz, Spain	Universidad de Extremadura	Costas, MJ (corresponding author), Univ Extremadura, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Fac Med, Badajoz, Spain.	macostas@unex.es	Costas, Maria Jesus/K-7394-2014; Ribeiro, João Meireles/K-6555-2014; Cameselle, Jose Carlos/K-6421-2014; Canales, Jose/K-8793-2014; Pinto, Rosa M/K-6560-2014; Cabezas, Alicia/K-6564-2014	Costas, Maria Jesus/0000-0001-8815-1839; Ribeiro, João Meireles/0000-0002-6548-1402; Cameselle, Jose Carlos/0000-0003-0005-081X; Canales, Jose/0000-0002-7897-9832; Pinto, Rosa M/0000-0003-4594-8113; Cabezas, Alicia/0000-0002-2908-9147	Gobierno de Extremadura or Junta de Extremadura - Fondo Europeo de Desarrollo Regional [GR10133, GR15143];  [2015/00481/001]	Gobierno de Extremadura or Junta de Extremadura - Fondo Europeo de Desarrollo Regional; 	Research in the authors' laboratory is supported by grants from the Gobierno de Extremadura or Junta de Extremadura cofinanced by Fondo Europeo de Desarrollo Regional (GR10133 and GR15143), and by a private donation from MJC (contract 2015/00481/001). The institutional funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, while the private donor is one of the authors.	Alves-Pereira I, 2008, J BACTERIOL, V190, P6153, DOI 10.1128/JB.00658-08; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; ANDERSON BM, 1985, J GEN MICROBIOL, V131, P2041; ANRAKU Y, 1964, J BIOL CHEM, V239, P3412; ANRAKU Y, 1964, J BIOL CHEM, V239, P3420; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bar-Even A, 2015, BIOCHEMISTRY-US, V54, P4969, DOI 10.1021/acs.biochem.5b00621; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; BEACHAM IR, 1980, J GEN MICROBIOL, V119, P31; BEACHAM IR, 1973, J BACTERIOL, V116, P957, DOI 10.1128/JB.116.2.957-964.1973; Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; CENTER MS, 1968, J BIOL CHEM, V243, P138; Chambert R, 2003, J BIOCHEM, V134, P655, DOI 10.1093/jb/mvg189; Chao L, 2013, J BACTERIOL, V195, P3827, DOI 10.1128/JB.00498-13; Cho KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069425; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; Fehrst A, 1998, A GUIDE TO ENZYME CA; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; Gandara C, 2015, DNA REPAIR, V27, P1, DOI 10.1016/j.dnarep.2014.12.007; GLASER L, 1967, J BIOL CHEM, V242, P1944; Gomelsky M, 2010, THE SECOND MESSENGER, P37; Hames BD., 1990, GEL ELECTROPHORESIS, P1; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Kakehi M, 2007, J MOL MICROB BIOTECH, V13, P96, DOI 10.1159/000103601; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Liu HF, 2015, MICROB PATHOGENESIS, V80, P21, DOI 10.1016/j.micpath.2015.01.002; LIU J, 1986, J BACTERIOL, V165, P1002, DOI 10.1128/jb.165.3.1002-1010.1986; Lovering AL, 2011, MBIO, V2, DOI 10.1128/mBio.00163-11; Luo YP, 2012, J FISH BIOL, V80, P842, DOI 10.1111/j.1095-8649.2012.03229.x; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; McDonough E, 2016, MOL MICROBIOL, V99, P453, DOI 10.1111/mmi.13128; Miner KD, 2013, BIOCHEMISTRY-US, V52, P5329, DOI 10.1021/bi4009215; NEU HC, 1968, BIOCHEMISTRY-US, V7, P3774, DOI 10.1021/bi00850a060; NEU HC, 1968, J BACTERIOL, V95, P1732, DOI 10.1128/JB.95.5.1732-1737.1968; NEU HC, 1967, J BIOL CHEM, V242, P3896; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Peng X, 2016, MOL MICROBIOL, V99, P945, DOI 10.1111/mmi.13277; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; RODDEN JL, 1972, ARCH BIOCHEM BIOPHYS, V153, P837, DOI 10.1016/0003-9861(72)90406-7; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1990, J BIOL CHEM, V265, P18933; RUIZ A, 1989, J BACTERIOL, V171, P6703, DOI 10.1128/jb.171.12.6703-6709.1989; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Savage CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125440; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; SHIMADA K, 1969, BIOCHIM BIOPHYS ACTA, V185, P367, DOI 10.1016/0005-2744(69)90430-6; Stelitano V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074920; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sundriyal A, 2014, J BIOL CHEM, V289, P6978, DOI 10.1074/jbc.M113.516195; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tang Q, 2015, INT J BIOL SCI, V11, P813, DOI 10.7150/ijbs.11797; Trulzsch K, 2001, MICROBIOL-UK, V147, P203; Tschowri N, 2016, J BACTERIOL, V198, P47, DOI 10.1128/JB.00423-15; Huynh TN, 2016, CURR OPIN MICROBIOL, V30, P22, DOI 10.1016/j.mib.2015.12.007; UNEMOTO T, 1969, BIOCHIM BIOPHYS ACTA, V171, P89, DOI 10.1016/0005-2744(69)90108-9; Wigley P, 2001, INFECT IMMUN, V69, P7873, DOI 10.1128/IAI.69.12.7873-7879.2001; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; YAGIL E, 1975, J BACTERIOL, V121, P401, DOI 10.1128/JB.121.2.401-405.1975; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14	86	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157308	10.1371/journal.pone.0157308	http://dx.doi.org/10.1371/journal.pone.0157308			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294396	gold, Green Submitted, Green Published			2022-12-26	WOS:000377821300033
J	Griffiths, ET; Keen, SC; Lanzone, M; Farnsworth, A				Griffiths, Emily T.; Keen, Sara C.; Lanzone, Michael; Farnsworth, Andrew			Can Nocturnal Flight Calls of the Migrating Songbird, American Redstart, Encode Sexual Dimorphism and Individual Identity?	PLOS ONE			English	Article							WOOD-WARBLERS; BIRD SONG; RECOGNITION; AGE; EVOLUTION; VOCALIZATIONS; NEIGHBORS; BEHAVIOR; SYSTEMS; WHALES	Bird species often use flight calls to engage in social behavior, for instance maintain group cohesion and to signal individual identity, kin or social associations, or breeding status of the caller. Additional uses also exist, in particular among migrating songbirds for communication during nocturnal migration. However, our understanding of the information that these vocalizations convey is incomplete, especially in nocturnal scenarios. To examine whether information about signaler traits could be encoded in flight calls we quantified several acoustic characteristics from calls of a nocturnally migrating songbird, the American Redstart. We recorded calls from temporarily captured wild specimens during mist-netting at the Powdermill Avian Research Center in Rector, PA. We measured call similarity among and within individuals, genders, and age groups. Calls from the same individual were significantly more similar to one another than to the calls of other individuals, and calls were significantly more similar among individuals of the same sex than between sexes. Flight calls from hatching-year and after hatching-year individuals were not significantly different. Our results suggest that American Redstart flight calls may carry identifiers of gender and individual identity. To our knowledge, this is the first evidence of individuality or sexual dimorphism in the flight calls of a migratory songbird. Furthermore, our results suggest that flight calls may have more explicit functions beyond simple group contact and cohesion. Nocturnal migration may require coordination among numerous individuals, and the use of flight calls to transmit information among intra-and conspecifics could be advantageous. Applying approaches that account for such individual and gender information may enable more advanced research using acoustic monitoring.	[Griffiths, Emily T.; Keen, Sara C.] Cornell Univ, Bioacoust Res Program, Cornell Lab Ornithol, Ithaca, NY USA; [Lanzone, Michael] Carnegie Museum Nat Hist, Powdermill Avian Res Ctr, Pittsburgh, PA USA; [Farnsworth, Andrew] Cornell Univ, Informat Sci, Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	Griffiths, ET (corresponding author), Cornell Univ, Bioacoust Res Program, Cornell Lab Ornithol, Ithaca, NY USA.	emilytgriffiths@gmail.com		Keen, Sara/0000-0002-2988-8280; Farnsworth, Andrew/0000-0002-9854-4449	National Science Foundation [IIS-1125098]; Department of Defense Legacy Resource Management Program [05-245, 06-245, 07-245, 10-245]; Leon Levy Foundation; Cornell Laboratory of Ornithology; Kenneth L. Harder Trust	National Science Foundation(National Science Foundation (NSF)); Department of Defense Legacy Resource Management Program; Leon Levy Foundation; Cornell Laboratory of Ornithology; Kenneth L. Harder Trust	This project was funded by multiple sources, including the National Science Foundation (IIS-1125098), Department of Defense Legacy Resource Management Program (05-245, 06-245, 07-245, and 10-245), and the Leon Levy Foundation. Private donations, such as the Kenneth L. Harder Trust, the Scott and Karen Harder Family, and several anonymous private donations to the Cornell Laboratory of Ornithology provided additional funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. That being said, though they had no active role, the Harder family's interest and enthusiasm in flight calls helped push this project forward. No additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript was undertaken.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], WHOI9413, DOI DOI 10.1016/j.marpolbul.2017.09.027; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown Eleanor D., 1997, P98, DOI 10.1017/CBO9780511758843.007; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Charif R. A., 2008, RAVEN PRO 1 3 USERS; CHENEY DL, 1982, AM ZOOL, V22, P519; Cortopassi K, 2006, AUTOMATED ROBUST MEA; Cortopassi KA, 2005, 2 INT WORKSH DET LOC; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; EMLEN S T, 1971, Zeitschrift fuer Tierpsychologie, V28, P241; Evans W. R, 2002, FLIGHT CALLS MIGRATO; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Farnsworth A, 2005, AUK, V122, P733, DOI 10.1642/0004-8038(2005)122[0733:FCATVF]2.0.CO;2; Farnsworth A., 2007, THESIS CORNELL U; Farnsworth A, 2008, BIOL J LINN SOC, V94, P155, DOI 10.1111/j.1095-8312.2008.00973.x; Farnsworth A, 2007, WILSON J ORNITHOL, V119, P334, DOI 10.1676/06-070.1; Farnsworth A, 2007, J FIELD ORNITHOL, V78, P279, DOI 10.1111/j.1557-9263.2007.00115.x; Farnsworth A, 2005, J AVIAN BIOL, V36, P337, DOI 10.1111/j.0908-8857.2005.03315.x; FICKEN MS, 1967, WILSON BULL, V79, P188; Fristrup K.M., 1992, WHOI9204; Germain RR, 2012, BEHAV ECOL SOCIOBIOL, V66, P419, DOI 10.1007/s00265-011-1288-x; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; GRIFFIN DR, 1969, Q REV BIOL, V44, P255, DOI 10.1086/406142; HAMILTON WILLIAM J. III, 1962, CONDOR, V64, P390; Herzing DL, 2000, SPR HDB AUD, V12, P225; Hopp SL, 2001, ANIM BEHAV, V62, P297, DOI 10.1006/anbe.2001.1745; Horton KG, 2015, ECOL APPL, V25, P390, DOI 10.1890/14-0279.1; HOWARD RD, 1974, EVOLUTION, V28, P428, DOI 10.1111/j.1558-5646.1974.tb00764.x; James PC, 1985, CALL BULWERS PETREL, P878; Keen S, 2014, ECOL INFORM, V21, P25, DOI 10.1016/j.ecoinf.2014.01.001; Kirschel ANG, 2011, IBIS, V153, P255, DOI 10.1111/j.1474-919X.2011.01102.x; Lanzone M, 2009, AUK, V126, P511, DOI 10.1525/auk.2009.08187; Lebbin DJ, 2007, WILSON J ORNITHOL, V119, P506, DOI 10.1676/06-139.1; LEMON RE, 1994, ANIM BEHAV, V47, P317, DOI 10.1006/anbe.1994.1045; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; MARLER P, 1955, NATURE, V176, P6, DOI 10.1038/176006a0; Marra PP, 1993, TERRITORIAL EXCLUSIO, P565; McDonald PG, 2007, J AVIAN BIOL, V38, P113, DOI 10.1111/j.2007.0908-8857.03753.x; McDonald PG, 2012, BIOL LETTERS, V8, P365, DOI 10.1098/rsbl.2011.1118; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; McKellar AE, 2014, OIKOS, V123, P356, DOI 10.1111/j.1600-0706.2013.00756.x; Mennill DJ, 2011, IBIS, V153, P235, DOI 10.1111/j.1474-919X.2011.01119.x; Mills H., 1995, J ACOUST SOC AM, V97, P3370; Molles LE, 2001, ANIM BEHAV, V61, P119, DOI 10.1006/anbe.2000.1561; Morse D. H., 2013, AM WARBLERS; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; NOWICKI S, 1983, BEHAV ECOL SOCIOBIOL, V12, P317, DOI 10.1007/BF00302899; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parrish JD, 1994, SEXUAL HABITAT SEGRE, P38; Payne RB, 1998, ANIM BEHAV, V55, P1537, DOI 10.1006/anbe.1997.0701; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Price JJ, 1998, P ROY SOC B-BIOL SCI, V265, P497, DOI 10.1098/rspb.1998.0322; R Core Team, 2021, R LANGUAGE ENV STAT; Rendell LE, 2003, P ROY SOC B-BIOL SCI, V270, P225, DOI 10.1098/rspb.2002.2239; Reudink MW, 2014, OECOLOGIA, P1; Saether B.-E., 1990, Current Ornithology, V7, P251; Sanders CE, 2014, CONDOR, V116, P371, DOI 10.1650/CONDOR-13-098.1; SHACKELL NL, 1988, AUK, V105, P609, DOI 10.1093/auk/105.4.609; SHERRY TW, 1989, BEHAV ECOL SOCIOBIOL, V25, P327, DOI 10.1007/BF00302990; Sherry TW, 1997, BIRDS N AM; Singer TL, 1998, AM ZOOL, V38, P394; Smith AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092218; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Sousa-Lima Renata S., 2008, Aquatic Mammals, V34, P109, DOI 10.1578/AM.34.1.2008.109; Staicer CA, 2006, WILSON J ORNITHOL, V118, P439, DOI 10.1676/05-056.1; Stephenson T., 2013, THE WARBLER GUIDE; Stewart RLM, 2002, WILSON BULL, V114, P264, DOI 10.1676/0043-5643(2002)114[0264:ARDTOS]2.0.CO;2; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; Taoka M, 1990, SEXUAL DIFFERENCES F, P571; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tonra CM, 2014, ECOL EVOL, V4, P1222, DOI 10.1002/ece3.994; U. S. Geological Survey (USGS), 2015, USGS SCI CHANG WORLD	76	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156578	10.1371/journal.pone.0156578	http://dx.doi.org/10.1371/journal.pone.0156578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284697	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000016
J	Ries, AJ; Touryan, J; Ahrens, B; Connolly, P				Ries, Anthony J.; Touryan, Jon; Ahrens, Barry; Connolly, Patrick			The Impact of Task Demands on Fixation-Related Brain Potentials during Guided Search	PLOS ONE			English	Article							EEG; ONSET; COMPONENT; ERPS; LOAD	Recording synchronous data from EEG and eye-tracking provides a unique methodological approach for measuring the sensory and cognitive processes of overt visual search. Using this approach we obtained fixation related potentials (FRPs) during a guided visual search task specifically focusing on the lambda and P3 components. An outstanding question is whether the lambda and P3 FRP components are influenced by concurrent task demands. We addressed this question by obtaining simultaneous eye-movement and electroencephalographic (EEG) measures during a guided visual search task while parametrically modulating working memory load using an auditory N-back task. Participants performed the guided search task alone, while ignoring binaurally presented digits, or while using the auditory information in a 0, 1, or 2-back task. The results showed increased reaction time and decreased accuracy in both the visual search and N-back tasks as a function of auditory load. Moreover, high auditory task demands increased the P3 but not the lambda latency while the amplitude of both lambda and P3 was reduced during high auditory task demands. The results show that both early and late stages of visual processing indexed by FRPs are significantly affected by concurrent task demands imposed by auditory working memory.	[Ries, Anthony J.; Touryan, Jon] US Army Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA; [Ahrens, Barry] Nova SE Univ, Coll Engn & Comp, Ft Lauderdale, FL 33314 USA; [Connolly, Patrick] Teledyne Sci Co, Durham, NC USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); Nova Southeastern University	Ries, AJ (corresponding author), US Army Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA.	anthony.j.ries2.civ@mail.mil	Touryan, Jonathan/AAA-7108-2019	Touryan, Jonathan/0000-0001-7343-7869	U.S. Army Prime [W911NF-09-D-0001]	U.S. Army Prime	U.S. Army Prime Contract No. W911NF-09-D-0001. The funder provided support in the form of salaries for authors [BA and PC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Steve Simons and David Kowachek for their valuable feedback on the manuscript. This research was supported by U.S. Army Prime Contract No. W911NF-09-D-0001.	ARMINGTON JC, 1974, J OPT SOC AM, V64, P1263, DOI 10.1364/JOSA.64.001263; BARLOW JS, 1969, ELECTROEN CLIN NEURO, V26, P183, DOI 10.1016/0013-4694(69)90209-0; BILLINGS RJ, 1989, ELECTROEN CLIN NEURO, V72, P95, DOI 10.1016/0013-4694(89)90170-3; Brouwer AM, 2013, J VISION, V13, DOI 10.1167/13.3.17; Dandekar S, 2012, J NEUROPHYSIOL, V107, P1776, DOI 10.1152/jn.00237.2011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Devillez H, 2015, J VISION, V15, DOI 10.1167/15.13.20; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Dimigen O, 2011, J EXP PSYCHOL GEN, V140, P552, DOI 10.1037/a0023885; Dimigen O, 2009, J NEUROSCI, V29, P12321, DOI 10.1523/JNEUROSCI.0911-09.2009; Drews FA, 2008, J EXP PSYCHOL-APPL, V14, P392, DOI 10.1037/a0013119; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; GAARDER K, 1964, SCIENCE, V146, P1481, DOI 10.1126/science.146.3650.1481; Gherri E, 2011, J COGNITIVE NEUROSCI, V23, P832, DOI 10.1162/jocn.2010.21468; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Kahneman D., 1973, ATTENTION EFFORT; Kasper RW, 2014, J COGNITIVE NEUROSCI, V26, P476, DOI 10.1162/jocn_a_00480; Kaunitz LN, 2014, NEUROIMAGE, V89, P297, DOI 10.1016/j.neuroimage.2013.12.006; Kazai K, 2005, INT CONGR SER, V1278, P61, DOI 10.1016/j.ics.2004.11.053; Kazai K, 1999, INT J PSYCHOPHYSIOL, V32, P193, DOI 10.1016/S0167-8760(99)00010-0; Kazai K, 2003, COGN AFFECT BEHAV NE, V3, P46, DOI 10.3758/CABN.3.1.46; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P1013, DOI 10.1111/j.1469-8986.2008.00700.x; Klemen J, 2010, J COGNITIVE NEUROSCI, V22, P437, DOI 10.1162/jocn.2009.21204; Li FL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15129; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Marathe AR, 2014, IEEE T NEUR SYS REH, V22, P201, DOI 10.1109/TNSRE.2014.2304884; MARTON M, 1982, STUD PSYCHOL, V24, P165; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Morimoto CH, 2005, COMPUT VIS IMAGE UND, V98, P4, DOI 10.1016/j.cviu.2004.07.010; Nikolaev AR, 2011, NEUROIMAGE, V56, P1598, DOI 10.1016/j.neuroimage.2011.03.021; Plochl M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00278; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Rajkai C, 2008, CEREB CORTEX, V18, P200, DOI 10.1093/cercor/bhm046; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Simola J, 2015, NEUROIMAGE, V106, P21, DOI 10.1016/j.neuroimage.2014.11.030; Sorqvist P, 2012, J COGNITIVE NEUROSCI, V24, P2147; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Takeda Y., 2012, KANSEI ENG INT J, V11, P121, DOI DOI 10.5057/KEI.11.121; THICKBROOM GW, 1991, BRAIN RES, V551, P150, DOI 10.1016/0006-8993(91)90927-N; Tian Y, 2013, PSYCHOPHYSIOLOGY, V50, P1282, DOI 10.1111/psyp.12130; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; YAGI A, 1981, ELECTROEN CLIN NEURO, V52, P604, DOI 10.1016/0013-4694(81)91434-6; YAGI A, 1979, PHYSIOL PSYCHOL, V7, P370; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	55	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157260	10.1371/journal.pone.0157260	http://dx.doi.org/10.1371/journal.pone.0157260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286248	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000051
J	Bergstrom, SH; Nilsson, M; Adamo, H; Thysell, E; Jernberg, E; Stattin, P; Widmark, A; Wikstrom, P; Bergh, A				Bergstrom, Sofia Halin; Nilsson, Maria; Adamo, Hanibal; Thysell, Elin; Jernberg, Emma; Stattin, Par; Widmark, Anders; Wikstrom, Pernilla; Bergh, Anders			Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth	PLOS ONE			English	Article							CANCER CELLS; INFLAMMATION; HOMEOSTASIS; ENVIRONMENT; PROGRESSION; MECHANISMS; CASTRATION; THERAPY; DENSITY; DISEASE	Aggressive tumors induce tumor-supporting changes in the benign parts of the prostate. One factor that has increased expression outside prostate tumors is hemoxygenase-1 (HO-1). To investigate HO-1 expression in more detail, we analyzed samples of tumor tissue and peritumoral normal prostate tissue from rats carrying cancers with different metastatic capacity, and human prostate cancer tissue samples from primary tumors and bone metastases. In rat prostate tumor samples, immunohistochemistry and quantitative RTPCR showed that the main site of HO-1 synthesis was HO-1(+) macrophages that accumulated in the tumor-bearing organ, and at the tumor-invasive front. Small metastatic tumors were considerably more effective in attracting HO-1(+) macrophages than larger non-metastatic ones. In clinical samples, accumulation of HO-1(+) macrophages was seen at the tumor invasive front, almost exclusively in high-grade tumors, and it correlated with the presence of bone metastases. HO-1(+) macrophages, located at the tumor invasive front, were more abundant in bone metastases than in primary tumors. HO-1 expression in bone metastases was variable, and positively correlated with the expression of macrophage markers but negatively correlated with androgen receptor expression, suggesting that elevated HO-1 could be a marker for a subgroup of bone metastases. Together with another recent observation showing that selective knockout of HO-1 in macrophages reduced prostate tumor growth and metastatic capacity in animals, the results of this study suggest that extratumoral HO-1(+) macrophages may have an important role in prostate cancer.	[Bergstrom, Sofia Halin; Nilsson, Maria; Adamo, Hanibal; Thysell, Elin; Jernberg, Emma; Wikstrom, Pernilla; Bergh, Anders] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, Urol, Umea, Sweden; [Widmark, Anders] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden	Umea University; Umea University; Umea University	Bergstrom, SH (corresponding author), Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden.	sofia.halin@umu.se		Halin Bergstrom, Sofia/0000-0003-3475-3230	Swedish Research Council [Co257301]; Swedish Cancer Foundation [130293]; Lion's Cancer Research Foundation; Queen Victorias Freemason Foundation; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Lion's Cancer Research Foundation; Queen Victorias Freemason Foundation; Umea University	This work was supported by grants from the Swedish Research Council (http://www.vr.se/) (AB), grant number Co257301; the Swedish Cancer Foundation, (https://www.cancerfonden.se/) (AB), grant number 130293; the Lion's Cancer Research Foundation, Umea University (http://www.cancerforskningsfonden.se/) (SHB); and the Queen Victorias Freemason Foundation (https://www.frimurarorden.se/organisation/barmhartighetsverksamhet/frimurarstiftelsen/) (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141601; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Blann AD, 2011, PROSTATE CANCER P D, V14, P114, DOI 10.1038/pcan.2010.56; Chau LY, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0128-0; Deng R, 2012, ONCOL RES, V20, P473, DOI 10.3727/096504013X13715991125684; Elguero B, 2012, NEOPLASIA, V14, P1043, DOI 10.1593/neo.121358; Ferrando M, 2011, ANGIOGENESIS, V14, P467, DOI 10.1007/s10456-011-9230-4; Gueron G, 2014, ONCOTARGET, V5, P4087, DOI 10.18632/oncotarget.1826; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2006, CLIN CANCER RES, V12, P7431, DOI 10.1158/1078-0432.CCR-06-1895; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Herroon MK, 2013, ONCOTARGET, V4, P2108, DOI 10.18632/oncotarget.1482; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hull TD, 2014, ANTIOXID REDOX SIGN, V20, P1770, DOI 10.1089/ars.2013.5673; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Jernberg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077407; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Li YR, 2011, J PATHOL, V224, P90, DOI 10.1002/path.2855; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Lundholm M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15651; Maines MD, 1996, UROLOGY, V47, P727, DOI 10.1016/S0090-4295(96)00010-6; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Nemeth Z, 2015, ONCOTARGET, V6, P33675, DOI 10.18632/oncotarget.5284; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P435, DOI 10.1097/MBC.0000000000000075; Nilsson M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19608; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140985; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sheehan D.C., 1980, THEORY PRACTICE HIST; Tesfay L, 2015, CANCER RES, V75, P2254, DOI 10.1158/0008-5472.CAN-14-2465; Tidehag V, 2014, EUR J CANCER, V50, P1829, DOI 10.1016/j.ejca.2014.03.278; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Vidal SJ, 2015, CANCER CELL, V27, P223, DOI 10.1016/j.ccell.2014.11.013; Wegiel B, 2013, CANCER RES, V73, P7009, DOI 10.1158/0008-5472.CAN-13-1075; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Wu ML, 2011, AM J CARDIOVASC DIS, V1, P150; Zhang CG, 2015, PROTEIN CELL, V6, P88, DOI 10.1007/s13238-014-0119-z	50	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157280	10.1371/journal.pone.0157280	http://dx.doi.org/10.1371/journal.pone.0157280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280718	Green Published, gold, Green Submitted			2022-12-26	WOS:000377563000117
J	Lin, SYC; Toyoda, H; Kumada, T; Liu, HF				Lin, Serena Y. C.; Toyoda, Hidenori; Kumada, Takashi; Liu, Hsin-Fu			Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CORE GENE; HEPATOCELLULAR-CARCINOMA; GEOGRAPHIC-DISTRIBUTION; POPULATION-DYNAMICS; SELECTION PRESSURE; HBV INFECTION; GENOTYPE-B; INFERENCE; STRAINS	Hepatitis B virus (HBV) is prevalent worldwide and causes liver diseases, including acute and chronic hepatitis. Ten HBV genotypes (A-J) with distinct geographic distributions have been reported. Cases of acute HBV infection with genotype A have increased in Japan nationwide since the 1990s, mainly through sexual transmission. To investigate the molecular evolution and phylodynamics of HBV genotypes, we collected acute HBV isolates acquired in Japan from 1992-2002. Full genomes were obtained for comprehensive phylogenetic and phylodynamic analysis, with other Japanese HBV sequences from GenBank that were isolated during 1991-2010. HBV genotypes were classified using the maximum-likelihood and Bayesian methods. The GMRF Bayesian Skyride was used to estimate the evolution and population dynamics of HBV. Four HBV genotypes (A, B, C, and H) were identified, of which C was the major genotype. The phylodynamic results indicated an exponential growth between the 1960s and early 1990s; this was followed by a population bottleneck after 1995, possibly linked with successful implementation of a nationwide vaccination program. However, HBV/A increased from 1990 to 2003-2004, and then started to decrease. The prevalence of genotype A has increased over the past 10 years. Phylodynamic inference clearly demonstrates a steady population growth compatible with an ongoing subepidemic; this might be due to the loss of immunity to HBV in adolescents and people being born before the vaccination program. This is the first phylodynamic study of HBV infection in Japan and will facilitate understanding the molecular epidemiology and long-term evolutionary dynamics of this virus in Japan.	[Lin, Serena Y. C.; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Lin, Serena Y. C.; Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Gifu, Japan; [Liu, Hsin-Fu] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan	National Taiwan Ocean University; Mackay Memorial Hospital; Ogaki Municipal Hospital; National Taipei University of Nursing & Health Science (NTUNHS)	Liu, HF (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.; Liu, HF (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.; Liu, HF (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan.	hsinfu@mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269	Ministry of Science and Technology, Taiwan [NSC 102-2314-B-195-013-MY2]; Mackay Memorial Hospital, Taiwan [MMH-103-19]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital, Taiwan	This study was supported in part by the Ministry of Science and Technology, Taiwan (grant NSC 102-2314-B-195-013-MY2) and the Mackay Memorial Hospital, Taiwan (grant MMH-103-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WGH, 2012, ANTIVIR RES, V96, P148, DOI 10.1016/j.antiviral.2012.08.007; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Chan HLY, 2011, J GASTROEN HEPATOL, V26, P8, DOI 10.1111/j.1440-1746.2010.06514.x; Chan HLY, 2009, CLIN GASTROENTEROL H, V7, P1361, DOI 10.1016/j.cgh.2009.08.004; Chan HLY, 2003, J CLIN MICROBIOL, V41, P1277, DOI 10.1128/JCM.41.3.1277-1279.2003; Chang MH, 2010, ANTIVIR THER, V15, P463, DOI 10.3851/IMP1555; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; Chen SJ, 2012, VIRUS RES, V163, P197, DOI 10.1016/j.virusres.2011.09.029; Cho Ji-Hyun, 2009, Korean J Hepatol, V15, P140, DOI 10.3350/kjhep.2009.15.2.140; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-226; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; GUNTHER S, 1995, J VIROL, V69, P5437; Hayashi K, 2007, J MED VIROL, V79, P366, DOI 10.1002/jmv.20824; Kao JH, 2002, J CLIN MICROBIOL, V40, P1207, DOI 10.1128/JCM.40.4.1207-1209.2002; Kao JH, 2002, J CLIN MICROBIOL, V40, P22, DOI 10.1128/JCM.40.1.22-25.2002; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Kiyohara T, 2015, VACCINE, V33, P6037, DOI 10.1016/j.vaccine.2015.08.034; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Lee CM, 2003, SCAND J GASTROENTERO, V38, P95, DOI 10.1080/00365520310000500; Li YR, 2008, J MED VIROL, V80, P1885, DOI 10.1002/jmv.21301; Liu HF, 2001, J PEDIATR GASTR NUTR, V32, P274, DOI 10.1097/00005176-200103000-00008; Liu Y, 2010, J CLIN VIROL, V47, P243, DOI 10.1016/j.jcv.2009.12.013; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; McMahon BJ, 2009, J INFECT DIS, V200, P1390, DOI 10.1086/606119; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Salemi M, 1999, P NATL ACAD SCI USA, V96, P13253, DOI 10.1073/pnas.96.23.13253; Schaefer S, 2005, J VIRAL HEPATITIS, V12, P111, DOI 10.1111/j.1365-2893.2005.00584.x; Szu-Ming C, 2011, J CLIN VIROL, V52, P11, DOI 10.1016/j.jcv.2011.06.012; Takeda Y, 2006, INFECTION, V34, P201, DOI 10.1007/s15010-006-5099-3; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; van de Klundert MAA, 2012, J VIRAL HEPATITIS, V19, pE34, DOI 10.1111/j.1365-2893.2011.01506.x; Warner BG, 2011, J GEN VIROL, V92, P1800, DOI 10.1099/vir.0.030478-0; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Wu TW, 2013, HEPATOLOGY, V57, P38, DOI 10.1002/hep.25988; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	48	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157103	10.1371/journal.pone.0157103	http://dx.doi.org/10.1371/journal.pone.0157103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280441	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000085
J	Merten, S; Ntalasha, H; Musheke, M				Merten, Sonja; Ntalasha, Harriet; Musheke, Maurice			Non-Uptake of HIV Testing in Children at Risk in Two Urban and Rural Settings in Zambia: A Mixed-Methods Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION PROGRAM; INFECTED CHILDREN; PREGNANT-WOMEN; PMTCT PROGRAMS; AIDS STIGMA; FOLLOW-UP; BARRIERS; PREVENTION; HEALTH	This article investigates reasons why children who were considered at risk of HIV were not taken for HIV testing by their caregivers. Qualitative and quantitative data collected in Zambia from 2010-11 revealed that twelve percent of caregivers who stated that they had been suspecting an HIV infection in a child in their custody had not had the child tested. Fears of negative reactions from the family were the most often stated reason for not testing a child. Experience of pre-existing conflicts between the couple or within the family (aOR 1.35, 95% CI 1.00-1.82) and observed stigmatisation of seropositive children in one's own neighbourhood (aOR 1.69, 95% CI 1.20-2.39) showed significant associations for not testing a child perceived at risk of HIV. Although services for HIV testing and treatment of children have been made available through national policies and programmes, some women and children were denied access leading to delayed diagnosis and treatment-not on the side of the health system, but on the household level. Social norms, such as assigning the male household head the power to decide over the use of healthcare services by his wife and children, jeopardize women's bargaining power to claim their rights to healthcare, especially in a conflict-affected relationship. Social norms and customary and statutory regulations that disadvantage women and their children must be addressed at every level-including the community and household-in order to effectively decrease barriers to HIV related care.	[Merten, Sonja] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57, CH-4002 Basel, Switzerland; [Merten, Sonja] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland; [Ntalasha, Harriet] Univ Zambia, Dept Populat Studies, Great East Rd Campus, Lusaka, Zambia; [Musheke, Maurice] Mwaleshi Rd,Olympia Pk, Lusaka, Zambia	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zambia	Merten, S (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57, CH-4002 Basel, Switzerland.; Merten, S (corresponding author), Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland.	sonja.merten@unibas.ch		Merten, Sonja/0000-0003-4115-106X	Swiss National Science Foundation [PMPDP3-123072]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded through a Research grant from the Swiss National Science Foundation, PMPDP3-123072.	Ahmed S, 2013, AIDS, V27, pS235, DOI 10.1097/QAD.0000000000000099; Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Babalola S, 2007, AIDS BEHAV, V11, P759, DOI 10.1007/s10461-006-9189-0; Berendes S, 2011, J ASSOC NURSE AIDS C, V22, P215, DOI 10.1016/j.jana.2010.08.005; Boender TS, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/817506; Brinda EM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1449-3; Buzdugan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053213; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; Daniel O J, 2006, J Obstet Gynaecol, V26, P191, DOI 10.1080/01443610500508196; Davies MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081037; Donahue MC, 2012, AIDS CARE, V24, P1233, DOI 10.1080/09540121.2012.656570; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; EPSTEIN J, 1992, AM IMAGO, V49, P293; Gari S, 2014, AIDS CARE, V26, P1258, DOI 10.1080/09540121.2014.897911; Gari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071922; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hardon A, 2013, SAHARA J-J SOC ASP H, V10, pS1, DOI 10.1080/02664763.2012.755317; Katowa N, 2013, EVALUATION SANCTITY; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kimani-Murage EW, 2013, AIDS CARE, V25, P744, DOI 10.1080/09540121.2012.748865; Kohler PK, 2014, AIDS PATIENT CARE ST, V28, P643, DOI 10.1089/apc.2014.0171; Koku EF, 2011, J COMMUN HEALTH, V36, P289, DOI 10.1007/s10900-010-9310-1; Kranzer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001649; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; McPake B, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-46; Meiberg Annemarie E, 2008, East Afr J Public Health, V5, P49; Meier BM, 2014, PUBLIC HEALTH, V128, P179, DOI 10.1016/j.puhe.2013.08.012; Ministry of Finance, 2014, REV 6 NAT DEV PLAN; Ministry of Health and Community Development Mother and Child Health, 2013, ZAMB CONS GUID TREAT; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Moyer E, 2012, CULT HEALTH SEX, V14, pS67, DOI 10.1080/13691058.2012.662524; Musheke M, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-12; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Mutanga JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029656; Namukwaya Z, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1213-5; National AIDS Council, 2015, ZAMB COUNTR REP MON; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Niehaus I, 2007, J S AFR STUD, V33, P845, DOI 10.1080/03057070701646944; Njunga J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-14; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Onono M., 2015, J AIDS CLIN RES, V6; Parker L, 2014, CULT HEALTH SEX, V16, P792, DOI 10.1080/13691058.2014.905707; Peltzer K, 2010, ACTA PAEDIATR, V99, P590, DOI 10.1111/j.1651-2227.2009.01670.x; Porter M, 2015, JAIDS-J ACQ IMM DEF, V69, P593, DOI 10.1097/QAI.0000000000000683; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Sambisa W, 2010, AIDS CARE, V22, P170, DOI 10.1080/09540120903038374; Schumaker LL, 2008, SOC SCI MED, V67, P2126, DOI 10.1016/j.socscimed.2008.09.006; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087028; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walcott MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1115; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; World Health Organization, 2022, GLOB HLTH OBS; Yeap AD, 2010, AIDS CARE, V22, P1101, DOI 10.1080/09540121003602218; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7	68	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155510	10.1371/journal.pone.0155510	http://dx.doi.org/10.1371/journal.pone.0155510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280282	Green Published, gold, Green Accepted			2022-12-26	WOS:000377563000003
J	Rangel, J; Boroczky, K; Schal, C; Tarpy, DR				Rangel, Juliana; Boroczky, Katalin; Schal, Coby; Tarpy, David R.			Honey Bee (Apis mellifera) Queen Reproductive Potential Affects Queen Mandibular Gland Pheromone Composition and Worker Retinue Response	PLOS ONE			English	Article							MASS-SPECTRAL FRAGMENTATION; EFFECTIVE PATERNITY; HYMENOPTERA; SECRETION; BEHAVIOR; AGE; COMMUNICATION; SUPPRESSION; MODULATION; COMPONENTS	Reproductive division of labor is one of the defining traits of honey bees (Apis mellifera), with non-reproductive tasks being performed by workers while a single queen normally monopolizes reproduction. The decentralized organization of a honey bee colony is maintained in large part by a bouquet of queen-produced pheromones, the distribution of which is facilitated by contact among workers throughout the hive. Previous studies have shown that the developmental fate of honey bee queens is highly plastic, with queens raised from younger worker larvae exhibiting higher measures of reproductive potential compared to queens raised from older worker larvae. We investigated differences in the chemical composition of the mandibular glands and attractiveness to workers of "high-quality" queens (i.e., raised from first instar worker larvae; more queen-like) and "low-quality" queens (i.e., raised from third instar worker larvae; more worker-like). We characterized the chemical profiles of the mandibular glands of high-quality queens and low-quality queens using GCMS and used the worker retinue response as a measure of the attractiveness to workers of high-quality queens vs. low-quality queens. We found that queen quality affected the chemical profiles of mandibular gland contents differently across years, showing significant differences in the production of the queen mandibular pheromone ("QMP") components HVA and 9-HDA in 2010, but no significant differences of any glandular compound in 2012. We also found that workers were significantly more attracted to high-quality queens than to low-quality queens in 2012, possibly because of increased attractiveness of their mandibular gland chemical profiles. Our results indicate that the age at which honey bee larvae enter the "queen-specific" developmental pathway influences the chemical composition of queen mandibular glands and worker behavior. However, these changes are not consistent across years, suggesting that other external factors may play important roles in modulating queen quality.	[Rangel, Juliana; Boroczky, Katalin; Schal, Coby; Tarpy, David R.] N Carolina State Univ, Dept Entomol, Campus Box 7613, Raleigh, NC 27695 USA; [Rangel, Juliana; Boroczky, Katalin; Schal, Coby; Tarpy, David R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Campus Box 7613, Raleigh, NC 27695 USA; Texas A&M Univ, Dept Entomol, 2475 TAMU, College Stn, TX 77843 USA; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Cornell University; Cornell University	Rangel, J (corresponding author), N Carolina State Univ, Dept Entomol, Campus Box 7613, Raleigh, NC 27695 USA.; Rangel, J (corresponding author), N Carolina State Univ, WM Keck Ctr Behav Biol, Campus Box 7613, Raleigh, NC 27695 USA.	jrangel@tamu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Tarpy, David/0000-0001-8601-6094	US National Science Foundation Postdoctoral Research Fellowship in Biology [1002465]; NC Department of Agriculture & Consumer Services; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2007-02281]	US National Science Foundation Postdoctoral Research Fellowship in Biology; NC Department of Agriculture & Consumer Services; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	Funding was provided to JR by the US National Science Foundation Postdoctoral Research Fellowship in Biology (Award number 1002465) and to DRT by the NC Department of Agriculture & Consumer Services and grant number 2007-02281 from the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN M. DELIA, 1957, BRIT JOUR ANIMAL BEHAVIOUR, V5, P81, DOI 10.1016/S0950-5601(57)80001-X; [Anonymous], 1971, INSECT SOC; Apsegaite V., 1999, Pheromones, V6, P27; Babis M, 2014, INSECT SOC, V61, P337, DOI 10.1007/s00040-014-0358-2; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Butler C.G., 1973, Journal apic Res, V12, P159; Butler C. G., 1963, Journal of Apicultural Research London, V2, P14; Crozier R.H., 1996, EVOLUTION SOCIAL INS; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Engels W, 1997, J INSECT PHYSIOL, V43, P307, DOI 10.1016/S0022-1910(96)00110-2; FELL RD, 1984, INSECT SOC, V31, P221, DOI 10.1007/BF02223608; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; Hatch S, 1999, INSECT SOC, V46, P372, DOI 10.1007/s000400050159; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Johnson JN, 2010, J INSECT PHYSIOL, V56, P761, DOI 10.1016/j.jinsphys.2010.01.004; KAMINSKI LA, 1990, J CHEM ECOL, V16, P841, DOI 10.1007/BF01016494; Katzav-Gozansky T, 2004, P ROY SOC B-BIOL SCI, V271, P2065, DOI 10.1098/rspb.2004.2839; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; Katzav-Gozansky T, 2007, NATURWISSENSCHAFTEN, V94, P407, DOI 10.1007/s00114-006-0206-y; Katzav-Gozansky T, 2006, J COMP PHYSIOL A, V192, P737, DOI 10.1007/s00359-006-0110-0; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; Keeling CI, 2001, APIDOLOGIE, V32, P243, DOI 10.1051/apido:2001126; Kocher SD, 2011, J CHEM ECOL, V37, P1263, DOI 10.1007/s10886-011-0036-z; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kraus FB, 2005, INSECT SOC, V52, P1, DOI 10.1007/s00040-004-0766-9; Laidlaw HH., 1997, QUEEN REARING BEE BR; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Maisonnasse A, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-18; Melathopoulos AP, 1996, CAN ENTOMOL, V128, P263, DOI 10.4039/Ent128263-2; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Moritz RFA, 2000, NATURWISSENSCHAFTEN, V87, P395, DOI 10.1007/s001140050748; Moritz RFA, 2004, P ROY SOC B-BIOL SCI, V271, pS98, DOI 10.1098/rsbl.2003.0113; Nino EL, 2012, J INSECT PHYSIOL, V58, P1082, DOI 10.1016/j.jinsphys.2012.04.015; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PANKIW T, 1995, INSECT SOC, V42, P371, DOI 10.1007/BF01242165; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; Pankiw T, 1996, J CHEM ECOL, V22, P605, DOI 10.1007/BF02033573; PETTIS JS, 1995, INSECT SOC, V42, P113, DOI 10.1007/BF01242447; PETTIS JS, 1995, ANN ENTOMOL SOC AM, V88, P580, DOI 10.1093/aesa/88.4.580; Pettis JS, 1997, INSECT SOC, V44, P311, DOI 10.1007/s000400050053; Pirk C.W.W., 2011, PHEROMONES, P207; Plettner E, 1997, J CHEM ECOL, V23, P363, DOI 10.1023/B:JOEC.0000006365.20996.a2; Rangel J, 2013, INSECT SOC, V60, P65, DOI 10.1007/s00040-012-0267-1; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Rontani JF, 2008, J AM SOC MASS SPECTR, V19, P66, DOI 10.1016/j.jasms.2007.10.014; Rontani JF, 2004, RAPID COMMUN MASS SP, V18, P1889, DOI 10.1002/rcm.1567; Schafer MO, 2006, J COMP PHYSIOL A, V192, P761, DOI 10.1007/s00359-006-0112-y; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1979, BEHAV ECOL SOCIOBIOL, V5, P391, DOI 10.1007/BF00292527; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; SLESSOR KN, 1990, J CHEM ECOL, V16, P851, DOI 10.1007/BF01016495; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Strauss K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1523, DOI 10.1007/s00265-008-0581-9; Tarpy DR, 2011, INSECT SOC, V58, P569, DOI 10.1007/s00040-011-0180-z; Tarpy DR, 2009, ETHOL ECOL EVOL, V21, P147, DOI 10.1080/08927014.2009.9522503; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2000, ANIM BEHAV, V59, P97, DOI 10.1006/anbe.1999.1311; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; VELTHUIS HH, 1970, Z VERGL PHYSIOL, V70, P210, DOI 10.1007/BF00297717; Villar G, 2015, J COMP PHYSIOL A, V201, P731, DOI 10.1007/s00359-015-1006-7; Winston M.L., 1991, BIOL HONEY BEE; WINSTON ML, 1989, INSECT SOC, V36, P15, DOI 10.1007/BF02225877; Wossler TC, 1999, J INSECT BEHAV, V12, P343, DOI 10.1023/A:1020839505622; Woyke J., 1971, J Apic Res, V10, P45; Yusuf AA, 2015, APIDOLOGIE, V46, P559, DOI 10.1007/s13592-014-0346-6	73	15	15	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156027	10.1371/journal.pone.0156027	http://dx.doi.org/10.1371/journal.pone.0156027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281328	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000012
J	Zhang, FH; Peng, B; Chang, HY; Zhang, R; Lu, FG; Wang, FY; Fang, F; Chen, Z				Zhang, Fenghua; Peng, Bo; Chang, Haiyan; Zhang, Ran; Lu, Fangguo; Wang, Fuyan; Fang, Fang; Chen, Ze			Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; T-CELL RESPONSES; AVIAN INFLUENZA; IMMUNE-RESPONSE; CROSS-PROTECTION; VACCINE; LIVE; DNA; HEMAGGLUTININ; INDUCTION	Maternally-derived antibodies (MDAs) can protect offspring against influenza virus infection but may also inhibit active immune responses. To overcome MDA-mediated inhibition, active immunization of offspring with an inactivated H5N1 whole-virion vaccine under the influence of MDAs was explored in mice. Female mice were vaccinated twice via the intraperitoneal (IP) or intranasal (IN) route with the vaccine prior to mating. One week after birth, the offspring were immunized twice via the IP or IN route with the same vaccine and then challenged with a lethal dose of a highly homologous virus strain. The results showed that, no matter which immunization route (IP or IN) was used for mothers, the presence of MDAs severely interfered with the active immune response of the offspring when the offspring were immunized via the IP route. Only via the IN immunization route did the offspring overcome the MDA interference. These results suggest that intranasal immunization could be a suitable inoculation route for offspring to overcome MDA interference in the defense against highly pathogenic H5N1 virus infection. This study may provide references for human and animal vaccination to overcome MDA-induced inhibition.	[Zhang, Fenghua; Peng, Bo; Chang, Haiyan; Fang, Fang; Chen, Ze] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Zhang, Ran] Hunan Normal Univ, Sch Med, Changsha, Hunan, Peoples R China; [Lu, Fangguo] Hunan Univ Chinese Med, Sch Med, Changsha, Hunan, Peoples R China; [Wang, Fuyan] Cent S Univ, Dept Immunol, Coll Basic Med Sci, Changsha, Hunan, Peoples R China; [Chen, Ze] Shanghai Inst Biol Prod, Shanghai, Peoples R China	Hunan Normal University; Hunan Normal University; Hunan University of Chinese Medicine; Central South University	Fang, F; Chen, Z (corresponding author), Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China.; Chen, Z (corresponding author), Shanghai Inst Biol Prod, Shanghai, Peoples R China.	fangfangc@263.net; chenze2005@263.net			Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]; National Natural Science Foundation of China [30972623]; Open Found of Hunan Provincial Key Laboratory for Molecular Microbiology [2014-04]; General Foundation of Hunan Provincial Science and Technology Department [2013SK3131]; Key Project of Hunan Province Program in the Field of Social Development [2015SK20331]	Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Found of Hunan Provincial Key Laboratory for Molecular Microbiology; General Foundation of Hunan Provincial Science and Technology Department; Key Project of Hunan Province Program in the Field of Social Development	This study was supported by Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (20134486), National Natural Science Foundation of China (30972623), Open Found of Hunan Provincial Key Laboratory for Molecular Microbiology (2014-04), General Foundation of Hunan Provincial Science and Technology Department(2013SK3131), and Key Project of Hunan Province Program in the Field of Social Development (2015SK20331).	Bailhache M, 2011, ARCH PEDIATRIE, V18, P383, DOI 10.1016/j.arcped.2011.01.022; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Block SL, 2008, VACCINE, V26, P4940, DOI 10.1016/j.vaccine.2008.07.013; Bonati M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-873; Chen JJ, 2009, VIRUS GENES, V38, P66, DOI 10.1007/s11262-008-0289-y; Chen JJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-118; Chen QJ, 2009, VIRUS GENES, V38, P30, DOI 10.1007/s11262-008-0305-2; Chiu SS, 2009, VACCINE, V27, P4834, DOI 10.1016/j.vaccine.2009.05.066; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Dickson M, 2011, BJOG-INT J OBSTET GY, V118, P1140, DOI 10.1111/j.1471-0528.2011.02957.x; Endsley JJ, 2003, BIOLOGICALS, V31, P123, DOI 10.1016/S1045-1056(03)00027-7; Enserink M, 2012, SCIENCE, V335, P20, DOI 10.1126/science.335.6064.20; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; HARTE PG, 1984, IMMUNOLOGY, V53, P401; Ichinohe T, 2008, EXPERT REV VACCINES, V7, P1435, DOI 10.1586/14760584.7.9.1435; Ichinohe T, 2010, J MED VIROL, V82, P128, DOI 10.1002/jmv.21670; Jensen TH, 2015, VACCINE, V33, P1375, DOI 10.1016/j.vaccine.2015.01.029; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Klipper E, 2004, VACCINE, V22, P493, DOI 10.1016/j.vaccine.2003.07.011; Kumagai T, 2004, VACCINE, V22, P3404, DOI 10.1016/j.vaccine.2004.02.030; Letson GW, 2004, J PEDIATR-US, V144, P327, DOI 10.1016/j.jpeds.2003.11.030; Lopez-Medina E, 2012, J PEDIATR-US, V160, P626, DOI 10.1016/j.jpeds.2011.09.060; Maas R, 2011, AVIAN PATHOL, V40, P87, DOI 10.1080/03079457.2010.541226; Okamoto S, 2012, CLIN VACCINE IMMUNOL, V19, P979, DOI 10.1128/CVI.00016-12; Oner AF, 2012, CLIN INFECT DIS, V55, P26, DOI 10.1093/cid/cis295; Pertmer TM, 2000, J VIROL, V74, P7787, DOI 10.1128/JVI.74.17.7787-7793.2000; Pomorska-Mol M, 2010, VET MICROBIOL, V144, P450, DOI 10.1016/j.vetmic.2010.01.015; Rauw F, 2009, VACCINE, V27, P3631, DOI 10.1016/j.vaccine.2009.03.068; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Sui ZW, 2010, VACCINE, V28, P7690, DOI 10.1016/j.vaccine.2010.09.019; Sui ZW, 2010, ARCH VIROL, V155, P535, DOI 10.1007/s00705-010-0621-4; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Tamura S, 2010, VACCINE, V28, P6393, DOI 10.1016/j.vaccine.2010.05.019; Trondsen M, 2015, SCAND J IMMUNOL, V81, P305, DOI 10.1111/sji.12288; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; VANMAANEN C, 1992, VET QUART, V14, P13, DOI 10.1080/01652176.1992.9694319; Vincent AL, 2012, J VIROL, V86, P10597, DOI 10.1128/JVI.01439-12; Wesley RD, 2006, VET MICROBIOL, V118, P67, DOI 10.1016/j.vetmic.2006.07.014; Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5; Zhang FH, 2013, ARCH VIROL, V158, P1253, DOI 10.1007/s00705-013-1621-y	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157041	10.1371/journal.pone.0157041	http://dx.doi.org/10.1371/journal.pone.0157041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280297	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000073
J	Scheetz, TE; Roos, BR; Solivan-Timpe, F; Miller, K; DeLuca, AP; Stone, EM; Kwon, YH; Alward, WLM; Wang, K; Fingert, JH				Scheetz, Todd E.; Roos, Ben R.; Solivan-Timpe, Frances; Miller, Kathy; DeLuca, Adam P.; Stone, Edwin M.; Kwon, Young H.; Alward, Wallace L. M.; Wang, Kai; Fingert, John H.			SQSTM1 Mutations and Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AMYOTROPHIC-LATERAL-SCLEROSIS; NORMAL-TENSION GLAUCOMA; OPTINEURIN SEQUENCE VARIATIONS; GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATIONS; FRONTOTEMPORAL DEMENTIA; RETINITIS-PIGMENTOSA; AUTOPHAGY; GENE	Glaucoma is the most common cause of irreversible blindness worldwide. One subset of glaucoma, normal tension glaucoma (NTG) occurs in the absence of high intraocular pressure. Mutations in two genes, optineurin (OPTN) and TANK binding kinase 1 (TBK1), cause familial NTG and have known roles in the catabolic cellular process autophagy. TKB1 encodes a kinase that phosphorylates OPTN, an autophagy receptor, which ultimately activates autophagy. The sequestosome (SQSTM1) gene also encodes an autophagy receptor and also is a target of TBK1 phosphorylation. Consequently, we hypothesized that mutations in SQSTM1 may also cause NTG. We tested this hypothesis by searching for glaucoma-causing mutations in a cohort of NTG patients (n = 308) and matched controls (n = 157) using Sanger sequencing. An additional 1098 population control samples were also analyzed using whole exome sequencing. A total of 17 non-synonymous mutations were detected which were not significantly skewed between cases and controls when analyzed separately, or as a group (p > 0.05). These data suggest that SQSTM1 mutations are not a common cause of NTG.	[Scheetz, Todd E.; Roos, Ben R.; Solivan-Timpe, Frances; Miller, Kathy; DeLuca, Adam P.; Stone, Edwin M.; Kwon, Young H.; Alward, Wallace L. M.; Fingert, John H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Scheetz, Todd E.; Roos, Ben R.; Solivan-Timpe, Frances; Miller, Kathy; DeLuca, Adam P.; Stone, Edwin M.; Kwon, Young H.; Alward, Wallace L. M.; Wang, Kai; Fingert, John H.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Wang, Kai] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Fingert, JH (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA.; Fingert, JH (corresponding author), Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA.	john-fingert@uiowa.edu	Fingert, John/AAX-4750-2021; Fingert, John/F-8787-2012; Alward, Wallace/AAY-4149-2020; DeLuca, Adam/AAO-6291-2021	Fingert, John/0000-0002-0377-0479; Fingert, John/0000-0002-0377-0479; DeLuca, Adam/0000-0001-7798-1538; Scheetz, Todd/0000-0002-1965-5811; Alward, Wallace/0000-0001-6368-9018; Kwon, Young/0000-0002-1116-8250; Stone, Edwin M./0000-0003-3343-4414	National Eye Institute [RO1EY023512]; Research to Prevent Blindness; Marlene S. and Leonard A. Hadley Glaucoma Research Fund; NATIONAL EYE INSTITUTE [R01EY023512] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Marlene S. and Leonard A. Hadley Glaucoma Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Eye Institute RO1EY023512, Research to Prevent Blindness, and Marlene S. and Leonard A. Hadley Glaucoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; [Anonymous], 2008, AUTOPHAGY PATHOGENES, V132, P27, DOI [10.1016/j.cell.2007.12.018, DOI 10.1016/J.CELL.2007.12.018]; Awadalla MS, 2015, AM J OPHTHALMOL, V159, P124, DOI 10.1016/j.ajo.2014.09.044; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; DeLuca AP, 2016, HUM MOL GENET, V25, P44, DOI 10.1093/hmg/ddv446; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; Hirano M, 2013, NEUROLOGY, V80, P458, DOI 10.1212/WNL.0b013e31827f0fe5; Kawase K, 2012, EXP EYE RES, V96, P178, DOI 10.1016/j.exer.2011.12.021; Kwok CT, 2014, EUR J HUM GENET, V22, P492, DOI 10.1038/ejhg.2013.184; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YT, 2014, INVEST OPHTH VIS SCI, V55, P8251, DOI 10.1167/iovs.14-15712; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nassif M, 2011, AUTOPHAGY, V7, P450, DOI 10.4161/auto.7.4.14700; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ritch R, 2014, JAMA OPHTHALMOL, V132, P544, DOI 10.1001/jamaophthalmol.2014.104; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Shimizu H, 2013, ACTA NEUROPATHOL, V126, P453, DOI 10.1007/s00401-013-1150-5; Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0; Tucker Budd A, 2014, J Stem Cell Res Ther, V3, P161; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wong YC, 2014, NATL ACAD SCI, V111, pE4439, DOI [10.1073/pnas.1405752111, DOI 10.1073/PNAS.1405752111]; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Yang Y, 2015, AMYOTROPH LAT SCL FR, V16, P378, DOI 10.3109/21678421.2015.1009466	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156001	10.1371/journal.pone.0156001	http://dx.doi.org/10.1371/journal.pone.0156001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275741	gold, Green Submitted, Green Published			2022-12-26	WOS:000377561700013
J	Dowall, SD; Graham, VA; Rayner, E; Hunter, L; Watson, R; Taylor, I; Rule, A; Carroll, MW; Hewson, R				Dowall, Stuart D.; Graham, Victoria A.; Rayner, Emma; Hunter, Laura; Watson, Robert; Taylor, Irene; Rule, Antony; Carroll, Miles W.; Hewson, Roger			Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses	PLOS ONE			English	Article							M-GENOME SEGMENT; CD8(+) T-CELLS; IMMUNE-RESPONSE; KNOCKOUT MICE; ANDES VIRUS; MOUSE MODEL; LETHAL; INTRAPERITONEAL; PATHOGENESIS; ANTIBODIES	Crimean-Congo Haemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. There is no approved vaccine currently available against CCHF. The most promising candidate, which has previously been shown to confer protection in the small animal model, is a modified Vaccinia Ankara virus vector expressing the CCHF viral glycoprotein (MVA-GP). It has been shown that MVA-GP induces both humoral and cellular immunogenicity. In the present study, sera and T-lymphocytes were passively and adoptively transferred into recipient mice prior to challenge with CCHF virus. Results demonstrated that mediators from both arms of the immune system were required to demonstrate protective effects against lethal challenge.	[Dowall, Stuart D.; Graham, Victoria A.; Rayner, Emma; Hunter, Laura; Watson, Robert; Taylor, Irene; Rule, Antony; Carroll, Miles W.; Hewson, Roger] Publ Hlth England, Salisbury, Wilts, England	Public Health England	Dowall, SD (corresponding author), Publ Hlth England, Salisbury, Wilts, England.	stuart.dowall@phe.gov.uk		Watson, Robert/0000-0003-3146-3457	Public Health England of the United Kingdom	Public Health England of the United Kingdom	This work was funded by a pipeline fund initiative from Public Health England of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Arda B, 2012, J MED ETHICS, V38, P117, DOI 10.1136/medethics-2011-100107; Ascioglu S, 2011, J ANTIMICROB CHEMOTH, V66, P1215, DOI 10.1093/jac/dkr136; Atkinson B, 2012, VECTOR-BORNE ZOONOT, V12, P786, DOI 10.1089/vbz.2011.0770; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; Bhardwaj N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000725; Buttigieg KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091516; Canakoglu N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003579; Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059; Custer DM, 2003, J VIROL, V77, P9894, DOI 10.1128/JVI.77.18.9894-9905.2003; Du XH, 2012, ONCOL REP, V28, P1743, DOI 10.3892/or.2012.2013; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Ghiasi SM, 2011, CLIN VACCINE IMMUNOL, V18, P2031, DOI 10.1128/CVI.05352-11; Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Keshtkar-Jahromi M, 2011, ANTIVIR RES, V90, P85, DOI 10.1016/j.antiviral.2011.02.010; Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48; Matheu Melanie P, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5565; MATTES MJ, 1987, J NATL CANCER I, V79, P855; Mousavi-Jazi M, 2012, VACCINE, V30, P6225, DOI 10.1016/j.vaccine.2012.08.003; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Papa A, 2011, SCAND J INFECT DIS, V43, P225, DOI 10.3109/00365548.2010.540036; Petersen CC, 2006, J IMMUNOTHER, V29, P241, DOI 10.1097/01.cji.0000203078.97493.c3; SCHMALJOHN CS, 1989, VIROLOGY, V170, P184, DOI 10.1016/0042-6822(89)90365-6; SHEPHERD AJ, 1989, REV INFECT DIS, V11, pS801; Shimizu S, 2004, LAB MOUSE, P527, DOI DOI 10.1016/B978-012336425-8/50085-6; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155	35	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156637	10.1371/journal.pone.0156637	http://dx.doi.org/10.1371/journal.pone.0156637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272940	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000025
J	Ren, H; Ferguson, K; Kirkpatrick, G; Vinning, T; Chow, V; Ma, S				Ren, He; Ferguson, Kyle; Kirkpatrick, Gordon; Vinning, Tanya; Chow, Victor; Ma, Sai			Altered Crossover Distribution and Frequency in Spermatocytes of Infertile Men with Azoospermia	PLOS ONE			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; SYNAPTONEMAL COMPLEX LENGTH; STRAND BREAK REPAIR; CHROMOSOME SYNAPSIS; UNSYNAPSED REGIONS; DNA METHYLATION; TELOMERES; MEIOSIS; PROTEIN; SPERM	During meiosis, homologous chromosomes pair to facilitate the exchange of DNA at crossover sites along the chromosomes. The frequency and distribution of crossover formation are tightly regulated to ensure the proper progression of meiosis. Using immunofluorescence techniques, our group and others have studied the meiotic proteins in spermatocytes of infertile men, showing that this population displays a reduced frequency of crossovers compared to fertile men. An insufficient number of crossovers is thought to promote chromosome missegregation, in which case the faulty cell may face meiotic arrest or contribute to the production of aneuploid sperm. Increasing evidence in model organisms has suggested that the distribution of crossovers may also be important for proper chromosome segregation. In normal males, crossovers are shown to be rare near centromeres and telomeres, while frequent in subtelomeric regions. Our study aims to characterize the crossover distribution in infertile men with non-obstructive (NOA) and obstructive azoospermia (OA) along chromosomes 13, 18 and 21. Eight of the 16 NOA men and five of the 21 OA men in our study displayed reduced crossover frequency compared to control fertile men. Seven NOA men and nine OA men showed altered crossover distributions on at least one of the chromosome arms studied compared to controls. We found that although both NOA and OA men displayed altered crossover distributions, NOA men may be at a higher risk of suffering both altered crossover frequencies and distributions compared to OA men. Our data also suggests that infertile men display an increase in crossover formation in regions where they are normally inhibited, specifically near centromeres and telomeres. Finally, we demonstrated a decrease in crossovers near subtelomeres, as well as increased average crossover distance to telomeres in infertile men. As telomere-guided mechanisms are speculated to play a role in crossover formation in subtelomeres, future studies linking crossover distribution with telomere integrity and sperm aneuploidy may provide new insight into the mechanisms underlying male infertility.	[Ren, He; Ferguson, Kyle; Kirkpatrick, Gordon; Vinning, Tanya; Chow, Victor; Ma, Sai] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Ma, S (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada.	sai@mail.ubc.ca			Canadian Institutes of Health Research, Ottawa, Canada [MOP-93801, OBM-101387]	Canadian Institutes of Health Research, Ottawa, Canada(Canadian Institutes of Health Research (CIHR))	This study is funded by the Canadian Institutes of Health Research, Ottawa, Canada, grant numbers MOP-93801 and OBM-101387 to S.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (http://www.cihr-irsc.gc.ca/e/193.html).	Barton AB, 2003, GENETICS, V165, P929; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Cherry SM, 2007, CURR BIOL, V17, P373, DOI 10.1016/j.cub.2006.12.048; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Ferfouri F, 2013, ANDROLOGY-US, V1, P815, DOI 10.1111/j.2047-2927.2013.00117.x; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Ferguson KA, 2009, HUM REPROD, V24, P1313, DOI 10.1093/humrep/dep021; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; HULTEN M, 1970, HEREDITAS-GENETISK A, V65, P285; Joseph I, 2007, CELL MOL LIFE SCI, V64, P125, DOI 10.1007/s00018-006-6464-1; Kirkpatrick G, 2008, HUM REPROD, V23, P1679, DOI 10.1093/humrep/den126; Kniewel R, 2009, EMBO J, V28, P81, DOI 10.1038/emboj.2008.277; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liu L, 2004, P NATL ACAD SCI USA, V101, P6496, DOI 10.1073/pnas.0400755101; Liu L, 2002, EMBO REP, V3, P230, DOI 10.1093/embo-reports/kvf055; Liu L, 2002, DEV BIOL, V249, P74, DOI 10.1006/dbio.2002.0735; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Ma S, 2006, HUM REPROD, V21, P980, DOI 10.1093/humrep/dei428; Mezard C, 2015, TRENDS GENET, V31, P393, DOI 10.1016/j.tig.2015.03.008; MICIC M, 1982, CLIN GENET, V22, P266; Minor A, 2011, REPRODUCTION, V141, P749, DOI 10.1530/REP-11-0008; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099560; Oliver TR, 2009, AM J MED GENET A, V149A, P1685, DOI 10.1002/ajmg.a.32942; Peoples-Holst TL, 2005, GENE DEV, V19, P863, DOI 10.1101/gad.1293605; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Reig-Viader R, 2014, FERTIL STERIL, V102, P728, DOI 10.1016/j.fertnstert.2014.06.005; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Ross LO, 1996, GENETICS, V142, P79; Ruan J, 2012, REPROD SCI, V19, P1190, DOI 10.1177/1933719112446076; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Shibuya H, 2014, NAT CELL BIOL, V16, P145, DOI 10.1038/ncb2896; Su YP, 2000, CHROMOSOMA, V109, P467, DOI 10.1007/s004120000098; Sun F, 2007, CYTOGENET GENOME RES, V119, P27, DOI 10.1159/000109615; Sun F, 2005, HUM MOL GENET, V14, P3013, DOI 10.1093/hmg/ddi332; Sun F, 2007, FERTIL STERIL, V87, P565, DOI 10.1016/j.fertnstert.2006.07.1531; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Thilagavathi J, 2013, ANDROLOGIA, V45, P289, DOI 10.1111/and.12008; Treff NR, 2011, PLOS GENET, V7, DOI DOI 10.1371/JOURNAL.PGEN.1002161; Wu HY, 2006, MOL CELL BIOL, V26, P3683, DOI 10.1128/MCB.26.10.3683-3694.2006; YAMAMOTO M, 1979, GENETICS, V93, P437; Yang F, 2008, J CELL BIOL, V180, P673, DOI 10.1083/jcb.200709057; Yang F, 2015, EMBO MOL MED, V7, P1198, DOI 10.15252/emmm.201404967; Zalenskaya IA, 2002, INT REV CYTOL, V218, P37; Zhang XH, 2015, SYST BIOL REPROD MED, V61, P187, DOI 10.3109/19396368.2015.1027014; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	54	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156817	10.1371/journal.pone.0156817	http://dx.doi.org/10.1371/journal.pone.0156817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27273078	Green Submitted, Green Published, gold			2022-12-26	WOS:000377560200017
J	Kim, S; Natesan, S; Cornilescu, G; Carlson, S; Tonelli, M; McClurg, UL; Binda, O; Robson, CN; Markley, JL; Balaz, S; Glass, KC				Kim, Sophia; Natesan, Senthil; Cornilescu, Gabriel; Carlson, Samuel; Tonelli, Marco; McClurg, Urszula L.; Binda, Olivier; Robson, Craig N.; Markley, John L.; Balaz, Stefan; Glass, Karen C.			Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone methylation; isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); PHD finger; Inhibitor of Growth 3; histone acetyltransferase; plant homeodomain	TUMOR-SUPPRESSOR GENE; PHD-FINGER; DNA-DAMAGE; CRYSTAL-STRUCTURE; PROSTATE-CANCER; PROTEIN; CHROMATIN; EXPRESSION; ING4; METHYLATION	Aberrant access to genetic information disrupts cellular homeostasis and can lead to cancer development. One molecular mechanism that regulates access to genetic information includes recognition of histone modifications, which is carried out by protein modules that interact with chromatin and serve as landing pads for enzymatic activities that regulate gene expression. The ING3 tumor suppressor protein contains a plant homeodomain (PHD) that reads the epigenetic code via recognition of histone H3 tri-methylated at lysine 4 (H3K4me3), and this domain is lost or mutated in various human cancers. However, the molecular mechanisms targeting ING3 to histones and the role of this interaction in the cell remain elusive. Thus, we employed biochemical and structural biology approaches to investigate the interaction of the ING3 PHD finger (ING3(PHD)) with the active transcription mark H3K4me3. Our results demonstrate that association of the ING3(PHD) with H3K4me3 is in the sub-micromolar range (K-D ranging between 0.63 and 0.93 m) and is about 200-fold stronger than with the unmodified histone H3. NMR and computational studies revealed an aromatic cage composed of Tyr-362, Ser-369, and Trp-385 that accommodate the tri-methylated side chain of H3K4. Mutational analysis confirmed the critical importance of Tyr-362 and Trp-385 in mediating the ING3(PHD)-H3K4me3 interaction. Finally, the biological relevance of ING3(PHD)-H3K4me3 binding was demonstrated by the failure of ING3(PHD) mutant proteins to enhance ING3-mediated DNA damage-dependent cell death. Together, our results reveal the molecular mechanism of H3K4me3 selection by the ING3(PHD) and suggest that this interaction is important for mediating ING3 tumor suppressive activities.	[Kim, Sophia; Natesan, Senthil; Carlson, Samuel; Balaz, Stefan; Glass, Karen C.] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 261 Mt View Dr, Colchester, VT 05446 USA; [Cornilescu, Gabriel; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Cornilescu, Gabriel; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [McClurg, Urszula L.; Binda, Olivier; Robson, Craig N.] Newcastle Univ, Northern Inst Canc Res, Newcastle Canc Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Albany College of Pharmacy & Health Sciences; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Newcastle University - UK	Glass, KC (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 261 Mt View Dr, Colchester, VT 05446 USA.	karen.glass@acphs.edu	Glass, Karen C./AAV-1076-2021; Balaz, Stefan/K-6776-2019; Cornilescu, Gabriel/H-3113-2011; Balaz, Stefan/B-2965-2008	Glass, Karen C./0000-0002-2761-733X; Balaz, Stefan/0000-0003-4378-8945; Cornilescu, Gabriel/0000-0002-1204-8904; Balaz, Stefan/0000-0003-4378-8945; Natesan, Senthil/0000-0001-5347-6940; Binda, Olivier/0000-0002-1539-0828; McClurg, Urszula/0000-0003-2631-4174; Carlson, Samuel/0000-0001-9881-4210	National Institutes of Health [P41GM103399, P41RR002301, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; University of Wisconsin-Madison; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR025062, S10RR029220, S10RR023438, S10RR008438, S10RR002781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, R01GM080508] Funding Source: NIH RePORTER; Breast Cancer Campaign [2013MaySP005] Funding Source: researchfish; Prostate Cancer UK [PG09-23] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Breast Cancer Campaign; Prostate Cancer UK	Isolated cDNA from human ING3 (Q9NXR8) was kindly provided by Dr. Jacques Cote at Universite Laval. This study made use of the National Magnetic Resonance Facility at Madison, WI, which is supported by National Institutes of Health Grants P41GM103399 (NIGMS), original Grant Number P41RR002301. NMRFAM equipment was purchased with funds from the University of Wisconsin-Madison; National Institutes of Health Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220; National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394; and the United States Department of Agriculture. DNA sequencing was performed in the University of Vermont Cancer Center DNA Analysis Facility.	Almami A., 2016, TUMOUR BIOL IN PRESS; Bahrami A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033173; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bismar TA, 2014, BJU INT, V113, P309, DOI 10.1111/bju.12262; Bua DJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02137; Bua DJ, 2009, CURR DRUG TARGETS, V10, P418, DOI 10.2174/138945009788185112; Carlson S, 2014, J CELL PHYSIOL, V229, P1571, DOI 10.1002/jcp.24617; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2014, AMBER 14; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Champagne KS, 2006, BIOCHEMISTRY-US, V45, P14933, DOI 10.1021/bi061802v; Champagne KS, 2009, CURR DRUG TARGETS, V10, P432, DOI 10.2174/138945009788185040; Clos LJ, 2013, METABOLOMICS, V9, P558, DOI 10.1007/s11306-012-0490-9; Colla S, 2007, BLOOD, V110, P4464, DOI 10.1182/blood-2007-02-074617; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Edelson MI, 1997, ONCOGENE, V14, P2979, DOI 10.1038/sj.onc.1201271; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Gou WF, 2014, INDIAN J MED RES, V139, P561; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Guerillon C, 2014, CANCER LETT, V345, P1, DOI 10.1016/j.canlet.2013.11.016; Gunduz M, 2002, ONCOGENE, V21, P4462, DOI 10.1038/sj.onc.1205540; Gunduz M, 2008, CANCER SCI, V99, P531, DOI 10.1111/j.1349-7006.2007.00708.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Latil A, 1995, CLIN CANCER RES, V1, P1385; Lee JS, 2011, P NATL ACAD SCI USA, V108, P13510, DOI 10.1073/pnas.1106106108; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Lee W, 2013, BIOINFORMATICS, V29, P515, DOI 10.1093/bioinformatics/bts692; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Musselman CA, 2014, BBA-GENE REGUL MECH, V1839, P686, DOI 10.1016/j.bbagrm.2014.04.001; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nabbi A, 2015, EUR J CELL BIOL, V94, P214, DOI 10.1016/j.ejcb.2015.03.002; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Neklason DW, 2008, CANCER RES, V68, P8993, DOI 10.1158/0008-5472.CAN-08-1376; O'Neill DJ, 2014, EPIGENETICS-US, V9, P942, DOI 10.4161/epi.28864; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Poplawski A, 2014, J MOL BIOL, V426, P1661, DOI 10.1016/j.jmb.2013.12.007; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shiseki M, 2003, CANCER RES, V63, P2373; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	68	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18326	18341		10.1074/jbc.M115.690651	http://dx.doi.org/10.1074/jbc.M115.690651			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27281824	hybrid, Green Published			2022-12-26	WOS:000383241800025
J	Haslacher, H; Nistler, S; Batmyagmar, D; Ponocny-Seliger, E; Perkmann, T; Scherzer, TM; Kundi, M; Endler, G; Ratzinger, F; Pilger, A; Wagner, OF; Winker, R				Haslacher, Helmuth; Nistler, Sonja; Batmyagmar, Delgerdalai; Ponocny-Seliger, Elisabeth; Perkmann, Thomas; Scherzer, Thomas M.; Kundi, Michael; Endler, Georg; Ratzinger, Franz; Pilger, Alexander; Wagner, Oswald F.; Winker, Robert			Low Vitamin D Levels Do Not Predict Hyperglycemia in Elderly Endurance Athletes (but in Controls)	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; BIOMARKERS; DIAGNOSIS; EXERCISE; OBESITY; RISK	Background and Aim Recent studies revealed a link between hypovitaminosis D-3 and the risk for hyperglycemia. Further mechanistic and interventional investigations suggested a common reason for both conditions rather than a causal relationship. Exposure to sunlight is the most relevant source of vitamin D-3(25(OH)D), whereas adipose tissue is able to store relevant amounts of the lipophilic vitamin. Since running/bicycling leads to increased out-door time and alters physiological response mechanisms, it can be hypothesized that the correlation between hypovitaminosis D-3 and hyperglycemia might be disturbed in outdoor athletes. Methods 47 elderly marathoners/bicyclists and 47 age/sex matched controls were studied in a longitudinal setting at baseline and after three years. HbA1c as a surrogate for (pre-)diabetic states was quantified via HPLC, 25(OH)D levels were measured by means of chemiluminescent assays. Physical performance was assessed by ergometry. Results When adjusted for seasonal variations, 25(OH)D was significantly higher in athletes than in controls. 25(OH)D levels inversely correlated with triglycerides in both groups, whereas only in controls an association between high BMI or low physical performance with hypovitaminosis D-3 had been found. Likewise, the presence of hypovitaminosis D-3 at baseline successfully predicted hyperglycemia at the follow up examinations within the control group (AUC = 0.85, 95% CI [0.74, 0.96], p < .001, statistically independent from BMI), but not in athletes. Conclusion Our data suggest that mechanisms of HbA(1c) elevation might differ between athletes and controls. Thus, intense physical activity must be taken into account as a potential pre-analytic confounder when it is aimed to predict metabolic risk by vitamin D-3 levels.	[Haslacher, Helmuth; Perkmann, Thomas; Ratzinger, Franz; Wagner, Oswald F.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Scherzer, Thomas M.; Winker, Robert] Sanat Hera, Hlth & Prevent Ctr, Vienna, Austria; [Batmyagmar, Delgerdalai; Kundi, Michael] Med Univ Vienna, Dept Publ Hlth, Vienna, Austria; [Endler, Georg] Gruppenpraxis Lab At, Vienna, Austria; [Pilger, Alexander] Med Univ Vienna, Div Occupat Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Haslacher, H (corresponding author), Med Univ Vienna, Dept Lab Med, Vienna, Austria.	helmuth.haslacher@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013; Perkmann, Thomas/F-3074-2012	Haslacher, Helmuth/0000-0003-4605-2503; Perkmann, Thomas/0000-0002-7976-0285; Ratzinger, Franz/0000-0002-1910-1018	Austrian National Bank [14511, 12979]	Austrian National Bank	This trial was supported by the Anniversary Fund of the Austrian National Bank (No. 14511, No. 12979), https://www.oenb.at/en/About-Us/Research-Promotion/The-OeNBAnniversary-Fund.html. Moreover, authors EP and GE are currently affiliated with commercial companies. However, neither these companies nor the funder (Austrian National Bank), who inter alia provided support in the form of salaries for authors (EP, DB), did have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Agawa H, 2008, INT J SPORTS MED, V29, P867, DOI 10.1055/s-2008-1038490; Al-Shoumer KAS, 2015, WORLD J DIABETES, V6, P1057, DOI 10.4239/wjd.v6.i8.1057; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohm H, 1978, OST ARZTEZTG, V33, P333; Clemente-Postigo M, 2015, J CLIN ENDOCR METAB, V100, pE591, DOI 10.1210/jc.2014-3016; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Hamstra-Wright KL, 2013, J STRENGTH COND RES, V27, P2828, DOI 10.1519/JSC.0b013e31828a4733; Haslacher H, 2012, INT J SPORTS MED, V33, P1034, DOI 10.1055/s-0032-1304637; Haslacher H, 2015, J SPORT EXERCISE PSY, V37, P637, DOI 10.1123/jsep.2015-0111; Haslacher H, 2015, NEUROPSYCHOBIOLOGY, V71, P168, DOI 10.1159/000381350; Heidari B, 2015, AM HEART J, V170, P573, DOI 10.1016/j.ahj.2015.06.017; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kabadi SM, 2012, DIABETES CARE, V35, P2048, DOI 10.2337/dc12-0235; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Lupton JR, 2016, J CLIN LIPIDOL, V10, P72, DOI 10.1016/j.jacl.2015.09.006; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Morgan WP, 1996, INT J SPORTS MED, V17, P305, DOI 10.1055/s-2007-972852; Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Peeling P, 2013, INT J SPORTS MED, V34, P248, DOI 10.1055/s-0032-1321894; Poolsup N, 2015, EFFECT VITAMIN D SUP; Sanchis-Gomar F, 2014, BIOCHEM MEDICA, V24, P68, DOI 10.11613/BM.2014.009; Saraff V, 2015, ARCH DIS CHILD; Sattar N, 2012, DIABETIC MED, V29, P5, DOI 10.1111/j.1464-5491.2011.03480.x; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Wamberg L, 2015, CAUSES VITAMIN D DEF; Winker R, 2010, WIEN KLIN WOCHENSCHR, V122, P704, DOI 10.1007/s00508-010-1485-z; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zilinski JL, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002487	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157695	10.1371/journal.pone.0157695	http://dx.doi.org/10.1371/journal.pone.0157695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304888	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800080
J	Michl, C; Vivarelli, F; Weigl, J; De Nicola, GR; Canistro, D; Paolini, M; Iori, R; Rascle, A				Michl, Carina; Vivarelli, Fabio; Weigl, Julia; De Nicola, Gina Rosalinda; Canistro, Donatella; Paolini, Moreno; Iori, Renato; Rascle, Anne			The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling	PLOS ONE			English	Article							NF-KAPPA-B; JAK-STAT PATHWAY; TRANSCRIPTION 3; GLUCOMORINGIN ISOTHIOCYANATE; DEACETYLASE INHIBITORS; ENDOTHELIAL-CELLS; CANCER PREVENTION; MONOCYTE ADHESION; MAMMARY-GLAND; SULFORAPHANE	Sulforaphane (SFN) and moringin (GMG-ITC) are edible isothiocyanates present as glucosinolate precursors in cruciferous vegetables and in the plant Moringa oleifera respectively, and recognized for their chemopreventive and medicinal properties. In contrast to the well-studied SFN, little is known about the molecular pathways targeted by GMG-ITC. We investigated the ability of GMG-ITC to inhibit essential signaling pathways that are frequently upregulated in cancer and immune disorders, such as JAK/STAT and NF-kappa B. We report for the first time that, similarly to SFN, GMG-ITC in the nanomolar range suppresses IL-3-induced expression of STAT5 target genes. GMG-ITC, like SFN, does not inhibit STAT5 phosphorylation, suggesting a downstream inhibitory event. Interestingly, treatment with GMG-ITC or SFN had a limited inhibitory effect on IFN alpha-induced STAT1 and STAT2 activity, indicating that both isothiocyanates differentially target JAK/STAT signaling pathways. Furthermore, we showed that GMG-ITC in the micromolar range is a more potent inhibitor of TNF-induced NF-kappa B activity than SFN. Finally, using a cellular system mimicking constitutive active STAT5-induced cell transformation, we demonstrated that SFN can reverse the survival and growth advantage mediated by oncogenic STAT5 and triggers cell death, therefore providing experimental evidence of a cancer chemopreventive activity of SFN. This work thus identified STAT5, and to a lesser extent STAT1/STAT2, as novel targets of moringin. It also contributes to a better understanding of the biological activities of the dietary isothiocyanates GMG-ITC and SFN and further supports their apparent beneficial role in the prevention of chronic illnesses such as cancer, inflammatory diseases and immune disorders.	[Michl, Carina; Vivarelli, Fabio; Weigl, Julia; Rascle, Anne] Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany; [Vivarelli, Fabio; Canistro, Donatella; Paolini, Moreno] Univ Bologna, Dept Pharm & Biotechnol, Mol Toxicol Unit, Bologna, Italy; [De Nicola, Gina Rosalinda; Iori, Renato] Ctr Ric Colture Ind CREA CIN, Consiglio Ric Agr & Anal Econ Agr, Bologna, Italy; [Weigl, Julia] GeneArt AG Thermo Fisher Sci, BioPk 11, D-93053 Regensburg, Germany	University of Regensburg; University of Bologna; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Thermo Fisher Scientific	Rascle, A (corresponding author), Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany.	anne.rascle@klinik.uni-regensburg.de	De Nicola, Gina Rosalinda/AAC-9218-2021; Rascle, Anne/AAC-1904-2019	De Nicola, Gina Rosalinda/0000-0002-2916-8662; Rascle, Anne/0000-0001-7464-8545; CANISTRO, DONATELLA/0000-0002-6378-1698; Vivarelli, Fabio/0000-0002-8734-0985	Deutsche Forschungsgemeinschaft [RA 2010/2-1]; Deutsche Krebshilfe [109750]; German Research Foundation (DFG) [INST 89/318-3]; institutional research funds (Foerderlinie C)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG)); institutional research funds (Foerderlinie C)	This work was supported by the Deutsche Forschungsgemeinschaft (Grant No. RA 2010/2-1 to AR), the Deutsche Krebshilfe (Grant No. 109750 to AR), and institutional research funds (Foerderlinie C to AR). Open access charges were covered by the funding programme "Open Access Publishing" of the German Research Foundation (DFG) (INST 89/318-3 to the University of Regensburg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brunelli D, 2010, BIOCHEM PHARMACOL, V79, P1141, DOI 10.1016/j.bcp.2009.12.008; Butturini E, 2013, FREE RADICAL BIO MED, V65, P1322, DOI 10.1016/j.freeradbiomed.2013.09.015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Cheenpracha S, 2010, BIOORGAN MED CHEM, V18, P6598, DOI 10.1016/j.bmc.2010.03.057; Chen CY, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0139-x; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; DiSanto JP, 1997, CURR BIOL, V7, pR424, DOI 10.1016/S0960-9822(06)00208-9; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Galuppo M, 2015, J BIOL REG HOMEOS AG, V29, P343; Galuppo M, 2014, FITOTERAPIA, V95, P160, DOI 10.1016/j.fitote.2014.03.018; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Geymayer S, 2000, FASEB J, V14, P1159, DOI 10.1096/fasebj.14.9.1159; Go VLW, 2004, J NUTR, V134, p3513S, DOI 10.1093/jn/134.12.3513S; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; Hahm ER, 2010, CANCER PREV RES, V3, P484, DOI 10.1158/1940-6207.CAPR-09-0250; Hanan EJ, 2012, J MED CHEM, V55, P10090, DOI 10.1021/jm3012239; Hayakawa F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.63; Heiss E, 2005, ANTIOXID REDOX SIGN, V7, P1601, DOI 10.1089/ars.2005.7.1601; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Huang CS, 2013, MOL NUTR FOOD RES, V57, P1918, DOI 10.1002/mnfr.201300063; Hung CN, 2014, J MED FOOD, V17, P1095, DOI 10.1089/jmf.2013.2901; Hutzen B, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-24; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; Jeong SI, 2010, ARCH PHARM RES, V33, P1867, DOI 10.1007/s12272-010-1120-6; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Keum YS, 2011, ANN NY ACAD SCI, V1229, P184, DOI 10.1111/j.1749-6632.2011.06092.x; Kim BH, 2013, BIOCHEM PHARMACOL, V86, P950, DOI 10.1016/j.bcp.2013.08.009; Kivela AM, 2010, ATHEROSCLEROSIS, V213, P122, DOI 10.1016/j.atherosclerosis.2010.07.015; Kraus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037207; Lampronti I, 2005, MED CHEM, V1, P327, DOI 10.2174/1573406054368684; Leone A, 2015, INT J MOL SCI, V16, P12791, DOI 10.3390/ijms160612791; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu YC, 2008, VASC PHARMACOL, V48, P54, DOI 10.1016/j.vph.2007.11.006; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Ma L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.6; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Muller C, 2015, PHYTOCHEMISTRY, V118, P139, DOI 10.1016/j.phytochem.2015.08.007; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muller J, 2008, ANAL BIOCHEM, V375, P249, DOI 10.1016/j.ab.2008.01.017; Nakamura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P242, DOI 10.1271/bbb.90731; Nallasamy P, 2014, J NUTR BIOCHEM, V25, P824, DOI 10.1016/j.jnutbio.2014.03.011; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nelson EA, 2011, ONCOTARGET, V2, P518; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pinz S, 2015, NUCLEIC ACIDS RES, V43, P3524, DOI 10.1093/nar/gkv188; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099391; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090275; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rajan TS, 2016, FITOTERAPIA, V110, P1, DOI 10.1016/j.fitote.2016.02.007; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Rascle A, 2009, EXP CELL RES, V315, P76, DOI 10.1016/j.yexcr.2008.10.012; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun CC, 2015, J BIOL CHEM, V290, P17784, DOI 10.1074/jbc.M115.655019; Ullrich A, 2004, ANN ONCOL, V15, P249, DOI 10.1093/annonc/mdh935; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Ward AC, 2000, BLOOD, V95, P19; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Weber A, 2013, PHARMACEUTICALS, V6, P960, DOI 10.3390/ph6080960; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yadav VR, 2011, INT IMMUNOPHARMACOL, V11, P295, DOI 10.1016/j.intimp.2010.12.006; Yang J, 2010, MOL CANCER THER, V9, P3386, DOI 10.1158/1535-7163.MCT-10-0416; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	86	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157430	10.1371/journal.pone.0157430	http://dx.doi.org/10.1371/journal.pone.0157430			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304884	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800058
J	Wu, Y; Adi, D; Long, M; Wang, J; Liu, F; Gai, MT; Aierken, A; Li, MY; Li, Q; Wu, LQ; Ma, YT; Hujiaaihemaiti, M				Wu, Yun; Adi, Dilare; Long, Mei; Wang, Jie; Liu, Fen; Gai, Min-Tao; Aierken, Alidan; Li, Ming-Yuan; Li, Qian; Wu, Lei-Qi; Ma, Yi-Tong; Hujiaaihemaiti, Minawaer			4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL-CELLS; ER-STRESS; OXIDATIVE STRESS; APOPTOSIS; PREVENTS; PATHWAY; PROLIFERATION; INHIBITION	Background Endoplasmic reticulum (ER) stress has been implicated in the pathophysiology of various pulmonary diseases via the activation of the unfolded protein response. However, the role of ER stress in pulmonary arterial hypertension (PAH) remains unclear. The well-known chemical chaperone 4-phenylbutyric acid (4-PBA) inhibits ER stress signaling. We hypothesized that known chemical chaperones, including 4-PBA, would inhibit the activation of ER stress and prevent and/or reverse PAH. Methods and Results Male Wistar rats were randomly divided into four groups: a normal control group (NORMAL group), a PAH group, and two PAH model plus 4-PBA treatment groups. The latter two groups included rats receiving 4-PBA by gavage each day as a preventive measure (the PRE group, with PBA starting on the day of PAH induction and continuing for 4 weeks) or as a reversal measure (the REV group, with PBA starting on the third week of PAH induction and continuing for 2 weeks). The PAH model was induced by intraperitoneally administering monocrotaline. The mean pulmonary artery pressure and mean right ventricular pressure were lower in the REV and PRE groups than in the NORMAL group. Furthermore, 4-PBA improved pulmonary arterial remodeling and suppressed the expression of ER stress indicators. Conclusion Our findings indicate that PAH induces ER stress and provokes pulmonary arterial and right ventricular remodeling. Additionally, we show that attenuation of ER stress has the potential to be an effective therapeutic strategy for protecting pulmonary arteries.	[Wu, Yun; Aierken, Alidan; Li, Ming-Yuan; Li, Qian; Wu, Lei-Qi; Hujiaaihemaiti, Minawaer] Xinjiang Med Univ, Affiliated Hosp 1, Dept Gen Practice, Urumqi 830011, Peoples R China; [Liu, Fen; Gai, Min-Tao; Ma, Yi-Tong] Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Cardiovasc Dis Res, Urumqi 830011, Peoples R China; [Wu, Yun; Adi, Dilare; Ma, Yi-Tong] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi 830011, Peoples R China; [Long, Mei] Xinjiang Med Univ, Dept Mech & Funct, Urumqi 830011, Peoples R China; [Wang, Jie] Xinjiang Med Univ, Affiliated Hosp 1, Dept Pharm, Urumqi 830011, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Hujiaaihemaiti, M (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Gen Practice, Urumqi 830011, Peoples R China.; Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Cardiovasc Dis Res, Urumqi 830011, Peoples R China.; Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi 830011, Peoples R China.	myt_xj@sina.com; 247477874@qq.com		Wu, Yun/0000-0002-2692-9067; Wang, Jie/0000-0002-1200-1196; Wang, Jie/0000-0001-7905-034X	Natural Science Foundation of Xinjiang Province [2014211C071]	Natural Science Foundation of Xinjiang Province	This work was supported by the Natural Science Foundation of Xinjiang Province (CN) (grant#: 2014211C071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Natural Science Foundation of Xinjiang Province (CN) (grant# 2014211C071).	Asmarinah, 2014, INT J ONCOL, V45, P1489, DOI 10.3892/ijo.2014.2576; Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Benoist D, 2011, AM J PHYSIOL-HEART C, V300, pH2230, DOI 10.1152/ajpheart.01226.2010; Bourdier G., 2015, AM J PHYSL HEART CIR; Bruchmann A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-96; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Cheng X, 2014, INT J MOL MED, V34, P772, DOI 10.3892/ijmm.2014.1822; Chin KM, 2008, J AM COLL CARDIOL, V51, P1527, DOI 10.1016/j.jacc.2008.01.024; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Dromparis P, 2013, CIRCULATION, V127, P115, DOI 10.1161/CIRCULATIONAHA.112.133413; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Feng JY, 2014, OPHTHALMIC RES, V52, P224, DOI 10.1159/000363387; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Frump AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080319; Galie N, 2015, EUR HEART J; Handoko ML, 2009, CIRCULATION, V120, P42, DOI 10.1161/CIRCULATIONAHA.108.829713; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Knowlton AA, 2007, CARDIOVASC RES, V73, P1, DOI 10.1016/j.cardiores.2006.11.002; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Koyama M, 2014, AM J PHYSIOL-HEART C, V306, pH1314, DOI 10.1152/ajpheart.00869.2013; Krajewska M, 1996, AM J PATHOL, V148, P1567; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Levy M, 2007, J AM COLL CARDIOL, V49, P803, DOI 10.1016/j.jacc.2006.09.049; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; Sanderson TH, 2010, NEUROSCIENCE, V169, P1307, DOI 10.1016/j.neuroscience.2010.05.076; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Sutendra G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002194; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Voelkel NF, 2004, CARDIOL CLIN, V22, P343, DOI 10.1016/j.ccl.2004.04.010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yeager Michael E, 2012, Pulm Circ, V2, P229, DOI 10.4103/2045-8932.97613; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhu M, 2014, ENDOCRINE, V47, P129, DOI 10.1007/s12020-013-0132-7	42	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157538	10.1371/journal.pone.0157538	http://dx.doi.org/10.1371/journal.pone.0157538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304885	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800069
J	Wang, Y; Chen, YJ; Ding, LP; Zhang, JW; Wei, JH; Wang, HZ				Wang, Ying; Chen, Yajuan; Ding, Liping; Zhang, Jiewei; Wei, Jianhua; Wang, Hongzhi			Validation of Reference Genes for Gene Expression by Quantitative Real-Time RT-PCR in Stem Segments Spanning Primary to Secondary Growth in Populus tomentosa	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RELIABLE REFERENCE GENES; ACCURATE NORMALIZATION; HOUSEKEEPING GENES; SELECTION; IDENTIFICATION; BIOSYNTHESIS; TRICHOCARPA; SOFTWARE; STRESSES	The vertical segments of Populus stems are an ideal experimental system for analyzing the gene expression patterns involved in primary and secondary growth during wood formation. Suitable internal control genes are indispensable to quantitative real time PCR (qRT-PCR) assays of gene expression. In this study, the expression stability of eight candidate reference genes was evaluated in a series of vertical stem segments of Populus tomentosa. Analysis through software packages geNorm, NormFinder and BestKeeper showed that genes ribosomal protein (RP) and tubulin beta (TUBB) were the most unstable across the developmental stages of P. tomentosa stems, and the combination of the three reference genes, eukaryotic translation initiation factor 5A (eIF5A), Actin (ACT6) and elongation factor 1-beta (EF1-beta) can provide accurate and reliable normalization of qRT-PCR analysis for target gene expression in stem segments undergoing primary and secondary growth in P. tomentosa. These results provide crucial information for transcriptional analysis in the P. tomentosa stem, which may help to improve the quality of gene expression data in these vertical stemsegments, which constitute an excellent plant system for the study of wood formation.	[Wang, Ying; Chen, Yajuan; Ding, Liping; Zhang, Jiewei; Wei, Jianhua; Wang, Hongzhi] Beijing Acad Agr & Forestry Sci, Beijing Key Lab Agr Gene Resource & Biotechnol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, JH; Wang, HZ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Key Lab Agr Gene Resource & Biotechnol, Beijing, Peoples R China.	weijianhua@baafs.net.cn; wanghongzhi@baafs.net.cn			National Natural Science Foundation of China [31270593]; State 863 High-Tech Program of China [2013AA102702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 863 High-Tech Program of China(National High Technology Research and Development Program of China)	This work was funded by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to HW (31270593) as a principal investigator and by the State 863 High-Tech Program of China (http://www.most.gov.cn/bszn/new/863/bslc/) to JW as one of the co-principal investigators (2013AA102702).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brentner LB, 2008, CHEMOSPHERE, V73, P657, DOI 10.1016/j.chemosphere.2008.07.059; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Duval I, 2009, PLANT CELL REP, V28, P811, DOI 10.1007/s00299-009-0670-x; Galeano Esteban, 2014, BMC Res Notes, V7, P464, DOI 10.1186/1756-0500-7-464; Galli V, 2015, GENE, V554, P205, DOI 10.1016/j.gene.2014.10.049; Groover A, 2006, CURR OPIN PLANT BIOL, V9, P55, DOI 10.1016/j.pbi.2005.11.013; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han KH, 2007, BIOFUEL BIOPROD BIOR, V1, P135, DOI 10.1002/bbb.14; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; LARSON P R, 1971, Canadian Journal of Forest Research, V1, P1, DOI 10.1139/x71-001; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Lu SF, 2001, ACTA BOT SIN, V43, P435; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Pettengill Emily A, 2012, BMC Res Notes, V5, P366, DOI 10.1186/1756-0500-5-366; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Prassinos C, 2005, PLANT CELL PHYSIOL, V46, P1213, DOI 10.1093/pcp/pci130; Ray Debashree L, 2014, BMC Res Notes, V7, P304, DOI 10.1186/1756-0500-7-304; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Simon Bindu, 2013, BMC Res Notes, V6, P397, DOI 10.1186/1756-0500-6-397; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; van Raemdonck D, 2005, J EXP BOT, V56, P2211, DOI 10.1093/jxb/eri221; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang XH, 2014, GENET MOL RES, V13, P9489, DOI 10.4238/2014.November.11.14; Zhang DQ, 2010, MOL GENET GENOMICS, V284, P105, DOI 10.1007/s00438-010-0552-5; Zhang L, 2013, INT J MOL SCI, V14, P24338, DOI 10.3390/ijms141224338; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	39	17	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157370	10.1371/journal.pone.0157370	http://dx.doi.org/10.1371/journal.pone.0157370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300480	Green Published, Green Submitted, gold			2022-12-26	WOS:000377822200041
J	Zhang, J; Qiao, CZ; Chang, L; Guo, YH; Fan, YB; Villacorta, L; Chen, YE; Zhang, JF				Zhang, Ji; Qiao, Congzhen; Chang, Lin; Guo, Yanhong; Fan, Yanbo; Villacorta, Luis; Chen, Y. Eugene; Zhang, Jifeng			Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACTIVATED RECEPTOR-GAMMA; CARDIAC-HYPERTROPHY; DIASTOLIC DYSFUNCTION; SIGNALING PATHWAY; ADIPOSE-TISSUE; IN-VIVO; ADIPOCYTE; EXPRESSION; DISEASE	Fatty acid binding protein 4 (FABP4) is a member of the intracellular lipid-binding protein family, responsible for the transportation of fatty acids. It is considered to express mainly in adipose tissues, and be strongly associated with inflammation, obesity, diabetes and cardiovasculardiseases. Here we report that FABP4 is also expressed in cardiomyocytes and plays an important role in regulating heart function under pressure overload. We generated heart-specific transgenic FABP4 (FABP4-TG) mice using a myosin-heavy chain (alpha-MHC) promoter and human FABP4 sequence, resulting in over-expression of FABP4 in cardiomyocytes. The FABP4-TG mice displayed normal cardiac morphology and contractile function. When they were subjected to the transverse aorta constriction (TAC) procedure, the FABP4-TG mice developed more cardiac hypertrophy correlated with significantly increased ERK phosphorylation, compared with wild type controls. FABP4 over-expression in cardiomyocytes activated phosphor-ERK signal and up-regulate the expression of cardiac hypertrophic marker genes. Conversely, FABP4 induced phosphor-ERK signal and hypertrophic gene expressions can be markedly inhibited by an ERK inhibitor PD098059 as well as the FABP4 inhibitor BMS309403. These results suggest that FABP4 over-expression in cardiomyocytes can aggravate the development of cardiac hypertrophy through the activation of ERK signal pathway.	[Zhang, Ji; Qiao, Congzhen; Chang, Lin; Guo, Yanhong; Fan, Yanbo; Villacorta, Luis; Chen, Y. Eugene; Zhang, Jifeng] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zhang, J; Chen, YE (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	jifengz@umich.edu; echenum@umich.edu	Villacorta, Luis/E-8937-2011; Fan, Yanbo/C-6360-2013; Guo, Yanhong/D-9764-2012; Fan, Yanbo/AAD-4710-2020	Villacorta, Luis/0000-0001-7824-7028; Fan, Yanbo/0000-0002-3845-7562; Fan, Yanbo/0000-0002-3845-7562	National Institute of Health [HL068878, HL105114, HL088391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088391, R01HL105114, R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported wholly by National Institute of Health Grants HL068878, HL105114, and HL088391 (to YEC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported, in whole or in part, by National Institute of Health Grants HL068878, HL105114, and HL088391 (to Y.E.C.). Special thanks are extended to Dr. Aimin Xu from the University of Hong Kong for the FABP4 knockout mouse tissue samples and other reagents.	Allard MF, 2004, CURR HYPERTENS REP, V6, P430, DOI 10.1007/s11906-004-0036-2; Baessler A, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.3; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Carvajal K, 2003, ARCH MED RES, V34, P89, DOI 10.1016/S0188-4409(03)00004-3; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chang L, 2009, CIRCULATION, V119, P2161, DOI 10.1161/CIRCULATIONAHA.108.815803; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; DEVEREUX RB, 1987, J CLIN HYPERTENS, V3, P87; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Kabaeva Z, 2008, AM J PHYSIOL-HEART C, V294, pH1667, DOI 10.1152/ajpheart.01144.2007; Kannel WB, 1997, CARDIOVASC DRUG THER, V11, P199, DOI 10.1023/A:1007792820944; Korner P I, 1995, Blood Press Suppl, V2, P6; Kostis JB, 2003, AM J HYPERTENS, V16, p18S, DOI 10.1016/S0895-7061(03)00966-X; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Lan H, 2011, J LIPID RES, V52, P646, DOI 10.1194/jlr.M012757; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Liu MY, 2013, CLIN SCI, V124, P115, DOI 10.1042/CS20120004; Liu QY, 2007, MOL CELL BIOCHEM, V302, P203, DOI 10.1007/s11010-007-9442-5; Agra R, 2014, INFLAMMATION, V37, P1504, DOI 10.1007/s10753-014-9876-3; Meng RS, 2011, ARCH BIOCHEM BIOPHYS, V511, P1, DOI 10.1016/j.abb.2011.04.010; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P2604, DOI 10.1001/jama.2013.284788; Nishikimi T, 1996, HYPERTENSION, V28, P22, DOI 10.1161/01.HYP.28.1.22; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; PASSMAN RS, 1994, J CLIN INVEST, V94, P2421, DOI 10.1172/JCI117609; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Ritchie RH, 2006, CLIN EXP PHARMACOL P, V33, P159, DOI 10.1111/j.1440-1681.2006.04342.x; Salgado-Somoza A, 2012, ATHEROSCLEROSIS, V224, P492, DOI 10.1016/j.atherosclerosis.2012.07.014; Schlottmann I, 2014, INT J OBESITY, V38, P1221, DOI 10.1038/ijo.2013.241; Shin J, 2009, J ANIM SCI, V87, P3923, DOI 10.2527/jas.2009-2124; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tso AWK, 2011, NEUROLOGY, V76, P1968, DOI 10.1212/WNL.0b013e31821e54b3; Usui S, 2006, J MOL CELL CARDIOL, V41, P219, DOI 10.1016/j.yjmcc.2006.05.006; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu HL, 2015, MOL CELL BIOL, V35, P1055, DOI 10.1128/MCB.01122-14; Yap LB, 2004, CLIN BIOCHEM, V37, P847, DOI 10.1016/j.clinbiochem.2004.06.002; Yeung DCY, 2009, DIABETES CARE, V32, P132, DOI 10.2337/dc08-1333; Zhang J, 2011, CARDIOVASC RES, V91, P90, DOI 10.1093/cvr/cvr068; Zhou M, 2015, CLIN SCI, V129, P547, DOI 10.1042/CS20150073	52	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157372	10.1371/journal.pone.0157372	http://dx.doi.org/10.1371/journal.pone.0157372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294862	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300037
J	Chen, DQ; Kluz, T; Fang, L; Zhang, XR; Sun, H; Jin, CY; Costa, M				Chen, Danqi; Kluz, Thomas; Fang, Lei; Zhang, Xiaoru; Sun, Hong; Jin, Chunyuan; Costa, Max			Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1	PLOS ONE			English	Article							CELL LUNG-CANCER; MISMATCH REPAIR; IN-VITRO; H4K16 ACETYLATION; MAMMALIAN-CELLS; GENE-EXPRESSION; DNA-DAMAGE; P8; CHROMATE; MOF	The environmental and occupational carcinogen Hexavalent Chromium (Cr(VI)) has been shown to cause lung cancer in humans when inhaled. In spite of a considerable research effort, the mechanisms of Cr(VI)-induced carcinogenesis remain largely unknown. Nupr1 (nuclear protein 1) is a small, highly basic, and unfolded protein with molecular weight of 8,800 daltons and is induced by a variety of stressors. Studies in animal models have suggested that Nupr1 is a key factor in the development of lung and pancreatic cancers, with little known about the underlying molecular mechanisms. Here we report that the level of Nupr1 is significantly increased in human bronchial epithelial BEAS2B cells following exposure to Cr(VI) through epigenetic mechanisms. Interestingly, Cr(VI) exposure also results in the loss of acetylation at histone H4K16, which is considered a 'hallmark' of human cancer. Cr(VI)-induced reduction of H4K16 acetylation appears to be caused by the induction of Nupr1, since (a) overexpression of Nupr1 decreased the levels of both H4K16 acetylation and the histone acetyltransferase MOF (male absent on the first; also known as Kat8, Myst 1), which specifically acetylates H4K16; (b) the loss of acetylation of H4K16 upon Cr(VI) exposure is greatly compromised by knockdown of Nupr1. Moreover, Nupr1-induced reduction of H4K16 acetylation correlates with the transcriptional down-regulation at several genomic loci. Notably, overexpression of Nupr1 induces anchorage-independent cell growth and knockdown of Nupr1 expression prevents Cr(VI)-induced cell transformation. We propose that Cr(VI) induces Nupr1 and rapidly perturbs gene expression by downregulating H4K16 acetylation, thereby contributing to Cr(VI)-induced carcinogenesis.	[Chen, Danqi; Kluz, Thomas; Fang, Lei; Zhang, Xiaoru; Sun, Hong; Jin, Chunyuan; Costa, Max] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Jin, Chunyuan; Costa, Max] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA	New York University; New York University	Jin, CY; Costa, M (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA.; Jin, CY; Costa, M (corresponding author), NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA.	Chunyuan.jin@nyumc.org; Max.costa@nyumc.org	Jin, Chunyuan/GRX-9623-2022; Chen, Danqi/AAP-1269-2020	Fang, Lei/0000-0002-2582-4845	National Institutes of Health, National Institute of Environmental Health Sciences [R01ES023174, P30ES000260, R01ES022935, 1R01ES026138-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022935, R01ES023174, R01ES026138] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health, National Institute of Environmental Health Sciences grants R01ES023174, P30ES000260, R01ES022935 (to MC), and 1R01ES026138-01 (to MC and CJ).	Aldrich MV, 2003, ENVIRON SCI TECHNOL, V37, P1859, DOI 10.1021/es0208916; [Anonymous], 2008, NATL TOXICOL PROGRAM, V546, P1; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Chowdhury U, 2009, CANCER METAST REV, V28, P225, DOI 10.1007/s10555-009-9183-x; Chun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119379; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Gironella M, 2009, J CELL PHYSIOL, V221, P594, DOI 10.1002/jcp.21889; Goruppi S, 2007, MOL CELL BIOL, V27, P993, DOI 10.1128/MCB.00996-06; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Guo XT, 2012, ANAT REC, V295, P2114, DOI 10.1002/ar.22571; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Horikoshi Nobuo, 2013, Genome Integr, V4, P3, DOI 10.1186/2041-9414-4-3; Ito Y, 2005, ANTICANCER RES, V25, P3419; Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Katoh H, 2011, MOL CELL, V44, P770, DOI 10.1016/j.molcel.2011.10.012; Kondo K, 2006, LUNG CANCER, V53, P295, DOI 10.1016/j.lungcan.2006.05.022; LeRoy G, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-20; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Lou JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071031; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Nickens KP, 2010, CHEM-BIOL INTERACT, V188, P276, DOI 10.1016/j.cbi.2010.04.018; Ovesen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097849; Peterson-Roth E, 2005, MOL CELL BIOL, V25, P3596, DOI 10.1128/MCB.25.9.3596-3607.2005; Proctor DM, 2014, TOXICOLOGY, V325, P160, DOI 10.1016/j.tox.2014.08.009; Ree AH, 1999, CANCER RES, V59, P4675; Reynolds M, 2007, CARCINOGENESIS, V28, P1613, DOI 10.1093/carcin/bgm031; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Sun H, 2009, TOXICOL APPL PHARM, V237, P258, DOI 10.1016/j.taap.2009.04.008; Taieb D, 2005, HEPATOLOGY, V42, P176, DOI 10.1002/hep.20759; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Veerla S, 2008, GENE CHROMOSOME CANC, V47, P368, DOI 10.1002/gcc.20542; Wei YD, 2004, J BIOL CHEM, V279, P4110, DOI 10.1074/jbc.M310800200; Zhitkovich A, 1996, BIOCHEMISTRY-US, V35, P7275, DOI 10.1021/bi960147w; ZHITKOVICH A, 1995, CARCINOGENESIS, V16, P907, DOI 10.1093/carcin/16.4.907; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	51	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157317	10.1371/journal.pone.0157317	http://dx.doi.org/10.1371/journal.pone.0157317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285315	gold, Green Submitted, Green Published			2022-12-26	WOS:000377564000056
J	Milojevich, HM; Lukowski, AF				Milojevich, Helen M.; Lukowski, Angela F.			Sleep and Mental Health in Undergraduate Students with Generally Healthy Sleep Habits	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; COLLEGE-STUDENTS; PSYCHIATRIC-DISORDERS; YOUNG-ADULTS; INSOMNIA; QUALITY; DEPRESSION; SYMPTOMS; ANXIETY; DISTURBANCES	Whereas previous research has indicated that sleep problems tend to co-occur with increased mental health issues in university students, relatively little is known about relations between sleep quality and mental health in university students with generally healthy sleep habits. Understanding relations between sleep and mental health in individuals with generally healthy sleep habits is important because (a) student sleep habits tend to worsen over time and (b) even time-limited experience of sleep problems may have significant implications for the onset of mental health problems. In the present research, 69 university students with generally healthy sleep habits completed questionnaires about sleep quality and mental health. Although participants did not report clinically concerning mental health issues as a group, global sleep quality was associated with mental health. Regression analyses revealed that nighttime sleep duration and the frequency of nighttime sleep disruptions were differentially related to total problems and clinically-relevant symptoms of psychological distress. These results indicate that understanding relations between sleep and mental health in university students with generally healthy sleep habits is important not only due to the large number of undergraduates who experience sleep problems and mental health issues over time but also due to the potential to intervene and improve mental health outcomes before they become clinically concerning.	[Milojevich, Helen M.; Lukowski, Angela F.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA	University of California System; University of California Irvine	Lukowski, AF (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA.	angela.lukowski@uci.edu	Milojevich, Helen/AFG-3672-2022	Milojevich, Helen/0000-0001-5337-7264	University of California-Irvine	University of California-Irvine(University of California System)	This research was funded by start-up money provided by the University of California-Irvine to the second author and by money provided to undergraduate research assistants through the Undergraduate Research Opportunities Program. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2005, J PERS ASSESS, V84, P49, DOI 10.1207/s15327752jpa8401_10; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Barclay NL, 2011, PSYCHOL MED, V41, P1029, DOI 10.1017/S0033291710001741; Bastien CH, 2004, J CONSULT CLIN PSYCH, V72, P653, DOI 10.1037/0022-006X.72.4.653; Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brown FC, 2006, J AM COLL HEALTH, V54, P231, DOI 10.3200/JACH.54.4.231-237; Buboltz WC, 2001, J AM COLL HEALTH, V50, P131, DOI 10.1080/07448480109596017; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caldwell K, 2010, J AM COLL HEALTH, V58, P433, DOI 10.1080/07448480903540481; Chapman DP, 2013, PSYCHIAT SERV, V64, P385, DOI 10.1176/appi.ps.201200226; Concepcion T, 2014, J AM COLL HEALTH, V62, P441, DOI 10.1080/07448481.2014.917652; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Galambos NL, 2011, J RES ADOLESCENCE, V21, P342, DOI 10.1111/j.1532-7795.2010.00679.x; Gao R, 2014, SLEEP BIOL RHYTHMS, V12, P194, DOI 10.1111/sbr.12063; Gau SSF, 2007, J BIOL RHYTHM, V22, P268, DOI 10.1177/0748730406298447; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; Gregory AM, 2011, J PSYCHOSOM RES, V71, P250, DOI 10.1016/j.jpsychores.2011.03.011; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kahn-Greene ET, 2007, SLEEP MED, V8, P215, DOI 10.1016/j.sleep.2006.08.007; Lavigne JV, 1999, J DEV BEHAV PEDIATR, V20, P164, DOI 10.1097/00004703-199906000-00005; Lukowski AF, 2014, BEHAV SLEEP MED, V12, P1; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Means MK, 2000, BEHAV RES THER, V38, P665, DOI 10.1016/S0005-7967(99)00091-1; Morphy H, 2007, SLEEP, V30, P274; Nyer M, 2014, DEPRESS ANXIETY, V30, P1; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Paavonen EJ, 2003, J DEV BEHAV PEDIATR, V24, P307, DOI 10.1097/00004703-200310000-00001; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Ramsawh HJ, 2009, J PSYCHIATR RES, V43, P926, DOI 10.1016/j.jpsychires.2009.01.009; Reid GJ, 2009, J SLEEP RES, V18, P49, DOI 10.1111/j.1365-2869.2008.00692.x; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Scharf R, 2010, J DEV BEHAV PEDIATR, V31, P384; Stein MB, 2008, PSYCHOSOM MED, V70, P913, DOI 10.1097/PSY.0b013e3181871405; Tabachnik G.B., 2007, EXPT DESIGNS USING A; Taras H, 2005, J SCHOOL HEALTH, V75, P248, DOI 10.1111/j.1746-1561.2005.00033.x; Taylor DJ, 2007, BEHAV THER, V38, P49, DOI 10.1016/j.beth.2006.04.002; Taylor DJ, 2011, BEHAV SLEEP MED, V9, P107, DOI 10.1080/15402002.2011.557992; Trockel M, 2011, J CLIN SLEEP MED, V7, P273, DOI 10.5664/JCSM.1072; Urponen H, 1991, SLEEP HLTH RISK, P555; Wong ML, 2013, J PSYCHOSOM RES, V74, P271, DOI 10.1016/j.jpsychores.2012.08.014; Yang CM, 2003, BEHAV MED, V29, P133, DOI 10.1080/08964280309596066; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001	51	65	65	8	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156372	10.1371/journal.pone.0156372	http://dx.doi.org/10.1371/journal.pone.0156372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280714	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000027
J	Baab, KL; Brown, P; Falk, D; Richtsmeier, JT; Hildebolt, CF; Smith, K; Jungers, W				Baab, Karen L.; Brown, Peter; Falk, Dean; Richtsmeier, Joan T.; Hildebolt, Charles F.; Smith, Kirk; Jungers, William			A Critical Evaluation of the Down Syndrome Diagnosis for LB1, Type Specimen of Homo floresiensis	PLOS ONE			English	Article							LIANG-BUA; LATE PLEISTOCENE; HUMAN OCCUPATION; SOUTHEAST-ASIA; PREMATURE LOSS; CRANIAL BASE; CHILDREN; SKULL; INDIVIDUALS; PREVALENCE	The Liang Bua hominins from Flores, Indonesia, have been the subject of intense scrutiny and debate since their initial description and classification in 2004. These remains have been assigned to a new species, Homo floresiensis, with the partial skeleton LB1 as the type specimen. The Liang Bua hominins are notable for their short stature, small endocranial volume, and many features that appear phylogenetically primitive relative to modern humans, despite their late Pleistocene age. Recently, some workers suggested that the remains represent members of a small-bodied island population of modern Austro-Melanesian humans, with LB1 exhibiting clinical signs of Down syndrome. Many classic Down syndrome signs are soft tissue features that could not be assessed in skeletal remains. Moreover, a definitive diagnosis of Down syndrome can only be made by genetic analysis as the phenotypes associated with Down syndrome are variable. Most features that contribute to the Down syndrome phenotype are not restricted to Down syndrome but are seen in other chromosomal disorders and in the general population. Nevertheless, we re-evaluated the presence of those phenotypic features used to support this classification by comparing LB1 to samples of modern humans diagnosed with Down syndrome and euploid modern humans using comparative morphometric analyses. We present new data regarding neurocranial, brain, and symphyseal shape in Down syndrome, additional estimates of stature for LB1, and analyses of inter- and intralimb proportions. The presence of cranial sinuses is addressed using CT images of LB1. We found minimal congruence between the LB1 phenotype and clinical descriptions of Down syndrome. We present important differences between the phenotypes of LB1 and individuals with Down syndrome, and quantitative data that characterize LB1 as an outlier compared with Down syndrome and non-Down syndrome groups. Homo floresiensis remains a phenotypically unique, valid species with its roots in Plio-Pleistocene Homo taxa.	[Baab, Karen L.] Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, 19555 N 59th Ave, Glendale, AZ 85308 USA; [Brown, Peter] Australian Natl Univ, Sch Archaeol & Anthropol, Bioanthropol, Acton, ACT 2601, Australia; [Falk, Dean] Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; [Falk, Dean] Sch Adv Res, Santa Fe, NM 87505 USA; [Richtsmeier, Joan T.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Hildebolt, Charles F.] Washington Univ, Mallinckrodt Inst Radiol, Dept Radiol, Sch Med, 510 South Kingshighway, St Louis, MO 63110 USA; [Smith, Kirk] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA; [Jungers, William] SUNY Stony Brook, Dept Anat Sci, Sch Med, Stony Brook, NY 11794 USA; [Jungers, William] Assoc Vahatra, BP 3972, Antananarivo 101, Madagascar	Midwestern University; Australian National University; State University System of Florida; Florida State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Washington University (WUSTL); University of Arkansas System; University of Arkansas Medical Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Baab, KL (corresponding author), Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, 19555 N 59th Ave, Glendale, AZ 85308 USA.	kbaab@midwestern.edu	Baab, Karen/I-4019-2019; Falk, Dean/C-6400-2019	Baab, Karen/0000-0002-6434-3681; Falk, Dean/0000-0003-1654-0469	National Science Foundation [BCS 04-24262]; L.S.B. Leakey Foundation; Sigma Xi Foundation; National Institutes of Health [R01-HD038384]; NSF [BCS 04-24262]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078233, R01HD038384] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); L.S.B. Leakey Foundation; Sigma Xi Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Grant support was provided to KLB by the National Science Foundation (BCS 04-24262; http://www.nsf.gov/), the L.S.B. Leakey Foundation (http://www.leakeyfoundation.org/), and the Sigma Xi Foundation (https://www.sigmaxi.org/). JTR was supported in part by a National Institutes of Health grant (R01-HD038384; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank Campbell Rolian, University of Calgary, for phalangeal data. We appreciate comments on an earlier version of this manuscript by Roger Reeves, Johns Hopkins University. We thank ARKENAS for access to the LB1 stereolithic model and the many institutions that permitted us to collect the comparative modern human datasets. PB would like to thank Dr. Tony Djubiantono, Arkeologi Nasional, Jakarta, for permission to examine the Liang Bua skeletal material. PB's research would not have been possible without the joint Indonesian-Australian excavations at Liang Bua directed by the late Radien Soejono (Arkeologi Nasional) and the late Mike Morwood (University of New England), with field and laboratory direction by Thomas Sutikna, Jatmiko, E. Wayhu Saptomo, and Rokhus Due Awe. Grant support was provided to KLB by NSF (BCS 04-24262), the L.S.B. Leakey Foundation, and the Sigma Xi Foundation. JTR was supported in part by R01-HD038384.	Aiello LC, 2010, AM J PHYS ANTHROPOL, V142, P167, DOI 10.1002/ajpa.21255; Aksakalli S, 2012, EUROPEAN J GEN DENT, V1, P58; Al-Shawaf R., 2011, KING SAUD U J DENT S, V2, P17, DOI [10.1016/j.ksujds.2010.12.001, DOI 10.1016/J.KSUJDS.2010.12.001]; Alam MK, 2014, PLOS ONE, V9, DOI [10. 1371/journal.pone.0101157, DOI 10.1371/J0URNAL.P0NE.0101157]; Alio JJ, 2008, AM J ORTHOD DENTOFAC, V133, P729, DOI 10.1016/j.ajodo.2006.03.036; Alpoz A R, 1997, J Clin Pediatr Dent, V22, P37; Andersson EMM, 2014, EUR J ORTHODONT, V36, P414, DOI 10.1093/ejo/cjt063; Argue D, 2009, J HUM EVOL, V57, P623, DOI 10.1016/j.jhevol.2009.05.002; Argue D, 2014, AAA ASHA ANN C CAIRN; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Aylward EH, 1997, ARCH NEUROL-CHICAGO, V54, P209, DOI 10.1001/archneur.1997.00550140077016; Baab KL, 2008, J HUM EVOL, V54, P827, DOI 10.1016/j.jhevol.2007.11.003; Baab KL, 2016, J ANTHROPOL SCI, V94, P5, DOI [10.4436/jass.94024, 10.4436/JASS.94024]; Baab KL, 2015, AM J PHYS ANTHROPOL, V156, P74; Baab KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069119; Baab KL, 2009, J HUM EVOL, V57, P608, DOI 10.1016/j.jhevol.2008.08.011; Bailleul-Forestier I, 2008, EUROPEAN J MED GENET, V51, P283; Balzeau A, 2016, J HUM EVOL, V93, P12, DOI 10.1016/j.jhevol.2015.12.008; BARDEN HS, 1983, HUM BIOL, V55, P539; BARDEN HS, 1980, AM J PHYS ANTHROPOL, V52, P169, DOI 10.1002/ajpa.1330520203; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Bauer D, 2012, INT J DENT, V2012, DOI 10.1155/2012/872367; Benda CE, 1941, J PEDIATR-US, V19, P800, DOI 10.1016/S0022-3476(41)80106-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOLGER WE, 1990, OTOLARYNG HEAD NECK, V103, P759, DOI 10.1177/019459989010300516; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; BROTHWELL DR, 1960, ANN HUM GENET, V24, P141; Brown Barbara, 1993, P161; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brown P, 2012, J HUM EVOL, V62, P201, DOI 10.1016/j.jhevol.2011.10.011; Brown P, 2009, J HUM EVOL, V57, P571, DOI 10.1016/j.jhevol.2009.06.002; Chen H, 2015, SYNDROME DIFFERENTIA; Concolino D, 2006, ACTA PAEDIATR, V95, P17, DOI 10.1080/08035250500325108; Crevecoeur I, 2012, AM J PHYS ANTHROPOL, V147, P121; CROME L, 1966, J MENT DEFIC RES, V10, P69; Czarnetzki A, 2003, LANCET, V362, P1000, DOI 10.1016/S0140-6736(03)14384-X; DAVIDSON RG, 1988, PEDIATRICS, V81, P857; Dayal RS, 1958, INDIAN J CHILD HLTH, V7, P960; De Coster PJ, 2009, J ORAL PATHOL MED, V38, P1, DOI 10.1111/j.1600-0714.2008.00699.x; Moraes Mari Eli Leonelli de, 2007, Braz. Dent. J., V18, P346, DOI 10.1590/S0103-64402007000400014; Dembo M, 2015, P ROY SOC B-BIOL SCI, V282, P133, DOI 10.1098/rspb.2015.0943; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Desai SS, 1999, ANGLE ORTHOD, V69, P85; Dingwall HL, 2014, AM J PHYS ANTHROPOL, V153, P106; Down J. T., 1866, LONDON HOSP REPORTS, V3, P259; Eckhardt RB, 2014, P NATL ACAD SCI USA, V111, P11961, DOI 10.1073/pnas.1407385111; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2007, P NATL ACAD SCI USA, V104, P2513, DOI 10.1073/pnas.0609185104; Falk D, 2009, AM J PHYS ANTHROPOL, V140, P52, DOI 10.1002/ajpa.21035; FISCHERBRANDIES H, 1988, EUR J ORTHODONT, V10, P255; FORT P, 1984, J PEDIATR-US, V104, P545, DOI 10.1016/S0022-3476(84)80544-2; Gauld SC, 1996, AM J PHYS ANTHROPOL, V100, P411; Gorlin RJ., 2001, SYNDROMES HEAD NECK, DOI 10.17245/jdapm.2019.19.5.261; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grabowski M, 2015, J HUM EVOL, V85, P75, DOI 10.1016/j.jhevol.2015.05.005; Groves C., 2007, HAYATI J BIOSCI, V14, P123, DOI DOI 10.4308/hjb.14.4.123; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Haier RJ, 2008, NEUROIMAGE, V39, P1324, DOI 10.1016/j.neuroimage.2007.09.064; HALL B, 1964, ACTA PAEDIATR, V53, P478, DOI 10.1111/j.1651-2227.1964.tb07254.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henneberg M., 2010, HOBBIT TRAP NEW SPEC; Henneberg M, 2014, P NATL ACAD SCI USA, V111, P11967, DOI 10.1073/pnas.1407382111; Hershkovitz I, 2007, AM J PHYS ANTHROPOL, V134, P198, DOI 10.1002/ajpa.20655; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; JASPERS MT, 1981, ORAL SURG ORAL MED O, V51, P632, DOI 10.1016/S0030-4220(81)80014-X; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P529, DOI 10.1001/archneur.1990.00530050049011; Juj H, 2009, J PEDIATR-US, V154, P234, DOI 10.1016/j.jpeds.2008.07.056; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Jungers William L., 2009, P93, DOI 10.1007/978-1-4020-9980-9_9; JUNGERS WL, 1988, AM J PHYS ANTHROPOL, V76, P227, DOI 10.1002/ajpa.1330760211; Kaifu Y, 2015, ANTHROPOL SCI, V123, P129, DOI 10.1537/ase.150501; Kaifu Y, 2011, J HUM EVOL, V61, P644, DOI 10.1016/j.jhevol.2011.08.008; Kaifu Y, 2009, AM J PHYS ANTHROPOL, V140, P177, DOI 10.1002/ajpa.21066; King K, 2014, IRISH J MED SCI, V183, P1, DOI 10.1007/s11845-013-0994-y; Kisling E, 1966, CRANIAL MORPHOLOGY S; Kliewer MA, 1996, RADIOLOGY, V201, P681, DOI 10.1148/radiology.201.3.8939215; Konigsberg LW, 1998, AM J PHYS ANTHROPOL, V107, P97, DOI 10.1002/(SICI)1096-8644(199809)107:1<97::AID-AJPA8>3.3.CO;2-S; Korayem MA, 2014, ANGLE ORTHOD, V84, P30, DOI 10.2319/030813-195.1; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; Kumasaka S, 1997, Spec Care Dentist, V17, P137, DOI 10.1111/j.1754-4505.1997.tb00884.x; Larson SG, 2009, J HUM EVOL, V57, P555, DOI 10.1016/j.jhevol.2008.06.007; Leonelli de Moraes ME, 2007, BRAZ DENT J, V18, P346, DOI [10.1590/ 50103 64402007000400014, DOI 10.1590/50103]; LESTREL PE, 1976, GROWTH, V40, P385; Lestrel PE, 1979, PROC 1ST INT CONG AU, V1, P108; Mann R. W., 2005, PHOTOGRAPHIC REGIONA; Margvelashvili A, 2013, P NATL ACAD SCI USA, V110, P17278, DOI 10.1073/pnas.1316052110; McKinney CM, 2009, PAEDIATR PERINAT EP, V23, P332, DOI 10.1111/j.1365-3016.2009.01038.x; MILLER JDR, 1986, J CAN ASSOC RADIOL, V37, P85; MIYAMOTO W, 1976, J DENT RES, V55, P584, DOI 10.1177/00220345760550040601; Moosa S, 2013, SAMJ S AFR MED J, V103, P966, DOI [10.7196/samj.7111, 10.7196/SAMJ.7111]; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Obendorf PJ, 2008, P ROY SOC B-BIOL SCI, V275, P1287, DOI 10.1098/rspb.2007.1488; Orr CM, 2013, J HUM EVOL, V64, P109, DOI 10.1016/j.jhevol.2012.10.003; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Oxnard C, 2012, HOMO, V63, P407, DOI 10.1016/j.jchb.2012.09.005; Oxnard C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013018; PEDERSEN J, 1978, COMMUNITY DENT ORAL, V6, P204, DOI 10.1111/j.1600-0528.1978.tb01151.x; Prasher V, 2011, J INTELL DISABIL RES, V55, P392, DOI 10.1111/j.1365-2788.2011.01384.x; Prasher V, 1994, DOWNS SYNDROME RES P, V2, P59, DOI 10.3104/reports.31; Quintanilla JS, 2002, PEDIATR RADIOL, V32, P635, DOI 10.1007/s00247-002-0703-x; Reuland-Bosma W, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.032; Richards GD, 2006, J EVOLUTION BIOL, V19, P1744, DOI 10.1111/j.1420-9101.2006.01179.x; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Rivollat M, 2014, INT J PALEOPATHOL, V7, P8, DOI 10.1016/j.ijpp.2014.05.004; ROBERTS GM, 1980, CLIN RADIOL, V31, P475, DOI 10.1016/S0009-9260(80)80199-1; ROCHE AF, 1961, AMER J ROENTGENOL RA, V85, P659; ROCHE AF, 1966, ACTA NEUROL SCAND, V42, P62, DOI 10.1111/j.1600-0404.1966.tb05985.x; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Roizen NJ, 2014, J PEDIATR-US, V164, P871, DOI 10.1016/j.jpeds.2013.11.032; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Ross C, 2011, J PROSTHET ORTHOT, V23, P149, DOI DOI 10.1097/JPO.0B013E318227285E; Scheid RC., 2010, WOELFELS DENT ANATOM; SEWARD FS, 1961, AMER J ROENTGENOL RA, V85, P653; Shapira J, 2000, ANGLE ORTHOD, V70, P290; Shimizu T, 2009, JPN DENT SCI REV, V45, P52, DOI 10.1016/j.jdsr.2008.12.001; Smith BA, 2008, GAIT POSTURE, V28, P448, DOI 10.1016/j.gaitpost.2008.02.002; SPITZER R, 1961, CAN MED ASSOC J, V84, P567; SPITZER R, 1955, BRIT J RADIOL, V28, P117, DOI 10.1259/0007-1285-28-327-117; SPITZER R, 1958, BRIT J RADIOL, V31, P596, DOI 10.1259/0007-1285-31-371-596; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Stevenson RE., 2006, HUMAN MALFORMATIONS; Subrata Dey, 2011, PRENATAL DIAGNOSIS S, P59; Suri S, 2011, ANGLE ORTHOD, V81, P260, DOI 10.2319/070910-391.1; Suri S, 2010, ANGLE ORTHOD, V80, P861, DOI 10.2319/111709-650.1; Sutikna T, 2016, NATURE, V532, P366, DOI 10.1038/nature17179; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Tuysuz B, 2012, AM J MED GENET A, V158A, P2656, DOI 10.1002/ajmg.a.35710; van Heteren AH, 2013, GENE, V528, P12, DOI 10.1016/j.gene.2013.06.010; Vannucci RC, 2011, P NATL ACAD SCI USA, V108, P14043, DOI 10.1073/pnas.1105585108; Walker PL, 1991, AM J PHYS ANTHR S12, V34, P179; WALLACE JA, 1977, AM J PHYS ANTHROPOL, V46, P483, DOI 10.1002/ajpa.1330460315; Westaway KE, 2007, QUAT GEOCHRONOL, V2, P337, DOI 10.1016/j.quageo.2006.03.015; Westaway MC, 2015, P NATL ACAD SCI USA, V112, pE604, DOI 10.1073/pnas.1418997112	138	6	6	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155731	10.1371/journal.pone.0155731	http://dx.doi.org/10.1371/journal.pone.0155731			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275928	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700008
J	Conroy-Beam, D; Buss, DM				Conroy-Beam, Daniel; Buss, David M.			How Are Mate Preferences Linked with Actual Mate Selection? Tests of Mate Preference Integration Algorithms Using Computer Simulations and Actual Mating Couples	PLOS ONE			English	Article							SEX-DIFFERENCES; EVOLUTIONARY	Prior mate preference research has focused on the content of mate preferences. Yet in real life, people must select mates among potentials who vary along myriad dimensions. How do people incorporate information on many different mate preferences in order to choose which partner to pursue? Here, in Study 1, we compare seven candidate algorithms for integrating multiple mate preferences in a competitive agent-based model of human mate choice evolution. This model shows that a Euclidean algorithm is the most evolvable solution to the problem of selecting fitness-beneficial mates. Next, across three studies of actual couples (Study 2: n = 214; Study 3: n = 259; Study 4: n = 294) we apply the Euclidean algorithm toward predicting mate preference fulfillment overall and preference fulfillment as a function of mate value. Consistent with the hypothesis that mate preferences are integrated according to a Euclidean algorithm, we find that actual mates lie close in multidimensional preference space to the preferences of their partners. Moreover, this Euclidean preference fulfillment is greater for people who are higher in mate value, highlighting theoretically-predictable individual differences in who gets what they want. These new Euclidean tools have important implications for understanding real-world dynamics of mate selection.	[Conroy-Beam, Daniel; Buss, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Conroy-Beam, D (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.	Dconroybeam@utexas.edu		Buss, David/0000-0002-4467-7019				Aktipis CA, 2011, HUM ECOL, V39, P131, DOI 10.1007/s10745-010-9364-9; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Christensen HT, 1947, MARRIAGE FAM LIVING, V9, P85, DOI 10.2307/347505; Conroy-Beam D, 2015, PERSONALITY SOCIAL P; DAWKINS R, 1979, Z TIERPSYCHOL, V51, P184; Eastwick PW, 2013, PREDICTIVE VALIDITY; Gangestad SW, 2006, PSYCHOL INQ, V17, P75, DOI 10.1207/s15327965pli1702_1; Gildersleeve K, 2014, PSYCHOL BULL, V140, P1205, DOI 10.1037/a0035438; Goldberg L, 1983, MAGICAL NUMBER 5 PLU; Hitsch GJ, 2010, QME-QUANT MARK ECON, V8, P393, DOI 10.1007/s11129-010-9088-6; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; KENRICK DT, 1993, J PERS SOC PSYCHOL, V64, P951, DOI 10.1037/0022-3514.64.6.951; Krasnow MM, 2015, GROUP COOPERATION GR; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; Lewis DM, 2015, EVOLUTION HUMAN BEHA; Li N.P., 2015, EVOLUTIONARY BEHAV S, V9, P89, DOI [DOI 10.1037/EBS0000036, 10.1037/ebs0000036]; Li NP, 2013, J PERS SOC PSYCHOL, V105, P757, DOI 10.1037/a0033777; Li NP, 2011, PERS INDIV DIFFER, V50, P291, DOI 10.1016/j.paid.2010.10.005; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; Norman P. Li, 2007, [心理学报, Acta Psychologica Sinica], V39, P528; Rozin P., 2015, EVOLUTIONARY PSYCHOL; Ryan Michael J., 2009, P137; Shackelford TK, 2005, COGNITION EMOTION, V19, P1262, DOI 10.1080/02699930500215249; Sugiyama L.S., 2005, HDB EVOLUTIONARY PSY, P292; Vazire S, 2010, J PERS SOC PSYCHOL, V98, P281, DOI 10.1037/a0017908	28	25	27	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156078	10.1371/journal.pone.0156078	http://dx.doi.org/10.1371/journal.pone.0156078			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27276030	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561700016
J	Kirkwood, JS; Miranda, CL; Bobe, G; Maier, CS; Stevens, JF				Kirkwood, Jay S.; Miranda, Cristobal L.; Bobe, Gerd; Maier, Claudia S.; Stevens, Jan F.			O-18-Tracer Metabolomics Reveals Protein Turnover and CDP-Choline Cycle Activity in Differentiating 3T3-L1 Pre-Adipocytes	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; HEME OXYGENASE; MATRIX METALLOPROTEINASES; PROLINE-OXIDASE; CELL-CYCLE; ADIPOGENESIS; PHOSPHATIDYLCHOLINE; OBESITY; OVEREXPRESSION; SPERMIDINE	The differentiation of precursor cells into mature adipocytes (adipogenesis) has been an area of increased focus, spurred by a rise in obesity rates. Though our understanding of adipogenesis and its regulation at the cellular level is growing, many questions remain, especially regarding the regulation of the metabolome. The 3T3-L1 cell line is the most well characterized cellular model of adipogenesis. Using a time course metabolomics approach, we show that the 3T3-L1 preadipocyte metabolome is greatly altered during the first 48 hours of differentiation, where cells go through about two rounds of cell division, a process known as mitotic clonal expansion. Short-chain peptides were among several small molecules that were increased during mitotic clonal expansion. Additional indicators of protein turnover were also increased, including bilirubin, a degradation product of heme-containing proteins, and 3-methylhistidine, a post-translationally modified amino acid that is not reutilized for protein synthesis. To study the origin of the peptides, we treated differentiating pre-adipocytes with O-18 labeled water and found that O-18 was incorporated into the short chain peptides, confirming them, at least in part, as products of hydrolysis. Inhibitors of the proteasome or matrix metalloproteinases affected the peptide levels during differentiation, but inhibitors of autophagy or peptidases did not. O-18 was also incorporated into several choline metabolites including cytidine 5'-diphosphocholine (CDP-choline), glycerophosphocholine, and several phosphatidylcholine species, indicative of phosphatidylcholine synthesis/degradation and of flux through the CDP-choline cycle, a hallmark of proliferating cells. O-18-Tracer metabolomics further showed metabolic labeling of glutamate, suggestive of glutaminolysis, also characteristic of proliferating cells. Together, these results highlight the utility of O-18 isotope labeling in combination with metabolomics to uncover changes in cellular metabolism that are not detectable by time-resolved metabolomics.	[Kirkwood, Jay S.; Miranda, Cristobal L.; Bobe, Gerd; Maier, Claudia S.; Stevens, Jan F.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Maier, Claudia S.] Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Stevens, JF (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.; Stevens, JF (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	fred.stevens@oregonstate.edu		Maier, Claudia S./0000-0003-0743-8956; Stevens, Jan Frederik/0000-0002-6348-9347	National Institutes of Health [S10RR027878, P30ES000120]; College of Pharmacy, Oregon State University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Pharmacy, Oregon State University	National Institutes of Health (Grants S10RR027878 to JFS; P30ES000120 Core to CSM) and the College of Pharmacy, Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; Bauters D, 2015, BBA-GEN SUBJECTS, V1850, P1449, DOI 10.1016/j.bbagen.2015.04.003; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Brenner S, 2015, J BIOL CHEM, V290, P27384, DOI 10.1074/jbc.M115.686980; Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Cheong LY, 2015, J CELL BIOCHEM, V116, P1361, DOI 10.1002/jcb.25093; Chutkow WA, 2011, J BIOL CHEM, V286, P29139, DOI 10.1074/jbc.M111.267666; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Dasuri K, 2011, FREE RADICAL BIO MED, V51, P1727, DOI 10.1016/j.freeradbiomed.2011.08.001; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Gao Y, 2014, ADIPOCYTE, V3, P160, DOI 10.4161/adip.28307; Gavin KM, 2016, FASEB J, V30, P1096, DOI 10.1096/fj.15-278994; Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6; Goldman S, 2010, AUTOPHAGY, V6, P179, DOI 10.4161/auto.6.1.10814; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Hyvonen MT, 2013, BIOCHEM J, V453, P467, DOI 10.1042/BJ20130263; Ishii I, 2012, AMINO ACIDS, V42, P619, DOI 10.1007/s00726-011-1037-5; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kirkwood JS, 2013, J BIOL CHEM, V288, P19000, DOI 10.1074/jbc.M112.445452; Kirkwood JS, 2013, CURR PROTOC TOXICOL; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee J, 2012, J BIOL CHEM, V287, P8839, DOI 10.1074/jbc.M111.263434; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; Pajonk F, 2002, FREE RADICAL BIO MED, V32, P536, DOI 10.1016/S0891-5849(02)00743-8; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Phang JM, 2008, PPAR RES, V2008, DOI 10.1155/2008/542694; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TERCE F, 1994, J LIPID RES, V35, P2130; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; VREMAN HJ, 1993, PEDIATR RES, V33, P195; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Yeo GSH, 2014, MOL CELL ENDOCRINOL, V397, P34, DOI 10.1016/j.mce.2014.09.012; YOUNG VR, 1973, METABOLISM, V22, P1429, DOI 10.1016/0026-0495(73)90257-6; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang HJ, 2002, J BIOL CHEM, V277, P20919, DOI 10.1074/jbc.M109801200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	58	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157118	10.1371/journal.pone.0157118	http://dx.doi.org/10.1371/journal.pone.0157118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275782	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700070
J	Wang, SY; Yang, BJ; Yang, QC; Lu, LL; Wang, XY; Peng, YY				Wang, Siyuan; Yang, Bojuan; Yang, Qichun; Lu, Linlin; Wang, Xiaoyue; Peng, Yaoyao			Temporal Trends and Spatial Variability of Vegetation Phenology over the Northern Hemisphere during 1982-2012	PLOS ONE			English	Article							SATELLITE-DERIVED PHENOLOGY; LAND-SURFACE PHENOLOGY; TERRESTRIAL VEGETATION; SPRING PHENOLOGY; PLANT PHENOLOGY; TIBETAN PLATEAU; CLIMATE-CHANGE; TIME-SERIES; RESPONSES; AVHRR	Satellite-derived vegetation phenology has been recognized as a key indicator for detecting changes in the terrestrial biosphere in response to global climate change. However, multi-decadal changes and spatial variation of vegetation phenology over the Northern Hemisphere and their relationship to climate change have not yet been fully investigated. In this article, we investigated the spatial variability and temporal trends of vegetation phenology over the Northern Hemisphere by calibrating and analyzing time series of the satellite-derived normalized difference vegetation index (NDVI) during 1982-2012, and then further examine how vegetation phenology responds to climate change within different ecological zones. We found that during the period from 1982 to 2012 most of the high latitude areas experienced an increase in growing period largely due to an earlier beginning of vegetation growing season (BGS), but there was no significant trend in the vegetation growing peaks. The spatial pattern of phenology within different eco-zones also experienced a large variation over the past three decades. Comparing the periods of 1982-1992, 1992-2002 with 2002-2012, the spatial pattern of change rate of phenology shift (RPS) shows a more significant trend in advancing of BGS, delaying of EGS (end of growing season) and prolonging of LGS (length of growing season) during 2002-2012, overall shows a trend of accelerating change. Temperature is a major determinant of phenological shifts, and the response of vegetation phenology to temperature varied across different eco-zones.	[Wang, Siyuan; Yang, Bojuan; Lu, Linlin; Wang, Xiaoyue; Peng, Yaoyao] Chinese Acad Sci, Key Lab Digital Earth, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Yang, Qichun] Auburn Univ, Sch Forestry & Wildlife Sci, Ecosyst Dynam & Global Ecol Lab, Auburn, AL 36849 USA	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Auburn University System; Auburn University	Wang, SY (corresponding author), Chinese Acad Sci, Key Lab Digital Earth, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	w_siyuan@126.com	Lu, Linlin/P-9200-2018	Lu, Linlin/0000-0003-1647-1950; Yang, Qichun/0000-0002-8689-2550	Natural Science Foundation of China [41271426, 41428103, 91547107]; National Basic Research Program of China [2011CB707100]; Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Natural Science Foundation of China (Grant No. 41271426, No. 41428103 and 91547107), National Basic Research Program of China (No. 2011CB707100), and "1-3-5 Project" of Chinese Academy of Sciences.	[Anonymous], 1999, MODIS VEGETATION IND; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Basler D, 2012, AGR FOREST METEOROL, V165, P73, DOI 10.1016/j.agrformet.2012.06.001; Broich M, 2014, BIOGEOSCIENCES, V11, P5181, DOI 10.5194/bg-11-5181-2014; Broich M, 2015, ENVIRON MODELL SOFTW, V64, P191, DOI 10.1016/j.envsoft.2014.11.017; Buus-Hinkler J, 2006, REMOTE SENS ENVIRON, V105, P237, DOI 10.1016/j.rse.2006.06.016; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; de Beurs KM, 2008, J CLIMATE, V21, P4257, DOI 10.1175/2008JCLI2074.1; de Beurs KM, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P177, DOI 10.1007/978-90-481-3335-2_9; de Beurs KM, 2005, GLOBAL CHANGE BIOL, V11, P779, DOI 10.1111/j.1365-2486.2005.00949.x; Delbart N, 2006, REMOTE SENS ENVIRON, V101, P52, DOI 10.1016/j.rse.2005.11.012; FAO, 2000, WORKSH CAMBR 28 30 J, P26; Fisher JI, 2007, REMOTE SENS ENVIRON, V109, P261, DOI 10.1016/j.rse.2007.01.004; Fontana F, 2008, SENSORS-BASEL, V8, P2833, DOI 10.3390/s8042833; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Geerken RA, 2009, ISPRS J PHOTOGRAMM, V64, P422, DOI 10.1016/j.isprsjprs.2009.03.001; Gong DY, 2003, J GEOPHYS RES-ATMOS, V108; GOWARD SN, 1985, VEGETATIO, V64, P3, DOI 10.1007/BF00033449; Hansen M., 1998, UMD GLOBAL LAND COVE, P1981; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Holdridge L. R., 1967, Life zone ecology.; Horion S, 2013, INT J APPL EARTH OBS, V20, P20, DOI 10.1016/j.jag.2011.12.010; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; Ide R, 2013, ECOL INFORM, V16, P25, DOI 10.1016/j.ecoinf.2013.04.003; Ivits E, 2013, ECOL INDIC, V26, P49, DOI 10.1016/j.ecolind.2012.10.012; Ivits E, 2012, GLOBAL PLANET CHANGE, V88-89, P85, DOI 10.1016/j.gloplacha.2012.03.010; Jeganathan C, 2014, REMOTE SENS ENVIRON, V143, P154, DOI 10.1016/j.rse.2013.11.020; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jin ZN, 2013, CLIMATIC CHANGE, V119, P435, DOI 10.1007/s10584-013-0722-7; Kaduk J, 1996, CLIMATE RES, V6, P1, DOI 10.3354/cr006001; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Krishnaswamy J, 2014, GLOBAL CHANGE BIOL, V20, P203, DOI 10.1111/gcb.12362; Lesica P, 2010, J ARID ENVIRON, V74, P1013, DOI 10.1016/j.jaridenv.2010.02.002; LLOYD D, 1990, INT J REMOTE SENS, V11, P2269, DOI 10.1080/01431169008955174; Odland A., 2011, ALPINE ENV GEOLOGY E, P85; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Prieto P, 2008, ANN BOT-LONDON, V102, P275, DOI 10.1093/aob/mcn090; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Shen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087977; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Shutova E, 2006, INT J BIOMETEOROL, V51, P155, DOI 10.1007/s00484-006-0042-y; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockli R, 2004, INT J REMOTE SENS, V25, P3303, DOI 10.1080/01431160310001618149; Stockli R, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001545; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Tucker CJ, 2004, NA94APR15BN116G U MA; Verstraete MM, 2008, ADV SPACE RES, V41, P1773, DOI 10.1016/j.asr.2007.05.066; Vitasse Y, 2013, EUR J FOREST RES, V132, P1, DOI 10.1007/s10342-012-0661-2; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Wielgolaski F.E., 2013, PHENOLOGY INTEGRATIV, P225; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zeng HQ, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045508; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang XY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031447; Zhang XY, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000217; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	69	40	40	14	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157134	10.1371/journal.pone.0157134	http://dx.doi.org/10.1371/journal.pone.0157134			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276082	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700072
J	Yang, F; Cao, HB; Xiao, QY; Guo, XQ; Zhuang, Y; Zhang, CY; Wang, TC; Lin, HY; Song, YL; Hu, GL; Liu, P				Yang, Fei; Cao, Huabin; Xiao, Qingyang; Guo, Xiaoquan; Zhuang, Yu; Zhang, Caiying; Wang, Tiancheng; Lin, Huayuan; Song, Yalu; Hu, Guoliang; Liu, Ping			Transcriptome Analysis and Gene Identification in the Pulmonary Artery of Broilers with Ascites Syndrome	PLOS ONE			English	Article							RIGHT-VENTRICULAR FAILURE; NITRIC-OXIDE; HYPERTENSION; EXPRESSION; CHICKENS; HYPOXIA; GROWTH; SUSCEPTIBILITY; PROTEIN; LUNGS	Background Pulmonary arterial hypertension, also known as Ascites syndrome (AS), remains a clinically challenging disease with a large impact on both humans and broiler chickens. Pulmonary arterial remodeling presents a key step in the development of AS. The precise molecular mechanism of pulmonary artery remodeling regulating AS progression remains unclear. Methodology/Principal Findings We obtained pulmonary arteries from two positive AS and two normal broilers for RNA sequencing (RNA-seq) analysis and pathological observation. RNA-seq analysis revealed a total of 895 significantly differentially expressed genes (DEGs) with 437 up-regulated and 458 down-regulated genes, which were significantly enriched to 12 GO (Gene Ontology) terms and 4 KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways (Padj<0.05) regulating pulmonary artery remodeling and consequently occurrence of AS. These GO terms and pathways include ribosome, Jak-STAT and NOD-like receptor signaling pathways which regulate pulmonary artery remodeling through vascular smooth cell proliferation, inflammation and vascular smooth cell proliferation together. Some notable DEGs within these pathways included downregulation of genes like RPL 5, 7, 8, 9, 14; upregulation of genes such as IL-6, K60, STAT3, STAT5 Pim1 and SOCS3; IKK alpha, I kappa B, P38, five cytokines IL-6, IL8, IL-1 beta, IL-18, and MIP-1 beta. Six important regulators of pulmonary artery vascular remodeling and construction like CYP1B1, ALDH7A1, MYLK, CAMK4, BMP7 and INOS were upregulated in the pulmonary artery of AS broilers. The pathology results showed that the pulmonary artery had remodeled and become thicker in the disease group. Conclusions/Significance Our present data suggested some specific components of the complex molecular circuitry regulating pulmonary arterial remodeling underlying AS progression in broilers. We revealed some valuable candidate genes and pathways that involved in pulmonary artery remodeling further contributing to the AS progression.	[Yang, Fei; Cao, Huabin; Xiao, Qingyang; Guo, Xiaoquan; Zhuang, Yu; Zhang, Caiying; Wang, Tiancheng; Lin, Huayuan; Song, Yalu; Hu, Guoliang; Liu, Ping] JiangXi Agr Univ, Inst Anim Populat Hlth, Coll Anim Sci & Technol, NO 1101,Zhimin Ave, Nanchang 330045, Peoples R China	Jiangxi Agricultural University	Hu, GL; Liu, P (corresponding author), JiangXi Agr Univ, Inst Anim Populat Hlth, Coll Anim Sci & Technol, NO 1101,Zhimin Ave, Nanchang 330045, Peoples R China.	hgljx@163.com; PingLiujx@163.com	liu, ping/T-8380-2019	Guo, Xiaoquan/0000-0001-6041-8765	National Natural Science Foundation of China [31402266]; Natural Science Foundation of Jiangxi Province [GJJ14311]; Technology R & D Program of Jiangxi Province [20141BBF60035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Technology R & D Program of Jiangxi Province	Funding provided by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) awarded to PL (No. 31402266), the Natural Science Foundation of Jiangxi Province (http://www.11467.com/nanchang/co/58361.htm) awarded to PL (No. GJJ14311); the Technology R & D Program of Jiangxi Province (http://www.jxstc.gov.cn/) awarded to PL (No. 20141BBF60035).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babcock HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101782; Bai H, 2014, PLOS ONE, P1; Behrooj N, 2012, BRIT POULTRY SCI, V53, P658, DOI 10.1080/00071668.2012.727082; Chen S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-82; Cheng NL, 2015, AGING CELL, V14, P200, DOI 10.1111/acel.12294; Church AC, 2015, AM J PHYSIOL-LUNG C, V309, pL333, DOI 10.1152/ajplung.00038.2015; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Das M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096043; Deng H, 2010, AM J PHYSIOL-LUNG C, V298, pL793, DOI 10.1152/ajplung.00108.2009; Dominguez-Avila N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/190382; Druyan S, 2007, POULTRY SCI, V86, P621, DOI 10.1093/ps/86.4.621; Fernandez Ruby A, 2012, J Signal Transduct, V2012, P951497, DOI 10.1155/2012/951497; Gore B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100310; Hamal KR, 2012, AVIAN PATHOL, V41, P211, DOI 10.1080/03079457.2012.663077; Hamal KR, 2010, AM J PHYSIOL-REG I, V298, pR235, DOI 10.1152/ajpregu.00451.2009; Hassanpour H, 2013, BRIT POULTRY SCI, V54, P581, DOI 10.1080/00071668.2013.828151; Hassanpour H, 2009, BRIT POULTRY SCI, V50, P725, DOI 10.1080/00071660903141005; JULIAN RJ, 1992, CAN VET J, V33, P382; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; JULIAN RJ, 1989, AVIAN PATHOL, V18, P675, DOI 10.1080/03079458908418641; JULIAN RJ, 1993, AVIAN PATHOL, V22, P419, DOI 10.1080/03079459308418934; Kalmar ID, 2013, VET J, V197, P169, DOI 10.1016/j.tvjl.2013.03.011; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lee TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117356; Li Y, 2013, AVIAN PATHOL, V42, P335, DOI 10.1080/03079457.2013.804903; Liongue Clifford, 2013, JAKSTAT, V2, pe22756, DOI 10.4161/jkst.22756; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullen LM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0645-y; Nain S, 2009, RES VET SCI, V86, P479, DOI 10.1016/j.rvsc.2008.08.008; Palenski TL, 2013, LAB INVEST, V93, P646, DOI 10.1038/labinvest.2013.55; Paulin Roxane, 2012, JAKSTAT, V1, P223, DOI 10.4161/jkst.22366; Qiao LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051514; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; RATH NC, 1995, AVIAN DIS, V39, P382, DOI 10.2307/1591883; Shi SR, 2014, MOL BIOSYST, V10, P2984, DOI 10.1039/c4mb00360h; Smolock EM, 2012, CIRCULATION, V126, P2418, DOI 10.1161/CIRCULATIONAHA.112.125971; Stenmark KR, 2015, J APPL PHYSIOL, V119, P1164, DOI 10.1152/japplphysiol.00283.2015; Tan X, 2007, AVIAN PATHOL, V36, P261, DOI 10.1080/03079450701460765; Wang J, 2007, J VET MED A, V54, P564, DOI 10.1111/j.1439-0442.2007.00988.x; Wideman RF, 2013, POULTRY SCI, V92, P64, DOI 10.3382/ps.2012-02745; Wideman RF, 2001, WORLD POULTRY SCI J, V57, P289, DOI 10.1079/WPS20010021; Yamauchi S, 2010, P NATL ACAD SCI USA, V107, P11924, DOI 10.1073/pnas.0913179107; Yang Y, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/352371; Yang Y, 2007, EUR J PHARMACOL, V561, P137, DOI 10.1016/j.ejphar.2007.01.036; Yang Y, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-28; Yang Y, 2010, ANIM SCI J, V81, P494, DOI 10.1111/j.1740-0929.2010.00762.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang JJ, 2013, POULTRY SCI, V92, P2044, DOI 10.3382/ps.2013-03097; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112695; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014; Zoranovic Tamara, 2013, JAKSTAT, V2, pe25408, DOI 10.4161/jkst.25408	56	22	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156045	10.1371/journal.pone.0156045	http://dx.doi.org/10.1371/journal.pone.0156045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275925	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700015
J	Yang, ST; Liao, Y; Cong, L; Lu, XL; Yang, RY				Yang, Suteng; Liao, Yong; Cong, Lin; Lu, Xuelian; Yang, Rongya			In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahii	PLOS ONE			English	Article							CANDIDA-ALBICANS BIOFILMS; AMPHOTERICIN-B; ACETYLSALICYLIC-ACID; FUNGAL BIOFILMS; INFECTIONS; RESISTANCE; FLUCONAZOLE; IBUPROFEN; COMBINATIONS; VORICONAZOLE	Increasing drug resistance has brought enormous challenges to the management of Trichosporon spp. infections. The in vitro antifungal activities of non-steroidal anti-inflammatory drugs (NSAIDs) against Candida spp. and Cryptococcus spp. were recently discovered. In the present study, the in vitro interactions between three NSAIDs (aspirin, ibuprofen and diclofenac sodium) and commonly used antifungal agents (fluconazole, itraconazole, voriconazole, caspofungin and amphotericin B) against planktonic and biofilm cells of T. asahii were evaluated using the checkerboard microdilution method. The spectrophotometric method and the XTT reduction assay were used to generate data on biofilm cells. The fractional inhibitory concentration index (FICI) and the.E model were compared to interpret drug interactions. Using the FICI, the highest percentages of synergistic effects against planktonic cells (86.67%) and biofilm cells (73.33%) were found for amphotericin B/ibuprofen, and caspofungin/ibuprofen showed appreciable percentages (73.33% for planktonic form and 60.00% for biofilm) as well. We did not observe antagonism. The.E model gave consistent results with FICI (86.67%). Our findings suggest that amphotericin B/ibuprofen and caspofungin/ibuprofen combinations have potential effects against T. asahii. Further in vivo and animal studies to investigate associated mechanisms need to be conducted.	[Yang, Suteng; Liao, Yong; Cong, Lin; Lu, Xuelian; Yang, Rongya] Gen Hosp Beijing Mil Command, Dept Dermatol, Beijing, Peoples R China; [Yang, Suteng; Liao, Yong] Second Mil Med Univ Peoples Liberat Army, Clin Med Coll Beijing Mil Reg, Shanghai, Peoples R China	Seventh Medical Center of Chinese PLA General Hospital; Naval Medical University	Yang, RY (corresponding author), Gen Hosp Beijing Mil Command, Dept Dermatol, Beijing, Peoples R China.	yangrya_l@sina.com		Yang, Rongya/0000-0002-4490-4007	National Natural Science Foundation of China [81301410]; Beijing Natural Science Foundation [7163225]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 81301410) (http://www.nsfc.gov.cn/) and Beijing Natural Science Foundation (NO. 7163225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0; Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004; Amir M, 2008, EUR J MED CHEM, V43, P2056, DOI 10.1016/j.ejmech.2007.09.025; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Bink A, 2012, J INFECT DIS, V206, P1790, DOI 10.1093/infdis/jis594; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Costa de Oliveira S, 2015, ANTIMICROB AGENTS CH; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Deva R, 2001, FEMS MICROBIOL LETT, V198, P37, DOI 10.1111/j.1574-6968.2001.tb10616.x; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Falk R, 2003, J CLIN MICROBIOL, V41, P911, DOI 10.1128/JCM.41.2.911.2003; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; GRAUER ME, 1994, INFECTION, V22, P283, DOI 10.1007/BF01739918; Hatipoglu N, 2013, EXPERT REV ANTI-INFE, V11, P523, DOI [10.1586/ERI.13.29, 10.1586/eri.13.29]; HOY J, 1986, REV INFECT DIS, V8, P959; Hynninen VV, 2006, ANTIMICROB AGENTS CH, V50, P1967, DOI 10.1128/AAC.01483-05; Kontoyiannis DP, 2004, SCAND J INFECT DIS, V36, P564, DOI 10.1080/00365540410017563; Kushima H, 2012, FEMS YEAST RES, V12, P662, DOI 10.1111/j.1567-1364.2012.00816.x; Leeuw NJ, 2007, ANTON LEEUW INT J G, V91, P393, DOI 10.1007/s10482-006-9124-4; Liao Y, 2014, ANTIMICROB AGENTS CH, V58, P7615, DOI 10.1128/AAC.03817-14; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Maligie MA, 2005, ANTIMICROB AGENTS CH, V49, P2851, DOI 10.1128/AAC.49.7.2851-2856.2005; Meletiadis J, 2003, ANTIMICROB AGENTS CH, V47, P106, DOI 10.1128/AAC.47.1.106-117.2003; Niwa T, 2014, CURR DRUG METAB, V15, P651; Oliveira Dos Santos C, 2016, BMC INFECT DIS, V16, P148, DOI [10.1186/s12879-016-1477-3, DOI 10.1186/S12879-016-1477-3]; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Pina-Vaz C, 2005, J ANTIMICROB CHEMOTH, V56, P678, DOI 10.1093/jac/dki264; Ricardo E, 2009, FEMS YEAST RES, V9, P618, DOI 10.1111/j.1567-1364.2009.00504.x; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Rodriguez-Tudela JL, 2005, ANTIMICROB AGENTS CH, V49, P4026, DOI 10.1128/AAC.49.10.4026-4034.2005; Ruan SY, 2009, CLIN INFECT DIS, V49, pE11, DOI 10.1086/599614; SCOTT EM, 1995, ANTIMICROB AGENTS CH, V39, P2610, DOI 10.1128/AAC.39.12.2610; Sebolai OM, 2008, CAN J MICROBIOL, V54, P111, DOI 10.1139/w07-116; Stepanovic S, 2004, J CHEMOTHER; Sun W, 2012, J MED MICROBIOL, V61, P1750, DOI 10.1099/jmm.0.049817-0; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Tsai MS, 2012, MYCOPATHOLOGIA, V174, P121, DOI 10.1007/s11046-012-9525-z; Vitale RG, 2005, METH MOLEC MED, V118, P143; WALSH TJ, 1990, J CLIN MICROBIOL, V28, P1616, DOI 10.1128/JCM.28.7.1616-1622.1990; Wolf DG, 2001, J CLIN MICROBIOL, V39, P4420, DOI 10.1128/JCM.39.12.4420-4425.2001; Yucesoy M, 2000, J CHEMOTHER; Zhou YB, 2012, ANTIMICROB AGENTS CH, V56, P3250, DOI 10.1128/AAC.06082-11	46	35	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157047	10.1371/journal.pone.0157047	http://dx.doi.org/10.1371/journal.pone.0157047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275608	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700061
J	Land, WM				Land, William M.			Action Effects and Task Knowledge: The Influence of Anticipatory Priming on the Identification of Task-Related Stimuli in Experts	PLOS ONE			English	Article							CHOICE REACTION-TIMES; ATTENTIONAL FOCUS; EXTERNAL FOCUS; AUTOMATIC INTEGRATION; TALENT IDENTIFICATION; MUSIC PERFORMANCE; AUDITORY-FEEDBACK; SKILL; EXECUTION; REPRESENTATION	The purpose of the present study was to examine the extent to which anticipation of an action's perceptual effect primes identification of task-related stimuli. Specifically, skilled (n = 16) and novice (n = 24) tennis players performed a choice-reaction time (CRT) test in which they identified whether the presented stimulus was a picture of a baseball bat or tennis racket. Following their response, auditory feedback associated with either baseball or tennis was presented. The CRT test was performed in blocks in which participants predictably received the baseball sound or tennis sound irrespective of which stimulus picture was displayed. Results indicated that skilled tennis players responded quicker to tennis stimuli when the response was predictably followed by the tennis auditory effect compared to the baseball auditory effect. These findings imply that, within an individual's area of expertise, domain-relevant knowledge is primed by anticipation of an action's perceptual effect, thus allowing the cognitive system to more quickly identify environmental information. This finding provides a more complete picture of the influence that anticipation can have on the cognitive-motor system. No differences existed for novices.	[Land, William M.] Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Land, WM (corresponding author), Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA.	William.land@utsa.edu		Land, William/0000-0003-3244-1348				Beckers T, 2002, PSYCHOL RES-PSYCH FO, V66, P166, DOI 10.1007/s00426-002-0090-9; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Blasing BE, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01008, 10.3389/fpsyg.2014.01500]; Castaneda B, 2007, J SPORT EXERCISE PSY, V29, P60, DOI 10.1123/jsep.29.1.60; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Fagioli S, 2007, PSYCHOL RES-PSYCH FO, V71, P22, DOI 10.1007/s00426-005-0033-3; Fischer MH, 1997, J EXP PSYCHOL HUMAN, V23, P404, DOI 10.1037/0096-1523.23.2.404; Fischman MG, 2003, RES Q EXERCISE SPORT, V74, P17, DOI 10.1080/02701367.2003.10609060; Flach R, 2006, ACTA PSYCHOL, V122, P11, DOI 10.1016/j.actpsy.2005.09.001; Ford P, 2007, J MOTOR BEHAV, V39, P481, DOI 10.3200/JMBR.39.6.481-490; Foster J, 2007, SOCIAL PSYCHOL HDB B, P201; Gray R, 2004, J EXP PSYCHOL-APPL, V10, P42, DOI 10.1037/1076-898X.10.1.42; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; Hommel B, 2008, OXFORD HDB HUMAN ACT, P369; Jackson RC, 2006, J SPORT EXERCISE PSY, V28, P49, DOI 10.1123/jsep.28.1.49; James W., 1890, PRINCIPLES PSYCHOL, V2; Keller PE, 2008, Q J EXP PSYCHOL, V61, P275, DOI 10.1080/17470210601160864; Kornblum S, 2002, ATTENTION PERFORM, V19, P9; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Kunde W, 2004, PSYCHOL RES-PSYCH FO, V68, P199, DOI 10.1007/s00426-003-0156-3; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Land WM, 2014, PSYCHOL SPORT EXERC, V15, P30, DOI 10.1016/j.psychsport.2013.09.006; Land WM, 2013, ACTA PSYCHOL, V144, P298, DOI 10.1016/j.actpsy.2013.06.002; Land WM, 2013, J SPORT EXERCISE PSY, V35, P250, DOI 10.1123/jsep.35.3.250; Luria A. R., 1961, ROLE SPEECH REGULATI, P50; LURIA AR, 1959, WORD, V15, P341, DOI 10.1080/00437956.1959.11659703; Lu┬tze R.H., 1852, MED PSYCHOL ODER PHY; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; MOWBRAY GH, 1960, Q J EXP PSYCHOL, V12, P193, DOI 10.1080/17470216008416726; MOWBRAY GH, 1959, Q J EXP PSYCHOL, V11, P16, DOI 10.1080/17470215908416282; Musseler J, 1997, J EXP PSYCHOL HUMAN, V23, P861, DOI 10.1037/0096-1523.23.3.861; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Nitsch JR., 2004, Z SPORTPSYCHOL, V11, P10, DOI [DOI 10.1026/1612-5010.11.1.10, 10.1026/1612-5010.11.1.10]; Pfordresher PQ, 2005, J EXP PSYCHOL HUMAN, V31, P1331, DOI 10.1037/0096-1523.31.6.1331; Pfordresher PQ, 2003, J EXP PSYCHOL HUMAN, V29, P949, DOI 10.1037/0096-1523.29.5.949; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1007/978-3-642-75348-0_7; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; ROSENBAUM DA, 1990, ATTENTION PERFORM, P321; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; Rosenbaum DA, 2006, MOTOR CONTROL AND LEARNING, P9, DOI 10.1007/0-387-28287-4_2; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Schack T., 2004, J SPORT EXERCISE PSY, V2, P403, DOI [10.1080/1612197x.2004.9671753, DOI 10.1080/1612197X.2004.9671753, 10.1080/1612197X.2004.9671753]; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shin YK, 2010, PSYCHOL BULL, V136, P943, DOI 10.1037/a0020541; Short MW, 1999, ACTA PSYCHOL, V100, P243, DOI 10.1016/S0001-6918(98)00020-1; Ste-marie D., 2003, EXPERT PERFORMANCE S, P169; Wenke D, 2007, PSYCHOL RES-PSYCH FO, V71, P92, DOI 10.1007/s00426-005-0038-y; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Williams A.M., 2007, HDB SPORT PSYCHOL, P203, DOI DOI 10.1002/9781118270011.CH9; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Williams AM., 2003, EXPERT PERFORMANCE S, P219; Wohlschlager A, 2000, VISION RES, V40, P925, DOI 10.1016/S0042-6989(99)00239-4; Wulf G, 2000, RES Q EXERCISE SPORT, V71, P229, DOI 10.1080/02701367.2000.10608903; Wulf G, 1998, J MOTOR BEHAV, V30, P169, DOI 10.1080/00222899809601334; Wulf G., 2007, ATTENTION MOTOR SKIL; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035; Ziessler M, 2004, PSYCHOL RES-PSYCH FO, V68, P163, DOI 10.1007/s00426-003-0153-6	59	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156928	10.1371/journal.pone.0156928	http://dx.doi.org/10.1371/journal.pone.0156928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272987	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000050
J	Goldsztein, GH				Goldsztein, Guillermo H.			Reactions of Standing Bipeds on Moving Platforms to Keep Their Balance May Increase the Amplitude of Oscillations of Platforms Satisfying Hooke's Law	PLOS ONE			English	Article							CENTER-OF-MASS; LATERAL PERTURBATIONS; INTERMITTENT CONTROL; QUIET STANCE; POSTURE; RESPONSES; ANKLE; FOOTBRIDGES; STABILITY; DYNAMICS	Consider a person standing on a platform that oscillates laterally, i.e. to the right and left of the person. Assume the platform satisfies Hooke's law. As the platform moves, the person reacts and moves its body attempting to keep its balance. We develop a simple model to study this phenomenon and show that the person, while attempting to keep its balance, may do positive work on the platform and increase the amplitude of its oscillations. The studies in this article are motivated by the oscillations in pedestrian bridges that are sometimes observed when large crowds cross them.	[Goldsztein, Guillermo H.] Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Goldsztein, GH (corresponding author), Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA.	ggold@math.gatech.edu						Balasubramaniam R, 2002, TRENDS COGN SCI, V6, P531, DOI 10.1016/S1364-6613(02)02021-1; Bardy BG, 2002, J EXP PSYCHOL HUMAN, V28, P499, DOI 10.1037//0096-1523.28.3.499; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bender C.M., 1999, ADVANCED MATHEMATICA; Bennett M, 2002, P ROY SOC A-MATH PHY, V458, P563, DOI 10.1098/rspa.2001.0888; BLACK FO, 1982, AM J OTOLARYNG, V3, P309, DOI 10.1016/S0196-0709(82)80002-1; Bocian M, 2012, J SOUND VIB, V331, P3914, DOI 10.1016/j.jsv.2012.03.023; Bodgi J, 2007, KEY ENG MATER, V347, P685, DOI 10.4028/www.scientific.net/KEM.347.685; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Bruno L, 2012, ENG STRUCT, V36, P228, DOI 10.1016/j.engstruct.2011.12.012; BRUNT D, 1992, MED SCI SPORT EXER, V24, P171; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Carver SG, 2009, CHAOS, V19, DOI 10.1063/1.3127577; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; DALLARD P., 2001, J BRIDGE ENG, V6, P412, DOI [10.1061/(ASCE)1084-0702(2001)6:6(412), DOI 10.1061/(ASCE)1084-0702(2001)6:6(412)]; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Henry SM, 2001, J NEUROPHYSIOL, V85, P559, DOI 10.1152/jn.2001.85.2.559; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Huygens C., 1986, GEOMETRICAL DEMONSTR; Ingolfsson ET, 2012, ENG STRUCT, V45, P21, DOI 10.1016/j.engstruct.2012.05.038; Ko JH, 2013, EXP BRAIN RES, V226, P183, DOI 10.1007/s00221-013-3424-5; Ko YG, 2001, HUM MOVEMENT SCI, V20, P737, DOI 10.1016/S0167-9457(01)00052-5; Ko YG, 2003, HUM MOVEMENT SCI, V22, P47, DOI 10.1016/S0167-9457(02)00177-X; Koluda P, 2014, COMMUN NONLINEAR SCI, V19, P977, DOI 10.1016/j.cnsns.2013.08.008; Kuo A.D., 1993, PROG BRAIN RES, V97, P349, DOI 10.1016/s0079-6123(08)62294-3; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; KUO AD, 1993, J BIOMECH, V26, P137, DOI 10.1016/0021-9290(93)90085-S; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Macdonald JH, 2008, PROCEEDINGS OF THE R; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; MCCOLLUM G, 1989, J MOTOR BEHAV, V21, P225; Nawayseh N, 2006, J SOUND VIB, V298, P725, DOI 10.1016/j.jsv.2006.06.027; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Otten E, 1999, PHILOS T ROY SOC B, V354, P869, DOI 10.1098/rstb.1999.0439; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Pai YC, 2000, J BIOMECH, V33, P387, DOI 10.1016/S0021-9290(99)00199-2; Pantaleone J, 2002, AM J PHYS, V70, P992, DOI 10.1119/1.1501118; Park S, 2004, EXP BRAIN RES, V154, P417, DOI 10.1007/s00221-003-1674-3; Rietdyk S, 1999, J BIOMECH, V32, P1149, DOI 10.1016/S0021-9290(99)00116-5; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Ulrichs H, 2009, CHAOS, V19, DOI 10.1063/1.3266924; Venuti F, 2009, PHYS LIFE REV, V6, P176, DOI 10.1016/j.plrev.2009.07.001; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085414; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; WINTER DA, 1993, NEUROSCI RES COMMUN, V12, P141; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	60	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157675	10.1371/journal.pone.0157675	http://dx.doi.org/10.1371/journal.pone.0157675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304857	Green Published, gold, Green Submitted			2022-12-26	WOS:000377824800079
J	Hayat, T; Bibi, S; Alsaadi, F; Rafiq, M				Hayat, Tasawar; Bibi, Shahida; Alsaadi, Fuad; Rafiq, Maimona			Peristaltic Transport of Prandtl-Eyring Liquid in a Convectively Heated Curved Channel	PLOS ONE			English	Article							NON-NEWTONIAN FLUID; MASS-TRANSFER; HEAT/MASS TRANSFER; COMPLIANT WALLS; MAGNETIC-FIELD; FLOW; VISCOSITY; ANNULUS; MOTION; MHD	Here peristaltic activity for flow of a Prandtl-Eyring material is modeled and analyzed for curved geometry. Heat transfer analysis is studied using more generalized convective conditions. The channel walls satisfy complaint walls properties. Viscous dissipation in the thermal equation accounted. Unlike the previous studies is for uniform magnetic field on this topic, the radial applied magnetic field has been utilized in the problems development. Solutions for stream function (psi), velocity (u), and temperature (theta) for small parameter beta have been derived. The salient features of heat transfer coefficient Z and trapping are also discussed for various parameters of interest including magnetic field, curvature, material parameters of fluid, Brinkman, Biot and compliant wall properties. Main observations of present communication have been included in the conclusion section.	[Hayat, Tasawar; Bibi, Shahida; Rafiq, Maimona] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaadi, Fuad] King Abdulaziz Univ, Dept Elect & Comp Engn, Fac Engn, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Rafiq, M (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	maimona_88@hotmail.com	Rafiq, Maimona/AAM-7714-2020; Alsaadi, Fuad E/Q-6022-2018; Hayat, Tasawar/Y-2524-2019	Alsaadi, Fuad E/0000-0001-6420-3948; 				Abbasi FM, 2015, J MAGN MAGN MATER, V382, P104, DOI 10.1016/j.jmmm.2015.01.040; Abd Elmaboud Y, 2011, APPL MATH MODEL, V35, P2695, DOI 10.1016/j.apm.2010.11.031; Abd-Alla AM, 2015, J MAGN MAGN MATER, V374, P680, DOI 10.1016/j.jmmm.2014.08.091; Abd-Alla AM, 2014, J MAGN MAGN MATER, V363, P166, DOI 10.1016/j.jmmm.2014.03.023; Ali N, 2010, EUR J MECH B-FLUID, V29, P387, DOI 10.1016/j.euromechflu.2010.04.002; Ali N, 2010, Z NATURFORSCH A, V65, P191, DOI 10.1515/zna-2010-0306; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Gad NS, 2014, APPL MATH COMPUT, V235, P546, DOI 10.1016/j.amc.2014.02.081; Gul T., 2015, UNSTEADY MHD THIN FI, V10; Gul T., 2014, HEAT TRANSFER ANAL M, V9; Gul T., 2014, THIN FILM FLOW MHD 3, V9; Hayat T, 2014, J MOL LIQ, V193, P74, DOI 10.1016/j.molliq.2013.12.036; Hayat T, 2013, J MECH, V29, P599, DOI 10.1017/jmech.2013.28; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P5126, DOI 10.1016/j.ijheatmasstransfer.2011.07.036; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P1615, DOI 10.1016/j.ijheatmasstransfer.2010.11.022; Hina S, 2015, APPL MATH COMPUT, V263, P378, DOI 10.1016/j.amc.2015.04.068; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3386, DOI 10.1016/j.ijheatmasstransfer.2012.02.074; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3511, DOI 10.1016/j.ijheatmasstransfer.2012.03.014; Hussain Q, 2015, J CENT SOUTH UNIV, V22, P392, DOI 10.1007/s11771-015-2534-6; Hussain Q, 2014, J BRAZ SOC MECH SCI, V36, P681, DOI 10.1007/s40430-013-0104-0; Javed M, 2014, APPL MATH COMPUT, V244, P654, DOI 10.1016/j.amc.2014.07.009; Kothandapani M, 2015, J MAGN MAGN MATER, V378, P152, DOI 10.1016/j.jmmm.2014.11.031; Lachiheb M, 2014, APPL MATH COMPUT, V244, P761, DOI 10.1016/j.amc.2014.07.062; Latham TW., 1996, FLUID MOTION PERISTA; Mekheimer K., 2014, J EGYPT MATH SOC, V22, P143, DOI [10.1016/j.joems.2013.05.003, DOI 10.1016/J.JOEMS.2013.05.003]; Nadeem S, 2009, INT J HEAT MASS TRAN, V52, P4722, DOI 10.1016/j.ijheatmasstransfer.2009.04.037; Saleem M, 2014, INT J HEAT MASS TRAN, V68, P514, DOI 10.1016/j.ijheatmasstransfer.2013.09.053; Sato H., 2000, T JAPAN SOC MECH ENG, V66, P679; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Sinha A, 2015, ALEX ENG J, V54, P691, DOI 10.1016/j.aej.2015.03.030; Srinivas S, 2009, COMPUT PHYS COMMUN, V180, P2115, DOI 10.1016/j.cpc.2009.06.015; Tripathi D, 2013, MATH COMPUT MODEL, V57, P1270, DOI 10.1016/j.mcm.2012.10.030; Vajravelu K, 2007, INT J NONLIN MECH, V42, P754, DOI 10.1016/j.ijnonlinmec.2007.02.014	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156995	10.1371/journal.pone.0156995	http://dx.doi.org/10.1371/journal.pone.0156995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304458	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800033
J	Viera, JT; El-Merahbi, R; Nieswandt, B; Stegner, D; Sumara, G				Viera, Jonathan Trujillo; El-Merahbi, Rabih; Nieswandt, Bernhard; Stegner, David; Sumara, Grzegorz			Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight	PLOS ONE			English	Article							SIGNALING PATHWAYS; HUMAN PLATELETS; PPAR-GAMMA; MTOR; INHIBITION; CANCER	Obesity is a major risk factor predisposing to the development of peripheral insulin resistance and type 2 diabetes (T2D). Elevated food intake and/or decreased energy expenditure promotes body weight gain and acquisition of adipose tissue. Number of studies implicated phospholipase D (PLD) enzymes and their product, phosphatidic acid (PA), in regulation of signaling cascades controlling energy intake, energy dissipation and metabolic homeostasis. However, the impact of PLD enzymes on regulation of metabolism has not been directly determined so far. In this study we utilized mice deficient for two major PLD isoforms, PLD1 and PLD2, to assess the impact of these enzymes on regulation of metabolic homeostasis. We showed that mice lacking PLD1 or PLD2 consume more food than corresponding control animals. Moreover, mice deficient for PLD2, but not PLD1, present reduced energy expenditure. In addition, deletion of either of the PLD enzymes resulted in development of elevated body weight and increased adipose tissue content in aged animals. Consistent with the fact that elevated content of adipose tissue predisposes to the development of hyperlipidemia and insulin resistance, characteristic for the pre-diabetic state, we observed that Pld1(-/-) and Pld2(-/-) mice present elevated free fatty acids (FFA) levels and are insulin as well as glucose intolerant. In conclusion, our data suggest that deficiency of PLD1 or PLD2 activity promotes development of overweight and diabetes.	[Viera, Jonathan Trujillo; El-Merahbi, Rabih; Nieswandt, Bernhard; Stegner, David; Sumara, Grzegorz] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, D-97080 Wurzburg, Germany; [Nieswandt, Bernhard; Stegner, David] Univ Hosp Wurzburg, Inst Expt Biomed, Josef Schneider Str 2,Haus D15, D-97080 Wurzburg, Germany	University of Wurzburg	Sumara, G (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, D-97080 Wurzburg, Germany.	grzegorz.sumara@uni-wuerzburg.de	Stegner, David/AAA-4948-2019	Stegner, David/0000-0003-1059-9865; Trujillo-Viera, Jonathan/0000-0003-0566-4589; Sumara, Grzegorz/0000-0003-1502-6265	German Research Foundation (DFG) [Su 820/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by Emmy Noether grant (Number Su 820/1-1) from German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors disclose no financial or competing interests.	Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bruntz RC, 2014, PHARMACOL REV, V66, P1033, DOI 10.1124/pr.114.009217; Burkhardt U, 2014, NEUROSCI LETT, V572, P48, DOI 10.1016/j.neulet.2014.04.052; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; COORSSEN JR, 1993, FEBS LETT, V316, P170, DOI 10.1016/0014-5793(93)81209-I; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Elia M, 1992, ENERGY EXPENDITURE F; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Frohman MA, 2015, TRENDS PHARMACOL SCI, V36, P137, DOI 10.1016/j.tips.2015.01.001; Ghim J, 2014, ARTERIOSCL THROM VAS, V34, P1697, DOI 10.1161/ATVBAHA.114.303416; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Joy JM, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-29; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; Provost JJ, 1996, BIOCHEM J, V319, P285, DOI 10.1042/bj3190285; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Stegner D, 2013, ARTERIOSCL THROM VAS, V33, P2212, DOI 10.1161/ATVBAHA.113.302030; Teng SZ, 2015, MOL BIOL CELL, V26, P506, DOI 10.1091/mbc.E14-03-0802; Thielmann I, 2012, J THROMB HAEMOST, V10, P2361, DOI 10.1111/j.1538-7836.2012.04924.x; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Vorland M, 2008, PLATELETS, V19, P211, DOI 10.1080/09537100701777329; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	33	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157607	10.1371/journal.pone.0157607	http://dx.doi.org/10.1371/journal.pone.0157607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299737	gold, Green Published, Green Submitted			2022-12-26	WOS:000377822200066
J	Li, FL; Zan, QJ; Hu, ZY; Shin, PKS; Cheung, SG; Wong, YS; Tam, NFY; Lei, AP				Li, Feng-Lan; Zan, Qi-Jie; Hu, Zheng-Yu; Shin, Paul-K. S.; Cheung, Siu-Gin; Wong, Yuk-Shan; Tam, Nora Fung-Yee; Lei, An-Ping			Are Photosynthetic Characteristics and Energetic Cost Important Invasive Traits for Alien Sonneratia Species in South China?	PLOS ONE			English	Article							LEAF CONSTRUCTION COST; GAS-EXCHANGE CHARACTERISTICS; NITROGEN-USE EFFICIENCY; MIKANIA-MICRANTHA; LITTER PRODUCTION; CELL-WALLS; ALLOCATION; AREA; ASSIMILATION; COMMUNITY	A higher photosynthesis and lower energetic cost are recognized as important characteristics for invasive species, but whether these traits are also important for the ability of alien mangrove species to become invasive has seldom been reported. A microcosm study was conducted to compare the photosynthetic characteristics, energetic cost indices and other growth traits between two alien species (Sonneratia apetala and S. caseolaris) and four native mangrove species over four seasons in a subtropical mangrove nature reserve in Shenzhen, South China. The aim of the study was to evaluate the invasive potential of Sonneratia based on these physiological responses. The annual average net photosynthetic rate (P-n), stomatal conductance (G(s)) and total carbon assimilation per unit leaf area (A(total)) of the two alien Sonneratia species were significantly higher than the values of the native mangroves. In contrast, the opposite results were obtained for the leaf construction cost (CC) per unit dry mass (CCM) and CC per unit area (CCA) values. The higher A(total) and lower CC values resulted in a 72% higher photosynthetic energy-use efficiency (PEUE) for Sonneratia compared to native mangroves, leading to a higher relative growth rate (RGR) of the biomass and height of Sonneratia with the respective values being 51% and 119% higher than those of the native species. Higher photosynthetic indices for Sonneratia compared to native species were found in all seasons except winter, whereas lower CC values were found in all four seasons. The present findings reveal that alien Sonneratia species may adapt well and become invasive in subtropical mangrove wetlands in Shenzhen due to their higher photosynthetic characteristics coupled with lower costs in energy use, leading to a higher PEUE. The comparison of these physiological responses between S. apetala and S. caseolaris reveal that the former species is more invasive than the latter one, thus requiring more attention in future.	[Li, Feng-Lan; Lei, An-Ping] Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China; [Li, Feng-Lan; Shin, Paul-K. S.; Cheung, Siu-Gin; Wong, Yuk-Shan; Tam, Nora Fung-Yee] City Univ Hong Kong, Futian CityU Mangrove Res & Dev Ctr, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China; [Zan, Qi-Jie] Guangdong Neilingding Futian Natl Nat Reserve, Shenzhen, Peoples R China; [Hu, Zheng-Yu] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Shin, Paul-K. S.; Cheung, Siu-Gin; Tam, Nora Fung-Yee] City Univ Hong Kong, Dept Biol & Chem, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China; [Wong, Yuk-Shan] Open Univ Hong Kong, Sch Sci & Technol, Kowloon, Hong Kong, Peoples R China	Shenzhen University; City University of Hong Kong; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; City University of Hong Kong; Hong Kong Metropolitan University	Lei, AP (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China.; Tam, NFY (corresponding author), City Univ Hong Kong, Futian CityU Mangrove Res & Dev Ctr, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.; Tam, NFY (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	bhntam@cityu.edu.hk; bioaplei@szu.edu.cn		CHEUNG, Siu Gin/0000-0001-8091-7385	National Natural Science Foundation of China [31170491, 30770393, 31470513, 41576086, 41306084]; Innovation Team Project from Shenzhen University [T201203]; Innovation of Science, Technology Commission of Shenzhen Municipality [JCYJ20150416163041307]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Project from Shenzhen University; Innovation of Science, Technology Commission of Shenzhen Municipality	This research was supported by the National Natural Science Foundation of China (URL: http://isisn.nsfc.gov.cn/egrantweb), no. 31170491, 30770393 (An-Ping Lei's funding), no. 31470513 (Qi-Jie Zan's funding), and no. 41576086, 41306084 (Nora Fung-Yee Tam's funding); Innovation Team Project from Shenzhen University (URL: http://www.szu.edu.cn), no. T201203 (An-Ping Lei's funding); and the Innovation of Science, Technology Commission of Shenzhen Municipality (URL: http://www.szsti.gov.cn/), no. JCYJ20150416163041307 (Nora Fung-Yee Tam's funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Chen LZ, 2008, ESTUAR COAST SHELF S, V79, P644, DOI 10.1016/j.ecss.2008.06.003; Deng X, 2004, BOT BULL ACAD SINICA, V45, P213; Ding J., 1996, CONSERVING CHINAS BI, P125; Drake J. A., 1989, BIOL INVASIONS GLOBA, P525; Durand LZ, 2001, OECOLOGIA, V126, P345, DOI 10.1007/s004420000535; Eamus D, 1998, TREE PHYSIOL, V18, P537; Ewe SML, 2003, FOREST ECOL MANAG, V179, P27, DOI 10.1016/S0378-1127(02)00531-5; Feng YL, 2008, PLANTA, V228, P383, DOI 10.1007/s00425-008-0732-2; Feng YL, 2008, PHYSIOL PLANTARUM, V133, P318, DOI 10.1111/j.1399-3054.2008.01072.x; Feng YL, 2008, PHYSIOL PLANTARUM, V132, P350, DOI 10.1111/j.1399-3054.2007.01019.x; Feng YL, 2011, J ECOL, V99, P1116, DOI 10.1111/j.1365-2745.2011.01843.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Funk JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064502; Han WD, 2004, GUANGXI SCI, V11, P243; Huang Min-shen, 2012, Shengtaixue Zazhi, V31, P2996; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Li FL, 2011, MAR POLLUT BULL, V62, P1957, DOI 10.1016/j.marpolbul.2011.06.032; Li Shichuan, 2014, Journal of Plant Resources and Environment, V23, P15, DOI 10.3969/j.issn.1674-7895.2014.03.03; Li Yun, 1998, Forest Research, V11, P39; [廖宝文 Liao Baowen], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P10; [林初夏 Lin Chuxia], 2004, [生态科学, Ecologic Science], V23, P118; Liu LN, 2014, MAR POLLUT BULL, V85, P747, DOI 10.1016/j.marpolbul.2014.04.047; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lu WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091238; Nagel JM, 2005, NEW PHYTOL, V166, P513, DOI 10.1111/j.1469-8137.2005.01341.x; Nagel JM, 2004, ECOLOGY, V85, P100, DOI 10.1890/02-3005; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pattison RR, 1998, OECOLOGIA, V117, P449, DOI 10.1007/s004420050680; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Schieving F, 1999, NEW PHYTOL, V143, P201, DOI 10.1046/j.1469-8137.1999.00431.x; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Song LY, 2007, BOT STUD, V48, P331; Song LY, 2009, ACTA OECOL, V35, P128, DOI 10.1016/j.actao.2008.09.002; Tam NFY, 1998, J EXP MAR BIOL ECOL, V226, P1, DOI 10.1016/S0022-0981(97)00233-5; Wang BS, 2002, MANGROVE FOREST ECOS, P133; Weltzin JF, 2003, FRONT ECOL ENVIRON, V1, P146, DOI 10.1890/1540-9295(2003)001[0146:BIIAGW]2.0.CO;2; WILLIAMS K, 1987, PLANT CELL ENVIRON, V10, P725; Yuk CL, 2006, THESIS CITY U HONG K; Zan Q.J., 2001, J WUHAN BOT RES, V19, P391; [昝启杰 Zan Qijie], 2002, [广西植物, Guihaia], V22, P331; Zan QJ, 2003, ACTA BOT SIN, V45, P544; [曾群英 Zeng Qunying], 2015, [西北林学院学报, Journal of Northwest Forestry University], V30, P28; Zeng XK, 2015, THESIS SHENZHEN U; Zeng XueQin, 2008, Biodiversity Science, V16, P236, DOI 10.3724/SP.J.1003.2008.07326; Zhang HD, 1998, STUDIES FUTIAN MANGR, P14	51	4	4	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157169	10.1371/journal.pone.0157169	http://dx.doi.org/10.1371/journal.pone.0157169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286250	Green Published, gold, Green Submitted			2022-12-26	WOS:000377564000042
J	Rivera, AR; Castillo-Pichardo, L; Gerena, Y; Dharmawardhane, S				Rivera, Amilcar Rivera; Castillo-Pichardo, Linette; Gerena, Yamil; Dharmawardhane, Suranganie			Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade	PLOS ONE			English	Article							GRAPE SEED EXTRACT; RED WINE POLYPHENOLS; MAMMARY-TUMOR GROWTH; FLAVONOID QUERCETIN; CELL-PROLIFERATION; PI3K PATHWAY; INHIBITION; AMPK; BIOAVAILABILITY; RESVERATROL	The Akt/adenosine monophosphate protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway has emerged as a critical signaling nexus for regulating cellular metabolism, energy homeostasis, and cell growth. Thus, dysregulation of this pathway contributes to the development of metabolic disorders such as obesity, type 2diabetes, and cancer. We previously reported that a combination of grape polyphenols (resveratrol, quercetin and catechin: RQC), at equimolar concentrations, reduces breast cancer (BC) growth and metastasis in nude mice, and inhibits Akt and mTOR activities and activates AMPK, an endogenous inhibitor of mTOR, in metastatic BC cells. The objective of the present study was to determine the contribution of individual polyphenols to the effect of combined RQC on mTOR signaling. Metastatic BC cells were treated with RQC individually or in combination, at various concentrations, and the activities (phosphorylation) of AMPK, Akt, and the mTOR downstream effectors, p70S6 kinase (p70S6K) and 4E binding protein (4EBP1), were determined by Western blot. Results show that quercetin was the most effective compound for Akt/mTOR inhibition. Treatment with quercetin at 15 mu M had a similar effect as the RQC combination in the inhibition of BC cell proliferation, apoptosis, and migration. However, cell cycle analysis showed that the RQC treatment arrested BC cells in the G1 phase, while quercetin arrested the cell cycle in G2/M. In vivo experiments, using SCID mice with implanted tumors from metastatic BC cells, demonstrated that administration of quercetin at 15mg/kg body weight resulted in a similar to 70% reduction in tumor growth. In conclusion, quercetin appears to be a viable grape polyphenol for future development as an anti BC therapeutic.	[Rivera, Amilcar Rivera; Castillo-Pichardo, Linette; Dharmawardhane, Suranganie] Univ Puerto Rico Med Sci Campus, Sch Med, Dept Biochem, San Juan, PR USA; [Castillo-Pichardo, Linette] Univ Cent Caribe, Dept Pathol & Lab Med, Bayamon, PR USA; [Gerena, Yamil] Univ Puerto Rico Med Sci Campus, Dept Pharmacol & Toxicol, San Juan, PR USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Dharmawardhane, S (corresponding author), Univ Puerto Rico Med Sci Campus, Sch Med, Dept Biochem, San Juan, PR USA.	su.d@upr.edu		Gerena, Yamil/0000-0002-5324-109X	National Institutes of Health (NIH)/National Institute of General Medicine (NIGMS) [SC3GM084824]; UPR RCM NIH/NIMHHD [G12MD007600, R25GM061838, U54CA096297]; NIH/NIMHHD [G12MD007583]; U.S. Department of Education [P031M10505, P031S130068]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, SC3GM084824, P20GM103475] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583, G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of General Medicine (NIGMS); UPR RCM NIH/NIMHHD; NIH/NIMHHD; U.S. Department of Education(US Department of Education); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by National Institutes of Health (NIH)/National Institute of General Medicine (NIGMS) Grant SC3GM084824 (to S.D.); UPR RCM NIH/NIMHHD grants G12MD007600, R25GM061838 (to A.R.R.), and U54CA096297 (to A.R.R.); NIH/NIMHHD G12MD007583, and Title V PPOHA P031M10505 and Title V Cooperative P031S130068 from U.S. Department of Education to UCC.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; Bonofiglio D, 2016, MINI-REV MED CHEM, V16, P596, DOI 10.2174/1389557515666150709110959; Bouvet Michael, 2015, Methods Mol Biol, V1267, P321, DOI 10.1007/978-1-4939-2297-0_16; Cao HH, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0367-4; Castillo-Pichardo L, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-6; Castillo-Pichardo L, 2012, NUTR CANCER, V64, P1058, DOI 10.1080/01635581.2012.716898; Castillo-Pichardo L, 2009, CLIN EXP METASTAS, V26, P505, DOI 10.1007/s10585-009-9250-2; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Damianaki A, 2000, J CELL BIOCHEM, V78, P429, DOI 10.1002/1097-4644(20000901)78:3<429::AID-JCB8>3.0.CO;2-M; Deng XH, 2013, EXP THER MED, V6, P1155, DOI 10.3892/etm.2013.1285; Faustino RS, 2003, MOL CELL BIOCHEM, V249, P11, DOI 10.1023/A:1024745513314; Ferry DR, 1996, CLIN CANCER RES, V2, P659; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7; Kim H, 2004, J NUTR, V134, p3445S, DOI 10.1093/jn/134.12.3445S; Kolker I I, 1979, Klin Med (Mosk), V57, P77; Lai WW, 2013, ANTICANCER RES, V33, P1941; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larson AJ, 2012, ADV NUTR, V3, P39, DOI 10.3945/an.111.001271; Casella ML, 2014, MOL NUTR FOOD RES, V58, P289, DOI 10.1002/mnfr.201300362; Levi F, 2005, EUR J CANCER PREV, V14, P139, DOI 10.1097/00008469-200504000-00009; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Lin CW, 2008, CARCINOGENESIS, V29, P1807, DOI 10.1093/carcin/bgn162; Lu JM, 2009, CARCINOGENESIS, V30, P636, DOI 10.1093/carcin/bgp009; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Martinez C, 2005, HISTOL HISTOPATHOL, V20, P1121, DOI 10.14670/HH-20.1121; Maurya AK, 2015, TUMOR BIOL, V36, P8913, DOI 10.1007/s13277-015-3634-5; Maurya AK, 2015, MOL BIOL REP, V42, P1419, DOI 10.1007/s11033-015-3921-7; Michaud-Levesque J, 2012, EXP CELL RES, V318, P925, DOI 10.1016/j.yexcr.2012.02.017; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mojsin M, 2014, FOOD FUNCT, V5, P2564, DOI [10.1039/c4fo00484a, 10.1039/C4FO00484A]; Morre DM, 2005, CANC LETT; Nigdikar SV, 1998, AM J CLIN NUTR, V68, P258, DOI 10.1093/ajcn/68.2.258; Perez-Vizcaino F, 2012, J SCI FOOD AGR, V92, P1822, DOI 10.1002/jsfa.5697; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326; Ranganathan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141370; Rein MJ, 2013, BRIT J CLIN PHARMACO, V75, P588, DOI 10.1111/j.1365-2125.2012.04425.x; Sak K, 2014, NUTR CANCER, V66, P177, DOI 10.1080/01635581.2014.864418; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Schlachterman A, 2008, TRANSL ONCOL, V1, P19, DOI 10.1593/tlo.07100; Singh RP, 2004, INT J CANCER, V108, P733, DOI 10.1002/ijc.11620; Singletary KW, 2003, J AGR FOOD CHEM, V51, P7280, DOI 10.1021/jf030278l; TOMATIS L, 1993, ENVIRON HEALTH PERSP, V101, P149, DOI 10.2307/3431859; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; van der Heijden MS, 2010, CLIN CANCER RES, V16, P3094, DOI 10.1158/1078-0432.CCR-09-3004; Vidya Priyadarsini R, 2010, Eur J Pharmacol, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Weixel KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078019; Zhou HY, 2010, CRIT REV EUKAR GENE, V20, P1	54	62	62	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157251	10.1371/journal.pone.0157251	http://dx.doi.org/10.1371/journal.pone.0157251			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285995	Green Submitted, gold, Green Published			2022-12-26	WOS:000377564000050
J	Ghosal, R; Xiong, PX; Sorensen, PW				Ghosal, Ratna; Xiong, Peter X.; Sorensen, Peter W.			Invasive Bighead and Silver Carps Form Different Sized Shoals that Readily Intermix	PLOS ONE			English	Article							DENSITY-DEPENDENT PREDATION; SELFISH HERD; FISH SCHOOLS; MISSISSIPPI RIVER; COMMON CARP; ASIAN CARP; BEHAVIOR; AGGREGATION; GROWTH; PREY	Two species of congeneric filter-feeding microphagous carps from Asia, the bighead and the silver carp, were recently introduced to North America and have become highly invasive. These species of carp have similar food habits but the silver carp has the unique habit of jumping when disturbed. Both species have complex but poorly understood social behaviors and while both are thought to aggregate (form groups) and shoal (form tight social groups), this possibility has not yet been examined in these species. The present study examined the grouping tendencies of these species in the laboratory and the effects of fish density and species identity on it. Using nearest neighbor distance (NND) as a metric, we showed that both juvenile bighead and juvenile silver carp grouped (aggregate) strongly (P<0.05) but to different extents, and that fish density had no effect (P>0.05) on this behavior. Within aggregations, bighead carp tended to form a single large shoal while silver carp formed shoals of 2-3 individuals. Further, when tested as mixed-species groups, bighead and silver carp readily shoaled with each other but not with the common carp, which is from Eurasia and a member of another feeding guild. Due to their similar feeding strategies, we speculate that the bighead and silver carp tend to aggregate and shoal to facilitate both their foraging efforts and to avoid predation, while the differences in the size of the shoals they form may seemingly reflect their different anti-predation strategies. These complex shoaling behaviors likely influence Asian carp distribution in rivers, and thus how they might be sampled and managed.	[Ghosal, Ratna; Xiong, Peter X.; Sorensen, Peter W.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ghosal, R (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	rghosal@umn.edu	GHOSAL, RATNA/AAB-9470-2020	Sorensen, Peter/0000-0003-0321-1279; Ghosal, RATNA/0000-0002-2295-453X	Minnesota Environment; Natural Resources Trust Fund; Minnesota Aquatic Invasive Species Research Centre	Minnesota Environment; Natural Resources Trust Fund; Minnesota Aquatic Invasive Species Research Centre	Funding for this project was provided by the Minnesota Environment and Natural Resources Trust Fund in association with Minnesota Aquatic Invasive Species Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRCC, 2015, AS CARP CONTR STRAT; Bajer PG, 2011, FISHERIES MANAG ECOL, V18, P497, DOI 10.1111/j.1365-2400.2011.00805.x; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; BOHNSACK JA, 1989, B MAR SCI, V44, P631; Brierley AS, 2010, CURR BIOL, V20, P1758, DOI 10.1016/j.cub.2010.08.041; CHRISTENSEN B, 1993, BEHAV ECOL SOCIOBIOL, V32, P1; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Cuddington K, 2014, BIOL INVASIONS, V16, P903, DOI 10.1007/s10530-013-0547-3; Degrandchamp KL, 2008, T AM FISH SOC, V137, P45, DOI 10.1577/T06-116.1; Dempster T, 2010, ESTUAR COAST SHELF S, V86, P271, DOI 10.1016/j.ecss.2009.11.007; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; GREEN BW, 1984, AQUACULTURE, V37, P87, DOI 10.1016/0044-8486(84)90046-2; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hansen A, 2014, J EXP BIOL, V217, P3945, DOI 10.1242/jeb.107870; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Kolar C.S., 2005, ASIAN CARPS GENUS HY; Kolar CS, 2007, AM FISH SOC, V33; KRAUSE J, 1993, ANIM BEHAV, V45, P1019, DOI 10.1006/anbe.1993.1119; Krause J, 2000, BIOL REV, V75, P477; Lamer JT, 2010, N AM J FISH MANAGE, V30, P1452, DOI 10.1577/M10-053.1; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LUBINSKI KS, 1986, HYDROBIOLOGIA, V136, P141, DOI 10.1007/BF00051511; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; MORSE DH, 1977, BIOSCIENCE, V27, P332, DOI 10.2307/1297632; OATEN A, 1977, AM NAT, V111, P1061, DOI 10.1086/283238; PARRISH JK, 1989, ENVIRON BIOL FISH, V26, P79, DOI 10.1007/BF00001024; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Patil JG, 2015, GEN COMP ENDOCR, V221, P173, DOI 10.1016/j.ygcen.2015.03.005; PITCHER TJ, 1983, ANIM BEHAV, V31, P546, DOI 10.1016/S0003-3472(83)80078-5; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Pitcher TJ, 1993, BEHAV TELEOST FISHES, V7, P294; Robinson CJ, 2007, J FISH BIOL, V71, P200, DOI 10.1111/j.1095-8649.2007.01484.x; RYER CH, 1995, ANIM BEHAV, V49, P411, DOI 10.1006/anbe.1995.0054; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Sandin SA, 2005, ECOLOGY, V86, P1520, DOI 10.1890/03-0654; Sorensen PW, 2015, FISH PHEROMONES AND RELATED CUES, P1; Ward AJW, 2003, P ROY SOC B-BIOL SCI, V270, P1157, DOI 10.1098/rspb.2003.2337; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Williamson CJ, 2005, T AM FISH SOC, V134, P1423, DOI 10.1577/T04-106.1	42	10	10	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157174	10.1371/journal.pone.0157174	http://dx.doi.org/10.1371/journal.pone.0157174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276024	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700079
J	Goncalves, AB; Souza, S; da Silva, GG; Cereda, MP; Pott, A; Naka, MH; Pistori, H				Goncalves, Ariadne Barbosa; Souza, Junior Silva; da Silva, Gercina Goncalves; Cereda, Marney Pascoli; Pott, Arnildo; Naka, Marco Hiroshi; Pistori, Hemerson			Feature Extraction and Machine Learning for the Classification of Brazilian Savannah Pollen Grains	PLOS ONE			English	Article								The classification of pollen species and types is an important task in many areas like forensic palynology, archaeological palynology and melissopalynology. This paper presents the first annotated image dataset for the Brazilian Savannah pollen types that can be used to train and test computer vision based automatic pollen classifiers. A first baseline human and computer performance for this dataset has been established using 805 pollen images of 23 pollen types. In order to access the computer performance, a combination of three feature extractors and four machine learning techniques has been implemented, fine tuned and tested. The results of these tests are also presented in this paper.	[Goncalves, Ariadne Barbosa; Naka, Marco Hiroshi; Pistori, Hemerson] Univ Catolica Dom Bosco, INOVISAO, Dept Biotechnol, Campo Grande, MG, Brazil; [Souza, Junior Silva; Pistori, Hemerson] Univ Fed Mato Grosso do Sul, Dept Comp Sci, Campo Grande, MG, Brazil; [da Silva, Gercina Goncalves; Cereda, Marney Pascoli; Pistori, Hemerson] Univ Catolica Dom Bosco, Dept Environm Sci & Agr Sustainabil, Campo Grande, MG, Brazil; [Pott, Arnildo] Univ Fed Mato Grosso do Sul, Lab Bot, Campo Grande, MG, Brazil; [Naka, Marco Hiroshi] Fed Inst Mato Grosso Sul, Direct Res Extens & Inst, Sci & Technol, Campo Grande, MG, Brazil	Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Mato Grosso do Sul; Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Mato Grosso do Sul; Instituto Federal de Mato Grosso do Sul	Goncalves, AB (corresponding author), Univ Catolica Dom Bosco, INOVISAO, Dept Biotechnol, Campo Grande, MG, Brazil.	ariadne.gon@gmail.com	Naka, Marco H/M-4287-2013; Cereda, Marney Pascoli/F-4439-2019; Pistori, Hemerson/G-3933-2012; Cereda, Marney Pascoli/AAH-9571-2020	Naka, Marco H/0000-0002-1440-8985; Cereda, Marney Pascoli/0000-0002-8181-7754; Pistori, Hemerson/0000-0001-8181-760X; Pott, Arnildo/0000-0002-8599-9276; BARBOSA GONCALVES, ARIADNE/0000-0003-2496-5723	Dom Bosco Catholic University, UCDB; Development of Education, Science and Technology; State of Mato Grosso do Sul, FUNDECT; Brazilian National Council of Technological and Scientific Development; CNPq; Coordination for the Improvement of Higher Education Personnel, CAPES	Dom Bosco Catholic University, UCDB; Development of Education, Science and Technology; State of Mato Grosso do Sul, FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Brazilian National Council of Technological and Scientific Development; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has received financial support from the Dom Bosco Catholic University, UCDB and the Foundation for the Support and Development of Education, Science and Technology from the State of Mato Grosso do Sul, FUNDECT. Some of the authors have been awarded with Scholarships from the the Brazilian National Council of Technological and Scientific Development, CNPq and the Coordination for the Improvement of Higher Education Personnel, CAPES.	Andrade WT, 2012, 25 C GRAPH PATT IM, P108; Bhargava N., 2013, PROC INT J ADV RES C, V3, P1114; Boucher Alain, 2002, Aerobiologia, V18, P195, DOI 10.1023/A:1021322813565; Chica M, 2012, J FOOD ENG, V112, P50, DOI 10.1016/j.jfoodeng.2012.03.028; del Pozo-Banos M, 2012, BIODIVERSITY ENRICHMENT IN A DIVERSE WORLD, P493, DOI 10.5772/47527; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; France I, 2000, QUATERNARY SCI REV, V19, P537, DOI 10.1016/S0277-3791(99)00021-9; Goncalves AB, 2011, 41 INT AP C BUEN AIR; Goncalves AB, 2013, CADERNOS AGROECOLOGI, V8, P14634; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; LANGFORD M, 1990, REV PALAEOBOT PALYNO, V64, P197, DOI 10.1016/0034-6667(90)90133-4; Lee H.-C., 2005, INTRO COLOR IMAGING; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Lozano-Vega G, 2013, LECT NOTES COMPUT SC, V8156, P712; Malik S., 2003, CSC2503F U TOR DEP C; Mateos I, 2008, 5 JORN TECN HABL BIL; Platt J., 1991, ADV KERNEL METHODS S, P185; Quinta LNB, 2013, VISAO COMPUTACIONAL; R Core Team, 2014, LANG ENV STAT COMP; Rodriguez-Damian M, 2006, IEEE T SYST MAN CY C, V36, P531, DOI 10.1109/TSMCC.2005.855426; Silva D. S. da, 2014, African Journal of Agricultural Research, V9, P908; Silva-Coiado DG, 2010, CARACTERIZACAO SETOR; Tuytelaars T., 2006, EUR C COMP VIS, V1, P404, DOI DOI 10.1007/11744023_32; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Witten I. H., 2005, DATA MINING PRACTICA; Yang J., 2007, P INT WORKSH MULT IN, P197, DOI DOI 10.1145/1290082.1290111; Zhang CH, 2013, PROCEDIA COMPUT SCI, V17, P1083, DOI 10.1016/j.procs.2013.05.137	28	40	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157044	10.1371/journal.pone.0157044	http://dx.doi.org/10.1371/journal.pone.0157044			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276196	gold, Green Submitted, Green Published			2022-12-26	WOS:000377561700059
J	Marti-Fabregas, J; Prats-Sanchez, L; Martinez-Domeno, A; Camps-Renom, P; Marin, R; Jimenez-Xarrie, E; Fuentes, B; Dorado, L; Purroy, F; Arias-Rivas, S; Delgado-Mederos, R				Marti-Fabregas, Joan; Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Marin, Rebeca; Jimenez-Xarrie, Elena; Fuentes, Blanca; Dorado, Laura; Purroy, Francisco; Arias-Rivas, Susana; Delgado-Mederos, Raquel			The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; STROKE; GUIDELINES; MANAGEMENT; SYSTEM; RISK; CT	Background and Purpose There are no generally accepted criteria for the etiologic classification of intracerebral hemorrhage (ICH). For this reason, we have developed a set of etiologic criteria and have applied them to a large number of patients to determine their utility. Methods The H-ATOMIC classification includes 7 etiologic categories: Hypertension, cerebral Amyloid angiopathy, Tumour, Oral anticoagulants, vascular Malformation, Infrequent causes and Cryptogenic. For each category, the etiology is scored with three degrees of certainty: Possible(3), Probable(2) and Definite(1). Our aim was to perform a basic study consisting of neuroimaging, blood tests, and CT-angio when a numerical score (SICH) suggested an underlying structural abnormality. Combinations of > 1 etiologic category for an individual patient were acceptable. The criteria were evaluated in a multicenter and prospective study of consecutive patients with spontaneous ICH. Results Our study included 439 patients (age 70.8 +/- 14.5 years; 61.3% were men). A definite etiology was achieved in 176 (40.1% of the patients: Hypertension 28.2%, cerebral Amyloid angiopathy 0.2%, Tumour 0.2%, Oral anticoagulants 2.2%, vascular Malformation 4.5%, Infrequent causes 4.5%). A total of 7 patients (1.6%) were cryptogenic. In the remaining 58.3% of the patients, ICH was attributable to a single (n = 56, 12.7%) or the combination of >= 2 (n = 200, 45.5%) possible/probable etiologies. The most frequent combinations of etiologies involved possible hypertension with possible CAA (H(3)A(3), n = 38) or with probable CAA (H(3)A(2), n = 29), and probable hypertension with probable OA (H2O2, n = 27). The most frequent category with any degree of certainty was hypertension (H1+2+3 = 80.6%) followed by cerebral amyloid angiopathy (A(1+2+3) = 30.9%). Conclusions According to our etiologic criteria, only about 40% patients received a definite diagnosis, while in the remaining patients ICH was attributable to a single possible/probable etiology or to more than one possible/ probable etiology. The use of these criteria would likely help in the management of patients with ICH.	[Marti-Fabregas, Joan; Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Marin, Rebeca; Jimenez-Xarrie, Elena; Delgado-Mederos, Raquel] Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Neurol, Stroke Unit, Barcelona, Spain; [Fuentes, Blanca] Hosp Univ La Paz, Dept Neurol, Madrid, Spain; [Dorado, Laura] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Purroy, Francisco] Hosp Arnau Vilanova, Lleida, Spain; [Arias-Rivas, Susana] Complejo Hosp Univ Santiago, Santiago De Compostela, Spain	Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; Hospital Germans Trias i Pujol; University Hospital Arnau de Vilanova; Complexo Hospitalario Universitario de Santiago de Compostela	Marti-Fabregas, J (corresponding author), Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Neurol, Stroke Unit, Barcelona, Spain.	jmarti@santpau.cat	Purroy, Francisco/D-4538-2009; Fuentes, Blanca/I-2114-2019; Martí-Fàbregas, Joan/I-5933-2019	Purroy, Francisco/0000-0002-1808-5968; Fuentes, Blanca/0000-0002-0363-862X; Martí-Fàbregas, Joan/0000-0001-9229-8649; CAMPS-RENOM, POL/0000-0001-6587-6271; Martinez-Domeno, Alejandro/0000-0002-9933-3192	Ministery of Health-Instituto de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS [RD012/0014]; FEDER (Fondo Europeo de Desarrollo Regional)	Ministery of Health-Instituto de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This work was supported by Ministery of Health-Instituto de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS RD012/0014 (JM-F, PC-R, AM-D, LP-S, RD-M), FEDER (Fondo Europeo de Desarrollo Regional). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; Almandoz JED, 2010, AM J NEURORADIOL, V31, P1653, DOI 10.3174/ajnr.A2156; Almandoz JED, 2009, AM J NEURORADIOL, V30, P1213, DOI 10.3174/ajnr.A1546; Amarenco P, 2009, CEREBROVASC DIS, V27, P502, DOI 10.1159/000210433; Bejot Y, 2013, BRAIN, V136, P658, DOI 10.1093/brain/aws349; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Cordonnier C, 2010, STROKE, V41, P685, DOI 10.1161/STROKEAHA.109.572495; Fiebach JB, 2004, STROKE, V35, P502, DOI 10.1161/01.STR.0000114203.75678.88; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Flaherty ML, 2010, SEMIN NEUROL, V30, P565, DOI 10.1055/s-0030-1268866; Greenberg SM, 2014, LANCET NEUROL, V13, P419, DOI 10.1016/S1474-4422(14)70003-1; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Macellari F, 2014, STROKE, V45, P903, DOI 10.1161/STROKEAHA.113.003701; Meretoja A, 2012, STROKE, V43, P2592, DOI 10.1161/STROKEAHA.112.661603; Ritter MA, 2005, NEUROLOGY, V64, P1233, DOI 10.1212/01.WNL.0000156522.93403.C3; Rodrigue KM, 2013, JAMA NEUROL, V70, P600, DOI 10.1001/jamaneurol.2013.1342; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503	25	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156992	10.1371/journal.pone.0156992	http://dx.doi.org/10.1371/journal.pone.0156992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275863	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561700056
J	Shimamura, Y; Aoki, N; Sugiyama, Y; Tanaka, T; Murata, M; Masuda, S				Shimamura, Yuko; Aoki, Natsumi; Sugiyama, Yuka; Tanaka, Takashi; Murata, Masatsune; Masuda, Shuichi			Plant-Derived Polyphenols Interact with Staphylococcal Enterotoxin A and Inhibit Toxin Activity	PLOS ONE			English	Article							FOOD; PROANTHOCYANIDINS; HEALTH; SUPERANTIGENS; METABOLITES; OUTBREAK; EXTRACTS; TANNINS; LEAVES; COLI	This study was performed to investigate the inhibitory effects of 16 different plant-derived polyphenols on the toxicity of staphylococcal enterotoxin A (SEA). Plant-derived polyphenols were incubated with the cultured Staphylococcus aureus C-29 to investigate the effects of these samples on SEA produced from C-29 using Western blot analysis. Twelve polyphenols (0.1-0.5 mg/mL) inhibited the interaction between the anti-SEA antibody and SEA. We examined whether the polyphenols could directly interact with SEA after incubation of these test samples with SEA. As a result, 8 polyphenols (0.25 mg/mL) significantly decreased SEA protein levels. In addition, the polyphenols that interacted with SEA inactivated the toxin activity of splenocyte proliferation induced by SEA. Polyphenols that exerted inhibitory effects on SEA toxic activity had a tendency to interact with SEA. In particular, polyphenol compounds with 1 or 2 hexahydroxydiphenoyl groups and/or a galloyl group, such as eugeniin, castalagin, punicalagin, pedunculagin, corilagin and geraniin, strongly interacted with SEA and inhibited toxin activity at a low concentration. These polyphenols may be used to prevent S. aureus infection and staphylococcal food poisoning.	[Shimamura, Yuko; Aoki, Natsumi; Sugiyama, Yuka; Masuda, Shuichi] Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Tanaka, Takashi] Nagasaki Univ, Grad Sch Biochem Sci, 1-14 Bukyo Machi, Nagasaki 8528521, Japan; [Murata, Masatsune] Ochanomizu Univ, Dept Nutr & Food Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan	University of Shizuoka; Nagasaki University; Ochanomizu University	Masuda, S (corresponding author), Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	masudas@u-shizuoka-ken.ac.jp		Tanaka, Takashi/0000-0001-7762-7432	JSPS KAKENHI Grant [24700806]; Japan Food Chemical Research Foundation; Charitable Trust Fund for Home Economics Research; Japan Cassis Association	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation); Charitable Trust Fund for Home Economics Research; Japan Cassis Association	This study was supported in part by JSPS KAKENHI Grant Number 24700806, a grant from the Japan Food Chemical Research Foundation, Charitable Trust Fund for Home Economics Research and Japan Cassis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao T, 2003, EPIDEMIOL INFECT, V130, P33, DOI 10.1017/S0950268802007951; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Cos P, 2004, CURR MED CHEM, V11, P1345, DOI 10.2174/0929867043365288; EVENSON ML, 1988, INT J FOOD MICROBIOL, V7, P311, DOI 10.1016/0168-1605(88)90057-8; Feldman KS, 2005, PHYTOCHEMISTRY, V66, P1984, DOI 10.1016/j.phytochem.2004.11.015; Friedman M, 2013, J FOOD SCI, V78, pM270, DOI 10.1111/1750-3841.12021; Friedman M, 2011, J FOOD SCI, V76, pM558, DOI 10.1111/j.1750-3841.2011.02365.x; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P2590, DOI 10.1021/jf971097k; Holtfreter S, 2005, ARCH IMMUNOL THER EX, V53, P13; Huang YL, 2011, PHYTOCHEMISTRY, V72, P2006, DOI 10.1016/j.phytochem.2011.07.007; Ito H, 2011, PLANTA MED, V77, P1110, DOI 10.1055/s-0030-1270749; Lee YA, 2007, J NUTR SCI VITAMINOL, V53, P287, DOI 10.3177/jnsv.53.287; Lina G, 2004, J INFECT DIS, V189, P2334, DOI 10.1086/420852; Maina EK, 2012, PEPTIDES, V38, P1, DOI 10.1016/j.peptides.2012.08.013; Maisch T, 2004, PHOTOCH PHOTOBIO SCI, V3, P907, DOI 10.1039/b407622b; Matsuo Y, 2010, FOOD CHEM, V121, P1073, DOI 10.1016/j.foodchem.2010.01.052; Mulaudzi RB, 2012, J ETHNOPHARMACOL, V143, P185, DOI 10.1016/j.jep.2012.06.022; Omoe K, 2013, INFECT IMMUN, V81, P3627, DOI 10.1128/IAI.00550-13; Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Rasooly A, 1998, INT J FOOD MICROBIOL, V41, P205, DOI 10.1016/S0168-1605(98)00050-6; Rasooly R, 2012, FOOD COMPOUNDS INHIB, P387; Rasooly R, 2010, J AGR FOOD CHEM, V58, P5421, DOI 10.1021/jf904021b; Shimamura Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1571, DOI 10.1271/bbb.50617; Shimamura Y, 2014, J FOOD SCI, V79, pM2294, DOI 10.1111/1750-3841.12566; Shimamura Y, 2008, FOOD SCI TECHNOL RES, V14, P513, DOI 10.3136/fstr.14.513; Taguri T, 2004, BIOL PHARM BULL, V27, P1965, DOI 10.1248/bpb.27.1965; Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226; Tajchakavit S, 2001, FOOD RES INT, V34, P431, DOI 10.1016/S0963-9969(00)00188-5; TANAKA T, 1986, CHEM PHARM BULL, V34, P650; TANAKA T, 1986, J CHEM SOC PERK T 1, P369, DOI 10.1039/p19860000369; Tanaka T, 2003, J NAT PROD, V66, P759, DOI 10.1021/np020608g; TANAKA T, 1985, J CHEM RES, P176; Tanaka T, 1996, CHEM PHARM BULL, V44, P2236, DOI 10.1248/cpb.44.2236; Taniguchi S, 2005, YAKUGAKU ZASSHI, V125, P499, DOI 10.1248/yakushi.125.499; Trombley JD, 2011, ANAL BIOANAL CHEM, V401, P1523, DOI 10.1007/s00216-011-4846-1; Verhelst R, 2013, VET MICROBIOL, V163, P319, DOI 10.1016/j.vetmic.2012.12.039	37	10	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157082	10.1371/journal.pone.0157082	http://dx.doi.org/10.1371/journal.pone.0157082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272505	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000062
J	Werden, SJ; Sphyris, N; Sarkar, TR; Paranjape, AN; LaBaff, AM; Taube, JH; Hollier, BG; Ramirez-Pena, EQ; Soundararajan, R; den Hollander, P; Powell, E; Echeverria, GV; Miura, N; Chang, JT; Piwnica-Worms, H; Rosen, JM; Mani, SA				Werden, S. J.; Sphyris, N.; Sarkar, T. R.; Paranjape, A. N.; LaBaff, A. M.; Taube, J. H.; Hollier, B. G.; Ramirez-Pena, E. Q.; Soundararajan, R.; den Hollander, P.; Powell, E.; Echeverria, G. V.; Miura, N.; Chang, J. T.; Piwnica-Worms, H.; Rosen, J. M.; Mani, S. A.			Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ACTIVATED PROTEIN-KINASE; STEM-CELLS; SIGNALING PATHWAYS; MIR-200 FAMILY; INVASION; EMT; EXPRESSION; PLASTICITY; INSIGHTS	Metastatic competence is contingent upon the aberrant activation of a latent embryonic program, known as the epithelial-mesenchymal transition (EMT), which bestows stem cell properties as well as migratory and invasive capabilities upon differentiated tumor cells. We recently identified the transcription factor FOXC2 as a downstream effector of multiple EMT programs, independent of the EMT-inducing stimulus, and as a key player linking EMT, stem cell traits and metastatic competence in breast cancer. As such, FOXC2 could serve as a potential therapeutic target to attenuate metastasis. However, as FOXC2 is a transcription factor, it is difficult to target by conventional means such as small-molecule inhibitors. Herein, we identify the serine/threonine-specific kinase p38 as a druggable upstream regulator of FOXC2 stability and function that elicits phosphorylation of FOXC2 at serine 367 (S367). Using an orthotopic syngeneic mouse tumor model, we make the striking observation that inhibition of p38-FOXC2 signaling selectively attenuates metastasis without impacting primary tumor growth. In this model, circulating tumor cell numbers are significantly reduced in mice treated with the p38 inhibitor SB203580, relative to vehicle-treated counterparts. Accordingly, genetic or pharmacological inhibition of p38 decreases FOXC2 protein levels, reverts the EMT phenotype and compromises stem cell attributes in vitro. We also identify the EMT-regulator ZEB1-known to directly repress E-cadherin/CDH1-as a downstream target of FOXC2, critically dependent on its activation by p38. Consistent with the notion that activation of the p38-FOXC2 signaling axis represents a critical juncture in the acquisition of metastatic competence, the phosphomimetic FOXC2(S367E) mutant is refractory to p38 inhibition both in vitro and in vivo, whereas the non-phosphorylatable FOXC2(S367A) mutant fails to elicit EMT and upregulate ZEB1. Collectively, our data demonstrate that FOXC2 regulates EMT, stem cell traits, ZEB1 expression and metastasis in a p38-dependent manner, and attest to the potential utility of p38 inhibitors as antimetastatic agents.	[Werden, S. J.; Sphyris, N.; Sarkar, T. R.; Paranjape, A. N.; Taube, J. H.; Hollier, B. G.; Ramirez-Pena, E. Q.; Soundararajan, R.; den Hollander, P.; Mani, S. A.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 W Holcombe Blvd, Houston, TX 77030 USA; [LaBaff, A. M.] Univ Texas MD Anderson Canc Ctr, Mol & Cellular Oncol, Houston, TX 77030 USA; [Powell, E.; Echeverria, G. V.; Piwnica-Worms, H.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Miura, N.] Hamamatsu Univ, Sch Med, Dept Biochem, Hamamatsu, Shizuoka, Japan; [Chang, J. T.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Rosen, J. M.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rosen, J. M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Mani, S. A.] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Houston, TX 77030 USA; [Mani, S. A.] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Taube, J. H.] Baylor Univ, Waco, TX 76798 USA; [Hollier, B. G.] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4102, Australia	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Hamamatsu University School of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor University; Queensland University of Technology (QUT)	Mani, SA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 2130 W Holcombe Blvd, Houston, TX 77030 USA.	smani@mdanderson.org	Paranjape, Anurag N./P-1255-2018; Mani, Sendurai A./A-7244-2009; SPHYRIS, NATHALIE/GQY-6349-2022	Paranjape, Anurag N./0000-0001-6119-0766; Mani, Sendurai A./0000-0002-5918-4276; Taube, Joseph/0000-0002-3636-5189; Ramirez-Pena, Esmeralda/0000-0002-5200-7488; Echeverria, Gloria/0000-0002-3772-9298; Sphyris, Nathalie/0000-0003-1860-1958	National Institute of Health [5RO1CA155243]; Cancer Prevention and Research Institute of Texas [RP-130485]; Cancer Center Support Grant from the National Cancer Institute [5P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA155243, P30CA016672] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Cancer Center Support Grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Dr Mike Lewis, Dr Patricia Thompson and Dr Jody Vykoukal for helpful discussions. We particularly thank Dr Jonathan Kurie, Dr Robert Weinberg and Dr Mien-Chie Hung for critically reading the manuscript. This research was supported by grants from the National Institute of Health (5RO1CA155243) and the Cancer Prevention and Research Institute of Texas (RP-130485). SAM is an American Cancer Society M Patricia Alexander Research Scholar (121958-RSG-12-102-01-DDC). SJW received a Susan G Komen Breast Cancer Foundation Postdoctoral Fellowship. Flow cytometry, animal imaging and histopathology were in part funded by the Cancer Center Support Grant from the National Cancer Institute (5P30CA016672).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alspach E, 2014, CANCER DISCOV, V4, P716, DOI 10.1158/2159-8290.CD-13-0743; Aomatsu K, 2012, INVEST OPHTH VIS SCI, V53, P751, DOI 10.1167/iovs.11-8222; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Blanco MA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2831; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Donnelly SM, 2014, CURR MED CHEM, V21, P501; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Fehm T, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1869; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Huang S, 2000, J BIOL CHEM, V275, P12266, DOI 10.1074/jbc.275.16.12266; Kawano H, 2003, J AM SOC NEPHROL, V14, P584, DOI 10.1097/01.ASN.0000050415.97942.2F; Kopper F, 2014, CELL CYCLE, V13, P884, DOI 10.4161/cc.28292; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Kume T, 2012, J ONCOL, V2012, DOI 10.1155/2012/204593; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Malinowsky K, 2012, TRANSL ONCOL, V5, P98, DOI 10.1593/tlo.11268; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pantel K, 1999, JNCI-J NATL CANCER I, V91, P1113, DOI 10.1093/jnci/91.13.1113; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Sarkar TR, 2015, ONCOGENE, V34, P2958, DOI 10.1038/onc.2014.245; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Taube JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02687; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vecchi M, 2008, ONCOGENE, V27, P2148, DOI 10.1038/sj.onc.1210858; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048; Yoshizuka N, 2012, MOL CELL BIOL, V32, P606, DOI 10.1128/MCB.06301-11	45	37	42	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					5977	5988		10.1038/onc.2016.203	http://dx.doi.org/10.1038/onc.2016.203			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	27292262	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000388509400005
J	Weider, E; Susan-Resiga, D; Essalmani, R; Hamelin, J; Asselin, MC; Nimesh, S; Ashraf, Y; Wycoff, KL; Zhang, JB; Prat, A; Seidah, NG				Weider, Elodie; Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Nimesh, Surendra; Ashraf, Yahya; Wycoff, Keith L.; Zhang, Jianbing; Prat, Annik; Seidah, Nabil G.			Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LDL CHOLESTEROL LEVELS; C-TERMINAL DOMAIN; MONOCLONAL-ANTIBODY; FAMILIAL HYPERCHOLESTEROLEMIA; LIVER-REGENERATION; NONHUMAN-PRIMATES; TARGETING PCSK9; EGF(A) DOMAIN; MOUSE-LIVER	Single domain antibodies (sdAbs) correspond to the antigen-binding domains of camelid antibodies. They have the same antigen-binding properties and specificity as monoclonal antibodies (mAbs) but are easier and cheaper to produce. We report here the development of sdAbs targeting human PCSK9 (proprotein convertase subtilisin/kexin type 9) as an alternative to anti-PCSK9 mAbs. After immunizing a llama with human PCSK9, we selected four sdAbs that bind PCSK9 with a high affinity and produced them as fusion proteins with a mouse Fc. All four sdAb-Fcs recognize the C-terminal Cys-His-rich domain of PCSK9. We performed multiple cellular assays and demonstrated that the selected sdAbs efficiently blocked PCSK9-mediated low density lipoprotein receptor (LDLR) degradation in cell lines, in human hepatocytes, and in mouse primary hepatocytes. We further showed that the sdAb-Fcs do not affect binding of PCSK9 to the LDLR but rather block its induced cellular LDLR degradation. Pcsk9 knock-out mice expressing a human bacterial artificial chromosome (BAC) transgene were generated, resulting in plasma levels of similar to 300 ng/ml human PCSK9. Mice were singly or doubly injected with the best sdAb-Fc and analyzed at day 4 or 11, respectively. After 4 days, mice exhibited a 32 and 44% decrease in the levels of total cholesterol and apolipoprotein B and similar to 1.8-fold higher liver LDLR protein levels. At 11 days, the equivalent values were 24 and 46% and similar to 2.3-fold higher LDLR proteins. These data constitute a proof-of-principle for the future usage of sdAbs as PCSK9-targeting drugs that can efficiently reduce LDL-cholesterol, and as tools to study the Cys-His-rich domain-dependent sorting the PCSK9-LDLR complex to lysosomes.	[Weider, Elodie; Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Nimesh, Surendra; Ashraf, Yahya; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Wycoff, Keith L.] Planet Biotechnol Inc, Hayward, CA 94545 USA; [Zhang, Jianbing] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; National Research Council Canada	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Nimesh, Surendra/T-8894-2019; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X	Canadian Institutes of Health Research [PP2-125775, MOP 102741]; Pfizer; Amorchem; Canada Research Chair [216684]; Fondation Leducq Grant [13CVD03]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer(Pfizer); Amorchem; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Fondation Leducq Grant(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Grants PP2-125775 and MOP 102741, Pfizer cardiovascular research awards, a grant from Amorchem, Canada Research Chair 216684, and Fondation Leducq Grant 13CVD03.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bartunek J, 2013, J CARDIOVASC TRANSL, V6, P355, DOI 10.1007/s12265-012-9435-y; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; Crossey E, 2015, VACCINE, V33, P5747, DOI 10.1016/j.vaccine.2015.09.044; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; dos Santos C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010501; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Galabova G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114469; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Guella I, 2010, J LIPID RES, V51, P3342, DOI 10.1194/jlr.M010009; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Huang Y, 2012, GENOME MED, V4, DOI 10.1186/gm358; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Lundin J, 2002, BLOOD, V100, P768, DOI 10.1182/blood-2002-01-0159; Ly K, 2014, J BIOL CHEM, V289, P17732, DOI 10.1074/jbc.M113.541094; Maclean J, 2007, J GEN VIROL, V88, P1460, DOI 10.1099/vir.0.82718-0; MARCINKIEWICZ M, 1994, ENDOCRINOLOGY, V135, P1651, DOI 10.1210/en.135.4.1651; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mitchell T, 2014, J PHARMACOL EXP THER, V350, P412, DOI 10.1124/jpet.114.214221; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Powers DB, 2001, J IMMUNOL METHODS, V251, P123, DOI 10.1016/S0022-1759(00)00290-8; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Sarker SA, 2013, GASTROENTEROLOGY, V145, P740, DOI 10.1053/j.gastro.2013.06.053; Schiele F, 2014, J MOL BIOL, V426, P843, DOI 10.1016/j.jmb.2013.11.011; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Shrank WH, 2015, JAMA-J AM MED ASSOC, V314, P1443, DOI 10.1001/jama.2015.10017; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Sun XW, 2012, NEOPLASIA, V14, P1122, DOI 10.1593/neo.121252; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yamamoto T, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.16; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang YN, 2012, J MOL BIOL, V422, P685, DOI 10.1016/j.jmb.2012.06.018	73	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16659	16671		10.1074/jbc.M116.717736	http://dx.doi.org/10.1074/jbc.M116.717736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27284008	hybrid, Green Published			2022-12-26	WOS:000380826700024
J	Yi, GH; Ybe, JA; Saha, SS; Caviness, G; Raymond, E; Ganesan, R; Mbow, ML; Kao, CC				Yi, Guanghui; Ybe, Joel A.; Saha, Siddhartha S.; Caviness, Gary; Raymond, Ernest; Ganesan, Rajkumar; Mbow, M. Lamine; Kao, C. Cheng			Structural and Functional Attributes of the Interleukin-36 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IL-36 RECEPTOR; ANTAGONIST; ACTIVATION; AGONIST; SIGNAL; EXPRESSION; INSIGHTS; MEMBERS; ADAPTER	Signal transduction by the IL-36 receptor (IL-36R) is linked to several human diseases. However, the structure and function of the IL-36R is not well understood. A molecular model of the IL-36R complex was generated and a cell-based reporter assay was established to assess the signal transduction of recombinant subunits of the IL-36R. Mutational analyses and functional assays have identified residues of the receptor subunit IL-1Rrp2 needed for cytokine recognition, stable protein expression, disulfide bond formation and glycosylation that are critical for signal transduction. We also observed that, overexpression of ectodomain (ECD) of Il-1Rrp2 or IL-1RAcP exhibited dominant-negative effect on IL-36R signaling. The presence of IL-36 cytokine significantly increased the interaction of IL-1Rrp2 ECD with the co-receptor IL-1RAcP. Finally, we found that single nucleotide polymorphism A471T in the Toll-interleukin 1 receptor domain (TIR) of the IL-1Rrp2 that is present in similar to 2% of the human population, down-regulated IL-36R signaling by a decrease of interaction with IL-1RAcP.	[Yi, Guanghui; Saha, Siddhartha S.; Kao, C. Cheng] Indiana Univ, Sch Publ Hlth, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Ybe, Joel A.] Indiana Univ, Sch Publ Hlth, Dept Environm Hlth, Bloomington, IN 47405 USA; [Caviness, Gary; Raymond, Ernest; Ganesan, Rajkumar; Mbow, M. Lamine] Boehringer Ingelheim Pharmaceut, Ridgefield, CT 06877 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Boehringer Ingelheim	Kao, CC (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu	Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664				Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Gabay C, 2015, J LEUKOCYTE BIOL, V97, P645, DOI 10.1189/jlb.3RI1014-495R; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Gunther S, 2014, J IMMUNOL, V193, P921, DOI 10.4049/jimmunol.1400538; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kuznetsov IB, 2008, BIOINFORMATION, V3, P134, DOI 10.6026/97320630003134; Latiano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062144; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Saha SS, 2015, J BIOL CHEM, V290, P23997, DOI 10.1074/jbc.M115.653378; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; Towne JE, 2012, CURR OPIN PHARMACOL, V12, P486, DOI 10.1016/j.coph.2012.02.009; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	30	30	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16597	16609		10.1074/jbc.M116.723064	http://dx.doi.org/10.1074/jbc.M116.723064			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27307043	hybrid, Green Published			2022-12-26	WOS:000380826700019
J	Abraham, N; Paul, B; Ragnarsson, L; Lewis, RJ				Abraham, Nikita; Paul, Blessy; Ragnarsson, Lotten; Lewis, Richard J.			Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs)	PLOS ONE			English	Article							NEURONAL NICOTINIC RECEPTORS; CRYSTAL-STRUCTURES; LIGAND RECOGNITION; REVEALS; PURIFICATION; DESIGN; COMPLEX; FUSION	Nicotinic acetylcholine receptors (nAChR) are ligand gated ion channels, identified as therapeutic targets for a range of human diseases. Drug design for nAChR related disorders is increasingly using structure-based approaches. Many of these structural insights for therapeutic lead development have been obtained from co-crystal structures of nAChR agonists and antagonists with the acetylcholine binding protein (AChBP). AChBP is a water soluble, structural and functional homolog of the extracellular, ligand-binding domain of nAChRs. Currently, AChBPs are recombinantly expressed in eukaryotic expression systems for structural and biophysical studies. Here, we report the establishment of an Escherichia coli (E. coli) expression system that significantly reduces the cost and time of production compared to the existing expression systems. E. coli can efficiently express unglycosylated AChBP for crystallography and makes the expression of isotopically labelled forms feasible for NMR. We used a pHUE vector containing an N-terminal His-tagged ubiquitin fusion protein to facilitate AChBP expression in the soluble fractions, and thus avoid the need to recover protein from inclusion bodies. The purified protein yield obtained from the E. coli expression system is comparable to that obtained from existing AChBP expression systems. E. coli expressed AChBP bound nAChR agonists and antagonists with affinities matching those previously reported. Thus, the E. coli expression system significantly simplifies the expression and purification of functional AChBP for structural and biophysical studies.	[Abraham, Nikita; Ragnarsson, Lotten; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld, Australia; [Paul, Blessy] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld, Australia.	r.lewis@imb.uq.edu.au	Abraham, Nikita/R-1691-2018; Lewis, Richard/T-8763-2019; Ragnarsson, Lotten/A-8632-2012	Abraham, Nikita/0000-0003-1790-6012; Lewis, Richard/0000-0003-3470-923X; Ragnarsson, Lotten/0000-0002-7137-1656; Paul, Blessy/0000-0001-6097-119X	NHMRC (National Health and Medical Research Council) Program Grant [APP1072113]	NHMRC (National Health and Medical Research Council) Program Grant	Funded by NHMRC (National Health and Medical Research Council) Program Grant APP1072113.	Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Baker RT, 1996, CURR OPIN BIOTECH, V7, P541, DOI 10.1016/S0958-1669(96)80059-0; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cassels BK, 2005, DRUG DISCOV TODAY, V10, P1657, DOI 10.1016/S1359-6446(05)03665-2; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Chasapis CT, 2011, BIOCHEMISTRY-US, V50, P9681, DOI 10.1021/bi201223u; Chen R, 2012, BIOTECHNOL ADV, V30, P1102, DOI 10.1016/j.biotechadv.2011.09.013; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Ihara Makoto, 2008, Invertebrate Neuroscience, V8, P71, DOI 10.1007/s10158-008-0069-3; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Lloyd GK, 2000, J PHARMACOL EXP THER, V292, P461; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McCormack T, 2010, BIOCHEMISTRY-US, V49, P2279, DOI 10.1021/bi902023y; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moon WJ, 2007, PROTEIN EXPRES PURIF, V51, P141, DOI 10.1016/j.pep.2006.07.010; Mowrey DD, 2015, BBA-BIOMEMBRANES, V1848, P307, DOI 10.1016/j.bbamem.2014.03.014; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Rosano GL, 2014, FRONT MICROBIOL, P5; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; San-Miguel T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-89; Sekiguchi H, 2014, SCI REPORTS, P4; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Stevens RC, 2000, STRUCTURE, V8, pR177, DOI 10.1016/S0969-2126(00)00193-3; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Weidner Maria, 2010, J Vis Exp, DOI 10.3791/1862; Wells GB, 2008, FRONT BIOSCI-LANDMRK, V13, P5479, DOI 10.2741/3094; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	55	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157363	10.1371/journal.pone.0157363	http://dx.doi.org/10.1371/journal.pone.0157363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304486	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800055
J	Lind, KR; Lee, N; Sizmur, T; Siemianowski, O; Van Bruggen, S; Ganapathysubramaniam, B; Cademartiri, L				Lind, Kara R.; Lee, Nigel; Sizmur, Tom; Siemianowski, Oskar; Van Bruggen, Shawn; Ganapathysubramaniam, Baskar; Cademartiri, Ludovico			Plant Growth Environments with Programmable Relative Humidity and Homogeneous Nutrient Availability	PLOS ONE			English	Article							PHENOMICS; RESPONSES; FUTURE; LIFE	We describe the design, characterization, and use of "programmable", sterile growth environments for individual (or small sets of) plants. The specific relative humidities and nutrient availability experienced by the plant is established (RH between 15% and 95%; nutrient concentration as desired) during the setup of the growth environment, which takes about 5 minutes and < 1$ in disposable cost. These systems maintain these environmental parameters constant for at least 14 days with minimal intervention (one minute every two days). The design is composed entirely of off-the-shelf components (e.g., LEGO1 bricks) and is characterized by (i) a separation of root and shoot environment (which is physiologically relevant and facilitates imposing specific conditions on the root system, e.g., darkness), (ii) the development of the root system on a flat surface, where the root enjoys constant contact with nutrient solution and air, (iii) a compatibility with root phenotyping. We demonstrate phenotyping by characterizing root systems of Brassica rapa plants growing in different relative humidities (55%, 75%, and 95%). While most phenotypes were found to be sensitive to these environmental changes, a phenotype tightly associated with root system topology-the size distribution of the areas encircled by roots-appeared to be remarkably and counter-intuitively insensitive to humidity changes. These setups combine many of the advantages of hydroponics conditions (e.g., root phenotyping, complete control over nutrient composition, scalability) and soil conditions (e.g., aeration of roots, shading of roots), while being comparable in cost and setup time to Magenta (R) boxes.	[Lind, Kara R.; Sizmur, Tom; Siemianowski, Oskar; Cademartiri, Ludovico] Iowa State Univ Sci & Technol, Dept Mat Sci & Engn, Ames, IA 50011 USA; [Lee, Nigel; Ganapathysubramaniam, Baskar] Iowa State Univ Sci & Technol, Dept Mech Engn, Ames, IA 50011 USA; [Sizmur, Tom] Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England; [Van Bruggen, Shawn; Cademartiri, Ludovico] Iowa State Univ Sci & Technol, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Sizmur, Tom; Cademartiri, Ludovico] US DOE, Ames Lab, Ames, IA 50011 USA	Iowa State University; Iowa State University; University of Reading; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Cademartiri, L (corresponding author), Iowa State Univ Sci & Technol, Dept Mat Sci & Engn, Ames, IA 50011 USA.; Cademartiri, L (corresponding author), Iowa State Univ Sci & Technol, Dept Chem & Biol Engn, Ames, IA 50011 USA.; Cademartiri, L (corresponding author), US DOE, Ames Lab, Ames, IA 50011 USA.	lcademar@iastate.edu	Siemianowski, Oskar/A-9904-2018; Cademartiri, Ludovico/A-4142-2008	Cademartiri, Ludovico/0000-0001-8805-9434; Siemianowski, Oskar/0000-0002-7842-8977	Arnold and Mabel Beckman Foundation; Plant Science Institute at Iowa State University	Arnold and Mabel Beckman Foundation; Plant Science Institute at Iowa State University	The work was funded by the Arnold and Mabel Beckman Foundation through a Young Investigator Award to LC. Root phenotyping work was separately funded by the Plant Science Institute at Iowa State University through a Faculty Scholar Award to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Automation and environmental control in plant tissue culture, 1995, AUTOMATION AND ENVIR; Chen CC, 2004, BIOSYST ENG, V88, P231, DOI 10.1016/j.biosystemseng.2004.02.007; Coyle Walter J, 2008, Curr Gastroenterol Rep, V10, P393, DOI 10.1007/s11894-008-0074-z; Dhondt S, 2013, TRENDS PLANT SCI, V18, P433, DOI 10.1016/j.tplants.2013.04.008; Fang FC, 2011, INFECT IMMUN, V79, P1401, DOI 10.1128/IAI.01343-10; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Garcia-Palacios P, 2012, J ECOL, V100, P1303, DOI 10.1111/j.1365-2745.2012.02014.x; Glass DJ, 2008, CELL, V134, P378, DOI 10.1016/j.cell.2008.07.033; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Hartmann A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-148; Haynes W.M., 2014, CRC HDB CHEM PHYS, V95th ed.; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Kozai T, 1997, PLANT CELL TISS ORG, V51, P49, DOI 10.1023/A:1005809518371; Lind KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100867; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Massonnet C, 2010, PLANT PHYSIOL, V152, P2142, DOI 10.1104/pp.109.148338; Mishra Y, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-6; Poorter H, 2012, FUNCT PLANT BIOL, V39, P821, DOI 10.1071/FP12028; Raoult D, 2010, FUTURE MICROBIOL, V5, P135, DOI 10.2217/FMB.09.119; ROLFE BG, 1980, PLANT SCI LETT, V19, P277, DOI 10.1016/0304-4211(80)90082-6; Saint Pierre C, 2012, J EXP BOT, V63, P1799, DOI 10.1093/jxb/err385; Shillito R D, 1983, Plant Cell Rep, V2, P244, DOI 10.1007/BF00269151; Sizmur T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096730; Spellman F., 2012, HDB NATURE; Spomer LA, 1997, HUMIDITY; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; WILLIAMS RR, 1993, AUST J BOT, V41, P237, DOI 10.1071/BT9930237; Yang WN, 2013, CURR OPIN PLANT BIOL, V16, P180, DOI 10.1016/j.pbi.2013.03.005; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	32	4	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155960	10.1371/journal.pone.0155960	http://dx.doi.org/10.1371/journal.pone.0155960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304431	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000377824800011
J	Ramya, P; Singh, GP; Jain, N; Singh, PK; Pandey, MK; Sharma, K; Kumar, A; Harikrishna; Prabhu, KV				Ramya, P.; Singh, Gyanendra Pratap; Jain, Neelu; Singh, Pradeep Kumar; Pandey, Manoj Kumar; Sharma, Kavita; Kumar, Arun; Harikrishna; Prabhu, Kumble Vinod			Effect of Recurrent Selection on Drought Tolerance and Related Morpho-Physiological Traits in Bread Wheat	PLOS ONE			English	Article							LOWLAND TROPICAL MAIZE; CARBON-ISOTOPE DISCRIMINATION; GRAIN-YIELD; 8 CYCLES; PHYSIOLOGICAL TRAITS; DWARFING GENES; KERNEL WEIGHT; EARLY VIGOR; POPULATION; RESPONSES	Drought is one of the major abiotic stresses affecting wheat yield. A recurrent selection program was conducted to improve the drought tolerance and yield of bread wheat using drought tolerant advanced breeding lines from a drought tolerant x susceptible cross (HI 1500 x HUW 510). The parental lines were evaluated for yield, biomass and harvest index (HI) in addition to the drought adaptive traits like Canopy Temperature (CT), chlorophyll content and Normalized Difference Vegetative Index (NDVI). After three rounds of recurrent selection, the half sib progenies exhibited a marked reduction in CT, chlorophyll content and biomass; whereas improvement was noted for yield, HI and NDVI. Drought tolerance of the half-sib population appeared enhanced as indicated by drought indices and grain yield. Compared to base population, half-sibs showed better HI, grain filling and a significant (17.1%) increase in grain yield under water stress conditions. Cooler canopies and increased early vigour might have contributed to drought tolerance. A favourable combination of gibberellin sensitive and insensitive Rhtalleles was observed in the recombinant progenies. However, increased yield under water stress had a negative trade off in reduction of biomass. The study also identified potential lines with high yield and drought tolerance for subsequent varietal development for water limited areas.	[Ramya, P.; Singh, Gyanendra Pratap; Jain, Neelu; Singh, Pradeep Kumar; Pandey, Manoj Kumar; Sharma, Kavita; Kumar, Arun; Harikrishna; Prabhu, Kumble Vinod] ICAR Indian Agr Res Inst, Div Genet, Delhi, India; [Ramya, P.] ICAR Indian Inst Hort Res, Div Vegetable Crops, Bangalore, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research	Ramya, P (corresponding author), ICAR Indian Agr Res Inst, Div Genet, Delhi, India.; Ramya, P (corresponding author), ICAR Indian Inst Hort Res, Div Vegetable Crops, Bangalore, Karnataka, India.	ramyakurian@gmail.com			Generation Challenge Project (GCP)	Generation Challenge Project (GCP)	The authors acknowledge the financial assistance from Generation Challenge Project (GCP) in conducting the study.	Allard R., 1960, PRINCIPLES PLANT BRE, P485; Araus JL, 2003, CROP SCI, V43, P170, DOI 10.2135/cropsci2003.0170; ARAUS JL, 1987, PLANT PHYSIOL, V85, P667, DOI 10.1104/pp.85.3.667; BAILEY TB, 1976, CROP SCI, V16, P363, DOI 10.2135/cropsci1976.0011183X001600030012x; Barreto HJ, 1997, DEV DROUGHT LOW N TO, P544; BLUM A, 1989, FIELD CROP RES, V22, P289, DOI 10.1016/0378-4290(89)90028-2; Blum A., 1988, Plant breeding for stress environments.; BOLANOS J, 1993, FIELD CROP RES, V31, P233, DOI 10.1016/0378-4290(93)90064-T; BOLANOS J, 1993, FIELD CROP RES, V31, P253, DOI 10.1016/0378-4290(93)90065-U; BOLANOS J, 1993, FIELD CROP RES, V31, P269, DOI 10.1016/0378-4290(93)90066-V; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; Borrell AK, 2014, J EXP BOT, V65, P6251, DOI 10.1093/jxb/eru232; Boyer JS, 1996, ADV AGRON, V56, P187, DOI 10.1016/S0065-2113(08)60182-0; BUSCH RH, 1982, CROP SCI, V22, P568, DOI 10.2135/cropsci1982.0011183X002200030032x; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; DELZER BW, 1995, CROP SCI, V35, P730, DOI 10.2135/cropsci1995.0011183X003500030014x; DONALD CM, 1976, ADV AGRON, V28, P361, DOI 10.1016/S0065-2113(08)60559-3; Edmeades G. O., 1999, DROUGHT RESISTANCE C; Fernandez GCJ, 1992, ADAPTATION FOOD CROP, P257, DOI DOI 10.22001/WVC.72511; FOROUGHIWEHR B, 1990, THEOR APPL GENET, V80, P564, DOI 10.1007/BF00226761; HOSSAIN ABS, 1990, CROP SCI, V30, P622, DOI 10.2135/cropsci1990.0011183X003000030030x; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; HULL FH, 1945, J AM SOC AGRON, V37, P134; JENKINS MERLE T., 1940, JOUR AMER SOC AGRON, V32, P55; Joshi AK, 2007, EUPHYTICA, V157, P431, DOI 10.1007/s10681-007-9385-7; Khanna-Chopra R, 2013, INDIAN J PLANT GENET, V26, P25; Kountche BA, 2013, FIELD CROP RES, V154, P82, DOI 10.1016/j.fcr.2013.07.008; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; LOFFLER CM, 1983, CROP SCI, V23, P1097, DOI 10.2135/cropsci1983.0011183X002300060018x; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; Lopes MS, 2010, FUNCT PLANT BIOL, V37, P147, DOI 10.1071/FP09121; Ludlow M. M., 1990, ADV AGRONOMY, V43, P107; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Mullan DJ, 2010, FUNCT PLANT BIOL, V37, P703, DOI 10.1071/FP09277; Olivares-Villegas JJ, 2007, FUNCT PLANT BIOL, V34, P189, DOI 10.1071/FP06148; OLMEDOARCEGA OB, 1995, CROP SCI, V35, P714, DOI 10.2135/cropsci1995.0011183X003500030011x; PARLEVLIET JE, 1988, EUPHYTICA, V37, P261, DOI 10.1007/BF00015122; Pask A, 2014, FIELD CROP RES, V168, P156, DOI 10.1016/j.fcr.2014.07.004; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Posadas LG, 2014, CROP SCI, V54, P2536, DOI 10.2135/cropsci2014.01.0090; Ramirez-Vallejo P, 1998, EUPHYTICA, V99, P127, DOI 10.1023/A:1018353200015; Ramya R, 2015, INDIAN J GENET PL BR, V75, P250, DOI 10.5958/0975-6906.2015.00038.3; Rebetzke GJ, 2012, FIELD CROP RES, V127, P17, DOI 10.1016/j.fcr.2011.11.003; Rebetzke GJ, 1999, AUST J AGR RES, V50, P291, DOI 10.1071/A98125; Rebetzke GJ, 2002, CROP SCI, V42, P739, DOI 10.2135/cropsci2002.0739; Reynolds M.P., 2001, APPL PHYSL WHEAT BRE, P88; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; ROSIELLE AA, 1981, CROP SCI, V21, P943, DOI 10.2135/cropsci1981.0011183X002100060033x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sheoran S, 2013, INDIAN J AGR SCI, V83, P820; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tehripour F, 2015, 2015 AAEA WAEA JOINT; Veillet S, 1996, THEOR APPL GENET, V92, P644, DOI 10.1007/BF00226084; Venuprasad R, 2007, CROP SCI, V47, P285, DOI 10.2135/cropsci2006.03.0181; Wiersma JJ, 2001, CROP SCI, V41, P999, DOI 10.2135/cropsci2001.414999x; Wilson PB, 2015, FIELD CROP RES, V183, P102, DOI 10.1016/j.fcr.2015.07.002; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zhang L, 2015, J EXP BOT, V66, P1215, DOI 10.1093/jxb/eru468	59	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156869	10.1371/journal.pone.0156869	http://dx.doi.org/10.1371/journal.pone.0156869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300000	gold, Green Published, Green Submitted			2022-12-26	WOS:000377822200018
J	Valente, TS; Baldi, F; Sant'Anna, AC; Albuquerque, LG; da Costa, MJRP				Valente, Tiago Silva; Baldi, Fernando; Sant'Anna, Aline Cristina; Albuquerque, Lucia Galvao; Rodrigues Paranhos da Costa, Mateus Jose			Genome-Wide Association Study between Single Nucleotide Polymorphisms and Flight Speed in Nellore Cattle	PLOS ONE			English	Article							SOLUBLE GUANYLYL CYCLASE; MAPPING INCLUDING PHENOTYPES; HUMAN CARBOXYPEPTIDASE-E; MEAT QUALITY TRAITS; BEEF-CATTLE; NITRIC-OXIDE; ANTHRAX TOXIN; AFFECTING TEMPERAMENT; GENETIC ASSOCIATIONS; FEEDING-BEHAVIOR	Introduction Cattle temperament is an important factor that affects the profitability of beef cattle enterprises, due to its relationship with productivity traits, animal welfare and labor safety. Temperament is a complex phenotype often assessed by measuring a series of behavioral traits, which result from the effects of multiple environmental and genetic factors, and their interactions. The aims of this study were to perform a genome-wide association study and detect genomic regions, potential candidate genes and their biological mechanisms underlying temperament, measured by flight speed (FS) test in Nellore cattle. Materials and Methods The genome-wide association study (GWAS) was performed using a single-step procedure (ssGBLUP) which combined simultaneously all 16,600 phenotypes from genotyped and non-genotyped animals, full pedigree information of 162,645 animals and 1,384 genotyped animals in one step. The animals were genotyped with High Density Bovine SNP BeadChip which contains 777,962 SNP markers. After quality control (QC) a total of 455,374 SNPs remained. Results Heritability estimated for FS was 0.21 +/- 0.02. Consecutive SNPs explaining 1% or more of the total additive genetic variance were considered as windows associated with FS. Nine candidate regions located on eight different Bos taurus chromosomes (BTA) (1 at 73 Mb, 2 at 65 Mb, 5 at 22 Mb and 119 Mb, 9 at 98 Mb, 11 at 67 Mb, 15 at 16 Mb, 17 at 63 Kb, and 26 at 47 Mb) were identified. The candidate genes identified in these regions were NCKAP5 (BTA2), PARK2 (BTA9), ANTXR1 (BTA11), GUCY1A2 (BTA15), CPE (BTA17) and DOCK1 (BTA26). Among these genes PARK2, GUCY1A2, CPE and DOCK1 are related to dopaminergic system, memory formation, biosynthesis of peptide hormone and neurotransmitter and brain development, respectively. Conclusions Our findings allowed us to identify nine genomic regions (SNP windows) associated with beef cattle temperament, measured by FS test. Within these windows, six promising candidate genes and their biological functions were identified. These results may contribute to a better comprehension into the genetic control of temperament expression in Nellore cattle.	[Valente, Tiago Silva; Baldi, Fernando; Albuquerque, Lucia Galvao; Rodrigues Paranhos da Costa, Mateus Jose] Univ Estadual Paulista, UNESP, Fac Ciencias Agr & Vet, Dept Zootecnia, Via Acesso Prof Paulo Donato Castellane, BR-14884900 Jaboticabal, SP, Brazil; [Sant'Anna, Aline Cristina] Univ Fed Juiz de Fora, Inst Ciencias Biol, Dept Zool, Rua Jose Lourenco Kelmer, BR-36036900 Juiz de Fora, MG, Brazil	Universidade Estadual Paulista; Universidade Federal de Juiz de Fora	da Costa, MJRP (corresponding author), Univ Estadual Paulista, UNESP, Fac Ciencias Agr & Vet, Dept Zootecnia, Via Acesso Prof Paulo Donato Castellane, BR-14884900 Jaboticabal, SP, Brazil.	mpcosta@fcav.unesp.br	Sant'Anna, Aline C/J-7529-2013; da Costa, Mateus J.R. Paranhos/C-5993-2012; da Costa, Mateus Paranhos/V-4750-2019; Baldi, Fernando/E-5492-2012; Albuquerque, Lucia/A-7402-2013	Sant'Anna, Aline C/0000-0002-5431-7199; da Costa, Mateus J.R. Paranhos/0000-0002-0088-4008; da Costa, Mateus Paranhos/0000-0002-0088-4008; Baldi, Fernando/0000-0003-4094-2011; Albuquerque, Lucia/0000-0002-2030-7590	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2009/53609-7, 2009/16118-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (Grant numbers: 2009/53609-7 and 2009/16118-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (Grant numbers: 2009/53609-7 and 2009/16118-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Agropecuaria Jacarezinho Ltda for allowing access to the animals and records. We would like to acknowledge Dr. Graham Plastow for the useful contributions to this paper.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Ambroziak W, 2015, J APPL GENET; [Anonymous], 2002, P 7 WORLD C GEN APPL; Bauer ME, 2001, PHYSIOL BEHAV, V73, P525, DOI 10.1016/S0031-9384(01)00503-0; Bayram Y, 2014, AM J MED GENET A, V164, P2328, DOI 10.1002/ajmg.a.36678; Besschetnova TY, 2015, MATRIX BIOL, V42, P56, DOI 10.1016/j.matbio.2014.12.002; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Burdick N. C., 2011, International Journal of Zoology, V2011, P373197, DOI 10.1155/2011/373197; Burdick NC, 2010, LIVEST SCI, V129, P166, DOI 10.1016/j.livsci.2010.01.020; Burrow H. M., 1997, Animal Breeding Abstracts, V65, P477; Burrow H.M., 1988, P AUST SOC ANIM PROD, V17, P154; Burrow HM, 2000, AUST J AGR RES, V51, P155, DOI 10.1071/AR99053; Burrow HM, 2001, LIVEST PROD SCI, V70, P213, DOI 10.1016/S0301-6226(01)00178-6; Capitanio JP, 2011, BRAIN BEHAV IMMUN, V25, P151, DOI 10.1016/j.bbi.2010.09.008; Cargill EJ, 1998, J ANIM SCI, V76, P2211; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Cavigelli SA, 2008, BRAIN BEHAV IMMUN, V22, P727, DOI 10.1016/j.bbi.2007.10.014; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Chen DH, 2013, CANCER RES, V73, P5821, DOI 10.1158/0008-5472.CAN-13-1080; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Curley KO, 2006, J ANIM SCI, V84, P3100, DOI 10.2527/jas.2006-055; de Mena L, 2013, J MOL NEUROSCI, V50, P264, DOI 10.1007/s12031-012-9942-y; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Dikmen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069202; Esmailizadeh AK, 2008, J ANIM SCI, V86, P1038, DOI 10.2527/jas.2007-0589; FORDYCE G, 1982, PROC AUST SOC ANIM P, V14, P329; Franke K, 2012, EMBO J, V31, P2908, DOI 10.1038/emboj.2012.130; Fricker LD, 1986, NATURE, V3, P666; Fukae J, 2009, FEBS LETT, V583, P521, DOI 10.1016/j.febslet.2008.12.055; Gerozissis K, 2004, EUR J PHARMACOL, V490, P59, DOI 10.1016/j.ejphar.2004.02.044; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GIANOLA D, 1986, J ANIM SCI, V63, P217, DOI 10.2527/jas1986.631217x; Gibb BJ, 2001, EUR J NEUROSCI, V13, P539, DOI 10.1046/j.1460-9568.2001.01421.x; Glenske K, 2011, ANIMAL, V5, P195, DOI 10.1017/S1751731110001801; Glenske K, 2010, ARCH TIERZUCHT, V53, P388, DOI 10.5194/aab-53-388-2010; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; GRANDIN T, 1993, APPL ANIM BEHAV SCI, V36, P1, DOI 10.1016/0168-1591(93)90094-6; Gupta G, 1997, J CLIN INVEST, V100, P1488, DOI 10.1172/JCI119670; Gutierrez-Gil B, 2008, J HERED, V99, P629, DOI 10.1093/jhered/esn060; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Haegeman A, 2003, ANIM GENET, V34, P349, DOI 10.1046/j.1365-2052.2003.01008.x; Hanna LLH, 2014, LIVEST SCI, V161, P17, DOI 10.1016/j.livsci.2013.12.012; HARTENECK C, 1991, FEBS LETT, V292, P217, DOI 10.1016/0014-5793(91)80871-Y; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; Hase A, 2002, BRAIN RES, V930, P143, DOI 10.1016/S0006-8993(02)02241-2; Haskell MJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00368; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Hejjas K, 2009, GENES BRAIN BEHAV, V8, P330, DOI 10.1111/j.1601-183X.2008.00475.x; Herrmann D, 2010, DEV DYNAM, V239, P680, DOI 10.1002/dvdy.22194; Hiendleder S, 2003, J HERED, V94, P496, DOI 10.1093/jhered/esg090; Hoppe S, 2010, J ANIM SCI, V88, P1982, DOI 10.2527/jas.2008-1557; Hori Yusuke, 2013, Journal of Equine Science, V24, P31, DOI 10.1294/jes.24.31; Hu ZL, 2013, NUCLEIC ACIDS RES, P41; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Ingram RJ, 2013, CLIN EXP IMMUNOL, V173, P84, DOI 10.1111/cei.12090; Jaber M, 1996, NEUROPHARMACOLOGY, V35, P1503, DOI 10.1016/S0028-3908(96)00100-1; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jensen P, 2008, APPL ANIM BEHAV SCI, V113, P383, DOI 10.1016/j.applanim.2008.01.012; Kadel MJ, 2006, AUST J AGR RES, V57, P1029, DOI 10.1071/AR05082; Keltikangas-Jarvinen L, 2003, PSYCHOSOM MED, V65, P471, DOI 10.1097/01.PSY.0000041547.31072.25; Khor SS, 2013, PEERJ, V1, DOI 10.7717/peerj.66; Kilgour RJ, 2006, APPL ANIM BEHAV SCI, V99, P21, DOI 10.1016/j.applanim.2005.09.012; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Koglin M, 2000, BBA-GENE STRUCT EXPR, V1494, P286, DOI 10.1016/S0167-4781(00)00211-6; Koshimizu H, 2009, J MOL NEUROSCI, V39, P1, DOI 10.1007/s12031-008-9164-5; Kuroda Y, 2006, BIOCHEM BIOPH RES CO, V348, P787, DOI 10.1016/j.bbrc.2006.06.201; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lindholm-Perry AK, 2015, ANIM GENET, V46, P60, DOI 10.1111/age.12244; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; MacKay JRD, 2013, J ANIM SCI, V91, P4917, DOI 10.2527/jas.2012-5473; Makino Y, 2006, J CELL SCI, V119, P923, DOI 10.1242/jcs.02797; MANSER E, 1990, BIOCHEM J, V267, P517, DOI 10.1042/bj2670517; Matuoka K, 1997, BIOCHEM BIOPH RES CO, V239, P488, DOI 10.1006/bbrc.1997.7492; McDonald L J, 1995, Adv Pharmacol, V34, P263; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Meyerhoff JL, 1985, PERSPECTIVES BEHAV M, P250; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Momozawa Y, 2005, MAMM GENOME, V16, P538, DOI 10.1007/s00335-005-0021-3; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Nkrumah JD, 2007, J ANIM SCI, V85, P2382, DOI 10.2527/jas.2006-657; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Petherick JC, 2002, AUST J EXP AGR, V42, P389, DOI 10.1071/EA01084; Pezeshkpour Gholam H, 2013, Genes Cancer, V4, P315, DOI 10.1177/1947601913497573; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Prayaga KC, 2009, ANIM PROD SCI, V49, P413, DOI 10.1071/EA08247; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Pugh KA, 2011, CAN J ANIM SCI, V91, P567, DOI [10.4141/CJAS2011-046, 10.4141/cjas2011-046]; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Robinson DL, 2001, PERS INDIV DIFFER, V31, P1233, DOI 10.1016/S0191-8869(00)00211-7; Rolfe KM, 2011, J ANIM SCI, V89, P3452, DOI 10.2527/jas.2011-3961; Russwurm M, 1998, BIOCHEM J, V335, P125, DOI 10.1042/bj3350125; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; SANDERS KM, 1992, JPN J PHARMACOL, V58, pP220; Sant'Anna AC, 2015, J ANIM BREED GENET, V132, P42, DOI 10.1111/jbg.12117; Sant'Anna AC, 2012, J ANIM SCI, V90, P3427, DOI 10.2527/jas.2011-5044; Santana MHA, 2014, J ANIM BREED GENET, V131, P210, DOI 10.1111/jbg.12084; Schaker K, 2015, J BIOL CHEM, V290, P6408, DOI 10.1074/jbc.M114.633701; Schmidt LA, 2009, PSYCHOL SCI, V20, P831, DOI 10.1111/j.1467-9280.2009.02374.x; Schmutz SM, 2001, J HERED, V92, P290, DOI 10.1093/jhered/92.3.290; Shi L, 2013, COMMUN INTEGR BIOL, P6; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin SC, 2007, ASIAN AUSTRAL J ANIM, V20, P1; Shiraishi JI, 2008, DOMEST ANIM ENDOCRIN, V34, P223, DOI 10.1016/j.domaniend.2007.05.002; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Spelman RJ, 1999, J DAIRY SCI, V82, P2514, DOI 10.3168/jds.S0022-0302(99)75503-7; St Croix B, 2000, SCIENCE, V289, P1197; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; STRITTMATTER SM, 1984, J BIOL CHEM, V259, P1812; Sun X., 2011, J ANIM SCI S2, V89, P28; Tiezzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114919; TIPTON RE, 1984, AM J MED GENET, V19, P209, DOI 10.1002/ajmg.1320190202; Tuominen L, 2013, PSYCHOL MED, V43, P881, DOI 10.1017/S003329171200164X; Valente TS, 2015, J APPL GENET, V56, P349, DOI 10.1007/s13353-014-0259-0; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vargas M, 2012, PLOS ONE, P8; Vetters MDD, 2013, J ANIM SCI, V91, P374, DOI 10.2527/jas.2012-5122; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; Wan M, 2013, ANIM GENET, V44, P717, DOI 10.1111/age.12058; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Wang J, 2008, ACTA PHARMACOL SIN, V29, P736, DOI 10.1111/j.1745-7254.2008.00798.x; Wang J, 2014, INT J GYNECOL CANCER, V24, P844, DOI 10.1097/IGC.0000000000000137; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Warner T D, 1994, Adv Pharmacol, V26, P171, DOI 10.1016/S1054-3589(08)60054-X; Webb LE, 2015, APPL ANIM BEHAV SCI, V165, P33, DOI 10.1016/j.applanim.2015.01.013; WEDEL B, 1995, J BIOL CHEM, V270, P24871, DOI 10.1074/jbc.270.42.24871; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Yang MY, 2011, BBA-MOL CELL RES, V1813, P39, DOI 10.1016/j.bbamcr.2010.11.013; Yoshino A, 2005, BIOL PSYCHIAT, V57, P1, DOI 10.1016/j.biopsych.2004.09.027; YUEN PST, 1990, BIOCHEMISTRY-US, V29, P10872, DOI 10.1021/bi00501a002; Zhang CY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0192-1; Zhao F, 2011, HISTOPATHOLOGY, V59, P1163, DOI 10.1111/j.1365-2559.2011.04045.x	152	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156956	10.1371/journal.pone.0156956	http://dx.doi.org/10.1371/journal.pone.0156956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300296	Green Submitted, gold, Green Published			2022-12-26	WOS:000377822200020
J	Prati, G; Zani, B; Pietrantoni, L; Scudiero, D; Perone, P; Cosmaro, L; Cerioli, A; Oldrini, M				Prati, Gabriele; Zani, Bruna; Pietrantoni, Luca; Scudiero, Diego; Perone, Patrizia; Cosmaro, Lella; Cerioli, Alessandra; Oldrini, Massimo			PEP and TasP Awareness among Italian MSM, PLWHA, and High-Risk Heterosexuals and Demographic, Behavioral, and Social Correlates	PLOS ONE			English	Article							HIV PREVENTION; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; GAY MEN; LIMITED KNOWLEDGE; ACCEPTABILITY; PEOPLE; MEDIA; POSTEXPOSURE	Post-exposure prophylaxis (PEP) has been proposed as a strategy to prevent the acquisition of HIV infection after certain high-risk exposures, and treatment as prevention (TasP) is also being advocated as a means to reduce sexual transmission of HIV. The aim of this study was to investigate the prevalence of PEP and TasP awareness and their demographic, behavioral, and social correlates in Italy. We conducted a cross-sectional survey of 1,028 high-risk heterosexual men and women, 1,874 non-HIV positive MSM (men who have sex with men), and 694 people living with HIV/AIDS (PLWHA). The majority of the participants was aware of PEP and unaware of TasP. MSM were less knowledgeable about PEP and TasP than were PLWHA and more knowledgeable about PEP and TasP than were high-risk heterosexual participants. The variables most consistently associated with PEP and TasP awareness were contact with HIV/ AIDS organizations, HIV testing, and HIV stigma. A positive relationship between unprotected sexual intercourse and PEP and TasP awareness was found among high risk heterosexual participants, while this association was not significant among MSM and PLWHA. Because PEP and TasP are currently recommended, effective educational and dissemination strategies are needed to increase the level of knowledge about PEP and TasP.	[Prati, Gabriele; Zani, Bruna; Pietrantoni, Luca] Univ Bologna, Dept Psychol, Bologna, Italy; [Scudiero, Diego; Perone, Patrizia; Cosmaro, Lella; Cerioli, Alessandra; Oldrini, Massimo] Italian League Fight AIDS, Como, Italy	University of Bologna	Prati, G (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	gabriele.prati@unibo.it	Prati, Gabriele/K-8426-2014; PIETRANTONI, LUCA/AAX-2518-2020	Prati, Gabriele/0000-0002-0749-183X; PIETRANTONI, LUCA/0000-0002-3966-3800; ZANI, BRUNA/0000-0001-7358-5001	Italian League for the Fight against AIDS (LILA)	Italian League for the Fight against AIDS (LILA)	This research was supported by a grant from the Italian League for the Fight against AIDS (LILA) that commissioned the research from the Department of Psychology of the University of Bologna. The funder participated in study design and data collection.	[Anonymous], 1974, Health Education Monograph, V2, P324; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Camoni L., 2015, NOT IST SUPER SANITA, V28, P3; Camoni L, 2014, ANN I SUPER SANITA, V50, P291, DOI 10.4415/ANN_14_03_12; Camoni L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/209619; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Cohen J, 2011, SCIENCE, V334, P1628, DOI 10.1126/science.334.6063.1628; Courtenay-Quirk C, 2006, AIDS EDUC PREV, V18, P56, DOI 10.1521/aeap.2006.18.1.56; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Delgado HM, 2007, CURR OPIN PEDIATR, V19, P405, DOI 10.1097/MOP.0b013e32823ed008; Dombrowski JC, 2010, AIDS PATIENT CARE ST, V24, P747, DOI 10.1089/apc.2010.0198; Doyle JS, 2014, CLIN INFECT DIS, V59, P1483, DOI 10.1093/cid/ciu602; Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Elford J, 2004, AIDS, V18, P2216, DOI 10.1097/00002030-200411050-00021; European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2015, HIV AIDS SURV EUR 20; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guse K, 2012, J ADOLESCENT HEALTH, V51, P535, DOI 10.1016/j.jadohealth.2012.03.014; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Hintze J., 2011, PASS 11; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2013, AIDS BEHAV, V17, P2156, DOI 10.1007/s10461-012-0313-z; Istat, 2012, RAPP ANN 2012; Jones K, 2014, SEX TRANSM DIS, V41, P413, DOI 10.1097/OLQ.0000000000000146; Kalichman SC, 2010, HIV MED, V11, P502, DOI 10.1111/j.1468-1293.2009.00818.x; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Lauby JL, 2008, ARCH SEX BEHAV, V37, P708, DOI 10.1007/s10508-008-9365-6; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mammone Alessia, 2016, AIDS, V30, P1131, DOI 10.1097/QAD.0000000000001034; McDonald K, 2011, CULT HEALTH SEX, V13, P1119, DOI 10.1080/13691058.2011.607242; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Nodin N, 2008, AIDS CARE, V20, P106, DOI 10.1080/09540120701449096; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Persson A, 2010, AIDS CARE, V22, P1487, DOI 10.1080/09540121.2010.482122; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Prati G., 2013, PRATICHE POSITIVE IN; Prati G, 2016, INT J SEX HEALTH, V28, P1, DOI 10.1080/19317611.2015.1068903; Prati G, 2016, QUAL QUANT, V50, P637, DOI 10.1007/s11135-015-0168-2; Prati G, 2016, SOC WORK PUBLIC HLTH, V31, P30, DOI 10.1080/19371918.2015.1087911; Prati G, 2015, J AGING HEALTH, V27, P123, DOI 10.1177/0898264314538664; Prati G, 2014, INT J STD AIDS, V25, P496, DOI 10.1177/0956462413515193; Rosenstock IM, 1960, AM J PUBLIC HEALTH, V50, DOI [10.2105/AJPH.50.3_Pt_1.295, DOI 10.2105/AJPH.50.3_PT1.295]; Swanton R, 2015, SEX TRANSM INFECT, V91, P14, DOI 10.1136/sextrans-2014-051743; Tapscott D., 2008, GROWING DIGITAL RISE; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038; Zablotska IB, 2011, JAIDS-J ACQ IMM DEF, V58, P424, DOI 10.1097/QAI.0b013e318230e885	54	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157339	10.1371/journal.pone.0157339	http://dx.doi.org/10.1371/journal.pone.0157339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294777	Green Submitted, Green Published, gold			2022-12-26	WOS:000377821300036
J	Biswal, DK; Debnath, M; Kharumnuid, G; Thongnibah, W; Tandon, V				Biswal, Devendra Kumar; Debnath, Manish; Kharumnuid, Graciously; Thongnibah, Welfrank; Tandon, Veena			Northeast India Helminth Parasite Information Database (NEIHPID): Knowledge Base for Helminth Parasites	PLOS ONE			English	Article							METACERCARIAE; GENOME	Most metazoan parasites that invade vertebrate hosts belong to three phyla: Platyhelminthes, Nematoda and Acanthocephala. Many of the parasitic members of these phyla are collectively known as helminths and are causative agents of many debilitating, deforming and lethal diseases of humans and animals. The North-East India Helminth Parasite Information Database (NEIHPID) project aimed to document and characterise the spectrum of helminth parasites in the north-eastern region of India, providing host, geographical distribution, diagnostic characters and image data. The morphology-based taxonomic data are supplemented with information on DNA sequences of nuclear, ribosomal and mitochondrial gene marker regions that aid in parasite identification. In addition, the database contains raw next generation sequencing (NGS) data for 3 foodborne trematode parasites, with more to follow. The database will also provide study material for students interested in parasite biology. Users can search the database at various taxonomic levels (phylum, class, order, superfamily, family, genus, and species), or by host, habitat and geographical location. Specimen collection locations are noted as co-ordinates in a MySQL database and can be viewed on Google maps, using Google Maps JavaScript API v3. The NEIHPID database has been made freely available at http://nepiac.nehu.ac.in/index.php	[Biswal, Devendra Kumar; Debnath, Manish; Kharumnuid, Graciously; Thongnibah, Welfrank] NE Hill Univ, Bioinformat Ctr, Shillong 793014, Meghalaya, India; [Tandon, Veena] NE Hill Univ, Dept Zool, Shillong 793014, Meghalaya, India; [Tandon, Veena] Biotech Pk, Lucknow, Uttar Pradesh, India	North Eastern Hill University; North Eastern Hill University	Tandon, V (corresponding author), NE Hill Univ, Dept Zool, Shillong 793014, Meghalaya, India.; Tandon, V (corresponding author), Biotech Pk, Lucknow, Uttar Pradesh, India.	tandonveena@gmail.com		Tandon, Veena/0000-0003-4315-2082; DEBNATH, MANISH/0000-0001-8631-9028; Biswal, Devendra/0000-0003-1093-7166	DIT, GOI in Bioinformatics Centre (BIC) at NEHU, Shillong [DIT/R&D/BIO/15(13)/2008]; Department of Biotechnology, GOI, under DBT-NER Twinning program [BT/48/NE/TBP/2010]; Indian Council of Medical Research Project	DIT, GOI in Bioinformatics Centre (BIC) at NEHU, Shillong; Department of Biotechnology, GOI, under DBT-NER Twinning program; Indian Council of Medical Research Project	This study was carried out under the project 'North East Parasite Information and Analysis Centre (NEPIAC): an in silico approach' sanctioned to Veena Tandon and Devendra Kumar Biswal by DIT, GOI (grant number: DIT/R&D/BIO/15(13)/2008 dated 29.09.2008) in the Bioinformatics Centre (BIC) at NEHU, Shillong. The NGS work was supported by the Department of Biotechnology, GOI, under the DBT-NER Twinning program (grant number BT/48/NE/TBP/2010 dated March 14, 2011) sanctioned to Veena Tandon and Devendra Kumar Biswal and partly by the Indian Council of Medical Research Project on worm zoonoses sanctioned to Veena Tandon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020; BAVERSTOCK PR, 1991, INT J PARASITOL, V21, P329, DOI 10.1016/0020-7519(91)90035-6; Biswal DK, 2014, PEERJ, V2, DOI 10.7717/peerj.484; Biswal DK, 2013, PEERJ, V1, DOI 10.7717/peerj.207; BLAIR D, 1993, INT J PARASITOL, V23, P169, DOI 10.1016/0020-7519(93)90138-O; CHAUHAN B. S., 1953, REC INDIAN MUS, V51, P113; Cwiklinski K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0632-2; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hunt P, 2006, T ROY SOC TROP MED H, V100, P603, DOI 10.1016/j.trstmh.2006.03.001; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Khalil LF, 1994, KEYS CESTODE PARASIT; MARIAUX J, 2001, INTERRELATIONSHIPS P, P127; Martin J, 2015, NUCLEIC ACIDS RES, V43, pD698, DOI 10.1093/nar/gku1128; Olson PD, 2005, ADV PARASIT, V60, P165, DOI 10.1016/S0065-308X(05)60003-6; Pandey K. C., 2008, ENCY INDIAN MONOGENO, P522; ROHDE K, 1993, INT J PARASITOL, V23, P705, DOI 10.1016/0020-7519(93)90067-9; SACHS R, 1990, ANN TROP MED PARASIT, V84, P277, DOI 10.1080/00034983.1990.11812467; Schmidt GD., 1986, HDB TAPEWORM IDENTIF; Shin Myeong-Heon, 1999, Korean Journal of Parasitology, V37, P55, DOI 10.3347/kjp.1999.37.1.55; Sugiyama H., 2007, SE ASIAN J TROPICAL, V38, P87; Nguyen TC, 2012, J VET MED SCI, V74, P1367, DOI 10.1292/jvms.12-0025; YAMAGUTI S, 1963, SYSTEMA HELMINTHUM, V4; Yamaguti S., 1959, SYSTEMA HELMINTHUM C, VII; Yamaguti S, 1975, SYNOPTICAL REV LIFE; Yu SenHai, 1994, Tropical Diseases Bulletin, V91, pR125	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157459	10.1371/journal.pone.0157459	http://dx.doi.org/10.1371/journal.pone.0157459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285615	Green Submitted, gold, Green Published			2022-12-26	WOS:000377564000067
J	Ambrosi, C; Ren, C; Spagnol, G; Cavin, G; Cone, A; Grintsevich, EE; Sosinsky, GE; Sorgen, PL				Ambrosi, Cinzia; Ren, Cynthia; Spagnol, Gaelle; Cavin, Gabriel; Cone, Angela; Grintsevich, Elena E.; Sosinsky, Gina E.; Sorgen, Paul L.			Connexin43 Forms Supramolecular Complexes through Non-Overlapping Binding Sites for Drebrin, Tubulin, and ZO-1	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; CARBOXYL-TERMINAL DOMAIN; DENDRITIC SPINE PROTEIN; BLOOD-BRAIN-BARRIER; ACTIN-BINDING; ALZHEIMERS-DISEASE; ZONULA OCCLUDENS-1; F-ACTIN; NEOCORTICAL DEVELOPMENT; STRUCTURAL-CHANGES	Gap junctions are membrane specialization domains identified in most tissue types where cells abut each other. The connexin channels found in these membrane domains are conduits for direct cell-to-cell transfer of ions and molecules. Connexin43 (Cx43) is the most ubiquitous connexin, with critical roles in heart, skin, and brain. Several studies described the interaction between Cx43 and the cytoskeleton involving the actin binding proteins Zonula occludens (ZO-1) and drebrin, as well as with tubulin. However, a direct interaction has not been identified between drebrin and Cx43. In this study, co-IP and NMR experiments were used to demonstrate that the Cx43-CT directly interacts with the highly conserved N-terminus region of drebrin. Three Cx43-CT areas were found to be involved in drebrin binding, with residues 264-275 being critical for the interaction. Mimicking Src phosphorylation within this region (Y265) significantly disrupted the interaction between the Cx43-CT and drebrin. Immunofluorescence showed colocalization of Cx43, drebrin, and F-actin in astrocytes and Vero cells membrane, indicating that Cx43 forms a submembrane protein complex with cytoskeletal and scaffolding proteins. The co-IP data suggest that Cx43 indirectly interacts with F-actin through drebrin. Along with the known interaction of the Cx43-CT with ZO-1 and tubulin, the data presented here for drebrin indicate non-overlapping and separated binding sites for all three proteins for which simultaneous binding could be important in regulating cytoskeleton rearrangements, especially for neuronal migration during brain development.	[Ambrosi, Cinzia; Ren, Cynthia; Cavin, Gabriel; Cone, Angela; Sosinsky, Gina E.] Univ Calif La Jolla, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA USA; [Sosinsky, Gina E.] Univ Calif La Jolla, Dept Neurosci, La Jolla, CA USA; [Grintsevich, Elena E.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Spagnol, Gaelle; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of Nebraska System; University of Nebraska Medical Center	Ambrosi, C (corresponding author), Univ Calif La Jolla, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA USA.; Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.	cinziambro@gmail.com; psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM065937, GM072881, GMGM072631]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM065937, R01GM072881, R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants GM065937 (awarded to GES), GM072881 (awarded to GES) and GMGM072631 (awarded to PLS).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bittman K, 1997, J NEUROSCI, V17, P7037; Brikci-Nigassa AS, 2012, BIOCHEMISTRY-US, V51, P4331, DOI 10.1021/bi201806j; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426; Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; Counts SE, 2012, NEURODEGENER DIS, V10, P216, DOI 10.1159/000333122; Danesh-Meyer HV, 2008, J CLIN NEUROSCI, V15, P1253, DOI 10.1016/j.jocn.2008.08.002; del Valle J, 2012, J ALZHEIMERS DIS, V32, P233, DOI 10.3233/JAD-2012-120718; DEWEY MM, 1962, SCIENCE, V137, P670, DOI 10.1126/science.137.3531.670-a; Duffy HS, 2002, J PHYSIOL-PARIS, V96, P243, DOI 10.1016/S0928-4257(02)00012-8; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533, DOI 10.14670/HH-25.533; Dunn CA, 2014, J CELL SCI, V127, P455, DOI 10.1242/jcs.142497; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Giepmans BNG, 2001, CELL COMMUN ADHES, V8, P219, DOI 10.3109/15419060109080727; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grintsevich EE, 2010, J MOL BIOL, V398, P542, DOI 10.1016/j.jmb.2010.03.039; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi T, 2009, J CELL SCI, V122, P1005, DOI 10.1242/jcs.028175; Homma N, 1998, CIRC RES, V83, P27, DOI 10.1161/01.RES.83.1.27; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Jin MH, 2002, GENOMICS, V79, P686, DOI 10.1006/geno.2002.6764; Julien C, 2008, J NEUROSCI RES, V86, P2292, DOI 10.1002/jnr.21667; Keller A, 2002, TRENDS NEUROSCI, V25, P541, DOI 10.1016/S0166-2236(02)02260-9; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; Kobayashi R, 2004, NEUROSCI RES, V49, P205, DOI 10.1016/j.neures.2004.02.014; KOJIMA N, 1993, MOL BRAIN RES, V19, P101, DOI 10.1016/0169-328X(93)90154-H; Kojima N, 1988, Brain Res, V464, P207; Kojima N, 2010, NEUROSCIENCE, V165, P138, DOI 10.1016/j.neuroscience.2009.10.016; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; Lewis Alberts, 2002, MOL BIOL CELL; Li HJ, 2014, J CELL SCI, V127, P3269, DOI 10.1242/jcs.145193; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Majoul I, 2007, HISTOCHEM CELL BIOL, V127, P355, DOI 10.1007/s00418-007-0273-y; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mizu T, 2005, MOL CELL NEUROSCI, V30, P149, DOI 10.1016/j.mcn.2005.06.008; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; Palatinus JA, 2011, AM J PHYSIOL-HEART C, V300, pH583, DOI 10.1152/ajpheart.00999.2010; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Peitsch WK, 2005, J INVEST DERMATOL, V125, P761, DOI 10.1111/j.0022-202X.2005.23793.x; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; SHIRAO T, 1988, MOL BRAIN RES, V4, P71, DOI 10.1016/0169-328X(88)90020-4; SHIRAO T, 1994, EXP CELL RES, V215, P145, DOI 10.1006/excr.1994.1326; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Spagnol G, 2016, J BIOL CHEM, V291, P7637, DOI 10.1074/jbc.M115.701417; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; TODA M, 1993, BIOCHEM BIOPH RES CO, V196, P468, DOI 10.1006/bbrc.1993.2273; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033	92	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157073	10.1371/journal.pone.0157073	http://dx.doi.org/10.1371/journal.pone.0157073			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280719	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000077
J	Auderset, L; Cullen, CL; Young, KM				Auderset, Loic; Cullen, Carlie L.; Young, Kaylene M.			Low Density Lipoprotein-Receptor Related Protein 1 Is Differentially Expressed by Neuronal and Glial Populations in the Developing and Mature Mouse Central Nervous System	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; PLASMINOGEN-ACTIVATOR; LRP1; CELLS; OLIGODENDROCYTES; PHOSPHORYLATION; TRANSCRIPTOME; PROGENITORS; METABOLISM; ASTROCYTES	The low density lipoprotein-receptor related protein 1 (LRP1) is a large endocytic cell surface receptor that is known to interact with a variety of ligands, intracellular adaptor proteins and other cell surface receptors to regulate cellular behaviours ranging from proliferation to cell fate specification, migration, axon guidance, and lipid metabolism. A number of studies have demonstrated that LRP1 is expressed in the brain, yet it is unclear which central nervous system cell types express LRP1 during development and in adulthood. Herein we undertake a detailed study of LRP1 expression within the mouse brain and spinal cord, examining a number of developmental stages ranging from embryonic day 13.5 to postnatal day 60. We report that LRP1 expression in the brain peaks during postnatal development. On a cellular level, LRP1 is expressed by radial glia, neuroblasts, microglia, oligodendrocyte progenitor cells (OPCs), astrocytes and neurons, with the exception of parvalbumin(+) interneurons in the cortex. Most cell populations exhibit stable expression of LRP1 throughout development; however, the proportion of OPCs that express LRP1 increases significantly from similar to 69% at E15.5 to similar to 99% in adulthood. We also report that LRP1 expression is rapidly lost as OPCs differentiate, and is absent from all oligodendrocytes, including newborn oligodendrocytes. While LRP1 function has been primarily examined in mature neurons, these expression data suggest it plays a more critical role in glial cell regulation where expression levels are much higher.	[Auderset, Loic; Cullen, Carlie L.; Young, Kaylene M.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia	University of Tasmania; Menzies Institute for Medical Research	Young, KM (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia.	kaylene.young@utas.edu.au	Cullen, Carlie/J-7706-2014	Cullen, Carlie/0000-0001-6929-6258; Young, Kaylene/0000-0002-1686-3463	National Health and Medical Research Council of Australia [1066025, 1045240]; University of Tasmania Research Enhancement Grant Scheme; Menzies Institute for Medical Research Development Grant Scheme; Multiple Sclerosis Research Australia [15054]; Morrell Family Trust Scholarship in Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Tasmania Research Enhancement Grant Scheme; Menzies Institute for Medical Research Development Grant Scheme; Multiple Sclerosis Research Australia; Morrell Family Trust Scholarship in Medical Research	This study was supported by the National Health and Medical Research Council of Australia (KMY applications 1066025 and 1045240), the University of Tasmania Research Enhancement Grant Scheme (CC), the Menzies Institute for Medical Research Development Grant Scheme (KMY and CC), Multiple Sclerosis Research Australia (CC 15054) and the Morrell Family Trust Scholarship in Medical Research (LA).; Work in the authors' laboratory was supported by the National Health and Medical Research Council of Australia, the University of Tasmania Research Enhancement Grant Scheme, the Menzies Institute for Medical Research Development Grant Scheme and Multiple Sclerosis Research Australia. Mr Loic Auderset was supported by the Morrell Family Trust Scholarship in Medical Research.	An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630; [Anonymous], 2015, J BIOL CHEM AM SOC B; Auderset L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2108495; Bu G., 2013, MOL NEURODEGENER, V8, DOI [10. 1186/1750-1326-8-s1-p33, DOI 10.1186/1750-1326-8-S1-P33]; BU GJ, 1994, J BIOL CHEM, V269, P18521; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Casse F, 2012, J NEUROSCI, V32, P5186, DOI 10.1523/JNEUROSCI.5296-11.2012; Chanas-Sacre G, 2000, DEV DYNAM, V219, P514, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1078>3.0.CO;2-0; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Craig J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070432; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113237; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Hennen E, 2013, J BIOL CHEM, V288, P16538, DOI 10.1074/jbc.M112.419812; Jeon H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-149; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Maier W, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-25; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.3.CO;2-C; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Nakajima C, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444364; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Pi XC, 2012, CIRC RES, V111, P564, DOI 10.1161/CIRCRESAHA.112.274597; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Ramanathan A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00136; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Uden E, 1999, MOL CELL NEUROSCI, V14, P129, DOI 10.1006/mcne.1999.0772; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Wang S., 2013, SEL TOP SIGNAL PROCE, V1, P1, DOI DOI 10.1016/J.SUSC0M.2010.10.002.(AVAILABLE; WOLF BB, 1992, AM J PATHOL, V141, P37; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	58	32	32	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155878	10.1371/journal.pone.0155878	http://dx.doi.org/10.1371/journal.pone.0155878			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280679	gold, Green Submitted, Green Published			2022-12-26	WOS:000377563000007
J	Castilla, AR; Pope, N; Jaffe, R; Jha, S				Castilla, Antonio R.; Pope, Nathaniel; Jaffe, Rodolfo; Jha, Shalene			Elevation, Not Deforestation, Promotes Genetic Differentiation in a Pioneer Tropical Tree	PLOS ONE			English	Article							FOREST FRAGMENTATION; MICROSATELLITE LOCI; MICONIA-CALVESCENS; RAIN-FOREST; HABITAT FRAGMENTATION; REPRODUCTIVE-BIOLOGY; SEED DISPERSAL; MATING SYSTEM; INVASIVE TREE; DIVERSITY	The regeneration of disturbed forest is an essential part of tropical forest ecology, both with respect to natural disturbance regimes and large-scale human-mediated logging, grazing, and agriculture. Pioneer tree species are critical for facilitating the transition from deforested land to secondary forest because they stabilize terrain and enhance connectivity between forest fragments by increasing matrix permeability and initiating disperser community assembly. Despite the ecological importance of early successional species, little is known about their ability to maintain gene flow across deforested landscapes. Utilizing highly polymorphic microsatellite markers, we examined patterns of genetic diversity and differentiation for the pioneer understory tree Miconia affinis across the Isthmus of Panama. Furthermore, we investigated the impact of geographic distance, forest cover, and elevation on genetic differentiation among populations using circuit theory and regression modeling within a landscape genetics framework. We report marked differences in historical and contemporary migration rates and moderately high levels of genetic differentiation in M. affinis populations across the Isthmus of Panama. Genetic differentiation increased significantly with elevation and geographic distance among populations; however, we did not find that forest cover enhanced or reduced genetic differentiation in the study region. Overall, our results reveal strong dispersal for M. affinis across human-altered landscapes, highlighting the potential use of this species for reforestation in tropical regions. Additionally, this study demonstrates the importance of considering topography when designing programs aimed at conserving genetic diversity within degraded tropical landscapes.	[Castilla, Antonio R.; Pope, Nathaniel; Jha, Shalene] Univ Texas Austin, Dept Integrat Biol, Biol Labs 401, Austin, TX 78712 USA; [Jaffe, Rodolfo] Vale Inst Technol Sustainable Dev, Rua Boaventura da Silva 955, BR-66055090 Belem, Para, Brazil; [Jaffe, Rodolfo] Univ Sao Paulo, Dept Ecol, Rua Matao 321, BR-05508090 Sao Paulo, SP, Brazil	University of Texas System; University of Texas Austin; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade de Sao Paulo	Jha, S (corresponding author), Univ Texas Austin, Dept Integrat Biol, Biol Labs 401, Austin, TX 78712 USA.	sjha@austin.utexas.edu	Jaffé, Rodolfo/K-3230-2013; Castilla, Antonio R./A-3877-2019	Jaffé, Rodolfo/0000-0002-2101-5282; Castilla, Antonio R./0000-0002-4124-738X	University of Texas at Austin; National Science Foundation [NSF DEB 0908661, NSF DEB 1110007]; FAPESP [23661-2]; U.S. National Science Foundation	University of Texas at Austin; National Science Foundation(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); U.S. National Science Foundation(National Science Foundation (NSF))	This study was supported by the University of Texas at Austin and the National Science Foundation (S.J.: NSF DEB 0908661). N.P. is funded by a predoctoral fellowship from the National Science Foundation (NSF DEB 1110007) and R.J. was funded by a FAPESP Grant (23661-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Herbario Universidad de Panama, J. Wright, R. Condit, J. Hall, A. Espinosa, N. Gottdenker, and R. A. Perez for their invaluable help in locating the M. affinis populations. We thank J. A. Ramirez, E. Sanchez, M. Urena, A. G. Castillo, and numerous volunteers for their help in the collection of leaf material. The BCI forest dynamics research project was founded by S.P. Hubbell and R.B. Foster and is now managed by R. Condit, S. Lao and R. Perez under the Center for Tropical Forest Science and the Smithsonian Tropical Research Institute in Panama. Numerous organizations have provided funding, principally the U.S. National Science Foundation, and hundreds of field workers have contributed to the project. Finally, we would also like to thank the Jha lab, Edgardo Ortiz, and three anonymous reviewers for helpful feedback on the analyses and manuscript.	Aragao DV, 2005, AM J BOT, V92, P456, DOI 10.3732/ajb.92.3.456; Banks SC, 2013, TRENDS ECOL EVOL, V28, P670, DOI 10.1016/j.tree.2013.08.005; Barton K., 2015, MUMIN MULTIMODEL INF; BEALS EW, 1969, SCIENCE, V165, P981, DOI 10.1126/science.165.3897.981; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Blignaut J, 2014, ECOL ENG, V65, P54, DOI 10.1016/j.ecoleng.2013.09.003; Breed MF, 2015, HEREDITY, V115, P100, DOI 10.1038/hdy.2012.72; Breed MF, 2015, HEREDITY, V115, P108, DOI 10.1038/hdy.2013.48; Brito VLG, 2012, PLANT SYST EVOL, V298, P1271, DOI 10.1007/s00606-012-0633-5; BROKAW NVL, 1987, J ECOL, V75, P9, DOI 10.2307/2260533; Byrne M, 2011, J APPL ECOL, V48, P1365, DOI 10.1111/j.1365-2664.2011.02045.x; Castilla AR, 2016, ANN BOT-LONDON, V117, P319, DOI 10.1093/aob/mcv170; Castilla AR, 2011, ACTA OECOL, V37, P269, DOI 10.1016/j.actao.2011.02.011; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Ciofi C, 1999, MOL ECOL, V8, pS17, DOI 10.1046/j.1365-294X.1999.00734.x; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Collevatti RG, 2001, MOL ECOL, V10, P349, DOI 10.1046/j.1365-294x.2001.01226.x; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Condit R, 2001, BIOSCIENCE, V51, P389, DOI 10.1641/0006-3568(2001)051[0389:TSOTPC]2.0.CO;2; Croat T.B., 1978, FLORA BARRO COLORADO; CRUDEN RW, 1972, SCIENCE, V176, P1439, DOI 10.1126/science.176.4042.1439; Dalsgaard B, 2009, OECOLOGIA, V159, P757, DOI 10.1007/s00442-008-1255-z; Davies SJ, 2015, HEREDITY, V115, P125, DOI 10.1038/hdy.2013.95; DIAMOND JM, 1976, P NATL ACAD SCI USA, V73, P2160, DOI 10.1073/pnas.73.6.2160; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fox J., 2011, R COMPANION APPL REG, DOI [10.1177/0049124105277200, DOI 10.1177/0049124105277200]; Gallagher MK, 2016, J APPL ECOL, V53, P251, DOI 10.1111/1365-2664.12564; Garen EJ, 2011, FOREST ECOL MANAG, V261, P1684, DOI 10.1016/j.foreco.2010.10.011; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gauzere J, 2013, MOL ECOL, V22, P5001, DOI 10.1111/mec.12435; Goldenberg R, 2008, INT J PLANT SCI, V169, P963, DOI 10.1086/589697; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hall JS, 2011, FOREST ECOL MANAG, V261, P1553, DOI 10.1016/j.foreco.2010.12.011; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hardesty B. D., 2010, Tropical Plant Biology, V3, P28, DOI 10.1007/s12042-010-9044-3; Herrera CM, 2008, HEREDITY, V100, P275, DOI 10.1038/sj.hdy.6801072; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Jaffe R, 2016, CONSERV GENET, V17, P267, DOI 10.1007/s10592-015-0779-0; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Jha S, 2015, MOL ECOL, V24, P993, DOI 10.1111/mec.13090; Jha S, 2009, MOL ECOL RESOUR, V9, P344, DOI 10.1111/j.1755-0998.2008.02428.x; Jha S, 2010, P NATL ACAD SCI USA, V107, P13760, DOI 10.1073/pnas.1002490107; Jha S, 2008, CURR BIOL, V18, pR1126, DOI 10.1016/j.cub.2008.11.017; Jones FA, 2013, J BIOGEOGR, V40, P720, DOI 10.1111/jbi.12037; Jordano P, 2000, MOL ECOL, V9, P1293, DOI 10.1046/j.1365-294x.2000.01009.x; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Le Roux JJ, 2008, DIVERS DISTRIB, V14, P935, DOI 10.1111/j.1472-4642.2008.00504.x; Le Roux JJ, 2008, MOL ECOL RESOUR, V8, P961, DOI 10.1111/j.1755-0998.2008.02102.x; Lemes MR, 2003, MOL ECOL, V12, P2875, DOI 10.1046/j.1365-294X.2003.01950.x; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lowe A, 2004, ANAL APPL OXFORD BLA; Lowe AJ, 2015, HEREDITY, V115, P97, DOI 10.1038/hdy.2015.40; Luck GW, 2003, ECOL APPL, V13, P235, DOI 10.1890/1051-0761(2003)013[0235:TCBARC]2.0.CO;2; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meyer JY, 1998, BIOTROPICA, V30, P609, DOI 10.1111/j.1744-7429.1998.tb00101.x; MONTAGNINI F, 1990, AMBIO, V19, P386; Montoya D, 2008, SCIENCE, V320, P1502, DOI 10.1126/science.1158404; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Parrotta JA, 2001, ECOL ENG, V17, P219, DOI 10.1016/S0925-8574(00)00141-5; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PELLMYR O, 1986, OECOLOGIA, V68, P304, DOI 10.1007/BF00384804; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pinheiro JJS, 2013, HUMAN SUPP, P1, DOI 10.14195/978-989-721-034-1; Primmer CR, 2006, MOL ECOL, V15, P653, DOI 10.1111/j.1365-294X.2005.02844.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RENNER SS, 1993, NORD J BOT, V13, P519, DOI 10.1111/j.1756-1051.1993.tb00096.x; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Schroder R, 2013, RESTOR ECOL, V21, P793, DOI 10.1111/rec.12018; SCHUSTER WS, 1989, AM J BOT, V76, P1395, DOI 10.2307/2444563; Shi MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021302; STILES FG, 1978, AM ZOOL, V18, P715; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; van Breugel M, 2011, FOREST ECOL MANAG, V261, P1580, DOI 10.1016/j.foreco.2010.08.019; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Wilson GA, 2003, GENETICS, V163, P1177; Wishnie MH, 2007, FOREST ECOL MANAG, V243, P39, DOI 10.1016/j.foreco.2007.02.001; Wright S, 1943, GENETICS, V28, P114; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	98	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156694	10.1371/journal.pone.0156694	http://dx.doi.org/10.1371/journal.pone.0156694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280872	Green Submitted, gold, Green Published			2022-12-26	WOS:000377563000039
J	Demarez, C; Hubert, C; Sempoux, C; Lemaigre, FP				Demarez, Celine; Hubert, Catherine; Sempoux, Christine; Lemaigre, Frederic P.			Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							CELL; MICRORNAS; PROGNOSIS; GROWTH; RNA; YAP	The differentiation status of tumor cells, defined by histomorphological criteria, is a prognostic factor for survival of patients affected with intrahepatic cholangiocarcinoma (ICC). To strengthen the value of morphological differentiation criteria, we wished to correlate histopathological differentiation grade with expression of molecular biliary differentiation markers and of microRNAs previously shown to be dysregulated in ICC. We analysed a series of tumors that were histologically classified as well, moderately or poorly differentiated, and investigated the expression of cytokeratin 7, 19 and 903 (CK7, CK19, CK903), SRY-related HMG box transcription factors 4 and 9 (SOX4, SOX9), osteopontin (OPN), Hepatocyte Nuclear Factor-1 beta (HNF1 beta), Yes-associated protein (YAP), Epithelial cell adhesion molecule (EPCAM), Mucin 1 (MUC1) and N-cadherin (NCAD) by qRT-PCR and immunostaining, and of miR-31, miR-135b, miR-132, miR-200c, miR-221 and miR-222. Unexpectedly, except for subcellular location of SOX9 and OPN, no correlation was found between the expression levels of these molecular markers and histopathological differentiation grade. Therefore, our data point toward necessary caution when investigating the evolution and prognosis of ICC on the basis of cell differentiation criteria.	[Demarez, Celine; Lemaigre, Frederic P.] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Hubert, Catherine] Catholic Univ Louvain, Clin Univ St Luc, Dept Abdominal Surg & Transplantat, Div Hepatobiliary & Pancreat Surg, Ave Hippocrate 10, B-1200 Brussels, Belgium; [Sempoux, Christine] Univ Lausanne, Serv Pathol Clin, CHU Vaudois, CH-1011 Lausanne, Switzerland	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lemaigre, FP (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	frederic.lemaigre@uclouvain.be		Lemaigre, Frederic/0000-0002-3609-434X; Hubert, Catherine/0000-0001-6837-2511; Sempoux, Christine/0000-0003-1375-3979	FRS-FNRS (Belgium) [T.0072.14]; Interuniversity Attraction Pole Programme (Belgian Science Policy BELSPO) [PVII-47]; Televie (Belgium) [7.4597.14-F]	FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole Programme (Belgian Science Policy BELSPO); Televie (Belgium)	The work was supported by the FRS-FNRS (Belgium; grant T.0072.14; http://www.fnrs.be), the Interuniversity Attraction Pole Programme (Belgian Science Policy BELSPO; grant PVII-47; http://www.belspo.be/). CD held a fellowship from Televie (Belgium; grant 7.4597.14-F; http://www.fnrs.be/index.php/mecenat-prix/l-operation-televie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2002, MODERN PATHOL, V15, P1181, DOI 10.1097/01.MP.0000032537.82380.69; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Braicu C, 2009, GASTROENTEROL RES, V2, P132, DOI 10.4021/gr2009.06.1299; Chakravarty G, 2011, CANCER BIOL THER, V11, P71, DOI 10.4161/cbt.11.1.13952; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Fan LN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-320; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Hyder O, 2014, JAMA SURG, V149, P432, DOI 10.1001/jamasurg.2013.5168; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Kawahigashi Yutaka, 2009, Journal of Nippon Medical School, V76, P188; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Matsushima H, 2015, DIGEST LIVER DIS, V47, P1067, DOI 10.1016/j.dld.2015.08.003; Mazur PK, 2012, AM J GASTROENTEROL, V107, P126, DOI 10.1038/ajg.2011.305; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mosnier JF, 2009, MODERN PATHOL, V22, P182, DOI 10.1038/modpathol.2008.123; Munoz-Garrido P, 2012, WORLD J GASTROENTERO, V18, P6189, DOI 10.3748/wjg.v18.i43.6189; Papaconstantinou I, 2012, EUR J GASTROEN HEPAT, V24, P223, DOI 10.1097/MEG.0b013e3283505063; Pei TM, 2015, ONCOTARGET, V6, P17206, DOI 10.18632/oncotarget.4043; Plieskatt J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1270-5; Plieskatt JL, 2014, J HEPATOL, V61, P850, DOI 10.1016/j.jhep.2014.05.035; Poncy A, 2015, DEV BIOL, V404, P136, DOI 10.1016/j.ydbio.2015.05.012; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Razumilava N, 2013, CLIN GASTROENTEROL H, V11, P13, DOI 10.1016/j.cgh.2012.09.009; Sirica AE, 2009, CLIN GASTROENTEROL H, V7, pS68, DOI 10.1016/j.cgh.2009.08.023; Sulpice L, 2014, J SURG RES, V192, P117, DOI 10.1016/j.jss.2014.05.017; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Terashi T, 2004, LIVER INT, V24, P38, DOI 10.1111/j.1478-3231.2004.00886.x; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wadsworth CA, 2013, HEPATOL INT, V7, P377, DOI 10.1007/s12072-012-9407-y; Wang WS, 2014, BIOCHEM BIOPH RES CO, V452, P614, DOI 10.1016/j.bbrc.2014.08.124; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Yu DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13319; Zhang MY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1067-6	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157140	10.1371/journal.pone.0157140	http://dx.doi.org/10.1371/journal.pone.0157140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280413	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000094
J	Kayad, AG; Al-Gaadi, KA; Tola, E; Madugundu, R; Zeyada, AM; Kalaitzidis, C				Kayad, Ahmed G.; Al-Gaadi, Khalid A.; Tola, ElKamil; Madugundu, Rangaswamy; Zeyada, Ahmed M.; Kalaitzidis, Chariton			Assessing the Spatial Variability of Alfalfa Yield Using Satellite Imagery and Ground-Based Data	PLOS ONE			English	Article							LEAF-AREA INDEX; VEGETATION INDEX; BIOMASS; NDVI; AGRICULTURE	Understanding the temporal and spatial variability in a crop yield is viewed as one of the key steps in the implementation of precision agriculture practices. Therefore, a study on a center pivot irrigated 23.5 ha field in Saudi Arabia was conducted to assess the variability in alfalfa yield using Landsat-8 imagery and a hay yield monitor data. In addition, the study was designed to also explore the potential of predicting the alfalfa yield using vegetation indices. A calibrated yield monitor mounted on a large rectangular hay baler was used to measure the actual alfalfa yield for four alfalfa harvests performed in the period from October 2013 to May 2014. A total of 18 Landsat-8 images, representing different crop growth stages, were used to derive different vegetation indices (VIs). Data from the yield monitor was used to generate yield maps, which illustrated a definite spatial variation in alfalfa yield across the experimental field for the four studied harvests as indicated by the high spatial correlation values (0.75 to 0.97) and the low P-values (4.7E-103 to 8.9E-27). The yield monitor-measured alfalfa actual yield was compared to the predicted yield form the Vis. Results of the study showed that there was a correlation between actual and predicted yield. The highest correlations were observed between actual yield and the predicted using NIR reflectance, SAVI and NDVI with maximum correlation coefficients of 0.69, 0.68 and 0.63, respectively.	[Kayad, Ahmed G.; Al-Gaadi, Khalid A.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Kayad, Ahmed G.; Al-Gaadi, Khalid A.; Tola, ElKamil; Madugundu, Rangaswamy; Zeyada, Ahmed M.] King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia; [Kayad, Ahmed G.] Agr Res Ctr, Agr Engn Res Inst AEnRI, Giza, Egypt; [Kalaitzidis, Chariton] Mediterranean Agron Inst Chania MAICh, Dept Geoinformat Environm Management, Khania, Greece	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; CIHEAM; CIHEAM IAM Chania	Kayad, AG (corresponding author), King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia.; Kayad, AG (corresponding author), King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia.; Kayad, AG (corresponding author), Agr Res Ctr, Agr Engn Res Inst AEnRI, Giza, Egypt.	akaiad@ksu.edu.sa	Tola, ElKamil/AAX-8777-2021; Kayad, Ahmed/E-7601-2017; Tola, ElKamil/E-8523-2017; Madugundu, Rangaswamy/N-9214-2013; Kalaitzidis, Chariton/D-6763-2012	Kayad, Ahmed/0000-0003-3396-938X; Tola, ElKamil/0000-0003-0927-9688; Madugundu, Rangaswamy/0000-0002-5326-4785; Kalaitzidis, Chariton/0000-0001-5217-7164	King Saud University, Vice Deanship of Research Chairs; Precision Agriculture Research Chair	King Saud University, Vice Deanship of Research Chairs; Precision Agriculture Research Chair	This study was financially supported by King Saud University, Vice Deanship of Research Chairs (http://chairs.ksu.edu.sa/en). The author who received the fund is KA (Precision Agriculture Research Chair Director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 2010, ISPRS P INT CAL OR W; Asner GP, 1998, REMOTE SENS ENVIRON, V64, P234, DOI 10.1016/S0034-4257(98)00014-5; Blackmore S., 2003, THESIS; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; Buick RD, 1997, PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, P176; Calvao T, 2004, INT J REMOTE SENS, V25, P3113, DOI 10.1080/01431160310001654978; Childs C., 2004, ARCUSER, V3235, P32, DOI DOI 10.1007/978-0-387-35973-1_369; Ferencz C, 2004, INT J REMOTE SENS, V25, P4113, DOI 10.1080/01431160410001698870; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Hancock DW., THESIS U KENTUCKY; Hanna MM., 1999, GEOCARTO INT, V14, P89, DOI [DOI 10.1080/10106049908542121, 10.1080/10106049908542121]; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Isaaks EH, 1989, APPL GEOSTATISTICS; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Jurgens C, 1997, INT J REMOTE SENS, V18, P3583, DOI 10.1080/014311697216810; Kastens JH, 2005, REMOTE SENS ENVIRON, V99, P341, DOI 10.1016/j.rse.2005.09.010; Kayad A. G., 2015, American-Eurasian Journal of Agricultural & Environmental Sciences, V15, P1025; Lambert D.M., 2004, ADOPTION PROFITABILI; LIU HQ, 1995, IEEE T GEOSCI REMOTE, V33, P457, DOI 10.1109/36.377946; Lu DS, 2005, PHOTOGRAMM ENG REM S, V71, P967, DOI 10.14358/PERS.71.8.967; Masek J, 2011, ENG RUR DEV INT C P; Maselli F, 2001, PHOTOGRAMM ENG REM S, V67, P593; Noureldin NA, 2013, EGYPT J REMOTE SENS, V16, P125, DOI 10.1016/j.ejrs.2013.04.005; Pan G, 2009, ENVIRON MODELL SOFTW, V24, P510, DOI 10.1016/j.envsoft.2008.09.014; Panda SS, 2010, REMOTE SENS-BASEL, V2, P673, DOI 10.3390/rs2030673; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Radovic J., 2009, Biotechnology in Animal Husbandry, V25, P465; Ross KW, 2008, APPL ENG AGRIC, V24, P309; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Schellberg J, 2008, EUR J AGRON, V29, P59, DOI 10.1016/j.eja.2008.05.005; Schmierer J. L., 2004, Proceedings of the 7th International Conference on Precision Agriculture and Other Precision Resources Management, Hyatt Regency, Minneapolis, MN, USA, 25-28 July, 2004, P2083; Schut AGT, 2003, GRASS FORAGE SCI, V58, P276, DOI 10.1046/j.1365-2494.2003.00379.x; Toulios L, 1998, P WORLD COTT RES C 2, P534; TRANGMAR BB, 1985, ADV AGRON, V38, P45; Trotter T., 2008, 9 INT C PREC AGR ICP; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Wang FM, 2007, RICE SCI, V14, P195, DOI 10.1016/S1672-6308(07)60027-4; Yang YJ, 2011, MATH COMPUT MODEL, V54, P1138, DOI 10.1016/j.mcm.2010.11.046	39	27	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157166	10.1371/journal.pone.0157166	http://dx.doi.org/10.1371/journal.pone.0157166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281189	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000101
J	Malarkey, CS; Gustafson, CE; Saifee, JF; Torres, RM; Churchill, MEA; Janoff, EN				Malarkey, Christopher S.; Gustafson, Claire E.; Saifee, Jessica F.; Torres, Raul M.; Churchill, Mair E. A.; Janoff, Edward N.			Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; HIGH BINDING-AFFINITY; NF-KAPPA-B; INFLAMMATORY RESPONSES; BACTERIAL-DNA; CIRCULAR-DICHROISM; NUCLEIC-ACIDS; FACTOR-I; ACTIVATION; PROTEIN	Mitochondrial transcription factor A (TFAM) had previously been shown to act as a damage associated molecular pattern with the ability to enhance CpG-A phosphorothioate oligodeoxynucleotide (ODN)-mediated stimulation of IFN alpha production from human plasmacytoid dendritic cells. Examination of the mechanism by which TFAM might influence CpG ODN mediated innate immune responses revealed that TFAM binds directly, tightly and selectively to the structurally related CpG-A, -B, and -C ODN. TFAM also modulated the ability of the CpG-B or -C to stimulate the production of antibodies from human B cells. TFAM showed a dose-dependent modulation of CpG-B, and -C -induced antibody production from human B cells in vitro, with enhancement of high dose and inhibition of low doses of CpG stimulation. This effect was linked to the ability of TFAM to directly inhibit the binding of CpG ODNs to B cells, in a manner consistent with the relative binding affinities of TFAM for the ODNs. These data suggest that TFAM alters the free concentration of the CpG available to stimulate B cells by sequestering this ODN in a TFAM-CpG complex. Thus, TFAM has the potential to decrease the pathogenic consequences of exposure to natural CpG-like hypomethylated DNA in vivo, as well as such as that found in traumatic injury, infection, autoimmune disease and during pregnancy.	[Malarkey, Christopher S.; Saifee, Jessica F.; Churchill, Mair E. A.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Malarkey, Christopher S.; Saifee, Jessica F.; Churchill, Mair E. A.] Univ Colorado, Sch Med, Program Struct Biol & Biochem, Aurora, CO 80045 USA; [Gustafson, Claire E.; Janoff, Edward N.] Univ Colorado, Sch Med, Mucosal & Vaccine Res Program Colorado MAVRC, Dept Med, Aurora, CO 80045 USA; [Gustafson, Claire E.; Janoff, Edward N.] Univ Colorado, Sch Med, Program Immunol, Aurora, CO 80045 USA; [Gustafson, Claire E.; Janoff, Edward N.] Denver Vet Affairs Med Ctr, Denver, CO 80220 USA; [Torres, Raul M.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Malarkey, Christopher S.] Regis Univ, Sch Pharm, Dept Pharmaceut Sci, 3333 Regis Blvd,H-28, Denver, CO 80221 USA; [Gustafson, Claire E.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Saifee, Jessica F.] 33 Dover Rd, Wellesley, MA 02482 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; Regis University; Stanford University	Churchill, MEA (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	Mair.Churchill@ucdenver.edu	Churchill, Mair E. A./C-5549-2014; Malarkey, Chris/V-2557-2019	Churchill, Mair E. A./0000-0003-0862-235X; Saifee, Jessica/0000-0002-7796-3572; Malarkey, Christopher/0000-0002-2384-2476	University of Colorado Cancer Center Support Grant [P30CA046934]; Veterans Affairs Research Service; Mucosal and Vaccine Research Program Colorado (MAVRC); University of Colorado Cancer Center [P30CA046934]; National Institutes of Health [T32AI052066, R01AI108479, R01GM111902]; American Heart Association [13POST16330009, 11GRNT7380064]; Gerber Foundation; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052066, R01AI052157, R01AI108479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111902] Funding Source: NIH RePORTER	University of Colorado Cancer Center Support Grant; Veterans Affairs Research Service(US Department of Veterans Affairs); Mucosal and Vaccine Research Program Colorado (MAVRC); University of Colorado Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gerber Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Colorado Cancer Center Support Grant (P30CA046934) partially supported the usage of core facilities. National Institutes of Health [T32AI052066 to C.E.G., R01AI108479 to E.N.J., R01GM111902 to M.E.A.C.]; American Heart Association [13POST16330009 to C.S.M., 11GRNT7380064 to M.E.A.C.]; Gerber Foundation [to C.E.G.].; We appreciate the ongoing support of the Veterans Affairs Research Service and the Mucosal and Vaccine Research Program Colorado (MAVRC). The University of Colorado Cancer Center Support Grant (P30CA046934) partially supported the usage of core facilities. This work was supported by the National Institutes of Health [T32AI052066 to C.E.G., R01AI108479 to E.N.J., R01GM111902 to M.E.A.C.]; American Heart Association [13POST16330009 to C.S.M., 11GRNT7380064 to M.E.A.C.]; Gerber Foundation [to C.E.G.].	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959; CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hanagata N, 2012, INT J NANOMED, V7, P2181, DOI 10.2147/IJN.S30197; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Hayashi T, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.12.028; Hopkins RJ, 2013, VACCINE, V31, P3051, DOI 10.1016/j.vaccine.2013.04.063; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; JOHNSON S, 1992, J INFECT DIS, V166, P1287, DOI 10.1093/infdis/166.6.1287; Julian MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072354; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Klein DCG, 2010, ULTRAMICROSCOPY, V110, P689, DOI 10.1016/j.ultramic.2010.02.033; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lamphier MS, 2006, ANN NY ACAD SCI, V1082, P31, DOI 10.1196/annals.1348.005; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lim EJ, 2007, EXP MOL MED, V39, P239, DOI 10.1038/emm.2007.27; Little JP, 2014, MOL CELL NEUROSCI, V60, P88, DOI 10.1016/j.mcn.2014.04.003; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Malarkey CS, 2012, NUCLEIC ACIDS RES, V40, P614, DOI 10.1093/nar/gkr787; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P4034, DOI 10.1021/bi952555q; Mou TC, 2002, NUCLEIC ACIDS RES, V30, P749, DOI 10.1093/nar/30.3.749; Mou TC, 2001, BIOCHEMISTRY-US, V40, P2267, DOI 10.1021/bi002136f; Muller S, 2001, BIOCHEMISTRY-US, V40, P10254, DOI 10.1021/bi0100900; Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; Redford TW, 1998, J IMMUNOL, V161, P3930; Rosa M, 2005, BIOMACROMOLECULES, V6, P2164, DOI 10.1021/bm050137n; Scharfe-Nugent A, 2012, J IMMUNOL, V188, P5706, DOI 10.4049/jimmunol.1103454; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Sursal T, 2013, SHOCK, V39, P55, DOI 10.1097/SHK.0b013e318276f4ca; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Wagner M, 2004, J IMMUNOL, V172, P954, DOI 10.4049/jimmunol.172.2.954; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yi AK, 1996, J IMMUNOL, V156, P558; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	58	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157157	10.1371/journal.pone.0157157	http://dx.doi.org/10.1371/journal.pone.0157157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280778	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000098
J	Pinchoff, J; Chaponda, M; Shields, TM; Sichivula, J; Muleba, M; Mulenga, M; Kobayashi, T; Curriero, FC; Moss, WJ				Pinchoff, Jessie; Chaponda, Mike; Shields, Timothy M.; Sichivula, James; Muleba, Mbanga; Mulenga, Modest; Kobayashi, Tamaki; Curriero, Frank C.; Moss, William J.		Southern Africa Int Ctr Excellence	Individual and Household Level Risk Factors Associated with Malaria in Nchelenge District, a Region with Perennial Transmission: A Serial Cross-Sectional Study from 2012 to 2015	PLOS ONE			English	Article							CONTROL INTERVENTIONS; PATTERNS; CHILDREN; AFRICA; BURDEN	Background The scale-up of malaria control interventions has resulted in substantial declines in transmission in some but not all regions of sub-Saharan Africa. Understanding factors associated with persistent malaria transmission despite control efforts may guide targeted interventions to high-risk areas and populations. Methods Household malaria surveys were conducted in Nchelenge District, Luapula Province, in northern Zambia. Structures that appeared to be households were enumerated from a high-resolution satellite image and randomly sampled for enrollment. Households were enrolled into cross-sectional (single visit) or longitudinal (visits every other month) cohorts but analyses were restricted to cross-sectional visits and the first visit to longitudinal households. During study visits, a questionnaire was administered to adults and caretakers of children and a blood sample was collected for a malaria rapid diagnostic test (RDT) from all household residents. Characteristics associated with RDT positivity were analyzed using multi-level models. Results A total of 2,486 individuals residing within 742 households were enrolled between April 2012 and July 2015. Over this period, 51% of participants were RDT positive. Forty-three percent of all RDT positive individuals were between the ages of 5 and 17 years although this age group comprised only 30% of study participants. In a multivariable model, the odds being RDT positive were highest in 5-17 year olds and did not vary by season. Children 5-17 years of age had 8.83 higher odds of being RDT positive compared with those >18 years of age (95% CI: 6.13, 12.71); there was an interaction between age and report of symptoms, with an almost 50% increased odds of report of symptoms with decreasing age category (OR = 1.49; 95% CI 1.11, 2.00). Conclusions Children and adolescents between the ages of 5 and 17 were at the highest risk of malaria infection throughout the year. School-based programs may be effective at targeting this high-risk group.	[Pinchoff, Jessie; Shields, Timothy M.; Kobayashi, Tamaki; Curriero, Frank C.; Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chaponda, Mike; Sichivula, James; Muleba, Mbanga; Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pinchoff, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	jpinchoff@gmail.com			Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research [U19 AI089680]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089680] Funding Source: NIH RePORTER	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Johns Hopkins Malaria Research Institute, the Bloomberg Family Foundation and the Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research (U19 AI089680).	Alonso P. L., 2011, PLOS MED, V8; Ardiet DL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-199; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Das S, 2016, AM J TROPICAL MED HY; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Greenwood BM, 2008, TRENDS PARASITOL, V24, P449, DOI 10.1016/j.pt.2008.07.002; Guillebaud J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-379; Hiwat H, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-10; Kamuliwo M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-437; Kanyangarara M, AM J TROPIC IN PRESS; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Lin J, 2014, TRENDS PARASITOLOGY, V30; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Mabaso MLH, 2007, AM J TROP MED HYG, V76, P33, DOI 10.4269/ajtmh.2007.76.33; malERA, 2011, PLOS MED, V8; Mharakurwa S, 2011, ACTA TROPICA; MOH, 2015, ZAMB NAT MAL IND SUR; MOH, 2010, ZAMB DEM HLTH SURV 2; Mukonka VM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-153; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; NMCP, 2012, NAT MAL CONTR PROGR; Omukunda E, 2012, J VECTOR DIS, V49, P61; Pinault LL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00059; Pinchoff J, AM J TROPICAL MED HY, V93; Pinchoff J, 2015, AM J TROPICAL MED HY, V93; Pinchoff J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0793-1; Russell T, 2013, MALARIA J, V12; Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396; Townes LR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-407; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, 2 WHO; Zhou G, 2011, PLOS ONE, V6; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	41	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156717	10.1371/journal.pone.0156717	http://dx.doi.org/10.1371/journal.pone.0156717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281028	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000040
J	Smith-Aguilar, SE; Ramos-Fernandez, G; Getz, WM				Smith-Aguilar, Sandra E.; Ramos-Fernandez, Gabriel; Getz, Wayne M.			Seasonal Changes in Socio-Spatial Structure in a Group of Free-Living Spider Monkeys (Ateles geoffroyi)	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; ASSOCIATION PATTERNS; SOCIAL-STRUCTURE; PAN-TROGLODYTES; NATIONAL-PARK; HOME RANGES; GROUP-SIZE; ECOLOGICAL CONSTRAINTS; FEEDING COMPETITION; FEMALE CHIMPANZEES	Ecological and social factors influence individual movement and group membership decisions, which ultimately determine how animal groups adjust their behavior in spatially and temporally heterogeneous environments. The mechanisms behind these behavioral adjustments can be better understood by studying the relationship between association and space use patterns of groups and how these change over time. We examined the socio-spatial patterns of adult individuals in a free-ranging group of spider monkeys (Ateles geoffroyi), a species with high fission-fusion dynamics. Data comprised 4916 subgroup scans collected during 325 days throughout a 20-month period and was used to evaluate changes from fruit-scarce to fruit-abundant periods in individual core-area size, subgroup size and two types of association measures: spatial (core-area overlap) and spatio-temporal (occurrence in the same subgroup) associations. We developed a 3-level analysis framework to distinguish passive associations, where individuals are mostly brought together by resources of common interest, from active association, where individuals actively seek or avoid certain others. Results indicated a more concentrated use of space, increased individual gregariousness and higher spatio-temporal association rates in the fruit-abundant seasons, as is compatible with an increase in passive associations. Nevertheless, results also suggested active associations in all the periods analyzed, although associations differed across seasons. In particular, females seem to actively avoid males, perhaps prompted by an increased probability of random encounters among individuals, resulting from the contraction of individual core areas. Our framework proved useful in investigating the interplay between ecological and social constraints and how these constraints can influence individual ranging and grouping decisions in spider monkeys, and possibly other species with high fission-fusion dynamics.	[Smith-Aguilar, Sandra E.; Ramos-Fernandez, Gabriel] Inst Politecn Nacl, Ctr Interdisciplinario Invest & Desarrollo Integr, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico; [Ramos-Fernandez, Gabriel] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Ciudad De Mexico, Mexico; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California Berkeley; University of Kwazulu Natal	Smith-Aguilar, SE (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest & Desarrollo Integr, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico.	galadrielent@yahoo.com	Smith-Aguilar, Sandra Elizabeth/AAR-2926-2021; Ramos-Fernandez, Gabriel/GQR-1310-2022	Smith-Aguilar, Sandra Elizabeth/0000-0003-2209-5496; Ramos-Fernandez, Gabriel/0000-0001-7175-3905	Consejo Nacional de Ciencia y Tecnologia of Mexico [157656, 207883]; Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia [2014-MZO2015]; Instituto Politecnico Nacional (ECOES)	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Politecnico Nacional (ECOES)	Funding for field work was provided by the Consejo Nacional de Ciencia y Tecnologia of Mexico (grant 157656: GRF and scholarship 207883: SESA) and by the Instituto Politecnico Nacional. Part of the analyses was conducted during a research stay by SESA at the Getz Lab, UC Berkeley supported by the Consejo Nacional de Ciencia y Tecnologia (scholarship 2014-MZO2015) and the Instituto Politecnico Nacional (ECOES grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Archie EA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1261; Asensio N, 2012, J ZOOL, V287, P250, DOI 10.1111/j.1469-7998.2012.00911.x; Asensio N, 2008, BEHAVIOUR, V145, P983, DOI 10.1163/156853908784089234; Asensio N, 2015, AM J PRIMATOL, V77, P777, DOI 10.1002/ajp.22400; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2006, AM J PHYS ANTHROPOL, V131, P486, DOI 10.1002/ajpa.20451; Aureli F, 2012, BEHAV ECOL, V23, P1308, DOI 10.1093/beheco/ars122; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Best EC, 2014, ANIM BEHAV, V89, P1, DOI 10.1016/j.anbehav.2013.12.011; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Bonilla-Moheno M., 2008, THESIS; Busia L, 2016, BEHAVIOUR, V153, P107, DOI 10.1163/1568539X-00003329; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Canty A., 2015, BOOT BOOTSTRAP R S P; CHAPMAN C, 1988, PRIMATES, V29, P177, DOI 10.1007/BF02381121; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; CHAPMAN CA, 1990, BEHAV ECOL SOCIOBIOL, V26, P409; Chapman CA, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P24; Chapman CA, 2009, PRIMATES, V50, P12, DOI 10.1007/s10329-008-0123-0; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Connor R, 2005, ANIM BEHAV, V69, P127, DOI 10.1016/j.anbehav.2004.02.022; Connor RC, 2000, CETACEAN SOCIETIES, P91; Conradt L, 2000, P ROY SOC B-BIOL SCI, V267, P2213, DOI 10.1098/rspb.2000.1271; Couzin ID, 2006, CURR BIOL, V16, pR169, DOI 10.1016/j.cub.2006.02.042; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; CROOK JH, 1976, ANIM BEHAV, V24, P261, DOI 10.1016/S0003-3472(76)80035-8; Cross PC, 2005, ANIM BEHAV, V69, P499, DOI 10.1016/j.anbehav.2004.08.006; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; FEDIGAN L M, 1984, Primates, V25, P279, DOI 10.1007/BF02382267; FEDIGAN LM, 1988, AM J PRIMATOL, V16, P19, DOI 10.1002/ajp.1350160104; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2012, PHILOS T R SOC B, V367, P1802, DOI 10.1098/rstb.2011.0214; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fury CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052987; Garcia-Frapolli E, 2007, LANDSCAPE URBAN PLAN, V83, P137, DOI 10.1016/j.landurbplan.2007.03.007; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; GINSBERG JR, 1992, ANIM BEHAV, V44, P377, DOI 10.1016/0003-3472(92)90042-8; Godde S, 2013, ANIM BEHAV, V85, P553, DOI 10.1016/j.anbehav.2012.12.010; Grove M, 2012, ANIM BEHAV, V83, P411, DOI 10.1016/j.anbehav.2011.11.011; Hartwell KS, 2014, INT J PRIMATOL, V35, P425, DOI 10.1007/s10764-013-9746-0; Hemelrijk CK, 2000, LEARN BEH WORKSH 2 I, P11; HEMELRIJK CK, 1998, COM ADAP SY, P307; Henzi SP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1015, DOI 10.1007/s00265-009-0720-y; Henzi SP, 2007, ADV STUD BEHAV, V37, P43, DOI 10.1016/S0065-3454(07)37002-2; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Holme P, 2007, PHYSICA A, V373, P821, DOI 10.1016/j.physa.2006.04.066; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Ilany A, 2015, ECOL LETT, V18, P687, DOI 10.1111/ele.12447; Isbell LA, 1998, BEHAV ECOL SOCIOBIOL, V42, P123, DOI 10.1007/s002650050420; Jose-Dominguez JM, 2015, AM J PRIMATOL, V77, P841, DOI 10.1002/ajp.22409; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Koenig A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0348; Lehmann J, 2003, BEHAV ECOL, V14, P642, DOI 10.1093/beheco/arg047; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lyons AJ, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-2; Miller JA, 2014, ANIM BEHAV, V87, P147, DOI 10.1016/j.anbehav.2013.10.023; Murray CM, 2008, CURR BIOL, V18, P20, DOI 10.1016/j.cub.2007.11.044; Murray CM, 2007, ANIM BEHAV, V74, P1795, DOI 10.1016/j.anbehav.2007.03.024; Murray CM, 2006, BEHAV ECOL, V17, P1020, DOI 10.1093/beheco/arl042; Newton-Fisher NE, 1999, BEHAVIOUR, V136, P705, DOI 10.1163/156853999501531; Pinacho Guendulain B, 2010, THESIS; Popa-Lisseanu AG, 2008, ANIM BEHAV, V75, P471, DOI 10.1016/j.anbehav.2007.05.011; Powell RA, 2000, METH C CONS, P65; Puga-Gonzalez I, 2015, BEHAV ECOL SOCIOBIOL, V69, P383, DOI 10.1007/s00265-014-1850-4; Ramos-Fernandez G, 2005, INT J PRIMATOL, V26, P1077, DOI 10.1007/s10764-005-6459-z; Ramos-Fernandez G, 2009, AM J PRIMATOL, V71; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Ramos-Fernandez Gabriel, 2003, Neotropical Primates, V11, P155; Ramos-Fernandez G, 2014, BEHAV ECOL SOCIOBIOL, V68, P1225, DOI 10.1007/s00265-014-1733-8; Ramos-Fernandez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062813; Ramos-Fernandez G, 2008, CAM S BIO EVOL ANTHR, V55, P220; Ramos-Fernandez G, 2009, BEHAV ECOL SOCIOBIOL, V63, P999, DOI 10.1007/s00265-009-0719-4; Romera Valero Angel, 2004, THESIS; Ryan SJ, 2008, INT J PRIMATOL, V29, P405, DOI 10.1007/s10764-007-9172-2; SAMUEL MD, 1985, J ANIM ECOL, V54, P711, DOI 10.2307/4373; Schaffner CM, 2012, INT J PRIMATOL, V33, P922, DOI 10.1007/s10764-012-9621-4; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Shimooka Y, 2003, PRIMATES, V44, P83, DOI 10.1007/s10329-002-0028-2; Shimooka Y, 2005, INT J PRIMATOL, V26, P385, DOI 10.1007/s10764-005-2930-0; Shimooka Y, 2008, CAM S BIO EVOL ANTHR, V55, P329; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Slater KY, 2007, ANIM BEHAV, V74, P455, DOI 10.1016/j.anbehav.2006.11.026; Slater KY, 2009, AM J PRIMATOL, V71, P21, DOI 10.1002/ajp.20618; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; SMN, 2015, NOMRALES CLIMATOLGIE, P1; Spehar SN, 2010, AM J PRIMATOL, V72, P129, DOI 10.1002/ajp.20763; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; SUGARDJITO J, 1987, INT J PRIMATOL, V8, P17, DOI 10.1007/BF02737112; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; te Boekhorst I, 1994, ARTIF LIFE, P119; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Thompson ME, 2006, DEV PRIMATOL, P209; Valero A, 2007, ANIM COGN, V10, P305, DOI 10.1007/s10071-006-0066-z; Valero A, 2006, AM J PRIMATOL, V68, P732, DOI 10.1002/ajp.20263; van der Post DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117027; VanderWaal KL, 2014, BEHAV ECOL, V25, P17, DOI 10.1093/beheco/art061; VANSCHAIK CP, 1983, BEHAVIOUR, V85, P91, DOI 10.1163/156853983X00057; Wakefield ML, 2013, ANIM BEHAV, V85, P1303, DOI 10.1016/j.anbehav.2013.03.019; Wallace RB, 2006, AM J PRIMATOL, V68, P313, DOI 10.1002/ajp.20227; WHITE FJ, 1988, BEHAVIOUR, V105, P148, DOI 10.1163/156853988X00494; White FJ, 1998, INT J PRIMATOL, V19, P1013, DOI 10.1023/A:1020374220004; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1991, BEHAV ECOL SOCIOBIOL, V29, P385, DOI 10.1007/BF00165964; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H., 2008, ANAL ANIMAL SOC; Whitehead H., 2005, ANIM BEHAV, V69, pE1, DOI [10.1016/j.anbehav.2004.11.004, DOI 10.1016/J.ANBEHAV.2004.11.004]; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Wiszniewski J, 2012, J MAMMAL, V93, P239, DOI 10.1644/10-MAMM-A-366.1; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wittemyer G, 2007, ANIM BEHAV, V73, P671, DOI 10.1016/j.anbehav.2006.10.008; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wolf JBW, 2007, ANIM BEHAV, V74, P1293, DOI 10.1016/j.anbehav.2007.02.024	127	20	21	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157228	10.1371/journal.pone.0157228	http://dx.doi.org/10.1371/journal.pone.0157228			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280800	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000109
J	Soprano, M; Sorriento, D; Rusciano, MR; Maione, AS; Limite, G; Forestieri, P; D'Angelo, D; D'Alessio, M; Campiglia, P; Formisano, P; Iaccarino, G; Bianco, R; Illario, M				Soprano, Maria; Sorriento, Daniela; Rusciano, Maria Rosaria; Maione, Angela Serena; Limite, Gennaro; Forestieri, Pietro; D'Angelo, Dario; D'Alessio, Matteo; Campiglia, Pietro; Formisano, Pietro; Iaccarino, Guido; Bianco, Roberto; Illario, Maddalena			Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells	PLOS ONE			English	Article							HIV PROTEASE INHIBITORS; ENDOPLASMIC-RETICULUM STRESS; PHASE-I TRIAL; NF-KAPPA-B; SUPEROXIDE-DISMUTASE; INSULIN-RESISTANCE; TRANSCRIPTION FACTORS; AKT PHOSPHORYLATION; REDOX REGULATION; CYCLE ARREST	The discovery of the anti-proliferative activity of nelfinavir in HIV-free models has encouraged its investigation as anticancer drug. Although the molecular mechanism by which nelfinavir exerts antitumor activity is still unknown, its effects have been related to Akt inhibition. Here we tested the effects of nelfinavir on cell proliferation, viability and death in two human breast cancer cell lines and in human normal primary breast cells. To identify the mechanism of action of nelfinavir in breast cancer, we evaluated the involvement of the Akt pathway as well as the effects of nelfinavir on reactive oxygen species (ROS) production and ROS-related enzymes activities. Nelfinavir reduced breast cancer cell viability by inducing apoptosis and necrosis, without affecting primary normal breast cells. The antitumor activity of nelfinavir was related to alterations of the cell redox state, coupled with an increase of intracellular ROS production limited to cancer cells. Nelfinavir treated tumor cells also displayed a downregulation of the Akt pathway due to disruption of the Akt-HSP90 complex, and subsequent degradation of Akt. These effects resulted to be ROS dependent, suggesting that ROS production is the primary step of nelfinavir anticancer activity. The analysis of ROS-producers and ROS-detoxifying enzymes revealed that nelfinavir-mediated ROS production was strictly linked to flavoenzymes activation. We demonstrated that ROS enhancement represents the main molecular mechanism required to induce cell death by nelfinavir in breast cancer cells, thus supporting the development of new and more potent oxidizing molecules for breast cancer therapy.	[Soprano, Maria; Rusciano, Maria Rosaria; Maione, Angela Serena; Formisano, Pietro; Illario, Maddalena] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Sorriento, Daniela] Italian Natl Res Council CNR, IBB, Naples, Italy; [Limite, Gennaro; Forestieri, Pietro] Univ Naples Federico II, Breast Unit, Dept Clin Med & Surg, Naples, Italy; [D'Angelo, Dario; D'Alessio, Matteo] Hosp Ctr A Cardarelli, Plast Surg Operat Unit, Dept Emergency & Recept, Naples, Italy; [Campiglia, Pietro] Univ Salerno, Dept Pharm, I-84100 Salerno, Italy; [Iaccarino, Guido] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Bianco, Roberto] Univ Naples Federico II, Div Oncol, Dept Clin Med & Surg, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Istituto di Neuroscienze (IN-CNR); University of Naples Federico II; Antonio Cardarelli Hospital; University of Salerno; University of Salerno; University of Naples Federico II	Illario, M (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	illario@unina.it	Iaccarino, Guido/D-4540-2009; Rusciano, Maria Rosaria/W-1958-2019; Maione, Angela Serena/H-3123-2018; Campiglia, Pietro/J-5625-2018; Formisano, Pietro/J-4237-2018; IACCARINO, Guido/A-7702-2010	Iaccarino, Guido/0000-0002-8997-835X; Maione, Angela Serena/0000-0003-1460-7033; IACCARINO, Guido/0000-0002-8997-835X; Formisano, Pietro/0000-0001-7020-6870; Campiglia, Pietro/0000-0002-1069-2181	Campania Bioscience [PON03PE_00060_8]	Campania Bioscience	This study was supported by the Campania Bioscience, grant PON03PE_00060_8.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Beck R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040795; Ben-Romano R, 2006, ANTIVIR THER, V11, P1051; Bernstein WB, 2008, CURR OPIN HIV AIDS, V3, P666, DOI 10.1097/COH.0b013e328313915d; Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Brown NS, 2000, CANCER RES, V60, P6298; Bruning A, 2009, CANCER BIOL THER, V8, P222; Bruning A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2602; Buijsen J, 2013, RADIOTHER ONCOL, V107, P184, DOI 10.1016/j.radonc.2013.03.023; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Chakravarty G, 2016, BIOCHIMIE, V124, P53, DOI 10.1016/j.biochi.2016.01.014; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chow WA, 2006, ANTI-CANCER DRUG, V17, P891, DOI 10.1097/01.cad.0000224448.08706.76; Conklin KA, 2004, J NUTR, V134, p3201S, DOI 10.1093/jn/134.11.3201S; Cuneo KC, 2007, CANCER RES, V67, P4886, DOI 10.1158/0008-5472.CAN-06-3684; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dean RT, 1997, BIOCHEM J, V324, P1; Deeks SG, 1997, JAMA-J AM MED ASSOC, V277, P145, DOI 10.1001/jama.277.2.145; Deng W, 2010, J MOL CELL CARDIOL, V49, P746, DOI 10.1016/j.yjmcc.2010.08.013; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Forman HJ, 2007, FREE RADICAL BIO MED, V42, P926, DOI 10.1016/j.freeradbiomed.2007.01.011; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Goldenberg MM, 1999, CLIN THER, V21, P309, DOI 10.1016/S0149-2918(00)88288-0; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Gupta AK, 2005, CANCER RES, V65, P8256, DOI 10.1158/0008-5472.CAN-05-1220; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Gupte A, 2009, CANCER TREAT REV, V35, P32, DOI 10.1016/j.ctrv.2008.07.004; Hoyt MT, 2011, INVEST NEW DRUG, V29, P562, DOI 10.1007/s10637-010-9390-x; Hsieh TC, 2005, BIOCHEM BIOPH RES CO, V337, P224, DOI 10.1016/j.bbrc.2005.09.040; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Iaccarino G, 2006, CLIN PHARMACOL THER, V80, P633, DOI 10.1016/j.clpt.2006.09.006; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Jareno EJ, 2002, FREE RADICAL RES, V36, P341, DOI 10.1080/10715760290019363; Jiang ZB, 2007, CANCER RES, V67, P4467, DOI 10.1158/0008-5472.CAN-06-3398; Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Kronenwett U, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-8; LaBarge MA, 2013, JOVE-J VIS EXP, DOI 10.3791/50011; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005; Manoharan S, 2004, CELL MOL BIOL LETT, V9, P699; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McEligot AJ, 2005, ANNU REV NUTR, V25, P261, DOI 10.1146/annurev.nutr.25.050304.092633; Meitzler JL, 2014, ANTIOXID REDOX SIGN, V20, P2873, DOI 10.1089/ars.2013.5603; Monini P, 2003, J ANTIMICROB CHEMOTH, V51, P207, DOI 10.1093/jac/dkg086; Moskowitz R, 1999, Congest Heart Fail, V5, P153; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; OBERLEY LW, 1979, CANCER RES, V39, P1141; Oberley TD, 2004, ANTIOXID REDOX SIGN, V6, P537, DOI 10.1089/152308604773934297; Olumi AF, 1999, CANCER RES, V59, P5002; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pajonk F, 2002, CANCER RES, V62, P5230; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plastaras JP, 2008, CANCER BIOL THER, V7, P628; Pore N, 2006, CANCER RES, V66, P9252, DOI 10.1158/0008-5472.CAN-06-1239; Portakal O, 2000, CLIN BIOCHEM, V33, P279, DOI 10.1016/S0009-9120(00)00067-9; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reliene R, 2006, DNA REPAIR, V5, P852, DOI 10.1016/j.dnarep.2006.05.003; Rengan R, 2012, J THORAC ONCOL, V7, P709, DOI 10.1097/JTO.0b013e3182435aa6; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Ridnour LA, 2004, ANTIOXID REDOX SIGN, V6, P501, DOI 10.1089/152308604773934260; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rudich A, 2005, ACTA PHYSIOL SCAND, V183, P75, DOI 10.1111/j.1365-201X.2004.01383.x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarkar S, 2013, INT J CANCER, V132, P695, DOI 10.1002/ijc.27687; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shim JS, 2012, JNCI-J NATL CANCER I, V104, P1576, DOI 10.1093/jnci/djs396; Sinha R. J., 2009, Indian Journal of Cancer, V46, P146; Sorriento D, 2015, BRIT J CANCER, V112, P77, DOI 10.1038/bjc.2014.577; Sorriento D, 2013, FEBS LETT, V587, P3487, DOI 10.1016/j.febslet.2013.09.002; Sorriento D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-97; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tebas P, 2000, Expert Opin Pharmacother, V1, P1429, DOI 10.1517/14656566.1.7.1429; Thomas S, 2012, CANCER LETT, V325, P63, DOI 10.1016/j.canlet.2012.05.030; Toschi E, 2011, INT J CANCER, V128, P82, DOI 10.1002/ijc.25550; Touzet O, 2010, AIDS, V24, P1437, DOI 10.1097/QAD.0b013e32833a6114; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsurutani J, 2007, LUNG CANCER, V55, P115, DOI 10.1016/j.lungcan.2006.09.026; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang XW, 2007, AM J PATHOL, V171, P304, DOI 10.2353/ajpath.2007.060965; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiang T, 2015, CANCER LETT, V364, P79, DOI 10.1016/j.canlet.2015.04.027; Yang Y, 2006, BRIT J CANCER, V95, P1653, DOI 10.1038/sj.bjc.6603435; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	96	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155970	10.1371/journal.pone.0155970	http://dx.doi.org/10.1371/journal.pone.0155970			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280849	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000009
J	Young, KH; Baird, JR; Savage, T; Cottam, B; Friedman, D; Bambina, S; Messenheimer, DJ; Fox, B; Newell, P; Bahjat, KS; Gough, MJ; Crittenden, MR				Young, Kristina H.; Baird, Jason R.; Savage, Talicia; Cottam, Benjamin; Friedman, David; Bambina, Shelly; Messenheimer, David J.; Fox, Bernard; Newell, Pippa; Bahjat, Keith S.; Gough, Michael J.; Crittenden, Marka R.			Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy	PLOS ONE			English	Article							ANTITUMOR IMMUNITY; LOCAL RADIATION; BREAST-CANCER; MOUSE MODEL; RADIOTHERAPY; OX40; INFILTRATION; EXPRESSION; METASTASES; ANTIBODIES	The anecdotal reports of promising results seen with immunotherapy and radiation in advanced malignancies have prompted several trials combining immunotherapy and radiation. However, the ideal timing of immunotherapy with radiation has not been clarified. Tumor bearing mice were treated with 20Gy radiation delivered only to the tumor combined with either anti-CTLA4 antibody or anti-OX40 agonist antibody. Immunotherapy was delivered at a single timepoint around radiation. Surprisingly, the optimal timing of these therapies varied. Anti-CTLA4 was most effective when given prior to radiation therapy, in part due to regulatory T cell depletion. Administration of anti-OX40 agonist antibody was optimal when delivered one day following radiation during the post-radiation window of increased antigen presentation. Combination treatment of anti-CTLA4, radiation, and anti-OX40 using the ideal timing in a transplanted spontaneous mammary tumor model demonstrated tumor cures. These data demonstrate that the combination of immunotherapy and radiation results in improved therapeutic efficacy, and that the ideal timing of administration with radiation is dependent on the mechanism of action of the immunotherapy utilized.	[Young, Kristina H.; Baird, Jason R.; Savage, Talicia; Cottam, Benjamin; Friedman, David; Bambina, Shelly; Messenheimer, David J.; Fox, Bernard; Bahjat, Keith S.; Gough, Michael J.; Crittenden, Marka R.] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, 4805 NE Glisan St, Portland, OR 97213 USA; [Young, Kristina H.; Newell, Pippa; Crittenden, Marka R.] Oregon Clin, Portland, OR 97213 USA; [Newell, Pippa] Providence Portland Med Ctr, Providence Hepatobiliary & Pancreat Canc Program, 4805 NE Glisan St, Portland, OR 97213 USA	Providence Portland Medical Center; Providence Portland Medical Center	Young, KH (corresponding author), Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, 4805 NE Glisan St, Portland, OR 97213 USA.; Young, KH (corresponding author), Oregon Clin, Portland, OR 97213 USA.	kristina.young@providence.org	Gough, Michael/AAY-3419-2020	Gough, Michael/0000-0002-5575-0074; Young, Kristina/0000-0002-3363-0063; Friedman, David/0000-0002-1295-1562	RSNA Research and Education Foundation; NIH [HHSN272201300006C]; RSNA RE Foundation; NATIONAL CANCER INSTITUTE [R01CA182311] Funding Source: NIH RePORTER	RSNA Research and Education Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RSNA RE Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KHY received an RSNA Research and Education Foundation Research Resident Grant.; We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of MHC tetramers. This study was funded, in part, by an RSNA R&E Foundation Research Resident Grant to KHY.	Barker CA, 2013, CANCER IMMUNOL RES, V1, P92, DOI 10.1158/2326-6066.CIR-13-0082; Belcaid Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101764; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; BRATTAIN MG, 1980, CANCER RES, V40, P2142; Crittenden MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069527; Crittenden MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039295; Curti BD, 2013, CANCER RES, V73, P7189, DOI 10.1158/0008-5472.CAN-12-4174; Demaria S, 2005, CLIN CANCER RES, V11, P728; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Evans DE, 2001, J IMMUNOL, V167, P6804, DOI 10.4049/jimmunol.167.12.6804; Filatenkov A, 2015, CLIN CANCER RES, V21, P3727, DOI 10.1158/1078-0432.CCR-14-2824; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Gough MJ, 2012, IMMUNOTHERAPY-UK, V4, P125, DOI [10.2217/IMT.11.157, 10.2217/imt.11.157]; Gough MJ, 2010, J IMMUNOTHER, V33, P798, DOI 10.1097/CJI.0b013e3181ee7095; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hiniker SM, 2012, TRANSL ONCOL, V5, P404, DOI 10.1593/tlo.12280; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang RR, 2011, CLIN CANCER RES, V17, P4101, DOI 10.1158/1078-0432.CCR-11-0407; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Liang H, 2013, J IMMUNOL, V190, P5874, DOI 10.4049/jimmunol.1202612; Pilones KA, 2009, CLIN CANCER RES, V15, P597, DOI 10.1158/1078-0432.CCR-08-1277; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Redmond WL, 2014, CANCER IMMUNOL RES, V2, P142, DOI 10.1158/2326-6066.CIR-13-0031-T; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Seung SK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003649; Sharabi AB, 2015, CANCER IMMUNOL RES, V3, P345, DOI 10.1158/2326-6066.CIR-14-0196; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Stein WD, 2011, CLIN CANCER RES, V17, P907, DOI 10.1158/1078-0432.CCR-10-1762; Thibault I, 2014, J NEUROSURG-SPINE, V21, P711, DOI 10.3171/2014.7.SPINE13895; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Videtic GMM, 2014, INT J RADIAT ONCOL, V90, P203, DOI 10.1016/j.ijrobp.2014.05.017; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Yokouchi H, 2008, CANCER SCI, V99, P361, DOI 10.1111/j.1349-7006.2007.00664.x; Young KH, 2014, CANCER IMMUNOL RES, V2, P1011, DOI 10.1158/2326-6066.CIR-13-0207; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	39	177	183	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157164	10.1371/journal.pone.0157164	http://dx.doi.org/10.1371/journal.pone.0157164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281029	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000100
J	Zhang, Y; Deng, WC; Xie, XB; Jiao, NZ				Zhang, Yao; Deng, Wenchao; Xie, Xiabing; Jiao, Nianzhi			Differential Incorporation of Carbon Substrates among Microbial Populations Identified by Field-Based, DNA Stable-Isotope Probing in South China Sea	PLOS ONE			English	Article							MAJOR BACTERIAL GROUPS; DISSOLVED ORGANIC-MATTER; MARINE-BACTERIA; BIOMASS PRODUCTION; SARGASSO SEA; TIME-SERIES; DIVERSITY; PACIFIC; ASSEMBLAGES; METABOLISM	To determine the adapted microbial populations to variant dissolved organic carbon (DOC) sources in the marine environment and improve the understanding of the interaction between microorganisms and marine DOC pool, field-based incubation experiments were carried out using supplemental C-13-labeled typical substrates D-glucose and D-glucosamine (D-Glc and D-GlcN, respectively), which are two important components in marine DOC pool in the South China Sea. C-13- and C-12-DNA were then fractionated by ultracentrifugation and the microbial community was analyzed by terminal-restriction fragment length polymorphism and 454 pyrosequencing of 16S rRNA gene. C-12-DNA-based communities showed relatively high similarities with their corresponding in situ communities, and their bacterial diversities were generally higher than C-13-DNA-based counterparts. Distinct differences in community composition were found between C-13- and C-12-DNA-based communities and between two substrate-supplemented C-13-DNA-based communities; these differences distinctly varied with depth and site. In most cases, there were more genera with relative abundances of >0.1% in D-Glc-incorporating communities than in D-GlcN-incorporating communities. The Roseobacter clade was one of the prominent actively substrate-incorporating bacterial populations in all C-13-DNA-based communities. Vibrio was another prominent actively D-GlcN-incorporating bacterial population in most incubations. However notably, different OTUs dominated this clade or genus in different treatments at different depths. Altogether, these results suggested that there were taxa-specific differences in DOC assimilations and, moreover, their differences varied among the typical water masses, which could have been caused by the variant compositions of original bacterial communities from different hydrological environments. This implies that ecologically, the levels of labile or recalcitrance of DOC can be maintained only in a specific environmental context with specific bacterial community composition.	[Zhang, Yao; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361101, Peoples R China; Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen 361101, Peoples R China	Xiamen University; Xiamen University	Zhang, Y; Jiao, NZ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361101, Peoples R China.	yaozhang@xmu.edu.cn; jiao@xmu.edu.cn			973 program [2013CB955700]; NSFC [41422603, 91428308]; SOA [GASI-03-01-02-03, GASI-03-01-02-05];  [973 CHOICE-C II 2015CB954000]	973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); SOA; 	This research was funded by the 973 program 2013CB955700, the NSFC projects 41422603 and 91428308, the SOA projects GASI-03-01-02-03 and GASI-03-01-02-05. The cruise was supported by 973 CHOICE-C II 2015CB954000.	Alonso C, 2006, ENVIRON MICROBIOL, V8, P2022, DOI 10.1111/j.1462-2920.2006.01082.x; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Birnie G. D., 1978, CENTRIFUGAL SEPARATI; Clarke K., 2001, PRIMER V5 USER MANUA; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Dumont MG, 2011, ENVIRON MICROBIOL, V13, P1153, DOI 10.1111/j.1462-2920.2010.02415.x; Hertkorn N, 2006, GEOCHIM COSMOCHIM AC, V70, P2990, DOI 10.1016/j.gca.2006.03.021; Hu J, 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Hutchens E, 2004, ENVIRON MICROBIOL, V6, P111, DOI 10.1046/j.1462-2920.2003.00543.x; Jiao N, 2014, BIOGEOSCIENCES, V11, P5285, DOI 10.5194/bg-11-5285-2014; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Jiao NZ, 2011, APPL ENVIRON MICROB, V77, P7439, DOI 10.1128/AEM.05640-11; Kaiser K, 2012, J GEOPHYS RES-OCEANS, P117; Kaiser K, 2009, MAR CHEM, V113, P63, DOI 10.1016/j.marchem.2008.12.004; Kirchman DL, 2005, LIMNOL OCEANOGR, V50, P1697, DOI 10.4319/lo.2005.50.5.1697; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee SH, 2010, SCI TOTAL ENVIRON, V408, P1349, DOI 10.1016/j.scitotenv.2009.10.061; Lennon JT, 2007, APPL ENVIRON MICROB, V73, P2799, DOI 10.1128/AEM.02674-06; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Mou X, 2005, NATURE, V451, P708; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Neufeld JD, 2007, ISME J, V1, P480, DOI 10.1038/ismej.2007.65; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Quast C., 2012, NUCLEIC ACIDS RES, V41, pD590, DOI DOI 10.1093/NAR/GKS1219; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Rich J, 1997, DEEP-SEA RES PT II, V44, P1645, DOI 10.1016/S0967-0645(97)00058-1; Rich JH, 1996, LIMNOL OCEANOGR, V41, P595, DOI 10.4319/lo.1996.41.4.0595; Riemann L, 2002, APPL ENVIRON MICROB, V68, P5554, DOI 10.1128/AEM.68.11.5554-5562.2002; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SUTTLE CA, 1991, MAR ECOL PROG SER, V70, P189, DOI 10.3354/meps070189; Tada Y, 2011, APPL ENVIRON MICROB, V77, P4055, DOI 10.1128/AEM.02952-10; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Uhlik O, 2009, SCI TOTAL ENVIRON, V407, P3611, DOI 10.1016/j.scitotenv.2008.05.012; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wong GTF, 2007, DEEP-SEA RES PT II, V54, P1434, DOI 10.1016/j.dsr2.2007.05.012; Zhang Y, 2006, AQUAT MICROB ECOL, V43, P233, DOI 10.3354/ame043233; Zhang Y, 2016, APPL ENVIRON MICROB, V82, P2100, DOI 10.1128/AEM.03678-15; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044593; Zhang Y, 2011, RES MICROBIOL, V162, P320, DOI 10.1016/j.resmic.2010.12.006; Zhang Y, 2009, AQUAT MICROB ECOL, V56, P65, DOI 10.3354/ame01324; Zubkov MV, 2008, J PLANKTON RES, V30, P211, DOI 10.1093/plankt/fbm091	49	7	7	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157178	10.1371/journal.pone.0157178	http://dx.doi.org/10.1371/journal.pone.0157178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280442	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000105
J	Sahoo, B; Arduini, I; Drombosky, KW; Kodali, R; Sanders, LH; Greenamyre, JT; Wetzel, R				Sahoo, Bankanidhi; Arduini, Irene; Drombosky, Kenneth W.; Kodali, Ravindra; Sanders, Laurie H.; Greenamyre, J. Timothy; Wetzel, Ronald			Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; NEURONAL INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE-EXPANSION; AGGREGATION BEHAVIOR; DISEASE PATHOLOGY; DNA-DAMAGE; IN-VITRO; PROTEIN; LENGTH; CELLS	Expansion of the polyglutamine (polyQ) track of the Huntingtin (HTT) protein above 36 is associated with a sharply enhanced risk of Huntington's disease (HD). Although there is general agreement that HTT toxicity resides primarily in N-terminal fragments such as the HTT exon1 protein, there is no consensus on the nature of the physical states of HTT exon1 that are induced by polyQ expansion, nor on which of these states might be responsible for toxicity. One hypothesis is that polyQ expansion induces an alternative, toxic conformation in the HTT exon1 monomer. Alternative hypotheses posit that the toxic species is one of several possible aggregated states. Defining the nature of the toxic species is particularly challenging because of facile interconversion between physical states as well as challenges to identifying these states, especially in vivo. Here we describe the use of fluorescence correlation spectroscopy (FCS) to characterize the detailed time and repeat length dependent self-association of HTT exon1-like fragments both with chemically synthesized peptides in vitro and with cell-produced proteins in extracts and in living cells. We find that, in vitro, mutant HTT exon1 peptides engage in polyQ repeat length dependent dimer and tetramer formation, followed by time dependent formation of diffusible spherical and fibrillar oligomers and finally by larger, sedimentable amyloid fibrils. For expanded polyQ HTT exon1 expressed in PC12 cells, monomers are absent, with tetramers being the smallest molecular form detected, followed in the incubation time course by small, diffusible aggregates at 6-9 hours and larger, sedimentable aggregates that begin to build up at 12 hrs. In these cell cultures, significant nuclear DNA damage appears by 6 hours, followed at later times by caspase 3 induction, mitochondrial dysfunction, and cell death. Our data thus defines limits on the sizes and concentrations of different physical states of HTT exon1 along the reaction profile in the context of emerging cellular distress. The data provide some new candidates for the toxic species and some new reservations about more well-established candidates. Compared to other known markers of HTT toxicity, nuclear DNA damage appears to be a relatively early pathological event.	[Sahoo, Bankanidhi; Arduini, Irene; Drombosky, Kenneth W.; Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Sahoo, Bankanidhi; Arduini, Irene; Drombosky, Kenneth W.; Kodali, Ravindra; Sanders, Laurie H.; Greenamyre, J. Timothy; Wetzel, Ronald] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Sanders, Laurie H.; Greenamyre, J. Timothy] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wetzel, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.; Wetzel, R (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.	rwetzel@pitt.edu	Wetzel, Ronald/G-7453-2011; Sahoo, Bankanidhi/C-2295-2017	Greenamyre, J. Timothy/0000-0003-3468-7878; Sahoo, Bankanidhi/0000-0002-3633-1616	National Institutes of Health [R01 AG019322, R01 ES020718]; Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by National Institutes of Health (http://www.nih.gov/) R01 AG019322 to RW (supported BS, IA, KWD, RK and RW); National Institutes of Health (http://www.nih.gov/) R01 ES020718 to JTG (supported LS and JTG); Hereditary Disease Foundation (http://hdfoundation.org/) research contract to RW (supported IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Arndt JR, 2015, BIOCHEMISTRY-US, V54, P4285, DOI 10.1021/acs.biochem.5b00478; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Bates G. P., 2002, HUNTINGTONS DIS, P429; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Brock R, 1999, P NATL ACAD SCI USA, V96, P10123, DOI 10.1073/pnas.96.18.10123; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Chemuru S, 2016, J MOL BIOL, V428, P274, DOI 10.1016/j.jmb.2015.06.008; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Duim WC, 2014, ACS CHEM BIOL, V9, P2767, DOI 10.1021/cb500335w; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Garai K, 2007, BIOPHYS J, V92, pL55, DOI 10.1529/biophysj.106.101485; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Hoop CL, 2016, P NATL ACAD SCI USA, V113, P1546, DOI 10.1073/pnas.1521933113; Huang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121055; Hughes A, 2014, HUNTINGTONS DIS, P323; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kheterpal I, 2003, BIOCHEMISTRY-US, V42, P14092, DOI 10.1021/bi0357816; Klein FAC, 2013, HUM MOL GENET, V22, P4215, DOI 10.1093/hmg/ddt273; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Li SH, 2000, HUM MOL GENET, V9, P2859, DOI 10.1093/hmg/9.19.2859; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; Marcellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044457; McCampbell A, 2001, NAT MED, V7, P528, DOI 10.1038/87842; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Monsellier E, 2015, J BIOL CHEM, V290, P2560, DOI 10.1074/jbc.M114.603332; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Owens GE, 2015, J MOL BIOL, V427, P2507, DOI 10.1016/j.jmb.2015.05.023; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Sahl SJ, 2016, Q REV BIOPHYS, V49, P1, DOI [10.1017/S0033583515000219, DOI 10.1017/S0033583515000219]; Sahoo B, 2016, METHODS MOL BIOL, V1345, P67, DOI 10.1007/978-1-4939-2978-8_5; Sahoo B, 2014, BIOCHEMISTRY-US, V53, P3897, DOI 10.1021/bi500300c; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Sapp E, 2012, J BIOL CHEM, V287, P13487, DOI 10.1074/jbc.M111.286609; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Snowden J., 2014, HUNTINGTONS DIS, P36; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Vitalis A, 2008, J MOL BIOL, V384, P279, DOI 10.1016/j.jmb.2008.09.026; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wetzel R., 2014, HUNTINGTONS DIS, P274; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Yano H, 2014, NAT NEUROSCI, V17, P822, DOI 10.1038/nn.3721; Youker RT, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.090801	70	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0155747	10.1371/journal.pone.0155747	http://dx.doi.org/10.1371/journal.pone.0155747			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271685	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000377560200003
J	Whitin, JC; Yu, TTS; Ling, XB; Kanegaye, JT; Burns, JC; Cohen, HJ				Whitin, John C.; Yu, Tom To-Sang; Ling, Xuefeng Bruce; Kanegaye, John T.; Burns, Jane C.; Cohen, Harvey J.			A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease	PLOS ONE			English	Article							ELEVATED LEVELS; ACUTE-PHASE; A-PROTEIN; DIAGNOSIS; BIOMARKER; MATRIX-METALLOPROTEINASE-9; DEGRADATION; PROTEOLYSIS; EXPRESSION; DISCOVERY	Background Kawasaki disease (KD) is an acute vasculitis in children that can cause coronary artery abnormalities. Its diagnosis is challenging, and many cytokines, chemokines, acute phase reactants, and growth factors have failed evaluation as specific biomarkers to distinguish KD from other febrile illnesses. We performed protein profiling, comparing plasma from children with KD with febrile control (FC) subjects to determine if there were specific proteins or peptides that could distinguish the two clinical states. Materials and Methods Plasma from three independent cohorts from the blood of 68 KD and 61 FC subjects was fractionated by anion exchange chromatography, followed by surface-enhanced laser desorption ionization (SELDI) mass spectrometry of the fractions. The mass spectra of KD and FC plasma samples were analyzed for peaks that were statistically significantly different. Results A mass spectrometry peak with a mass of 7,860 Da had high intensity in acute KD subjects compared to subacute KD (p = 0.0003) and FC (p = 7.9 x 10(-10)) subjects. We identified this peak as a novel truncated form of serum amyloid A with N-terminal at Lys-34 of the circulating form and validated its identity using a hybrid mass spectrum immunoassay technique. The truncated form of serum amyloid A was present in plasma of KD subjects when blood was collected in tubes containing protease inhibitors. This peak disappeared when the patients were examined after their symptoms resolved. Intensities of this peptide did not correlate with KD-associated laboratory values or with other mass spectrum peaks from the plasma of these KD subjects. Conclusions Using SELDI mass spectrometry, we have discovered a novel truncated form of serum amyloid A that is elevated in the plasma of KD when compared with FC subjects. Future studies will evaluate its relevance as a diagnostic biomarker and its potential role in the pathophysiology of KD.	[Whitin, John C.; Yu, Tom To-Sang; Cohen, Harvey J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Ling, Xuefeng Bruce] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Kanegaye, John T.; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kanegaye, John T.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA	Stanford University; Stanford University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Cohen, HJ (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	punko@Stanford.edu		Whitin, John/0000-0002-6229-4628; Ling, Bruce/0000-0002-5386-3884	National Institutes of Health (US) [HL69413, HL086835]	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (US) award HL69413 to JCB; and National Institutes of Health (US) award HL086835 to HJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1824; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cabana VG, 1997, PEDIATR RES, V42, P651, DOI 10.1203/00006450-199711000-00017; Carlson SM, 2007, PROTEOMICS, V7, P1037, DOI 10.1002/pmic.200600514; Chua PK, 2003, CLIN DIAGN LAB IMMUN, V10, P308, DOI 10.1128/CDLI.10.2.308-314.2003; DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776; Fung ET, 2005, INT J CANCER, V115, P783, DOI 10.1002/ijc.20928; Gavin PJ, 2003, ARTERIOSCL THROM VAS, V23, P576, DOI 10.1161/01.ATV.0000065385.47152.FD; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kawasaki T, 1967, Arerugi, V16, P178; Kiernan UA, 2003, FEBS LETT, V537, P166, DOI 10.1016/S0014-5793(03)00097-8; Kiernan UA, 2006, J PROTEOME RES, V5, P2928, DOI 10.1021/pr060062+; Ling XB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-130; Ling XB, 2009, BIOINFORMATICS, V25, P1461, DOI 10.1093/bioinformatics/btp176; Madan A, 2007, PEDIATR RES, V61, P215, DOI 10.1203/pdr.0b013e31802d776d; Minich LL, 2007, PEDIATRICS, V120, pE1434, DOI 10.1542/peds.2007-0815; Mitani Y, 2005, CIRCULATION, V111, P38, DOI 10.1161/01.CIR.0000151311.38708.29; MIWATA H, 1993, ARCH DIS CHILD, V68, P210, DOI 10.1136/adc.68.2.210; MORENS DM, 1978, HOSP PRACT, V13, P109, DOI 10.1080/21548331.1978.11707402; NASH MC, 1995, CLIN EXP IMMUNOL, V101, P13; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Niederkofler EE, 2003, J LIPID RES, V44, P630, DOI 10.1194/jlr.D200034-JLR200; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; SALO E, 1993, SCAND J INFECT DIS, V25, P497, DOI 10.3109/00365549309008532; SCHILLER B, 1995, ACTA PAEDIATR, V84, P769, DOI 10.1111/j.1651-2227.1995.tb13753.x; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; Stix B, 2001, AM J PATHOL, V159, P561, DOI 10.1016/S0002-9440(10)61727-0; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Takeshita S, 1997, CLIN EXP IMMUNOL, V108, P446, DOI 10.1046/j.1365-2249.1997.3852128.x; TAUBERT KA, 1994, PEDIATR INFECT DIS J, V13, P704, DOI 10.1097/00006454-199408000-00005; Terai M, 1999, AM J CARDIOL, V83, P337, DOI 10.1016/S0002-9149(98)00864-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weiss PF, 2012, PEDIATR CLIN N AM, V59, P407, DOI 10.1016/j.pcl.2012.03.013; Whitin John C, 2013, BMC Res Notes, V6, P358, DOI 10.1186/1756-0500-6-358; Whitin JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049724; Wong M, 1997, J RHEUMATOL, V24, P1179; YAMADA T, 1995, SCAND J IMMUNOL, V41, P94, DOI 10.1111/j.1365-3083.1995.tb03538.x; YAMADA T, 1995, SCAND J IMMUNOL, V41, P570, DOI 10.1111/j.1365-3083.1995.tb03609.x; Yanagawa H, 1996, J Epidemiol, V6, P148; Yang Q, 2009, PEDIATR RES, V66, P11, DOI 10.1203/PDR.0b013e3181a207e3	42	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157024	10.1371/journal.pone.0157024	http://dx.doi.org/10.1371/journal.pone.0157024			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271757	gold, Green Submitted, Green Published			2022-12-26	WOS:000377560200029
J	da Motta, LL; Ledaki, I; Purshouse, K; Haider, S; De Bastiani, MA; Baban, D; Morotti, M; Steers, G; Wigfield, S; Bridges, E; Li, JL; Knapp, S; Ebner, D; Klamt, F; Harris, AL; McIntyre, A				da Motta, L. L.; Ledaki, I.; Purshouse, K.; Haider, S.; De Bastiani, M. A.; Baban, D.; Morotti, M.; Steers, G.; Wigfield, S.; Bridges, E.; Li, J-L; Knapp, S.; Ebner, D.; Klamt, F.; Harris, A. L.; McIntyre, A.			The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer	ONCOGENE			English	Article							BROMODOMAIN INHIBITION; EPIGENETIC READERS; ENERGY-METABOLISM; CELL METABOLISM; GENE-EXPRESSION; LYSYL OXIDASE; STEM-CELLS; CHIP-SEQ; IN-VIVO; C-MYC	The availability of bromodomain and extra-terminal inhibitors (BETi) has enabled translational epigenetic studies in cancer. BET proteins regulate transcription by selectively recognizing acetylated lysine residues on chromatin. BETi compete with this process leading to both downregulation and upregulation of gene expression. Hypoxia enables progression of triple negative breast cancer (TNBC), the most aggressive form of breast cancer, partly by driving metabolic adaptation, angiogenesis and metastasis through upregulation of hypoxia-regulated genes (for example, carbonic anhydrase 9 (CA9) and vascular endothelial growth factor A (VEGF-A). Responses to hypoxia can be mediated epigenetically, thus we investigated whether BETi JQ1 could impair the TNBC response induced by hypoxia and exert anti-tumour effects. JQ1 significantly modulated 44% of hypoxia-induced genes, of which two-thirds were downregulated including CA9 and VEGF-A. JQ1 prevented HIF binding to the hypoxia response element in CA9 promoter, but did not alter HIF expression or activity, suggesting some HIF targets are BET-dependent. JQ1 reduced TNBC growth in vitro and in vivo and inhibited xenograft vascularization. These findings identify that BETi dually targets angiogenesis and the hypoxic response, an effective combination at reducing tumour growth in preclinical studies.	[da Motta, L. L.; Ledaki, I.; Purshouse, K.; Haider, S.; Morotti, M.; Steers, G.; Wigfield, S.; Bridges, E.; Li, J-L; Harris, A. L.; McIntyre, A.] Univ Oxford, Weatherall Inst Mol Med, Mol Oncol Labs, Oxford OX1 2JD, England; [da Motta, L. L.; De Bastiani, M. A.; Klamt, F.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [da Motta, L. L.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Baban, D.] Univ Oxford, Wellcome Trust Ctr Human Genet, High Throughput Genom, Oxford OX1 2JD, England; [Li, J-L] Univ Plymouth, Peninsula Schools Med & Dent, Inst Translat & Stratified Med, Plymouth PL4 8AA, Devon, England; [Knapp, S.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Knapp, S.] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Campus Riedberg, Frankfurt, Germany; [Knapp, S.] Buchmann Inst Life Sci, Campus Riedberg, Frankfurt, Germany; [Ebner, D.] Univ Oxford, TDI, Nuffield Dept Med, Oxford, England; [McIntyre, A.] Univ Nottingham, Div Canc & Stem Cells, Canc Biol, Nottingham NG7 2UH, England	University of Oxford; Universidade Federal do Rio Grande do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); University of Oxford; Wellcome Centre for Human Genetics; University of Plymouth; University of Oxford; Goethe University Frankfurt; University of Oxford; University of Nottingham	McIntyre, A (corresponding author), Univ Nottingham, Div Canc & Stem Cells, Canc Biol, Nottingham NG7 2UH, England.; Harris, AL (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Dept Oncol, Mol Oncol Labs, Oxford OX3 9DS, England.	aharris.lab@imm.ox.ac.uk; alan.mcintyre@nottingham.ac.uk	Harris, Adrian L/ABA-3343-2020; Morotti, Matteo/AAE-8922-2020; De Bastiani, Marco Antônio/AAD-8366-2019; De Bastiani, Marco Antônio/AAO-3798-2020; Motta, Leonardo L/C-1551-2015; Knapp, Stefan/AAG-2347-2019	Harris, Adrian L/0000-0003-1376-8409; Morotti, Matteo/0000-0002-1790-1185; De Bastiani, Marco Antônio/0000-0003-3924-5278; Motta, Leonardo L/0000-0001-6364-5007; Knapp, Stefan/0000-0001-5995-6494; Ebner, Daniel/0000-0002-6495-7026; McIntyre, Alan/0000-0002-4791-7292; Purshouse, Karin/0000-0003-0942-6342	Cancer Research UK; Breast Cance Research Foundation; Breast Cancer Now; Oxford NIHR Biomedical Research Centre; CRUK Oxford Centre; CAPES Foundation/Brazil; Cancer Research UK [18974, 16466, 11359] Funding Source: researchfish; Medical Research Council [G0300648] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163, ACF-2015-13-008] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cance Research Foundation; Breast Cancer Now; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); CRUK Oxford Centre; CAPES Foundation/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by grants from Cancer Research UK (ALH), Breast Cance Research Foundation (ALH), Breast Cancer Now (AM), Oxford NIHR Biomedical Research Centre, and the CRUK Oxford Centre (ALH). Leonardo Lisboa da Motta has been awarded a scholarship from the CAPES Foundation/Brazil to conduct this study.	Alghamdi S, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0278-3; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Baker AM, 2013, CANCER RES, V73, P583, DOI 10.1158/0008-5472.CAN-12-2447; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bernardi R, 2014, CELL RES, V24, P904, DOI 10.1038/cr.2014.61; Bid HK, MOL CANC THER; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Castro MAA, 2009, BIOINFORMATICS, V25, P1468, DOI 10.1093/bioinformatics/btp246; Chaidos A, 2015, THER ADV HEMATOL, V6, P128, DOI 10.1177/2040620715576662; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dubois L, 2011, RADIOTHER ONCOL, V99, P424, DOI 10.1016/j.radonc.2011.05.045; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gieling RG, 2013, J ENZYM INHIB MED CH, V28, P360, DOI 10.3109/14756366.2012.736979; Gonzales-Cope M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2414-y; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Halliday GM, 2009, INT J BIOCHEM CELL B, V41, P725, DOI 10.1016/j.biocel.2008.04.026; Horne GA, 2015, STEM CELLS DEV, V24, P879, DOI 10.1089/scd.2014.0302; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kumler I, 2014, CANCER TREAT REV, V40, P960, DOI 10.1016/j.ctrv.2014.05.006; Lee DH, 2015, INT J CANCER, V136, P2055, DOI 10.1002/ijc.29269; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; McIntyre A, 2015, EMBO MOL MED, V7, P368, DOI 10.15252/emmm.201404271; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Qiu HF, 2015, ONCOTARGET, V6, P6915, DOI 10.18632/oncotarget.3126; Rajagopalan V, 2014, CELL MOL NEUROBIOL, V34, P1059, DOI 10.1007/s10571-014-0083-4; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Sena JA, 2013, MOL CELL BIOL, V33, P3849, DOI 10.1128/MCB.00731-13; Sengupta S, 2015, BREAST CANCER RES TR, V150, P265, DOI 10.1007/s10549-015-3319-1; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Tang YJ, 2014, NAT MED, V20, P732, DOI 10.1038/nm.3613; Tsai YP, 2014, INT J CANCER, V134, P249, DOI 10.1002/ijc.28190; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wani NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3665; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Waschow M., 2012, NAT METHODS, V9; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu Q, 2015, J CELL PHYSIOL, V230, P2683, DOI 10.1002/jcp.24991; Wu T, 2015, STEM CELL REP, V4, P390, DOI 10.1016/j.stemcr.2015.01.012; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	59	93	93	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					122	132		10.1038/onc.2016.184	http://dx.doi.org/10.1038/onc.2016.184			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27292261	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000394069100011
J	Yao, JJ; Zhao, QR; Liu, DD; Chow, CW; Mei, YA				Yao, Jin-jing; Zhao, Qian-Ru; Liu, Dong-Dong; Chow, Chi-Wing; Mei, Yan-Ai			Neuritin Up-regulates Kv4.2-Subunit of Potassium Channel Expression and Affects Neuronal Excitability by Regulating the Calcium-Calcineurin-NFATc4 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcineurin; calcium; neurotrophic factor; potassium channel; transcription factor	ACTIVATED T-CELLS; CORTICAL PYRAMIDAL NEURONS; CEREBELLAR GRANULE CELLS; NUCLEAR FACTOR; K+ CURRENTS; IN-VIVO; TRANSCRIPTIONAL REGULATION; INSULIN-RECEPTOR; PROTEIN-KINASE; AXON GROWTH	Neuritin is an important neurotrophin that regulates neural development, synaptic plasticity, and neuronal survival. Elucidating the downstream molecular signaling is important for potential therapeutic applications of neuritin in neuronal dysfunctions. We previously showed that neuritin up-regulates transient potassium outward current (I-A) subunit Kv4.2 expression and increases I-A densities, in part by activating the insulin receptor signaling pathway. Molecular mechanisms of neuritin-induced Kv4.2 expression remain elusive. Here, we report that the Ca2+/calcineurin (CaN)/nuclear factor of activated T-cells (NFAT) c4 axis is required for neuritin-induced Kv4.2 transcriptional expression and potentiation of I-A densities in cerebellum granule neurons. We found that neuritin elevates intracellular Ca2+ and increases Kv4.2 expression and I-A densities; this effect was sensitive to CaN inhibition and was eliminated in Nfatc4(-/-) mice but not in Nfatc2(-/-) mice. Stimulation with neuritin significantly increased nuclear accumulation of NFATc4 in cerebellum granule cells and HeLa cells, which expressed IR. Furthermore, NFATc4 was recruited to the Kv4.2 gene promoter loci detected by luciferase reporter and chromatin immunoprecipitation assays. More importantly, data obtained from cortical neurons following adeno-associated virus-mediated overexpression of neuritin indicated that reduced neuronal excitability and increased formation of dendritic spines were abrogated in the Nfatc4(-/-) mice. Together, these data demonstrate an indispensable role for the CaN/NFATc4 signaling pathway in neuritin-regulated neuronal functions.	[Yao, Jin-jing; Zhao, Qian-Ru; Liu, Dong-Dong; Mei, Yan-Ai] Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China; [Yao, Jin-jing; Zhao, Qian-Ru; Liu, Dong-Dong; Mei, Yan-Ai] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10461 USA	Fudan University; Fudan University; Yeshiva University	Chow, CW (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.; Mei, YA (corresponding author), Fudan Univ, Sch Life Sci, 220 Handan Rd, Shanghai 200433, Peoples R China.; Mei, YA (corresponding author), Fudan Univ, Inst Brain Sci, 220 Handan Rd, Shanghai 200433, Peoples R China.	chi-wing.chow@einstein.yu.edu; yamei@fudan.edu.cn			National Natural Science Foundation of China [NSFC 31428003, 31370827]; Shanghai Leading Academic Discipline Project [B111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China Grants NSFC 31428003 and 31370827 and Shanghai Leading Academic Discipline Project B111. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Bradley DC, 2005, J NEUROPHYSIOL, V93, P1659, DOI 10.1152/jn.01213.2003; Buffo A, 2000, J NEUROSCI, V20, P2275; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Carrasquillo Y, 2012, J PHYSIOL-LONDON, V590, P3877, DOI 10.1113/jphysiol.2012.229013; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Ding BJ, 2013, J NEUROSCI, V33, P2860, DOI 10.1523/JNEUROSCI.3533-12.2013; Gong NL, 2006, J BIOL CHEM, V281, P38498, DOI 10.1074/jbc.M607774200; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo NN, 2007, NEUROSCIENCE, V146, P298, DOI 10.1016/j.neuroscience.2007.01.013; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; Jacques C, 2012, J BIOL CHEM, V287, P15100, DOI 10.1074/jbc.M112.350215; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Ji XH, 2008, CEREB CORTEX, V18, P1506, DOI 10.1093/cercor/bhm177; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Lunde IG, 2011, J APPL PHYSIOL, V111, P1278, DOI 10.1152/japplphysiol.01383.2010; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Mei YA, 2000, BRAIN RES, V873, P46, DOI 10.1016/S0006-8993(00)02469-0; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; O'Neill KM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00285; Petrecca K, 2000, J NEUROSCI, V20, P8736; Quadrato G, 2014, J NEUROSCI, V34, P8630, DOI 10.1523/JNEUROSCI.0047-14.2014; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rossow CF, 2004, CIRC RES, V94, P1340, DOI 10.1161/01.RES.0000128406.08418.34; Rossow CF, 2009, J MOL CELL CARDIOL, V46, P249, DOI 10.1016/j.yjmcc.2008.10.016; Sato M, 2005, P NATL ACAD SCI USA, V102, P5874, DOI 10.1073/pnas.0501972102; Shibata R, 2000, J NEUROSCI, V20, P4145; Son H, 2012, P NATL ACAD SCI USA, V109, P11378, DOI 10.1073/pnas.1201191109; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Velazquez-Marrero C, 2014, J NEUROSCI, V34, P3733, DOI 10.1523/JNEUROSCI.2505-13.2014; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Xiong JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083561; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yao JJ, 2012, J BIOL CHEM, V287, P41534, DOI 10.1074/jbc.M112.390260; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhao QR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11768; Zhou S, 2014, CURR MED CHEM, V21, P1212, DOI 10.2174/0929867321666131218093327	54	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17369	17381		10.1074/jbc.M115.708883	http://dx.doi.org/10.1074/jbc.M115.708883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27307045	Green Published, hybrid			2022-12-26	WOS:000382643800036
J	Lawrence, CF; Margetts, MB; Menting, JG; Smith, NA; Smith, BJ; Ward, CW; Lawrence, MC				Lawrence, Callum F.; Margetts, Mai B.; Menting, John G.; Smith, Nicholas A.; Smith, Brian J.; Ward, Colin W.; Lawrence, Michael C.			Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST 3 DOMAINS; LIGAND-BINDING; SYSTEM; CRYSTALLIZATION; ACTIVATION; RESOLUTION; TOOLS; MODEL	Sets of synthetic peptides that interact with the insulin receptor ectodomain have been discovered by phage display and reported in the literature. These peptides were grouped into three classes termed Site 1, Site 2, and Site 3 based on their mutual competition of binding to the receptor. Further refinement has yielded, in particular, a 36-residue Site 2-Site 1 fusion peptide, S519, that binds the insulin receptor with subnanomolar affinity and exhibits agonist activity in both lipogenesis and glucose uptake assays. Here, we report three-dimensional crystallographic detail of the interaction of the C-terminal, 16-residue Site 1 component (S519C16) of S519 with the first leucine-rich repeat domain (L1) of the insulin receptor. Our structure shows that S519C16 binds to the same site on the L1 surface as that occupied by a critical component of the primary binding site, namely the helical C-terminal segment of the insulin receptor alpha-chain (termed alpha CT). In particular, the two phenylalanine residues within the FYXWF motif of S519C16 are seen to engage the insulin receptor L1 domain surface in a fashion almost identical to the respective alpha CT residues Phe701 and Phe705. The structure provides a platform for the further development of peptidic and/or small molecule agents directed toward the insulin receptor and/or the type 1 insulin-like growth factor receptor.	[Lawrence, Callum F.; Margetts, Mai B.; Menting, John G.; Ward, Colin W.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Smith, Nicholas A.; Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; La Trobe University; University of Melbourne	Lawrence, MC (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	lawrence@wehi.edu.au	Smith, Brian J/F-8282-2011; Lawrence, Michael C/A-5357-2009; Smith, Nicholas A/I-7422-2016	Smith, Brian J/0000-0003-0498-1910; Smith, Nicholas A/0000-0001-8894-4249; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801	Australian National Health and Medical Research Council (NHMRC) [1005896, 1058233]; Hazel and Pip Appel Fund; NHMRC Independent Research Institutes Infrastructure Support Scheme Grant [361646]; Victorian State Government; Sanofi (Germany); Australian Postgraduate Awards	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; NHMRC Independent Research Institutes Infrastructure Support Scheme Grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Sanofi (Germany)(Sanofi-Aventis); Australian Postgraduate Awards(Australian Government)	This work was supported in part by Australian National Health and Medical Research Council (NHMRC) Project Grants 1005896 and 1058233 and the Hazel and Pip Appel Fund (to M.C.L.) and by NHMRC Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government operational infrastructure support grant (to the Walter and Eliza Hall Institute of Medical Research). Part of the research of M.C.L. was funded by Sanofi (Germany).r Recipients of Australian Postgraduate Awards.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G., 2011, BUSTER VERSION 2 10; CLARK S, 1983, J BIOL CHEM, V258, P1434; CLARK S, 1982, J BIOL CHEM, V257, P2239; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Griffin L, 2011, CLIN EXP IMMUNOL, V165, P285, DOI 10.1111/j.1365-2249.2011.04427.x; Jensen M, 2008, BIOCHEM J, V412, P435, DOI 10.1042/BJ20080279; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McKern NM, 1997, PROTEIN SCI, V6, P2663; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Menting JG, 2009, BIOCHEMISTRY-US, V48, P5492, DOI 10.1021/bi900261q; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pillutla R., 2007, U. S. Patent, Patent No. [7,173,005 B2, 7173005]; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zuercher WJ, 2016, CELL CHEM BIOL, V23, P173, DOI 10.1016/j.chembiol.2015.12.005	39	25	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15473	15481		10.1074/jbc.M116.732180	http://dx.doi.org/10.1074/jbc.M116.732180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27281820	Green Published, hybrid			2022-12-26	WOS:000380584200005
J	Isla, RAT; Ameh, OI; Mapiye, D; Swanepoel, CR; Bello, AK; Ratsela, AR; Okpechi, IG				Isla, Ramon A. Tamayo; Ameh, Oluwatoyin I.; Mapiye, Darlington; Swanepoel, Charles R.; Bello, Aminu K.; Ratsela, Andrew R.; Okpechi, Ikechi G.			Baseline Predictors of Mortality among Predominantly Rural-Dwelling End-Stage Renal Disease Patients on Chronic Dialysis Therapies in Limpopo, South Africa	PLOS ONE			English	Article							AMBULATORY PERITONEAL-DIALYSIS; HEMODIALYSIS-PATIENTS; SURVIVAL; MODALITY; IMPACT; RISK	Background Dialysis therapy for end-stage renal disease (ESRD) continues to be the readily available renal replacement option in developing countries. While the impact of rural/remote dwelling on mortality among dialysis patients in developed countries is known, it remains to be defined in sub-Saharan Africa. Methods A single-center database of end-stage renal disease patients on chronic dialysis therapies treated between 2007 and 2014 at the Polokwane Kidney and Dialysis Centre (PKDC) of the Pietersburg Provincial Hospital, Limpopo South Africa, was retrospectively reviewed. All-cause, cardiovascular, and infection-related mortalities were assessed and associated baseline predictors determined. Results Of the 340 patients reviewed, 52.1% were male, 92.9% were black Africans, 1.8% were positive for the human immunodeficiency virus (HIV), and 87.5% were rural dwellers. The average distance travelled to the dialysis centre was 112.3 +/- 73.4 Km while 67.6% of patients lived in formal housing. Estimated glomerular filtration rate (eGFR) at dialysis initiation was 7.1 +/- 3.7 mls/min while hemodialysis (HD) was the predominant modality offered (57.1%). Ninety-two (92) deaths were recorded over the duration of follow-up with the majority (34.8%) of deaths arising from infection-related causes. Continuous ambulatory peritoneal dialysis(CAPD) was a significant predictor of all-cause mortality (HR: 1.62, CI: 1.07-2.46) and infection-related mortality (HR: 2.27, CI: 1.13-4.60). On multivariable cox regression, CAPD remained a significant predictor of all-cause mortality (HR: 2.00, CI: 1.29-3.10) while the risk of death among CAPD patients was also significantly modified by diabetes mellitus(DM) status (HR: 4.99, CI: 2.13-11.71). Conclusion CAPD among predominantly rural dwelling patients in the Limpopo province of South Africa is associated with an increased risk of death from all-causes and infection-related causes.	[Isla, Ramon A. Tamayo; Ratsela, Andrew R.] Pietersburg Prov Hosp, Polokwane Kidney & Dialysis Ctr, Polokwane, South Africa; [Isla, Ramon A. Tamayo; Ratsela, Andrew R.] Univ Limpopo, Polokwane, South Africa; [Ameh, Oluwatoyin I.; Swanepoel, Charles R.; Okpechi, Ikechi G.] Univ Cape Town, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa; [Mapiye, Darlington] Univ Western Cape, South African Natl Bioinformat Inst, South Africa Bioinformat Unit, MRC, Cape Town, South Africa; [Bello, Aminu K.] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada	University of Limpopo; University of Cape Town; University of the Western Cape; University of Alberta	Ameh, OI (corresponding author), Univ Cape Town, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa.	amethystpj2@yahoo.co.uk	Bello, Aminu K/D-2213-2013	Bello, Aminu K/0000-0002-6905-5937				Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; GAMBA G, 1993, NEPHRON, V65, P23, DOI 10.1159/000187435; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Isla RAT, 2014, PERITON DIALYSIS INT, V34, P518, DOI 10.3747/pdi.2013.00334; Johnson DW, 2009, AM J KIDNEY DIS, V53, P290, DOI 10.1053/j.ajkd.2008.06.032; MAILLOUX LU, 1991, AM J KIDNEY DIS, V18, P326, DOI 10.1016/S0272-6386(12)80091-6; Obiagwu PN, 2015, TROP MED INT HEALTH, V20, P2, DOI 10.1111/tmi.12409; Okpechi IG, 2012, J NEPHROL, V25, P551, DOI 10.5301/jn.5000032; Okpechi IG, 2012, PERITON DIALYSIS INT, V32, P254, DOI 10.3747/pdi.2011.00100; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; Piraino B, 2010, BLOOD PURIFICAT, V29, P145, DOI 10.1159/000245641; Rizvi S Adibul Hasan, 2003, Kidney Int Suppl, pS96; Robson NZMH, 2010, ASIA-PAC J PUBLIC HE, V22, P271, DOI 10.1177/1010539509357446; Schroijen MA, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-69; Stack AG, 2003, KIDNEY INT, V64, P1071, DOI 10.1046/j.1523-1755.2003.00165.x; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Thompson S, 2012, KIDNEY INT, V82, P352, DOI 10.1038/ki.2012.167; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Yu XQ, 2015, AM J KIDNEY DIS, V65, P147, DOI 10.1053/j.ajkd.2014.08.023; ZENT R, 1994, PERITON DIALYSIS INT, V14, P48	26	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156642	10.1371/journal.pone.0156642	http://dx.doi.org/10.1371/journal.pone.0156642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300372	Green Published, gold, Green Submitted			2022-12-26	WOS:000377822200011
J	Muhlebner, A; van Scheppingen, J; Hulshof, HM; Scholl, T; Iyer, AM; Anink, JJ; van den Ouweland, AMW; Nellist, MD; Jansen, FE; Spliet, WGM; Krsek, P; Benova, B; Zamecnik, J; Crino, PB; Prayer, D; Czech, T; Wohrer, A; Rahimi, J; Hoftberger, R; Hainfellner, JA; Feucht, M; Aronica, E				Muehlebner, Angelika; van Scheppingen, Jackelien; Hulshof, Hanna M.; Scholl, Theresa; Iyer, Anand M.; Anink, Jasper J.; van den Ouweland, Ans M. W.; Nellist, Mark D.; Jansen, Floor E.; Spliet, Wim G. M.; Krsek, Pavel; Benova, Barbora; Zamecnik, Josef; Crino, Peter B.; Prayer, Daniela; Czech, Thomas; Woehrer, Adelheid; Rahimi, Jasmin; Hoeftberger, Romana; Hainfellner, Johannes A.; Feucht, Martha; Aronica, Eleonora			Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex	PLOS ONE			English	Article							CONSENSUS CLASSIFICATION; HIPPOCAMPAL SCLEROSIS; ILAE CLASSIFICATION; MRI FEATURES; MALFORMATIONS; DYSPLASIA; INTEROBSERVER; EXPRESSION; CHILDREN; LESIONS	Tuberous Sclerosis Complex (TSC) is a genetic hamartoma syndrome frequently associated with severe intractable epilepsy. In some TSC patients epilepsy surgery is a promising treatment option provided that the epileptogenic zone can be precisely delineated. TSC brain lesions (cortical tubers) contain dysmorphic neurons, brightly eosinophilic giant cells and white matter alterations in various proportions. However, a histological classification system has not been established for tubers. Therefore, the aim of this study was to define distinct histological patterns within tubers based on semi-automated histological quantification and to find clinically significant correlations. In total, we studied 28 cortical tubers and seven samples of perituberal cortex from 28 TSC patients who had undergone epilepsy surgery. We assessed mammalian target of rapamycin complex 1 (mTORC1) activation, the numbers of giant cells, dysmorphic neurons, neurons, and oligodendrocytes, and calcification, gliosis, angiogenesis, inflammation, and myelin content. Three distinct histological profiles emerged based on the proportion of calcifications, dysmorphic neurons and giant cells designated types A, B, and C. In the latter two types we were able to subsequently associate them with specific features on presurgical MRI. Therefore, these histopathological patterns provide consistent criteria for improved definition of the clinico-pathological features of cortical tubers identified by MRI and provide a basis for further exploration of the functional and molecular features of cortical tubers in TSC.	[Muehlebner, Angelika; Scholl, Theresa; Feucht, Martha] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Muehlebner, Angelika; van Scheppingen, Jackelien; Iyer, Anand M.; Anink, Jasper J.; Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Hulshof, Hanna M.; Jansen, Floor E.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Pediat Neurol, Utrecht, Netherlands; [van den Ouweland, Ans M. W.; Nellist, Mark D.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Spliet, Wim G. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Krsek, Pavel; Benova, Barbora] Charles Univ Prague, Dept Pediat Neurol, Sch Med 2, Motol Univ Hosp, Prague, Czech Republic; [Zamecnik, Josef] Charles Univ Prague, Dept Pathol & Mol Med, Sch Med 2, Motol Univ Hosp, Prague, Czech Republic; [Crino, Peter B.] Temple Univ, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19122 USA; [Crino, Peter B.] Temple Univ, Dept Neurol, Philadelphia, PA 19122 USA; [Prayer, Daniela] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Czech, Thomas] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Woehrer, Adelheid; Rahimi, Jasmin; Hoeftberger, Romana; Hainfellner, Johannes A.] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Aronica, Eleonora] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Nederland, Hemstede, Netherlands	Medical University of Vienna; University of Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Charles University Prague; Motol University Hospital; Charles University Prague; Motol University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Amsterdam	Aronica, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Aronica, E (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands.; Aronica, E (corresponding author), Stichting Epilepsie Nederland, Hemstede, Netherlands.	e.aronica@amc.uva.nl	Mühlebner, Angelika/L-3734-2019; Benova, Barbora/AAB-3423-2019; Mühlebner, Angelika/ABC-9873-2021	Mühlebner, Angelika/0000-0001-9102-7353; Benova, Barbora/0000-0001-8448-2833; Mühlebner, Angelika/0000-0001-9102-7353; Krsek, Pavel/0000-0002-5740-3690; Feucht, Martha/0000-0001-7691-8158; Woehrer, Adelheid/0000-0001-8435-8189; Aronica, Eleonora/0000-0002-3542-3770; Iyer, Anand/0000-0001-6821-1048; Scholl, Theresa/0000-0002-9835-7328	Austrian Science Fund (FWF) [J3499]; Czech Ministry of Health [IGA NT/11443-5]; Framework Programme FP7 under the project acronym EPISTOP [602391]; MH CZ - DRO [00064203]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Czech Ministry of Health(Ministry of Health, Czech Republic); Framework Programme FP7 under the project acronym EPISTOP; MH CZ - DRO	This work was supported by the Austrian Science Fund (FWF): project no. J3499 (AM), Czech Ministry of Health grant: IGA NT/11443-5 (PK), MH CZ - DRO nr. 00064203 (JZ) and by the Framework Programme FP7/2007-2013 under the project acronym EPISTOP (grant agreement no. 602391; JvS, AI, HH, TS, EA, FJ, MF, BB, PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2014, NEUROTHERAPEUTICS, V11, P251, DOI 10.1007/s13311-013-0251-0; Blumcke I, 2011, CLIN NEUROPATHOL, V30, P164, DOI 10.5414/NP300398; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2013, LANCET NEUROL, V12, P844, DOI 10.1016/S1474-4422(13)70175-3; Boer K, 2008, EPILEPSY RES, V78, P7, DOI 10.1016/j.eplepsyres.2007.10.002; Boer K, 2008, NEUROPATHOLOGY, V28, P577, DOI 10.1111/j.1440-1789.2008.00920.x; Boer K, 2009, EPILEPSIA, V50, P2629, DOI 10.1111/j.1528-1167.2009.02191.x; Chamberlain WA, 2009, EPILEPSIA, V50, P2593, DOI 10.1111/j.1528-1167.2009.02344.x; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Coras R, 2014, EPILEPSIA, V55, P2003, DOI 10.1111/epi.12828; Coras R, 2012, EPILEPSIA, V53, P1341, DOI 10.1111/j.1528-1167.2012.03508.x; Crino PB, 2004, J CHILD NEUROL, V19, P716, DOI 10.1177/08830738040190091301; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Curatolo P, 2008, HAND CLINIC, V87, P129, DOI 10.1016/S0072-9752(07)87009-6; Engel J Jr, 1996, NEW ENGL J MED, V334, P647, DOI DOI 10.1056/NEJM199603073341008; Fauser S, 2015, EPILEPSIA, V56, P66, DOI 10.1111/epi.12876; Gallagher A, 2010, J NEUROL, V257, P1373, DOI 10.1007/s00415-010-5535-2; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; Jahodova A, 2014, EUR J RADIOL, V83, P703, DOI 10.1016/j.ejrad.2013.12.024; Jansen FE, 2007, EPILEPSIA, V48, P1477, DOI 10.1111/j.1528-1167.2007.01117.x; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; LAGOS JC, 1967, MAYO CLIN PROC, V42, P26; Li S, 2012, BRAIN RES, V1453, P46, DOI 10.1016/j.brainres.2012.03.009; Liu JYW, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-72; Luders H, 2006, CURR OPIN NEUROL, V19, P169; Muhlebner A, 2014, EPILEPSY RES, V108, P1652, DOI 10.1016/j.eplepsyres.2014.08.012; Muhlebner A, 2012, ACTA NEUROPATHOL, V123, P259, DOI 10.1007/s00401-011-0920-1; Prabowo AS, 2013, BRAIN PATHOL, V23, P45, DOI 10.1111/j.1750-3639.2012.00616.x; Qin W, 2010, BRAIN PATHOL, V20, P1096, DOI 10.1111/j.1750-3639.2010.00416.x; Ruppe V, 2014, EPILEPSIA, V55, P539, DOI 10.1111/epi.12545; Schurr J, 2017, BRAIN PATHOL, V27, P26, DOI 10.1111/bpa.12347; Shepherd C, 2013, EPILEPSIA, V54, P898, DOI 10.1111/epi.12143; Shu HF, 2013, BRAIN DEV-JPN, V35, P252, DOI 10.1016/j.braindev.2012.04.007; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Surbeck W, 2011, EPILEPSIA, V52, P458, DOI 10.1111/j.1528-1167.2010.02910.x; Talos DM, 2012, ANN NEUROL, V71, P539, DOI 10.1002/ana.22696; Tsai V, 2014, CEREB CORTEX, V24, P315, DOI 10.1093/cercor/bhs310; Wong M, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2007.01270.x	39	51	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157396	10.1371/journal.pone.0157396	http://dx.doi.org/10.1371/journal.pone.0157396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295297	Green Published, Green Submitted, gold			2022-12-26	WOS:000377821300042
J	Kashima, H; Momose, F; Umehara, H; Miyoshi, N; Ogo, N; Muraoka, D; Shiku, H; Harada, N; Asai, A				Kashima, Hajime; Momose, Fumiyasu; Umehara, Hiroshi; Miyoshi, Nao; Ogo, Naohisa; Muraoka, Daisuke; Shiku, Hiroshi; Harada, Naozumi; Asai, Akira			Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity	PLOS ONE			English	Article							FACTOR-KAPPA-B; NUCLEAR-FACTOR; EFFECTOR FUNCTIONS; ANTITUMOR-ACTIVITY; CARCINOMA; IMMUNOTHERAPY; DOXORUBICIN; ACTIVATION; INSIGHTS; ANALOGS	Forkhead box protein p3 (Foxp3) is crucial to the development and suppressor function of regulatory T cells (Tregs) that have a significant role in tumor-associated immune suppression. Development of small molecule inhibitors of Foxp3 function is therefore considered a promising strategy to enhance anti-tumor immunity. In this study, we developed a novel cell-based assay system in which the NF-kappa B luciferase reporter signal is suppressed by the co-expressed Foxp3 protein. Using this system, we screened our chemical library consisting of approximately 2,100 compounds and discovered that a cancer chemotherapeutic drug epirubicin restored the Foxp3-inhibited NF-kappa B activity in a concentration-dependent manner without influencing cell viability. Using immunoprecipitation assay in a Treg-like cell line Karpas-299, we found that epirubicin inhibited the interaction between Foxp3 and p65. In addition, epirubicin inhibited the suppressor function of murine Tregs and thereby improved effector T cell stimulation in vitro. Administration of low dose epirubicin into tumor-bearing mice modulated the function of immune cells at the tumor site and promoted their IFN-gamma production without direct cytotoxicity. In summary, we identified the novel action of epirubicin as a Foxp3 inhibitor using a newly established luciferase-based cellular screen. Our work also demonstrated our screen system is useful in accelerating discovery of Foxp3 inhibitors.	[Kashima, Hajime; Umehara, Hiroshi; Miyoshi, Nao; Ogo, Naohisa; Muraoka, Daisuke; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan; [Momose, Fumiyasu] Mie Univ, Grad Sch Med, Dept Immunogene Therapy, Tsu, Mie 5148507, Japan; [Shiku, Hiroshi; Harada, Naozumi] Mie Univ, Ctr Comprehens Canc Immunotherapy, Tsu, Mie 5148507, Japan	University of Shizuoka; Mie University; Mie University	Asai, A (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan.; Harada, N (corresponding author), Mie Univ, Ctr Comprehens Canc Immunotherapy, Tsu, Mie 5148507, Japan.	nharada@clin.medic.mie-u.ac.jp; aasai@u-shizuoka-ken.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Pharma Valley Center (PVC) Shizuoka, Japan	Pharma Valley Center (PVC) Shizuoka, Japan	This work was supported by Pharma Valley Center (PVC) Shizuoka, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa K, 2004, BIOCHEM PHARMACOL, V67, P353, DOI 10.1016/j.bcp.2003.08.039; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bottero V, 2001, CANCER RES, V61, P7785; Carson BD, 2006, FRONT BIOSCI-LANDMRK, V11, P1607, DOI 10.2741/1908; Casares N, 2010, J IMMUNOL, V185, P5150, DOI 10.4049/jimmunol.1001114; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Ihenetu K, 2008, INFLAMM RES, V57, P519, DOI 10.1007/s00011-008-7249-9; Kwon HK, 2008, MOL IMMUNOL, V45, P3205, DOI 10.1016/j.molimm.2008.02.021; Larmonier N, 2008, J IMMUNOL, V181, P6955, DOI 10.4049/jimmunol.181.10.6955; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Li LF, 2013, ASIAN PAC J CANCER P, V14, P1721, DOI 10.7314/APJCP.2013.14.3.1721; Liu WM, 2010, BRIT J CANCER, V102, P115, DOI 10.1038/sj.bjc.6605465; Lozano T, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00294; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nishikawa H, 2001, P NATL ACAD SCI USA, V98, P14571, DOI 10.1073/pnas.251547298; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Schlecht U, 2012, P NATL ACAD SCI USA, V109, P9213, DOI 10.1073/pnas.1204952109; Shaul P, 2013, ACS MED CHEM LETT, V4, P323, DOI 10.1021/ml3002852; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; WEISS RB, 1986, CANCER CHEMOTH PHARM, V18, P185; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wolke C, 2006, INT J MOL MED, V17, P275; Zhou ZC, 2008, IMMUNOL RES, V42, P19, DOI 10.1007/s12026-008-8029-x; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	35	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156643	10.1371/journal.pone.0156643	http://dx.doi.org/10.1371/journal.pone.0156643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284967	gold, Green Published, Green Submitted			2022-12-26	WOS:000377564000018
J	Ohno, T; Adachi, S; Okuno, M; Horibe, Y; Goto, N; Iwama, M; Yamauchi, O; Kojima, T; Saito, K; Ibuka, T; Yasuda, I; Araki, H; Moriwaki, H; Shimizu, M				Ohno, Tomohiko; Adachi, Seiji; Okuno, Mitsuru; Horibe, Yohei; Goto, Naoe; Iwama, Midori; Yamauchi, Osamu; Kojima, Takao; Saito, Koshiro; Ibuka, Takashi; Yasuda, Ichiro; Araki, Hiroshi; Moriwaki, Hisataka; Shimizu, Masahito			Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study	PLOS ONE			English	Article							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; CANCER-RISK; ALCOHOL-CONSUMPTION; FOLLOW-UP; MORTALITY; POLYPS; METAANALYSIS; PREVENTION; GUIDELINES; ASPIRIN	Objective The purpose of this study was to develop a novel scoring system to screen subjects who have a high risk for colorectal neoplasia. Study Design and Setting We retrospectively analyzed 1061 subjects undergoing total colonoscopy (TCS) for the first time at Gihoku Kosei Hospital. The characteristics and habits of the subjects were analyzed using a multivariate logistic regression analysis. The risk score was established according to each odds ratio of the individual risk factors, and the correlations between the sum of the risk scores and the prevalence of colorectal neoplasia for each individual were evaluated. Results Age 45-59 (risk score: 2 points) and >= 60 (3 points), male gender (1 point), and habitual alcohol consumption >= 21g daily (1 point) were extracted as the significant risk factors for colorectal neoplasia. When the risk groups were determined by summing up these risk scores, the prevalence rates of colorectal neoplasia were 8.8% for the low risk group (0-2 points), 30.5% for the low-moderate risk group (3 points), 39.1% for the high-moderate risk group (4 points), and 57.6% for the high risk group (5 points). In comparison with the low risk group, the odds ratio of the low-moderate risk, the high-moderate risk, and the high risk groups were 4.6, 6.7, and 14.1 folds, respectively. Conclusion Our scoring system, which linearly correlates with the prevalence rate of colorectal neoplasia, may be an effective tool for screening the subjects who have a high risk for colorectal neoplasia. These subjects, therefore, should be recommended to undergo TCS.	[Ohno, Tomohiko; Adachi, Seiji; Okuno, Mitsuru; Horibe, Yohei; Goto, Naoe; Iwama, Midori; Yamauchi, Osamu; Kojima, Takao; Saito, Koshiro] Gihoku Kosei Hosp, Dept Gastroenterol Internal Med, Yamagata 5012105, Japan; [Ibuka, Takashi; Yasuda, Ichiro] Gifu Univ, Grad Sch Med, Div Reg Canc Control, Gifu 5011194, Japan; [Ibuka, Takashi; Araki, Hiroshi; Moriwaki, Hisataka; Shimizu, Masahito] Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu 5011194, Japan	Gifu University; Gifu University	Adachi, S (corresponding author), Gihoku Kosei Hosp, Dept Gastroenterol Internal Med, Yamagata 5012105, Japan.	sadachi-gif@umin.ac.jp						Ahlawat SK, 2011, J CLIN GASTROENTEROL, V45, P347, DOI 10.1097/MCG.0b013e3181f3a2e0; Aldridge AJ, 2001, EUR J SURG, V167, P777; Atkin WS, 2012, ENDOSCOPY, V44, pSE151, DOI 10.1055/s-0032-1309821; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Bu WJ, 2014, BRIT J CLIN PHARMACO, V78, P301, DOI 10.1111/bcp.12350; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Cardel M, 2014, CANCER MED-US, V3, P1458, DOI 10.1002/cam4.306; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; Colucci Philomena M, 2003, Clin Med Res, V1, P261; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; Heitman SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000370; HIWATASHI N, 1993, JPN J CANCER RES, V84, P1110, DOI 10.1111/j.1349-7006.1993.tb02809.x; Hoffmeister M, 2007, INT J CANCER, V121, P1325, DOI 10.1002/ijc.22796; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Kaminski MF, 2014, GUT, V63, P1112, DOI 10.1136/gutjnl-2013-304965; Kedika R, 2011, J CLIN GASTROENTEROL, V45, pE12, DOI 10.1097/MCG.0b013e3181ea1044; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Limburg PJ, 2006, AM J GASTROENTEROL, V101, P1872, DOI 10.1111/j.1572-0241.2006.00725.x; Limsui D, 2010, JNCI-J NATL CANCER I, V102, P1012, DOI 10.1093/jnci/djq201; Makar GA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt374; Nishihara R, 2015, EUR J EPIDEMIOL, V30, P1129, DOI 10.1007/s10654-015-0088-4; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Saito H, 2000, ONCOL REP, V7, P815; SAITO H, 1995, INT J CANCER, V61, P465, DOI 10.1002/ijc.2910610406; Sakamoto T, 2013, COLORECTAL DIS, V15, pE295, DOI 10.1111/codi.12210; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Steffen A, 2014, CANCER EPIDEM BIOMAR, V23, P2543, DOI 10.1158/1055-9965.EPI-14-0206; Tsugane S, 1999, AM J EPIDEMIOL, V150, P1201, DOI 10.1093/oxfordjournals.aje.a009946; van Duijnhoven Franzel J B, 2011, Gut, V60, P1094, DOI 10.1136/gut.2010.225011; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168; Zappa M, 1999, EUR J CANCER, V35, P326; Zappa M, 1998, EUR J CANCER, V34, P773; Zhu JZ, 2014, ALIMENT PHARM THER, V40, P325, DOI 10.1111/apt.12841	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157269	10.1371/journal.pone.0157269	http://dx.doi.org/10.1371/journal.pone.0157269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284907	Green Published, Green Submitted, gold			2022-12-26	WOS:000377564000053
J	Sankari, S; O'Brian, MR				Sankari, Siva; O'Brian, Mark R.			Synthetic Lethality of the bfr and mbfA Genes Reveals a Functional Relationship between Iron Storage and Iron Export in Managing Stress Responses in Bradyrhizobium japonicum	PLOS ONE			English	Article							HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; OXIDATIVE STRESS; IRR PROTEIN; BACTERIOFERRITIN; RESISTANCE; REGULATOR; INVOLVEMENT; HOMEOSTASIS; METABOLISM	An mbfA mutant of Bradyrhizobium japonicum defective in iron export is sensitive to short term exposure to high levels iron or H2O2. Here, we found that the mbfA strain grown in elevated iron media (100 mu M) became resistant to those treatments, suggesting a stress response adaptation. The bfr gene encodes the iron storage protein bacterioferritin, and its expression is derepressed by iron. An mbfA bfr double mutant showed a loss of stress adaptation, and had a severe growth phenotype in high iron media. Moreover, a bfr(up) allele in which bfr is constitutively derepressed conferred stress tolerance on an mbfA mutant without elevating the iron content in the growth media. The intracellular iron content of the mbfA bfr double mutant was substantially higher than that found in the wild type, even when grown in relatively low iron media (5 mu M). Under that condition, iron-responsive gene expression was aberrant in the mbfA bfr strain. Moreover, the double mutant was sensitive to the iron-activated antibiotic streptonigrin. We conclude that MbfA and Bfr work in concert to manage iron and oxidative stresses. In addition, the need for iron detoxification is not limited to extreme environments, but is also required for normal cellular function.	[Sankari, Siva; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA.	mrobrian@buffalo.edu	sankaran, Siva Sankari iyer mani/AAB-5222-2020		National Institutes of Health [R01 GM099667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health, R01 GM099667.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Bhubhanil S, 2014, MICROBIOL-SGM, V160, P863, DOI 10.1099/mic.0.076802-0; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Expert D, 2008, J BIOL CHEM, V283, P36564, DOI 10.1074/jbc.M807749200; Frawley ER, 2013, P NATL ACAD SCI USA, V110, P12054, DOI 10.1073/pnas.1218274110; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Guan GH, 2015, MOL MICROBIOL, V98, P787, DOI 10.1111/mmi.13158; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Jaggavarapu S, 2014, MOL MICROBIOL, V92, P609, DOI 10.1111/mmi.12584; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Nicolaou SA, 2013, APPL ENVIRON MICROB, V79, P7210, DOI 10.1128/AEM.02322-13; O'Brian MR, 2015, ANNU REV MICROBIOL, V69, P229, DOI 10.1146/annurev-micro-091014-104432; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ruangkiattikul N, 2012, FEMS MICROBIOL LETT, V329, P87, DOI 10.1111/j.1574-6968.2012.02509.x; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Small SK, 2011, J BACTERIOL, V193, P4088, DOI 10.1128/JB.05064-11; Wittenberg JB, 1996, PLANT SOIL, V178, P161, DOI 10.1007/BF00011579; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; ZUBAY G, 1972, P NATL ACAD SCI USA, V69, P1100, DOI 10.1073/pnas.69.5.1100	22	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157250	10.1371/journal.pone.0157250	http://dx.doi.org/10.1371/journal.pone.0157250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285822	Green Submitted, gold, Green Published			2022-12-26	WOS:000377564000049
J	Spiegelhalder, K; Regen, W; Nissen, C; Feige, B; Baglioni, C; Riemann, D; Hennig, J; Lange, T				Spiegelhalder, Kai; Regen, Wolfram; Nissen, Christoph; Feige, Bernd; Baglioni, Chiara; Riemann, Dieter; Hennig, Juergen; Lange, Thomas			Magnetic Resonance Spectroscopy in Patients with Insomnia: A Repeated Measurement Study	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; CORTICAL GABA LEVELS; IN-VIVO; HUMAN BRAIN; SLEEP; REPRODUCIBILITY; ASSOCIATIONS; METABOLITES; VALIDATION; DISORDER	Chronic insomnia is one of the most prevalent central nervous system disorders. It is characterized by increased arousal levels, however, the neurobiological causes and correlates of hyperarousal in insomnia remain to be further determined. In the current study, magnetic resonance spectroscopy was used in the morning and evening in a well-characterized sample of 20 primary insomnia patients (12 females; 8 males; 42.7 +/- 13.4 years) and 20 healthy good sleepers (12 females; 8 males; 44.1 +/- 10.6 years). The most important inhibitory and excitatory neurotransmitters of the central nervous system, gamma-aminobutyric acid (GABA) and glutamate/glutamine (Glx), were assessed in the anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC). The primary hypothesis, a diurnal effect on GABA levels in patients with insomnia, could not be confirmed. Moreover, the current results did not support previous findings of altered GABA levels in individuals with insomnia. Exploratory analyses, however, suggested that GABA levels in the ACC may be positively associated with habitual sleep duration, and, thus, reduced GABA levels may be a trait marker of objective sleep disturbances. Moreover, there was a significant GROUP x MEASUREMENT TIME interaction effect on Glx in the DLPFC with increasing Glx levels across the day in the patients but not in the control group. Therefore, Glx levels may reflect hyperarousal at bedtime in those with insomnia. Future confirmatory studies should include larger sample sizes to investigate brain metabolites in different subgroups of insomnia.	[Spiegelhalder, Kai; Regen, Wolfram; Nissen, Christoph; Feige, Bernd; Baglioni, Chiara; Riemann, Dieter] Univ Med Ctr Freiburg, Dept Clin Psychol & Psychophysiol, Ctr Mental Disorders, Freiburg, Germany; [Spiegelhalder, Kai; Lange, Thomas] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Hugstetter Str 55, D-79106 Freiburg, Germany; [Hennig, Juergen] Univ Med Ctr Freiburg, Med Phys, Dept Radiol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Spiegelhalder, K (corresponding author), Univ Med Ctr Freiburg, Dept Clin Psychol & Psychophysiol, Ctr Mental Disorders, Freiburg, Germany.; Spiegelhalder, K (corresponding author), Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Hugstetter Str 55, D-79106 Freiburg, Germany.	Kai.Spiegelhalder@uniklinik-freiburg.de	Spiegelhalder, Kai/B-7861-2019; Feige, Bernd/C-6690-2012; Lange, Thomas/P-5582-2018; Hennig, Jürgen/F-2424-2010; Riemann, Dieter/R-4013-2019; Nissen, Christoph/C-7642-2015; Baglioni, Chiara/ABC-3423-2020; Baglioni, Chiara/AAC-2605-2019	Feige, Bernd/0000-0002-9436-1258; Lange, Thomas/0000-0002-7467-8143; Hennig, Jürgen/0000-0002-2273-3497; Nissen, Christoph/0000-0001-9809-0275; Riemann, Dieter/0000-0002-1968-6220	Freiburg Institute for Advanced Studies (FRIAS); Helmholtz Alliance; "Deutsche Forschungsgemeinschaft" (DFG); German Research Foundation (DFG); University of Freiburg	Freiburg Institute for Advanced Studies (FRIAS)(Fonds de la Recherche Scientifique - FNRS); Helmholtz Alliance; "Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The Freiburg Institute for Advanced Studies (FRIAS) provided grant support for KS and TL. The Helmholtz Alliance, and the "Deutsche Forschungsgemeinschaft" (DFG) provided grant support for TL. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baglioni C, 2014, SLEEP, V37, P1907, DOI 10.5665/sleep.4240; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck A.T., 1987, BECK DEPRESSION INVE; Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410; Bhattacharyya PK, 2014, NEUROIMAGE, V84, P1111, DOI 10.1016/j.neuroimage.2013.08.050; Bogner W, 2010, EUR J RADIOL, V73, P526, DOI 10.1016/j.ejrad.2009.01.014; Broomfield NM, 2005, J SLEEP RES, V14, P401, DOI 10.1111/j.1365-2869.2005.00481.x; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; De Bondt T, 2015, BRAIN RES, V1597, P129, DOI 10.1016/j.brainres.2014.11.051; Edden RAE, 2012, J MAGN RESON IMAGING, V35, P229, DOI 10.1002/jmri.22865; Evans CJ, 2010, J MAGN RESON IMAGING, V31, P204, DOI 10.1002/jmri.21996; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Ganji SK, 2012, NMR BIOMED, V25, P523, DOI 10.1002/nbm.1767; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huedo-Medina TB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8343; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Johann A, 2015, SOMNOLOGIE, V19, P88; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kucharczyk Erica R, 2012, Sleep Med Rev, V16, P547, DOI 10.1016/j.smrv.2012.01.005; Kyle SD, 2010, SLEEP MED REV, V14, P69, DOI 10.1016/j.smrv.2009.07.004; Lanfranchi PA, 2009, SLEEP, V32, P760, DOI 10.1093/sleep/32.6.760; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Leger D, 2010, SLEEP MED REV, V14, P379, DOI 10.1016/j.smrv.2010.01.003; Long ZY, 2015, NMR BIOMED, V28, P1315, DOI 10.1002/nbm.3381; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Meyerhoff DJ, 2014, SLEEP, V37, P893, DOI 10.5665/sleep.3654; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Morgan PT, 2012, SLEEP, V35, P807, DOI 10.5665/sleep.1880; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, NAT REV DIS IN PRESS; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Near J, 2014, NEUROIMAGE, V99, P191, DOI 10.1016/j.neuroimage.2014.05.059; Near J, 2013, NMR BIOMED, V26, P1353, DOI 10.1002/nbm.2960; Near J, 2011, NMR BIOMED, V24, P1277, DOI 10.1002/nbm.1688; NICASSIO PM, 1985, BEHAV RES THER, V23, P263, DOI 10.1016/0005-7967(85)90004-X; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Plante DT, 2012, SLEEP, V35, P741, DOI 10.5665/sleep.1854; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2013, J MAGN RESON IMAGING, V37, P999, DOI 10.1002/jmri.23817; Regen W, J PSYCHIAT IN PRESS; Reinhard MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109336; Riemann D, 2015, LANCET NEUROL, V14, P547, DOI 10.1016/S1474-4422(15)00021-6; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Spiegelhalder K, 2015, SOMNOLOGIE, V19, P93; Spiegelhalder K, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0527-3; Spiegelhalder K, 2014, HUM BRAIN MAPP, V35, P3431, DOI 10.1002/hbm.22412; Spiegelhalder K, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0364-5; Spiegelhalder K, 2013, SLEEP, V36, P731, DOI 10.5665/sleep.2638; Spiegelhalder K, 2011, J SLEEP RES, V20, P137, DOI 10.1111/j.1365-2869.2010.00863.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Winkelman JW, 2008, SLEEP, V31, P1499, DOI 10.1093/sleep/31.11.1499	64	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156771	10.1371/journal.pone.0156771	http://dx.doi.org/10.1371/journal.pone.0156771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285311	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000020
J	Wessler, I; Gartner, HA; Michel-Schmidt, R; Brochhausen, C; Schmitz, L; Anspach, L; Grunewald, B; Kirkpatrick, CJ				Wessler, Ignaz; Gaertner, Hedwig-Annabel; Michel-Schmidt, Rosmarie; Brochhausen, Christoph; Schmitz, Luise; Anspach, Laura; Gruenewald, Bernd; Kirkpatrick, Charles James			Honeybees Produce Millimolar Concentrations of Non-Neuronal Acetylcholine for Breeding: Possible Adverse Effects of Neonicotinoids	PLOS ONE			English	Article							CHOLINERGIC SYSTEM; BIOLOGICAL-SYSTEMS; HUMANS; BEES; MOLECULE; EXPRESSION; RECEPTORS; NICOTINE; TISSUES; GROWTH	The worldwide use of neonicotinoid pesticides has caused concern on account of their involvement in the decline of bee populations, which are key pollinators in most ecosystems. Here we describe a role of non-neuronal acetylcholine (ACh) for breeding of Apis mellifera carnica and a so far unknown effect of neonicotinoids on non-target insects. Royal jelly or larval food are produced by the hypopharyngeal gland of nursing bees and contain unusually high ACh concentrations (4-8 mM). ACh is extremely well conserved in royal jelly or brood food because of the acidic pH of 4.0. This condition protects ACh from degradation thus ensuring delivery of intact ACh to larvae. Raising the pH to >= 5.5 and applying cholinesterase reduced the content of ACh substantially (by 75-90%) in larval food. When this manipulated brood was tested in artificial larval breeding experiments, the survival rate was higher with food supplemented by 100% with ACh (6 mM) than with food not supplemented with ACh. ACh release from the hypopharyngeal gland and its content in brood food declined by 80%, when honeybee colonies were exposed for 4 weeks to high concentrations of the neonicotinoids clothianidin (100 parts per billion [ppb]) or thiacloprid (8,800 ppb). Under these conditions the secretory cells of the gland were markedly damaged and brood development was severely compromised. Even field-relevant low concentrations of thiacloprid (200 ppb) or clothianidin (1 and 10 ppb) reduced ACh level in the brood food and showed initial adverse effects on brood development. Our findings indicate a hitherto unknown target of neonicotinoids to induce adverse effects on non-neuronal ACh which should be considered when re-assessing the environmental risks of these compounds. To our knowledge this is a new biological mechanism, and we suggest that, in addition to their well documented neurotoxic effects, neonicotinoids may contribute to honeybee colony losses consecutive to a reduction of the ACh content in the brood food.	[Wessler, Ignaz; Michel-Schmidt, Rosmarie; Schmitz, Luise; Anspach, Laura; Kirkpatrick, Charles James] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Langenbeckstr 1, D-55122 Mainz, Germany; [Gaertner, Hedwig-Annabel; Gruenewald, Bernd] Goethe Univ Frankfurt, Inst Bienenkunde, Polytech Gesell Frankfurt Main, Fachbereich Biowissensch, Karl von Frisch Weg 2, D-61440 Oberursel, Germany; [Brochhausen, Christoph] Univ Regensburg, Inst Pathol, Franz Josef Str Allee 11, D-93053 Regensburg, Germany	Johannes Gutenberg University of Mainz; Goethe University Frankfurt; University of Regensburg	Wessler, I (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Langenbeckstr 1, D-55122 Mainz, Germany.	wessler@uni-mainz.de	Grünewald, Bernd/G-2060-2012	Kirkpatrick, Charles James/0000-0002-0088-418X	Deutsche Forschungsgemeinschaft [Ki 601/8-02]; German Federal Ministry of Food and Agriculture (FitBee)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Food and Agriculture (FitBee)	This work was supported by: 1) Deutsche Forschungsgemeinschaft (grant Ki 601/8-02) to CJK, and 2) German Federal Ministry of Food and Agriculture (FitBee) to BG.	Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Catone C, 2003, J NEUROSCI RES, V72, P46, DOI 10.1002/jnr.10550; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Ewins AJ, 1914, BIOCHEM J, V8, P44, DOI 10.1042/bj0080044; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Grando SA, 2015, INT IMMUNOPHARMACOL, V29, P1, DOI 10.1016/j.intimp.2015.08.023; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Horiuchi Y, 2003, LIFE SCI, V72, P1745, DOI 10.1016/S0024-3205(02)02478-5; Kheyri H, 2012, CYTOSKELETON, V69, P1032, DOI 10.1002/cm.21059; KILBINGER H, 1980, N-S ARCH PHARMACOL, V314, P259, DOI 10.1007/BF00498547; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; SASTRY BVR, 1978, PHARMACOL REV, V30, P65; SCHULLER HM, 1990, LIFE SCI, V47, P571, DOI 10.1016/0024-3205(90)90618-2; Smodis-Skerl MI, 2010, APIDOLOGIE, V41, P467; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wang Y, 2008, J PHARMACEUT BIOMED, V47, P870, DOI 10.1016/j.jpba.2008.02.022; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wessler I, 1999, CLIN EXP PHARMACOL P, V26, P198, DOI 10.1046/j.1440-1681.1999.03016.x; Wessler I, 2001, JPN J PHARMACOL, V85, P2, DOI 10.1254/jjp.85.2; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; Wessler I, 2013, NEUROSCI LETT, V547, P32, DOI 10.1016/j.neulet.2013.04.052; Wessler IK, 2012, HDB EXP PHARM, V208, P469; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	36	27	27	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156886	10.1371/journal.pone.0156886	http://dx.doi.org/10.1371/journal.pone.0156886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285384	Green Submitted, Green Published, gold			2022-12-26	WOS:000377564000029
J	Dalmasso, M; Strain, R; Neve, H; Franz, CMAP; Cousin, FJ; Ross, RP; Hill, C				Dalmasso, Marion; Strain, Ronan; Neve, Horst; Franz, Charles M. A. P.; Cousin, Fabien J.; Ross, R. Paul; Hill, Colin			Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SHIGELLA-SONNEI; BACTERIOPHAGE; COCKTAIL; GENERATION; VOLUNTEERS; BIOCONTROL; O157-H7; BLAST	With the emergence of multi-drug resistant bacteria the use of bacteriophages (phages) is gaining renewed interest as promising anti-microbial agents. The aim of this study was to isolate and characterize phages from human fecal samples. Three new coliphages, phi APCEc01, phi APCEc02 and phi APCEc03, were isolated. Their phenotypic and genomic characteristics, and lytic activity against biofilm, and in combination with ciprofloxacin, were investigated. All three phages reduced the growth of E. coli strain DPC6051 at multiplicity of infection (MOI) between 10(-3) and 10(5). A cocktail of all three phages completely inhibited the growth of E. coli. The phage cocktail also reduced biofilm formation and prevented the emergence of phage-resistant mutants which occurred with single phage. When combined with ciprofloxacin, phage alone or in cocktail inhibited the growth of E. coli and prevented the emergence of resistant mutants. These three new phages are promising biocontrol agents for E. coli infections.	[Dalmasso, Marion; Strain, Ronan; Cousin, Fabien J.; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Dalmasso, Marion; Strain, Ronan; Cousin, Fabien J.; Ross, R. Paul; Hill, Colin] Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [Neve, Horst; Franz, Charles M. A. P.] Max Rubner Inst, Dept Microbiol & Biotechnol, Kiel, Germany; [Ross, R. Paul] TEAGASC, Ctr Biotechnol, Moorepk Food Res Ctr, Fermoy, Cork, Ireland; [Dalmasso, Marion] Normandie Univ, UNICAEN, ABTE EA4651, F-14032 Caen, France	University College Cork; University College Cork; Teagasc; Universite de Caen Normandie	Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.; Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.	c.hill@ucc.ie	Hill, Colin/A-5611-2012; Ross, Paul/A-7584-2015	Hill, Colin/0000-0002-8527-1445; Ross, Paul/0000-0003-4876-8839; Cousin, Fabien/0000-0001-6874-387X; Strain, Ronan/0000-0003-2465-4626; Dalmasso, Marion/0000-0003-1875-2748	Science Foundation Ireland [SFI/12/RC/2273]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors received financial support from Science Foundation Ireland (http://www.sfi.ie/) under Grant Number SFI/12/RC/2273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0059-2; Baron F, 2006, LAIT, V86, P251, DOI 10.1051/lait:2006005; Brussow H, 2012, VIROLOGY, V434, P138, DOI 10.1016/j.virol.2012.09.015; Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Casey E, 2015, APPL ENVIRON MICROB, V81, P1319, DOI 10.1128/AEM.03413-14; Cha SB, 2012, J VET MED SCI, V74, P1037, DOI 10.1292/jvms.11-0556; Chang HW, 2011, J MICROBIOL, V49, P927, DOI 10.1007/s12275-011-1577-0; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799; Coulter LB, 2014, VIRUSES-BASEL, V6, P3778, DOI 10.3390/v6103778; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Cusack S, 2013, GERONTOLOGY, V59, P114, DOI 10.1159/000343158; Dalmasso M, 2014, TRENDS MICROBIOL, V22, P399, DOI 10.1016/j.tim.2014.02.010; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Denou E, 2009, VIROLOGY, V388, P21, DOI 10.1016/j.virol.2009.03.009; Dufour N, 2015, CRIT CARE MED, V43, pE190, DOI 10.1097/CCM.0000000000000968; Endersen L, 2014, ANNU REV FOOD SCI T, V5, P327, DOI 10.1146/annurev-food-030713-092415; Field D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119684; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hejnova J, 2005, MICROBIOL-SGM, V151, P385, DOI 10.1099/mic.0.27469-0; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Hoyles L, 2014, RES MICROBIOL, V165, P803, DOI 10.1016/j.resmic.2014.10.006; Hu J, 2015, CLIN MICROBIOL INFEC, V21, P729, DOI 10.1016/j.cmi.2015.01.015; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jeffery IB, 2016, ISME J, V10, P170, DOI 10.1038/ismej.2015.88; Kamal F, 2015, APPL ENVIRON MICROB, V81, P1132, DOI 10.1128/AEM.02850-14; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Kropinski AM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-76; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Lu ZJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00067; Ly-Chatain MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00051; Mahony J, 2011, CURR OPIN BIOTECH, V22, P157, DOI 10.1016/j.copbio.2010.10.008; Maura D, 2012, ANTIMICROB AGENTS CH, V56, P6235, DOI 10.1128/AAC.00602-12; Mirzaei MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118557; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murphy J, 2013, J DAIRY SCI, V96, P4945, DOI 10.3168/jds.2013-6748; O'Flaherty S, 2005, J BACTERIOL, V187, P7161, DOI 10.1128/JB.187.20.7161-7164.2005; O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parasion S, 2014, POL J MICROBIOL, V63, P137; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Rahmani R, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.17744; Sarker SA, 2012, VIROLOGY, V434, P222, DOI 10.1016/j.virol.2012.09.002; Subramanian S, 2008, INFLAMM BOWEL DIS, V14, P162, DOI 10.1002/ibd.20296; Tang F, 2012, J VIROL, V86, P13871, DOI 10.1128/JVI.02698-12; TARR PI, 1995, CLIN INFECT DIS, V20, P1, DOI 10.1093/clinids/20.1.1; Truncaite L, 2012, ARCH VIROL, V157, P2431, DOI 10.1007/s00705-012-1449-x; Tsonos J, 2014, VET MICROBIOL, V171, P470, DOI 10.1016/j.vetmic.2013.10.021; Tunney MM, 2004, ANTIMICROB AGENTS CH, V48, P1879, DOI 10.1128/AAC.48.5.1879-1881.2004; Viertel TM, 2014, J ANTIMICROB CHEMOTH, V69, P2326, DOI 10.1093/jac/dku173; Wittebole X, 2014, VIRULENCE, V5, P226, DOI 10.4161/viru.25991; Yap ML, 2014, FUTURE MICROBIOL, V9, P1319, DOI 10.2217/fmb.14.91	60	42	44	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156773	10.1371/journal.pone.0156773	http://dx.doi.org/10.1371/journal.pone.0156773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280590	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000046
J	Rowland, IJ; Goodman, WG				Rowland, Ian J.; Goodman, Walter G.			Magnetic Resonance Imaging of Alimentary Tract Development in Manduca sexta	PLOS ONE			English	Article							PUPAL-ADULT DEVELOPMENT; TOBACCO HORNWORM; ECDYSTEROID TITER; NMR MICROSCOPY; INSECT BRAIN; BOMBYX-MORI; 3D MRI; METAMORPHOSIS; MIDGUT; LARVAL	Non-invasive 3D magnetic resonance imaging techniques were used to investigate metamorphosis of the alimentary tract of Manduca sexta from the larval to the adult stage. The larval midgut contracts in volume immediately following cessation of feeding and then greatly enlarges during the late pharate pupal period. Magnetic resonance imaging revealed that the foregut and hindgut of the pharate pupa undergo ecdysis considerably earlier than the external exoskeleton. Expansion of air sacs in the early pupa and development of flight muscles several days later appear to orient the midgut into its adult position in the abdomen. The crop, an adult auxiliary storage organ, begins development as a dorsal outgrowth of the foregut. This coincides with a reported increase in pupal ecdysteroid titers. An outgrowth of the hindgut, the rectal sac, appears several days later and continues to expand until it nearly fills the dorsal half of the abdominal cavity. This development correlates with a second rise in pupal ecdysteroid titers. In the pharate pupa, the presence of paramagnetic species renders the silk glands hyperintense.	[Rowland, Ian J.; Goodman, Walter G.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Rowland, IJ (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	irowland@wisc.edu		Rowland, Ian/0000-0001-8738-4550				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alleyne M, 2007, J INSECT SCI, V7, P2; BAHADUR J, 1971, International Journal of Insect Morphology and Embryology, V1, P21, DOI 10.1016/0020-7322(71)90005-5; BAKER FC, 1987, INSECT BIOCHEM, V17, P989, DOI 10.1016/0020-1790(87)90108-9; Baldwin K. M., 1996, P31; Barbehenn RV, 2004, J INSECT PHYSIOL, V50, P783, DOI 10.1016/j.jinsphys.2004.05.012; BOLLENBACHER WE, 1981, GEN COMP ENDOCR, V44, P302, DOI 10.1016/0016-6480(81)90005-8; CIOFFI M, 1979, TISSUE CELL, V11, P467, DOI 10.1016/0040-8166(79)90057-0; CONNER WE, 1988, EXPERIENTIA, V44, P11, DOI 10.1007/BF01960223; CORNELL JC, 1983, J EXP BIOL, V107, P501; Davis NT, 2006, ARTHROPOD STRUCT DEV, V35, P15, DOI 10.1016/j.asd.2005.07.001; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Dow JAT, 1986, INSECT MIDGUT FUNCTI, P187; EATON JL, 1982, INT J INSECT MORPHOL, V11, P355, DOI 10.1016/0020-7322(82)90024-1; Eaton JL, 1988, LEPIDOPTERAN ANATOMY; GOODMAN BA, 1995, J INSECT PHYSIOL, V41, P419, DOI 10.1016/0022-1910(94)00115-W; GOODMAN WG, 1985, ANN ENTOMOL SOC AM, V78, P70, DOI 10.1093/aesa/78.1.70; Gorman MJ, 2000, J INVERTEBR PATHOL, V75, P296, DOI 10.1006/jipa.2000.4930; Grant JB, 2006, J EXP BIOL, V209, P3018, DOI 10.1242/jeb.02335; GRAY JOHN, 1931, ANN ENT SOC AMERICA, V24, P45; Haddad D, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.7; HAKIM RS, 1976, DEV BIOL, V49, P369, DOI 10.1016/0012-1606(76)90181-0; Hallock KJ, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.1001; Hart AG, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.5; HENSON H, 1946, BIOL REV, V21, P1, DOI 10.1111/j.1469-185X.1946.tb00449.x; Henson H, 1929, Q J MICROSC SCI, V73, P87; Ihara F, 2008, JPN J APPL ENTOMOL Z, V52, P123, DOI 10.1303/jjaez.2008.123; Jasanoff A, 2002, J MAGN RESON, V158, P79, DOI 10.1016/S1090-7807(02)00063-0; JUDY K, 1970, J MORPHOL, V131, P277, DOI 10.1002/jmor.1051310304; JUDY KJ, 1969, ANN ENTOMOL SOC AM, V62, P1438, DOI 10.1093/aesa/62.6.1438; Kaneko J, 2010, APPL ENTOMOL ZOOL, V45, P253, DOI 10.1303/aez.2010.253; Kayser H, 2006, ARCH BIOCHEM BIOPHYS, V453, P179, DOI 10.1016/j.abb.2006.07.001; Konig H, 2006, J APPL MICROBIOL, V101, P620, DOI 10.1111/j.1365-2672.2006.02914.x; LEVENBOOK L, 1971, J INSECT PHYSIOL, V17, P1321, DOI 10.1016/0022-1910(71)90197-1; Lowe Tristan, 2013, Journal of the Royal Society Interface, V10, P1; Mapelli M, 1997, MAGN RESON IMAGING, V15, P693, DOI 10.1016/S0730-725X(97)00006-4; Meme S, 2013, MAGN RESON IMAGING, V31, P109, DOI 10.1016/j.mri.2012.06.019; Michaelis T, 2005, NEUROIMAGE, V24, P596, DOI 10.1016/j.neuroimage.2004.08.048; Mietchen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003826; Null B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002817; Peterson Alvah, 1912, Annals of the Entomological Society of America, V5; Plotkin Marian, 2006, Physiological Chemistry and Physics and Medical NMR, V38, P43; Reynolds S, 2013, ENDOCRINE SYSTEM, P675; RIDDIFORD LM, 1976, NATURE, V259, P115, DOI 10.1038/259115a0; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; RUSSELL VW, 1991, ARCH INSECT BIOCHEM, V17, P67, DOI 10.1002/arch.940170202; RYERSE JS, 1992, TISSUE CELL, V24, P751, DOI 10.1016/0040-8166(92)90047-B; Sehnal F., 1996, P55; SKIBBE U, 1995, MAGN RESON IMAGING, V13, P471, DOI 10.1016/0730-725X(94)00116-K; Stringer Richard P., 2000, Metamorphosis, V11, P132; Suzuki T, 2010, PESTIC BIOCHEM PHYS, V97, P199, DOI 10.1016/j.pestbp.2010.01.005; Suzuki T, 2009, J INSECT PHYSIOL, V55, P250, DOI 10.1016/j.jinsphys.2008.11.014; Tomanek B, 1996, J APICULT RES, V35, P3, DOI 10.1080/00218839.1996.11100907; WAKU Y, 1971, TISSUE CELL, V3, P127, DOI 10.1016/S0040-8166(71)80035-6; WARREN JT, 1986, INSECT BIOCHEM, V16, P65, DOI 10.1016/0020-1790(86)90080-6; Watanabe T, 2006, J NEUROSCI METH, V158, P50, DOI 10.1016/j.jneumeth.2006.05.012; Wecker S, 2002, MAGN RESON IMAGING, V20, P105, DOI 10.1016/S0730-725X(01)00445-3; Young JK, 2003, MOL CELL ENDOCRINOL, V208, P41, DOI 10.1016/S0303-7207(03)00259-4	59	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157124	10.1371/journal.pone.0157124	http://dx.doi.org/10.1371/journal.pone.0157124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280776	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000089
J	Andrew, ME; Ruthrof, KX; Matusick, G; Hardy, GES				Andrew, Margaret E.; Ruthrof, Katinka X.; Matusick, George; Hardy, Giles E. St. J.			Spatial Configuration of Drought Disturbance and Forest Gap Creation across Environmental Gradients	PLOS ONE			English	Article							INDUCED TREE MORTALITY; DIE-OFF; CANOPY GAPS; DYNAMICS; PATTERNS; VEGETATION; RECOVERY; DIEBACK; SENSITIVITY; LANDSCAPE	Climate change is increasing the risk of drought to forested ecosystems. Although drought impacts are often anecdotally noted to occur in discrete patches of high canopy mortality, the landscape effects of drought disturbances have received virtually no study. This study characterized the landscape configuration of drought impact patches and investigated the relationships between patch characteristics, as indicators of drought impact intensity, and environmental gradients related to water availability to determine factors influencing drought vulnerability. Drought impact patches were delineated from aerial surveys following an extreme drought in 2011 in southwestern Australia, which led to patchy canopy dieback of the Northern Jarrah Forest, a Mediterranean forest ecosystem. On average, forest gaps produced by drought-induced dieback were moderate in size (6.6 +/- 9.7 ha, max = 85.7 ha), compact in shape, and relatively isolated from each other at the scale of several kilometers. However, there was considerable spatial variation in the size, shape, and clustering of forest gaps. Drought impact patches were larger and more densely clustered in xeric areas, with significant relationships observed with topographic wetness index, meteorological variables, and stand height. Drought impact patch clustering was more strongly associated with the environmental factors assessed (R-2 = 0.32) than was patch size (R-2 = 0.21); variation in patch shape remained largely unexplained (R-2 = 0.02). There is evidence that the xeric areas with more intense drought impacts are ` chronic disturbance patches' susceptible to recurrent drought disturbance. The spatial configuration of drought disturbances is likely to influence ecological processes including forest recovery and interacting disturbances such as fire. Regime shifts to an alternate, non-forested ecosystem may occur preferentially in areas with large or clustered drought impact patches. Improved understanding of drought impacts and their patterning in space and time will expand our knowledge of forest ecosystems and landscape processes, informing management of these dynamic systems in an uncertain future.	[Andrew, Margaret E.; Ruthrof, Katinka X.; Hardy, Giles E. St. J.] Murdoch Univ, Sch Vet & Life Sci, Environm & Conservat Sci, Murdoch, WA 6150, Australia; [Ruthrof, Katinka X.; Matusick, George; Hardy, Giles E. St. J.] Murdoch Univ, Ctr Excellence Climate Change Woodland & Forest H, Murdoch, WA 6150, Australia; [Matusick, George] Nature Conservancy, Georgia Chapter, Ft Benning, GA 31905 USA	Murdoch University; Murdoch University; Nature Conservancy	Andrew, ME (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Environm & Conservat Sci, Murdoch, WA 6150, Australia.	m.andrew@murdoch.edu.au		Andrew, Margaret/0000-0003-3285-3684; Ruthrof, Katinka/0000-0003-2038-2264; Hardy, Giles/0000-0001-7419-5064	State Centre of Excellence for Climate Change, Woodland and Forest Health, a partnership between private industry, community groups, Universities; Government of Western Australia	State Centre of Excellence for Climate Change, Woodland and Forest Health, a partnership between private industry, community groups, Universities; Government of Western Australia	The authors received no specific funding for this work. It analyzed pre-existing data, the development of which was funded by the State Centre of Excellence for Climate Change, Woodland and Forest Health, a partnership between private industry, community groups, Universities, and the Government of Western Australia.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Angelini C, 2012, ECOLOGY, V93, P101, DOI 10.1890/11-0557.1; [Anonymous], 2011, 1 2 SRTM DERIVED DIG; [Anonymous], 2011, MODIS VEGETATION CON; Asner GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060875; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P301, DOI 10.1016/0378-1127(94)90115-5; Bailey RM, 2011, P ROY SOC B-BIOL SCI, V278, P1064, DOI 10.1098/rspb.2010.1750; Bates BC, 2008, CLIMATIC CHANGE, V89, P339, DOI 10.1007/s10584-007-9390-9; Bennett JM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1238, DOI 10.1111/geb.12083; Blackburn GA, 2014, J VEG SCI, V25, P1341, DOI 10.1111/jvs.12201; Bowker MA, 2012, J ARID ENVIRON, V76, P9, DOI 10.1016/j.jaridenv.2011.08.012; Boyd DS, 2013, ECOL APPL, V23, P1588, DOI 10.1890/12-0371.1; Bradshaw F. J., 1999, Australian Forestry, V62, P255; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brouwers NC, 2015, FORESTRY, V88, P454, DOI 10.1093/forestry/cpv014; Brouwers N, 2013, LANDSCAPE ECOL, V28, P69, DOI 10.1007/s10980-012-9815-3; Burrows ND, 2008, FOREST ECOL MANAG, V255, P2394, DOI 10.1016/j.foreco.2008.01.009; Burrows N. D., 1995, Australian Forestry, V58, P7; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CLINTON BD, 1993, ECOLOGY, V74, P1551, DOI 10.2307/1940082; Collins BM, 2007, LANDSCAPE ECOL, V22, P545, DOI 10.1007/s10980-006-9047-5; Collins BM, 2010, LANDSCAPE ECOL, V25, P927, DOI 10.1007/s10980-010-9470-5; Croton JT, 2014, SUSTAINABLE FOREST M; Curzon MT, 2010, CAN J FOREST RES, V40, P13, DOI 10.1139/X09-157; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Fensham RJ, 2007, J VEG SCI, V18, P71, DOI 10.1111/j.1654-1103.2007.tb02517.x; Fensham RJ, 1999, J APPL ECOL, V36, P1035, DOI 10.1046/j.1365-2664.1999.00460.x; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Gallant J, 2012, DATA COLLECTION, DOI [10.4225/08/50A9DF3968422, DOI 10.4225/08/50A9DF3968422]; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; Greenwood DL, 2008, FOREST ECOL MANAG, V255, P2129, DOI 10.1016/j.foreco.2007.12.048; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; Hartmann H, 2011, GLOBAL CHANGE BIOL, V17, P642, DOI 10.1111/j.1365-2486.2010.02248.x; Hessburg PF, 1999, ECOL APPL, V9, P1232, DOI 10.1890/1051-0761(1999)009[1232:DCIFSP]2.0.CO;2; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Hughes JD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050797; Hytteborn H, 2014, J VEG SCI, V25, P100, DOI 10.1111/jvs.12057; *IOCI, 2002, CLIM VAR CHANG S W W; Lozano FJ, 2012, INT J WILDLAND FIRE, V21, P666, DOI 10.1071/WF10072; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Suarez ML, 2010, J ECOL, V98, P1023, DOI 10.1111/j.1365-2745.2010.01698.x; Laurance WF, 2011, BIOL CONSERV, V144, P1472, DOI 10.1016/j.biocon.2011.01.016; Lloret F, 2004, GLOBAL CHANGE BIOL, V10, P2092, DOI 10.1111/j.1365-2486.2004.00870.x; MacGregor SD, 2002, AUSTRAL ECOL, V27, P385, DOI 10.1046/j.1442-9993.2002.01192.x; Matusick G, 2012, OPEN J FOR, V2, P183; Matusick G, 2016, J VEG SCI, V27, P493, DOI 10.1111/jvs.12378; Matusick G, 2014, TREES-STRUCT FUNCT, V28, P1449, DOI 10.1007/s00468-014-1048-4; Matusick G, 2013, EUR J FOREST RES, V132, P497, DOI 10.1007/s10342-013-0690-5; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2006, ECOL APPL, V16, P1164, DOI 10.1890/1051-0761(2006)016[1164:HMOPPG]2.0.CO;2; McGarigal K., 1995, SPATIAL PATTERN ANAL; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Miller JD, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00158.1; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; O'Donnell AJ, 2011, J BIOGEOGR, V38, P112, DOI 10.1111/j.1365-2699.2010.02381.x; Olano JM, 2003, FOREST ECOL MANAG, V174, P139, DOI 10.1016/S0378-1127(02)00033-6; Oliver TH, 2013, ECOGRAPHY, V36, P579, DOI 10.1111/j.1600-0587.2012.07665.x; Parisien MA, 2006, INT J WILDLAND FIRE, V15, P361, DOI 10.1071/WF06009; Petrone KC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043102; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Raupach MR, 2009, 3 CTR AUSTR WEATH CL; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Roberts S. L., 2008, Fire Ecology, V4, P83; RUPRECHT JK, 1993, J HYDROL, V150, P369, DOI 10.1016/0022-1694(93)90117-R; Ruthrof KX, 2016, INT J WILDLAND FIRE, V25, P819, DOI 10.1071/WF15028; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schulte LA, 2005, ECOLOGY, V86, P431, DOI 10.1890/03-4065; Shearer BL, 2007, AUST J BOT, V55, P225, DOI 10.1071/BT06019; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Starzomski BM, 2007, OIKOS, V116, P690, DOI 10.1111/j.2007.0030-1299.15547.x; Suarez ML, 2004, J ECOL, V92, P954, DOI 10.1111/j.1365-2745.2004.00941.x; Torimaru T, 2012, FOREST ECOL MANAG, V284, P1, DOI 10.1016/j.foreco.2012.07.044; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Turner MG, 1997, ECOL MONOGR, V67, P411, DOI 10.1890/0012-9615(1997)067[0411:EOFSAP]2.0.CO;2; Twidwell D, 2014, APPL VEG SCI, V17, P42, DOI 10.1111/avsc.12044; Vepakomma U, 2012, J ECOL, V100, P1257, DOI 10.1111/j.1365-2745.2012.01996.x; Vesk PA, 2004, J ECOL, V92, P310, DOI 10.1111/j.0022-0477.2004.00871.x; Wang WF, 2012, ENVIRON REV, V20, P109, DOI [10.1139/A2012-004, 10.1139/a2012-004]; Western Australia Climate Services Center, 2010, VER DRY YEAR SO FAR; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Williams K., 2001, BIODIVERSITY AUDIT W, P369; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; Worrall JJ, 2005, J ECOL, V93, P178, DOI 10.1111/j.1365-2745.2004.00937.x	92	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157154	10.1371/journal.pone.0157154	http://dx.doi.org/10.1371/journal.pone.0157154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275744	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561700076
J	Bicart-See, A; Rottman, M; Cartwright, M; Seiler, B; Gamini, N; Rodas, M; Penary, M; Giordano, G; Oswald, E; Super, M; Ingber, DE				Bicart-See, A.; Rottman, M.; Cartwright, M.; Seiler, B.; Gamini, N.; Rodas, M.; Penary, M.; Giordano, G.; Oswald, E.; Super, M.; Ingber, D. E.			Rapid Isolation of Staphylococcus aureus Pathogens from Infected Clinical Samples Using Magnetic Beads Coated with Fc-Mannose Binding Lectin	PLOS ONE			English	Article							COMPLEMENT-MEDIATED OPSONOPHAGOCYTOSIS; INNATE IMMUNITY; SYNOVIAL-FLUID; PROTEIN-A; ACID; DIAGNOSIS; BACTERIA; THERAPY; ASSAY	Here we describe how Staphylococcus aureus bacteria can be rapidly isolated from clinical samples of articular fluid and synovial tissue using magnetic beads coated with the engineered chimeric human opsonin protein, Fc-mannose-binding lectin (FcMBL). The FcMBL-beads were used to capture and magnetically remove bacteria from purified cultures of 12 S. aureus strains, and from 8 articular fluid samples and 4 synovial tissue samples collected from patients with osteoarthritis or periprosthetic infections previously documented by positive S. aureus cultures. While the capture efficiency was high (85%) with purified S. aureus strains grown in vitro, direct FcMBL-bead capture from the clinical samples was initially disappointing (< 5% efficiency). Further analysis revealed that inhibition of FcMBL binding was due to coating of the bacteria by immunoglobulins and immune cells that masked FcMBL binding sites, and to the high viscosity of these complex biological samples. Importantly, capture of pathogens using the FcMBL-beads was increased to 76% efficiency by pretreating clinical specimens with hypotonic washes, hyaluronidase and a protease cocktail. Using this approach, S. aureus bacteria could be isolated from infected osteoarthritic tissues within 2 hours after sample collection. This FcMBL-enabled magnetic method for rapid capture and concentration of pathogens from clinical samples could be integrated upstream of current processes used in clinical microbiology laboratories to identify pathogens and perform antibiotic sensitivity testing when bacterial culture is not possible or before colonies can be detected.	[Bicart-See, A.; Rottman, M.; Cartwright, M.; Seiler, B.; Gamini, N.; Rodas, M.; Super, M.; Ingber, D. E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Bicart-See, A.; Giordano, G.] Hosp Joseph Ducuing, Toulouse, France; [Rottman, M.] Univ Versailles, St Quentin en Yvelines, France; [Penary, M.; Oswald, E.] INSERM 1043, Toulouse, France; [Ingber, D. E.] Harvard Univ, Sch Med, Boston, MA USA; [Ingber, D. E.] Boston Childrens Hosp, Boston, MA USA; [Ingber, D. E.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Boston, MA USA.; Ingber, DE (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	don.ingber@wyss.harvard.edu	Rottman, Martin/AAD-9075-2021; Ingber, Donald E/AAC-5894-2019; Super, Michael/AAW-7952-2021; Rottman, Martin/I-3005-2012	Rottman, Martin/0000-0001-5953-3344; Oswald, Eric/0000-0002-3017-0081	Defense Advanced Research Projects Agency (DARPA) [N66001-11-1-4180]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by grants N66001-11-1-4180 from the Defense Advanced Research Projects Agency (DARPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEUNG AL, 1987, INFECT IMMUN, V55, P843, DOI 10.1128/IAI.55.4.843-847.1987; CHEUNG AL, 1988, INFECT IMMUN, V56, P1061, DOI 10.1128/IAI.56.5.1061-1065.1988; de Prost N, 2013, CRIT CARE, V17, DOI 10.1186/cc13022; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Didar TF, 2015, BIOMATERIALS, V67, P382, DOI 10.1016/j.biomaterials.2015.07.046; Douglas IS, 2015, AM J RESP CRIT CARE, V191, P566, DOI 10.1164/rccm.201408-1468OC; Dubouix-Bourandy A, 2011, J CLIN MICROBIOL, V49, P4225, DOI 10.1128/JCM.00334-11; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Guenther LE, 2014, P I MECH ENG H, V228, P127, DOI 10.1177/0954411913517880; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Jayadev C, 2012, J IMMUNOL METHODS, V386, P22, DOI 10.1016/j.jim.2012.08.012; Jung DJ, 2012, J IMMUNOL, V189, P4951, DOI 10.4049/jimmunol.1201294; Kang JH, 2014, NAT MED, V20, P1211, DOI 10.1038/nm.3640; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Kurokawa K, 2013, J BIOL CHEM, V288, P30956, DOI 10.1074/jbc.M113.509893; Lee W, 2014, ANAL CHEM, V86, P6683, DOI 10.1021/ac501436d; LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Michelow IC, 2011, J INFECT DIS, V203, P175, DOI 10.1093/infdis/jiq025; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Roux AL, 2011, CLIN MICROBIOL INFEC, V17, P447, DOI 10.1111/j.1469-0691.2010.03359.x; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; SUPER M, 1989, LANCET, V2, P1236; Takahashi K, 2005, CLIN INFECT DIS, V41, pS440, DOI 10.1086/431987; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588	25	21	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156287	10.1371/journal.pone.0156287	http://dx.doi.org/10.1371/journal.pone.0156287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275840	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561700021
J	Fekri, F; Delos Santos, RC; Karshafian, R; Antonescu, CN				Fekri, Farnaz; Delos Santos, Ralph Christian; Karshafian, Raffi; Antonescu, Costin N.			Ultrasound Microbubble Treatment Enhances Clathrin-Mediated Endocytosis and Fluid-Phase Uptake through Distinct Mechanisms	PLOS ONE			English	Article							PLASMA-MEMBRANE REPAIR; DRUG-DELIVERY; EXOCYTOSIS; CERAMIDE; GROWTH; SPHINGOMYELINASE; PRESSURE; DYNAMIN; SYSTEM; TUMORS	Drug delivery to tumors is limited by several factors, including drug permeability of the target cell plasma membrane. Ultrasound in combination with microbubbles (USMB) is a promising strategy to overcome these limitations. USMB treatment elicits enhanced cellular uptake of materials such as drugs, in part as a result of sheer stress and formation of transient membrane pores. Pores formed upon USMB treatment are rapidly resealed, suggesting that other processes such as enhanced endocytosis may contribute to the enhanced material uptake by cells upon USMB treatment. How USMB regulates endocytic processes remains incompletely understood. Cells constitutively utilize several distinct mechanisms of endocytosis, including clathrin-mediated endocytosis (CME) for the internalization of receptor-bound macromolecules such as Transferrin Receptor (TfR), and distinct mechanism(s) that mediate the majority of fluid-phase endocytosis. Tracking the abundance of TfR on the cell surface and the internalization of its ligand transferrin revealed that USMB acutely enhances the rate of CME. Total internal reflection fluorescence microscopy experiments revealed that USMB treatment altered the assembly of clathrin-coated pits, the basic structural units of CME. In addition, the rate of fluid-phase endocytosis was enhanced, but with delayed onset upon USMB treatment relative to the enhancement of CME, suggesting that the two processes are distinctly regulated by USMB. Indeed, vacuolin-1 or desipramine treatment prevented the enhancement of CME but not of fluid phase endocytosis upon USMB, suggesting that lysosome exocytosis and acid sphingomyelinase, respectively, are required for the regulation of CME but not fluid phase endocytosis upon USMB treatment. These results indicate that USMB enhances both CME and fluid phase endocytosis through distinct signaling mechanisms, and suggest that strategies for potentiating the enhancement of endocytosis upon USMB treatment may improve targeted drug delivery.	[Fekri, Farnaz; Delos Santos, Ralph Christian; Antonescu, Costin N.] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Karshafian, Raffi] Ryerson Univ, Dept Med Phys, Toronto, ON, Canada; [Fekri, Farnaz; Delos Santos, Ralph Christian; Karshafian, Raffi; Antonescu, Costin N.] Ryerson Univ, Grad Program Mol Sci, Toronto, ON, Canada; [Karshafian, Raffi] Inst Biomed Engn Sci & Technol, Toronto, ON, Canada; [Karshafian, Raffi; Antonescu, Costin N.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada	Toronto Metropolitan University; Toronto Metropolitan University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Antonescu, CN (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.; Karshafian, R (corresponding author), Ryerson Univ, Dept Med Phys, Toronto, ON, Canada.; Karshafian, R; Antonescu, CN (corresponding author), Ryerson Univ, Grad Program Mol Sci, Toronto, ON, Canada.; Karshafian, R (corresponding author), Inst Biomed Engn Sci & Technol, Toronto, ON, Canada.; Karshafian, R; Antonescu, CN (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	karshafian@ryerson.ca; cantonescu@ryerson.ca		Antonescu, Costin/0000-0001-9192-6340	Canadian Institutes of Health Research (CIHR) [125854]; Natural Sciences and Engineering Research Council (of Canada); Canadian Institutes of Health Research [125854]; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funded by Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca/e/193.html), an Operating Grant to CNA (grant number 125854), and Natural Sciences and Engineering Research Council (of Canada), a Discovery Grant to R.K. (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided by an Operating Grant from the Canadian Institutes of Health Research to C.N.A. (grant no. 125854) and by a Discovery Grant from the Natural Sciences and Engineering Research Council to R.K.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Antonescu CN, 2013, COLD SPRING IN PRESS; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen H, 2013, J THER ULTRASOUND, V1, DOI 10.1186/2050-5736-1-10; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Czarnota GJ, 2012, P NATL ACAD SCI USA, V109, pE2033, DOI 10.1073/pnas.1200053109; De Cock I, 2015, J CONTROL RELEASE, V197, P20, DOI 10.1016/j.jconrel.2014.10.031; Derieppe M, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/046010; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Garay C, 2015, MOL BIOL CELL, V26, P3504, DOI 10.1091/mbc.E14-09-1412; Goertz DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052307; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Hilgemann DW, 2013, ELIFE, V2, DOI 10.7554/eLife.01293; Hilgemann DW, 2011, J GEN PHYSIOL, V137, P155, DOI 10.1085/jgp.201010470; Ho CM, 2005, CELL SIGNAL, V17, P837, DOI 10.1016/j.cellsig.2004.11.005; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Holopainen JM, 1997, CHEM PHYS LIPIDS, V88, P1, DOI 10.1016/S0009-3084(97)00040-6; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Ibsen S, 2013, ULTRASONICS, V53, P178, DOI 10.1016/j.ultras.2012.05.006; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; Johnston I, 2008, BBA-BIOMEMBRANES, V1778, P185, DOI 10.1016/j.bbamem.2007.09.021; Karshafian R, 2010, ULTRASONICS, V50, P691, DOI 10.1016/j.ultras.2010.01.009; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Kiessling F, 2012, J NUCL MED, V53, P345, DOI 10.2967/jnumed.111.099754; Kim HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102343; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Loerke D, 2011, TRAFFIC; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meijering BDM, 2009, CIRC RES, V104, P679, DOI 10.1161/CIRCRESAHA.108.183806; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Nomikou N, 2010, CANCER LETT, V288, P94, DOI 10.1016/j.canlet.2009.06.028; Pakkanen K, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046004; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ross E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128013; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaughnessy R, 2014, FEBS J, V281, P2172, DOI 10.1111/febs.12770; Silva L, 2006, MOL MEMBR BIOL, V23, P137, DOI 10.1080/09687860500439474; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sot J, 2005, BIOPHYS J, V88, P3368, DOI 10.1529/biophysj.104.057851; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Tardoski S, 2015, ULTRASOUND MED BIOL, V41, P2740, DOI 10.1016/j.ultrasmedbio.2015.06.006; Todorova M, 2013, INT J CANCER, V132, P2956, DOI 10.1002/ijc.27977; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yang F, 2008, J CONTROL RELEASE, V131, P205, DOI 10.1016/j.jconrel.2008.07.038; Zeghimi A, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066007	64	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156754	10.1371/journal.pone.0156754	http://dx.doi.org/10.1371/journal.pone.0156754			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275866	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561700035
J	Pinkenburg, O; Meyer, T; Bannert, N; Norley, S; Bolte, K; Czudai-Matwich, V; Herold, S; Gessner, A; Schnare, M				Pinkenburg, Olaf; Meyer, Torben; Bannert, Norbert; Norley, Steven; Bolte, Kathrin; Czudai-Matwich, Volker; Herold, Susanne; Gessner, Andre; Schnare, Markus			The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; HUMAN ALPHA-DEFENSINS; REPLICATION; MECHANISMS; LL-37; SUBTYPES; PEPTIDE	In addition to their well-known antibacterial activity some antimicrobial peptides and proteins (AMPs) display also antiviral effects. A 27 aa peptide from the N-terminal part of human bactericidal/permeability-increasing protein (BPI) previously shown to harbour antibacterial activity inhibits the infectivity of multiple Influenza A virus strains (H1N1, H3N2 and H5N1) the causing agent of the Influenza pneumonia. In contrast, the homologous murine BPI-peptide did not show activity against Influenza A virus. In addition human BPI-peptide inhibits the activation of immune cells mediated by Influenza A virus. By changing the human BPI-peptide to the sequence of the mouse homologous peptide the antiviral activity was completely abolished. Furthermore, the human BPI-peptide also inhibited the pathogenicity of the Vesicular Stomatitis Virus but failed to interfere with HIV and measles virus. Electron microscopy indicate that the human BPI-peptide interferes with the virus envelope and at high concentrations was able to destroy the particles completely.	[Pinkenburg, Olaf; Meyer, Torben; Schnare, Markus] Univ Marburg, Inst Immunol, Robert Koch Str 17, D-35032 Marburg, Germany; [Bannert, Norbert; Norley, Steven] Robert Koch Inst, Dept HIV & Other Retroviruses, Berlin, Germany; [Bolte, Kathrin] Univ Marburg, Cell Biol Lab, Marburg, Germany; [Czudai-Matwich, Volker] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Herold, Susanne] Univ Giessen, Dept Internal Med 2, Lung Ctr, D-35390 Giessen, Germany; [Herold, Susanne] German Ctr Lung Res, Giessen, Germany; [Gessner, Andre] Univ Regensburg, Inst Clin Microbiol & Hyg, D-93053 Regensburg, Germany	Philipps University Marburg; Robert Koch Institute; Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; University of Regensburg	Schnare, M (corresponding author), Univ Marburg, Inst Immunol, Robert Koch Str 17, D-35032 Marburg, Germany.	markus.schnare@staff.uni-marburg.de		Herold, Susanne/0000-0001-6343-0911	DFG [SCHN635/4-1]; von-Behring-Rontgen Stiftung Giessen and Marburg [61-0053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); von-Behring-Rontgen Stiftung Giessen and Marburg; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by DFG grant SCHN635/4-1 (http://www.dfg.de), von-Behring-Rontgen Stiftung Giessen and Marburg (grant number 61-0053 to MS)(http://www.br-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele D, 2006, INFECT IMMUN, V74, P4708, DOI 10.1128/IAI.02066-05; AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Benincasa M, 2003, PEPTIDES, V24, P1723, DOI 10.1016/j.peptides.2003.07.025; Bergman P, 2007, CURR HIV RES, V5, P410; Bingle CD, 2011, BIOCHEM SOC T, V39, P961, DOI 10.1042/BST0390961; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10311, DOI 10.1021/bi970177e; Wittmann I, 2008, J IMMUNOL, V180, P7546, DOI 10.4049/jimmunol.180.11.7546; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; YEWDELL JW, 1981, ANNU REV MICROBIOL, V35, P185, DOI 10.1146/annurev.mi.35.100181.001153	32	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156929	10.1371/journal.pone.0156929	http://dx.doi.org/10.1371/journal.pone.0156929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27273104	Green Submitted, Green Published, gold			2022-12-26	WOS:000377560200026
J	Ghadakzadeh, S; Kannu, P; Whetstone, H; Howard, A; Alman, BA				Ghadakzadeh, Saber; Kannu, Peter; Whetstone, Heather; Howard, Andrew; Alman, Benjamin A.			beta-Catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications	FASEB JOURNAL			English	Article						neurofibromin; Wnt signaling; tibial congenital pseudarthrosis; osteoblast differentiation; fracture nonunion	EMBRYONIC STEM-CELLS; CONGENITAL PSEUDOARTHROSIS; TGF-BETA; OSTEOBLAST DIFFERENTIATION; MURINE MODEL; FRACTURE REPAIR; MINERAL DENSITY; MOUSE MODEL; NF1; WNT	Tibial pseudarthrosis causes substantial morbidity in patients with neurofibromatosis type 1 (NF1). We studied tibial pseudarthrosis tissue from patients with NF1 and found elevated levels of -catenin compared to unaffected bone. To elucidate the role of -catenin in fracture healing, we used a surgically induced tibial fracture model in conditional knockout (KO) Nfl (Nf1(flox/flox)) mice. When treated with a Cre-expressing adenovirus (Ad-Cre), there was a localized knockdown of Nf1 in the healing fracture and a subsequent development of a fibrous pseudarthrosis. Consistent with human data, elevated -catenin levels were found in the murine fracture sites. The increased fibrous tissue at the fracture site was rescued by local treatment with a Wingless-type MMTV integration site (Wnt) antagonist, Dickkopf-1 (Dkk1). The murine pseudarthrosis phenotype was also rescued by conditional -catenin gene inactivation. The number of colony-forming unit osteoblasts (CFU-Os), a surrogate marker of undifferentiated mesenchymal cells able to differentiate to osteoblasts, correlated with the capacity to form bone at the fracture site. Our findings indicate that the protein level of -catenin must be precisely regulated for normal osteoblast differentiation. An up-regulation of -catenin in NF1 causes a shift away from osteoblastic differentiation resulting in a pseudarthrosis in vivo. These results support the notion that pharmacological modulation of -catenin can be used to treat pseudarthrosis in patients with NF1.Ghadakzadeh, S., Kannu, P., Whetstone, H., Howard A., Alman, B. A. -catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications.	[Ghadakzadeh, Saber; Kannu, Peter; Whetstone, Heather; Alman, Benjamin A.] Univ Toronto, Div Dev & Stem Cell Biol, Toronto, ON, Canada; [Ghadakzadeh, Saber; Kannu, Peter; Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kannu, Peter; Howard, Andrew] Hosp Sick Children, Bone Hlth Ctr, Toronto, ON, Canada; [Howard, Andrew] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON, Canada; [Alman, Benjamin A.] Duke Univ, Dept Orthopaed Surg, Durham, NC 27710 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Duke University	Alman, BA (corresponding author), Duke Univ, Dept Orthopaed Surg, Durham, NC 27710 USA.	ben.alman@duke.edu		Howard, Andrew/0000-0001-7226-6471	U.S. Army Medical Research Acquisition Activity [W81XWH-13-1-0113]	U.S. Army Medical Research Acquisition Activity	The authors thank the families involved in this study and the NF Society of Ontario (NFSO) for their kind contribution and participation. This study was funded by Grant W81XWH-13-1-0113 from the U.S. Army Medical Research Acquisition Activity. Author contributions: S. Ghadakzadeh and B. A. Alman designed the study; S. Ghadakzadeh and H. Whetstone performed the research; and S. Ghadakzadeh, P. Kannu, A. Howard, and B. A. Alman analyzed the data and wrote the paper. The authors declare no conflicts of interest.	Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Birke O, 2010, J CHILD ORTHOP, V4, P507, DOI 10.1007/s11832-010-0293-3; Brault V, 2001, DEVELOPMENT, V128, P1253; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cho TJ, 2008, J BONE JOINT SURG AM, V90A, P2735, DOI 10.2106/JBJS.H.00014; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dulai S, 2007, J PEDIATR ORTHOPED, V27, P472, DOI 10.1097/01.bpb.0000271310.87997.ae; El Khassawna T, 2012, BONE, V51, P651, DOI 10.1016/j.bone.2012.07.011; El-Hoss J, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00862; El-Hoss J, 2012, J BONE MINER RES, V27, P68, DOI 10.1002/jbmr.528; Elefteriou F, 2009, AM J MED GENET A, V149A, P2327, DOI 10.1002/ajmg.a.33045; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heerva E, 2012, BONE, V50, P798, DOI 10.1016/j.bone.2011.12.011; Heerva E, 2010, BONE, V47, P583, DOI 10.1016/j.bone.2010.06.001; Ippolito E, 2000, J PEDIATR ORTHOP B, V9, P3, DOI 10.1097/01202412-200001000-00002; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Johnston CE, 2002, J BONE JOINT SURG AM, V84A, P1799, DOI 10.2106/00004623-200210000-00010; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Kuorilehto T, 2004, J BONE MINER RES, V19, P983, DOI 10.1359/JBMR.040130; Kuorilehto T, 2005, OSTEOPOROSIS INT, V16, P928, DOI 10.1007/s00198-004-1801-4; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Lee DY, 2011, CLIN ORTHOP SURG, V3, P230, DOI 10.4055/cios.2011.3.3.230; Lee SM, 2012, J ORTHOP RES, V30, P1535, DOI 10.1002/jor.22121; Lemieux E, 2015, ONCOGENE, V34, P4914, DOI 10.1038/onc.2014.416; Leskela HV, 2009, BONE, V44, P243, DOI 10.1016/j.bone.2008.10.050; Li HM, 2009, PEDIATR RES, V65, P613, DOI 10.1203/PDR.0b013e3181a1c607; Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; PARFITT AM, 1988, BONE MINER, V4, P1; Paria N, 2014, J BONE MINER RES, V29, P2636, DOI 10.1002/jbmr.2298; Rhodes SD, 2013, J BONE MINER RES, V28, P2476, DOI 10.1002/jbmr.1992; Rosa Adalberto Luiz, 2005, Braz. Dent. J., V16, P225, DOI 10.1590/S0103-64402005000300010; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schindeler A, 2011, J BONE JOINT SURG BR, V93B, P1134, DOI 10.1302/0301-620X.93B8.25940; Schindeler A, 2008, BONE, V42, P616, DOI 10.1016/j.bone.2007.11.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Sharma R, 2013, HUM MOL GENET, V22, P4818, DOI 10.1093/hmg/ddt333; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Stevenson DA, 2011, CLIN GENET, V80, P566, DOI 10.1111/j.1399-0004.2010.01619.x; Theos A, 2006, ANN INTERN MED, V144, P842, DOI 10.7326/0003-4819-144-11-200606060-00010; van den Bosch MH, 2014, CELL SIGNAL, V26, P951, DOI 10.1016/j.cellsig.2014.01.021; Wang WX, 2010, J BONE MINER RES, V25, P1658, DOI 10.1002/jbmr.42; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Weivoda MM, 2016, J BONE MINER RES, V31, P65, DOI 10.1002/jbmr.2599; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yan JC, 2008, HUM MOL GENET, V17, P936, DOI 10.1093/hmg/ddm366; Yang FC, 2006, J CLIN INVEST, V116, P2880, DOI 10.1172/JCI29092; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	59	11	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3227	3237		10.1096/fj.201500190RR	http://dx.doi.org/10.1096/fj.201500190RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27306335				2022-12-26	WOS:000382816300022
J	Rossing, K; Bosselmann, HS; Gustafsson, F; Zhang, ZY; Gu, YM; Kuznetsova, T; Nkuipou-Kenfack, E; Mischak, H; Staessen, JA; Koeck, T; Schou, M				Rossing, Kasper; Bosselmann, Helle Skovmand; Gustafsson, Finn; Zhang, Zhen-Yu; Gu, Yu-Mei; Kuznetsova, Tatiana; Nkuipou-Kenfack, Esther; Mischak, Harald; Staessen, Jan A.; Koeck, Thomas; Schou, Morten			Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MASS-SPECTROMETRY; PROGNOSTIC-SIGNIFICANCE; CLINICAL PROTEOMICS; DIASTOLIC FUNCTION; BLOOD-PRESSURE; FOLLOW-UP; MS; OUTPATIENTS; DYSFUNCTION	Background Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection fraction (HFrEF) may emerge from recent advances in high-throughput urinary proteomics. This could lead to improved diagnosis, risk stratification and management of HFrEF. Methods and Results Urine samples were analyzed by on-line capillary electrophoresis coupled to electrospray ionization micro time-of-flight mass spectrometry (CE-MS) to generate individual urinary proteome profiles. In an initial biomarker discovery cohort, analysis of urinary proteome profiles from 33 HFrEF patients and 29 age- and sex-matched individuals without HFrEF resulted in identification of 103 peptides that were significantly differentially excreted in HFrEF. These 103 peptides were used to establish the support vector machine-based HFrEF classifier HFrEF103. In a subsequent validation cohort, HFrEF103 very accurately (area under the curve, AUC = 0.972) discriminated between HFrEF patients (N = 94, sensitivity = 93.6%) and control individuals with and without impaired renal function and hypertension ( N = 552, specificity = 92.9%). Interestingly, HFrEF103 showed low sensitivity (12.6%) in individuals with diastolic left ventricular dysfunction (N = 176). The HFrEF-related peptide biomarkers mainly included fragments of fibrillar type I and III collagen but also, e.g., of fibrinogen beta and alpha-1-antitrypsin. Conclusion CE-MS based urine proteome analysis served as a sensitive tool to determine a vast array of HFrEF-related urinary peptide biomarkers which might help improving our understanding and diagnosis of heart failure.	[Rossing, Kasper; Gustafsson, Finn] Univ Copenhagen Hosp, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Bosselmann, Helle Skovmand] Univ Copenhagen, North Zealand Hosp, Dept Cardio Nephro & Endocrinol, Copenhagen, Denmark; [Zhang, Zhen-Yu; Gu, Yu-Mei; Kuznetsova, Tatiana; Staessen, Jan A.] Katholieke Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium; [Nkuipou-Kenfack, Esther; Mischak, Harald; Koeck, Thomas] Mosa Diagnost & Therapeut AG, Hannover, Germany; [Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Schou, Morten] Herlev Hosp, Inst Clin Med, DK-2730 Herlev, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; KU Leuven; University of Glasgow; University of Copenhagen; Herlev & Gentofte Hospital	Rossing, K (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark.	kasper.rossing@regionh.dk	Staessen, Jan A/A-1065-2011; Kuznetsova, Tatiana/ABI-5662-2020; Zhang, Zhenyu/GZL-8479-2022	Staessen, Jan A/0000-0002-3026-1637; Kuznetsova, Tatiana/0000-0003-4293-4576; Zhang, Zhenyu/0000-0002-3785-7417; Mischak, Harald/0000-0003-0323-0306; Gustafsson, Finn/0000-0003-2144-341X	European Union grant EU-MASCARA [HEALTH-2011.2.4.2-2]; Muremester Laurits P Christensens Fund; Kaptajnlojtnant Harald Jensen og Hustrus Fund; Mosaiques Diagnostics GmbH; European Union grant HOMAGE [HEALTH-F7-305507 HOMAGE]	European Union grant EU-MASCARA; Muremester Laurits P Christensens Fund; Kaptajnlojtnant Harald Jensen og Hustrus Fund; Mosaiques Diagnostics GmbH; European Union grant HOMAGE	The funding organization (European Union; grants EU-MASCARA [HEALTH-2011.2.4.2-2] and HOMAGE [HEALTH-F7- 305507 HOMAGE] as well as the Muremester Laurits P Christensens Fund and the Kaptajnlojtnant Harald Jensen og Hustrus Fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support. Harald Mischak, Thomas Koeck and Esther Nkuipou-Kenfack were employed by and received salary from Mosaiques Diagnostics GmbH. Being employed by Mosaiques Diagnostics GmbH did not influence study design, decision to publish or preparation of the manuscript. Urinary proteomic data collection and analysis was performed at Mosaiques Diagnostics GmbH following established standard operating procedures.; The project was partly funded by the European Union grants EU-MASCARA (HEALTH-2011.2.4.2-2) and HOMAGE (HEALTH-F7-305507 HOMAGE) as well as the Murermester Laurits P Christensens Fund and the Kaptajnlojtnant Harald Jensen og Hustrus Fund. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasch E, 2011, CIRC-HEART FAIL, V4, P733, DOI 10.1161/CIRCHEARTFAILURE.111.962027; Barasch E, 2009, CIRC-HEART FAIL, V2, P303, DOI 10.1161/CIRCHEARTFAILURE.108.828343; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosselmann H, 2014, INT J CARDIOL, V177, P942, DOI 10.1016/j.ijcard.2014.09.202; Bosselmann H, 2013, INT J CARDIOL, V170, P202, DOI 10.1016/j.ijcard.2013.10.064; Braam B, 2014, NAT REV NEPHROL, V10, P48, DOI 10.1038/nrneph.2013.250; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; BRILLA CG, 1995, AM J CARDIOL, V76, pD8, DOI 10.1016/S0002-9149(99)80485-8; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; Kuznetsova T, 2012, EUR HEART J, V33, P2342, DOI 10.1093/eurheartj/ehs185; Lemesle G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119265; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lofsjogard J, 2014, J CARDIOVASC MED, V15, P463, DOI 10.2459/01.JCM.0000435617.86180.0b; Lubrano V, 2017, J CARDIOVASC MED, V18, P774, DOI 10.2459/JCM.0000000000000016; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Passino C, 2015, CLIN CHIM ACTA, V443, P29, DOI 10.1016/j.cca.2014.09.006; Pejchinovski M, 2015, PROTEOM CLIN APPL, V9, P453, DOI 10.1002/prca.201400113; Pouleur AC, 2015, CLIN CHIM ACTA, V443, P9, DOI 10.1016/j.cca.2014.10.046; R Core Team, 2018, R LANG ENV STAT COMP; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; STAESSEN J, 1985, J CHRON DIS, V38, P397, DOI 10.1016/0021-9681(85)90135-3; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2005, ELECTROPHORESIS, V26, P2797, DOI 10.1002/elps.200400208; Toprak G, 2013, EUR REV MED PHARMACO, V17, P2302; Valente MAE, 2014, EUR HEART J, V35, P1284, DOI 10.1093/eurheartj/ehu065; Weber KT, 1997, CIRCULATION, V96, P4065; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Wittke S, 2005, ELECTROPHORESIS, V26, P1476, DOI 10.1002/elps.200410140; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014	43	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157167	10.1371/journal.pone.0157167	http://dx.doi.org/10.1371/journal.pone.0157167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308822	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000378029800039
J	Gentile, AM; Lhamyani, S; Coin-Araguez, L; Oliva-Olivera, W; Zayed, H; Vega-Rioja, A; Monteseirin, J; Romero-Zerbo, SY; Tinahones, FJ; Bermudez-Silva, FJ; El Bekay, R				Gentile, Adriana-Mariel; Lhamyani, Said; Coin-Araguez, Leticia; Oliva-Olivera, Wilfredo; Zayed, Hatem; Vega-Rioja, Antonio; Monteseirin, Javier; Romero-Zerbo, Silvana-Yanina; Tinahones, Francisco-Jose; Bermudez-Silva, Francisco-Javier; El Bekay, Rajaa			RPL13A and EEF1A1 Are Suitable Reference Genes for qPCR during Adipocyte Differentiation of Vascular Stromal Cells from Patients with Different BMI and HOMA-IR	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN ADIPOSE-TISSUE; INSULIN-RESISTANCE; STEM-CELLS; HOUSEKEEPING GENES; DATA NORMALIZATION; METABOLIC SYNDROME; LINKING OBESITY; QUANTIFICATION; INFLAMMATION	Real-time or quantitative PCR (qPCR) is a useful technique that requires reliable reference genes for data normalization in gene expression analysis. Adipogenesis is among the biological processes suitable for this technique. The selection of adequate reference genes is essential for qPCR gene expression analysis of human Vascular Stromal Cells (hVSCs) during their differentiation into adipocytes. To the best of our knowledge, there are no studies validating reference genes for the analyses of visceral and subcutaneous adipose tissue hVSCs from subjects with different Body Mass Index (BMI) and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index. The present study was undertaken to analyze this question. We first analyzed the stability of expression of five potential reference genes: CYC, GAPDH, RPL13A, EEF1A1, and 18S ribosomal RNA, during in vitro adipogenic differentiation, in samples from these types of patients. The expression of RPL13A and EEF1A1 was not affected by differentiation, thus being these genes the most stable candidates, while CYC, GAPDH, and 18S were not suitable for this sort of analysis. This work highlights that RPL13A and EEF1A1 are good candidates as reference genes for qPCR analysis of hVSCs differentiation into adipocytes from subjects with different BMI and HOMA-IR.	[Gentile, Adriana-Mariel; Lhamyani, Said] Univ Malaga, IBIMA, Campus Teatinos S-N, Malaga 29010, Spain; [Coin-Araguez, Leticia; Oliva-Olivera, Wilfredo; Tinahones, Francisco-Jose; El Bekay, Rajaa] Carlos III Hlth Inst, CIBER Pathophysiol Obes & Nutr CB06 03, Malaga 29010, Spain; [Coin-Araguez, Leticia; Oliva-Olivera, Wilfredo; Tinahones, Francisco-Jose; El Bekay, Rajaa] Virgen de la Victoria Clin Univ Hosp, Biomed Res Lab, Malaga 29010, Spain; [Zayed, Hatem] Qatar Univ, Program Biomed Sci, Dept Hlth Sci, Coll Arts & Sci, POB 2713, Doha, Qatar; [Vega-Rioja, Antonio; Monteseirin, Javier] Hosp Univ Virgen Macarena, Unidad Gest Clin Alergia Interctr, Seville, Spain; [Romero-Zerbo, Silvana-Yanina; Bermudez-Silva, Francisco-Javier] Univ Malaga, Unidad Gest Clin Interctr Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA, Hosp Reg Univ Malaga, Malaga 29009, Spain; [Romero-Zerbo, Silvana-Yanina; Bermudez-Silva, Francisco-Javier] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Malaga, Spain; [Tinahones, Francisco-Jose] Virgen de la Victoria Clin Univ Hosp, Serv Endocrinol, Malaga 29010, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Qatar University; Hospital Universitario Virgen Macarena; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	El Bekay, R (corresponding author), Carlos III Hlth Inst, CIBER Pathophysiol Obes & Nutr CB06 03, Malaga 29010, Spain.; El Bekay, R (corresponding author), Virgen de la Victoria Clin Univ Hosp, Biomed Res Lab, Malaga 29010, Spain.; Vega-Rioja, A (corresponding author), Hosp Univ Virgen Macarena, Unidad Gest Clin Alergia Interctr, Seville, Spain.; Bermudez-Silva, FJ (corresponding author), Univ Malaga, Unidad Gest Clin Interctr Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA, Hosp Reg Univ Malaga, Malaga 29009, Spain.; Bermudez-Silva, FJ (corresponding author), Ctr Invest Biomed Red Diabet & Enfermedades Metab, Malaga, Spain.	macrofago@us.es; javier.bermudez@ibima.eu; elbekay@gmail.com	Bekay, Rajaa El/AAZ-3959-2020; Zayed, Hatem/R-1800-2019; GENTILE, Adriana Mariel/AAB-3350-2020; Bermudez-Silva, Francisco-Javier/Q-6920-2016; LHAMYANI, said/AAQ-1973-2020; Tinahones, Francisco José/AAB-2882-2020; El Bekay, RAJAA/AGN-6069-2022	Zayed, Hatem/0000-0001-8838-6638; GENTILE, Adriana Mariel/0000-0002-2296-9117; Bermudez-Silva, Francisco-Javier/0000-0003-3133-9691; LHAMYANI, said/0000-0002-9830-9772; El Bekay, RAJAA/0000-0003-3332-3431; Oliva Olivera, Wilfredo/0000-0003-3473-7898; Romero-Zerbo, Silvana-Yanina/0000-0002-6737-992X; Vega Rioja, Antonio/0000-0003-4698-9697; Tinahones, Francisco J/0000-0001-6871-4403	Instituto de Salud Carlos III [PI10/01947, PI13/02628, CPII13/00041]; Fondos FEDER; Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia [CTS-7895]; "Miguel Servet II" research contract [CPII13/00042]; Consejeria de Salud [C-0070-2012]; FIS-Thematic Networks and Co-Operative Research Centres RIRAAF [RD07-0064]; Consejeria de Salud de la Junta de Andalucia [RH-0070-2013]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondos FEDER(European Commission); Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia); "Miguel Servet II" research contract; Consejeria de Salud; FIS-Thematic Networks and Co-Operative Research Centres RIRAAF; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Instituto de Salud Carlos III (PI10/01947, PI13/02628) with Fondos FEDER and the Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia (CTS-7895) with Fondos FEDER. R. El Bekay is under a contract Miguel Servet type II (CPII13/00041) from the Instituto de Salud Carlos III. F-JB-S is a recipient of a "Miguel Servet II" research contract (CPII13/00042) and also belongs to the regional "Nicolas Monardes" research program of the Consejeria de Salud (C-0070-2012; Junta de Andalucia, Spain). This work was supported by the FIS-Thematic Networks and Co-Operative Research Centres RIRAAF (RD07-0064). JM is under the Programa de Intensificacion de la Actividad Investigadora del Sistema Nacional de Salud. AV-R is under a contract Proyectos de I+D+i para jovenes investigadores from the Ministerio de Economia y Competitividad (SAF2014-60649-JIN). S-YR-Z is recipient of a post-doctoral contract from Consejeria de Salud de la Junta de Andalucia (RH-0070-2013).	Amable PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073792; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Farrokhi A, 2012, CELL MOL BIOL, V58, P1660, DOI 10.1170/193; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu LY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-49; Quiroz FG, 2010, CYTOTECHNOLOGY, V62, P109, DOI 10.1007/s10616-010-9265-1; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kollmer Melanie, 2013, J Dev Biol Tissue Eng, V5, P18; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Roca-Rodriguez MM, 2015, J CLIN ENDOCR METAB, V100, pE826, DOI 10.1210/jc.2014-4132; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Oliva-Olivera W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144401; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Seo KW, 2013, CELL TRANSPLANT, V22, P29, DOI 10.3727/096368912X654948; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Studer D, 2012, TISSUE ENG PART C-ME, V18, P761, DOI 10.1089/ten.tec.2012.0081; Tratwal J, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-11; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Xie F., 2012, PLANT MOL BIOL; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157002	10.1371/journal.pone.0157002	http://dx.doi.org/10.1371/journal.pone.0157002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304673	Green Published, Green Submitted, gold			2022-12-26	WOS:000377824800034
J	Soto, C; Ofek, G; Joyce, MG; Zhang, BS; Mckee, K; Longo, NS; Yang, YP; Huang, JH; Parks, R; Eudailey, J; Lloyd, KE; Alam, SM; Haynes, BF; Mullikin, JC; Connors, M; Mascola, JR; Shapiro, L; Kwong, PD				Soto, Cinque; Ofek, Gilad; Joyce, M. Gordon; Zhang, Baoshan; Mckee, Krisha; Longo, Nancy S.; Yang, Yongping; Huang, Jinghe; Parks, Robert; Eudailey, Joshua; Lloyd, Krissey E.; Alam, S. Munir; Haynes, Barton F.; Mullikin, James C.; Connors, Mark; Mascola, John R.; Shapiro, Lawrence; Kwong, Peter D.		NISC Comparative Sequencing	Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8	PLOS ONE			English	Article							POTENT NEUTRALIZATION; HIV-1 NEUTRALIZATION; IMMUNOGEN DESIGN; STRUCTURAL BASIS; EPITOPE; BROAD; GP41; AUTOREACTIVITY; MATURATION; GERMLINE	Antibody 10E8 targets the membrane-proximal external region (MPER) of HIV-1 gp41, neutralizes >97% of HIV-1 isolates, and lacks the auto-reactivity often associated with MPER-directed antibodies. The developmental pathway of 10E8 might therefore serve as a promising template for vaccine design, but samples from time-of-infection-often used to infer the B cell record-are unavailable. In this study, we used crystallography, next-generation sequencing (NGS), and functional assessments to infer the 10E8 developmental pathway from a single time point. Mutational analysis indicated somatic hypermutation of the 2nd-heavy chain-complementarity determining region (CDR H2) to be critical for neutralization, and structures of 10E8 variants with V-gene regions reverted to genomic origin for heavy- nd-light chains or heavy chain-only showed structural differences > 2 angstrom relative to mature 10E8 in the CDR H2 and H3. To understand these developmental changes, we used bioinformatic sieving, maximum likelihood, and parsimony analyses of immunoglobulin transcripts to identify 10E8-lineage members, to infer the 10E8-unmutated common ancestor (UCA), and to calculate 10E8-developmental intermediates. We were assisted in this analysis by the preservation of a critical D-gene segment, which was unmutated in most 10E8-lineage sequences. UCA and early intermediates weakly bound a 26-residue-MPER peptide, whereas HIV-1 neutralization and epitope recognition in liposomes were only observed with late intermediates. Antibody 10E8 thus develops from a UCA with weak MPER affinity and substantial differences in CDR H2 and H3 from the mature 10E8; only after extensive somatic hypermutation do 10E8-lineage members gain recognition in the context of membrane and HIV-1 neutralization.	[Soto, Cinque; Ofek, Gilad; Joyce, M. Gordon; Zhang, Baoshan; Mckee, Krisha; Longo, Nancy S.; Yang, Yongping; Mascola, John R.; Shapiro, Lawrence; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Huang, Jinghe; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Parks, Robert; Eudailey, Joshua; Lloyd, Krissey E.; Alam, S. Munir; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Mullikin, James C.; NISC Comparative Sequencing] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Columbia University	Mascola, JR; Shapiro, L; Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA.	jmascola@nih.gov; shapiro@convex.hhmi.columbia.edu; pdkwong@nih.gov	Alam, S. Munir/AAC-6711-2019; Mascola, John/AAI-7193-2021; Shapiro, Lawrence/AAE-7172-2019; Huang, Jinghe/P-8068-2019	Huang, Jinghe/0000-0002-1968-871X	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Human Genome Research Institute, National Institutes of Health; Center for HIV/AIDS Vaccine Immunology-Immunogen Design grant from the Division of AIDS National Institutes of Infectious Disease, NIH [UM1 AI100645]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZIAAI005022, ZICAI005111, UM1AI100645] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for HIV/AIDS Vaccine Immunology-Immunogen Design grant from the Division of AIDS National Institutes of Infectious Disease, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute, National Institutes of Health, and by the Center for HIV/AIDS Vaccine Immunology-Immunogen Design grant UM1 AI100645 to BFH from the Division of AIDS National Institutes of Infectious Disease, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aouinti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142353; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kabat EA, 1991, SEQUENCES PROTEINS I; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2007, ARCH VIROL, V152, P1799, DOI 10.1007/s00705-007-1019-9; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2014, J VIROL, V88, P2426, DOI 10.1128/JVI.02837-13; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	38	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157409	10.1371/journal.pone.0157409	http://dx.doi.org/10.1371/journal.pone.0157409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299673	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200046
J	Zainabadi, K				Zainabadi, Kayvan			Malaria Parasite CLAG3, a Protein Linked to Nutrient Channels, Participates in High Molecular Weight Membrane-Associated Complexes in the Infected Erythrocyte	PLOS ONE			English	Article							SURFACE ANION CHANNEL; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; PERMEATION PATHWAYS; MULTIGENE FAMILY; PERMEABILITY; RESISTANCE; INVASION; REVEALS	Malaria infected erythrocytes show increased permeability to a number of solutes important for parasite growth as mediated by the Plasmodial Surface Anion Channel (PSAC). The P. falciparum clag3 genes have recently been identified as key determinants of PSAC, though exactly how they contribute to channel function and whether additional host/ parasite proteins are required remain unknown. To begin to answer these questions, I have taken a biochemical approach. Here I have used an epitope-tagged CLAG3 parasite to perform coimmunoprecipitation experiments using membrane fractions of infected erythrocytes. Native PAGE and mass spectrometry studies reveal that CLAG3 participate in at least three different high molecular weight complexes: a similar to 720kDa complex consisting of CLAG3, RHOPH2 and RHOPH3; a similar to 620kDa complex consisting of CLAG3 and RHOPH2; and a similar to 480kDa complex composed solely of CLAG3. Importantly, these complexes can be found throughout the parasite lifecycle but are absent in untransfected controls. Extracellular biotin labeling and protease susceptibility studies localize the 480kDa complex to the erythrocyte membrane. This complex, likely composed of a homo-oligomer of 160kDa CLAG3, may represent a functional subunit, possibly the pore, of PSAC.	[Zainabadi, Kayvan] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Zainabadi, Kayvan] Univ Maryland, Sch Med, Inst Global Hlth, Div Malaria Res, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore	Zainabadi, K (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.; Zainabadi, K (corresponding author), Univ Maryland, Sch Med, Inst Global Hlth, Div Malaria Res, Baltimore, MD 21201 USA.	kzainabadi@medicine.umaryland.edu			Malaria Infection Biology Research Fellowship (NIAID); Intramural Research Program of NIAID, National Institutes of Health	Malaria Infection Biology Research Fellowship (NIAID); Intramural Research Program of NIAID, National Institutes of Health	This research was supported by a Malaria Infection Biology Research Fellowship (NIAID) and by the Intramural Research Program of NIAID, National Institutes of Health.; I would like to thank Susan Pierce for her encouragement, Louis Miller and Tom Wellems for their support and critical reading of the manuscript, Sanjay Desai for helpful discussions and feedback on experiments, and the Research Technologies Branch of the National Institutes of Allergy and Infectious Diseases (NIAD), particularly Renee Olano, for their help with mass spectrometry experiments. This research was supported by a Malaria Infection Biology Research Fellowship (NIAID) and by the Intramural Research Program of NIAID, National Institutes of Health.	Alkhalil A, 2004, BLOOD, V104, P4279, DOI 10.1182/blood-2004-05-2047; Alkhalil A, 2012, BBA-BIOMEMBRANES, V1818, P367, DOI 10.1016/j.bbamem.2011.11.010; Baumeister S, 2003, MOL BIOCHEM PARASIT, V132, P35, DOI 10.1016/j.molbiopara.2003.08.003; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Comeaux CA, 2011, MOL MICROBIOL, V80, P378, DOI 10.1111/j.1365-2958.2011.07572.x; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; GINSBURG H, 1986, BIOCHIM BIOPHYS ACTA, V861, P194, DOI 10.1016/0005-2736(86)90418-9; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Gupta A, 2015, DRUG RESIST UPDATE, V18, P47, DOI 10.1016/j.drup.2014.10.004; Heinz C, 2003, J BIOL CHEM, V278, P8678, DOI 10.1074/jbc.M212280200; HOMEWOOD CA, 1974, NATURE, V252, P718, DOI 10.1038/252718a0; Huber SM, 2004, J BIOL CHEM, V279, P41444, DOI 10.1074/jbc.M407618200; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; Nguitragool W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093759; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Sharma P, 2015, INFECT IMMUN, V83, P2566, DOI 10.1128/IAI.02966-14; Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Thevenin D, 2008, PROTEIN SCI, V17, P1188, DOI 10.1110/ps.034843.108; Verloo P, 2004, J BIOL CHEM, V279, P10316, DOI 10.1074/jbc.M311540200; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002	35	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157390	10.1371/journal.pone.0157390	http://dx.doi.org/10.1371/journal.pone.0157390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299521	Green Submitted, Green Published, gold			2022-12-26	WOS:000377822200045
J	Leithner, K; Hirschmugl, B; Li, YJ; Tang, B; Papp, R; Nagaraj, C; Stacher, E; Stiegler, P; Lindenmann, J; Olschewski, A; Olschewski, H; Hrzenjak, A				Leithner, Katharina; Hirschmugl, Birgit; Li, Yingji; Tang, Bi; Papp, Rita; Nagaraj, Chandran; Stacher, Elvira; Stiegler, Philipp; Lindenmann, Joerg; Olschewski, Andrea; Olschewski, Horst; Hrzenjak, Andelko			TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers	PLOS ONE			English	Article							DEPENDENT MULTIVITAMIN TRANSPORTER; POTASSIUM CHANNELS; K+ CHANNELS; FUNCTIONAL EXPRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION; N2A CELLS; KCNK9; HYPOXIA; CULTURE	Lung cancer is the leading cause of cancer deaths worldwide; survival times are poor despite therapy. The role of the two-pore domain K+ (K2P) channel TASK-1 (KCNK3) in lung cancer is at present unknown. We found that TASK-1 is expressed in non-small cell lung cancer (NSCLC) cell lines at variable levels. In a highly TASK-1 expressing NSCLC cell line, A549, a characteristic pH-and hypoxia-sensitive non-inactivating K+ current was measured, indicating the presence of functional TASK-1 channels. Inhibition of TASK-1 led to significant depolarization in these cells. Knockdown of TASK-1 by siRNA significantly enhanced apoptosis and reduced proliferation in A549 cells, but not in weakly TASK-1 expressing NCI-H358 cells. Na+ -coupled nutrient transport across the cell membrane is functionally coupled to the efflux of K+ via K+ channels, thus TASK-1 may potentially influence Na+-coupled nutrient transport. In contrast to TASK-1, which was not differentially expressed in lung cancer vs. normal lung tissue, we found the Na+-coupled nutrient transporters, SLC5A3, SLC5A6, and SLC38A1, transporters for myo-inositol, biotin and glutamine, respectively, to be significantly overexpressed in lung adenocarcinomas. In summary, we show for the first time that the TASK-1 channel regulates apoptosis and proliferation in a subset of NSCLC.	[Leithner, Katharina; Li, Yingji; Tang, Bi; Olschewski, Horst; Hrzenjak, Andelko] Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria; [Hirschmugl, Birgit] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Papp, Rita; Nagaraj, Chandran; Olschewski, Andrea; Hrzenjak, Andelko] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Nagaraj, Chandran] Med Univ Graz, Univ Clin Anesthesiol & Intens Care Med, Expt Anesthesiol, Graz, Austria; [Stacher, Elvira] Med Univ Graz, Inst Pathol, Graz, Austria; [Stiegler, Philipp] Med Univ Graz, Dept Surg, Div Transplant Surg, Graz, Austria; [Lindenmann, Joerg] Med Univ Graz, Dept Surg, Div Thorac & Hyperbar Surg, Graz, Austria; [Olschewski, Andrea] Med Univ Graz, Inst Physiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Hrzenjak, A (corresponding author), Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria.; Hrzenjak, A (corresponding author), Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria.	andelko.hrzenjak@medunigraz.at	Chandran, Nagaraj/AAP-2007-2020; Olschewski, Horst/L-3547-2019; Leithner, Katharina, MD, PhD/E-7662-2011	Chandran, Nagaraj/0000-0003-3825-8587; Olschewski, Horst/0000-0002-2834-7466; Leithner, Katharina, MD, PhD/0000-0002-8252-9279; Olschewski, Andrea/0000-0002-8189-3634; Stiegler, Philipp/0000-0002-0952-3030	Oesterreichische Nationalbank (Anniversary Fund) [12713]	Oesterreichische Nationalbank (Anniversary Fund)	The study was supported by funds of the Oesterreichische Nationalbank (Anniversary Fund, project number 12713 to HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bittner S, 2012, EXP NEUROL, V238, P149, DOI 10.1016/j.expneurol.2012.08.021; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Brenner T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1480, DOI 10.1152/ajpendo.90652.2008; Burg ED, 2008, BRIT J PHARMACOL, V153, pS99, DOI 10.1038/sj.bjp.0707635; Chen LH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010043; Czirjak G, 2003, MOL PHARMACOL, V63, P646, DOI 10.1124/mol.63.3.646; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Durlacher CT, 2015, CLIN EXP PHARMACOL P, V42, P427, DOI 10.1111/1440-1681.12385; Ernest NJ, 2010, J MEMBRANE BIOL, V237, P59, DOI 10.1007/s00232-010-9306-x; Garnett JP, 2012, EUR RESPIR J, V40, P1269, DOI 10.1183/09031936.00052612; Hamilton KL, 2012, AM J PHYSIOL-RENAL, V302, pF1069, DOI 10.1152/ajprenal.00646.2011; Hao XR, 2015, J MOL NEUROSCI, V55, P314, DOI 10.1007/s12031-014-0323-6; Hao XR, 2014, J MEMBRANE BIOL, V247, P273, DOI 10.1007/s00232-014-9632-5; Hougaard C, 2001, PFLUG ARCH EUR J PHY, V442, P622, DOI 10.1007/s004240100585; Innamaa A, 2013, ANTICANCER RES, V33, P1401; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Kilisch M, 2015, PFLUG ARCH EUR J PHY, V467, P1105, DOI 10.1007/s00424-014-1672-2; Kim CJ, 2004, APMIS, V112, P588, DOI 10.1111/j.1600-0463.2004.apm1120905.x; Kondratskyi A, 2015, BBA-BIOMEMBRANES, V1848, P2532, DOI 10.1016/j.bbamem.2014.10.030; Kosztka L, 2011, MELANOMA RES, V21, P308, DOI 10.1097/CMR.0b013e3283462713; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lang F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0108; Lee GW, 2012, ACTA PHYSIOL, V204, P513, DOI 10.1111/j.1748-1716.2011.02359.x; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Li XT, 2013, ONCOL LETT, V5, P865, DOI 10.3892/ol.2012.1088; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Manegold Christian, 2007, Lung Cancer, V57 Suppl 2, pS3, DOI 10.1016/S0169-5002(07)70420-8; Mant A, 2013, J BIOL CHEM, V288, P3251, DOI 10.1074/jbc.M112.405167; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Meuth SG, 2008, J NEURO-ONCOL, V87, P263, DOI 10.1007/s11060-008-9517-5; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nagaraj C, 2013, EUR RESPIR J, V41, P85, DOI 10.1183/09031936.00211811; O'Kelly I, 2015, PFLUG ARCH EUR J PHY, V467, P1133, DOI 10.1007/s00424-014-1641-9; Olschewski A, 2010, ADV EXP MED BIOL, V661, P459, DOI 10.1007/978-1-60761-500-2_30; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Patel M, 2012, INT J PHARMACEUT, V436, P324, DOI 10.1016/j.ijpharm.2012.06.011; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Pochini L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00061; Pocsai K, 2006, CELL MOL LIFE SCI, V63, P2364, DOI 10.1007/s00018-006-6166-8; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rusznak Z, 2008, VIRCHOWS ARCH, V452, P415, DOI 10.1007/s00428-007-0545-x; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Vadlapudi AD, 2013, INT J PHARMACEUT, V441, P535, DOI 10.1016/j.ijpharm.2012.10.047; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wohlkoenig C, 2011, CANCER LETT, V308, P134, DOI 10.1016/j.canlet.2011.03.014; Zempleni J, 2009, J NUTR, V139, P163, DOI 10.3945/jn.108.091967	55	32	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157453	10.1371/journal.pone.0157453	http://dx.doi.org/10.1371/journal.pone.0157453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294516	Green Published, gold, Green Submitted			2022-12-26	WOS:000377821300046
J	Dobierzewska, A; Palominos, M; Sanchez, M; Dyhr, M; Helgert, K; Venegas-Araneda, P; Tong, S; Illanes, SE				Dobierzewska, Aneta; Palominos, Macarena; Sanchez, Marianela; Dyhr, Michael; Helgert, Katja; Venegas-Araneda, Pia; Tong, Stephen; Illanes, Sebastian E.			Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia	PLOS ONE			English	Article							TROPHOBLAST DIFFERENTIATION; SPHINGOLIPID METABOLISM; SPHINGOSINE-1-PHOSPHATE; HYPOXIA; EXPRESSION; KINASE; 1-PHOSPHATE; CONTRIBUTES; INHIBITION; PROLIFERATION	Preeclampsia (PE), is a serious pregnancy disorder characterized in the early gestation by shallow trophoblast invasion, impaired placental neo-angiogenesis, placental hypoxia and ischemia, which leads to maternal and fetal morbidity and mortality. Here we hypothesized that angiogenic sphingosine kinase-1 (SPHK1)/sphingosine-1-phosphate (S1P) receptors pathway is impaired in PE. We found that SPHK1 mRNA and protein expression are downregulated in term placentae and term chorionic villous explants from patients with PE or severe PE (PES), compared with controls. Moreover, mRNA expression of angiogenic S1PR1 and S1PR3 receptors were decreased in placental samples of PE and PES patients, whereas anti-angiogenic S1PR2 was up-regulated in chorionic villous tissue of PES subjects, pointing to its potential atherogenic and inflammatory properties. Furthermore, in in vitro (JAR cells) and ex vivo (chorionic villous explants) models of placental hypoxia, SPHK1 mRNA and protein were strongly up-regulated under low oxygen tension (1% O-2). In contrast, there was no change in SPHK1 expression under the conditions of placental physiological hypoxia (8% O-2). In both models, nuclear protein levels of HIF1A were increased at 1% O-2 during the time course, but there was no up-regulation at 8% O-2, suggesting that SPHK1 and HIF1A might be the part of the same canonical pathway during hypoxia and that both contribute to placental neovascularization during early gestation. Taken together, this study suggest the SPHK1 pathway may play a role in the human early placentation process and may be involved in the pathogenesis of PE.	[Dobierzewska, Aneta; Palominos, Macarena; Sanchez, Marianela; Dyhr, Michael; Helgert, Katja; Venegas-Araneda, Pia; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Dept Obstet & Gynecol, Santiago, Chile; [Dobierzewska, Aneta; Palominos, Macarena; Sanchez, Marianela; Dyhr, Michael; Helgert, Katja; Venegas-Araneda, Pia; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Reprod Biol Lab, Santiago, Chile; [Tong, Stephen] Univ Melbourne, Dept Obstet & Gynecol, Translat Obstet Grp, Mercy Hosp Women, Heidelberg, Vic, Australia; [Illanes, Sebastian E.] Clin Davila, Dept Maternal Fetal Med, Santiago, Chile	Universidad de los Andes - Chile; Universidad de los Andes - Chile; University of Melbourne; Clinica Davila	Dobierzewska, A (corresponding author), Univ Los Andes, Fac Med, Dept Obstet & Gynecol, Santiago, Chile.	adobierzewska@uandes.cl		Tong, Stephen/0000-0002-2319-0586; Illanes, Sebastian/0000-0001-5433-9315	FAI Inicacion grant (Fondo de Ayuda a la Investigacion of Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) [1140119]; International DAAD-Rise scholarships [CL-BI-330, CL-ME-1454]	FAI Inicacion grant (Fondo de Ayuda a la Investigacion of Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); International DAAD-Rise scholarships	This work was supported by FAI Inicacion grant (Fondo de Ayuda a la Investigacion of Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia" to AD and Fondecyt Regular 1140119 (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) to SEI. (http://www.conicyt.cl/fondecyt). MD and KH were supported by International DAAD-Rise scholarships (CL-BI-330 and CL-ME-1454) "Search for sphingolipids-related biomarkers of pregnancy disease: preeclampsia" to conduct internships in our laboratory (http://www.daad.de/rise). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chauvin S, 2015, J CLIN ENDOCR METAB, V100, pE986, DOI 10.1210/jc.2015-1288; De Marco CS, 2002, PLACENTA, V23, pS58, DOI 10.1053/plac.2002.0809; Dobierzewska A, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.124644; Dunlap KA, 2010, BIOL REPROD, V82, P876, DOI 10.1095/biolreprod.109.081604; Egerman RS, 1999, CLIN OBSTET GYNECOL, V42, P381, DOI 10.1097/00003081-199906000-00022; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Fayyad AM, 2005, EARLY HUM DEV, V81, P865, DOI 10.1016/j.earlhumdev.2005.09.005; French KJ, 2003, CANCER RES, V63, P5962; Heringdorf DM, 1999, FEBS LETT, V461, P217, DOI 10.1016/S0014-5793(99)01463-5; Heringdorf DMZ, 2001, EUR J PHARMACOL, V414, P145, DOI 10.1016/S0014-2999(01)00789-0; Inoki I, 2006, BIOCHEM BIOPH RES CO, V346, P293, DOI 10.1016/j.bbrc.2006.05.119; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kihara A, 2008, BIOCHIM BIOPHYS ACTA, V1781, P483; Kono M, 2004, J BIOL CHEM; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Lanoix D, 2012, PLACENTA, V33, P151, DOI 10.1016/j.placenta.2011.12.008; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Singh AT, 2012, REPROD BIOMED ONLINE, V24, P224, DOI 10.1016/j.rbmo.2011.10.012; Skaznik-Wikiel ME, 2006, BIOL REPROD, V74, P569, DOI 10.1095/biolreprod.105.046714; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Takuwa Yoh, 2010, World J Biol Chem, V1, P298, DOI 10.4331/wjbc.v1.i10.298; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tao R, 2007, CARDIOVASC RES, V74, P56, DOI 10.1016/j.cardiores.2007.01.015; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yang WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106725; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zhang H, 2012, CELL PROLIFERAT, V45, P167, DOI 10.1111/j.1365-2184.2012.00807.x; Zhang JH, 2013, HUM REPROD, V28, P3026, DOI 10.1093/humrep/det339; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhao J, 2015, CURR ATHEROSCLER REP, V17, P1	45	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157221	10.1371/journal.pone.0157221	http://dx.doi.org/10.1371/journal.pone.0157221			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284992	Green Published, gold			2022-12-26	WOS:000377564000045
J	Czyzewska, U; Siemionow, K; Zareba, I; Miltyk, W				Czyzewska, Urszula; Siemionow, Katarzyna; Zareba, Ilona; Miltyk, Wojciech			Proapoptotic Activity of Propolis and Their Components on Human Tongue Squamous Cell Carcinoma Cell Line (CAL-27)	PLOS ONE			English	Article							ORAL-CANCER; CHEMICAL-COMPOSITION; MASS-SPECTROMETRY; TEA POLYPHENOLS; CAFFEIC ACID; COLON-CANCER; NECK-CANCER; IN-VITRO; APOPTOSIS; FLAVONOIDS	Propolis has been used since ancient times in folk medicine. It is a popular medicine possessing a broad spectrum of biological activities. This material is one of the richest sources of polyphenolic compounds such as flavonoids and phenolic acids. The ethanolic extract of propolis (EEP) evokes antibacterial, antiviral, antifungal and anticancer properties. Due to pharmacological properties it is used in the commercial production of nutritional supplements. In this study, gas chromatography coupled with mass spectrometry (GC-MS) was used to quantify main polyphenols in EEPs. The effect of EEPs, individual EEPs components (chrysin, galangin, pinocembrin, caffeic acid, p-coumaric acid, ferulic acid) and their mixture on viability of human tongue squamous cell carcinoma cell line (CAL-27) as well as the molecular mechanisms of the process were examined. The results of MTTs assay demonstrated that EEP, polyphenols and mixture of polyphenolic compounds were cytotoxic for CAL-27 cells in a dose dependent manner. The mechanism of cytotoxicity induced by these components undergoes through apoptosis as detected by flow cytometry. The ethanolic extracts of propolis activated caspases -3, -8, -9. Mixture of polyphenols was found as the most potent inducer of apoptosis thorough both intrinsic and extrinsic pathway. Therefore, we suggest that anticancer properties of propolis is related to synergistic activity of its main components.	[Czyzewska, Urszula; Siemionow, Katarzyna; Miltyk, Wojciech] Med Univ Bialystok, Dept Pharmaceut Anal, Bialystok, Poland; [Zareba, Ilona] Med Univ Bialystok, Dept Med Chem, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok	Czyzewska, U (corresponding author), Med Univ Bialystok, Dept Pharmaceut Anal, Bialystok, Poland.	urszula.czyzewska@umb.edu.pl	Frazao, Maria/O-4407-2016; Miltyk, Wojciech/P-6937-2018; Zareba, Ilona/T-6930-2018	Miltyk, Wojciech/0000-0001-5150-6093; Zareba, Ilona/0000-0002-7934-6973	Medical University of Bialystok as part of the OP DEP [POPW.01.03.00-20-008/09]; Medical University of Bialystok, Poland (KNOW) [124/KNOW/15]	Medical University of Bialystok as part of the OP DEP; Medical University of Bialystok, Poland (KNOW)	This study was conducted with the use of equipment purchased by Medical University of Bialystok as part of the OP DEP 2007-2013, Priority Axis I.3, contract No. POPW.01.03.00-20-008/09 and financially supported by the Medical University of Bialystok, Poland (KNOW Project No. 124/KNOW/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIG 2015; [Anonymous], CANC POL 2012; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Barlak Y, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-74; Barnes L, 2005, PATHLOGY GENETICS HE; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chang YC, 2012, J AGR FOOD CHEM, V60, P8395, DOI 10.1021/jf302223g; Chen ZY, 2013, BANGL J PHARMACOL, V8, P255, DOI 10.3329/bjp.v8i3.14795; Czyzewska U, 2015, J MED FOOD, V18, P584, DOI 10.1089/jmf.2014.0069; Watanabe MAE, 2011, J PHARM PHARMACOL, V63, P1378, DOI 10.1111/j.2042-7158.2011.01331.x; Fan MJ, 2015, NUTR CANCER, V67, P327, DOI 10.1080/01635581.2015.990576; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Galeone C, 2015, INT J CANCER, V136, P904, DOI 10.1002/ijc.29044; Gardana C, 2007, J PHARMACEUT BIOMED, V45, P390, DOI 10.1016/j.jpba.2007.06.022; Gazzani G, 2012, CURR OPIN BIOTECH, V23, P153, DOI 10.1016/j.copbio.2011.09.003; Gomez-Caravaca AM, 2006, J PHARMACEUT BIOMED, V41, P1220, DOI 10.1016/j.jpba.2006.03.002; Guo SJ, 2011, ADV BIOM ENG, P98; Hashim YZHY, 2008, INT J CANCER, V122, P495, DOI 10.1002/ijc.23148; Iriti M, 2013, NUTRIENTS, V5, P2564, DOI 10.3390/nu5072564; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kasala ER, 2015, TOXICOL LETT, V233, P214, DOI 10.1016/j.toxlet.2015.01.008; Kim JW, 2010, CANCER PREV RES, V3, P900, DOI 10.1158/1940-6207.CAPR-09-0131; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Kubina R, 2015, ADV CLIN EXP MED, V24, P203, DOI 10.17219/acem/31792; Kuntz S, 1999, EUR J NUTR, V38, P133, DOI 10.1007/s003940050054; Lin CL, 2012, INT J MOL SCI, V13, P6236, DOI 10.3390/ijms13056236; Lin J.-K., 2006, FLAVONOIDS NUTRACEUT; Mangalath U, 2014, J INT SOC PREV COMMU, V4, pS131, DOI 10.4103/2231-0762.149018; Markiewicz-Zukowska R, 2012, ADV MED SCI-POLAND, V57, P208, DOI 10.2478/v10039-012-0042-6; Prasad NR, 2011, MOL CELL BIOCHEM, V349, P11, DOI 10.1007/s11010-010-0655-7; Premratanachai Pongsathon, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P337, DOI 10.12980/APJTB.4.2014C1262; Rasul A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379850; Roleira FMF, 2015, FOOD CHEM, V183, P235, DOI 10.1016/j.foodchem.2015.03.039; Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.5603/FHC.2012.0004, 10.2478/18693]; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Toreti VC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/697390; Torkin R, 2005, MOL CANCER THER, V4, P1; Turan I, 2015, TROP J PHARM RES, V14, P777, DOI 10.4314/tjpr.v14i5.5; Walle T, 2007, BIOCHEM PHARMACOL, V73, P1288, DOI 10.1016/j.bcp.2006.12.028	39	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157091	10.1371/journal.pone.0157091	http://dx.doi.org/10.1371/journal.pone.0157091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281369	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000082
J	Eybpoosh, S; Bahrampour, A; Karamouzian, M; Azadmanesh, K; Jahanbakhsh, F; Mostafavi, E; Zolala, F; Haghdoost, AA				Eybpoosh, Sana; Bahrampour, Abbas; Karamouzian, Mohammad; Azadmanesh, Kayhan; Jahanbakhsh, Fatemeh; Mostafavi, Ehsan; Zolala, Farzaneh; Haghdoost, Ali Akbar			Spatio-Temporal History of HIV-1 CRF35_AD in Afghanistan and Iran	PLOS ONE			English	Article							INJECTING DRUG-USERS; MOLECULAR EPIDEMIOLOGY; MIDDLE-EAST; EVOLUTIONARY HISTORY; POPULATION-DYNAMICS; TYPE-1 SUBTYPE; NORTH-AFRICA; PHYLODYNAMICS; INFECTION; TRANSMISSION	HIV-1 Circulating Recombinant Form 35_AD (CRF35_AD) has an important position in the epidemiological profile of Afghanistan and Iran. Despite the presence of this clade in Afghanistan and Iran for over a decade, our understanding of its origin and dissemination patterns is limited. In this study, we performed a Bayesian phylogeographic analysis to reconstruct the spatio-temporal dispersion pattern of this clade using eligible CRF35_AD gag and pol sequences available in the Los Alamos HIV database (432 sequences available from Iran, 16 sequences available from Afghanistan, and a single CRF35_AD-like pol sequence available from USA). Bayesian Markov Chain Monte Carlo algorithm was implemented in BEAST v1.8.1. Between-country dispersion rates were tested with Bayesian stochastic search variable selection method and were considered significant where Bayes factor values were greater than three. The findings suggested that CRF35_AD sequences were genetically similar to parental sequences from Kenya and Uganda, and to a set of subtype A1 sequences available from Afghan refugees living in Pakistan. Our results also showed that across all phylogenies, Afghan and Iranian CRF35_AD sequences formed a monophyletic cluster (posterior clade credibility> 0.7). The divergence date of this cluster was estimated to be between 1990 and 1992. Within this cluster, a bidirectional dispersion of the virus was observed across Afghanistan and Iran. We could not clearly identify if Afghanistan or Iran first established or received this epidemic, as the root location of this cluster could not be robustly estimated. Three CRF35_AD sequences from Afghan refugees living in Pakistan nested among Afghan and Iranian CRF35_AD branches. However, the CRF35_AD-like sequence available from USA diverged independently from Kenyan subtype A1 sequences, suggesting it not to be a true CRF35_AD lineage. Potential factors contributing to viral exchange between Afghanistan and Iran could be injection drug networks and mass migration of Afghan refugees and labours to Iran, which calls for extensive preventive efforts.	[Eybpoosh, Sana; Karamouzian, Mohammad; Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Eybpoosh, Sana; Karamouzian, Mohammad; Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Bahrampour, Abbas; Zolala, Farzaneh] Kerman Univ Med Sci, Inst Futures Studies Hlth, Modeling Hlth Res Ctr, Kerman, Iran; [Karamouzian, Mohammad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Azadmanesh, Kayhan; Jahanbakhsh, Fatemeh] Pasteur Inst Iran, Dept Virol, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Emerging & Reemerging Infect Dis Res Ctr, Kabudar Ahang, Hamadan, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; University of British Columbia; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Haghdoost, AA (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran.; Haghdoost, AA (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran.	ahaghdoost@kmu.ac.ir	Mostafavi, Ehsan/A-7627-2011; Haghdoost, Ali Akbar/C-2823-2009; Bahrampour, Abbas/B-7260-2011; Karamouzian, Mohammad/C-9277-2018; Eybpoosh, Sana/K-4836-2017; Zolala, Farzaneh/S-7088-2016; Azadmanesh, Kayhan/W-2445-2017	Mostafavi, Ehsan/0000-0002-1997-517X; Haghdoost, Ali Akbar/0000-0003-4628-4849; Bahrampour, Abbas/0000-0002-8950-2925; Karamouzian, Mohammad/0000-0002-5631-4469; Eybpoosh, Sana/0000-0002-2304-8352; Zolala, Farzaneh/0000-0002-1848-183X; Azadmanesh, Kayhan/0000-0002-7165-9043	Kerman University of Medical Sciences; Pasteur Institute of Iran [92-10-8-29690]	Kerman University of Medical Sciences; Pasteur Institute of Iran	This project was supported by Kerman University of Medical Sciences and Pasteur Institute of Iran (Grant No. 92-10-8-29690). The grant was received by AAH and EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi-Shavazi MJ, 2005, RETURN AFGHANISTAN S; Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Al Rifai R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007703; [Anonymous], 2014, AFGH AIDS PROGR REP; [Anonymous], 2004, BITT SWEET HARV AFGH; Ansari AS, 2011, AIDS, V25, P1427, DOI 10.1097/QAD.0b013e32834800e7; Apetrei C, LOS ALAMOS HIV DATAB; Baesi K, 2012, IRAN J BIOTECHNOL, V10, P1; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bozicevic I, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18962; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Chen JJ, 2011, MOD SIMUL ENG, V2011, DOI 10.1155/2011/259401; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Garcia V, 2007, J RURAL HEALTH, V23, P61, DOI 10.1111/j.1748-0361.2007.00125.x; Gokengin D, 2016, INT J INFECT DIS, V44, P66, DOI 10.1016/j.ijid.2015.11.008; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Hamkar R, 2010, AIDS ACTION, V2, pS85; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hu Wei-Shau, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006882; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Inciardi JA, 1999, SUBST USE MISUSE, V34, P653, DOI 10.3109/10826089909037236; Jahanbakhsh F, 2013, AIDS RES HUM RETROV, V29, P198, DOI [10.1089/AID.2012.0186, 10.1089/aid.2012.0186]; Jahanbakhsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061864; Khan S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-164; Khanani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022449; Koepke B., 2011, SITUATION AFGHANS IS; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P362; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li Yanrui, 2010, J Biomed Biotechnol, V2010, P716515, DOI 10.1155/2010/716515; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Memarnejadian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126955; Mumtaz G, 2011, SEX TRANSM INFECT, V87, P101, DOI 10.1136/sti.2010.043711; Mumtaz GR, 2014, CURR OPIN HIV AIDS, V9, P183, DOI 10.1097/COH.0000000000000038; Murillo W, 2013, J VIROL, V87, P7463, DOI 10.1128/JVI.01602-12; MZ K, 2004, IRANIAN EC RES J, P57; Naderi H R, 2006, Infect Agent Cancer, V1, P4, DOI 10.1186/1750-9378-1-4; Pagan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069218; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pourhossein B, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015002; Pyne MT, 2013, J CLIN MICROBIOL, V51, P2662, DOI 10.1128/JCM.00880-13; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2002, TREEANNOTATOR V1 8 1; Rambaut A, 2002, LOGCOMBINER V1 8 1; Rambaut A, FIGTREE V1 4 TREE FI; Ray SC, 1999, SIMPLOT V2 5 0; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; Sanders-Buell E, 2010, AIDS RES HUM RETROV, V26, P605, DOI 10.1089/aid.2009.0226; Sarrami-Forooshani R, 2006, J MED VIROL, V78, P853, DOI 10.1002/jmv.20634; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Soheilli ZS, 2009, AIDS RES HUM RETROV, V25, P123, DOI 10.1089/aid.2008.0199; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Tagliamonte M, 2007, AIDS RES HUM RETROV, V23, P1569, DOI 10.1089/aid.2007.0169; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; United Nations Office on Drugs and Crime (UNODC), 2018, WORLD DRUG REPORT 20; UNODC United Nations Office on Drugs and Crime Vienna, 2010, WORLD DRUG REP 2010; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yebra G, 2015, J GEN VIROL, V96, P1890, DOI 10.1099/vir.0.000107; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	72	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156499	10.1371/journal.pone.0156499	http://dx.doi.org/10.1371/journal.pone.0156499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280293	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000033
J	Nagai-Okatani, C; Minamino, N				Nagai-Okatani, Chiaki; Minamino, Naoto			Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure	PLOS ONE			English	Article							MUSCLE LIM PROTEIN; BRAIN NATRIURETIC PEPTIDE; GROWTH-FACTOR RECEPTOR; SALT-SENSITIVE RATS; O-GLYCOSYLATION; POSTTRANSLATIONAL MODIFICATIONS; HUMAN GLYCOME; CORE FUCOSE; LECTIN; GLYCOPROTEIN	Targeted proteomics focusing on post-translational modifications, including glycosylation, is a useful strategy for discovering novel biomarkers. To apply this strategy effectively to cardiac hypertrophy and resultant heart failure, we aimed to characterize glycosylation profiles in the left ventricle and plasma of rats with cardiac hypertrophy. Dahl salt-sensitive hypertensive rats, a model of hypertension-induced cardiac hypertrophy, were fed a high-salt (8% NaCl) diet starting at 6 weeks. As a result, they exhibited cardiac hypertrophy at 12 weeks and partially impaired cardiac function at 16 weeks compared with control rats fed a low-salt (0.3% NaCl) diet. Gene expression analysis revealed significant changes in the expression of genes encoding glycosyltransferases and glycosidases. Glycoproteome profiling using lectin microarrays indicated upregulation of mucin-type O-glycosylation, especially disialyl-T, and downregulation of core fucosylation on N-glycans, detected by specific interactions with Amaranthus caudatus and Aspergillus oryzae lectins, respectively. Upregulation of plasma a-L-fucosidase activity was identified as a biomarker candidate for cardiac hypertrophy, which is expected to support the existing marker, atrial natriuretic peptide and its related peptides. Proteomic analysis identified cysteine and glycine-rich protein 3, a master regulator of cardiac muscle function, as an O-glycosylated protein with altered glycosylation in the rats with cardiac hypertrophy, suggesting that alternations in O-glycosylation affect its oligomerization and function. In conclusion, our data provide evidence of significant changes in glycosylation pattern, specifically mucin-type O-glycosylation and core defucosylation, in the pathogenesis of cardiac hypertrophy and heart failure, suggesting that they are potential biomarkers for these diseases.	[Nagai-Okatani, Chiaki; Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Res Inst, Suita, Osaka, Japan; [Nagai-Okatani, Chiaki] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Glycosci & Glycotechnol Res Grp, Tsukuba, Ibaraki, Japan; [Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr, Om Res Ctr, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Cerebral & Cardiovascular Center - Japan	Minamino, N (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Res Inst, Suita, Osaka, Japan.; Minamino, N (corresponding author), Natl Cerebral & Cardiovasc Ctr, Om Res Ctr, Suita, Osaka, Japan.	minamino@ncvc.go.jp	Nagai-Okatani, Chiaki/L-2883-2018	Nagai-Okatani, Chiaki/0000-0003-4084-3128	Intramural Research Fund of the National Cerebral and Cardiovascular Center of Japan [22-1-4, 25-6-16, 27-1-5]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation of Japan [10-44]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24890306]	Intramural Research Fund of the National Cerebral and Cardiovascular Center of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was from the Intramural Research Fund of the National Cerebral and Cardiovascular Center of Japan (http://www.ncvc.go.jp/english/), 22-1-4, 25-6-16, and 27-1-5; the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation of Japan (http://www.nibio.go.jp/english/), 10-44; and KAKENHI Grant-in-Aid for Research Activity Start-up of the Ministry of Education, Culture, Sports, Science and Technology, Japan (https://www.jsps.go.jp/english/), 24890306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABURAYA M, 1989, BIOCHEM BIOPH RES CO, V165, P880, DOI 10.1016/S0006-291X(89)80048-8; Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Boateng SY, 2009, J MOL CELL CARDIOL, V47, P426, DOI 10.1016/j.yjmcc.2009.04.006; Chowdhury P, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0372-4; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Hirabayashi J, 2013, CHEM SOC REV, V42, P4443, DOI 10.1039/c3cs35419a; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Kasper BT, 2014, BIOCHEM BIOPH RES CO, V445, P774, DOI 10.1016/j.bbrc.2014.01.034; Katafuchi T, 2003, J BIOL CHEM, V278, P12046, DOI 10.1074/jbc.M207970200; Kessler EL, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00482; Kuno A, 2008, J PROTEOM BIOINFORM, V1, P68, DOI DOI 10.4172/JPB.1000011; Kuzmanov U, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-31; Liddy KA, 2013, GENOME MED, V5, DOI 10.1186/gm424; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Nagai C, 2014, ANAL BIOCHEM, V461, P10, DOI 10.1016/j.ab.2014.05.022; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Nishikimi T, 2003, HYPERTENSION, V42, P1034, DOI 10.1161/01.HYP.0000097604.64716.D2; Nishikimi T, 2011, J CARDIOL, V57, P131, DOI 10.1016/j.jjcc.2011.01.002; Ogihara T, 2002, HYPERTENSION, V40, P83, DOI 10.1161/01.HYP.0000022880.45113.C9; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; RINDERLE SJ, 1989, J BIOL CHEM, V264, P16123; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stefaniuk P, 2010, WORLD J GASTROENTERO, V16, P418, DOI 10.3748/wjg.v16.i4.418; Tateno H, 2010, METHOD ENZYMOL, V478, P181, DOI 10.1016/S0076-6879(10)78008-3; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Vafiadaki E, 2015, GENE, V566, P1, DOI 10.1016/j.gene.2015.04.077; Van Eyk JE, 2011, CIRC RES, V108, P490, DOI 10.1161/CIRCRESAHA.110.226894; van Kimmenade RRJ, 2012, CLIN CHEM, V58, P127, DOI 10.1373/clinchem.2011.165720; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; WOOD S, 1975, CLIN CHIM ACTA, V58, P251, DOI 10.1016/0009-8981(75)90444-1; Yu HJ, 2012, J PROTEOME RES, V11, P5277, DOI 10.1021/pr300484j; Zhao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094536	55	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0150210	10.1371/journal.pone.0150210	http://dx.doi.org/10.1371/journal.pone.0150210			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281159	Green Published, Green Submitted, gold			2022-12-26	WOS:000377563000001
J	Poirier, S; Hamouda, HA; Villeneuve, L; Demers, A; Mayer, G				Poirier, Steve; Hamouda, Hocine Ait; Villeneuve, Louis; Demers, Annie; Mayer, Gaetan			Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PROPROTEIN CONVERTASE PCSK9; PRECURSOR-LIKE PROTEIN-2; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; SECRETED PCSK9; PCSK9-MEDIATED DEGRADATION; HEPG2 CELLS; CHOLESTEROL	PCSK9 is a secreted ligand and negative post-translational regulator of low-density lipoprotein receptor (LDLR) in hepatocytes. Gain-of-function (GOF) or loss-of-function (LOF) mutations in PCSK9 are directly correlated with high or low plasma LDL-cholesterol levels, respectively. Therefore, PCSK9 is a prevailing lipid-lowering target to prevent coronary heart diseases and stroke. Herein, we fused monomeric fluorescent proteins to PCSK9 and LDLR to visualize their intra-and extracellular trafficking dynamics by live confocal microscopy. Fluorescence recovery after photobleaching (FRAP) showed that PCSK9 LOF R46L mutant and GOF mutations S127R and D129G, but not the LDLR high-affinity mutant D374Y, significantly accelerate PCSK9 exit from the endoplasmic reticulum (ER). Quantitative analysis of inverse FRAP revealed that only R46L presented a much slower trafficking from the trans-Golgi network (TGN) to the plasma membrane and a lower mobile fraction likely suggesting accumulation or delayed exit at the TGN as an underlying mechanism. While not primarily involved in LDLR binding, PCSK9 C-terminal domain (CTD) was found to be essential to induce LDLR degradation both upon its overexpression in cells or via the extracellular pathway. Our data revealed that PCSK9 CTD is required for the localization of PCSK9 at the TGN and increases its LDLR-mediated endocytosis. Interestingly, intracellular lysosomal targeting of PCSK9-Delta CTD was able to rescue its capacity to induce LDLR degradation emphasizing a role of the CTD in the sorting of PCSK9-LDLR complex towards late endocytic compartments. Finally, we validated our dual fluorescence system as a cell based-assay by preventing PCSK9 internalization using a PCSK9-LDLR blocking antibody, which may be expended to identify protein, peptide or small molecule inhibitors of PCSK9.	[Poirier, Steve; Hamouda, Hocine Ait; Villeneuve, Louis; Demers, Annie; Mayer, Gaetan] Montreal Heart Inst Res Ctr, Mol Cell Biol Lab, Montreal, PQ, Canada; [Poirier, Steve; Hamouda, Hocine Ait; Mayer, Gaetan] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Mayer, Gaetan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Mayer, G (corresponding author), Montreal Heart Inst Res Ctr, Mol Cell Biol Lab, Montreal, PQ, Canada.; Mayer, G (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.; Mayer, G (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	gaetan.mayer@icm-mhi.org			Canadian Institutes of Health Research (CIHR - Institute of Nutrition, Metabolism and Diabetes) [MOP133598]; Heart and Stroke Foundation of Canada; Fonds de Recherche du Quebec - Sante; Montreal Heart Institute Foundation	Canadian Institutes of Health Research (CIHR - Institute of Nutrition, Metabolism and Diabetes)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Montreal Heart Institute Foundation	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR - Institute of Nutrition, Metabolism and Diabetes; MOP133598), the Heart and Stroke Foundation of Canada, the Fonds de Recherche du Quebec - Sante and the Montreal Heart Institute Foundation to G.M.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; BENDAYAN M, 1995, PROG HISTOCHEM CYTOC, V29, P1; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Bergeron N, 2015, CIRCULATION, V132, P1648, DOI 10.1161/CIRCULATIONAHA.115.016080; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Demers A, 2015, ARTERIOSCL THROM VAS, V35, P2517, DOI 10.1161/ATVBAHA.115.306032; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nguyen MA, 2014, J LIPID RES, V55, P266, DOI 10.1194/jlr.M044156; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Poirier S, 2014, J BIOL CHEM, V289, P18736, DOI 10.1074/jbc.M114.563650; Poirier S, 2013, DRUG DES DEV THER, V7, P1135, DOI 10.2147/DDDT.S36984; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; Tveten K, 2013, J LIPID RES, V54, P1560, DOI 10.1194/jlr.M034371; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	61	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157230	10.1371/journal.pone.0157230	http://dx.doi.org/10.1371/journal.pone.0157230			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280970	gold, Green Published, Green Submitted			2022-12-26	WOS:000377563000110
J	Vacaflores, A; Chapman, NM; Harty, JT; Richer, MJ; Houtman, JCD				Vacaflores, Aldo; Chapman, Nicole M.; Harty, John T.; Richer, Martin J.; Houtman, Jon C. D.			Exposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism	PLOS ONE			English	Article							INTERFERON-GAMMA; IFN-GAMMA; EFFECTOR FUNCTION; GENE-EXPRESSION; DENDRITIC CELLS; INTERLEUKIN-12; KINASE; PHOSPHORYLATION; ACTIVATION; PLASTICITY	Human CD4 T cells are constantly exposed to IL-12 during infections and certain autoimmune disorders. The current paradigm is that IL-12 promotes the differentiation of naive CD4 T cells into Th1 cells, but recent studies suggest IL-12 may play a more complex role in T cell biology. We examined if exposure to IL-12 alters human CD4 T cell responses to subsequent TCR stimulation. We found that IL-12 pretreatment increased TCR-induced IFN-gamma, TNF-alpha, IL-13, IL-4 and IL-10 production. This suggests that prior exposure to IL-12 potentiates the TCR-induced release of a range of cytokines. We observed that IL-12 mediated its effects through both transcriptional and post-transcriptional mechanisms. IL-12 pretreatment increased the phosphorylation of AKT, p38 and LCK following TCR stimulation without altering other TCR signaling molecules, potentially mediating the increase in transcription of cytokines. In addition, the IL-12-mediated enhancement of cytokines that are not transcriptionally regulated was partially driven by increased oxidative metabolism. Our data uncover a novel function of IL-12 in human CD4 T cells; specifically, it enhances the release of a range of cytokines potentially by altering TCR signaling pathways and by enhancing oxidative metabolism.	[Vacaflores, Aldo; Chapman, Nicole M.; Harty, John T.; Houtman, Jon C. D.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Harty, John T.; Richer, Martin J.; Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Chapman, Nicole M.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Richer, Martin J.] McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada	University of Iowa; University of Iowa; University of Iowa; University of Iowa; St Jude Children's Research Hospital; McGill University	Houtman, JCD (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA.; Houtman, JCD (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.; Houtman, JCD (corresponding author), Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA.	jon-houtman@uiowa.edu		Houtman, Jon/0000-0002-5307-9854; Harty, John/0000-0001-7266-2802	National Cancer Institute at the National Institutes of Health [CA136729]; American Heart Association [11PRE7390070]; NIH [T32 AI007485, AI42767, AI085515, AI95178, AI100527, AI106776]; Canadian Institutes of Health Research from American Heart Association Midwest Affiliate; Holden Comprehensive Cancer Center [P30CA086862]; NATIONAL CANCER INSTITUTE [R01CA136729, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research from American Heart Association Midwest Affiliate; Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The JCDH laboratory was supported by the National Cancer Institute at the National Institutes of Health (CA136729). NMC was supported by the American Heart Association Predoctoral (11PRE7390070) and the NIH Predoctoral Training Grant in Immunology (T32 AI007485). MJR was supported by a Canadian Institutes of Health Research fellowship and a fellowship from the American Heart Association Midwest Affiliate. The JTH laboratory is supported by NIH grants (AI42767, AI085515, AI95178, AI100527, AI106776). The ESR Facility (Seahorse experiments) is supported in part by the Holden Comprehensive Cancer Center (P30CA086862).	Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Athie-M V, 2000, EUR J IMMUNOL, V30, P1425, DOI 10.1002/(SICI)1521-4141(200005)30:5<1425::AID-IMMU1425>3.0.CO;2-Q; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Bellanger AP, 2013, CLIN VACCINE IMMUNOL, V20, P1133, DOI 10.1128/CVI.00043-13; Bilal MY, 2015, IMMUNOL CELL BIOL, V93, P896, DOI 10.1038/icb.2015.59; Bright JJ, 1998, J NEUROIMMUNOL, V82, P22, DOI 10.1016/S0165-5728(97)00184-7; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chehimi J, 1995, RES IMMUNOL, V146, P605, DOI 10.1016/0923-2494(96)83038-0; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Cruz-Orcutt N, 2014, CELL SIGNAL, V26, P797, DOI 10.1016/j.cellsig.2013.12.022; Cruz-Orcutt N, 2009, MOL IMMUNOL, V46, P2274, DOI 10.1016/j.molimm.2009.04.006; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; El-Shabrawi Y, 1998, OPHTHALMOLOGY, V105, P1659, DOI 10.1016/S0161-6420(98)99035-2; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; JUNE CH, 1990, J IMMUNOL, V144, P1591; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kim C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004137; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lee TS, 1999, ARTERIOSCL THROM VAS, V19, P734, DOI 10.1161/01.ATV.19.3.734; Ley Klaus, 2014, F1000Res, V3, P37, DOI 10.12688/f1000research.3-37.v1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhumitha H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-1; Martinez-Pomar N, 2006, CLIN EXP IMMUNOL, V144, P233, DOI 10.1111/j.1365-2249.2006.03063.x; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Meyaard L, 1996, J IMMUNOL, V156, P2776; Mingari MC, 1996, EUR J IMMUNOL, V26, P1083, DOI 10.1002/eji.1830260519; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pope RM, 2013, NAT REV RHEUMATOL, V9, P252, DOI 10.1038/nrrheum.2012.170; Portielje JEA, 2003, CLIN CANCER RES, V9, P76; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Renner K, 2015, EUR J IMMUNOL, V45, P2504, DOI 10.1002/eji.201545473; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Tokano Y, 1999, CLIN EXP IMMUNOL, V116, P169; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Tremblay MM, 2015, J IMMUNOL METHODS, V416, P137, DOI 10.1016/j.jim.2014.11.009; Tremblay MM, 2014, MOL IMMUNOL, V57, P161, DOI 10.1016/j.molimm.2013.09.002; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tugues S, 2015, CELL DEATH DIFFER, V22, P237, DOI 10.1038/cdd.2014.134; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Windhagen A, 1996, J IMMUNOL, V157, P1127; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	62	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157175	10.1371/journal.pone.0157175	http://dx.doi.org/10.1371/journal.pone.0157175			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280403	Green Submitted, Green Published, gold			2022-12-26	WOS:000377563000104
J	Thanos, PK; Kim, R; Delis, F; Ananth, M; Chachati, G; Rocco, MJ; Masad, I; Muniz, JA; Grant, SC; Gold, MS; Cadet, JL; Volkow, ND				Thanos, Panayotis K.; Kim, Ronald; Delis, Foteini; Ananth, Mala; Chachati, George; Rocco, Mark J.; Masad, Ihssan; Muniz, Jose A.; Grant, Samuel C.; Gold, Mark S.; Cadet, Jean Lud; Volkow, Nora D.			Chronic Methamphetamine Effects on Brain Structure and Function in Rats	PLOS ONE			English	Article							HIGH-DOSE METHAMPHETAMINE; MICROGLIAL ACTIVATION; DOPAMINE TRANSPORTERS; NEUROTROPHIC FACTOR; METABOLISM; RECEPTORS; GLUTAMATE; STRIATUM; ABUSERS; INDUCE	Methamphetamine (MA) addiction is a growing epidemic worldwide. Chronic MA use has been shown to lead to neurotoxicity in rodents and humans. Magnetic resonance imaging (MRI) studies in MA users have shown enlarged striatal volumes and positron emission tomography (PET) studies have shown decreased brain glucose metabolism (BGluM) in the striatum of detoxified MA users. The present study examines structural changes of the brain, observes microglial activation, and assesses changes in brain function, in response to chronic MA treatment. Rats were randomly split into three distinct treatment groups and treated daily for four months, via i.p. injection, with saline (controls), or low dose (LD) MA (4 mg/kg), or high dose (HD) MA (8 mg/kg). Sixteen weeks into the treatment period, rats were injected with a glucose analog, [F-18] fluorodeoxyglucose (FDG), and their brains were scanned with micro-PET to assess regional BGluM. At the end of MA treatment, magnetic resonance imaging at 21T was performed on perfused rats to determine regional brain volume and in vitro [H-3]PK 11195 autoradiography was performed on fresh-frozen brain tissue to measure microglia activation. When compared with controls, chronic HD MA-treated rats had enlarged striatal volumes and increases in [H-3]PK 11195 binding in striatum, the nucleus accumbens, frontal cortical areas, the rhinal cortices, and the cerebellar nuclei. FDG microPET imaging showed that LD MA-treated rats had higher BGluM in insular and somatosensory cortices, face sensory nucleus of the thalamus, and brainstem reticular formation, while HD MA-treated rats had higher BGluM in primary and higher order somatosensory and the retrosplenial cortices, compared with controls. HD and LD MA-treated rats had lower BGluM in the tail of the striatum, rhinal cortex, and subiculum and HD MA also had lower BGluM in hippocampus than controls. These results corroborate clinical findings and help further examine the mechanisms behind MA-induced neurotoxicity.	[Thanos, Panayotis K.; Chachati, George; Rocco, Mark J.] Univ Buffalo, Behav Neuropharmacol & Neuroimaging Lab Addict, Res Inst Addict, Buffalo, NY USA; [Kim, Ronald] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Delis, Foteini] Univ Ioannina, Sch Med, Dept Pharmacol, GR-45110 Ioannina, Greece; [Ananth, Mala] SUNY Stony Brook, Dept Neurosci, Stony Brook, NY 11794 USA; [Masad, Ihssan; Muniz, Jose A.; Grant, Samuel C.] Natl High Magnet Field Lab, Tallahassee, FL USA; [Gold, Mark S.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cadet, Jean Lud] NIDA, Mol Neuropsychiat Res Branch, NIH, Dept Hlth & Human Serv, Baltimore, MD USA; [Volkow, Nora D.] NIAAA, Lab Neuroimaging, NIH, Dept Hlth & Human Serv, Bethesda, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; University of Ioannina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida State University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Thanos, PK (corresponding author), Univ Buffalo, Behav Neuropharmacol & Neuroimaging Lab Addict, Res Inst Addict, Buffalo, NY USA.	pthanos@ria.buffalo.edu	Grant, Samuel Colles/D-8744-2013	Grant, Samuel Colles/0000-0001-7738-168X; Kim, Ronald/0000-0001-7078-0995; Ananth, Mala/0000-0003-1736-2350	National Institutes of Health; National Institute on Alcohol and Alcoholism [AA11034]; Research Foundation of New York [RIAQ094]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Research Foundation of New York; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by National Institutes of Health; National Institute on Alcohol and Alcoholism, AA11034; and Research Foundation of New York, RIAQ094.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Berman SM, 2008, MOL PSYCHIATR, V13, P897, DOI 10.1038/sj.mp.4002107; Burrows KB, 1999, NEUROSCIENCE, V90, P833, DOI 10.1016/S0306-4522(98)00506-5; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Chang L, 2005, BIOL PSYCHIAT, V57, P967, DOI 10.1016/j.biopsych.2005.01.039; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chin KM, 2006, CHEST, V130, P1657, DOI 10.1378/chest.130.6.1657; Chung YA, 2010, DRUG ALCOHOL DEPEN, V111, P155, DOI 10.1016/j.drugalcdep.2010.04.005; Churchwell JC, 2012, DEV NEUROSCI-BASEL, V34, P310, DOI 10.1159/000337724; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Escubedo E, 1998, BRAIN RES, V814, P120, DOI 10.1016/S0006-8993(98)01065-8; Ferrucci M, 2013, CURR NEUROPHARMACOL, V11, P80, DOI 10.2174/157015913804999522; Fujita S, 2010, NEUROSCIENCE, V165, P278, DOI 10.1016/j.neuroscience.2009.09.073; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Grobler Sias R, 2011, ISRN Dent, V2011, P974768, DOI 10.5402/2011/974768; Groman SM, 2013, PSYCHOPHARMACOLOGY, V229, P527, DOI 10.1007/s00213-013-3159-9; Halpin LE, 2014, LIFE SCI, V97, P37, DOI 10.1016/j.lfs.2013.07.014; Hoffman W, 2008, PSYCHOPHARMACOLOGY, V201, P183, DOI 10.1007/s00213-008-1261-1; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Huang YH, 1999, NEUROPSYCHOPHARMACOL, V21, P427, DOI 10.1016/S0893-133X(99)00029-9; Isgor C, 2015, NEUROSCIENCE, V288, P10, DOI 10.1016/j.neuroscience.2014.12.036; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; Jan RK, 2012, BRAIN SCI, V2, P553, DOI 10.3390/brainsci2040553; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; Kim R, 2011, METHAMPHETAMINE EFFE; Kobayashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021736; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krubitzer LPJ., 2008, ENCYCLOPEDIC REFEREN, P1225; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; LaVoie MJ, 2004, EXP NEUROL, V187, P47, DOI 10.1016/j.expneurol.2004.01.010; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Marks GA, 2008, NEUROSCIENCE, V156, P1, DOI 10.1016/j.neuroscience.2008.06.067; Marshall JF, 2007, ADDICTION, V102, P61, DOI 10.1111/j.1360-0443.2006.01780.x; Michaelides M, 2010, EUR J NEUROSCI, V32, P668, DOI 10.1111/j.1460-9568.2010.07319.x; MITLER MM, 1993, SLEEP, V16, P306; MITLER MM, 1994, SLEEP, V17, pS103, DOI 10.1093/sleep/17.suppl_8.S103; MYERS R, 1991, J CEREBR BLOOD F MET, V11, P314, DOI 10.1038/jcbfm.1991.64; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; O'Dell SJ, 2005, SYNAPSE, V55, P137, DOI 10.1002/syn.20098; O'Dell SJ, 2002, SYNAPSE, V43, P122, DOI 10.1002/syn.10016; Paxinos G., 2007, THE RAT BRAIN IN STE; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Pfefferbaum A, 2011, CEREB CORTEX, V21, P233, DOI 10.1093/cercor/bhq090; Polesskaya O, 2011, BRAIN RES, V1373, P91, DOI 10.1016/j.brainres.2010.12.017; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Royal Pharmaceutical Society of Great Britain, 1999, MARTINDALE THE COMPL; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Thanos PK, 2013, J NEUROSCI, V33, P6343, DOI 10.1523/JNEUROSCI.4997-12.2013; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Thrash B, 2009, PHARMACOL REP, V61, P966, DOI 10.1016/S1734-1140(09)70158-6; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Volkow ND, 2001, AM J PSYCHIAT, V158, P383, DOI 10.1176/appi.ajp.158.3.383; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Volkow ND, 2015, NEUROIMAGE, V121, P20, DOI 10.1016/j.neuroimage.2015.07.035; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015269; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Wang GJ, 2004, AM J PSYCHIAT, V161, P242, DOI 10.1176/appi.ajp.161.2.242; Watson CJ, 2011, J NEUROCHEM, V118, P571, DOI 10.1111/j.1471-4159.2011.07350.x; Winslow BT, 2007, AM FAM PHYSICIAN, V76, P1169	75	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155457	10.1371/journal.pone.0155457	http://dx.doi.org/10.1371/journal.pone.0155457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275601	Green Published, gold			2022-12-26	WOS:000377561700005
J	Qualai, J; Cantero, J; Li, LX; Carrascosa, JM; Cabre, E; Dern, O; Sumoy, L; Requena, G; McSorley, SJ; Genesca, M				Qualai, Jamal; Cantero, Jon; Li, Lin-Xi; Manuel Carrascosa, Jose; Cabre, Eduard; Dern, Olga; Sumoy, Lauro; Requena, Gerard; McSorley, Stephen J.; Genesca, Meritxell			Adhesion Molecules Associated with Female Genital Tract Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; CHLAMYDIA-TRACHOMATIS INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; INFLAMMATORY-BOWEL-DISEASE; RESIDENT MEMORY; MEDIATED PROTECTION; BACTERIAL VAGINOSIS; IMMUNE-RESPONSE; IN-VIVO; EXPRESSION	Efforts to develop vaccines that can elicit mucosal immune responses in the female genital tract against sexually transmitted infections have been hampered by an inability to measure immune responses in these tissues. The differential expression of adhesion molecules is known to confer site-dependent homing of circulating effector T cells to mucosal tissues. Specific homing molecules have been defined that can be measured in blood as surrogate markers of local immunity (e.g. alpha 4 beta 7 for gut). Here we analyzed the expression pattern of adhesion molecules by circulating effector T cells following mucosal infection of the female genital tract in mice and during a symptomatic episode of vaginosis in women. While CCR2, CCR5, CXCR6 and CD11c were preferentially expressed in a mouse model of Chlamydia infection, only CCR5 and CD11c were clearly expressed by effector T cells during bacterial vaginosis in women. Other homing molecules previously suggested as required for homing to the genital mucosa such as alpha 4 beta 1 and alpha 4 beta 7 were also differentially expressed in these patients. However, CD11c expression, an integrin chain rarely analyzed in the context of T cell immunity, was the most consistently elevated in all activated effector CD8(+) T cell subsets analyzed. This molecule was also induced after systemic infection in mice, suggesting that CD11c is not exclusive of genital tract infection. Still, its increase in response to genital tract disorders may represent a novel surrogate marker of mucosal immunity in women, and warrants further exploration for diagnostic and therapeutic purposes.	[Qualai, Jamal; Cantero, Jon; Genesca, Meritxell] AIDS Res Inst IrsiCaixa HIVACAT, Inst Invest Ciencies Salut Germans Trias & Pujol, Mucosal Immunol Unit, Can Ruti Campus, Badalona, Spain; [Li, Lin-Xi] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Manuel Carrascosa, Jose] Univ Autonoma Barcelona, Univ Hosp Germans Trias & Pujol, Dept Dermatol, Badalona, Spain; [Cabre, Eduard] Univ Hosp Germans Trias & Pujol, Dept Gastroenterol, Can Ruti Campus, Badalona, Catalonia, Spain; [Cabre, Eduard] CIBERehd, Madrid, Spain; [Dern, Olga] Ctr Atencio Primaria CAP St Felix, ASSIR, ICS, Sabadell, Spain; [Sumoy, Lauro] Inst Predict & Personalized Med Canc IMPPC, Genom & Bioinformat Grp, Can Ruti Campus, Badalona, Spain; [Requena, Gerard] Inst Invest Ciencies Salut Germans Trias & Pujol, Flow Cytometry Unit, Badalona, Spain; [McSorley, Stephen J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University of Arkansas System; University of Arkansas Medical Sciences; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); University of California System; University of California Davis	Genesca, M (corresponding author), AIDS Res Inst IrsiCaixa HIVACAT, Inst Invest Ciencies Salut Germans Trias & Pujol, Mucosal Immunol Unit, Can Ruti Campus, Badalona, Spain.	mgenesca@igtp.cat	Genescà, Meritxell/AFT-2336-2022; Genescà, Meritxell/AAF-9074-2020; Requena, Gerard/R-4814-2019; Sumoy, Lauro/AGZ-3186-2022; Sumoy, Lauro/K-1680-2013	Genescà, Meritxell/0000-0001-6413-3812; Sumoy, Lauro/0000-0003-0005-4618; Sumoy, Lauro/0000-0003-0005-4618; Li, Lin-Xi/0000-0002-5526-8966; Cantero, Jon/0000-0003-4844-6143; McSorley, Stephen/0000-0002-6363-3222	European Commission; Proyecto de Investigacion en Salud from the Spanish Instituto de Salud Carlos III [PI14/01235]; Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117303, R01AI103422] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Proyecto de Investigacion en Salud from the Spanish Instituto de Salud Carlos III; Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Marie Curie Career Integration Grant (CIG) from the European Commission, a Proyecto de Investigacion en Salud from the Spanish Instituto de Salud Carlos III (PI14/01235) and a fellowship award from the Dexeus foundation for women's health research. MG is currently supported by a Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2015, J CLIN INVEST, V125, P1827, DOI 10.1172/JCI77990; Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Anton G, 2008, INFECTION, V36, P147, DOI 10.1007/s15010-007-7152-2; Beyer M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-70; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Chen ZB, 2013, J IMMUNOL, V190, P6145, DOI 10.4049/jimmunol.1300060; Cooney LA, 2013, INFECT IMMUN, V81, P4171, DOI 10.1128/IAI.00871-13; Davila SJ, 2014, J IMMUNOL, V192, P4284, DOI 10.4049/jimmunol.1303238; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Ferguson AR, 2010, J IMMUNOL, V184, P4079, DOI 10.4049/jimmunol.0901903; Ferran M, 2008, EUR J DERMATOL, V18, P647, DOI 10.1684/ejd.2008.0513; Fujiwara D, 2011, AM J PHYSIOL-GASTR L, V300, pG939, DOI 10.1152/ajpgi.00032.2010; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Genesca M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103924; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Goodsell A, 2008, IMMUNOLOGY, V123, P378, DOI 10.1111/j.1365-2567.2007.02702.x; Hladik F, 1999, J IMMUNOL, V163, P2306; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Joag VR, 2016, MUCOSAL IMMUNOL, V9, P1, DOI 10.1038/mi.2015.28; Johansson EL, 1999, IMMUNOLOGY, V96, P272; Kelly KA, 2009, AM J REPROD IMMUNOL, V61, P436, DOI 10.1111/j.1600-0897.2009.00704.x; Koelle DM, 2002, J CLIN INVEST, V110, P537, DOI [10.1172/JCI200215537, 10.1172/JCI0215537]; Kubota K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00026; Kuka M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2223; Lewis DA, 2007, SEX TRANSM INFECT, V83, P508, DOI 10.1136/sti.2007.028142; Lewis DJM, 2014, J VIROL, V88, P11648, DOI 10.1128/JVI.01621-14; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Marelli-Berg FM, 2010, IMMUNOLOGY, V130, P158, DOI 10.1111/j.1365-2567.2010.03278.x; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mitchell C, 2014, AM J REPROD IMMUNOL, V71, P555, DOI 10.1111/aji.12264; Miyairi I, 2010, J INFECT DIS, V201, pS96, DOI 10.1086/652393; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Shannon B, 2014, J IMMUNOL, V192, P5074, DOI 10.4049/jimmunol.1302916; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Teraki Y, 2004, CLIN EXP DERMATOL, V29, P658, DOI 10.1111/j.1365-2230.2004.01638.x; Youn H, 2008, BIOMARKERS, V13, P257, DOI [10.1080/13547500701843338, 10.1080/13547500701843338 ]	47	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156605	10.1371/journal.pone.0156605	http://dx.doi.org/10.1371/journal.pone.0156605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272720	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000023
J	Zhang, C; Chen, M; Wang, GZ; Fang, W; Ye, C; Hu, HH; Fa, ZZ; Yi, J; Liao, WQ				Zhang, Chao; Chen, Mei; Wang, Guizhen; Fang, Wei; Ye, Chen; Hu, Hanhua; Fa, Zhenzong; Yi, Jiu; Liao, Wan-qing			Pd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal Effect	PLOS ONE			English	Article							SILVER NANOPARTICLES; ANTIFUNGAL ACTIVITY; ESCHERICHIA-COLI; ANTIBACTERIAL; FLUCONAZOLE; RESISTANCE; MENINGITIS; EPIDEMIOLOGY; NEOFORMANS; AGENTS	Silver nanoparticles have received considerable interest as new "nanoantibiotics" with the potential to kill drug-resistant microorganisms. Recently, a class of new core-shell nanostructures, Pd@Ag nanosheets (Pd@Ag NSs), were created using deposition techniques and demonstrated excellent inhibitory effects on various bacteria in vitro. In this study, we evaluated the antifungal activity of Pd@Ag NSs against common invasive fungal pathogens. Among these organisms, Cryptococcus neoformans complex species was most susceptible to Pd@Ag NSs, which exhibited potent antifungal activity against various molecular types or sources of cryptococcal strains including fluconazole-resistant isolates. The anticryptococcal activity of Pd@Ag NSs was significantly greater than fluconazole and similar to that of amphotericin B (AmB). At relatively high concentrations, Pd@Ag NSs exhibited fungicidal activity against Cryptococcus spp., which can likely be attributed to the disruption of cell integrity, intracellular protein synthesis, and energy metabolism. Intriguingly, Pd@Ag NSs also exhibited strong synergistic anti-cryptococcal fungicidal effects at low concentrations in combination with AmB but exhibitedmuch better safety in erythrocytes than AmB, even at the minimal fungicidal concentration. Therefore, Pd@Ag NSs may be a promising adjunctive agent for treating cryptococcosis, and further investigation for clinical applications is required.	[Zhang, Chao; Yi, Jiu; Liao, Wan-qing] Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Zhang, Chao; Fang, Wei; Fa, Zhenzong] Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China; [Chen, Mei] Xiamen Univ, Coll Chem & Chem Engn, Collaborat Innovat Ctr Chem Energy Mat, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China; [Chen, Mei] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China; [Wang, Guizhen] Urumuqi Army Gen Hosp, ICU Dept, Urumqi, Xinjiang, Peoples R China; [Ye, Chen] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Hu, Hanhua] Xinjiang Med Univ, UEM Dept, Urumqi, Xinjiang, Peoples R China	Naval Medical University; Naval Medical University; Xiamen University; Xiamen University; Naval Medical University; Xinjiang Medical University	Liao, WQ (corresponding author), Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.; Fang, W (corresponding author), Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China.	weifang081782@163.com; liaowanqing@sohu.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Key Basic Research Programs of China [2013CB531601]; National Natural Science Foundation of China [81401651, 81471926, 31170139]; Shanghai Municipal Natural Science Foundation [12JC1411000, 12ZR1454400, 14495800500]; Shanghai Key Laboratory of Molecular Medical Mycology [14DZ2272900]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Key Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Shanghai Key Laboratory of Molecular Medical Mycology; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by the National Key Basic Research Programs of China (2013CB531601), the National Natural Science Foundation of China (81401651, 81471926, and 31170139), the Shanghai Municipal Natural Science Foundation (12JC1411000, 12ZR1454400, and 14495800500), and the Shanghai Key Laboratory of Molecular Medical Mycology (14DZ2272900).	AbuSalah KM, 1996, BRIT J BIOMED SCI, V53, P122; Ajesh K, 2013, J APPL MICROBIOL, V115, P1287, DOI 10.1111/jam.12324; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Chowdhary A, 2011, J MED MICROBIOL, V60, P961, DOI 10.1099/jmm.0.029025-0; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; CLSI, 2008, M27A3 CLSI; Despax B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/17/175101; Fang W, 2015, FUNGAL GENET BIOL, V78, P7, DOI 10.1016/j.fgb.2014.10.017; Fang WJ, 2012, SMALL, V8, P3816, DOI 10.1002/smll.201200962; Fang WJ, 2012, ADV FUNCT MATER, V22, P842, DOI 10.1002/adfm.201101960; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fortun J, 2011, ENFERM INFEC MICR CL, V29, P38, DOI 10.1016/S0213-005X(11)70042-8; Friese G, 2001, AIDS, V15, P2344, DOI 10.1097/00002030-200111230-00026; Georgopapadakou NH, 1998, CURR OPIN MICROBIOL, V1, P547, DOI 10.1016/S1369-5274(98)80087-8; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P316, DOI 10.1128/AAC.4.3.316; Huang XQ, 2011, ADV MATER, V23, P3420, DOI 10.1002/adma.201100905; Huang XQ, 2011, NAT NANOTECHNOL, V6, P28, DOI 10.1038/NNANO.2010.235; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Ishida K, 2014, MEM I OSWALDO CRUZ, V109, P220, DOI 10.1590/0074-0276130269; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Jebali A, 2014, MED MYCOL, V52, P65, DOI 10.3109/13693786.2013.822996; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2; Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103442; Lortholary O, 2007, CLIN INFECT DIS, V45, P81, DOI 10.1086/518583; Manfredi R, 2006, AIDS PATIENT CARE ST, V20, P227, DOI 10.1089/apc.2006.20.227; Mares D, 1998, MED MYCOL, V36, P379, DOI 10.1080/02681219880000601; Mdodo R, 2010, East Afr Med J, V87, P481; Mo SG, 2015, J MATER CHEM B, V3, P6255, DOI 10.1039/c5tb00830a; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Niazi JH, 2011, APPL BIOCHEM BIOTECH, V164, P1278, DOI 10.1007/s12010-011-9212-4; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Osumi M, 1998, MICRON, V29, P207; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Richardson M, 2008, CLIN MICROBIOL INFEC, V14, P5, DOI 10.1111/j.1469-0691.2008.01978.x; Roling EE, 2002, DIAGN MICR INFEC DIS, V43, P13, DOI 10.1016/S0732-8893(02)00361-9; Sar B, 2004, J ANTIMICROB CHEMOTH, V54, P563, DOI 10.1093/jac/dkh361; Selvaraj M, 2014, APPL BIOCHEM BIOTECH, V173, P55, DOI 10.1007/s12010-014-0782-9; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sifuentes-Osornio J, 2012, CURR FUNGAL INFECT R, V6, P23, DOI 10.1007/s12281-011-0081-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Tang SH, 2014, SMALL, V10, P3139, DOI 10.1002/smll.201303631; Vazquez-Munoz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108876; Xu Y, 2013, J OCUL PHARMACOL TH, V29, P270, DOI 10.1089/jop.2012.0155; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhao ZX, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/28/285701	69	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157000	10.1371/journal.pone.0157000	http://dx.doi.org/10.1371/journal.pone.0157000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27611217	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000058
J	Zhang, N; Becares, L; Chandola, T				Zhang, Nan; Becares, Laia; Chandola, Tarani			Patterns and Determinants of Double-Burden of Malnutrition among Rural Children: Evidence from China	PLOS ONE			English	Article							LEFT-BEHIND CHILDREN; DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; RISK-FACTORS; PARENTAL MIGRATION; PHYSICAL-ACTIVITY; GROWTH STANDARDS; OLDER CHILDREN; HEALTH-STATUS; LIFE-COURSE	Chinese children are facing dual burden of malnutrition-coexistence of under-and overnutrition. Little systematic evidence exists for explaining the simultaneous presence of under-and over-nutrition. This study aims to explore underlying mechanisms of under-and over-nutrition among children in rural China. This study used a nationwide longitudinal data-set of children (N = 5,017) from 9 provinces across China, with four exclusively categories of nutritional outcomes including under-nutrition (stunting and underweight), over-nutrition (overweight only including obesity), paradox (stunted overweight), with normal nutrition as reference. Multinomial logit models (Level-1: occasions; Level-2: children; Level-3: villages) were fitted which corrected for non-independence of observations due to geographic clustering and repeated observations of individuals. A mixture of risk factors at the individual, household and neighbourhood levels predicted under-and over-nutrition among children in rural China. Improved socioeconomic status and living in more urbanised villages reduced the risk of stunted overweight among rural children in China. Young girls appeared to have higher risk of under-nutrition, and the risk decreased with age more markedly than for boys up to age 5. From age 5 onwards, boys tended to have higher risk of under-nutrition than girls. Girls aged around 12 and older were less likely to suffer from under-nutrition, while boys' higher risk of under-nutrition persisted throughout adolescence. Children were less likely to suffer from over-nutrition compared to normal nutrition. Boys tended to have an even lower risk of over-nutrition than girls and the gender difference widened with age until adolescence. Our results have important policy implications that improving household economic status, in particular, maternal education and health insurance for children, and living environment are important to enhance rural children's nutritional status in China. Investments in early years of childhood can be effective to reduce gender inequality in nutritional health in rural China.	[Zhang, Nan; Becares, Laia; Chandola, Tarani] Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England; [Becares, Laia] Univ Manchester, Ctr Dynam Ethn CoDE, Sch Social Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Zhang, N (corresponding author), Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England.	nancytju@gmail.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	ESRC; National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre [5 R24 HD050924]; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R24 HD050924, R01-HD38700]; Fogarty International Centre, NIH; China-Japan Friendship Hospital, Ministry of Health; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); China-Japan Friendship Hospital, Ministry of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supporting by an ESRC postgraduate scholarship to NZ. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an ESRC postgraduate scholarship to NZ. We use data from China Health and Nutrition Survey (CHNS), which is available for public use from http://www.cpc.unc.edu/projects/china/data. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009.	All-China Women's Federation, 2013, RES REP RUR LEFT CHI; [Anonymous], 2000, MODERNISATION SON PR; ASTRUP A, 1994, AM J PHYSIOL, V266, pE592, DOI 10.1152/ajpendo.1994.266.4.E592; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1998, MOTHERS BABIES HLTH; Berk LE., 2013, CHILD DEV; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Bredenkamp C, 2006, INCOME CHILD NUTR ST; Brown J, 2007, NUTR LIFE CYCLE; Browne W.J., 2015, MCMC ESTIMATION MLWI; Chang S, 2000, Wei Sheng Yan Jiu, V29, P270; Chang Suying, 2006, Wei Sheng Yan Jiu, V35, P768; Chen CM, 2011, BIOMED ENVIRON SCI, V24, P321, DOI 10.3967/0895-3988.2011.04.001; Dang SN, 2014, J CHILD HEALTH CARE, V18, P358, DOI 10.1177/1367493513496669; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Ge XJ, 2001, SOC PSYCHOL QUART, V64, P363, DOI 10.2307/3090160; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Harris NS, 2001, NEW ENGL J MED, V344, P341, DOI 10.1056/NEJM200102013440504; He W, 2014, AM J PUBLIC HEALTH, V104, pE14, DOI 10.2105/AJPH.2013.301669; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Hui L, 2003, HEALTH PLACE, V9, P371, DOI 10.1016/S1353-8292(03)00049-2; Jia X-y, 2012, CHINESE J PUBLIC HLT, V1; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Jiang Y, 2015, CHILD CARE HLTH DEV, V41, P45, DOI 10.1111/cch.12148; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li YP, 2009, BIOMED ENVIRON SCI, V22, P130, DOI 10.1016/S0895-3988(09)60035-0; Liu Y, 2007, ECON BULL, V15; Luo JY, 2008, PUBLIC HEALTH REP, V123, P382; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Morgan SL, 2000, CHINA J, V44, P1, DOI 10.2307/2667475; Mu R, 2015, J POPUL ECON, V28, P631, DOI 10.1007/s00148-015-0550-3; Na Zhang, 2015, 2015 Visual Communications and Image Processing (VCIP), P1, DOI 10.1109/VCIP.2015.7457813; Ning MX, 2013, AGR ECON-CZECH, V59, P467, DOI 10.17221/19/2013-AGRICECON; Pei LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-121; Piernas C, 2015, EUROPEAN J CLIN NUTR; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Poskitt EME, 2009, ANN TROP PAEDIATR, V29, P1, DOI 10.1179/146532809X401971; Rasbash J, 2013, MLWIN VERSION 2 28; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Ren WW, 2014, CHINA ECON REV, V31, P145, DOI 10.1016/j.chieco.2014.09.001; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Shen TF, 1996, NEW ENGL J MED, V335, P400, DOI 10.1056/NEJM199608083350606; Shetty P, 2013, INDIAN J PEDIATR, V80, pS21, DOI 10.1007/s12098-013-0971-5; Shi ZM, 2005, J ADOLESCENT HEALTH, V37, P313, DOI 10.1016/j.jadohealth.2004.10.013; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Strauss J, 1998, J ECON LIT, V36, P766; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tan C, 2010, PUBLIC HEALTH NUTR, V13, P1663, DOI 10.1017/S1368980010000078; Tassoni P., 2007, CHILD DEV 6 16 YEARS; United Nations Children's Fund, 1998, STAT WORLDS CHILDR 1; United Nations Children's Fund, 1990, STRAT IMPR NUTR STAT; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Wang Y, 1998, EUR J CLIN NUTR, V52, P908, DOI 10.1038/sj.ejcn.1600664; Wang Y., 2012, HDB ANTHROPOMETRY PH, V1, P29, DOI DOI 10.1007/978-1-4419-1788-1_2; Wang YF, 2003, PUBLIC HEALTH NUTR, V6, P549, DOI 10.1079/PHN2003470; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Wei SG, 2011, AUSTRALAS MED J, V4, P123, DOI 10.4066/AMJ.2011.584; Zhang J, 2011, ASIA PAC J CLIN NUTR, V20, P584; Zhang N, 2016, PARENTAL MIGRATION I; Zhang N, 2015, APPETITE, V95, P484, DOI 10.1016/j.appet.2015.08.024; Zhang N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2296-y; Zhang YX, 2014, INT J CARDIOL, V176, P1212, DOI 10.1016/j.ijcard.2014.07.222; Zong XN, 2014, B WORLD HEALTH ORGAN, V92, P555, DOI 10.2471/BLT.13.126243; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	91	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158119	10.1371/journal.pone.0158119	http://dx.doi.org/10.1371/journal.pone.0158119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27611217	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400031
J	Zhang, MH; Xin, M				Zhang, Miaohui; Xin, Ming			Human Detection Using Random Color Similarity Feature and Random Ferns Classifier	PLOS ONE			English	Article								We explore a novel approach for human detection based on random color similarity feature (RCS) and random ferns classifier which is also known as semi-naive Bayesian classifier. In contrast to other existing features employed by human detection, color-based features are rarely used in vision-based human detection because of large intra-class variations. In this paper, we propose a novel color-based feature, RCS feature, which is yielded by simple color similarity computation between image cells randomly picked in still images, and can effectively characterize human appearances. In addition, a histogram of oriented gradient based local binary feature (HOG-LBF) is also introduced to enrich the human descriptor set. Furthermore, random ferns classifier is used in the proposed approach because of its faster speed in training and testing than traditional classifiers such as SupportVector Machine (SVM) classifier, without a loss in performance. Finally, the proposed method is conducted in public datasets and achieves competitive detection results.	[Zhang, Miaohui] Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China; [Xin, Ming] Beihang Univ, Sch Comp Sci & Engn, Beijing Key Lab Digital Media, Beijing, Peoples R China	Henan University; Beihang University	Zhang, MH (corresponding author), Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China.	zhmh@henu.edu.cn	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Natural Science Foundation of China [61305042, 61503250, 61503173]; Science and Technology Research Key Project of Education Department of Henan Province [152102210057]; Postdoctoral Science Fund of China [2015M582182]; Henan University Fund [2012YBZR005]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Key Project of Education Department of Henan Province; Postdoctoral Science Fund of China(China Postdoctoral Science Foundation); Henan University Fund; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by the National Natural Science Foundation of China (No. 61305042, No. 61503250, No. 61503173), the Science and Technology Research Key Project of Education Department of Henan Province (No. 152102210057), the Postdoctoral Science Fund of China (No. 2015M582182), Henan University Fund (2012YBZR005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng WC, 2013, ENG APPL ARTIF INTEL, V26, P1016, DOI 10.1016/j.engappai.2012.08.013; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dalal N, 2006, LECT NOTES COMPUT SC, V3952, P428, DOI 10.1007/11744047_33; Everingham P. M., 2009, P INT C COMP VIS KYO; Kalal Z., 2010, P COMP VIS PATT REC; Kong KK, 2015, PATTERN RECOGN LETT, V68, P63, DOI 10.1016/j.patrec.2015.07.043; Laptev I, 2006, BMVC, V3, P949; Liu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142820; Luo P, 2014, IEEE C CVPR; Maji S, 2008, PROC CVPR IEEE, P2245; Mikolajczyk K, 2004, LECT NOTES COMPUT SC, V3021, P69; Mohan A, 2001, IEEE T PATTERN ANAL, V23, P349, DOI 10.1109/34.917571; Ozuysal M, 2010, IEEE T PATTERN ANAL, V32, P448, DOI 10.1109/TPAMI.2009.23; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Schwartz W.R., 2009, P INT C COMP VIS KYO; Tuzel O., 2007, CVPR, V1; Villamizar M., 2010, CVPR; WALK S, 2010, PROC CVPR IEEE, P1030, DOI DOI 10.1109/CVPR.2010.5540102; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Winn J., 2006, CVPR; Wu B, 2005, IEEE I CONF COMP VIS, P90; Wu B., 2008, P IEEE COMP SOC C CO; Yao SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134242; Zhang M., 2011, OPTICAL ENG, V9; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhao Y, 2013, IEEE INTELLIGENT TRA, V7, P459	30	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162830	10.1371/journal.pone.0162830	http://dx.doi.org/10.1371/journal.pone.0162830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611217	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900174
